Citrus Sinensis ID: 045787

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320----
Protein Sequence
MGKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLINRKKKLGVDNGWAGTQCLTIF
Secondary Structure (PSIPRED)
ccccccccccEEcEEcccccEEEEEEEEcccccEEEEEEEcccccccccccHHHHHHHHHccccccccEEEEEEEEEccEEEEEEEcccHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccEEEcccccccccccccccccccEEccccccccccccccccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHcccccccccccccccccccccccccccccHHHHcccccHHHHHHHHHcccccccccccHHHHHccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccHHcEEEEEEEEccccccEEEEEEcccccEEEEEEEccEccccEccHHHHHHHHHHcccccccEccEEEEEEccccEEEEEEcccEEHHHHHHHcccHccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEEccccccEEccccccccccccccHHHccHHHHccccccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHccccccccccHHHcccccccccccccccHHHccccccHHHHHHHHHHccccHHHcccHHHHHHcHHHHcccccccccccccccccccccccccccEEEEcc
Coil and Loop (DISEMBL)
mgklknlnyKKIKKigaggygevykcrntvtGQKVAIKMMTIQteqegvpsYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILhrdlkpnnllidlkRNTVKLADFGLaraigvpqkeysrdcvyspykapelllgytgystpidVWAVGCIFAemitgkplfpskkhdHLSLIFSLlgtptdeswaestyiseilplyphfepanlaekfpnlepaGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLINRkkklgvdngwagtqcltif
Flexible Loop (DISEMBL)
mgklknlnykkikkigaggygevykCRNTVTGQKVAIKMMTiqteqegvpsYIIREVSLLKELEHENIVRlldvqssrkDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARaigvpqkeysrdcVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLINrkkklgvdngwagtqcltif
Low Complexity Region (SEG)
MgklknlnykkikkigaggygEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLINRKKKLGVDNGWAGTQCLTIF
Disordered region (IsUnstruct)
******LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLINRKKKLGVDNGWAGTQCLTI*
Disordered Region (DISOPRED)
******L**KKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENV***************************F
Disordered Region (DISEMBL)
MGKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLINRKKKLGVDNGWAGTQCLTIF
Disordered Region (DISPRO)
****KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLINRKKKLGVDNGWAGTQCLTIF
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MGKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLINRKKKLGVDNGWAGTQCLTIF
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	324	2.2.26 [Sep-21-2011]
Q41639	294	Cell division control pro	N/A	no	0.882	0.972	0.516	2e-83
P93101	294	Cell division control pro	N/A	no	0.895	0.986	0.523	3e-83
Q05006	294	Cell division control pro	N/A	no	0.895	0.986	0.523	5e-83
P24100	294	Cyclin-dependent kinase A	yes	no	0.895	0.986	0.510	2e-82
P23111	294	Cell division control pro	N/A	no	0.891	0.982	0.522	2e-81
P29618	294	Cyclin-dependent kinase A	yes	no	0.891	0.982	0.518	4e-81
Q38772	294	Cell division control pro	N/A	no	0.895	0.986	0.506	8e-81
P24923	291	Cell division control pro	N/A	no	0.888	0.989	0.506	1e-80
P29619	292	Cyclin-dependent kinase A	no	no	0.885	0.982	0.5	3e-80
P52389	294	Cell division control pro	N/A	no	0.882	0.972	0.510	8e-78

>sp|Q41639|CDC2_VIGAC Cell division control protein 2 homolog OS=Vigna aconitifolia GN=CDC2 PE=2 SV=1

 Score =  309 bits (791), Expect = 2e-83,   Method: Compositional matrix adjust.
 Identities = 153/296 (51%), Positives = 206/296 (69%), Gaps = 10/296 (3%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y+K++KIG G YG VYK R+ VT + +A+K + ++ E EGVPS  IRE+SLLKE++H N
Sbjct: 3   QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHRN 62

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLV-----IKAILKQILLGLAYC 122
           IVRL DV  S K ++LVFEYLDLDL     +H ++    V     +K  L QIL G+AYC
Sbjct: 63  IVRLQDVVHSEKRLYLVFEYLDLDL----KKHMDSSPEFVKDPRQVKMFLYQILCGIAYC 118

Query: 123 HSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGY 182
           HS ++LHRDLKP NLLID + N++KLADFGLARA G+P + ++ + V   Y+APE+LLG 
Sbjct: 119 HSHRVLHRDLKPQNLLIDRRTNSLKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGS 178

Query: 183 TGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEIL 241
             YSTP+DVW+VGCIFAEM+  +PLFP     D L  IF +LGTP +E+W   T + +  
Sbjct: 179 RHYSTPVDVWSVGCIFAEMVNRRPLFPGDSEIDELFKIFRILGTPNEETWPGVTALPDFK 238

Query: 242 PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
             +P + P +LA   PNL+ AG++LLS MLCL+P +RITA  A++HEY   ++ VP
Sbjct: 239 STFPKWPPKDLATVVPNLDAAGLNLLSSMLCLDPSKRITARIAVEHEYFKDIKFVP 294

Plays a key role in the control of the eukaryotic cell cycle. Component of the kinase complex that phosphorylates the repetitive C-terminus of RNA polymerase II.
Vigna aconitifolia (taxid: 3918)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 3

>sp|P93101|CDC2_CHERU Cell division control protein 2 homolog OS=Chenopodium rubrum GN=CDC2 PE=2 SV=1

 Score =  308 bits (789), Expect = 3e-83,   Method: Compositional matrix adjust.
 Identities = 153/292 (52%), Positives = 204/292 (69%), Gaps = 2/292 (0%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y+K++KIG G YG VYK R+ VT + +A+K + ++ E EGVPS  IRE+SLLKE++H N
Sbjct: 3   QYEKVEKIGEGTYGVVYKARDKVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKN-TLNLLVIKAILKQILLGLAYCHSLK 126
           IVRL DV  S K ++LVFEYLDLDL   +    +   +  +IK  L QIL G+AYCHS +
Sbjct: 63  IVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSCPDFAKDPRMIKRFLYQILRGIAYCHSHR 122

Query: 127 ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYS 186
           +LHRDLKP NLLID + N +KLADFGLARA G+P + ++ + V   Y+APE+LLG   YS
Sbjct: 123 VLHRDLKPQNLLIDRQTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYS 182

Query: 187 TPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYP 245
           TP+DVW+VGCIFAEM+  KPLFP     D L  IF  LGTP +E+W   T + +    +P
Sbjct: 183 TPVDVWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRTLGTPNEETWPGVTSLPDFKSSFP 242

Query: 246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
            +   +L+   PNL+PAG+DLL++MLCL+P +RITA +AL+HEY   +  VP
Sbjct: 243 KWISKDLSAVVPNLDPAGIDLLNKMLCLDPSKRITARNALEHEYFKDIGFVP 294

Plays a key role in the control of the eukaryotic cell cycle. Component of the kinase complex that phosphorylates the repetitive C-terminus of RNA polymerase II.

Chenopodium rubrum (taxid: 3560)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|Q05006|CDC22_MEDSA Cell division control protein 2 homolog 2 OS=Medicago sativa GN=CDC2B PE=2 SV=1

 Score =  307 bits (787), Expect = 5e-83,   Method: Compositional matrix adjust.
 Identities = 153/292 (52%), Positives = 200/292 (68%), Gaps = 2/292 (0%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y+K++KIG G YG VYK R+  T + +A+K + ++ E EGVPS  IRE+SLLKE++H N
Sbjct: 3   QYEKVEKIGEGTYGVVYKARDRATNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHRN 62

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFI-TRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
           IVRL DV  S K ++LVFEYLDLDL  F+ +  +   +   IK  L QIL G+AYCHS +
Sbjct: 63  IVRLQDVVHSEKRLYLVFEYLDLDLKKFMDSSPEFAKDQRQIKMFLYQILCGIAYCHSHR 122

Query: 127 ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYS 186
           +LHRDLKP NLLID   N VKLADFGLARA G+P + ++ + V   Y+APE+LLG   YS
Sbjct: 123 VLHRDLKPQNLLIDRSSNAVKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYS 182

Query: 187 TPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYP 245
           TP+DVW+VGCIFAEMI  +PLFP     D L  IF + GTP +E+W   T + +    +P
Sbjct: 183 TPVDVWSVGCIFAEMINQRPLFPGDSEIDELFKIFRITGTPNEETWPGVTSLPDFKSAFP 242

Query: 246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
            +   +LA + PNLEPAG+DLLS    L+P +RITA  AL+HEY   ++ VP
Sbjct: 243 KWPAKDLATQVPNLEPAGLDLLSSTCRLDPTRRITARGALEHEYFKDIKFVP 294

Plays a key role in the control of the eukaryotic cell cycle. Component of the kinase complex that phosphorylates the repetitive C-terminus of RNA polymerase II.

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|P24100|CDKA1_ARATH Cyclin-dependent kinase A-1 OS=Arabidopsis thaliana GN=CDKA-1 PE=1 SV=1

 Score =  306 bits (783), Expect = 2e-82,   Method: Compositional matrix adjust.
 Identities = 149/292 (51%), Positives = 206/292 (70%), Gaps = 2/292 (0%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y+K++KIG G YG VYK R+ VT + +A+K + ++ E EGVPS  IRE+SLLKE++H N
Sbjct: 3   QYEKVEKIGEGTYGVVYKARDKVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHSN 62

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKN-TLNLLVIKAILKQILLGLAYCHSLK 126
           IV+L DV  S K ++LVFEYLDLDL   +    + + +L +IK  L QIL G+AYCHS +
Sbjct: 63  IVKLQDVVHSEKRLYLVFEYLDLDLKKHMDSTPDFSKDLHMIKTYLYQILRGIAYCHSHR 122

Query: 127 ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYS 186
           +LHRDLKP NLLID + N++KLADFGLARA G+P + ++ + V   Y+APE+LLG   YS
Sbjct: 123 VLHRDLKPQNLLIDRRTNSLKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSHHYS 182

Query: 187 TPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYP 245
           TP+D+W+VGCIFAEMI+ KPLFP     D L  IF ++GTP +++W   T + +    +P
Sbjct: 183 TPVDIWSVGCIFAEMISQKPLFPGDSEIDQLFKIFRIMGTPYEDTWRGVTSLPDYKSAFP 242

Query: 246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
            ++P +L    PNL+P GVDLLS+ML ++P +RI A  AL+HEY   +  +P
Sbjct: 243 KWKPTDLETFVPNLDPDGVDLLSKMLLMDPTKRINARAALEHEYFKDLGGMP 294

Involved in the control of the cell cycle. Essential for both G1/S and G2/M (mitosis) phase transitions. Functions in cell morphogenesis as well as cell proliferation. Required for cell division (entry into mitosis) of the generative cell in male gametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|P23111|CDC2_MAIZE Cell division control protein 2 homolog OS=Zea mays GN=CDC2 PE=2 SV=1

 Score =  303 bits (775), Expect = 2e-81,   Method: Compositional matrix adjust.
 Identities = 152/291 (52%), Positives = 201/291 (69%), Gaps = 2/291 (0%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y+K++KIG G YG VYK  +  T + +A+K + ++ E EGVPS  IRE+SLLKE+ H N
Sbjct: 3   QYEKVEKIGEGTYGVVYKALDKATNETIALKKIRLEQEDEGVPSTAIREISLLKEMNHGN 62

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFITR-HKNTLNLLVIKAILKQILLGLAYCHSLK 126
           IVRL DV  S K ++LVFEYLDLDL  F+    +   N  +IK+ L QIL G+AYCHS +
Sbjct: 63  IVRLHDVVHSEKRIYLVFEYLDLDLKKFMDSCPEFAKNPTLIKSYLYQILHGVAYCHSHR 122

Query: 127 ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYS 186
           +LHRDLKP NLLID + N +KLADFGLARA G+P + ++ + V   Y+APE+LLG   YS
Sbjct: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGARQYS 182

Query: 187 TPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYP 245
           TP+DVW+VGCIFAEM+  KPLFP     D L  IF +LGTP ++SW   + + +    +P
Sbjct: 183 TPVDVWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEQSWPGVSCLPDFKTAFP 242

Query: 246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENV 296
            ++  +LA   PNL+PAG+DLLS+ML   P +RITA  AL+HEY   +E V
Sbjct: 243 RWQAQDLATVVPNLDPAGLDLLSKMLRYEPSKRITARQALEHEYFKDLEVV 293

Plays a key role in the control of the eukaryotic cell cycle. Component of the kinase complex that phosphorylates the repetitive C-terminus of RNA polymerase II.

Zea mays (taxid: 4577)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|P29618|CDKA1_ORYSJ Cyclin-dependent kinase A-1 OS=Oryza sativa subsp. japonica GN=CDKA-1 PE=1 SV=1

 Score =  301 bits (771), Expect = 4e-81,   Method: Compositional matrix adjust.
 Identities = 151/291 (51%), Positives = 201/291 (69%), Gaps = 2/291 (0%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y+K +KIG G YG VY+ R+ VT + +A+K + ++ E EGVPS  IRE+SLLKE+ H N
Sbjct: 3   QYEKEEKIGEGTYGVVYRARDKVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMHHGN 62

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFITR-HKNTLNLLVIKAILKQILLGLAYCHSLK 126
           IVRL DV  S K ++LVFEYLDLDL  F+    +   N  +IK+ L QIL G+AYCHS +
Sbjct: 63  IVRLHDVIHSEKRIYLVFEYLDLDLKKFMDSCPEFAKNPTLIKSYLYQILRGVAYCHSHR 122

Query: 127 ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYS 186
           +LHRDLKP NLLID + N +KLADFGLARA G+P + ++ + V   Y+APE+LLG   YS
Sbjct: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRQYS 182

Query: 187 TPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYP 245
           TP+D+W+VGCIFAEM+  KPLFP     D L  IF +LGTP ++SW   + + +    +P
Sbjct: 183 TPVDMWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRVLGTPNEQSWPGVSSLPDYKSAFP 242

Query: 246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENV 296
            ++  +LA   P L+PAG+DLLS+ML   P +RITA  AL+HEY   +E V
Sbjct: 243 KWQAQDLATIVPTLDPAGLDLLSKMLRYEPNKRITARQALEHEYFKDLEMV 293

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|Q38772|CDC2A_ANTMA Cell division control protein 2 homolog A OS=Antirrhinum majus GN=CDC2A PE=2 SV=2

 Score =  300 bits (769), Expect = 8e-81,   Method: Compositional matrix adjust.
 Identities = 148/292 (50%), Positives = 202/292 (69%), Gaps = 2/292 (0%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y+K++KIG G YG VYK R+ VT + +A+K + ++ E EGVPS  IRE+SLLKE++H N
Sbjct: 3   QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFITR-HKNTLNLLVIKAILKQILLGLAYCHSLK 126
           IVRL DV  S K ++LVFEYLDLDL   +    + + +  ++K  L QIL G+AYCHS +
Sbjct: 63  IVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSCPEFSQDPRLVKMFLYQILRGIAYCHSHR 122

Query: 127 ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYS 186
           +LHRDLKP NLLID + N +KLADFGLARA G+P + ++ + V   Y+APE+LLG   YS
Sbjct: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYS 182

Query: 187 TPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYP 245
           TP+DVW+VGCIFAEM+  +PLFP     D L  IF ++GTP +E+W   T + +    +P
Sbjct: 183 TPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRVMGTPNEETWPGVTSLPDFKSAFP 242

Query: 246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
            +    LA   PNL+ +G+DLL +ML L+P +RITA +AL+HEY   +  VP
Sbjct: 243 KWPAKELAAVVPNLDASGLDLLDKMLRLDPSKRITARNALQHEYFKDIGFVP 294

Plays a key role in the control of the eukaryotic cell cycle.

Antirrhinum majus (taxid: 4151)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|P24923|CDC21_MEDSA Cell division control protein 2 homolog 1 (Fragment) OS=Medicago sativa GN=CDC2A PE=2 SV=1

 Score =  300 bits (767), Expect = 1e-80,   Method: Compositional matrix adjust.
 Identities = 147/290 (50%), Positives = 200/290 (68%), Gaps = 2/290 (0%)

Query: 10  KKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIV 69
           + ++KIG G YG VYK R+ VT + +A+K + ++ E EGVPS  IRE+SLLKE++H NIV
Sbjct: 2   ENVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHRNIV 61

Query: 70  RLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTL-NLLVIKAILKQILLGLAYCHSLKIL 128
           RL DV  S K ++LVFEYLDLDL   +      + +   +K  L Q+L G+AYCHS ++L
Sbjct: 62  RLQDVVHSDKRLYLVFEYLDLDLKKHMDSSPEFIKDPRQVKMFLYQMLCGIAYCHSHRVL 121

Query: 129 HRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTP 188
           HRDLKP NLLID + N++KLADFGLARA G+P + ++ + V   Y+APE+LLG   YSTP
Sbjct: 122 HRDLKPQNLLIDRRTNSLKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTP 181

Query: 189 IDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHF 247
           +DVW+VGCIFAEM   +PL P     D L  IF +LGTP +++W   T + +    +P +
Sbjct: 182 VDVWSVGCIFAEMANRRPLSPGDSEIDELFKIFRILGTPNEDTWPGVTSLPDFKSTFPRW 241

Query: 248 EPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
              +LA   PNLEPAG+DLL+ MLCL+P +RITA  A++HEY   ++ VP
Sbjct: 242 PSKDLATVVPNLEPAGLDLLNSMLCLDPTKRITARSAVEHEYFKDIKFVP 291

Plays a key role in the control of the eukaryotic cell cycle. Component of the kinase complex that phosphorylates the repetitive C-terminus of RNA polymerase II.

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|P29619|CDKA2_ORYSJ Cyclin-dependent kinase A-2 OS=Oryza sativa subsp. japonica GN=CDKA-2 PE=2 SV=1

 Score =  298 bits (764), Expect = 3e-80,   Method: Compositional matrix adjust.
 Identities = 144/288 (50%), Positives = 200/288 (69%), Gaps = 1/288 (0%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y+K++KIG G YG VYK ++  T + +A+K + ++ E EGVPS  IRE+SLLKE++H N
Sbjct: 3   QYEKVEKIGEGTYGVVYKGKHRHTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHRN 62

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
           IVRL DV    K ++LVFEYLDLDL   +    +  N  ++K+ L QIL G+AYCHS ++
Sbjct: 63  IVRLQDVVHKEKCIYLVFEYLDLDLKKHMDSSPDFKNHRIVKSFLYQILRGIAYCHSHRV 122

Query: 128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYST 187
           LHRDLKP NLLID + N++KLADFGLARA G+P + ++ + V   Y+APE+LLG   YST
Sbjct: 123 LHRDLKPQNLLIDRRTNSLKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGARHYST 182

Query: 188 PIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPH 246
           P+D+W+VGCIFAEM+  KPLFP     D L  IFS++GTP +E+W     + + +  +P 
Sbjct: 183 PVDMWSVGCIFAEMVNQKPLFPGDSEIDELFKIFSIMGTPNEETWPGVASLPDYISTFPK 242

Query: 247 FEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVE 294
           +   +LA   P L+ +G+DLLS+ML L+P +RI A  AL+HEY   +E
Sbjct: 243 WPSVDLATVVPTLDSSGLDLLSKMLRLDPSKRINARAALEHEYFKDLE 290

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|P52389|CDC2_VIGUN Cell division control protein 2 homolog OS=Vigna unguiculata GN=CDC2 PE=2 SV=1

 Score =  290 bits (743), Expect = 8e-78,   Method: Compositional matrix adjust.
 Identities = 151/296 (51%), Positives = 205/296 (69%), Gaps = 10/296 (3%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y+K++KIG G YG VYK R+ VT + +A+K + ++ E EGVPS  IRE+SLLKE++H N
Sbjct: 3   QYEKVEKIGEGTYGVVYKARDRVTDETIALKKIRLEQEDEGVPSTAIREISLLKEMQHRN 62

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLV-----IKAILKQILLGLAYC 122
           IVRL DV  S K ++LVFEYLDLDL     +H ++    V     +K  L QIL G+AYC
Sbjct: 63  IVRLQDVVHSEKRLYLVFEYLDLDL----KKHMDSSPEFVKDPRQVKMFLYQILCGIAYC 118

Query: 123 HSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGY 182
           HS ++LHRDLKP NLLID + N++KLADFGLARA G+P + ++ + V   Y+APE+LLG 
Sbjct: 119 HSHRVLHRDLKPQNLLIDRRTNSLKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGS 178

Query: 183 TGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEIL 241
             YSTP+DVW+VGC+FAEM+  +PLFP     D L  IF +LGTP +E+W   T + +  
Sbjct: 179 RHYSTPVDVWSVGCLFAEMVNRRPLFPGDSEIDELFKIFRILGTPNEETWPGVTALPDFK 238

Query: 242 PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
             +P + P +LA   PNL+ AG++LLS ML L+P +RITA  A++HEY   ++ VP
Sbjct: 239 STFPKWPPKDLATMVPNLDAAGLNLLSSMLSLDPSKRITARIAVEHEYFKDIKFVP 294

Plays a key role in the control of the eukaryotic cell cycle. Component of the kinase complex that phosphorylates the repetitive C-terminus of RNA polymerase II.

Vigna unguiculata (taxid: 3917)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	324
359489125	294	PREDICTED: cell division control protein	0.895	0.986	0.530	8e-84
358348197	294	Cyclin-dependent kinase A [Medicago trun	0.895	0.986	0.530	2e-83
147843679	294	hypothetical protein VITISV_034166 [Viti	0.895	0.986	0.523	5e-83
449465537	294	PREDICTED: cell division control protein	0.895	0.986	0.523	7e-83
388504228	294	unknown [Medicago truncatula]	0.895	0.986	0.527	2e-82
319439585	294	cyclin dependent kinase A [Cucurbita max	0.895	0.986	0.523	9e-82
454980	294	cdc2Pa [Picea abies] gi|116778762|gb|ABK	0.882	0.972	0.527	1e-81
24636266	294	RecName: Full=Cell division control prot	0.882	0.972	0.516	1e-81
86611379	294	cyclin-dependent kinase type A [Prunus d	0.895	0.986	0.520	2e-81
24636265	294	RecName: Full=Cell division control prot	0.895	0.986	0.523	2e-81

>gi|359489125|ref|XP_002266125.2| PREDICTED: cell division control protein 2 homolog [Vitis vinifera] gi|297744790|emb|CBI38058.3| unnamed protein product [Vitis vinifera]

 Score =  316 bits (810), Expect = 8e-84,   Method: Compositional matrix adjust.
 Identities = 155/292 (53%), Positives = 205/292 (70%), Gaps = 2/292 (0%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y+K++KIG G YG VYK R+ VT + +A+K + ++ E EGVPS  IRE+SLLKE++H N
Sbjct: 3   QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKN-TLNLLVIKAILKQILLGLAYCHSLK 126
           IVRL DV  S K ++LVFEYLDLDL   +    +   +L +IK  L QIL G+AYCHS +
Sbjct: 63  IVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKDLRLIKMFLHQILRGIAYCHSHR 122

Query: 127 ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYS 186
           +LHRDLKP NLLID + N +KLADFGLARA G+P + ++ + V   Y+APE+LLG   YS
Sbjct: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYS 182

Query: 187 TPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYP 245
           TP+DVW+VGCIFAEM+  +PLFP     D L  IF +LGTP +++W   T + +    +P
Sbjct: 183 TPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFP 242

Query: 246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
            + P +LA   PNLE AG+DLLS+MLCL+P +RITA  AL+HEY   +  VP
Sbjct: 243 KWPPKDLATVVPNLESAGIDLLSKMLCLDPSRRITARSALEHEYFKDIGFVP 294

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|358348197|ref|XP_003638135.1| Cyclin-dependent kinase A [Medicago truncatula] gi|355504070|gb|AES85273.1| Cyclin-dependent kinase A [Medicago truncatula]

 Score =  315 bits (808), Expect = 2e-83,   Method: Compositional matrix adjust.
 Identities = 155/292 (53%), Positives = 203/292 (69%), Gaps = 2/292 (0%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y+K++KIG G YG VYK R+  T + +A+K + ++ E EGVPS  IRE+SLLKE++H N
Sbjct: 3   QYEKVEKIGEGTYGVVYKARDRATNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHRN 62

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFI-TRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
           IVRL DV  S K ++LVFEYLDLDL  F+ +  +   +   IK  L QIL G+AYCHS +
Sbjct: 63  IVRLQDVVHSEKRLYLVFEYLDLDLKKFMDSSPEFAKDQRQIKMFLYQILCGIAYCHSHR 122

Query: 127 ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYS 186
           +LHRDLKP NLLID   N +KLADFGLARA G+P + ++ + V   Y+APE+LLG   YS
Sbjct: 123 VLHRDLKPQNLLIDRSSNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYS 182

Query: 187 TPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYP 245
           TP+DVW+VGCIFAEMI  +PLFP     D L  IF + GTP +E+W   T + +    +P
Sbjct: 183 TPVDVWSVGCIFAEMINQRPLFPGDSEIDELFKIFRITGTPNEETWPGVTSLPDFKSAFP 242

Query: 246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
            +   +LA + PNLEPAG+DLLS MLCL+P +RITA  AL+HEY   ++ VP
Sbjct: 243 KWPAKDLATQVPNLEPAGLDLLSNMLCLDPTRRITARGALEHEYFKDIKFVP 294

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147843679|emb|CAN84154.1| hypothetical protein VITISV_034166 [Vitis vinifera]

 Score =  313 bits (803), Expect = 5e-83,   Method: Compositional matrix adjust.
 Identities = 153/292 (52%), Positives = 204/292 (69%), Gaps = 2/292 (0%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y+K++KIG G YG VYK R+ VT + +A+K + ++ E EGVPS  IRE+SLLKE++H N
Sbjct: 3   QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKN-TLNLLVIKAILKQILLGLAYCHSLK 126
           IVRL DV  S K ++LVFEYLDLDL   +    +   +L +IK  L QIL G+AYCHS +
Sbjct: 63  IVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKDLRLIKMFLHQILRGIAYCHSHR 122

Query: 127 ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYS 186
           +LHRDLKP NLLID + N +KLADFGLARA G+P + ++ + V   Y+APE+LLG   YS
Sbjct: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYS 182

Query: 187 TPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYP 245
           TP+DVW+VGCIFAEM+  +PLFP     D L  IF +LGTP +++W   T + +    +P
Sbjct: 183 TPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFP 242

Query: 246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
            + P +LA   PNLE AG+DLLS+MLC +P +RIT   AL+HEYL  +  +P
Sbjct: 243 KWPPKDLATVVPNLESAGIDLLSKMLCXDPNRRITTRSALEHEYLKDIRFMP 294

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449465537|ref|XP_004150484.1| PREDICTED: cell division control protein 2 homolog A-like [Cucumis sativus]

 Score =  313 bits (802), Expect = 7e-83,   Method: Compositional matrix adjust.
 Identities = 153/292 (52%), Positives = 206/292 (70%), Gaps = 2/292 (0%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y+K++KIG G YG VYK R+ VT + +A+K + ++ E EGVPS  IRE+SLLKE++H N
Sbjct: 3   QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFI-TRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
           IVRL DV  S K ++LVFEYLDLDL   + +  + + +   +K  L QIL G+AYCHS +
Sbjct: 63  IVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPEFSKDPRQVKMFLYQILRGIAYCHSHR 122

Query: 127 ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYS 186
           +LHRDLKP NLLID + N +KLADFGLARA G+P + ++ + V   Y+APE+LLG   YS
Sbjct: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYS 182

Query: 187 TPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYP 245
           TP+DVW+VGCIFAEM+  +PLFP     D L  IF +LGTP +++W   T + +    +P
Sbjct: 183 TPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSTFP 242

Query: 246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
            + P +LA   PNLE AG+DLLS+MLCL+P +R+TA +AL+HEY   V  VP
Sbjct: 243 KWSPKDLASVVPNLEAAGIDLLSKMLCLDPTKRVTARNALEHEYFKDVGFVP 294

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|388504228|gb|AFK40180.1| unknown [Medicago truncatula]

 Score =  311 bits (798), Expect = 2e-82,   Method: Compositional matrix adjust.
 Identities = 154/292 (52%), Positives = 202/292 (69%), Gaps = 2/292 (0%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y+K++KIG G YG VYK R+  T + +A+K + ++ E EGVPS  IRE+SLLKE++H N
Sbjct: 3   QYEKVEKIGEGTYGVVYKARDRATNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHRN 62

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFI-TRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
           IVRL DV  S K ++LVFEYLDLDL  F+ +  +   +   IK  L QIL G+AYCHS +
Sbjct: 63  IVRLQDVVHSEKRLYLVFEYLDLDLKKFMDSSPEFAKDQRQIKMFLYQILCGIAYCHSHR 122

Query: 127 ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYS 186
           +LHRDLKP NLLID   N +KLADF LARA G+P + ++ + V   Y+APE+LLG   +S
Sbjct: 123 VLHRDLKPQNLLIDRSSNALKLADFELARAFGIPVRTFTHEVVTLWYRAPEILLGSRHHS 182

Query: 187 TPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYP 245
           TP+DVW+VGCIFAEMI  +PLFP     D L  IF + GTP +E+W   T + E    +P
Sbjct: 183 TPVDVWSVGCIFAEMINQRPLFPGDSEIDELFKIFRITGTPNEETWPGVTSLPEFKSAFP 242

Query: 246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
            +   +LA + PNLEPAG+DLLS MLCL+P +RITA  AL+HEY   ++ VP
Sbjct: 243 KWPAKDLATQVPNLEPAGLDLLSNMLCLDPTRRITARGALEHEYFKDIKFVP 294

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|319439585|emb|CBJ18166.1| cyclin dependent kinase A [Cucurbita maxima]

 Score =  309 bits (792), Expect = 9e-82,   Method: Compositional matrix adjust.
 Identities = 153/292 (52%), Positives = 203/292 (69%), Gaps = 2/292 (0%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y+K++KIG G YG VYK R+ VT + +A+K + ++ E EGVPS  IRE+SLLKE++H N
Sbjct: 3   QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFI-TRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
           IVRL DV  S K ++LVFEYLDLDL   + +  +   +   +K  L QIL G+AYCHS +
Sbjct: 63  IVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPEFAKDPRQVKRFLYQILRGIAYCHSHR 122

Query: 127 ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYS 186
           +LHRDLKP NLLID + N +KLADFGLARA G+P + ++ + V   Y+APE+LLG   YS
Sbjct: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYS 182

Query: 187 TPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYP 245
           TP+DVW+VGCIFAEM+  +PLFP     D L  IF +LGTP ++SW   T + +    +P
Sbjct: 183 TPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDSWPGVTSLPDFKSAFP 242

Query: 246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
            +   +LA   PNLE AG+DLLS+MLCL+P +R+TA  AL+HEY   V  VP
Sbjct: 243 KWPSKDLASVVPNLESAGIDLLSKMLCLDPTKRVTARSALEHEYFKDVGFVP 294

Source: Cucurbita maxima

Species: Cucurbita maxima

Genus: Cucurbita

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|454980|emb|CAA54746.1| cdc2Pa [Picea abies] gi|116778762|gb|ABK20983.1| unknown [Picea sitchensis]

 Score =  309 bits (792), Expect = 1e-81,   Method: Compositional matrix adjust.
 Identities = 156/296 (52%), Positives = 204/296 (68%), Gaps = 10/296 (3%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y+K++KIG G YG VYK R+ +T + +A+K + ++ E EGVPS  IRE+SLLKE++H N
Sbjct: 3   QYEKVEKIGEGTYGVVYKARDRLTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLL-----VIKAILKQILLGLAYC 122
           IVRL DV  S K ++LVFEYLDLDL     +H ++   L     +IK  L QIL G+AYC
Sbjct: 63  IVRLQDVVHSEKRLYLVFEYLDLDL----KKHMDSCPELAKDPRLIKTFLYQILRGIAYC 118

Query: 123 HSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGY 182
           HS ++LHRDLKP NLLID K N +KLADFGLARA G+P + ++ + V   Y+APE+LLG 
Sbjct: 119 HSHRVLHRDLKPQNLLIDRKTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGS 178

Query: 183 TGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEIL 241
             YSTP+DVW+VGCIFAEM+  +PLFP     D L  IF +LGTP +E+W   T + +  
Sbjct: 179 RHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEETWPGVTSLPDFK 238

Query: 242 PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
             +P +   +LA   P LEPAG+DLLS+MLCL P +RITA  AL+HEY   +  VP
Sbjct: 239 SAFPKWPAKDLATVVPGLEPAGIDLLSKMLCLEPSKRITARSALEHEYFKDLGFVP 294

Source: Picea abies

Species: Picea abies

Genus: Picea

Family: Pinaceae

Order: Coniferales

Class: Coniferopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|24636266|sp|Q41639.1|CDC2_VIGAC RecName: Full=Cell division control protein 2 homolog; AltName: Full=p34cdc2 gi|170642|gb|AAA34241.1| protein kinase [Vigna aconitifolia]

 Score =  309 bits (791), Expect = 1e-81,   Method: Compositional matrix adjust.
 Identities = 153/296 (51%), Positives = 206/296 (69%), Gaps = 10/296 (3%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y+K++KIG G YG VYK R+ VT + +A+K + ++ E EGVPS  IRE+SLLKE++H N
Sbjct: 3   QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHRN 62

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLV-----IKAILKQILLGLAYC 122
           IVRL DV  S K ++LVFEYLDLDL     +H ++    V     +K  L QIL G+AYC
Sbjct: 63  IVRLQDVVHSEKRLYLVFEYLDLDL----KKHMDSSPEFVKDPRQVKMFLYQILCGIAYC 118

Query: 123 HSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGY 182
           HS ++LHRDLKP NLLID + N++KLADFGLARA G+P + ++ + V   Y+APE+LLG 
Sbjct: 119 HSHRVLHRDLKPQNLLIDRRTNSLKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGS 178

Query: 183 TGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEIL 241
             YSTP+DVW+VGCIFAEM+  +PLFP     D L  IF +LGTP +E+W   T + +  
Sbjct: 179 RHYSTPVDVWSVGCIFAEMVNRRPLFPGDSEIDELFKIFRILGTPNEETWPGVTALPDFK 238

Query: 242 PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
             +P + P +LA   PNL+ AG++LLS MLCL+P +RITA  A++HEY   ++ VP
Sbjct: 239 STFPKWPPKDLATVVPNLDAAGLNLLSSMLCLDPSKRITARIAVEHEYFKDIKFVP 294

Source: Vigna aconitifolia

Species: Vigna aconitifolia

Genus: Vigna

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|86611379|gb|ABD14373.1| cyclin-dependent kinase type A [Prunus dulcis]

 Score =  308 bits (789), Expect = 2e-81,   Method: Compositional matrix adjust.
 Identities = 152/292 (52%), Positives = 204/292 (69%), Gaps = 2/292 (0%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y+K++KIG G YG VYK R+ +T + +A+K + ++ E EGVPS  IRE+SLLKE++H N
Sbjct: 3   QYEKVEKIGEGTYGVVYKARDRITNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFI-TRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
           IVRL DV  S K ++LVFEYLDLDL   + +  +   +   IK  L QIL G+AYCHS +
Sbjct: 63  IVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSTPEFAKDPRQIKMFLYQILRGIAYCHSHR 122

Query: 127 ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYS 186
           +LHRDLKP NLLID + N++KLADFGLARA G+P + ++ + V   Y+APE+LLG   YS
Sbjct: 123 VLHRDLKPQNLLIDRRTNSLKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYS 182

Query: 187 TPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYP 245
           TP+DVW+VGCIFAEM+  +PLFP     D L  IF ++GTPT+++W     + +    +P
Sbjct: 183 TPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRIMGTPTEDTWPGVNSLPDFKSSFP 242

Query: 246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
            +   +LA   PNLE AGVDLLS+MLCL+P +RITA  AL+HEY   +  VP
Sbjct: 243 KWLAKDLATAVPNLESAGVDLLSKMLCLDPSKRITARTALEHEYFKDIAFVP 294

Source: Prunus dulcis

Species: Prunus dulcis

Genus: Prunus

Family: Rosaceae

Order: Rosales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|24636265|sp|P93101.1|CDC2_CHERU RecName: Full=Cell division control protein 2 homolog; AltName: Full=p34cdc2 gi|1770186|emb|CAA71242.1| cyclin dependent kinase p34 [Chenopodium rubrum]

 Score =  308 bits (789), Expect = 2e-81,   Method: Compositional matrix adjust.
 Identities = 153/292 (52%), Positives = 204/292 (69%), Gaps = 2/292 (0%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y+K++KIG G YG VYK R+ VT + +A+K + ++ E EGVPS  IRE+SLLKE++H N
Sbjct: 3   QYEKVEKIGEGTYGVVYKARDKVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKN-TLNLLVIKAILKQILLGLAYCHSLK 126
           IVRL DV  S K ++LVFEYLDLDL   +    +   +  +IK  L QIL G+AYCHS +
Sbjct: 63  IVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSCPDFAKDPRMIKRFLYQILRGIAYCHSHR 122

Query: 127 ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYS 186
           +LHRDLKP NLLID + N +KLADFGLARA G+P + ++ + V   Y+APE+LLG   YS
Sbjct: 123 VLHRDLKPQNLLIDRQTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYS 182

Query: 187 TPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYP 245
           TP+DVW+VGCIFAEM+  KPLFP     D L  IF  LGTP +E+W   T + +    +P
Sbjct: 183 TPVDVWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRTLGTPNEETWPGVTSLPDFKSSFP 242

Query: 246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
            +   +L+   PNL+PAG+DLL++MLCL+P +RITA +AL+HEY   +  VP
Sbjct: 243 KWISKDLSAVVPNLDPAGIDLLNKMLCLDPSKRITARNALEHEYFKDIGFVP 294

Source: Chenopodium rubrum

Species: Oxybasis rubra

Genus: Oxybasis

Family: Amaranthaceae

Order: Caryophyllales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	324
TAIR|locus:2099478	294	CDC2 "cell division control 2"	0.848	0.935	0.509	2.9e-71
UNIPROTKB|P29618	294	CDKA-1 "Cyclin-dependent kinas	0.845	0.931	0.518	9.9e-71
UNIPROTKB|Q00526	305	CDK3 "Cyclin-dependent kinase	0.845	0.898	0.490	3.2e-65
DICTYBASE|DDB_G0288677	292	cdk5 "cyclin-dependent kinase	0.839	0.931	0.492	6.7e-65
UNIPROTKB|A5PJJ9	305	CDK3 "Uncharacterized protein"	0.836	0.888	0.492	6e-64
UNIPROTKB|F1RW06	305	CDK3 "Uncharacterized protein"	0.845	0.898	0.487	9.7e-64
UNIPROTKB|P51958	302	cdk1 "Cyclin-dependent kinase	0.820	0.880	0.477	2e-63
UNIPROTKB|F1NA68	327	CDK3 "Uncharacterized protein"	0.820	0.813	0.490	3.3e-63
UNIPROTKB|E2RPT8	304	CDK3 "Uncharacterized protein"	0.842	0.898	0.487	3.3e-63
MGI|MGI:88351	297	Cdk1 "cyclin-dependent kinase	0.839	0.915	0.474	4.2e-63

TAIR|locus:2099478 CDC2 "cell division control 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 721 (258.9 bits), Expect = 2.9e-71, P = 2.9e-71
 Identities = 141/277 (50%), Positives = 195/277 (70%)

Query:    23 VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
             VYK R+ VT + +A+K + ++ E EGVPS  IRE+SLLKE++H NIV+L DV  S K ++
Sbjct:    18 VYKARDKVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHSNIVKLQDVVHSEKRLY 77

Query:    83 LVFEYLDLDLHSFITRHKN-TLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
             LVFEYLDLDL   +    + + +L +IK  L QIL G+AYCHS ++LHRDLKP NLLID 
Sbjct:    78 LVFEYLDLDLKKHMDSTPDFSKDLHMIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDR 137

Query:   142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
             + N++KLADFGLARA G+P + ++ + V   Y+APE+LLG   YSTP+D+W+VGCIFAEM
Sbjct:   138 RTNSLKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSHHYSTPVDIWSVGCIFAEM 197

Query:   202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
             I+ KPLFP     D L  IF ++GTP +++W   T + +    +P ++P +L    PNL+
Sbjct:   198 ISQKPLFPGDSEIDQLFKIFRIMGTPYEDTWRGVTSLPDYKSAFPKWKPTDLETFVPNLD 257

Query:   261 PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
             P GVDLLS+ML ++P +RI A  AL+HEY   +  +P
Sbjct:   258 PDGVDLLSKMLLMDPTKRINARAALEHEYFKDLGGMP 294

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS;IMP

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0042023 "DNA endoreduplication" evidence=RCA;IMP

GO:0009555 "pollen development" evidence=IMP

GO:0008284 "positive regulation of cell proliferation" evidence=IMP

GO:0009793 "embryo development ending in seed dormancy" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0040020 "regulation of meiosis" evidence=IMP

GO:0048229 "gametophyte development" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=ISS

GO:0005737 "cytoplasm" evidence=IDA

GO:0000278 "mitotic cell cycle" evidence=RCA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

GO:0010048 "vernalization response" evidence=RCA

GO:0010440 "stomatal lineage progression" evidence=RCA

GO:0045736 "negative regulation of cyclin-dependent protein serine/threonine kinase activity" evidence=RCA

GO:0008356 "asymmetric cell division" evidence=IGI

GO:0000910 "cytokinesis" evidence=IMP

GO:0009409 "response to cold" evidence=IEP

GO:0009574 "preprophase band" evidence=TAS

GO:0010005 "cortical microtubule, transverse to long axis" evidence=IDA

UNIPROTKB|P29618 CDKA-1 "Cyclin-dependent kinase A-1" [Oryza sativa Japonica Group (taxid:39947)]

 Score = 716 (257.1 bits), Expect = 9.9e-71, P = 9.9e-71
 Identities = 143/276 (51%), Positives = 190/276 (68%)

Query:    23 VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
             VY+ R+ VT + +A+K + ++ E EGVPS  IRE+SLLKE+ H NIVRL DV  S K ++
Sbjct:    18 VYRARDKVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMHHGNIVRLHDVIHSEKRIY 77

Query:    83 LVFEYLDLDLHSFITRHKN-TLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
             LVFEYLDLDL  F+        N  +IK+ L QIL G+AYCHS ++LHRDLKP NLLID 
Sbjct:    78 LVFEYLDLDLKKFMDSCPEFAKNPTLIKSYLYQILRGVAYCHSHRVLHRDLKPQNLLIDR 137

Query:   142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
             + N +KLADFGLARA G+P + ++ + V   Y+APE+LLG   YSTP+D+W+VGCIFAEM
Sbjct:   138 RTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRQYSTPVDMWSVGCIFAEM 197

Query:   202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
             +  KPLFP     D L  IF +LGTP ++SW   + + +    +P ++  +LA   P L+
Sbjct:   198 VNQKPLFPGDSEIDELFKIFRVLGTPNEQSWPGVSSLPDYKSAFPKWQAQDLATIVPTLD 257

Query:   261 PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENV 296
             PAG+DLLS+ML   P +RITA  AL+HEY   +E V
Sbjct:   258 PAGLDLLSKMLRYEPNKRITARQALEHEYFKDLEMV 293

GO:0005515 "protein binding" evidence=IPI

UNIPROTKB|Q00526 CDK3 "Cyclin-dependent kinase 3" [Homo sapiens (taxid:9606)]

 Score = 664 (238.8 bits), Expect = 3.2e-65, P = 3.2e-65
 Identities = 136/277 (49%), Positives = 184/277 (66%)

Query:    23 VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
             VYK +N  TGQ VA+K + +  E EGVPS  IRE+SLLKEL+H NIVRLLDV  + + ++
Sbjct:    18 VYKAKNRETGQLVALKKIRLDLEMEGVPSTAIREISLLKELKHPNIVRLLDVVHNERKLY 77

Query:    83 LVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
             LVFE+L  DL  ++     + L L +IK+ L Q+L G+++CHS +++HRDLKP NLLI+ 
Sbjct:    78 LVFEFLSQDLKKYMDSTPGSELPLHLIKSYLFQLLQGVSFCHSHRVIHRDLKPQNLLIN- 136

Query:   142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
             +   +KLADFGLARA GVP + Y+ + V   Y+APE+LLG   Y+T +D+W++GCIFAEM
Sbjct:   137 ELGAIKLADFGLARAFGVPLRTYTHEVVTLWYRAPEILLGSKFYTTAVDIWSIGCIFAEM 196

Query:   202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
             +T K LFP     D L  IF +LGTP++++W   T + +    +P +    L E  PNLE
Sbjct:   197 VTRKALFPGDSEIDQLFRIFRMLGTPSEDTWPGVTQLPDYKGSFPKWTRKGLEEIVPNLE 256

Query:   261 PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
             P G DLL Q+L  +P QRITA  AL H Y    E  P
Sbjct:   257 PEGRDLLMQLLQYDPSQRITAKTALAHPYFSSPEPSP 293

GO:0005524 "ATP binding" evidence=IEA

GO:0007067 "mitosis" evidence=IEA

GO:0051301 "cell division" evidence=IEA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IEA

GO:0045023 "G0 to G1 transition" evidence=TAS

GO:0000082 "G1/S transition of mitotic cell cycle" evidence=TAS

GO:0008283 "cell proliferation" evidence=TAS

DICTYBASE|DDB_G0288677 cdk5 "cyclin-dependent kinase 5" [Dictyostelium discoideum (taxid:44689)]

 Score = 661 (237.7 bits), Expect = 6.7e-65, P = 6.7e-65
 Identities = 136/276 (49%), Positives = 186/276 (67%)

Query:    23 VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
             VYK +N  TG+ VA+K + + +E EGVP   IRE+SLLKEL+H NIVRL DV  + + + 
Sbjct:    18 VYKAKNRETGEIVALKRIRLDSEDEGVPCTAIREISLLKELKHPNIVRLHDVIHTERKLT 77

Query:    83 LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK 142
             LVFEYLD DL  ++      ++   IK+ + Q+L G+A+CH  ++LHRDLKP NLLI+ +
Sbjct:    78 LVFEYLDQDLKKYLDECGGEISKPTIKSFMYQLLKGVAFCHDHRVLHRDLKPQNLLIN-R 136

Query:   143 RNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMI 202
             +  +KLADFGLARA G+P + YS + V   Y+AP++L+G   YSTPID+W+ GCIFAEM 
Sbjct:   137 KGELKLADFGLARAFGIPVRTYSHEVVTLWYRAPDVLMGSRKYSTPIDIWSAGCIFAEMA 196

Query:   203 TGKPLFP-SKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPAN-LAEKFPNLE 260
             +G+PLFP S   D L  IF +LGTP +ESW   T + E    +P   PA+ L+     L+
Sbjct:   197 SGRPLFPGSGTSDQLFRIFKILGTPNEESWPSITELPEYKTDFP-VHPAHQLSSIVHGLD 255

Query:   261 PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENV 296
               G++LLS+ML  +P QRITA  ALKH Y  G+E +
Sbjct:   256 EKGLNLLSKMLQYDPNQRITAAAALKHPYFDGLEPI 291

GO:0031157 "regulation of aggregate size involved in sorocarp development" evidence=IMP

GO:0031152 "aggregation involved in sorocarp development" evidence=IMP

GO:0030435 "sporulation resulting in formation of a cellular spore" evidence=IMP

GO:0008283 "cell proliferation" evidence=IMP

GO:0006909 "phagocytosis" evidence=IMP

GO:0006907 "pinocytosis" evidence=IMP

GO:0007049 "cell cycle" evidence=IEA;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0005622 "intracellular" evidence=IDA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

GO:0072686 "mitotic spindle" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0005654 "nucleoplasm" evidence=IDA

GO:0005634 "nucleus" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0005516 "calmodulin binding" evidence=IPI

GO:0044351 "macropinocytosis" evidence=RCA

UNIPROTKB|A5PJJ9 CDK3 "Uncharacterized protein" [Bos taurus (taxid:9913)]

 Score = 652 (234.6 bits), Expect = 6.0e-64, P = 6.0e-64
 Identities = 135/274 (49%), Positives = 179/274 (65%)

Query:    23 VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
             VYK RN  TGQ VA+K + +  E EGVPS  IRE+SLLKEL+H NIVRLLDV  S K ++
Sbjct:    18 VYKARNKETGQLVALKKIRLDLETEGVPSTAIREISLLKELKHPNIVRLLDVVHSEKKLY 77

Query:    83 LVFEYLDLDLHSFI-TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
             LVFE+L  DL  ++ +   + L L ++K  L Q+L G+ +CH+ +++HRDLKP NLLI  
Sbjct:    78 LVFEFLSQDLKKYMDSTPASELPLHLVKRYLFQLLQGVNFCHTHRVIHRDLKPQNLLIS- 136

Query:   142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
             +  T+KLADFGLARA GVP + Y+ + V   Y+APE+LLG   YST +D+W++GCIFAEM
Sbjct:   137 ELGTIKLADFGLARAFGVPLRTYTHEVVTLWYRAPEILLGCKFYSTAVDIWSIGCIFAEM 196

Query:   202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
             +T + LFP     D L  IF  LGTP++  W   T + +    +P +    L E  PNLE
Sbjct:   197 VTRRALFPGDSEIDQLFRIFRTLGTPSEAMWPGVTQLPDYKGSFPKWTSKGLEEVVPNLE 256

Query:   261 PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVE 294
             P G DLL Q+L  +P +RI+A  AL H Y    E
Sbjct:   257 PEGQDLLLQLLQYDPSRRISAKAALAHPYFSSTE 290

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|F1RW06 CDK3 "Uncharacterized protein" [Sus scrofa (taxid:9823)]

 Score = 650 (233.9 bits), Expect = 9.7e-64, P = 9.7e-64
 Identities = 135/277 (48%), Positives = 181/277 (65%)

Query:    23 VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
             VYK +N  TGQ VA+K + +  E EGVPS  IRE+SLLKEL+H NIVRLLDV  S K ++
Sbjct:    18 VYKAKNKETGQLVALKKIRLDLETEGVPSTAIREISLLKELKHPNIVRLLDVVHSEKKLY 77

Query:    83 LVFEYLDLDLHSFI-TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
             LVFE+L  DL  ++     + L L ++K+ L Q+L G+ +CHS +++HRDLKP NLLI  
Sbjct:    78 LVFEFLSQDLKKYMDATPASELPLHLVKSYLFQLLQGVNFCHSHRVIHRDLKPQNLLIS- 136

Query:   142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
             +   +KLADFGLARA GVP + Y+ + V   Y+APE+LLG   YST +DVW++GCIFAEM
Sbjct:   137 ELGAIKLADFGLARAFGVPLRTYTHEVVTLWYRAPEILLGCKFYSTAVDVWSIGCIFAEM 196

Query:   202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
             +T + LFP     D L  IF  LGTP++  W   T + +    +P +    L E  P+LE
Sbjct:   197 VTRRALFPGDSEIDQLFRIFRTLGTPSEAMWPGVTQLPDYKGSFPKWTRKGLEEIVPSLE 256

Query:   261 PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
             P G DLL+Q+L  +P +RI+A  AL H Y    E+ P
Sbjct:   257 PEGRDLLTQLLQYDPSRRISAKAALAHPYFSSTESSP 293

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|P51958 cdk1 "Cyclin-dependent kinase 1" [Carassius auratus (taxid:7957)]

 Score = 647 (232.8 bits), Expect = 2.0e-63, P = 2.0e-63
 Identities = 129/270 (47%), Positives = 182/270 (67%)

Query:    23 VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
             VYK RN  TGQ VA+K + +++E+EGVPS  +RE+SLLKEL+H N+VRLLDV      ++
Sbjct:    18 VYKGRNKTTGQVVAMKKIRLESEEEGVPSTAVREISLLKELQHPNVVRLLDVLMQESKLY 77

Query:    83 LVFEYLDLDLHSFITRHKNT--LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLID 140
             LVFE+L +DL  ++    +   ++ +++K+ L QIL G+ +CH  ++LHRDLKP NLLID
Sbjct:    78 LVFEFLSMDLKKYLDSIPSGQFMDPMLVKSYLYQILEGILFCHCRRVLHRDLKPQNLLID 137

Query:   141 LKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAE 200
              K   +KLADFGLARA GVP + Y+ + V   Y+APE+LLG + YSTP+DVW++G IFAE
Sbjct:   138 NK-GVIKLADFGLARAFGVPVRVYTHEVVTLWYRAPEVLLGASRYSTPVDVWSIGTIFAE 196

Query:   201 MITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNL 259
             + T KPLF      D L  IF  LGTP +E W +   + +    +P ++  NLA    NL
Sbjct:   197 LATKKPLFHGDSEIDQLFRIFRTLGTPNNEVWPDVESLPDYKNTFPKWKSGNLASTVKNL 256

Query:   260 EPAGVDLLSQMLCLNPKQRITAMDALKHEY 289
             +  G+DLL++ML  +P +RI+A  A+ H Y
Sbjct:   257 DKNGIDLLTKMLIYDPPKRISARQAMTHPY 286

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=ISS

UNIPROTKB|F1NA68 CDK3 "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 645 (232.1 bits), Expect = 3.3e-63, P = 3.3e-63
 Identities = 132/269 (49%), Positives = 180/269 (66%)

Query:    23 VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
             VYK RN  TGQ VA+K + +  E EGVPS  IRE+SLLKEL+H NIVRLLDV  S+K ++
Sbjct:    40 VYKARNKRTGQLVALKKIRLDAETEGVPSTAIREISLLKELKHPNIVRLLDVVHSQKKLY 99

Query:    83 LVFEYLDLDLHSFI-TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
             LVFEYL+ DL  +I +       L ++K  L Q+L G+++CHS +++HRDLKP NLLI+ 
Sbjct:   100 LVFEYLNQDLKKYIDSSQTGEFPLSLVKNYLFQLLQGVSFCHSHRVIHRDLKPQNLLIN- 158

Query:   142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
             +   +KLADFGLARA GVP + Y+ + V   Y+APE+LLG   YST +D+W++GCIFAEM
Sbjct:   159 EAGAIKLADFGLARAFGVPLRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSIGCIFAEM 218

Query:   202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
             +T K LF      D L  IF  LGTPT+ +W   + + +    +P +    + E  PNL+
Sbjct:   219 VTRKALFQGDSEIDQLFRIFRTLGTPTEATWPGVSQLPDYKGDFPQWARKEMKEIVPNLD 278

Query:   261 PAGVDLLSQMLCLNPKQRITAMDALKHEY 289
               G DLL+Q+L  +P +RI+A  AL H+Y
Sbjct:   279 RHGRDLLAQLLLYDPSKRISAKAALSHQY 307

GO:0005524 "ATP binding" evidence=IEA

GO:0000307 "cyclin-dependent protein kinase holoenzyme complex" evidence=IEA

GO:0000781 "chromosome, telomeric region" evidence=IEA

GO:0000793 "condensed chromosome" evidence=IEA

GO:0000805 "X chromosome" evidence=IEA

GO:0000806 "Y chromosome" evidence=IEA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IEA

GO:0005667 "transcription factor complex" evidence=IEA

GO:0006813 "potassium ion transport" evidence=IEA

GO:0030332 "cyclin binding" evidence=IEA

GO:0032298 "positive regulation of DNA-dependent DNA replication initiation" evidence=IEA

GO:0045893 "positive regulation of transcription, DNA-dependent" evidence=IEA

UNIPROTKB|E2RPT8 CDK3 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 645 (232.1 bits), Expect = 3.3e-63, P = 3.3e-63
 Identities = 135/277 (48%), Positives = 182/277 (65%)

Query:    23 VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
             VYK +N  TGQ VA+K + +  E EGVPS  IRE+SL KEL+H NIVRLLDV  S K ++
Sbjct:    18 VYKAKNKETGQLVALKKIRLDLETEGVPSTAIREISL-KELKHPNIVRLLDVVHSEKKLY 76

Query:    83 LVFEYLDLDLHSFI-TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
             LVFE+L  DL  ++ +   + L L ++K+ L Q+L G+++CHS +++HRDLKP NLLI+ 
Sbjct:    77 LVFEFLSQDLKKYMDSAPASELPLHLVKSYLFQLLQGVSFCHSHRVIHRDLKPQNLLIN- 135

Query:   142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
             +   +KLADFGLARA GVP + Y+ + V   Y+APE+LLG   YST +DVW++GCIFAEM
Sbjct:   136 ELGAIKLADFGLARAFGVPLRTYTHEVVTLWYRAPEILLGTKFYSTAVDVWSIGCIFAEM 195

Query:   202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
             +T + LFP     D L  IF  LGTP++ +W   T + +    +P +    L E  P+LE
Sbjct:   196 VTRRALFPGDSEIDQLFRIFRTLGTPSEATWPGVTQLPDYKGSFPKWTRKGLEEIVPSLE 255

Query:   261 PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
             P G DLL Q+L  +P QRI+A  AL H Y    E  P
Sbjct:   256 PEGKDLLMQLLQYDPSQRISAKAALVHPYFSSAETSP 292

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

MGI|MGI:88351 Cdk1 "cyclin-dependent kinase 1" [Mus musculus (taxid:10090)]

 Score = 644 (231.8 bits), Expect = 4.2e-63, P = 4.2e-63
 Identities = 131/276 (47%), Positives = 183/276 (66%)

Query:    23 VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
             VYK R+ VTGQ VA+K + +++E+EGVPS  IRE+SLLKEL H NIV L DV      ++
Sbjct:    18 VYKGRHRVTGQIVAMKKIRLESEEEGVPSTAIREISLLKELRHPNIVSLQDVLMQDSRLY 77

Query:    83 LVFEYLDLDLHSFITRHK--NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLID 140
             L+FE+L +DL  ++        ++  ++K+ L QIL G+ +CHS ++LHRDLKP NLLID
Sbjct:    78 LIFEFLSMDLKKYLDSIPPGQFMDSSLVKSYLHQILQGIVFCHSRRVLHRDLKPQNLLID 137

Query:   141 LKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAE 200
              K  T+KLADFGLARA G+P + Y+ + V   Y++PE+LLG   YSTP+D+W++G IFAE
Sbjct:   138 DK-GTIKLADFGLARAFGIPIRVYTHEVVTLWYRSPEVLLGSARYSTPVDIWSIGTIFAE 196

Query:   201 MITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNL 259
             + T KPLF      D L  IF  LGTP +E W E   + +    +P ++P +LA    NL
Sbjct:   197 LATKKPLFHGDSEIDQLFRIFRALGTPNNEVWPEVESLQDYKNTFPKWKPGSLASHVKNL 256

Query:   260 EPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVEN 295
             +  G+DLLS+ML  +P +RI+   ALKH Y   ++N
Sbjct:   257 DENGLDLLSKMLVYDPAKRISGKMALKHPYFDDLDN 292

GO:0000166 "nucleotide binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=ISO;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISO

GO:0005737 "cytoplasm" evidence=ISO

GO:0005739 "mitochondrion" evidence=IEA

GO:0005856 "cytoskeleton" evidence=IEA

GO:0005876 "spindle microtubule" evidence=ISO

GO:0006461 "protein complex assembly" evidence=ISO

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0006915 "apoptotic process" evidence=IEA

GO:0007049 "cell cycle" evidence=IEA

GO:0007067 "mitosis" evidence=IEA

GO:0007095 "mitotic G2 DNA damage checkpoint" evidence=IDA

GO:0007569 "cell aging" evidence=ISO

GO:0008353 "RNA polymerase II carboxy-terminal domain kinase activity" evidence=ISO

GO:0010243 "response to organic nitrogen" evidence=ISO

GO:0010628 "positive regulation of gene expression" evidence=ISO

GO:0016301 "kinase activity" evidence=IDA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016572 "histone phosphorylation" evidence=ISO

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030261 "chromosome condensation" evidence=ISO

GO:0030332 "cyclin binding" evidence=ISO

GO:0030496 "midbody" evidence=ISO

GO:0030544 "Hsp70 protein binding" evidence=IPI

GO:0031100 "organ regeneration" evidence=ISO

GO:0033160 "positive regulation of protein import into nucleus, translocation" evidence=ISO

GO:0034501 "protein localization to kinetochore" evidence=ISO

GO:0035173 "histone kinase activity" evidence=ISO

GO:0043066 "negative regulation of apoptotic process" evidence=ISO

GO:0045471 "response to ethanol" evidence=ISO

GO:0045740 "positive regulation of DNA replication" evidence=ISO

GO:0045931 "positive regulation of mitotic cell cycle" evidence=ISO

GO:0051301 "cell division" evidence=IEA

GO:0060045 "positive regulation of cardiac muscle cell proliferation" evidence=ISO

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q41639	CDC2_VIGAC	2, ., 7, ., 1, 1, ., 2, 3	0.5168	0.8827	0.9727	N/A	no
Q27032	CDC2H_THEPA	2, ., 7, ., 1, 1, ., 2, 3	0.4758	0.8858	0.9630	yes	no
Q26671	CDC2H_THEAN	2, ., 7, ., 1, 1, ., 2, 3	0.4840	0.8641	0.9395	yes	no
P39951	CDK1_RAT	2, ., 7, ., 1, 1, ., 2, 3	0.4742	0.8858	0.9663	yes	no
P48734	CDK1_BOVIN	2, ., 7, ., 1, 1, ., 2, 3	0.4755	0.8703	0.9494	yes	no
Q00526	CDK3_HUMAN	2, ., 7, ., 1, 1, ., 2, 2	0.4914	0.8888	0.9442	yes	no
P24100	CDKA1_ARATH	2, ., 7, ., 1, 1, ., 2, 3	0.5102	0.8950	0.9863	yes	no
P11440	CDK1_MOUSE	2, ., 7, ., 1, 1, ., 2, 3	0.4776	0.8858	0.9663	yes	no
Q05006	CDC22_MEDSA	2, ., 7, ., 1, 1, ., 2, 2	0.5239	0.8950	0.9863	N/A	no
P23111	CDC2_MAIZE	2, ., 7, ., 1, 1, ., 2, 3	0.5223	0.8919	0.9829	N/A	no
P61075	CDC2H_PLAF7	2, ., 7, ., 1, 1, ., 2, 3	0.4699	0.8641	0.9722	yes	no
P24923	CDC21_MEDSA	2, ., 7, ., 1, 1, ., 2, 3	0.5068	0.8888	0.9896	N/A	no
Q38772	CDC2A_ANTMA	2, ., 7, ., 1, 1, ., 2, 3	0.5068	0.8950	0.9863	N/A	no
Q38773	CDC2B_ANTMA	2, ., 7, ., 1, 1, ., 2, 3	0.5145	0.8395	0.9714	N/A	no
P29618	CDKA1_ORYSJ	2, ., 7, ., 1, 1, ., 2, 3	0.5189	0.8919	0.9829	yes	no
P34117	CDK5_DICDI	2, ., 7, ., 1, 1, ., 2, 2	0.4913	0.8858	0.9828	yes	no
P04551	CDK1_SCHPO	2, ., 7, ., 1, 1, ., 2, 3	0.4589	0.8703	0.9494	yes	no
P52389	CDC2_VIGUN	2, ., 7, ., 1, 1, ., 2, 3	0.5101	0.8827	0.9727	N/A	no
P93101	CDC2_CHERU	2, ., 7, ., 1, 1, ., 2, 3	0.5239	0.8950	0.9863	N/A	no
O96821	CDC2H_PLAKH	2, ., 7, ., 1, 1, ., 2, 3	0.4734	0.8641	0.9722	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.22	0.914
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.921

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00000820001 SubName- Full=Chromosome undetermined scaffold_108, whole genome shotgun sequence; (294 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	324
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-138
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-121
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-118
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-106
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-106
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-106
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-103
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-102
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-102
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-101
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-101
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-101
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-96
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	8e-96
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-92
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	6e-91
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-90
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-89
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-86
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-86
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-86
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-86
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	5e-85
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	6e-83
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	5e-82
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	4e-77
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-76
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-76
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	8e-76
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-75
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	5e-75
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	7e-75
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	5e-74
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-73
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-73
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	7e-71
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-70
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-70
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	7e-70
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-68
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	3e-62
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-61
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	7e-61
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-60
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-59
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-58
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-57
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-57
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	7e-55
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	8e-55
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	8e-52
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-50
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-49
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-49
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	5e-49
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	8e-48
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	9e-47
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-46
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	5e-46
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	8e-46
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	5e-45
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	5e-44
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	9e-44
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-42
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	7e-42
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-41
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-41
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-41
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	5e-41
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	5e-41
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	9e-41
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-39
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	4e-39
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	9e-39
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-37
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	5e-36
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	5e-36
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	9e-36
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	4e-35
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-34
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	7e-34
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-32
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-31
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	7e-31
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-30
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	5e-30
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	9e-30
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-29
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-29
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-29
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-29
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-29
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-29
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	7e-29
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	8e-29
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	9e-29
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-28
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	5e-28
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	6e-28
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	7e-28
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	8e-28
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-27
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-27
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-27
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-26
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-26
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-26
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-26
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-26
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-26
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	7e-26
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-25
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-25
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	4e-25
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-25
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	6e-25
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-24
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-24
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-24
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	4e-24
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	8e-24
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	9e-24
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-23
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-23
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	9e-23
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-22
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-22
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-22
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	9e-22
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-21
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-21
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-21
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-21
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-21
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-21
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-21
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	5e-21
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	5e-21
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	5e-21
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	9e-21
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-20
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-20
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-20
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-20
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-20
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	4e-20
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	4e-20
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-20
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-20
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	5e-20
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	6e-20
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	7e-20
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	8e-20
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-19
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-19
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-19
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-19
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-19
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-19
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-19
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	4e-19
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	7e-19
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	8e-19
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	8e-19
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	9e-19
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-18
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-18
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-18
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-18
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-18
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	4e-18
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	5e-18
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	5e-18
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	6e-18
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	8e-18
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	8e-18
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-17
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-17
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-17
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-17
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-17
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-17
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-17
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-17
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-17
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-17
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	4e-17
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	4e-17
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	7e-17
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-16
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-16
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-16
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-16
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-16
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-16
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-16
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-16
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-16
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-16
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-16
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	5e-16
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	5e-16
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	6e-16
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	7e-16
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	8e-16
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	8e-16
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	9e-16
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-15
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-15
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-15
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-15
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-15
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-15
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-15
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-15
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-15
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-15
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-15
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	4e-15
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	4e-15
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	5e-15
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	5e-15
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	6e-15
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	6e-15
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	6e-15
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	7e-15
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	8e-15
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	8e-15
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-14
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-14
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-14
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-14
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-14
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-14
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-14
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-14
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-14
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	3e-14
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-14
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-14
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	4e-14
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	4e-14
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	5e-14
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	6e-14
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	7e-14
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	7e-14
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	8e-14
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-13
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-13
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-13
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-13
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	4e-13
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	4e-13
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	6e-13
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-12
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-12
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	4e-12
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	5e-12
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	7e-12
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	8e-12
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-11
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-11
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-11
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-11
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-11
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-11
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-11
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	5e-11
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	7e-11
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	8e-11
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	8e-11
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	9e-11
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-10
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-10
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-10
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-10
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	5e-10
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	5e-10
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	7e-10
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-09
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-09
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-09
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	2e-09
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-09
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	6e-09
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	8e-09
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	9e-09
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-08
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	3e-08
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	4e-08
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-07
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-07
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	5e-07
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	6e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	7e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-06
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-06
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	8e-06
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	9e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-05
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	9e-05
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	1e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	6e-04
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	0.002
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	0.002
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	0.002

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  391 bits (1007), Expect = e-138
 Identities = 149/283 (52%), Positives = 205/283 (72%), Gaps = 2/283 (0%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           Y+K++K+G G YG VYK R+  TG+ VA+K + +  E+EG+PS  +RE+SLLKEL+H NI
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60

Query: 69  VRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKIL 128
           V+LLDV  + + ++LVFEY D+DL  ++ +    L+  +IK+I+ Q+L GLAYCHS +IL
Sbjct: 61  VKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRIL 120

Query: 129 HRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTP 188
           HRDLKP N+LI+ +   +KLADFGLARA G+P + Y+ + V   Y+APE+LLG   YST 
Sbjct: 121 HRDLKPQNILIN-RDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTA 179

Query: 189 IDVWAVGCIFAEMITGKPLFPSK-KHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHF 247
           +D+W+VGCIFAEMITGKPLFP   + D L  IF +LGTPT+ESW   T + +  P +P F
Sbjct: 180 VDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKF 239

Query: 248 EPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            P +L +  P L+P G+DLLS+ML  NP +RI+A +ALKH Y 
Sbjct: 240 PPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  349 bits (898), Expect = e-121
 Identities = 147/284 (51%), Positives = 199/284 (70%), Gaps = 3/284 (1%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           Y+K++KIG G YG VYK R+ +TG+ VA+K + ++TE EGVPS  IRE+SLLKEL H NI
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNI 60

Query: 69  VRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKI 127
           VRLLDV  S   ++LVFE+LDLDL  ++     T L+  +IK+ L Q+L G+AYCHS ++
Sbjct: 61  VRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRV 120

Query: 128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYST 187
           LHRDLKP NLLID +   +KLADFGLARA GVP + Y+ + V   Y+APE+LLG   YST
Sbjct: 121 LHRDLKPQNLLID-REGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYST 179

Query: 188 PIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPH 246
           P+D+W++GCIFAEM+  +PLFP     D L  IF  LGTP ++ W   T + +  P +P 
Sbjct: 180 PVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPK 239

Query: 247 FEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           +   +L++  PNL+  G+DLLS+ML  +P +RI+A  AL+H Y 
Sbjct: 240 WARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  342 bits (880), Expect = e-118
 Identities = 155/291 (53%), Positives = 203/291 (69%), Gaps = 2/291 (0%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           Y+K++KIG G YG VYK R+ VT + +A+K + ++ E EGVPS  IRE+SLLKE++H NI
Sbjct: 4   YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63

Query: 69  VRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKN-TLNLLVIKAILKQILLGLAYCHSLKI 127
           VRL DV  S K ++LVFEYLDLDL   +    +   N  +IK  L QIL G+AYCHS ++
Sbjct: 64  VRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRV 123

Query: 128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYST 187
           LHRDLKP NLLID + N +KLADFGLARA G+P + ++ + V   Y+APE+LLG   YST
Sbjct: 124 LHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYST 183

Query: 188 PIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPH 246
           P+D+W+VGCIFAEM+  KPLFP     D L  IF +LGTP +E+W   T + +    +P 
Sbjct: 184 PVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPK 243

Query: 247 FEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
           + P +LA   P LEPAGVDLLS+ML L+P +RITA  AL+HEY   + + P
Sbjct: 244 WPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGDAP 294

Length = 294

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  311 bits (799), Expect = e-106
 Identities = 140/284 (49%), Positives = 190/284 (66%), Gaps = 3/284 (1%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
           N++K++KIG G YG VYK RN +TG+ VA+K + + TE EGVPS  IRE+SLLKEL H N
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFI-TRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
           IV+LLDV  +   ++LVFE+L  DL  F+     + + L +IK+ L Q+L GLA+CHS +
Sbjct: 61  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR 120

Query: 127 ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYS 186
           +LHRDLKP NLLI+     +KLADFGLARA GVP + Y+ + V   Y+APE+LLG   YS
Sbjct: 121 VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 179

Query: 187 TPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYP 245
           T +D+W++GCIFAEM+T + LFP     D L  IF  LGTP +  W   T + +  P +P
Sbjct: 180 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFP 239

Query: 246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEY 289
            +   + ++  P L+  G DLLSQML  +P +RI+A  AL H +
Sbjct: 240 KWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  311 bits (798), Expect = e-106
 Identities = 136/286 (47%), Positives = 189/286 (66%), Gaps = 4/286 (1%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
           +Y KI+KIG G YG VYK RN  TGQ VA+K + +++E+EGVPS  IRE+SLLKEL+H N
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFI--TRHKNTLNLLVIKAILKQILLGLAYCHSL 125
           IV L DV      ++L+FE+L +DL  ++        ++  ++K+ L QIL G+ +CHS 
Sbjct: 61  IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120

Query: 126 KILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGY 185
           ++LHRDLKP NLLID  +  +KLADFGLARA G+P + Y+ + V   Y+APE+LLG   Y
Sbjct: 121 RVLHRDLKPQNLLID-NKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRY 179

Query: 186 STPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLY 244
           STP+D+W++G IFAEM T KPLF      D L  IF +LGTPT++ W   T + +    +
Sbjct: 180 STPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTF 239

Query: 245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           P ++  +L     NL+  G+DLL +ML  +P +RI+A  AL H Y 
Sbjct: 240 PKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  311 bits (798), Expect = e-106
 Identities = 141/284 (49%), Positives = 186/284 (65%), Gaps = 3/284 (1%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           Y+K+ KIG G YG VYK R+ +TG+ VAIK + ++ E EG+P   +RE+ LLKEL H NI
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 69  VRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKIL 128
           ++LLDV   + D++LVFE++D DL+  I   +  L   +IK+ L Q+L GLA+CHS  IL
Sbjct: 61  IKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGIL 120

Query: 129 HRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTP 188
           HRDLKP NLLI+     +KLADFGLAR+ G P + Y+   V   Y+APELLLG  GYSTP
Sbjct: 121 HRDLKPENLLIN-TEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTP 179

Query: 189 IDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAE-STYISEILPLYPH 246
           +D+W+VGCIFAE+++ +PLFP K   D L  IF  LGTP  E W + ++        +P 
Sbjct: 180 VDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPK 239

Query: 247 FEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                L + FPN  P  +DLLSQML  +P +RITA  AL H Y 
Sbjct: 240 KAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  304 bits (780), Expect = e-103
 Identities = 140/285 (49%), Positives = 196/285 (68%), Gaps = 5/285 (1%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
           N+K+++K+G G Y  VYK RN  TG+ VA+K + +  E EG PS  IRE+SL+KEL+HEN
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHEN 59

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKN--TLNLLVIKAILKQILLGLAYCHSL 125
           IVRL DV  +   + LVFEY+D DL  ++  H     L+   +K+   Q+L G+A+CH  
Sbjct: 60  IVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119

Query: 126 KILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGY 185
           ++LHRDLKP NLLI+ KR  +KLADFGLARA G+P   +S + V   Y+AP++LLG   Y
Sbjct: 120 RVLHRDLKPQNLLIN-KRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTY 178

Query: 186 STPIDVWAVGCIFAEMITGKPLFP-SKKHDHLSLIFSLLGTPTDESWAESTYISEILPLY 244
           ST ID+W+VGCI AEMITG+PLFP +   D L  IF ++GTPT+ +W   + + E  P +
Sbjct: 179 STSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTF 238

Query: 245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEY 289
           P + P +L + FP+ +P G+DLL ++L LNP+ RI+A DAL+H +
Sbjct: 239 PRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  302 bits (775), Expect = e-102
 Identities = 126/296 (42%), Positives = 179/296 (60%), Gaps = 25/296 (8%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           Y+KI +IG G YG+VYK RN  TG+ VA+K + ++ E+EG P   IRE+ LL++L H NI
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60

Query: 69  VRLLDVQSSRK--DVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
           VRL ++ +S+    +++VFEY+D DL   +   +       IK  +KQ+L GL Y HS  
Sbjct: 61  VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG 120

Query: 127 ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP------YKAPELLL 180
           ILHRD+K +N+LI+     +KLADFGLAR              Y+       Y+ PELLL
Sbjct: 121 ILHRDIKGSNILIN-NDGVLKLADFGLARPY-----TKRNSADYTNRVITLWYRPPELLL 174

Query: 181 GYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISE 239
           G T Y   +D+W+VGCI AE+  GKP+F      + L  IF L G+PTDE+W     +S+
Sbjct: 175 GATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPG---VSK 231

Query: 240 ILPLYPHFEP-----ANLAEKFPNLE-PAGVDLLSQMLCLNPKQRITAMDALKHEY 289
            LP + + +P       L E F +L  P+ +DLL ++L L+PK+RI+A  AL+HEY
Sbjct: 232 -LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  302 bits (774), Expect = e-102
 Identities = 135/285 (47%), Positives = 182/285 (63%), Gaps = 5/285 (1%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y+K++KIG G YG V+K +N  T + VA+K + +  + EGVPS  +RE+ LLKEL+H+N
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
           IVRL DV  S K + LVFEY D DL  +       ++  ++K+ + Q+L GLA+CHS  +
Sbjct: 61  IVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNV 120

Query: 128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYST 187
           LHRDLKP NLLI+ K   +KLADFGLARA G+P + YS + V   Y+ P++L G   YST
Sbjct: 121 LHRDLKPQNLLIN-KNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 179

Query: 188 PIDVWAVGCIFAEMIT-GKPLFPSKK-HDHLSLIFSLLGTPTDESWAESTYISEILPLYP 245
            ID+W+ GCIFAE+   G+PLFP     D L  IF LLGTPT+ESW   + + +    YP
Sbjct: 180 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD-YKPYP 238

Query: 246 HFEP-ANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEY 289
            +    +L    P L   G DLL  +L  NP QRI+A +AL+H Y
Sbjct: 239 MYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  300 bits (769), Expect = e-101
 Identities = 141/297 (47%), Positives = 186/297 (62%), Gaps = 15/297 (5%)

Query: 2   GKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLK 61
           GKL+   YKK+ K+G G Y  VYK R+ +TGQ VA+K + ++ E EG P   IRE SLLK
Sbjct: 2   GKLET--YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE-EGAPFTAIREASLLK 58

Query: 62  ELEHENIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAY 121
           +L+H NIV L D+  ++K + LVFEYLD DL  ++      L++  ++  L Q+L GLAY
Sbjct: 59  DLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAY 118

Query: 122 CHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLG 181
           CH  ++LHRDLKP NLLI  +R  +KLADFGLARA  VP K YS + V   Y+ P++LLG
Sbjct: 119 CHQRRVLHRDLKPQNLLIS-ERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLG 177

Query: 182 YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH--DHLSLIFSLLGTPTDESW----AEST 235
            T YST +D+W VGCIF EM TG+PLFP      D L  IF +LGTPT+E+W    +   
Sbjct: 178 STEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237

Query: 236 YISEILPLYPHFEPANLAEKFPNLE--PAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           +     P YP   P  L    P L+  P G +L  + L   PK+RI+A +A+KH Y 
Sbjct: 238 FKPYSFPFYP---PRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  299 bits (767), Expect = e-101
 Identities = 129/293 (44%), Positives = 187/293 (63%), Gaps = 12/293 (4%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y+K++KIG G YG+VYK R+  TG+ VA+K   ++ ++EG+P   +RE+SLL+ L    
Sbjct: 2   AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESI 61

Query: 68  -IVRLLDVQSSRKD-----VFLVFEYLDLDLHSFITRHK----NTLNLLVIKAILKQILL 117
            IVRLLDV+   +      ++LVFEYLD DL  F+  +       L    IK+ + Q+L 
Sbjct: 62  YIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLK 121

Query: 118 GLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPE 177
           G+A+CH   ++HRDLKP NLL+D ++  +K+AD GL RA  +P K Y+ + V   Y+APE
Sbjct: 122 GVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPE 181

Query: 178 LLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTY 236
           +LLG T YSTP+D+W+VGCIFAEM   +PLFP       L  IF LLGTPT++ W   + 
Sbjct: 182 VLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSK 241

Query: 237 ISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEY 289
           + +    +P ++P +L+   P+L P G+DLL +ML  +P +RI+A  AL H Y
Sbjct: 242 LRD-WHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  299 bits (768), Expect = e-101
 Identities = 126/289 (43%), Positives = 167/289 (57%), Gaps = 12/289 (4%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMM---TIQTEQEGVPSYIIREVSLLKELE 64
            Y+K KK+G G Y  VYK R+  TG+ VAIK +     +  ++G+    +RE+ LL+EL+
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60

Query: 65  HENIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
           H NI+ LLDV   + ++ LVFE+++ DL   I      L    IK+ +   L GL Y HS
Sbjct: 61  HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS 120

Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTG 184
             ILHRDLKPNNLLI      +KLADFGLAR+ G P ++ +   V   Y+APELL G   
Sbjct: 121 NWILHRDLKPNNLLIA-SDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARH 179

Query: 185 YSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPL 243
           Y   +D+W+VGCIFAE++   P  P     D L  IF  LGTPT+E+W   T     LP 
Sbjct: 180 YGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS----LPD 235

Query: 244 Y---PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEY 289
           Y     F P  L + FP      +DLL ++L LNP +RITA  AL+H Y
Sbjct: 236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  286 bits (733), Expect = 4e-96
 Identities = 125/288 (43%), Positives = 181/288 (62%), Gaps = 7/288 (2%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y+K+ +I  G YG VY+ R+  TG+ VA+K + ++ E+EG P   +RE+++L +L+H N
Sbjct: 6   EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPN 65

Query: 68  IVRLLD--VQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSL 125
           IV + +  V S+   +++V EY++ DL S +   K       +K ++ Q+L G+A+ H  
Sbjct: 66  IVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN 125

Query: 126 KILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGY 185
            ILHRDLK +NLL++  R  +K+ DFGLAR  G P K Y++  V   Y+APELLLG   Y
Sbjct: 126 WILHRDLKTSNLLLN-NRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEY 184

Query: 186 STPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLY 244
           ST ID+W+VGCIFAE++T KPLFP K   D L+ IF LLGTPT++ W   + +       
Sbjct: 185 STAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKT 244

Query: 245 PHFEPAN-LAEKFPN--LEPAGVDLLSQMLCLNPKQRITAMDALKHEY 289
               P N L +KFP   L   G DLL+++L  +P +RI+A DALKH Y
Sbjct: 245 FTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  286 bits (734), Expect = 8e-96
 Identities = 121/298 (40%), Positives = 169/298 (56%), Gaps = 23/298 (7%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIK--MMTIQTEQEGVPSYIIREVSLLKELEHE 66
           Y+ +K IG+G YG V    +  TG+KVAIK          +     I+RE+ LL+ L HE
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDA--KRILREIKLLRHLRHE 59

Query: 67  NIVRLLDV-----QSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAY 121
           NI+ LLD+          DV++V E ++ DLH  I +    L    I+  L QIL GL Y
Sbjct: 60  NIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVI-KSPQPLTDDHIQYFLYQILRGLKY 118

Query: 122 CHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK------EYSRDCVYSPYKA 175
            HS  ++HRDLKP+N+L++     +K+ DFGLAR +   +       EY    V   Y+A
Sbjct: 119 LHSANVIHRDLKPSNILVN-SNCDLKICDFGLARGVDPDEDEKGFLTEY---VVTRWYRA 174

Query: 176 PELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDE--SWA 232
           PELLL  + Y+  ID+W+VGCIFAE++T KPLFP + + D L+LI  +LGTP++E   + 
Sbjct: 175 PELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234

Query: 233 ESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            S      L   P      L++ FP   P  +DLL +ML  +PK+RITA +AL H YL
Sbjct: 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYL 292

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  275 bits (705), Expect = 2e-92
 Identities = 104/284 (36%), Positives = 156/284 (54%), Gaps = 32/284 (11%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           Y+ ++K+G G +G+VY  R+  TG+ VAIK++  + + +     I+RE+ +LK+L+H NI
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKK-KIKKDRERILREIKILKKLKHPNI 59

Query: 69  VRLLDVQSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
           VRL DV      ++LV EY +  DL   + +    L+    +  L+QIL  L Y HS  I
Sbjct: 60  VRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRG-RLSEDEARFYLRQILSALEYLHSKGI 118

Query: 128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGYTGYS 186
           +HRDLKP N+L+D +   VKLADFGLAR +   +K      V +P Y APE+LLG  GY 
Sbjct: 119 VHRDLKPENILLD-EDGHVKLADFGLARQLDPGEK--LTTFVGTPEYMAPEVLLG-KGYG 174

Query: 187 TPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPH 246
             +D+W++G I  E++TGKP FP    D L  +F  +G P          IS        
Sbjct: 175 KAVDIWSLGVILYELLTGKPPFPG--DDQLLELFKKIGKPKPPFPPPEWDIS-------- 224

Query: 247 FEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                         P   DL+ ++L  +P++R+TA +AL+H + 
Sbjct: 225 --------------PEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  272 bits (698), Expect = 6e-91
 Identities = 111/290 (38%), Positives = 167/290 (57%), Gaps = 12/290 (4%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            YK + +IG G +G V+K ++  TG+ VA+K + ++  + G+P+  +RE+  L+  +H  
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
           +V+LLDV        LV EY+  DL   +   +  L    +K+ ++ +L G+AY H+  I
Sbjct: 61  VVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGI 120

Query: 128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP-QKEYSRDCVYSPYKAPELLLGYTGYS 186
           +HRDLKP NLLI      +K+ADFGLAR       + YS       Y+APELL G   Y 
Sbjct: 121 MHRDLKPANLLIS-ADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYD 179

Query: 187 TPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLY- 244
             +D+WAVGCIFAE++ G PLFP +   + L+++F  LGTP +E+W   T     LP Y 
Sbjct: 180 PGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLT----SLPDYN 235

Query: 245 ----PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
               P  +P  L E FP+  P  +DLL  +L  +P +R++A +AL+H Y 
Sbjct: 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  271 bits (695), Expect = 2e-90
 Identities = 118/298 (39%), Positives = 182/298 (61%), Gaps = 27/298 (9%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE---H 65
           Y+++ +IG G YG VYK R+  TG+ VA+K + +   +EG+P   +RE++LLK+LE   H
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60

Query: 66  ENIVRLLDV----QSSRK-DVFLVFEYLDLDLHSFITRH-KNTLNLLVIKAILKQILLGL 119
            NIVRLLDV    ++ R+  + LVFE++D DL +++++  K  L    IK +++Q+L G+
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGV 120

Query: 120 AYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP------Y 173
            + HS +I+HRDLKP N+L+      VK+ADFGLAR        YS +   +       Y
Sbjct: 121 DFLHSHRIVHRDLKPQNILVT-SDGQVKIADFGLARI-------YSFEMALTSVVVTLWY 172

Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWA 232
           +APE+LL  + Y+TP+D+W+VGCIFAE+   +PLF      D L  IF ++G P++E W 
Sbjct: 173 RAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWP 231

Query: 233 ESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            +  +      +P + P +     P +   G+DLL +ML  NP +RI+A +AL+H Y 
Sbjct: 232 RNVSLPRS--SFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  267 bits (686), Expect = 2e-89
 Identities = 99/284 (34%), Positives = 152/284 (53%), Gaps = 26/284 (9%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           Y+ ++K+G+G +G VYK ++  TG+ VA+K++  ++E+        RE+ +L+ L H NI
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 69  VRLLDVQSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
           VRL+D    +  ++LV EY +  DL  +++R    L+    K I  QIL GL Y HS  I
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP-LSEDEAKKIALQILRGLEYLHSNGI 119

Query: 128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYST 187
           +HRDLKP N+L+D +   VK+ADFGLA+ +       +       Y APE+LLG  GY  
Sbjct: 120 IHRDLKPENILLD-ENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGP 178

Query: 188 PIDVWAVGCIFAEMITGKPLFPSKK-HDHLSLIFSLLGTPTDESWAESTYISEILPLYPH 246
            +DVW++G I  E++TGKP F  +   D L LI  +LG P +    + +  SE       
Sbjct: 179 KVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSE------- 231

Query: 247 FEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                             DL+ + L  +P +R TA + L+H + 
Sbjct: 232 ---------------EAKDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  262 bits (670), Expect = 1e-86
 Identities = 139/291 (47%), Positives = 185/291 (63%), Gaps = 6/291 (2%)

Query: 2   GKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLK 61
           GKL+   Y K+ K+G G Y  VYK R+ +T   VA+K + ++ E EG P   IREVSLLK
Sbjct: 3   GKLET--YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLK 59

Query: 62  ELEHENIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAY 121
           +L+H NIV L D+  + K + LVFEYLD DL  ++    N++N+  +K  L Q+L GL Y
Sbjct: 60  DLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNY 119

Query: 122 CHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLG 181
           CH  K+LHRDLKP NLLI+ +R  +KLADFGLARA  +P K YS + V   Y+ P++LLG
Sbjct: 120 CHRRKVLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLG 178

Query: 182 YTGYSTPIDVWAVGCIFAEMITGKPLFP-SKKHDHLSLIFSLLGTPTDESWAESTYISEI 240
            T YST ID+W VGCIF EM TG+PLFP S   + L  IF +LGTPT+E+W       E 
Sbjct: 179 STDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238

Query: 241 LPL-YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
               YP +    L    P L+  G +LLS++L    ++RI+A +A+KH Y 
Sbjct: 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF 289

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  261 bits (669), Expect = 1e-86
 Identities = 140/291 (48%), Positives = 185/291 (63%), Gaps = 6/291 (2%)

Query: 2   GKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLK 61
           GKL+   Y K+ K+G G Y  V+K R+ +T   VA+K + ++ E EG P   IREVSLLK
Sbjct: 2   GKLET--YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLK 58

Query: 62  ELEHENIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAY 121
            L+H NIV L D+  + + + LVFEYLD DL  ++    N +++  +K  + Q+L GL+Y
Sbjct: 59  NLKHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSY 118

Query: 122 CHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLG 181
           CH  KILHRDLKP NLLI+ ++  +KLADFGLARA  VP K YS + V   Y+ P++LLG
Sbjct: 119 CHKRKILHRDLKPQNLLIN-EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLG 177

Query: 182 YTGYSTPIDVWAVGCIFAEMITGKPLFP-SKKHDHLSLIFSLLGTPTDESWAESTYISEI 240
            T YSTPID+W VGCI  EM TG+P+FP S   + L LIF LLGTPT+E+W   T   E 
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237

Query: 241 LP-LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
              L+P +    L    P L+  G+DLLS +L    K RI+A  AL+H Y 
Sbjct: 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  261 bits (670), Expect = 2e-86
 Identities = 120/307 (39%), Positives = 173/307 (56%), Gaps = 30/307 (9%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
           +Y+ + K+G G +GEVYK R   TG+ VA+K + +  E++G P   +RE+ +LK+L+H N
Sbjct: 9   DYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPN 68

Query: 68  IVRLLDV--------QSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGL 119
           +V L+D+        +  R  V++V  Y+D DL   +      L    IK  + Q+L G+
Sbjct: 69  VVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGI 128

Query: 120 AYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAI-----------GVPQKEYSRDC 168
            Y H   ILHRD+K  N+LID  +  +K+ADFGLAR             G   ++Y+   
Sbjct: 129 NYLHENHILHRDIKAANILID-NQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLV 187

Query: 169 VYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPT 227
           V   Y+ PELLLG   Y+T +D+W +GC+FAEM T +P+   K   D L LIF L GTPT
Sbjct: 188 VTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPT 247

Query: 228 DESWAESTYISEILPLYPHF-----EPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAM 282
           +E+W         LP           P  L E+F  L P G+DLLS++L L+P +R+TA 
Sbjct: 248 EETWPGWRS----LPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTAS 303

Query: 283 DALKHEY 289
           DAL+H Y
Sbjct: 304 DALEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  260 bits (667), Expect = 2e-86
 Identities = 126/294 (42%), Positives = 173/294 (58%), Gaps = 23/294 (7%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMM--TIQTEQEGVPSYIIREV-SLLKELEH 65
           YK IK++G G +G VY  RN  TG+ VAIK M     + +E +    +REV SL K  EH
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN---LREVKSLRKLNEH 57

Query: 66  ENIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILLGLAYCHS 124
            NIV+L +V     +++ VFEY++ +L+  +   K    +  VI++I+ QIL GLA+ H 
Sbjct: 58  PNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK 117

Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY------KAPEL 178
               HRDLKP NLL+      VK+ADFGLAR I       SR   Y+ Y      +APE+
Sbjct: 118 HGFFHRDLKPENLLVS-GPEVVKIADFGLAREI------RSRP-PYTDYVSTRWYRAPEI 169

Query: 179 LLGYTGYSTPIDVWAVGCIFAEMITGKPLFP-SKKHDHLSLIFSLLGTPTDESWAESTYI 237
           LL  T YS+P+D+WA+GCI AE+ T +PLFP S + D L  I S+LGTPT + W E   +
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL 229

Query: 238 SEILPL-YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           +  L   +P F P +L +  PN  P  +DL+  ML  +PK+R TA  AL+H Y 
Sbjct: 230 ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  258 bits (660), Expect = 5e-85
 Identities = 140/291 (48%), Positives = 190/291 (65%), Gaps = 6/291 (2%)

Query: 2   GKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLK 61
           GK++   Y K++K+G G Y  V+K R+ +T   VA+K + ++ E EG P   IREVSLLK
Sbjct: 3   GKMET--YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLK 59

Query: 62  ELEHENIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAY 121
           +L+H NIV L D+  + K + LVFEYLD DL  ++    N +++  +K  L QIL GLAY
Sbjct: 60  DLKHANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAY 119

Query: 122 CHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLG 181
           CH  K+LHRDLKP NLLI+ +R  +KLADFGLARA  VP K YS + V   Y+ P++LLG
Sbjct: 120 CHRRKVLHRDLKPQNLLIN-ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLG 178

Query: 182 YTGYSTPIDVWAVGCIFAEMITGKPLFP-SKKHDHLSLIFSLLGTPTDESWAESTYISEI 240
            + YST ID+W VGCIF EM +G+PLFP S   D L LIF LLGTPT+E+W   +   E 
Sbjct: 179 SSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238

Query: 241 LPL-YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
               +P ++P  L    P L+  G++LL++ L    K+RI+A +A+KH Y 
Sbjct: 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYF 289

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  253 bits (647), Expect = 6e-83
 Identities = 125/290 (43%), Positives = 174/290 (60%), Gaps = 13/290 (4%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            ++K+ +IG G YG VY+ R+T +G+ VA+K + +  E++G+P   +RE++LL  L H N
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67

Query: 68  IVRLLDV-QSSRKD-VFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSL 125
           IV L +V      D +FLV EY + DL S +       +   +K ++ Q+L GL Y H  
Sbjct: 68  IVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN 127

Query: 126 KILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGY 185
            I+HRDLK +NLL+   +  +K+ADFGLAR  G+P K  +   V   Y+APELLLG T Y
Sbjct: 128 FIIHRDLKVSNLLLT-DKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTY 186

Query: 186 STPIDVWAVGCIFAEMITGKPLFPSKKHDH-LSLIFSLLGTPTDESWAESTYISEILPLY 244
           +T ID+WAVGCI AE++  KPL P K     L LI  LLGTP +  W      S+ LPL 
Sbjct: 187 TTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPG---FSD-LPLV 242

Query: 245 PHF----EP-ANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEY 289
             F    +P  NL  KFP L  AG+ LL+ +L  +PK+R TA +AL+  Y
Sbjct: 243 GKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSY 292

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  249 bits (639), Expect = 5e-82
 Identities = 108/291 (37%), Positives = 156/291 (53%), Gaps = 12/291 (4%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y+ +  +G G YG V KCRN  TG+ VAIK      + E V    +REV +L++L HEN
Sbjct: 2   KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHEN 61

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
           IV L +    +  ++LVFEY++  L   +      L    +++ + Q+L  +AYCHS  I
Sbjct: 62  IVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNI 121

Query: 128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGYTGYS 186
           +HRD+KP N+L+  +   +KL DFG ARA+         D V +  Y+APELL+G T Y 
Sbjct: 122 IHRDIKPENILVS-ESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYG 180

Query: 187 TPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAE-----STYISEI 240
            P+DVWA+GCI AE++ G+PLFP     D L LI   LG P   S  E       +    
Sbjct: 181 KPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLG-PLPPSHQELFSSNPRFAGVA 239

Query: 241 LPLYPHFEPANLAEKFPN-LEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            P     E   L  ++P  +    +D L   L ++PK+R+T  + L+H Y 
Sbjct: 240 FPEPSQPES--LERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  239 bits (611), Expect = 4e-77
 Identities = 111/296 (37%), Positives = 174/296 (58%), Gaps = 20/296 (6%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMM--TIQTEQEGVPSYIIREVSLLKEL-EH 65
           Y+ ++K+G G YG V+K  +  T + VA+K +    +   +   ++  RE+  L+EL +H
Sbjct: 9   YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTF--REIMFLQELGDH 66

Query: 66  ENIVRLLDV--QSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCH 123
            NIV+LL+V    + KD++LVFEY++ DLH+ I    N L  +  + I+ Q+L  L Y H
Sbjct: 67  PNIVKLLNVIKAENDKDIYLVFEYMETDLHAVI--RANILEDVHKRYIMYQLLKALKYIH 124

Query: 124 SLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY------KAPE 177
           S  ++HRDLKP+N+L++     VKLADFGLAR++    +E   + V + Y      +APE
Sbjct: 125 SGNVIHRDLKPSNILLNSD-CRVKLADFGLARSLS-ELEENPENPVLTDYVATRWYRAPE 182

Query: 178 LLLGYTGYSTPIDVWAVGCIFAEMITGKPLFP-SKKHDHLSLIFSLLGTPTDESWA--ES 234
           +LLG T Y+  +D+W+VGCI  EM+ GKPLFP +   + L  I  ++G P+ E     +S
Sbjct: 183 ILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKS 242

Query: 235 TYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            + + +L   P      L E  P      +DLL ++L  NP +R+TA +AL+H Y+
Sbjct: 243 PFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYV 298

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  236 bits (604), Expect = 3e-76
 Identities = 119/307 (38%), Positives = 164/307 (53%), Gaps = 36/307 (11%)

Query: 13  KKIGAGGYGEVYKCRNTVTGQKVAIKMMT---IQTEQEGVPSYI---------IREVSLL 60
             +G G YG+V K  +T+TG+ VAIK +    I  +       +         +RE+ ++
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 61  KELEHENIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLA 120
            E++HENI+ L+DV      + LV + +  DL   + R K  L    +K IL QIL GL 
Sbjct: 75  NEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDR-KIRLTESQVKCILLQILNGLN 133

Query: 121 YCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ--KEYSRDCVYSP------ 172
             H    +HRDL P N+ I+  +   K+ADFGLAR  G P      S+D           
Sbjct: 134 VLHKWYFMHRDLSPANIFIN-SKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTS 192

Query: 173 ------YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGT 225
                 Y+APELL+G   Y   +D+W+VGCIFAE++TGKPLFP +   D L  IF LLGT
Sbjct: 193 KVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGT 252

Query: 226 PTDESWAESTYISEILPLYPHFEPAN---LAEKFPNLEPAGVDLLSQMLCLNPKQRITAM 282
           P +++W ++      LPLY  F P     L   FPN     +DLL  +L LNP +RI+A 
Sbjct: 253 PNEDNWPQAKK----LPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAK 308

Query: 283 DALKHEY 289
           +ALKHEY
Sbjct: 309 EALKHEY 315

Length = 335

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  234 bits (599), Expect = 4e-76
 Identities = 113/288 (39%), Positives = 175/288 (60%), Gaps = 12/288 (4%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYI-IREVSLLKELEHEN 67
           Y+K+ KIG G YG V+KCRN  TGQ VAIK   +++E + V   I +RE+ +LK+L+H N
Sbjct: 3   YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKF-VESEDDPVIKKIALREIRMLKQLKHPN 61

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
           +V L++V   ++ + LVFEY D  + + + ++   +   +IK I+ Q L  + +CH    
Sbjct: 62  LVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNC 121

Query: 128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGYTGYS 186
           +HRD+KP N+LI  K+  +KL DFG AR +  P  +Y+ D V +  Y+APELL+G T Y 
Sbjct: 122 IHRDVKPENILIT-KQGQIKLCDFGFARILTGPGDDYT-DYVATRWYRAPELLVGDTQYG 179

Query: 187 TPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLG--TPTDES-WAESTYISEI-L 241
            P+DVWA+GC+FAE++TG+PL+P K   D L LI   LG   P  +  ++ + +   + +
Sbjct: 180 PPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSI 239

Query: 242 PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEY 289
           P     EP  L  KFPN+    +  L   L ++P +R++  + L+H Y
Sbjct: 240 PEPETREP--LESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  235 bits (602), Expect = 8e-76
 Identities = 121/294 (41%), Positives = 167/294 (56%), Gaps = 18/294 (6%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           Y  IK IG G YG V   +N+ T +KVAIK +    +        +RE+ LL+ L+HEN+
Sbjct: 7   YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENV 66

Query: 69  VRLLDV-----QSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCH 123
           + + D+     + +  DV++V+E +D DLH  I R   TL+    +  L Q+L GL Y H
Sbjct: 67  IAIKDIMPPPHREAFNDVYIVYELMDTDLHQII-RSSQTLSDDHCQYFLYQLLRGLKYIH 125

Query: 124 SLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYT 183
           S  +LHRDLKP+NLL++     +K+ DFGLAR         +   V   Y+APELLL  +
Sbjct: 126 SANVLHRDLKPSNLLLNAN-CDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCS 184

Query: 184 GYSTPIDVWAVGCIFAEMITGKPLFPSKKHDH-LSLIFSLLGTPTDESWAEST------Y 236
            Y+T IDVW+VGCIFAE++  KPLFP K + H L LI  LLG+P++E            Y
Sbjct: 185 EYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRY 244

Query: 237 ISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           I   LP  P     + A  FP+  P  +DLL +ML  +P +RIT  +AL H YL
Sbjct: 245 IRS-LPYTPR---QSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYL 294

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  233 bits (596), Expect = 3e-75
 Identities = 113/301 (37%), Positives = 164/301 (54%), Gaps = 25/301 (8%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           Y+K+ KIG G +GEV+K R+  T Q VA+K + ++ E+EG P   +RE+ +L+ L+HEN+
Sbjct: 14  YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENV 73

Query: 69  VRLLDVQSS--------RKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLA 120
           V L+++  +        +   +LVFE+ + DL   ++       L  IK ++K +L GL 
Sbjct: 74  VNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLY 133

Query: 121 YCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE----YSRDCVYSPYKAP 176
           Y H  KILHRD+K  N+LI  K   +KLADFGLARA  + +      Y+   V   Y+ P
Sbjct: 134 YIHRNKILHRDMKAANILIT-KDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPP 192

Query: 177 ELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDH-LSLIFSLLGTPTDESWAEST 235
           ELLLG   Y  PID+W  GCI AEM T  P+       H L+LI  L G+ T E W    
Sbjct: 193 ELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPG-- 250

Query: 236 YISEILPLYPHFE-PANLAEKFP------NLEPAGVDLLSQMLCLNPKQRITAMDALKHE 288
              + L L+   E P     K          +P  +DL+ ++L L+P +RI A  AL H+
Sbjct: 251 --VDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHD 308

Query: 289 Y 289
           +
Sbjct: 309 F 309

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  233 bits (596), Expect = 5e-75
 Identities = 111/302 (36%), Positives = 172/302 (56%), Gaps = 25/302 (8%)

Query: 6   NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEH 65
              YK I+ IG+G YG V    +T +G+KVAIK +    +   +    +RE+ +L+  +H
Sbjct: 4   GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKH 63

Query: 66  ENIVRLLDVQSSR----KDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAY 121
           +NI+ + D+        KDV++V + ++ DLH  I      L    I+  L Q+L GL Y
Sbjct: 64  DNIIAIRDILRPPGADFKDVYVVMDLMESDLHHII-HSDQPLTEEHIRYFLYQLLRGLKY 122

Query: 122 CHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSR---DCVYS-PYKAPE 177
            HS  ++HRDLKP+NLL++ +   +++ DFG+AR +     E+     + V +  Y+APE
Sbjct: 123 IHSANVIHRDLKPSNLLVN-EDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPE 181

Query: 178 LLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDH-LSLIFSLLGTPTDESWAESTY 236
           LLL    Y+T ID+W+VGCIFAEM+  + LFP K + H L LI S+LG+P++E       
Sbjct: 182 LLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEE------V 235

Query: 237 ISEI--------LPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHE 288
           ++ I        +   P  +P   ++ FP   P  +DLLSQML  +P++RIT   AL+H 
Sbjct: 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295

Query: 289 YL 290
           +L
Sbjct: 296 FL 297

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  233 bits (596), Expect = 7e-75
 Identities = 118/310 (38%), Positives = 165/310 (53%), Gaps = 47/310 (15%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIK--------MMTIQTEQEGVPSYIIREVSL 59
            Y+ +  IG G YG V    +  TG KVAIK            +T         +RE+ +
Sbjct: 6   RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT---------LREIKI 56

Query: 60  LKELEHENIVRLLDVQSSR-----KDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQ 114
           L+  +HENI+ +LD+          DV++V E ++ DL+  I      L+   I+  L Q
Sbjct: 57  LRRFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQH--LSNDHIQYFLYQ 114

Query: 115 ILLGLAYCHSLKILHRDLKPNNLLIDLKRNT---VKLADFGLARAIGVPQKEYSRDCV-Y 170
           IL GL Y HS  +LHRDLKP+NLL+    NT   +K+ DFGLAR I  P+ +++     Y
Sbjct: 115 ILRGLKYIHSANVLHRDLKPSNLLL----NTNCDLKICDFGLAR-IADPEHDHTGFLTEY 169

Query: 171 SP---YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-HDHLSLIFSLLGTP 226
                Y+APE++L   GY+  ID+W+VGCI AEM++ +PLFP K     L+LI  +LGTP
Sbjct: 170 VATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTP 229

Query: 227 TDESWAEST------YISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRIT 280
           + E            YI + LP  P        + FPN +P  +DLL +ML  NP +RIT
Sbjct: 230 SQEDLNCIISLRARNYI-KSLPFKP---KVPWNKLFPNADPKALDLLDKMLTFNPHKRIT 285

Query: 281 AMDALKHEYL 290
             +AL H YL
Sbjct: 286 VEEALAHPYL 295

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  230 bits (588), Expect = 5e-74
 Identities = 119/314 (37%), Positives = 173/314 (55%), Gaps = 33/314 (10%)

Query: 9   YKKIKKIGAGGYGEVYKCR--NTVTGQKVAIKMM-TIQTEQEGVPSYIIREVSLLKELEH 65
           Y+    IG G YG VYK +  N   G++ AIK     + +  G+     RE++LL+EL+H
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61

Query: 66  ENIVRLLDV--QSSRKDVFLVFEYLDLDLHSFITRHKNT----LNLLVIKAILKQILLGL 119
           EN+V L++V  + + K V+L+F+Y + DL   I  H+      +   ++K++L QIL G+
Sbjct: 62  ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121

Query: 120 AYCHSLKILHRDLKPNNLLI---DLKRNTVKLADFGLARAIGVPQKE-YSRD--CVYSPY 173
            Y HS  +LHRDLKP N+L+     +R  VK+ D GLAR    P K     D   V   Y
Sbjct: 122 HYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWY 181

Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK----------HDHLSLIFSLL 223
           +APELLLG   Y+  ID+WA+GCIFAE++T +P+F  ++           D L  IF +L
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVL 241

Query: 224 GTPTDESWAESTYISEILPL--------YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNP 275
           GTPT++ W +   + E   L        YP    A   EK    +  G DLL ++L  +P
Sbjct: 242 GTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDP 301

Query: 276 KQRITAMDALKHEY 289
            +RITA +AL+H Y
Sbjct: 302 TKRITAEEALEHPY 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  228 bits (583), Expect = 1e-73
 Identities = 124/291 (42%), Positives = 174/291 (59%), Gaps = 13/291 (4%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
           +Y  ++K+G G Y  VYK  + + GQ VA+K+++++TE EGVP   IRE SLLK L+H N
Sbjct: 6   SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHAN 64

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
           IV L D+  +++ +  VFEY+  DL  ++ +H   L+   ++  + Q+L GLAY H   I
Sbjct: 65  IVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHI 124

Query: 128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYST 187
           LHRDLKP NLLI      +KLADFGLARA  +P + YS + V   Y+ P++LLG T YS+
Sbjct: 125 LHRDLKPQNLLISY-LGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSS 183

Query: 188 PIDVWAVGCIFAEMITGKPLFP--SKKHDHLSLIFSLLGTPTDESWAEST----YISEIL 241
            +D+W  GCIF EM+ G+P FP  S   + L  I+++LG PT+++W   +    Y  E  
Sbjct: 184 ALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWF 243

Query: 242 PLYPHFEPANLAEKFPNLE--PAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                  P  L   +  L   P   DL SQML + PK RI+A DAL H Y 
Sbjct: 244 LPCK---PQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  227 bits (580), Expect = 3e-73
 Identities = 123/298 (41%), Positives = 174/298 (58%), Gaps = 27/298 (9%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE---H 65
           Y+ + +IG G YG VYK R+  +G  VA+K + +QT ++G+P   +REV+LLK LE   H
Sbjct: 2   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61

Query: 66  ENIVRLLDV-QSSRKD----VFLVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILLGL 119
            NIVRL+DV  +SR D    V LVFE++D DL +++ +     L    IK +++Q L GL
Sbjct: 62  PNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGL 121

Query: 120 AYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP------Y 173
            + H+  I+HRDLKP N+L+      VKLADFGLAR        YS     +P      Y
Sbjct: 122 DFLHANCIVHRDLKPENILVT-SGGQVKLADFGLARI-------YSCQMALTPVVVTLWY 173

Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF-PSKKHDHLSLIFSLLGTPTDESWA 232
           +APE+LL  T Y+TP+D+W+VGCIFAEM   KPLF  + + D L  IF L+G P ++ W 
Sbjct: 174 RAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 232

Query: 233 ESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
               +      +    P  +    P +E +G  LL +ML  NP +RI+A  AL+H + 
Sbjct: 233 RDVTLPR--GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  222 bits (569), Expect = 7e-71
 Identities = 117/297 (39%), Positives = 173/297 (58%), Gaps = 27/297 (9%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMT--IQTEQEGVPSYIIREVSLLKELEHE 66
           Y+ +  +G+G YG+V    +T TG+KVAIK ++   Q+      +Y  RE+ LLK ++HE
Sbjct: 17  YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY--RELRLLKHMDHE 74

Query: 67  NIVRLLDV---QSSR---KDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLA 120
           N++ LLDV    SS    +DV+LV   +  DL++ +   K  L+   I+ ++ QIL GL 
Sbjct: 75  NVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQK--LSDDHIQFLVYQILRGLK 132

Query: 121 YCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLL 180
           Y HS  I+HRDLKP+N+ ++ +   +K+ DFGLAR       E +       Y+APE++L
Sbjct: 133 YIHSAGIIHRDLKPSNIAVN-EDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIML 188

Query: 181 GYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAE 233
            +  Y+  +D+W+VGCI AE++TGK LFP   H D L  I +L+GTP +E      S + 
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESA 248

Query: 234 STYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
             YI + LP  P     +  E F    P  +DLL +ML L+P +RITA +AL H YL
Sbjct: 249 RNYI-QSLPQMPK---KDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYL 301

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  220 bits (562), Expect = 2e-70
 Identities = 105/284 (36%), Positives = 160/284 (56%), Gaps = 4/284 (1%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           Y+ +  +G G YG V KC++  TGQ VAIK      + + V    +RE+ +LK+L HEN+
Sbjct: 3   YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENL 62

Query: 69  VRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKIL 128
           V L++V   +K ++LVFE++D  +   + ++ N L+   ++  L QIL G+ +CHS  I+
Sbjct: 63  VNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNII 122

Query: 129 HRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTP 188
           HRD+KP N+L+  +   VKL DFG AR +  P + Y+       Y+APELL+G T Y   
Sbjct: 123 HRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRA 181

Query: 189 IDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGT--PTDESWAESTYISEILPLYP 245
           +D+WAVGC+  EM+TG+PLFP     D L  I   LG   P  +   +   +   + L  
Sbjct: 182 VDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPE 241

Query: 246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEY 289
             E   L ++FP L    +DL  Q L ++P  R ++   L HE+
Sbjct: 242 VKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  220 bits (561), Expect = 4e-70
 Identities = 129/295 (43%), Positives = 175/295 (59%), Gaps = 21/295 (7%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
           +Y+K++K+G G Y  VYK ++ V G+ VA+K++ +Q E+EG P   IRE SLLK L+H N
Sbjct: 6   SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQ-EEEGTPFTAIREASLLKGLKHAN 64

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
           IV L D+  +++ + LVFEY+  DL  ++ +H   L+   +K  L Q+L GL+Y H   I
Sbjct: 65  IVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYI 124

Query: 128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYST 187
           LHRDLKP NLLI      +KLADFGLARA  VP   YS + V   Y+ P++LLG T YST
Sbjct: 125 LHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYST 183

Query: 188 PIDVWAVGCIFAEMITGKPLFPSKK--HDHLSLIFSLLGTPTDESWAESTYISEILPLYP 245
            +D+W VGCIF EMI G   FP  K   D L  IF +LGTP +++W     +       P
Sbjct: 184 CLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL-------P 236

Query: 246 HFEP--------ANLAEKFPNLEPA--GVDLLSQMLCLNPKQRITAMDALKHEYL 290
           HF+P         NL + +  L       DL S++L   PK R++A  AL HEY 
Sbjct: 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  220 bits (561), Expect = 7e-70
 Identities = 119/286 (41%), Positives = 166/286 (58%), Gaps = 10/286 (3%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           Y  ++ +G G +G V   R+ +TGQ VAIK +        +     RE+ LLK L HENI
Sbjct: 12  YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENI 71

Query: 69  VRLLDV-QSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
           + L D+  S  +D++ V E L  DLH  +T     L    I+  L QIL GL Y HS  +
Sbjct: 72  ISLSDIFISPLEDIYFVTELLGTDLHRLLTSRP--LEKQFIQYFLYQILRGLKYVHSAGV 129

Query: 128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYST 187
           +HRDLKP+N+LI+ +   +K+ DFGLAR I  PQ        Y  Y+APE++L +  Y  
Sbjct: 130 VHRDLKPSNILIN-ENCDLKICDFGLAR-IQDPQMTGYVSTRY--YRAPEIMLTWQKYDV 185

Query: 188 PIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDE--SWAESTYISEILPLY 244
            +D+W+ GCIFAEM+ GKPLFP K H +  S+I  LLGTP D+  +   S      +   
Sbjct: 186 EVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSL 245

Query: 245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           P  EP   +EKF N +P+ +DLL +ML  +P++RI+A +AL H YL
Sbjct: 246 PKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL 291

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  216 bits (551), Expect = 1e-68
 Identities = 111/299 (37%), Positives = 164/299 (54%), Gaps = 22/299 (7%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           +  I +IG G YG+VYK R+  TG+ VA+K + +  E+EG P   IRE+ +L++L H NI
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68

Query: 69  VRLLDVQSSRKDV----------FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLG 118
           V L ++ + ++D           +LVFEY+D DL   +       +   IK+ +KQ+L G
Sbjct: 69  VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEG 128

Query: 119 LAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARA-IGVPQKEYSRDCVYSPYKAPE 177
           L YCH    LHRD+K +N+L++  +  +KLADFGLAR       + Y+   +   Y+ PE
Sbjct: 129 LNYCHKKNFLHRDIKCSNILLN-NKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPE 187

Query: 178 LLLGYTGYSTPIDVWAVGCIFAEMITGKPLF-PSKKHDHLSLIFSLLGTPTDESWAESTY 236
           LLLG   Y   IDVW+ GCI  E+ T KP+F  +++   L LI  L G+P    W +   
Sbjct: 188 LLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIK 247

Query: 237 ISEILPLYPHFEPAN-----LAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
               LP +   +P       L E+F  +    +DLL  ML L+P +R TA +AL   +L
Sbjct: 248 ----LPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  196 bits (501), Expect = 3e-62
 Identities = 77/189 (40%), Positives = 111/189 (58%), Gaps = 4/189 (2%)

Query: 15  IGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDV 74
           +G GG+G VY  R+  TG+KVAIK++  +     +   ++RE+ +LK+L H NIV+L  V
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGV 59

Query: 75  QSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLK 133
                 ++LV EY +   L   +  ++  L+   I  IL QIL GL Y HS  I+HRDLK
Sbjct: 60  FEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLK 119

Query: 134 PNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGYTGYSTPIDVW 192
           P N+L+D     VKLADFGL++ +    K   +  V +P Y APE+LLG   YS   D+W
Sbjct: 120 PENILLDSDNGKVKLADFGLSKLLT-SDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIW 178

Query: 193 AVGCIFAEM 201
           ++G I  E+
Sbjct: 179 SLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  196 bits (501), Expect = 3e-61
 Identities = 111/293 (37%), Positives = 160/293 (54%), Gaps = 24/293 (8%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQ--EGVPSYIIREVSLLKELE-H 65
           YK + KIG G + EV K ++  TG+  AIK M  +  +  E V +   RE+  L+ L  H
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNL--REIQALRRLSPH 57

Query: 66  ENIVRLLDVQSSRKD--VFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCH 123
            NI+RL++V   RK   + LVFE +D++L+  I   K  L    +K+ + Q+L  L + H
Sbjct: 58  PNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH 117

Query: 124 SLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGV--PQKEY--SRDCVYSPYKAPELL 179
              I HRD+KP N+LI  K + +KLADFG  R I    P  EY  +R      Y+APE L
Sbjct: 118 RNGIFHRDIKPENILI--KDDILKLADFGSCRGIYSKPPYTEYISTR-----WYRAPECL 170

Query: 180 L--GYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTY 236
           L  GY  Y   +D+WAVGC+F E+++  PLFP     D ++ I  +LGTP  E   +   
Sbjct: 171 LTDGY--YGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRK 228

Query: 237 ISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEY 289
              +   +P  +   L +  PN    G+DLL ++L  +P +RITA  AL+H Y
Sbjct: 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  195 bits (498), Expect = 7e-61
 Identities = 118/295 (40%), Positives = 172/295 (58%), Gaps = 22/295 (7%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQK-VAIKMMTIQTEQEGVPSYIIREVSLLKELE--- 64
           Y+ + +IG G YG+V+K R+   G + VA+K + +QT +EG+P   IREV++L+ LE   
Sbjct: 3   YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 62

Query: 65  HENIVRLLDVQS-SRKD----VFLVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILLG 118
           H N+VRL DV + SR D    + LVFE++D DL +++ +     +    IK ++ Q+L G
Sbjct: 63  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 122

Query: 119 LAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPEL 178
           L + HS +++HRDLKP N+L+      +KLADFGLAR I   Q   +   V   Y+APE+
Sbjct: 123 LDFLHSHRVVHRDLKPQNILVT-SSGQIKLADFGLAR-IYSFQMALTSVVVTLWYRAPEV 180

Query: 179 LLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYI 237
           LL  + Y+TP+D+W+VGCIFAEM   KPLF      D L  I  ++G P +E W     +
Sbjct: 181 LL-QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 239

Query: 238 --SEILPLYPHFEPANLAEKF-PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEY 289
                       + A   EKF  +++  G DLL + L  NP +RI+A  AL H Y
Sbjct: 240 PRQAFHS-----KSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  193 bits (493), Expect = 2e-60
 Identities = 88/288 (30%), Positives = 143/288 (49%), Gaps = 33/288 (11%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            + + + +G G +G VY   +  TG+ +A+K + +  + E     + RE+ +L  L+H N
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 68  IVRLLDVQSSR-KDVFLVF-EYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
           IVR    +    K+   +F EY+    L S + +    L   VI+   +QIL GLAY HS
Sbjct: 61  IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGK-LPEPVIRKYTRQILEGLAYLHS 119

Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIG-VPQKEYSRDCVYSP-YKAPELLLGY 182
             I+HRD+K  N+L+D     VKLADFG A+ +G +   E +     +P + APE++ G 
Sbjct: 120 NGIVHRDIKGANILVDSDGV-VKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG- 177

Query: 183 TGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILP 242
             Y    D+W++GC   EM TGKP +     + ++ ++ +           S    EI  
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPPWSELG-NPMAALYKI---------GSSGEPPEI-- 225

Query: 243 LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                 P +L+E+         D L + L  +PK+R TA + L+H +L
Sbjct: 226 ------PEHLSEE-------AKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  193 bits (491), Expect = 2e-59
 Identities = 106/298 (35%), Positives = 161/298 (54%), Gaps = 16/298 (5%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVT--GQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-E 64
            Y+ IK++G G YG V   RN  T   + VAIK +T    ++ +    +RE+ LL+    
Sbjct: 1   RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG 60

Query: 65  HENIVRLLDVQ----SSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLA 120
           H+NI  L D+      +  +++L  E ++ DLH  I R    L     ++ + QIL GL 
Sbjct: 61  HKNITCLYDMDIVFPGNFNELYLYEELMEADLHQII-RSGQPLTDAHFQSFIYQILCGLK 119

Query: 121 YCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE---YSRDCVYSP-YKAP 176
           Y HS  +LHRDLKP NLL++     +K+ DFGLAR       E   +  + V +  Y+AP
Sbjct: 120 YIHSANVLHRDLKPGNLLVNAD-CELKICDFGLARGFSENPGENAGFMTEYVATRWYRAP 178

Query: 177 ELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAE-- 233
           E++L +  Y+  IDVW+VGCI AE++  KP+F  K + D L+ I  +LGTP +E+ +   
Sbjct: 179 EIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238

Query: 234 STYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLI 291
           S      +   P+         FPN  P  +DLL ++L  +P +RI+  +AL+H YL 
Sbjct: 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLA 296

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  191 bits (487), Expect = 1e-58
 Identities = 118/306 (38%), Positives = 169/306 (55%), Gaps = 26/306 (8%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           YK  + IG G YG V    +T TG+KVAIK +    E     + I+RE+ LL+ L H +I
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61

Query: 69  VRLLDVQ--SSR---KDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCH 123
           V +  +    SR   KD+++VFE ++ DLH  I +  + L     +  L Q+L  L Y H
Sbjct: 62  VEIKHIMLPPSRREFKDIYVVFELMESDLHQVI-KANDDLTPEHHQFFLYQLLRALKYIH 120

Query: 124 SLKILHRDLKPNNLLI--DLKRNTVKLADFGLARAI--GVPQKEYSRDCVYSP-YKAPEL 178
           +  + HRDLKP N+L   D K   +K+ DFGLAR      P   +  D V +  Y+APEL
Sbjct: 121 TANVFHRDLKPKNILANADCK---LKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 177

Query: 179 LLG-YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDH-LSLIFSLLGTPTDESWAE--- 233
               ++ Y+  ID+W++GCIFAE++TGKPLFP K   H L LI  LLGTP+ E+ +    
Sbjct: 178 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN 237

Query: 234 ---STYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                Y+S +       +P   ++KFPN +P  + LL ++L  +PK R TA +AL   Y 
Sbjct: 238 EKARRYLSSMRKK----QPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYF 293

Query: 291 IGVENV 296
            G+  V
Sbjct: 294 KGLAKV 299

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  188 bits (479), Expect = 2e-57
 Identities = 112/297 (37%), Positives = 165/297 (55%), Gaps = 24/297 (8%)

Query: 7   LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHE 66
             Y  +K++G+G YG V    +  TG+KVAIK ++   + E       RE++LLK ++HE
Sbjct: 15  ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHE 74

Query: 67  NIVRLLDVQSSR------KDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLA 120
           N++ LLDV +S       +D +LV  Y+  DL   +      L+   ++ ++ Q+L GL 
Sbjct: 75  NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHP---LSEDKVQYLVYQMLCGLK 131

Query: 121 YCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLL 180
           Y HS  I+HRDLKP NL ++ +   +K+ DFGLAR        Y    V   Y+APE++L
Sbjct: 132 YIHSAGIIHRDLKPGNLAVN-EDCELKILDFGLARHADAEMTGY---VVTRWYRAPEVIL 187

Query: 181 GYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAE 233
            +  Y+  +D+W+VGCI AEM+TGK LF  K + D L+ I  + G P  E        A 
Sbjct: 188 NWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAA 247

Query: 234 STYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            +YI   LP YP  + + L   FP   P  VDLL +ML L+  +R+TA +AL+H Y 
Sbjct: 248 KSYIKS-LPKYPRKDFSTL---FPKASPQAVDLLEKMLELDVDKRLTATEALEHPYF 300

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  187 bits (477), Expect = 3e-57
 Identities = 107/291 (36%), Positives = 158/291 (54%), Gaps = 15/291 (5%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           Y+ +K++G+G YG V    +  TG KVAIK +    + E       RE+ LLK ++HEN+
Sbjct: 17  YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENV 76

Query: 69  VRLLDVQSSRK------DVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYC 122
           + LLDV +         D +LV  ++  DL   +   K  L+   I+ ++ Q+L GL Y 
Sbjct: 77  IGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEK--LSEDRIQFLVYQMLKGLKYI 134

Query: 123 HSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGY 182
           H+  I+HRDLKP NL ++ +   +K+ DFGLAR       E +   V   Y+APE++L +
Sbjct: 135 HAAGIIHRDLKPGNLAVN-EDCELKILDFGLARQT---DSEMTGYVVTRWYRAPEVILNW 190

Query: 183 TGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWA--ESTYISE 239
             Y+  +D+W+VGCI AEM+TGKPLF    H D L  I  + GTP+ E     +S     
Sbjct: 191 MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKN 250

Query: 240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            +   P F   +     PN  P  V++L +ML L+ + RITA +AL H Y 
Sbjct: 251 YVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYF 301

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  182 bits (462), Expect = 7e-55
 Identities = 110/297 (37%), Positives = 163/297 (54%), Gaps = 27/297 (9%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMT--IQTEQEGVPSYIIREVSLLKELEHE 66
           Y+ +  +G+G YG V    +T TG +VA+K ++   Q+      +Y  RE+ LLK ++HE
Sbjct: 19  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHE 76

Query: 67  NIVRLLDVQSSRK------DVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLA 120
           N++ LLDV +  +      DV+LV   +  DL++ +   K T +   ++ ++ QIL GL 
Sbjct: 77  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLK 134

Query: 121 YCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLL 180
           Y HS  I+HRDLKP+NL ++ +   +K+ DFGLAR       E +       Y+APE++L
Sbjct: 135 YIHSADIIHRDLKPSNLAVN-EDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIML 190

Query: 181 GYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAE 233
            +  Y+  +D+W+VGCI AE++TG+ LFP   H D L LI  L+GTP  E      S + 
Sbjct: 191 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 250

Query: 234 STYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
             YI  +          N A  F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 251 RNYIQSL----TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 303

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  182 bits (463), Expect = 8e-55
 Identities = 115/320 (35%), Positives = 167/320 (52%), Gaps = 61/320 (19%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMT--IQTEQEGVPSYIIREVSLLKELEHE 66
           Y+ +K IG+G  G V    +TVTGQ VAIK ++   Q       +Y  RE+ L+K + H+
Sbjct: 18  YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAY--RELVLMKLVNHK 75

Query: 67  NIVRLLDVQSSRK------DVFLVFEYLDLDLHSFITR---HKNTLNLLVIKAILKQILL 117
           NI+ LL+V + +K      DV+LV E +D +L   I     H+    LL       Q+L 
Sbjct: 76  NIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLY------QMLC 129

Query: 118 GLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP----- 172
           G+ + HS  I+HRDLKP+N+++     T+K+ DFGLAR  G          + +P     
Sbjct: 130 GIKHLHSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGT-------SFMMTPYVVTR 181

Query: 173 -YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDES 230
            Y+APE++LG  GY   +D+W+VGCI  EMI G  LFP   H D  + I   LGTP+DE 
Sbjct: 182 YYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDE- 239

Query: 231 WAESTYISEILPL-------YPHFEPANLAEKFP-NLEPAGV------------DLLSQM 270
                ++S + P         P +   +  E FP  L P               DLLS+M
Sbjct: 240 -----FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKM 294

Query: 271 LCLNPKQRITAMDALKHEYL 290
           L ++P++RI+  DAL+H Y+
Sbjct: 295 LVIDPEKRISVDDALQHPYI 314

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  174 bits (443), Expect = 8e-52
 Identities = 104/292 (35%), Positives = 156/292 (53%), Gaps = 18/292 (6%)

Query: 12  IKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRL 71
            + IG G +G V+   +   G++VA+K M    +       + RE+ +L   +H+N++  
Sbjct: 5   DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSA 64

Query: 72  LDV-----QSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
           LD+         +++++V E +  DLH  I   +  L+   +K  L QIL GL Y HS  
Sbjct: 65  LDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLHSAG 123

Query: 127 ILHRDLKPNNLLIDLKRNTV-KLADFGLARAIGV-PQKEYSRDCVYSPYKAPELLLGYTG 184
           ILHRD+KP NLL++   N V K+ DFGLAR       K  +++ V   Y+APE+L+G   
Sbjct: 124 ILHRDIKPGNLLVN--SNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRH 181

Query: 185 YSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTP--TDESWAESTYISEIL 241
           Y++ +D+W+VGCIFAE++  + LF ++     L LI  LLGTP       A     + IL
Sbjct: 182 YTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHIL 241

Query: 242 PLYPHFEPANLAEKFPNLEPA---GVDLLSQMLCLNPKQRITAMDALKHEYL 290
              PH  P+ L   +     A    V LL +ML  +P +RI+A DAL H YL
Sbjct: 242 RG-PHKPPS-LPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYL 291

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  171 bits (434), Expect = 1e-50
 Identities = 99/308 (32%), Positives = 161/308 (52%), Gaps = 37/308 (12%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           Y  ++ +G G  G V+   ++   ++VA+K + +   Q     + +RE+ +++ L+H+NI
Sbjct: 7   YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQS--VKHALREIKIIRRLDHDNI 64

Query: 69  VRLLDV--------------QSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQ 114
           V++ +V               +    V++V EY++ DL + +   +  L+    +  + Q
Sbjct: 65  VKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVL--EQGPLSEEHARLFMYQ 122

Query: 115 ILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY----SRDCVY 170
           +L GL Y HS  +LHRDLKP N+ I+ +   +K+ DFGLAR I  P   +    S   V 
Sbjct: 123 LLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLAR-IVDPHYSHKGYLSEGLVT 181

Query: 171 SPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFP-SKKHDHLSLIFSLLGTPTDE 229
             Y++P LLL    Y+  ID+WA GCIFAEM+TGKPLF  + + + + LI   +    +E
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREE 241

Query: 230 SWAESTYISEILPLYPHF------EPAN-LAEKFPNLEPAGVDLLSQMLCLNPKQRITAM 282
                   +E+L + P F      EP   L +  P + P  +D L Q+L  NP  R+TA 
Sbjct: 242 D------RNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAE 295

Query: 283 DALKHEYL 290
           +AL H Y+
Sbjct: 296 EALMHPYM 303

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  168 bits (426), Expect = 1e-49
 Identities = 100/294 (34%), Positives = 164/294 (55%), Gaps = 19/294 (6%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMT--IQTEQEGVPSYIIREVSLLKELEHE 66
           Y+ +  +G+G YG V    +T   QKVA+K ++   Q+      +Y  RE+ LLK ++HE
Sbjct: 17  YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTY--RELRLLKHMKHE 74

Query: 67  NIVRLLDVQSSR------KDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLA 120
           N++ LLDV +         +V+LV   +  DL++ +   K  L+   ++ ++ Q+L GL 
Sbjct: 75  NVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQK--LSDEHVQFLIYQLLRGLK 132

Query: 121 YCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLL 180
           Y HS  I+HRDLKP+N+ ++ +   +++ DFGLAR       E +       Y+APE++L
Sbjct: 133 YIHSAGIIHRDLKPSNVAVN-EDCELRILDFGLARQ---ADDEMTGYVATRWYRAPEIML 188

Query: 181 GYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAE--STYI 237
            +  Y+  +D+W+VGCI AE++ GK LFP   + D L  I  ++GTP+ E   +  S + 
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHA 248

Query: 238 SEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLI 291
            + +   PH    +L + F    P  +DLL +ML L+  +RI+A +AL H Y  
Sbjct: 249 RKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFS 302

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  166 bits (422), Expect = 1e-49
 Identities = 91/286 (31%), Positives = 148/286 (51%), Gaps = 37/286 (12%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           YK ++KIG G  GEVYK  +  TG++VAIK M ++ + +     II E+ ++K+ +H NI
Sbjct: 21  YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNK---ELIINEILIMKDCKHPNI 77

Query: 69  VRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
           V   D      ++++V EY+D   L   IT++   +N   I  + +++L GL Y HS  +
Sbjct: 78  VDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNV 137

Query: 128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY-KAPELLLGYTGYS 186
           +HRD+K +N+L+  K  +VKLADFG A A    +K      V +PY  APE++     Y 
Sbjct: 138 IHRDIKSDNILLS-KDGSVKLADFGFA-AQLTKEKSKRNSVVGTPYWMAPEVIKR-KDYG 194

Query: 187 TPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIF--SLLGTPTDESWAESTYISEILPLY 244
             +D+W++G +  EM  G+P  P  +   L  +F  +  G P               PL 
Sbjct: 195 PKVDIWSLGIMCIEMAEGEP--PYLREPPLRALFLITTKGIP---------------PLK 237

Query: 245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
               P   + +F        D L++ L  +P++R +A + L+H +L
Sbjct: 238 ---NPEKWSPEF-------KDFLNKCLVKDPEKRPSAEELLQHPFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  169 bits (429), Expect = 5e-49
 Identities = 112/298 (37%), Positives = 164/298 (55%), Gaps = 31/298 (10%)

Query: 6   NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEH 65
           N +YK    IG G +G VY+     T +KVAIK    +  Q+  P Y  RE+ ++K L H
Sbjct: 65  NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIK----KVLQD--PQYKNRELLIMKNLNH 118

Query: 66  ENIVRLLD------VQSSRKDVFL--VFEYLDLDLHSFI---TRHKNTLNLLVIKAILKQ 114
            NI+ L D       + + K++FL  V E++   +H ++    R+ + L L ++K    Q
Sbjct: 119 INIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQ 178

Query: 115 ILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK 174
           +   LAY HS  I HRDLKP NLLID   +T+KL DFG A+ +   Q+  S  C    Y+
Sbjct: 179 LCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF-YR 237

Query: 175 APELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAE 233
           APEL+LG T Y+T ID+W++GCI AEMI G P+F  +   D L  I  +LGTPT++    
Sbjct: 238 APELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQ--- 294

Query: 234 STYISEILPLY-----PHFEPANLAEKFPNLEP-AGVDLLSQMLCLNPKQRITAMDAL 285
              + E+ P Y     P  +P +L + FP   P   ++ +SQ L   P +R+  ++AL
Sbjct: 295 ---LKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEAL 349

Length = 440

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score =  162 bits (412), Expect = 8e-48
 Identities = 110/314 (35%), Positives = 164/314 (52%), Gaps = 41/314 (13%)

Query: 14  KIGAGGYGEVYKCR--NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRL 71
           K+G G YG VYK +  +    ++ A+K    Q E  G+     RE++LL+EL+H N++ L
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALK----QIEGTGISMSACREIALLRELKHPNVIAL 63

Query: 72  LDVQSSRKD--VFLVFEYLDLDLHSFITRHKNT--------LNLLVIKAILKQILLGLAY 121
             V  S  D  V+L+F+Y + DL   I  H+ +        L   ++K++L QIL G+ Y
Sbjct: 64  QKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123

Query: 122 CHSLKILHRDLKPNNLLI---DLKRNTVKLADFGLARAIGVPQK---EYSRDCVYSPYKA 175
            H+  +LHRDLKP N+L+     +R  VK+AD G AR    P K   +     V   Y+A
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183

Query: 176 PELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK----------HDHLSLIFSLLGT 225
           PELLLG   Y+  ID+WA+GCIFAE++T +P+F  ++          HD L  IFS++G 
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGF 243

Query: 226 PTDESWAESTYISEILPLYPHFEPANLAE----KFPNLEPAGVD-----LLSQMLCLNPK 276
           P D+ W +   + E   L   F     A     K+        D     LL ++L ++P 
Sbjct: 244 PADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPT 303

Query: 277 QRITAMDALKHEYL 290
           +RIT+  AL+  Y 
Sbjct: 304 KRITSEQALQDPYF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  162 bits (409), Expect = 9e-47
 Identities = 89/296 (30%), Positives = 140/296 (47%), Gaps = 31/296 (10%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEG-VPSYIIREVSLLKEL-EH 65
           +Y+ ++K+G G +GEVY  R+    + VA+K++  + E +       +RE+ +L  L   
Sbjct: 1   SYRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 66  ENIVRLLDVQSSRKDVFLVFEYLD-LDLHSFITRH--KNTLNLLVIKAILKQILLGLAYC 122
            NIV+L D       ++LV EY+D   L   + +   K  L+      IL QIL  L Y 
Sbjct: 58  PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117

Query: 123 HSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIG------VPQKEYSRDCVYSPYKAP 176
           HS  I+HRD+KP N+L+D     VKL DFGLA+ +             S       Y AP
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177

Query: 177 ELLLGYTG--YSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAES 234
           E+LLG +    S+  D+W++G    E++TG P F  +K+   +              +++
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSAT--------------SQT 223

Query: 235 TYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
             I   LP  P             +  A  DLL ++L  +PK R+++   L H+ L
Sbjct: 224 LKIILELP-TPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLL 278

Length = 384

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  157 bits (399), Expect = 2e-46
 Identities = 85/291 (29%), Positives = 141/291 (48%), Gaps = 49/291 (16%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           ++ ++KIG GG+GEVYK R+  TG++VAIK++ ++++++     II E+ +LK+ +H NI
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEK--KEKIINEIQILKKCKHPNI 59

Query: 69  VRLLDVQSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
           V+       + ++++V E+     L   +     TL    I  + K++L GL Y HS  I
Sbjct: 60  VKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGI 119

Query: 128 LHRDLKPNNLLIDLKRNT---VKLADFGLARAIGVPQKEYSRDC---VYSPY-KAPELLL 180
           +HRD+K  N+L+     +   VKL DFGL+      Q   ++     V +PY  APE++ 
Sbjct: 120 IHRDIKAANILL----TSDGEVKLIDFGLSA-----QLSDTKARNTMVGTPYWMAPEVIN 170

Query: 181 GYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIF--SLLGTPTDESWAESTYIS 238
           G   Y    D+W++G    E+  GKP  P  +   +  +F  +  G P   +       S
Sbjct: 171 G-KPYDYKADIWSLGITAIELAEGKP--PYSELPPMKALFKIATNGPPGLRN---PEKWS 224

Query: 239 EILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEY 289
           +                         D L + L  NP++R TA   LKH +
Sbjct: 225 DEF----------------------KDFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  156 bits (397), Expect = 5e-46
 Identities = 87/285 (30%), Positives = 137/285 (48%), Gaps = 33/285 (11%)

Query: 13  KKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLL 72
            KIG G +G+VY   N  TG+ +A+K + IQ         I  E+ +L+ L+H N+V+  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 73  DVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDL 132
            V+  R+ V++  EY        +  H   L+  VI+    Q+L GLAY HS  I+HRD+
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDI 125

Query: 133 KPNNLLIDLKRNTVKLADFGLARAI---GVPQKEYSRDCVYSP-YKAPELLLG--YTGYS 186
           KP N+ +D     +KL DFG A  +        E  +    +P Y APE++ G    G+ 
Sbjct: 126 KPANIFLD-HNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHG 184

Query: 187 TPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSL-LGTPTDESWAESTYISEILPLYP 245
              D+W++GC+  EM TGK  + S+  +   ++F +  G                 P  P
Sbjct: 185 RAADIWSLGCVVLEMATGKRPW-SELDNEFQIMFHVGAGHK---------------PPIP 228

Query: 246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
             +   L+       P G D L + L  +PK+R TA + L+H ++
Sbjct: 229 --DSLQLS-------PEGKDFLDRCLESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  155 bits (395), Expect = 8e-46
 Identities = 82/289 (28%), Positives = 129/289 (44%), Gaps = 45/289 (15%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y+ IK+IG G +G+VY  R    G+   +K + +    E      + EV +LK+L H N
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60

Query: 68  IVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILK---QILLGLAYCH 123
           I++  +    +  + +V EY D  DL   I + K        + IL    Q+ L L Y H
Sbjct: 61  IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120

Query: 124 SLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDC----VYSP-YKAPEL 178
           S KILHRD+KP N+ +      VKL DFG+++         + D     V +P Y +PEL
Sbjct: 121 SRKILHRDIKPQNIFLT-SNGLVKLGDFGISK-----VLSSTVDLAKTVVGTPYYLSPEL 174

Query: 179 LLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLL-GTPTDESWAESTYI 237
                 Y+   D+W++GC+  E+ T K  F  +  + L L   +L G         S Y 
Sbjct: 175 CQNK-PYNYKSDIWSLGCVLYELCTLKHPF--EGENLLELALKILKGQYPPIP---SQYS 228

Query: 238 SEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK 286
           SE+                        +L+S +L  +P++R +    L+
Sbjct: 229 SEL-----------------------RNLVSSLLQKDPEERPSIAQILQ 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score =  155 bits (393), Expect = 5e-45
 Identities = 107/314 (34%), Positives = 162/314 (51%), Gaps = 41/314 (13%)

Query: 14  KIGAGGYGEVYKCR--NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRL 71
           K+G G YG VYK +  +    +  A+K    Q E  G+     RE++LL+EL+H N++ L
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALK----QIEGTGISMSACREIALLRELKHPNVISL 63

Query: 72  LDVQSSRKD--VFLVFEYLDLDLHSFITRHKNT--------LNLLVIKAILKQILLGLAY 121
             V  S  D  V+L+F+Y + DL   I  H+ +        L   ++K++L QIL G+ Y
Sbjct: 64  QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 123

Query: 122 CHSLKILHRDLKPNNLLI---DLKRNTVKLADFGLARAIGVPQK---EYSRDCVYSPYKA 175
            H+  +LHRDLKP N+L+     +R  VK+AD G AR    P K   +     V   Y+A
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183

Query: 176 PELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK----------HDHLSLIFSLLGT 225
           PELLLG   Y+  ID+WA+GCIFAE++T +P+F  ++          HD L  IF+++G 
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGF 243

Query: 226 PTDESWAESTYISEILPLYPHFEPANLAE----KFPNLEPAGVD-----LLSQMLCLNPK 276
           P D+ W +   + E   L   F           K+        D     LL ++L ++P 
Sbjct: 244 PADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPI 303

Query: 277 QRITAMDALKHEYL 290
           +RIT+  A++  Y 
Sbjct: 304 KRITSEQAMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  151 bits (383), Expect = 5e-44
 Identities = 84/285 (29%), Positives = 131/285 (45%), Gaps = 33/285 (11%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
           NY+    IG G +G VYK  N  TG  VAIK ++++  +E     I++E+ LLK L+H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 68  IVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
           IV+ +    +   ++++ EY +   L   I +        ++   + Q+L GLAY H   
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQG 119

Query: 127 ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY-KAPELLLGYTGY 185
           ++HRD+K  N+L   K   VKLADFG+A  +     +     V +PY  APE++   +G 
Sbjct: 120 VIHRDIKAANILTT-KDGVVKLADFGVATKLN-DVSKDDASVVGTPYWMAPEVIEM-SGA 176

Query: 186 STPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYP 245
           ST  D+W++GC   E++TG P +           + L          +  +     PL  
Sbjct: 177 STASDIWSLGCTVIELLTGNPPY-----------YDLNPMAALFRIVQDDHP----PLPE 221

Query: 246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
              P               D L Q    +P  R TA   LKH ++
Sbjct: 222 GISPELK------------DFLMQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  150 bits (382), Expect = 9e-44
 Identities = 83/295 (28%), Positives = 136/295 (46%), Gaps = 44/295 (14%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           Y+ ++ IG G +G V K R    G+ +  K +      E     ++ EV++L+EL+H NI
Sbjct: 2   YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61

Query: 69  VRLLD--VQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLL---VIKAILKQILLGLAYC 122
           VR  D  +  S + +++V EY +  DL   I + K     +    I  IL Q+LL L  C
Sbjct: 62  VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYEC 121

Query: 123 H-----SLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAP 176
           H        +LHRDLKP N+ +D   N VKL DFGLA+ +G     +++  V +P Y +P
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLD-ANNNVKLGDFGLAKILGH-DSSFAKTYVGTPYYMSP 179

Query: 177 ELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY 236
           E L   + Y    D+W++GC+  E+    P F ++    L                 ++ 
Sbjct: 180 EQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQL-----------------ASK 221

Query: 237 ISE-ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           I E      P+   + L E           ++  ML ++P +R +  + L+   +
Sbjct: 222 IKEGKFRRIPYRYSSELNE-----------VIKSMLNVDPDKRPSTEELLQLPLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  148 bits (375), Expect = 1e-42
 Identities = 93/280 (33%), Positives = 142/280 (50%), Gaps = 11/280 (3%)

Query: 15  IGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDV 74
           +G G YG V KCR+  T + VAIK      E E V    +RE+ +L+ L+ ENIV L + 
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68

Query: 75  QSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKP 134
              R  ++LVFEY++ ++   +    N +    +++ + Q++  + +CH   I+HRD+KP
Sbjct: 69  FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKP 128

Query: 135 NNLLIDLKRNTVKLADFGLARAIGV-PQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
            NLLI    + +KL DFG AR +       Y+       Y++PELLLG   Y   +D+W+
Sbjct: 129 ENLLIS-HNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG-APYGKAVDMWS 186

Query: 194 VGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDES----WAESTYISEILPLYPHFE 248
           VGCI  E+  G+PLFP +   D L  I  +LG    E     ++   +     P   H  
Sbjct: 187 VGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNH-- 244

Query: 249 PANLAEKFPN-LEPAGVDLLSQMLCLNPKQRITAMDALKH 287
           P +L  ++   L    +DL+  +L LNP  R      L H
Sbjct: 245 PQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  145 bits (368), Expect = 7e-42
 Identities = 84/288 (29%), Positives = 144/288 (50%), Gaps = 37/288 (12%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTI----QTEQEGVPSYIIREVSLLKELE 64
           ++K + +G+G +G VY+  N   G   A+K +++    QT QE V   + +E++LL +L+
Sbjct: 2   WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAV-KQLEQEIALLSKLQ 60

Query: 65  HENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCH 123
           H NIV+ L  +    ++++  E +    L   + ++  +    VI+   +QILLGL Y H
Sbjct: 61  HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLH 119

Query: 124 SLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY-KAPELLLGY 182
               +HRD+K  N+L+D     VKLADFG+A+   V +  +++    SPY  APE++   
Sbjct: 120 DRNTVHRDIKGANILVD-TNGVVKLADFGMAKQ--VVEFSFAKSFKGSPYWMAPEVIAQQ 176

Query: 183 TGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILP 242
            GY    D+W++GC   EM TGKP  P  + + ++ +F +  +               LP
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGKP--PWSQLEGVAAVFKIGRSKE-------------LP 221

Query: 243 LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
             P            +L     D + + L  +P  R TA + L+H ++
Sbjct: 222 PIPD-----------HLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score =  147 bits (372), Expect = 1e-41
 Identities = 102/308 (33%), Positives = 161/308 (52%), Gaps = 38/308 (12%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           Y+ +K IG+G  G V    + V  + VAIK ++   + +       RE+ L+K + H+NI
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78

Query: 69  VRLLDVQSSRK------DVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYC 122
           + LL+V + +K      DV+LV E +D +L   I   +  L+   +  +L Q+L G+ + 
Sbjct: 79  ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHL 135

Query: 123 HSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGY 182
           HS  I+HRDLKP+N+++     T+K+ DFGLAR  G      +   V   Y+APE++LG 
Sbjct: 136 HSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG- 192

Query: 183 TGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEIL 241
            GY   +D+W+VGCI  EM+  K LFP + + D  + +   LGTP  E      ++ ++ 
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE------FMKKLQ 246

Query: 242 PL---YPHFEPANLAEKFPNLEPAGV----------------DLLSQMLCLNPKQRITAM 282
           P    Y    P      FP L P  +                DLLS+ML ++P +RI+  
Sbjct: 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 306

Query: 283 DALKHEYL 290
           +AL+H Y+
Sbjct: 307 EALQHPYI 314

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  144 bits (366), Expect = 1e-41
 Identities = 63/219 (28%), Positives = 115/219 (52%), Gaps = 20/219 (9%)

Query: 10  KKIKKIGAGGYGEVYKCR----NTVTGQKVAIKMM----TIQTEQEGVPSYIIREVSLLK 61
              KK+G G +GEVYK +          +VA+K +    + Q  +E      +RE  +++
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEE-----FLREARIMR 56

Query: 62  ELEHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLA 120
           +L+H N+V+LL V +  + +++V EY++  DL S++ +++  L+L  + +   QI  G+ 
Sbjct: 57  KLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGME 116

Query: 121 YCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APEL 178
           Y  S   +HRDL   N L+  +   VK++DFGL+R +      Y +     P +  APE 
Sbjct: 117 YLESKNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLYD-DDYYRKRGGKLPIRWMAPES 174

Query: 179 LLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHL 216
           L     +++  DVW+ G +  E+ T G+  +P   ++ +
Sbjct: 175 LK-EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEV 212

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  146 bits (370), Expect = 3e-41
 Identities = 99/308 (32%), Positives = 160/308 (51%), Gaps = 38/308 (12%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           Y+++K IG+G  G V    +TV G  VA+K ++   + +       RE+ LLK + H+NI
Sbjct: 23  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82

Query: 69  VRLLDVQSSRK------DVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYC 122
           + LL+V + +K      DV+LV E +D +L   I  H   L+   +  +L Q+L G+ + 
Sbjct: 83  ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI--HME-LDHERMSYLLYQMLCGIKHL 139

Query: 123 HSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP------YKAP 176
           HS  I+HRDLKP+N+++     T+K+ DFGLAR           + + +P      Y+AP
Sbjct: 140 HSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTA-------CTNFMMTPYVVTRYYRAP 191

Query: 177 ELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAE-S 234
           E++LG  GY   +D+W+VGCI  E++ G  +F    H D  + +   LGTP+ E      
Sbjct: 192 EVILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ 250

Query: 235 TYISEILPLYPHFEPANLAEKFPNL------------EPAGVDLLSQMLCLNPKQRITAM 282
             +   +   P +   +  E FP+                  DLLS+ML ++P +RI+  
Sbjct: 251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVD 310

Query: 283 DALKHEYL 290
           +AL+H Y+
Sbjct: 311 EALRHPYI 318

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  143 bits (363), Expect = 5e-41
 Identities = 68/202 (33%), Positives = 101/202 (50%), Gaps = 10/202 (4%)

Query: 10  KKIKKIGAGGYGEVYKCR----NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEH 65
           +  KK+G G +GEVYK         T  KVA+K +     +E      + E S++K+L H
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREE-FLEEASIMKKLSH 60

Query: 66  ENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
            NIVRLL V +  + +++V EY+   DL  F+ +H   L L  +  +  QI  G+ Y  S
Sbjct: 61  PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLES 120

Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGY 182
              +HRDL   N L+  +   VK++DFGL+R I        R     P K  APE L   
Sbjct: 121 KNFVHRDLAARNCLVT-ENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLK-D 178

Query: 183 TGYSTPIDVWAVGCIFAEMITG 204
             +++  DVW+ G +  E+ T 
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTL 200

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  143 bits (362), Expect = 5e-41
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 21/220 (9%)

Query: 10  KKIKKIGAGGYGEVYKCR----NTVTGQKVAIKMM----TIQTEQEGVPSYIIREVSLLK 61
              KK+G G +GEVYK            +VA+K +    + Q  +E      +RE  +++
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEE-----FLREARIMR 56

Query: 62  ELEHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNT-LNLLVIKAILKQILLGL 119
           +L+H NIV+LL V +  + + +V EY+   DL  ++ +++   L+L  + +   QI  G+
Sbjct: 57  KLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGM 116

Query: 120 AYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APE 177
            Y  S   +HRDL   N L+  +   VK++DFGL+R +      Y       P +  APE
Sbjct: 117 EYLESKNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLY-DDDYYKVKGGKLPIRWMAPE 174

Query: 178 LLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHL 216
            L     +++  DVW+ G +  E+ T G+  +P   +  +
Sbjct: 175 SLK-EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEV 213

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score =  145 bits (367), Expect = 9e-41
 Identities = 102/306 (33%), Positives = 161/306 (52%), Gaps = 34/306 (11%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           Y+ +K IG+G  G V    + +  + VAIK ++   + +       RE+ L+K + H+NI
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85

Query: 69  VRLLDVQSSRK------DVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYC 122
           + LL+V + +K      DV++V E +D +L   I   +  L+   +  +L Q+L G+ + 
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHL 142

Query: 123 HSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGY 182
           HS  I+HRDLKP+N+++     T+K+ DFGLAR  G      +   V   Y+APE++LG 
Sbjct: 143 HSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG- 199

Query: 183 TGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAE-----STY 236
            GY   +D+W+VGCI  EMI G  LFP   H D  + +   LGTP  E   +      TY
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 259

Query: 237 ISEILPLYPHFEPANLAEKFPN-LEPA-----------GVDLLSQMLCLNPKQRITAMDA 284
           +       P +   +  + FP+ L PA             DLLS+ML ++  +RI+  +A
Sbjct: 260 VEN----RPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315

Query: 285 LKHEYL 290
           L+H Y+
Sbjct: 316 LQHPYI 321

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  138 bits (351), Expect = 3e-39
 Identities = 80/294 (27%), Positives = 136/294 (46%), Gaps = 41/294 (13%)

Query: 10  KKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIV 69
           +++K +G G  G VYK R+  TG+  A+K + +    E     ++RE+  L+  E   +V
Sbjct: 4   ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHV-DGDEEFRKQLLRELKTLRSCESPYVV 62

Query: 70  RLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS-LKI 127
           +         ++ +V EY+D   L   + +    +   V+  I +QIL GL Y H+   I
Sbjct: 63  KCYGAFYKEGEISIVLEYMDGGSLADLLKKVG-KIPEPVLAYIARQILKGLDYLHTKRHI 121

Query: 128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS-----PYKAPELLLGY 182
           +HRD+KP+NLLI+ K   VK+ADFG+++ +     E + D   +      Y +PE + G 
Sbjct: 122 IHRDIKPSNLLINSKGE-VKIADFGISKVL-----ENTLDQCNTFVGTVTYMSPERIQGE 175

Query: 183 TGYSTPIDVWAVGCIFAEMITGK-PLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEIL 241
           + YS   D+W++G    E   GK P  P  +     L+ ++   P       +   S   
Sbjct: 176 S-YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPS--LPAEEFS--- 229

Query: 242 PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVEN 295
              P F                 D +S  L  +PK+R +A + L+H ++   +N
Sbjct: 230 ---PEFR----------------DFISACLQKDPKKRPSAAELLQHPFIKKADN 264

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  138 bits (351), Expect = 4e-39
 Identities = 84/306 (27%), Positives = 133/306 (43%), Gaps = 59/306 (19%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMM-TIQTEQEGVPSYIIREVSLLKELE-H 65
           ++K  K IG G +  V   +   T ++ AIK++   Q  +E    Y+  E  +L  L  H
Sbjct: 2   DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGH 61

Query: 66  ENIVRLLDVQSSRKDVFLVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
             I++L       ++++ V EY  + +L  +I ++ + L+    +    +ILL L Y HS
Sbjct: 62  PGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS-LDEKCTRFYAAEILLALEYLHS 120

Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP------------ 172
             I+HRDLKP N+L+D K   +K+ DFG A+ +       S     +             
Sbjct: 121 KGIIHRDLKPENILLD-KDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRF 179

Query: 173 --------YKAPELLL-GYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLL 223
                   Y +PELL     G S+  D+WA+GCI  +M+TGKP F         L F   
Sbjct: 180 ASFVGTAEYVSPELLNEKPAGKSS--DLWALGCIIYQMLTGKPPFRGSNEY---LTFQK- 233

Query: 224 GTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITA-- 281
                        I ++   +P          FP   P   DL+ ++L L+P+ R+    
Sbjct: 234 -------------ILKLEYSFP--------PNFP---PDAKDLIEKLLVLDPQDRLGVNE 269

Query: 282 -MDALK 286
             D LK
Sbjct: 270 GYDELK 275

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  137 bits (347), Expect = 9e-39
 Identities = 79/272 (29%), Positives = 128/272 (47%), Gaps = 39/272 (14%)

Query: 15  IGAGGYGEVYKCRNTVTGQKVAIKMM---TIQTEQEGVPSYIIREVSLLKELEHENIVRL 71
           +G G +G+V   R   TG+  A+K++    I   +E    + + E ++L  + H  IV+L
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKE--VEHTLTERNILSRINHPFIVKL 58

Query: 72  LDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHR 130
                + + ++LV EY    +L S +   +   +    +    +I+L L Y HSL I++R
Sbjct: 59  HYAFQTEEKLYLVLEYAPGGELFSHL-SKEGRFSEERARFYAAEIVLALEYLHSLGIIYR 117

Query: 131 DLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPID 190
           DLKP N+L+D     +KL DFGLA+ +       +  C    Y APE+LLG  GY   +D
Sbjct: 118 DLKPENILLD-ADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLG-KGYGKAVD 175

Query: 191 VWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPA 250
            W++G +  EM+TGKP F ++       I+                   IL         
Sbjct: 176 WWSLGVLLYEMLTGKPPFYAEDRK---EIYEK-----------------IL--------- 206

Query: 251 NLAEKFP-NLEPAGVDLLSQMLCLNPKQRITA 281
               +FP  L P   DL+S +L  +P +R+ +
Sbjct: 207 KDPLRFPEFLSPEARDLISGLLQKDPTKRLGS 238

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  133 bits (338), Expect = 2e-37
 Identities = 86/286 (30%), Positives = 139/286 (48%), Gaps = 44/286 (15%)

Query: 12  IKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRL 71
           ++K+G G YG VYK  +  TGQ VAIK++ ++ + +     II+E+S+LK+ +   IV+ 
Sbjct: 8   LEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQE----IIKEISILKQCDSPYIVKY 63

Query: 72  LDVQSSRKDVFLVFEYLDLDLHSFITRHKN-TLNLLVIKAILKQILLGLAYCHSLKILHR 130
                   D+++V EY      S I +  N TL    I AIL Q L GL Y HS K +HR
Sbjct: 64  YGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHR 123

Query: 131 DLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVY-SPY-KAPELLLGYTGYSTP 188
           D+K  N+L++ +    KLADFG++  +     +  R+ V  +P+  APE++    GY+  
Sbjct: 124 DIKAGNILLN-EEGQAKLADFGVSGQLTDTMAK--RNTVIGTPFWMAPEVIQE-IGYNNK 179

Query: 189 IDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFE 248
            D+W++G    EM  GKP +                             S+I P+   F 
Sbjct: 180 ADIWSLGITAIEMAEGKPPY-----------------------------SDIHPMRAIFM 210

Query: 249 -PANLAEKFPNLE---PAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            P        + E   P   D + + L  +P++R +A+  L+H ++
Sbjct: 211 IPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  130 bits (329), Expect = 5e-36
 Identities = 80/274 (29%), Positives = 132/274 (48%), Gaps = 39/274 (14%)

Query: 15  IGAGGYGEVYKCRNTVTGQKVAIKMMT-IQTEQEGVPSYIIREVSLLKELEHENIVRLLD 73
           I  G YG V+  +   TG   AIK++      ++     ++ E  +L + +   +V+L  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 74  VQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDL 132
               +K+++LV EYL   DL S +  +  +L+  V +  + +I+L L Y HS  I+HRDL
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLL-ENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDL 119

Query: 133 KPNNLLIDLKRNTVKLADFGLA------RAIGVPQKEY-SRDCVYSP-YKAPELLLGYTG 184
           KP+N+LID     +KL DFGL+      R I +   E   +  V +P Y APE++LG  G
Sbjct: 120 KPDNILID-SNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG-QG 177

Query: 185 YSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLY 244
           +S  +D W++GCI  E + G P F    H             T E   ++    +I    
Sbjct: 178 HSKTVDWWSLGCILYEFLVGIPPF----HGE-----------TPEEIFQNILNGKIEW-- 220

Query: 245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQR 278
                     +   +    +DL+S++L  +P++R
Sbjct: 221 ---------PEDVEVSDEAIDLISKLLVPDPEKR 245

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  130 bits (329), Expect = 5e-36
 Identities = 88/291 (30%), Positives = 144/291 (49%), Gaps = 38/291 (13%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQ----TEQEGVPSYIIREVSLLKEL 63
            + K +++G G +   Y+ R+  TG  +A+K +T      +EQE V   + +E+ L+  L
Sbjct: 1   EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60

Query: 64  EHENIVRLL--DVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAY 121
            H +I+R+L    + S  ++F+  E++     S +          VI    +Q+L GL+Y
Sbjct: 61  NHPHIIRMLGATCEDSHFNLFV--EWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSY 118

Query: 122 CHSLKILHRDLKPNNLLIDLKRNTVKLADFGLA---RAIGVPQKEYSRDCVYS-PYKAPE 177
            H  +I+HRD+K  NLLID     +++ADFG A    A G    E+    + +  + APE
Sbjct: 119 LHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178

Query: 178 LLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTY 236
           +L G   Y    DVW+VGC+  EM T KP + ++KH +HL+LIF +         A +T 
Sbjct: 179 VLRGEQ-YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKI---------ASAT- 227

Query: 237 ISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH 287
                         ++ E   +L P   D+  + L L P+ R  + + LKH
Sbjct: 228 -----------TAPSIPE---HLSPGLRDVTLRCLELQPEDRPPSRELLKH 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  129 bits (327), Expect = 9e-36
 Identities = 84/289 (29%), Positives = 136/289 (47%), Gaps = 40/289 (13%)

Query: 15  IGAGGYGEVYKCRNTVTGQKVAIKMMTI-QTE-------QEGVPSYIIREVSLLKELEHE 66
           IG G YG VY   N  TG+ +A+K + +  T        Q+ +   +  E+  LK+L+H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 67  NIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
           NIV+ L  +++ + + +  EY+         R        +++   +Q+L GLAY HS  
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG 128

Query: 127 ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-----YKAPELLLG 181
           ILHRDLK +NLL+D      K++DFG+++        Y  D   S      + APE++  
Sbjct: 129 ILHRDLKADNLLVDAD-GICKISDFGISKK---SDDIYDNDQNMSMQGSVFWMAPEVIHS 184

Query: 182 Y-TGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEI 240
           Y  GYS  +D+W++GC+  EM  G+   P    + ++ +F  LG                
Sbjct: 185 YSQGYSAKVDIWSLGCVVLEMFAGRR--PWSDEEAIAAMFK-LGN-----------KRSA 230

Query: 241 LPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEY 289
            P+ P        +   NL P  +D L+    +NP  R TA + L+H +
Sbjct: 231 PPIPP--------DVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  128 bits (322), Expect = 4e-35
 Identities = 80/287 (27%), Positives = 133/287 (46%), Gaps = 36/287 (12%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIR---EVSLLKELE 64
           N+++ K +G G +G VY C +  TG+++A+K +    +       +     E+ LLK L+
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62

Query: 65  HENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCH 123
           HE IV+        + + +  EY+    +   +  +   L   V +   +QIL G+ Y H
Sbjct: 63  HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLH 121

Query: 124 SLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGV--PQKEYSRDCVYSPY-KAPELLL 180
           S  I+HRD+K  N+L D   N VKL DFG ++ +          +    +PY  +PE++ 
Sbjct: 122 SNMIVHRDIKGANILRDSAGN-VKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS 180

Query: 181 GYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEI 240
           G  GY    DVW+VGC   EM+T KP  P  + + ++ IF +   PT+            
Sbjct: 181 GE-GYGRKADVWSVGCTVVEMLTEKP--PWAEFEAMAAIFKIATQPTN------------ 225

Query: 241 LPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH 287
            P  P            ++ P   + L +    N K+R +A + L+H
Sbjct: 226 -PQLP-----------SHVSPDARNFLRRTFVENAKKRPSAEELLRH 260

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  125 bits (316), Expect = 3e-34
 Identities = 74/271 (27%), Positives = 128/271 (47%), Gaps = 38/271 (14%)

Query: 15  IGAGGYGEVYKCRNTVTGQKVAIKMMT----IQTEQEGVPSYIIREVSLLKELEHENIVR 70
           +G GG+G V   +     +  A+K +     ++T Q+    +I  E  +L+E  H  IV+
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQ---EHIFSEKEILEECNHPFIVK 57

Query: 71  LLDVQSSRKDVFLVFEY-LDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILH 129
           L      +K ++++ EY L  +L + + R +   +    +  +  ++L   Y H+  I++
Sbjct: 58  LYRTFKDKKYIYMLMEYCLGGELWTIL-RDRGLFDEYTARFYIACVVLAFEYLHNRGIIY 116

Query: 130 RDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPI 189
           RDLKP NLL+D     VKL DFG A+ +   QK ++  C    Y APE++L   GY   +
Sbjct: 117 RDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTF-CGTPEYVAPEIILN-KGYDFSV 173

Query: 190 DVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEIL-PLYPHFE 248
           D W++G +  E++TG+P F     D +                   Y ++IL        
Sbjct: 174 DYWSLGILLYELLTGRPPFGEDDEDPM-----------------EIY-NDILKGNGKLEF 215

Query: 249 PANLAEKFPNLEPAGVDLLSQMLCLNPKQRI 279
           P         ++ A  DL+ Q+L  NP++R+
Sbjct: 216 P-------NYIDKAAKDLIKQLLRRNPEERL 239

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  124 bits (314), Expect = 7e-34
 Identities = 61/209 (29%), Positives = 107/209 (51%), Gaps = 25/209 (11%)

Query: 13  KKIGAGGYGEVYKCR---NTVTGQKVAIKMM----TIQTEQEGVPSYIIREVSLLKELEH 65
           KK+G G +GEVYK +         +VA+K +    + +  ++      ++E  ++K+L H
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKD-----FLKEARVMKKLGH 55

Query: 66  ENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHK--------NTLNLLVIKAILKQIL 116
            N+VRLL V +  + ++LV EY++  DL  ++ + +        +TL+L  + +   QI 
Sbjct: 56  PNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIA 115

Query: 117 LGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK-- 174
            G+ Y  S K +HRDL   N L+  +   VK++DFGL+R +        +     P +  
Sbjct: 116 KGMEYLASKKFVHRDLAARNCLVG-EDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM 174

Query: 175 APELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           APE L     +++  DVW+ G +  E+ T
Sbjct: 175 APESLKDGI-FTSKSDVWSFGVLLWEIFT 202

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  122 bits (308), Expect = 2e-32
 Identities = 78/289 (26%), Positives = 135/289 (46%), Gaps = 32/289 (11%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQT-EQEGVPSYIIREVSLLKELEHEN 67
           ++ + ++G GGYG+V+  +   TG+ VA+K M      +     +++ E  +L   + E 
Sbjct: 3   FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62

Query: 68  IVRLLDVQSSRKDVFLVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
           +V+LL      + ++L  EY+   D  + +  +   L+    +  + ++   +   H L 
Sbjct: 63  LVKLLYAFQDDEYLYLAMEYVPGGDFRTLLN-NLGVLSEDHARFYMAEMFEAVDALHELG 121

Query: 127 ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGYTGY 185
            +HRDLKP N LID     +KL DFGL++ I      Y+   V SP Y APE+L G  GY
Sbjct: 122 YIHRDLKPENFLID-ASGHIKLTDFGLSKGI----VTYANSVVGSPDYMAPEVLRG-KGY 175

Query: 186 STPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYP 245
              +D W++GC+  E + G P F               G+  +E+W    Y  E L   P
Sbjct: 176 DFTVDYWSLGCMLYEFLCGFPPFS--------------GSTPNETWENLKYWKETLQ-RP 220

Query: 246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAM-DALKHEYLIGV 293
            ++         NL     DL+++++  +P +R  ++ D   H +   V
Sbjct: 221 VYDDPRF-----NLSDEAWDLITKLI-NDPSRRFGSLEDIKNHPFFKEV 263

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  118 bits (298), Expect = 1e-31
 Identities = 88/290 (30%), Positives = 139/290 (47%), Gaps = 41/290 (14%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           Y+ I++IG+G YG+VYK R+  TG+ VAIK++ +    +     I +E+S+LKE  H NI
Sbjct: 5   YELIQRIGSGTYGDVYKARDIATGELVAIKVIKL-EPGDDF-EIIQQEISMLKECRHPNI 62

Query: 69  VRLLDVQSSRKDVFLVFEY-----LDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCH 123
           V        R  +++V EY     L  D++  +TR    L+ L I  + ++ L GLAY H
Sbjct: 63  VAYFGSYLRRDKLWIVMEYCGGGSLQ-DIYQ-VTRG--PLSELQIAYVCRETLKGLAYLH 118

Query: 124 SLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP-QKEYSRDCVYSPY-KAPELLL- 180
               +HRD+K  N+L+  +   VKLADFG++  +     K  S   + +PY  APE+   
Sbjct: 119 ETGKIHRDIKGANILLT-EDGDVKLADFGVSAQLTATIAKRKS--FIGTPYWMAPEVAAV 175

Query: 181 -GYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISE 239
               GY    D+WA+G    E+   +P  P      +  +F                   
Sbjct: 176 ERKGGYDGKCDIWALGITAIELAELQP--PMFDLHPMRALF------------------- 214

Query: 240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEY 289
           ++    +F P  L +K     P   D + + L  +PK+R TA   L+H +
Sbjct: 215 LIS-KSNFPPPKLKDK-EKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score =  122 bits (307), Expect = 7e-31
 Identities = 94/316 (29%), Positives = 155/316 (49%), Gaps = 60/316 (18%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           Y+ IKKIG G +GEV+  ++  T +    K ++ +  +E   S ++ EV++++EL+H+NI
Sbjct: 15  YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNI 74

Query: 69  VRLLD--VQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLL---VIKAILKQILLGLAYC 122
           VR +D  +  + + ++++ E+ D  DL   I +       +    I  I +Q+L  LAYC
Sbjct: 75  VRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYC 134

Query: 123 HSLK-------ILHRDLKPNNLLIDL----------------KRNTVKLADFGLARAIGV 159
           H+LK       +LHRDLKP N+ +                   R   K+ DFGL++ IG+
Sbjct: 135 HNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGI 194

Query: 160 PQKEYSRDCVYSPYK-APELLLGYT-GYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLS 217
               +S  CV +PY  +PELLL  T  Y    D+WA+GCI  E+ +GK   P  K ++ S
Sbjct: 195 ESMAHS--CVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT--PFHKANNFS 250

Query: 218 LIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQ 277
            + S L    D            LP+    +  N+             L+  +L L+ K+
Sbjct: 251 QLISELKRGPD------------LPIKGKSKELNI-------------LIKNLLNLSAKE 285

Query: 278 RITAMDALKHEYLIGV 293
           R +A+  L ++ +  V
Sbjct: 286 RPSALQCLGYQIIKNV 301

Length = 1021

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  115 bits (289), Expect = 2e-30
 Identities = 81/278 (29%), Positives = 127/278 (45%), Gaps = 44/278 (15%)

Query: 12  IKKIGAGGYGEVYKCRNTVTGQKVAIKMM----TIQTEQEGVPSYIIREVSLLKELEHEN 67
           +K I  G +G VY  +   TG   AIK++     I   Q  V +       ++ + E   
Sbjct: 1   LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQ--VTNVKAERAIMMIQGESPY 58

Query: 68  IVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
           + +L     S+  ++LV EYL+  D  S I +    L     K  + +++LG+   H   
Sbjct: 59  VAKLYYSFQSKDYLYLVMEYLNGGDCASLI-KTLGGLPEDWAKQYIAEVVLGVEDLHQRG 117

Query: 127 ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGYTGY 185
           I+HRD+KP NLLID +   +KL DFGL+R         ++  V +P Y APE +LG  G 
Sbjct: 118 IIHRDIKPENLLID-QTGHLKLTDFGLSRNG-----LENKKFVGTPDYLAPETILG-VGD 170

Query: 186 STPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWA--ESTYISEILPL 243
               D W++GC+  E + G P F +              TP D  +    S  I+     
Sbjct: 171 DKMSDWWSLGCVIFEFLFGYPPFHA-------------ETP-DAVFDNILSRRIN----- 211

Query: 244 YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITA 281
           +P        E      P  VDL++++LC++P +R+ A
Sbjct: 212 WP-------EEVKEFCSPEAVDLINRLLCMDPAKRLGA 242

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  114 bits (288), Expect = 5e-30
 Identities = 81/291 (27%), Positives = 136/291 (46%), Gaps = 34/291 (11%)

Query: 10  KKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQ-EGVPSYIIREVSLLKELEHENI 68
           + + ++GAG  G V K  +  TG+ +A+K  TI+ E  E +   I+RE+ +L +     I
Sbjct: 4   EYLGELGAGNSGVVSKVLHRPTGKIMAVK--TIRLEINEAIQKQILRELDILHKCNSPYI 61

Query: 69  VRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS-LK 126
           V       +  D+ +  EY+D   L   +   +  +   ++  I   +L GL Y H   K
Sbjct: 62  VGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK 121

Query: 127 ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYS 186
           I+HRD+KP+N+L++  R  +KL DFG++  +     +       S Y APE + G   YS
Sbjct: 122 IIHRDVKPSNILVN-SRGQIKLCDFGVSGQLVNSLAKTFVGT--SSYMAPERIQG-NDYS 177

Query: 187 TPIDVWAVGCIFAEMITGKPLFPSKKHDHLSL-IFSLLGTPTDESWAESTYI-SEILPLY 244
              D+W++G    E+ TG+  FP    +     IF LL            YI +E  P  
Sbjct: 178 VKSDIWSLGLSLIELATGR--FPYPPENDPPDGIFELL-----------QYIVNEPPPRL 224

Query: 245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVEN 295
           P       + KF    P   D ++  L  +P++R +  + L+H ++   E+
Sbjct: 225 P-------SGKFS---PDFQDFVNLCLIKDPRERPSYKELLEHPFIKKYES 265

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  113 bits (285), Expect = 9e-30
 Identities = 75/292 (25%), Positives = 132/292 (45%), Gaps = 43/292 (14%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQ--TEQEGVPSYIIREVSLLKELEH 65
           +++ ++ IG G +G+V   +   T +  A+K M  Q   E+  V + ++ E  +L+EL H
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRN-VLNERRILQELNH 59

Query: 66  ENIVRLLDVQSSRKDVFLVFEYL---DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYC 122
             +V L       ++++LV + L   DL  H      K   +   +K  + +I+L L Y 
Sbjct: 60  PFLVNLWYSFQDEENMYLVVDLLLGGDLRYH---LSQKVKFSEEQVKFWICEIVLALEYL 116

Query: 123 HSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLG 181
           HS  I+HRD+KP+N+L+D ++  V + DF +A    V     +     +P Y APE+L  
Sbjct: 117 HSKGIIHRDIKPDNILLD-EQGHVHITDFNIATK--VTPDTLTTSTSGTPGYMAPEVLCR 173

Query: 182 YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEIL 241
             GYS  +D W++G    E + GK   P + H                     T   +I 
Sbjct: 174 Q-GYSVAVDWWSLGVTAYECLRGKR--PYRGHS-------------------RTIRDQIR 211

Query: 242 PLYPHFEPANLAEKFPNLEP-AGVDLLSQMLCLNPKQRIT-AMDALK-HEYL 290
                 +       +P       +D ++++L  +P++R+   +  LK H Y 
Sbjct: 212 ----AKQETA-DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  114 bits (286), Expect = 1e-29
 Identities = 75/282 (26%), Positives = 135/282 (47%), Gaps = 38/282 (13%)

Query: 13  KKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLL 72
            KIG G  G V    +  TG++VA+K M ++ +Q      +  EV ++++ +H NIV + 
Sbjct: 25  VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQR--RELLFNEVVIMRDYQHPNIVEMY 82

Query: 73  DVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDL 132
                  ++++V E+L+    + I  H   +N   I  +   +L  L++ H+  ++HRD+
Sbjct: 83  SSYLVGDELWVVMEFLEGGALTDIVTHTR-MNEEQIATVCLAVLKALSFLHAQGVIHRDI 141

Query: 133 KPNNLLIDLKRN-TVKLADFGLARAIG--VPQKEYSRDCVYSPY-KAPELLLGYTGYSTP 188
           K +++L  L  +  VKL+DFG    +   VP++   +  V +PY  APE ++    Y T 
Sbjct: 142 KSDSIL--LTSDGRVKLSDFGFCAQVSKEVPRR---KSLVGTPYWMAPE-VISRLPYGTE 195

Query: 189 IDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFE 248
           +D+W++G +  EM+ G+P +           F+      +        I + LP  P  +
Sbjct: 196 VDIWSLGIMVIEMVDGEPPY-----------FN------EPPLQAMKRIRDNLP--PKLK 236

Query: 249 PANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
             +       + P     L +ML  +P QR TA + L H +L
Sbjct: 237 NLH------KVSPRLRSFLDRMLVRDPAQRATAAELLNHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  114 bits (286), Expect = 1e-29
 Identities = 82/284 (28%), Positives = 141/284 (49%), Gaps = 34/284 (11%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           Y + +KIG G  G VY   +  TGQ+VAIK M +Q  Q+     II E+ +++E +H NI
Sbjct: 21  YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKHPNI 78

Query: 69  VRLLDVQSSRKDVFLVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
           V  LD      ++++V EYL    L   +T  +  ++   I A+ ++ L  L + HS ++
Sbjct: 79  VNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQV 136

Query: 128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY-KAPELLLGYTGYS 186
           +HRD+K +N+L+ +   +VKL DFG    I  P++      V +PY  APE++     Y 
Sbjct: 137 IHRDIKSDNILLGMD-GSVKLTDFGFCAQI-TPEQSKRSTMVGTPYWMAPEVVT-RKAYG 193

Query: 187 TPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPH 246
             +D+W++G +  EM+ G+P  P    + L  ++ +    T              P   +
Sbjct: 194 PKVDIWSLGIMAIEMVEGEP--PYLNENPLRALYLIATNGT--------------PELQN 237

Query: 247 FEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            E          L     D L++ L ++ ++R +A + L+H +L
Sbjct: 238 PE---------KLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  113 bits (284), Expect = 2e-29
 Identities = 77/291 (26%), Positives = 137/291 (47%), Gaps = 46/291 (15%)

Query: 15  IGAGGYGEVYKCRNTVTGQKVAIKMMTIQT-------EQEGVPSYIIREVSLLKELEHEN 67
           IG+G +G VY   N  +G+ +A+K + + +        +  +   + RE++LLKEL+HEN
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
           IV+ L        + +  EY+     + +  +       +++  ++QIL GL Y H+  I
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGI 127

Query: 128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIGV--------PQKEYSRDCVYSPYKAPELL 179
           +HRD+K  N+L+D K   +K++DFG+++ +            +   +  V+  + APE +
Sbjct: 128 IHRDIKGANILVDNK-GGIKISDFGISKKLEANSLSTKTNGARPSLQGSVF--WMAPE-V 183

Query: 180 LGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISE 239
           +  T Y+   D+W++GC+  EM+TGK  FP      L  IF +                 
Sbjct: 184 VKQTSYTRKADIWSLGCLVVEMLTGKHPFP--DCTQLQAIFKIGE--------------N 227

Query: 240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
             P  P            N+    +D L +   ++  +R TA + LKH +L
Sbjct: 228 ASPEIPS-----------NISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  112 bits (281), Expect = 3e-29
 Identities = 69/206 (33%), Positives = 106/206 (51%), Gaps = 10/206 (4%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y+KI+ +G G +G V+ CR     + V IK + ++   +        E  +LK L H N
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 68  IVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILK---QILLGLAYCH 123
           I+   +     K + +V EY     L  +I +  N+L  L    IL    QILL L + H
Sbjct: 61  IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSL--LDEDTILHFFVQILLALHHVH 118

Query: 124 SLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGY 182
           +  ILHRDLK  N+L+D  +  VK+ DFG+++ +    K Y+   V +P Y +PEL  G 
Sbjct: 119 TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYISPELCEGK 176

Query: 183 TGYSTPIDVWAVGCIFAEMITGKPLF 208
             Y+   D+WA+GC+  E+ + K  F
Sbjct: 177 P-YNQKSDIWALGCVLYELASLKRAF 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  112 bits (282), Expect = 3e-29
 Identities = 68/206 (33%), Positives = 103/206 (50%), Gaps = 21/206 (10%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIK------MMTIQTEQEGVPSYIIREVSLLK 61
           N+K  KKIG G +  VYK    + G+ VA+K      MM  +  Q+      ++E+ LLK
Sbjct: 3   NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQD-----CLKEIDLLK 57

Query: 62  ELEHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILK---QILL 117
           +L+H N+++ L       ++ +V E  D  DL   I   K    L+  + I K   Q+  
Sbjct: 58  QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS 117

Query: 118 GLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE-YSRDCVYSP-YKA 175
            L + HS +I+HRD+KP N+ I      VKL D GL R         +S   V +P Y +
Sbjct: 118 ALEHMHSKRIMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSL--VGTPYYMS 174

Query: 176 PELLLGYTGYSTPIDVWAVGCIFAEM 201
           PE +    GY+   D+W++GC+  EM
Sbjct: 175 PERIHE-NGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  112 bits (282), Expect = 4e-29
 Identities = 84/301 (27%), Positives = 142/301 (47%), Gaps = 42/301 (13%)

Query: 12  IKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRL 71
           I ++G G +G+VYK ++  TG   A K++ I++E+E +  +++ E+ +L E +H NIV L
Sbjct: 10  IGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEE-LEDFMV-EIDILSECKHPNIVGL 67

Query: 72  LDVQSSRKDVFLVFEYLD---LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKIL 128
            +       ++++ E+ D   LD  S +   +  L    I+ + +Q+L  L + HS K++
Sbjct: 68  YEAYFYENKLWILIEFCDGGALD--SIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVI 125

Query: 129 HRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY-KAPELLLGYTGYST 187
           HRDLK  N+L+ L    VKLADFG++ A      +     + +PY  APE++   T    
Sbjct: 126 HRDLKAGNILLTLD-GDVKLADFGVS-AKNKSTLQKRDTFIGTPYWMAPEVVACETFKDN 183

Query: 188 P----IDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPL 243
           P     D+W++G    E+   +P      H  L+ +  LL     E              
Sbjct: 184 PYDYKADIWSLGITLIELAQMEP-----PHHELNPMRVLLKILKSEP------------- 225

Query: 244 YPHFE-PANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV-ENVPLVIL 301
            P  + P+  +  F        D L   L  +P  R TA + LKH ++    +N  +  L
Sbjct: 226 -PTLDQPSKWSSSFN-------DFLKSCLVKDPDDRPTAAELLKHPFVSDQSDNKAIKDL 277

Query: 302 L 302
           L
Sbjct: 278 L 278

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  112 bits (281), Expect = 7e-29
 Identities = 69/208 (33%), Positives = 110/208 (52%), Gaps = 17/208 (8%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTV----TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL 63
           + K IK++G G +G+V  CR       TG++VA+K +    E E   S   RE+ +L+ L
Sbjct: 5   HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE-EQHRSDFEREIEILRTL 63

Query: 64  EHENIVRLLDVQSS--RKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLA 120
           +HENIV+   V      + + L+ EYL    L  ++ RH++ +NL  +     QI  G+ 
Sbjct: 64  DHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMD 123

Query: 121 YCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE---YSRDCVYSP--YKA 175
           Y  S + +HRDL   N+L++   + VK++DFGLA+ +  P+ +   Y ++   SP  + A
Sbjct: 124 YLGSQRYIHRDLAARNILVE-SEDLVKISDFGLAKVL--PEDKDYYYVKEPGESPIFWYA 180

Query: 176 PELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           PE L      S   DVW+ G    E+ T
Sbjct: 181 PECLRTSKFSSAS-DVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  111 bits (280), Expect = 8e-29
 Identities = 83/313 (26%), Positives = 137/313 (43%), Gaps = 55/313 (17%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           +  ++ IG G +GEVYK  +  T Q VAIK++ ++  ++ +   I +E+  L +     I
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEI-EDIQQEIQFLSQCRSPYI 61

Query: 69  VRLLDVQSSRKDVFL--VFEYLD----LDLHSFITRHKNTLNLLVIKAILKQILLGLAYC 122
            +     S  K   L  + EY      LDL          L+   I  IL+++LLGL Y 
Sbjct: 62  TKYYG--SFLKGSKLWIIMEYCGGGSCLDL-----LKPGKLDETYIAFILREVLLGLEYL 114

Query: 123 HSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY-KAPELLLG 181
           H    +HRD+K  N+L+  +   VKLADFG++  +     +     V +P+  APE++  
Sbjct: 115 HEEGKIHRDIKAANILLS-EEGDVKLADFGVSGQLTSTMSK-RNTFVGTPFWMAPEVIKQ 172

Query: 182 YTGYSTPIDVWAVGCIFAEMITGKP----LFPSKKHDHLSLIFSLLGTPTDESWAESTYI 237
            +GY    D+W++G    E+  G+P    L P +                          
Sbjct: 173 -SGYDEKADIWSLGITAIELAKGEPPLSDLHPMR-------------------------- 205

Query: 238 SEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL---IGVE 294
             +L L P   P +L            D +S  L  +PK+R +A + LKH+++       
Sbjct: 206 --VLFLIPKNNPPSLEG--NKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKKTS 261

Query: 295 NVPLVILLINRKK 307
            + L+I  I + K
Sbjct: 262 YLTLLIERIKKWK 274

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  111 bits (279), Expect = 9e-29
 Identities = 87/306 (28%), Positives = 145/306 (47%), Gaps = 42/306 (13%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEH--- 65
           Y++++ IG G YG VY+ ++  TG+ VA+K++ + T  + V S I REV+LL +L     
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDV-SDIQREVALLSQLRQSQP 61

Query: 66  ENIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHS 124
            NI +          ++++ EY +    S  T  K   +    I  I++++L+ L Y H 
Sbjct: 62  PNITKYYGSYLKGPRLWIIMEYAEGG--SVRTLMKAGPIAEKYISVIIREVLVALKYIHK 119

Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY-KAPELLLGYT 183
           + ++HRD+K  N+L+    N VKL DFG+A  +     + S   V +PY  APE++    
Sbjct: 120 VGVIHRDIKAANILVTNTGN-VKLCDFGVAALLNQNSSKRS-TFVGTPYWMAPEVITEGK 177

Query: 184 GYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPL 243
            Y T  D+W++G    EM TG P  P    D    +                       L
Sbjct: 178 YYDTKADIWSLGITIYEMATGNP--PYSDVDAFRAMM----------------------L 213

Query: 244 YPHFEPANLAEKFPNLEPAGVDLLSQMLCLN--PKQRITAMDALKHEYLIGVENVPLVIL 301
            P  +P  L +          + ++   CL+  PK+R++A + LK +++      P+ IL
Sbjct: 214 IPKSKPPRLEDN--GYSKLLREFVA--ACLDEEPKERLSAEELLKSKWIKAHSKTPVSIL 269

Query: 302 --LINR 305
             LI+R
Sbjct: 270 KELISR 275

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  109 bits (273), Expect = 4e-28
 Identities = 63/204 (30%), Positives = 100/204 (49%), Gaps = 6/204 (2%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
           +++ + KIG G +G V+K       +  A+K + +           I E  +L +L+   
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 68  IVRLLDVQSSRKDVFLVFEYL-DLDLHSFI-TRHKNTLNLLVIKAILKQILLGLAYCHSL 125
           I+R  +    +  + +V EY  + DLH  +  +    L    +     QILLGLA+ HS 
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120

Query: 126 KILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK-APELLLGYTG 184
           KILHRD+K  NL +D   + VK+ D G+A+ +      ++   V +PY  +PEL      
Sbjct: 121 KILHRDIKSLNLFLD-AYDNVKIGDLGVAKLLS-DNTNFANTIVGTPYYLSPELCED-KP 177

Query: 185 YSTPIDVWAVGCIFAEMITGKPLF 208
           Y+   DVWA+G +  E  TGK  F
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHPF 201

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  109 bits (276), Expect = 5e-28
 Identities = 66/217 (30%), Positives = 111/217 (51%), Gaps = 36/217 (16%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMT----IQTEQEGVPSYIIREVSLLKEL 63
           +++ IK +G G +G V   R+  +G+  A+K+++    ++ +Q     +++ E  +L+ +
Sbjct: 2   DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQV---EHVLNEKRILQSI 58

Query: 64  EHENIVRLLDVQSSRKD---VFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGL 119
            H  +V L     S +D   ++LV EY+   +L S + R        V +    Q++L L
Sbjct: 59  RHPFLVNLY---GSFQDDSNLYLVMEYVPGGELFSHL-RKSGRFPEPVARFYAAQVVLAL 114

Query: 120 AYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAI--------GVPQKEYSRDCVYS 171
            Y HSL I++RDLKP NLL+D     +K+ DFG A+ +        G P+          
Sbjct: 115 EYLHSLDIVYRDLKPENLLLD-SDGYIKITDFGFAKRVKGRTYTLCGTPE---------- 163

Query: 172 PYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
            Y APE++L   GY   +D WA+G +  EM+ G P F
Sbjct: 164 -YLAPEIILS-KGYGKAVDWWALGILIYEMLAGYPPF 198

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  109 bits (274), Expect = 6e-28
 Identities = 81/284 (28%), Positives = 145/284 (51%), Gaps = 34/284 (11%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           Y + +KIG G  G VY   +  TGQ+VAI+ M +Q  Q+     II E+ +++E ++ NI
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMRENKNPNI 79

Query: 69  VRLLDVQSSRKDVFLVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
           V  LD      ++++V EYL    L   +T  +  ++   I A+ ++ L  L + HS ++
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQV 137

Query: 128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY-KAPELLLGYTGYS 186
           +HRD+K +N+L+ +   +VKL DFG    I  P++      V +PY  APE++     Y 
Sbjct: 138 IHRDIKSDNILLGMD-GSVKLTDFGFCAQI-TPEQSKRSTMVGTPYWMAPEVVT-RKAYG 194

Query: 187 TPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPH 246
             +D+W++G +  EMI G+P + ++       + +  GTP  ++                
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN---------------- 238

Query: 247 FEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
             P  L+  F        D L++ L ++ ++R +A + L+H++L
Sbjct: 239 --PEKLSAIFR-------DFLNRCLDMDVEKRGSAKELLQHQFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  108 bits (272), Expect = 7e-28
 Identities = 66/216 (30%), Positives = 109/216 (50%), Gaps = 10/216 (4%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
           ++K +KK+G G YG VYK +     Q  A+K + + +  +      + E+ +L  + H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 68  IVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLL---VIKAILKQILLGLAYCH 123
           I+   +       + +V EY    DL   I++ K    L+    I  I  Q+L GL   H
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 124 SLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGY 182
             KILHRDLK  N+L+ +  + VK+ D G+++ +   +K  ++  + +P Y APE+  G 
Sbjct: 121 EQKILHRDLKSANILL-VANDLVKIGDLGISKVL---KKNMAKTQIGTPHYMAPEVWKG- 175

Query: 183 TGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSL 218
             YS   D+W++GC+  EM T  P F ++    L  
Sbjct: 176 RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRY 211

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  109 bits (273), Expect = 8e-28
 Identities = 80/298 (26%), Positives = 145/298 (48%), Gaps = 36/298 (12%)

Query: 14  KIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLD 73
           KIG G  G V   R   +G++VA+KMM ++ +Q      +  EV ++++ +H+N+V +  
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQR--RELLFNEVVIMRDYQHQNVVEMYK 85

Query: 74  VQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLK 133
                ++++++ E+L     + I   +  LN   I  + + +L  L Y HS  ++HRD+K
Sbjct: 86  SYLVGEELWVLMEFLQGGALTDIVS-QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIK 144

Query: 134 PNNLLIDLKRNTVKLADFGLARAIG--VPQKEYSRDCVYSPY-KAPELLLGYTGYSTPID 190
            +++L+ L    VKL+DFG    I   VP++   +  V +PY  APE++   T Y T +D
Sbjct: 145 SDSILLTLD-GRVKLSDFGFCAQISKDVPKR---KSLVGTPYWMAPEVI-SRTPYGTEVD 199

Query: 191 VWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPA 250
           +W++G +  EM+ G+P + S              +P          +  +  L     P 
Sbjct: 200 IWSLGIMVIEMVDGEPPYFSD-------------SP----------VQAMKRLRD--SPP 234

Query: 251 NLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLINRKKK 308
              +    + P   D L +ML   P++R TA + L H +L+       ++ LI + +K
Sbjct: 235 PKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPECLVPLIQQYRK 292

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  109 bits (275), Expect = 1e-27
 Identities = 81/289 (28%), Positives = 140/289 (48%), Gaps = 40/289 (13%)

Query: 11  KIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVR 70
           ++ +IG+G  G VYK  +  TG+  A+K++    E + V   I RE+ +L+++ H N+V+
Sbjct: 78  RVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHE-DTVRRQICREIEILRDVNHPNVVK 136

Query: 71  LLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHR 130
             D+     ++ ++ E++D    S    H      L   A  +QIL G+AY H   I+HR
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGG--SLEGTHIADEQFLADVA--RQILSGIAYLHRRHIVHR 192

Query: 131 DLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPE-----LLLG-YTG 184
           D+KP+NLLI+  +N VK+ADFG++R +       +       Y +PE     L  G Y G
Sbjct: 193 DIKPSNLLINSAKN-VKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDG 251

Query: 185 YSTPIDVWAVGCIFAEMITGK-PLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPL 243
           Y+   D+W++G    E   G+ P    ++ D  SL+ ++  +   E+             
Sbjct: 252 YAG--DIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEA------------- 296

Query: 244 YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIG 292
                PA  + +F +        +S  L   P +R +AM  L+H +++ 
Sbjct: 297 -----PATASREFRH-------FISCCLQREPAKRWSAMQLLQHPFILR 333

Length = 353

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  108 bits (272), Expect = 2e-27
 Identities = 93/314 (29%), Positives = 145/314 (46%), Gaps = 44/314 (14%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVP-SYIIREVSLLKELEHEN 67
           +  +++IG G +G VY  R+  T + VAIK M+   +Q       II+EV  L++L H N
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
            +            +LV EY        +  HK  L  + I AI    L GLAY HS + 
Sbjct: 77  TIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHER 136

Query: 128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY-KAPELLLGYT--G 184
           +HRD+K  N+L+  +  TVKLADFG A ++  P   +    V +PY  APE++L      
Sbjct: 137 IHRDIKAGNILLT-EPGTVKLADFGSA-SLVSPANSF----VGTPYWMAPEVILAMDEGQ 190

Query: 185 YSTPIDVWAVGCIFAEMITGK-PLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPL 243
           Y   +DVW++G    E+   K PLF      +++ + +L     ++S             
Sbjct: 191 YDGKVDVWSLGITCIELAERKPPLF------NMNAMSALYHIAQNDS------------- 231

Query: 244 YPHFEPANLAEKFPNLEPAGVDLLSQMLCLN--PKQRITAMDALKHEYLIGVENVPLVIL 301
            P     + ++ F N     VD      CL   P+ R ++ + LKH +++      ++I 
Sbjct: 232 -PTLSSNDWSDYFRNF----VD-----SCLQKIPQDRPSSEELLKHRFVLRERPPTVIID 281

Query: 302 LINRKKK--LGVDN 313
           LI R K     +DN
Sbjct: 282 LIQRTKDAVRELDN 295

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  106 bits (266), Expect = 5e-27
 Identities = 72/201 (35%), Positives = 104/201 (51%), Gaps = 12/201 (5%)

Query: 15  IGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDV 74
           +G G YG VY  R+  T  ++AIK +  +  +   P  +  E++L   L+H NIV+ L  
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQP--LHEEIALHSYLKHRNIVQYLG- 72

Query: 75  QSSRKDVFLVF-EYLDLDLHSFITRHK---NTLNLLVIKAILKQILLGLAYCHSLKILHR 130
             S    F +F E +     S + R K      N   I    KQIL GL Y H  +I+HR
Sbjct: 73  SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHR 132

Query: 131 DLKPNNLLIDLKRNTVKLADFGLA-RAIGV-PQKEYSRDCVYSPYKAPELL-LGYTGYST 187
           D+K +N+L++     VK++DFG + R  G+ P  E     +   Y APE++  G  GY  
Sbjct: 133 DIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTL--QYMAPEVIDKGPRGYGA 190

Query: 188 PIDVWAVGCIFAEMITGKPLF 208
           P D+W++GC   EM TGKP F
Sbjct: 191 PADIWSLGCTIVEMATGKPPF 211

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  106 bits (265), Expect = 1e-26
 Identities = 81/284 (28%), Positives = 145/284 (51%), Gaps = 34/284 (11%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           Y + +KIG G  G V+   +  TGQ+VAIK + +Q + +     II E+ ++KEL++ NI
Sbjct: 21  YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPK--KELIINEILVMKELKNPNI 78

Query: 69  VRLLDVQSSRKDVFLVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
           V  LD      ++F+V EYL    L   +T  +  ++   I A+ ++ L  L + H+ ++
Sbjct: 79  VNFLDSFLVGDELFVVMEYLAGGSLTDVVT--ETCMDEAQIAAVCRECLQALEFLHANQV 136

Query: 128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY-KAPELLLGYTGYS 186
           +HRD+K +N+L+ +   +VKL DFG    I  P++      V +PY  APE++     Y 
Sbjct: 137 IHRDIKSDNVLLGMD-GSVKLTDFGFCAQI-TPEQSKRSTMVGTPYWMAPEVVT-RKAYG 193

Query: 187 TPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPH 246
             +D+W++G +  EM+ G+P + ++       + +  GTP  ++                
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQN---------------- 237

Query: 247 FEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                  EK   L P   D L++ L ++ ++R +A + L+H +L
Sbjct: 238 ------PEK---LSPIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  105 bits (265), Expect = 1e-26
 Identities = 61/209 (29%), Positives = 112/209 (53%), Gaps = 20/209 (9%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTI-------QTEQEGVPSYIIREVSLL 60
           + ++IK +G G +G V+  R+ ++    A+K+M I       Q +      ++  E  +L
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQ------HVHNEKRVL 55

Query: 61  KELEHENIVRLLDVQSSRKDVFLVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQILLGL 119
           KE+ H  I+RL   +  ++ ++++ EY+   +L S++ R+    +         +I+  L
Sbjct: 56  KEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYL-RNSGRFSNSTGLFYASEIVCAL 114

Query: 120 AYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELL 179
            Y HS +I++RDLKP N+L+D K   +KL DFG A+   +  + ++  C    Y APE +
Sbjct: 115 EYLHSKEIVYRDLKPENILLD-KEGHIKLTDFGFAKK--LRDRTWTL-CGTPEYLAPE-V 169

Query: 180 LGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
           +   G++  +D WA+G +  EM+ G P F
Sbjct: 170 IQSKGHNKAVDWWALGILIYEMLVGYPPF 198

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  105 bits (264), Expect = 2e-26
 Identities = 81/284 (28%), Positives = 143/284 (50%), Gaps = 34/284 (11%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           Y + +KIG G  G VY   +  TGQ+VAIK M +Q  Q+     II E+ +++E ++ NI
Sbjct: 21  YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKNPNI 78

Query: 69  VRLLDVQSSRKDVFLVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
           V  LD      ++++V EYL    L   +T  +  ++   I A+ ++ L  L + HS ++
Sbjct: 79  VNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALDFLHSNQV 136

Query: 128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY-KAPELLLGYTGYS 186
           +HRD+K +N+L+ +   +VKL DFG    I  P++      V +PY  APE++     Y 
Sbjct: 137 IHRDIKSDNILLGMD-GSVKLTDFGFCAQI-TPEQSKRSTMVGTPYWMAPEVVT-RKAYG 193

Query: 187 TPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPH 246
             +D+W++G +  EM+ G+P + ++       + +  GTP  ++                
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQN---------------- 237

Query: 247 FEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
             P  L+  F        D L++ L ++  +R +A + L+H +L
Sbjct: 238 --PERLSAVFR-------DFLNRCLEMDVDRRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  105 bits (262), Expect = 2e-26
 Identities = 67/213 (31%), Positives = 99/213 (46%), Gaps = 3/213 (1%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y+ IKKIG G +G++Y  +     +   IK + +            +EV LL +++H N
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 68  IVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTL-NLLVIKAILKQILLGLAYCHSL 125
           IV           +F+V EY D  DL   I R +  L +   I +   QI LGL + H  
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120

Query: 126 KILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGY 185
           KILHRD+K  N+ +       KL DFG+AR +     E +  CV +PY     +     Y
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSMELAYTCVGTPYYLSPEICQNRPY 179

Query: 186 STPIDVWAVGCIFAEMITGKPLFPSKKHDHLSL 218
           +   D+W++GC+  E+ T K  F       L L
Sbjct: 180 NNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVL 212

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  104 bits (261), Expect = 2e-26
 Identities = 69/215 (32%), Positives = 110/215 (51%), Gaps = 10/215 (4%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           Y K+KKIG G +G+    ++   G++  IK + I            +EV++L  ++H NI
Sbjct: 2   YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61

Query: 69  VRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILK---QILLGLAYCHS 124
           V+  +      ++++V +Y +  DL+  I   +  L       IL    QI L L + H 
Sbjct: 62  VQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVL--FPEDQILDWFVQICLALKHVHD 119

Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK-APELLLGYT 183
            KILHRD+K  N+ +  K  T+KL DFG+AR +     E +R C+ +PY  +PE+     
Sbjct: 120 RKILHRDIKSQNIFL-TKDGTIKLGDFGIARVLN-STVELARTCIGTPYYLSPEICENRP 177

Query: 184 GYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSL 218
            Y+   D+WA+GC+  EM T K  F +    +L L
Sbjct: 178 -YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVL 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  104 bits (262), Expect = 2e-26
 Identities = 86/286 (30%), Positives = 130/286 (45%), Gaps = 38/286 (13%)

Query: 15  IGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQ----EGVPSYIIREVSLLKELEHENIVR 70
           +G G YG VY C  T  GQ +A+K + + T      E     +  EV LLK L+H NIV+
Sbjct: 8   LGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66

Query: 71  LLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHR 130
            L        + +  E++     S I      L   V     KQIL G+AY H+  ++HR
Sbjct: 67  YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHR 126

Query: 131 DLKPNNLLIDLKRNTVKLADFGLARAIG-----VPQKEYSRDCVYSPY-KAPELLLGYTG 184
           D+K NN+++ +    +KL DFG AR +             +    +PY  APE++   +G
Sbjct: 127 DIKGNNVML-MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI-NESG 184

Query: 185 YSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLY 244
           Y    D+W++GC   EM TGKP  P    D L+ +F               YI     L 
Sbjct: 185 YGRKSDIWSIGCTVFEMATGKP--PLASMDRLAAMF---------------YIGAHRGLM 227

Query: 245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           P      L + F     A +D ++  L  +  +R +A+  L+H++L
Sbjct: 228 P-----RLPDSF---SAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  103 bits (258), Expect = 7e-26
 Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 6/204 (2%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
           +Y  I+ +G G +GE    R T     V  K + +    E      + E+ +L  L+H N
Sbjct: 1   HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPN 60

Query: 68  IVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTL-NLLVIKAILKQILLGLAYCHSL 125
           I+   +       + +  EY +   L+  I R K  L    ++   L QI+  ++Y H  
Sbjct: 61  IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120

Query: 126 KILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGYTG 184
            ILHRD+K  N+ +  K   +KL DFG+++ +G  +   +   V +P Y +PEL  G   
Sbjct: 121 GILHRDIKTLNIFLT-KAGLIKLGDFGISKILG-SEYSMAETVVGTPYYMSPELCQGVK- 177

Query: 185 YSTPIDVWAVGCIFAEMITGKPLF 208
           Y+   D+WA+GC+  E++T K  F
Sbjct: 178 YNFKSDIWALGCVLYELLTLKRTF 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  103 bits (257), Expect = 1e-25
 Identities = 74/230 (32%), Positives = 118/230 (51%), Gaps = 12/230 (5%)

Query: 7   LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVP---SYIIREVSLLKEL 63
           +N+++ K +G G +G VY C +  TG+++A K +    E        S +  E+ LLK L
Sbjct: 2   INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61

Query: 64  EHENIVRLLDVQSSR--KDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAY 121
           +HE IV+       R  K + +  EY+         +    L   V +   +QIL G++Y
Sbjct: 62  QHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSY 121

Query: 122 CHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYS--RDCVYSPY-KAPEL 178
            HS  I+HRD+K  N+L D   N VKL DFG ++ +       +  R    +PY  +PE+
Sbjct: 122 LHSNMIVHRDIKGANILRDSAGN-VKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV 180

Query: 179 LLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTD 228
           + G  GY    DVW++GC   EM+T KP  P  +++ ++ IF +   PT+
Sbjct: 181 ISG-EGYGRKADVWSLGCTVVEMLTEKP--PWAEYEAMAAIFKIATQPTN 227

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  103 bits (258), Expect = 3e-25
 Identities = 72/249 (28%), Positives = 110/249 (44%), Gaps = 62/249 (24%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMT----IQTEQEGVPSYIIREVSLLKEL 63
           +++ IK IG G +GEV+  R+  TGQ  A+K++     I+  Q    +++  E  +L + 
Sbjct: 2   DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQI---AHVRAERDILADA 58

Query: 64  EHENIVRLLDVQSSRKDVFLVFEYL---DLDLHSFITRHKNTLNLLVIKAILK------- 113
           +   IV+L       + ++LV EY+   DL            +NLL+ K +         
Sbjct: 59  DSPWIVKLYYSFQDEEHLYLVMEYMPGGDL------------MNLLIRKDVFPEETARFY 106

Query: 114 --QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLA----------------- 154
             +++L L   H L  +HRD+KP+N+LID     +KLADFGL                  
Sbjct: 107 IAELVLALDSVHKLGFIHRDIKPDNILID-ADGHIKLADFGLCKKMNKAKDREYYLNDSH 165

Query: 155 --------RAIGVPQKEYSRDC---VYSP-YKAPELLLGYTGYSTPIDVWAVGCIFAEMI 202
                          K+        V +P Y APE+L G T Y    D W++G I  EM+
Sbjct: 166 NLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEML 224

Query: 203 TGKPLFPSK 211
            G P F S 
Sbjct: 225 YGFPPFYSD 233

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  101 bits (253), Expect = 4e-25
 Identities = 64/218 (29%), Positives = 105/218 (48%), Gaps = 21/218 (9%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           Y+ I+ IG G    VY        +KVAIK + ++  Q  V   + +EV  + +  H N+
Sbjct: 3   YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDE-LRKEVQAMSQCNHPNV 61

Query: 69  VRLLDVQSSRKDVFLVFEYLD----LDLHSFITRHKNTLNLL---VIKAILKQILLGLAY 121
           V+         +++LV  YL     LD    I +       L   +I  +LK++L GL Y
Sbjct: 62  VKYYTSFVVGDELWLVMPYLSGGSLLD----IMKSSYPRGGLDEAIIATVLKEVLKGLEY 117

Query: 122 CHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAI---GVPQKEYSRDCVYSP-YKAPE 177
            HS   +HRD+K  N+L+  +  +VK+ADFG++ ++   G   ++  +  V +P + APE
Sbjct: 118 LHSNGQIHRDIKAGNILLG-EDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176

Query: 178 LLLGYTGYSTPIDVWAVGCIFAEMITGKP----LFPSK 211
           ++    GY    D+W+ G    E+ TG        P K
Sbjct: 177 VMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK 214

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score =  102 bits (255), Expect = 5e-25
 Identities = 86/284 (30%), Positives = 134/284 (47%), Gaps = 22/284 (7%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVP-SYIIREVSLLKELEHEN 67
           +  +++IG G +G VY  R+  T + VAIK M+   +Q       II+EV  L+ ++H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
            +            +LV EY        +  HK  L  + I AI    L GLAY HS  +
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 146

Query: 128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY-KAPELLLGYT--G 184
           +HRD+K  N+L+  +   VKLADFG A +I  P   +    V +PY  APE++L      
Sbjct: 147 IHRDIKAGNILLT-EPGQVKLADFGSA-SIASPANSF----VGTPYWMAPEVILAMDEGQ 200

Query: 185 YSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLG--TPTDESWAESTYISEILP 242
           Y   +DVW++G    E+   KP  P    + +S ++ +    +PT +S   S Y      
Sbjct: 201 YDGKVDVWSLGITCIELAERKP--PLFNMNAMSALYHIAQNESPTLQSNEWSDY------ 252

Query: 243 LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK 286
            + +F  + L +K P   P   +LL  M  L  +     +D ++
Sbjct: 253 -FRNFVDSCL-QKIPQDRPTSEELLKHMFVLRERPETVLIDLIQ 294

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  100 bits (251), Expect = 6e-25
 Identities = 85/285 (29%), Positives = 135/285 (47%), Gaps = 30/285 (10%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
           +Y+ I+++G+G YG+VYK RN  TG+  A+K+  I+ E     S I +E+ ++KE +H N
Sbjct: 10  DYELIQRVGSGTYGDVYKARNLHTGELAAVKI--IKLEPGDDFSLIQQEIFMVKECKHCN 67

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
           IV       SR+ +++  EY        I      L+ L I  + ++ L GLAY HS   
Sbjct: 68  IVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK 127

Query: 128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY-KAPEL--LLGYTG 184
           +HRD+K  N+L+      VKLADFG+A  I     +  +  + +PY  APE+  +    G
Sbjct: 128 MHRDIKGANILLT-DNGDVKLADFGVAAKITATIAK-RKSFIGTPYWMAPEVAAVEKNGG 185

Query: 185 YSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLY 244
           Y+   D+WAVG    E+   +P  P      +  +F +  +                   
Sbjct: 186 YNQLCDIWAVGITAIELAELQP--PMFDLHPMRALFLMSKS------------------- 224

Query: 245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEY 289
            +F+P  L +K         + +   L  NPK+R TA   L H +
Sbjct: 225 -NFQPPKLKDKT-KWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 99.7 bits (248), Expect = 2e-24
 Identities = 73/230 (31%), Positives = 118/230 (51%), Gaps = 16/230 (6%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIR---EVSLLKELE 64
           N++  K +G G +GEVY C +  TG+++A+K +    + +     +     E+ LLK L 
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 65  HENIVR----LLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLA 120
           H+ IV+    L D +  +  +F+  EY+         +    L   V +   +QIL G++
Sbjct: 63  HDRIVQYYGCLRDPEEKKLSIFV--EYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVS 120

Query: 121 YCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYS--RDCVYSPY-KAPE 177
           Y HS  I+HRD+K  N+L D   N VKL DFG ++ I       +  +    +PY  +PE
Sbjct: 121 YLHSNMIVHRDIKGANILRDSAGN-VKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPE 179

Query: 178 LLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPT 227
           ++ G  GY    DVW+V C   EM+T KP  P  +++ ++ IF +   PT
Sbjct: 180 VISG-EGYGRKADVWSVACTVVEMLTEKP--PWAEYEAMAAIFKIATQPT 226

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  100 bits (250), Expect = 2e-24
 Identities = 87/298 (29%), Positives = 134/298 (44%), Gaps = 52/298 (17%)

Query: 12  IKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVR 70
           ++ IG G YG+VYK R+  TGQ VAIK+M I  ++E     I  E ++L++   H NI  
Sbjct: 11  VEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE---EEIKEEYNILRKYSNHPNIAT 67

Query: 71  ------LLDVQSSRKDVFLVFEYLD----LDLHSFITRHKNTLNLLVIKAILKQILLGLA 120
                   +   +   ++LV E        DL   + +    L    I  IL++ L GLA
Sbjct: 68  FYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLA 127

Query: 121 YCHSLKILHRDLKPNNLLIDLKRNT-VKLADFGLARAIGVPQKEYSRD-CVYSPY-KAPE 177
           Y H  K++HRD+K  N+L  L +N  VKL DFG++    +      R+  + +PY  APE
Sbjct: 128 YLHENKVIHRDIKGQNIL--LTKNAEVKLVDFGVSAQ--LDSTLGRRNTFIGTPYWMAPE 183

Query: 178 LL-----LGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWA 232
           ++        + Y    DVW++G    E+  GKP      H   +L F +   P      
Sbjct: 184 VIACDEQPDAS-YDARSDVWSLGITAIELADGKPPL-CDMHPMRAL-FKIPRNPP----- 235

Query: 233 ESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                    P      P N ++KF        D +S+ L  N +QR    + L+H ++
Sbjct: 236 ---------PTLKS--PENWSKKF-------NDFISECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 99.1 bits (247), Expect = 2e-24
 Identities = 63/210 (30%), Positives = 105/210 (50%), Gaps = 21/210 (10%)

Query: 12  IKKIGAGGYGEVY--KCRNTVTGQKVAIKMMTIQTEQEGVPSY--IIREVSLLKELEHEN 67
           +K++G+G +G V+  K R  +    VAIKM+     +EG  S    I E  ++ +L H N
Sbjct: 9   LKELGSGQFGVVHLGKWRGKI---DVAIKMI-----REGAMSEDDFIEEAKVMMKLSHPN 60

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
           +V+L  V + ++ +F+V EY+    L +++   K  L    +  +   +   + Y  S  
Sbjct: 61  LVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG 120

Query: 127 ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY-SRDCVYSPYK--APELLLGYT 183
            +HRDL   N L+  + N VK++DFGLAR   V   +Y S      P K   PE+   Y+
Sbjct: 121 FIHRDLAARNCLVG-EDNVVKVSDFGLARY--VLDDQYTSSQGTKFPVKWAPPEVFD-YS 176

Query: 184 GYSTPIDVWAVGCIFAEMIT-GKPLFPSKK 212
            +S+  DVW+ G +  E+ + GK  +    
Sbjct: 177 RFSSKSDVWSFGVLMWEVFSEGKMPYERFS 206

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 99.2 bits (247), Expect = 4e-24
 Identities = 72/204 (35%), Positives = 111/204 (54%), Gaps = 15/204 (7%)

Query: 10  KKIKKIGAGGYGEV----YKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEH 65
           KKI+ +G G +G+V    Y   N  TG+ VA+K +  +  Q+    +  +E+++LK L H
Sbjct: 7   KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWK-KEINILKTLYH 65

Query: 66  ENIVRLLDVQSSR--KDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYC 122
           ENIV+     S +  K + L+ EY+ L  L  ++ +HK  L  L++ A  +QI  G+AY 
Sbjct: 66  ENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFA--QQICEGMAYL 123

Query: 123 HSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYS-RDCVYSP--YKAPELL 179
           HS   +HRDL   N+L+D     VK+ DFGLA+A+    + Y  R+   SP  + A E L
Sbjct: 124 HSQHYIHRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECL 182

Query: 180 LGYTGYSTPIDVWAVGCIFAEMIT 203
                +S   DVW+ G    E++T
Sbjct: 183 KENK-FSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 98.2 bits (244), Expect = 8e-24
 Identities = 65/221 (29%), Positives = 106/221 (47%), Gaps = 17/221 (7%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIK------MMTIQTEQEGVPSYIIREVSLLK 61
           N++  KKIG G + EVY+    +  + VA+K      MM  +  Q+      ++E+ LLK
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQD-----CVKEIDLLK 57

Query: 62  ELEHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILK---QILL 117
           +L H N+++ LD      ++ +V E  D  DL   I   K    L+  + + K   Q+  
Sbjct: 58  QLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117

Query: 118 GLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPE 177
            + + HS +++HRD+KP N+ I      VKL D GL R     +   +   V +PY    
Sbjct: 118 AVEHMHSRRVMHRDIKPANVFIT-ATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSP 175

Query: 178 LLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSL 218
             +   GY+   D+W++GC+  EM   +  F   K +  SL
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSL 216

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 98.6 bits (245), Expect = 9e-24
 Identities = 86/301 (28%), Positives = 137/301 (45%), Gaps = 38/301 (12%)

Query: 12  IKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVP-SYIIREVSLLKELEHENIVR 70
           + +IG G +G VY   N+ T + VA+K M+   +Q       II+EV  L++L+H N + 
Sbjct: 26  LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE 85

Query: 71  LLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHR 130
                      +LV EY        +  HK  L  + I AI    L GLAY HS  ++HR
Sbjct: 86  YKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR 145

Query: 131 DLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY-KAPELLLGYT--GYST 187
           D+K  N+L+  +   VKLADFG A +   P   +    V +PY  APE++L      Y  
Sbjct: 146 DIKAGNILLT-EPGQVKLADFGSA-SKSSPANSF----VGTPYWMAPEVILAMDEGQYDG 199

Query: 188 PIDVWAVGCIFAEMITGKP-LFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPH 246
            +DVW++G    E+   KP LF      +++ + +L     ++S              P 
Sbjct: 200 KVDVWSLGITCIELAERKPPLF------NMNAMSALYHIAQNDS--------------PT 239

Query: 247 FEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLINRK 306
            +     + F       VD   Q +   P++R  + + L+H+++       ++I LI R 
Sbjct: 240 LQSNEWTDSFRGF----VDYCLQKI---PQERPASAELLRHDFVRRDRPARVLIDLIQRT 292

Query: 307 K 307
           K
Sbjct: 293 K 293

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 96.6 bits (240), Expect = 2e-23
 Identities = 74/235 (31%), Positives = 116/235 (49%), Gaps = 24/235 (10%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIR---EVSLLKELE 64
           N++  K +G G +G VY C +  TG+++A+K +    E       +     E+ LLK L 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 65  HENIVR----LLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLA 120
           HE IV+    L D       +F+  E++         +    L   V +   +QIL G++
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFM--EHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVS 120

Query: 121 YCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAI------GVPQKEYSRDCVYSPY- 173
           Y HS  I+HRD+K  N+L D   N VKL DFG ++ +      G   K  +     +PY 
Sbjct: 121 YLHSNMIVHRDIKGANILRDSVGN-VKLGDFGASKRLQTICLSGTGMKSVTG----TPYW 175

Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTD 228
            +PE++ G  GY    D+W+VGC   EM+T KP  P  + + ++ IF +   PT+
Sbjct: 176 MSPEVISG-EGYGRKADIWSVGCTVVEMLTEKP--PWAEFEAMAAIFKIATQPTN 227

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 97.0 bits (241), Expect = 4e-23
 Identities = 89/304 (29%), Positives = 140/304 (46%), Gaps = 38/304 (12%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVP-SYIIREVSLLKELEHEN 67
           +  +++IG G +G VY  R+    + VAIK M+   +Q       II+EV  L++L H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
            ++           +LV EY        +  HK  L  + I A+    L GLAY HS  +
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136

Query: 128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY-KAPELLLGYT--G 184
           +HRD+K  N+L+  +   VKL DFG A +I  P   +    V +PY  APE++L      
Sbjct: 137 IHRDVKAGNILLS-EPGLVKLGDFGSA-SIMAPANXF----VGTPYWMAPEVILAMDEGQ 190

Query: 185 YSTPIDVWAVGCIFAEMITGK-PLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPL 243
           Y   +DVW++G    E+   K PLF      +++ + +L     +ES             
Sbjct: 191 YDGKVDVWSLGITCIELAERKPPLF------NMNAMSALYHIAQNES------------- 231

Query: 244 YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLI 303
            P  +  + +E F N     VD   Q +   P+ R T+   LKH +++      +++ LI
Sbjct: 232 -PALQSGHWSEYFRNF----VDSCLQKI---PQDRPTSEVLLKHRFVLRERPPTVIMDLI 283

Query: 304 NRKK 307
            R K
Sbjct: 284 QRTK 287

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 95.1 bits (237), Expect = 9e-23
 Identities = 59/206 (28%), Positives = 108/206 (52%), Gaps = 16/206 (7%)

Query: 8   NYKKIKK-IGAGGYGEVYKCRNTVTGQK---VAIKMMTIQTEQEGVPSYIIREVSLLKEL 63
           +Y  I+K IG G +GEV + R  + G+K   VAIK +   +  +      + E S++ + 
Sbjct: 4   SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQF 62

Query: 64  EHENIVRLLDVQSSRKDVFLVFEYLD---LDLHSFITRHKNTLNLLVIKAILKQILLGLA 120
           +H NI+RL  V +  + V ++ EY++   LD   F+  +     +  +  +L+ I  G+ 
Sbjct: 63  DHPNIIRLEGVVTKSRPVMIITEYMENGSLD--KFLRENDGKFTVGQLVGMLRGIASGMK 120

Query: 121 YCHSLKILHRDLKPNNLLIDLKRNTV-KLADFGLARAIGVPQKEYSRDCVYSP--YKAPE 177
           Y   +  +HRDL   N+L++   N V K++DFGL+R +   +  Y+      P  + APE
Sbjct: 121 YLSEMNYVHRDLAARNILVN--SNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPE 178

Query: 178 LLLGYTGYSTPIDVWAVGCIFAEMIT 203
             + Y  +++  DVW+ G +  E+++
Sbjct: 179 -AIAYRKFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 94.4 bits (235), Expect = 2e-22
 Identities = 63/199 (31%), Positives = 102/199 (51%), Gaps = 19/199 (9%)

Query: 13  KKIGAGGYGEVY--KCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVR 70
           +K+G+G +GEV+    +N V   +VAIK   ++++         +EV  LK L H++++ 
Sbjct: 12  RKLGSGYFGEVWEGLWKNRV---RVAIK--ILKSDDLLKQQDFQKEVQALKRLRHKHLIS 66

Query: 71  LLDVQSSRKDVFLVFEYLDL-DLHSFI-TRHKNTLNLLVIKAILKQILLGLAYCHSLKIL 128
           L  V S  + V+++ E ++   L +F+ +     L +  +  +  Q+  G+AY      +
Sbjct: 67  LFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSI 126

Query: 129 HRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE--YSRDCVYSPYK--APELLLGYTG 184
           HRDL   N+L+  +    K+ADFGLAR I    KE  Y       PYK  APE    +  
Sbjct: 127 HRDLAARNILVG-EDLVCKVADFGLARLI----KEDVYLSSDKKIPYKWTAPE-AASHGT 180

Query: 185 YSTPIDVWAVGCIFAEMIT 203
           +ST  DVW+ G +  EM T
Sbjct: 181 FSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 94.2 bits (234), Expect = 2e-22
 Identities = 64/204 (31%), Positives = 110/204 (53%), Gaps = 13/204 (6%)

Query: 10  KKIKKIGAGGYGEVYKCR----NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEH 65
           K+I+ +G G +G+V  CR       TG++VA+K +  ++    +   + +E+ +L+ L H
Sbjct: 7   KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD-LKKEIEILRNLYH 65

Query: 66  ENIVRLLDV--QSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYC 122
           ENIV+   +  +     + L+ E+L    L  ++ R+KN +NL        QI  G+ Y 
Sbjct: 66  ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL 125

Query: 123 HSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYS-RDCVYSP--YKAPELL 179
            S + +HRDL   N+L++   + VK+ DFGL +AI   ++ Y+ +D + SP  + APE L
Sbjct: 126 GSRQYVHRDLAARNVLVE-SEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184

Query: 180 LGYTGYSTPIDVWAVGCIFAEMIT 203
           +    Y    DVW+ G    E++T
Sbjct: 185 IQSKFYIAS-DVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 95.3 bits (237), Expect = 3e-22
 Identities = 75/302 (24%), Positives = 120/302 (39%), Gaps = 41/302 (13%)

Query: 7   LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHE 66
           L Y  IK +  G  G V+          V +K+        G     + E  LL+ + H 
Sbjct: 66  LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKI--------GQKGTTLIEAMLLQNVNHP 117

Query: 67  NIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
           +++R+ D   S     +V  +   DL++++T+    L +     I KQIL GL Y H+ +
Sbjct: 118 SVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR 177

Query: 127 ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYS 186
           I+HRD+K  N+ I+   + V + D G A+   V               APE +L    Y+
Sbjct: 178 IIHRDVKTENIFIN-DVDQVCIGDLGAAQFPVVAPAFLGLAGTVET-NAPE-VLARDKYN 234

Query: 187 TPIDVWAVGCIFAEMIT-GKPLF---------PSKK-HDHLSLIFSLLGTPTDE--SWAE 233
           +  D+W+ G +  EM+     +F           K  H HL  I S L    +E      
Sbjct: 235 SKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPG 294

Query: 234 STYISEILPL----------YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMD 283
           S  +   +            YP F+  NL          G  L+ +ML  +   R +A +
Sbjct: 295 SRLVRGFIEYASLERQPYTRYPCFQRVNLPID-------GEFLVHKMLTFDAAMRPSAEE 347

Query: 284 AL 285
            L
Sbjct: 348 IL 349

Length = 357

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 92.8 bits (230), Expect = 9e-22
 Identities = 91/316 (28%), Positives = 149/316 (47%), Gaps = 58/316 (18%)

Query: 12  IKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRL 71
           I ++G G +G+VYK +N  TG   A K++  ++E+E +  Y++ E+ +L    H  IV+L
Sbjct: 17  IGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE-LEDYMV-EIEILATCNHPYIVKL 74

Query: 72  LDVQSSRKDVFLVFEY----------LDLDLHSFITRHKNTLNLLVIKAILKQILLGLAY 121
           L        ++++ E+          L+LD           L    I+ I +Q+L  L Y
Sbjct: 75  LGAFYWDGKLWIMIEFCPGGAVDAIMLELD---------RGLTEPQIQVICRQMLEALQY 125

Query: 122 CHSLKILHRDLKPNNLLIDLKRNTVKLADFGL-ARAIGVPQKEYSRDC-VYSPY-KAPEL 178
            HS+KI+HRDLK  N+L+ L  + +KLADFG+ A+ +   Q+   RD  + +PY  APE+
Sbjct: 126 LHSMKIIHRDLKAGNVLLTLDGD-IKLADFGVSAKNVKTLQR---RDSFIGTPYWMAPEV 181

Query: 179 LLGYTGYSTP----IDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAES 234
           ++  T   TP     D+W++G    EM   +P      H  L+ +  LL     E    S
Sbjct: 182 VMCETMKDTPYDYKADIWSLGITLIEMAQIEP-----PHHELNPMRVLLKIAKSEPPTLS 236

Query: 235 TYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV- 293
                         P+  + +F        D L   L  +P+ R +A   L+H ++  V 
Sbjct: 237 Q-------------PSKWSMEFR-------DFLKTALDKHPETRPSAAQLLEHPFVSSVT 276

Query: 294 ENVPLVILLINRKKKL 309
            N PL  L+   K ++
Sbjct: 277 SNRPLRELVAEAKAEV 292

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 92.0 bits (229), Expect = 1e-21
 Identities = 68/203 (33%), Positives = 102/203 (50%), Gaps = 25/203 (12%)

Query: 12  IKKIGAGGYGEVYKC--RNTVTGQKVAIKMMTIQTEQEGV--PSYIIREVSLLKELEHEN 67
            +K+GAG +GEV+      T    KVA+K +     + G   P   ++E  ++K+L H+ 
Sbjct: 11  ERKLGAGQFGEVWMGTWNGTT---KVAVKTL-----KPGTMSPEAFLQEAQIMKKLRHDK 62

Query: 68  IVRLLDVQSSRKDVFLVFEYLD----LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCH 123
           +V+L  V S  + +++V EY+     LD        K  L  LV  A   QI  G+AY  
Sbjct: 63  LVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMA--AQIAEGMAYLE 120

Query: 124 SLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYS-RDCVYSPYK--APELLL 180
           S   +HRDL   N+L+  +    K+ADFGLAR I     EY+ R+    P K  APE   
Sbjct: 121 SRNYIHRDLAARNILVG-ENLVCKIADFGLARLI--EDDEYTAREGAKFPIKWTAPEAAN 177

Query: 181 GYTGYSTPIDVWAVGCIFAEMIT 203
            Y  ++   DVW+ G +  E++T
Sbjct: 178 -YGRFTIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 93.3 bits (232), Expect = 1e-21
 Identities = 62/201 (30%), Positives = 100/201 (49%), Gaps = 18/201 (8%)

Query: 15  IGAGGYGEVYKCRNTVTGQKVAIKMM----TIQTEQEGVPSYIIREVSLLKELEHENIVR 70
           +G G +G V   ++  TG+  AIK +     ++ +Q     ++ +E S+L EL H  IV 
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQV---QHVAQEKSILMELSHPFIVN 82

Query: 71  LLDVQSSRKDVFLVFEYL---DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
           ++        V+ + E++   +L  H    R        V K    +++L   Y HS  I
Sbjct: 83  MMCSFQDENRVYFLLEFVVGGELFTH---LRKAGRFPNDVAKFYHAELVLAFEYLHSKDI 139

Query: 128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYST 187
           ++RDLKP NLL+D K + VK+ DFG A+   VP + ++  C    Y APE++    G+  
Sbjct: 140 IYRDLKPENLLLDNKGH-VKVTDFGFAKK--VPDRTFTL-CGTPEYLAPEVIQS-KGHGK 194

Query: 188 PIDVWAVGCIFAEMITGKPLF 208
            +D W +G +  E I G P F
Sbjct: 195 AVDWWTMGVLLYEFIAGYPPF 215

Length = 329

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 92.2 bits (229), Expect = 1e-21
 Identities = 77/282 (27%), Positives = 132/282 (46%), Gaps = 38/282 (13%)

Query: 15  IGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDV 74
           +G G  G VYK  + +T + +A+K++ +    E +   I+ E+ +L + +   I+     
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVE-LQKQIMSELEILYKCDSPYIIGFYGA 67

Query: 75  QSSRKDVFLVFEYLD---LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRD 131
                 + +  E++D   LD++  I  H       V+  I   ++ GL Y  SLKILHRD
Sbjct: 68  FFVENRISICTEFMDGGSLDVYRKIPEH-------VLGRIAVAVVKGLTYLWSLKILHRD 120

Query: 132 LKPNNLLIDLKRNTVKLADFGLARA-IGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPID 190
           +KP+N+L++  R  VKL DFG++   +    K Y      + Y APE + G   Y    D
Sbjct: 121 VKPSNMLVN-TRGQVKLCDFGVSTQLVNSIAKTYVGT---NAYMAPERISG-EQYGIHSD 175

Query: 191 VWAVGCIFAEMITGKPLFPSKKHDHLSLI-FSLLGTPTDESWAESTYISEILPLYPHFEP 249
           VW++G  F E+  G+  +P  + +  SL+   LL    DE          +LP+      
Sbjct: 176 VWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-------PPVLPV------ 222

Query: 250 ANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLI 291
              +EKF       V  ++Q +   PK+R    + + H +++
Sbjct: 223 GQFSEKF-------VHFITQCMRKQPKERPAPENLMDHPFIV 257

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 92.4 bits (229), Expect = 1e-21
 Identities = 91/310 (29%), Positives = 145/310 (46%), Gaps = 53/310 (17%)

Query: 12  IKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRL 71
           I ++G G +G+VYK +N  TG   A K++  ++E+E +  Y++ E+ +L   +H NIV+L
Sbjct: 10  IGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEE-LEDYMV-EIDILASCDHPNIVKL 67

Query: 72  LDVQSSRKDVFLVFEY--------LDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCH 123
           LD      +++++ E+        + L+L   +T  +       I+ + KQ L  L Y H
Sbjct: 68  LDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQ-------IRVVCKQTLEALNYLH 120

Query: 124 SLKILHRDLKPNNLLIDLKRNTVKLADFGL-ARAIGVPQKEYSRDC-VYSPY-KAPELLL 180
             KI+HRDLK  N+L  L  + +KLADFG+ A+     Q+   RD  + +PY  APE+++
Sbjct: 121 ENKIIHRDLKAGNILFTLDGD-IKLADFGVSAKNTRTIQR---RDSFIGTPYWMAPEVVM 176

Query: 181 GYTGYSTP----IDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY 236
             T    P     DVW++G    EM   +P      H  L+ +  LL        A+S  
Sbjct: 177 CETSKDRPYDYKADVWSLGITLIEMAQIEP-----PHHELNPMRVLLKI------AKS-- 223

Query: 237 ISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENV 296
                      EP  LA+          D L + L  N   R T    L+H ++    N 
Sbjct: 224 -----------EPPTLAQP-SRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNK 271

Query: 297 PLVILLINRK 306
           P+  L+   K
Sbjct: 272 PIRELIAEAK 281

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 91.8 bits (228), Expect = 1e-21
 Identities = 67/220 (30%), Positives = 104/220 (47%), Gaps = 22/220 (10%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQK-VAIKMMTIQTEQEGVPSY--------IIREVS 58
            Y  ++ +G+G +G VYK R    GQ  +A+K + +     G            I+ EV+
Sbjct: 1   EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60

Query: 59  LLKE-LEHENIVRLLDVQSSRKDVFLVFEYLD----LDLHSFITRHKNTLNLLVIKAILK 113
           ++KE L H NIVR          +++V + ++     +  + +   K       I  I  
Sbjct: 61  IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120

Query: 114 QILLGLAYCHSLK-ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSR--DCVY 170
           Q++L L Y H  K I+HRDL PNN+++  + + V + DFGLA+      K  S     +Y
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLG-EDDKVTITDFGLAKQKQPESKLTSVVGTILY 179

Query: 171 SPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPS 210
           S    PE++     Y    DVWA GCI  +M T +P F S
Sbjct: 180 S---CPEIVKNEP-YGEKADVWAFGCILYQMCTLQPPFYS 215

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 91.0 bits (226), Expect = 3e-21
 Identities = 70/211 (33%), Positives = 109/211 (51%), Gaps = 28/211 (13%)

Query: 10  KKIKKIGAGGYGEVYKCR----NTVTGQKVAIKMMTIQTEQEGVPSYII---REVSLLKE 62
           K I+++G G +G V  CR       TG+ VA+K +     Q     ++    RE+ +LK 
Sbjct: 7   KFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKL-----QHSTAEHLRDFEREIEILKS 61

Query: 63  LEHENIVRLLDVQSS--RKDVFLVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQILLGL 119
           L+H+NIV+   V  S  R+++ LV EYL    L  ++ +H+  L+   +     QI  G+
Sbjct: 62  LQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGM 121

Query: 120 AYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ-KEYSRDCVYSP------ 172
            Y  S + +HRDL   N+L++   N VK+ DFGL + +  PQ KEY +  V  P      
Sbjct: 122 EYLGSKRYVHRDLATRNILVE-SENRVKIGDFGLTKVL--PQDKEYYK--VREPGESPIF 176

Query: 173 YKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           + APE  L  + +S   DVW+ G +  E+ T
Sbjct: 177 WYAPE-SLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 91.8 bits (228), Expect = 4e-21
 Identities = 65/203 (32%), Positives = 103/203 (50%), Gaps = 11/203 (5%)

Query: 15  IGAGGYGEVYKCRNTVTGQKVAIKMM--TIQTEQEGVPSYIIREVSLLKELEHENIVRLL 72
           +G G +GEV   R   TG   A+K+M  ++   QE V S+   E  +L       I +L 
Sbjct: 9   VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETV-SFFEEERDILSISNSPWIPQLQ 67

Query: 73  DVQSSRKDVFLVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRD 131
                + +++LV EY    DL S + R+++  +  + +  L +++L +   H +  +HRD
Sbjct: 68  YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRD 127

Query: 132 LKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGYTG-----Y 185
           +KP N+LID +   +KLADFG A  +   +   S+  V +P Y APE+L    G     Y
Sbjct: 128 IKPENVLID-RTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTY 186

Query: 186 STPIDVWAVGCIFAEMITGKPLF 208
               D W++G I  EMI G+  F
Sbjct: 187 GVECDWWSLGVIAYEMIYGRSPF 209

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 91.0 bits (226), Expect = 5e-21
 Identities = 81/312 (25%), Positives = 142/312 (45%), Gaps = 58/312 (18%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQT-------EQEGVPSYIIREVSLL 60
           +++ IK I  G YG VY  R+  T Q+ A+K +  Q        +Q      +  E  +L
Sbjct: 2   DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQ------VFVERDIL 55

Query: 61  KELEHENIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLA 120
              E+  +V +     +++ + +V EY++    + + ++   L + + +    + +L L 
Sbjct: 56  TFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALE 115

Query: 121 YCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARA-------------IGVPQKEYSRD 167
           Y H+  I+HRDLKP+NLLI      +KL DFGL++              I    +E+   
Sbjct: 116 YLHNYGIVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDK 174

Query: 168 CVY-SP-YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGT 225
            V  +P Y APE++L   GY  P+D WA+G I  E + G   F               G 
Sbjct: 175 QVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPF--------------FGD 219

Query: 226 PTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRI---TAM 282
             +E + +   IS+ +  +P  + A        L     DL+S++L  NP +R+    A 
Sbjct: 220 TPEELFGQV--ISDDI-EWPEGDEA--------LPADAQDLISRLLRQNPLERLGTGGAF 268

Query: 283 DALKHEYLIGVE 294
           +  +H + +G++
Sbjct: 269 EVKQHRFFLGLD 280

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 90.5 bits (224), Expect = 5e-21
 Identities = 77/289 (26%), Positives = 137/289 (47%), Gaps = 43/289 (14%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           + K+++IG G +GEV+K  +  T Q VAIK++ ++  ++ +   I +E+++L + +   +
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIED-IQQEITVLSQCDSPYV 64

Query: 69  VRLLDVQSSRKDVFLVFEYLD----LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
            +          ++++ EYL     LDL           +   I  +LK+IL GL Y HS
Sbjct: 65  TKYYGSYLKGTKLWIIMEYLGGGSALDL-----LRAGPFDEFQIATMLKEILKGLDYLHS 119

Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTG 184
            K +HRD+K  N+L+  ++  VKLADFG+A  +   Q + +       + APE ++  + 
Sbjct: 120 EKKIHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIQQSA 177

Query: 185 YSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLY 244
           Y +  D+W++G    E+  G+P  P+     + ++F                      L 
Sbjct: 178 YDSKADIWSLGITAIELAKGEP--PNSDMHPMRVLF----------------------LI 213

Query: 245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLN--PKQRITAMDALKHEYLI 291
           P   P  L  +F       +D      CLN  P  R TA + LKH++++
Sbjct: 214 PKNNPPTLTGEFSKPFKEFID-----ACLNKDPSFRPTAKELLKHKFIV 257

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 89.9 bits (223), Expect = 5e-21
 Identities = 70/216 (32%), Positives = 113/216 (52%), Gaps = 31/216 (14%)

Query: 8   NYKKIKKIGAGGYGEV----YKCRNTVTGQKVAIKMMTIQTEQEGV--PSYIIREVSLLK 61
             K +KK+GAG +GEV    Y         KVAIK +     ++G   P   + E +L+K
Sbjct: 7   TLKLVKKLGAGQFGEVWMGYYN-----GHTKVAIKSL-----KQGSMSPEAFLAEANLMK 56

Query: 62  ELEHENIVRLLDVQSSRKDVFLVFEYLD----LDLHSFITRHKNTLNLLVIKAILKQILL 117
           +L+H  +VRL  V  +++ ++++ EY++    +D        K T+N L+  A   QI  
Sbjct: 57  QLQHPRLVRLYAV-VTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMA--AQIAE 113

Query: 118 GLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY-SRDCVYSPYK-- 174
           G+A+      +HRDL+  N+L+  +    K+ADFGLAR I     EY +R+    P K  
Sbjct: 114 GMAFIERKNYIHRDLRAANILVS-ETLCCKIADFGLARLI--EDNEYTAREGAKFPIKWT 170

Query: 175 APELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFP 209
           APE  + Y  ++   DVW+ G +  E++T G+  +P
Sbjct: 171 APE-AINYGTFTIKSDVWSFGILLTEIVTYGRIPYP 205

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 90.2 bits (224), Expect = 9e-21
 Identities = 84/297 (28%), Positives = 133/297 (44%), Gaps = 37/297 (12%)

Query: 12  IKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVR- 70
           + ++G G  G V KCR   TG   A+K +T     + +   I+RE+ + K  +   IV+ 
Sbjct: 6   LSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPD-LQKQILRELEINKSCKSPYIVKY 64

Query: 71  ---LLDVQSSRKDVFLVFEYLD---LD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCH 123
               LD  SS   + +  EY +   LD ++  + +    +   V+  I + +L GL+Y H
Sbjct: 65  YGAFLDESSS--SIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH 122

Query: 124 SLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYT 183
           S KI+HRD+KP+N+L+  K   VKL DFG++  +            +  Y APE + G  
Sbjct: 123 SRKIIHRDIKPSNILLTRKGQ-VKLCDFGVSGELVNSLAGTFTGTSF--YMAPERIQGKP 179

Query: 184 GYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPL 243
            YS   DVW++G    E+   +  FP +    L  I  LL           +YI  +   
Sbjct: 180 -YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPI-ELL-----------SYIVNMPNP 226

Query: 244 YPHFEPAN---LAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
               EP N    +E+F        D + Q L  +P +R T  D L+H ++       
Sbjct: 227 ELKDEPGNGIKWSEEFK-------DFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKK 276

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 89.8 bits (223), Expect = 1e-20
 Identities = 65/207 (31%), Positives = 108/207 (52%), Gaps = 11/207 (5%)

Query: 4   LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQK----VAIKMMTIQTEQEGVPSYIIREVSL 59
           LK    +KIK +G+G +G VYK      G+K    VAIK++  +T  +     I+ E  +
Sbjct: 4   LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKE-ILDEAYV 62

Query: 60  LKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLG 118
           +  ++H ++VRLL +  S   V L+ + + L  L  ++  HK+ +    +     QI  G
Sbjct: 63  MASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKG 121

Query: 119 LAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--AP 176
           ++Y    +++HRDL   N+L+      VK+ DFGLA+ + V +KEY  +    P K  A 
Sbjct: 122 MSYLEEKRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMAL 180

Query: 177 ELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           E +L +  Y+   DVW+ G    E++T
Sbjct: 181 ESIL-HRIYTHKSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 89.3 bits (222), Expect = 1e-20
 Identities = 58/214 (27%), Positives = 102/214 (47%), Gaps = 36/214 (16%)

Query: 13  KKIGAGGYGEV----YKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           K++G G +G V    Y  ++     +VA+K +  +    G     +RE S++ +L+H  I
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKE-VEVAVKTLKQEHIAAG-KKEFLREASVMAQLDHPCI 58

Query: 69  VRLLDVQSSRKDVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
           VRL+ V    + + LV E   L  L  ++ + +    +  +K +  Q+ +G+AY  S   
Sbjct: 59  VRLIGV-CKGEPLMLVMELAPLGPLLKYLKKRREI-PVSDLKELAHQVAMGMAYLESKHF 116

Query: 128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIGV-------------PQKEYSRDCVYSPYK 174
           +HRDL   N+L+ + R+  K++DFG++RA+G              P K Y+ +C+     
Sbjct: 117 VHRDLAARNVLL-VNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECIN---- 171

Query: 175 APELLLGYTGYSTPIDVWAVGCIFAEMIT--GKP 206
                  Y  +S+  DVW+ G    E  +   KP
Sbjct: 172 -------YGKFSSKSDVWSYGVTLWEAFSYGAKP 198

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 89.3 bits (221), Expect = 2e-20
 Identities = 80/305 (26%), Positives = 145/305 (47%), Gaps = 40/305 (13%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           + K+++IG G +GEVYK  +  T + VAIK++ ++  ++ +   I +E+++L + +   I
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIED-IQQEITVLSQCDSPYI 64

Query: 69  VRLLDVQSSRKDVFLVFEYLD----LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
            R          ++++ EYL     LDL          L    I  IL++IL GL Y HS
Sbjct: 65  TRYYGSYLKGTKLWIIMEYLGGGSALDL-----LKPGPLEETYIATILREILKGLDYLHS 119

Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTG 184
            + +HRD+K  N+L+  ++  VKLADFG+A  +   Q + +       + APE ++  + 
Sbjct: 120 ERKIHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIKQSA 177

Query: 185 YSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLY 244
           Y    D+W++G    E+  G+P  P+     + ++F                      L 
Sbjct: 178 YDFKADIWSLGITAIELAKGEP--PNSDLHPMRVLF----------------------LI 213

Query: 245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIG-VENVPLVILLI 303
           P   P  L  ++   +P   + +   L  +P+ R TA + LKH+++    +    +  LI
Sbjct: 214 PKNSPPTLEGQYS--KPFK-EFVEACLNKDPRFRPTAKELLKHKFITRYTKKTSFLTELI 270

Query: 304 NRKKK 308
           +R K+
Sbjct: 271 DRYKR 275

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 89.1 bits (221), Expect = 2e-20
 Identities = 73/240 (30%), Positives = 109/240 (45%), Gaps = 62/240 (25%)

Query: 8   NYKKIKKIGAGGYGEVYKCR--NTVTGQK---VAIKMM----TIQTEQEGVPSYIIREVS 58
           N + ++ IG G +G V++ R    +  +    VA+KM+    +   + +       RE +
Sbjct: 6   NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD-----FQREAA 60

Query: 59  LLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRH------------------ 99
           L+ E +H NIV+LL V +  K + L+FEY+   DL+ F+ RH                  
Sbjct: 61  LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFL-RHRSPRAQCSLSHSTSSARK 119

Query: 100 ----KNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLAR 155
                  L+      I KQ+  G+AY    K +HRDL   N L+  +   VK+ADFGL+R
Sbjct: 120 CGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVG-ENMVVKIADFGLSR 178

Query: 156 AIGVPQKEYSRDCVYSPYKA------------PELLLGYTGYSTPIDVWAVGCIFAEMIT 203
            I      YS D  Y  YKA            PE +  Y  Y+T  DVWA G +  E+ +
Sbjct: 179 NI------YSAD--Y--YKASENDAIPIRWMPPESIF-YNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 88.2 bits (218), Expect = 3e-20
 Identities = 61/202 (30%), Positives = 107/202 (52%), Gaps = 7/202 (3%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
           +++ I++IG+G YG+VYK RN  TG+  AIK++ ++  ++   + + +E+ ++K+ +H N
Sbjct: 10  DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDF--AVVQQEIIMMKDCKHSN 67

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
           IV        R  +++  E+        I      L+   I  + ++ L GL Y HS   
Sbjct: 68  IVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK 127

Query: 128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY-KAPEL--LLGYTG 184
           +HRD+K  N+L+      VKLADFG++  I     +  +  + +PY  APE+  +    G
Sbjct: 128 MHRDIKGANILLT-DNGHVKLADFGVSAQITATIAK-RKSFIGTPYWMAPEVAAVERKGG 185

Query: 185 YSTPIDVWAVGCIFAEMITGKP 206
           Y+   D+WAVG    E+   +P
Sbjct: 186 YNQLCDIWAVGITAIELAELQP 207

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 87.8 bits (217), Expect = 4e-20
 Identities = 65/216 (30%), Positives = 103/216 (47%), Gaps = 7/216 (3%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEG-VPSYIIREVSLLKELEHE 66
           N++  KKIG G + EVY+    + G  VA+K + I    +    +  I+E+ LLK+L H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 67  NIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILK---QILLGLAYC 122
           N+++         ++ +V E  D  DL   I   K    L+  K + K   Q+   L + 
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122

Query: 123 HSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGY 182
           HS +++HRD+KP N+ I      VKL D GL R     +   +   V +PY      +  
Sbjct: 123 HSRRVMHRDIKPANVFIT-ATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERIHE 180

Query: 183 TGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSL 218
            GY+   D+W++GC+  EM   +  F   K +  SL
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL 216

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 87.7 bits (217), Expect = 4e-20
 Identities = 72/285 (25%), Positives = 126/285 (44%), Gaps = 37/285 (12%)

Query: 13  KKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIR---EVSLLKELEHENIV 69
           +++G G +G VY  ++     +  +K++      E  P+  ++   E  LL +L+H  IV
Sbjct: 6   QRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65

Query: 70  RLLDVQSSRKDVFLVFEYL-DLDLHSFITRHKNTLNLLVIKAILK---QILLGLAYCHSL 125
           +       R    ++ EY    DL   +   K+T   L    + +   Q+LLG+ Y H  
Sbjct: 66  KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR 125

Query: 126 KILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGY 185
           +ILHRDLK  N+   LK N +K+ DFG++R + +   + +     +PY      L + GY
Sbjct: 126 RILHRDLKAKNIF--LKNNLLKIGDFGVSRLL-MGSCDLATTFTGTPYYMSPEALKHQGY 182

Query: 186 STPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYP 245
            +  D+W++GCI  EM      F     + LS++  ++  PT              P  P
Sbjct: 183 DSKSDIWSLGCILYEMCCLAHAFEG--QNFLSVVLRIVEGPT--------------PSLP 226

Query: 246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                 L     N       ++  ML  +P  R +A + L++ ++
Sbjct: 227 ETYSRQL-----NS------IMQSMLNKDPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 88.5 bits (219), Expect = 4e-20
 Identities = 80/299 (26%), Positives = 146/299 (48%), Gaps = 37/299 (12%)

Query: 14  KIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLD 73
           KIG G  G V       +G+ VA+K M ++ +Q      +  EV ++++ +HEN+V + +
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYN 84

Query: 74  VQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLK 133
                 ++++V E+L+    + I  H   +N   I A+   +L  L+  H+  ++HRD+K
Sbjct: 85  SYLVGDELWVVMEFLEGGALTDIVTHTR-MNEEQIAAVCLAVLKALSVLHAQGVIHRDIK 143

Query: 134 PNNLLIDLKRNTVKLADFGLARAIG--VPQKEYSRDCVYSPY-KAPELLLGYTGYSTPID 190
            +++L+      VKL+DFG    +   VP++   +  V +PY  APEL+     Y   +D
Sbjct: 144 SDSILLT-HDGRVKLSDFGFCAQVSKEVPRR---KSLVGTPYWMAPELI-SRLPYGPEVD 198

Query: 191 VWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPA 250
           +W++G +  EM+ G+P +                 P  ++      I + LP  P  +  
Sbjct: 199 IWSLGIMVIEMVDGEPPY--------------FNEPPLKAM---KMIRDNLP--PKLK-- 237

Query: 251 NLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLINRKKKL 309
           NL +  P+L+      L ++L  +P QR TA + LKH +L      P  I+ + R+ ++
Sbjct: 238 NLHKVSPSLK----GFLDRLLVRDPAQRATAAELLKHPFL-AKAGPPSCIVPLMRQNRM 291

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 87.3 bits (216), Expect = 4e-20
 Identities = 76/287 (26%), Positives = 127/287 (44%), Gaps = 36/287 (12%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           Y  ++ +G G YGEV   R+   G++  IK + ++           +E  LL +L+H NI
Sbjct: 2   YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61

Query: 69  VRLLDV-QSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILK---QILLGLAYCH 123
           V   +  +     +++V  + +  DL+  +   K    LL    +++   QI + L Y H
Sbjct: 62  VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKG--KLLPENQVVEWFVQIAMALQYLH 119

Query: 124 SLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYT 183
              ILHRDLK  N+ +  + N +K+ D G+AR +   Q + +   + +PY     L    
Sbjct: 120 EKHILHRDLKTQNVFLT-RTNIIKVGDLGIARVLE-NQCDMASTLIGTPYYMSPELFSNK 177

Query: 184 GYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPL 243
            Y+   DVWA+GC   EM T K  F +K  D  SL++ +              I   LP 
Sbjct: 178 PYNYKSDVWALGCCVYEMATLKHAFNAK--DMNSLVYRI--------------IEGKLPP 221

Query: 244 YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            P            +  P   +L++ ML   P++R +    L+  Y+
Sbjct: 222 MPK-----------DYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 87.8 bits (217), Expect = 5e-20
 Identities = 83/309 (26%), Positives = 146/309 (47%), Gaps = 48/309 (15%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           + K++KIG G +GEV+K  +  T + VAIK++ ++  ++ +   I +E+++L + +   +
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIED-IQQEITVLSQCDSPYV 64

Query: 69  VRLLDVQSSRKDVFLVFEYLD----LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
            +          ++++ EYL     LDL          L+   I  IL++IL GL Y HS
Sbjct: 65  TKYYGSYLKDTKLWIIMEYLGGGSALDL-----LEPGPLDETQIATILREILKGLDYLHS 119

Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTG 184
            K +HRD+K  N+L+  +   VKLADFG+A  +   Q + +       + APE ++  + 
Sbjct: 120 EKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIKQSA 177

Query: 185 YSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLY 244
           Y +  D+W++G    E+  G+P  P  +   + ++F                      L 
Sbjct: 178 YDSKADIWSLGITAIELAKGEP--PHSELHPMKVLF----------------------LI 213

Query: 245 PHFEPANLAEKFPNLEPAGVDLLSQML--CLN--PKQRITAMDALKHEYLI-GVENVPLV 299
           P   P       P LE      L + +  CLN  P  R TA + LKH++++   +    +
Sbjct: 214 PKNNP-------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAKKTSYL 266

Query: 300 ILLINRKKK 308
             LI+R K+
Sbjct: 267 TELIDRYKR 275

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 87.3 bits (216), Expect = 6e-20
 Identities = 63/203 (31%), Positives = 111/203 (54%), Gaps = 15/203 (7%)

Query: 11  KIKK-IGAGGYGEVYKCRNTVTGQK---VAIKMMTI-QTEQEGVPSYIIREVSLLKELEH 65
           KI+K IGAG +GEV   R  + G++   VAIK +    TE++      + E S++ + +H
Sbjct: 7   KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQ--RRDFLSEASIMGQFDH 64

Query: 66  ENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
            NI+ L  V +  K V +V EY++   L +F+ +H     ++ +  +L+ I  G+ Y   
Sbjct: 65  PNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD 124

Query: 125 LKILHRDLKPNNLLIDLKRNTV-KLADFGLARAI-GVPQKEYSRDCVYSP--YKAPELLL 180
           +  +HRDL   N+L++   N V K++DFGL+R +   P+  Y+      P  + APE  +
Sbjct: 125 MGYVHRDLAARNILVN--SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE-AI 181

Query: 181 GYTGYSTPIDVWAVGCIFAEMIT 203
            Y  +++  DVW+ G +  E+++
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 87.8 bits (217), Expect = 7e-20
 Identities = 76/280 (27%), Positives = 137/280 (48%), Gaps = 36/280 (12%)

Query: 14  KIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLD 73
           KIG G  G V       TG++VA+K M ++ +Q      +  EV ++++  HEN+V + +
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQR--RELLFNEVVIMRDYHHENVVDMYN 86

Query: 74  VQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLK 133
                 ++++V E+L+    + I  H   +N   I  +   +L  L+Y H+  ++HRD+K
Sbjct: 87  SYLVGDELWVVMEFLEGGALTDIVTHTR-MNEEQIATVCLSVLRALSYLHNQGVIHRDIK 145

Query: 134 PNNLLIDLKRNTVKLADFGLARAIG--VPQKEYSRDCVYSPY-KAPELLLGYTGYSTPID 190
            +++L+      +KL+DFG    +   VP++   +  V +PY  APE++     Y T +D
Sbjct: 146 SDSILLT-SDGRIKLSDFGFCAQVSKEVPKR---KSLVGTPYWMAPEVI-SRLPYGTEVD 200

Query: 191 VWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPA 250
           +W++G +  EMI G+P +                 P  ++      I + LP  P  + +
Sbjct: 201 IWSLGIMVIEMIDGEPPY--------------FNEPPLQAMRR---IRDNLP--PRVKDS 241

Query: 251 NLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           +   K  ++    +DL   ML   P QR TA + L+H +L
Sbjct: 242 H---KVSSVLRGFLDL---MLVREPSQRATAQELLQHPFL 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 87.2 bits (216), Expect = 8e-20
 Identities = 72/291 (24%), Positives = 126/291 (43%), Gaps = 25/291 (8%)

Query: 4   LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL 63
           L+N + + I  +GAG  G V K ++  TG  +A K++ I  +   V   I+RE+ ++ E 
Sbjct: 2   LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSS-VRKQILRELQIMHEC 60

Query: 64  EHENIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCH 123
               IV       +  ++ +  E++D      I +    + + ++  I   ++ GL Y +
Sbjct: 61  RSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLY 120

Query: 124 S-LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCV-YSPYKAPELLLG 181
           +  +I+HRD+KP+N+L++  R  +KL DFG++   G      +   V  S Y +PE + G
Sbjct: 121 NVHRIMHRDIKPSNILVN-SRGQIKLCDFGVS---GELINSIADTFVGTSTYMSPERIQG 176

Query: 182 YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEIL 241
              Y+   DVW++G    E+  GK  F     D             D+   +   I ++L
Sbjct: 177 G-KYTVKSDVWSLGISIIELALGKFPFAFSNID-------------DDGQDDPMGILDLL 222

Query: 242 PLYPHFEPANL-AEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLI 291
                  P  L +  FP       D +   L  +P +R T          I
Sbjct: 223 QQIVQEPPPRLPSSDFP---EDLRDFVDACLLKDPTERPTPQQLCAMPPFI 270

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 89.9 bits (223), Expect = 1e-19
 Identities = 62/189 (32%), Positives = 93/189 (49%), Gaps = 16/189 (8%)

Query: 31  TGQKVAIKMM-TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKD-VFLVFEYL 88
           TG +VAIK++ T   E+E   +   RE +L   L H NIV LLD   +    +F VFEY+
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61

Query: 89  DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLI---DLKRNT 145
                  +      L       ++ Q+L  LA  H+  I+HRDLKP N+++    ++ + 
Sbjct: 62  PGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHA 121

Query: 146 VKLADFGL------ARAIGVPQKEYSRDCVYSP-YKAPELLLGYTGYSTP-IDVWAVGCI 197
            K+ DFG+       R   V     + + + +P Y APE L G     TP  D++A G I
Sbjct: 122 -KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEP--VTPNSDLYAWGLI 178

Query: 198 FAEMITGKP 206
           F E +TG+ 
Sbjct: 179 FLECLTGQR 187

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 86.4 bits (214), Expect = 1e-19
 Identities = 59/201 (29%), Positives = 102/201 (50%), Gaps = 24/201 (11%)

Query: 14  KIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLD 73
           K+G G YGEVY+         VA+K  T++ +   V  ++ +E +++KE++H N+V+LL 
Sbjct: 13  KLGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTMEVEEFL-KEAAVMKEIKHPNLVQLLG 69

Query: 74  VQSSRKDVFLVFEYLDL-DLHSFITR-HKNTLNLLVIKAILKQILLGLAYCHSLKILHRD 131
           V +     +++ E++   +L  ++   ++  +N +V+  +  QI   + Y      +HRD
Sbjct: 70  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 129

Query: 132 LKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS-------PYK--APELLLGY 182
           L   N L+  + + VK+ADFGL+R +            Y+       P K  APE  L Y
Sbjct: 130 LAARNCLVG-ENHLVKVADFGLSRLM--------TGDTYTAHAGAKFPIKWTAPE-SLAY 179

Query: 183 TGYSTPIDVWAVGCIFAEMIT 203
             +S   DVWA G +  E+ T
Sbjct: 180 NKFSIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 86.6 bits (214), Expect = 1e-19
 Identities = 58/201 (28%), Positives = 104/201 (51%), Gaps = 12/201 (5%)

Query: 11  KIKKIGAGGYGEVYKCRNTVTGQK---VAIKMMTI-QTEQEGVPSYIIREVSLLKELEHE 66
           K K IGAG +GEV++    + G+K   VAIK +    TE++      + E S++ +  H 
Sbjct: 9   KQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQD--FLSEASIMGQFSHH 66

Query: 67  NIVRLLDVQSSRKDVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSL 125
           NI+RL  V +  K   ++ EY++   L  ++  H    +   +  +L+ I  G+ Y   +
Sbjct: 67  NIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM 126

Query: 126 KILHRDLKPNNLLIDLKRNTVKLADFGLARAI-GVPQKEYSRDCVYSP--YKAPELLLGY 182
             +HRDL   N+L++      K++DFGL+R +   P+  Y+      P  + APE  + Y
Sbjct: 127 NYVHRDLAARNILVN-SNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPE-AIAY 184

Query: 183 TGYSTPIDVWAVGCIFAEMIT 203
             +++  DVW+ G +  E+++
Sbjct: 185 RKFTSASDVWSFGIVMWEVMS 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 86.3 bits (214), Expect = 1e-19
 Identities = 62/202 (30%), Positives = 103/202 (50%), Gaps = 19/202 (9%)

Query: 10  KKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIV 69
           + ++K+GAG +GEV++     T   VA+K +   T     P   + E  ++K+L H  ++
Sbjct: 9   QLLRKLGAGQFGEVWEGLWNNT-TPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLI 64

Query: 70  RLLDVQSSRKDVFLVFEYLD----LD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
           +L  V +  + +++V E +     L+ L     R      L+ + A   Q+  G+AY  +
Sbjct: 65  QLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAA---QVASGMAYLEA 121

Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY-SRDCVYSPYK--APELLLG 181
              +HRDL   N+L+  + N  K+ADFGLAR I   +  Y +R+    P K  APE  L 
Sbjct: 122 QNYIHRDLAARNVLVG-ENNICKVADFGLARVIK--EDIYEAREGAKFPIKWTAPEAAL- 177

Query: 182 YTGYSTPIDVWAVGCIFAEMIT 203
           Y  +S   DVW+ G +  E++T
Sbjct: 178 YNRFSIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 86.8 bits (215), Expect = 1e-19
 Identities = 70/270 (25%), Positives = 120/270 (44%), Gaps = 34/270 (12%)

Query: 15  IGAGGYGEVYKCRNTVTGQKVAIKMMTIQ-TEQEGVPSYIIREVSLLKELEHENIVRLLD 73
           +G GG+GEV  C+   TG+  A K +  +  ++       + E  +L+++    IV L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 74  VQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAIL--KQILLGLAYCHSLKILHR 130
              ++ D+ LV   ++  DL   I            +AI    QI+ GL + H  +I++R
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNV-GEPGFPEARAIFYAAQIICGLEHLHQRRIVYR 119

Query: 131 DLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGYTGYSTPI 189
           DLKP N+L+D   N V+++D GL  A+ +   +  +    +P Y APE+L G   Y   +
Sbjct: 120 DLKPENVLLDDHGN-VRISDLGL--AVELKGGKKIKGRAGTPGYMAPEVLQGEV-YDFSV 175

Query: 190 DVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEP 249
           D +A+GC   EMI G+  F  +K               ++   +   +            
Sbjct: 176 DWFALGCTLYEMIAGRSPFRQRK------------EKVEKEELKRRTLE---------MA 214

Query: 250 ANLAEKFPNLEPAGVDLLSQMLCLNPKQRI 279
               +KF    P   DL   +L  +P++R+
Sbjct: 215 VEYPDKF---SPEAKDLCEALLQKDPEKRL 241

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 87.3 bits (216), Expect = 1e-19
 Identities = 75/272 (27%), Positives = 121/272 (44%), Gaps = 38/272 (13%)

Query: 13  KKIGAGGYGEVYKCRNTVTGQKVAIKMMT--IQTEQEGVPSYIIREVSLLKELEHENIVR 70
           K +G G +G+V+      T Q  AIK +   +    + V   ++ +  L    EH  +  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 71  LLDVQSSRKDVFLVFEYL---DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
           L     +++++F V EYL   DL  H   + HK  L      A   +I+ GL + HS  I
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFH-IQSCHKFDLPRATFYA--AEIICGLQFLHSKGI 117

Query: 128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYST 187
           ++RDLK +N+L+D     +K+ADFG+ +   +   +    C    Y APE+LLG   Y+T
Sbjct: 118 VYRDLKLDNILLD-TDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQK-YNT 175

Query: 188 PIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHF 247
            +D W+ G +  EM+ G+   P   HD   L  S+     D             P YP +
Sbjct: 176 SVDWWSFGVLLYEMLIGQS--PFHGHDEEELFQSI---RMDN------------PCYPRW 218

Query: 248 EPANLAEKFPNLEPAGVDLLSQMLCLNPKQRI 279
                      L     D+L ++    P++R+
Sbjct: 219 -----------LTREAKDILVKLFVREPERRL 239

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 87.8 bits (218), Expect = 2e-19
 Identities = 68/242 (28%), Positives = 106/242 (43%), Gaps = 49/242 (20%)

Query: 12  IKKIGAGGYGEVYKCRNTVTGQKVAIKMM----TIQTEQEGVPSYIIREVSLLKELEHEN 67
           IK IG G +GEV   +   TG   A+K +     ++ EQ     ++  E  +L E ++  
Sbjct: 6   IKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVA---HVRAERDILAEADNPW 62

Query: 68  IVRLLDVQSSRKDVFLVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
           +V+L         ++L+ EYL   D+ + + + K+T      +  + + +L +   H L 
Sbjct: 63  VVKLYYSFQDENYLYLIMEYLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHKLG 121

Query: 127 ILHRDLKPNNLLIDLKRNTVKLADFGL------------------------ARAIGVPQ- 161
            +HRD+KP+NLL+D  +  +KL+DFGL                           I  P  
Sbjct: 122 YIHRDIKPDNLLLD-AKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMS 180

Query: 162 --------KEYSRDCVYSP-----YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
                   K   R   YS      Y APE+ L  TGY+   D W++G I  EM+ G P F
Sbjct: 181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVFL-QTGYNKECDWWSLGVIMYEMLVGYPPF 239

Query: 209 PS 210
            S
Sbjct: 240 CS 241

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 85.2 bits (211), Expect = 4e-19
 Identities = 75/251 (29%), Positives = 117/251 (46%), Gaps = 44/251 (17%)

Query: 12  IKKIGAGGYGEVYKCR-----NTVTGQKVAIKMMTIQTEQEG-VPSYIIREVSLLKELEH 65
           ++++G G +G+VYK         ++   VAIK  T++   E  V     +E  L+ +L+H
Sbjct: 10  LEELGEGAFGKVYKGELTGPNERLSATSVAIK--TLKENAEPKVQQEFRQEAELMSDLQH 67

Query: 66  ENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRH---------------KNTLNLLVIK 109
            NIV LL V +  +   ++FEYL   DLH F+ R+               K++L+     
Sbjct: 68  PNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127

Query: 110 AILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCV 169
            I  QI  G+ Y  S   +HRDL   N L+     TVK++DFGL+R I      YS D  
Sbjct: 128 HIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL-TVKISDFGLSRDI------YSADYY 180

Query: 170 YSPYK--------APELLLGYTGYSTPIDVWAVGCIFAEMIT--GKPLFPSKKHDHLSLI 219
               K         PE +L Y  ++T  D+W+ G +  E+ +   +P +     + + +I
Sbjct: 181 RVQSKSLLPVRWMPPEAIL-YGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239

Query: 220 FS--LLGTPTD 228
            S  LL  P D
Sbjct: 240 RSRQLLPCPED 250

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 85.2 bits (211), Expect = 7e-19
 Identities = 64/207 (30%), Positives = 106/207 (51%), Gaps = 12/207 (5%)

Query: 13  KKIGAGGYGEVYKCRNTVTGQKVAIKMMT---IQTEQEGVPSYIIREVS-LLKELEHENI 68
           K IG G +G+V   ++   G+  A+K++    I  ++E    +I+ E + LLK ++H  +
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQ--KHIMAERNVLLKNVKHPFL 58

Query: 69  VRL-LDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
           V L    Q++ K ++ V +Y++  +L   + R ++       +    +I   L Y HSL 
Sbjct: 59  VGLHYSFQTADK-LYFVLDYVNGGELFFHLQRERSFPEPRA-RFYAAEIASALGYLHSLN 116

Query: 127 ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYS 186
           I++RDLKP N+L+D + + V L DFGL +      K  S  C    Y APE+L     Y 
Sbjct: 117 IIYRDLKPENILLDSQGHVV-LTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQP-YD 174

Query: 187 TPIDVWAVGCIFAEMITGKPLFPSKKH 213
             +D W +G +  EM+ G P F S+  
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSRDT 201

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 84.3 bits (209), Expect = 8e-19
 Identities = 65/225 (28%), Positives = 97/225 (43%), Gaps = 52/225 (23%)

Query: 12  IKKIGAGGYGEVYK-----CRNTVTGQKVAIKM------MTIQTEQEGVPSYIIREVSLL 60
           I+++G G +G VY+             +VAIK       M  + E        + E S++
Sbjct: 11  IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIE-------FLNEASVM 63

Query: 61  KELEHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHK----NTLNLLVIKAILK-- 113
           KE    ++VRLL V S+ +   +V E +   DL S++   +    N   L          
Sbjct: 64  KEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQ 123

Query: 114 ---QILLGLAYCHSLKILHRDLKPNNLLI--DLKRNTVKLADFGLARAIGVPQKEYSRDC 168
              +I  G+AY  + K +HRDL   N ++  DL   TVK+ DFG+ R I      Y  D 
Sbjct: 124 MAAEIADGMAYLAAKKFVHRDLAARNCMVAEDL---TVKIGDFGMTRDI------YETD- 173

Query: 169 VYSP---------YKAPELLL-GYTGYSTPIDVWAVGCIFAEMIT 203
            Y           + APE L  G   ++T  DVW+ G +  EM T
Sbjct: 174 YYRKGGKGLLPVRWMAPESLKDGV--FTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 85.1 bits (210), Expect = 8e-19
 Identities = 81/309 (26%), Positives = 146/309 (47%), Gaps = 28/309 (9%)

Query: 3   KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKE 62
           +LK+ +++KI ++GAG  G V+K  +  +G  +A K++ ++  +  + + IIRE+ +L E
Sbjct: 1   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHE 59

Query: 63  LEHENIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYC 122
                IV       S  ++ +  E++D      + +    +   ++  +   ++ GL Y 
Sbjct: 60  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 119

Query: 123 HSL-KILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS-PYKAPELLL 180
               KI+HRD+KP+N+L++  R  +KL DFG++   G      +   V +  Y +PE L 
Sbjct: 120 REKHKIMHRDVKPSNILVN-SRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQ 175

Query: 181 GYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIF--SLLGTPTDESWAE----- 233
           G T YS   D+W++G    EM  G+   P      L L+F   + G P +   +      
Sbjct: 176 G-THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP 234

Query: 234 ----STYISEILPLYPHFEPAN--LAEKFPNLEPAGV------DLLSQMLCLNPKQRITA 281
               S+Y  +  P    FE  +  + E  P L P+GV      D +++ L  NP +R   
Sbjct: 235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKL-PSGVFGAEFQDFVNKCLIKNPAERADL 293

Query: 282 MDALKHEYL 290
              + H ++
Sbjct: 294 KQLMVHAFI 302

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 84.0 bits (208), Expect = 9e-19
 Identities = 60/212 (28%), Positives = 106/212 (50%), Gaps = 17/212 (8%)

Query: 13  KKIGAGGYGEVYKCRNTVTGQK-----VAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
           + IG G +G+VY+        +     VA+K     T    V    ++E  ++++ +H +
Sbjct: 12  RCIGEGQFGDVYQ--GVYMSPENEKIAVAVKTCKNCTSPS-VREKFLQEAYIMRQFDHPH 68

Query: 68  IVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
           IV+L+ V  +   V++V E   L +L S++  +K +L+L  +     Q+   LAY  S +
Sbjct: 69  IVKLIGV-ITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR 127

Query: 127 ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTG 184
            +HRD+   N+L+    + VKL DFGL+R +   +  Y       P K  APE  + +  
Sbjct: 128 FVHRDIAARNVLVSSP-DCVKLGDFGLSRYLE-DESYYKASKGKLPIKWMAPE-SINFRR 184

Query: 185 YSTPIDVWAVG-CIFAEMITG-KPLFPSKKHD 214
           +++  DVW  G C++  ++ G KP    K +D
Sbjct: 185 FTSASDVWMFGVCMWEILMLGVKPFQGVKNND 216

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 85.3 bits (211), Expect = 1e-18
 Identities = 74/303 (24%), Positives = 120/303 (39%), Gaps = 43/303 (14%)

Query: 6   NLNYKKIKKIGAGGYGEVYKC--RNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL 63
            + Y  +  +  G  GEV+ C        +KV +K +T             RE+ +LK +
Sbjct: 91  RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPG-------REIDILKTI 143

Query: 64  EHENIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCH 123
            H  I+ L+     +  V +V      DL +++ R    L L     I +++L  LAY H
Sbjct: 144 SHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLH 202

Query: 124 SLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP----------Y 173
              I+HRD+K  N+ +D   N V L DFG A  +             +P           
Sbjct: 203 GRGIIHRDVKTENIFLDEPENAV-LGDFGAACKLD--------AHPDTPQCYGWSGTLET 253

Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEM-ITGKPLF----PSKKHDHLSLIFSLLGTPTD 228
            +PE LL    Y    D+W+ G +  EM +    LF     S      S+I  +   P +
Sbjct: 254 NSPE-LLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLE 312

Query: 229 ESWAESTYISE-----ILPLYPHFEPANLAEKFPNLEPAGVD-LLSQMLCLNPKQRITAM 282
                ST + +      + L P +    +  K        V+ L+++ML  + + R +A 
Sbjct: 313 FPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRK--YGMHMDVEYLIAKMLTFDQEFRPSAQ 370

Query: 283 DAL 285
           D L
Sbjct: 371 DIL 373

Length = 392

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 83.5 bits (206), Expect = 1e-18
 Identities = 70/208 (33%), Positives = 114/208 (54%), Gaps = 18/208 (8%)

Query: 10  KKIKKIGAGGYGEVYKC-RNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           K +KK+GAG +GEV+    N  T  KVA+K  T++     V +++  E +L+K L+H+ +
Sbjct: 9   KLVKKLGAGQFGEVWMGYYNNST--KVAVK--TLKPGTMSVQAFL-EEANLMKTLQHDKL 63

Query: 69  VRLLDVQSSRKDVFLVFEYL-DLDLHSFITRHKNTLNLLVIKAI--LKQILLGLAYCHSL 125
           VRL  V +  + ++++ EY+    L  F+   +    +L+ K I    QI  G+AY    
Sbjct: 64  VRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGG-KVLLPKLIDFSAQIAEGMAYIERK 122

Query: 126 KILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYS-RDCVYSPYK--APELLLGY 182
             +HRDL+  N+L+  +    K+ADFGLAR I     EY+ R+    P K  APE  + +
Sbjct: 123 NYIHRDLRAANVLVS-ESLMCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPE-AINF 178

Query: 183 TGYSTPIDVWAVGCIFAEMIT-GKPLFP 209
             ++   DVW+ G +  E++T GK  +P
Sbjct: 179 GSFTIKSDVWSFGILLYEIVTYGKIPYP 206

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 84.7 bits (209), Expect = 2e-18
 Identities = 65/242 (26%), Positives = 119/242 (49%), Gaps = 42/242 (17%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMM--TIQTEQEGVPSYIIREVSLLKELEH 65
           +++ +K IG G +GEV   +   TG   A+K++      E+E V ++I  E  +L E + 
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQV-AHIRAERDILVEADG 60

Query: 66  ENIVRLLDVQSSRKDVFLVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
             +V++      +++++L+ E+L   D+ + + + K+TL+    +  + + +L +   H 
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQ 119

Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK-EYSRDCVYSP----------- 172
           L  +HRD+KP+NLL+D  +  VKL+DFGL   +    + E+ R+  ++P           
Sbjct: 120 LGFIHRDIKPDNLLLD-AKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNS 178

Query: 173 -----------------------YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFP 209
                                  Y APE+ +  TGY+   D W++G I  EM+ G P F 
Sbjct: 179 KRKAETWKKNRRQLAYSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPFC 237

Query: 210 SK 211
           S+
Sbjct: 238 SE 239

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 82.4 bits (204), Expect = 3e-18
 Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 22/204 (10%)

Query: 13  KKIGAGGYGEVYKCR-NTVTGQKVAIKMMTIQTEQ-EGVPSYIIREVSLLKELEHENIVR 70
           KK+G G +G V +   +T  G+ + + +  +++++   +    ++E +++  L+HEN++R
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60

Query: 71  LLDVQSSRKDVFLVFEYLDLDLHSFITR-HKNTLNLLVIKAILK---QILLGLAYCHSLK 126
           L  V  +   + +V E   L   S + R  K+ L   +I  +     QI  G+ Y  S +
Sbjct: 61  LYGVVLTHP-LMMVTELAPLG--SLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117

Query: 127 ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK-------APELL 179
            +HRDL   N+L+    + VK+ DFGL RA+   +  Y    V   +        APE  
Sbjct: 118 FIHRDLAARNILL-ASDDKVKIGDFGLMRALPQNEDHY----VMEEHLKVPFAWCAPE-S 171

Query: 180 LGYTGYSTPIDVWAVGCIFAEMIT 203
           L    +S   DVW  G    EM T
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 82.0 bits (202), Expect = 4e-18
 Identities = 55/191 (28%), Positives = 97/191 (50%), Gaps = 6/191 (3%)

Query: 13  KKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLL 72
           ++IG G +GEV+  R       VA+K    +T    + +  ++E  +LK+  H NIVRL+
Sbjct: 1   ERIGRGNFGEVFSGRLRADNTPVAVKSCR-ETLPPDLKAKFLQEARILKQYSHPNIVRLI 59

Query: 73  DVQSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRD 131
            V + ++ +++V E +   D  +F+      L +  +  +++    G+ Y  S   +HRD
Sbjct: 60  GVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRD 119

Query: 132 LKPNNLLIDLKRNTVKLADFGLAR--AIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPI 189
           L   N L+  ++N +K++DFG++R    GV         +   + APE  L Y  YS+  
Sbjct: 120 LAARNCLVT-EKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPE-ALNYGRYSSES 177

Query: 190 DVWAVGCIFAE 200
           DVW+ G +  E
Sbjct: 178 DVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 81.7 bits (202), Expect = 4e-18
 Identities = 55/197 (27%), Positives = 98/197 (49%), Gaps = 11/197 (5%)

Query: 13  KKIGAGGYGEVYKCRNTVTGQKVAIKM--MTIQTEQEGVPSYIIREVSLLKELEHENIVR 70
           +KIG G +G+VYK        +VA+K    T+  + +      ++E  +LK+ +H NIV+
Sbjct: 1   EKIGKGNFGDVYKGVLK-GNTEVAVKTCRSTLPPDLK---RKFLQEAEILKQYDHPNIVK 56

Query: 71  LLDVQSSRKDVFLVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILH 129
           L+ V   ++ +++V E +    L +F+ + KN L +  +  +      G+ Y  S   +H
Sbjct: 57  LIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIH 116

Query: 130 RDLKPNNLLIDLKRNTVKLADFGLAR--AIGVPQKEYSRDCVYSPYKAPELLLGYTGYST 187
           RDL   N L+    N +K++DFG++R    G+         +   + APE  L Y  Y++
Sbjct: 117 RDLAARNCLVGEN-NVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPE-ALNYGRYTS 174

Query: 188 PIDVWAVGCIFAEMITG 204
             DVW+ G +  E  + 
Sbjct: 175 ESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 82.5 bits (204), Expect = 5e-18
 Identities = 78/307 (25%), Positives = 135/307 (43%), Gaps = 34/307 (11%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
           +++K+ ++GAG  G V K  +  +G  +A K++ ++ +   + + IIRE+ +L E     
Sbjct: 2   DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPA-IRNQIIRELKVLHECNSPY 60

Query: 68  IVRLLDVQSSRKDVFLVFEYLD---LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
           IV       S  ++ +  E++D   LD    + +    +   ++  I   +L GL Y   
Sbjct: 61  IVGFYGAFYSDGEISICMEHMDGGSLDQ---VLKKAGRIPENILGKISIAVLRGLTYLRE 117

Query: 125 -LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS-PYKAPELLLGY 182
             KI+HRD+KP+N+L++  R  +KL DFG++   G      +   V +  Y +PE L G 
Sbjct: 118 KHKIMHRDVKPSNILVN-SRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQG- 172

Query: 183 TGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILP 242
           T Y+   D+W++G    EM  G+   P      L  +F         S  E+      + 
Sbjct: 173 THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMF-----GRPVSEGEAKESHRPVS 227

Query: 243 LYPHFEPANLA----------EKFPNLEPAG-----VDLLSQMLCLNPKQRITAMDALKH 287
            +P   P  +A          E  P L          D + + L  NPK+R    +  KH
Sbjct: 228 GHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287

Query: 288 EYLIGVE 294
            ++   E
Sbjct: 288 PFIKRAE 294

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 82.0 bits (202), Expect = 5e-18
 Identities = 70/204 (34%), Positives = 105/204 (51%), Gaps = 19/204 (9%)

Query: 14  KIGAGGYGEVYKCRNTVTGQ-KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLL 72
           K+G G +GEV+    T  G  +VAIK +   T     P   ++E  ++K+L HE +V+L 
Sbjct: 13  KLGQGCFGEVW--MGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLY 67

Query: 73  DVQSSRKDVFLVFEYLDL-DLHSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHR 130
            V  S + +++V EY+    L  F+       L L  +  +  QI  G+AY   +  +HR
Sbjct: 68  AV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 126

Query: 131 DLKPNNLLIDLKRNTV-KLADFGLARAIGVPQKEYS-RDCVYSPYK--APELLLGYTGYS 186
           DL+  N+L+    N V K+ADFGLAR I     EY+ R     P K  APE  L Y  ++
Sbjct: 127 DLRAANILVG--ENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAAL-YGRFT 181

Query: 187 TPIDVWAVGCIFAEMIT-GKPLFP 209
              DVW+ G +  E+ T G+  +P
Sbjct: 182 IKSDVWSFGILLTELTTKGRVPYP 205

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 82.0 bits (203), Expect = 6e-18
 Identities = 66/244 (27%), Positives = 108/244 (44%), Gaps = 55/244 (22%)

Query: 13  KKIGAGGYGEVYKCRNTVTGQK----------------VAIKMMTIQTEQEGVPSYIIRE 56
           +K+G G +GEV+ C                        VA+K++      +      ++E
Sbjct: 11  EKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLR-PDASDNAREDFLKE 69

Query: 57  VSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRH----------KNTLNL 105
           V +L  L   NI RLL V +    + ++ EY++  DL+ F+ +H            +L+ 
Sbjct: 70  VKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSF 129

Query: 106 LVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYS 165
             +  +  QI  G+ Y  SL  +HRDL   N L+  K  T+K+ADFG++R +      YS
Sbjct: 130 STLLYMATQIASGMRYLESLNFVHRDLATRNCLVG-KNYTIKIADFGMSRNL------YS 182

Query: 166 RDCVYSPYK------------APELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH 213
            D  Y  Y+            A E +L    ++T  DVWA G    E++T   L   + +
Sbjct: 183 SD--Y--YRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWAFGVTLWEILT---LCREQPY 234

Query: 214 DHLS 217
           +HL+
Sbjct: 235 EHLT 238

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 81.7 bits (202), Expect = 8e-18
 Identities = 63/228 (27%), Positives = 98/228 (42%), Gaps = 49/228 (21%)

Query: 12  IKKIGAGGYGEVYK--CRNTVTGQK---VAIKMMTIQTEQEGVPSYIIREVSLLKELEHE 66
            +++G G +G+V+   C +         VA+K +      +    +  RE  LL   +HE
Sbjct: 10  KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFE-REAELLTNFQHE 68

Query: 67  NIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKA-------------IL 112
           NIV+   V +      +VFEY++  DL+ F+  H      L                 I 
Sbjct: 69  NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128

Query: 113 KQILLGLAYCHSLKILHRDLKPNNLLI--DLKRNTVKLADFGLARAIGVPQKEYSRDCVY 170
            QI  G+ Y  S   +HRDL   N L+  DL    VK+ DFG++R +      Y+ D  Y
Sbjct: 129 VQIASGMVYLASQHFVHRDLATRNCLVGYDL---VVKIGDFGMSRDV------YTTD--Y 177

Query: 171 SPYK------------APELLLGYTGYSTPIDVWAVGCIFAEMIT-GK 205
             Y+             PE ++ Y  ++T  DVW+ G +  E+ T GK
Sbjct: 178 --YRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVVLWEIFTYGK 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 81.2 bits (200), Expect = 8e-18
 Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 9/215 (4%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y  ++ +G G +G     ++  + QK A+K + +      V     +E  LL +++H N
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSR-KEAVLLAKMKHPN 59

Query: 68  IVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILK---QILLGLAYCH 123
           IV   +   +   +++V EY D  DL   I   +    L     IL+   Q+ LG+ + H
Sbjct: 60  IVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRG--KLFPEDTILQWFVQMCLGVQHIH 117

Query: 124 SLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYT 183
             ++LHRD+K  N+ +  +   VKL DFG AR +  P   Y+   V +PY  P  +    
Sbjct: 118 EKRVLHRDIKSKNIFLT-QNGKVKLGDFGSARLLTSPGA-YACTYVGTPYYVPPEIWENM 175

Query: 184 GYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSL 218
            Y+   D+W++GCI  E+ T K  F +    +L L
Sbjct: 176 PYNNKSDIWSLGCILYELCTLKHPFQANSWKNLIL 210

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 80.4 bits (198), Expect = 1e-17
 Identities = 68/205 (33%), Positives = 106/205 (51%), Gaps = 17/205 (8%)

Query: 12  IKKIGAGGYGEVYKCRNTVTGQ-KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVR 70
           IKK+G G +GEV+    T  G  KVA+K +   T     P   + E  ++K+L H+ +V+
Sbjct: 11  IKKLGNGQFGEVW--MGTWNGNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQ 65

Query: 71  LLDVQSSRKDVFLVFEYLDL-DLHSFITRHKN-TLNLLVIKAILKQILLGLAYCHSLKIL 128
           L  V  S + +++V EY+    L  F+   +   L L  +  +  Q+  G+AY   +  +
Sbjct: 66  LYAV-VSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYI 124

Query: 129 HRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYS-RDCVYSPYK--APELLLGYTGY 185
           HRDL+  N+L+       K+ADFGLAR I     EY+ R     P K  APE  L Y  +
Sbjct: 125 HRDLRSANILVG-DGLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAAL-YGRF 180

Query: 186 STPIDVWAVGCIFAEMIT-GKPLFP 209
           +   DVW+ G +  E++T G+  +P
Sbjct: 181 TIKSDVWSFGILLTELVTKGRVPYP 205

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 80.5 bits (198), Expect = 2e-17
 Identities = 61/204 (29%), Positives = 106/204 (51%), Gaps = 17/204 (8%)

Query: 13  KKIGAGGYGEVYKCR-NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRL 71
           KK+GAG +GEV+    N  T  KVA+K M   +         + E +++K L+H+ +V+L
Sbjct: 12  KKLGAGQFGEVWMATYNKHT--KVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKL 66

Query: 72  LDVQSSRKDVFLVFEYLDL-DLHSFI-TRHKNTLNLLVIKAILKQILLGLAYCHSLKILH 129
             V  +++ ++++ E++    L  F+ +   +   L  +     QI  G+A+      +H
Sbjct: 67  HAV-VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIH 125

Query: 130 RDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY-SRDCVYSPYK--APELLLGYTGYS 186
           RDL+  N+L+       K+ADFGLAR I     EY +R+    P K  APE  + +  ++
Sbjct: 126 RDLRAANILVS-ASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPE-AINFGSFT 181

Query: 187 TPIDVWAVGCIFAEMIT-GKPLFP 209
              DVW+ G +  E++T G+  +P
Sbjct: 182 IKSDVWSFGILLMEIVTYGRIPYP 205

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 80.9 bits (199), Expect = 2e-17
 Identities = 65/210 (30%), Positives = 107/210 (50%), Gaps = 9/210 (4%)

Query: 4   LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKM-MTIQTEQEGVPSYI--IREVSLL 60
           LK    K++K +G+G +G VYK      G+ V I + + I  E  G  + +  + E  ++
Sbjct: 4   LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIM 63

Query: 61  KELEHENIVRLLDVQSSRKDVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAILKQILLGL 119
             ++H ++VRLL V  S   + LV + +    L  ++  HK+ +   ++     QI  G+
Sbjct: 64  ASMDHPHLVRLLGVCLS-PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGM 122

Query: 120 AYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPEL- 178
            Y    +++HRDL   N+L+    N VK+ DFGLAR +   +KEY+ D    P K   L 
Sbjct: 123 MYLEERRLVHRDLAARNVLVK-SPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 181

Query: 179 LLGYTGYSTPIDVWAVGCIFAEMIT--GKP 206
            + Y  ++   DVW+ G    E++T  GKP
Sbjct: 182 CIHYRKFTHQSDVWSYGVTIWELMTFGGKP 211

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 79.8 bits (197), Expect = 2e-17
 Identities = 59/204 (28%), Positives = 96/204 (47%), Gaps = 23/204 (11%)

Query: 7   LNYKKIKK---IGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL 63
           +N K++K    IG G +G+V        GQKVA+K +  + +     +++  E S++  L
Sbjct: 3   INSKELKLGATIGKGEFGDVML--GDYRGQKVAVKCL--KDDSTAAQAFLA-EASVMTTL 57

Query: 64  EHENIVRLLDVQSSRKDVFLVFEYLD----LDLHSFITRHKNTLNLLVIKAILKQILLGL 119
            H N+V+LL V      +++V EY+     +D      R   TL   +  A+   +  G+
Sbjct: 58  RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFAL--DVCEGM 115

Query: 120 AYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APE 177
            Y      +HRDL   N+L+  +    K++DFGLA+          +D    P K  APE
Sbjct: 116 EYLEEKNFVHRDLAARNVLVS-EDLVAKVSDFGLAKE-----ASQGQDSGKLPVKWTAPE 169

Query: 178 LLLGYTGYSTPIDVWAVGCIFAEM 201
             L    +ST  DVW+ G +  E+
Sbjct: 170 -ALREKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 80.7 bits (199), Expect = 2e-17
 Identities = 56/197 (28%), Positives = 99/197 (50%), Gaps = 7/197 (3%)

Query: 15  IGAGGYGEVYKCRNTVTGQKVAIKMMT---IQTEQEGVPSYIIREVSLLKELEHENIVRL 71
           IG G +G+V + R   T +  A+K +    I +  E   ++ + E ++L ++    IV L
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSE--VTHTLAERTVLAQVNCPFIVPL 58

Query: 72  LDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRD 131
                S + ++LV  +++        + +   +L   +    ++L  L   H   +++RD
Sbjct: 59  KFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRD 118

Query: 132 LKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDV 191
           LKP N+L+D + + + L DFGL +       + +  C    Y APELLLG+ GY+  +D 
Sbjct: 119 LKPENILLDYQGH-IALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGH-GYTKAVDW 176

Query: 192 WAVGCIFAEMITGKPLF 208
           W +G +  EM+TG P F
Sbjct: 177 WTLGVLLYEMLTGLPPF 193

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 79.9 bits (197), Expect = 2e-17
 Identities = 58/214 (27%), Positives = 116/214 (54%), Gaps = 25/214 (11%)

Query: 6   NLNYKKIKK-IGAGGYGEVYKCRNTVTGQK---VAIKMMTI-QTEQEGVPSYIIREVSLL 60
           +++  KI++ IGAG +GEV + R  + G++   VAIK +    TE++      + E S++
Sbjct: 2   DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQ--RRDFLSEASIM 59

Query: 61  KELEHENIVRLLDVQSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGL 119
            + +H NI+ L  V +  + V ++ E+++   L SF+ ++     ++ +  +L+ I  G+
Sbjct: 60  GQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGM 119

Query: 120 AYCHSLKILHRDLKPNNLLIDLKRNTV-KLADFGLARAIGVPQKEYSRDCVYSP------ 172
            Y   +  +HRDL   N+L++   N V K++DFGL+R +    ++ + D  Y+       
Sbjct: 120 KYLSEMNYVHRDLAARNILVN--SNLVCKVSDFGLSRFL----EDDTSDPTYTSSLGGKI 173

Query: 173 ---YKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
              + APE  + Y  +++  DVW+ G +  E+++
Sbjct: 174 PIRWTAPE-AIAYRKFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 80.5 bits (198), Expect = 3e-17
 Identities = 61/220 (27%), Positives = 112/220 (50%), Gaps = 8/220 (3%)

Query: 3   KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKE 62
           +LK+ ++++I ++GAG  G V K ++  +G  +A K++ ++  +  + + IIRE+ +L E
Sbjct: 1   ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHE 59

Query: 63  LEHENIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYC 122
                IV       S  ++ +  E++D      + +    +   ++  +   +L GLAY 
Sbjct: 60  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYL 119

Query: 123 HSL-KILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS-PYKAPELLL 180
               +I+HRD+KP+N+L++  R  +KL DFG++   G      +   V +  Y +PE L 
Sbjct: 120 REKHQIMHRDVKPSNILVN-SRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQ 175

Query: 181 GYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIF 220
           G T YS   D+W++G    E+  G+   P      L  IF
Sbjct: 176 G-THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIF 214

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 79.3 bits (195), Expect = 3e-17
 Identities = 64/204 (31%), Positives = 105/204 (51%), Gaps = 32/204 (15%)

Query: 15  IGAGGYGEVYKCRNTVTGQK-VAIKMMTIQTEQEGVPSYI----IREVSLLKELEHENIV 69
           +G G +GEV+K   T+  +  VA+K     T +E +P  +    + E  +LK+ +H NIV
Sbjct: 3   LGKGNFGEVFK--GTLKDKTPVAVK-----TCKEDLPQELKIKFLSEARILKQYDHPNIV 55

Query: 70  RLLDVQSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKIL 128
           +L+ V + R+ +++V E +   D  SF+ + K+ L    +         G+AY  S   +
Sbjct: 56  KLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCI 115

Query: 129 HRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS-------PYK--APELL 179
           HRDL   N L+  + N +K++DFG++R     Q++   D +YS       P K  APE  
Sbjct: 116 HRDLAARNCLVG-ENNVLKISDFGMSR-----QED---DGIYSSSGLKQIPIKWTAPE-A 165

Query: 180 LGYTGYSTPIDVWAVGCIFAEMIT 203
           L Y  YS+  DVW+ G +  E  +
Sbjct: 166 LNYGRYSSESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 79.6 bits (196), Expect = 4e-17
 Identities = 75/287 (26%), Positives = 125/287 (43%), Gaps = 41/287 (14%)

Query: 15  IGAGGYGEVYKCRNTVTGQKVAIKMM-TIQTEQEGVPSYIIREVSLLKELEHENIVRLLD 73
           +G GG+GEV   +   TG+  A K +   + +++      + E  +L+++    IV L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 74  VQSSRKDVFLVFEYL---DLDLHSFITRHKNTLNLLVIKAIL--KQILLGLAYCHSLKIL 128
              S+  + LV   +   DL  H +   +     L + + I    QI  G+ + HS+ I+
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIY---NVGERGLEMERVIHYSAQITCGILHLHSMDIV 117

Query: 129 HRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ-KEYSRDCVYSPYKAPELLLGYTGYST 187
           +RD+KP N+L+D + N  +L+D GL  A+ +   K  ++    + Y APE+L     YS 
Sbjct: 118 YRDMKPENVLLDDQGN-CRLSDLGL--AVELKDGKTITQRAGTNGYMAPEILKEEP-YSY 173

Query: 188 PIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHF 247
           P+D +A+GC   EM+ G+  F   K                E  A+       L     F
Sbjct: 174 PVDWFAMGCSIYEMVAGRTPFKDHK----------------EKVAKEELKRRTLEDEVKF 217

Query: 248 EPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAM----DALKHEYL 290
           E  N  E+         D+    L   P+ R+ +     D  KHE+ 
Sbjct: 218 EHQNFTEE-------SKDICRLFLAKKPEDRLGSREKNDDPRKHEFF 257

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 79.2 bits (195), Expect = 4e-17
 Identities = 66/202 (32%), Positives = 107/202 (52%), Gaps = 24/202 (11%)

Query: 12  IKKIGAGGYGEVY--KCRNTVTGQ-KVAIKMMTIQTEQEGVPSY--IIREVSLLKELEHE 66
           +K++G G +G V   K R    GQ  VAIKM+     +EG  S    I E  ++ +L HE
Sbjct: 9   LKELGTGQFGVVKYGKWR----GQYDVAIKMI-----KEGSMSEDEFIEEAKVMMKLSHE 59

Query: 67  NIVRLLDVQSSRKDVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSL 125
            +V+L  V + ++ +++V EY+    L +++  H        +  + K +  G+AY  S 
Sbjct: 60  KLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK 119

Query: 126 KILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY----KAPELLLG 181
           + +HRDL   N L+D  +  VK++DFGL+R   V   EY+   V S +      PE+LL 
Sbjct: 120 QFIHRDLAARNCLVD-DQGCVKVSDFGLSRY--VLDDEYTSS-VGSKFPVRWSPPEVLL- 174

Query: 182 YTGYSTPIDVWAVGCIFAEMIT 203
           Y+ +S+  DVWA G +  E+ +
Sbjct: 175 YSKFSSKSDVWAFGVLMWEVYS 196

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 80.2 bits (198), Expect = 4e-17
 Identities = 65/207 (31%), Positives = 112/207 (54%), Gaps = 17/207 (8%)

Query: 12  IKKIGAGGYGEVYKCRNTV---TGQKVAIKMM---TIQTEQEGVPSYIIREVSLLKELEH 65
           +K +G GGYG+V++ R      TG+  A+K++   TI   Q+   ++   E ++L+ ++H
Sbjct: 1   LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDT-AHTKAERNILEAVKH 59

Query: 66  ENIVRLLDVQSSRKDVFLVFEYL---DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYC 122
             IV L+    +   ++L+ EYL   +L +H  + R    +        L +I L L + 
Sbjct: 60  PFIVDLIYAFQTGGKLYLILEYLSGGELFMH--LEREGIFMED-TACFYLSEISLALEHL 116

Query: 123 HSLKILHRDLKPNNLLIDLKRNTVKLADFGLAR-AIGVPQKEYSRDCVYSPYKAPELLLG 181
           H   I++RDLKP N+L+D  +  VKL DFGL + +I      ++  C    Y APE+L+ 
Sbjct: 117 HQQGIIYRDLKPENILLD-AQGHVKLTDFGLCKESIHEGTVTHTF-CGTIEYMAPEILM- 173

Query: 182 YTGYSTPIDVWAVGCIFAEMITGKPLF 208
            +G+   +D W++G +  +M+TG P F
Sbjct: 174 RSGHGKAVDWWSLGALMYDMLTGAPPF 200

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 80.0 bits (197), Expect = 4e-17
 Identities = 61/205 (29%), Positives = 103/205 (50%), Gaps = 12/205 (5%)

Query: 13  KKIGAGGYGEV----YKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVS-LLKELEHEN 67
           K IG G +G+V     K   +    KV  K   ++ +++   ++I+ E + LLK L+H  
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQ---NHIMAERNVLLKNLKHPF 57

Query: 68  IVRL-LDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
           +V L    Q++ K ++ V +Y++     F  + +        +    ++   + Y HSL 
Sbjct: 58  LVGLHYSFQTAEK-LYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN 116

Query: 127 ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYS 186
           I++RDLKP N+L+D + + V L DFGL +    P++  S  C    Y APE+L     Y 
Sbjct: 117 IIYRDLKPENILLDSQGHVV-LTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEP-YD 174

Query: 187 TPIDVWAVGCIFAEMITGKPLFPSK 211
             +D W +G +  EM+ G P F S+
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSR 199

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 80.1 bits (197), Expect = 7e-17
 Identities = 65/244 (26%), Positives = 116/244 (47%), Gaps = 46/244 (18%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMM----TIQTEQEGVPSYIIREVSLLKEL 63
           +++ +K IG G +GEV   +   TG   A+K++     ++ EQ G   +I  E  +L E 
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVG---HIRAERDILVEA 58

Query: 64  EHENIVRLLDVQSSRKDVFLVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYC 122
           +   +V++      + +++L+ E+L   D+ + + + K+TL     +  + + +L +   
Sbjct: 59  DSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSI 117

Query: 123 HSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK-EYSRDCVYS---------- 171
           H L  +HRD+KP+NLL+D  +  VKL+DFGL   +    + E+ R+  +S          
Sbjct: 118 HQLGFIHRDIKPDNLLLD-SKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNM 176

Query: 172 ------------------------PYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPL 207
                                    Y APE+ +  TGY+   D W++G I  EM+ G P 
Sbjct: 177 NSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPP 235

Query: 208 FPSK 211
           F S+
Sbjct: 236 FCSE 239

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 78.6 bits (194), Expect = 1e-16
 Identities = 65/216 (30%), Positives = 99/216 (45%), Gaps = 31/216 (14%)

Query: 11  KIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQ---TEQEGVPSYIIREVSLLKELE--- 64
            I+++G G YG V K R+  TG  +A+K +       EQ+           LL +L+   
Sbjct: 5   VIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQK----------RLLMDLDISM 54

Query: 65  ----HENIVRLLDVQSSRKDVFLVFEYLDLDLHSF---ITRHKNTLNLLVIKAILKQILL 117
                   V          DV++  E +D  L  F   +     T+   ++  I   I+ 
Sbjct: 55  RSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVK 114

Query: 118 GLAYCHS-LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAP 176
            L Y HS L ++HRD+KP+N+LI+ +   VKL DFG++  + V     + D    PY AP
Sbjct: 115 ALEYLHSKLSVIHRDVKPSNVLIN-RNGQVKLCDFGISGYL-VDSVAKTIDAGCKPYMAP 172

Query: 177 ELL---LGYTGYSTPIDVWAVGCIFAEMITGKPLFP 209
           E +   L   GY    DVW++G    E+ TG+  FP
Sbjct: 173 ERINPELNQKGYDVKSDVWSLGITMIELATGR--FP 206

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 78.5 bits (193), Expect = 1e-16
 Identities = 65/215 (30%), Positives = 103/215 (47%), Gaps = 30/215 (13%)

Query: 12  IKKIGAGGYGEVYKCRNTVTGQKVAIKMMT----IQTEQEGVPSYIIREVSLLKEL-EHE 66
           I+ IG G YG+V+K  N   G K A+K++     I  E E        E ++LK L +H 
Sbjct: 23  IETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEA-------EYNILKALSDHP 75

Query: 67  NIVRLLDVQSSRKDV------FLVFEYLD----LDLHSFITRHKNTLNLLVIKAILKQIL 116
           N+V+   +   +KDV      +LV E  +     DL     +    +   +I  IL + L
Sbjct: 76  NVVKFYGMYY-KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEAL 134

Query: 117 LGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY-KA 175
           +GL + H  K +HRD+K NN+L+  +   VKL DFG++  +    +      V +P+  A
Sbjct: 135 MGLQHLHVNKTIHRDVKGNNILLTTE-GGVKLVDFGVSAQL-TSTRLRRNTSVGTPFWMA 192

Query: 176 PELLLGY----TGYSTPIDVWAVGCIFAEMITGKP 206
           PE++       + Y    DVW++G    E+  G P
Sbjct: 193 PEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP 227

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 78.1 bits (192), Expect = 1e-16
 Identities = 63/216 (29%), Positives = 102/216 (47%), Gaps = 34/216 (15%)

Query: 14  KIGAGGYGEVY--KCRNTVTGQ-KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVR 70
           ++G G +G+V+  +C N +  Q K+ + +  ++   E       RE  LL  L+H++IVR
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 71  LLDVQSSRKDVFLVFEYLDL-DLHSFITRHK--------------NTLNLLVIKAILKQI 115
              V +  + + +VFEY+   DL+ F+  H                 L L  + AI  QI
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 116 LLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRD-------- 167
             G+ Y  SL  +HRDL   N L+  +   VK+ DFG++R I      YS D        
Sbjct: 132 ASGMVYLASLHFVHRDLATRNCLVG-QGLVVKIGDFGMSRDI------YSTDYYRVGGRT 184

Query: 168 CVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
            +   +  PE +L Y  ++T  D+W+ G +  E+ T
Sbjct: 185 MLPIRWMPPESIL-YRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 78.1 bits (192), Expect = 1e-16
 Identities = 66/216 (30%), Positives = 105/216 (48%), Gaps = 27/216 (12%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHEN 67
           ++ ++ +G G YG+VYK R+  TGQ  AIK+M +  ++E     I  E+++LK+   H N
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE---EEIKLEINMLKKYSHHRN 74

Query: 68  IVRLLDVQSSRK------DVFLVFEYLDL-DLHSFITRHK-NTLNLLVIKAILKQILLGL 119
           I         +        ++LV E+     +   +   K N L    I  I ++IL GL
Sbjct: 75  IATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGL 134

Query: 120 AYCHSLKILHRDLKPNNLLIDLKRNTVKLADFG----LARAIGVPQKEYSRDCVYSPY-K 174
           A+ H+ K++HRD+K  N+L+  +   VKL DFG    L R +G          + +PY  
Sbjct: 135 AHLHAHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVG-----RRNTFIGTPYWM 188

Query: 175 APELLL----GYTGYSTPIDVWAVGCIFAEMITGKP 206
           APE++         Y    D+W++G    EM  G P
Sbjct: 189 APEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP 224

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 79.3 bits (195), Expect = 1e-16
 Identities = 76/315 (24%), Positives = 130/315 (41%), Gaps = 80/315 (25%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQ-TEQEGVPSYIIREVSLLKELEHEN 67
           + KIK +G G +GEV       T    A+K +  +        +++  E  +L E ++E 
Sbjct: 3   FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62

Query: 68  IVRLLDVQSSRKDVFLVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
           +V+L      + +++ V +Y+   D+ S + R +    +L  +  + ++ L +   H + 
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLA-RFYIAELTLAIESVHKMG 121

Query: 127 ILHRDLKPNNLLIDLKRNTVKLADFGLA-------------------------------- 154
            +HRD+KP+N+LIDL  + +KL DFGL                                 
Sbjct: 122 FIHRDIKPDNILIDLDGH-IKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180

Query: 155 --------------RAIGVPQKEYSRDCVYSP-YKAPELLLGYTGYSTPIDVWAVGCIFA 199
                         RA    Q+  +   V +P Y APE+LL   GY+   D W+VG I  
Sbjct: 181 SNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQLCDWWSVGVILF 239

Query: 200 EMITGKPLF--PSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFP 257
           EM+ G+P F  P+     L +I          +W  + +I           P  +     
Sbjct: 240 EMLVGQPPFLAPTPTETQLKVI----------NWENTLHI-----------PPQV----- 273

Query: 258 NLEPAGVDLLSQMLC 272
            L P  VDL++++ C
Sbjct: 274 KLSPEAVDLITKLCC 288

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 78.3 bits (193), Expect = 2e-16
 Identities = 69/226 (30%), Positives = 115/226 (50%), Gaps = 19/226 (8%)

Query: 12  IKKIGAGGYGEVY---KCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           +K +G G +G+V+   K      GQ  A+K++   T +         E  +L E+ H  I
Sbjct: 1   LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFI 60

Query: 69  VRLLDVQSSRKDVFLVFEYL---DLDLHSFITRHKNTLNLLV--IKAILKQILLGLAYCH 123
           V+L     +   ++L+ ++L   DL      TR    +      +K  L ++ L L + H
Sbjct: 61  VKLHYAFQTEGKLYLILDFLRGGDL-----FTRLSKEVMFTEEDVKFYLAELALALDHLH 115

Query: 124 SLKILHRDLKPNNLLIDLKRNTVKLADFGLAR-AIGVPQKEYSRDCVYSPYKAPELLLGY 182
           SL I++RDLKP N+L+D +   +KL DFGL++ +I   +K YS  C    Y APE ++  
Sbjct: 116 SLGIIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSF-CGTVEYMAPE-VVNR 172

Query: 183 TGYSTPIDVWAVGCIFAEMITGKPLFPSK-KHDHLSLIF-SLLGTP 226
            G++   D W+ G +  EM+TG   F  K + + +++I  + LG P
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMP 218

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 77.8 bits (191), Expect = 2e-16
 Identities = 66/216 (30%), Positives = 107/216 (49%), Gaps = 27/216 (12%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           ++ ++ +G G YG+VYK R+  TGQ  AIK+M +  ++E     I +E+++LK+  H   
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE---EEIKQEINMLKKYSHHRN 64

Query: 69  VRLLDVQSSRKD-------VFLVFEYLDL-DLHSFITRHK-NTLNLLVIKAILKQILLGL 119
           +        +K+       ++LV E+     +   I   K NTL    I  I ++IL GL
Sbjct: 65  IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 124

Query: 120 AYCHSLKILHRDLKPNNLLIDLKRNTVKLADFG----LARAIGVPQKEYSRDCVYSPY-K 174
           ++ H  K++HRD+K  N+L+  +   VKL DFG    L R +G          + +PY  
Sbjct: 125 SHLHQHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVG-----RRNTFIGTPYWM 178

Query: 175 APELLL----GYTGYSTPIDVWAVGCIFAEMITGKP 206
           APE++         Y    D+W++G    EM  G P
Sbjct: 179 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 214

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 77.8 bits (192), Expect = 2e-16
 Identities = 64/223 (28%), Positives = 98/223 (43%), Gaps = 39/223 (17%)

Query: 15  IGAGGYGEVYKCRNTVTGQKVAIKMM---TIQTEQEGVPSYIIREVSLLKELEH------ 65
           IG G +G V K  +  +G  +A+K +     + EQ+           LL +L+       
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQK----------RLLMDLDVVMRSSD 61

Query: 66  -ENIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYC-- 122
              IV+         D ++  E +D+ L  F       L       I ++IL  +A    
Sbjct: 62  CPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLK----SVIPEEILGKIAVATV 117

Query: 123 -------HSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKA 175
                    LKI+HRD+KP+N+L+D   N +KL DFG++  + V     +RD    PY A
Sbjct: 118 KALNYLKEELKIIHRDVKPSNILLDRNGN-IKLCDFGISGQL-VDSIAKTRDAGCRPYMA 175

Query: 176 PELLL--GYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHL 216
           PE +      GY    DVW++G    E+ TGK  FP  K + +
Sbjct: 176 PERIDPSARDGYDVRSDVWSLGITLYEVATGK--FPYPKWNSV 216

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 77.7 bits (191), Expect = 3e-16
 Identities = 66/218 (30%), Positives = 108/218 (49%), Gaps = 15/218 (6%)

Query: 4   LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQK----VAIKMMTIQTEQEGVPSYIIREVSL 59
           LK   +KKIK +G+G +G VYK      G+K    VAIK +   T  +     I+ E  +
Sbjct: 4   LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-ANKEILDEAYV 62

Query: 60  LKELEHENIVRLLDVQSSRKDVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAILKQILLG 118
           +  +++ ++ RLL +  +   V L+ + +    L  ++  HK+ +    +     QI  G
Sbjct: 63  MASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 121

Query: 119 LAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--AP 176
           + Y    +++HRDL   N+L+      VK+ DFGLA+ +G  +KEY  +    P K  A 
Sbjct: 122 MNYLEERRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMAL 180

Query: 177 ELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD 214
           E +L    Y+   DVW+ G    E++T    F SK +D
Sbjct: 181 ESILHRI-YTHQSDVWSYGVTVWELMT----FGSKPYD 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 78.1 bits (192), Expect = 3e-16
 Identities = 72/289 (24%), Positives = 126/289 (43%), Gaps = 48/289 (16%)

Query: 8   NYKKIKKIGAGGYGEVYKCR-------NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLL 60
           N++ +K +G G YG+V+  R         +   KV  K   +Q  +    +   R V   
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNV--- 57

Query: 61  KELEHEN----IVRLLDVQSSRKDVFLVFEYL---DLDLHSFITRHKNTLNLLVIKAILK 113
             LEH      +V L     +   + L+ +Y+   ++  H +    ++  +   ++    
Sbjct: 58  --LEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY---QRDNFSEDEVRFYSG 112

Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRD-CVYSP 172
           +I+L L + H L I++RD+K  N+L+D + + V L DFGL++     +KE +   C    
Sbjct: 113 EIILALEHLHKLGIVYRDIKLENILLDSEGHVV-LTDFGLSKEFLSEEKERTYSFCGTIE 171

Query: 173 YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWA 232
           Y APE++ G  G+   +D W++G +  E++TG   F                T   E   
Sbjct: 172 YMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPF----------------TLEGERNT 215

Query: 233 ESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITA 281
           +S     IL   P F           + P   DLL ++L  +PK+R+ A
Sbjct: 216 QSEVSRRILKCDPPFPSF--------IGPEAQDLLHKLLRKDPKKRLGA 256

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 77.2 bits (190), Expect = 3e-16
 Identities = 58/211 (27%), Positives = 104/211 (49%), Gaps = 14/211 (6%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQ-TEQEGVPSYIIREVSLLKELEHEN 67
           ++  + +G GG+GEV  C+   TG+  A K +  +  ++    +  + E  +L+++    
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 68  IVRLLDVQSSRKDVFLVFEYL---DLDLHSFITRHKNTLNLLVIKAIL--KQILLGLAYC 122
           +V L     ++  + LV   +   DL  H +   +         +A+    +I  GL   
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIY---NMGNPGFDEERAVFYAAEITCGLEDL 118

Query: 123 HSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS-PYKAPELLLG 181
           H  +I++RDLKP N+L+D     ++++D GL  A+ +P+ E  R  V +  Y APE ++ 
Sbjct: 119 HRERIVYRDLKPENILLD-DYGHIRISDLGL--AVEIPEGETIRGRVGTVGYMAPE-VVK 174

Query: 182 YTGYSTPIDVWAVGCIFAEMITGKPLFPSKK 212
              Y+   D W +GC+  EMI GK  F  +K
Sbjct: 175 NERYTFSPDWWGLGCLIYEMIEGKSPFRQRK 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 76.4 bits (189), Expect = 5e-16
 Identities = 73/298 (24%), Positives = 126/298 (42%), Gaps = 54/298 (18%)

Query: 4   LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREV---SLL 60
           LKN    K  K+  G +G+V   ++  T QK+ ++   I+ +      +   E     L+
Sbjct: 13  LKNCEIVKKLKLIDGKFGKVSVLKHKPT-QKLFVQK-IIKAKN-----FNAIEPMVHQLM 65

Query: 61  KELEHENIVRLLDVQSSRKDVFLVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQILLGL 119
           K+  + N ++L    ++ K   L+ +Y+ D DL   + + +  L+   +K I++Q++  L
Sbjct: 66  KD--NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL-KKEGKLSEAEVKKIIRQLVEAL 122

Query: 120 AYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ-----KEYSRDCVYSPYK 174
              H   I+H D+K  N+L D  ++ + L D+GL + IG P       +Y     +SP K
Sbjct: 123 NDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGTLDY-----FSPEK 177

Query: 175 APELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAES 234
               + G+  Y    D WAVG +  E++TG       KH            P  E   E 
Sbjct: 178 ----IKGHN-YDVSFDWWAVGVLTYELLTG-------KH------------PFKEDEDEE 213

Query: 235 TYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDA-LKHEYLI 291
             +  +L                N+     D +  ML  N   R+T  +  +KH +L 
Sbjct: 214 LDLESLLKRQ-----QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266

Length = 267

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 77.5 bits (191), Expect = 5e-16
 Identities = 63/222 (28%), Positives = 103/222 (46%), Gaps = 29/222 (13%)

Query: 3   KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMT-IQTEQEGVPSYIIREVSLLK 61
           ++K  ++  IK IG G +GEV   R+  + Q  A+K+++  +  +    ++   E  ++ 
Sbjct: 39  RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMA 98

Query: 62  ELEHENIVRLLDVQSSRKDVFLVFEYL---DLDLHSFITRHKNTLNLLVIKAI------- 111
               E IV+L       K +++V EY+   DL            +NL+    I       
Sbjct: 99  HANSEWIVQLHYAFQDDKYLYMVMEYMPGGDL------------VNLMSNYDIPEKWARF 146

Query: 112 -LKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVY 170
              +++L L   HS+  +HRD+KP+N+L+D K   +KLADFG    +           V 
Sbjct: 147 YTAEVVLALDAIHSMGFIHRDVKPDNMLLD-KSGHLKLADFGTCMKMDANGMVRCDTAVG 205

Query: 171 SP-YKAPELLL--GYTG-YSTPIDVWAVGCIFAEMITGKPLF 208
           +P Y +PE+L   G  G Y    D W+VG    EM+ G   F
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 76.5 bits (188), Expect = 6e-16
 Identities = 66/237 (27%), Positives = 110/237 (46%), Gaps = 52/237 (21%)

Query: 5   KNLNYKKIKKIGAGGYGEVYKCRNTVTGQK------------------VAIKMMTIQTEQ 46
           K L +K+  K+G G +GEV+ C     G +                  VA+KM+     +
Sbjct: 5   KRLTFKE--KLGEGQFGEVHLCE--AEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK 60

Query: 47  EGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRH------ 99
                ++ +E+ ++  L+  NI+RLL V  +   + ++ EY++  DL+ F++RH      
Sbjct: 61  NARNDFL-KEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAA 119

Query: 100 ----KNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLAR 155
                 T++   +  +  QI  G+ Y  SL  +HRDL   N L+  K  T+K+ADFG++R
Sbjct: 120 EKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVG-KNYTIKIADFGMSR 178

Query: 156 AIGVPQKEYSRDCVYSPYKA---------PELLLGYTGYSTPIDVWAVGCIFAEMIT 203
            +      YS D      +A           +LLG   ++T  DVWA G    E++T
Sbjct: 179 NL------YSGDYYRIQGRAVLPIRWMSWESILLG--KFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 77.2 bits (190), Expect = 7e-16
 Identities = 74/319 (23%), Positives = 123/319 (38%), Gaps = 79/319 (24%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMM----TIQTEQEGVPSYIIREVSLLKELE 64
           + KIK IG G +GEV   R   T    A+K +     +   Q     ++  E  +L E +
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAA---HVKAERDILAEAD 59

Query: 65  HENIVRLLDVQSSRKDVFLVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCH 123
           +E +V+L      + +++ V +Y+   D+ S + R        + +  + ++   +   H
Sbjct: 60  NEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIR-LGIFEEDLARFYIAELTCAIESVH 118

Query: 124 SLKILHRDLKPNNLLIDLKRNTVKLADFGLA----------------------------- 154
            +  +HRD+KP+N+LID +   +KL DFGL                              
Sbjct: 119 KMGFIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEW 177

Query: 155 -------------RAIGVPQKEYSRDCVYSP-YKAPELLLGYTGYSTPIDVWAVGCIFAE 200
                        R     Q+  +   V +P Y APE+LL  TGY+   D W+VG I  E
Sbjct: 178 SEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVILYE 236

Query: 201 MITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
           M+ G+P F             L  TP +       + + +     H            L 
Sbjct: 237 MLVGQPPF-------------LADTPAETQLKVINWETTL-----HIPSQ------AKLS 272

Query: 261 PAGVDLLSQMLCLNPKQRI 279
               DL+ + LC   + R+
Sbjct: 273 REASDLILR-LCCGAEDRL 290

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 77.6 bits (191), Expect = 8e-16
 Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 29/208 (13%)

Query: 18  GGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS 77
           G  G V++  +    Q+V +K         G  +  + E  LL+ L H  ++ LLDV+  
Sbjct: 180 GSEGCVFESSHPDYPQRVVVK--------AGWYASSVHEARLLRRLSHPAVLALLDVRVV 231

Query: 78  RKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
                LV      DL++++      L L  + A+ +Q+L  + Y H   I+HRD+K  N+
Sbjct: 232 GGLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENV 291

Query: 138 LIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY----------KAPELLLGYTGYST 187
           L++   + + L DFG A         ++R    +P+           APE+L G   Y+ 
Sbjct: 292 LVNGPED-ICLGDFGAAC--------FARGSWSTPFHYGIAGTVDTNAPEVLAG-DPYTP 341

Query: 188 PIDVWAVG-CIFAEMITGKPLFPSKKHD 214
            +D+W+ G  IF   +    LF + + D
Sbjct: 342 SVDIWSAGLVIFEAAVHTASLFSASRGD 369

Length = 461

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 76.4 bits (188), Expect = 8e-16
 Identities = 73/293 (24%), Positives = 126/293 (43%), Gaps = 48/293 (16%)

Query: 13  KKIGAGGYGEVYKCRNTVTGQKVAIKMM---TIQTEQEGVPSYIIREVSLLKELEHENIV 69
           K +G G +G+V   R   TG+  A+K++    I  + E   ++ + E  +L+   H  + 
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDE--VAHTLTESRVLQNTRHPFLT 58

Query: 70  RLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILH 129
            L     +   +  V EY +     F    +   +    +    +I+  L Y HS  +++
Sbjct: 59  ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVY 118

Query: 130 RDLKPNNLLIDLKRNTVKLADFGLAR---AIGVPQKEYSRDCVYSPYKAPELLLGYTGYS 186
           RDLK  NL++D K   +K+ DFGL +   + G   K +   C    Y APE+L     Y 
Sbjct: 119 RDLKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTF---CGTPEYLAPEVLED-NDYG 173

Query: 187 TPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPH 246
             +D W +G +  EM+ G+  F ++ H+ L   F L+             + EI      
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---FELI------------LMEEI------ 212

Query: 247 FEPANLAEKFP-NLEPAGVDLLSQMLCLNPKQRI-----TAMDALKHEYLIGV 293
                   +FP  L P    LL+ +L  +PKQR+      A + ++H +   +
Sbjct: 213 --------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI 257

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 75.8 bits (186), Expect = 9e-16
 Identities = 66/226 (29%), Positives = 106/226 (46%), Gaps = 45/226 (19%)

Query: 13  KKIGAGGYGEVYKCR------------NTVTGQK--VAIKMMTIQTEQEGVPSYIIREVS 58
           +K+G G +GEV+ C                 GQ   VA+KM+     +     ++ +E+ 
Sbjct: 11  EKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFL-KEIK 69

Query: 59  LLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITR--------HKNTLNLLVIK 109
           ++  L++ NI+RLL V  S   + ++ EY++  DL+ F+++        H N +  + I 
Sbjct: 70  IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIA 129

Query: 110 AIL---KQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSR 166
            +L    QI  G+ Y  SL  +HRDL   N L+     T+K+ADFG++R +      YS 
Sbjct: 130 NLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG-NHYTIKIADFGMSRNL------YSG 182

Query: 167 DCVYSPYKA---------PELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           D      +A           +LLG   ++T  DVWA G    EM T
Sbjct: 183 DYYRIQGRAVLPIRWMAWESILLG--KFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 75.9 bits (187), Expect = 1e-15
 Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 14/211 (6%)

Query: 13  KKIGAGGYGEVYKCRNTVTGQKVAIKMM----TIQTEQEGVPSYIIREVSLLKELEHENI 68
           K +G G +G+V       T +  A+K++     +Q +         R ++L  +  H  +
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGK--HPFL 58

Query: 69  VRLLDVQSSRKDVFLVFEYL---DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSL 125
            +L     ++  +F V EY+   DL  H      +         A   +I+LGL + H  
Sbjct: 59  TQLHSCFQTKDRLFFVMEYVNGGDLMFH-IQRSGRFDEPRARFYAA--EIVLGLQFLHER 115

Query: 126 KILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGY 185
            I++RDLK +N+L+D     +K+ADFG+ +   +     S  C    Y APE+L  Y  Y
Sbjct: 116 GIIYRDLKLDNVLLD-SEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILS-YQPY 173

Query: 186 STPIDVWAVGCIFAEMITGKPLFPSKKHDHL 216
              +D WA+G +  EM+ G+  F     D L
Sbjct: 174 GPAVDWWALGVLLYEMLAGQSPFEGDDEDEL 204

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 75.0 bits (184), Expect = 1e-15
 Identities = 54/198 (27%), Positives = 100/198 (50%), Gaps = 12/198 (6%)

Query: 10  KKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSY--IIREVSLLKELEHEN 67
             +++IG+G +G V+     +  +KVAIK     T +EG  S    I E  ++ +L H  
Sbjct: 7   TLVQEIGSGQFGLVWL-GYWLEKRKVAIK-----TIREGAMSEEDFIEEAQVMMKLSHPK 60

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
           +V+L  V + R  + LVFE+++   L  ++   +   +   +  +   +  G+AY  S  
Sbjct: 61  LVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN 120

Query: 127 ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS-PYKAPELLLGYTGY 185
           ++HRDL   N L+  +   VK++DFG+ R +   Q   S    +   + +PE +  ++ Y
Sbjct: 121 VIHRDLAARNCLVG-ENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPE-VFSFSKY 178

Query: 186 STPIDVWAVGCIFAEMIT 203
           S+  DVW+ G +  E+ +
Sbjct: 179 SSKSDVWSFGVLMWEVFS 196

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 75.0 bits (184), Expect = 1e-15
 Identities = 60/216 (27%), Positives = 112/216 (51%), Gaps = 16/216 (7%)

Query: 14  KIGAGGYG----EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIV 69
           ++G+G +G     VYK R       VAIK++  + E+  V   ++RE  ++ +L++  IV
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQI--DVAIKVLKNENEK-SVRDEMMREAEIMHQLDNPYIV 58

Query: 70  RLLDVQSSRKDVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKIL 128
           R++ V  + + + LV E      L+ F++  K+ + +  +  ++ Q+ +G+ Y      +
Sbjct: 59  RMIGVCEA-EALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFV 117

Query: 129 HRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY-SRDCVYSPYK--APELLLGYTGY 185
           HRDL   N+L+ + ++  K++DFGL++A+G     Y +R     P K  APE +  +  +
Sbjct: 118 HRDLAARNVLL-VNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECIN-FRKF 175

Query: 186 STPIDVWAVGCIFAEMIT--GKPLFPSKKHDHLSLI 219
           S+  DVW+ G    E  +   KP    K  + +S I
Sbjct: 176 SSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFI 211

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 75.4 bits (185), Expect = 1e-15
 Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 14/211 (6%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQ-TEQEGVPSYIIREVSLLKELEHEN 67
           +++ + +G GG+GEV  C+   TG+  A K +  +  ++    S  + E  +L+++    
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 68  IVRLLDVQSSRKDVFLVFEYL---DLDLHSFITRHKNTLNLLVIKAIL--KQILLGLAYC 122
           +V L     ++  + LV   +   DL  H +   H         +A+    +I  GL   
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIY---HMGEAGFEEGRAVFYAAEICCGLEDL 118

Query: 123 HSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS-PYKAPELLLG 181
           H  +I++RDLKP N+L+D     ++++D GL  A+ VP+ +  +  V +  Y APE++  
Sbjct: 119 HQERIVYRDLKPENILLD-DHGHIRISDLGL--AVHVPEGQTIKGRVGTVGYMAPEVVKN 175

Query: 182 YTGYSTPIDVWAVGCIFAEMITGKPLFPSKK 212
              Y+   D WA+GC+  EMI G+  F  +K
Sbjct: 176 ER-YTFSPDWWALGCLLYEMIAGQSPFQQRK 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 76.7 bits (188), Expect = 1e-15
 Identities = 56/224 (25%), Positives = 104/224 (46%), Gaps = 28/224 (12%)

Query: 9   YKKIKKIGAGGYGEVYKCR-NTVTGQKVAIKMMTIQTEQEGVP----------------- 50
           ++ I  + AG +G+++ C     T +  A +   + +  +G P                 
Sbjct: 150 FRVIDDLPAGAFGKIFICALRASTEEAEARR--GVNSTNQGKPKCERLIAKRVKAGSRAA 207

Query: 51  SYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDLDLHSFIT----RHKNTLNLL 106
             +  E+  L  L HENI+++ ++  S  + +++ +  D DL+SF+       K+   L 
Sbjct: 208 IQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLK 267

Query: 107 VIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSR 166
             +AI+KQ+L  + Y H  K++HRD+K  N+ ++     V L DFG A      ++ +  
Sbjct: 268 QTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIV-LGDFGTAMPFEKEREAFDY 326

Query: 167 DCVYS-PYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFP 209
             V +    +PE+L G  GY    D+W+ G I  +M++     P
Sbjct: 327 GWVGTVATNSPEILAG-DGYCEITDIWSCGLILLDMLS-HDFCP 368

Length = 501

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 75.2 bits (185), Expect = 1e-15
 Identities = 69/296 (23%), Positives = 123/296 (41%), Gaps = 55/296 (18%)

Query: 8   NYKKIKKIGAGGYGEVYKCR-------NTVTGQKVAIKMMTIQ-------TEQEGVPSYI 53
           N++ ++ +G G YG+V+  R         +   KV  K   +Q       T  E      
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 54  IREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYL---DLDLHSFITRHKNTLNLLVIKA 110
           +R    L  L +         Q+  K + L+ +Y+   +L  H +    +       ++ 
Sbjct: 61  VRRCPFLVTLHYA-------FQTDTK-LHLILDYVNGGELFTHLY---QREHFTESEVRV 109

Query: 111 ILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRD-CV 169
            + +I+L L + H L I++RD+K  N+L+D     V L DFGL++     ++E +   C 
Sbjct: 110 YIAEIVLALDHLHQLGIIYRDIKLENILLD-SEGHVVLTDFGLSKEFLAEEEERAYSFCG 168

Query: 170 YSPYKAPELLLGYT-GYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTD 228
              Y APE++ G + G+   +D W++G +  E++TG   F                T   
Sbjct: 169 TIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPF----------------TVDG 212

Query: 229 ESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDA 284
           E  ++S     IL   P F           +     D + ++L  +PK+R+ A  A
Sbjct: 213 EQNSQSEISRRILKSKPPFP--------KTMSAEARDFIQKLLEKDPKKRLGANGA 260

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 74.8 bits (184), Expect = 2e-15
 Identities = 68/240 (28%), Positives = 112/240 (46%), Gaps = 39/240 (16%)

Query: 13  KKIGAGGYGEVYK-----CRNTVTGQKVAIKMMTIQ-TEQEGVPSYIIREVSLLKEL-EH 65
           K +G G +G+V K       N      VA+KM+    TE++   S ++ E+ ++K + +H
Sbjct: 18  KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKH 75

Query: 66  ENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHK------NTLNLLVIKAILK----- 113
           +NI+ LL V +    +++V EY    +L  F+   +      +  +    +  L      
Sbjct: 76  KNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLV 135

Query: 114 ----QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCV 169
               Q+  G+ +  S K +HRDL   N+L+  + + +K+ADFGLAR   +   +Y R   
Sbjct: 136 SFAYQVARGMEFLASKKCIHRDLAARNVLVT-EDHVMKIADFGLAR--DIHHIDYYRKTT 192

Query: 170 YS--PYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT--GKPLFPSKKHDHLSLIFSLL 223
               P K  APE L     Y+   DVW+ G +  E+ T  G P +P    + L   F LL
Sbjct: 193 NGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSP-YPGIPVEEL---FKLL 247

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 75.0 bits (184), Expect = 2e-15
 Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 4/206 (1%)

Query: 13  KKIGAGGYGEVYKCRNTVTGQKVAIKMMT--IQTEQEGVPSYIIREVSLLKELEHENIVR 70
           K +G G +G+V        G+  A+K +   +    + V   ++ +  L    E+  +  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 71  LLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHR 130
           L     +++ +F V E+L+     F  + K   +L        +I+ GL + HS  I++R
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120

Query: 131 DLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPID 190
           DLK +N+++D +   +K+ADFG+ +         S  C    Y APE+L G   Y+  +D
Sbjct: 121 DLKLDNVMLD-RDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLK-YTFSVD 178

Query: 191 VWAVGCIFAEMITGKPLFPSKKHDHL 216
            W+ G +  EM+ G+  F     D L
Sbjct: 179 WWSFGVLLYEMLIGQSPFHGDDEDEL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 74.8 bits (184), Expect = 3e-15
 Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 10/209 (4%)

Query: 13  KKIGAGGYGEVYKCRNTVTGQKVAIKMMT--IQTEQEGVPSYIIREVSLLKELEHENIVR 70
           K +G G +G+V       T +  AIK +   +  E + V   ++    L    EH  +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60

Query: 71  LLDVQSSRKDVFLVFEYL---DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
           L     +++ +F V EYL   DL  H    +     +    +    +I+ GL + H   I
Sbjct: 61  LFCTFQTKEHLFFVMEYLNGGDLMFH---IQSSGRFDEARARFYAAEIICGLQFLHKKGI 117

Query: 128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYST 187
           ++RDLK +N+L+D K   +K+ADFG+ +     + + S  C    Y APE+L G   Y+ 
Sbjct: 118 IYRDLKLDNVLLD-KDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQK-YNE 175

Query: 188 PIDVWAVGCIFAEMITGKPLFPSKKHDHL 216
            +D W+ G +  EM+ G+  F  +  D L
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGEDEDEL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 74.6 bits (183), Expect = 3e-15
 Identities = 58/209 (27%), Positives = 103/209 (49%), Gaps = 10/209 (4%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQ-TEQEGVPSYIIREVSLLKELEHEN 67
           +++ + +G GG+GEV  C+   TG+  A K +  +  ++    S  + E  +L+++  + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 68  IVRLLDVQSSRKDVFLVFEYL---DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
           +V L     ++  + LV   +   DL  H +   +        +     +IL GL   H 
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERAL-FYAAEILCGLEDLHR 120

Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS-PYKAPELLLGYT 183
              ++RDLKP N+L+D     ++++D GL  A+ +P+ E  R  V +  Y APE +L   
Sbjct: 121 ENTVYRDLKPENILLD-DYGHIRISDLGL--AVKIPEGESIRGRVGTVGYMAPE-VLNNQ 176

Query: 184 GYSTPIDVWAVGCIFAEMITGKPLFPSKK 212
            Y+   D W +GC+  EMI G+  F  +K
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSPFRGRK 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 75.4 bits (185), Expect = 3e-15
 Identities = 66/254 (25%), Positives = 106/254 (41%), Gaps = 62/254 (24%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQ-TEQEGVPSYIIREVSLLKELEHEN 67
           + KIK +G G +GEV   R   T    A+K +  +        +++  E  +L E ++E 
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62

Query: 68  IVRLLDVQSSRKDVFLVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYC---- 122
           +VRL      + +++ V +Y+   D+ S + R      + +    L +  +    C    
Sbjct: 63  VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIR------MGIFPEDLARFYIAELTCAVES 116

Query: 123 -HSLKILHRDLKPNNLLIDLKRNTVKLADFGLA--------------------------- 154
            H +  +HRD+KP+N+LID +   +KL DFGL                            
Sbjct: 117 VHKMGFIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSN 175

Query: 155 -------------------RAIGVPQKEYSRDCVYSP-YKAPELLLGYTGYSTPIDVWAV 194
                              RA    Q+  +   V +P Y APE+LL  TGY+   D W+V
Sbjct: 176 EWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSV 234

Query: 195 GCIFAEMITGKPLF 208
           G I  EM+ G+P F
Sbjct: 235 GVILYEMLVGQPPF 248

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 73.9 bits (181), Expect = 4e-15
 Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 24/211 (11%)

Query: 13  KKIGAGGYGEVY--KCRNTVTGQ-KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIV 69
           +++G G +G+V+  +C N    Q K+ + + T++   +       RE  LL  L+HE+IV
Sbjct: 11  RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIV 70

Query: 70  RLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLV------------IKAILKQIL 116
           +   V      + +VFEY+   DL+ F+  H     L+             +  I +QI 
Sbjct: 71  KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130

Query: 117 LGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS----P 172
            G+ Y  S   +HRDL   N L+  +   VK+ DFG++R   V   +Y R   ++     
Sbjct: 131 AGMVYLASQHFVHRDLATRNCLVG-ENLLVKIGDFGMSR--DVYSTDYYRVGGHTMLPIR 187

Query: 173 YKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           +  PE ++ Y  ++T  DVW++G +  E+ T
Sbjct: 188 WMPPESIM-YRKFTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 74.3 bits (183), Expect = 4e-15
 Identities = 76/283 (26%), Positives = 117/283 (41%), Gaps = 59/283 (20%)

Query: 15  IGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIR--EV-SLLKE--------- 62
           +G G +G+V       TG+  AIK +            II   EV SL+ E         
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKG--------DIIARDEVESLMCEKRIFETANS 58

Query: 63  LEHENIVRLLDVQSSRKDVFLVFEYL---DLDLHSFITRHKNTLNLLVIKAILKQILLGL 119
             H  +V L     +   V  V EY    DL +H     H +  +          ++LGL
Sbjct: 59  ERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHI----HTDVFSEPRAVFYAACVVLGL 114

Query: 120 AYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELL 179
            Y H  KI++RDLK +NLL+D +   VK+ADFGL +         S  C    + APE+L
Sbjct: 115 QYLHENKIVYRDLKLDNLLLDTE-GFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVL 173

Query: 180 LGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIF-SLLGTPTDESWAESTYIS 238
              T Y+  +D W +G +  EM+ G+  FP    +    +F S++    DE         
Sbjct: 174 TE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE---VFDSIV---NDE--------- 217

Query: 239 EILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITA 281
                YP F                + ++ ++L  NP++R+ +
Sbjct: 218 ---VRYPRFLSRE-----------AISIMRRLLRRNPERRLGS 246

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 74.2 bits (183), Expect = 5e-15
 Identities = 58/241 (24%), Positives = 97/241 (40%), Gaps = 60/241 (24%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMT------------IQTEQEGVPSYIIRE 56
           +KKIK +G G  G V+  R   TG+  A+K++             + TEQE         
Sbjct: 3   FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQE--------- 53

Query: 57  VSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD-LDLHSFI-TRHKNTLNLLVIKAILKQ 114
             +L  L+H  +  L     +   + LV +Y    +L   +  +    L+  V +    +
Sbjct: 54  --ILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAE 111

Query: 115 ILLGLAYCHSLKILHRDLKPNNLLIDLKRNT--VKLADFGLARAIGVP------------ 160
           +LL L Y H L I++RDLKP N+L+     +  + L+DF L++   V             
Sbjct: 112 VLLALEYLHLLGIVYRDLKPENILL---HESGHIMLSDFDLSKQSDVEPPPVSKALRKGS 168

Query: 161 ----QKEYSRDCVYSP-------------YKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
                     +                  Y APE++ G  G+ + +D W +G +  EM+ 
Sbjct: 169 RRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEMLY 227

Query: 204 G 204
           G
Sbjct: 228 G 228

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 74.2 bits (182), Expect = 5e-15
 Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 23/203 (11%)

Query: 15  IGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDV 74
           IG G +G+VY+ R   T +  A+K+++ +         I+ +  +   +   NI+    +
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKE--------IVAKKEVAHTIGERNILVRTLL 52

Query: 75  QSSRKDVFLVFEY-LDLDLHSFITRHKNTLNLL------------VIKAILKQILLGLAY 121
             S   V L F +  D DL+  +T + +   L               K  + +++L L +
Sbjct: 53  DESPFIVGLKFSFQTDSDLY-LVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEH 111

Query: 122 CHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLG 181
            H   I++RDLKP N+L+D   + + L DFGL++A     K  +  C  + Y APE+LL 
Sbjct: 112 LHKYDIVYRDLKPENILLDATGH-IALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLD 170

Query: 182 YTGYSTPIDVWAVGCIFAEMITG 204
             GY+  +D W++G +  EM  G
Sbjct: 171 EKGYTKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 74.5 bits (183), Expect = 6e-15
 Identities = 79/344 (22%), Positives = 143/344 (41%), Gaps = 90/344 (26%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE--QEGVPSYIIREVSLLKELEH 65
           ++  +K IG G +GEV   +   TG+  A+K + +++E  ++   +++  E  +L E + 
Sbjct: 2   DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTL-LKSEMFKKDQLAHVKAERDVLAESDS 60

Query: 66  ENIVRLLDVQSSRKDVFLVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
             +V L       + ++L+ E+L   DL + + ++ +T +  V +  + + +L +   H 
Sbjct: 61  PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHK 119

Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLA----------------------------RA 156
           L  +HRD+KP+N+LID +   +KL+DFGL+                             +
Sbjct: 120 LGFIHRDIKPDNILID-RGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNS 178

Query: 157 IGVPQ--------------KEYSRDCVYSP-----YKAPELLLGYTGYSTPIDVWAVGCI 197
           + V                K+  R   YS      Y APE+ L   GY    D W++G I
Sbjct: 179 VAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ-GYGQECDWWSLGAI 237

Query: 198 FAEMITGKPLFPSKK-HDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKF 256
             E + G P F S+  H+    I          +W E+ Y                   F
Sbjct: 238 MFECLIGWPPFCSENSHETYRKII---------NWRETLY-------------------F 269

Query: 257 PN---LEPAGVDLLSQMLCLNPKQRI---TAMDALKHEYLIGVE 294
           P+   L     DL+ +++  N + R+    A +   H +  GV+
Sbjct: 270 PDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVD 312

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 73.2 bits (179), Expect = 6e-15
 Identities = 69/204 (33%), Positives = 106/204 (51%), Gaps = 19/204 (9%)

Query: 14  KIGAGGYGEVYKCRNTVTGQ-KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLL 72
           K+G G +GEV+    T  G  KVAIK +   T    +P   ++E  ++K+L H+ +V L 
Sbjct: 13  KLGQGCFGEVWM--GTWNGTTKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLY 67

Query: 73  DVQSSRKDVFLVFEYLDL-DLHSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHR 130
            V  S + +++V E++    L  F+       L L  +  +  QI  G+AY   +  +HR
Sbjct: 68  AV-VSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHR 126

Query: 131 DLKPNNLLIDLKRNTV-KLADFGLARAIGVPQKEYS-RDCVYSPYK--APELLLGYTGYS 186
           DL+  N+L+    N V K+ADFGLAR I     EY+ R     P K  APE  L Y  ++
Sbjct: 127 DLRAANILV--GDNLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAAL-YGRFT 181

Query: 187 TPIDVWAVGCIFAEMIT-GKPLFP 209
              DVW+ G +  E++T G+  +P
Sbjct: 182 IKSDVWSFGILLTELVTKGRVPYP 205

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 73.9 bits (181), Expect = 6e-15
 Identities = 71/292 (24%), Positives = 126/292 (43%), Gaps = 44/292 (15%)

Query: 13  KKIGAGGYGEVYKCRNTVTGQKVAIKMM---TIQTEQEGVPSYIIREVSLLKELEHENIV 69
           K +G G +G+V   R   TG+  A+K++    I  + E   ++ + E  +L+   H  + 
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE--VAHTVTESRVLQNTRHPFLT 58

Query: 70  RLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILH 129
            L     +   +  V EY +     F    +        +    +I+  L Y HS  +++
Sbjct: 59  ALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVY 118

Query: 130 RDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGYTGYSTP 188
           RD+K  NL++D K   +K+ DFGL +  G+      +    +P Y APE+L     Y   
Sbjct: 119 RDIKLENLMLD-KDGHIKITDFGLCKE-GISDGATMKTFCGTPEYLAPEVLED-NDYGRA 175

Query: 189 IDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFE 248
           +D W +G +  EM+ G+  F ++ H+ L   F L+             + EI        
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQDHERL---FELI------------LMEEI-------- 212

Query: 249 PANLAEKFP-NLEPAGVDLLSQMLCLNPKQRI-----TAMDALKHEYLIGVE 294
                 +FP  L P    LL+ +L  +PKQR+      A + ++H + + + 
Sbjct: 213 ------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 258

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 73.9 bits (181), Expect = 7e-15
 Identities = 56/204 (27%), Positives = 104/204 (50%), Gaps = 10/204 (4%)

Query: 13  KKIGAGGYGEVYKCRNTVTGQKVAIKMM---TIQTEQEGVPSYIIREVS-LLKELEHENI 68
           K IG G +G+V   +  + G+  A+K++    +   +E    +I+ E + LLK ++H  +
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKE--QKHIMAERNVLLKNVKHPFL 58

Query: 69  VRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKIL 128
           V L     + + ++ V ++++     F  + + +      +    +I   L Y HS+ I+
Sbjct: 59  VGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIV 118

Query: 129 HRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGYTGYST 187
           +RDLKP N+L+D + + V L DFGL +  G+ Q + +     +P Y APE++     Y  
Sbjct: 119 YRDLKPENILLDSQGHVV-LTDFGLCKE-GIAQSDTTTTFCGTPEYLAPEVIRKQP-YDN 175

Query: 188 PIDVWAVGCIFAEMITGKPLFPSK 211
            +D W +G +  EM+ G P F  +
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYCR 199

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 72.7 bits (178), Expect = 8e-15
 Identities = 59/202 (29%), Positives = 103/202 (50%), Gaps = 19/202 (9%)

Query: 13  KKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLL 72
           + IG G +G V +     TGQKVA+K +      +      + E +++ +L H+N+VRLL
Sbjct: 12  EIIGEGEFGAVLQ--GEYTGQKVAVKNIKCDVTAQA----FLEETAVMTKLHHKNLVRLL 65

Query: 73  DVQSSRKDVFLVFEYLDL-DLHSFI-TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHR 130
            V      +++V E +   +L +F+ TR +  ++++ +      +  G+ Y  S K++HR
Sbjct: 66  GV-ILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHR 124

Query: 131 DLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTP 188
           DL   N+L+  +    K++DFGLAR           D    P K  APE  L +  +S+ 
Sbjct: 125 DLAARNILVS-EDGVAKVSDFGLARV-----GSMGVDNSKLPVKWTAPE-ALKHKKFSSK 177

Query: 189 IDVWAVGCIFAEMIT-GKPLFP 209
            DVW+ G +  E+ + G+  +P
Sbjct: 178 SDVWSYGVLLWEVFSYGRAPYP 199

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 72.9 bits (179), Expect = 8e-15
 Identities = 59/219 (26%), Positives = 105/219 (47%), Gaps = 34/219 (15%)

Query: 8   NYKKIKKIGAGGYGEVYKCR-----NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKE 62
           N ++I  +G G +GEV+  +            V +K +  +T+ E + S   RE+ + ++
Sbjct: 6   NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQ-KTKDENLQSEFRRELDMFRK 64

Query: 63  LEHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSF--ITRHKNT------LNLLVIKAILK 113
           L H+N+VRLL +    +  +++ EY DL DL  F   T+ K+       L+     A+  
Sbjct: 65  LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124

Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           QI LG+ +  + + +HRDL   N L+  +R  VK++   L++ +      Y+ +  Y   
Sbjct: 125 QIALGMDHLSNARFVHRDLAARNCLVSSQR-EVKVSLLSLSKDV------YNSE--YYKL 175

Query: 174 K---------APELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           +         APE +     +ST  DVW+ G +  E+ T
Sbjct: 176 RNALIPLRWLAPEAVQE-DDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 73.9 bits (181), Expect = 1e-14
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 9/212 (4%)

Query: 3   KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMT-IQTEQEGVPSYIIREVSLLK 61
           ++K  +Y  +K IG G +GEV   R+  + +  A+K+++  +  +    ++   E  ++ 
Sbjct: 39  QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 98

Query: 62  ELEHENIVRLLDVQSSRKDVFLVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQILLGLA 120
                 +V+L       K +++V EY+   DL + ++ +         K    +++L L 
Sbjct: 99  FANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKW--AKFYTAEVVLALD 156

Query: 121 YCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELL 179
             HS+ ++HRD+KP+N+L+D K   +KLADFG    +           V +P Y +PE+L
Sbjct: 157 AIHSMGLIHRDVKPDNMLLD-KHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVL 215

Query: 180 LGYTG---YSTPIDVWAVGCIFAEMITGKPLF 208
               G   Y    D W+VG    EM+ G   F
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 74.4 bits (183), Expect = 1e-14
 Identities = 90/337 (26%), Positives = 139/337 (41%), Gaps = 69/337 (20%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQ-TEQEGVPSYIIREVSLLKELEHEN 67
           Y  I+ IG GG GEVY   + V  ++VA+K +    +E   +    +RE  +  +L H  
Sbjct: 4   YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPG 63

Query: 68  IVRLLDVQSSRKDVFLVFEYLD-LDLHSFI--TRHKNTLNL-LVIK-------AILKQIL 116
           IV +  + S    V+    Y++   L S +     K +L+  L  K       +I  +I 
Sbjct: 64  IVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123

Query: 117 LGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARA------------IGVPQKEY 164
             + Y HS  +LHRDLKP+N+L+ L    V L D+G A              +      Y
Sbjct: 124 ATIEYVHSKGVLHRDLKPDNILLGLFGEVVIL-DWGAAIFKKLEEEDLLDIDVDERNICY 182

Query: 165 SR-----DCVYSP-YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSL 218
           S        V +P Y APE LLG    S   D++A+G I  +M+T    +  KK   +S 
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLTLSFPYRRKKGRKISY 241

Query: 219 IFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQ----MLCLN 274
              +L +P            E+ P Y    P                 LSQ     L ++
Sbjct: 242 RDVIL-SP-----------IEVAP-YREIPP----------------FLSQIAMKALAVD 272

Query: 275 PKQRITAMDALKHE---YLIG-VENVPLVILLINRKK 307
           P +R +++  LK +   +L G  E      L+  +K 
Sbjct: 273 PAERYSSVQELKQDLEPHLQGSPEWTVKATLMTKKKS 309

Length = 932

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 72.3 bits (177), Expect = 1e-14
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 27/214 (12%)

Query: 13  KKIGAGGYGEVY--KCRN-TVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIV 69
           +++G G +G+V+  +C N + T  K+ + +  ++           RE  LL  L+HE+IV
Sbjct: 11  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 70

Query: 70  RLLDVQSSRKDVFLVFEYLDL-DLHSFITRH---------------KNTLNLLVIKAILK 113
           +   V      + +VFEY+   DL+ F+  H               K  L L  +  I  
Sbjct: 71  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130

Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS-- 171
           QI  G+ Y  S   +HRDL   N L+      VK+ DFG++R   V   +Y R   ++  
Sbjct: 131 QIASGMVYLASQHFVHRDLATRNCLVG-ANLLVKIGDFGMSR--DVYSTDYYRVGGHTML 187

Query: 172 --PYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
              +  PE ++ Y  ++T  DVW+ G I  E+ T
Sbjct: 188 PIRWMPPESIM-YRKFTTESDVWSFGVILWEIFT 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 72.5 bits (178), Expect = 1e-14
 Identities = 66/229 (28%), Positives = 102/229 (44%), Gaps = 41/229 (17%)

Query: 13  KKIGAGGYGEV-----YKCRNTVTGQKVAIKMMTIQ---TEQEGVPSYIIREVSLLKEL- 63
           K +GAG +G+V     Y    +    KVA+KM+      +E+E + S    E+ ++  L 
Sbjct: 41  KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMS----ELKIMSHLG 96

Query: 64  EHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILK---QILLGL 119
            HENIV LL   +    + ++ EY    DL +F+   +   + L ++ +L    Q+  G+
Sbjct: 97  NHENIVNLLGACTIGGPILVITEYCCYGDLLNFL--RRKRESFLTLEDLLSFSYQVAKGM 154

Query: 120 AYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APE 177
           A+  S   +HRDL   N+L+   +  VK+ DFGLAR I        +     P K  APE
Sbjct: 155 AFLASKNCIHRDLAARNVLLTHGK-IVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPE 213

Query: 178 LLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTP 226
            +     Y+   DVW+ G +  E                  IFSL   P
Sbjct: 214 SIF-NCVYTFESDVWSYGILLWE------------------IFSLGSNP 243

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 72.2 bits (177), Expect = 2e-14
 Identities = 73/294 (24%), Positives = 127/294 (43%), Gaps = 37/294 (12%)

Query: 11  KIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVR 70
            + ++G G YG VYK  +  TG  +A+K + ++ + E   + II E+ +L +     IV 
Sbjct: 5   VLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELD-ESKFNQIIMELDILHKAVSPYIVD 63

Query: 71  LLDVQSSRKDVFLVFEYLD---LDLHSFITRHKNTLNLLVIKAILKQILLGLAYC-HSLK 126
                     V++  EY+D   LD           +   V++ I   ++ GL +      
Sbjct: 64  FYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123

Query: 127 ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELL--LGYTG 184
           I+HRD+KP N+L++     VKL DFG++  +     + +  C    Y APE +   G   
Sbjct: 124 IIHRDVKPTNVLVNGN-GQVKLCDFGVSGNLVASLAKTNIGC--QSYMAPERIKSGGPNQ 180

Query: 185 ---YSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEIL 241
              Y+   DVW++G    EM  G+  +P + + +   IF+ L              S I+
Sbjct: 181 NPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---IFAQL--------------SAIV 223

Query: 242 PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVEN 295
                 +P  L   +        D +++ L   P +R T    L+H +L+  +N
Sbjct: 224 ----DGDPPTLPSGY---SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKN 270

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 72.2 bits (177), Expect = 2e-14
 Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 13/202 (6%)

Query: 15  IGAGGYGEVYKCRNTVTGQKVAIKMMTIQ--TEQEGVPSYIIREVSLLKELEHENIVRLL 72
           +G GG+GEV  C+   TG+  A K +  +   +++G    ++ E  +L ++    IV L 
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMV-EKRILAKVHSRFIVSLA 59

Query: 73  DVQSSRKDVFLVFEYL---DLDLHSFITRHKNTLNLLVIKAIL--KQILLGLAYCHSLKI 127
               ++ D+ LV   +   DL  H +    +N       +A     QI+ GL + H  +I
Sbjct: 60  YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENP-GFPEPRACFYTAQIISGLEHLHQRRI 118

Query: 128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGYTGYS 186
           ++RDLKP N+L+D   N V+++D GLA  +   Q + ++    +P + APELL G   Y 
Sbjct: 119 IYRDLKPENVLLDNDGN-VRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQGEE-YD 175

Query: 187 TPIDVWAVGCIFAEMITGKPLF 208
             +D +A+G    EMI  +  F
Sbjct: 176 FSVDYFALGVTLYEMIAARGPF 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 72.7 bits (178), Expect = 2e-14
 Identities = 67/215 (31%), Positives = 102/215 (47%), Gaps = 21/215 (9%)

Query: 3   KLKNLNYKKIKKIGAGGYGEV----YKCRNTVTGQKVAIKMM----TIQTEQEGVPSYII 54
           K+K  ++  I+ +G G +G V    YK  +      VAIK       I+ +Q     ++ 
Sbjct: 26  KMKYEDFNFIRTLGTGSFGRVILATYKNEDF---PPVAIKRFEKSKIIKQKQ---VDHVF 79

Query: 55  REVSLLKELEHENIVRLLDVQSSRKDVFLVFEY-LDLDLHSFITRHKNTLNLLVIKAILK 113
            E  +L  + H   V L         ++LV E+ +  +  +F+ R+K   N  V      
Sbjct: 80  SERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPND-VGCFYAA 138

Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           QI+L   Y  SL I++RDLKP NLL+D K   +K+ DFG A+   V  + Y+  C    Y
Sbjct: 139 QIVLIFEYLQSLNIVYRDLKPENLLLD-KDGFIKMTDFGFAKV--VDTRTYTL-CGTPEY 194

Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
            APE+LL   G+    D W +G    E++ G P F
Sbjct: 195 IAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPF 228

Length = 340

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 71.4 bits (175), Expect = 2e-14
 Identities = 60/209 (28%), Positives = 107/209 (51%), Gaps = 21/209 (10%)

Query: 12  IKKIGAGGYGEVY--KCRNTVTGQKVAIKMMTIQTEQEGVPSY--IIREVSLLKELEHEN 67
           +K++G+G +G V+  K R  +   KVAIK +      EG  S    I E  ++ +L H  
Sbjct: 9   MKELGSGQFGVVHLGKWRAQI---KVAIKAI-----NEGAMSEEDFIEEAKVMMKLSHPK 60

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
           +V+L  V + +K +++V E+++   L +++ + +  L+  ++ ++ + +  G+ Y     
Sbjct: 61  LVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS 120

Query: 127 ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDC-VYSPYK--APELLLGYT 183
            +HRDL   N L+      VK++DFG+ R   V   EY+       P K   PE+   ++
Sbjct: 121 FIHRDLAARNCLVS-STGVVKVSDFGMTRY--VLDDEYTSSSGAKFPVKWSPPEVFN-FS 176

Query: 184 GYSTPIDVWAVGCIFAEMIT-GKPLFPSK 211
            YS+  DVW+ G +  E+ T GK  F  K
Sbjct: 177 KYSSKSDVWSFGVLMWEVFTEGKMPFEKK 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 72.0 bits (176), Expect = 3e-14
 Identities = 62/204 (30%), Positives = 101/204 (49%), Gaps = 10/204 (4%)

Query: 13  KKIGAGGYGEVYKCRNTVTGQKVAIKMM---TIQTEQEGVPSYIIREVS-LLKELEHENI 68
           K IG G +G+V   R+    +  A+K++    I  ++E    +I+ E + LLK ++H  +
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKE--EKHIMSERNVLLKNVKHPFL 58

Query: 69  VRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
           V L     +   ++ V +Y++  +L   + R +  L     +    +I   L Y HSL I
Sbjct: 59  VGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRA-RFYAAEIASALGYLHSLNI 117

Query: 128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYST 187
           ++RDLKP N+L+D + + V L DFGL +         S  C    Y APE +L    Y  
Sbjct: 118 VYRDLKPENILLDSQGHIV-LTDFGLCKENIEHNGTTSTFCGTPEYLAPE-VLHKQPYDR 175

Query: 188 PIDVWAVGCIFAEMITGKPLFPSK 211
            +D W +G +  EM+ G P F S+
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYSR 199

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 72.0 bits (176), Expect = 3e-14
 Identities = 56/212 (26%), Positives = 102/212 (48%), Gaps = 9/212 (4%)

Query: 3   KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMT-IQTEQEGVPSYIIREVSLLK 61
           ++K  +Y+ +K IG G +GEV   R+  T +  A+K+++  +  +    ++   E  ++ 
Sbjct: 39  RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 98

Query: 62  ELEHENIVRLLDVQSSRKDVFLVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQILLGLA 120
                 +V+L       + +++V EY+   DL + ++ +         +    +++L L 
Sbjct: 99  FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKW--ARFYTAEVVLALD 156

Query: 121 YCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELL 179
             HS+  +HRD+KP+N+L+D K   +KLADFG    +           V +P Y +PE+L
Sbjct: 157 AIHSMGFIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVL 215

Query: 180 LGYTG---YSTPIDVWAVGCIFAEMITGKPLF 208
               G   Y    D W+VG    EM+ G   F
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 70.8 bits (173), Expect = 3e-14
 Identities = 51/196 (26%), Positives = 108/196 (55%), Gaps = 14/196 (7%)

Query: 13  KKIGAGGYGEV----YKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
            ++G+G +G V    YK + +   + VA+K++        +   ++RE +++++L++  I
Sbjct: 1   GELGSGNFGTVKKGMYKMKKSE--KTVAVKILKNDNNDPALKDELLREANVMQQLDNPYI 58

Query: 69  VRLLDVQSSRKDVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
           VR++ +  + +   LV E  +L  L+ F+ ++K+     + + ++ Q+ +G+ Y      
Sbjct: 59  VRMIGICEA-ESWMLVMELAELGPLNKFLQKNKHVTEKNITE-LVHQVSMGMKYLEETNF 116

Query: 128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY-SRDCVYSPYK--APELLLGYTG 184
           +HRDL   N+L+ + ++  K++DFGL++A+G  +  Y ++     P K  APE  + Y  
Sbjct: 117 VHRDLAARNVLL-VTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPE-CMNYYK 174

Query: 185 YSTPIDVWAVGCIFAE 200
           +S+  DVW+ G +  E
Sbjct: 175 FSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 71.1 bits (174), Expect = 4e-14
 Identities = 61/210 (29%), Positives = 105/210 (50%), Gaps = 23/210 (10%)

Query: 15  IGAGGYGEVYKCRNTVTGQKVAIKMM------TIQTEQEGVPSYIIREVSLLKELEHENI 68
           IG GG+GEVY CR   TG+  A+K +        Q E   +   I+  +SL+   +   I
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM--LSLVSTGDCPFI 59

Query: 69  VRL-LDVQSSRKDVFLVFEYLDL----DLHSFITRHKNTLNLLVIKAILKQILLGLAYCH 123
           V +     +  K  F+    LDL    DLH  +++H    +   ++    +I+LGL + H
Sbjct: 60  VCMSYAFHTPDKLSFI----LDLMNGGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMH 114

Query: 124 SLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYT 183
           +  +++RDLKP N+L+D +   V+++D GL  A    +K+         Y APE+L    
Sbjct: 115 NRFVVYRDLKPANILLD-EHGHVRISDLGL--ACDFSKKKPHASVGTHGYMAPEVLQKGV 171

Query: 184 GYSTPIDVWAVGCIFAEMITGKPLFPSKKH 213
            Y +  D +++GC+  +++ G    P ++H
Sbjct: 172 AYDSSADWFSLGCMLFKLLRGH--SPFRQH 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 71.2 bits (174), Expect = 4e-14
 Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 18/213 (8%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHE 66
            ++ I+ IG G YG+VYK  N   G   A+K++   ++   V   I  E ++L+ L  H 
Sbjct: 23  TWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD---VDEEIEAEYNILQSLPNHP 79

Query: 67  NIVRLLDV-----QSSRKDVFLVFEYLD----LDLHSFITRHKNTLNLLVIKAILKQILL 117
           N+V+   +     +     ++LV E  +     +L   +      L+  +I  IL   LL
Sbjct: 80  NVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALL 139

Query: 118 GLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPE 177
           GL + H+ +I+HRD+K NN+L+  +   VKL DFG++  +   +   +       + APE
Sbjct: 140 GLQHLHNNRIIHRDVKGNNILLTTE-GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE 198

Query: 178 LLLGY----TGYSTPIDVWAVGCIFAEMITGKP 206
           ++         Y    DVW++G    E+  G P
Sbjct: 199 VIACEQQYDYSYDARCDVWSLGITAIELGDGDP 231

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 70.7 bits (173), Expect = 4e-14
 Identities = 63/219 (28%), Positives = 99/219 (45%), Gaps = 43/219 (19%)

Query: 15  IGAGGYGEVYKCRNTV-----TG-QKVAIKMM----TIQTEQEGVPSYIIREVSLLKELE 64
           +G+G +GEVY+   T      +G  +VA+K +    T Q ++E      ++E  L+    
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKE-----FLKEAHLMSNFN 57

Query: 65  HENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNT------LNLLVIKAILKQILL 117
           H NIV+LL V    +  +++ E ++  DL S++   +        L L  +  I   +  
Sbjct: 58  HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117

Query: 118 GLAYCHSLKILHRDLKPNNLLIDLK----RNTVKLADFGLARAIGVPQKEYSRDCVYSP- 172
           G  Y   +  +HRDL   N L+  K       VK+ DFGLAR I      Y  D  Y   
Sbjct: 118 GCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI------YKSD-YYRKE 170

Query: 173 --------YKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
                   + APE LL    ++T  DVW+ G +  E++T
Sbjct: 171 GEGLLPVRWMAPESLLDGK-FTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 70.9 bits (174), Expect = 5e-14
 Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 18/209 (8%)

Query: 10  KKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMT-IQTEQEGVPSYIIREVS-LLKELEHEN 67
           + + +IG+G  G+VYK R   TG  +A+K M     ++E     I+ ++  +LK  +   
Sbjct: 18  ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEEN--KRILMDLDVVLKSHDCPY 75

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK- 126
           IV+      +  DVF+  E +   L   + R +  +   ++  +   I+  L Y   LK 
Sbjct: 76  IVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHY---LKE 132

Query: 127 ---ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELL---L 180
              ++HRD+KP+N+L+D     VKL DFG++  + V  K  +R    + Y APE +    
Sbjct: 133 KHGVIHRDVKPSNILLD-ASGNVKLCDFGISGRL-VDSKAKTRSAGCAAYMAPERIDPPD 190

Query: 181 GYTGYSTPIDVWAVGCIFAEMITGKPLFP 209
               Y    DVW++G    E+ TG+  FP
Sbjct: 191 PNPKYDIRADVWSLGISLVELATGQ--FP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 70.9 bits (173), Expect = 6e-14
 Identities = 73/290 (25%), Positives = 124/290 (42%), Gaps = 42/290 (14%)

Query: 13  KKIGAGGYGEVYKCRNTVTGQKVAIKMM---TIQTEQEGVPSYIIREVSLLKELEHENIV 69
           K +G G +G+V   R   +G+  A+K++    I  + E   ++ + E  +LK   H  + 
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDE--VAHTLTESRVLKNTRHPFLT 58

Query: 70  RLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILH 129
            L     ++  +  V EY++     F    +   +    +    +I+  L Y HS KI++
Sbjct: 59  SLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVY 118

Query: 130 RDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPI 189
           RDLK  NL++D K   +K+ DFGL +            C    Y APE+L     Y   +
Sbjct: 119 RDLKLENLMLD-KDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLED-NDYGRAV 176

Query: 190 DVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEP 249
           D W +G +  EM+ G+  F ++ H+ L   F L+             + +I         
Sbjct: 177 DWWGLGVVMYEMMCGRLPFYNQDHEKL---FELI------------LMEDI--------- 212

Query: 250 ANLAEKFP-NLEPAGVDLLSQMLCLNPKQRI-----TAMDALKHEYLIGV 293
                KFP  L      LLS +L  +P +R+      A + ++H +  GV
Sbjct: 213 -----KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGV 257

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 70.4 bits (172), Expect = 7e-14
 Identities = 57/211 (27%), Positives = 104/211 (49%), Gaps = 14/211 (6%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQ-TEQEGVPSYIIREVSLLKELEHEN 67
           ++  + +G GG+GEV  C+   TG+  A K +  +  ++    +  + E  +L+++    
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 68  IVRLLDVQSSRKDVFLVFEYL---DLDLHSFITRHKNTLNLLVIKAIL--KQILLGLAYC 122
           +V L     ++  + LV   +   DL  H +   +         +AI    ++  GL   
Sbjct: 62  VVSLAYAYETKDALCLVLTIMNGGDLKFHIY---NMGNPGFDEQRAIFYAAELCCGLEDL 118

Query: 123 HSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS-PYKAPELLLG 181
              +I++RDLKP N+L+D  R  ++++D GL  A+ +P+ E  R  V +  Y APE++  
Sbjct: 119 QRERIVYRDLKPENILLD-DRGHIRISDLGL--AVQIPEGETVRGRVGTVGYMAPEVINN 175

Query: 182 YTGYSTPIDVWAVGCIFAEMITGKPLFPSKK 212
              Y+   D W +GC+  EMI G+  F  +K
Sbjct: 176 EK-YTFSPDWWGLGCLIYEMIQGQSPFRKRK 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 70.4 bits (172), Expect = 7e-14
 Identities = 57/205 (27%), Positives = 103/205 (50%), Gaps = 13/205 (6%)

Query: 15  IGAGGYGEVYKCRNTVTGQKVAIKMM------TIQTEQEGVPSYIIREVSLLKELEHENI 68
           IG GG+GEVY CR   TG+  A+K +        Q E   +   I+  +SL+   +   I
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM--LSLVSTGDCPFI 59

Query: 69  VRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
           V +     +   +  + + ++  DLH  +++H    +   ++    +I+LGL + H+  +
Sbjct: 60  VCMTYAFHTPDKLCFILDLMNGGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNRFV 118

Query: 128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYST 187
           ++RDLKP N+L+D +   V+++D GL  A    +K+         Y APE+L   T Y +
Sbjct: 119 VYRDLKPANILLD-EHGHVRISDLGL--ACDFSKKKPHASVGTHGYMAPEVLQKGTAYDS 175

Query: 188 PIDVWAVGCIFAEMITGKPLFPSKK 212
             D +++GC+  +++ G   F   K
Sbjct: 176 SADWFSLGCMLFKLLRGHSPFRQHK 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 70.4 bits (172), Expect = 8e-14
 Identities = 64/247 (25%), Positives = 112/247 (45%), Gaps = 42/247 (17%)

Query: 13  KKIGAGGYGEVYKCRNT-VTGQ----KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
           K +G G +G+V K     + G+     VA+KM+        +   ++ E +LLK++ H +
Sbjct: 6   KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRD-LLSEFNLLKQVNHPH 64

Query: 68  IVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNT-----------------------L 103
           +++L    S    + L+ EY     L SF+   +                         L
Sbjct: 65  VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124

Query: 104 NLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE 163
            +  + +   QI  G+ Y   +K++HRDL   N+L+   R  +K++DFGL+R +   +  
Sbjct: 125 TMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGR-KMKISDFGLSRDV-YEEDS 182

Query: 164 Y---SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT--GKPLFPSKKHDHLSL 218
           Y   S+  +   + A E L  +  Y+T  DVW+ G +  E++T  G P +P    + L  
Sbjct: 183 YVKRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNP-YPGIAPERL-- 238

Query: 219 IFSLLGT 225
            F+LL T
Sbjct: 239 -FNLLKT 244

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 69.6 bits (170), Expect = 1e-13
 Identities = 66/222 (29%), Positives = 106/222 (47%), Gaps = 40/222 (18%)

Query: 12  IKKIGAGGYGEVYKCRNTVTG----QKVAIKMMT-IQTEQEGVPSYIIREVSLLKELEHE 66
           ++++G   +G++YK    + G    Q VAIK +  I   Q+       +E SL+ EL H 
Sbjct: 10  MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQW--GEFQQEASLMAELHHP 67

Query: 67  NIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRH----------------KNTLNLLVIK 109
           NIV LL V +  + V ++FEYL+  DLH F+                   K++L+     
Sbjct: 68  NIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127

Query: 110 AILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCV 169
            I  QI  G+ Y  S   +H+DL   N+LI  + + VK++D GL+R I      YS D  
Sbjct: 128 HIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH-VKISDLGLSREI------YSADYY 180

Query: 170 YSPYKA--------PELLLGYTGYSTPIDVWAVGCIFAEMIT 203
               K+        PE ++ Y  +S+  D+W+ G +  E+ +
Sbjct: 181 RVQPKSLLPIRWMPPEAIM-YGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 69.0 bits (169), Expect = 2e-13
 Identities = 55/212 (25%), Positives = 95/212 (44%), Gaps = 22/212 (10%)

Query: 8   NYKKIKKIGAGGYGEVYK-----CRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKE 62
           +   ++ +G G +GEVY+             +VA+K +     ++    +++ E  ++ +
Sbjct: 7   SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLM-EALIMSK 65

Query: 63  LEHENIVRLLDVQSSRKDVFLVFEYLD-LDLHSFITRHKNTLN---LLVIKAILK---QI 115
             H+NIVRL+ V   R   F++ E +   DL SF+  ++        L +K +L     +
Sbjct: 66  FNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDV 125

Query: 116 LLGLAYCHSLKILHRDLKPNNLLIDLK--RNTVKLADFGLARAIGVPQKEYSR--DCVYS 171
             G  Y      +HRD+   N L+  K      K+ADFG+AR I   +  Y R       
Sbjct: 126 AKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDI--YRASYYRKGGRAML 183

Query: 172 PYK--APELLLGYTGYSTPIDVWAVGCIFAEM 201
           P K   PE  L    +++  DVW+ G +  E+
Sbjct: 184 PIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEI 214

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 68.7 bits (168), Expect = 2e-13
 Identities = 56/218 (25%), Positives = 102/218 (46%), Gaps = 39/218 (17%)

Query: 13  KKIGAGGYGEVYKCR---NTVTGQKVAIKMMTI----QTEQEGVPSYIIREVSLLKELEH 65
           K +G G +G V + +   +  +  KVA+K M +     +E E      + E + +K+ +H
Sbjct: 5   KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEE----FLSEAACMKDFDH 60

Query: 66  ENIVRLLDV--QSSRKDVF----LVFEYLDL-DLHSFITRHKNTLN--LLVIKAILK--- 113
            N+++L+ V  ++S         ++  ++   DLHSF+   +       L ++ +LK   
Sbjct: 61  PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120

Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
            I LG+ Y  +   +HRDL   N ++  +  TV +ADFGL++ I      YS D  Y   
Sbjct: 121 DIALGMEYLSNRNFIHRDLAARNCMLR-EDMTVCVADFGLSKKI------YSGD-YYRQG 172

Query: 174 KAPELLLGYTG--------YSTPIDVWAVGCIFAEMIT 203
           +  ++ + +          Y++  DVWA G    E+ T
Sbjct: 173 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 68.3 bits (167), Expect = 3e-13
 Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 27/212 (12%)

Query: 15  IGAGGYGEVYK---CRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRL 71
           IG G +G VY      +       A+K +   T+ E V    ++E  ++K+  H N++ L
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEV-EQFLKEGIIMKDFSHPNVLSL 61

Query: 72  LDVQ-SSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILH 129
           L +   S     +V  Y+   DL +FI    +   +  +     Q+  G+ Y  S K +H
Sbjct: 62  LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVH 121

Query: 130 RDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK-----------APEL 178
           RDL   N ++D +  TVK+ADFGLAR   +  KEY     YS +            A E 
Sbjct: 122 RDLAARNCMLD-ESFTVKVADFGLAR--DIYDKEY-----YSVHNHTGAKLPVKWMALES 173

Query: 179 LLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFP 209
           L     ++T  DVW+ G +  E++T G P +P
Sbjct: 174 LQTQK-FTTKSDVWSFGVLLWELMTRGAPPYP 204

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 68.1 bits (166), Expect = 4e-13
 Identities = 64/221 (28%), Positives = 108/221 (48%), Gaps = 15/221 (6%)

Query: 1   MGKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQK----VAIKMMTIQTEQEGVPSYIIRE 56
           M  LK    KK+K +G+G +G VYK      G+     VAIK++   T  +     I+ E
Sbjct: 1   MRILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKE-ILDE 59

Query: 57  VSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAILKQI 115
             ++  +    + RLL +  +   V LV + +    L  ++  +K+ +    +     QI
Sbjct: 60  AYVMAGVGSPYVCRLLGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI 118

Query: 116 LLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK- 174
             G++Y   ++++HRDL   N+L+    N VK+ DFGLAR + + + EY  D    P K 
Sbjct: 119 AKGMSYLEEVRLVHRDLAARNVLVK-SPNHVKITDFGLARLLDIDETEYHADGGKVPIKW 177

Query: 175 -APELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD 214
            A E +L +  ++   DVW+ G    E++T    F +K +D
Sbjct: 178 MALESIL-HRRFTHQSDVWSYGVTVWELMT----FGAKPYD 213

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 68.7 bits (168), Expect = 4e-13
 Identities = 36/103 (34%), Positives = 56/103 (54%), Gaps = 2/103 (1%)

Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           +I +GL + HS  I++RDLK +N+++D     +K+ADFG+ +      K     C    Y
Sbjct: 109 EIAIGLFFLHSKGIIYRDLKLDNVMLD-AEGHIKIADFGMCKENIFGGKTTRTFCGTPDY 167

Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHL 216
            APE++  Y  Y   +D WA G +  EM+ G+P F  +  D L
Sbjct: 168 IAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL 209

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 68.5 bits (167), Expect = 6e-13
 Identities = 50/195 (25%), Positives = 86/195 (44%), Gaps = 12/195 (6%)

Query: 12  IKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRL 71
           ++    G  G  + C +  T + V IK      ++ G       E  +L+ + H +I++L
Sbjct: 97  LETFTPGAEGFAFACIDNKTCEHVVIK----AGQRGGT----ATEAHILRAINHPSIIQL 148

Query: 72  LDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRD 131
               +  K   L+      DL+ ++   +N + +  I AI + +L  + Y H  +I+HRD
Sbjct: 149 KGTFTYNKFTCLILPRYKTDLYCYLAAKRN-IAICDILAIERSVLRAIQYLHENRIIHRD 207

Query: 132 LKPNNLLIDLKRNTVKLADFGLA-RAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPID 190
           +K  N+ I+     V L DFG A   + +   +Y          APE LL    Y   +D
Sbjct: 208 IKAENIFIN-HPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPE-LLARDPYGPAVD 265

Query: 191 VWAVGCIFAEMITGK 205
           +W+ G +  EM T  
Sbjct: 266 IWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 66.1 bits (161), Expect = 2e-12
 Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 21/209 (10%)

Query: 13  KKIGAGGYGEVYKCR---NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIV 69
           + +G G +G V + +      + QKVA+KM+             +RE + +KE +H N++
Sbjct: 5   RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64

Query: 70  RLLDVQSSRKD--------VFLVFEYLDLDLHSF-----ITRHKNTLNLLVIKAILKQIL 116
           +L+ V    +         V L F     DLH+F     I     TL L  +   +  I 
Sbjct: 65  KLIGVSLRSRAKGRLPIPMVILPFMKHG-DLHTFLLMSRIGEEPFTLPLQTLVRFMIDIA 123

Query: 117 LGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS-PYKA 175
            G+ Y  S   +HRDL   N +++ +  TV +ADFGL++ I      Y + C    P K 
Sbjct: 124 SGMEYLSSKNFIHRDLAARNCMLN-ENMTVCVADFGLSKKI-YSGDYYRQGCASKLPVKW 181

Query: 176 PEL-LLGYTGYSTPIDVWAVGCIFAEMIT 203
             L  L    Y+T  DVWA G    E++T
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 65.9 bits (160), Expect = 3e-12
 Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 24/206 (11%)

Query: 15  IGAGGYGEVYKCRNTVTGQKVAIKMMT------------IQTEQEGVPSYIIREVSLLKE 62
           IG G Y +V   R   T +  A+K++             +QTE+     ++  + S    
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEK-----HVFEQAS---- 53

Query: 63  LEHENIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYC 122
             H  +V L     +   +F V EY++     F  + +  L     +    +I L L Y 
Sbjct: 54  -NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 112

Query: 123 HSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGY 182
           H   I++RDLK +N+L+D     +KL D+G+ +    P    S  C    Y APE+L G 
Sbjct: 113 HERGIIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG- 170

Query: 183 TGYSTPIDVWAVGCIFAEMITGKPLF 208
             Y   +D WA+G +  EM+ G+  F
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 66.1 bits (161), Expect = 4e-12
 Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 46/217 (21%)

Query: 111 ILKQILLGLAYCHS-LKILHRDLKPNNLLIDLKRNTV---------------KLADFGLA 154
           I+ Q  + L Y H+ L ++H DLKP N+L++     V               ++ D G  
Sbjct: 236 IIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG-- 293

Query: 155 RAIGVPQKEYSRDCVYSP--YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK 212
              G   + +SR  + S   Y++PE++LG  G+    D+W++GCI  E+ TGK L+ +  
Sbjct: 294 ---GCCDERHSRTAIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIYELYTGKLLYDT-- 347

Query: 213 HD---HLSLIFSLLGT-PTDESWAESTYISEILPLY-------PHFEPANLAE------- 254
           HD   HL L+   LG  P++  WA      E   LY       P  +P +LA        
Sbjct: 348 HDNLEHLHLMEKTLGRLPSE--WAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPV 405

Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLI 291
           +    +    DL+  +L  + ++R+ A     H Y++
Sbjct: 406 REVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVL 442

Length = 467

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 65.0 bits (158), Expect = 5e-12
 Identities = 66/286 (23%), Positives = 126/286 (44%), Gaps = 45/286 (15%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTV---TGQKVAIKMMTIQT--EQEGVPSYIIREVSLLKE 62
           N++ +K +G G YG+V+  R      +G+  A+K++   T  ++     +   E  +L+ 
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 63  LEHEN-IVRLLDVQSSRKDVFLVFEYL---DLDLHSFITRHKNTLNLLVIKAILKQILLG 118
           +     +V L     +   + L+ +Y+   +L  H    R +     + I     +I+L 
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTH-LSQRERFKEQEVQI--YSGEIVLA 117

Query: 119 LAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRD-CVYSPYKAPE 177
           L + H L I++RD+K  N+L+D   + V L DFGL++     + E +   C    Y AP+
Sbjct: 118 LEHLHKLGIIYRDIKLENILLDSNGHVV-LTDFGLSKEFHEDEVERAYSFCGTIEYMAPD 176

Query: 178 LLL-GYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY 236
           ++  G  G+   +D W++G +  E++TG   F                T   E  +++  
Sbjct: 177 IVRGGDGGHDKAVDWWSMGVLMYELLTGASPF----------------TVDGEKNSQAEI 220

Query: 237 ISEIL---PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRI 279
              IL   P YP             +     D++ ++L  +PK+R+
Sbjct: 221 SRRILKSEPPYPQ-----------EMSALAKDIIQRLLMKDPKKRL 255

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 64.3 bits (156), Expect = 7e-12
 Identities = 67/231 (29%), Positives = 111/231 (48%), Gaps = 35/231 (15%)

Query: 13  KKIGAGGYGEVYKCRNTVTGQ--KVAIKMMTI----QTEQEGVPSYIIREVSLLKELEHE 66
           K +G G +G V + +        KVA+K M I    ++E E      + E   +KE +H 
Sbjct: 5   KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMED----FLSEAVCMKEFDHP 60

Query: 67  NIVRLLDV--QSSRKDVF----LVFEYLDL-DLHSFI--TRHKNTLNLLVIKAILK---Q 114
           N++RL+ V  Q+   + +    ++  ++   DLHSF+  +R  +    L  + ++K    
Sbjct: 61  NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120

Query: 115 ILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS--P 172
           I  G+ Y  S   +HRDL   N +++   N V +ADFGL++ I     +Y R    +  P
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENMN-VCVADFGLSKKI--YNGDYYRQGRIAKMP 177

Query: 173 YK--APELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFP----SKKHDHL 216
            K  A E L     Y+T  DVW+ G    E+ T G+  +P    S+ +D+L
Sbjct: 178 VKWIAIESLADRV-YTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYL 227

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 64.6 bits (157), Expect = 8e-12
 Identities = 37/106 (34%), Positives = 58/106 (54%), Gaps = 8/106 (7%)

Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARA---IGVPQKEYSRDCVY 170
           +I +GL + HS  I++RDLK +N+++D     +K+ADFG+ +     GV  K +   C  
Sbjct: 109 EIAIGLFFLHSKGIIYRDLKLDNVMLD-SEGHIKIADFGMCKENMWDGVTTKTF---CGT 164

Query: 171 SPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHL 216
             Y APE++  Y  Y   +D WA G +  EM+ G+  F  +  D L
Sbjct: 165 PDYIAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 209

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 75/295 (25%), Positives = 128/295 (43%), Gaps = 49/295 (16%)

Query: 13  KKIGAGGYGEVYKCRNTVTGQKVAIKMM---TIQTEQEGVPSYIIREVSLLKELEHENIV 69
           K +G G +G+V   +   TG+  A+K++    I  + E   ++ + E  +L+   H  + 
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE--VAHTLTENRVLQNSRHPFLT 58

Query: 70  RLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK-IL 128
            L     +   +  V EY +     F    +   +    +    +I+  L Y HS K ++
Sbjct: 59  ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVV 118

Query: 129 HRDLKPNNLLIDLKRNTVKLADFGLAR---AIGVPQKEYSRDCVYSPYKAPELLLGYTGY 185
           +RDLK  NL++D K   +K+ DFGL +     G   K +   C    Y APE+L     Y
Sbjct: 119 YRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMKTF---CGTPEYLAPEVLED-NDY 173

Query: 186 STPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYP 245
              +D W +G +  EM+ G+  F ++ H+ L   F L+             + EI     
Sbjct: 174 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---FELI------------LMEEI----- 213

Query: 246 HFEPANLAEKFP-NLEPAGVDLLSQMLCLNPKQRI-----TAMDALKHEYLIGVE 294
                    +FP  L P    LLS +L  +PKQR+      A + ++H++  G+ 
Sbjct: 214 ---------RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIV 259

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 79/281 (28%), Positives = 118/281 (41%), Gaps = 47/281 (16%)

Query: 27  RNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE 86
           R +   +KV  K + +  E++   +Y   E+  L   +H  IV+  D   S   + L+ E
Sbjct: 88  RGSDPKEKVVAKFVMLNDERQA--AYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145

Query: 87  Y-LDLDLHSFIT-RHKNTLNLLVIKA--ILKQILLGLAYCHSLKILHRDLKPNNLLIDLK 142
           Y    DL+  I  R K  L     +   +  QI+L L   HS K++HRDLK  N+ + + 
Sbjct: 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL-MP 204

Query: 143 RNTVKLADFGLARAI--GVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAE 200
              +KL DFG ++     V     S  C    Y APE L     YS   D+W++G I  E
Sbjct: 205 TGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPE-LWERKRYSKKADMWSLGVILYE 263

Query: 201 MITGKPLF--PSKKHDHLSLIFSLLGTPTDESWAESTYISEILP--LYPHFEPANLAEKF 256
           ++T    F  PS++                          EI+   LY  ++P      F
Sbjct: 264 LLTLHRPFKGPSQR--------------------------EIMQQVLYGKYDP------F 291

Query: 257 PNLEPAGVD-LLSQMLCLNPKQRITAMDALKHEYLIGVENV 296
           P    +G+  LL  +L  NP  R T    L  E+L  V N+
Sbjct: 292 PCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYVANL 332

Length = 478

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 64.2 bits (156), Expect = 1e-11
 Identities = 35/103 (33%), Positives = 57/103 (55%), Gaps = 2/103 (1%)

Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           +I +GL + H   I++RDLK +N+++D + + +K+ADFG+ +   V        C    Y
Sbjct: 109 EISVGLFFLHRRGIIYRDLKLDNVMLDSEGH-IKIADFGMCKEHMVDGVTTRTFCGTPDY 167

Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHL 216
            APE++  Y  Y   +D WA G +  EM+ G+P F  +  D L
Sbjct: 168 IAPEII-AYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL 209

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 64.2 bits (156), Expect = 1e-11
 Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 42/228 (18%)

Query: 13  KKIGAGGYGEVYKCR--------------NTVTGQK--VAIKMMTIQTEQEGVPSYIIRE 56
           +K+G G +GEV+ C               N   G+   VA+K++     +     ++ +E
Sbjct: 11  EKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFL-KE 69

Query: 57  VSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHK--------------- 100
           V +L  L+  NI+RLL V      + ++ EY++  DL+ F++ H                
Sbjct: 70  VKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPA 129

Query: 101 ---NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAI 157
                ++   +  +  QI  G+ Y  SL  +HRDL   N L+     T+K+ADFG++R +
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENL-TIKIADFGMSRNL 188

Query: 158 --GVPQKEYSRDCVYSPYKAPE-LLLGYTGYSTPIDVWAVGCIFAEMI 202
             G   +   R  +   + A E +L+G   ++T  DVWA G    E++
Sbjct: 189 YAGDYYRIQGRAVLPIRWMAWECILMG--KFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 63.8 bits (155), Expect = 2e-11
 Identities = 70/244 (28%), Positives = 113/244 (46%), Gaps = 45/244 (18%)

Query: 13  KKIGAGGYGEVYKCR----------NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKE 62
           K +G G +G+V +             TVT   VA+KM+      + + + +I E+ L+K 
Sbjct: 18  KPLGEGCFGQVVRAEAYGIDKSRPDQTVT---VAVKMLKDNATDKDL-ADLISEMELMKL 73

Query: 63  L-EHENIVRLLDVQSSRKDVFLVFEYLD---------------LDLHSFITR-HKNTLNL 105
           + +H+NI+ LL V +    ++++ EY                  D    IT+  +  L+ 
Sbjct: 74  IGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSF 133

Query: 106 LVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYS 165
             + +   Q+  G+ Y  S + +HRDL   N+L+  + N +K+ADFGLAR  GV   +Y 
Sbjct: 134 KDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT-EDNVMKIADFGLAR--GVHDIDYY 190

Query: 166 RDCVYS--PYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT--GKPLFPSKKHDHLSLI 219
           +       P K  APE L     Y+   DVW+ G +  E+ T  G P +P    + L   
Sbjct: 191 KKTSNGRLPVKWMAPEALFDRV-YTHQSDVWSFGILMWEIFTLGGSP-YPGIPVEEL--- 245

Query: 220 FSLL 223
           F LL
Sbjct: 246 FKLL 249

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 54/208 (25%), Positives = 103/208 (49%), Gaps = 8/208 (3%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREV-SLLKELEHE 66
           +++ IK IG G +GEV   +   T +  A+K++      +   +   RE  ++L   + +
Sbjct: 2   DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQ 61

Query: 67  NIVRLLDVQSSRKDVFLVFEY-LDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSL 125
            I  L         ++LV +Y +  DL + +++ ++ L   + +  + +++L +   H L
Sbjct: 62  WITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL 121

Query: 126 KILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLL---- 180
             +HRD+KP+N+L+D+  + ++LADFG    +       S   V +P Y +PE+L     
Sbjct: 122 HYVHRDIKPDNVLLDMNGH-IRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMED 180

Query: 181 GYTGYSTPIDVWAVGCIFAEMITGKPLF 208
           G   Y    D W++G    EM+ G+  F
Sbjct: 181 GMGKYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 62.7 bits (152), Expect = 3e-11
 Identities = 62/224 (27%), Positives = 105/224 (46%), Gaps = 35/224 (15%)

Query: 13  KKIGAGGYGEVYKCR---------NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL 63
           K +G G +G+V             N VT  KVA+KM+     ++ + S +I E+ ++K +
Sbjct: 24  KPLGEGCFGQVVMAEAIGLDKEKPNRVT--KVAVKMLKSDATEKDL-SDLISEMEMMKMI 80

Query: 64  -EHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHK------------NTLNLLVIK 109
            +H+NI+ LL   +    ++++ EY    +L  ++   +                 L  K
Sbjct: 81  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140

Query: 110 AILK---QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ--KEY 164
            ++    Q+  G+ Y  S K +HRDL   N+L+  + N +K+ADFGLAR I      K+ 
Sbjct: 141 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT-EDNVMKIADFGLARDIHHIDYYKKT 199

Query: 165 SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT--GKP 206
           +   +   + APE L     Y+   DVW+ G +  E+ T  G P
Sbjct: 200 TNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSP 242

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 62.5 bits (152), Expect = 5e-11
 Identities = 56/208 (26%), Positives = 102/208 (49%), Gaps = 8/208 (3%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMT-IQTEQEGVPSYIIREVSLLKELEHE 66
           +++ +K IG G +GEV   +   TGQ  A+K++   +  +    +    E  +L   +  
Sbjct: 2   DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRR 61

Query: 67  NIVRLLDVQSSRKDVFLVFEY-LDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSL 125
            I  L        +++LV +Y +  DL + +++ ++ L   + +  L +++L +   H L
Sbjct: 62  WITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL 121

Query: 126 KILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLL---- 180
             +HRD+KP+N+L+D K   ++LADFG    +       S   V +P Y +PE+L     
Sbjct: 122 GYVHRDIKPDNVLLD-KNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMED 180

Query: 181 GYTGYSTPIDVWAVGCIFAEMITGKPLF 208
           G   Y    D W++G    EM+ G+  F
Sbjct: 181 GKGRYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 61.8 bits (150), Expect = 7e-11
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 10/207 (4%)

Query: 15  IGAGGYGEVYKCRNTVTGQKVAIKMMT--IQTEQEGVPSYIIREVSLLKELEHENIVRLL 72
           +G G +G+V   R   +G+  A+K++   +  + + V   +  +  L     H  + +L 
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 73  DVQSSRKDVFLVFEYL---DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILH 129
               +   +F V E++   DL  H   +R  +        A   +I   L + H   I++
Sbjct: 63  CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAA---EITSALMFLHDKGIIY 119

Query: 130 RDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPI 189
           RDLK +N+L+D      KLADFG+ +      K  S  C    Y APE+L     Y   +
Sbjct: 120 RDLKLDNVLLD-HEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEML-YGPSV 177

Query: 190 DVWAVGCIFAEMITGKPLFPSKKHDHL 216
           D WA+G +  EM+ G   F ++  D L
Sbjct: 178 DWWAMGVLLYEMLCGHAPFEAENEDDL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 61.6 bits (149), Expect = 8e-11
 Identities = 52/208 (25%), Positives = 103/208 (49%), Gaps = 8/208 (3%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREV-SLLKELEHE 66
           +++ +K IG G +GEV   +     +  A+K++      +   +   RE   +L   +++
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61

Query: 67  NIVRLLDVQSSRKDVFLVFEY-LDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSL 125
            I  L        +++LV +Y +  DL + +++ ++ L   + +  L ++++ +   H L
Sbjct: 62  WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL 121

Query: 126 KILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLL---- 180
             +HRD+KP+N+L+D+  + ++LADFG    +       S   V +P Y +PE+L     
Sbjct: 122 HYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMED 180

Query: 181 GYTGYSTPIDVWAVGCIFAEMITGKPLF 208
           G   Y    D W++G    EM+ G+  F
Sbjct: 181 GKGKYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 61.2 bits (148), Expect = 8e-11
 Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 19/212 (8%)

Query: 4   LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL 63
           L     K ++ IG G +G+V        G KVA+K +    + +      + E S++ +L
Sbjct: 3   LNMKELKLLQTIGKGEFGDVM--LGDYRGNKVAVKCI----KNDATAQAFLAEASVMTQL 56

Query: 64  EHENIVRLLDVQSSRK-DVFLVFEYLDL-DLHSFI-TRHKNTLNLLVIKAILKQILLGLA 120
            H N+V+LL V    K  +++V EY+    L  ++ +R ++ L    +      +   + 
Sbjct: 57  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 116

Query: 121 YCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APEL 178
           Y  +   +HRDL   N+L+  + N  K++DFGL +     Q     D    P K  APE 
Sbjct: 117 YLEANNFVHRDLAARNVLVS-EDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEA 170

Query: 179 LLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFP 209
           L     +ST  DVW+ G +  E+ + G+  +P
Sbjct: 171 LREKK-FSTKSDVWSFGILLWEIYSFGRVPYP 201

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 61.2 bits (148), Expect = 9e-11
 Identities = 59/216 (27%), Positives = 103/216 (47%), Gaps = 28/216 (12%)

Query: 12  IKKIGAGGYGEVYKCR--NTVTG---QKVAIKMMTIQTEQEGVPSYIIREVSLLK-ELEH 65
           ++++G   +G+VYK     T  G   Q VAIK  T++ + EG      +  ++++  L+H
Sbjct: 10  MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIK--TLKDKAEGPLREEFKHEAMMRSRLQH 67

Query: 66  ENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRH---------------KNTLNLLVIK 109
            NIV LL V +  + + ++F Y    DLH F+                  K+TL      
Sbjct: 68  PNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFV 127

Query: 110 AILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ--KEYSRD 167
            I+ QI  G+ +  S  ++H+DL   N+L+  K N VK++D GL R +      K     
Sbjct: 128 HIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN-VKISDLGLFREVYAADYYKLMGNS 186

Query: 168 CVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
            +   + +PE ++ Y  +S   D+W+ G +  E+ +
Sbjct: 187 LLPIRWMSPEAIM-YGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 61.0 bits (148), Expect = 1e-10
 Identities = 54/200 (27%), Positives = 91/200 (45%), Gaps = 12/200 (6%)

Query: 15  IGAGGYGEVYKCRNTVTGQKVAIKMMT--IQTEQEGVPSYIIREVSLLKELE-HENIVRL 71
           IG G Y +V       T +  A+K++   +  + E +  ++  E  + +    H  +V L
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDI-DWVQTEKHVFETASNHPFLVGL 61

Query: 72  LDVQSSRKDVFLVFEYL---DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKIL 128
                +   +F V E++   DL  H    + +  L     +    +I L L + H   I+
Sbjct: 62  HSCFQTESRLFFVIEFVSGGDLMFH---MQRQRKLPEEHARFYSAEISLALNFLHERGII 118

Query: 129 HRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTP 188
           +RDLK +N+L+D     +KL D+G+ +    P    S  C    Y APE+L G   Y   
Sbjct: 119 YRDLKLDNVLLD-AEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRG-EDYGFS 176

Query: 189 IDVWAVGCIFAEMITGKPLF 208
           +D WA+G +  EM+ G+  F
Sbjct: 177 VDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 61.0 bits (148), Expect = 1e-10
 Identities = 34/103 (33%), Positives = 54/103 (52%), Gaps = 2/103 (1%)

Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           ++ L L + H   +++RDLK +N+L+D      KLADFG+ +   +     +  C    Y
Sbjct: 104 EVTLALMFLHRHGVIYRDLKLDNILLD-AEGHCKLADFGMCKEGILNGVTTTTFCGTPDY 162

Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHL 216
            APE+L     Y   +D WA+G +  EM+ G+P F +   D L
Sbjct: 163 IAPEILQELE-YGPSVDWWALGVLMYEMMAGQPPFEADNEDDL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 24/206 (11%)

Query: 15  IGAGGYGEVYKCRNTVTGQKVAIKMMT------------IQTEQEGVPSYIIREVSLLKE 62
           IG G Y +V   R     Q  A+K++             +QTE+     ++  + S    
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEK-----HVFEQAS---- 53

Query: 63  LEHENIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYC 122
             +  +V L     +   +FLV EY++     F  + +  L     +    +I + L + 
Sbjct: 54  -SNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFL 112

Query: 123 HSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGY 182
           H   I++RDLK +N+L+D     +KL D+G+ +    P    S  C    Y APE+L G 
Sbjct: 113 HERGIIYRDLKLDNVLLD-ADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG- 170

Query: 183 TGYSTPIDVWAVGCIFAEMITGKPLF 208
             Y   +D WA+G +  EM+ G+  F
Sbjct: 171 EEYGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 59.7 bits (144), Expect = 3e-10
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 28/212 (13%)

Query: 13  KKIGAGGYGEVYK--CRNTVTGQ---KVAIKMMTIQTEQEGVPSYI--IREVSLLKELEH 65
           +++G G +G VY+   +  V  +   +VAIK +    E   +   I  + E S++KE   
Sbjct: 12  RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASVMKEFNC 68

Query: 66  ENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFI------TRHKNTLNLLVIKAILK---QI 115
            ++VRLL V S  +   ++ E +   DL S++        +        +K +++   +I
Sbjct: 69  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEI 128

Query: 116 LLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRD----CVYS 171
             G+AY ++ K +HRDL   N ++  +  TVK+ DFG+ R I   + +Y R      +  
Sbjct: 129 ADGMAYLNANKFVHRDLAARNCMV-AEDFTVKIGDFGMTRDI--YETDYYRKGGKGLLPV 185

Query: 172 PYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
            + +PE L     ++T  DVW+ G +  E+ T
Sbjct: 186 RWMSPESLKDGV-FTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 59.3 bits (143), Expect = 5e-10
 Identities = 58/225 (25%), Positives = 103/225 (45%), Gaps = 37/225 (16%)

Query: 13  KKIGAGGYGEVY----------KCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKE 62
           K +G G +G+V           K +  VT   VA+KM+     ++ + S ++ E+ ++K 
Sbjct: 21  KPLGEGCFGQVVMAEALGIDKDKPKEAVT---VAVKMLKDDATEKDL-SDLVSEMEMMKM 76

Query: 63  L-EHENIVRLLDVQSSRKDVFLVFEY---------------LDLDLHSFITR-HKNTLNL 105
           + +H+NI+ LL   +    ++++ EY                 ++    I R     +  
Sbjct: 77  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTF 136

Query: 106 LVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ--KE 163
             + +   Q+  G+ Y  S K +HRDL   N+L+  + N +K+ADFGLAR +      K+
Sbjct: 137 KDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLARDVNNIDYYKK 195

Query: 164 YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT--GKP 206
            +   +   + APE L     Y+   DVW+ G +  E+ T  G P
Sbjct: 196 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSP 239

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 59.2 bits (143), Expect = 5e-10
 Identities = 60/217 (27%), Positives = 104/217 (47%), Gaps = 36/217 (16%)

Query: 12  IKKIGAGGYGEVYK--CRNTVTGQ---KVAIKMMTIQTEQEGVPSYI--IREVSLLKELE 64
           ++++G G +G VY+   R+ + G+   +VA+K +    E   +   I  + E S++K   
Sbjct: 11  LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN---ESASLRERIEFLNEASVMKGFT 67

Query: 65  HENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFIT-----------RHKNTLNLLVIKAIL 112
             ++VRLL V S  +   +V E +   DL S++            R   TL  ++  A  
Sbjct: 68  CHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA-- 125

Query: 113 KQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRD----C 168
            +I  G+AY ++ K +HRDL   N ++     TVK+ DFG+ R I   + +Y R      
Sbjct: 126 AEIADGMAYLNAKKFVHRDLAARNCMV-AHDFTVKIGDFGMTRDI--YETDYYRKGGKGL 182

Query: 169 VYSPYKAPELLLG--YTGYSTPIDVWAVGCIFAEMIT 203
           +   + APE L    +T  S   D+W+ G +  E+ +
Sbjct: 183 LPVRWMAPESLKDGVFTTSS---DMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 58.6 bits (142), Expect = 7e-10
 Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 30/207 (14%)

Query: 18  GGYGEVY--KCRNTVTG--QKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLD 73
           G +G ++     +   G  ++V +K +     +  V + +++E  LL  L H+NI+ +L 
Sbjct: 17  GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQV-TLLLQESCLLYGLSHQNILPILH 75

Query: 74  VQSSRKDV-FLVFEYLDL-DLHSFIT--RHKNTLNL-------LVIKAILKQILLGLAYC 122
           V     +  F+++ Y++  +L  F+   R     N        LV  AI  QI  G++Y 
Sbjct: 76  VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAI--QIACGMSYL 133

Query: 123 HSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCV----YSPYK--AP 176
           H   ++H+D+   N +ID +   VK+ D  L+R +  P  +Y   C+      P K  A 
Sbjct: 134 HKRGVIHKDIAARNCVIDEELQ-VKITDNALSRDL-FPM-DY--HCLGDNENRPVKWMAL 188

Query: 177 ELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           E L+    YS+  DVW+ G +  E++T
Sbjct: 189 ESLVNKE-YSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 45/146 (30%), Positives = 71/146 (48%), Gaps = 4/146 (2%)

Query: 12  IKKIGAGGYGEVYKCRNTVTGQKVAIKMM-TIQTEQEGVPSYIIREVSLLKELEHENIVR 70
           +K I  G +G+VY  R     +  A+K++       + +   +  E   L   +   IV 
Sbjct: 9   VKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVH 68

Query: 71  LLDVQSSRKDVFLVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILH 129
           L     S  +V+LV EYL   D+ S +  +      + +K I  ++ L L Y H   I+H
Sbjct: 69  LYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYI-SEVALALDYLHRHGIIH 127

Query: 130 RDLKPNNLLIDLKRNTVKLADFGLAR 155
           RDLKP+N+LI      +KL DFGL++
Sbjct: 128 RDLKPDNMLIS-NEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 58.1 bits (141), Expect = 1e-09
 Identities = 45/205 (21%), Positives = 86/205 (41%), Gaps = 29/205 (14%)

Query: 18  GGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS 77
                + K     T   VA+K + + +  +     + +E+   ++L+H NI+  +     
Sbjct: 13  LMIVHLAKH--KPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV 70

Query: 78  RKDVFLVFEYLDL----DLHSFITRH-KNTLNLLVIKAILKQILLGLAYCHSLKILHRDL 132
             ++++V   +      DL   +  H    L  L I  ILK +L  L Y HS   +HR +
Sbjct: 71  DSELYVVSPLMAYGSCEDL---LKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSV 127

Query: 133 KPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS---------PYKAPELL---- 179
           K +++L+      V L+    + ++ +   +  R  V+          P+ +PE+L    
Sbjct: 128 KASHILLS-GDGKVVLSGLRYSVSM-IKHGKRQR-VVHDFPKSSVKNLPWLSPEVLQQNL 184

Query: 180 LGYTGYSTPIDVWAVGCIFAEMITG 204
            GY   S   D+++VG    E+  G
Sbjct: 185 QGYNEKS---DIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 57.7 bits (139), Expect = 1e-09
 Identities = 60/208 (28%), Positives = 106/208 (50%), Gaps = 13/208 (6%)

Query: 4   LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQ--KVAIKMMTIQTEQEGVPSY--IIREVSL 59
           LK    +K+K +G+G +G V+K      G   K+ + + TIQ ++ G  ++  I   +  
Sbjct: 4   LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQ-DRSGRQTFQEITDHMLA 62

Query: 60  LKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLG 118
           +  L+H  IVRLL +      + LV +   L  L   + +H+++L+   +     QI  G
Sbjct: 63  MGSLDHAYIVRLLGI-CPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKG 121

Query: 119 LAYCHSLKILHRDLKPNNLLIDLKRNT-VKLADFGLARAIGVPQKEYSRDCVYSPYK--A 175
           + Y    +++HR+L   N+L  LK ++ V++ADFG+A  +    K+Y      +P K  A
Sbjct: 122 MYYLEEHRMVHRNLAARNIL--LKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMA 179

Query: 176 PELLLGYTGYSTPIDVWAVGCIFAEMIT 203
            E +L +  Y+   DVW+ G    EM++
Sbjct: 180 LESIL-FGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 60/224 (26%), Positives = 95/224 (42%), Gaps = 44/224 (19%)

Query: 107 VIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSR 166
           +I+ I++QIL  L   HS  I+HRD+KP N++      + K+ D G A  + V      +
Sbjct: 256 IIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPK 315

Query: 167 DCVYSP-YKAPELLLGYT----GYSTPI-----------------DVWAVGCIFAEMITG 204
           + +  P Y APE  +  T      S P+                 D+++ G IF +M   
Sbjct: 316 EFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMA-- 373

Query: 205 KPLFPSKKHDHLSLI-FSLLGTPTDES---WAESTYISEILPLYPHFEPANLAEKFPNLE 260
              FP+ + D  +LI F+      D     W +         + P   P +L   F  L+
Sbjct: 374 ---FPNLRSDS-NLIQFNRQLKRNDYDLVAWRKL--------VEPRASP-DLRRGFEVLD 420

Query: 261 ---PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVIL 301
               AG +LL  M+    +QRI+A  AL H Y      + L ++
Sbjct: 421 LDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDREGLLGLSVM 464

Length = 566

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 56.5 bits (136), Expect = 4e-09
 Identities = 60/213 (28%), Positives = 92/213 (43%), Gaps = 25/213 (11%)

Query: 15  IGAGGYGEVYKCRNTVTGQKV--AIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLL 72
           IG G +G+V K R    G ++  AIK M     ++    +      L K   H NI+ LL
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74

Query: 73  DVQSSRKDVFLVFEY------LDLDLHSFI----------TRHKNTLNLLVIKAILKQIL 116
                R  ++L  EY      LD    S +              +TL+   +      + 
Sbjct: 75  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134

Query: 117 LGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGV-PQKEYSRDCVYSPYKA 175
            G+ Y    + +HRDL   N+L+  +    K+ADFGL+R   V  +K   R  V   + A
Sbjct: 135 RGMDYLSQKQFIHRDLAARNILVG-ENYVAKIADFGLSRGQEVYVKKTMGRLPVR--WMA 191

Query: 176 PELLLGYTGYSTPIDVWAVGCIFAEMIT--GKP 206
            E L  Y+ Y+T  DVW+ G +  E+++  G P
Sbjct: 192 IESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTP 223

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 55.8 bits (134), Expect = 6e-09
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 27/214 (12%)

Query: 15  IGAGGYGEVYKCRNTVTGQKV--AIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRL 71
           IG G +G+V +      G K+  AIKM+  +   E        E+ +L +L  H NI+ L
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLK-EFASENDHRDFAGELEVLCKLGHHPNIINL 68

Query: 72  LDVQSSRKDVFLVFEY------LD-------LDLHSFITRHKNTLNLLVIKAILK---QI 115
           L    +R  +++  EY      LD       L+      +   T + L  + +L+    +
Sbjct: 69  LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128

Query: 116 LLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGV-PQKEYSRDCVYSPYK 174
             G+ Y    + +HRDL   N+L+  +    K+ADFGL+R   V  +K   R  V   + 
Sbjct: 129 ATGMQYLSEKQFIHRDLAARNVLVG-ENLASKIADFGLSRGEEVYVKKTMGRLPVR--WM 185

Query: 175 APELLLGYTGYSTPIDVWAVGCIFAEMIT--GKP 206
           A E L  Y+ Y+T  DVW+ G +  E+++  G P
Sbjct: 186 AIESL-NYSVYTTKSDVWSFGVLLWEIVSLGGTP 218

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 55.8 bits (134), Expect = 8e-09
 Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 33/219 (15%)

Query: 13  KKIGAGGYGEVYKCR-------NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-E 64
           K +G G +G+V                  VA+KM+      + + S ++ E+ ++K + +
Sbjct: 18  KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDL-SDLVSEMEMMKMIGK 76

Query: 65  HENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHK---------------NTLNLLVI 108
           H+NI+ LL   +    ++++ EY    +L  ++   +                 L    +
Sbjct: 77  HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136

Query: 109 KAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDC 168
            +   Q+  G+ Y  S K +HRDL   N+L+  + N +K+ADFGLAR   V   +Y +  
Sbjct: 137 VSCAYQVARGMEYLASQKCIHRDLAARNVLVT-EDNVMKIADFGLAR--DVHNIDYYKKT 193

Query: 169 VYS--PYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT 203
                P K  APE L     Y+   DVW+ G +  E+ T
Sbjct: 194 TNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 55.3 bits (133), Expect = 9e-09
 Identities = 49/215 (22%), Positives = 97/215 (45%), Gaps = 26/215 (12%)

Query: 3   KLKNLNYKKIKKIGAGGYGEVYKCRN--TVTGQK---VAIKMMTIQTEQEGVPSYIIREV 57
           +L N + K  + +G G +GE+  CR    +  ++   VAI  +      +    ++  E 
Sbjct: 1   ELDNKSIKIERILGTGRFGEL--CRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFL-AEA 57

Query: 58  SLLKELEHENIVRLLDVQSSRKDVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAILKQIL 116
             L + +H NIVRL  V +    + +V EY+    L SF+ +H+  L    +  +L  + 
Sbjct: 58  LTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLA 117

Query: 117 LGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP---- 172
            G+ Y   +  +H+ L  + +L++      K++ F          +E   + +Y+     
Sbjct: 118 SGMKYLSEMGYVHKGLAAHKVLVN-SDLVCKISGFR-------RLQEDKSEAIYTTMSGK 169

Query: 173 ----YKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
               + APE  + Y  +S+  DVW+ G +  E+++
Sbjct: 170 SPVLWAAPE-AIQYHHFSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 53.9 bits (129), Expect = 3e-08
 Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 25/213 (11%)

Query: 15  IGAGGYGEVYKCRNTVTGQKV--AIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLL 72
           IG G +G+V K R    G ++  AIK M     ++    +      L K   H NI+ LL
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 73  DVQSSRKDVFLVFEY------LD-------LDLHSFITRHKNTLNLLVIKAILK---QIL 116
                R  ++L  EY      LD       L+         +T + L  + +L     + 
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122

Query: 117 LGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGV-PQKEYSRDCVYSPYKA 175
            G+ Y    + +HRDL   N+L+  +    K+ADFGL+R   V  +K   R  V   + A
Sbjct: 123 RGMDYLSQKQFIHRDLAARNILVG-ENYVAKIADFGLSRGQEVYVKKTMGRLPVR--WMA 179

Query: 176 PELLLGYTGYSTPIDVWAVGCIFAEMIT--GKP 206
            E L  Y+ Y+T  DVW+ G +  E+++  G P
Sbjct: 180 IESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTP 211

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 53.3 bits (128), Expect = 3e-08
 Identities = 47/156 (30%), Positives = 75/156 (48%), Gaps = 10/156 (6%)

Query: 67  NIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSL 125
           N+V L     S   VFLV ++ +   L S I++  N     V K    ++++ L   H  
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECV-KRWAAEMVVALDALHRE 104

Query: 126 KILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGY 185
            I+ RDL PNN+L+D  R  ++L  F     +   +     + V + Y APE + G +  
Sbjct: 105 GIVCRDLNPNNILLD-DRGHIQLTYFSRWSEV---EDSCDGEAVENMYCAPE-VGGISEE 159

Query: 186 STPIDVWAVGCIFAEMITGKPLF---PSKKHDHLSL 218
           +   D W++G I  E++TGK L    PS  + H +L
Sbjct: 160 TEACDWWSLGAILFELLTGKTLVECHPSGINTHTTL 195

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 54.3 bits (130), Expect = 4e-08
 Identities = 23/48 (47%), Positives = 33/48 (68%), Gaps = 1/48 (2%)

Query: 107 VIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLA 154
           VIK +++Q+L GL   H + I+HRD+KP NLL+ +    VK+ DFG A
Sbjct: 310 VIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVD-GQVKIIDFGAA 356

Length = 507

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 51.0 bits (122), Expect = 2e-07
 Identities = 53/174 (30%), Positives = 83/174 (47%), Gaps = 34/174 (19%)

Query: 46  QEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITR---HKN 101
           Q+G P  I         L+H NI++ L          LVFEY +L DL S++++   H+ 
Sbjct: 44  QQGDPYRI---------LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRR 94

Query: 102 TLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNN--LLIDLKRNTVKLADFGLARAIGV 159
              LL+++ +  +I  G+ + H    LH DL   N  L  DL   TVK+ D+G    IG 
Sbjct: 95  NSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDL---TVKVGDYG----IGP 147

Query: 160 P--QKEY--SRDCVYSPYK--APELLLGYTG------YSTPIDVWAVGCIFAEM 201
              +++Y  + D    P +  APEL+  + G       + P +VWA+G    E+
Sbjct: 148 SRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 45/149 (30%), Positives = 66/149 (44%), Gaps = 22/149 (14%)

Query: 103 LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK 162
           L  L + +   Q+  G+ +  S   +HRDL   N+L+  +   VK+ DFGLAR I     
Sbjct: 234 LTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA-QGKIVKICDFGLARDIMHDSN 292

Query: 163 EYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIF 220
             S+   + P K  APE +     Y+T  DVW+ G +  E                  IF
Sbjct: 293 YVSKGSTFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWE------------------IF 333

Query: 221 SLLGTPTDESWAESTYISEILPLYPHFEP 249
           SL GTP      +ST+ ++I   Y   +P
Sbjct: 334 SLGGTPYPGMIVDSTFYNKIKSGYRMAKP 362

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 50.8 bits (121), Expect = 3e-07
 Identities = 35/104 (33%), Positives = 51/104 (49%), Gaps = 5/104 (4%)

Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           Q+  G+ +  S K +HRDL   N+L+  + N VK+ DFGLAR I        +     P 
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245

Query: 174 K--APELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHD 214
           K  APE +     Y+   DVW+ G +  E+ + G   +P  K D
Sbjct: 246 KWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKID 288

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 50.0 bits (119), Expect = 5e-07
 Identities = 32/92 (34%), Positives = 47/92 (51%), Gaps = 4/92 (4%)

Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           Q+  G+ +  S K +HRDL   N+L+  + N VK+ DFGLAR I        +     P 
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240

Query: 174 K--APELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           K  APE +     Y+T  DVW+ G +  E+ +
Sbjct: 241 KWMAPESIFDKV-YTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 49.9 bits (119), Expect = 6e-07
 Identities = 54/210 (25%), Positives = 94/210 (44%), Gaps = 25/210 (11%)

Query: 13  KKIGAGGYGEVYKC---RNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIV 69
            +IG G +G+V      R     + V  ++    T  E +    ++EV   +EL H N++
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQL--LFLQEVQPYRELNHPNVL 58

Query: 70  RLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILK----QILLGLAYCHS 124
           + L          LV E+  L DL +++  ++  +  +  K +L+    ++  GL + H 
Sbjct: 59  QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118

Query: 125 LKILHRDLKPNNLLI--DLKRNTVKLADFGLARAIGVPQKEY-SRDCVYSPYK--APELL 179
              +H DL   N  +  DL   +VK+ D+GLA     P+  Y ++DC   P +  APEL+
Sbjct: 119 ADFIHSDLALRNCQLTADL---SVKIGDYGLALE-QYPEDYYITKDCHAVPLRWLAPELV 174

Query: 180 LGYTGYSTPID------VWAVGCIFAEMIT 203
                   P D      +W++G    E+ T
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 50.0 bits (119), Expect = 7e-07
 Identities = 43/144 (29%), Positives = 64/144 (44%), Gaps = 22/144 (15%)

Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           Q+  G+ +  S   +HRDL   N+LI  +   VK+ DFGLAR I       S+   + P 
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLI-CEGKLVKICDFGLARDIMRDSNYISKGSTFLPL 305

Query: 174 K--APELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESW 231
           K  APE +     Y+T  DVW+ G +  E                  IF+L GTP  E  
Sbjct: 306 KWMAPESIF-NNLYTTLSDVWSFGILLWE------------------IFTLGGTPYPELP 346

Query: 232 AESTYISEILPLYPHFEPANLAEK 255
               + + I   Y   +PA+ +++
Sbjct: 347 MNEQFYNAIKRGYRMAKPAHASDE 370

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 49.5 bits (118), Expect = 1e-06
 Identities = 37/105 (35%), Positives = 54/105 (51%), Gaps = 7/105 (6%)

Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDC-VYSP 172
           Q+  G+ +  S K +HRDL   N+L+  + N VK+ DFGLAR I     +Y R      P
Sbjct: 181 QVARGMEFLASRKCIHRDLAARNILLS-ENNVVKICDFGLARDI-YKDPDYVRKGDARLP 238

Query: 173 YK--APELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHD 214
            K  APE +     Y+T  DVW+ G +  E+ + G   +P  + D
Sbjct: 239 LKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQID 282

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 63/280 (22%), Positives = 119/280 (42%), Gaps = 47/280 (16%)

Query: 15  IGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLD- 73
           +G+G  G V   +    G+  A+K++ ++   E   +    EV  L   +  +IV+  + 
Sbjct: 40  LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHED 99

Query: 74  -VQSSRKD------VFLVFEYLDL-DLHSFI-TRHKNTLNLLVIKA--ILKQILLGLAYC 122
             +   ++      + LV +Y +  DL   I +R K        +A  +  Q+LL + + 
Sbjct: 100 FAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHV 159

Query: 123 HSLKILHRDLKPNNLLIDLKRNTVKLADFGLAR--AIGVPQKEYSRDCVYSPYKAPELLL 180
           HS  ++HRD+K  N+L+      VKL DFG ++  A  V        C    Y APE+  
Sbjct: 160 HSKHMIHRDIKSANILL-CSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWR 218

Query: 181 GYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEI 240
               YS   D++++G +  E++T K  F                        +   + E+
Sbjct: 219 -RKPYSKKADMFSLGVLLYELLTLKRPF------------------------DGENMEEV 253

Query: 241 L--PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQR 278
           +   L   ++P       P++ P   ++++ +L  +PK+R
Sbjct: 254 MHKTLAGRYDPLP-----PSISPEMQEIVTALLSSDPKRR 288

Length = 496

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 46.5 bits (110), Expect = 8e-06
 Identities = 46/173 (26%), Positives = 80/173 (46%), Gaps = 20/173 (11%)

Query: 13  KKIGAGGYGEVY--KCR-NTVTGQKVAIKMMTIQTEQEGVPS------YIIREVSL---L 60
           K IG GG+G VY  +C  +     +   K+  ++ E   + +      Y I +++L   +
Sbjct: 18  KLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNI 77

Query: 61  KELEHENIVRLLDVQSSRKDV----FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQIL 116
             ++H  I +     S ++      F++ E L  +      R K   N  +IK I+K +L
Sbjct: 78  HNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIK-CKNKKLIKNIMKDML 136

Query: 117 LGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK--EYSRD 167
             L Y H   I H D+KP N+++D   N   + D+G+A    +  K  EYS++
Sbjct: 137 TTLEYIHEHGISHGDIKPENIMVD-GNNRGYIIDYGIASHFIIHGKHIEYSKE 188

Length = 294

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 46.0 bits (109), Expect = 9e-06
 Identities = 52/217 (23%), Positives = 100/217 (46%), Gaps = 27/217 (12%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           +K I++   G YGE++K        +V +K++  ++ +    S+     S++ +L H+++
Sbjct: 12  FKGIRR-EVGDYGELHK-------TEVLLKVLD-KSHRNYSESFF-EAASMMSQLSHKHL 61

Query: 69  VRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
           V    V     +  +V EY+    L +++ ++KN +N+     + KQ+   L +     +
Sbjct: 62  VLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGL 121

Query: 128 LHRDLKPNNLLI----DLKRNT---VKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLL 180
            H ++   N+L+    D K      +KL+D G+  +I V  KE   + +  P+  PE + 
Sbjct: 122 THGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI--SITVLPKEILLERI--PWVPPECIE 177

Query: 181 GYTGYSTPIDVWAVGCIFAEMITG--KPLF---PSKK 212
                S   D W+ G    E+ +G  KPL      KK
Sbjct: 178 NPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK 214

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 46.0 bits (109), Expect = 1e-05
 Identities = 31/100 (31%), Positives = 47/100 (47%), Gaps = 5/100 (5%)

Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           Q+  G+ +  S   +HRD+   N+L+   R   K+ DFGLAR I        +     P 
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDGR-VAKICDFGLARDIMNDSNYVVKGNARLPV 278

Query: 174 K--APELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPS 210
           K  APE +     Y+   DVW+ G +  E+ + GK  +P 
Sbjct: 279 KWMAPESIF-DCVYTVQSDVWSYGILLWEIFSLGKSPYPG 317

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 43.0 bits (101), Expect = 9e-05
 Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 27/223 (12%)

Query: 13  KKIGAGGYGEVY--KCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKELEHENIV 69
           K+IG G +G+V   +  +  T  +V +K + +    QE +    + E    + L+H N++
Sbjct: 1   KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQM--KFLEEAQPYRSLQHSNLL 58

Query: 70  RLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKN----TLNLLVIKAILKQILLGLAYCHS 124
           + L   +      LV E+  L DL  ++   +     T +   ++ +  +I LGL + H 
Sbjct: 59  QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118

Query: 125 LKILHRDLKPNNLLI--DLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELL- 179
              +H DL   N L+  DL   TVK+ D+GL+          + D ++ P +  APEL+ 
Sbjct: 119 NNFIHSDLALRNCLLTADL---TVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVD 175

Query: 180 -----LGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLS 217
                L     +   +VW++G    E+        S+ + HLS
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWELFE----LGSQPYRHLS 214

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 43.0 bits (101), Expect = 1e-04
 Identities = 52/226 (23%), Positives = 94/226 (41%), Gaps = 17/226 (7%)

Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           VY  R+T TG  V +++  ++   E     +  EV L     H NI+    V ++   ++
Sbjct: 16  VYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLW 75

Query: 83  LVFEYLDLDL--HSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLID 140
           ++  ++          T     ++  +I  IL   L GL Y H    +HR++K +++LI 
Sbjct: 76  VISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILIS 135

Query: 141 LKRNTVKLADFGLARAIGVPQKEYSRDCVYS---------PYKAPELL-LGYTGYSTPID 190
                V L+  GL+    + +       VY          P+ +PELL     GY+   D
Sbjct: 136 -GDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSD 192

Query: 191 VWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY 236
           +++VG    E+ TG+   P +      ++   L  P       +T+
Sbjct: 193 IYSVGITACELATGR--VPFQDMLRTQMLLQKLKGPPYSPLDITTF 236

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 40.6 bits (95), Expect = 6e-04
 Identities = 30/92 (32%), Positives = 45/92 (48%), Gaps = 4/92 (4%)

Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           Q+  G+++  S   +HRDL   N+L+   R T K+ DFGLAR I        +     P 
Sbjct: 222 QVAKGMSFLASKNCIHRDLAARNILLTHGRIT-KICDFGLARDIRNDSNYVVKGNARLPV 280

Query: 174 K--APELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           K  APE +     Y+   DVW+ G +  E+ +
Sbjct: 281 KWMAPESIFNCV-YTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 39.8 bits (93), Expect = 0.002
 Identities = 52/198 (26%), Positives = 86/198 (43%), Gaps = 27/198 (13%)

Query: 15  IGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDV 74
           I  G  G  YK ++   G +  +K      E   V S    E++ + +L+H NIV+L+ +
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVK------EINDVNSIPSSEIADMGKLQHPNIVKLIGL 751

Query: 75  QSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCH---SLKILHRD 131
             S K  +L+ EY++    S + R    L+    + I   I   L + H   S  ++  +
Sbjct: 752 CRSEKGAYLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGN 808

Query: 132 LKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPI-- 189
           L P  ++ID K +   L    L   +    K +    + S Y APE     T  +  I  
Sbjct: 809 LSPEKIIIDGK-DEPHLR-LSLPGLLCTDTKCF----ISSAYVAPE-----TRETKDITE 857

Query: 190 --DVWAVGCIFAEMITGK 205
             D++  G I  E++TGK
Sbjct: 858 KSDIYGFGLILIELLTGK 875

Length = 968

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 41/187 (21%), Positives = 86/187 (45%), Gaps = 17/187 (9%)

Query: 31  TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL 90
           TG+ V ++ + ++     + +++  E+ + K   H NIV       +  ++++V  ++  
Sbjct: 24  TGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAY 83

Query: 91  ----DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK---- 142
               DL    T   + ++ L I  IL+ +L  L Y H +  +HR +K +++LI +     
Sbjct: 84  GSAKDL--ICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVY 141

Query: 143 ----RNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELL-LGYTGYSTPIDVWAVGCI 197
               R+ + + + G    +     +YS   +  P+ +PE+L     GY    D+++VG  
Sbjct: 142 LSGLRSNLSMINHGQRLRVVHDFPKYSVKVL--PWLSPEVLQQNLQGYDAKSDIYSVGIT 199

Query: 198 FAEMITG 204
             E+  G
Sbjct: 200 ACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 38.6 bits (90), Expect = 0.002
 Identities = 40/162 (24%), Positives = 72/162 (44%), Gaps = 13/162 (8%)

Query: 54  IREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAIL 112
               SL+ +L H+++V+L  V   R +  +V EY+    L  F+ R KN ++L     + 
Sbjct: 49  FETASLMSQLSHKHLVKLYGV-CVRDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVA 107

Query: 113 KQILLGLAYCHSLKILHRDLKPNNLLI---DLKRNT---VKLADFGLARAIGVPQKEYSR 166
           KQ+   L Y    K++H ++   N+L+    L       +KL+D G+   +   ++   R
Sbjct: 108 KQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVER 167

Query: 167 DCVYSPYKAPELL-LGYTGYSTPIDVWAVGCIFAEMITGKPL 207
                P+ APE +  G    +   D W+ G    E+ +    
Sbjct: 168 ----IPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEE 205

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	324
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	99.98
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.94
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.93
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.93
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.92
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.92
PRK09188	365	serine/threonine protein kinase; Provisional	99.92
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.91
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.9
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.89
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.88
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.88
PRK12274	218	serine/threonine protein kinase; Provisional	99.87
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.84
smart00090	237	RIO RIO-like kinase.	99.82
PRK10345	210	hypothetical protein; Provisional	99.81
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.81
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.76
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.76
PRK14879	211	serine/threonine protein kinase; Provisional	99.76
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.74
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.73
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.71
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.7
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.69
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.67
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.66
KOG1243	690	consensus Protein kinase [General function predict	99.63
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.53
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.52
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.51
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.42
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.41
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.38
KOG3087	229	consensus Serine/threonine protein kinase [General	99.37
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.36
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.34
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.29
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.29
COG4248	637	Uncharacterized protein with protein kinase and he	99.24
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.21
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.21
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.18
PRK09902	216	hypothetical protein; Provisional	99.12
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.05
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.04
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.85
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.7
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.7
PF01636	239	APH: Phosphotransferase enzyme family This family	98.57
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.46
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.46
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.45
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.45
PLN02876	822	acyl-CoA dehydrogenase	98.33
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.28
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.28
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.17
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.08
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.08
PRK09550	401	mtnK methylthioribose kinase; Reviewed	98.04
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.03
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.99
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.98
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.91
KOG2270	520	consensus Serine/threonine protein kinase involved	97.85
PRK10593	297	hypothetical protein; Provisional	97.83
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.67
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.67
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.65
PRK05231	319	homoserine kinase; Provisional	97.65
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.59
PLN02236	344	choline kinase	97.58
PLN02756	418	S-methyl-5-thioribose kinase	97.55
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.53
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.52
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.36
PRK12396	409	5-methylribose kinase; Reviewed	97.18
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	97.09
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.07
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.06
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.96
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.95
PTZ00384	383	choline kinase; Provisional	96.79
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.73
PTZ00296	442	choline kinase; Provisional	96.58
COG2334	331	Putative homoserine kinase type II (protein kinase	96.03
PRK11768	325	serine/threonine protein kinase; Provisional	95.98
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.91
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.91
PRK06148	1013	hypothetical protein; Provisional	95.73
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	95.1

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-58  Score=389.43  Aligned_cols=290  Identities=36%  Similarity=0.606  Sum_probs=262.6

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcC-CCCeeEEEeeeecCC-eE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-HENIVRLLDVQSSRK-DV   81 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~-~~   81 (324)
                      +.-+||+++++||.|.||.||+|+.+.+|..||+|.++.....-+..- -.+|+..|++++ ||||+++.+++.++. .+
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~-nLREvksL~kln~hpniikL~Evi~d~~~~L   85 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECM-NLREVKSLRKLNPHPNIIKLKEVIRDNDRIL   85 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHH-HHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence            345799999999999999999999999999999999876553322122 347999999999 999999999998887 99


Q ss_pred             EEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC
Q 045787           82 FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        82 ~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~  161 (324)
                      |+||||++.+|.+.+..++.+++++.++.|+.||++||.|+|++|+.|||+||+|||+. ....+||+|||+|+.+. +.
T Consensus        86 ~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~-~~~~iKiaDFGLARev~-Sk  163 (538)
T KOG0661|consen   86 YFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILIS-GNDVIKIADFGLAREVR-SK  163 (538)
T ss_pred             eeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEec-ccceeEecccccccccc-cC
Confidence            99999999999999999999999999999999999999999999999999999999999 78999999999999886 45


Q ss_pred             CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHHcCCCCcccccchhh-hhc
Q 045787          162 KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-HDHLSLIFSLLGTPTDESWAESTY-ISE  239 (324)
Q Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~-~~~  239 (324)
                      ..+.....|.+|+|||++.....|+.+.|+|++||+++|+.+-++.|.+.+ .+++.++..++|.|....|..... ...
T Consensus       164 pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~  243 (538)
T KOG0661|consen  164 PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASA  243 (538)
T ss_pred             CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHH
Confidence            667777899999999999887899999999999999999999999999888 788999999999999999998544 445


Q ss_pred             ccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCc
Q 045787          240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENV  296 (324)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~  296 (324)
                      ..-.++......+....+..+.++.++|.+||.|||.+||||.++++||||+.....
T Consensus       244 mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~  300 (538)
T KOG0661|consen  244 MNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRAS  300 (538)
T ss_pred             hccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccc
Confidence            555688888999999999999999999999999999999999999999999987754

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7e-57  Score=376.59  Aligned_cols=267  Identities=29%  Similarity=0.473  Sum_probs=225.1

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeecccc-----CCCchHHHHHHHHHHhcCCCCeeEEEeeeecCC
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQ-----EGVPSYIIREVSLLKELEHENIVRLLDVQSSRK   79 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   79 (324)
                      ..+-|.+-+.||+|+||.|-+|..+.+|+.||+|++......     ......+.+|+++|++++||+|++++++|...+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            467799999999999999999999999999999999765422     122344679999999999999999999999999


Q ss_pred             eEEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecC--CCcEEEeeccceee
Q 045787           80 DVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK--RNTVKLADFGLARA  156 (324)
Q Consensus        80 ~~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~--~~~v~l~d~g~~~~  156 (324)
                      ..|+|+||++ |.|.+.+... +.+.+...+.+++|++.|+.|||+.||+||||||+|||+..+  +-.+||+|||++..
T Consensus       250 s~YmVlE~v~GGeLfd~vv~n-k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~  328 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVAN-KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV  328 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhc-cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence            9999999998 5999998885 458999999999999999999999999999999999999732  26799999999998


Q ss_pred             ccCCCCcccccccccccCCchhhcC--CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhH-HHHHHHHcCCCCcccccc
Q 045787          157 IGVPQKEYSRDCVYSPYKAPELLLG--YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDH-LSLIFSLLGTPTDESWAE  233 (324)
Q Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~  233 (324)
                      .+ ....+...||||.|.|||++.+  ...+..+.|+|||||++|-+++|.+||.....+. +...+....-        
T Consensus       329 ~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y--------  399 (475)
T KOG0615|consen  329 SG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRY--------  399 (475)
T ss_pred             cc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcc--------
Confidence            87 5666777899999999999965  2334558999999999999999999998777554 4443332211        


Q ss_pred             hhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCch
Q 045787          234 STYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP  297 (324)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~  297 (324)
                                      ...+..|..+++++++||++||..||++|||++|+|+||||+.+.-..
T Consensus       400 ----------------~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~~s  447 (475)
T KOG0615|consen  400 ----------------AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPCLS  447 (475)
T ss_pred             ----------------cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccccc
Confidence                            111223457999999999999999999999999999999999887433

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-55  Score=386.72  Aligned_cols=255  Identities=29%  Similarity=0.518  Sum_probs=227.1

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeecc-ccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQT-EQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLV   84 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   84 (324)
                      ..+|+..+.||+|||+.||.+.+..+|+.||+|++.+.. ......+++.+|++++++|+|||||+++++|++..+.|||
T Consensus        17 ~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYiv   96 (592)
T KOG0575|consen   17 SKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIV   96 (592)
T ss_pred             cceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEE
Confidence            368999999999999999999999999999999998765 3444568899999999999999999999999999999999


Q ss_pred             EEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCc
Q 045787           85 FEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE  163 (324)
Q Consensus        85 ~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~  163 (324)
                      .|.|. ++|..++. ..++++|.+++.+++||+.||.|||+.+|+|||||..|+|++ ++.+|||+|||+|..+..+.++
T Consensus        97 LELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~-~~~~VKIgDFGLAt~le~~~Er  174 (592)
T KOG0575|consen   97 LELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLN-ENMNVKIGDFGLATQLEYDGER  174 (592)
T ss_pred             EEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeec-CcCcEEecccceeeeecCcccc
Confidence            99998 46665555 678899999999999999999999999999999999999999 9999999999999999988888


Q ss_pred             ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCC
Q 045787          164 YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPL  243 (324)
Q Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (324)
                      ....||||.|.|||++.. ...+..+||||+||++|.|++|++||...+-......+....-.                 
T Consensus       175 k~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~-----------------  236 (592)
T KOG0575|consen  175 KKTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYS-----------------  236 (592)
T ss_pred             cceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcc-----------------
Confidence            889999999999999986 67799999999999999999999999988754444333322111                 


Q ss_pred             CCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCcccc
Q 045787          244 YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLI  291 (324)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~  291 (324)
                                 ....++.++++||.+||+.||.+|||+++||.|+||.
T Consensus       237 -----------~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~  273 (592)
T KOG0575|consen  237 -----------MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFK  273 (592)
T ss_pred             -----------cccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhh
Confidence                       1126899999999999999999999999999999993

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=3.8e-55  Score=346.83  Aligned_cols=288  Identities=45%  Similarity=0.763  Sum_probs=263.4

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE   86 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   86 (324)
                      .+|...+.||+|.||.||+|++..+|+.||+|.+..............+|+..|+.++|+||+.++++|...+.+.+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            58999999999999999999999999999999999887666666778899999999999999999999999999999999


Q ss_pred             ecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcccc
Q 045787           87 YLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSR  166 (324)
Q Consensus        87 ~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~  166 (324)
                      |++.+|...+......++...++.++.+++.||+|+|++.+.||||||+|+|++ ++|.+||+|||+++..+.+......
T Consensus        82 fm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis-~~g~lKiADFGLAr~f~~p~~~~~~  160 (318)
T KOG0659|consen   82 FMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLIS-SDGQLKIADFGLARFFGSPNRIQTH  160 (318)
T ss_pred             eccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEc-CCCcEEeecccchhccCCCCccccc
Confidence            999999999999988999999999999999999999999999999999999999 9999999999999999988888877


Q ss_pred             cccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHHcCCCCcccccchhhhhcccCCCC
Q 045787          167 DCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-HDHLSLIFSLLGTPTDESWAESTYISEILPLYP  245 (324)
Q Consensus       167 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (324)
                      ...|.+|+|||.+.+...|+...|+||.||++.||+.+.+.|.+.+ -+++..++..+|.|....|.+.....+..... 
T Consensus       161 ~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~-  239 (318)
T KOG0659|consen  161 QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ-  239 (318)
T ss_pred             ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHh-
Confidence            7899999999999998999999999999999999999999998776 78999999999999999999877766655443 


Q ss_pred             CCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCc
Q 045787          246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENV  296 (324)
Q Consensus       246 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~  296 (324)
                      ..........++..+.++.+|+.+||..||.+|+++.|+|+|+||.+.+.+
T Consensus       240 ~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~p  290 (318)
T KOG0659|consen  240 QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLP  290 (318)
T ss_pred             cCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCC
Confidence            233333344778899999999999999999999999999999999986643

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.9e-56  Score=360.47  Aligned_cols=288  Identities=37%  Similarity=0.682  Sum_probs=248.8

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE   86 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   86 (324)
                      +.|+.+.++|+|++|+||+++++.+|+.||+|.|.-+...+...+-..+|+++|++++|+|+|.++++|.....+++|||
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            46999999999999999999999999999999998777767666778899999999999999999999999999999999


Q ss_pred             ecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcccc
Q 045787           87 YLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSR  166 (324)
Q Consensus        87 ~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~  166 (324)
                      ||+.++++.++..+...+++.++.+++|++.|+.|+|+++++||||||+|||++ .++.+||||||+|+....++..+..
T Consensus        82 ~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit-~~gvvKLCDFGFAR~L~~pgd~YTD  160 (396)
T KOG0593|consen   82 YCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILIT-QNGVVKLCDFGFARTLSAPGDNYTD  160 (396)
T ss_pred             ecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEe-cCCcEEeccchhhHhhcCCcchhhh
Confidence            999999999999999999999999999999999999999999999999999999 9999999999999999878888888


Q ss_pred             cccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHHcCCCCc---ccccchhhhhcccC
Q 045787          167 DCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-HDHLSLIFSLLGTPTD---ESWAESTYISEILP  242 (324)
Q Consensus       167 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~  242 (324)
                      ...|.+|+|||.+.+...|+...|||++||++.||++|.+.|.+.+ .+++..+...+|.-.+   ..+....+.... .
T Consensus       161 YVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv-~  239 (396)
T KOG0593|consen  161 YVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV-R  239 (396)
T ss_pred             hhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee-e
Confidence            9999999999999998999999999999999999999999998887 4555555555554432   122221111110 1


Q ss_pred             CCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCc
Q 045787          243 LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENV  296 (324)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~  296 (324)
                      .-...........++.++.-+.+|+++||+.||.+|++.++++.||||.+....
T Consensus       240 lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~er  293 (396)
T KOG0593|consen  240 LPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIER  293 (396)
T ss_pred             cCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHHH
Confidence            111123455667788899999999999999999999999999999999765533

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-55  Score=361.25  Aligned_cols=266  Identities=29%  Similarity=0.499  Sum_probs=231.4

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF   82 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   82 (324)
                      ...++|++++.||+|+||.|++|+.+.+++.||+|++++..- .....+....|..++.+++||+|++++..|++.+.+|
T Consensus        22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy  101 (357)
T KOG0598|consen   22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY  101 (357)
T ss_pred             CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence            456899999999999999999999999999999999987763 2234577889999999999999999999999999999


Q ss_pred             EEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC
Q 045787           83 LVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        83 iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~  161 (324)
                      +|++|+.| .|...+++ .+.+++..++.++..|+.||.|||++||+|||+||+|||++ .+|+++|+|||++...-...
T Consensus       102 lVld~~~GGeLf~hL~~-eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd-~~GHi~LtDFgL~k~~~~~~  179 (357)
T KOG0598|consen  102 LVLDYLNGGELFYHLQR-EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLD-EQGHIKLTDFGLCKEDLKDG  179 (357)
T ss_pred             EEEeccCCccHHHHHHh-cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeec-CCCcEEEeccccchhcccCC
Confidence            99999985 77777666 45699999999999999999999999999999999999999 99999999999998665455


Q ss_pred             CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhccc
Q 045787          162 KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEIL  241 (324)
Q Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (324)
                      .....-|||+.|||||++.+ ..++.++|.||||+++|+|++|.+||...+...+...+.....+.              
T Consensus       180 ~~t~tfcGT~eYmAPEil~~-~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~--------------  244 (357)
T KOG0598|consen  180 DATRTFCGTPEYMAPEILLG-KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPL--------------  244 (357)
T ss_pred             CccccccCCccccChHHHhc-CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCC--------------
Confidence            55566799999999999998 689999999999999999999999999888655544433222111              


Q ss_pred             CCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCC----CHHHHhcCccccCCCCchhh
Q 045787          242 PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRI----TAMDALKHEYLIGVENVPLV  299 (324)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp----s~~~~l~hp~~~~~~~~~~~  299 (324)
                                   ....++.+++++++++|.+||.+|.    ++.++-+||||.++++..+.
T Consensus       245 -------------~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~  293 (357)
T KOG0598|consen  245 -------------PPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLL  293 (357)
T ss_pred             -------------CCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHH
Confidence                         1113789999999999999999996    68999999999999987763

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-54  Score=359.29  Aligned_cols=261  Identities=27%  Similarity=0.483  Sum_probs=221.7

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCC-eEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK-DVFLVF   85 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~iv~   85 (324)
                      .+.+.++.||+|+.|+||+|+|+.+++.+|+|++... .++...+.+.+|+++++..+||+||.+++.|.++. ..+|+|
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~-~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m  157 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN-IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM  157 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc-CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence            4788999999999999999999999999999999543 33444677899999999999999999999999988 599999


Q ss_pred             EecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCc
Q 045787           86 EYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS-LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE  163 (324)
Q Consensus        86 e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~  163 (324)
                      |||+| +|...+... +.+++.....++.+++.||.|||. .+|+||||||+|||++ ..|.|||+|||.+..+-..  .
T Consensus       158 EYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvN-skGeVKicDFGVS~~lvnS--~  233 (364)
T KOG0581|consen  158 EYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVN-SKGEVKICDFGVSGILVNS--I  233 (364)
T ss_pred             hhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeec-cCCCEEeccccccHHhhhh--h
Confidence            99995 666666654 679999999999999999999995 9999999999999999 9999999999999877544  3


Q ss_pred             ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC---hhHHHHHHHHcCCCCcccccchhhhhcc
Q 045787          164 YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK---HDHLSLIFSLLGTPTDESWAESTYISEI  240 (324)
Q Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (324)
                      .....||..|||||.+.+ ..|+.++||||||+.++|+.+|+.||....   ......+..+...+++..          
T Consensus       234 a~tfvGT~~YMsPERi~g-~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~l----------  302 (364)
T KOG0581|consen  234 ANTFVGTSAYMSPERISG-ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRL----------  302 (364)
T ss_pred             cccccccccccChhhhcC-CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCC----------
Confidence            345579999999999999 789999999999999999999999997752   233334444444333221          


Q ss_pred             cCCCCCCCCcchhhhCC-CCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchh
Q 045787          241 LPLYPHFEPANLAEKFP-NLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       241 ~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~  298 (324)
                                     .. .+++++++||..||++||.+||++.|+++|||+++..+...
T Consensus       303 ---------------P~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~v  346 (364)
T KOG0581|consen  303 ---------------PEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPNV  346 (364)
T ss_pred             ---------------CcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcccccc
Confidence                           11 48999999999999999999999999999999998776443

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.9e-54  Score=367.38  Aligned_cols=288  Identities=40%  Similarity=0.709  Sum_probs=254.2

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecC--CeE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR--KDV   81 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~   81 (324)
                      ...+.|+.+++||+|.||.||+|++..+|+.||+|.+..+...+.......+|+.+|++|.||||+++.+...+.  ..+
T Consensus       114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si  193 (560)
T KOG0600|consen  114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI  193 (560)
T ss_pred             cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence            345679999999999999999999999999999999999888888888889999999999999999999988766  689


Q ss_pred             EEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC
Q 045787           82 FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        82 ~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~  161 (324)
                      |+||||++.+|..++....-.+++.+++.+++||+.||.|+|++|++|||||.+|||+| .+|.+||+|||+++......
T Consensus       194 YlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLid-n~G~LKiaDFGLAr~y~~~~  272 (560)
T KOG0600|consen  194 YLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILID-NNGVLKIADFGLARFYTPSG  272 (560)
T ss_pred             EEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEc-CCCCEEeccccceeeccCCC
Confidence            99999999999998888666899999999999999999999999999999999999999 99999999999999776544


Q ss_pred             C-cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHHcCCCCcccccchhhhhc
Q 045787          162 K-EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-HDHLSLIFSLLGTPTDESWAESTYISE  239 (324)
Q Consensus       162 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
                      . .......|.+|+|||.+.+...|+.+.|+||.|||+.||+.|++.|.+.+ .+++..++.+.+.|.+..|.....-..
T Consensus       273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~  352 (560)
T KOG0600|consen  273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHA  352 (560)
T ss_pred             CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcc
Confidence            3 36667889999999999999999999999999999999999999999888 778899999999999999873322211


Q ss_pred             ccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccC
Q 045787          240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIG  292 (324)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~  292 (324)
                      ....-...-...+.+.+..++....+|+..||..||.+|.||.++|.|+||..
T Consensus       353 ~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t  405 (560)
T KOG0600|consen  353 TIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT  405 (560)
T ss_pred             cccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence            11222222245566778889999999999999999999999999999999933

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.3e-53  Score=345.89  Aligned_cols=290  Identities=40%  Similarity=0.689  Sum_probs=259.1

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeee--cCCeEEE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQS--SRKDVFL   83 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~i   83 (324)
                      .+.|+.+..|++|.||.||+|+++.+++.||+|.++.........-.-.+|+.+|.+.+|||||.+.++..  +-+.+|+
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            46799999999999999999999999999999999988766665566679999999999999999998764  3457999


Q ss_pred             EEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCc
Q 045787           84 VFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE  163 (324)
Q Consensus        84 v~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~  163 (324)
                      ||||++.+|.+.+...+.++...+++.++.|++.|+.|||.+.|+||||||+|+|++ ..|.+||+|||+|+..+.+...
T Consensus       155 VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~-~~G~lKiaDFGLAR~ygsp~k~  233 (419)
T KOG0663|consen  155 VMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLS-HKGILKIADFGLAREYGSPLKP  233 (419)
T ss_pred             eHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeec-cCCcEEecccchhhhhcCCccc
Confidence            999999999999999999999999999999999999999999999999999999999 9999999999999999988888


Q ss_pred             ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHHcCCCCcccccchhhhhccc-
Q 045787          164 YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-HDHLSLIFSLLGTPTDESWAESTYISEIL-  241 (324)
Q Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  241 (324)
                      ......|.+|+|||.+.+...|+.+.|+||+|||+.||+++.+.|.+.. .+++.+++..++.|.+..|..-....... 
T Consensus       234 ~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~  313 (419)
T KOG0663|consen  234 YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKK  313 (419)
T ss_pred             CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhc
Confidence            8888999999999999998999999999999999999999999999988 78899999999999999998765555442 


Q ss_pred             CCCCCCCCcchhhhCCCC--ChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCc
Q 045787          242 PLYPHFEPANLAEKFPNL--EPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENV  296 (324)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~--~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~  296 (324)
                      ..+.......+...++.+  ++...+|++.+|..||.+|.||.+.|.|+||.+.+.+
T Consensus       314 ~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p  370 (419)
T KOG0663|consen  314 MTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLP  370 (419)
T ss_pred             cccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCC
Confidence            334444445555555554  4899999999999999999999999999999996543

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=6.9e-52  Score=343.16  Aligned_cols=293  Identities=46%  Similarity=0.831  Sum_probs=266.4

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCC-eeEEEeeeecCC------
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN-IVRLLDVQSSRK------   79 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~------   79 (324)
                      ..|+.+++||+|.+|+||+|+++.+|+.||+|.+......+.......+|+.++++++|++ |+++++++.+.+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            3588899999999999999999999999999999988765555566789999999999999 999999998776      


Q ss_pred             eEEEEEEecCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceee
Q 045787           80 DVFLVFEYLDLDLHSFITRHK---NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARA  156 (324)
Q Consensus        80 ~~~iv~e~~~g~l~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~  156 (324)
                      .+++||||.+-+|..++....   ...+...++.+++||+.||+|||++||+||||||.||+++ ..|.+||+|||+++.
T Consensus        91 ~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~-~~G~lKlaDFGlAra  169 (323)
T KOG0594|consen   91 KLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLIS-SSGVLKLADFGLARA  169 (323)
T ss_pred             eEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEEC-CCCcEeeeccchHHH
Confidence            899999999999999999877   3588899999999999999999999999999999999999 899999999999998


Q ss_pred             ccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHHcCCCCcccccchh
Q 045787          157 IGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-HDHLSLIFSLLGTPTDESWAEST  235 (324)
Q Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~  235 (324)
                      ...+........+|.+|+|||++.+...|+...|+||+|||++||++++..|.+.. .++...+....+.|....|....
T Consensus       170 ~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~  249 (323)
T KOG0594|consen  170 FSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVS  249 (323)
T ss_pred             hcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCcc
Confidence            87777778888999999999999998889999999999999999999999998877 77888999999999999999988


Q ss_pred             hhhcccCCCCCCC-CcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchhhh
Q 045787          236 YISEILPLYPHFE-PANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVI  300 (324)
Q Consensus       236 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~~~  300 (324)
                      ...+.-..+..+. +.......+..+++..+++.+||+.+|.+|.|++.+++||||.++.......
T Consensus       250 ~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~~~~  315 (323)
T KOG0594|consen  250 SLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKSSQL  315 (323)
T ss_pred             ccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccchhhh
Confidence            8888777777776 7777788888889999999999999999999999999999999997665543

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-52  Score=362.03  Aligned_cols=269  Identities=29%  Similarity=0.449  Sum_probs=231.8

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeecc-ccCCCchHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQT-EQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDVF   82 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~   82 (324)
                      ...+|...+.||.|+|++|++|.++.+++.||+|++.+.. ..+...+.+..|-..|.+| .||+|++++-.|+++..+|
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY  150 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY  150 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence            4578999999999999999999999999999999998765 3334457788899999999 6999999999999999999


Q ss_pred             EEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC
Q 045787           83 LVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        83 iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~  161 (324)
                      +|+||++ |+|++++.+. +.+++..++.++.+|+.||+|||++||+||||||+|||++ .+++++|+|||.+..+....
T Consensus       151 FvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd-~dmhikITDFGsAK~l~~~~  228 (604)
T KOG0592|consen  151 FVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLD-KDGHIKITDFGSAKILSPSQ  228 (604)
T ss_pred             EEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEc-CCCcEEEeeccccccCChhh
Confidence            9999997 7999999986 5699999999999999999999999999999999999999 99999999999998774322


Q ss_pred             Cc-------------ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCc
Q 045787          162 KE-------------YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTD  228 (324)
Q Consensus       162 ~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  228 (324)
                      ..             ...-.||-.|.+||++.. ...++++|+|+|||++|+|+.|.+||.+.++-...+.+..+.-.  
T Consensus       229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~--  305 (604)
T KOG0592|consen  229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYE--  305 (604)
T ss_pred             ccccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhccc--
Confidence            11             133578888999999988 77899999999999999999999999988865554443322211  


Q ss_pred             ccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchhhhhhhh
Q 045787          229 ESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLIN  304 (324)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~~~~~~~  304 (324)
                                                ..+++++.+++||+++|..||++|+++.+|.+||||.++.+..+-....|
T Consensus       306 --------------------------fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nlw~~~PP  355 (604)
T KOG0592|consen  306 --------------------------FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENLWQQTPP  355 (604)
T ss_pred             --------------------------CCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhhhhcCCC
Confidence                                      12368899999999999999999999999999999999998876443333

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=4.2e-51  Score=351.61  Aligned_cols=283  Identities=47%  Similarity=0.825  Sum_probs=233.9

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      -++|++++.||.|++|.||+|.+..++..||+|.+...... .....+.+|+.++++++||||+++++++..++..++|+
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF   82 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence            46799999999999999999999999999999998755322 22356778999999999999999999999999999999


Q ss_pred             EecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccc
Q 045787           86 EYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYS  165 (324)
Q Consensus        86 e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~  165 (324)
                      ||++|++.+++......+++..+..++.|++.||.+||++|++|+||||+||+++ .++.++|+|||.+...........
T Consensus        83 e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~-~~~~~kl~DfG~~~~~~~~~~~~~  161 (288)
T cd07871          83 EYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLIN-EKGELKLADFGLARAKSVPTKTYS  161 (288)
T ss_pred             eCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC-CCCCEEECcCcceeeccCCCcccc
Confidence            9999999999887766789999999999999999999999999999999999999 899999999999876554444444


Q ss_pred             ccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHHcCCCCcccccchhhhhcccCC-
Q 045787          166 RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-HDHLSLIFSLLGTPTDESWAESTYISEILPL-  243 (324)
Q Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  243 (324)
                      ...+++.|+|||++.+...++.++|+||||+++|+|++|+.||.+.+ .+....+....+.++...|.......+.... 
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (288)
T cd07871         162 NEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYL  241 (288)
T ss_pred             CceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccc
Confidence            45678899999998776778999999999999999999999998777 4455566666777776665543322222111 


Q ss_pred             CCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          244 YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                      ++...........+.++.+++++|.+||+.||.+|||++|+++||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         242 FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             cCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            11222223334455788999999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-52  Score=345.51  Aligned_cols=292  Identities=41%  Similarity=0.663  Sum_probs=257.5

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeec-----CC
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS-----RK   79 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~   79 (324)
                      ...+|..++.||.|++|.|..|.++.+|..||+|.+.......-..++..+|+.+++.++|+||+.+.+++..     -.
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            3556777899999999999999999999999999998777777667888999999999999999999998855     34


Q ss_pred             eEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccC
Q 045787           80 DVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGV  159 (324)
Q Consensus        80 ~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~  159 (324)
                      .+|+|+|+++.+|.+.+... ..+++..+..+++|++.||.|+|+.|++|||+||.|++++ .+..+||+|||+++....
T Consensus       100 DvYiV~elMetDL~~iik~~-~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n-~~c~lKI~DFGLAR~~~~  177 (359)
T KOG0660|consen  100 DVYLVFELMETDLHQIIKSQ-QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLN-ADCDLKICDFGLARYLDK  177 (359)
T ss_pred             eeEEehhHHhhHHHHHHHcC-ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeec-cCCCEEeccccceeeccc
Confidence            69999999988888887774 4599999999999999999999999999999999999999 999999999999998764


Q ss_pred             C--CCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHHcCCCCcccccc--h
Q 045787          160 P--QKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-HDHLSLIFSLLGTPTDESWAE--S  234 (324)
Q Consensus       160 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~--~  234 (324)
                      .  .........|.+|+|||++.+...|+.+.||||.|||+.||++|++.|.+.+ ..++..+....+.|+.+....  +
T Consensus       178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s  257 (359)
T KOG0660|consen  178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRS  257 (359)
T ss_pred             cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhcc
Confidence            2  2334556789999999999988999999999999999999999999999988 667788888888887655544  3


Q ss_pred             hhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchh
Q 045787          235 TYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~  298 (324)
                      ......+...+...+..+...+++.++.+.+|+++||..||.+|+|++|+|+||||...-++.-
T Consensus       258 ~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~d  321 (359)
T KOG0660|consen  258 EKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPED  321 (359)
T ss_pred             HHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCcc
Confidence            4455577778888899999999999999999999999999999999999999999998775443

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.5e-50  Score=350.78  Aligned_cols=289  Identities=43%  Similarity=0.733  Sum_probs=231.6

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLV   84 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   84 (324)
                      ..++|++.+.||.|++|.||+|.+..+++.+|+|++....... ....+.+|+.+++.++|||++++++++.++...++|
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   81 (303)
T cd07869           3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-TPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV   81 (303)
T ss_pred             ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc-cchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence            3578999999999999999999999999999999987554322 234567899999999999999999999999999999


Q ss_pred             EEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcc
Q 045787           85 FEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY  164 (324)
Q Consensus        85 ~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~  164 (324)
                      |||+++++.+.+......+++..++.++.|++.||.|||+.|++|+||||+||+++ .++.++|+|||.+..........
T Consensus        82 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~  160 (303)
T cd07869          82 FEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHTY  160 (303)
T ss_pred             EECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC-CCCCEEECCCCcceeccCCCccC
Confidence            99999999999988777899999999999999999999999999999999999999 89999999999987654443344


Q ss_pred             cccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC--hhHHHHHHHHcCCCCcccccchhhhhcccC
Q 045787          165 SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK--HDHLSLIFSLLGTPTDESWAESTYISEILP  242 (324)
Q Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (324)
                      ....+++.|+|||++.+...++.++|+|||||++|+|++|..||.+..  ......+....+.+....|..........+
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (303)
T cd07869         161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKP  240 (303)
T ss_pred             CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccc
Confidence            445678899999998775678999999999999999999999998755  344455555555555544433222111111


Q ss_pred             C-CCCCCCcchhhhCC--CCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCC
Q 045787          243 L-YPHFEPANLAEKFP--NLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVEN  295 (324)
Q Consensus       243 ~-~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~  295 (324)
                      . .....+......+.  .++..+.+++.+||+.||.+|||+.++++||||+++..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~  296 (303)
T cd07869         241 ERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP  296 (303)
T ss_pred             ccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence            0 11111111111111  35678999999999999999999999999999998865

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-51  Score=329.67  Aligned_cols=262  Identities=26%  Similarity=0.456  Sum_probs=227.8

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   83 (324)
                      .-++|++++.||.|+||.|.+++++.+|..||+|++.+..- .....+...+|..+|+.+.||+++++++.+.+.+.+|+
T Consensus        42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym  121 (355)
T KOG0616|consen   42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM  121 (355)
T ss_pred             chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence            45689999999999999999999999999999999986641 12224557789999999999999999999999999999


Q ss_pred             EEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC
Q 045787           84 VFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK  162 (324)
Q Consensus        84 v~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~  162 (324)
                      ||||.+| .+.+++.+. +++++..++.++.+|+.||+|||++++++||+||+|||+| .+|.+||+|||.+....   .
T Consensus       122 vmeyv~GGElFS~Lrk~-~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD-~~G~iKitDFGFAK~v~---~  196 (355)
T KOG0616|consen  122 VMEYVPGGELFSYLRKS-GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLD-QNGHIKITDFGFAKRVS---G  196 (355)
T ss_pred             EEeccCCccHHHHHHhc-CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeec-cCCcEEEEeccceEEec---C
Confidence            9999984 888887775 5699999999999999999999999999999999999999 99999999999999875   3


Q ss_pred             cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccC
Q 045787          163 EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILP  242 (324)
Q Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (324)
                      +....||||.|+|||++.. .++..++|.|+||+++|||+.|.+||...+.-.+...+....-                 
T Consensus       197 rT~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v-----------------  258 (355)
T KOG0616|consen  197 RTWTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV-----------------  258 (355)
T ss_pred             cEEEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc-----------------
Confidence            3567799999999999998 8889999999999999999999999988886554443332111                 


Q ss_pred             CCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCC-----CHHHHhcCccccCCCCchhhh
Q 045787          243 LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRI-----TAMDALKHEYLIGVENVPLVI  300 (324)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~~l~hp~~~~~~~~~~~~  300 (324)
                                 ...+.++.++++||+++|+.|-++|.     ...+|..||||+++.+..+..
T Consensus       259 -----------~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~  310 (355)
T KOG0616|consen  259 -----------KFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQ  310 (355)
T ss_pred             -----------cCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhh
Confidence                       12236899999999999999999993     578999999999999877743

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-50  Score=351.15  Aligned_cols=260  Identities=32%  Similarity=0.526  Sum_probs=225.0

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeecccc---CCCchHHHHHHHHHHhcC-CCCeeEEEeeeecCC
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQ---EGVPSYIIREVSLLKELE-HENIVRLLDVQSSRK   79 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~---~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~   79 (324)
                      ...++|++.+.||+|+||.|++|.+..++..+|+|++......   ....+.+.+|+.+++++. ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            4567999999999999999999999999999999977664211   244567889999999999 999999999999999


Q ss_pred             eEEEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCC-CcEEEeeccceeec
Q 045787           80 DVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKR-NTVKLADFGLARAI  157 (324)
Q Consensus        80 ~~~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~-~~v~l~d~g~~~~~  157 (324)
                      .+|+||||+.| +|++++.. .+++.+..++.++.|++.|++|+|++|++||||||+||+++ .+ +.+||+|||++...
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld-~~~~~~Kl~DFG~s~~~  171 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLD-GNEGNLKLSDFGLSAIS  171 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEec-CCCCCEEEecccccccc
Confidence            99999999985 99999999 77899999999999999999999999999999999999999 66 99999999999987


Q ss_pred             cCCCCcccccccccccCCchhhcCCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhh
Q 045787          158 GVPQKEYSRDCVYSPYKAPELLLGYT-GYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY  236 (324)
Q Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (324)
                      ..........+|++.|+|||++.+.. ..+.++||||+|++||.|++|..||...+...+...+......          
T Consensus       172 ~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~----------  241 (370)
T KOG0583|consen  172 PGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFK----------  241 (370)
T ss_pred             CCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCcc----------
Confidence            53455667789999999999999866 5578999999999999999999999886655554442211100          


Q ss_pred             hhcccCCCCCCCCcchhhhCCCC-ChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCC
Q 045787          237 ISEILPLYPHFEPANLAEKFPNL-EPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV  293 (324)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~  293 (324)
                                        ....+ +.++++++.+||..||.+|+++.+++.||||+..
T Consensus       242 ------------------~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~  281 (370)
T KOG0583|consen  242 ------------------IPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQKE  281 (370)
T ss_pred             ------------------CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence                              11134 8899999999999999999999999999999983

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-50  Score=337.59  Aligned_cols=276  Identities=24%  Similarity=0.352  Sum_probs=233.0

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF   82 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   82 (324)
                      .+..+.|++...||.|..++||+|+....+..||+|++..+....+ .+.+++|+..+..++||||++++..|..++.+|
T Consensus        22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LW  100 (516)
T KOG0582|consen   22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELW  100 (516)
T ss_pred             CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecceeE
Confidence            3567899999999999999999999999999999999998776555 688999999999999999999999999999999


Q ss_pred             EEEEecC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           83 LVFEYLD-LDLHSFITRH-KNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        83 iv~e~~~-g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      +||+++. |++++.+... +..+++..+..++++++.||.|||++|.+|||||+.|||++ ++|.|+|+|||.+..+...
T Consensus       101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~-~dG~VkLadFgvsa~l~~~  179 (516)
T KOG0582|consen  101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILID-SDGTVKLADFGVSASLFDS  179 (516)
T ss_pred             EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEc-CCCcEEEcCceeeeeeccc
Confidence            9999998 6888888653 45699999999999999999999999999999999999999 9999999999988766544


Q ss_pred             CCcc----cccccccccCCchh-hcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchh
Q 045787          161 QKEY----SRDCVYSPYKAPEL-LLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAEST  235 (324)
Q Consensus       161 ~~~~----~~~~~~~~y~aPE~-~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (324)
                      ..+.    ....++++|+|||+ ......|+.|+||||||+++.|+.+|+.||....+-.+...-.. +.|+...-    
T Consensus       180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLq-n~pp~~~t----  254 (516)
T KOG0582|consen  180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQ-NDPPTLLT----  254 (516)
T ss_pred             CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhc-CCCCCccc----
Confidence            4332    33479999999999 45556789999999999999999999999988877666544333 33332110    


Q ss_pred             hhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchh
Q 045787          236 YISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~  298 (324)
                                   .....+....++..++.+|..||++||.+|||+.++|+|+||+.+.....
T Consensus       255 -------------~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~~  304 (516)
T KOG0582|consen  255 -------------SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKEY  304 (516)
T ss_pred             -------------ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchhh
Confidence                         01111222357789999999999999999999999999999999986544

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=5.7e-50  Score=345.58  Aligned_cols=269  Identities=30%  Similarity=0.502  Sum_probs=223.3

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF   82 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   82 (324)
                      +..++|++++.||+|+||.||+|+.+.+|..||+|++.++.. .....+.++.|..+|..-.+|.||+++..|++.+++|
T Consensus       138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY  217 (550)
T KOG0605|consen  138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY  217 (550)
T ss_pred             CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence            346799999999999999999999999999999999998763 2334567889999999999999999999999999999


Q ss_pred             EEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccC--
Q 045787           83 LVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGV--  159 (324)
Q Consensus        83 iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~--  159 (324)
                      +||||++| ++...+.. .+.+++..++.++.+++.|+..+|+.|++|+||||+|+|+| ..|++||+|||++.....  
T Consensus       218 LiMEylPGGD~mTLL~~-~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD-~~GHiKLSDFGLs~gl~~~~  295 (550)
T KOG0605|consen  218 LIMEYLPGGDMMTLLMR-KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLID-AKGHIKLSDFGLSTGLDKKH  295 (550)
T ss_pred             EEEEecCCccHHHHHHh-cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeec-CCCCEeeccccccchhhhhh
Confidence            99999985 77776666 56799999999999999999999999999999999999999 999999999999733210  


Q ss_pred             -------------------C--CC-----c-------------------ccccccccccCCchhhcCCCCCCCchhhHHH
Q 045787          160 -------------------P--QK-----E-------------------YSRDCVYSPYKAPELLLGYTGYSTPIDVWAV  194 (324)
Q Consensus       160 -------------------~--~~-----~-------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl  194 (324)
                                         +  ..     .                   .....|||.|+|||++.+ ..++..+|.|||
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~-kgY~~~cDwWSL  374 (550)
T KOG0605|consen  296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG-KGYGKECDWWSL  374 (550)
T ss_pred             hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc-CCCCccccHHHH
Confidence                               0  00     0                   011368899999999999 668999999999


Q ss_pred             HHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCC
Q 045787          195 GCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLN  274 (324)
Q Consensus       195 G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d  274 (324)
                      |||+|||+.|.+||.+.++...-..+.....              ......          -..++.++++||.+||. |
T Consensus       375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~--------------~l~fP~----------~~~~s~eA~DLI~rll~-d  429 (550)
T KOG0605|consen  375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRE--------------TLKFPE----------EVDLSDEAKDLITRLLC-D  429 (550)
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhh--------------hccCCC----------cCcccHHHHHHHHHHhc-C
Confidence            9999999999999999886554433321110              000000          01467899999999999 9


Q ss_pred             CCCCCC---HHHHhcCccccCCCCchhhh
Q 045787          275 PKQRIT---AMDALKHEYLIGVENVPLVI  300 (324)
Q Consensus       275 P~~Rps---~~~~l~hp~~~~~~~~~~~~  300 (324)
                      |.+|..   +.||.+||||+++++..+..
T Consensus       430 ~~~RLG~~G~~EIK~HPfF~~v~W~~l~~  458 (550)
T KOG0605|consen  430 PENRLGSKGAEEIKKHPFFKGVDWDHLRE  458 (550)
T ss_pred             HHHhcCcccHHHHhcCCccccCCcchhhc
Confidence            999985   99999999999999998854

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=6.7e-49  Score=341.30  Aligned_cols=290  Identities=47%  Similarity=0.811  Sum_probs=236.3

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLV   84 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   84 (324)
                      .-++|++.+.||.|++|.||++.+..++..+|+|.+....... ....+.+|+.++++++|||++++++++..++..++|
T Consensus         4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   82 (309)
T cd07872           4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG-APCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV   82 (309)
T ss_pred             CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC-cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence            4578999999999999999999999999999999987654322 234567899999999999999999999999999999


Q ss_pred             EEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcc
Q 045787           85 FEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY  164 (324)
Q Consensus        85 ~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~  164 (324)
                      |||+++++.+++......++...++.++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+..........
T Consensus        83 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~  161 (309)
T cd07872          83 FEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLIN-ERGELKLADFGLARAKSVPTKTY  161 (309)
T ss_pred             EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC-CCCCEEECccccceecCCCcccc
Confidence            99999999999887777789999999999999999999999999999999999999 88999999999987654444444


Q ss_pred             cccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHHcCCCCcccccchhhhhccc-C
Q 045787          165 SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-HDHLSLIFSLLGTPTDESWAESTYISEIL-P  242 (324)
Q Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  242 (324)
                      ....+++.|+|||++.+...++.++||||||+++|+|++|+.||...+ .+....+....+.+....|.......... .
T Consensus       162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
T cd07872         162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY  241 (309)
T ss_pred             ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhh
Confidence            445678889999998775678999999999999999999999998777 44455566666666655544322111110 0


Q ss_pred             CCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCc
Q 045787          243 LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENV  296 (324)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~  296 (324)
                      ..............+.+++++.++|.+||+.||.+|||+.++++||||+.....
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~  295 (309)
T cd07872         242 NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTR  295 (309)
T ss_pred             hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcccc
Confidence            111112222334445789999999999999999999999999999999987643

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-50  Score=350.74  Aligned_cols=271  Identities=30%  Similarity=0.505  Sum_probs=238.3

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE   86 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   86 (324)
                      ..|+...++|.|+.|.||.|....+++.||+|.+.......  .+.+.+|+.+++..+|+|||.+++.|...+.+|+|||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~--keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME  350 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK--KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME  350 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc--hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence            46888999999999999999999999999999998766544  5779999999999999999999999988899999999


Q ss_pred             ecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccc
Q 045787           87 YLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYS  165 (324)
Q Consensus        87 ~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~  165 (324)
                      |++| +|.+.+...  .+++.+++.+++.++.||.|||.+|++|+|||.+|||+. .+|.+||+|||++...........
T Consensus       351 ym~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~-~~g~vKltDFGFcaqi~~~~~KR~  427 (550)
T KOG0578|consen  351 YMEGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLT-MDGSVKLTDFGFCAQISEEQSKRS  427 (550)
T ss_pred             ecCCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEec-cCCcEEEeeeeeeeccccccCccc
Confidence            9985 777766653  499999999999999999999999999999999999999 999999999999998887776778


Q ss_pred             ccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCC
Q 045787          166 RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYP  245 (324)
Q Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (324)
                      .-.|||.|||||+... ..|+++.||||||++++||+-|.+||-..++-....++...+.|.-..               
T Consensus       428 TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~---------------  491 (550)
T KOG0578|consen  428 TMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKN---------------  491 (550)
T ss_pred             cccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCC---------------
Confidence            8899999999999988 789999999999999999999999998766655555555555543322               


Q ss_pred             CCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchhhhhhhhcccC
Q 045787          246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLINRKKK  308 (324)
Q Consensus       246 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~~~~~~~~~~~  308 (324)
                                ...+++.+++|+.+||+.||.+|++|.++|+||||+.......+.+++...++
T Consensus       492 ----------~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~p~ssL~pLi~~~~~  544 (550)
T KOG0578|consen  492 ----------PEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMAKPESSLNPLILAARK  544 (550)
T ss_pred             ----------ccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhcCCHHHhHHHHHHHHH
Confidence                      23689999999999999999999999999999999988888777777665543

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.1e-50  Score=334.14  Aligned_cols=285  Identities=35%  Similarity=0.599  Sum_probs=239.1

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCC-----e
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK-----D   80 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~   80 (324)
                      .-.|+-.+.+|.|+||.||.|....+++.+|+|....+....      .+|+.+++.+.||||+++.-+|....     .
T Consensus        23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~   96 (364)
T KOG0658|consen   23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVY   96 (364)
T ss_pred             EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence            346889999999999999999999999999999987554332      37999999999999999988775422     4


Q ss_pred             EEEEEEecCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeec
Q 045787           81 VFLVFEYLDLDLHSFITRH---KNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAI  157 (324)
Q Consensus        81 ~~iv~e~~~g~l~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~  157 (324)
                      ..+||||++-+|...+...   +..++.-.++-+.+||+.||.|||+.|++||||||.|+|+|.+.|.+||+|||+|...
T Consensus        97 lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen   97 LNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            6789999999999988853   4568888999999999999999999999999999999999988899999999999988


Q ss_pred             cCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHHcCCCCcccccchhh
Q 045787          158 GVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-HDHLSLIFSLLGTPTDESWAESTY  236 (324)
Q Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  236 (324)
                      .....+ .....|..|+|||.+.+...|+.+.||||.||++.||+-|++.|.+.+ .+++..++..+|.|..+.....+.
T Consensus       177 ~~~epn-iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~  255 (364)
T KOG0658|consen  177 VKGEPN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNP  255 (364)
T ss_pred             ccCCCc-eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCc
Confidence            754444 444567779999999999999999999999999999999999999987 778889999999998766544332


Q ss_pred             hhcccCCCCCCCCcchhh-hCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchh
Q 045787          237 ISEILPLYPHFEPANLAE-KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~  298 (324)
                      ... ...+++.....+.+ .....++++.+|+.++|+.+|.+|.++.+++.||||.++++...
T Consensus       256 ~y~-~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~  317 (364)
T KOG0658|consen  256 NYT-EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNT  317 (364)
T ss_pred             ccc-cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCc
Confidence            211 22233333344434 45678999999999999999999999999999999999998743

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-50  Score=333.87  Aligned_cols=263  Identities=32%  Similarity=0.537  Sum_probs=225.6

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLV   84 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   84 (324)
                      ..++|.+.+.||+|+|++||+++++.++..||+|.+.+........+.+..|+.+|+.++||||+.+++++..++.+|+|
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV   87 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV   87 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence            45789999999999999999999999999999999988765555567788999999999999999999999999999999


Q ss_pred             EEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecC-C----CcEEEeeccceeecc
Q 045787           85 FEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK-R----NTVKLADFGLARAIG  158 (324)
Q Consensus        85 ~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~-~----~~v~l~d~g~~~~~~  158 (324)
                      ||||+ |+|..++...+ .+++..++.++.||+.||++||+++|+||||||+|||++.. +    -.+||+|||+++.+.
T Consensus        88 MEyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~  166 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ  166 (429)
T ss_pred             EEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence            99998 58888877754 69999999999999999999999999999999999999843 2    358999999999887


Q ss_pred             CCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhh
Q 045787          159 VPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYIS  238 (324)
Q Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (324)
                       +.......||+|.|||||++.. ..|+.|+|+||+|+++|+|++|+.||...+..++..-+......            
T Consensus       167 -~~~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~------------  232 (429)
T KOG0595|consen  167 -PGSMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEI------------  232 (429)
T ss_pred             -chhHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccc------------
Confidence             5556677899999999999987 77899999999999999999999999888877665532211111            


Q ss_pred             cccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCC
Q 045787          239 EILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVEN  295 (324)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~  295 (324)
                                   ........+....+++...|+.+|..|-+..+-+.|+++..-..
T Consensus       233 -------------~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p~  276 (429)
T KOG0595|consen  233 -------------VPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANPQ  276 (429)
T ss_pred             -------------cCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCcc
Confidence                         01111246677779999999999999999999999999987763

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=7.6e-49  Score=337.49  Aligned_cols=281  Identities=32%  Similarity=0.555  Sum_probs=221.5

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE   86 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   86 (324)
                      ++|++.+.||+|++|.||+|.+..+++.+|+|++..........+.+.+|+.+++.++|||++++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            57999999999999999999999999999999998665444455678899999999999999999999999999999999


Q ss_pred             ecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC-ccc
Q 045787           87 YLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK-EYS  165 (324)
Q Consensus        87 ~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~-~~~  165 (324)
                      |++++++..+......+++..++.++.|++.||.+||+.|++|+||||+||+++ .++.++|+|||.+........ ...
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~  159 (287)
T cd07848          81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLIS-HNDVLKLCDFGFARNLSEGSNANYT  159 (287)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc-CCCcEEEeeccCccccccccccccc
Confidence            999888887777667799999999999999999999999999999999999999 899999999999876543222 223


Q ss_pred             ccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhH-HHHHHHHcCCCCcccccchhhhh----cc
Q 045787          166 RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDH-LSLIFSLLGTPTDESWAESTYIS----EI  240 (324)
Q Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~----~~  240 (324)
                      ...+++.|+|||++.+ ..++.++|+||||+++|+|++|++||...+... ...+....+..+...+.......    ..
T Consensus       160 ~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (287)
T cd07848         160 EYVATRWYRSPELLLG-APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLR  238 (287)
T ss_pred             ccccccccCCcHHHcC-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccc
Confidence            3467889999999987 567999999999999999999999998776433 22333333332221111100000    00


Q ss_pred             cCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          241 LPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                      .+. ..............++.++.+||++||+.||.+|||++++++||||
T Consensus       239 ~~~-~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         239 FPA-VNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             cCc-ccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            000 0000111122234578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.7e-48  Score=334.99  Aligned_cols=282  Identities=48%  Similarity=0.855  Sum_probs=233.2

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEe
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEY   87 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   87 (324)
                      +|++++.||+|++|.||+|.+..++..|++|.+............+.+|+.++++++|||++++++++.++...|+|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            58999999999999999999999999999999876654444456788999999999999999999999999999999999


Q ss_pred             cCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccc
Q 045787           88 LDLDLHSFITRHK--NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYS  165 (324)
Q Consensus        88 ~~g~l~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~  165 (324)
                      +++++.+++....  ..+++..++.++.|++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+...........
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~  159 (285)
T cd07861          81 LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLID-NKGVIKLADFGLARAFGIPVRVYT  159 (285)
T ss_pred             CCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEc-CCCcEEECcccceeecCCCccccc
Confidence            9999988886543  4689999999999999999999999999999999999999 899999999999876654443344


Q ss_pred             ccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHHcCCCCcccccchhhhhcccCCC
Q 045787          166 RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLY  244 (324)
Q Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (324)
                      ...+++.|+|||++.+...++.++|+||||+++|+|++|+.||..... ..........+.+....|.............
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
T cd07861         160 HEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTF  239 (285)
T ss_pred             CCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhc
Confidence            456678899999987756678999999999999999999999987663 3344444455555555554444333333333


Q ss_pred             CCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                      ..............+++++.++|.+||+.||.+|||+.++++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         240 PKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             cccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            4444444445556789999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6e-52  Score=331.29  Aligned_cols=256  Identities=27%  Similarity=0.444  Sum_probs=220.3

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEe-ee-ecCCeEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLD-VQ-SSRKDVFLV   84 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~-~~-~~~~~~~iv   84 (324)
                      .+|+|+++||.|+||+||+|++..+|..+|.|.+.....+....+.+..|+.+|++|+||||+++++ .+ ++..-++||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            4699999999999999999999999999999999866665555677889999999999999999998 33 444459999


Q ss_pred             EEecC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh--CC--CcccCCCCCceEeecCCCcEEEeeccceee
Q 045787           85 FEYLD-LDLHSFITRH---KNTLNLLVIKAILKQILLGLAYCHS--LK--ILHRDLKPNNLLIDLKRNTVKLADFGLARA  156 (324)
Q Consensus        85 ~e~~~-g~l~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~--~g--~~H~di~p~nIll~~~~~~v~l~d~g~~~~  156 (324)
                      ||+|+ |+|.+.+...   ...+++..+|+++.|++.||.++|+  ..  +.||||||.||+++ .+|.|||+|||+++.
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~-~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLT-ANGVVKLGDFGLGRF  177 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEc-CCCceeeccchhHhH
Confidence            99998 6888777653   4569999999999999999999999  44  99999999999999 999999999999999


Q ss_pred             ccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhh
Q 045787          157 IGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY  236 (324)
Q Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (324)
                      ..+.........|||.||+||.+.. .+++.+|||||+||++|||+.-++||.+.+...+...+.....|+-+.      
T Consensus       178 l~s~~tfA~S~VGTPyYMSPE~i~~-~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~------  250 (375)
T KOG0591|consen  178 LSSKTTFAHSLVGTPYYMSPERIHE-SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPD------  250 (375)
T ss_pred             hcchhHHHHhhcCCCcccCHHHHhc-CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcH------
Confidence            8877666777899999999999998 789999999999999999999999999998777777666554443221      


Q ss_pred             hhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCC
Q 045787          237 ISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVEN  295 (324)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~  295 (324)
                                          ..+|.++..+|..|+..||..||+.     +|+++.+..
T Consensus       251 --------------------~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~di~~  284 (375)
T KOG0591|consen  251 --------------------EHYSTDLRELINMCIAVDPEQRPDT-----VPYVQDIQS  284 (375)
T ss_pred             --------------------HHhhhHHHHHHHHHccCCcccCCCc-----chHHHHHHH
Confidence                                1578899999999999999999996     555554443

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-49  Score=334.64  Aligned_cols=263  Identities=31%  Similarity=0.471  Sum_probs=215.2

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCC--eEEE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK--DVFL   83 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~i   83 (324)
                      ..+|+..+.||+|+||+||++.+..+|...|+|.........  .+.+.+|+.+|.+++||+||++++......  .+++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~--~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i   93 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT--SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI   93 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh--HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence            356899999999999999999999889999999988763222  566899999999999999999999754444  6999


Q ss_pred             EEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccC---
Q 045787           84 VFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGV---  159 (324)
Q Consensus        84 v~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~---  159 (324)
                      +|||+. |+|.+++...++.+++..++.+.++|+.||.|||++|++||||||+|||++..++.+||+|||.+.....   
T Consensus        94 ~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~  173 (313)
T KOG0198|consen   94 FMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT  173 (313)
T ss_pred             eeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence            999997 6999999887768999999999999999999999999999999999999993379999999998887663   


Q ss_pred             CCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhc
Q 045787          160 PQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISE  239 (324)
Q Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
                      .........||+.|+|||++.+......++|||||||++.||+||..||... ......+..+....             
T Consensus       174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~~~~~~~~~ig~~~-------------  239 (313)
T KOG0198|consen  174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-FEEAEALLLIGRED-------------  239 (313)
T ss_pred             cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-cchHHHHHHHhccC-------------
Confidence            1223444678999999999986233446999999999999999999999764 11111111111100             


Q ss_pred             ccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCC
Q 045787          240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVEN  295 (324)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~  295 (324)
                                 ..+.....++.++++||.+||..||.+||||+++|+|||.++...
T Consensus       240 -----------~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  240 -----------SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             -----------CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence                       111233468999999999999999999999999999999988665

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.2e-48  Score=343.93  Aligned_cols=287  Identities=38%  Similarity=0.636  Sum_probs=224.9

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecC-----CeEE
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR-----KDVF   82 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   82 (324)
                      +|++.+.||+|++|.||+|.+..++..||+|.+............+.+|+.++++++||||+++++++...     ...|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            69999999999999999999999999999999875443333345688999999999999999999987543     3589


Q ss_pred             EEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC
Q 045787           83 LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK  162 (324)
Q Consensus        83 iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~  162 (324)
                      +||||++++|.+.+... ..+++..+..++.|++.||.|||++|++|+||||+||+++ .++.++|+|||.+........
T Consensus        81 lv~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~~~  158 (338)
T cd07859          81 VVFELMESDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILAN-ADCKLKICDFGLARVAFNDTP  158 (338)
T ss_pred             EEEecCCCCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC-CCCcEEEccCccccccccccC
Confidence            99999999999887764 4699999999999999999999999999999999999999 899999999999875432211


Q ss_pred             ---cccccccccccCCchhhcC-CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHHcCCCCcccccchh--
Q 045787          163 ---EYSRDCVYSPYKAPELLLG-YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD-HLSLIFSLLGTPTDESWAEST--  235 (324)
Q Consensus       163 ---~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~--  235 (324)
                         ......+++.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+.. ....+....+.++........  
T Consensus       159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  238 (338)
T cd07859         159 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE  238 (338)
T ss_pred             ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence               1233468889999999865 256789999999999999999999999877643 333344444444433222110  


Q ss_pred             hhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCc
Q 045787          236 YISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENV  296 (324)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~  296 (324)
                      ...+.........+......++.+++.+.+++.+||+.||.+|||+.++++||||+++...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~  299 (338)
T cd07859         239 KARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKV  299 (338)
T ss_pred             hHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCcc
Confidence            0111111122223333445566788999999999999999999999999999999987763

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=6.6e-48  Score=333.88  Aligned_cols=289  Identities=46%  Similarity=0.792  Sum_probs=233.3

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   83 (324)
                      ..-++|++++.||.|++|.||++.+..+++.||+|.+....... ....+.+|+.+++.++||||+++++++..+...++
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l   81 (301)
T cd07873           3 GKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG-APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL   81 (301)
T ss_pred             ccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC-chhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence            35578999999999999999999999999999999987554322 23456789999999999999999999999999999


Q ss_pred             EEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCc
Q 045787           84 VFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE  163 (324)
Q Consensus        84 v~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~  163 (324)
                      |+||+++++.+++......+++..+..++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+.........
T Consensus        82 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~  160 (301)
T cd07873          82 VFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKT  160 (301)
T ss_pred             EEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEEC-CCCcEEECcCcchhccCCCCCc
Confidence            999999999999888777799999999999999999999999999999999999999 8899999999998765443333


Q ss_pred             ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHHcCCCCcccccchhhhhcc-c
Q 045787          164 YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEI-L  241 (324)
Q Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  241 (324)
                      .....+++.|+|||++.+...++.++||||||+++|+|++|++||...+. +.........+.+....|......... .
T Consensus       161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (301)
T cd07873         161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS  240 (301)
T ss_pred             ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccc
Confidence            34445688899999987756788999999999999999999999987764 344445555555555444332111111 0


Q ss_pred             CCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCC
Q 045787          242 PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVE  294 (324)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~  294 (324)
                      ...............+.+++.+.++|.+||+.||.+|||+.++++||||+.+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~  293 (301)
T cd07873         241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG  293 (301)
T ss_pred             cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            11111122222334457889999999999999999999999999999998876

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=3.3e-49  Score=349.22  Aligned_cols=288  Identities=32%  Similarity=0.537  Sum_probs=237.9

Q ss_pred             CcccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcC-C-----CCeeEEEeee
Q 045787            2 GKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-H-----ENIVRLLDVQ   75 (324)
Q Consensus         2 ~~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~-----~~i~~~~~~~   75 (324)
                      ++.+..+|+|++.||+|.||.|.+|.+..+++.||||+++.....   ......|+.+|..++ |     -|+++++++|
T Consensus       181 ~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f---~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F  257 (586)
T KOG0667|consen  181 NDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRF---LRQAQIEIRILELLNKHDPDDKYNIVRMLDYF  257 (586)
T ss_pred             cceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHH---HHHHHHHHHHHHHHhccCCCCCeeEEEeeecc
Confidence            455667999999999999999999999999999999999865433   355678999999997 3     5899999999


Q ss_pred             ecCCeEEEEEEecCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEee-cCCCcEEEeeccc
Q 045787           76 SSRKDVFLVFEYLDLDLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLID-LKRNTVKLADFGL  153 (324)
Q Consensus        76 ~~~~~~~iv~e~~~g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~-~~~~~v~l~d~g~  153 (324)
                      ...+++|||+|.++-+|.+++.... ..++...++.++.||+.+|..||+.||+||||||+|||+. .....|||+|||+
T Consensus       258 ~fr~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGS  337 (586)
T KOG0667|consen  258 YFRNHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGS  337 (586)
T ss_pred             ccccceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccc
Confidence            9999999999999999999998765 3699999999999999999999999999999999999995 3446899999999


Q ss_pred             eeeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHHcCCCCccccc
Q 045787          154 ARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-HDHLSLIFSLLGTPTDESWA  232 (324)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~  232 (324)
                      ++...   ...-..+.+..|+|||++.+ .+|+.+.|+||||||++||++|.+.|.+.+ .+++..+...+|.|+...++
T Consensus       338 Sc~~~---q~vytYiQSRfYRAPEVILG-lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~  413 (586)
T KOG0667|consen  338 SCFES---QRVYTYIQSRFYRAPEVILG-LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLD  413 (586)
T ss_pred             ccccC---Ccceeeeeccccccchhhcc-CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            98754   22235567778999999999 889999999999999999999999998888 78899999999999987776


Q ss_pred             chhhhhcccCC-CCCC--------------------------------CCcchhhhCC-CCChhHHHHHHHhhcCCCCCC
Q 045787          233 ESTYISEILPL-YPHF--------------------------------EPANLAEKFP-NLEPAGVDLLSQMLCLNPKQR  278 (324)
Q Consensus       233 ~~~~~~~~~~~-~~~~--------------------------------~~~~~~~~~~-~~~~~l~~li~~~l~~dP~~R  278 (324)
                      .......+... ...+                                .......... .-...+.+||++||.+||.+|
T Consensus       414 ~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R  493 (586)
T KOG0667|consen  414 TAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAER  493 (586)
T ss_pred             hccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhc
Confidence            65444443333 1110                                0111111111 234567899999999999999


Q ss_pred             CCHHHHhcCccccCCCCc
Q 045787          279 ITAMDALKHEYLIGVENV  296 (324)
Q Consensus       279 ps~~~~l~hp~~~~~~~~  296 (324)
                      +|+.++|+||||.+....
T Consensus       494 ~tp~qal~Hpfl~~~~~~  511 (586)
T KOG0667|consen  494 ITPAQALNHPFLTGTSLE  511 (586)
T ss_pred             CCHHHHhcCccccccccc
Confidence            999999999999965543

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.4e-48  Score=333.84  Aligned_cols=282  Identities=46%  Similarity=0.783  Sum_probs=226.4

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEe
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEY   87 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   87 (324)
                      +|++++.||.|++|.||+|.+..+|+.+++|.+............+.+|+.++++++|||++++++++.+....++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            69999999999999999999999999999999986654444456678899999999999999999999999999999999


Q ss_pred             cCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccccc
Q 045787           88 LDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRD  167 (324)
Q Consensus        88 ~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~~  167 (324)
                      +++++.+++......+++..++.++.||+.||.+||+.|++|+||+|+||+++ .++.++|+|||.+.............
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~  159 (284)
T cd07839          81 CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLIN-KNGELKLADFGLARAFGIPVRCYSAE  159 (284)
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEc-CCCcEEECccchhhccCCCCCCcCCC
Confidence            99999998887667799999999999999999999999999999999999999 88999999999987655433333444


Q ss_pred             ccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCC-CCC-hhHHHHHHHHcCCCCcccccchhhhhcccCCCC
Q 045787          168 CVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFP-SKK-HDHLSLIFSLLGTPTDESWAESTYISEILPLYP  245 (324)
Q Consensus       168 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (324)
                      .+++.|+|||.+.+...++.++||||||+++|+|++|..|+. +.+ ......+....+.+....|..............
T Consensus       160 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd07839         160 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPM  239 (284)
T ss_pred             ccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCC
Confidence            567889999998775667999999999999999999988853 333 334444455555554444332222111111101


Q ss_pred             CCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       246 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                      ...........+.+++++.++|.+||+.||.+|||++++++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         240 YPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             CCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            111112234445789999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=6.1e-48  Score=332.37  Aligned_cols=279  Identities=39%  Similarity=0.705  Sum_probs=221.4

Q ss_pred             cCcceeEeecccCceEEEEEEEc-cCCceEEEEEeeeccccCCCchHHHHHHHHHHhc---CCCCeeEEEeeee-----c
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNT-VTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL---EHENIVRLLDVQS-----S   77 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~-~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~-----~   77 (324)
                      ++|++++.||+|++|.||+|.+. .++..+|+|.+............+.+|+.+++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            47999999999999999999985 4567899999876654444445566787777766   5999999999875     3


Q ss_pred             CCeEEEEEEecCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceee
Q 045787           78 RKDVFLVFEYLDLDLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARA  156 (324)
Q Consensus        78 ~~~~~iv~e~~~g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~  156 (324)
                      ....++|+||+++++.+++.... ..+++..++.++.+++.||.+||+.|++|+||||+||+++ .++.++|+|||.+..
T Consensus        81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~-~~~~~kl~Dfg~~~~  159 (290)
T cd07862          81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT-SSGQIKLADFGLARI  159 (290)
T ss_pred             CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEc-CCCCEEEccccceEe
Confidence            45689999999999999887653 3589999999999999999999999999999999999999 889999999999976


Q ss_pred             ccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHHcCCCCcccccchh
Q 045787          157 IGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAEST  235 (324)
Q Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~  235 (324)
                      .... .......+++.|+|||++.+ ..++.++||||||+++|+|++|.+||.+.+. +.+..+....+.+....|....
T Consensus       160 ~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (290)
T cd07862         160 YSFQ-MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV  237 (290)
T ss_pred             ccCC-cccccccccccccChHHHhC-CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhh
Confidence            6533 23344568889999999977 6689999999999999999999999987764 4455555555555544443322


Q ss_pred             hhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          236 YISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                      .....  .+............+.+++.+.+++.+||+.||.+|||+.++++||||
T Consensus       238 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         238 ALPRQ--AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             cccch--hccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence            11111  111222333444556789999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=9.8e-50  Score=345.44  Aligned_cols=257  Identities=33%  Similarity=0.492  Sum_probs=232.3

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE   86 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   86 (324)
                      ++|.+.+.||+|+||+||+++.+.+.+.||+|.+.+........+.+.+|+++++.++||||+.+++.|+...++|+|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            57999999999999999999999999999999999888777777889999999999999999999999999999999999


Q ss_pred             ecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcccc
Q 045787           87 YLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSR  166 (324)
Q Consensus        87 ~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~  166 (324)
                      |+.|+|..++.+. +.++++.+..+..++..||.|||+.+|.|+|+||.||+++ .++.+|++|||+++.++........
T Consensus        82 ~a~g~L~~il~~d-~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~-~~~~~KlcdFg~Ar~m~~~t~vlts  159 (808)
T KOG0597|consen   82 YAVGDLFTILEQD-GKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLE-KGGTLKLCDFGLARAMSTNTSVLTS  159 (808)
T ss_pred             hhhhhHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeec-CCCceeechhhhhhhcccCceeeee
Confidence            9999999988874 5699999999999999999999999999999999999999 9999999999999999888888888


Q ss_pred             cccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCC
Q 045787          167 DCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPH  246 (324)
Q Consensus       167 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (324)
                      ..|||.|||||++.+ .+++..+|.|||||++||++.|++||......++-+.+.-....+                   
T Consensus       160 ikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~-------------------  219 (808)
T KOG0597|consen  160 IKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKP-------------------  219 (808)
T ss_pred             ccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCC-------------------
Confidence            899999999999997 889999999999999999999999998777555444333211111                   


Q ss_pred             CCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCC
Q 045787          247 FEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVE  294 (324)
Q Consensus       247 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~  294 (324)
                               ....+..+..|++.+|.+||.+|.+=.+++.|||.++.-
T Consensus       220 ---------p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~  258 (808)
T KOG0597|consen  220 ---------PSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKI  258 (808)
T ss_pred             ---------cccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhh
Confidence                     125788999999999999999999999999999998653

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=4.7e-48  Score=350.00  Aligned_cols=285  Identities=35%  Similarity=0.554  Sum_probs=220.8

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeec------
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS------   77 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------   77 (324)
                      ....+|++.+.||+|+||.||+|.+..+++.||+|.+....      ....+|+.+++.++|||++++++++..      
T Consensus        63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~  136 (440)
T PTZ00036         63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN  136 (440)
T ss_pred             CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence            34568999999999999999999999999999999875432      234579999999999999999887632      


Q ss_pred             --CCeEEEEEEecCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeecc
Q 045787           78 --RKDVFLVFEYLDLDLHSFITR---HKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFG  152 (324)
Q Consensus        78 --~~~~~iv~e~~~g~l~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g  152 (324)
                        ...+++||||+++++.+++..   ....+++..++.++.||+.||.|||+.|++||||||+||+++..++.++|+|||
T Consensus       137 ~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        137 EKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             CCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence              225779999999998877654   345689999999999999999999999999999999999999445679999999


Q ss_pred             ceeeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHHcCCCCcccc
Q 045787          153 LARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-HDHLSLIFSLLGTPTDESW  231 (324)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~  231 (324)
                      ++...... .......+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+ .+.+..+....+.+....+
T Consensus       217 la~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~  295 (440)
T PTZ00036        217 SAKNLLAG-QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL  295 (440)
T ss_pred             cchhccCC-CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            99866432 222334678899999998775678999999999999999999999998776 4555566666666554332


Q ss_pred             cchhhhhcccCCCCCCCCcchhhhC-CCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCc
Q 045787          232 AESTYISEILPLYPHFEPANLAEKF-PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENV  296 (324)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~  296 (324)
                      ......-.. ..+...........+ ...+.++.+||.+||+.||.+|||+.++++||||+++.+.
T Consensus       296 ~~~~~~~~~-~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~  360 (440)
T PTZ00036        296 KEMNPNYAD-IKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDP  360 (440)
T ss_pred             HHhchhhhc-ccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhcc
Confidence            211100000 001111112222222 3578899999999999999999999999999999988764

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-48  Score=345.99  Aligned_cols=266  Identities=24%  Similarity=0.379  Sum_probs=231.2

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeecc-ccCCCchHHHHHHHHHHhcC-CCCeeEEEeeeecCCe
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQT-EQEGVPSYIIREVSLLKELE-HENIVRLLDVQSSRKD   80 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~   80 (324)
                      .+.-++|+.++.||+|+||.|++|..+.+++.||+|++++.. ...+..+..+.|.+++.... ||+++.++..|+..++
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            456689999999999999999999999999999999999876 44455677888999988885 9999999999999999


Q ss_pred             EEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           81 VFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        81 ~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      +|+||||+.|+... ...+.+.+++..++.++..|+.||.|||++||++||||.+|||+| .+|.+||+|||++...-..
T Consensus       444 l~fvmey~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD-~eGh~kiADFGlcKe~m~~  521 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLD-TEGHVKIADFGLCKEGMGQ  521 (694)
T ss_pred             EEEEEEecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEc-ccCcEEecccccccccCCC
Confidence            99999999875522 233346799999999999999999999999999999999999999 9999999999999877666


Q ss_pred             CCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcc
Q 045787          161 QKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEI  240 (324)
Q Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (324)
                      ....+.-||||.|+|||++.+ ..|+.+.|.||||++||+|+.|+.||.+.+.+.+-..+......              
T Consensus       522 g~~TsTfCGTpey~aPEil~e-~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~--------------  586 (694)
T KOG0694|consen  522 GDRTSTFCGTPEFLAPEVLTE-QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVR--------------  586 (694)
T ss_pred             CCccccccCChhhcChhhhcc-CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC--------------
Confidence            677888899999999999998 88999999999999999999999999998877664433321111              


Q ss_pred             cCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCC-----HHHHhcCccccCCCCchhh
Q 045787          241 LPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRIT-----AMDALKHEYLIGVENVPLV  299 (324)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~~~l~hp~~~~~~~~~~~  299 (324)
                                    ....++.++.++++++|.+||++|+.     +.+|..||||+++++..+.
T Consensus       587 --------------yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~  636 (694)
T KOG0694|consen  587 --------------YPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLL  636 (694)
T ss_pred             --------------CCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHh
Confidence                          12358899999999999999999986     5788889999999987763

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-50  Score=316.32  Aligned_cols=280  Identities=32%  Similarity=0.467  Sum_probs=236.7

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   83 (324)
                      ...+.|.+.+.||+|+|+.|+++.+..+|+.+++|++..........+.+.+|+++.+.|+||||+++.+.+.+.+..|+
T Consensus         8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl   87 (355)
T KOG0033|consen    8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL   87 (355)
T ss_pred             ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence            45688999999999999999999999999999999998776666678899999999999999999999999999999999


Q ss_pred             EEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCC--CcEEEeeccceeeccCC
Q 045787           84 VFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKR--NTVKLADFGLARAIGVP  160 (324)
Q Consensus        84 v~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~--~~v~l~d~g~~~~~~~~  160 (324)
                      |||.+.| +|...+-++ .-.++..+-.++.||+.+|.|+|.+||+|+|+||+|+++-+.+  .-+||+|||.+..++ .
T Consensus        88 vFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-~  165 (355)
T KOG0033|consen   88 VFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-D  165 (355)
T ss_pred             EEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC-C
Confidence            9999986 777666664 4588899999999999999999999999999999999995333  468999999999988 5


Q ss_pred             CCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcc
Q 045787          161 QKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEI  240 (324)
Q Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (324)
                      ........|||.|+|||+++. .+++..+|||+-|+++|-++.|.+||.+.+...+.+.+....                
T Consensus       166 g~~~~G~~GtP~fmaPEvvrk-dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~----------------  228 (355)
T KOG0033|consen  166 GEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGA----------------  228 (355)
T ss_pred             ccccccccCCCcccCHHHhhc-CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccc----------------
Confidence            555566689999999999988 788999999999999999999999999877555544333211                


Q ss_pred             cCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchh---hhhhhhcccCCC
Q 045787          241 LPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPL---VILLINRKKKLG  310 (324)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~---~~~~~~~~~~~~  310 (324)
                              .......|+.+++++++||++||..||.+|.|+.|+|+|||+++-+-...   .+..+++.++++
T Consensus       229 --------yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~As~~H~~dtvd~lrkfN  293 (355)
T KOG0033|consen  229 --------YDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRERVASAIHRQDTVDCLKKFN  293 (355)
T ss_pred             --------cCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchHHHHHHhhhHHHHHHHHHhh
Confidence                    11122345689999999999999999999999999999999998653322   345566666555

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-48  Score=344.09  Aligned_cols=264  Identities=35%  Similarity=0.549  Sum_probs=232.3

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeecc-ccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQT-EQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLV   84 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   84 (324)
                      -+-|+..+.||.|+.|.|-+|++..+|+..|||++.... ........+.+|+-+++-+.|||++.++++++++.++|+|
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv   90 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV   90 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence            356899999999999999999999999999999998773 3444567799999999999999999999999999999999


Q ss_pred             EEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCc
Q 045787           85 FEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE  163 (324)
Q Consensus        85 ~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~  163 (324)
                      .||++ |.|.+++... +++++..++++++||+.|+.|+|..+++|+|+||+|+|++ ..+.+||+|||.|..-. ++.-
T Consensus        91 lEyv~gGELFdylv~k-G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd-~~~nIKIADFGMAsLe~-~gkl  167 (786)
T KOG0588|consen   91 LEYVPGGELFDYLVRK-GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLD-VKNNIKIADFGMASLEV-PGKL  167 (786)
T ss_pred             EEecCCchhHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhh-cccCEeeeccceeeccc-CCcc
Confidence            99997 6999998885 5699999999999999999999999999999999999999 77779999999997654 5566


Q ss_pred             ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCC
Q 045787          164 YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPL  243 (324)
Q Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (324)
                      ....||+|-|.|||++.+....+.++||||-|+|+|.|++|+.||.+.+...+..........                 
T Consensus       168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~-----------------  230 (786)
T KOG0588|consen  168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFE-----------------  230 (786)
T ss_pred             ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCccc-----------------
Confidence            777899999999999999888899999999999999999999999977766554443321111                 


Q ss_pred             CCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchhhh
Q 045787          244 YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVI  300 (324)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~~~  300 (324)
                                 ....++.++++||.+||..||++|.|.++|++|||+++....+...
T Consensus       231 -----------MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~~  276 (786)
T KOG0588|consen  231 -----------MPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSSK  276 (786)
T ss_pred             -----------CCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChhh
Confidence                       1237999999999999999999999999999999999998777653

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1e-47  Score=329.97  Aligned_cols=266  Identities=23%  Similarity=0.356  Sum_probs=217.2

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeecccc-CCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEE
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQ-EGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE   86 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   86 (324)
                      .|++.+.||+|+||.||+|.+..+|+.||+|.+...... ......+.+|+.++++++|++++++.+++.+++..++|+|
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            489999999999999999999999999999998765422 2223457789999999999999999999999999999999


Q ss_pred             ecCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcc
Q 045787           87 YLDL-DLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY  164 (324)
Q Consensus        87 ~~~g-~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~  164 (324)
                      |+.+ +|...+.... ..+++..+..++.+++.||.+||+.|++|+||||+||+++ .++.++|+|||.+...... ...
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~-~~~~~kl~Dfg~~~~~~~~-~~~  158 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLD-DRGHIRISDLGLAVQIPEG-ETV  158 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEEC-CCCCEEEeeCCCcEEcCCC-Cee
Confidence            9984 7776665433 3689999999999999999999999999999999999999 8899999999998765422 222


Q ss_pred             cccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHH-HHcCCCCcccccchhhhhcccCC
Q 045787          165 SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIF-SLLGTPTDESWAESTYISEILPL  243 (324)
Q Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  243 (324)
                      ....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+........ ......                 
T Consensus       159 ~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~-----------------  220 (285)
T cd05631         159 RGRVGTVGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED-----------------  220 (285)
T ss_pred             cCCCCCCCccCHhhhcC-CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc-----------------
Confidence            34468899999999987 67899999999999999999999999876532211111 100000                 


Q ss_pred             CCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCC-----HHHHhcCccccCCCCchhhhh
Q 045787          244 YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRIT-----AMDALKHEYLIGVENVPLVIL  301 (324)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~~~l~hp~~~~~~~~~~~~~  301 (324)
                              .......++..+.+|+++||+.||.+||+     ++++++||||++++...+...
T Consensus       221 --------~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~  275 (285)
T cd05631         221 --------QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEAN  275 (285)
T ss_pred             --------cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHhC
Confidence                    00112357889999999999999999997     899999999999998777654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=5e-47  Score=327.31  Aligned_cols=291  Identities=53%  Similarity=0.926  Sum_probs=238.3

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE   86 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   86 (324)
                      ++|++.+.||.|++|.||++.++.+|+.+++|.+..........+.+.+|+.++++++||+++++++++.++...|+|+|
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            57999999999999999999999999999999987655444445678899999999999999999999999999999999


Q ss_pred             ecCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccc
Q 045787           87 YLDLDLHSFITRHKN-TLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYS  165 (324)
Q Consensus        87 ~~~g~l~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~  165 (324)
                      |+++++.+.+..... .+++..++.++.+|+.||.+||++|++|+||+|+||+++..++.++|+|||.+...........
T Consensus        82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~  161 (294)
T PLN00009         82 YLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT  161 (294)
T ss_pred             cccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccccc
Confidence            999999888766443 3688899999999999999999999999999999999984567899999999876544333333


Q ss_pred             ccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHHcCCCCcccccchhhhhcccCCC
Q 045787          166 RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLY  244 (324)
Q Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (324)
                      ...+++.|+|||.+.+...++.++|+||||+++|+|++|..||...+. +.........+.+....|.............
T Consensus       162 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (294)
T PLN00009        162 HEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAF  241 (294)
T ss_pred             cCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhc
Confidence            445678899999987756678999999999999999999999987663 4444555566666666655444433333333


Q ss_pred             CCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCch
Q 045787          245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP  297 (324)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~  297 (324)
                      ..+.........+.+++.+.+++.+||+.||.+||++.++++||||.++...|
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~~~  294 (294)
T PLN00009        242 PKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGDAP  294 (294)
T ss_pred             ccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhcCC
Confidence            34444444555677899999999999999999999999999999999987643

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.9e-48  Score=338.29  Aligned_cols=257  Identities=25%  Similarity=0.413  Sum_probs=214.4

Q ss_pred             EeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEecCC-
Q 045787           13 KKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-   90 (324)
Q Consensus        13 ~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~g-   90 (324)
                      +.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.++++++||+|+++++.+..++..|+||||+.| 
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            469999999999999999999999999976532 222235577899999999999999999999999999999999985 


Q ss_pred             CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcccccccc
Q 045787           91 DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVY  170 (324)
Q Consensus        91 ~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~  170 (324)
                      +|.+.+.. .+.+++..++.++.||+.||.|||+.|++|+||||+||+++ .++.++|+|||.+.............+|+
T Consensus        81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~-~~~~~kl~DfG~a~~~~~~~~~~~~~~gt  158 (323)
T cd05571          81 ELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGT  158 (323)
T ss_pred             cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEEC-CCCCEEEeeCCCCcccccCCCcccceecC
Confidence            77777665 45799999999999999999999999999999999999999 89999999999987543333344455789


Q ss_pred             cccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCc
Q 045787          171 SPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPA  250 (324)
Q Consensus       171 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (324)
                      +.|+|||++.+ ..++.++|||||||++|+|++|..||...+............ .                        
T Consensus       159 ~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~-~------------------------  212 (323)
T cd05571         159 PEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-I------------------------  212 (323)
T ss_pred             ccccChhhhcC-CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC-C------------------------
Confidence            99999999987 668999999999999999999999998776554433322100 0                        


Q ss_pred             chhhhCCCCChhHHHHHHHhhcCCCCCCC-----CHHHHhcCccccCCCCchhhh
Q 045787          251 NLAEKFPNLEPAGVDLLSQMLCLNPKQRI-----TAMDALKHEYLIGVENVPLVI  300 (324)
Q Consensus       251 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~~l~hp~~~~~~~~~~~~  300 (324)
                         .....+++++.++|++||+.||.+||     ++.++++||||.++.+.....
T Consensus       213 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~~~~  264 (323)
T cd05571         213 ---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQ  264 (323)
T ss_pred             ---CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHh
Confidence               01135788999999999999999999     899999999999988766653

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.8e-47  Score=339.92  Aligned_cols=282  Identities=23%  Similarity=0.322  Sum_probs=219.3

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   83 (324)
                      +...+|++++.||+|++|.||+|.+..+++.||+|...        ...+.+|+.++++++||||+++++++..+...++
T Consensus        89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l  160 (391)
T PHA03212         89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCL  160 (391)
T ss_pred             cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence            34578999999999999999999999999999999643        1346789999999999999999999999999999


Q ss_pred             EEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC-CC
Q 045787           84 VFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP-QK  162 (324)
Q Consensus        84 v~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~-~~  162 (324)
                      |+|++.+++..++... ..+++..++.++.|++.||.|||++|++|+||||+||+++ .++.++|+|||.+...... ..
T Consensus       161 v~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~-~~~~vkL~DFG~a~~~~~~~~~  238 (391)
T PHA03212        161 ILPRYKTDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFIN-HPGDVCLGDFGAACFPVDINAN  238 (391)
T ss_pred             EEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEc-CCCCEEEEeCCccccccccccc
Confidence            9999999999888764 4689999999999999999999999999999999999999 8899999999998653322 22


Q ss_pred             cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC--------hhHHHHHHHHcCCCCcccccc-
Q 045787          163 EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK--------HDHLSLIFSLLGTPTDESWAE-  233 (324)
Q Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--------~~~~~~~~~~~~~~~~~~~~~-  233 (324)
                      ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||....        ...+..+....+.++...... 
T Consensus       239 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~  317 (391)
T PHA03212        239 KYYGWAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA  317 (391)
T ss_pred             ccccccCccCCCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence            2334578999999999987 678999999999999999999998774332        234444555455444322111 


Q ss_pred             hhhhhcc----cC-CCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCc
Q 045787          234 STYISEI----LP-LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENV  296 (324)
Q Consensus       234 ~~~~~~~----~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~  296 (324)
                      .......    .. ................++.++.++|.+||+.||.+|||+.|+|+||||+++..+
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~  385 (391)
T PHA03212        318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP  385 (391)
T ss_pred             hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence            1100000    00 000000111112223467889999999999999999999999999999997654

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=5.8e-47  Score=325.91  Aligned_cols=278  Identities=42%  Similarity=0.755  Sum_probs=220.8

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhc---CCCCeeEEEeeeec-----CC
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL---EHENIVRLLDVQSS-----RK   79 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~-----~~   79 (324)
                      +|++++.||+|++|.||+|.+..+++.+|+|.+..............+|+.+++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            69999999999999999999999999999999876544433344566777777665   69999999998754     34


Q ss_pred             eEEEEEEecCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeecc
Q 045787           80 DVFLVFEYLDLDLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIG  158 (324)
Q Consensus        80 ~~~iv~e~~~g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~  158 (324)
                      ..++++|++.+++.+++.... ..+++..++.++.|++.||.|||+.|++|+||||+||+++ .++.++|+|||.+....
T Consensus        81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~-~~~~~kl~dfg~~~~~~  159 (288)
T cd07863          81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVT-SGGQVKLADFGLARIYS  159 (288)
T ss_pred             eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC-CCCCEEECccCcccccc
Confidence            589999999999998887654 3589999999999999999999999999999999999999 89999999999987654


Q ss_pred             CCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHHcCCCCcccccchhhh
Q 045787          159 VPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYI  237 (324)
Q Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  237 (324)
                      .. .......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||..... +....+....+.+....|......
T Consensus       160 ~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07863         160 CQ-MALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTL  237 (288)
T ss_pred             Cc-ccCCCccccccccCchHhhC-CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccc
Confidence            22 22233457888999999977 6689999999999999999999999977663 445555555555554444322111


Q ss_pred             hcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          238 SEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                      ..  ..+............+.++..+.++|.+||+.||.+|||+.+++.||||
T Consensus       238 ~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         238 PR--GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             cc--cccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            10  1112222333445556788999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-48  Score=331.93  Aligned_cols=259  Identities=27%  Similarity=0.420  Sum_probs=216.8

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      ++|++++.||+|++|.||+|.+..+++.+|+|++..... .....+.+.+|+.++++++||||+++++++.+....|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            479999999999999999999999999999999875432 2223456888999999999999999999999999999999


Q ss_pred             EecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcc
Q 045787           86 EYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY  164 (324)
Q Consensus        86 e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~  164 (324)
                      ||+. |+|.+++... +.+++..++.++.|++.||.+||++|++|+||||+||+++ .++.++|+|||.+......   .
T Consensus        81 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~-~~~~~kl~Dfg~~~~~~~~---~  155 (291)
T cd05612          81 EYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLD-KEGHIKLTDFGFAKKLRDR---T  155 (291)
T ss_pred             eCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC-CCCCEEEEecCcchhccCC---c
Confidence            9997 5888887664 4689999999999999999999999999999999999999 8999999999998765422   2


Q ss_pred             cccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCC
Q 045787          165 SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLY  244 (324)
Q Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (324)
                      ....+++.|+|||++.+ ..++.++||||||+++|+|++|..||...+.............                   
T Consensus       156 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~-------------------  215 (291)
T cd05612         156 WTLCGTPEYLAPEVIQS-KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKL-------------------  215 (291)
T ss_pred             ccccCChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc-------------------
Confidence            23468899999999987 6679999999999999999999999987765443332221100                   


Q ss_pred             CCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCC-----HHHHhcCccccCCCCchhh
Q 045787          245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRIT-----AMDALKHEYLIGVENVPLV  299 (324)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~~~l~hp~~~~~~~~~~~  299 (324)
                               .....++..++++|++||+.||.+|++     +.++++||||+.+++....
T Consensus       216 ---------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~  266 (291)
T cd05612         216 ---------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVP  266 (291)
T ss_pred             ---------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHHHHh
Confidence                     011246788999999999999999995     9999999999998866543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.4e-47  Score=335.54  Aligned_cols=262  Identities=26%  Similarity=0.397  Sum_probs=218.5

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF   82 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   82 (324)
                      ..-++|++.+.||+|++|.||+|.+..+++.||+|++..... .....+.+.+|+.++++++||||+++++++.+++..|
T Consensus        15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   94 (329)
T PTZ00263         15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVY   94 (329)
T ss_pred             CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEE
Confidence            345789999999999999999999999999999999876532 2233466889999999999999999999999999999


Q ss_pred             EEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC
Q 045787           83 LVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        83 iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~  161 (324)
                      +||||+. |+|.+.+... +.+++..++.++.|++.||.|||++|++|+||||+||+++ .++.++|+|||.+...... 
T Consensus        95 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~-  171 (329)
T PTZ00263         95 FLLEFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLD-NKGHVKVTDFGFAKKVPDR-  171 (329)
T ss_pred             EEEcCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEC-CCCCEEEeeccCceEcCCC-
Confidence            9999997 4788777664 5689999999999999999999999999999999999999 8999999999998865422 


Q ss_pred             CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhccc
Q 045787          162 KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEIL  241 (324)
Q Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (324)
                        .....+++.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......... +..               
T Consensus       172 --~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~-~~~---------------  232 (329)
T PTZ00263        172 --TFTLCGTPEYLAPEVIQS-KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA-GRL---------------  232 (329)
T ss_pred             --cceecCChhhcCHHHHcC-CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhc-CCc---------------
Confidence              233468899999999987 5678999999999999999999999977664433222111 000               


Q ss_pred             CCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCC-----HHHHhcCccccCCCCchhh
Q 045787          242 PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRIT-----AMDALKHEYLIGVENVPLV  299 (324)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~~~l~hp~~~~~~~~~~~  299 (324)
                                  .....++..+.+||.+||+.||.+|++     ++++++||||.++.+..+.
T Consensus       233 ------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~~~  283 (329)
T PTZ00263        233 ------------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLY  283 (329)
T ss_pred             ------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHHHHH
Confidence                        011236788999999999999999997     7999999999998766554

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.9e-48  Score=323.43  Aligned_cols=265  Identities=27%  Similarity=0.418  Sum_probs=220.1

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeecccc-CCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQ-EGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF   82 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   82 (324)
                      +--..|++++.||.|.-|+||+|....++..+|+|++.+.... .....+.+.|.+||+.++||.++.++..++.+...|
T Consensus        74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~c  153 (459)
T KOG0610|consen   74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSC  153 (459)
T ss_pred             cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeE
Confidence            3446789999999999999999999999999999999877633 444567888999999999999999999999999999


Q ss_pred             EEEEecCC-CHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           83 LVFEYLDL-DLHSFITRHKN-TLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        83 iv~e~~~g-~l~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      ++||||.| +|....+.+++ .++++.++.++..++.||+|||..||++|||||+|||+. ++|++.|+||+++..+...
T Consensus       154 l~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvr-edGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  154 LVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVR-EDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             EEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEe-cCCcEEeeeccccccCCCC
Confidence            99999985 77777776654 699999999999999999999999999999999999999 9999999999987433110


Q ss_pred             ----------------------------------C----------------------CcccccccccccCCchhhcCCCC
Q 045787          161 ----------------------------------Q----------------------KEYSRDCVYSPYKAPELLLGYTG  184 (324)
Q Consensus       161 ----------------------------------~----------------------~~~~~~~~~~~y~aPE~~~~~~~  184 (324)
                                                        .                      .+...-.||-.|+|||++.+ ..
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G-~G  311 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG-EG  311 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec-CC
Confidence                                              0                      00011245666999999999 55


Q ss_pred             CCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHH
Q 045787          185 YSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGV  264 (324)
Q Consensus       185 ~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  264 (324)
                      -+.+.|.|+||+.+|||+.|..||.+.+...-...+.  .++..                       +.+ .+.++..++
T Consensus       312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv--~~~l~-----------------------Fp~-~~~vs~~ak  365 (459)
T KOG0610|consen  312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIV--GQPLK-----------------------FPE-EPEVSSAAK  365 (459)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHh--cCCCc-----------------------CCC-CCcchhHHH
Confidence            6999999999999999999999999888554333222  11111                       011 125778999


Q ss_pred             HHHHHhhcCCCCCCCC----HHHHhcCccccCCCCc
Q 045787          265 DLLSQMLCLNPKQRIT----AMDALKHEYLIGVENV  296 (324)
Q Consensus       265 ~li~~~l~~dP~~Rps----~~~~l~hp~~~~~~~~  296 (324)
                      +||+++|.+||++|..    |.||.+||||++++|.
T Consensus       366 DLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWa  401 (459)
T KOG0610|consen  366 DLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWA  401 (459)
T ss_pred             HHHHHHhccChhhhhccccchHHhhcCccccCCChh
Confidence            9999999999999998    9999999999999987

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=4.1e-47  Score=326.23  Aligned_cols=282  Identities=50%  Similarity=0.881  Sum_probs=232.2

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEe
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEY   87 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   87 (324)
                      +|++++.||.|++|.||+|.+..++..+++|.+............+.+|++++++++|||++++++++.+++..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            58999999999999999999999999999999876655444456788999999999999999999999999999999999


Q ss_pred             cCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcccc
Q 045787           88 LDLDLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSR  166 (324)
Q Consensus        88 ~~g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~  166 (324)
                      +.+++..++.... ..+++..++.++.+++.||.|||+.|++|+||+|+||+++ .++.++|+|||.+............
T Consensus        81 ~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~-~~~~~~l~dfg~~~~~~~~~~~~~~  159 (284)
T cd07860          81 LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTH  159 (284)
T ss_pred             cccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC-CCCCEEEeeccchhhcccCcccccc
Confidence            9988888876643 4689999999999999999999999999999999999999 8999999999998766544333344


Q ss_pred             cccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHHcCCCCcccccchhhhhcccCCCC
Q 045787          167 DCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYP  245 (324)
Q Consensus       167 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (324)
                      ..+++.|+|||.+.+...++.++|+||||+++|+|++|+.||...+. ..........+.+....|.......+....+.
T Consensus       160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd07860         160 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFP  239 (284)
T ss_pred             ccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcc
Confidence            45678899999987756678899999999999999999999987663 44445555556655544443333333333334


Q ss_pred             CCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       246 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                      ...........+.++..+.++|.+||+.||.+||++++++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         240 KWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             cccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            444444455556788999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=8.7e-47  Score=334.60  Aligned_cols=285  Identities=34%  Similarity=0.565  Sum_probs=218.2

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCC-----
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK-----   79 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----   79 (324)
                      ..++|++.+.||+|+||.||++.+..+|..+|+|.+............+.+|+.+++.++|||++++++++....     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            468999999999999999999999999999999999765444444566789999999999999999999886543     


Q ss_pred             -eEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeecc
Q 045787           80 -DVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIG  158 (324)
Q Consensus        80 -~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~  158 (324)
                       ..|+||||+++++.+.+..   .+++..+..++.|++.||.+||++|++|+||||+||+++ .++.++|+|||.+....
T Consensus        99 ~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~-~~~~~kl~Dfg~a~~~~  174 (359)
T cd07876          99 QDVYLVMELMDANLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAC  174 (359)
T ss_pred             ceeEEEEeCCCcCHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC-CCCCEEEecCCCccccc
Confidence             5799999999998887643   488999999999999999999999999999999999999 89999999999987543


Q ss_pred             CCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHHcCCCCcccccchhh-
Q 045787          159 VPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTY-  236 (324)
Q Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~-  236 (324)
                      . ........+++.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+. ..........+.+.......... 
T Consensus       175 ~-~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (359)
T cd07876         175 T-NFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPT  252 (359)
T ss_pred             c-CccCCCCcccCCCCCchhccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHH
Confidence            2 222334467888999999987 6789999999999999999999999987763 23333344444433221111000 


Q ss_pred             hhc---ccCCCCC---------CCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCC
Q 045787          237 ISE---ILPLYPH---------FEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVEN  295 (324)
Q Consensus       237 ~~~---~~~~~~~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~  295 (324)
                      ...   ..+....         +............+..+++||.+||+.||.+|||+.|+++||||+...+
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~  323 (359)
T cd07876         253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYD  323 (359)
T ss_pred             HHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcC
Confidence            000   0000000         0000011112235678999999999999999999999999999986443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=5.2e-47  Score=332.79  Aligned_cols=263  Identities=25%  Similarity=0.371  Sum_probs=218.0

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccCC-ceEEEEEeeeccc-cCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCe
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVTG-QKVAIKMMTIQTE-QEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKD   80 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~-~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   80 (324)
                      .+..++|++.+.||+|++|.||+|.+...+ ..+|+|.+..... .....+.+.+|+.+++.++||||+++++++.+++.
T Consensus        26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~  105 (340)
T PTZ00426         26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESY  105 (340)
T ss_pred             CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCE
Confidence            355678999999999999999999876554 6899999875432 22334567889999999999999999999999999


Q ss_pred             EEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccC
Q 045787           81 VFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGV  159 (324)
Q Consensus        81 ~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~  159 (324)
                      .|+||||+. |+|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++ .++.++|+|||.+.....
T Consensus       106 ~~lv~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~-~~~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        106 LYLVLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLD-KDGFIKMTDFGFAKVVDT  183 (340)
T ss_pred             EEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEEC-CCCCEEEecCCCCeecCC
Confidence            999999997 5787777654 4699999999999999999999999999999999999999 899999999999876542


Q ss_pred             CCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhc
Q 045787          160 PQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISE  239 (324)
Q Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
                         ......|++.|+|||++.+ ..++.++|+|||||++|+|++|..||...+............               
T Consensus       184 ---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~---------------  244 (340)
T PTZ00426        184 ---RTYTLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI---------------  244 (340)
T ss_pred             ---CcceecCChhhcCHHHHhC-CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC---------------
Confidence               2234568899999999987 667899999999999999999999998776543322221100               


Q ss_pred             ccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCC-----CHHHHhcCccccCCCCchhh
Q 045787          240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRI-----TAMDALKHEYLIGVENVPLV  299 (324)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~~l~hp~~~~~~~~~~~  299 (324)
                                   ......++..+.++|++||+.||.+|+     ++.++++||||.++++....
T Consensus       245 -------------~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~  296 (340)
T PTZ00426        245 -------------IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLL  296 (340)
T ss_pred             -------------CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHH
Confidence                         001124678899999999999999995     89999999999999876654

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=4.9e-47  Score=337.70  Aligned_cols=285  Identities=34%  Similarity=0.554  Sum_probs=223.2

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCC-----eEE
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK-----DVF   82 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~   82 (324)
                      +|++.+.||+|++|.||+|.+..+++.||+|.+............+.+|+.+++.++|+||+++++++....     ..|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            588999999999999999999999999999998654333333456889999999999999999999988766     789


Q ss_pred             EEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC
Q 045787           83 LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK  162 (324)
Q Consensus        83 iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~  162 (324)
                      +|+||+.+++.+.+.. ...+++..++.++.||+.||.|||+.|++|+||||+||+++ .++.++|+|||.+........
T Consensus        81 lv~e~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~-~~~~~kL~Dfg~a~~~~~~~~  158 (372)
T cd07853          81 VVTELMQSDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVN-SNCVLKICDFGLARVEEPDES  158 (372)
T ss_pred             EEeeccccCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEEC-CCCCEEeccccceeecccCcc
Confidence            9999999998888765 35699999999999999999999999999999999999999 899999999999876543221


Q ss_pred             -cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHHcCCCCcccccchhh-hhc
Q 045787          163 -EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTY-ISE  239 (324)
Q Consensus       163 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~-~~~  239 (324)
                       ......+++.|+|||++.+...++.++|||||||++|+|++|+.||...+. .....+....+.++...+..... ...
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  238 (372)
T cd07853         159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARA  238 (372)
T ss_pred             ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHH
Confidence             223345678899999998756689999999999999999999999987773 34445555556555433222110 000


Q ss_pred             -ccCCCCC-CCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCC
Q 045787          240 -ILPLYPH-FEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVE  294 (324)
Q Consensus       240 -~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~  294 (324)
                       ....... .............++++.+||.+||+.||.+|||+.++++||||++..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  295 (372)
T cd07853         239 HILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR  295 (372)
T ss_pred             HHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence             0000000 011111122345688999999999999999999999999999999864

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-47  Score=325.25  Aligned_cols=266  Identities=29%  Similarity=0.483  Sum_probs=215.5

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeecccc------------CCCchHHHHHHHHHHhcCCCCeeEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQ------------EGVPSYIIREVSLLKELEHENIVRL   71 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~------------~~~~~~~~~e~~~l~~l~~~~i~~~   71 (324)
                      ..-+.|++.+.||+|.+|.|-+|++..+++.||+|++.+....            ....++.++|+.+++++.|||||++
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            3457899999999999999999999999999999999754321            1123578999999999999999999


Q ss_pred             Eeeeec--CCeEEEEEEecCCCHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEE
Q 045787           72 LDVQSS--RKDVFLVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKL  148 (324)
Q Consensus        72 ~~~~~~--~~~~~iv~e~~~g~l~~~~~~~~~~-~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l  148 (324)
                      +++..+  .+.+|+|+|||...-..+.-. ..+ +++.+++.++++++.||.|||.+|++||||||+|+|++ ++|+|||
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p~-d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~-~~g~VKI  251 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCPP-DKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLS-SDGTVKI  251 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCCC-CcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEc-CCCcEEe
Confidence            999866  467999999998433333333 334 99999999999999999999999999999999999999 8899999


Q ss_pred             eeccceeeccC-----CCCcccccccccccCCchhhcC---CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 045787          149 ADFGLARAIGV-----PQKEYSRDCVYSPYKAPELLLG---YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIF  220 (324)
Q Consensus       149 ~d~g~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~  220 (324)
                      +|||.+.....     .........|||.|+|||...+   ....+.+.||||+|++||.|+.|+.||-+...-.....+
T Consensus       252 sDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KI  331 (576)
T KOG0585|consen  252 SDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKI  331 (576)
T ss_pred             eccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHH
Confidence            99999886622     2223445789999999999876   345688999999999999999999999776644333222


Q ss_pred             HHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCch
Q 045787          221 SLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP  297 (324)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~  297 (324)
                      .  ..|..                       ++ ..+.+.+.+++||.+||++||++|.++.+|..|||...--+.+
T Consensus       332 v--n~pL~-----------------------fP-~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~  382 (576)
T KOG0585|consen  332 V--NDPLE-----------------------FP-ENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSP  382 (576)
T ss_pred             h--cCccc-----------------------CC-CcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCC
Confidence            2  11110                       00 1125788999999999999999999999999999998875544

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.4e-47  Score=333.54  Aligned_cols=287  Identities=34%  Similarity=0.602  Sum_probs=226.1

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecC------
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR------   78 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------   78 (324)
                      ..++|++++.||+|+||.||+|.+..++..||+|.+............+.+|+.++++++||||+++++++...      
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            46799999999999999999999999999999999876543333345677899999999999999999887543      


Q ss_pred             CeEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeecc
Q 045787           79 KDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIG  158 (324)
Q Consensus        79 ~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~  158 (324)
                      ...|++++++++++..++..  ..+++..++.++.|++.||.|||+.|++|+||||+||+++ .++.++|+|||.+....
T Consensus        93 ~~~~~~~~~~~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~-~~~~~kl~Dfg~~~~~~  169 (343)
T cd07878          93 NEVYLVTNLMGADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVN-EDCELRILDFGLARQAD  169 (343)
T ss_pred             CcEEEEeecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEEC-CCCCEEEcCCccceecC
Confidence            35799999998898877653  4699999999999999999999999999999999999999 89999999999988654


Q ss_pred             CCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHHcCCCCcccccc--hh
Q 045787          159 VPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAE--ST  235 (324)
Q Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~--~~  235 (324)
                      .   ......+++.|+|||++.+...++.++|||||||++|+|++|+.||...+. +....+....+.+....+..  ..
T Consensus       170 ~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (343)
T cd07878         170 D---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSE  246 (343)
T ss_pred             C---CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchh
Confidence            2   223346788999999998766789999999999999999999999987663 33344444444443322211  11


Q ss_pred             hhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCch
Q 045787          236 YISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP  297 (324)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~  297 (324)
                      ........................++.+.+||.+||..||.+|||+.++++||||.....+.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~  308 (343)
T cd07878         247 HARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPE  308 (343)
T ss_pred             hHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCc
Confidence            11112222222333334445556788899999999999999999999999999999876543

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=6.4e-46  Score=322.64  Aligned_cols=291  Identities=41%  Similarity=0.704  Sum_probs=229.3

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecC--CeEE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR--KDVF   82 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~   82 (324)
                      ..++|++.+.||.|++|.||++.+..+|+.||+|.+..............+|+.++++++|++++++++++...  +..+
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF   84 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence            35789999999999999999999999999999999876654444344567899999999999999999998654  5689


Q ss_pred             EEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC
Q 045787           83 LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK  162 (324)
Q Consensus        83 iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~  162 (324)
                      +|+||+++++.+++......+++..++.++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+........
T Consensus        85 lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~-~~~~~kL~dfg~~~~~~~~~~  163 (309)
T cd07845          85 LVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLT-DKGCLKIADFGLARTYGLPAK  163 (309)
T ss_pred             EEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC-CCCCEEECccceeeecCCccC
Confidence            9999999999998887667899999999999999999999999999999999999999 889999999999987654433


Q ss_pred             cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHHcCCCCcccccchhhhhccc
Q 045787          163 EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD-HLSLIFSLLGTPTDESWAESTYISEIL  241 (324)
Q Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (324)
                      ......+++.|+|||.+.+...++.++|+||||+++|+|++|..||...+.. ....+....+.+....|..........
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (309)
T cd07845         164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG  243 (309)
T ss_pred             CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccc
Confidence            3333345777999999877667899999999999999999999999877643 344444545554444333211111100


Q ss_pred             CC-CCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCc
Q 045787          242 PL-YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENV  296 (324)
Q Consensus       242 ~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~  296 (324)
                      .. ................++.+.++|.+||+.||++|||+.++++||||++..-.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~  299 (309)
T cd07845         244 KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP  299 (309)
T ss_pred             cccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence            00 01111122233344578899999999999999999999999999999865543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-46  Score=330.38  Aligned_cols=266  Identities=25%  Similarity=0.415  Sum_probs=217.9

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeecccc-CCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQ-EGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      ++|++++.||+|++|.||+|.+..+++.||+|++...... ......+.+|+.++..++||||+++++++......|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            4799999999999999999999999999999999765422 223456788999999999999999999999999999999


Q ss_pred             EecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcc
Q 045787           86 EYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY  164 (324)
Q Consensus        86 e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~  164 (324)
                      ||++| +|.+++.. ...+++..++.++.+++.||.+||+.|++|+||||+||+++ .++.++|+|||.+.....   ..
T Consensus        81 e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~-~~~~~kL~Dfg~a~~~~~---~~  155 (333)
T cd05600          81 EYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLID-ASGHIKLTDFGLSKGIVT---YA  155 (333)
T ss_pred             eCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC-CCCCEEEEeCcCCccccc---cc
Confidence            99974 78777765 45689999999999999999999999999999999999999 899999999999876542   23


Q ss_pred             cccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCC
Q 045787          165 SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLY  244 (324)
Q Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (324)
                      ....+++.|+|||++.+ ..++.++|||||||++|+|++|..||...+................                
T Consensus       156 ~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----------------  218 (333)
T cd05600         156 NSVVGSPDYMAPEVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQ----------------  218 (333)
T ss_pred             CCcccCccccChhHhcC-CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccccc----------------
Confidence            34568899999999987 5789999999999999999999999987765443322221110000                


Q ss_pred             CCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchh
Q 045787          245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~  298 (324)
                       .   .........++.++.++|.+||..+|.+||++.++++||||.++....+
T Consensus       219 -~---~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~~~~  268 (333)
T cd05600         219 -R---PVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWNEL  268 (333)
T ss_pred             -C---CCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCHHHH
Confidence             0   0000001357889999999999999999999999999999999865443

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-47  Score=285.29  Aligned_cols=288  Identities=45%  Similarity=0.795  Sum_probs=265.3

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE   86 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   86 (324)
                      ..|.-.++||+|.+|+||++++..+++.||+|..+.+...+.......+|+-+++.++|.||++++++...+..+.+|+|
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe   81 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence            35777899999999999999999999999999999988888878888999999999999999999999999999999999


Q ss_pred             ecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcccc
Q 045787           87 YLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSR  166 (324)
Q Consensus        87 ~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~  166 (324)
                      ||..+|..++...++.++++.++.++.|++.+|.++|++++.|+|+||.|.+++ .+|.+||.|||+++..+.+-.-.+.
T Consensus        82 ~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin-~ngelkladfglarafgipvrcysa  160 (292)
T KOG0662|consen   82 FCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLIN-RNGELKLADFGLARAFGIPVRCYSA  160 (292)
T ss_pred             HhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEec-cCCcEEecccchhhhcCCceEeeec
Confidence            999999999999999999999999999999999999999999999999999999 9999999999999998877777888


Q ss_pred             cccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCC-hhHHHHHHHHcCCCCcccccchhhhhcccCCC
Q 045787          167 DCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKK-HDHLSLIFSLLGTPTDESWAESTYISEILPLY  244 (324)
Q Consensus       167 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (324)
                      ...|.+|++|.++.+..-++.+.|+||-||++.|+.. |.+.|.+++ .++..+++...+.|.++.|.......+..+.-
T Consensus       161 evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp  240 (292)
T KOG0662|consen  161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYP  240 (292)
T ss_pred             eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccC
Confidence            8899999999999997889999999999999999998 667788888 78899999999999999999888777776655


Q ss_pred             CCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCC
Q 045787          245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVEN  295 (324)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~  295 (324)
                      .-..-..+....+.++..-+++++++|..+|..|.+++++++||||.....
T Consensus       241 ~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s~  291 (292)
T KOG0662|consen  241 IYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFSP  291 (292)
T ss_pred             CccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccCC
Confidence            555566677777888888999999999999999999999999999987653

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=8.9e-47  Score=329.64  Aligned_cols=256  Identities=25%  Similarity=0.424  Sum_probs=211.6

Q ss_pred             EeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEecCC-
Q 045787           13 KKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-   90 (324)
Q Consensus        13 ~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~g-   90 (324)
                      +.||+|+||.||+|.+..+|..||+|++..... .......+.+|+.+++.++||+++++++.+..++..|+||||+++ 
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            468999999999999999999999999976532 222235567899999999999999999999999999999999985 


Q ss_pred             CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcccccccc
Q 045787           91 DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVY  170 (324)
Q Consensus        91 ~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~  170 (324)
                      +|...+.. ...+++..++.++.+|+.||.|||++|++|+||||+||+++ .++.++|+|||.+..............++
T Consensus        81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  158 (323)
T cd05595          81 ELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGT  158 (323)
T ss_pred             cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEc-CCCCEEecccHHhccccCCCCccccccCC
Confidence            77666655 45699999999999999999999999999999999999999 89999999999887543333333445688


Q ss_pred             cccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCc
Q 045787          171 SPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPA  250 (324)
Q Consensus       171 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (324)
                      +.|+|||++.+ ..++.++|+|||||++|+|++|..||...+.............                         
T Consensus       159 ~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~-------------------------  212 (323)
T cd05595         159 PEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI-------------------------  212 (323)
T ss_pred             cCcCCcccccC-CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-------------------------
Confidence            99999999977 6679999999999999999999999987765443332221000                         


Q ss_pred             chhhhCCCCChhHHHHHHHhhcCCCCCCC-----CHHHHhcCccccCCCCchhh
Q 045787          251 NLAEKFPNLEPAGVDLLSQMLCLNPKQRI-----TAMDALKHEYLIGVENVPLV  299 (324)
Q Consensus       251 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~~l~hp~~~~~~~~~~~  299 (324)
                         .....+++.+.++|.+||+.||.+|+     ++.++++||||.++.+....
T Consensus       213 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~~~~  263 (323)
T cd05595         213 ---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVV  263 (323)
T ss_pred             ---CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCHHHHH
Confidence               01135788999999999999999998     89999999999998765543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-47  Score=334.93  Aligned_cols=265  Identities=28%  Similarity=0.479  Sum_probs=218.8

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeecccc-CCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQ-EGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      ++|++++.||+|++|+||+|.+..+++.||+|++...... ......+.+|+.++..++||+++++++++.+++..|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            5799999999999999999999999999999999865422 233466888999999999999999999999999999999


Q ss_pred             EecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC---
Q 045787           86 EYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ---  161 (324)
Q Consensus        86 e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~---  161 (324)
                      ||+. ++|.+++... ..+++..++.++.|++.||.+||+.|++|+||||+||+++ .++.++|+|||.+.......   
T Consensus        81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~  158 (350)
T cd05573          81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILID-ADGHIKLADFGLCKKMNKAKDRE  158 (350)
T ss_pred             cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC-CCCCEEeecCCCCccCcccCccc
Confidence            9997 5888887765 6799999999999999999999999999999999999999 89999999999987654332   


Q ss_pred             --------------------------CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhH
Q 045787          162 --------------------------KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDH  215 (324)
Q Consensus       162 --------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~  215 (324)
                                                .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||...+...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~  237 (350)
T cd05573         159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE  237 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccCccccCHHHHcC-CCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence                                      12234568899999999988 578999999999999999999999998776443


Q ss_pred             HHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCC-HHHHhcCccccCCC
Q 045787          216 LSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRIT-AMDALKHEYLIGVE  294 (324)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-~~~~l~hp~~~~~~  294 (324)
                      ............                    .    ......+++.+.++|.+||. ||.+||+ ++++++||||+++.
T Consensus       238 ~~~~i~~~~~~~--------------------~----~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~  292 (350)
T cd05573         238 TYNKIINWKESL--------------------R----FPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGID  292 (350)
T ss_pred             HHHHHhccCCcc--------------------c----CCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCC
Confidence            322211100000                    0    00011378999999999997 9999999 99999999999987


Q ss_pred             Cchhh
Q 045787          295 NVPLV  299 (324)
Q Consensus       295 ~~~~~  299 (324)
                      .....
T Consensus       293 ~~~~~  297 (350)
T cd05573         293 WENLR  297 (350)
T ss_pred             HHHHh
Confidence            65443

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-46  Score=325.99  Aligned_cols=264  Identities=31%  Similarity=0.516  Sum_probs=229.4

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccC-CCchHHHHHHHHHHhcC-CCCeeEEEeeeecCCeEE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQE-GVPSYIIREVSLLKELE-HENIVRLLDVQSSRKDVF   82 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~   82 (324)
                      ....|++.+.||.|.||.||+++++.+|+.+|+|++.+..... .....+.+|+.++++++ |||++.++++|++...++
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            3457999999999999999999999999999999998766432 23567899999999998 999999999999999999


Q ss_pred             EEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCC---CcEEEeeccceeecc
Q 045787           83 LVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKR---NTVKLADFGLARAIG  158 (324)
Q Consensus        83 iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~---~~v~l~d~g~~~~~~  158 (324)
                      +|||++. |.|.+.+... . +++..+..++.+++.++.|||+.|++|+|+||+|+|+...+   +.++++|||++....
T Consensus       113 lvmEL~~GGeLfd~i~~~-~-~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~  190 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK-H-YSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK  190 (382)
T ss_pred             EEEEecCCchHHHHHHHc-c-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence            9999998 5999999887 3 99999999999999999999999999999999999996442   479999999999887


Q ss_pred             CCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhh
Q 045787          159 VPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYIS  238 (324)
Q Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (324)
                      . .......+||+.|+|||++.. .+++..+|+||+|+++|.|++|.+||.+.+.......+.....             
T Consensus       191 ~-~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~-------------  255 (382)
T KOG0032|consen  191 P-GERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF-------------  255 (382)
T ss_pred             C-CceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC-------------
Confidence            5 667777899999999999987 7889999999999999999999999988886554443221111             


Q ss_pred             cccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCc
Q 045787          239 EILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENV  296 (324)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~  296 (324)
                                 ......|+.++..+.++|++||..||.+|+|+.++|+|||+++....
T Consensus       256 -----------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~  302 (382)
T KOG0032|consen  256 -----------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEA  302 (382)
T ss_pred             -----------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCccc
Confidence                       22223456789999999999999999999999999999999987433

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=9.5e-47  Score=330.04  Aligned_cols=255  Identities=26%  Similarity=0.428  Sum_probs=210.9

Q ss_pred             EeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEecCC-
Q 045787           13 KKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-   90 (324)
Q Consensus        13 ~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~g-   90 (324)
                      +.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||+++++++.+..++..|+||||+++ 
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            468999999999999999999999999976432 222345677899999999999999999999999999999999985 


Q ss_pred             CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcccccccc
Q 045787           91 DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVY  170 (324)
Q Consensus        91 ~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~  170 (324)
                      +|...+.. ...+++..++.++.+|+.||.|||++|++|+||||+||+++ .++.++|+|||.+.............+++
T Consensus        81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~-~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  158 (328)
T cd05593          81 ELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLD-KDGHIKITDFGLCKEGITDAATMKTFCGT  158 (328)
T ss_pred             CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEEC-CCCcEEEecCcCCccCCCcccccccccCC
Confidence            77666655 45699999999999999999999999999999999999999 89999999999987543333333445789


Q ss_pred             cccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCc
Q 045787          171 SPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPA  250 (324)
Q Consensus       171 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (324)
                      +.|+|||++.+ ..++.++|||||||++|+|++|+.||...+............                          
T Consensus       159 ~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~--------------------------  211 (328)
T cd05593         159 PEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED--------------------------  211 (328)
T ss_pred             cCccChhhhcC-CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC--------------------------
Confidence            99999999987 667999999999999999999999997766544322211000                          


Q ss_pred             chhhhCCCCChhHHHHHHHhhcCCCCCCC-----CHHHHhcCccccCCCCchh
Q 045787          251 NLAEKFPNLEPAGVDLLSQMLCLNPKQRI-----TAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       251 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~~l~hp~~~~~~~~~~  298 (324)
                        ......++.++.++|++||+.||.+|+     ++.++++||||.++.+..+
T Consensus       212 --~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~  262 (328)
T cd05593         212 --IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDV  262 (328)
T ss_pred             --ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHH
Confidence              011235788999999999999999997     8999999999999876544

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=4.7e-46  Score=321.06  Aligned_cols=284  Identities=43%  Similarity=0.753  Sum_probs=228.3

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecC--CeEEE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR--KDVFL   83 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~i   83 (324)
                      .++|++.+.||.|++|.||+|.+..+++.+++|.+............+.+|+.++++++|||++++++++...  ...|+
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence            4689999999999999999999998999999999987655544445677899999999999999999988776  88999


Q ss_pred             EEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCc
Q 045787           84 VFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE  163 (324)
Q Consensus        84 v~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~  163 (324)
                      |+||++++|.+.+......+++..++.++.+++.||.+||++|++|+||+|+||+++ .++.++|+|||.+.........
T Consensus        84 v~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~-~~~~~~l~d~g~~~~~~~~~~~  162 (293)
T cd07843          84 VMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLN-NRGILKICDFGLAREYGSPLKP  162 (293)
T ss_pred             EehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEEC-CCCcEEEeecCceeeccCCccc
Confidence            999999999998887666799999999999999999999999999999999999999 8899999999998877654344


Q ss_pred             ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHHcCCCCcccccchhhhhcccC
Q 045787          164 YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-HDHLSLIFSLLGTPTDESWAESTYISEILP  242 (324)
Q Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (324)
                      .....+++.|+|||.+.+....+.++|+||||+++|+|++|..||.... ......+....+.+....|...........
T Consensus       163 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (293)
T cd07843         163 YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKK  242 (293)
T ss_pred             cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcc
Confidence            4445677889999998775667899999999999999999999998766 334445555555555544433222111110


Q ss_pred             -CCCCCCCcchhhhCCC--CChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          243 -LYPHFEPANLAEKFPN--LEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       243 -~~~~~~~~~~~~~~~~--~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                       .............++.  +++.+.++|++||+.||++|||+.|++.||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         243 KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence             1111111122223333  48889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-46  Score=319.36  Aligned_cols=281  Identities=52%  Similarity=0.942  Sum_probs=231.6

Q ss_pred             cceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEec
Q 045787            9 YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYL   88 (324)
Q Consensus         9 y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   88 (324)
                      |++.+.||.|++|.||++.+..+|..|++|++............+.+|+.++++++||+++++++++.++...|+++||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            78899999999999999999999999999999876544444566889999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccccc
Q 045787           89 DLDLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRD  167 (324)
Q Consensus        89 ~g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~~  167 (324)
                      ++++.+++.... ..+++..+..++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+.............
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~  159 (283)
T cd07835          81 DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLID-REGALKLADFGLARAFGVPVRTYTHE  159 (283)
T ss_pred             CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc-CCCcEEEeecccccccCCCccccCcc
Confidence            989998887654 3689999999999999999999999999999999999999 79999999999987654333333344


Q ss_pred             ccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHHcCCCCcccccchhhhhcccCCCCC
Q 045787          168 CVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPH  246 (324)
Q Consensus       168 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (324)
                      .+++.|+|||++.+...++.++|+||||+++|+|++|+.||...+. ............+....|.......+.......
T Consensus       160 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (283)
T cd07835         160 VVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPK  239 (283)
T ss_pred             ccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhccc
Confidence            5678899999987655678999999999999999999999987663 333444455555555554444333343333444


Q ss_pred             CCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          247 FEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       247 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                      ..........+.++..+.++|.+||+.||.+||++.+++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         240 WARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             ccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            44444455567789999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.7e-46  Score=331.77  Aligned_cols=264  Identities=24%  Similarity=0.399  Sum_probs=212.7

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      ++|++++.||+|++|+||+|.+..+++.||+|++..... .......+.+|+.++.+++|++|+++++.+.+...+|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            479999999999999999999999999999999976432 2223456788999999999999999999999999999999


Q ss_pred             EecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC--
Q 045787           86 EYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK--  162 (324)
Q Consensus        86 e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~--  162 (324)
                      ||++| +|.+++... +.+++..++.++.|++.||.|||++|++||||||+||+++ .++.++|+|||++........  
T Consensus        81 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~-~~~~vkL~DFGla~~~~~~~~~~  158 (363)
T cd05628          81 EFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLD-SKGHVKLSDFGLCTGLKKAHRTE  158 (363)
T ss_pred             cCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC-CCCCEEEeeccCccccccccccc
Confidence            99974 788877664 5799999999999999999999999999999999999999 889999999999865431100  


Q ss_pred             ---------------------------------cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCC
Q 045787          163 ---------------------------------EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFP  209 (324)
Q Consensus       163 ---------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~  209 (324)
                                                       .....+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~Pf~  237 (363)
T cd05628         159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFC  237 (363)
T ss_pred             ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-CCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence                                             0123468999999999987 668999999999999999999999998


Q ss_pred             CCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCC---CCCCHHHHhc
Q 045787          210 SKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPK---QRITAMDALK  286 (324)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~---~Rps~~~~l~  286 (324)
                      +.+.......+........               +        . ....+++++.++|.+|+. +|.   .||+++++++
T Consensus       238 ~~~~~~~~~~i~~~~~~~~---------------~--------p-~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~  292 (363)
T cd05628         238 SETPQETYKKVMNWKETLI---------------F--------P-PEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKT  292 (363)
T ss_pred             CCCHHHHHHHHHcCcCccc---------------C--------C-CcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhC
Confidence            7765443322221100000               0        0 011478899999999875 444   4589999999


Q ss_pred             CccccCCCCchh
Q 045787          287 HEYLIGVENVPL  298 (324)
Q Consensus       287 hp~~~~~~~~~~  298 (324)
                      ||||+++.+..+
T Consensus       293 hp~f~~~~~~~~  304 (363)
T cd05628         293 NPFFEGVDWEHI  304 (363)
T ss_pred             CCCCCCCCHHHH
Confidence            999999987665

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=3.6e-46  Score=331.26  Aligned_cols=285  Identities=34%  Similarity=0.549  Sum_probs=218.8

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecC------
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR------   78 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------   78 (324)
                      ..++|++.+.||+|++|.||+|.+...++.+|+|.+............+.+|+.+++.++|||++++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            45799999999999999999999999999999999876554444456678899999999999999999987543      


Q ss_pred             CeEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeecc
Q 045787           79 KDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIG  158 (324)
Q Consensus        79 ~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~  158 (324)
                      ...|+||||+++++...+..   .+++..+..++.|++.||.+||++|++|+||||+||+++ .++.++|+|||.+....
T Consensus       102 ~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~~kL~DfG~a~~~~  177 (364)
T cd07875         102 QDVYIVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAG  177 (364)
T ss_pred             CeEEEEEeCCCCCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEEC-CCCcEEEEeCCCccccC
Confidence            35799999999999887754   488899999999999999999999999999999999999 89999999999997654


Q ss_pred             CCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHHcCCCCcccccchhhh
Q 045787          159 VPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYI  237 (324)
Q Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  237 (324)
                      .. .......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+. +.........+.+....+......
T Consensus       178 ~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (364)
T cd07875         178 TS-FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT  255 (364)
T ss_pred             CC-CcccCCcccCCcCCHHHHhC-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHH
Confidence            32 22233467889999999987 6789999999999999999999999987773 333444444444433221111000


Q ss_pred             -h---cccCCCCCC---------CCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCC
Q 045787          238 -S---EILPLYPHF---------EPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVEN  295 (324)
Q Consensus       238 -~---~~~~~~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~  295 (324)
                       .   +..+.+...         ............+..++++|.+||+.||.+|||+.++|+||||....+
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~  326 (364)
T cd07875         256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD  326 (364)
T ss_pred             HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccC
Confidence             0   000000000         000011111234568899999999999999999999999999986443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-45  Score=317.94  Aligned_cols=283  Identities=48%  Similarity=0.845  Sum_probs=225.7

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      -++|++.+.||.|++|.||++.++.+++.|++|.+....... ....+.+|+.++++++|++++++++++.++...++|+
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF   82 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC-CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence            478999999999999999999999899999999987654322 2344668999999999999999999999999999999


Q ss_pred             EecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccc
Q 045787           86 EYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYS  165 (324)
Q Consensus        86 e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~  165 (324)
                      ||++++|.+++......+++..++.++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+...........
T Consensus        83 e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~  161 (291)
T cd07844          83 EYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLIS-ERGELKLADFGLARAKSVPSKTYS  161 (291)
T ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEc-CCCCEEECccccccccCCCCcccc
Confidence            9999999998887766789999999999999999999999999999999999999 889999999998875543333233


Q ss_pred             ccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC--hhHHHHHHHHcCCCCcccccchhhhhcccCC
Q 045787          166 RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK--HDHLSLIFSLLGTPTDESWAESTYISEILPL  243 (324)
Q Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (324)
                      ...++..|+|||++.+...++.++|+||+|+++|+|++|..||....  .+....+....+.+....+............
T Consensus       162 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (291)
T cd07844         162 NEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPY  241 (291)
T ss_pred             ccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccc
Confidence            33467789999998765667899999999999999999999997655  3444555555555555444333222111111


Q ss_pred             -CCCCCCcchhhhCCCCC--hhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          244 -YPHFEPANLAEKFPNLE--PAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       244 -~~~~~~~~~~~~~~~~~--~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                       ...............++  ..+.+++.+||+.||.+|||+.++++||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         242 SFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             cccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence             11112222333334455  888999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-46  Score=333.75  Aligned_cols=264  Identities=26%  Similarity=0.449  Sum_probs=214.1

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      ++|++++.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||+|+++++.+.++..+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            479999999999999999999999999999999976532 2223456788999999999999999999999999999999


Q ss_pred             EecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC--
Q 045787           86 EYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK--  162 (324)
Q Consensus        86 e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~--  162 (324)
                      ||+.| +|.+++.. .+.+++..++.++.|++.||.|||+.|++|+||||+||+++ .++.++|+|||.+........  
T Consensus        81 E~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~  158 (364)
T cd05599          81 EYLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLD-AKGHIKLSDFGLCTGLKKSHRTE  158 (364)
T ss_pred             CCCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC-CCCCEEEeecccceecccccccc
Confidence            99974 77777665 45699999999999999999999999999999999999999 899999999998865421110  


Q ss_pred             ------------------------------------cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCC
Q 045787          163 ------------------------------------EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKP  206 (324)
Q Consensus       163 ------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~  206 (324)
                                                          .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~G~~  237 (364)
T cd05599         159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEMLVGYP  237 (364)
T ss_pred             ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhHHHHhhcCCC
Confidence                                                0012358999999999977 668999999999999999999999


Q ss_pred             CCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCC---HHH
Q 045787          207 LFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRIT---AMD  283 (324)
Q Consensus       207 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps---~~~  283 (324)
                      ||...+..............                 ...       .....+++++.++|.+||. +|.+|++   +++
T Consensus       238 Pf~~~~~~~~~~~i~~~~~~-----------------~~~-------~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~  292 (364)
T cd05599         238 PFCSDNPQETYRKIINWKET-----------------LQF-------PDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNE  292 (364)
T ss_pred             CCCCCCHHHHHHHHHcCCCc-----------------cCC-------CCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHH
Confidence            99877644332221110000                 000       0011478899999999997 9999998   999


Q ss_pred             HhcCccccCCCCchh
Q 045787          284 ALKHEYLIGVENVPL  298 (324)
Q Consensus       284 ~l~hp~~~~~~~~~~  298 (324)
                      +++||||+++.+...
T Consensus       293 ll~h~~~~~~~~~~~  307 (364)
T cd05599         293 IKSHPFFKGVDWEHI  307 (364)
T ss_pred             HhcCCCcCCCCHHHH
Confidence            999999999876543

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-46  Score=326.26  Aligned_cols=252  Identities=26%  Similarity=0.439  Sum_probs=209.1

Q ss_pred             ecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEecC-CCH
Q 045787           15 IGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD-LDL   92 (324)
Q Consensus        15 Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~-g~l   92 (324)
                      ||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.++++++||||+++++.+...+..|+||||+. |+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            6999999999999999999999999875431 22234567789999999999999999999999999999999998 478


Q ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcccccccccc
Q 045787           93 HSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP  172 (324)
Q Consensus        93 ~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~  172 (324)
                      .+++.. .+.+++..+..++.|++.||.|||++|++|+||||+||+++ .++.++|+|||.+..............|++.
T Consensus        81 ~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~  158 (312)
T cd05585          81 FHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLD-YQGHIALCDFGLCKLNMKDDDKTNTFCGTPE  158 (312)
T ss_pred             HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEEC-CCCcEEEEECcccccCccCCCccccccCCcc
Confidence            787765 45699999999999999999999999999999999999999 8999999999998754333333444578999


Q ss_pred             cCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcch
Q 045787          173 YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANL  252 (324)
Q Consensus       173 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (324)
                      |+|||++.+ ..++.++|||||||++|+|++|..||...+.........  ..+                          
T Consensus       159 y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~--~~~--------------------------  209 (312)
T cd05585         159 YLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKIL--QEP--------------------------  209 (312)
T ss_pred             cCCHHHHcC-CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHH--cCC--------------------------
Confidence            999999987 668999999999999999999999998766544332211  100                          


Q ss_pred             hhhCCCCChhHHHHHHHhhcCCCCCCC---CHHHHhcCccccCCCCch
Q 045787          253 AEKFPNLEPAGVDLLSQMLCLNPKQRI---TAMDALKHEYLIGVENVP  297 (324)
Q Consensus       253 ~~~~~~~~~~l~~li~~~l~~dP~~Rp---s~~~~l~hp~~~~~~~~~  297 (324)
                      ......+++.+.++|.+||..||.+||   ++.+++.||||.+.....
T Consensus       210 ~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~~~~  257 (312)
T cd05585         210 LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKK  257 (312)
T ss_pred             CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCCHHH
Confidence            011135788999999999999999997   589999999999986543

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.2e-46  Score=331.55  Aligned_cols=286  Identities=34%  Similarity=0.540  Sum_probs=220.0

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecC------
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR------   78 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------   78 (324)
                      ..++|++++.||+|+||.||+|.+...++.+|+|.+............+.+|+.+++.++|||++++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            46899999999999999999999999999999999876554444456677899999999999999999987543      


Q ss_pred             CeEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeecc
Q 045787           79 KDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIG  158 (324)
Q Consensus        79 ~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~  158 (324)
                      ...|+||||+++++.+.+..   .+++..+..++.|++.||.+||+.|++|+||||+||+++ .++.++|+|||.+....
T Consensus        95 ~~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~-~~~~~kl~Dfg~~~~~~  170 (355)
T cd07874          95 QDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAG  170 (355)
T ss_pred             ceeEEEhhhhcccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEC-CCCCEEEeeCcccccCC
Confidence            35799999999998887754   488999999999999999999999999999999999999 89999999999997654


Q ss_pred             CCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHHcCCCCcccccchhh-
Q 045787          159 VPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-HDHLSLIFSLLGTPTDESWAESTY-  236 (324)
Q Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~-  236 (324)
                      .. .......+++.|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+ .+.........+.+....+..... 
T Consensus       171 ~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (355)
T cd07874         171 TS-FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT  248 (355)
T ss_pred             Cc-cccCCccccCCccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHH
Confidence            32 22233467889999999987 668999999999999999999999998776 333444444444443322111100 


Q ss_pred             hhcc---cCCCC---------CCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCc
Q 045787          237 ISEI---LPLYP---------HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENV  296 (324)
Q Consensus       237 ~~~~---~~~~~---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~  296 (324)
                      ....   .+...         ..............+..+.++|.+||+.||.+|||+.|+++||||+...+.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~  320 (355)
T cd07874         249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDP  320 (355)
T ss_pred             HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccCh
Confidence            0000   00000         000000111222356788999999999999999999999999999866543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=4.5e-46  Score=325.54  Aligned_cols=261  Identities=23%  Similarity=0.367  Sum_probs=214.9

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhcCC-CCeeEEEeeeecCCeEEEEE
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKELEH-ENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~iv~   85 (324)
                      +|++++.||+|++|.||+|.+..+++.||+|++..... .....+.+..|..++..+.| ++++++++.+...+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            58999999999999999999999999999999976532 22334567788999999976 46888999999999999999


Q ss_pred             EecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcc
Q 045787           86 EYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY  164 (324)
Q Consensus        86 e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~  164 (324)
                      ||++ |+|...+... ..+++..+..++.|++.||.|||++|++|+||||+||+++ .++.++|+|||.+..........
T Consensus        81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~  158 (324)
T cd05587          81 EYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD-AEGHIKIADFGMCKENIFGGKTT  158 (324)
T ss_pred             cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEc-CCCCEEEeecCcceecCCCCCce
Confidence            9997 5777777653 4689999999999999999999999999999999999999 89999999999887543333334


Q ss_pred             cccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCC
Q 045787          165 SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLY  244 (324)
Q Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (324)
                      ...+|++.|+|||++.+ ..++.++|+|||||++|+|++|+.||...+............                    
T Consensus       159 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~--------------------  217 (324)
T cd05587         159 RTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN--------------------  217 (324)
T ss_pred             eeecCCccccChhhhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--------------------
Confidence            44578999999999987 667999999999999999999999998776544332221100                    


Q ss_pred             CCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCH-----HHHhcCccccCCCCchhh
Q 045787          245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITA-----MDALKHEYLIGVENVPLV  299 (324)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~~~l~hp~~~~~~~~~~~  299 (324)
                              ......++..+.+++.+||..||.+|++.     .++++||||+.+++..+.
T Consensus       218 --------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~~~  269 (324)
T cd05587         218 --------VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLE  269 (324)
T ss_pred             --------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHH
Confidence                    00112578899999999999999999986     899999999998876553

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=9.8e-46  Score=317.61  Aligned_cols=281  Identities=49%  Similarity=0.919  Sum_probs=228.6

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEe
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEY   87 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   87 (324)
                      +|++++.||.|++|.||+|.+..+|..+++|.+...... .....+.+|+.++++++|+|++++++.+.+.+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY   79 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence            599999999999999999999999999999998765432 2245677899999999999999999999999999999999


Q ss_pred             cCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccc
Q 045787           88 LDLDLHSFITRHK--NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYS  165 (324)
Q Consensus        88 ~~g~l~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~  165 (324)
                      +++++.+++....  ..+++..+..++.+++.||.+||+.|++|+||+|+||+++ +++.++|+|||.+...........
T Consensus        80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~-~~~~~~l~d~g~~~~~~~~~~~~~  158 (284)
T cd07836          80 MDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLIN-KRGELKLADFGLARAFGIPVNTFS  158 (284)
T ss_pred             CCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEC-CCCcEEEeecchhhhhcCCccccc
Confidence            9999999887654  4689999999999999999999999999999999999999 899999999998876543333333


Q ss_pred             ccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHHcCCCCcccccchhhhhcccCCC
Q 045787          166 RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLY  244 (324)
Q Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (324)
                      ...+++.|+|||.+.+...++.++|+||||+++|+|++|..||...+. +....+......+....+.............
T Consensus       159 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd07836         159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTF  238 (284)
T ss_pred             cccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccc
Confidence            445678899999987756678999999999999999999999987663 3444555555555554444333323222223


Q ss_pred             CCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                      ............+.++..+.++|.+||+.||.+||++.++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         239 PRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             cCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            3322333334445678899999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-48  Score=329.96  Aligned_cols=278  Identities=28%  Similarity=0.462  Sum_probs=236.6

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   83 (324)
                      .....|+.++.||+|.||.||+|++..+++.||+|++.......+ .+.+++|+.++.+++++||.++++.+..+..+++
T Consensus        10 ~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~de-Iediqqei~~Ls~~~~~~it~yygsyl~g~~Lwi   88 (467)
T KOG0201|consen   10 DPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDE-IEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWI   88 (467)
T ss_pred             CcccccccchhccccccceeeeeeeccccceEEEEEechhhcchh-hHHHHHHHHHHHhcCcchHHhhhhheeecccHHH
Confidence            345679999999999999999999999999999999987765443 4678999999999999999999999999999999


Q ss_pred             EEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC
Q 045787           84 VFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK  162 (324)
Q Consensus        84 v~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~  162 (324)
                      +|||++| ++++.+.. +..+++..+..++++++.||.|||..+.+|+|||+.||++. .+|.|+|+|||.+........
T Consensus        89 iMey~~gGsv~~lL~~-~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s-~~g~vkl~DfgVa~ql~~~~~  166 (467)
T KOG0201|consen   89 IMEYCGGGSVLDLLKS-GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLS-ESGDVKLADFGVAGQLTNTVK  166 (467)
T ss_pred             HHHHhcCcchhhhhcc-CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEe-ccCcEEEEecceeeeeechhh
Confidence            9999985 66666554 45568999999999999999999999999999999999999 779999999999988876666


Q ss_pred             cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccC
Q 045787          163 EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILP  242 (324)
Q Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (324)
                      ......|||.|||||++.. ..|+.++||||||++++||++|.+|+....+-.+..+                       
T Consensus       167 rr~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl-----------------------  222 (467)
T KOG0201|consen  167 RRKTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL-----------------------  222 (467)
T ss_pred             ccccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe-----------------------
Confidence            6677789999999999996 7899999999999999999999999976665221111                       


Q ss_pred             CCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchhhhhhhhcccCCCCC
Q 045787          243 LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLINRKKKLGVD  312 (324)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~~~  312 (324)
                       .++..+..   .-..+++.+++||..||++||+.||+|.++|.|+|++...........+.+.++....
T Consensus       223 -Ipk~~PP~---L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~k~s~L~~~i~r~~~~~~~  288 (467)
T KOG0201|consen  223 -IPKSAPPR---LDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAKKTSELKELIDRYKRWRVK  288 (467)
T ss_pred             -ccCCCCCc---cccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcCCchHHHHHHHHHHHHhhc
Confidence             11111111   1126899999999999999999999999999999999999888888888877665554

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1e-45  Score=317.80  Aligned_cols=283  Identities=38%  Similarity=0.737  Sum_probs=227.2

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEe
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEY   87 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   87 (324)
                      +|++.+.||.|++|.||+|.+..+|..+++|.+............+.+|+.++++++||+++++++++..+...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            69999999999999999999998999999999887654444456788999999999999999999999999999999999


Q ss_pred             cCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC-cccc
Q 045787           88 LDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK-EYSR  166 (324)
Q Consensus        88 ~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~-~~~~  166 (324)
                      ++++|.+.+.....++++..++.++.+++.+|.+||+.|++|+||+|+||+++ .++.++|+|||.+........ ....
T Consensus        81 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~-~~~~~~l~dfg~~~~~~~~~~~~~~~  159 (286)
T cd07832          81 MPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLIS-ADGVLKIADFGLARLFSEEEPRLYSH  159 (286)
T ss_pred             cCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEc-CCCcEEEeeeeecccccCCCCCcccc
Confidence            97799998887677899999999999999999999999999999999999999 899999999999877653322 2334


Q ss_pred             cccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHHcCCCCcccccchhhhhcccCC-C
Q 045787          167 DCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPL-Y  244 (324)
Q Consensus       167 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  244 (324)
                      ..++..|+|||.+.+...++.++||||||+++|+|++|.+||.+... ..........+.+....|............ .
T Consensus       160 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T cd07832         160 QVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITF  239 (286)
T ss_pred             ccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccC
Confidence            56788899999987656679999999999999999999888876653 333444444444443333221111111110 1


Q ss_pred             CCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCcccc
Q 045787          245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLI  291 (324)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~  291 (324)
                      ............+..+..+.++|.+||+.||.+||+++++++||||.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         240 PESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             CCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence            11112223344567789999999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=9.1e-46  Score=324.45  Aligned_cols=285  Identities=25%  Similarity=0.403  Sum_probs=218.5

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   83 (324)
                      +..++|++++.||+|++|.||+|.+..++..+|+|.+..... ......+.+|++++++++|||++++++++..++..++
T Consensus         2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (331)
T cd06649           2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (331)
T ss_pred             CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccC-HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            567899999999999999999999999999999999876432 2224568899999999999999999999999999999


Q ss_pred             EEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCCCCceEeecCCCcEEEeeccceeeccCCC
Q 045787           84 VFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSL-KILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        84 v~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~  161 (324)
                      ||||++| +|.+++... ..+++..+..++.+++.||.|||+. +++|+||||+||+++ .++.++|+|||.+...... 
T Consensus        81 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~-  157 (331)
T cd06649          81 CMEHMDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDS-  157 (331)
T ss_pred             EeecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEc-CCCcEEEccCccccccccc-
Confidence            9999985 787777653 4689999999999999999999986 699999999999999 8899999999988755322 


Q ss_pred             CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhh-hh--
Q 045787          162 KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY-IS--  238 (324)
Q Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~--  238 (324)
                       ......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+...+....   +.+.......... ..  
T Consensus       158 -~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  232 (331)
T cd06649         158 -MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIF---GRPVVDGEEGEPHSISPR  232 (331)
T ss_pred             -ccccCCCCcCcCCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh---cccccccccCCccccCcc
Confidence             2233468889999999987 66899999999999999999999999876655443322   2111100000000 00  


Q ss_pred             -----ccc-----CCCCCC---------CCcchh-hhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCch
Q 045787          239 -----EIL-----PLYPHF---------EPANLA-EKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP  297 (324)
Q Consensus       239 -----~~~-----~~~~~~---------~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~  297 (324)
                           ...     ......         ...... .....++.++.+||.+||++||++|||+.++++||||+......
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~~~  311 (331)
T cd06649         233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEVEE  311 (331)
T ss_pred             cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhccccc
Confidence                 000     000000         000000 00124678999999999999999999999999999999876543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.7e-46  Score=326.20  Aligned_cols=255  Identities=25%  Similarity=0.383  Sum_probs=210.6

Q ss_pred             EeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEEEEEEecCC
Q 045787           13 KKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDVFLVFEYLDL   90 (324)
Q Consensus        13 ~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~g   90 (324)
                      +.||+|++|.||+|.++.+++.||+|++..... .......+..|..++..+ +||+++++++++...+.+|+||||++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            468999999999999999999999999876532 223345567788888776 699999999999999999999999985


Q ss_pred             -CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccccccc
Q 045787           91 -DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCV  169 (324)
Q Consensus        91 -~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~~~~  169 (324)
                       +|...+... ..+++..+..++.|++.||.|||+.|++|+||||+||+++ .++.++|+|||.+..............|
T Consensus        81 g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~-~~~~~kL~DfG~~~~~~~~~~~~~~~~g  158 (320)
T cd05590          81 GDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLD-HEGHCKLADFGMCKEGIFNGKTTSTFCG  158 (320)
T ss_pred             chHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEEC-CCCcEEEeeCCCCeecCcCCCccccccc
Confidence             777766654 5699999999999999999999999999999999999999 8999999999998764333334445578


Q ss_pred             ccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCC
Q 045787          170 YSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEP  249 (324)
Q Consensus       170 ~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (324)
                      ++.|+|||++.+ ..++.++|+||||+++|+|++|+.||...+............ .                       
T Consensus       159 t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~-~-----------------------  213 (320)
T cd05590         159 TPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE-V-----------------------  213 (320)
T ss_pred             CccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-C-----------------------
Confidence            999999999987 667999999999999999999999998877554433322100 0                       


Q ss_pred             cchhhhCCCCChhHHHHHHHhhcCCCCCCCCH------HHHhcCccccCCCCchh
Q 045787          250 ANLAEKFPNLEPAGVDLLSQMLCLNPKQRITA------MDALKHEYLIGVENVPL  298 (324)
Q Consensus       250 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~------~~~l~hp~~~~~~~~~~  298 (324)
                          .....++.++.++|++||+.||.+||++      +++++||||+++.+..+
T Consensus       214 ----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~~  264 (320)
T cd05590         214 ----VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKL  264 (320)
T ss_pred             ----CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHHHH
Confidence                0112468899999999999999999998      99999999999876544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.1e-46  Score=330.30  Aligned_cols=267  Identities=25%  Similarity=0.373  Sum_probs=219.3

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      ++|++.+.||+|++|.||+|.+..+|+.||+|++..... .......+.+|+.+++.++|++++++++.+.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            479999999999999999999999999999999986543 2233466888999999999999999999999999999999


Q ss_pred             EecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCc-
Q 045787           86 EYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE-  163 (324)
Q Consensus        86 e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~-  163 (324)
                      ||++ |+|.+++......+++..++.++.|++.||.+||+.|++|+||||+||+++ .++.++|+|||.+......... 
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~-~~~~~kL~Dfg~a~~~~~~~~~~  159 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLID-RTGHIKLADFGSAARLTANKMVN  159 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEEC-CCCCEEeccCCCCeECCCCCcee
Confidence            9997 588888887767899999999999999999999999999999999999999 8999999999999766433222 


Q ss_pred             ccccccccccCCchhhcC-----CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhh
Q 045787          164 YSRDCVYSPYKAPELLLG-----YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYIS  238 (324)
Q Consensus       164 ~~~~~~~~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (324)
                      .....+++.|+|||++..     ...++.++||||||+++|+|++|..||..................            
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~------------  227 (330)
T cd05601         160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRF------------  227 (330)
T ss_pred             eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCc------------
Confidence            223468899999999863     355788999999999999999999999776643322211110000            


Q ss_pred             cccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchhh
Q 045787          239 EILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLV  299 (324)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~~  299 (324)
                            ..     . ...+.++..+.++|.+||. ||.+||+++++++||||+++++..+.
T Consensus       228 ------~~-----~-~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~~~~  275 (330)
T cd05601         228 ------LK-----F-PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWNNIR  275 (330)
T ss_pred             ------cC-----C-CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHHHHh
Confidence                  00     0 0113578899999999998 99999999999999999998766554

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=3e-45  Score=315.77  Aligned_cols=283  Identities=42%  Similarity=0.752  Sum_probs=223.4

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      .++|++++.||+|++|.||++.+..+|..+++|.+...... .....+.+|+.+++.++|+|++++++++..+...|+|+
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            36899999999999999999999999999999998755432 22345678999999999999999999999999999999


Q ss_pred             EecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccc
Q 045787           86 EYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYS  165 (324)
Q Consensus        86 e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~  165 (324)
                      ||+++++.+.+......+++..+..++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+...........
T Consensus        83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~-~~~~~~l~Dfg~~~~~~~~~~~~~  161 (291)
T cd07870          83 EYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLIS-YLGELKLADFGLARAKSIPSQTYS  161 (291)
T ss_pred             ecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEc-CCCcEEEeccccccccCCCCCCCC
Confidence            9999999988877666788899999999999999999999999999999999999 889999999998876543333334


Q ss_pred             ccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh--hHHHHHHHHcCCCCcccccchhhhhcccCC
Q 045787          166 RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH--DHLSLIFSLLGTPTDESWAESTYISEILPL  243 (324)
Q Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (324)
                      ...+++.|+|||.+.+...++.++|+||||+++|+|++|..||...+.  +.........+.+....+............
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (291)
T cd07870         162 SEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPE  241 (291)
T ss_pred             CccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccch
Confidence            445688899999987655678899999999999999999999976653  344455555555555444333222222111


Q ss_pred             CCCC-CCcchhhhCC--CCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          244 YPHF-EPANLAEKFP--NLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       244 ~~~~-~~~~~~~~~~--~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                      .... ........+.  ..+..+.+++.+||..||.+|||+.+++.||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         242 WFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             hccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence            1111 1111111111  236788999999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=3.3e-45  Score=314.66  Aligned_cols=282  Identities=37%  Similarity=0.690  Sum_probs=220.5

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE   86 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   86 (324)
                      ++|++.+.||+|++|.||+|.++.+|+.+++|.+..........+.+.+|+.++++++|+|++++++++......++|+|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            57999999999999999999999899999999987655444444667899999999999999999999999999999999


Q ss_pred             ecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcccc
Q 045787           87 YLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSR  166 (324)
Q Consensus        87 ~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~  166 (324)
                      |++++++..+......+++..++.++.+++.+|.+||+.|++|+||+|+||+++ .++.++|+|||.+............
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~  159 (286)
T cd07847          81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILIT-KQGQIKLCDFGFARILTGPGDDYTD  159 (286)
T ss_pred             ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEc-CCCcEEECccccceecCCCcccccC
Confidence            999877777766666799999999999999999999999999999999999999 8899999999999876544333334


Q ss_pred             cccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhH-HHHHHHHcCCCCc---ccccchhhhhcccC
Q 045787          167 DCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDH-LSLIFSLLGTPTD---ESWAESTYISEILP  242 (324)
Q Consensus       167 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~~~~~~  242 (324)
                      ..++..|+|||++.+...++.++|+||||+++|+|++|..||.+..... ...+....+....   ..+......... .
T Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  238 (286)
T cd07847         160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL-S  238 (286)
T ss_pred             cccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc-c
Confidence            4567789999998765667899999999999999999999998766432 2222222221111   001000000000 0


Q ss_pred             CCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          243 LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                      ..............+.++..+.+++.+||+.||++||++.+++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         239 IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             CCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            000011112223345678999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.1e-45  Score=319.50  Aligned_cols=288  Identities=43%  Similarity=0.735  Sum_probs=231.0

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeecccc---CCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQ---EGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLV   84 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   84 (324)
                      +|++.+.||.|++|.||+|.+..+++.|++|.+......   ......+..|++++++++|+|++++++++.++...++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            589999999999999999999989999999999866543   33345577899999999999999999999999999999


Q ss_pred             EEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcc
Q 045787           85 FEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY  164 (324)
Q Consensus        85 ~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~  164 (324)
                      +||++++|.+++......+++..++.++.||+.||.+||++|++|+||+|+||+++ .++.++|+|||.+..........
T Consensus        81 ~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~-~~~~~~l~dfg~~~~~~~~~~~~  159 (298)
T cd07841          81 FEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIA-SDGVLKLADFGLARSFGSPNRKM  159 (298)
T ss_pred             EcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEc-CCCCEEEccceeeeeccCCCccc
Confidence            99998899998876554799999999999999999999999999999999999999 89999999999998776544444


Q ss_pred             cccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHHcCCCCcccccchhhhhcccCC
Q 045787          165 SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPL  243 (324)
Q Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (324)
                      ....+++.|+|||.+.+...++.++|+||||+++|+|++|.+||..... +.........+.+....+........... 
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  238 (298)
T cd07841         160 THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVE-  238 (298)
T ss_pred             cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccccc-
Confidence            4445677899999987656779999999999999999999888876653 33344444444444444333222211111 


Q ss_pred             CCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCch
Q 045787          244 YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP  297 (324)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~  297 (324)
                      ................+..+.++|.+||..||.+|||+.+++.||||++.....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~  292 (298)
T cd07841         239 FKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT  292 (298)
T ss_pred             ccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence            111122223334456788999999999999999999999999999999977554

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.3e-47  Score=305.45  Aligned_cols=260  Identities=30%  Similarity=0.528  Sum_probs=221.8

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccC------CCchHHHHHHHHHHhcC-CCCeeEEEeeeecC
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQE------GVPSYIIREVSLLKELE-HENIVRLLDVQSSR   78 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~------~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~   78 (324)
                      .+.|...+.||.|..++|-++.++.+|..+++|++.......      ...+.-.+|+++|+++. ||+|+++.++|+.+
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~   95 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD   95 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence            356888899999999999999999999999999997654221      12234567899999985 99999999999999


Q ss_pred             CeEEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeec
Q 045787           79 KDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAI  157 (324)
Q Consensus        79 ~~~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~  157 (324)
                      ...++|++.++ |.|.+++... -.+++...++++++++.++.|||.++|+|+|+||+|||++ ++.+++|+|||+++.+
T Consensus        96 sF~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILld-dn~~i~isDFGFa~~l  173 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLD-DNMNIKISDFGFACQL  173 (411)
T ss_pred             chhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeec-cccceEEeccceeecc
Confidence            99999999998 8999998874 3599999999999999999999999999999999999999 9999999999999988


Q ss_pred             cCCCCcccccccccccCCchhhc-----CCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCccccc
Q 045787          158 GVPQKEYSRDCVYSPYKAPELLL-----GYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWA  232 (324)
Q Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  232 (324)
                      . ++......||||+|+|||.+.     +.+.|+...|.|+.|+|+|.++.|.+||....+--+...+....-       
T Consensus       174 ~-~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGky-------  245 (411)
T KOG0599|consen  174 E-PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKY-------  245 (411)
T ss_pred             C-CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhccc-------
Confidence            7 566777889999999999985     346689999999999999999999999977665555544432211       


Q ss_pred             chhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccC
Q 045787          233 ESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIG  292 (324)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~  292 (324)
                                       ......|.+++...++||.+||+.||.+|.|++|+|+||||+.
T Consensus       246 -----------------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q  288 (411)
T KOG0599|consen  246 -----------------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ  288 (411)
T ss_pred             -----------------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence                             1111234578999999999999999999999999999999954

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.4e-45  Score=317.00  Aligned_cols=284  Identities=45%  Similarity=0.834  Sum_probs=224.4

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcC-CCCeeEEEeeeecCCe-----
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-HENIVRLLDVQSSRKD-----   80 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~-----   80 (324)
                      ++|++.+.||.|++|.||+|.+..+++.|++|..............+.+|+.+++.+. ||+++++++++.....     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            4799999999999999999999999999999998766554445567888999999995 6999999998876655     


Q ss_pred             EEEEEEecCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceee
Q 045787           81 VFLVFEYLDLDLHSFITRHK----NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARA  156 (324)
Q Consensus        81 ~~iv~e~~~g~l~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~  156 (324)
                      .|+|+||+++++.+++....    ..+++..++.++.+|+.||.+||+.|++|+||+|+||+++..++.++|+|||.+..
T Consensus        81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~  160 (295)
T cd07837          81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA  160 (295)
T ss_pred             EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence            89999999999988886542    35899999999999999999999999999999999999993389999999999876


Q ss_pred             ccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHHcCCCCcccccchh
Q 045787          157 IGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAEST  235 (324)
Q Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~  235 (324)
                      ............+++.|+|||++.+...++.++|+||||+++|+|++|..||.+.+. .....+....+.+....+....
T Consensus       161 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (295)
T cd07837         161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS  240 (295)
T ss_pred             cCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchh
Confidence            644433334445678899999987656679999999999999999999999987653 3333344444444443332211


Q ss_pred             hhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCcccc
Q 045787          236 YISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLI  291 (324)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~  291 (324)
                      ...... .+............+.++..+.++|.+||..||.+||++.+++.||||+
T Consensus       241 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         241 KLRDWH-EFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             hccchh-hcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence            111110 1222233334444567899999999999999999999999999999995

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=7.9e-46  Score=317.51  Aligned_cols=259  Identities=24%  Similarity=0.333  Sum_probs=209.0

Q ss_pred             ecccCceEEEEEEEccCCceEEEEEeeecccc-CCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEecCC-CH
Q 045787           15 IGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQ-EGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DL   92 (324)
Q Consensus        15 Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~g-~l   92 (324)
                      ||+|+||+||++.+..+++.+|+|.+...... ....+.+..|+.+++.++|++++++.+++..+...|+||||++| +|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            69999999999999999999999998754322 22235567899999999999999999999999999999999975 77


Q ss_pred             HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccccccc
Q 045787           93 HSFITR---HKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCV  169 (324)
Q Consensus        93 ~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~~~~  169 (324)
                      ...+..   ....+++..+..++.|++.||.|||+.|++|+||+|+||+++ .++.++|+|||.+..............+
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~g  159 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLD-NDGNVRISDLGLAVELKDGQSKTKGYAG  159 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC-CCCCEEEeeCccceecCCCCccccccCC
Confidence            666543   234689999999999999999999999999999999999999 8899999999998776544333344568


Q ss_pred             ccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHH-HHHHHcCCCCcccccchhhhhcccCCCCCCC
Q 045787          170 YSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLS-LIFSLLGTPTDESWAESTYISEILPLYPHFE  248 (324)
Q Consensus       170 ~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (324)
                      ++.|+|||++.+ ..++.++|+||||+++|+|++|+.||......... .........                      
T Consensus       160 ~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------------------  216 (280)
T cd05608         160 TPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND----------------------  216 (280)
T ss_pred             CcCccCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc----------------------
Confidence            889999999987 67789999999999999999999999765432111 111100000                      


Q ss_pred             CcchhhhCCCCChhHHHHHHHhhcCCCCCCC-----CHHHHhcCccccCCCCchhhh
Q 045787          249 PANLAEKFPNLEPAGVDLLSQMLCLNPKQRI-----TAMDALKHEYLIGVENVPLVI  300 (324)
Q Consensus       249 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~~l~hp~~~~~~~~~~~~  300 (324)
                         .......++..+.+++.+||+.||.+||     +++++++||||+++.+..+..
T Consensus       217 ---~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~  270 (280)
T cd05608         217 ---SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEA  270 (280)
T ss_pred             ---CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhHHhh
Confidence               0011235788999999999999999999     889999999999988776533

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=8.1e-46  Score=323.89  Aligned_cols=258  Identities=26%  Similarity=0.384  Sum_probs=211.2

Q ss_pred             cceeEeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHH---HhcCCCCeeEEEeeeecCCeEEEE
Q 045787            9 YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLL---KELEHENIVRLLDVQSSRKDVFLV   84 (324)
Q Consensus         9 y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l---~~l~~~~i~~~~~~~~~~~~~~iv   84 (324)
                      |++++.||+|++|.||+|.+..+++.||+|++..... .....+.+.+|..++   +.++||||+++++++.+.+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            7899999999999999999999999999999976532 222345566776665   456799999999999999999999


Q ss_pred             EEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCc
Q 045787           85 FEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE  163 (324)
Q Consensus        85 ~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~  163 (324)
                      |||+.| +|...+..  ..+++..+..++.+++.||.|||+.|++|+||||+||+++ .++.++|+|||.+.........
T Consensus        81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~-~~~~~kL~Dfg~~~~~~~~~~~  157 (324)
T cd05589          81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLD-TEGFVKIADFGLCKEGMGFGDR  157 (324)
T ss_pred             EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC-CCCcEEeCcccCCccCCCCCCc
Confidence            999985 66665543  4699999999999999999999999999999999999999 8999999999988754333333


Q ss_pred             ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCC
Q 045787          164 YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPL  243 (324)
Q Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (324)
                      .....+++.|+|||++.+ ..++.++|+||||+++|+|++|..||...+.............                  
T Consensus       158 ~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~------------------  218 (324)
T cd05589         158 TSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV------------------  218 (324)
T ss_pred             ccccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC------------------
Confidence            445578899999999987 6679999999999999999999999987765443322211000                  


Q ss_pred             CCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCC-----CHHHHhcCccccCCCCchh
Q 045787          244 YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRI-----TAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~~l~hp~~~~~~~~~~  298 (324)
                                .....++..+.++|.+||+.||.+||     ++.++++||||+++.....
T Consensus       219 ----------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~~~  268 (324)
T cd05589         219 ----------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDL  268 (324)
T ss_pred             ----------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHHHH
Confidence                      01125788999999999999999999     7999999999999875544

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-45  Score=317.38  Aligned_cols=265  Identities=24%  Similarity=0.365  Sum_probs=215.8

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeecccc-CCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEE
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQ-EGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE   86 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   86 (324)
                      +|++.+.||+|++|.||++.+..+++.||+|.+...... ......+.+|+.++++++||+++++++.+..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            589999999999999999999989999999998764322 2223456789999999999999999999999999999999


Q ss_pred             ecC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcc
Q 045787           87 YLD-LDLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY  164 (324)
Q Consensus        87 ~~~-g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~  164 (324)
                      |+. |+|...+.... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++ +++.++|+|||.+...... ...
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~-~~~~~~l~Dfg~~~~~~~~-~~~  158 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLD-DYGHIRISDLGLAVEIPEG-ETI  158 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEEC-CCCCEEEeeCCCceecCCC-Ccc
Confidence            997 57777665533 4689999999999999999999999999999999999999 8899999999998765422 222


Q ss_pred             cccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHH-HHHHcCCCCcccccchhhhhcccCC
Q 045787          165 SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSL-IFSLLGTPTDESWAESTYISEILPL  243 (324)
Q Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  243 (324)
                      ....+++.|+|||++.+ ..++.++|+||+|+++|+|++|..||.+.+...... .........                
T Consensus       159 ~~~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~----------------  221 (285)
T cd05605         159 RGRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ----------------  221 (285)
T ss_pred             ccccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc----------------
Confidence            33467889999999977 668999999999999999999999998765332211 111100000                


Q ss_pred             CCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCC-----CHHHHhcCccccCCCCchhhh
Q 045787          244 YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRI-----TAMDALKHEYLIGVENVPLVI  300 (324)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~~l~hp~~~~~~~~~~~~  300 (324)
                               ......++..+.+++.+||+.||.+||     +++++++||||.+....+...
T Consensus       222 ---------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~  274 (285)
T cd05605         222 ---------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEA  274 (285)
T ss_pred             ---------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHHhh
Confidence                     011235788999999999999999999     899999999999988777654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-46  Score=332.32  Aligned_cols=264  Identities=25%  Similarity=0.403  Sum_probs=211.3

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      ++|++++.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.++++++||||+++++++.++...|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            479999999999999999999999999999999875432 2223456788999999999999999999999999999999


Q ss_pred             EecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC---
Q 045787           86 EYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ---  161 (324)
Q Consensus        86 e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~---  161 (324)
                      ||++ |+|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||+++ .++.++|+|||++.......   
T Consensus        81 E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~-~~~~~kl~DfGla~~~~~~~~~~  158 (377)
T cd05629          81 EFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILID-RGGHIKLSDFGLSTGFHKQHDSA  158 (377)
T ss_pred             eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEC-CCCCEEEeecccccccccccccc
Confidence            9997 5888877654 5689999999999999999999999999999999999999 89999999999885321100   


Q ss_pred             ---------C-----------------------------------cccccccccccCCchhhcCCCCCCCchhhHHHHHH
Q 045787          162 ---------K-----------------------------------EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCI  197 (324)
Q Consensus       162 ---------~-----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i  197 (324)
                               .                                   .....+||+.|+|||++.+ ..++.++|||||||+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvi  237 (377)
T cd05629         159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLGAI  237 (377)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-CCCCCceeeEecchh
Confidence                     0                                   0012358899999999977 668999999999999


Q ss_pred             HHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCC
Q 045787          198 FAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQ  277 (324)
Q Consensus       198 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~  277 (324)
                      +|+|++|..||...+...............  .             .         .....++.++.++|.+||. +|.+
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~--~-------------~---------p~~~~~s~~~~dli~~lL~-~~~~  292 (377)
T cd05629         238 MFECLIGWPPFCSENSHETYRKIINWRETL--Y-------------F---------PDDIHLSVEAEDLIRRLIT-NAEN  292 (377)
T ss_pred             hhhhhcCCCCCCCCCHHHHHHHHHccCCcc--C-------------C---------CCCCCCCHHHHHHHHHHhc-CHhh
Confidence            999999999997766433322211100000  0             0         0012478899999999998 7776


Q ss_pred             C---CCHHHHhcCccccCCCCchh
Q 045787          278 R---ITAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       278 R---ps~~~~l~hp~~~~~~~~~~  298 (324)
                      |   +++.++++||||+++++..+
T Consensus       293 r~~r~~~~~~l~hp~~~~~~~~~~  316 (377)
T cd05629         293 RLGRGGAHEIKSHPFFRGVDWDTI  316 (377)
T ss_pred             cCCCCCHHHHhcCCCcCCCCHHHH
Confidence            5   59999999999999876554

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1e-45  Score=323.16  Aligned_cols=261  Identities=22%  Similarity=0.341  Sum_probs=215.2

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEEEEE
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      +|++.+.||+|+||.||+|.+..+++.+|+|++..... ..........|..++..+ .|++++++++.+...+..|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            58999999999999999999999999999999886542 222234466677888777 4789999999999999999999


Q ss_pred             EecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcc
Q 045787           86 EYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY  164 (324)
Q Consensus        86 e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~  164 (324)
                      ||++ |+|...+... ..+++..+..++.+++.||.|||+.|++|+||||+||+++ .++.++|+|||.+..........
T Consensus        81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~-~~~~~kL~DfG~~~~~~~~~~~~  158 (323)
T cd05616          81 EYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD-SEGHIKIADFGMCKENMWDGVTT  158 (323)
T ss_pred             cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEEC-CCCcEEEccCCCceecCCCCCcc
Confidence            9997 5887777654 4699999999999999999999999999999999999999 89999999999987654333334


Q ss_pred             cccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCC
Q 045787          165 SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLY  244 (324)
Q Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (324)
                      ...+|++.|+|||++.+ ..++.++|+|||||++|+|++|+.||...+.......+.....                   
T Consensus       159 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-------------------  218 (323)
T cd05616         159 KTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-------------------  218 (323)
T ss_pred             ccCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-------------------
Confidence            45578899999999987 6789999999999999999999999987775544333221100                   


Q ss_pred             CCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCC-----HHHHhcCccccCCCCchhh
Q 045787          245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRIT-----AMDALKHEYLIGVENVPLV  299 (324)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~~~l~hp~~~~~~~~~~~  299 (324)
                               .....++.++.+++.+||+.||.+|++     ..++++||||+.+++....
T Consensus       219 ---------~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~~  269 (323)
T cd05616         219 ---------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLE  269 (323)
T ss_pred             ---------CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHHH
Confidence                     011257889999999999999999998     4899999999998866554

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.1e-47  Score=296.42  Aligned_cols=257  Identities=25%  Similarity=0.460  Sum_probs=223.9

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeecc-ccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQT-EQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   83 (324)
                      .-++|++.+.||+|-||.||+|+.+.++..+|+|++.++. ........+.+|+++...|+||||++++++|.++...|+
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL   99 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL   99 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence            4578999999999999999999999999999999998765 233345678999999999999999999999999999999


Q ss_pred             EEEecC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC
Q 045787           84 VFEYLD-LDLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        84 v~e~~~-g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~  161 (324)
                      ++||.. |++...+.... .++++...+.++.|++.||.|+|.++++||||||+|+|++ ..+.+|++|||.+....  .
T Consensus       100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg-~~~~lkiAdfGwsV~~p--~  176 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLG-SAGELKIADFGWSVHAP--S  176 (281)
T ss_pred             EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccC-CCCCeeccCCCceeecC--C
Confidence            999997 79998888543 4699999999999999999999999999999999999999 99999999999998754  4


Q ss_pred             CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhccc
Q 045787          162 KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEIL  241 (324)
Q Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (324)
                      ......|||..|.|||...+ ...+...|+|++|++.||++.|.+||.........+.+......               
T Consensus       177 ~kR~tlcgt~dyl~pEmv~~-~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~---------------  240 (281)
T KOG0580|consen  177 NKRKTLCGTLDYLPPEMVEG-RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLK---------------  240 (281)
T ss_pred             CCceeeecccccCCHhhcCC-CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcccc---------------
Confidence            55667799999999999988 77799999999999999999999999887744443333322111               


Q ss_pred             CCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCC
Q 045787          242 PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV  293 (324)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~  293 (324)
                                   ....++.++.++|.+||..+|.+|.+..|++.|||....
T Consensus       241 -------------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  241 -------------FPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             -------------CCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence                         113689999999999999999999999999999998754

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.3e-46  Score=327.48  Aligned_cols=256  Identities=25%  Similarity=0.413  Sum_probs=210.8

Q ss_pred             EeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEecCC-
Q 045787           13 KKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-   90 (324)
Q Consensus        13 ~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~g-   90 (324)
                      +.||+|+||.||+|.+..+|..||+|++..... .......+.+|+.+++.++||+|+++++.+..++..|+||||++| 
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            468999999999999999999999999976532 222235567899999999999999999999999999999999985 


Q ss_pred             CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccccccc
Q 045787           91 DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS-LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCV  169 (324)
Q Consensus        91 ~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~~~~  169 (324)
                      +|...+.. ...+++..++.++.||+.||.|||+ .|++|+||||+||+++ .++.++|+|||.+..............+
T Consensus        81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  158 (325)
T cd05594          81 ELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMKTFCG  158 (325)
T ss_pred             cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEEC-CCCCEEEecCCCCeecCCCCcccccccC
Confidence            67666554 4569999999999999999999997 8999999999999999 8999999999998754333333344568


Q ss_pred             ccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCC
Q 045787          170 YSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEP  249 (324)
Q Consensus       170 ~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (324)
                      ++.|+|||++.+ ..++.++||||||+++|+|++|..||...+.............                        
T Consensus       159 t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~------------------------  213 (325)
T cd05594         159 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI------------------------  213 (325)
T ss_pred             CcccCCHHHHcc-CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCC------------------------
Confidence            999999999987 6679999999999999999999999987665444333221100                        


Q ss_pred             cchhhhCCCCChhHHHHHHHhhcCCCCCCC-----CHHHHhcCccccCCCCchhh
Q 045787          250 ANLAEKFPNLEPAGVDLLSQMLCLNPKQRI-----TAMDALKHEYLIGVENVPLV  299 (324)
Q Consensus       250 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~~l~hp~~~~~~~~~~~  299 (324)
                          .....+++++.++|.+||+.||.+|+     ++.++++||||.++.+....
T Consensus       214 ----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~  264 (325)
T cd05594         214 ----RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVY  264 (325)
T ss_pred             ----CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHHHHH
Confidence                01125788999999999999999997     99999999999998766543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=7.1e-46  Score=323.85  Aligned_cols=255  Identities=25%  Similarity=0.378  Sum_probs=210.7

Q ss_pred             EeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEEEEEEecCC
Q 045787           13 KKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDVFLVFEYLDL   90 (324)
Q Consensus        13 ~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~g   90 (324)
                      +.||+|+||.||+|.+..+++.||+|++..... .....+.+..|.+++..+ +||+|+++++++.+++..|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            368999999999999999999999999976542 223345567788888866 799999999999999999999999985


Q ss_pred             -CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccccccc
Q 045787           91 -DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCV  169 (324)
Q Consensus        91 -~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~~~~  169 (324)
                       +|...+... ..+++..+..++.+++.||.|||++|++|+||||+||+++ .++.++|+|||.+..............+
T Consensus        81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  158 (321)
T cd05591          81 GDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLD-AEGHCKLADFGMCKEGILNGVTTTTFCG  158 (321)
T ss_pred             CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC-CCCCEEEeecccceecccCCcccccccc
Confidence             777776654 5689999999999999999999999999999999999999 8999999999998765433333444568


Q ss_pred             ccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCC
Q 045787          170 YSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEP  249 (324)
Q Consensus       170 ~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (324)
                      ++.|+|||++.+ ..++.++|+||||+++|+|++|+.||...+.............                        
T Consensus       159 t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~------------------------  213 (321)
T cd05591         159 TPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV------------------------  213 (321)
T ss_pred             CccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC------------------------
Confidence            899999999987 6789999999999999999999999987775544332221000                        


Q ss_pred             cchhhhCCCCChhHHHHHHHhhcCCCCCCC-------CHHHHhcCccccCCCCchh
Q 045787          250 ANLAEKFPNLEPAGVDLLSQMLCLNPKQRI-------TAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       250 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-------s~~~~l~hp~~~~~~~~~~  298 (324)
                          .....++.++.++|.+||+.||.+|+       ++.++++||||.++.+..+
T Consensus       214 ----~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~~  265 (321)
T cd05591         214 ----LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLL  265 (321)
T ss_pred             ----CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHHHH
Confidence                01124678999999999999999999       8999999999999876655

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=4.2e-46  Score=332.23  Aligned_cols=264  Identities=26%  Similarity=0.425  Sum_probs=212.6

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      ++|++++.||+|++|.||+|.+..+++.||+|++..... .......+.+|+.++++++|++|+++++.+.+++.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            479999999999999999999999999999999875432 2223466889999999999999999999999999999999


Q ss_pred             EecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC---
Q 045787           86 EYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ---  161 (324)
Q Consensus        86 e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~---  161 (324)
                      ||++ |+|.+++... +.+++..++.++.||+.||.|||++|++|+||||+||+++ .++.++|+|||++.......   
T Consensus        81 E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~-~~~~ikL~DFG~a~~~~~~~~~~  158 (376)
T cd05598          81 DYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSK  158 (376)
T ss_pred             eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEEC-CCCCEEEEeCCCCcccccccccc
Confidence            9997 5888887664 4689999999999999999999999999999999999999 89999999999874221000   


Q ss_pred             ----------------------------------------CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHH
Q 045787          162 ----------------------------------------KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM  201 (324)
Q Consensus       162 ----------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l  201 (324)
                                                              ......+||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyel  237 (376)
T cd05598         159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILYEM  237 (376)
T ss_pred             ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-CCCCcceeeeeccceeeeh
Confidence                                                    00112368899999999987 6679999999999999999


Q ss_pred             HhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCC--
Q 045787          202 ITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRI--  279 (324)
Q Consensus       202 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp--  279 (324)
                      ++|+.||...+...............                        .......+++.+.++|.+|+ .+|.+|+  
T Consensus       238 l~G~~Pf~~~~~~~~~~~i~~~~~~~------------------------~~~~~~~~s~~~~~li~~l~-~~p~~R~~~  292 (376)
T cd05598         238 LVGQPPFLADTPAETQLKVINWETTL------------------------HIPSQAKLSREASDLILRLC-CGAEDRLGK  292 (376)
T ss_pred             hhCCCCCCCCCHHHHHHHHhccCccc------------------------cCCCCCCCCHHHHHHHHHHh-cCHhhcCCC
Confidence            99999998776443322211100000                        00011257889999999976 5999999  


Q ss_pred             -CHHHHhcCccccCCCCchh
Q 045787          280 -TAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       280 -s~~~~l~hp~~~~~~~~~~  298 (324)
                       ++.++++||||+++.....
T Consensus       293 ~t~~ell~h~~~~~~~~~~~  312 (376)
T cd05598         293 NGADEIKAHPFFKGIDFASL  312 (376)
T ss_pred             CCHHHHhCCCCcCCCCHHHH
Confidence             9999999999999875444

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.2e-45  Score=329.64  Aligned_cols=264  Identities=26%  Similarity=0.427  Sum_probs=210.1

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      ..|++++.||+|+||+||+|.+..+++.||+|++..... .......+.+|+.++++++||+|+++++.+.+.+.+|+||
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~   80 (381)
T cd05626           1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (381)
T ss_pred             CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence            369999999999999999999999999999999976432 2233456889999999999999999999999999999999


Q ss_pred             EecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC--
Q 045787           86 EYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK--  162 (324)
Q Consensus        86 e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~--  162 (324)
                      ||++ |+|.+++... ..+++..++.++.|++.||.+||+.|++|+||||+||+++ .++.++|+|||++........  
T Consensus        81 E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~-~~~~~kL~DFGl~~~~~~~~~~~  158 (381)
T cd05626          81 DYIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILID-LDGHIKLTDFGLCTGFRWTHNSK  158 (381)
T ss_pred             ecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEEC-CCCCEEEeeCcCCcccccccccc
Confidence            9997 4787777654 4689999999999999999999999999999999999999 899999999998643210000  


Q ss_pred             ---------------------------------------------cccccccccccCCchhhcCCCCCCCchhhHHHHHH
Q 045787          163 ---------------------------------------------EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCI  197 (324)
Q Consensus       163 ---------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i  197 (324)
                                                                   .....+||+.|+|||++.+ ..++.++|||||||+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlG~i  237 (381)
T cd05626         159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSVGVI  237 (381)
T ss_pred             cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-CCCCCccceeehhhH
Confidence                                                         0012368899999999987 668999999999999


Q ss_pred             HHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhc--CCC
Q 045787          198 FAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLC--LNP  275 (324)
Q Consensus       198 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~--~dP  275 (324)
                      +|+|++|..||...+................                        ......+++++.++|.+|+.  .+|
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~------------------------~~~~~~~s~~~~dli~~ll~~~~~~  293 (381)
T cd05626         238 LFEMLVGQPPFLAPTPTETQLKVINWENTLH------------------------IPPQVKLSPEAVDLITKLCCSAEER  293 (381)
T ss_pred             HHHHHhCCCCCcCCCHHHHHHHHHccccccC------------------------CCCCCCCCHHHHHHHHHHccCcccc
Confidence            9999999999987664332221111000000                        00012478899999999665  455


Q ss_pred             CCCCCHHHHhcCccccCCCCch
Q 045787          276 KQRITAMDALKHEYLIGVENVP  297 (324)
Q Consensus       276 ~~Rps~~~~l~hp~~~~~~~~~  297 (324)
                      ..|+++.++++||||+++.+..
T Consensus       294 ~~R~~~~~~l~hp~f~~~~~~~  315 (381)
T cd05626         294 LGRNGADDIKAHPFFSEVDFSS  315 (381)
T ss_pred             cCCCCHHHHhcCcccCCCChhH
Confidence            5599999999999999987544

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=8e-46  Score=331.06  Aligned_cols=263  Identities=26%  Similarity=0.423  Sum_probs=211.4

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      .+|++++.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.++++++||+|+++++.+.+++..|+||
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~   80 (382)
T cd05625           1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM   80 (382)
T ss_pred             CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence            369999999999999999999999999999999875432 2223456888999999999999999999999999999999


Q ss_pred             EecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC---
Q 045787           86 EYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ---  161 (324)
Q Consensus        86 e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~---  161 (324)
                      ||++ |+|.+.+... +.+++..++.++.||+.||.+||+.|++|+||||+|||++ .++.++|+|||++.......   
T Consensus        81 E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~-~~g~~kL~DFGla~~~~~~~~~~  158 (382)
T cd05625          81 DYIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSK  158 (382)
T ss_pred             eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC-CCCCEEEeECCCCcccccccccc
Confidence            9997 4788877654 5689999999999999999999999999999999999999 89999999999864321000   


Q ss_pred             --------------------------------------------CcccccccccccCCchhhcCCCCCCCchhhHHHHHH
Q 045787          162 --------------------------------------------KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCI  197 (324)
Q Consensus       162 --------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i  197 (324)
                                                                  ......+||+.|+|||++.+ ..++.++|||||||+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvi  237 (382)
T cd05625         159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVI  237 (382)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC-CCCCCeeeEEechHH
Confidence                                                        00112368899999999987 668999999999999


Q ss_pred             HHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCC
Q 045787          198 FAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQ  277 (324)
Q Consensus       198 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~  277 (324)
                      +|+|++|+.||...+................                        ......+++++.++|.+|+ .||.+
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~------------------------~p~~~~~s~~~~~li~~l~-~~p~~  292 (382)
T cd05625         238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLH------------------------IPPQAKLSPEASDLIIKLC-RGPED  292 (382)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHccCCCcC------------------------CCCcccCCHHHHHHHHHHc-cCHhH
Confidence            9999999999987664433222211100000                        0001257889999999976 59999


Q ss_pred             CCC---HHHHhcCccccCCCCch
Q 045787          278 RIT---AMDALKHEYLIGVENVP  297 (324)
Q Consensus       278 Rps---~~~~l~hp~~~~~~~~~  297 (324)
                      |++   +.++++||||+++....
T Consensus       293 R~~~~~~~ei~~hp~f~~~~~~~  315 (382)
T cd05625         293 RLGKNGADEIKAHPFFKTIDFSS  315 (382)
T ss_pred             cCCCCCHHHHhcCCCcCCcChHH
Confidence            997   99999999999987554

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.5e-45  Score=320.01  Aligned_cols=275  Identities=36%  Similarity=0.640  Sum_probs=208.5

Q ss_pred             eEeecccCceEEEEEEEc--cCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeec--CCeEEEEEEe
Q 045787           12 IKKIGAGGYGEVYKCRNT--VTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS--RKDVFLVFEY   87 (324)
Q Consensus        12 ~~~Lg~g~~~~v~~a~~~--~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv~e~   87 (324)
                      .++||+|+||.||+|.++  .+++.+|+|.+.....    ...+.+|+.++++++||||+++++++..  +...|+++||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY   81 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence            358999999999999965  4668899998864322    3457789999999999999999998854  4578999999


Q ss_pred             cCCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEee---cCCCcEEEeeccceee
Q 045787           88 LDLDLHSFITRHK--------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLID---LKRNTVKLADFGLARA  156 (324)
Q Consensus        88 ~~g~l~~~~~~~~--------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~---~~~~~v~l~d~g~~~~  156 (324)
                      +++++..++....        ..+++..++.++.|++.||.|||+.|++|+||||+||++.   ..++.++|+|||.+..
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07868          82 AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             cCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence            9999988876431        2588999999999999999999999999999999999994   2557899999999976


Q ss_pred             ccCCCC---cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh----------hHHHHHHHHc
Q 045787          157 IGVPQK---EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH----------DHLSLIFSLL  223 (324)
Q Consensus       157 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----------~~~~~~~~~~  223 (324)
                      ......   ......+|+.|+|||++.+...++.++|+||+||++|+|++|++||.....          ..+..+....
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  241 (317)
T cd07868         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM  241 (317)
T ss_pred             cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence            643221   223456788999999998756789999999999999999999999965442          3445566666


Q ss_pred             CCCCcccccchhhhhcccCCCCCC--------CC-cchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          224 GTPTDESWAESTYISEILPLYPHF--------EP-ANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~--------~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                      +.+....|.......+........        .. ..........+..+.++|.+||+.||.+|||++|+++||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            666655554432221111100000        00 00111112345678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.2e-45  Score=325.05  Aligned_cols=278  Identities=25%  Similarity=0.340  Sum_probs=211.4

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLV   84 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   84 (324)
                      ...+|++++.||.|++|.||+|.+..++..+|+|+....        ....|+.++++++||||+++++++......++|
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  135 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV  135 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence            356799999999999999999999999999999974322        234689999999999999999999999999999


Q ss_pred             EEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcc
Q 045787           85 FEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY  164 (324)
Q Consensus        85 ~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~  164 (324)
                      +|++.+++.+++.....++++..+..++.||+.||.|||+.|++|+||||+||+++ .++.++|+|||.+..... ....
T Consensus       136 ~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~-~~~~~kl~DfG~a~~~~~-~~~~  213 (357)
T PHA03209        136 LPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIN-DVDQVCIGDLGAAQFPVV-APAF  213 (357)
T ss_pred             EEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC-CCCCEEEecCcccccccc-Cccc
Confidence            99999999999988777899999999999999999999999999999999999999 899999999998875332 1222


Q ss_pred             cccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCC-CCCCCh----------hHHHHHHHHcCCCCcccc--
Q 045787          165 SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPL-FPSKKH----------DHLSLIFSLLGTPTDESW--  231 (324)
Q Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p-f~~~~~----------~~~~~~~~~~~~~~~~~~--  231 (324)
                      ....+++.|+|||++.+ ..++.++|||||||++|+|+++..| |.....          ..+..+....+..+....  
T Consensus       214 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  292 (357)
T PHA03209        214 LGLAGTVETNAPEVLAR-DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRD  292 (357)
T ss_pred             ccccccccccCCeecCC-CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCC
Confidence            33468889999999987 5689999999999999999986544 443221          122223333332222111  


Q ss_pred             cchhhhhcccC---CCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCC
Q 045787          232 AESTYISEILP---LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV  293 (324)
Q Consensus       232 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~  293 (324)
                      ...........   ................++.++.++|.+||+.||.+|||+.|+++||||+++
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~  357 (357)
T PHA03209        293 PGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL  357 (357)
T ss_pred             CccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence            00011111100   000000000111123577888999999999999999999999999999874

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-45  Score=318.45  Aligned_cols=252  Identities=28%  Similarity=0.418  Sum_probs=213.1

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCce-EEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCC-eEEE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQK-VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK-DVFL   83 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~-~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~i   83 (324)
                      .....+.+.+|.|+||+||++...  |.. +|+|.+..........+.+.+|+.++.+++||||++++|++.++. .++|
T Consensus        40 ~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~i  117 (362)
T KOG0192|consen   40 PDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCI  117 (362)
T ss_pred             hHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEE
Confidence            344556677999999999999875  556 999999876644433678999999999999999999999999887 7999


Q ss_pred             EEEecC-CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC-CcccCCCCCceEeecCCC-cEEEeeccceeeccC
Q 045787           84 VFEYLD-LDLHSFITR-HKNTLNLLVIKAILKQILLGLAYCHSLK-ILHRDLKPNNLLIDLKRN-TVKLADFGLARAIGV  159 (324)
Q Consensus        84 v~e~~~-g~l~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~g-~~H~di~p~nIll~~~~~-~v~l~d~g~~~~~~~  159 (324)
                      ||||++ |+|..++.. ....++...+..++.+|+.|+.|||+++ ++|+||||+|||++ .++ ++||+|||+++....
T Consensus       118 VtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~-~~~~~~KI~DFGlsr~~~~  196 (362)
T KOG0192|consen  118 VTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVD-LKGKTLKIADFGLSREKVI  196 (362)
T ss_pred             EEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEc-CCCCEEEECCCccceeecc
Confidence            999998 688888877 3678999999999999999999999999 99999999999999 776 999999999988764


Q ss_pred             CCCcccccccccccCCchhhcC-CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhh
Q 045787          160 PQKEYSRDCVYSPYKAPELLLG-YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYIS  238 (324)
Q Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (324)
                      .........||+.|||||++.+ ...++.++||||||+++|||+||..||...............+..+..         
T Consensus       197 ~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~---------  267 (362)
T KOG0192|consen  197 SKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPI---------  267 (362)
T ss_pred             ccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCC---------
Confidence            4344455789999999999995 267999999999999999999999999988875554444433333221         


Q ss_pred             cccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          239 EILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                       ....++.+..++.+|+..||.+||+..+++.
T Consensus       268 -----------------p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  268 -----------------PKECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             -----------------CccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence                             1137889999999999999999999999985

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.8e-46  Score=323.90  Aligned_cols=259  Identities=30%  Similarity=0.436  Sum_probs=228.9

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCe-EEEE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKD-VFLV   84 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~iv   84 (324)
                      -++|.+++.+|.|+||.+++++++.+++.|++|.+..........+...+|+.+++++.||+|+.+.+.|..++. .+||
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            368999999999999999999999999999999999887666666678899999999999999999999998888 9999


Q ss_pred             EEecCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC
Q 045787           85 FEYLDL-DLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK  162 (324)
Q Consensus        85 ~e~~~g-~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~  162 (324)
                      |+|++| ++.+.+...+ ..++++.+..|+.|++.|+.|||+++++|||||+.|||+. .++.|+|+|||++...++...
T Consensus        83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Niflt-k~~~VkLgDfGlaK~l~~~~~  161 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLT-KDKKVKLGDFGLAKILNPEDS  161 (426)
T ss_pred             EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcc-ccCceeecchhhhhhcCCchh
Confidence            999985 8888887766 4699999999999999999999999999999999999999 888899999999999987765


Q ss_pred             cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHH-HHHHcCCCCcccccchhhhhccc
Q 045787          163 EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSL-IFSLLGTPTDESWAESTYISEIL  241 (324)
Q Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  241 (324)
                      ......|||.|++||++.+ .+|..++|||||||++|||++-+++|...+...+.. +......|.              
T Consensus       162 ~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Pl--------------  226 (426)
T KOG0589|consen  162 LASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPL--------------  226 (426)
T ss_pred             hhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCC--------------
Confidence            6777899999999999998 889999999999999999999999999888554433 222221221              


Q ss_pred             CCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCC
Q 045787          242 PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVE  294 (324)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~  294 (324)
                                    ...++.+++.+|+.||..+|..||++.++|.+|.++...
T Consensus       227 --------------p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~~  265 (426)
T KOG0589|consen  227 --------------PSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRYL  265 (426)
T ss_pred             --------------CccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhHH
Confidence                          236899999999999999999999999999999888443

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3e-45  Score=335.06  Aligned_cols=284  Identities=21%  Similarity=0.363  Sum_probs=211.3

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCC------CCeeEEEeeeecC
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEH------ENIVRLLDVQSSR   78 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~------~~i~~~~~~~~~~   78 (324)
                      ..++|++++.||+|+||+||+|.+...++.||+|++.....   .......|+.+++.++|      .+++++++++..+
T Consensus       127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~  203 (467)
T PTZ00284        127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK---YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE  203 (467)
T ss_pred             CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh---hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence            35789999999999999999999999999999999864322   12345667777777754      4588888888764


Q ss_pred             -CeEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCceEeecCCC------------
Q 045787           79 -KDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS-LKILHRDLKPNNLLIDLKRN------------  144 (324)
Q Consensus        79 -~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~g~~H~di~p~nIll~~~~~------------  144 (324)
                       ..+|+|+++++++|.+++... +.+++..++.++.||+.||.|||+ .|++|+||||+|||++ .++            
T Consensus       204 ~~~~~iv~~~~g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~-~~~~~~~~~~~~~~~  281 (467)
T PTZ00284        204 TGHMCIVMPKYGPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILME-TSDTVVDPVTNRALP  281 (467)
T ss_pred             CceEEEEEeccCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEe-cCCcccccccccccC
Confidence             579999999999999988764 469999999999999999999998 5999999999999998 443            


Q ss_pred             ----cEEEeeccceeeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh-hHHHHH
Q 045787          145 ----TVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLI  219 (324)
Q Consensus       145 ----~v~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~  219 (324)
                          .+||+|||.+....   .......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+. +.+..+
T Consensus       282 ~~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i  357 (467)
T PTZ00284        282 PDPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM  357 (467)
T ss_pred             CCCceEEECCCCccccCc---cccccccCCccccCcHHhhc-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence                49999999875432   22344578999999999987 6789999999999999999999999987774 344445


Q ss_pred             HHHcCCCCcccccchh--hhhcccCCCC----CCCCcchhhhC-------CCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          220 FSLLGTPTDESWAEST--YISEILPLYP----HFEPANLAEKF-------PNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       220 ~~~~~~~~~~~~~~~~--~~~~~~~~~~----~~~~~~~~~~~-------~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      ....+..+........  ...+......    ...+.......       ...++.+.+||.+||++||.+|||++|+|+
T Consensus       358 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~  437 (467)
T PTZ00284        358 EKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT  437 (467)
T ss_pred             HHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence            5555555432211100  0000000000    00000000000       012456789999999999999999999999


Q ss_pred             CccccCCCCch
Q 045787          287 HEYLIGVENVP  297 (324)
Q Consensus       287 hp~~~~~~~~~  297 (324)
                      ||||++.....
T Consensus       438 Hp~~~~~~~~~  448 (467)
T PTZ00284        438 HPYVLKYYPEC  448 (467)
T ss_pred             CccccccCCcc
Confidence            99999865533

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.5e-45  Score=321.29  Aligned_cols=255  Identities=26%  Similarity=0.391  Sum_probs=210.1

Q ss_pred             EeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEEEEEEecCC
Q 045787           13 KKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDVFLVFEYLDL   90 (324)
Q Consensus        13 ~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~g   90 (324)
                      +.||+|+||.||+|.+..++..||+|++..... .......+..|..+++.+ +|||++++++++.+.+.+|+||||+.|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            469999999999999999999999999986542 222345567888888888 699999999999999999999999975


Q ss_pred             -CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccccccc
Q 045787           91 -DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCV  169 (324)
Q Consensus        91 -~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~~~~  169 (324)
                       +|...+.. ...+++..+..++.+++.||.|||+.|++|+||||+||+++ .++.++|+|||.+.............++
T Consensus        81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (318)
T cd05570          81 GDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLD-SEGHIKIADFGMCKEGILGGVTTSTFCG  158 (318)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEEC-CCCcEEecccCCCeecCcCCCcccceec
Confidence             77766655 45699999999999999999999999999999999999999 8999999999988654333333344568


Q ss_pred             ccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCC
Q 045787          170 YSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEP  249 (324)
Q Consensus       170 ~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (324)
                      ++.|+|||++.+ ..++.++|+|||||++|+|++|+.||...+............                         
T Consensus       159 ~~~y~aPE~~~~-~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~-------------------------  212 (318)
T cd05570         159 TPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE-------------------------  212 (318)
T ss_pred             CccccCHHHhcC-CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC-------------------------
Confidence            899999999987 678999999999999999999999998776544433221100                         


Q ss_pred             cchhhhCCCCChhHHHHHHHhhcCCCCCCCCH-----HHHhcCccccCCCCchh
Q 045787          250 ANLAEKFPNLEPAGVDLLSQMLCLNPKQRITA-----MDALKHEYLIGVENVPL  298 (324)
Q Consensus       250 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~~~l~hp~~~~~~~~~~  298 (324)
                         ......++..+.++|++||+.||.+||++     .++++||||..+.+...
T Consensus       213 ---~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~~~  263 (318)
T cd05570         213 ---VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKL  263 (318)
T ss_pred             ---CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHH
Confidence               00112478899999999999999999999     99999999999876543

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.4e-45  Score=323.57  Aligned_cols=264  Identities=25%  Similarity=0.424  Sum_probs=210.8

Q ss_pred             CcceeEeecccCceEEEEEEEc---cCCceEEEEEeeeccc--cCCCchHHHHHHHHHHhcC-CCCeeEEEeeeecCCeE
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNT---VTGQKVAIKMMTIQTE--QEGVPSYIIREVSLLKELE-HENIVRLLDVQSSRKDV   81 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~---~~~~~~~~K~~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~   81 (324)
                      +|++++.||+|++|.||+|.+.   .+++.||+|++.....  .....+.+..|+.+++.++ |++++++++++..++.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            5899999999999999999864   4788999999875432  2223456788999999995 89999999999999999


Q ss_pred             EEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           82 FLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        82 ~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      ++||||+.| +|.+++... ..+++..++.++.+|+.||.|||++|++|+||||+|||++ .++.++|+|||++......
T Consensus        81 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~-~~~~~kl~DfG~~~~~~~~  158 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLD-SEGHVVLTDFGLSKEFLSE  158 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEEC-CCCCEEEeeCcCCcccccc
Confidence            999999984 888877654 4699999999999999999999999999999999999999 8899999999998764322


Q ss_pred             CC-cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhH-HHHHHHHcCCCCcccccchhhhh
Q 045787          161 QK-EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDH-LSLIFSLLGTPTDESWAESTYIS  238 (324)
Q Consensus       161 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  238 (324)
                      .. ......|++.|+|||++.+...++.++|||||||++|+|++|..||....... .......                
T Consensus       159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~----------------  222 (332)
T cd05614         159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRR----------------  222 (332)
T ss_pred             CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHH----------------
Confidence            22 22335689999999999875667899999999999999999999996433111 0000000                


Q ss_pred             cccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCC-----CHHHHhcCccccCCCCchh
Q 045787          239 EILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRI-----TAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~~l~hp~~~~~~~~~~  298 (324)
                       ....    .    ......++..+.+++.+||+.||.+||     ++.++++||||++......
T Consensus       223 -~~~~----~----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~  278 (332)
T cd05614         223 -ILKC----D----PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEAL  278 (332)
T ss_pred             -HhcC----C----CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHH
Confidence             0000    0    011235788999999999999999999     8889999999998765444

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.6e-45  Score=320.73  Aligned_cols=255  Identities=25%  Similarity=0.407  Sum_probs=207.9

Q ss_pred             EeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEEEEEEecCC
Q 045787           13 KKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDVFLVFEYLDL   90 (324)
Q Consensus        13 ~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~g   90 (324)
                      +.||+|+||.||+|.++.+|..||+|.+..... ..........|..++... +||+++++++.+.+++..|+||||+.|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            469999999999999999999999999976532 122234566777777654 899999999999999999999999985


Q ss_pred             -CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccccccc
Q 045787           91 -DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCV  169 (324)
Q Consensus        91 -~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~~~~  169 (324)
                       +|...+.. ...+++..+..++.|++.||.|||++|++|+||||+||+++ .++.++|+|||.+.............+|
T Consensus        81 g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (316)
T cd05620          81 GDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLD-RDGHIKIADFGMCKENVFGDNRASTFCG  158 (316)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC-CCCCEEeCccCCCeecccCCCceeccCC
Confidence             77777665 45689999999999999999999999999999999999999 8899999999988754323333444578


Q ss_pred             ccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCC
Q 045787          170 YSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEP  249 (324)
Q Consensus       170 ~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (324)
                      ++.|+|||++.+ ..++.++||||||+++|+|++|..||...+............ +                       
T Consensus       159 t~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~-~-----------------------  213 (316)
T cd05620         159 TPDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT-P-----------------------  213 (316)
T ss_pred             CcCccCHHHHcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-C-----------------------
Confidence            999999999987 678999999999999999999999998776554433222110 0                       


Q ss_pred             cchhhhCCCCChhHHHHHHHhhcCCCCCCCCH-HHHhcCccccCCCCchh
Q 045787          250 ANLAEKFPNLEPAGVDLLSQMLCLNPKQRITA-MDALKHEYLIGVENVPL  298 (324)
Q Consensus       250 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-~~~l~hp~~~~~~~~~~  298 (324)
                          .....++.++.++|++||+.||.+||++ .++++||||+++....+
T Consensus       214 ----~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~~~~~  259 (316)
T cd05620         214 ----HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINWTAL  259 (316)
T ss_pred             ----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCCHHHH
Confidence                0112467889999999999999999998 57888999999875543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-45  Score=323.93  Aligned_cols=297  Identities=40%  Similarity=0.639  Sum_probs=238.4

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCC-----eEE
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK-----DVF   82 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~   82 (324)
                      +|++.+.||.|++|.||+|.+..++..+++|.+..........+.+.+|+.+++.++|++++++.+++....     ..|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            699999999999999999999988999999998866544445567889999999999999999999987765     789


Q ss_pred             EEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC-
Q 045787           83 LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ-  161 (324)
Q Consensus        83 iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~-  161 (324)
                      ++++|+++++.+.+... .++++..++.++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+....... 
T Consensus        81 lv~e~~~~~l~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~-~~~~~~L~dfg~~~~~~~~~~  158 (330)
T cd07834          81 IVTELMETDLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVN-SNCDLKICDFGLARGVDPDED  158 (330)
T ss_pred             EEecchhhhHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc-CCCCEEEcccCceEeeccccc
Confidence            99999998888887654 4799999999999999999999999999999999999999 88999999999998775443 


Q ss_pred             --CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHHcCCCCccccc--chhh
Q 045787          162 --KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD-HLSLIFSLLGTPTDESWA--ESTY  236 (324)
Q Consensus       162 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~--~~~~  236 (324)
                        .......+++.|+|||++.+....+.++|+||||+++|+|++|..||...+.. ....+....+.++...+.  ....
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  238 (330)
T cd07834         159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK  238 (330)
T ss_pred             ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence              12333457788999999988547899999999999999999999999887743 344445555555543332  1122


Q ss_pred             hhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchhhhhhhhcc
Q 045787          237 ISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLINRK  306 (324)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~~~~~~~~~  306 (324)
                      ..+.................+.++..+.++|.+||++||.+||++.+++.||||+++...+.........
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~~~~~  308 (330)
T cd07834         239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKPPF  308 (330)
T ss_pred             hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCCCCCcc
Confidence            2222222233333444455667899999999999999999999999999999999998876544443333

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.2e-45  Score=326.31  Aligned_cols=266  Identities=23%  Similarity=0.341  Sum_probs=215.7

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF   82 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   82 (324)
                      +..++|++.+.||+|++|.||+|.+..++..||+|.+..... .......+.+|+.+++.++||+++++++++.++...|
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~  119 (370)
T cd05596          40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY  119 (370)
T ss_pred             CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            455789999999999999999999999999999999875432 2222345778999999999999999999999999999


Q ss_pred             EEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC
Q 045787           83 LVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        83 iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~  161 (324)
                      +||||++ |+|.+++..  ..+++..+..++.+++.||.|||+.|++|+||||+||+++ .++.++|+|||.+.......
T Consensus       120 lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~-~~~~~kL~DfG~~~~~~~~~  196 (370)
T cd05596         120 MVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD-KSGHLKLADFGTCMKMDANG  196 (370)
T ss_pred             EEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEc-CCCCEEEEeccceeeccCCC
Confidence            9999997 578877654  3588999999999999999999999999999999999999 89999999999987654322


Q ss_pred             C-cccccccccccCCchhhcCC---CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhh
Q 045787          162 K-EYSRDCVYSPYKAPELLLGY---TGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYI  237 (324)
Q Consensus       162 ~-~~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (324)
                      . ......|++.|+|||++.+.   ..++.++|+|||||++|+|++|..||...+.......+..  ......+      
T Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~--~~~~~~~------  268 (370)
T cd05596         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMD--HKNSLTF------  268 (370)
T ss_pred             cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHc--CCCcCCC------
Confidence            2 22345689999999998652   3478899999999999999999999987765433222211  0000000      


Q ss_pred             hcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCC--CCCHHHHhcCccccCCCCc
Q 045787          238 SEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQ--RITAMDALKHEYLIGVENV  296 (324)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~~~l~hp~~~~~~~~  296 (324)
                                      .....++.++.++|.+||+.+|.+  |++++++++||||++..+.
T Consensus       269 ----------------~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~~  313 (370)
T cd05596         269 ----------------PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWT  313 (370)
T ss_pred             ----------------CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCChh
Confidence                            011257899999999999999998  9999999999999986643

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.9e-45  Score=322.02  Aligned_cols=264  Identities=25%  Similarity=0.381  Sum_probs=207.4

Q ss_pred             EeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEEEEEEecCC
Q 045787           13 KKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDVFLVFEYLDL   90 (324)
Q Consensus        13 ~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~g   90 (324)
                      +.||+|++|.||+|.+..+++.||+|++..... .....+.+..|..+++.+ +||+|+++++++.+...+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            468999999999999999999999999986542 222345678899999888 699999999999999999999999985


Q ss_pred             -CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccccccc
Q 045787           91 -DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCV  169 (324)
Q Consensus        91 -~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~~~~  169 (324)
                       +|...+.. .+.+++..++.++.|++.||.|||++|++|+||||+||+++ .++.++|+|||.+.............+|
T Consensus        81 g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  158 (329)
T cd05588          81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLD-AEGHIKLTDYGMCKEGIRPGDTTSTFCG  158 (329)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC-CCCCEEECcCccccccccCCCccccccC
Confidence             77776655 35799999999999999999999999999999999999999 8999999999988753323333445578


Q ss_pred             ccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCC
Q 045787          170 YSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEP  249 (324)
Q Consensus       170 ~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (324)
                      ++.|+|||++.+ ..++.++|+||||+++|+|++|+.||........         +...  ............      
T Consensus       159 t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~---------~~~~--~~~~~~~~~~~~------  220 (329)
T cd05588         159 TPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDN---------PDQN--TEDYLFQVILEK------  220 (329)
T ss_pred             CccccCHHHHcC-CCCCCccceechHHHHHHHHHCCCCccccccccc---------cccc--chHHHHHHHHcC------
Confidence            999999999987 6679999999999999999999999953221100         0000  000000000000      


Q ss_pred             cchhhhCCCCChhHHHHHHHhhcCCCCCCCC------HHHHhcCccccCCCCchh
Q 045787          250 ANLAEKFPNLEPAGVDLLSQMLCLNPKQRIT------AMDALKHEYLIGVENVPL  298 (324)
Q Consensus       250 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps------~~~~l~hp~~~~~~~~~~  298 (324)
                        .......++..+.++|++||+.||.+|++      ++++++||||.++.+...
T Consensus       221 --~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~~~  273 (329)
T cd05588         221 --QIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLL  273 (329)
T ss_pred             --CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHH
Confidence              00112357888999999999999999987      789999999998876544

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.4e-45  Score=328.32  Aligned_cols=277  Identities=22%  Similarity=0.310  Sum_probs=212.6

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLV   84 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   84 (324)
                      ...+|.+.+.||+|++|.||+|.+...++.|++|...        ...+.+|+.++++++|+||+++++++..++..++|
T Consensus       167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv  238 (461)
T PHA03211        167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV  238 (461)
T ss_pred             ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence            4568999999999999999999999999999999532        12356899999999999999999999999999999


Q ss_pred             EEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCc-
Q 045787           85 FEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE-  163 (324)
Q Consensus        85 ~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~-  163 (324)
                      ++++.++|..++......+++..++.++.|++.||.|||++|++|+||||+|||++ .++.++|+|||++......... 
T Consensus       239 ~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~-~~~~vkL~DFGla~~~~~~~~~~  317 (461)
T PHA03211        239 LPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVN-GPEDICLGDFGAACFARGSWSTP  317 (461)
T ss_pred             EEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEEC-CCCCEEEcccCCceecccccccc
Confidence            99999999999887767899999999999999999999999999999999999999 8899999999998765432221 


Q ss_pred             -ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC--------hhHHHHHHHHcCCCCccccc--
Q 045787          164 -YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK--------HDHLSLIFSLLGTPTDESWA--  232 (324)
Q Consensus       164 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--------~~~~~~~~~~~~~~~~~~~~--  232 (324)
                       .....||+.|+|||++.+ ..++.++|||||||++|+|++|..|+-...        ...+..++............  
T Consensus       318 ~~~~~~GT~~Y~APE~~~~-~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~  396 (461)
T PHA03211        318 FHYGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA  396 (461)
T ss_pred             cccccCCCcCCcCHHHHcC-CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence             123468999999999987 668999999999999999999876542221        22333333332221111100  


Q ss_pred             chhhhhccc-----CCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccC
Q 045787          233 ESTYISEIL-----PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIG  292 (324)
Q Consensus       233 ~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~  292 (324)
                      .........     .......... ...+..++..+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       397 ~~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        397 GSRLVSQYRHRAARNRRPAYTRPA-WTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             chHHHHHHHhhhhcccCCccCCcc-hhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence            000000000     0011111111 1222356778999999999999999999999999999975

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.2e-45  Score=319.90  Aligned_cols=255  Identities=26%  Similarity=0.404  Sum_probs=207.3

Q ss_pred             EeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEEEEEEecCC
Q 045787           13 KKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDVFLVFEYLDL   90 (324)
Q Consensus        13 ~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~g   90 (324)
                      +.||+|+||.||+|.+..+++.||+|++..... .....+....|..++... +||+|+++++++..++..|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            469999999999999999999999999986542 222234455666766654 799999999999999999999999974


Q ss_pred             -CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccccccc
Q 045787           91 -DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCV  169 (324)
Q Consensus        91 -~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~~~~  169 (324)
                       +|...+.. ...+++..+..++.|++.||.|||+.|++|+||||+||+++ .++.++|+|||.+.............+|
T Consensus        81 g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~-~~~~~kL~Dfg~a~~~~~~~~~~~~~~g  158 (316)
T cd05592          81 GDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLD-KDGHIKIADFGMCKENMNGEGKASTFCG  158 (316)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEEC-CCCCEEEccCcCCeECCCCCCccccccC
Confidence             77777665 45699999999999999999999999999999999999999 8999999999998765433334445578


Q ss_pred             ccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCC
Q 045787          170 YSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEP  249 (324)
Q Consensus       170 ~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (324)
                      ++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..........  ..+                      
T Consensus       159 t~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--~~~----------------------  213 (316)
T cd05592         159 TPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN--DRP----------------------  213 (316)
T ss_pred             CccccCHHHHcC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCC----------------------
Confidence            999999999987 5679999999999999999999999987775544332211  000                      


Q ss_pred             cchhhhCCCCChhHHHHHHHhhcCCCCCCCCHH-HHhcCccccCCCCchh
Q 045787          250 ANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAM-DALKHEYLIGVENVPL  298 (324)
Q Consensus       250 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~-~~l~hp~~~~~~~~~~  298 (324)
                          .....++.++.+++.+||+.||.+||++. +++.||||.++.+...
T Consensus       214 ----~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~~~  259 (316)
T cd05592         214 ----HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDWERL  259 (316)
T ss_pred             ----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCCHHHH
Confidence                01124788899999999999999999865 7889999999876554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=7.7e-45  Score=311.71  Aligned_cols=278  Identities=36%  Similarity=0.581  Sum_probs=216.0

Q ss_pred             cceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcC-CCCeeEEEeeeecC--CeEEEEE
Q 045787            9 YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-HENIVRLLDVQSSR--KDVFLVF   85 (324)
Q Consensus         9 y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--~~~~iv~   85 (324)
                      |++++.||.|++|.||++.+..+++.+++|.+......... ....+|+..++++. |+|++++++++.++  +..++|+
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~   79 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF   79 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence            78999999999999999999999999999998754332222 23457888888885 99999999999887  8899999


Q ss_pred             EecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccc
Q 045787           86 EYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYS  165 (324)
Q Consensus        86 e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~  165 (324)
                      ||+++++++.+......+++..++.++.+++.||.+||+.|++|+||+|+||+++ . +.++|+|||.+....... ...
T Consensus        80 e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~-~-~~~kl~dfg~~~~~~~~~-~~~  156 (282)
T cd07831          80 ELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIK-D-DILKLADFGSCRGIYSKP-PYT  156 (282)
T ss_pred             ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEc-C-CCeEEEecccccccccCC-CcC
Confidence            9999999999887666799999999999999999999999999999999999999 5 999999999987664322 222


Q ss_pred             ccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHHcCCCCcccccchhhhhcccCCC
Q 045787          166 RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD-HLSLIFSLLGTPTDESWAESTYISEILPLY  244 (324)
Q Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (324)
                      ...+++.|+|||.+.+....+.++|+||||+++|+|++|..||...+.. .........+.+..................
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
T cd07831         157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF  236 (282)
T ss_pred             CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence            3456788999998765466789999999999999999999999876643 333444444443332210000000000011


Q ss_pred             CCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                      ............+.++..+.++|.+||+.||.+||++.++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            1112222333445679999999999999999999999999999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.2e-45  Score=327.45  Aligned_cols=264  Identities=25%  Similarity=0.419  Sum_probs=213.8

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeecc-ccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQT-EQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      ++|++++.||+|++|.||+|.+..+++.||+|++.... ........+..|+.++.+++||+++++++.+.+++.+|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999997543 22333567888999999999999999999999999999999


Q ss_pred             EecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC--
Q 045787           86 EYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK--  162 (324)
Q Consensus        86 e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~--  162 (324)
                      ||++| +|.+++... ..+++..++.++.|++.||.+||+.|++|+||||+||+++ .++.++|+|||.+........  
T Consensus        81 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~-~~~~vkL~DfG~~~~~~~~~~~~  158 (360)
T cd05627          81 EFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLD-AKGHVKLSDFGLCTGLKKAHRTE  158 (360)
T ss_pred             eCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEEC-CCCCEEEeeccCCcccccccccc
Confidence            99975 788877653 5699999999999999999999999999999999999999 899999999998764421100  


Q ss_pred             ---------------------------------cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCC
Q 045787          163 ---------------------------------EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFP  209 (324)
Q Consensus       163 ---------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~  209 (324)
                                                       .....+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyel~tG~~Pf~  237 (360)
T cd05627         159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFC  237 (360)
T ss_pred             cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-CCCCCcceeccccceeeecccCCCCCC
Confidence                                             0112468899999999987 668999999999999999999999998


Q ss_pred             CCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCC---CHHHHhc
Q 045787          210 SKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRI---TAMDALK  286 (324)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp---s~~~~l~  286 (324)
                      ..+...............                       ... ....++..+.++|.+|+ .||.+|+   ++.++++
T Consensus       238 ~~~~~~~~~~i~~~~~~~-----------------------~~p-~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  292 (360)
T cd05627         238 SETPQETYRKVMNWKETL-----------------------VFP-PEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKS  292 (360)
T ss_pred             CCCHHHHHHHHHcCCCce-----------------------ecC-CCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence            776544322221100000                       000 01147889999999977 4999998   4899999


Q ss_pred             CccccCCCCchh
Q 045787          287 HEYLIGVENVPL  298 (324)
Q Consensus       287 hp~~~~~~~~~~  298 (324)
                      ||||+++++..+
T Consensus       293 hp~f~~~~~~~~  304 (360)
T cd05627         293 HPFFEGVDWGHI  304 (360)
T ss_pred             CCCCCCCCHHHH
Confidence            999999987665

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-46  Score=295.53  Aligned_cols=257  Identities=25%  Similarity=0.383  Sum_probs=206.6

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCC----
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK----   79 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----   79 (324)
                      +.++||+|.+.||.|||+-||+++..+++..||+|++.+...+  ..+..++|++..++++|||+++++++...+.    
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~--~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~   95 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQE--DIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK   95 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchH--HHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence            6789999999999999999999999999999999999988733  3577889999999999999999998764433    


Q ss_pred             -eEEEEEEecC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC--CcccCCCCCceEeecCCCcEEEeecc
Q 045787           80 -DVFLVFEYLD-LDLHSFITRHK---NTLNLLVIKAILKQILLGLAYCHSLK--ILHRDLKPNNLLIDLKRNTVKLADFG  152 (324)
Q Consensus        80 -~~~iv~e~~~-g~l~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~Lh~~g--~~H~di~p~nIll~~~~~~v~l~d~g  152 (324)
                       ..||+++|+. |++++.++...   ..+++.++.+|+.++..||.+||...  +.|+||||.||+++ +.+.++|.|||
T Consensus        96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls-~~~~~vl~D~G  174 (302)
T KOG2345|consen   96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLS-DSGLPVLMDLG  174 (302)
T ss_pred             eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEec-CCCceEEEecc
Confidence             4999999997 89999988753   36899999999999999999999998  99999999999999 89999999999


Q ss_pred             ceeeccCCCC---------cccccccccccCCchhhcC--CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 045787          153 LARAIGVPQK---------EYSRDCVYSPYKAPELLLG--YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFS  221 (324)
Q Consensus       153 ~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~  221 (324)
                      +++.....-.         .......|..|+|||.+.-  ....+.++|||||||++|.||.|..||...-..       
T Consensus       175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~-------  247 (302)
T KOG2345|consen  175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ-------  247 (302)
T ss_pred             CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc-------
Confidence            9876643222         1233356788999999853  355789999999999999999999999422110       


Q ss_pred             HcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcC
Q 045787          222 LLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH  287 (324)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~h  287 (324)
                          ..+-.+            ........+++.. .+++.+.++|++||+.||.+||++.+++++
T Consensus       248 ----GgSlaL------------Av~n~q~s~P~~~-~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  248 ----GGSLAL------------AVQNAQISIPNSS-RYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             ----CCeEEE------------eeeccccccCCCC-CccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence                000000            0000011111222 389999999999999999999999999863

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.9e-45  Score=320.15  Aligned_cols=256  Identities=29%  Similarity=0.458  Sum_probs=208.9

Q ss_pred             eEeecccCceEEEEEEEc---cCCceEEEEEeeeccc--cCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEE
Q 045787           12 IKKIGAGGYGEVYKCRNT---VTGQKVAIKMMTIQTE--QEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE   86 (324)
Q Consensus        12 ~~~Lg~g~~~~v~~a~~~---~~~~~~~~K~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   86 (324)
                      ++.||+|+||.||+|.+.   ..++.||+|++.....  .......+.+|+.+++.++||||+++++.+..++..|+|||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            468999999999999864   4688999999876432  22233557789999999999999999999999999999999


Q ss_pred             ecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccc
Q 045787           87 YLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYS  165 (324)
Q Consensus        87 ~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~  165 (324)
                      |+.| +|.+.+.. .+.+++..+..++.|++.||.+||++|++|+||||+||+++ .++.++|+|||.+...........
T Consensus        81 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~  158 (323)
T cd05584          81 YLSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLD-AQGHVKLTDFGLCKESIHEGTVTH  158 (323)
T ss_pred             CCCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC-CCCCEEEeeCcCCeecccCCCccc
Confidence            9985 77777665 45688999999999999999999999999999999999999 899999999999875433333333


Q ss_pred             ccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCC
Q 045787          166 RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYP  245 (324)
Q Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (324)
                      ...+++.|+|||++.+ ..++.++||||||+++|+|++|+.||...+........... .                    
T Consensus       159 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~-~--------------------  216 (323)
T cd05584         159 TFCGTIEYMAPEILMR-SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG-K--------------------  216 (323)
T ss_pred             ccCCCccccChhhccC-CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-C--------------------
Confidence            4568899999999987 56789999999999999999999999876644322211100 0                    


Q ss_pred             CCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCC-----CHHHHhcCccccCCCCchh
Q 045787          246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRI-----TAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       246 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~~l~hp~~~~~~~~~~  298 (324)
                             ....+.+++.+.++|.+||+.||.+||     ++.++++||||....+...
T Consensus       217 -------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~~~  267 (323)
T cd05584         217 -------LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDL  267 (323)
T ss_pred             -------CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCHHHH
Confidence                   011235788999999999999999999     8999999999998765444

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=9.2e-45  Score=312.88  Aligned_cols=272  Identities=26%  Similarity=0.370  Sum_probs=220.4

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLV   84 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   84 (324)
                      .++.|++++.||.|++|.||++.+..++..+++|.+......  ....+.+|+.+++.++|+|++++++.+..+...++|
T Consensus        10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (292)
T cd06644          10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE--ELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM   87 (292)
T ss_pred             cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHH--HHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence            346799999999999999999999999999999998754322  245677899999999999999999999999999999


Q ss_pred             EEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCc
Q 045787           85 FEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE  163 (324)
Q Consensus        85 ~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~  163 (324)
                      |||++| ++...+.+....+++..+..++.+++.+|.+||+.|++|+||+|+||+++ .++.++|+|||.+.........
T Consensus        88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~-~~~~~kl~dfg~~~~~~~~~~~  166 (292)
T cd06644          88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLT-LDGDIKLADFGVSAKNVKTLQR  166 (292)
T ss_pred             EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEc-CCCCEEEccCccceeccccccc
Confidence            999986 66666666566799999999999999999999999999999999999999 8999999999988765433333


Q ss_pred             ccccccccccCCchhhcC----CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhc
Q 045787          164 YSRDCVYSPYKAPELLLG----YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISE  239 (324)
Q Consensus       164 ~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
                      .....+++.|+|||++.+    ...++.++|+||||+++|+|++|..||...+.............+.            
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~------------  234 (292)
T cd06644         167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT------------  234 (292)
T ss_pred             cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCcc------------
Confidence            344467788999999852    3456889999999999999999999997665332221111100000            


Q ss_pred             ccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchhhhhhhh
Q 045787          240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLIN  304 (324)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~~~~~~~  304 (324)
                                   ......++.++.++|.+||..||++||++.++++||||..+...+.....++
T Consensus       235 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~~~~~~  286 (292)
T cd06644         235 -------------LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNRPLRELVA  286 (292)
T ss_pred             -------------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccchhHHHHHH
Confidence                         0011256778999999999999999999999999999999998887665544

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.1e-44  Score=315.13  Aligned_cols=288  Identities=41%  Similarity=0.722  Sum_probs=226.0

Q ss_pred             CcccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecC---
Q 045787            2 GKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR---   78 (324)
Q Consensus         2 ~~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---   78 (324)
                      |....++|++.+.||+|++|.||+|.+..+++.+++|.+..............+|+++++.++||+++++++++...   
T Consensus         3 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (311)
T cd07866           3 GCSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDK   82 (311)
T ss_pred             CCcccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccc
Confidence            44567899999999999999999999999999999999876654443345567899999999999999999876443   


Q ss_pred             -----CeEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccc
Q 045787           79 -----KDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGL  153 (324)
Q Consensus        79 -----~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~  153 (324)
                           ..+++|++|+++++...+......+++..+..++.+++.||.+||+.|++|+||+|+||+++ +++.++|+|||.
T Consensus        83 ~~~~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~-~~~~~~l~dfg~  161 (311)
T cd07866          83 SKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILID-NQGILKIADFGL  161 (311)
T ss_pred             ccccCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC-CCCCEEECcCcc
Confidence                 35799999999999988877666799999999999999999999999999999999999999 899999999998


Q ss_pred             eeeccCCCCc-----------ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChh-HHHHHHH
Q 045787          154 ARAIGVPQKE-----------YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD-HLSLIFS  221 (324)
Q Consensus       154 ~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~  221 (324)
                      +.........           .....+++.|+|||.+.+...++.++|+||||+++|+|++|.+||.+.+.. ....+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~  241 (311)
T cd07866         162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK  241 (311)
T ss_pred             chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            8765432211           112245677999999876566899999999999999999999999877643 3344444


Q ss_pred             HcCCCCcccccchhhhhcccC-CCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          222 LLGTPTDESWAESTYISEILP-LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                      ..+.+....+........... ......+......+..+++.+.++|.+||+.||.+|||+.++++||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            455554444433322222211 111112222333455677889999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=8.8e-46  Score=313.70  Aligned_cols=258  Identities=35%  Similarity=0.572  Sum_probs=212.4

Q ss_pred             cceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEec
Q 045787            9 YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYL   88 (324)
Q Consensus         9 y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   88 (324)
                      |++++.||+|++|+||++.+..+++.+|+|.+..............+|+.++++++||+|+++++++.+....++|||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            89999999999999999999999999999999877654433334456999999999999999999999999999999999


Q ss_pred             CC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccccc
Q 045787           89 DL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRD  167 (324)
Q Consensus        89 ~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~~  167 (324)
                      ++ +|.+++.. ...+++..+..++.+++.||.+||++|++|+||+|+||+++ .++.++|+|||.+.............
T Consensus        81 ~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~-~~~~~~l~Dfg~~~~~~~~~~~~~~~  158 (260)
T PF00069_consen   81 PGGSLQDYLQK-NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLD-ENGEVKLIDFGSSVKLSENNENFNPF  158 (260)
T ss_dssp             TTEBHHHHHHH-HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEES-TTSEEEESSGTTTEESTSTTSEBSSS
T ss_pred             ccccccccccc-ccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccc
Confidence            97 88888873 45689999999999999999999999999999999999999 99999999999988654344555566


Q ss_pred             ccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHH-HHcCCCCcccccchhhhhcccCCCCC
Q 045787          168 CVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIF-SLLGTPTDESWAESTYISEILPLYPH  246 (324)
Q Consensus       168 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (324)
                      .+++.|+|||++......+.++|+||||+++++|++|..||............ ...........               
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------------  223 (260)
T PF00069_consen  159 VGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSS---------------  223 (260)
T ss_dssp             SSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHT---------------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccc---------------
Confidence            78889999999983477899999999999999999999999877422221111 11111100000               


Q ss_pred             CCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          247 FEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       247 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                             ......+..+.++|.+||+.||++||++.++++||||
T Consensus       224 -------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  224 -------QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             -------TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             -------cccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence                   0000123789999999999999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-45  Score=310.31  Aligned_cols=271  Identities=27%  Similarity=0.441  Sum_probs=225.4

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE   86 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   86 (324)
                      ++|++.+.||.|++|.||++.+..++..+++|.+..... ......+.+|+.+++.++|+|++++++.+.++...++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA-EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME   79 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc-chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence            579999999999999999999999999999999875532 2224567889999999999999999999999999999999


Q ss_pred             ecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccc
Q 045787           87 YLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYS  165 (324)
Q Consensus        87 ~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~  165 (324)
                      |+++ +|.+.+...  ++++..++.++.+++.++.+||+.|++|+||+|+||+++ +++.++|+|||.+...........
T Consensus        80 ~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~~~~~~~~  156 (274)
T cd06609          80 YCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLS-EEGDVKLADFGVSGQLTSTMSKRN  156 (274)
T ss_pred             eeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC-CCCCEEEcccccceeecccccccc
Confidence            9985 888877654  789999999999999999999999999999999999999 899999999999987765444444


Q ss_pred             ccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCC
Q 045787          166 RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYP  245 (324)
Q Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (324)
                      ...+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.............+.                  
T Consensus       157 ~~~~~~~y~~PE~~~~-~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~------------------  217 (274)
T cd06609         157 TFVGTPFWMAPEVIKQ-SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPS------------------  217 (274)
T ss_pred             cccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCC------------------
Confidence            5567788999999987 558999999999999999999999997655332221111100000                  


Q ss_pred             CCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchhhhhhhhcccC
Q 045787          246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLINRKKK  308 (324)
Q Consensus       246 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~~~~~~~~~~~  308 (324)
                            ..  ...++..+.+++.+||..||++||+++++++||||++.........+...+++
T Consensus       218 ------~~--~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~~~~~~~~~~~~  272 (274)
T cd06609         218 ------LE--GNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKKTSYLTLLIERIKK  272 (274)
T ss_pred             ------Cc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCCcccHHHHHHHHHHh
Confidence                  00  01278889999999999999999999999999999999999887777766654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-45  Score=318.83  Aligned_cols=269  Identities=22%  Similarity=0.355  Sum_probs=215.8

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeecc-ccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQT-EQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      ++|++++.||+|+||.||++.+..+++.||+|++.... ........+.+|+.+++.++|++|+++++.+.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            57999999999999999999999999999999987533 22223455788999999999999999999999999999999


Q ss_pred             EecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC-c
Q 045787           86 EYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK-E  163 (324)
Q Consensus        86 e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~-~  163 (324)
                      ||+. |+|.+++......+++..++.++.||+.||.+||++|++|+||||+||+++ .++.++|+|||.+........ .
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~  159 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLD-KNGHIRLADFGSCLRLLADGTVQ  159 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEEC-CCCCEEEEECCceeecCCCCCcc
Confidence            9996 588888877666799999999999999999999999999999999999999 899999999999876543322 2


Q ss_pred             ccccccccccCCchhhcC----CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhc
Q 045787          164 YSRDCVYSPYKAPELLLG----YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISE  239 (324)
Q Consensus       164 ~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
                      .....+++.|+|||++..    ...++.++|||||||++|+|++|+.||...+.............              
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~--------------  225 (331)
T cd05597         160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE--------------  225 (331)
T ss_pred             ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCC--------------
Confidence            223468999999999863    24568899999999999999999999977654332221110000              


Q ss_pred             ccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCC--CCCHHHHhcCccccCCCCchhh
Q 045787          240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQ--RITAMDALKHEYLIGVENVPLV  299 (324)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~~~l~hp~~~~~~~~~~~  299 (324)
                               ..........++..++++|++||..++.+  |+++.++++||||.++++....
T Consensus       226 ---------~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~~~~  278 (331)
T cd05597         226 ---------HFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDNIR  278 (331)
T ss_pred             ---------cccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHHHHh
Confidence                     00011112358899999999999765544  7899999999999998765553

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.9e-45  Score=321.40  Aligned_cols=255  Identities=27%  Similarity=0.441  Sum_probs=207.0

Q ss_pred             EeecccCceEEEEEEEccCCceEEEEEeeecccc-CCCchHHHHHHH-HHHhcCCCCeeEEEeeeecCCeEEEEEEecCC
Q 045787           13 KKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQ-EGVPSYIIREVS-LLKELEHENIVRLLDVQSSRKDVFLVFEYLDL   90 (324)
Q Consensus        13 ~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~-~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~g   90 (324)
                      +.||+|++|+||+|.+..+|+.||+|++...... ......+..|.. +++.++|||++++++.+.+.+..|+||||+.|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            4689999999999999999999999999765321 112233445544 56788999999999999999999999999985


Q ss_pred             -CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccccccc
Q 045787           91 -DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCV  169 (324)
Q Consensus        91 -~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~~~~  169 (324)
                       +|..++.. ...+++..++.++.||+.||.|||++|++|+||||+||+++ .++.++|+|||.+.............+|
T Consensus        81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (323)
T cd05575          81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLD-SQGHVVLTDFGLCKEGIEHSKTTSTFCG  158 (323)
T ss_pred             CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEEC-CCCcEEEeccCCCcccccCCCccccccC
Confidence             77777665 45799999999999999999999999999999999999999 8999999999988754333333444578


Q ss_pred             ccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCC
Q 045787          170 YSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEP  249 (324)
Q Consensus       170 ~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (324)
                      ++.|+|||++.+ ..++.++||||||+++|+|++|..||...+.........  ..+                       
T Consensus       159 t~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~--~~~-----------------------  212 (323)
T cd05575         159 TPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL--NKP-----------------------  212 (323)
T ss_pred             ChhhcChhhhcC-CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHH--cCC-----------------------
Confidence            899999999987 668999999999999999999999998766544322211  000                       


Q ss_pred             cchhhhCCCCChhHHHHHHHhhcCCCCCCCCH----HHHhcCccccCCCCchh
Q 045787          250 ANLAEKFPNLEPAGVDLLSQMLCLNPKQRITA----MDALKHEYLIGVENVPL  298 (324)
Q Consensus       250 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~----~~~l~hp~~~~~~~~~~  298 (324)
                         ....+.++..+.++|.+||+.||.+||++    .++++||||..+.+..+
T Consensus       213 ---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~~~~  262 (323)
T cd05575         213 ---LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDL  262 (323)
T ss_pred             ---CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCHHHH
Confidence               01123578899999999999999999998    69999999998876554

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.9e-46  Score=313.68  Aligned_cols=262  Identities=27%  Similarity=0.475  Sum_probs=227.1

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeecc-ccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQT-EQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   83 (324)
                      +..+|++.+.||+|.+|.|-+|.+..+|+.||+|.++++. ....+.-.+++|++++..|+||||+.++++|++.+.+.|
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi  130 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI  130 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence            3468999999999999999999999999999999998776 333345679999999999999999999999999999999


Q ss_pred             EEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC
Q 045787           84 VFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK  162 (324)
Q Consensus        84 v~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~  162 (324)
                      ||||.. |.|++++..++ .+++.+++.+++||..|+.|+|+++++|+|||.+|||+| +++.+||.|||++.... ...
T Consensus       131 vMEYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD-~N~NiKIADFGLSNly~-~~k  207 (668)
T KOG0611|consen  131 VMEYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLD-QNNNIKIADFGLSNLYA-DKK  207 (668)
T ss_pred             EEEecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHhhccceecccchhheeec-CCCCeeeeccchhhhhc-ccc
Confidence            999987 69999998864 699999999999999999999999999999999999999 99999999999998765 334


Q ss_pred             cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccC
Q 045787          163 EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILP  242 (324)
Q Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (324)
                      -....||+|.|.+||+..+...-++..|.||||+++|.++.|..||.+.+...+-+.+......                
T Consensus       208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYr----------------  271 (668)
T KOG0611|consen  208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYR----------------  271 (668)
T ss_pred             HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccccc----------------
Confidence            4556799999999999999777899999999999999999999999998866554443321111                


Q ss_pred             CCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchh
Q 045787          243 LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~  298 (324)
                                   -+.-+..+.-||+.||..||.+|.|+.++.+|=|+.=.-..+.
T Consensus       272 -------------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNwgy~~~V  314 (668)
T KOG0611|consen  272 -------------EPETPSDASGLIRWMLMVNPERRATIEDIASHWWVNWGYNMPV  314 (668)
T ss_pred             -------------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhheeeccccccc
Confidence                         0245667789999999999999999999999999875544443

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-46  Score=318.76  Aligned_cols=265  Identities=30%  Similarity=0.509  Sum_probs=234.2

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      .+-|...+.||+|-|..|-+|++--+|..||||++.+.....-....+.+|++.++..+|||||++|++...+..+|+|+
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            34588899999999999999999999999999999988777666677999999999999999999999999999999999


Q ss_pred             EecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcc
Q 045787           86 EYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY  164 (324)
Q Consensus        86 e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~  164 (324)
                      |.-+ |+|.+++.++...++++.+++++.||+.|+.|+|+..++|+||||+||.+...-|.|||+|||++.... +....
T Consensus        97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~-PG~kL  175 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ-PGKKL  175 (864)
T ss_pred             EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCC-Ccchh
Confidence            9987 599999999999999999999999999999999999999999999999887577999999999998776 55667


Q ss_pred             cccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhH-HHHHHHHcCCCCcccccchhhhhcccCC
Q 045787          165 SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDH-LSLIFSLLGTPTDESWAESTYISEILPL  243 (324)
Q Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (324)
                      ...||+..|-|||++.+.....++.||||||+|+|-+++|++||...++.+ +..+.. .                    
T Consensus       176 ~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImD-C--------------------  234 (864)
T KOG4717|consen  176 TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMD-C--------------------  234 (864)
T ss_pred             hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhc-c--------------------
Confidence            778999999999999997888999999999999999999999996655432 222211 0                    


Q ss_pred             CCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchhhh
Q 045787          244 YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVI  300 (324)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~~~  300 (324)
                              -......++.+.++||.+||..||.+|.+.++|..++|++.+.......
T Consensus       235 --------KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT~  283 (864)
T KOG4717|consen  235 --------KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLSTA  283 (864)
T ss_pred             --------cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCcccc
Confidence                    0112236788999999999999999999999999999999998777665

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=5.4e-45  Score=317.34  Aligned_cols=255  Identities=27%  Similarity=0.442  Sum_probs=207.9

Q ss_pred             EeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEEEEEEecC-
Q 045787           13 KKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDVFLVFEYLD-   89 (324)
Q Consensus        13 ~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~-   89 (324)
                      +.||+|+||.||+|.+..+++.||+|++..... ..........|..++... +||+++++++++.+.+.+++||||++ 
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            469999999999999999999999999976532 122234456677777764 89999999999999999999999997 


Q ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccccccc
Q 045787           90 LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCV  169 (324)
Q Consensus        90 g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~~~~  169 (324)
                      |+|...+.. ...+++..+..++.|++.||.|||+.|++|+||||+||+++ .++.++|+|||.+..............+
T Consensus        81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (316)
T cd05619          81 GDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLD-TDGHIKIADFGMCKENMLGDAKTCTFCG  158 (316)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEEC-CCCCEEEccCCcceECCCCCCceeeecC
Confidence            588777765 35689999999999999999999999999999999999999 8899999999998754333333344568


Q ss_pred             ccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCC
Q 045787          170 YSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEP  249 (324)
Q Consensus       170 ~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (324)
                      ++.|+|||++.+ ..++.++|+|||||++|+|++|..||...+............ +.                      
T Consensus       159 t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~-~~----------------------  214 (316)
T cd05619         159 TPDYIAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN-PC----------------------  214 (316)
T ss_pred             CccccCHHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CC----------------------
Confidence            899999999987 668999999999999999999999998776544333222110 00                      


Q ss_pred             cchhhhCCCCChhHHHHHHHhhcCCCCCCCCHH-HHhcCccccCCCCchh
Q 045787          250 ANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAM-DALKHEYLIGVENVPL  298 (324)
Q Consensus       250 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~-~~l~hp~~~~~~~~~~  298 (324)
                           ....++..+.++|.+||+.||.+||++. ++++||||+++.+...
T Consensus       215 -----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~~~  259 (316)
T cd05619         215 -----YPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDWSAL  259 (316)
T ss_pred             -----CCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCHHHH
Confidence                 0124678899999999999999999996 8999999999876544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=4.8e-45  Score=323.80  Aligned_cols=264  Identities=22%  Similarity=0.343  Sum_probs=212.9

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF   82 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   82 (324)
                      +..++|++.+.||+|+||.||+|.+..+++.+|+|++..... .......+.+|+.+++.++||+++++++.+.++...|
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY  119 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence            456789999999999999999999999999999999875332 2223455778999999999999999999999999999


Q ss_pred             EEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC
Q 045787           83 LVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        83 iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~  161 (324)
                      +||||++ |+|.+++..  ..+++..+..++.+|+.||.+||++|++|+||||+||+++ .++.++|+|||.+.......
T Consensus       120 lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~-~~~~~kL~DFG~a~~~~~~~  196 (370)
T cd05621         120 MVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLD-KHGHLKLADFGTCMKMDETG  196 (370)
T ss_pred             EEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC-CCCCEEEEecccceecccCC
Confidence            9999997 588887754  3588999999999999999999999999999999999999 89999999999998764322


Q ss_pred             C-cccccccccccCCchhhcCC---CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhh
Q 045787          162 K-EYSRDCVYSPYKAPELLLGY---TGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYI  237 (324)
Q Consensus       162 ~-~~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (324)
                      . ......||+.|+|||++.+.   ..++.++|+|||||++|+|++|..||...+.......+.......  .+      
T Consensus       197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~--~~------  268 (370)
T cd05621         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSL--NF------  268 (370)
T ss_pred             ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccc--CC------
Confidence            2 22345789999999998753   237889999999999999999999998776433322211100000  00      


Q ss_pred             hcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCC--CCCHHHHhcCccccCCC
Q 045787          238 SEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQ--RITAMDALKHEYLIGVE  294 (324)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~~~l~hp~~~~~~  294 (324)
                                     . ....++..+++++.+||..++.+  |+++.++++||||++..
T Consensus       269 ---------------p-~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~  311 (370)
T cd05621         269 ---------------P-EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQ  311 (370)
T ss_pred             ---------------C-CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCC
Confidence                           0 01247889999999999866554  89999999999999864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.1e-45  Score=322.40  Aligned_cols=257  Identities=27%  Similarity=0.411  Sum_probs=211.7

Q ss_pred             eEeecccCceEEEEEEEc---cCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEec
Q 045787           12 IKKIGAGGYGEVYKCRNT---VTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYL   88 (324)
Q Consensus        12 ~~~Lg~g~~~~v~~a~~~---~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   88 (324)
                      ++.||+|++|.||++.+.   .+|+.+|+|++............+.+|+.++++++||||+++++++.+++..|+||||+
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL   80 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence            367999999999999863   57899999999865543333455778999999999999999999999999999999999


Q ss_pred             C-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccccc
Q 045787           89 D-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRD  167 (324)
Q Consensus        89 ~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~~  167 (324)
                      + |+|.+.+.. ...+++..++.++.||+.||.|||+.|++|+||||+||+++ .++.++|+|||.+.............
T Consensus        81 ~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~-~~~~~kL~Dfg~~~~~~~~~~~~~~~  158 (318)
T cd05582          81 RGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSF  158 (318)
T ss_pred             CCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEEC-CCCcEEEeeccCCcccCCCCCceecc
Confidence            7 588887765 34689999999999999999999999999999999999999 88999999999987654333333445


Q ss_pred             ccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCC
Q 045787          168 CVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHF  247 (324)
Q Consensus       168 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (324)
                      .+++.|+|||++.+ ..++.++||||||+++|+|++|+.||...+............                       
T Consensus       159 ~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~-----------------------  214 (318)
T cd05582         159 CGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK-----------------------  214 (318)
T ss_pred             cCChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC-----------------------
Confidence            78899999999987 567899999999999999999999998766443322211000                       


Q ss_pred             CCcchhhhCCCCChhHHHHHHHhhcCCCCCCCC-----HHHHhcCccccCCCCchhh
Q 045787          248 EPANLAEKFPNLEPAGVDLLSQMLCLNPKQRIT-----AMDALKHEYLIGVENVPLV  299 (324)
Q Consensus       248 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~~~l~hp~~~~~~~~~~~  299 (324)
                           ......+++.+.++|++||+.||.+||+     +.+++.||||+.+.+..+.
T Consensus       215 -----~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~~~~  266 (318)
T cd05582         215 -----LGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLY  266 (318)
T ss_pred             -----CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHHHHH
Confidence                 0011257889999999999999999999     7789999999998766554

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=5.8e-45  Score=319.42  Aligned_cols=284  Identities=27%  Similarity=0.447  Sum_probs=216.1

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF   82 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   82 (324)
                      ++..++|++.+.||.|++|.||++.+..++..+++|.+..... ......+.+|++++++++||||+++++++.+++..+
T Consensus         1 ~l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (333)
T cd06650           1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   79 (333)
T ss_pred             CcchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccC-HHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence            3678999999999999999999999999999999998875432 222356889999999999999999999999999999


Q ss_pred             EEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           83 LVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSL-KILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        83 iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      +||||+. |+|.+++... +.+++..+..++.+++.||.|||+. +++|+||||+||+++ .++.++|+|||.+......
T Consensus        80 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~-~~~~~kL~Dfg~~~~~~~~  157 (333)
T cd06650          80 ICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDS  157 (333)
T ss_pred             EEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEc-CCCCEEEeeCCcchhhhhh
Confidence            9999997 5888887664 4689999999999999999999975 799999999999999 8899999999988654322


Q ss_pred             CCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcc
Q 045787          161 QKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEI  240 (324)
Q Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (324)
                        ......+++.|+|||++.+ ..++.++|+|||||++|+|++|+.||.............   .+..............
T Consensus       158 --~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~  231 (333)
T cd06650         158 --MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFG---CPVEGDPAESETSPRP  231 (333)
T ss_pred             --ccccCCCCccccCHHHhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhc---CcccCCccccccCccc
Confidence              1223467888999999987 668999999999999999999999997766544332221   1111000000000000


Q ss_pred             cC------CC-CCCCCc-------------chhh-hCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCC
Q 045787          241 LP------LY-PHFEPA-------------NLAE-KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVEN  295 (324)
Q Consensus       241 ~~------~~-~~~~~~-------------~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~  295 (324)
                      ..      .. ....+.             .... ....++.++.+||.+||+.||++|||+.+++.||||+....
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~  307 (333)
T cd06650         232 RPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSEA  307 (333)
T ss_pred             CCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCcc
Confidence            00      00 000000             0000 01135778999999999999999999999999999988753

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=7.8e-45  Score=317.40  Aligned_cols=261  Identities=23%  Similarity=0.364  Sum_probs=213.5

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhcC-CCCeeEEEeeeecCCeEEEEE
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKELE-HENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      +|+..+.||+|++|.||+|.+..+|+.||+|++..... .......+..|..++..+. |++++++++.+.+++..|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            58899999999999999999999999999999876532 2223355677888888886 577888999999999999999


Q ss_pred             EecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcc
Q 045787           86 EYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY  164 (324)
Q Consensus        86 e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~  164 (324)
                      ||++ |+|..++.. ...+++..+..++.+++.||.+||++|++|+||||+||+++ .++.++|+|||.+..........
T Consensus        81 Ey~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~-~~~~ikL~Dfg~~~~~~~~~~~~  158 (323)
T cd05615          81 EYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLD-SEGHIKIADFGMCKEHMVDGVTT  158 (323)
T ss_pred             cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC-CCCCEEEeccccccccCCCCccc
Confidence            9997 477776655 35699999999999999999999999999999999999999 89999999999987544333333


Q ss_pred             cccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCC
Q 045787          165 SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLY  244 (324)
Q Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (324)
                      ....|++.|+|||++.+ ..++.++|+||||+++|+|++|..||...+.............                   
T Consensus       159 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~-------------------  218 (323)
T cd05615         159 RTFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV-------------------  218 (323)
T ss_pred             cCccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-------------------
Confidence            44568899999999987 6689999999999999999999999987765443332221100                   


Q ss_pred             CCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCC-----HHHHhcCccccCCCCchhh
Q 045787          245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRIT-----AMDALKHEYLIGVENVPLV  299 (324)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~~~l~hp~~~~~~~~~~~  299 (324)
                               .....++.++.+++.+||+.||.+|++     ..++++||||+++.+..+.
T Consensus       219 ---------~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~~~  269 (323)
T cd05615         219 ---------SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLE  269 (323)
T ss_pred             ---------CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHHHHh
Confidence                     011246788999999999999999997     5789999999998865553

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2e-45  Score=325.05  Aligned_cols=260  Identities=25%  Similarity=0.425  Sum_probs=207.4

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      ..+|++++.||+|++|.||+|.+..+++.||+|++..... ......+.+|+.+++.++|+||+++++++..++.+++|+
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  151 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHE-DTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL  151 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCc-HHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence            4578999999999999999999999999999999864322 222456889999999999999999999999999999999


Q ss_pred             EecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcc
Q 045787           86 EYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY  164 (324)
Q Consensus        86 e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~  164 (324)
                      ||+.+ +|..     ....++..+..++.+|+.||.|||++|++|+||||+||+++ .++.++|+|||.+..........
T Consensus       152 e~~~~~~L~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~-~~~~~kL~DfG~~~~~~~~~~~~  225 (353)
T PLN00034        152 EFMDGGSLEG-----THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLIN-SAKNVKIADFGVSRILAQTMDPC  225 (353)
T ss_pred             ecCCCCcccc-----cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc-CCCCEEEcccccceecccccccc
Confidence            99986 5432     22466778889999999999999999999999999999999 89999999999988765333333


Q ss_pred             cccccccccCCchhhcC----CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcc
Q 045787          165 SRDCVYSPYKAPELLLG----YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEI  240 (324)
Q Consensus       165 ~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (324)
                      ....++..|+|||++..    ....+.++|||||||++|+|++|+.||..................              
T Consensus       226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~--------------  291 (353)
T PLN00034        226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMS--------------  291 (353)
T ss_pred             cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhcc--------------
Confidence            44578899999998743    133456899999999999999999999744432222211111000              


Q ss_pred             cCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCc
Q 045787          241 LPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENV  296 (324)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~  296 (324)
                                ........++.++.+||.+||+.||.+||++.++++||||.+....
T Consensus       292 ----------~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~~  337 (353)
T PLN00034        292 ----------QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPG  337 (353)
T ss_pred             ----------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCCcc
Confidence                      0011123578899999999999999999999999999999997543

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=7.4e-45  Score=319.53  Aligned_cols=292  Identities=39%  Similarity=0.650  Sum_probs=228.6

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecC-----C
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR-----K   79 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~   79 (324)
                      ..++|++.+.||.|++|+||+|.+..++..|++|.+............+.+|+.+++.++|+|++++++++...     .
T Consensus         3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (337)
T cd07858           3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN   82 (337)
T ss_pred             cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence            45789999999999999999999999999999999876543333345677899999999999999999987544     3


Q ss_pred             eEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccC
Q 045787           80 DVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGV  159 (324)
Q Consensus        80 ~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~  159 (324)
                      ..|+|+||+++++.+++... +++++..+..++.+++.||.+||++|++|+||+|+||+++ .++.++|+|||.+.....
T Consensus        83 ~~~lv~e~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~-~~~~~kL~Dfg~~~~~~~  160 (337)
T cd07858          83 DVYIVYELMDTDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLN-ANCDLKICDFGLARTTSE  160 (337)
T ss_pred             cEEEEEeCCCCCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc-CCCCEEECcCccccccCC
Confidence            58999999999998887764 5699999999999999999999999999999999999999 889999999999876653


Q ss_pred             CCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHHcCCCCcccccc--hhh
Q 045787          160 PQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD-HLSLIFSLLGTPTDESWAE--STY  236 (324)
Q Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~--~~~  236 (324)
                      .........++..|+|||.+.+...++.++|+||||+++|+|++|+.||.+.+.. ....+....+.+....+..  ...
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd07858         161 KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK  240 (337)
T ss_pred             CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchh
Confidence            3222333457788999999876455889999999999999999999999876633 3334444444444333211  111


Q ss_pred             hhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchh
Q 045787          237 ISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~  298 (324)
                      ..+.................+.+++.+.++|++||+.||.+|||+.++++||||..+.+...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~  302 (337)
T cd07858         241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSD  302 (337)
T ss_pred             hhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCccc
Confidence            11111111111222233345578999999999999999999999999999999999877665

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=3.8e-44  Score=303.28  Aligned_cols=254  Identities=28%  Similarity=0.421  Sum_probs=210.8

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeec-CCeEEEEEE
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS-RKDVFLVFE   86 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~iv~e   86 (324)
                      +|++.+.||.|++|.||++.+..+++.+++|.+..........+.+.+|+.++++++|++++++++.+.. +..+|+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            5999999999999999999999999999999987655444445668889999999999999999998764 456899999


Q ss_pred             ecC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcc
Q 045787           87 YLD-LDLHSFITRH-KNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY  164 (324)
Q Consensus        87 ~~~-g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~  164 (324)
                      |++ +++.+++... ...+++..++.++.+++.+|.+||+.|++|+||+|+||+++ .++.++|+|||.+..........
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~-~~~~~~l~df~~~~~~~~~~~~~  159 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLT-RTNIIKVGDLGIARVLENQCDMA  159 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEe-cCCcEEEecccceEEecccCCcc
Confidence            997 5888887764 34689999999999999999999999999999999999999 89999999999987765444444


Q ss_pred             cccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCC
Q 045787          165 SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLY  244 (324)
Q Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (324)
                      ....+++.|+|||+..+ ..++.++|+||||++++++++|+.||...+.......... +..                  
T Consensus       160 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~-~~~------------------  219 (257)
T cd08223         160 STLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE-GKL------------------  219 (257)
T ss_pred             ccccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh-cCC------------------
Confidence            44567888999999887 6678999999999999999999999976664433221111 000                  


Q ss_pred             CCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                              ......+++.+.+++.+|++.||.+||++.++++||||
T Consensus       220 --------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         220 --------PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             --------CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                    00112578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-44  Score=324.18  Aligned_cols=283  Identities=23%  Similarity=0.310  Sum_probs=216.7

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEc--cCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNT--VTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV   81 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~--~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   81 (324)
                      +...+|++++.||.|++|.||++...  ..+..+++|.+...       ....+|+.++++++||+|+++++.+..+...
T Consensus        89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~  161 (392)
T PHA03207         89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTV  161 (392)
T ss_pred             hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence            45668999999999999999999754  35678999987532       2345899999999999999999999999999


Q ss_pred             EEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC
Q 045787           82 FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        82 ~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~  161 (324)
                      |++||++.+++.+++.. ...+++..++.++.||+.||.|||++|++|+||||+||+++ .++.++|+|||.+.......
T Consensus       162 ~lv~e~~~~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~-~~~~~~l~DfG~a~~~~~~~  239 (392)
T PHA03207        162 CMVMPKYKCDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLD-EPENAVLGDFGAACKLDAHP  239 (392)
T ss_pred             EEEehhcCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc-CCCCEEEccCccccccCccc
Confidence            99999999999998844 45799999999999999999999999999999999999999 89999999999987654332


Q ss_pred             Cc--ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC----hhHHHHHHHHcCCCCcccccc-h
Q 045787          162 KE--YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK----HDHLSLIFSLLGTPTDESWAE-S  234 (324)
Q Consensus       162 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~-~  234 (324)
                      ..  .....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+..    ...+..+....+..+...... .
T Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~  318 (392)
T PHA03207        240 DTPQCYGWSGTLETNSPELLAL-DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS  318 (392)
T ss_pred             ccccccccccccCccCHhHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence            21  223468899999999987 668999999999999999999999997654    233444444333322211100 0


Q ss_pred             ----hhhhcccCCCCCCCCcchhhh--CCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchh
Q 045787          235 ----TYISEILPLYPHFEPANLAEK--FPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       235 ----~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~  298 (324)
                          .............  ......  ...++.++.++|.+||..||.+||++.++++||||++.+.+.+
T Consensus       319 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~~~  386 (392)
T PHA03207        319 TNLCKHFKQYAIVLRPP--YTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPINLL  386 (392)
T ss_pred             hhHHHHHHhhcccccCC--ccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchhhh
Confidence                0000110000000  000011  1246778999999999999999999999999999998776554

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.4e-44  Score=310.85  Aligned_cols=282  Identities=37%  Similarity=0.662  Sum_probs=219.0

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE   86 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   86 (324)
                      ++|++++.||+|++|.||+|.+..+++.+++|.+..........+.+.+|+++++.++|||++++++++..+...++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            47999999999999999999999889999999987654443445667889999999999999999999999999999999


Q ss_pred             ecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcccc
Q 045787           87 YLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSR  166 (324)
Q Consensus        87 ~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~  166 (324)
                      |++++++..+......+++..+..++.+++.+|.|||+.|++|+||+|+||+++ +++.++|+|||.+............
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~-~~~~~~l~dfg~~~~~~~~~~~~~~  159 (286)
T cd07846          81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYTD  159 (286)
T ss_pred             cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC-CCCcEEEEeeeeeeeccCCccccCc
Confidence            999877666665556699999999999999999999999999999999999999 8999999999998776544333334


Q ss_pred             cccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHHcCCCCccc---ccchhhhhcccC
Q 045787          167 DCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD-HLSLIFSLLGTPTDES---WAESTYISEILP  242 (324)
Q Consensus       167 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  242 (324)
                      ..++..|+|||++.+...++.++||||||+++|+|++|.+||...+.. ....+....+......   +........ ..
T Consensus       160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  238 (286)
T cd07846         160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG-MR  238 (286)
T ss_pred             ccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc-cc
Confidence            457788999999876566788999999999999999999999766532 2222222222211100   000000000 00


Q ss_pred             CCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          243 LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                      ..............+.++..+.+++.+||+.||.+||++.++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         239 LPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             cccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            000001122223455789999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=4.5e-45  Score=319.57  Aligned_cols=264  Identities=25%  Similarity=0.393  Sum_probs=205.8

Q ss_pred             EeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEEEEEEecCC
Q 045787           13 KKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDVFLVFEYLDL   90 (324)
Q Consensus        13 ~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~g   90 (324)
                      +.||+|+||.||+|.+..+++.+|+|++..... .......+.+|+.++.++ +||+|+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            469999999999999999999999999986532 222345577888888777 799999999999999999999999985


Q ss_pred             -CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccccccc
Q 045787           91 -DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCV  169 (324)
Q Consensus        91 -~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~~~~  169 (324)
                       +|...+.. ...+++..++.++.+++.||.|||++|++|+||||+||+++ .++.++|+|||.+..............|
T Consensus        81 ~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~-~~~~~kL~DfG~~~~~~~~~~~~~~~~g  158 (329)
T cd05618          81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTSTFCG  158 (329)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEC-CCCCEEEeeCCccccccCCCCccccccC
Confidence             77666654 45699999999999999999999999999999999999999 8999999999998754333333445578


Q ss_pred             ccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCC
Q 045787          170 YSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEP  249 (324)
Q Consensus       170 ~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (324)
                      ++.|+|||++.+ ..++.++|+||||+++|+|++|..||........            ..........+...       
T Consensus       159 t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~------------~~~~~~~~~~~~i~-------  218 (329)
T cd05618         159 TPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN------------PDQNTEDYLFQVIL-------  218 (329)
T ss_pred             CccccCHHHHcC-CCCCCccceecccHHHHHHhhCCCCCccCCCcCC------------cccccHHHHHHHHh-------
Confidence            999999999987 6779999999999999999999999953211000            00000000000000       


Q ss_pred             cchhhhCCCCChhHHHHHHHhhcCCCCCCCC------HHHHhcCccccCCCCchh
Q 045787          250 ANLAEKFPNLEPAGVDLLSQMLCLNPKQRIT------AMDALKHEYLIGVENVPL  298 (324)
Q Consensus       250 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps------~~~~l~hp~~~~~~~~~~  298 (324)
                      .........++..+.++|++||+.||.+||+      ..++++||||+++.+...
T Consensus       219 ~~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~~~  273 (329)
T cd05618         219 EKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLM  273 (329)
T ss_pred             cCCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHH
Confidence            0000122357888999999999999999998      579999999999875433

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.4e-45  Score=310.95  Aligned_cols=268  Identities=26%  Similarity=0.389  Sum_probs=219.4

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE   86 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   86 (324)
                      ++|++++.||.|++|.||++.+..++..+++|.+......  ..+.+.+|+.++++++|++++++++.+..+...++|||
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEE--ELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE   82 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHH--HHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence            5799999999999999999999888999999998754322  23567789999999999999999999999999999999


Q ss_pred             ecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccc
Q 045787           87 YLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYS  165 (324)
Q Consensus        87 ~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~  165 (324)
                      |+++ ++.+++...+..+++..++.++.+++.+|.+||+.|++|+||+|+||+++ .++.++|+|||.+...........
T Consensus        83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~  161 (280)
T cd06611          83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLT-LDGDVKLADFGVSAKNKSTLQKRD  161 (280)
T ss_pred             ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEC-CCCCEEEccCccchhhcccccccc
Confidence            9985 78777777667799999999999999999999999999999999999999 899999999998876554444444


Q ss_pred             ccccccccCCchhhcC----CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhccc
Q 045787          166 RDCVYSPYKAPELLLG----YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEIL  241 (324)
Q Consensus       166 ~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (324)
                      ...+++.|+|||.+..    ...++.++|+||||+++|+|++|+.||...+.......... +.++.             
T Consensus       162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~-------------  227 (280)
T cd06611         162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILK-SEPPT-------------  227 (280)
T ss_pred             eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhc-CCCCC-------------
Confidence            4567888999999752    24568899999999999999999999977654332221111 00000             


Q ss_pred             CCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchhhhhh
Q 045787          242 PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILL  302 (324)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~~~~~  302 (324)
                                 ......++..+.++|.+||+.||.+||++.++++||||.+..+.+-.+.+
T Consensus       228 -----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~~~~~  277 (280)
T cd06611         228 -----------LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSDNKAIKDL  277 (280)
T ss_pred             -----------cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccchhHHHHHH
Confidence                       00112467889999999999999999999999999999998766554443

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-44  Score=310.65  Aligned_cols=281  Identities=53%  Similarity=0.973  Sum_probs=232.4

Q ss_pred             cceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEec
Q 045787            9 YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYL   88 (324)
Q Consensus         9 y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   88 (324)
                      |++.+.||+|++|.||++....+++.+++|.+..........+.+.+|+.++++++|++++++++++.+.+..++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            67889999999999999999999999999999876645555677889999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcccccc
Q 045787           89 DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDC  168 (324)
Q Consensus        89 ~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~~~  168 (324)
                      +++|.+++......+++..+..++.+++.+|.+||+.|++|+||+|+||+++ .++.++|+|||.+..............
T Consensus        81 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~-~~~~~~l~d~g~~~~~~~~~~~~~~~~  159 (282)
T cd07829          81 DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILIN-RDGVLKLADFGLARAFGIPLRTYTHEV  159 (282)
T ss_pred             CcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEc-CCCCEEEecCCcccccCCCccccCccc
Confidence            9999999988656799999999999999999999999999999999999999 899999999999877654433334445


Q ss_pred             cccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHHcCCCCcccccchhhhhcccCCCCCC
Q 045787          169 VYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHF  247 (324)
Q Consensus       169 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (324)
                      .+..|+|||.+.+...++.++|+||||++++++++|..||...+. .....+....+.+....|................
T Consensus       160 ~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
T cd07829         160 VTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKF  239 (282)
T ss_pred             cCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccccc
Confidence            667799999987755789999999999999999999999987763 3344455555555555444333332222233333


Q ss_pred             CCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          248 EPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       248 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                      .........+.++..+.++|++||..||.+||++.++++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         240 PPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             CccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            3444445566778999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3.7e-44  Score=303.16  Aligned_cols=254  Identities=28%  Similarity=0.380  Sum_probs=213.4

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEe
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEY   87 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   87 (324)
                      +|++.+.||+|++|.||+|.+..++..+++|.+............+.+|++++++++|||++++++.+.+++..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            58899999999999999999999999999999876544444456788999999999999999999999999999999999


Q ss_pred             cC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccc
Q 045787           88 LD-LDLHSFITRH-KNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYS  165 (324)
Q Consensus        88 ~~-g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~  165 (324)
                      +. ++|.+++... ...+++..++.++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+...........
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~-~~~~~~l~df~~~~~~~~~~~~~~  159 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLD-AYDNVKIGDLGVAKLLSDNTNFAN  159 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEe-CCCCEEEcccccceeccCccchhh
Confidence            97 5888888765 45789999999999999999999999999999999999999 889999999999887654433333


Q ss_pred             ccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCC
Q 045787          166 RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYP  245 (324)
Q Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (324)
                      ...+++.|+|||++.+ ..++.++|+||||+++++|++|..||...+.............                    
T Consensus       160 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------------  218 (256)
T cd08529         160 TIVGTPYYLSPELCED-KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVF--------------------  218 (256)
T ss_pred             ccccCccccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--------------------
Confidence            4467888999999987 5678999999999999999999999977764433222111000                    


Q ss_pred             CCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       246 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                             ......++..+.+++.+|++.+|++||++.++++|||+
T Consensus       219 -------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         219 -------PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             -------CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence                   00111467899999999999999999999999999996

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-44  Score=309.77  Aligned_cols=281  Identities=51%  Similarity=0.869  Sum_probs=227.6

Q ss_pred             cceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEec
Q 045787            9 YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYL   88 (324)
Q Consensus         9 y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   88 (324)
                      |++++.||.|++|.||++.+..+++.+++|.+............+.+|+.++++++|++++++++++..+...++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            78899999999999999999989999999998766554444567889999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcccccc
Q 045787           89 DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDC  168 (324)
Q Consensus        89 ~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~~~  168 (324)
                      ++++.+.+......+++..+..++.+++.+|.+||+.|++|+||+|+||+++ .++.++|+|||.+..............
T Consensus        81 ~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~-~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (283)
T cd05118          81 DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLIN-TEGVLKLADFGLARSFGSPVRPYTHYV  159 (283)
T ss_pred             CCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEEC-CCCcEEEeeeeeeEecCCCcccccCcc
Confidence            9999999888667899999999999999999999999999999999999999 889999999999887764432333345


Q ss_pred             cccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHHcCCCCcccccchhhh-hcccCCCCC
Q 045787          169 VYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYI-SEILPLYPH  246 (324)
Q Consensus       169 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  246 (324)
                      ++..|+|||.+.+....+.++|+||||+++|+|++|+.||...+. +.........+.+....+...... ......+..
T Consensus       160 ~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (283)
T cd05118         160 VTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPK  239 (283)
T ss_pred             CcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhcc
Confidence            677899999998755789999999999999999999999977763 333444444444443333322111 111111122


Q ss_pred             CCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          247 FEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       247 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                      ..........+.++..+.++|.+||+.||.+||++.+++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         240 KAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             ccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence            22223344455789999999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=9e-45  Score=318.69  Aligned_cols=292  Identities=37%  Similarity=0.661  Sum_probs=231.7

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeec----CCe
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS----RKD   80 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~   80 (324)
                      ...+|++.+.||.|++|.||++.+..+|..|++|.+............+.+|+.+++.++||+++++++++..    ...
T Consensus         3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (334)
T cd07855           3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD   82 (334)
T ss_pred             hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence            4589999999999999999999999999999999987655444445677889999999999999999987753    356


Q ss_pred             EEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           81 VFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        81 ~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      .++|+||+++++.+++... ..+++..++.++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+......
T Consensus        83 ~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~-~~~~~kl~dfg~~~~~~~~  160 (334)
T cd07855          83 VYVVMDLMESDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVN-EDCELRIGDFGMARGLSSS  160 (334)
T ss_pred             EEEEEehhhhhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc-CCCcEEecccccceeeccc
Confidence            8999999999988887654 4599999999999999999999999999999999999999 8999999999998765432


Q ss_pred             CCc----ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHHcCCCCcccccch-
Q 045787          161 QKE----YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAES-  234 (324)
Q Consensus       161 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~-  234 (324)
                      ...    .....++..|+|||.+.+...++.++|+||||+++|+|++|+.||...+. ..+..+....+.++...+... 
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~  240 (334)
T cd07855         161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG  240 (334)
T ss_pred             CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence            221    12336778899999987656689999999999999999999999977663 344444455555554433221 


Q ss_pred             -hhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchh
Q 045787          235 -TYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       235 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~  298 (324)
                       ....+.................+..+..+.++|.+||+.||.+||++.+++.||||++......
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~  305 (334)
T cd07855         241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDD  305 (334)
T ss_pred             hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcc
Confidence             1111122222223333344555678999999999999999999999999999999998876655

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=5e-44  Score=309.77  Aligned_cols=288  Identities=38%  Similarity=0.677  Sum_probs=226.4

Q ss_pred             CcccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCC--
Q 045787            2 GKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK--   79 (324)
Q Consensus         2 ~~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--   79 (324)
                      |....++|++.+.||.|++|.||++.++.+|+.+++|.+............+.+|+.++++++|||++++++++.+..  
T Consensus         2 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~   81 (302)
T cd07864           2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA   81 (302)
T ss_pred             chhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence            556778999999999999999999999999999999999866544444566788999999999999999999886654  


Q ss_pred             --------eEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeec
Q 045787           80 --------DVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADF  151 (324)
Q Consensus        80 --------~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~  151 (324)
                              .+++|+||+++++...+......+++..++.++.+++.||.+||+.|++|+||+|+||+++ +++.++|+||
T Consensus        82 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~-~~~~~kl~df  160 (302)
T cd07864          82 LDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLN-NKGQIKLADF  160 (302)
T ss_pred             hhccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC-CCCcEEeCcc
Confidence                    7999999999999888887666799999999999999999999999999999999999999 8999999999


Q ss_pred             cceeeccCCCC-cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHHcCCCCcc
Q 045787          152 GLARAIGVPQK-EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-HDHLSLIFSLLGTPTDE  229 (324)
Q Consensus       152 g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~  229 (324)
                      |.+........ ......++..|+|||.+.+....+.++||||||+++++|++|++||...+ ......+....+.+...
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (302)
T cd07864         161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA  240 (302)
T ss_pred             cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence            98876643332 12223456779999998765567899999999999999999999998666 33444444555555444


Q ss_pred             cccchhhhhcccCCC-CCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          230 SWAESTYISEILPLY-PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       230 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                      .+............. ..............++..+.+++.+||+.||.+||++.++++||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         241 VWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             hcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            333221111110000 0001112223344578999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=3.8e-44  Score=312.58  Aligned_cols=274  Identities=37%  Similarity=0.627  Sum_probs=206.8

Q ss_pred             EeecccCceEEEEEEEcc--CCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeee--cCCeEEEEEEec
Q 045787           13 KKIGAGGYGEVYKCRNTV--TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQS--SRKDVFLVFEYL   88 (324)
Q Consensus        13 ~~Lg~g~~~~v~~a~~~~--~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~iv~e~~   88 (324)
                      .+||+|+||.||+|.+..  ++..+|+|.+.....    ...+.+|+.++++++|||++++++++.  .+...++|+||+
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA   82 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence            579999999999999654  567899998764322    345778999999999999999999874  456789999999


Q ss_pred             CCCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEee---cCCCcEEEeeccceeec
Q 045787           89 DLDLHSFITRH--------KNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLID---LKRNTVKLADFGLARAI  157 (324)
Q Consensus        89 ~g~l~~~~~~~--------~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~---~~~~~v~l~d~g~~~~~  157 (324)
                      ++++.+++...        ...+++..++.++.|++.||.+||+.|++|+||||+||++.   ..++.++|+|||.+...
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~  162 (317)
T cd07867          83 EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF  162 (317)
T ss_pred             CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence            99998887532        12488899999999999999999999999999999999993   25678999999999866


Q ss_pred             cCCCC---cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh----------hHHHHHHHHcC
Q 045787          158 GVPQK---EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH----------DHLSLIFSLLG  224 (324)
Q Consensus       158 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----------~~~~~~~~~~~  224 (324)
                      .....   ......+++.|+|||++.+...++.++||||||+++|+|++|.+||.....          ..........+
T Consensus       163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (317)
T cd07867         163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG  242 (317)
T ss_pred             CCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcC
Confidence            43322   123346788899999998756689999999999999999999999975442          33445556666


Q ss_pred             CCCcccccchhhhhcccCCCCC--------CCC-cchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          225 TPTDESWAESTYISEILPLYPH--------FEP-ANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~--------~~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                      .+....|...............        ... ..........+..+.+++.+||+.||.+|||+.|+++||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         243 FPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             CCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            6655555442222111000000        000 00111112346678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=7e-44  Score=313.26  Aligned_cols=292  Identities=39%  Similarity=0.654  Sum_probs=230.8

Q ss_pred             CcccCcCccee-EeecccCceEEEEEEEccCCceEEEEEeeeccccCC------------CchHHHHHHHHHHhcCCCCe
Q 045787            2 GKLKNLNYKKI-KKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEG------------VPSYIIREVSLLKELEHENI   68 (324)
Q Consensus         2 ~~~~~~~y~i~-~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~------------~~~~~~~e~~~l~~l~~~~i   68 (324)
                      ..-..++|..+ +.||.|++|+||+|.+..+++.||+|.+........            ....+.+|+.++++++|+|+
T Consensus         3 ~~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   82 (335)
T PTZ00024          3 SFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENI   82 (335)
T ss_pred             ccccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcce
Confidence            34456788755 679999999999999999999999999875432210            11246789999999999999


Q ss_pred             eEEEeeeecCCeEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEE
Q 045787           69 VRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKL  148 (324)
Q Consensus        69 ~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l  148 (324)
                      +++++++..++..++|+||++|++.+++.. ...+++..+..++.|++.||.+||+.|++|+||+|+||+++ .++.++|
T Consensus        83 v~~~~~~~~~~~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~-~~~~~kl  160 (335)
T PTZ00024         83 MGLVDVYVEGDFINLVMDIMASDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFIN-SKGICKI  160 (335)
T ss_pred             eeeeEEEecCCcEEEEEeccccCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEEC-CCCCEEE
Confidence            999999999999999999999999988865 34689999999999999999999999999999999999999 8899999


Q ss_pred             eeccceeeccC--------------CCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh-
Q 045787          149 ADFGLARAIGV--------------PQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-  213 (324)
Q Consensus       149 ~d~g~~~~~~~--------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-  213 (324)
                      +|||.+.....              .........+++.|+|||.+.+...++.++|+||||+++|+|++|..||...+. 
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~  240 (335)
T PTZ00024        161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI  240 (335)
T ss_pred             CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            99998876541              111222334577899999987756679999999999999999999999987774 


Q ss_pred             hHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCC
Q 045787          214 DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV  293 (324)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~  293 (324)
                      +.+..+....+.+....|..........+ +....+.......+..+..+.++|.+||+.||.+||++++++.||||++-
T Consensus       241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~  319 (335)
T PTZ00024        241 DQLGRIFELLGTPNEDNWPQAKKLPLYTE-FTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD  319 (335)
T ss_pred             HHHHHHHHHhCCCchhhCcchhhcccccc-cCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence            34445556666666554444332221111 11222333444556678899999999999999999999999999999977


Q ss_pred             CCc
Q 045787          294 ENV  296 (324)
Q Consensus       294 ~~~  296 (324)
                      ...
T Consensus       320 ~~~  322 (335)
T PTZ00024        320 PLP  322 (335)
T ss_pred             CCC
Confidence            544

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=7e-44  Score=309.89  Aligned_cols=284  Identities=38%  Similarity=0.685  Sum_probs=216.5

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCC------
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------   79 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------   79 (324)
                      .++|++.+.||.|++|.||+|.+..+++.||+|.+............+.+|+.++++++||+++++++++....      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            35799999999999999999999999999999998765544443455678999999999999999999876543      


Q ss_pred             --eEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeec
Q 045787           80 --DVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAI  157 (324)
Q Consensus        80 --~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~  157 (324)
                        ..++|+||+++++.+.+......+++..++.++.|++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+...
T Consensus        91 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~  169 (310)
T cd07865          91 KGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILIT-KDGILKLADFGLARAF  169 (310)
T ss_pred             CceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEC-CCCcEEECcCCCcccc
Confidence              4699999999999998887666799999999999999999999999999999999999999 8999999999998765


Q ss_pred             cCCCCc----ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHH-HHHHHHcCCCCccccc
Q 045787          158 GVPQKE----YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHL-SLIFSLLGTPTDESWA  232 (324)
Q Consensus       158 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~  232 (324)
                      ......    .....++..|+|||.+.+...++.++|+||||+++|+|++|..||...+.... ..+....+..+...+.
T Consensus       170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (310)
T cd07865         170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWP  249 (310)
T ss_pred             cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence            432221    12234677799999987755678899999999999999999999987764433 3333334443333322


Q ss_pred             chhhhhcccC-CCCCCCCcchhhhC--CCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          233 ESTYISEILP-LYPHFEPANLAEKF--PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       233 ~~~~~~~~~~-~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                      .......... ..............  ...+..+.++|.+||..||.+|||++++++||||
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         250 GVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             cccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            2211110000 00000000011100  1235678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.8e-44  Score=315.59  Aligned_cols=255  Identities=25%  Similarity=0.391  Sum_probs=207.2

Q ss_pred             EeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEEEEEEecCC
Q 045787           13 KKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDVFLVFEYLDL   90 (324)
Q Consensus        13 ~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~g   90 (324)
                      +.||+|++|.||+|.+..+++.+|+|++..... .....+.+.+|..++.++ +||+++++++.+.+...+|+||||+.|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            469999999999999999999999999986542 222345678899999888 599999999999999999999999975


Q ss_pred             -CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccccccc
Q 045787           91 -DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCV  169 (324)
Q Consensus        91 -~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~~~~  169 (324)
                       +|...+.. .+.+++..++.++.||+.||.|||++|++|+||||+||+++ .++.++|+|||.+.............+|
T Consensus        81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (327)
T cd05617          81 GDLMFHMQR-QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLD-ADGHIKLTDYGMCKEGLGPGDTTSTFCG  158 (327)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEe-CCCCEEEeccccceeccCCCCceecccC
Confidence             77766655 35699999999999999999999999999999999999999 8999999999988754333334445678


Q ss_pred             ccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChh-------HHHHHHHHcCCCCcccccchhhhhcccC
Q 045787          170 YSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD-------HLSLIFSLLGTPTDESWAESTYISEILP  242 (324)
Q Consensus       170 ~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (324)
                      ++.|+|||++.+ ..++.++|+||||+++|+|++|..||......       .......  ..+                
T Consensus       159 t~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~----------------  219 (327)
T cd05617         159 TPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL--EKP----------------  219 (327)
T ss_pred             CcccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH--hCC----------------
Confidence            999999999987 67799999999999999999999999543211       1111100  000                


Q ss_pred             CCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCC------HHHHhcCccccCCCCchh
Q 045787          243 LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRIT------AMDALKHEYLIGVENVPL  298 (324)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps------~~~~l~hp~~~~~~~~~~  298 (324)
                                ......++..+.+++.+||..||.+|++      ..++++||||.++.+..+
T Consensus       220 ----------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~  271 (327)
T cd05617         220 ----------IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLL  271 (327)
T ss_pred             ----------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHHH
Confidence                      0112257888999999999999999998      579999999999886554

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.1e-44  Score=315.91  Aligned_cols=269  Identities=20%  Similarity=0.352  Sum_probs=216.5

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeecc-ccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQT-EQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      ++|++++.||+|+||.||++.++.+++.+|+|++.... ........+.+|+.++..++|++++++++.+.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47999999999999999999999999999999986533 22222345788999999999999999999999999999999


Q ss_pred             EecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC-c
Q 045787           86 EYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK-E  163 (324)
Q Consensus        86 e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~-~  163 (324)
                      ||+. |+|.+++......+++..++.++.|++.||.+||+.|++|+||||+||+++ .++.++|+|||.+........ .
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~-~~~~~kL~DfG~a~~~~~~~~~~  159 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD-MNGHIRLADFGSCLKLMEDGTVQ  159 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC-CCCCEEEeecchheecccCCcce
Confidence            9997 689999887667799999999999999999999999999999999999999 899999999998875532222 2


Q ss_pred             ccccccccccCCchhhcC----CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhc
Q 045787          164 YSRDCVYSPYKAPELLLG----YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISE  239 (324)
Q Consensus       164 ~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
                      .....|++.|+|||++..    ...++.++|+||||+++|+|++|+.||...+.........  ....            
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~--~~~~------------  225 (332)
T cd05623         160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM--NHKE------------  225 (332)
T ss_pred             ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHh--CCCc------------
Confidence            233568999999999863    3457889999999999999999999998766433322211  1000            


Q ss_pred             ccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCC--CCCHHHHhcCccccCCCCchhh
Q 045787          240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQ--RITAMDALKHEYLIGVENVPLV  299 (324)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~~~l~hp~~~~~~~~~~~  299 (324)
                               ..........+++++.+++++||..++.+  |++++++++||||+++.+..+.
T Consensus       226 ---------~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~~~~  278 (332)
T cd05623         226 ---------RFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDNIR  278 (332)
T ss_pred             ---------cccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHHHHh
Confidence                     00011122357899999999999765554  6899999999999998866554

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.3e-44  Score=309.17  Aligned_cols=264  Identities=25%  Similarity=0.405  Sum_probs=212.3

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccC-CCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEE
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQE-GVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE   86 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   86 (324)
                      +|++.+.||+|+||.||++.+..+++.||+|.+....... .....+.+|+.++++++|++++++++.+.+++..++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            5889999999999999999999999999999987543222 223456789999999999999999999999999999999


Q ss_pred             ecC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcc
Q 045787           87 YLD-LDLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY  164 (324)
Q Consensus        87 ~~~-g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~  164 (324)
                      |+. ++|.+.+.... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+...... ...
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~-~~~~~~l~Dfg~~~~~~~~-~~~  158 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLD-DHGHIRISDLGLAVHVPEG-QTI  158 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEEC-CCCCEEEeeccceeecCCC-ccc
Confidence            997 57877775433 3589999999999999999999999999999999999999 8899999999988765422 222


Q ss_pred             cccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCC
Q 045787          165 SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLY  244 (324)
Q Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (324)
                      ....+++.|+|||++.+ ..++.++|+||+|+++|+|++|+.||.................             .     
T Consensus       159 ~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~-------------~-----  219 (285)
T cd05630         159 KGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK-------------E-----  219 (285)
T ss_pred             cCCCCCccccChHHHcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhh-------------h-----
Confidence            33467889999999987 6689999999999999999999999976543211111000000             0     


Q ss_pred             CCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCC-----HHHHhcCccccCCCCchh
Q 045787          245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRIT-----AMDALKHEYLIGVENVPL  298 (324)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~~~l~hp~~~~~~~~~~  298 (324)
                            ........+++++.+++.+||+.||.+|||     +.++++||||+++.....
T Consensus       220 ------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~~~  272 (285)
T cd05630         220 ------VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRL  272 (285)
T ss_pred             ------hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHHHH
Confidence                  000112357888999999999999999999     999999999999766544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2.2e-44  Score=318.47  Aligned_cols=283  Identities=36%  Similarity=0.582  Sum_probs=218.0

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecC-----
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR-----   78 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----   78 (324)
                      ...++|++++.||.|++|.||+|.+..+++.+|+|.+............+.+|+.++++++|+|++++++++..+     
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            357899999999999999999999999999999999875544333445677899999999999999999987643     


Q ss_pred             -CeEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeec
Q 045787           79 -KDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAI  157 (324)
Q Consensus        79 -~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~  157 (324)
                       ...|+|+||+++++.+.+...   +++..+..++.|++.||.+||+.|++|+||||+||+++ .++.++|+|||.+...
T Consensus        93 ~~~~~lv~e~~~~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~-~~~~~kL~Dfg~~~~~  168 (353)
T cd07850          93 FQDVYLVMELMDANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTA  168 (353)
T ss_pred             cCcEEEEEeccCCCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC-CCCCEEEccCccceeC
Confidence             357999999999998887653   88999999999999999999999999999999999999 8899999999999876


Q ss_pred             cCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHHcCCCCcccccchhh
Q 045787          158 GVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-HDHLSLIFSLLGTPTDESWAESTY  236 (324)
Q Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  236 (324)
                      ..... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||...+ ......+....+.++.........
T Consensus       169 ~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (353)
T cd07850         169 GTSFM-MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP  246 (353)
T ss_pred             CCCCC-CCCCcccccccCHHHHhC-CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence            53222 223356788999999987 678999999999999999999999998766 334445555555554322111100


Q ss_pred             h-hcccCCCCCCCCc-------------chhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccC
Q 045787          237 I-SEILPLYPHFEPA-------------NLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIG  292 (324)
Q Consensus       237 ~-~~~~~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~  292 (324)
                      . .............             .........+..++++|.+||+.||++|||+.++|.||||+.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~  316 (353)
T cd07850         247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV  316 (353)
T ss_pred             hhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence            0 0000000000000             000012235667899999999999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=3e-44  Score=307.30  Aligned_cols=260  Identities=27%  Similarity=0.390  Sum_probs=205.3

Q ss_pred             ecccCceEEEEEEEccCCceEEEEEeeeccccC-CCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEecCC-CH
Q 045787           15 IGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQE-GVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DL   92 (324)
Q Consensus        15 Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~g-~l   92 (324)
                      ||+|+||.||+|.++.+|+.|++|.+....... .....+..|++++++++|||++++++.+.++...|+||||+.| +|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999999999999999987543221 1223456799999999999999999999999999999999974 77


Q ss_pred             HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccccccccc
Q 045787           93 HSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS  171 (324)
Q Consensus        93 ~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~  171 (324)
                      .+.+.... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+...... .......+++
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~-~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~  158 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLD-DQGNCRLSDLGLAVELKDG-KTITQRAGTN  158 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEc-CCCCEEEeeceeeeecCCC-ceeeccCCCC
Confidence            77765433 3588999999999999999999999999999999999999 8999999999998766432 2223346788


Q ss_pred             ccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcc
Q 045787          172 PYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPAN  251 (324)
Q Consensus       172 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (324)
                      .|+|||++.+ ..++.++|+||||+++|+|++|+.||...............                ....       .
T Consensus       159 ~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~----------------~~~~-------~  214 (277)
T cd05607         159 GYMAPEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRR----------------TLED-------E  214 (277)
T ss_pred             CccCHHHHcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHH----------------hhcc-------c
Confidence            9999999987 55899999999999999999999999754422111110000                0000       0


Q ss_pred             hhhhCCCCChhHHHHHHHhhcCCCCCCCCH----HHHhcCccccCCCCchhhh
Q 045787          252 LAEKFPNLEPAGVDLLSQMLCLNPKQRITA----MDALKHEYLIGVENVPLVI  300 (324)
Q Consensus       252 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~----~~~l~hp~~~~~~~~~~~~  300 (324)
                      .......++.++.+++.+||+.||.+||++    .+++.||||++++...+..
T Consensus       215 ~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~~~~  267 (277)
T cd05607         215 VKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRLEA  267 (277)
T ss_pred             cccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHHHHhc
Confidence            000112578899999999999999999999    6788999999987765543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-44  Score=315.72  Aligned_cols=288  Identities=38%  Similarity=0.645  Sum_probs=223.4

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecC-----C
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR-----K   79 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~   79 (324)
                      ..++|++.+.||+|++|.||++.+..+|+.|++|.+..... ......+.+|+.++++++|+|++++++++...     .
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   81 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH-QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN   81 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence            45789999999999999999999999999999999864322 22345677899999999999999999876543     3


Q ss_pred             eEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccC
Q 045787           80 DVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGV  159 (324)
Q Consensus        80 ~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~  159 (324)
                      ..|+++||+++++.+.+..  ..+++..++.++.|++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+.....
T Consensus        82 ~~~lv~e~~~~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~-~~~~~kl~dfg~~~~~~~  158 (336)
T cd07849          82 DVYIVQELMETDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN-TNCDLKICDFGLARIADP  158 (336)
T ss_pred             eEEEEehhcccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEC-CCCCEEECcccceeeccc
Confidence            5899999999998887754  4699999999999999999999999999999999999999 899999999999876543


Q ss_pred             CCCc---ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHHcCCCCcccccchh
Q 045787          160 PQKE---YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAEST  235 (324)
Q Consensus       160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~  235 (324)
                      ....   .....+++.|+|||.+.+...++.++|+||||+++|+|++|+.||...+. ..........+.+....+....
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (336)
T cd07849         159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCII  238 (336)
T ss_pred             cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence            2221   12245778899999987656789999999999999999999999977663 3334444445554443322110


Q ss_pred             --hhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCc
Q 045787          236 --YISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENV  296 (324)
Q Consensus       236 --~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~  296 (324)
                        .....................+.++.++.+++.+||+.||.+|||+.++++||||....+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~  301 (336)
T cd07849         239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP  301 (336)
T ss_pred             chhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence              0001111111112222233445678999999999999999999999999999999988865

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-44  Score=307.27  Aligned_cols=283  Identities=36%  Similarity=0.656  Sum_probs=220.6

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE   86 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   86 (324)
                      ++|++.+.||.|++|.||+|.+..+++.|++|.+............+.+|++++++++|+|++++++++..++..++++|
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            47999999999999999999999899999999987655555556778999999999999999999999999999999999


Q ss_pred             ecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC-ccc
Q 045787           87 YLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK-EYS  165 (324)
Q Consensus        87 ~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~-~~~  165 (324)
                      |++++++..+......+++..++.++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+........ ...
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~-~~~~~kl~d~g~~~~~~~~~~~~~~  159 (288)
T cd07833          81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVS-ESGVLKLCDFGFARALRARPASPLT  159 (288)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC-CCCCEEEEeeecccccCCCcccccc
Confidence            999988887777667799999999999999999999999999999999999999 899999999999877654332 233


Q ss_pred             ccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHHcCCCCcccccchhhhhcccC-C
Q 045787          166 RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD-HLSLIFSLLGTPTDESWAESTYISEILP-L  243 (324)
Q Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  243 (324)
                      ...++..|+|||++.+...++.++|+||||+++|+|++|+.||...... .........+..+............... .
T Consensus       160 ~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T cd07833         160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVA  239 (288)
T ss_pred             CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccc
Confidence            3456788999999988547899999999999999999999999766533 2222222222222111000000000000 0


Q ss_pred             CCCC-CCcchhhhC-CCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          244 YPHF-EPANLAEKF-PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       244 ~~~~-~~~~~~~~~-~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                      .... ......... ..++..+.++|++||..||++||+++++++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         240 FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            0000 111111122 2358899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.7e-44  Score=319.27  Aligned_cols=266  Identities=21%  Similarity=0.338  Sum_probs=213.2

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeE
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV   81 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   81 (324)
                      .+..++|++++.||+|+||.||+|.+..+++.+|+|++..... .......+.+|+.+++.++||+++++++.+.++...
T Consensus        39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (371)
T cd05622          39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL  118 (371)
T ss_pred             CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence            3556899999999999999999999999999999999875332 222235577899999999999999999999999999


Q ss_pred             EEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           82 FLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        82 ~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      |+||||++ |+|.+++..  ..+++..+..++.+|+.||.+||++|++|+||||+||+++ .++.++|+|||.+......
T Consensus       119 ~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~-~~~~ikL~DfG~a~~~~~~  195 (371)
T cd05622         119 YMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKE  195 (371)
T ss_pred             EEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEC-CCCCEEEEeCCceeEcCcC
Confidence            99999997 578777754  3588999999999999999999999999999999999999 8999999999999876433


Q ss_pred             CC-cccccccccccCCchhhcCC---CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhh
Q 045787          161 QK-EYSRDCVYSPYKAPELLLGY---TGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY  236 (324)
Q Consensus       161 ~~-~~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (324)
                      .. ......||+.|+|||++.+.   ..++.++|||||||++|+|++|..||...+.......+.....  ...+     
T Consensus       196 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~--~~~~-----  268 (371)
T cd05622         196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN--SLTF-----  268 (371)
T ss_pred             CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--cccC-----
Confidence            22 22345689999999998753   2378899999999999999999999987765433222211000  0000     


Q ss_pred             hhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCC--CCCHHHHhcCccccCCCC
Q 045787          237 ISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQ--RITAMDALKHEYLIGVEN  295 (324)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~~~l~hp~~~~~~~  295 (324)
                                       .....++..+.++|..||..++.+  |+++.++++||||++...
T Consensus       269 -----------------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~  312 (371)
T cd05622         269 -----------------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW  312 (371)
T ss_pred             -----------------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence                             011358899999999999844443  789999999999988653

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-44  Score=311.35  Aligned_cols=282  Identities=41%  Similarity=0.703  Sum_probs=217.3

Q ss_pred             CcceeEeecccCceEEEEEEEcc--CCceEEEEEeeecc-ccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecC--CeEE
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTV--TGQKVAIKMMTIQT-EQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR--KDVF   82 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~--~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~   82 (324)
                      +|++.+.||+|++|.||+|.+..  .+..||+|.+.... ........+.+|+.++++++|||++++++++.+.  ..++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            58999999999999999999988  88999999998644 2233346678899999999999999999999887  7899


Q ss_pred             EEEEecCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecC----CCcEEEeeccce
Q 045787           83 LVFEYLDLDLHSFITRHK----NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK----RNTVKLADFGLA  154 (324)
Q Consensus        83 iv~e~~~g~l~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~----~~~v~l~d~g~~  154 (324)
                      +|+||+++++.+.+....    ..+++..++.++.|++.||.+||+.|++|+||+|+||+++ .    ++.++|+|||.+
T Consensus        81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~-~~~~~~~~~kl~Dfg~~  159 (316)
T cd07842          81 LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVM-GEGPERGVVKIGDLGLA  159 (316)
T ss_pred             EEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEc-CCCCccceEEECCCccc
Confidence            999999998888775432    2689999999999999999999999999999999999999 7    889999999998


Q ss_pred             eeccCCCC---cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChh----------HHHHHHH
Q 045787          155 RAIGVPQK---EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD----------HLSLIFS  221 (324)
Q Consensus       155 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~----------~~~~~~~  221 (324)
                      ........   ......+++.|+|||++.+...++.++|+||||+++|+|++|..||......          .+..+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (316)
T cd07842         160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE  239 (316)
T ss_pred             cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence            76543322   1222356788999999877566799999999999999999999999766533          2334444


Q ss_pred             HcCCCCcccccchhhhhcccC--------CCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          222 LLGTPTDESWAESTYISEILP--------LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                      .++.+....+.......+...        .................+..+.+++.+||+.||.+|||+.+++.||||
T Consensus       240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            444443332221111111000        000011111112223678889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-45  Score=320.73  Aligned_cols=254  Identities=26%  Similarity=0.421  Sum_probs=204.4

Q ss_pred             ecccCceEEEEEEEccCCceEEEEEeeecccc-CCCchHHHHHHHHHHhc---CCCCeeEEEeeeecCCeEEEEEEecC-
Q 045787           15 IGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQ-EGVPSYIIREVSLLKEL---EHENIVRLLDVQSSRKDVFLVFEYLD-   89 (324)
Q Consensus        15 Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~-~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~~~iv~e~~~-   89 (324)
                      ||+|+||+||+|.+..+++.||+|++...... .........|..++...   .||+++++++.+......|+||||+. 
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            79999999999999999999999998754321 11223344566666655   69999999999999999999999997 


Q ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccccccc
Q 045787           90 LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCV  169 (324)
Q Consensus        90 g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~~~~  169 (324)
                      |+|...+.. ...+++..++.++.||+.||.|||++|++|+||||+||+++ .++.++|+|||.+.............+|
T Consensus        81 g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~g  158 (330)
T cd05586          81 GELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLD-ATGHIALCDFGLSKANLTDNKTTNTFCG  158 (330)
T ss_pred             ChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC-CCCCEEEecCCcCcCCCCCCCCccCccC
Confidence            477777665 45699999999999999999999999999999999999999 8899999999998754433333444578


Q ss_pred             ccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCC
Q 045787          170 YSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEP  249 (324)
Q Consensus       170 ~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (324)
                      ++.|+|||++.+...++.++|||||||++|+|++|..||...+..............                 .   . 
T Consensus       159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-----------------~---~-  217 (330)
T cd05586         159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVR-----------------F---P-  217 (330)
T ss_pred             CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCC-----------------C---C-
Confidence            999999999977566899999999999999999999999877654443322211000                 0   0 


Q ss_pred             cchhhhCCCCChhHHHHHHHhhcCCCCCCC----CHHHHhcCccccCCCCch
Q 045787          250 ANLAEKFPNLEPAGVDLLSQMLCLNPKQRI----TAMDALKHEYLIGVENVP  297 (324)
Q Consensus       250 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp----s~~~~l~hp~~~~~~~~~  297 (324)
                            ...++.++.++|++||+.||.+||    ++.++++||||.+..+..
T Consensus       218 ------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~~~  263 (330)
T cd05586         218 ------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDL  263 (330)
T ss_pred             ------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCHHH
Confidence                  013688899999999999999998    799999999999876443

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=6.8e-45  Score=318.19  Aligned_cols=255  Identities=24%  Similarity=0.421  Sum_probs=205.7

Q ss_pred             EeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHH-HHHhcCCCCeeEEEeeeecCCeEEEEEEecCC
Q 045787           13 KKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVS-LLKELEHENIVRLLDVQSSRKDVFLVFEYLDL   90 (324)
Q Consensus        13 ~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~g   90 (324)
                      +.||+|+||.||+|.+..+|+.+|+|++..... .......+..|.. +++.++||||+++++.+...+..|+||||+.|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            468999999999999999999999999976532 1222234445554 46778999999999999999999999999985


Q ss_pred             -CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccccccc
Q 045787           91 -DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCV  169 (324)
Q Consensus        91 -~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~~~~  169 (324)
                       +|...+.. ...+++..+..++.||+.||.|||+.|++|+||||+||+++ .++.++|+|||.+..............+
T Consensus        81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~-~~~~~kL~DfG~~~~~~~~~~~~~~~~g  158 (325)
T cd05604          81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLD-SQGHVVLTDFGLCKEGIAQSDTTTTFCG  158 (325)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC-CCCCEEEeecCCcccCCCCCCCcccccC
Confidence             77666654 45799999999999999999999999999999999999999 8999999999998754333333445578


Q ss_pred             ccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCC
Q 045787          170 YSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEP  249 (324)
Q Consensus       170 ~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (324)
                      ++.|+|||++.+ ..++.++|||||||++|+|++|..||...+...+......  ..                       
T Consensus       159 t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~--~~-----------------------  212 (325)
T cd05604         159 TPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILH--KP-----------------------  212 (325)
T ss_pred             ChhhCCHHHHcC-CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHc--CC-----------------------
Confidence            899999999987 6678999999999999999999999987764443222110  00                       


Q ss_pred             cchhhhCCCCChhHHHHHHHhhcCCCCCCCCH----HHHhcCccccCCCCchh
Q 045787          250 ANLAEKFPNLEPAGVDLLSQMLCLNPKQRITA----MDALKHEYLIGVENVPL  298 (324)
Q Consensus       250 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~----~~~l~hp~~~~~~~~~~  298 (324)
                         ....+.++..+.++|++||+.||.+||++    .++++||||..+.+..+
T Consensus       213 ---~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~~~~  262 (325)
T cd05604         213 ---LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDL  262 (325)
T ss_pred             ---ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCHHHH
Confidence               01123578889999999999999999987    58999999998765443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.2e-44  Score=316.75  Aligned_cols=255  Identities=27%  Similarity=0.411  Sum_probs=205.9

Q ss_pred             EeecccCceEEEEEEEccCCceEEEEEeeecccc-CCCchHHHHHH-HHHHhcCCCCeeEEEeeeecCCeEEEEEEecCC
Q 045787           13 KKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQ-EGVPSYIIREV-SLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL   90 (324)
Q Consensus        13 ~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~-~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~g   90 (324)
                      +.||+|+||.||+|.+..+++.||+|++...... ......+..|. .+++.++||||+++++.+..++..|+||||+.|
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            4699999999999999999999999999754321 11123344444 356788999999999999999999999999985


Q ss_pred             -CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccccccc
Q 045787           91 -DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCV  169 (324)
Q Consensus        91 -~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~~~~  169 (324)
                       +|.+.+.. ...+++..++.++.||+.||.+||+.|++|+||||+||+++ .++.++|+|||.+..............|
T Consensus        81 ~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~-~~~~~kl~DfG~a~~~~~~~~~~~~~~g  158 (325)
T cd05602          81 GELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNGTTSTFCG  158 (325)
T ss_pred             CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC-CCCCEEEccCCCCcccccCCCCcccccC
Confidence             77776655 45688999999999999999999999999999999999999 8999999999998754333333445578


Q ss_pred             ccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCC
Q 045787          170 YSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEP  249 (324)
Q Consensus       170 ~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (324)
                      ++.|+|||++.+ ..++.++|||||||++|+|++|..||...+..........  .+                       
T Consensus       159 t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~--~~-----------------------  212 (325)
T cd05602         159 TPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN--KP-----------------------  212 (325)
T ss_pred             CccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHh--CC-----------------------
Confidence            999999999987 6789999999999999999999999987665443222110  00                       


Q ss_pred             cchhhhCCCCChhHHHHHHHhhcCCCCCCCCHH----HHhcCccccCCCCchh
Q 045787          250 ANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAM----DALKHEYLIGVENVPL  298 (324)
Q Consensus       250 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~----~~l~hp~~~~~~~~~~  298 (324)
                         ....+.++..+.++|.+||+.||.+|+++.    ++++|+||..+.+..+
T Consensus       213 ---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~~~~  262 (325)
T cd05602         213 ---LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDL  262 (325)
T ss_pred             ---cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCHHHH
Confidence               011236788999999999999999999876    8999999998876554

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4.2e-44  Score=327.99  Aligned_cols=262  Identities=22%  Similarity=0.311  Sum_probs=214.3

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCC----
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK----   79 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----   79 (324)
                      ...++|++.+.||+|+||+||+|.+..+|+.||+|++............+.+|+..+..++|++++++++.+....    
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            3568999999999999999999999999999999999766544333456788999999999999999988764322    


Q ss_pred             ----eEEEEEEecC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeec
Q 045787           80 ----DVFLVFEYLD-LDLHSFITRH---KNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADF  151 (324)
Q Consensus        80 ----~~~iv~e~~~-g~l~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~  151 (324)
                          .+++||||+. |+|.+.+...   ...+++..++.++.|++.||.|||+.|++|+||||+||+++ .++.++|+||
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~-~~~~vkL~DF  187 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLC-SNGLVKLGDF  187 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEe-CCCCEEEEec
Confidence                3789999998 5888887653   34689999999999999999999999999999999999999 8999999999


Q ss_pred             cceeeccCC--CCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcc
Q 045787          152 GLARAIGVP--QKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDE  229 (324)
Q Consensus       152 g~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  229 (324)
                      |++......  .......+|++.|+|||++.+ ..++.++||||||+++|+|++|+.||...+.............    
T Consensus       188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~----  262 (496)
T PTZ00283        188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY----  262 (496)
T ss_pred             ccCeeccccccccccccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC----
Confidence            998765422  122234568999999999987 6689999999999999999999999987665433222111000    


Q ss_pred             cccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCC
Q 045787          230 SWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVE  294 (324)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~  294 (324)
                                             ....+.+++++.+++.+||+.||.+||++.++++|||++...
T Consensus       263 -----------------------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~  304 (496)
T PTZ00283        263 -----------------------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFI  304 (496)
T ss_pred             -----------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhh
Confidence                                   001235788999999999999999999999999999987643

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=5.9e-44  Score=308.44  Aligned_cols=262  Identities=29%  Similarity=0.479  Sum_probs=214.8

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      ..+|++++.||.|++|.||++.+..+++.|++|.+......  ..+.+.+|+.+++.++|+|++++++.+..+...++|+
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   95 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   95 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence            47899999999999999999999989999999998754332  2466788999999999999999999999999999999


Q ss_pred             EecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcc
Q 045787           86 EYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY  164 (324)
Q Consensus        86 e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~  164 (324)
                      ||+++ ++.+++..  ..+++..+..++.+++.+|.+||+.|++|+||+|+||+++ .++.++|+|||.+..........
T Consensus        96 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~-~~~~~~l~Dfg~~~~~~~~~~~~  172 (297)
T cd06656          96 EYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKR  172 (297)
T ss_pred             cccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC-CCCCEEECcCccceEccCCccCc
Confidence            99975 77777654  4588999999999999999999999999999999999999 89999999999887654333333


Q ss_pred             cccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCC
Q 045787          165 SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLY  244 (324)
Q Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (324)
                      ....+++.|+|||.+.+ ..++.++|+||||+++|++++|..||...+...........+.+                  
T Consensus       173 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~------------------  233 (297)
T cd06656         173 STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP------------------  233 (297)
T ss_pred             CcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCC------------------
Confidence            34567888999999987 66789999999999999999999999665432211100000000                  


Q ss_pred             CCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchh
Q 045787          245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~  298 (324)
                             .......++..+.+++.+||..||.+||++++++.||||+..+..+-
T Consensus       234 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~  280 (297)
T cd06656         234 -------ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSS  280 (297)
T ss_pred             -------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccccccc
Confidence                   00112357788999999999999999999999999999998875544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=8.1e-44  Score=305.48  Aligned_cols=270  Identities=26%  Similarity=0.382  Sum_probs=218.0

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEe
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEY   87 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   87 (324)
                      -|++.+.||.|++|.||++.+..++..+++|.+......  ....+.+|+.+++.++|||++++++.+..+...++|+||
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~   83 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEE--ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   83 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHH--HHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence            368999999999999999999999999999998654322  235677899999999999999999999999999999999


Q ss_pred             cCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcccc
Q 045787           88 LDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSR  166 (324)
Q Consensus        88 ~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~  166 (324)
                      +++ ++...+.....++++..+..++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+............
T Consensus        84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~-~~~~~kl~dfg~~~~~~~~~~~~~~  162 (282)
T cd06643          84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFT-LDGDIKLADFGVSAKNTRTIQRRDS  162 (282)
T ss_pred             cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEc-cCCCEEEcccccccccccccccccc
Confidence            985 66666665556799999999999999999999999999999999999999 8899999999988765433333344


Q ss_pred             cccccccCCchhhc----CCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccC
Q 045787          167 DCVYSPYKAPELLL----GYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILP  242 (324)
Q Consensus       167 ~~~~~~y~aPE~~~----~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (324)
                      ..+++.|+|||++.    ....++.++|+||||+++|+|++|+.||...+........... .++.              
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~-~~~~--------------  227 (282)
T cd06643         163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-EPPT--------------  227 (282)
T ss_pred             ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhc-CCCC--------------
Confidence            56788899999984    2345688999999999999999999999766543322211110 0000              


Q ss_pred             CCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchhhhhhhhc
Q 045787          243 LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLINR  305 (324)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~~~~~~~~  305 (324)
                                ......++..+.++|.+||+.||.+||++.++++||||......+.....+.+
T Consensus       228 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~~~~~~~  280 (282)
T cd06643         228 ----------LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNKPIRELIAEA  280 (282)
T ss_pred             ----------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEeccCCCCHHHHHHhh
Confidence                      00112467889999999999999999999999999999998888776655544

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=4.7e-44  Score=313.25  Aligned_cols=283  Identities=20%  Similarity=0.289  Sum_probs=208.7

Q ss_pred             eeEeeccc--CceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEec
Q 045787           11 KIKKIGAG--GYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYL   88 (324)
Q Consensus        11 i~~~Lg~g--~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   88 (324)
                      +++.||+|  ++++||++.++.+|+.||+|.+............+.+|+.+++.++||||+++++++..++..++|+||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            56789999  7899999999999999999998765444444566888999999999999999999999999999999999


Q ss_pred             C-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC----
Q 045787           89 D-LDLHSFITRH-KNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK----  162 (324)
Q Consensus        89 ~-g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~----  162 (324)
                      + |++.+++... ...+++..++.++.+++.||.|||++|++|+||||+||+++ .++.++++||+..........    
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~-~~~~~~l~~~~~~~~~~~~~~~~~~  160 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS-VDGKVYLSGLRSNLSMINHGQRLRV  160 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEe-cCCcEEEcccchhhccccccccccc
Confidence            8 5888887654 34589999999999999999999999999999999999999 889999999986543321111    


Q ss_pred             ---cccccccccccCCchhhcCC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcc---------
Q 045787          163 ---EYSRDCVYSPYKAPELLLGY-TGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDE---------  229 (324)
Q Consensus       163 ---~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------  229 (324)
                         ......++..|+|||++.+. ..++.++|||||||++|+|++|..||............. .+..+..         
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  239 (327)
T cd08227         161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL-NGTVPCLLDTTTIPAE  239 (327)
T ss_pred             cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHh-cCCccccccccchhhh
Confidence               11223456679999998753 457899999999999999999999997655433222111 1111100         


Q ss_pred             ccc-ch------hhhhcccC---CCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCC
Q 045787          230 SWA-ES------TYISEILP---LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVEN  295 (324)
Q Consensus       230 ~~~-~~------~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~  295 (324)
                      ... ..      ........   ................+++.+.++|.+||+.||.+|||++++++||||+++..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~~  315 (327)
T cd08227         240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKR  315 (327)
T ss_pred             hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcch
Confidence            000 00      00000000   00000000011122346788999999999999999999999999999998753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-43  Score=305.34  Aligned_cols=281  Identities=43%  Similarity=0.761  Sum_probs=223.8

Q ss_pred             cceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecC--CeEEEEEE
Q 045787            9 YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR--KDVFLVFE   86 (324)
Q Consensus         9 y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~iv~e   86 (324)
                      |++++.||.|++|.||+|.+..+++.+++|.+............+.+|+.++++++|++++++++++...  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            7899999999999999999999999999999987654444456688899999999999999999999888  89999999


Q ss_pred             ecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC-ccc
Q 045787           87 YLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK-EYS  165 (324)
Q Consensus        87 ~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~-~~~  165 (324)
                      |+++++.+.+......+++..++.++.+++.||.+||+.|++|+||+|+||+++ +++.++|+|||.+........ ...
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~-~~~~~~l~d~g~~~~~~~~~~~~~~  159 (287)
T cd07840          81 YMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILIN-NDGVLKLADFGLARPYTKRNSADYT  159 (287)
T ss_pred             cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEc-CCCCEEEccccceeeccCCCccccc
Confidence            999999988877656799999999999999999999999999999999999999 899999999999887654322 122


Q ss_pred             ccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHHcCCCCcccccchhhhhcccC-C
Q 045787          166 RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILP-L  243 (324)
Q Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  243 (324)
                      ...++..|+|||.+.+...++.++||||||+++|+|++|..||...+. .....+....+.+....|........... .
T Consensus       160 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (287)
T cd07840         160 NRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLK  239 (287)
T ss_pred             ccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhcc
Confidence            334567799999887656679999999999999999999999987774 33444445555555444433222100000 0


Q ss_pred             CCCCCCcchhhhCCCC-ChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          244 YPHFEPANLAEKFPNL-EPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       244 ~~~~~~~~~~~~~~~~-~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                      ................ +..+.+++++||+.||.+||++.++++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         240 PKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             ccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence            0111111222333343 8899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=8.2e-44  Score=301.11  Aligned_cols=254  Identities=28%  Similarity=0.428  Sum_probs=211.3

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEe
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEY   87 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   87 (324)
                      +|++++.||+|++|.+|.+.+..+|+.|++|.+............+.+|+.++++++|||++++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            69999999999999999999999999999999876543333345688999999999999999999999999999999999


Q ss_pred             cC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccc
Q 045787           88 LD-LDLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYS  165 (324)
Q Consensus        88 ~~-g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~  165 (324)
                      +. +++.+.+.... ..+++..+..++.+++.+|.+||+.|++|+||+|+||+++ .++.++|+|||.+...........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~  159 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT-KDGTIKLGDFGIARVLNSTVELAR  159 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc-CCCCEEEeeccceeecCcchhhhh
Confidence            97 58888876643 3578999999999999999999999999999999999999 889999999999876654333333


Q ss_pred             ccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCC
Q 045787          166 RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYP  245 (324)
Q Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (324)
                      ...+++.|+|||++.+ ...+.++|+||||+++++|++|..||...+.............+                   
T Consensus       160 ~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~-------------------  219 (256)
T cd08218         160 TCIGTPYYLSPEICEN-RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYP-------------------  219 (256)
T ss_pred             hccCCccccCHHHhCC-CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCC-------------------
Confidence            3457788999999877 56788999999999999999999999766543332221111000                   


Q ss_pred             CCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       246 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                              .....++.++.++|.+||+.+|.+||++.++++||||
T Consensus       220 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         220 --------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             --------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence                    0122568889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.6e-43  Score=305.60  Aligned_cols=262  Identities=29%  Similarity=0.491  Sum_probs=214.9

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      ..+|++.+.||+|++|.||++.+..++..+++|.+.......  ...+.+|+.+++.++|+|++++++.+..+...|+|+
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~--~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~   96 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch--HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence            469999999999999999999999999999999887644332  466888999999999999999999999999999999


Q ss_pred             EecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcc
Q 045787           86 EYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY  164 (324)
Q Consensus        86 e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~  164 (324)
                      ||+.| +|.+++..  ..+++..+..++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+..........
T Consensus        97 e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~-~~~~~kl~dfg~~~~~~~~~~~~  173 (296)
T cd06654          97 EYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKR  173 (296)
T ss_pred             cccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc-CCCCEEECccccchhcccccccc
Confidence            99974 78877654  3588999999999999999999999999999999999999 88999999999887654333333


Q ss_pred             cccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCC
Q 045787          165 SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLY  244 (324)
Q Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (324)
                      ....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||.................+.                 
T Consensus       174 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-----------------  235 (296)
T cd06654         174 STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE-----------------  235 (296)
T ss_pred             CcccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCC-----------------
Confidence            34467888999999887 667899999999999999999999997655422111111000000                 


Q ss_pred             CCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchh
Q 045787          245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~  298 (324)
                              ......++..+.+++.+||..||.+||++.++++||||...+....
T Consensus       236 --------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~~~  281 (296)
T cd06654         236 --------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSS  281 (296)
T ss_pred             --------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccCCccc
Confidence                    0011257788999999999999999999999999999998765543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.2e-43  Score=305.54  Aligned_cols=260  Identities=27%  Similarity=0.483  Sum_probs=219.1

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      ++|++.+.||.|++|.||++.+..+++.+++|++..... .....+.+.+|++++++++|||++++++.+.+....++|+
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            479999999999999999999999999999999875432 2233466889999999999999999999999999999999


Q ss_pred             EecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcc
Q 045787           86 EYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY  164 (324)
Q Consensus        86 e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~  164 (324)
                      ||++ ++|.+++... ..+++..+..++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+......   .
T Consensus        81 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~-~~~~~kl~dfg~~~~~~~~---~  155 (290)
T cd05580          81 EYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLD-SDGYIKITDFGFAKRVKGR---T  155 (290)
T ss_pred             ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC-CCCCEEEeeCCCccccCCC---C
Confidence            9995 6888887765 5699999999999999999999999999999999999999 8899999999998766433   3


Q ss_pred             cccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCC
Q 045787          165 SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLY  244 (324)
Q Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (324)
                      ....+++.|+|||.+.+ ...+.++|+||||+++|+|++|..||...+.......... +.+                  
T Consensus       156 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~------------------  215 (290)
T cd05580         156 YTLCGTPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE-GKV------------------  215 (290)
T ss_pred             CCCCCCccccChhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-CCc------------------
Confidence            34467888999999876 5678999999999999999999999977664333222211 000                  


Q ss_pred             CCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCC-----CHHHHhcCccccCCCCchhhh
Q 045787          245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRI-----TAMDALKHEYLIGVENVPLVI  300 (324)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~~l~hp~~~~~~~~~~~~  300 (324)
                               .....++..+.++|.+||..||.+|+     +++++++||||..+.+..+..
T Consensus       216 ---------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~  267 (290)
T cd05580         216 ---------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQ  267 (290)
T ss_pred             ---------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHHHHhh
Confidence                     01124678999999999999999999     999999999999999877754

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.6e-44  Score=315.35  Aligned_cols=255  Identities=27%  Similarity=0.439  Sum_probs=205.1

Q ss_pred             EeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHH-HHHhcCCCCeeEEEeeeecCCeEEEEEEecCC
Q 045787           13 KKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVS-LLKELEHENIVRLLDVQSSRKDVFLVFEYLDL   90 (324)
Q Consensus        13 ~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~g   90 (324)
                      +.||.|++|.||+|.+..+++.||+|++..... .......+..|.. +++.++|||++++++.+.+.+..|+||||++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            469999999999999999999999999875432 1112233445544 67889999999999999999999999999985


Q ss_pred             -CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccccccc
Q 045787           91 -DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCV  169 (324)
Q Consensus        91 -~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~~~~  169 (324)
                       +|...+.. ...+++..++.++.||+.||.|||+.|++|+||||+||+++ .++.++|+|||.+..............+
T Consensus        81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (321)
T cd05603          81 GELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLD-SQGHVVLTDFGLCKEGVEPEETTSTFCG  158 (321)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC-CCCCEEEccCCCCccCCCCCCccccccC
Confidence             77666654 45689999999999999999999999999999999999999 8999999999988754323333344568


Q ss_pred             ccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCC
Q 045787          170 YSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEP  249 (324)
Q Consensus       170 ~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (324)
                      ++.|+|||++.+ ..++.++|||||||++|+|++|..||...+.........  ..+                       
T Consensus       159 t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~--~~~-----------------------  212 (321)
T cd05603         159 TPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNIL--HKP-----------------------  212 (321)
T ss_pred             CcccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHh--cCC-----------------------
Confidence            899999999987 668999999999999999999999998776544322211  100                       


Q ss_pred             cchhhhCCCCChhHHHHHHHhhcCCCCCCCCH----HHHhcCccccCCCCchh
Q 045787          250 ANLAEKFPNLEPAGVDLLSQMLCLNPKQRITA----MDALKHEYLIGVENVPL  298 (324)
Q Consensus       250 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~----~~~l~hp~~~~~~~~~~  298 (324)
                         ....+..+..+.++|.+||+.||.+||++    .++++|+||..+.+..+
T Consensus       213 ---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~~~~  262 (321)
T cd05603         213 ---LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDDL  262 (321)
T ss_pred             ---CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCHHHH
Confidence               01123567889999999999999999976    49999999998876544

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7.9e-44  Score=325.94  Aligned_cols=257  Identities=25%  Similarity=0.333  Sum_probs=211.1

Q ss_pred             CcCcceeEeecccCceEEEEEEEccC-CceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVT-GQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLV   84 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   84 (324)
                      ...|.+.+.||+|++|.||+|.+..+ +..+++|........  ....+.+|+.+++.++||||+++++++..++..|+|
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~--~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv  143 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDER--QAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI  143 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHH--HHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence            34599999999999999999998877 778888876544322  235677899999999999999999999999999999


Q ss_pred             EEecC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           85 FEYLD-LDLHSFITRH---KNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        85 ~e~~~-g~l~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      |||+. |+|.+.+...   ..++++..+..++.|++.||.+||+.|++||||||+||+++ .++.++|+|||++......
T Consensus       144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~~kL~DFgla~~~~~~  222 (478)
T PTZ00267        144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLM-PTGIIKLGDFGFSKQYSDS  222 (478)
T ss_pred             EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEEC-CCCcEEEEeCcCceecCCc
Confidence            99997 5888776542   34689999999999999999999999999999999999999 8999999999999876432


Q ss_pred             CC--cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhh
Q 045787          161 QK--EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYIS  238 (324)
Q Consensus       161 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (324)
                      ..  .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..............+           
T Consensus       223 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~-----------  290 (478)
T PTZ00267        223 VSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP-----------  290 (478)
T ss_pred             cccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-----------
Confidence            21  2334568999999999987 678999999999999999999999997766543322221111000           


Q ss_pred             cccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCC
Q 045787          239 EILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV  293 (324)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~  293 (324)
                                      ....++..+.++|.+||..||.+||++++++.|||++.+
T Consensus       291 ----------------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        291 ----------------FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             ----------------CCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence                            112577889999999999999999999999999999754

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2e-43  Score=304.92  Aligned_cols=261  Identities=30%  Similarity=0.507  Sum_probs=215.1

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      ..+|++++.||.|++|.||++.+..+++.+++|.+......  ..+.+.+|+..++.++|||++++++.+......++|+
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   95 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP--KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM   95 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc--hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence            36799999999999999999999999999999998754322  2466889999999999999999999999999999999


Q ss_pred             EecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcc
Q 045787           86 EYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY  164 (324)
Q Consensus        86 e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~  164 (324)
                      ||+.+ +|..++..  ..+++..+..++.+++.+|.+||+.|++|+||+|+||+++ .++.++|+|||.+..........
T Consensus        96 e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~-~~~~~kl~dfg~~~~~~~~~~~~  172 (296)
T cd06655          96 EYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLG-MDGSVKLTDFGFCAQITPEQSKR  172 (296)
T ss_pred             EecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC-CCCCEEEccCccchhcccccccC
Confidence            99985 77666654  3589999999999999999999999999999999999999 89999999999887654333333


Q ss_pred             cccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCC
Q 045787          165 SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLY  244 (324)
Q Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (324)
                      ....+++.|+|||.+.+ ..++.++|+||||+++|++++|..||...+.............+.                 
T Consensus       173 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~-----------------  234 (296)
T cd06655         173 STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPE-----------------  234 (296)
T ss_pred             CCcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcc-----------------
Confidence            34467788999999877 567899999999999999999999997766433222211111110                 


Q ss_pred             CCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCch
Q 045787          245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP  297 (324)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~  297 (324)
                              ......+++.+.++|.+||..||.+||++.+++.||||+......
T Consensus       235 --------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~~~  279 (296)
T cd06655         235 --------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKPLS  279 (296)
T ss_pred             --------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccccc
Confidence                    001225788999999999999999999999999999999877543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=4.8e-44  Score=313.44  Aligned_cols=268  Identities=21%  Similarity=0.351  Sum_probs=215.6

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeecc-ccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQT-EQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.... ........+.+|..++..++|++|+++++++.+++..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            58999999999999999999999999999999987532 22222345778899999999999999999999999999999


Q ss_pred             EecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC-c
Q 045787           86 EYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK-E  163 (324)
Q Consensus        86 e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~-~  163 (324)
                      ||+. |+|.+++......+++..+..++.|++.||.+||+.|++|+||||+||+++ .++.++|+|||.+........ .
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~-~~~~~kl~DfG~a~~~~~~~~~~  159 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLD-MNGHIRLADFGSCLKMNQDGTVQ  159 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEc-CCCCEEEEeccceeeccCCCcee
Confidence            9997 588888887666799999999999999999999999999999999999999 889999999999876643322 1


Q ss_pred             ccccccccccCCchhhcCC----CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhc
Q 045787          164 YSRDCVYSPYKAPELLLGY----TGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISE  239 (324)
Q Consensus       164 ~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
                      .....|++.|+|||++.+.    ..++.++|+||||+++|+|++|+.||...+.............              
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~--------------  225 (331)
T cd05624         160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEE--------------  225 (331)
T ss_pred             eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCC--------------
Confidence            2234689999999998642    3568899999999999999999999977664332222111000              


Q ss_pred             ccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCC--CCCHHHHhcCccccCCCCchh
Q 045787          240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQ--RITAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~~~l~hp~~~~~~~~~~  298 (324)
                               ..........++.+++++|.+||..++.+  |++++++++||||+++.+..+
T Consensus       226 ---------~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~~~  277 (331)
T cd05624         226 ---------RFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWENI  277 (331)
T ss_pred             ---------cccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHHHH
Confidence                     00011122357899999999999976655  568999999999999876554

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-43  Score=299.49  Aligned_cols=255  Identities=28%  Similarity=0.478  Sum_probs=208.4

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccC---CCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQE---GVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   83 (324)
                      ++|++.+.||+|++|.||.+.+..+++.+++|.+.......   .....+.+|+.++++++|||++++++++.++...++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57999999999999999999999899999999987553221   123567889999999999999999999999999999


Q ss_pred             EEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC
Q 045787           84 VFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK  162 (324)
Q Consensus        84 v~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~  162 (324)
                      |+||+.| ++.+.+... ..+++..+..++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+........
T Consensus        82 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~-~~~~~~l~dfg~~~~~~~~~~  159 (263)
T cd06625          82 FMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICS  159 (263)
T ss_pred             EEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc-CCCCEEEeecccceecccccc
Confidence            9999975 777777654 4689999999999999999999999999999999999999 889999999999876542221


Q ss_pred             cc---cccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhc
Q 045787          163 EY---SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISE  239 (324)
Q Consensus       163 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
                      ..   ....++..|+|||++.+ ..++.++|+||||+++|+|++|+.||...+.........  ....            
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~--~~~~------------  224 (263)
T cd06625         160 SGTGMKSVTGTPYWMSPEVISG-EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA--TQPT------------  224 (263)
T ss_pred             ccccccCCCcCccccCcceecc-CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHh--ccCC------------
Confidence            11   23456778999999987 558999999999999999999999996654322111111  0000            


Q ss_pred             ccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                                  .......++..+.++|.+||..||.+||++.++++||||
T Consensus       225 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         225 ------------NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             ------------CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence                        011123578899999999999999999999999999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.1e-43  Score=300.14  Aligned_cols=254  Identities=30%  Similarity=0.499  Sum_probs=212.8

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      .++|++.+.||+|++|.||++.+..++..+++|.+.....    .+.+.+|++++++++|++++++++.+..+...|+++
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~   77 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM   77 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence            4789999999999999999999998899999999875533    467889999999999999999999999999999999


Q ss_pred             EecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcc
Q 045787           86 EYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY  164 (324)
Q Consensus        86 e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~  164 (324)
                      ||+++ +|.+++......+++..++.++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+..........
T Consensus        78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~-~~~~~~l~dfg~~~~~~~~~~~~  156 (256)
T cd06612          78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLN-EEGQAKLADFGVSGQLTDTMAKR  156 (256)
T ss_pred             ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEC-CCCcEEEcccccchhcccCcccc
Confidence            99985 88888776667899999999999999999999999999999999999999 88999999999988765443333


Q ss_pred             cccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCC
Q 045787          165 SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLY  244 (324)
Q Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (324)
                      ....++..|+|||++.+ ..++.++|+||||+++|+|++|..||.............  ....                 
T Consensus       157 ~~~~~~~~y~~PE~~~~-~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~-----------------  216 (256)
T cd06612         157 NTVIGTPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIP--NKPP-----------------  216 (256)
T ss_pred             ccccCCccccCHHHHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhc--cCCC-----------------
Confidence            44457788999999877 567999999999999999999999997655432211110  0000                 


Q ss_pred             CCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                            ........++..+.+++.+||+.||.+|||+.+++.||||
T Consensus       217 ------~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         217 ------PTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             ------CCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence                  0001112467889999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.6e-43  Score=304.03  Aligned_cols=264  Identities=24%  Similarity=0.373  Sum_probs=214.0

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeecccc-CCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEE
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQ-EGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE   86 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   86 (324)
                      .|+..+.||+|+||+||++.+..+++.+|+|.+...... ......+.+|+.+++.++|++++.+.+.+..++..++++|
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            488999999999999999999999999999998765322 2223456789999999999999999999999999999999


Q ss_pred             ecCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcc
Q 045787           87 YLDL-DLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY  164 (324)
Q Consensus        87 ~~~g-~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~  164 (324)
                      |+.+ ++...+.... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+...... ...
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~-~~~~~kl~Dfg~~~~~~~~-~~~  158 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLD-DYGHIRISDLGLAVKIPEG-ESI  158 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEC-CCCCEEEecCCcceecCCC-Ccc
Confidence            9985 7776665543 3699999999999999999999999999999999999999 8899999999988765422 222


Q ss_pred             cccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCC
Q 045787          165 SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLY  244 (324)
Q Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (324)
                      ....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||....................                
T Consensus       159 ~~~~g~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~----------------  221 (285)
T cd05632         159 RGRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE----------------  221 (285)
T ss_pred             cCCCCCcCccChHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc----------------
Confidence            33467889999999977 6689999999999999999999999977654322211110000000                


Q ss_pred             CCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCC-----HHHHhcCccccCCCCchh
Q 045787          245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRIT-----AMDALKHEYLIGVENVPL  298 (324)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~~~l~hp~~~~~~~~~~  298 (324)
                              ......++..+.+|+.+||+.||.+||+     +.+++.|+||++....+.
T Consensus       222 --------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~  272 (285)
T cd05632         222 --------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRL  272 (285)
T ss_pred             --------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHHH
Confidence                    0012357888999999999999999999     889999999999977654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.3e-45  Score=297.38  Aligned_cols=289  Identities=42%  Similarity=0.681  Sum_probs=241.7

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCc----eEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeec-CCeE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQ----KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS-RKDV   81 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~----~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~   81 (324)
                      ..|+++..||+|.+|.||+|..+.++.    .||+|.|.-...........-+|+..++.++|||++.+..++.+ +...
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            468999999999999999996554332    68999998776666656667789999999999999999998877 7889


Q ss_pred             EEEEEecCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCC----CcEEEeeccc
Q 045787           82 FLVFEYLDLDLHSFITRHKN----TLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKR----NTVKLADFGL  153 (324)
Q Consensus        82 ~iv~e~~~g~l~~~~~~~~~----~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~----~~v~l~d~g~  153 (324)
                      +++++|.+.+|.+.+..++.    .++...++.++.||+.|+.|||++=+.||||||.|||+. .+    |.|||+|+|+
T Consensus       104 ~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvm-gdgperG~VKIaDlGl  182 (438)
T KOG0666|consen  104 WLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVM-GDGPERGRVKIADLGL  182 (438)
T ss_pred             EEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEe-ccCCccCeeEeecccH
Confidence            99999999999999987643    588999999999999999999999999999999999997 44    8999999999


Q ss_pred             eeeccCCCCcc---cccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC----------hhHHHHHH
Q 045787          154 ARAIGVPQKEY---SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK----------HDHLSLIF  220 (324)
Q Consensus       154 ~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~----------~~~~~~~~  220 (324)
                      ++....+-...   .....|.+|+|||.+.+...|+++.|+|++|||+.||++-.+.|.+..          .+++.+++
T Consensus       183 aR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf  262 (438)
T KOG0666|consen  183 ARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIF  262 (438)
T ss_pred             HHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHH
Confidence            99887554433   234678999999999998999999999999999999999999996533          45788999


Q ss_pred             HHcCCCCcccccchhhhhcccCCCCCCC--------CcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccC
Q 045787          221 SLLGTPTDESWAESTYISEILPLYPHFE--------PANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIG  292 (324)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~  292 (324)
                      .+++.|....|..-....+.........        ..........-++...+|+.+||..||.+|.|++++++|+||.+
T Consensus       263 ~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~  342 (438)
T KOG0666|consen  263 EVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTE  342 (438)
T ss_pred             HHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccccc
Confidence            9999999999988666655532222211        12233344456777999999999999999999999999999998


Q ss_pred             CCCc
Q 045787          293 VENV  296 (324)
Q Consensus       293 ~~~~  296 (324)
                      -+-+
T Consensus       343 d~lp  346 (438)
T KOG0666|consen  343 DPLP  346 (438)
T ss_pred             CCCC
Confidence            7655

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.1e-43  Score=312.59  Aligned_cols=310  Identities=30%  Similarity=0.515  Sum_probs=226.8

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecC------
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR------   78 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------   78 (324)
                      .+.+|++.+.||.|++|.||+|.+..+|..|++|.+.....  ...+.+.+|+++++.++||+++++++.+...      
T Consensus         3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (342)
T cd07854           3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE   80 (342)
T ss_pred             cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence            36899999999999999999999999999999999865543  2346688899999999999999999776543      


Q ss_pred             --------CeEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEee
Q 045787           79 --------KDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLAD  150 (324)
Q Consensus        79 --------~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d  150 (324)
                              ...|+|+||+++++.+.+..  ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.+++.++|+|
T Consensus        81 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d  158 (342)
T cd07854          81 DVGSLTELNSVYIVQEYMETDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD  158 (342)
T ss_pred             ccccccccceEEEEeecccccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence                    35799999999988887754  36899999999999999999999999999999999999985667899999


Q ss_pred             ccceeeccCCCCc---ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHH-HHHHHHcCCC
Q 045787          151 FGLARAIGVPQKE---YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHL-SLIFSLLGTP  226 (324)
Q Consensus       151 ~g~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~  226 (324)
                      ||.+.........   .....++..|+|||.+.+...++.++|||||||++|+|++|+.||...+.... ..........
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~  238 (342)
T cd07854         159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV  238 (342)
T ss_pred             cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            9998765322111   12235677899999886656678999999999999999999999976664322 2222211111


Q ss_pred             Ccccccch-hhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchhhhhhhhc
Q 045787          227 TDESWAES-TYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLINR  305 (324)
Q Consensus       227 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~~~~~~~~  305 (324)
                      ........ ......................+.++.++.++|.+||+.||.+|||+.++++||||+....++..+..   
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~~~~~~~---  315 (342)
T cd07854         239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPFDEPVS---  315 (342)
T ss_pred             ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCCccccCC---
Confidence            11110000 00000000001111122233445788999999999999999999999999999999976554322222   


Q ss_pred             ccCCCCCCCcccceee
Q 045787          306 KKKLGVDNGWAGTQCL  321 (324)
Q Consensus       306 ~~~~~~~~~~~~~~~~  321 (324)
                      ...+..++.|.++..+
T Consensus       316 ~~~~~~~~~~~~~~~~  331 (342)
T cd07854         316 LHPFHIEDELDDILLM  331 (342)
T ss_pred             CCCccccccccccccH
Confidence            2344466666666544

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.9e-44  Score=315.00  Aligned_cols=288  Identities=36%  Similarity=0.617  Sum_probs=227.1

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCe----
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKD----   80 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~----   80 (324)
                      ..++|++.+.||+|++|.||+|.+..++..|++|++............+.+|+.+++.++|+|++++.+++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            4678999999999999999999999999999999987654333334567789999999999999999987765544    


Q ss_pred             --EEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeecc
Q 045787           81 --VFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIG  158 (324)
Q Consensus        81 --~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~  158 (324)
                        .++|+||++++|.+++..  .++++..++.++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+....
T Consensus        93 ~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~-~~~~~kL~dfg~~~~~~  169 (343)
T cd07851          93 QDVYLVTHLMGADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN-EDCELKILDFGLARHTD  169 (343)
T ss_pred             ccEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC-CCCCEEEcccccccccc
Confidence              899999999999888765  4699999999999999999999999999999999999999 89999999999987654


Q ss_pred             CCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHHcCCCCcccccch--h
Q 045787          159 VPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD-HLSLIFSLLGTPTDESWAES--T  235 (324)
Q Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~--~  235 (324)
                      ..   .....+++.|+|||.+.+....+.++||||||+++|++++|..||...... ....+....+.+++..+...  .
T Consensus       170 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  246 (343)
T cd07851         170 DE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSE  246 (343)
T ss_pred             cc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccch
Confidence            22   233456778999999876556789999999999999999999999776643 33444444444433222111  1


Q ss_pred             hhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchh
Q 045787          236 YISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~  298 (324)
                      .......................++..+.++|.+||+.||.+|||+.++++||||++......
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~  309 (343)
T cd07851         247 SARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPED  309 (343)
T ss_pred             hHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCcc
Confidence            111111222223333444455567999999999999999999999999999999998876643

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=5.5e-43  Score=296.07  Aligned_cols=254  Identities=26%  Similarity=0.406  Sum_probs=214.3

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEe
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEY   87 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   87 (324)
                      +|++++.||.|++|.||.+.+..++..+++|.+............+.+|+.++++++|+|++++++++.+++..++++||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            69999999999999999999999999999999887654444456788999999999999999999999999999999999


Q ss_pred             cC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccc
Q 045787           88 LD-LDLHSFITRH-KNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYS  165 (324)
Q Consensus        88 ~~-g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~  165 (324)
                      ++ ++|.+++... ...+++..+..++.+++.+|.+||+.|++|+||+|+||+++ .++.++|+|||.+...........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~-~~~~~kl~d~~~~~~~~~~~~~~~  159 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLT-KAGLIKLGDFGISKILGSEYSMAE  159 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEe-CCCCEEECcCcceEEccccccccc
Confidence            97 5888888765 34689999999999999999999999999999999999999 889999999999887654443334


Q ss_pred             ccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCC
Q 045787          166 RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYP  245 (324)
Q Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (324)
                      ...+++.|.|||.+.+ ...+.++|+||||+++++|++|..||.............. +...                  
T Consensus       160 ~~~~~~~y~ape~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~-~~~~------------------  219 (256)
T cd08221         160 TVVGTPYYMSPELCQG-VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ-GNYT------------------  219 (256)
T ss_pred             ccCCCccccCHhhcCC-CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc-CCCC------------------
Confidence            4567888999999887 5578999999999999999999999977654433222211 1000                  


Q ss_pred             CCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       246 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                              .....++..+.+++.+||..||.+||++.++++|||+
T Consensus       220 --------~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         220 --------PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             --------CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence                    0013578899999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=3.2e-43  Score=297.37  Aligned_cols=254  Identities=28%  Similarity=0.417  Sum_probs=211.6

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEe
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEY   87 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   87 (324)
                      +|++.+.||.|++|.||+|.+..+++.+++|.+............+.+|+.++++++||+++++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            69999999999999999999999999999999986654444456788999999999999999999999999999999999


Q ss_pred             cCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccc
Q 045787           88 LDL-DLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYS  165 (324)
Q Consensus        88 ~~g-~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~  165 (324)
                      ++| +|.+++.... ..+++..+..++.+++.+|.+||++|++|+||+|+||+++..++.++|+|||.+....... ...
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~~~  159 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-KAY  159 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-ccc
Confidence            975 8888887653 4589999999999999999999999999999999999998455678999999988765322 223


Q ss_pred             ccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCC
Q 045787          166 RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYP  245 (324)
Q Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (324)
                      ...++..|+|||.+.+ ...+.++|+||||+++|+|++|+.||...+..............                   
T Consensus       160 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~-------------------  219 (256)
T cd08220         160 TVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA-------------------  219 (256)
T ss_pred             ccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCC-------------------
Confidence            3457788999999887 56789999999999999999999999776644332222110000                   


Q ss_pred             CCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       246 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                              .....++..+.+++.+||..||.+|||+.++++||||
T Consensus       220 --------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         220 --------PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             --------CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence                    0112478889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-43  Score=307.62  Aligned_cols=266  Identities=26%  Similarity=0.431  Sum_probs=215.9

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccC-CCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQE-GVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      ++|++.+.||.|++|+||+|.+..+++.+++|.+....... .....+.+|+..++.++|++++++++.+.+....|+|+
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            47999999999999999999999999999999997654321 23456888999999999999999999999999999999


Q ss_pred             EecCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC-
Q 045787           86 EYLDL-DLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK-  162 (324)
Q Consensus        86 e~~~g-~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~-  162 (324)
                      ||+.| +|.+++.... ..+++..+..++.+++.+|.+||+.|++|+||||+||+++ .++.++|+|||.+........ 
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~~~~~~~  159 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLH-ESGHIMLSDFDLSKQSDVEPPP  159 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEc-CCCCEEEeecchhhcccccccc
Confidence            99975 8888776543 4689999999999999999999999999999999999999 889999999998765432111 


Q ss_pred             ----------------------------cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChh
Q 045787          163 ----------------------------EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD  214 (324)
Q Consensus       163 ----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~  214 (324)
                                                  ......++..|+|||++.+ ..++.++||||||+++|+|++|..||...+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~  238 (316)
T cd05574         160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG-DGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD  238 (316)
T ss_pred             cccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC-CCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence                                        0112246778999999987 56799999999999999999999999766644


Q ss_pred             HHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCC----HHHHhcCccc
Q 045787          215 HLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRIT----AMDALKHEYL  290 (324)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps----~~~~l~hp~~  290 (324)
                      .......  .....                  .      .....++..+.++|.+||..||.+||+    +++++.||||
T Consensus       239 ~~~~~~~--~~~~~------------------~------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~  292 (316)
T cd05574         239 ETFSNIL--KKEVT------------------F------PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFF  292 (316)
T ss_pred             HHHHHHh--cCCcc------------------C------CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchh
Confidence            3222111  00000                  0      001137889999999999999999999    9999999999


Q ss_pred             cCCCCchhhh
Q 045787          291 IGVENVPLVI  300 (324)
Q Consensus       291 ~~~~~~~~~~  300 (324)
                      ++.++..+..
T Consensus       293 ~~~~~~~~~~  302 (316)
T cd05574         293 RGVNWALIRH  302 (316)
T ss_pred             hcCChhhccc
Confidence            9988665544

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2.4e-43  Score=302.10  Aligned_cols=263  Identities=22%  Similarity=0.377  Sum_probs=210.7

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE   86 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   86 (324)
                      ++|++++.||+|++|.||++.+..+++.+++|.+..... ......+.+|+.++++++||+++++++.+..++..++|+|
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   79 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT-VELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE   79 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC-hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence            478999999999999999999999999999999875422 2223568889999999999999999999999999999999


Q ss_pred             ecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcccc
Q 045787           87 YLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSR  166 (324)
Q Consensus        87 ~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~  166 (324)
                      |+++..+...    ..+++..+..++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+......  ....
T Consensus        80 ~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~-~~~~~~l~dfg~~~~~~~~--~~~~  152 (279)
T cd06619          80 FMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVN-TRGQVKLCDFGVSTQLVNS--IAKT  152 (279)
T ss_pred             cCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEEC-CCCCEEEeeCCcceecccc--cccC
Confidence            9997444432    2478889999999999999999999999999999999999 8999999999998765432  2233


Q ss_pred             cccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHH----HHHHHHcCCCCcccccchhhhhcccC
Q 045787          167 DCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHL----SLIFSLLGTPTDESWAESTYISEILP  242 (324)
Q Consensus       167 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (324)
                      ..+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||........    ............              
T Consensus       153 ~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--------------  217 (279)
T cd06619         153 YVGTNAYMAPERISG-EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP--------------  217 (279)
T ss_pred             CCCChhhcCceeecC-CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC--------------
Confidence            467888999999987 5679999999999999999999999965321110    000000000000              


Q ss_pred             CCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchhhhh
Q 045787          243 LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVIL  301 (324)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~~~~  301 (324)
                             ..  .....+++++.+++.+||+.||.+||+++++++||||+..+..+....
T Consensus       218 -------~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~~~~~~~  267 (279)
T cd06619         218 -------PV--LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNAEVV  267 (279)
T ss_pred             -------CC--CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccCccHHHH
Confidence                   00  001246788999999999999999999999999999999988777554

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-43  Score=311.40  Aligned_cols=288  Identities=36%  Similarity=0.626  Sum_probs=223.5

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecC------
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR------   78 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------   78 (324)
                      +.++|.+.+.||.|++|.||+|.+..+|+.+|+|.+............+.+|+.+++.++|||++++++++...      
T Consensus        13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~   92 (342)
T cd07879          13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF   92 (342)
T ss_pred             cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence            46799999999999999999999998999999999876544444445678999999999999999999988654      


Q ss_pred             CeEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeecc
Q 045787           79 KDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIG  158 (324)
Q Consensus        79 ~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~  158 (324)
                      ..+++|+||+..++....   ...+++..+..++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+....
T Consensus        93 ~~~~lv~e~~~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~-~~~~~kL~dfg~~~~~~  168 (342)
T cd07879          93 QDFYLVMPYMQTDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVN-EDCELKILDFGLARHAD  168 (342)
T ss_pred             ceEEEEecccccCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC-CCCCEEEeeCCCCcCCC
Confidence            246999999988776654   23689999999999999999999999999999999999999 89999999999987543


Q ss_pred             CCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHHcCCCCcccccchhh-
Q 045787          159 VPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTY-  236 (324)
Q Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~-  236 (324)
                      .   ......+++.|+|||.+.+...++.++|+||||+++|+|++|+.||...+. .....+....+.+.......... 
T Consensus       169 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (342)
T cd07879         169 A---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK  245 (342)
T ss_pred             C---CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhccc
Confidence            2   222345678899999987656688999999999999999999999987763 33344444444333221111100 


Q ss_pred             -hhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchhh
Q 045787          237 -ISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLV  299 (324)
Q Consensus       237 -~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~~  299 (324)
                       ....................+..+..+.++|.+||+.||.+||++.+++.||||+++++....
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~  309 (342)
T cd07879         246 AAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEE  309 (342)
T ss_pred             chHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccccc
Confidence             011111112222333444456788899999999999999999999999999999999865443

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-44  Score=312.05  Aligned_cols=262  Identities=28%  Similarity=0.465  Sum_probs=211.4

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcC-CCCeeEEEeeeecCCeEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-HENIVRLLDVQSSRKDVF   82 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~   82 (324)
                      +++..|+++++||+||.+.||+|.... .+.||+|.+.....+......+.+|+..|.+|+ |.+|+++++|-..++.+|
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY  436 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY  436 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence            567889999999999999999999754 456677766655555555677999999999996 899999999999999999


Q ss_pred             EEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC
Q 045787           83 LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK  162 (324)
Q Consensus        83 iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~  162 (324)
                      +|||+-+.+|-.++.+.........++.+-.|++.++.++|+.||+|.||||.|+++-  .|.+||+|||.+..+.....
T Consensus       437 mvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV--kG~LKLIDFGIA~aI~~DTT  514 (677)
T KOG0596|consen  437 MVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV--KGRLKLIDFGIANAIQPDTT  514 (677)
T ss_pred             EEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE--eeeEEeeeechhcccCcccc
Confidence            9999999999999998776666668889999999999999999999999999999987  89999999999987754433


Q ss_pred             --cccccccccccCCchhhcC----------CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCccc
Q 045787          163 --EYSRDCVYSPYKAPELLLG----------YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDES  230 (324)
Q Consensus       163 --~~~~~~~~~~y~aPE~~~~----------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  230 (324)
                        -....+||+.||+||.+..          .-..++++||||||||||+|+.|+.||...... ..++..+..+..+-.
T Consensus       515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~-~aKl~aI~~P~~~Ie  593 (677)
T KOG0596|consen  515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ-IAKLHAITDPNHEIE  593 (677)
T ss_pred             ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH-HHHHHhhcCCCcccc
Confidence              2455689999999999853          122578999999999999999999999544322 122222222111111


Q ss_pred             ccchhhhhcccCCCCCCCCcchhhhCCCCC--hhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCC
Q 045787          231 WAESTYISEILPLYPHFEPANLAEKFPNLE--PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVE  294 (324)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~  294 (324)
                                               ++.++  .++.++++.||.+||.+||++.++|+|||++...
T Consensus       594 -------------------------fp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~  634 (677)
T KOG0596|consen  594 -------------------------FPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQP  634 (677)
T ss_pred             -------------------------ccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccccc
Confidence                                     11222  2388999999999999999999999999999743

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.8e-43  Score=300.95  Aligned_cols=260  Identities=30%  Similarity=0.445  Sum_probs=208.5

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF   82 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   82 (324)
                      ....++|++.+.||+|++|.||++.+..+++.+++|++......  ....+.+|+.++++++||+++++++.+..++..+
T Consensus         5 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~--~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~   82 (267)
T cd06646           5 RNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD--DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLW   82 (267)
T ss_pred             cCchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc--hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEE
Confidence            44567899999999999999999999999999999998754322  2356788999999999999999999999999999


Q ss_pred             EEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC
Q 045787           83 LVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        83 iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~  161 (324)
                      +|+||+++ +|.+++.. ..++++..+..++.|++.||.+||+.|++|+|++|+||+++ .++.++|+|||.+.......
T Consensus        83 iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~-~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06646          83 ICMEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLT-DNGDVKLADFGVAAKITATI  160 (267)
T ss_pred             EEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC-CCCCEEECcCccceeecccc
Confidence            99999985 77777654 45689999999999999999999999999999999999999 88999999999988764333


Q ss_pred             CcccccccccccCCchhhcC--CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhc
Q 045787          162 KEYSRDCVYSPYKAPELLLG--YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISE  239 (324)
Q Consensus       162 ~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
                      .......+++.|+|||.+..  ...++.++|+||+|+++|+|++|+.||...+..........                 
T Consensus       161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~-----------------  223 (267)
T cd06646         161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSK-----------------  223 (267)
T ss_pred             cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeec-----------------
Confidence            33334467788999999752  34568899999999999999999999854432211000000                 


Q ss_pred             ccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCcc
Q 045787          240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEY  289 (324)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~  289 (324)
                           ....... ......++..+.+++++||+.||.+||+++++++|+|
T Consensus       224 -----~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         224 -----SNFQPPK-LKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             -----CCCCCCC-CccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence                 0000000 0112256889999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=9.3e-44  Score=312.67  Aligned_cols=291  Identities=37%  Similarity=0.640  Sum_probs=227.6

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhc-CCCCeeEEEeeeecC--C
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSR--K   79 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~   79 (324)
                      ....++|++.+.||+|++|.||++.+..++..+++|.+............+.+|+.+++++ +|||++++++++...  .
T Consensus         3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~   82 (337)
T cd07852           3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK   82 (337)
T ss_pred             chhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence            4567899999999999999999999998899999998865433333345577899999999 999999999988653  4


Q ss_pred             eEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccC
Q 045787           80 DVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGV  159 (324)
Q Consensus        80 ~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~  159 (324)
                      ..|+|+||++++|..++...  .+++..+..++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+.....
T Consensus        83 ~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~-~~~~~kl~d~g~~~~~~~  159 (337)
T cd07852          83 DIYLVFEYMETDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLN-SDCRVKLADFGLARSLSE  159 (337)
T ss_pred             eEEEEecccccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc-CCCcEEEeeccchhcccc
Confidence            68999999999998887664  688899999999999999999999999999999999999 899999999998876543


Q ss_pred             CCC-----cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHHcCCCCcccccc
Q 045787          160 PQK-----EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD-HLSLIFSLLGTPTDESWAE  233 (324)
Q Consensus       160 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~  233 (324)
                      ...     ......+++.|+|||++.+....+.++|+||||+++|+|++|+.||...... .........+.+....+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
T cd07852         160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES  239 (337)
T ss_pred             ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            221     1223357788999999876567789999999999999999999999776633 3344444444443322221


Q ss_pred             h--hhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCc
Q 045787          234 S--TYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENV  296 (324)
Q Consensus       234 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~  296 (324)
                      .  ......................+.++..+.++|.+||+.||.+|||+.++++||||+.....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~  304 (337)
T cd07852         240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNP  304 (337)
T ss_pred             HHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccC
Confidence            1  11112222222333334445556689999999999999999999999999999999987544

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-43  Score=297.49  Aligned_cols=258  Identities=30%  Similarity=0.462  Sum_probs=212.2

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      .++|++.+.||.|++|.||+|.+..+++.+++|++......  ..+.+.+|+.++++++||+++++++.+.+...+|++|
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~   79 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM   79 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh--hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence            46899999999999999999999988999999999865433  3577889999999999999999999999999999999


Q ss_pred             EecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcc
Q 045787           86 EYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY  164 (324)
Q Consensus        86 e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~  164 (324)
                      ||+++ ++.+++......+++..++.++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+..........
T Consensus        80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~~~~~~~  158 (262)
T cd06613          80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLT-EDGDVKLADFGVSAQLTATIAKR  158 (262)
T ss_pred             eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEEC-CCCCEEECccccchhhhhhhhcc
Confidence            99985 77777766556799999999999999999999999999999999999999 89999999999987665433333


Q ss_pred             cccccccccCCchhhcCC--CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccC
Q 045787          165 SRDCVYSPYKAPELLLGY--TGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILP  242 (324)
Q Consensus       165 ~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (324)
                      ....++..|+|||.+.+.  ..++.++|+||||+++|+|++|..||...+..............+..             
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~-------------  225 (262)
T cd06613         159 KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPK-------------  225 (262)
T ss_pred             ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCcc-------------
Confidence            344677789999998762  26788999999999999999999999776643322221111000000             


Q ss_pred             CCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCcc
Q 045787          243 LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEY  289 (324)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~  289 (324)
                                ......++.++.+++++||..||.+||++.+++.|+|
T Consensus       226 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         226 ----------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             ----------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence                      0011245778999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=6.1e-43  Score=306.01  Aligned_cols=289  Identities=39%  Similarity=0.677  Sum_probs=227.4

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeec-CCeEEE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS-RKDVFL   83 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~i   83 (324)
                      ..++|++++.||.|++|.||+|.+..++..+++|.+............+.+|+.+++.++|||++++.+++.. ....++
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l   87 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF   87 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence            5678999999999999999999999999999999987554444445668899999999999999999998865 567899


Q ss_pred             EEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCc
Q 045787           84 VFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE  163 (324)
Q Consensus        84 v~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~  163 (324)
                      ++||+++++...+..  .++++..+..++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+.....   .
T Consensus        88 v~e~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~-~~~~~~l~dfg~~~~~~~---~  161 (328)
T cd07856          88 VTELLGTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILIN-ENCDLKICDFGLARIQDP---Q  161 (328)
T ss_pred             EeehhccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeEC-CCCCEEeCccccccccCC---C
Confidence            999999888877654  3588888999999999999999999999999999999999 889999999998875432   2


Q ss_pred             ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHHcCCCCcccccchh--hhhcc
Q 045787          164 YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAEST--YISEI  240 (324)
Q Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~--~~~~~  240 (324)
                      .....+++.|+|||.+.+...++.++|+||||+++|+|++|..||..... .....+....+.++........  ...+.
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (328)
T cd07856         162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF  241 (328)
T ss_pred             cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHH
Confidence            22335677899999986656689999999999999999999999987764 3334444444554432221100  00111


Q ss_pred             cCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchhh
Q 045787          241 LPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLV  299 (324)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~~  299 (324)
                      ................+.++..+.++|.+||+.||.+||++.+++.||||.....+...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~  300 (328)
T cd07856         242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDE  300 (328)
T ss_pred             HhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccc
Confidence            11122222333344556788999999999999999999999999999999888776554

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.9e-43  Score=334.79  Aligned_cols=266  Identities=32%  Similarity=0.510  Sum_probs=212.8

Q ss_pred             CcccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeec--CC
Q 045787            2 GKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS--RK   79 (324)
Q Consensus         2 ~~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~   79 (324)
                      |....++|++++.||.|+||+||+|.+..++..+++|.+............+..|+.++++++||+|+++++++..  ..
T Consensus         8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~   87 (1021)
T PTZ00266          8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ   87 (1021)
T ss_pred             CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence            5667789999999999999999999999999999999987655444445678899999999999999999998854  45


Q ss_pred             eEEEEEEecC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-------CCcccCCCCCceEeec-------
Q 045787           80 DVFLVFEYLD-LDLHSFITRH---KNTLNLLVIKAILKQILLGLAYCHSL-------KILHRDLKPNNLLIDL-------  141 (324)
Q Consensus        80 ~~~iv~e~~~-g~l~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~-------g~~H~di~p~nIll~~-------  141 (324)
                      .+|+||||++ |+|.+++...   ...+++..++.|+.||+.||.|||+.       +|+|+||||+|||++.       
T Consensus        88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~  167 (1021)
T PTZ00266         88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK  167 (1021)
T ss_pred             EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence            7999999998 5888887653   34699999999999999999999984       4999999999999962       


Q ss_pred             ---------CCCcEEEeeccceeeccCCCCcccccccccccCCchhhcC-CCCCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 045787          142 ---------KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLG-YTGYSTPIDVWAVGCIFAEMITGKPLFPSK  211 (324)
Q Consensus       142 ---------~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~il~~l~~g~~pf~~~  211 (324)
                               ....++|+|||++...... .......+++.|+|||++.+ ...++.++|||||||++|+|++|..||...
T Consensus       168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~-s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        168 ITAQANNLNGRPIAKIGDFGLSKNIGIE-SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             ccccccccCCCCceEEccCCcccccccc-ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                     1235899999998765422 22233468999999999864 245789999999999999999999999655


Q ss_pred             ChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCcccc
Q 045787          212 KHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLI  291 (324)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~  291 (324)
                      +....  +.......+..                         .....+.++.+||..||+.+|.+||++.++|.|||++
T Consensus       247 ~~~~q--li~~lk~~p~l-------------------------pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik  299 (1021)
T PTZ00266        247 NNFSQ--LISELKRGPDL-------------------------PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIK  299 (1021)
T ss_pred             CcHHH--HHHHHhcCCCC-------------------------CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHh
Confidence            42211  11111110000                         0124678899999999999999999999999999998


Q ss_pred             CCCC
Q 045787          292 GVEN  295 (324)
Q Consensus       292 ~~~~  295 (324)
                      .+..
T Consensus       300 ~i~~  303 (1021)
T PTZ00266        300 NVGP  303 (1021)
T ss_pred             hcCC
Confidence            7754

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.4e-43  Score=300.10  Aligned_cols=257  Identities=27%  Similarity=0.418  Sum_probs=208.1

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      .++|++.+.||.|++|.||+|.+..+++.+++|.+......  ....+.+|+.+++.++||+++++++.+...+..++|+
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~   85 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGE--DFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM   85 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence            46899999999999999999999999999999998755322  2345778999999999999999999999999999999


Q ss_pred             EecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcc
Q 045787           86 EYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY  164 (324)
Q Consensus        86 e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~  164 (324)
                      ||+++ +|.+++.. .+.+++..+..++.+++.+|.+||+.|++|+||+|+||+++ .++.++|+|||.+..........
T Consensus        86 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~-~~~~~~l~dfg~~~~~~~~~~~~  163 (267)
T cd06645          86 EFCGGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLT-DNGHVKLADFGVSAQITATIAKR  163 (267)
T ss_pred             eccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC-CCCCEEECcceeeeEccCccccc
Confidence            99985 77777655 45699999999999999999999999999999999999999 88999999999987665443334


Q ss_pred             cccccccccCCchhhc--CCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccC
Q 045787          165 SRDCVYSPYKAPELLL--GYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILP  242 (324)
Q Consensus       165 ~~~~~~~~y~aPE~~~--~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (324)
                      ....+++.|+|||++.  ....++.++|+||||+++|+|++|..||..................                
T Consensus       164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~----------------  227 (267)
T cd06645         164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQ----------------  227 (267)
T ss_pred             ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCC----------------
Confidence            4457888999999974  2345788999999999999999999998654432211111100000                


Q ss_pred             CCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCcc
Q 045787          243 LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEY  289 (324)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~  289 (324)
                            +... .....++..+.++|.+||..||.+||++++++.|||
T Consensus       228 ------~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         228 ------PPKL-KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             ------CCcc-cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence                  0000 011246788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.3e-43  Score=309.68  Aligned_cols=286  Identities=36%  Similarity=0.623  Sum_probs=222.3

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCC-----
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK-----   79 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----   79 (324)
                      ..++|++++.||+|++|.||++.+..++..||+|.+............+.+|+.++++++||||+++++++..+.     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            467899999999999999999999999999999998654333333456789999999999999999999886553     


Q ss_pred             -eEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeecc
Q 045787           80 -DVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIG  158 (324)
Q Consensus        80 -~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~  158 (324)
                       .+++|++++++++..++..  ..+++..++.++.|++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+....
T Consensus        93 ~~~~lv~e~~~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~-~~~~~kl~dfg~~~~~~  169 (343)
T cd07880          93 HDFYLVMPFMGTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN-EDCELKILDFGLARQTD  169 (343)
T ss_pred             ceEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc-CCCCEEEeecccccccc
Confidence             4689999998888877654  4689999999999999999999999999999999999999 88999999999987654


Q ss_pred             CCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHH-HHHHHHcCCCCcccccch---
Q 045787          159 VPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHL-SLIFSLLGTPTDESWAES---  234 (324)
Q Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~---  234 (324)
                      ..   .....+++.|+|||.+.+...++.++|+||||+++|++++|..||...+.... .........++.. +...   
T Consensus       170 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  245 (343)
T cd07880         170 SE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE-FVQKLQS  245 (343)
T ss_pred             cC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH-HHHhhcc
Confidence            22   22335678899999987655678999999999999999999999987764322 2222322222211 1110   


Q ss_pred             hhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCch
Q 045787          235 TYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP  297 (324)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~  297 (324)
                      ......................+.++..+.++|.+||+.||.+|||+.+++.||||+......
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~  308 (343)
T cd07880         246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPE  308 (343)
T ss_pred             hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcc
Confidence            001111112222223334445567889999999999999999999999999999999886543

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=3.8e-43  Score=301.43  Aligned_cols=262  Identities=26%  Similarity=0.417  Sum_probs=207.6

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHH-HHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSL-LKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      ++|++++.||+|+||.||+|.+..+|+.||+|.+........ ...+..|+.. ++.++|||++++++++..++..|+++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~   79 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM   79 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence            479999999999999999999999999999999876543222 2344456554 56668999999999999999999999


Q ss_pred             EecCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCCCCceEeecCCCcEEEeeccceeeccCCC
Q 045787           86 EYLDLDLHSFITRH---KNTLNLLVIKAILKQILLGLAYCHSL-KILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        86 e~~~g~l~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~-g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~  161 (324)
                      ||++|++.+++...   ...+++..++.++.|++.||.+||++ +++|+||+|+||+++ .++.++|+|||.+...... 
T Consensus        80 e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~-~~~~~kl~dfg~~~~~~~~-  157 (283)
T cd06617          80 EVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLIN-RNGQVKLCDFGISGYLVDS-  157 (283)
T ss_pred             hhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEEC-CCCCEEEeecccccccccc-
Confidence            99999888777652   34689999999999999999999997 999999999999999 8999999999998765422 


Q ss_pred             CcccccccccccCCchhhcCC---CCCCCchhhHHHHHHHHHHHhCCCCCCCCCh--hHHHHHHHHcCCCCcccccchhh
Q 045787          162 KEYSRDCVYSPYKAPELLLGY---TGYSTPIDVWAVGCIFAEMITGKPLFPSKKH--DHLSLIFSLLGTPTDESWAESTY  236 (324)
Q Consensus       162 ~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  236 (324)
                      .......++..|+|||.+.+.   ..++.++|+||||+++|+|++|+.||.....  +.......   .....       
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~-------  227 (283)
T cd06617         158 VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE---EPSPQ-------  227 (283)
T ss_pred             cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh---cCCCC-------
Confidence            122224577889999998642   3468899999999999999999999964332  11111110   00000       


Q ss_pred             hhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchh
Q 045787          237 ISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~  298 (324)
                             .          ....++.++.++|.+||..||.+||++.++++||||+.......
T Consensus       228 -------~----------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~  272 (283)
T cd06617         228 -------L----------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNT  272 (283)
T ss_pred             -------C----------CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcccccH
Confidence                   0          00147889999999999999999999999999999999876643

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=5.7e-43  Score=298.58  Aligned_cols=255  Identities=27%  Similarity=0.408  Sum_probs=206.2

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhc-CCCCeeEEEeeeec------C
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSS------R   78 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~------~   78 (324)
                      .++|++.+.||.|++|.||++.+..+++.+++|.+.....   ....+.+|+.+++++ +|+|++++++++..      +
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            4689999999999999999999999999999999875432   235678899999998 69999999998864      2


Q ss_pred             CeEEEEEEecC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceee
Q 045787           79 KDVFLVFEYLD-LDLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARA  156 (324)
Q Consensus        79 ~~~~iv~e~~~-g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~  156 (324)
                      ...|+++||++ ++|.+++.... ..+++..+..++.|++.||.+||++|++|+||+|+||+++ +++.++|+|||.+..
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~-~~~~~~l~Dfg~~~~  160 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQ  160 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEEC-CCCCEEEccCCCcee
Confidence            46899999998 48888877643 4689999999999999999999999999999999999999 889999999999876


Q ss_pred             ccCCCCcccccccccccCCchhhcC----CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCccccc
Q 045787          157 IGVPQKEYSRDCVYSPYKAPELLLG----YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWA  232 (324)
Q Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  232 (324)
                      ............+++.|+|||++.+    ...++.++|+||+|+++|+|++|..||.............  ..+.     
T Consensus       161 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~--~~~~-----  233 (272)
T cd06637         161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP--RNPA-----  233 (272)
T ss_pred             cccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHh--cCCC-----
Confidence            5433333344567888999999863    2457889999999999999999999996554322211110  0000     


Q ss_pred             chhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          233 ESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                                         .......++..+.+++.+||..||.+|||+.+++.||||
T Consensus       234 -------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         234 -------------------PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             -------------------CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence                               000112467889999999999999999999999999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=7.5e-43  Score=303.07  Aligned_cols=271  Identities=28%  Similarity=0.404  Sum_probs=220.4

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   83 (324)
                      -..+|++.+.||+|++|.||++.+..+++.|++|.+..... .......+.+|+.+++.++|||++++++++.+++..++
T Consensus        13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l   92 (307)
T cd06607          13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL   92 (307)
T ss_pred             cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence            45679999999999999999999998999999999865432 22223567889999999999999999999999999999


Q ss_pred             EEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCc
Q 045787           84 VFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE  163 (324)
Q Consensus        84 v~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~  163 (324)
                      |+||+.|++.+.+.....++++..+..++.+++.+|.+||+.|++|+||+|+||+++ .++.++|+|||.+......   
T Consensus        93 v~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~-~~~~~kL~dfg~~~~~~~~---  168 (307)
T cd06607          93 VMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLT-EPGTVKLADFGSASLVSPA---  168 (307)
T ss_pred             EHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEC-CCCCEEEeecCcceecCCC---
Confidence            999999999998887667899999999999999999999999999999999999999 8899999999988755322   


Q ss_pred             ccccccccccCCchhhcC--CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhccc
Q 045787          164 YSRDCVYSPYKAPELLLG--YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEIL  241 (324)
Q Consensus       164 ~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (324)
                       ....+++.|+|||++.+  ...++.++||||||+++|+|++|..||...+.......... ..++.             
T Consensus       169 -~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~-~~~~~-------------  233 (307)
T cd06607         169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-NDSPT-------------  233 (307)
T ss_pred             -CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc-CCCCC-------------
Confidence             22356778999998752  35578899999999999999999999976654332211110 00000             


Q ss_pred             CCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchhhhhhhhcc
Q 045787          242 PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLINRK  306 (324)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~~~~~~~~~  306 (324)
                           .       ....++..+.++|.+||..||.+||++.+++.||||...........+..+.
T Consensus       234 -----~-------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~~~~~~~~  286 (307)
T cd06607         234 -----L-------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERPPTVIIDLIQRT  286 (307)
T ss_pred             -----C-------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccCCcHHHHHHHHHH
Confidence                 0       0013677899999999999999999999999999999887666555555444

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=8.1e-43  Score=296.69  Aligned_cols=260  Identities=25%  Similarity=0.401  Sum_probs=211.2

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE   86 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   86 (324)
                      ++|++.+.||.|++|+||+|....++..+++|++....... ..+.+.+|+..++.++|++++++++.+......++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   79 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP   79 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence            57999999999999999999998889999999987544333 45678899999999999999999999999999999999


Q ss_pred             ecCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCc
Q 045787           87 YLDL-DLHSFITRHK--NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE  163 (324)
Q Consensus        87 ~~~g-~l~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~  163 (324)
                      ++.| ++.+.+....  ..+++..++.++.+++.||.+||+.|++|+||+|+||+++ +++.++|+|||.+.........
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~-~~~~~~l~df~~~~~~~~~~~~  158 (267)
T cd06610          80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLG-EDGSVKIADFGVSASLADGGDR  158 (267)
T ss_pred             ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEc-CCCCEEEcccchHHHhccCccc
Confidence            9975 7777776532  4689999999999999999999999999999999999999 8899999999988766533222


Q ss_pred             ----ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhc
Q 045787          164 ----YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISE  239 (324)
Q Consensus       164 ----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
                          .....++..|+|||++......+.++|+||||+++++|++|+.||...+.........  ...+. .         
T Consensus       159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~--~~~~~-~---------  226 (267)
T cd06610         159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTL--QNDPP-S---------  226 (267)
T ss_pred             cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHh--cCCCC-C---------
Confidence                1233577889999998875578999999999999999999999997655432211111  11000 0         


Q ss_pred             ccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                                .........++..+.+++.+||..||.+||++.++++||||
T Consensus       227 ----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         227 ----------LETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             ----------cCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence                      00000134678899999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=4.2e-43  Score=300.29  Aligned_cols=271  Identities=25%  Similarity=0.420  Sum_probs=221.1

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      ...|+.++.||.|++|.||+|.+..++..+++|.+...... .....+.+|+.+++++.|++++++++.+.++...++|+
T Consensus         3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06640           3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            45789999999999999999999988999999998754322 12456888999999999999999999999999999999


Q ss_pred             EecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcc
Q 045787           86 EYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY  164 (324)
Q Consensus        86 e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~  164 (324)
                      ||++| +|.+++..  +++++..+..++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+..........
T Consensus        82 e~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06640          82 EYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKR  158 (277)
T ss_pred             ecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEc-CCCCEEEcccccceeccCCcccc
Confidence            99975 88877654  4689999999999999999999999999999999999999 88999999999987665433333


Q ss_pred             cccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCC
Q 045787          165 SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLY  244 (324)
Q Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (324)
                      ....++..|+|||++.+ ...+.++|+||||+++|+|++|..||................                    
T Consensus       159 ~~~~~~~~y~apE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~--------------------  217 (277)
T cd06640         159 NTFVGTPFWMAPEVIQQ-SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN--------------------  217 (277)
T ss_pred             ccccCcccccCHhHhcc-CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCC--------------------
Confidence            33456778999999877 567999999999999999999999997655332221110000                    


Q ss_pred             CCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCC-chhhhhhhhcccC
Q 045787          245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVEN-VPLVILLINRKKK  308 (324)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~-~~~~~~~~~~~~~  308 (324)
                             .......++..+.+++.+||+.||.+||++.++++||||..... .+....++.++++
T Consensus       218 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~~~~~~~~~~~  275 (277)
T cd06640         218 -------PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKKTSYLTELIDRFKR  275 (277)
T ss_pred             -------CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcchhhhHHHHHHHHHHh
Confidence                   01112246788999999999999999999999999999998886 5556677777654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=6.9e-43  Score=296.63  Aligned_cols=254  Identities=29%  Similarity=0.484  Sum_probs=210.6

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeec--CCeEEEEE
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS--RKDVFLVF   85 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv~   85 (324)
                      +|++.+.||.|++|.||+|.+..++..+++|.+..........+.+.+|+.++++++|++++++++.+..  +...++++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            5899999999999999999999999999999987654444344668889999999999999999997753  45689999


Q ss_pred             EecC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH-----hCCCcccCCCCCceEeecCCCcEEEeeccceee
Q 045787           86 EYLD-LDLHSFITRH---KNTLNLLVIKAILKQILLGLAYCH-----SLKILHRDLKPNNLLIDLKRNTVKLADFGLARA  156 (324)
Q Consensus        86 e~~~-g~l~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~Lh-----~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~  156 (324)
                      ||++ ++|.+++...   ..++++..++.++.+++.||.+||     +.+++|+||+|+||+++ .++.++|+|||.+..
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~-~~~~~kl~d~g~~~~  159 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLD-ANNNVKLGDFGLAKI  159 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEe-cCCCEEEeccccccc
Confidence            9997 5888887654   457899999999999999999999     88999999999999999 889999999999887


Q ss_pred             ccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhh
Q 045787          157 IGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY  236 (324)
Q Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (324)
                      ............+++.|+|||.+.+ ..++.++|+||||+++++|++|..||...+...+.........           
T Consensus       160 ~~~~~~~~~~~~~~~~~~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----------  227 (265)
T cd08217         160 LGHDSSFAKTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKF-----------  227 (265)
T ss_pred             ccCCcccccccccCCCccChhhhcC-CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCC-----------
Confidence            6543332334467888999999877 5578999999999999999999999987764443332221100           


Q ss_pred             hhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          237 ISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                                      ......++..+.+++.+||+.+|.+||++.++++|||+
T Consensus       228 ----------------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         228 ----------------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             ----------------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence                            01122577899999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=8.9e-43  Score=296.60  Aligned_cols=253  Identities=29%  Similarity=0.526  Sum_probs=205.7

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCC-------CchHHHHHHHHHHhcCCCCeeEEEeeeecCCe
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEG-------VPSYIIREVSLLKELEHENIVRLLDVQSSRKD   80 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   80 (324)
                      +|++.+.||.|++|.||+|.+..++..+++|.+........       ..+.+.+|+.++++++||+++++++++.....
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            58899999999999999999988899999999875543211       12457889999999999999999999999999


Q ss_pred             EEEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccC
Q 045787           81 VFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGV  159 (324)
Q Consensus        81 ~~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~  159 (324)
                      .++++||+++ +|.+++... +.+++..+..++.+++.||.+||+.|++|+||+|+||+++ +++.++|+|||.+.....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~-~~~~~~l~dfg~~~~~~~  158 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVD-NKGGIKISDFGISKKLEA  158 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEc-CCCCEEecccCCCccccc
Confidence            9999999975 777777654 5689999999999999999999999999999999999999 899999999998876642


Q ss_pred             CCC------cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccc
Q 045787          160 PQK------EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAE  233 (324)
Q Consensus       160 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  233 (324)
                      ...      ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+.....  ......        
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~~--------  227 (267)
T cd06628         159 NSLSTKTNGARPSLQGSVFWMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI--FKIGEN--------  227 (267)
T ss_pred             ccccCCccccccccCCCcCccChhHhcc-CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHH--HHHhcc--------
Confidence            111      1122346778999999877 56789999999999999999999999765432211  111000        


Q ss_pred             hhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          234 STYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                                       ........++..+.++|++||+.||.+||++.++++||||
T Consensus       228 -----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         228 -----------------ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             -----------------CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence                             0001113578899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-46  Score=302.55  Aligned_cols=267  Identities=27%  Similarity=0.476  Sum_probs=228.3

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEe
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEY   87 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   87 (324)
                      -|.++++||+|++|.||+|+++.+|..+|+|.++..+.    .+.+-+|+.++++...|++|++++.|..+..++|||||
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD----LQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY  109 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD----LQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY  109 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch----HHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence            37789999999999999999999999999999876543    45688999999999999999999999999999999999


Q ss_pred             cC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcccc
Q 045787           88 LD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSR  166 (324)
Q Consensus        88 ~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~  166 (324)
                      |+ |+.-+.+..+++++++.++..++++.+.+|+|||...-+|+|||..|||++ .+|..||.|||.+-.+...-.....
T Consensus       110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLN-T~G~AKLADFGVAGQLTDTMAKRNT  188 (502)
T KOG0574|consen  110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLN-TDGIAKLADFGVAGQLTDTMAKRNT  188 (502)
T ss_pred             cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEc-ccchhhhhhccccchhhhhHHhhCc
Confidence            98 899999999999999999999999999999999999999999999999999 9999999999998766544445566


Q ss_pred             cccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCC
Q 045787          167 DCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPH  246 (324)
Q Consensus       167 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (324)
                      ..|||.|+|||++.. ..|..++||||||++..||..|++||..-.+-.  .++-+...|++ .+               
T Consensus       189 VIGTPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR--AIFMIPT~PPP-TF---------------  249 (502)
T KOG0574|consen  189 VIGTPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR--AIFMIPTKPPP-TF---------------  249 (502)
T ss_pred             cccCcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCcccccccc--eeEeccCCCCC-CC---------------
Confidence            789999999999987 667999999999999999999999996544211  11111111111 11               


Q ss_pred             CCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchhhhhhhhc
Q 045787          247 FEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLINR  305 (324)
Q Consensus       247 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~~~~~~~~  305 (324)
                             ......+.++.+||++||.+.|++|-|+.++++|||.++.+...+...+++.
T Consensus       250 -------~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g~~I~~~~I~~  301 (502)
T KOG0574|consen  250 -------KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPGCDIMQLMIQD  301 (502)
T ss_pred             -------CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCcccHHHHHHHH
Confidence                   1112467888999999999999999999999999999999999888777654

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=5.3e-43  Score=304.03  Aligned_cols=280  Identities=25%  Similarity=0.395  Sum_probs=211.4

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE   86 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   86 (324)
                      ++|++.+.||.|++|.||++.+..++..+++|.+..... ......+.+|++++++++|||++++++.+..++.+++|+|
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   79 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK-PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME   79 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence            479999999999999999999999999999998865422 2223557889999999999999999999999999999999


Q ss_pred             ecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcc
Q 045787           87 YLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS-LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY  164 (324)
Q Consensus        87 ~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~  164 (324)
                      |++| +|.+++... +.+++..+..++.+++.||.|||+ .|++|+||+|+||+++ .++.++|+|||.+......  ..
T Consensus        80 y~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~--~~  155 (308)
T cd06615          80 HMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDS--MA  155 (308)
T ss_pred             ccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEe-cCCcEEEccCCCccccccc--cc
Confidence            9985 787777654 568999999999999999999997 5999999999999999 8899999999987654322  12


Q ss_pred             cccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccc-----------
Q 045787          165 SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAE-----------  233 (324)
Q Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----------  233 (324)
                      ....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+..................-..           
T Consensus       156 ~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (308)
T cd06615         156 NSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSP  234 (308)
T ss_pred             ccCCCCcCccChhHhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCcc
Confidence            33467888999999876 567899999999999999999999997665443332222111000000000           


Q ss_pred             -hhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCC
Q 045787          234 -STYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVE  294 (324)
Q Consensus       234 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~  294 (324)
                       .....+............  .-...++.++.+++.+||..||++||++.++++||||.+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  294 (308)
T cd06615         235 RPMAIFELLDYIVNEPPPK--LPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAE  294 (308)
T ss_pred             chhhHHHHHHHHhcCCCcc--CcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcc
Confidence             000000000000000000  00013677899999999999999999999999999998754

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-42  Score=298.00  Aligned_cols=277  Identities=41%  Similarity=0.780  Sum_probs=215.8

Q ss_pred             cceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhc---CCCCeeEEEeeeecCCe-----
Q 045787            9 YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL---EHENIVRLLDVQSSRKD-----   80 (324)
Q Consensus         9 y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~-----   80 (324)
                      |++.+.||.|++|.||++.++.+++.+++|.+............+.+|+.+++++   +|++++++++.+...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            7899999999999999999998899999999976554433345566788877766   59999999999987776     


Q ss_pred             EEEEEEecCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccC
Q 045787           81 VFLVFEYLDLDLHSFITRHKN-TLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGV  159 (324)
Q Consensus        81 ~~iv~e~~~g~l~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~  159 (324)
                      .++++||+++++.+++..... .+++..++.++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+.....
T Consensus        81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~-~~~~~~l~dfg~~~~~~~  159 (287)
T cd07838          81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVT-SDGQVKIADFGLARIYSF  159 (287)
T ss_pred             eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEc-cCCCEEEeccCcceeccC
Confidence            999999999999888876443 589999999999999999999999999999999999999 889999999999877643


Q ss_pred             CCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHHcCCCCcccccchhhhh
Q 045787          160 PQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD-HLSLIFSLLGTPTDESWAESTYIS  238 (324)
Q Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  238 (324)
                      .. ......++..|+|||++.+ ..++.++|+||||+++|+|++|.+||...... ....+......+....+...... 
T Consensus       160 ~~-~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  236 (287)
T cd07838         160 EM-ALTSVVVTLWYRAPEVLLQ-SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSL-  236 (287)
T ss_pred             Cc-ccccccccccccChHHhcc-CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCccc-
Confidence            32 2223346778999999987 56789999999999999999999999876643 33344443333332222211110 


Q ss_pred             cccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          239 EILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                       ....+............+.++..+.++|.+||+.||.+||++.++++||||
T Consensus       237 -~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         237 -PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             -chhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence             011112222222344445678889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.5e-42  Score=304.41  Aligned_cols=286  Identities=36%  Similarity=0.622  Sum_probs=221.6

Q ss_pred             CcceeEeecccCceEEEEEEEccC--CceEEEEEeeeccccCCCchHHHHHHHHHHhc-CCCCeeEEEeeeec----CCe
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVT--GQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSS----RKD   80 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~----~~~   80 (324)
                      +|++.+.||.|++|.||++.+...  +..||+|.+............+.+|+.+++++ +||||+++++....    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            589999999999999999999877  88999999875443333445678899999999 59999999986432    246


Q ss_pred             EEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           81 VFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        81 ~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      .++++++++++|.+.+.. ...+++..++.++.|++.||.+||+.|++|+||||+||+++ .++.++|+|||.+......
T Consensus        81 ~~~~~e~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~-~~~~~kl~Dfg~a~~~~~~  158 (332)
T cd07857          81 LYLYEELMEADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVN-ADCELKICDFGLARGFSEN  158 (332)
T ss_pred             EEEEEecccCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEc-CCCCEEeCcCCCceecccc
Confidence            889999999999888865 34689999999999999999999999999999999999999 8899999999998765422


Q ss_pred             CC----cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHHcCCCCcccccchh
Q 045787          161 QK----EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAEST  235 (324)
Q Consensus       161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~  235 (324)
                      ..    ......+++.|+|||++.+...++.++|+||||+++|++++|.+||...+. ..........+.++...+....
T Consensus       159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (332)
T cd07857         159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG  238 (332)
T ss_pred             cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence            11    122346788899999987656789999999999999999999999987663 3444555555554433221110


Q ss_pred             --hhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCC
Q 045787          236 --YISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVEN  295 (324)
Q Consensus       236 --~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~  295 (324)
                        .....................+.++..+.+++.+||+.||.+|||+.+++.||||++..+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~  300 (332)
T cd07857         239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHD  300 (332)
T ss_pred             hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcC
Confidence              001111111122223333445567889999999999999999999999999999987765

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.7e-43  Score=299.38  Aligned_cols=258  Identities=26%  Similarity=0.474  Sum_probs=211.9

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE   86 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   86 (324)
                      ++|++.+.||.|++|.||+|.+..+++.+++|.+...... .....+.+|+.++++++||+++++++.+..+..+++++|
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE-AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME   79 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh-HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence            4789999999999999999999999999999998765432 334568899999999999999999999999999999999


Q ss_pred             ecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcc
Q 045787           87 YLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS-LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY  164 (324)
Q Consensus        87 ~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~  164 (324)
                      |++ ++|.+++.....++++..+..++.+++.+|.+||+ .|++|+||+|+||+++ .++.++|+|||.+......... 
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~-~~~~~~l~d~g~~~~~~~~~~~-  157 (265)
T cd06605          80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVN-SRGQIKLCDFGVSGQLVNSLAK-  157 (265)
T ss_pred             ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEEC-CCCCEEEeecccchhhHHHHhh-
Confidence            999 58888887765789999999999999999999999 9999999999999999 8999999999988655322211 


Q ss_pred             cccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh---hHHHHHHHHcCCCCcccccchhhhhccc
Q 045787          165 SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH---DHLSLIFSLLGTPTDESWAESTYISEIL  241 (324)
Q Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (324)
                       ...++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.   ...............             
T Consensus       158 -~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-------------  222 (265)
T cd06605         158 -TFVGTSSYMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPP-------------  222 (265)
T ss_pred             -cccCChhccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCC-------------
Confidence             1567788999999977 5789999999999999999999999965531   111111111111000             


Q ss_pred             CCCCCCCCcchhhhCC-CCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCC
Q 045787          242 PLYPHFEPANLAEKFP-NLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVE  294 (324)
Q Consensus       242 ~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~  294 (324)
                                  .... .++..+.++|.+||..||.+|||+.+++.||||+.-+
T Consensus       223 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~~  264 (265)
T cd06605         223 ------------RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKYE  264 (265)
T ss_pred             ------------CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhccc
Confidence                        0001 2788899999999999999999999999999998654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-42  Score=297.15  Aligned_cols=256  Identities=29%  Similarity=0.423  Sum_probs=206.9

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhc-CCCCeeEEEeeeecCC-----
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRK-----   79 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~-----   79 (324)
                      .++|++.+.||.|++|.||+|.+..+++.+++|++......   .+.+.+|+.+++++ .|+|++++++.+....     
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE---EEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchh---HHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            58999999999999999999999988999999998755432   35688999999999 6999999999986543     


Q ss_pred             -eEEEEEEecCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccce
Q 045787           80 -DVFLVFEYLDL-DLHSFITRH---KNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLA  154 (324)
Q Consensus        80 -~~~iv~e~~~g-~l~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~  154 (324)
                       .+++|+||+++ +|.+.+...   +..+++..++.++.|++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~-~~~~~~l~d~~~~  160 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLT-KNAEVKLVDFGVS  160 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEc-cCCeEEECCCccc
Confidence             58999999985 777776543   35789999999999999999999999999999999999999 8899999999998


Q ss_pred             eeccCCCCcccccccccccCCchhhcC----CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCccc
Q 045787          155 RAIGVPQKEYSRDCVYSPYKAPELLLG----YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDES  230 (324)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  230 (324)
                      ..............+++.|+|||++..    ...++.++|+||||+++|+|++|+.||...........  ....+... 
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~--~~~~~~~~-  237 (275)
T cd06608         161 AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFK--IPRNPPPT-  237 (275)
T ss_pred             eecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHH--hhccCCCC-
Confidence            766544444444567888999999753    24467899999999999999999999975443222111  11110000 


Q ss_pred             ccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          231 WAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                                            ......++..+.++|.+||..||++|||+.++++|||+
T Consensus       238 ----------------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         238 ----------------------LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             ----------------------CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence                                  00112367889999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-44  Score=305.10  Aligned_cols=268  Identities=24%  Similarity=0.376  Sum_probs=222.2

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeecc-ccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQT-EQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF   82 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   82 (324)
                      +..+.|+..+.||+|+||.|+-++...+|+.||.|.+.+.. ..........+|-.++++++.++||.+-..|++.+.+|
T Consensus       182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC  261 (591)
T KOG0986|consen  182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC  261 (591)
T ss_pred             ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence            56788999999999999999999999999999999987654 22333455678999999999999999999999999999


Q ss_pred             EEEEecCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           83 LVFEYLDL-DLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        83 iv~e~~~g-~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      +|+..++| +|.-.+-+.+ ..+++..+..++.+|+.||.+||+.+||+||+||+|||+| +.|+++|+|+|++..+...
T Consensus       262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLD-d~GhvRISDLGLAvei~~g  340 (591)
T KOG0986|consen  262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLD-DHGHVRISDLGLAVEIPEG  340 (591)
T ss_pred             EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeec-cCCCeEeeccceEEecCCC
Confidence            99999986 5544443333 3699999999999999999999999999999999999999 9999999999999988744


Q ss_pred             CCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcc
Q 045787          161 QKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEI  240 (324)
Q Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (324)
                      .. .....||.+|||||++.+ ..|+.+.|.|||||+||+|+.|+.||.......-........                
T Consensus       341 ~~-~~~rvGT~GYMAPEvl~n-e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~----------------  402 (591)
T KOG0986|consen  341 KP-IRGRVGTVGYMAPEVLQN-EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRT----------------  402 (591)
T ss_pred             Cc-cccccCcccccCHHHHcC-CcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHH----------------
Confidence            33 333489999999999998 559999999999999999999999997655332211111111                


Q ss_pred             cCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCC-----HHHHhcCccccCCCCchh
Q 045787          241 LPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRIT-----AMDALKHEYLIGVENVPL  298 (324)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~~~l~hp~~~~~~~~~~  298 (324)
                              .....+....++++++++.+.+|++||.+|+.     ++++.+||||+.+++..+
T Consensus       403 --------~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rl  457 (591)
T KOG0986|consen  403 --------LEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRL  457 (591)
T ss_pred             --------hcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHH
Confidence                    11122223478999999999999999999984     779999999999998776

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.3e-42  Score=293.94  Aligned_cols=255  Identities=29%  Similarity=0.456  Sum_probs=210.5

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEe
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEY   87 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   87 (324)
                      +|++.+.||.|++|.||++.+..+|..+++|.+..........+.+.+|+.+++.++|++++++++.+..+...++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            68999999999999999999999999999999877544334456788999999999999999999999999999999999


Q ss_pred             cC-CCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccc
Q 045787           88 LD-LDLHSFITRHKN-TLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYS  165 (324)
Q Consensus        88 ~~-g~l~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~  165 (324)
                      +. ++|.+++..... .+++..+..++.+++.||.+||+.|++|+||+|+||+++..+..++|+|||.+...........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~  160 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY  160 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCccccc
Confidence            97 488888766443 5789999999999999999999999999999999999993335679999998877654333333


Q ss_pred             ccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCC
Q 045787          166 RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYP  245 (324)
Q Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (324)
                      ...+++.|+|||++.+ ..++.++|+||||+++++|++|..||...+.........  ...                   
T Consensus       161 ~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~-------------------  218 (257)
T cd08225         161 TCVGTPYYLSPEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKIC--QGY-------------------  218 (257)
T ss_pred             ccCCCccccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh--ccc-------------------
Confidence            3457788999999877 567899999999999999999999997665433222111  000                   


Q ss_pred             CCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       246 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                            .....+.++..+.++|.+|+..+|.+|||+.++++||||
T Consensus       219 ------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         219 ------FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             ------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence                  001123578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-42  Score=306.54  Aligned_cols=287  Identities=36%  Similarity=0.605  Sum_probs=219.9

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecC------
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR------   78 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------   78 (324)
                      ..++|++.+.||+|++|.||++.+..+++.||+|.+............+.+|+.++++++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (345)
T cd07877          15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   94 (345)
T ss_pred             ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence            45889999999999999999999998999999999876543333345677899999999999999999987543      


Q ss_pred             CeEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeecc
Q 045787           79 KDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIG  158 (324)
Q Consensus        79 ~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~  158 (324)
                      ...|++++++++++.+.+..  ..+++..++.++.|++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+....
T Consensus        95 ~~~~lv~~~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~-~~~~~kl~dfg~~~~~~  171 (345)
T cd07877          95 NDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLARHTD  171 (345)
T ss_pred             ccEEEEehhcccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEc-CCCCEEEeccccccccc
Confidence            34789999998888877654  3589999999999999999999999999999999999999 88999999999887543


Q ss_pred             CCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhH-HHHHHHHcCCCCcccccchh--
Q 045787          159 VPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDH-LSLIFSLLGTPTDESWAEST--  235 (324)
Q Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~--  235 (324)
                      .   ......+++.|+|||.+.+...++.++|+||||+++|+|++|..||...+... ...+....+.++...+....  
T Consensus       172 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (345)
T cd07877         172 D---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE  248 (345)
T ss_pred             c---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccH
Confidence            2   22334567889999998775667899999999999999999999997766433 33333333333322221110  


Q ss_pred             hhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCch
Q 045787          236 YISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP  297 (324)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~  297 (324)
                      ........................++.+.++|.+||+.||.+||++.++++||||++...+.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~  310 (345)
T cd07877         249 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD  310 (345)
T ss_pred             hHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCC
Confidence            00011111111111222222335688899999999999999999999999999999876544

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=3.1e-43  Score=303.16  Aligned_cols=269  Identities=25%  Similarity=0.411  Sum_probs=217.3

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE   86 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   86 (324)
                      +.|.....||.|++|.||++.+..++..+++|.+......  ..+.+.+|+.+++.++|+|++++++.+...+..++|+|
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e   99 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQ--RRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME   99 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHH--HHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence            4566678899999999999999989999999988654322  24567899999999999999999999999999999999


Q ss_pred             ecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccc
Q 045787           87 YLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYS  165 (324)
Q Consensus        87 ~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~  165 (324)
                      |+++ ++.+++..  ..+++..+..++.+|+.+|.+||+.|++|+||+|+||+++ .++.++|+|||.+...........
T Consensus       100 ~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~-~~~~~kL~dfg~~~~~~~~~~~~~  176 (292)
T cd06658         100 FLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLT-SDGRIKLSDFGFCAQVSKEVPKRK  176 (292)
T ss_pred             CCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc-CCCCEEEccCcchhhcccccccCc
Confidence            9986 66665533  3589999999999999999999999999999999999999 889999999998876543333333


Q ss_pred             ccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCC
Q 045787          166 RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYP  245 (324)
Q Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (324)
                      ...+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.............+.                  
T Consensus       177 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~------------------  237 (292)
T cd06658         177 SLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPR------------------  237 (292)
T ss_pred             eeecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCc------------------
Confidence            4567888999999876 667899999999999999999999997665433222111100000                  


Q ss_pred             CCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchhhhhhhhcc
Q 045787          246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLINRK  306 (324)
Q Consensus       246 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~~~~~~~~~  306 (324)
                             ......++..+.+++.+||..||.+|||+.++++||||.....+...+++..+.
T Consensus       238 -------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~~~~~~~~~~  291 (292)
T cd06658         238 -------VKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPSCIVPLMRQY  291 (292)
T ss_pred             -------cccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCccccchhhhhc
Confidence                   001124678899999999999999999999999999999999888766665543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-42  Score=297.15  Aligned_cols=261  Identities=26%  Similarity=0.485  Sum_probs=213.0

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcC---CCCeeEEEeeeecCCeEEEE
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE---HENIVRLLDVQSSRKDVFLV   84 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~iv   84 (324)
                      .|++++.||.|++|.||+|.+..+++.+++|.+..... ......+.+|+.++++++   ||+++++++++......++|
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv   80 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP-DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII   80 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence            58899999999999999999999999999999875432 223456788999999996   99999999999999999999


Q ss_pred             EEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCc
Q 045787           85 FEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE  163 (324)
Q Consensus        85 ~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~  163 (324)
                      +||+.| +|.+++..  ..+++..+..++.+++.+|.+||+.|++|+||+|+||+++ .++.++|+|||.+.........
T Consensus        81 ~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06917          81 MEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVT-NTGNVKLCDFGVAALLNQNSSK  157 (277)
T ss_pred             EecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEc-CCCCEEEccCCceeecCCCccc
Confidence            999975 77777654  3689999999999999999999999999999999999999 8999999999998876544433


Q ss_pred             ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCC
Q 045787          164 YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPL  243 (324)
Q Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (324)
                      .....++..|+|||.+.+...++.++|+||||+++|+|++|..||.............  ..                  
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~--~~------------------  217 (277)
T cd06917         158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP--KS------------------  217 (277)
T ss_pred             cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccc--cC------------------
Confidence            4445678889999998765667899999999999999999999997654322111000  00                  


Q ss_pred             CCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchh
Q 045787          244 YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~  298 (324)
                          .....  ....++.++.+++.+||+.||.+||++.++++||||++....+.
T Consensus       218 ----~~~~~--~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~~~~~  266 (277)
T cd06917         218 ----KPPRL--EDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHSKTPV  266 (277)
T ss_pred             ----CCCCC--CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccccCch
Confidence                00000  00136788999999999999999999999999999998776544

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.7e-42  Score=294.20  Aligned_cols=260  Identities=27%  Similarity=0.470  Sum_probs=215.2

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE   86 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   86 (324)
                      ++|++.+.||.|++|.||+|.+..+++.+++|.+...... .....+.+|+..+.+++|++++++++.+......++|+|
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE   79 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence            4799999999999999999999999999999998765432 335678899999999999999999999999999999999


Q ss_pred             ecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcc
Q 045787           87 YLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS-LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY  164 (324)
Q Consensus        87 ~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~  164 (324)
                      |++ ++|.+++... .++++..++.++.+++.++.+||+ .|++|+||+|+||+++ .++.++|+|||.+..........
T Consensus        80 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~-~~~~~~l~df~~~~~~~~~~~~~  157 (264)
T cd06623          80 YMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLIN-SKGEVKIADFGISKVLENTLDQC  157 (264)
T ss_pred             ecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEEC-CCCCEEEccCccceecccCCCcc
Confidence            998 5888877664 679999999999999999999999 9999999999999999 89999999999988765444333


Q ss_pred             cccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCC
Q 045787          165 SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLY  244 (324)
Q Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (324)
                      ....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||....................                
T Consensus       158 ~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~----------------  220 (264)
T cd06623         158 NTFVGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP----------------  220 (264)
T ss_pred             cceeecccccCHhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCC----------------
Confidence            34567788999999877 5778999999999999999999999977642111111111000000                


Q ss_pred             CCCCCcchhhhCCC-CChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCC
Q 045787          245 PHFEPANLAEKFPN-LEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVE  294 (324)
Q Consensus       245 ~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~  294 (324)
                              ...... ++..+.++|.+||..+|++||++.++++||||+.++
T Consensus       221 --------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~  263 (264)
T cd06623         221 --------PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD  263 (264)
T ss_pred             --------CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence                    001123 788999999999999999999999999999998765

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-45  Score=296.49  Aligned_cols=265  Identities=27%  Similarity=0.420  Sum_probs=229.1

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeecccc-CCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQ-EGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   83 (324)
                      .-++|..++.||+|.||.|.+++.+.+++.||+|++++.--- .+....-..|-++|+..+||.+..+-..|+.++.+|+
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence            457899999999999999999999999999999999876422 1223445678899999999999999999999999999


Q ss_pred             EEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC
Q 045787           84 VFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK  162 (324)
Q Consensus        84 v~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~  162 (324)
                      ||||.+| .|...+.. ...+++...+.+...|+.||.|||+.+++++|+|.+|.|+| .+|++||+|||++..--....
T Consensus       246 VMeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLD-kDGHIKitDFGLCKE~I~~g~  323 (516)
T KOG0690|consen  246 VMEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLD-KDGHIKITDFGLCKEEIKYGD  323 (516)
T ss_pred             EEEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheec-cCCceEeeecccchhcccccc
Confidence            9999985 66555444 55799999999999999999999999999999999999999 999999999999987655566


Q ss_pred             cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccC
Q 045787          163 EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILP  242 (324)
Q Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (324)
                      .....||||.|+|||++.. ..|+.+.|.|.+|+++|||++|+.||...+.+.+..++....                  
T Consensus       324 t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed------------------  384 (516)
T KOG0690|consen  324 TTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMED------------------  384 (516)
T ss_pred             eeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhh------------------
Confidence            7777899999999999988 889999999999999999999999999888777665544221                  


Q ss_pred             CCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCC-----CHHHHhcCccccCCCCchhhh
Q 045787          243 LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRI-----TAMDALKHEYLIGVENVPLVI  300 (324)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~~l~hp~~~~~~~~~~~~  300 (324)
                                ......++++++.|+..+|.+||.+|+     .+.|+.+|+||.++++...+.
T Consensus       385 ----------~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~  437 (516)
T KOG0690|consen  385 ----------LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYR  437 (516)
T ss_pred             ----------ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHH
Confidence                      122347899999999999999999998     499999999999999877644

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=8.4e-43  Score=306.77  Aligned_cols=254  Identities=24%  Similarity=0.361  Sum_probs=197.6

Q ss_pred             ccCcCcceeEeecccCceEEEEEEE-----ccCCceEEEEEeeeccccCCCchHHHHHHHHHHhc-CCCCeeEEEeeeec
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRN-----TVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSS   77 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~-----~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   77 (324)
                      +-.++|++.+.||+|+||.||+|.+     ...+..||+|++..... ......+.+|+.++..+ +||||+++++++..
T Consensus         4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (338)
T cd05102           4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT-ASEHKALMSELKILIHIGNHLNVVNLLGACTK   82 (338)
T ss_pred             cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc-hHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence            4567999999999999999999974     24456899999874322 22235688999999999 89999999998765


Q ss_pred             C-CeEEEEEEecC-CCHHHHHHhcC-------------------------------------------------------
Q 045787           78 R-KDVFLVFEYLD-LDLHSFITRHK-------------------------------------------------------  100 (324)
Q Consensus        78 ~-~~~~iv~e~~~-g~l~~~~~~~~-------------------------------------------------------  100 (324)
                      . ..+++||||++ |+|.+++....                                                       
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (338)
T cd05102          83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE  162 (338)
T ss_pred             CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence            4 46899999998 58888876532                                                       


Q ss_pred             ------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC--cccccccccc
Q 045787          101 ------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK--EYSRDCVYSP  172 (324)
Q Consensus       101 ------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~--~~~~~~~~~~  172 (324)
                            .++++..+..++.|++.||.|||+.|++|+||||+||+++ .++.++|+|||.+........  ......+++.
T Consensus       163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         163 TDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             ccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEc-CCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence                  2477888899999999999999999999999999999999 889999999999876532211  1222344577


Q ss_pred             cCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcc
Q 045787          173 YKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPAN  251 (324)
Q Consensus       173 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (324)
                      |+|||++.+ ..++.++||||||+++|+|++ |..||...............+..                         
T Consensus       242 y~aPE~~~~-~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~-------------------------  295 (338)
T cd05102         242 WMAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR-------------------------  295 (338)
T ss_pred             ccCcHHhhc-CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCC-------------------------
Confidence            999999977 667999999999999999997 99999775532211111100000                         


Q ss_pred             hhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          252 LAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       252 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                       .......++.+.+++.+||+.||.+|||+.++++
T Consensus       296 -~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         296 -MRAPENATPEIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             -CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence             0011256788999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.5e-43  Score=303.08  Aligned_cols=271  Identities=26%  Similarity=0.416  Sum_probs=217.2

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      ...|++++.||.|++|.||++.+..++..+++|.+....... ..+.+.+|+.++++++||+++++++.+..+...++|+
T Consensus         3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06642           3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAED-EIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchH-HHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence            356889999999999999999998889999999887543222 2456889999999999999999999999999999999


Q ss_pred             EecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcc
Q 045787           86 EYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY  164 (324)
Q Consensus        86 e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~  164 (324)
                      ||+++ ++.+++..  ..+++..++.++.+++.|+.+||++|++|+||+|+||+++ .++.++|+|||.+..........
T Consensus        82 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06642          82 EYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKR  158 (277)
T ss_pred             EccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEe-CCCCEEEccccccccccCcchhh
Confidence            99985 77776643  4689999999999999999999999999999999999999 88999999999987655333223


Q ss_pred             cccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCC
Q 045787          165 SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLY  244 (324)
Q Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (324)
                      ....++..|+|||++.+ ..++.++|+||||+++|+|++|..||................                    
T Consensus       159 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~--------------------  217 (277)
T cd06642         159 NTFVGTPFWMAPEVIKQ-SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNS--------------------  217 (277)
T ss_pred             hcccCcccccCHHHhCc-CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCC--------------------
Confidence            33456778999999987 567899999999999999999999986544332211110000                    


Q ss_pred             CCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCch-hhhhhhhcccC
Q 045787          245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP-LVILLINRKKK  308 (324)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~-~~~~~~~~~~~  308 (324)
                             .......++..+.++|.+||+.+|.+||++.++++||||....... ....+..++++
T Consensus       218 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~~~~~~~~~~~  275 (277)
T cd06642         218 -------PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTKKTSFLTELIDRYKR  275 (277)
T ss_pred             -------CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHhhhHHHHHHHHHHhhc
Confidence                   0011124678899999999999999999999999999998776444 34455555543

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2e-42  Score=296.81  Aligned_cols=255  Identities=27%  Similarity=0.412  Sum_probs=204.8

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhc-CCCCeeEEEeeee------cC
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQS------SR   78 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~------~~   78 (324)
                      .++|++.+.||.|++|.||+|.+..+++.+++|.+......   ...+..|+.+++++ +|+|++++++.+.      .+
T Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   91 (282)
T cd06636          15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE---EEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD   91 (282)
T ss_pred             hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHH---HHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence            47899999999999999999999999999999998654322   35577899999998 6999999999874      34


Q ss_pred             CeEEEEEEecCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceee
Q 045787           79 KDVFLVFEYLDL-DLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARA  156 (324)
Q Consensus        79 ~~~~iv~e~~~g-~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~  156 (324)
                      ...|++|||+++ ++.+++.... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++ .++.++|+|||.+..
T Consensus        92 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~-~~~~~~l~dfg~~~~  170 (282)
T cd06636          92 DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQ  170 (282)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC-CCCCEEEeeCcchhh
Confidence            678999999985 8888776643 3588888999999999999999999999999999999999 889999999998876


Q ss_pred             ccCCCCcccccccccccCCchhhcC----CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCccccc
Q 045787          157 IGVPQKEYSRDCVYSPYKAPELLLG----YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWA  232 (324)
Q Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  232 (324)
                      ............+++.|+|||.+..    ...++.++|+||||+++|+|++|..||...........  ......     
T Consensus       171 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~--~~~~~~-----  243 (282)
T cd06636         171 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL--IPRNPP-----  243 (282)
T ss_pred             hhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh--HhhCCC-----
Confidence            5433333344567888999999753    24578899999999999999999999965442211111  000000     


Q ss_pred             chhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          233 ESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                                         .......++.++.++|.+||+.||.+||++.+++.||||
T Consensus       244 -------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         244 -------------------PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             -------------------CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence                               000112578899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=4.5e-42  Score=297.92  Aligned_cols=266  Identities=28%  Similarity=0.447  Sum_probs=214.3

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      ++|++++.||+|++|.||++.+..+++.|++|.+..... .......+.+|+.+++.++|||++++++.+..++..++|+
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            479999999999999999999999999999999875532 1222456778999999999999999999999999999999


Q ss_pred             EecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC--
Q 045787           86 EYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK--  162 (324)
Q Consensus        86 e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~--  162 (324)
                      ||++| +|.+++... +.+++..+..++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+........  
T Consensus        81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~-~~~~~~l~dfg~~~~~~~~~~~~  158 (305)
T cd05609          81 EYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLTTN  158 (305)
T ss_pred             ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEEC-CCCCEEEeeCCCccccCcCcccc
Confidence            99985 777777654 5689999999999999999999999999999999999999 899999999998753210000  


Q ss_pred             -------------cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcc
Q 045787          163 -------------EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDE  229 (324)
Q Consensus       163 -------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  229 (324)
                                   ......++..|+|||.+.+ ..++.++|+||||+++|++++|..||.+...............+.. 
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-  236 (305)
T cd05609         159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP-  236 (305)
T ss_pred             ccccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC-
Confidence                         0111246677999999877 5679999999999999999999999987665443332221110000 


Q ss_pred             cccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCC---HHHHhcCccccCCCCchhhh
Q 045787          230 SWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRIT---AMDALKHEYLIGVENVPLVI  300 (324)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps---~~~~l~hp~~~~~~~~~~~~  300 (324)
                                              .....++..+.++|.+||+.||.+||+   +.++++||||.+.+......
T Consensus       237 ------------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~~~~  286 (305)
T cd05609         237 ------------------------EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGLLR  286 (305)
T ss_pred             ------------------------CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHHHhh
Confidence                                    001247888999999999999999998   79999999999988777654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=3.4e-42  Score=291.13  Aligned_cols=254  Identities=28%  Similarity=0.454  Sum_probs=214.6

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEe
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEY   87 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   87 (324)
                      +|++.+.||.|++|.||++.+..++..+++|.+............+.+|+++++.++|++++++.+.+......++|+|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            68999999999999999999998999999999987655445566788999999999999999999999999999999999


Q ss_pred             cCC-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCc
Q 045787           88 LDL-DLHSFITRHK---NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE  163 (324)
Q Consensus        88 ~~g-~l~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~  163 (324)
                      +++ +|.+.+....   ..+++..+..++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+.........
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~  159 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLT-SNGLVKLGDFGISKVLSSTVDL  159 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEc-CCCcEEECCccceeecccCcce
Confidence            985 8888887753   6799999999999999999999999999999999999999 8899999999998876544323


Q ss_pred             ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCC
Q 045787          164 YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPL  243 (324)
Q Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (324)
                      .....+++.|+|||...+ ...+.++|+||+|+++++|++|..||...+.............                  
T Consensus       160 ~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~------------------  220 (258)
T cd08215         160 AKTVVGTPYYLSPELCQN-KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQY------------------  220 (258)
T ss_pred             ecceeeeecccChhHhcc-CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCC------------------
Confidence            334567888999999877 5578999999999999999999999976664433222111000                  


Q ss_pred             CCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          244 YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                               ......++..+.+++.+||..+|.+||++.++++||||
T Consensus       221 ---------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         221 ---------PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence                     00112567889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-42  Score=296.60  Aligned_cols=279  Identities=43%  Similarity=0.725  Sum_probs=222.6

Q ss_pred             cceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcC-CCCeeEEEeeeecCCeEEEEEEe
Q 045787            9 YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-HENIVRLLDVQSSRKDVFLVFEY   87 (324)
Q Consensus         9 y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv~e~   87 (324)
                      |++.+.||.|++|.||+|....+++.+++|.+....... ......+|+..+.+++ |++++++++++..++..++||||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~   79 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW-EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY   79 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch-hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence            788999999999999999998889999999987554322 1234557899999999 99999999999999999999999


Q ss_pred             cCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcccc
Q 045787           88 LDLDLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSR  166 (324)
Q Consensus        88 ~~g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~  166 (324)
                      ++|++.+.+.... ..+++..+..++.+++.+|.+||++|++|+||+|+||+++ +++.++|+|||.+....... ....
T Consensus        80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~-~~~~~~l~d~~~~~~~~~~~-~~~~  157 (283)
T cd07830          80 MEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVS-GPEVVKIADFGLAREIRSRP-PYTD  157 (283)
T ss_pred             CCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEc-CCCCEEEeecccceeccCCC-CcCC
Confidence            9999999887754 4689999999999999999999999999999999999999 89999999999987664322 2223


Q ss_pred             cccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHHcCCCCcccccchhhhhcccC-CC
Q 045787          167 DCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-HDHLSLIFSLLGTPTDESWAESTYISEILP-LY  244 (324)
Q Consensus       167 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  244 (324)
                      ..++..|+|||++.+...++.++|+||||+++++|++|++||.... .+.........+.+....|........... ..
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd07830         158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRF  237 (283)
T ss_pred             CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccc
Confidence            4567789999998765667999999999999999999999997776 445555666666666555444322222111 11


Q ss_pred             CCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                      ............+..+..+.++|++||+.||.+||++.|++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         238 PQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             cccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            1111222233344557889999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=4.3e-42  Score=295.11  Aligned_cols=260  Identities=25%  Similarity=0.436  Sum_probs=213.1

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE   86 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   86 (324)
                      ..|+-.+.||.|++|.||++.+..+++.+++|.+......  ..+.+.+|+.+++.++||+++++++++...+..++++|
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e   96 (285)
T cd06648          19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME   96 (285)
T ss_pred             HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchh--HHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence            3677788999999999999999889999999987643322  23557889999999999999999999999999999999


Q ss_pred             ecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccc
Q 045787           87 YLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYS  165 (324)
Q Consensus        87 ~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~  165 (324)
                      |+.| +|.+++..  .++++..+..++.+++.+|.+||+.|++|+||+|+||+++ .++.++|+|||.+...........
T Consensus        97 ~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~-~~~~~~l~d~g~~~~~~~~~~~~~  173 (285)
T cd06648          97 FLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLT-SDGRVKLSDFGFCAQVSKEVPRRK  173 (285)
T ss_pred             ccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEc-CCCcEEEcccccchhhccCCcccc
Confidence            9975 88777766  4689999999999999999999999999999999999999 899999999998765543333333


Q ss_pred             ccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCC
Q 045787          166 RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYP  245 (324)
Q Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (324)
                      ...+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.............+ .                 
T Consensus       174 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~-~-----------------  234 (285)
T cd06648         174 SLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPP-K-----------------  234 (285)
T ss_pred             cccCCccccCHHHhcC-CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCC-C-----------------
Confidence            4467888999999877 56789999999999999999999999766543332222111000 0                 


Q ss_pred             CCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCch
Q 045787          246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP  297 (324)
Q Consensus       246 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~  297 (324)
                             ......++..+.+++.+||+.||.+||++.++++||||++.++..
T Consensus       235 -------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~  279 (285)
T cd06648         235 -------LKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPS  279 (285)
T ss_pred             -------CcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCCcc
Confidence                   001124778899999999999999999999999999999988744

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=4.2e-42  Score=290.54  Aligned_cols=251  Identities=26%  Similarity=0.390  Sum_probs=207.8

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEe
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEY   87 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   87 (324)
                      +|++.+.||.|++|.||++.+..++..+++|.+...... ...+.+.+|+.++++++|+|++++++.+..++..|+++||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS-SAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY   79 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcch-HHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence            589999999999999999999999999999998754322 2346678899999999999999999999999999999999


Q ss_pred             cC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccc
Q 045787           88 LD-LDLHSFITRH-KNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYS  165 (324)
Q Consensus        88 ~~-g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~  165 (324)
                      ++ +++.+.+... ...+++..+..++.+++.||.+||+.|++|+||+|+||+++ +++.++|+|||.+...........
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~-~~~~~~l~dfg~~~~~~~~~~~~~  158 (255)
T cd08219          80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLT-QNGKVKLGDFGSARLLTSPGAYAC  158 (255)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEC-CCCcEEEcccCcceeecccccccc
Confidence            97 5888877653 34589999999999999999999999999999999999999 899999999999876654433333


Q ss_pred             ccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCC
Q 045787          166 RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYP  245 (324)
Q Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (324)
                      ...+++.|+|||++.+ ..++.++|+||||+++|+|++|..||...+..............                   
T Consensus       159 ~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------------------  218 (255)
T cd08219         159 TYVGTPYYVPPEIWEN-MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK-------------------  218 (255)
T ss_pred             cccCCccccCHHHHcc-CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCC-------------------
Confidence            4567888999999877 56899999999999999999999999776544332221111000                   


Q ss_pred             CCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCc
Q 045787          246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHE  288 (324)
Q Consensus       246 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp  288 (324)
                              .....++..+.++|.+||+.||.+||++.++++.-
T Consensus       219 --------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~  253 (255)
T cd08219         219 --------PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSRG  253 (255)
T ss_pred             --------CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhcc
Confidence                    01124677899999999999999999999999743

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=4.3e-42  Score=291.83  Aligned_cols=257  Identities=32%  Similarity=0.531  Sum_probs=209.3

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEe
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEY   87 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   87 (324)
                      +|++.+.||+|++|.||++.+..+++.+++|.+..........+.+.+|+.++++++|++++++++.....+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            69999999999999999999988999999999886655444567789999999999999999999999999999999999


Q ss_pred             cCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccc-
Q 045787           88 LDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYS-  165 (324)
Q Consensus        88 ~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~-  165 (324)
                      +.+ +|.+++.. ...+++..+..++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+........... 
T Consensus        81 ~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~-~~~~~kl~d~g~~~~~~~~~~~~~~  158 (264)
T cd06626          81 CSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLD-HNGVIKLGDFGCAVKLKNNTTTMGE  158 (264)
T ss_pred             CCCCcHHHHHhh-cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC-CCCCEEEcccccccccCCCCCcccc
Confidence            985 77777665 34588999999999999999999999999999999999999 899999999999877654333222 


Q ss_pred             ---ccccccccCCchhhcCCC--CCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcc
Q 045787          166 ---RDCVYSPYKAPELLLGYT--GYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEI  240 (324)
Q Consensus       166 ---~~~~~~~y~aPE~~~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (324)
                         ...+++.|+|||++.+..  ..+.++|+||||++++++++|+.||...+...........+..+.            
T Consensus       159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------------  226 (264)
T cd06626         159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPP------------  226 (264)
T ss_pred             cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCC------------
Confidence               245677899999987633  378999999999999999999999975542211111111111000            


Q ss_pred             cCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          241 LPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                                  ......++..+.++|.+||+.||.+||++.+++.|||+
T Consensus       227 ------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         227 ------------IPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             ------------CCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence                        00012458889999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.5e-42  Score=299.18  Aligned_cols=264  Identities=29%  Similarity=0.484  Sum_probs=214.5

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      .++|++++.||+|++|.||++.+..++..+++|.+......  ..+.+.+|+.+++.++|||++++++.+...+..|+|+
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~   95 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQP--KKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM   95 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccch--HHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence            47899999999999999999999888999999998644322  2466888999999999999999999999999999999


Q ss_pred             EecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcc
Q 045787           86 EYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY  164 (324)
Q Consensus        86 e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~  164 (324)
                      ||+. +++.+++..  ..+++..+..++.+++.||.+||++|++|+||+|+||+++ .++.++|+|||.+..........
T Consensus        96 e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~-~~~~~kL~dfg~~~~~~~~~~~~  172 (293)
T cd06647          96 EYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKR  172 (293)
T ss_pred             ecCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEc-CCCCEEEccCcceeccccccccc
Confidence            9997 488877764  3578899999999999999999999999999999999999 88999999999887655433333


Q ss_pred             cccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCC
Q 045787          165 SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLY  244 (324)
Q Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (324)
                      ....+++.|+|||.+.+ ..++.++|+||||+++|++++|..||...+...........+.+                  
T Consensus       173 ~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~------------------  233 (293)
T cd06647         173 STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP------------------  233 (293)
T ss_pred             ccccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCC------------------
Confidence            44467788999999876 56789999999999999999999999765432211100000000                  


Q ss_pred             CCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchhhh
Q 045787          245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVI  300 (324)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~~~  300 (324)
                             .......++..+.++|++||..||.+||++++++.||||+..+...-.+
T Consensus       234 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~~~~~  282 (293)
T cd06647         234 -------ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSSLT  282 (293)
T ss_pred             -------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCccccccc
Confidence                   0001224677899999999999999999999999999999988554444

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-44  Score=315.68  Aligned_cols=268  Identities=25%  Similarity=0.379  Sum_probs=227.2

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEe
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEY   87 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   87 (324)
                      -|.|+..||.|+||.||+|..+..+-..|.|++...+..+  .+.+.-|+++|....||+|+++++.|-.++.++|+.|+
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEE--LEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF  110 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEE--LEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF  110 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhH--HhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence            4789999999999999999999888888899887554333  45677899999999999999999999999999999999


Q ss_pred             cCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcccc
Q 045787           88 LDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSR  166 (324)
Q Consensus        88 ~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~  166 (324)
                      |+| -....+...+..+++.++..++++++.||.|||+++|+|+|||..|||+. -+|.++|.|||.+............
T Consensus       111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~T-ldGdirLADFGVSAKn~~t~qkRDs  189 (1187)
T KOG0579|consen  111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLT-LDGDIRLADFGVSAKNKSTRQKRDS  189 (1187)
T ss_pred             cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEE-ecCcEeeecccccccchhHHhhhcc
Confidence            986 66677777788999999999999999999999999999999999999999 9999999999998776655556677


Q ss_pred             cccccccCCchhhc----CCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccC
Q 045787          167 DCVYSPYKAPELLL----GYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILP  242 (324)
Q Consensus       167 ~~~~~~y~aPE~~~----~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (324)
                      ..|||.|||||+..    ...+|+.++||||||+++.+|..+.+|....++-.+...+..-.+|.-.             
T Consensus       190 FIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLl-------------  256 (1187)
T KOG0579|consen  190 FIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLL-------------  256 (1187)
T ss_pred             ccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCccc-------------
Confidence            78999999999974    3478999999999999999999999998776654443333322222111             


Q ss_pred             CCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchhhhhhh
Q 045787          243 LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLI  303 (324)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~~~~~~  303 (324)
                                  .....+.++.+|+.+||.+||..||++++++.||||+++..+++...++
T Consensus       257 ------------qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~SnK~ireLl  305 (1187)
T KOG0579|consen  257 ------------QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSNKMIRELL  305 (1187)
T ss_pred             ------------CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcchHHHHHH
Confidence                        1235677889999999999999999999999999999999888866554

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.3e-42  Score=300.03  Aligned_cols=268  Identities=26%  Similarity=0.471  Sum_probs=217.2

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEe
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEY   87 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   87 (324)
                      .|.....||.|++|.||+|.+..+++.+++|.+......  ....+.+|+.+++.++|||++++++.+..++..++|+||
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~   99 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF   99 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc--hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence            355667899999999999999989999999998654332  245688999999999999999999999999999999999


Q ss_pred             cCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcccc
Q 045787           88 LDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSR  166 (324)
Q Consensus        88 ~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~  166 (324)
                      +++ ++...+..  ..+++..++.++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+............
T Consensus       100 ~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~-~~~~~kL~dfg~~~~~~~~~~~~~~  176 (297)
T cd06659         100 LQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKS  176 (297)
T ss_pred             CCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEc-cCCcEEEeechhHhhcccccccccc
Confidence            985 66665433  4589999999999999999999999999999999999999 8999999999988655433333344


Q ss_pred             cccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCC
Q 045787          167 DCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPH  246 (324)
Q Consensus       167 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (324)
                      ..++..|+|||++.+ ..++.++|+||||+++|+|++|+.||.............  ..+..                  
T Consensus       177 ~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~--~~~~~------------------  235 (297)
T cd06659         177 LVGTPYWMAPEVISR-TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR--DSPPP------------------  235 (297)
T ss_pred             eecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--ccCCC------------------
Confidence            567888999999987 567999999999999999999999997665433222211  10000                  


Q ss_pred             CCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchhhhhhhhcc
Q 045787          247 FEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLINRK  306 (324)
Q Consensus       247 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~~~~~~~~~  306 (324)
                           .......++..+.++|.+||+.||.+||++.++++||||.+...+....++.++-
T Consensus       236 -----~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~~~~~~~~~~~  290 (297)
T cd06659         236 -----KLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPECLVPLIQQY  290 (297)
T ss_pred             -----CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCCcccccchHHHH
Confidence                 0111235778899999999999999999999999999999988776666655544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-44  Score=289.32  Aligned_cols=267  Identities=30%  Similarity=0.437  Sum_probs=216.8

Q ss_pred             cCccee-EeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhc-CCCCeeEEEeeeec----CCe
Q 045787            7 LNYKKI-KKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSS----RKD   80 (324)
Q Consensus         7 ~~y~i~-~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~----~~~   80 (324)
                      ++|++- +.||-|-.|.|..+.++.+|+.+|+|++...       .+.++|++..=.. .|||||.++++|++    ...
T Consensus        61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            445553 5789999999999999999999999998643       3456888877555 59999999998865    456


Q ss_pred             EEEEEEecC-CCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeec--CCCcEEEeeccceee
Q 045787           81 VFLVFEYLD-LDLHSFITRHKN-TLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL--KRNTVKLADFGLARA  156 (324)
Q Consensus        81 ~~iv~e~~~-g~l~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~--~~~~v~l~d~g~~~~  156 (324)
                      +.+|||.++ |.|.+.+++++. .+++.++..|+++|..|+.|||+.+|.||||||+|+|+..  .+..+||+|||++..
T Consensus       134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~  213 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKE  213 (400)
T ss_pred             eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccc
Confidence            889999998 599999988764 6999999999999999999999999999999999999962  345799999999987


Q ss_pred             ccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChh----HHHHHHHHcCCCCccccc
Q 045787          157 IGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD----HLSLIFSLLGTPTDESWA  232 (324)
Q Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~  232 (324)
                      ... ......+|-||.|.|||++.. ..++...|+||+|+++|-|++|.+||.++.-.    .+...+..          
T Consensus       214 t~~-~~~L~TPc~TPyYvaPevlg~-eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~----------  281 (400)
T KOG0604|consen  214 TQE-PGDLMTPCFTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRT----------  281 (400)
T ss_pred             cCC-CccccCCcccccccCHHHhCc-hhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhc----------
Confidence            653 345566788999999999887 77999999999999999999999999776632    12111110          


Q ss_pred             chhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchhhhhhhhcc
Q 045787          233 ESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLINRK  306 (324)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~~~~~~~~~  306 (324)
                                    -........|..+|++++++|+.+|..+|++|.|+.+++.|||+.+.+..+-.++.-.++
T Consensus       282 --------------gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl~t~~~  341 (400)
T KOG0604|consen  282 --------------GQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPLSTSRM  341 (400)
T ss_pred             --------------cCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCchhhhh
Confidence                          011112234457899999999999999999999999999999999998877766555544

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=8.5e-42  Score=294.24  Aligned_cols=257  Identities=25%  Similarity=0.385  Sum_probs=204.9

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhc-CCCCeeEEEeeeecC-----C
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSR-----K   79 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-----~   79 (324)
                      .++|++.+.||+|++|.||+|.+..+++.+++|.+.....   ....+.+|+.+++++ +|||++++++++...     +
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   97 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD---VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG   97 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc---HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence            5789999999999999999999999999999999864322   235677899999999 799999999988643     3


Q ss_pred             eEEEEEEecCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeecccee
Q 045787           80 DVFLVFEYLDL-DLHSFITR---HKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLAR  155 (324)
Q Consensus        80 ~~~iv~e~~~g-~l~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~  155 (324)
                      ..++|+||++| +|.+.+..   ....+++..++.++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+.
T Consensus        98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~-~~~~~kl~dfg~~~  176 (291)
T cd06639          98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLT-TEGGVKLVDFGVSA  176 (291)
T ss_pred             eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEc-CCCCEEEeecccch
Confidence            68999999975 77776653   345689999999999999999999999999999999999999 88999999999987


Q ss_pred             eccCCCCcccccccccccCCchhhcCCC----CCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccc
Q 045787          156 AIGVPQKEYSRDCVYSPYKAPELLLGYT----GYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESW  231 (324)
Q Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  231 (324)
                      .............++..|+|||.+....    .++.++|+||||+++|+|++|+.||..........  .....+...  
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~--~~~~~~~~~--  252 (291)
T cd06639         177 QLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF--KIPRNPPPT--  252 (291)
T ss_pred             hcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHH--HHhcCCCCC--
Confidence            6553333333456778899999986422    35889999999999999999999997655322211  111110000  


Q ss_pred             cchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCcccc
Q 045787          232 AESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLI  291 (324)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~  291 (324)
                                           ......++..+.++|.+||+.||.+||++.++++||||+
T Consensus       253 ---------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         253 ---------------------LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             ---------------------CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence                                 000124567899999999999999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=4.9e-42  Score=293.65  Aligned_cols=269  Identities=26%  Similarity=0.430  Sum_probs=217.6

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE   86 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   86 (324)
                      +-|++.+.||+|++|.||++.+..++..+|+|.+...... .....+.+|+..+++++||+++++++.+..+...++|+|
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   82 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME   82 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccch-HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence            4588999999999999999999888999999987644322 224568889999999999999999999999999999999


Q ss_pred             ecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccc
Q 045787           87 YLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYS  165 (324)
Q Consensus        87 ~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~  165 (324)
                      |+++ ++.+++..  ..++...+..++.+++.++.+||+.|++|+||+|+||+++ .++.++|+|||.+...........
T Consensus        83 ~~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~-~~~~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06641          83 YLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             eCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEEC-CCCCEEEeecccceecccchhhhc
Confidence            9985 77776653  4689999999999999999999999999999999999999 889999999998876654333333


Q ss_pred             ccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCC
Q 045787          166 RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYP  245 (324)
Q Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (324)
                      ...++..|+|||.+.+ ...+.++|+||||+++|+|++|..||................ +                   
T Consensus       160 ~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~-------------------  218 (277)
T cd06641         160 TFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN-P-------------------  218 (277)
T ss_pred             cccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCC-C-------------------
Confidence            3457788999999876 567889999999999999999999997655333222211000 0                   


Q ss_pred             CCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCc-hhhhhhhhccc
Q 045787          246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENV-PLVILLINRKK  307 (324)
Q Consensus       246 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~-~~~~~~~~~~~  307 (324)
                             ......++.++.+++.+||+.||.+||++.++++||||.+.... .....+..+++
T Consensus       219 -------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  274 (277)
T cd06641         219 -------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAKKTSYLTELIDRYK  274 (277)
T ss_pred             -------CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhhhhccchHHHHHHHhh
Confidence                   01112578889999999999999999999999999999987653 34456666554

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=7.3e-42  Score=290.87  Aligned_cols=255  Identities=28%  Similarity=0.484  Sum_probs=203.3

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccC---CCchHHHHHHHHHHhcCCCCeeEEEeeeec--CCeE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQE---GVPSYIIREVSLLKELEHENIVRLLDVQSS--RKDV   81 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~   81 (324)
                      .+|++.+.||+|++|.||+|.+..++..+++|.+.......   .....+.+|+.++++++|||++++++.+..  +...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            57999999999999999999999999999999987554222   123457889999999999999999998865  4678


Q ss_pred             EEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           82 FLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        82 ~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      ++++||+++ +|.+.+... ..+++...+.++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+......
T Consensus        82 ~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~-~~~~~~l~dfg~~~~~~~~  159 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRD-SAGNVKLGDFGASKRLQTI  159 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC-CCCCEEEccCCCccccccc
Confidence            999999975 788877654 4589999999999999999999999999999999999999 8899999999988755321


Q ss_pred             C---CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhh
Q 045787          161 Q---KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYI  237 (324)
Q Consensus       161 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (324)
                      .   .......++..|+|||.+.+ ..++.++|+||+|+++|++++|+.||...........  ....+..         
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~--~~~~~~~---------  227 (266)
T cd06651         160 CMSGTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFK--IATQPTN---------  227 (266)
T ss_pred             cccCCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHH--HhcCCCC---------
Confidence            1   11223457788999999977 6679999999999999999999999976543222111  1111100         


Q ss_pred             hcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCcccc
Q 045787          238 SEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLI  291 (324)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~  291 (324)
                                     ......+++.+.+++ +|+..+|.+||+++++++||||+
T Consensus       228 ---------------~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         228 ---------------PQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             ---------------CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence                           011124677888898 67778999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=4.6e-42  Score=295.17  Aligned_cols=266  Identities=30%  Similarity=0.509  Sum_probs=220.2

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLV   84 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   84 (324)
                      ..+.|++.+.||.|++|.||++.+..++..+++|++.....   ....+.+|++.+++++|+|++++++.+..+...+++
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   93 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV   93 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence            35679999999999999999999998899999999876544   346688999999999999999999999999999999


Q ss_pred             EEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCc
Q 045787           85 FEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE  163 (324)
Q Consensus        85 ~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~  163 (324)
                      +||++ ++|.+++......++...+..++.+++.+|.+||+.|++|+||+|+||+++ .++.++|+|||.+.........
T Consensus        94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~~~  172 (286)
T cd06614          94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLS-KDGSVKLADFGFAAQLTKEKSK  172 (286)
T ss_pred             EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEc-CCCCEEECccchhhhhccchhh
Confidence            99998 589888887655799999999999999999999999999999999999999 8999999999987665433333


Q ss_pred             ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCC
Q 045787          164 YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPL  243 (324)
Q Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (324)
                      .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.............+.                
T Consensus       173 ~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------------  235 (286)
T cd06614         173 RNSVVGTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPP----------------  235 (286)
T ss_pred             hccccCCcccCCHhHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC----------------
Confidence            333456788999999877 567999999999999999999999997665443222211111100                


Q ss_pred             CCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchhhh
Q 045787          244 YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVI  300 (324)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~~~  300 (324)
                               ......++..+.++|.+||+.+|.+||++.++++||||.+..+.+-.-
T Consensus       236 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~~~~  283 (286)
T cd06614         236 ---------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACPKEEFA  283 (286)
T ss_pred             ---------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccCchHhhh
Confidence                     001123678899999999999999999999999999999977766543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=5.3e-42  Score=291.05  Aligned_cols=254  Identities=28%  Similarity=0.503  Sum_probs=207.0

Q ss_pred             ecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEecC-CCH
Q 045787           15 IGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD-LDL   92 (324)
Q Consensus        15 Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~-g~l   92 (324)
                      ||.|++|.||+|.+..+++.+++|++..... .....+.+.+|+.+++.++||+++++++.+.++...++++||++ ++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            6899999999999998899999999976542 22334678899999999999999999999999999999999987 588


Q ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcccccccccc
Q 045787           93 HSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP  172 (324)
Q Consensus        93 ~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~  172 (324)
                      .+++... ..+++..+..++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+....... ......+++.
T Consensus        81 ~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~-~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~  157 (262)
T cd05572          81 WTILRDR-GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQ-KTWTFCGTPE  157 (262)
T ss_pred             HHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEc-CCCCEEEeeCCcccccCccc-ccccccCCcC
Confidence            8877664 4589999999999999999999999999999999999999 88999999999988765332 2233457788


Q ss_pred             cCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcch
Q 045787          173 YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANL  252 (324)
Q Consensus       173 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (324)
                      |+|||.+.+ ..++.++|+||||+++|+|++|..||.....+..............                        
T Consensus       158 ~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------------------------  212 (262)
T cd05572         158 YVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGK------------------------  212 (262)
T ss_pred             ccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCC------------------------
Confidence            999999876 5678999999999999999999999976663222111111100000                        


Q ss_pred             hhhCCCCChhHHHHHHHhhcCCCCCCCC-----HHHHhcCccccCCCCc
Q 045787          253 AEKFPNLEPAGVDLLSQMLCLNPKQRIT-----AMDALKHEYLIGVENV  296 (324)
Q Consensus       253 ~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~~~l~hp~~~~~~~~  296 (324)
                      .......+.++.++|.+||+.||.+||+     ++++++||||++.++.
T Consensus       213 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~  261 (262)
T cd05572         213 LEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWE  261 (262)
T ss_pred             CCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCCC
Confidence            0011234788999999999999999999     9999999999987664

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.7e-42  Score=297.86  Aligned_cols=261  Identities=24%  Similarity=0.405  Sum_probs=209.5

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE   86 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   86 (324)
                      ++|++++.||.|++|.||+|.+..++..+++|.+..... ......+.+|+.++++++|+|++++++.+..++..++|+|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELD-ESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME   79 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccC-HHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence            479999999999999999999998999999998865422 1123567889999999999999999999999999999999


Q ss_pred             ecCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC
Q 045787           87 YLDL-DLHSFITRH--KNTLNLLVIKAILKQILLGLAYCHS-LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK  162 (324)
Q Consensus        87 ~~~g-~l~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~-~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~  162 (324)
                      |++| ++.+++...  ...+++..+..++.+++.||.+||+ .|++|+||+|+||+++ .++.++|+|||.+......  
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~--  156 (286)
T cd06622          80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVN-GNGQVKLCDFGVSGNLVAS--  156 (286)
T ss_pred             ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEEC-CCCCEEEeecCCcccccCC--
Confidence            9986 676665543  2368999999999999999999996 5999999999999999 7999999999988755322  


Q ss_pred             cccccccccccCCchhhcCC-----CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHH-HHHcCCCCcccccchhh
Q 045787          163 EYSRDCVYSPYKAPELLLGY-----TGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLI-FSLLGTPTDESWAESTY  236 (324)
Q Consensus       163 ~~~~~~~~~~y~aPE~~~~~-----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  236 (324)
                      ......+++.|+|||.+.+.     ..++.++|+||||+++|+|++|..||........... .......+         
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---------  227 (286)
T cd06622         157 LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP---------  227 (286)
T ss_pred             ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC---------
Confidence            22234567789999998642     2358899999999999999999999966543322211 11111110         


Q ss_pred             hhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCc
Q 045787          237 ISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENV  296 (324)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~  296 (324)
                                      ....+.++.++.++|.+||+.||.+||++.+++.||||......
T Consensus       228 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~  271 (286)
T cd06622         228 ----------------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA  271 (286)
T ss_pred             ----------------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence                            11223578899999999999999999999999999999887654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.7e-42  Score=293.70  Aligned_cols=258  Identities=30%  Similarity=0.505  Sum_probs=206.0

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccC----CCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQE----GVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   83 (324)
                      +|++.+.||+|++|.||++.+..+++.+++|++.......    ...+.+.+|+.++++++|++++++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            5889999999999999999999999999999987543211    123568899999999999999999999999999999


Q ss_pred             EEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC
Q 045787           84 VFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK  162 (324)
Q Consensus        84 v~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~  162 (324)
                      |+||+.| +|.+++.. ..++++..+..++.+++.||.+||++|++|+||+|+||+++..+..++|+|||.+........
T Consensus        81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~  159 (268)
T cd06630          81 FVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT  159 (268)
T ss_pred             EEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence            9999985 77776655 457899999999999999999999999999999999999983445799999999876643211


Q ss_pred             ----cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhH-HHHHHHHcCCCCcccccchhhh
Q 045787          163 ----EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDH-LSLIFSLLGTPTDESWAESTYI  237 (324)
Q Consensus       163 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  237 (324)
                          ......++..|+|||.+.+ ..++.++|+||||++++++++|..||....... ............          
T Consensus       160 ~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----------  228 (268)
T cd06630         160 GAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATT----------  228 (268)
T ss_pred             cCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCC----------
Confidence                1123356788999999876 667899999999999999999999996544221 111111100000          


Q ss_pred             hcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCcccc
Q 045787          238 SEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLI  291 (324)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~  291 (324)
                                    .......+++++.+++.+||..||.+||++.+++.||||+
T Consensus       229 --------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         229 --------------APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             --------------CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence                          0011125788999999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.1e-41  Score=296.33  Aligned_cols=267  Identities=28%  Similarity=0.394  Sum_probs=217.0

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeecccc-CCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQ-EGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLV   84 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   84 (324)
                      .+.|...+.||.|++|.||++.+..++..+++|.+...... ......+.+|+.+++.++||+++++++++.++...|+|
T Consensus        20 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   99 (313)
T cd06633          20 EEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLV   99 (313)
T ss_pred             HHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence            34577788999999999999999999999999998755332 22234578899999999999999999999999999999


Q ss_pred             EEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcc
Q 045787           85 FEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY  164 (324)
Q Consensus        85 ~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~  164 (324)
                      +||+.|++.+.+.....++++..+..++.+++.+|.+||+.|++|+||+|+||+++ .++.++|+|||.+....    ..
T Consensus       100 ~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~-~~~~~kL~dfg~~~~~~----~~  174 (313)
T cd06633         100 MEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT-EPGQVKLADFGSASKSS----PA  174 (313)
T ss_pred             EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEEC-CCCCEEEeecCCCcccC----CC
Confidence            99999999998887777899999999999999999999999999999999999999 88999999999876432    22


Q ss_pred             cccccccccCCchhhcC--CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccC
Q 045787          165 SRDCVYSPYKAPELLLG--YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILP  242 (324)
Q Consensus       165 ~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (324)
                      ....++..|+|||.+..  ...++.++|+||||+++|+|++|..||...+.............+.               
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~---------------  239 (313)
T cd06633         175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPT---------------  239 (313)
T ss_pred             CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC---------------
Confidence            23467788999999852  3557889999999999999999999997665332222111111100               


Q ss_pred             CCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchhhhhhh
Q 045787          243 LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLI  303 (324)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~~~~~~  303 (324)
                                 .....++..+.+++.+||+.+|.+||++.++++||||...+........+
T Consensus       240 -----------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~~~~~~~~~  289 (313)
T cd06633         240 -----------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRPARVLIDLI  289 (313)
T ss_pred             -----------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCchhHHHHHHH
Confidence                       00124677899999999999999999999999999999877666654433

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.6e-42  Score=293.64  Aligned_cols=254  Identities=26%  Similarity=0.428  Sum_probs=210.4

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccC-CCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEE
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQE-GVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE   86 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   86 (324)
                      +|++.+.||.|++|.||+|.+..++..+++|.+....... ...+.+.+|+.++++++|||++++++.+.+....++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            5999999999999999999999899999999998654322 345678899999999999999999999999999999999


Q ss_pred             ecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccc
Q 045787           87 YLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYS  165 (324)
Q Consensus        87 ~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~  165 (324)
                      |+.| +|...+... .++++..+..++.+++.+|.+||+.|++|+||+|+||+++ +++.++|+|||.+....... ...
T Consensus        81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~-~~~~~~l~d~~~~~~~~~~~-~~~  157 (258)
T cd05578          81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLD-EQGHVHITDFNIATKVTPDT-LTT  157 (258)
T ss_pred             CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEc-CCCCEEEeecccccccCCCc-ccc
Confidence            9985 777776654 5799999999999999999999999999999999999999 89999999999987665332 223


Q ss_pred             ccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCC
Q 045787          166 RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYP  245 (324)
Q Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (324)
                      ...++..|+|||.+.+ ...+.++|+||||+++|+|++|..||...+.............                    
T Consensus       158 ~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------------  216 (258)
T cd05578         158 STSGTPGYMAPEVLCR-QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET--------------------  216 (258)
T ss_pred             ccCCChhhcCHHHHcc-cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc--------------------
Confidence            3456778999999987 5579999999999999999999999977664222111111110                    


Q ss_pred             CCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCH--HHHhcCccc
Q 045787          246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITA--MDALKHEYL  290 (324)
Q Consensus       246 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~--~~~l~hp~~  290 (324)
                           ........++..+.++|.+||..||.+||++  .++++||||
T Consensus       217 -----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         217 -----ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             -----ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence                 0001112467899999999999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-42  Score=319.26  Aligned_cols=292  Identities=21%  Similarity=0.305  Sum_probs=206.6

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCC-ceEEEEEe--------------eec-cccCCCchHHHHHHHHHHhcCCCCe
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTG-QKVAIKMM--------------TIQ-TEQEGVPSYIIREVSLLKELEHENI   68 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~-~~~~~K~~--------------~~~-~~~~~~~~~~~~e~~~l~~l~~~~i   68 (324)
                      ..++|++++.||+|+||.||++..+... ...+.|..              ... .........+.+|+.++++++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            4578999999999999999998754322 12222211              000 0111123457899999999999999


Q ss_pred             eEEEeeeecCCeEEEEEEecCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCC
Q 045787           69 VRLLDVQSSRKDVFLVFEYLDLDLHSFITRHK----NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN  144 (324)
Q Consensus        69 ~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~  144 (324)
                      +++++++...+..|+|++++++++..++....    .......++.++.||+.||.|||++|++|+||||+|||++ .++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~-~~~  304 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN-CDG  304 (501)
T ss_pred             CcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC-CCC
Confidence            99999999999999999999999988876532    2234667888999999999999999999999999999999 899


Q ss_pred             cEEEeeccceeeccCCCCc-ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCC-CCCCCC---hhHHHHH
Q 045787          145 TVKLADFGLARAIGVPQKE-YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKP-LFPSKK---HDHLSLI  219 (324)
Q Consensus       145 ~v~l~d~g~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~-pf~~~~---~~~~~~~  219 (324)
                      .++|+|||++......... .....|++.|+|||++.+ ..++.++|||||||++|+|++|.. |+....   ...+...
T Consensus       305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~  383 (501)
T PHA03210        305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI  383 (501)
T ss_pred             CEEEEeCCCceecCcccccccccccCCcCCCCchhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence            9999999999876533222 223468899999999987 668999999999999999999875 454333   2333333


Q ss_pred             HHHcCCCCcccccchhhhhcccCCCC-CCCCcchhhh--CCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCc
Q 045787          220 FSLLGTPTDESWAESTYISEILPLYP-HFEPANLAEK--FPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENV  296 (324)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~  296 (324)
                      ............+......+.+.... ..........  ...++.++.++|.+||+.||.+|||+.|+|+||||.+....
T Consensus       384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~~~  463 (501)
T PHA03210        384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEEEE  463 (501)
T ss_pred             HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCCch
Confidence            33333222211111111111111000 0000111111  12467788999999999999999999999999999987755


Q ss_pred             hh
Q 045787          297 PL  298 (324)
Q Consensus       297 ~~  298 (324)
                      .+
T Consensus       464 ~~  465 (501)
T PHA03210        464 EI  465 (501)
T ss_pred             HH
Confidence            54

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=8.1e-42  Score=292.50  Aligned_cols=256  Identities=25%  Similarity=0.395  Sum_probs=199.9

Q ss_pred             eecccCceEEEEEEEccCCceEEEEEeeeccccCCC-chHHHHHHHHHHh---cCCCCeeEEEeeeecCCeEEEEEEecC
Q 045787           14 KIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGV-PSYIIREVSLLKE---LEHENIVRLLDVQSSRKDVFLVFEYLD   89 (324)
Q Consensus        14 ~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~l~~---l~~~~i~~~~~~~~~~~~~~iv~e~~~   89 (324)
                      .||+|+||.||++.+..+++.+|+|.+......... .....+|..+++.   ..||+++.+++.+..++..++||||+.
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999999999999999998765432211 2223344443333   468999999999999999999999998


Q ss_pred             C-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcccccc
Q 045787           90 L-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDC  168 (324)
Q Consensus        90 g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~~~  168 (324)
                      | +|.+++.. .+.+++..+..++.|++.||.+||+.|++|+||||+||+++ .++.++|+|||.+......  ......
T Consensus        81 ~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~-~~~~~~l~dfg~~~~~~~~--~~~~~~  156 (279)
T cd05633          81 GGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKK--KPHASV  156 (279)
T ss_pred             CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEEC-CCCCEEEccCCcceecccc--CccCcC
Confidence            5 77666655 45699999999999999999999999999999999999999 8999999999988755422  223346


Q ss_pred             cccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCC
Q 045787          169 VYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFE  248 (324)
Q Consensus       169 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (324)
                      +++.|+|||.+.+...++.++|+||+|+++|+|++|..||.................                       
T Consensus       157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-----------------------  213 (279)
T cd05633         157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-----------------------  213 (279)
T ss_pred             CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhc-----------------------
Confidence            888999999987546678999999999999999999999965443221111111000                       


Q ss_pred             CcchhhhCCCCChhHHHHHHHhhcCCCCCCC-----CHHHHhcCccccCCCCchh
Q 045787          249 PANLAEKFPNLEPAGVDLLSQMLCLNPKQRI-----TAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       249 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~~l~hp~~~~~~~~~~  298 (324)
                        ........++..+.++|.+||..||.+||     ++.++++||||++++....
T Consensus       214 --~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~~  266 (279)
T cd05633         214 --VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQV  266 (279)
T ss_pred             --CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhHH
Confidence              00011235788999999999999999999     6999999999999885554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=8.5e-42  Score=293.50  Aligned_cols=257  Identities=25%  Similarity=0.398  Sum_probs=203.4

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhc-CCCCeeEEEeeee-----cC
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQS-----SR   78 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~-----~~   78 (324)
                      ..++|++++.||.|++|.||+|.+..+++.+++|.+......   ...+.+|+.+++.+ +|||++++++++.     .+
T Consensus        16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   92 (286)
T cd06638          16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI---DEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNG   92 (286)
T ss_pred             cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccch---HHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCC
Confidence            457899999999999999999999999999999987643221   35677899999999 6999999999873     44


Q ss_pred             CeEEEEEEecCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccce
Q 045787           79 KDVFLVFEYLDL-DLHSFITR---HKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLA  154 (324)
Q Consensus        79 ~~~~iv~e~~~g-~l~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~  154 (324)
                      ...++||||++| +|.+++..   ....+++..++.++.+++.||.+||+.+++|+||+|+||+++ .++.++|+|||.+
T Consensus        93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~-~~~~~kl~dfg~~  171 (286)
T cd06638          93 DQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLT-TEGGVKLVDFGVS  171 (286)
T ss_pred             CeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEEC-CCCCEEEccCCce
Confidence            579999999975 77776643   234688999999999999999999999999999999999999 8889999999998


Q ss_pred             eeccCCCCcccccccccccCCchhhcC----CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCccc
Q 045787          155 RAIGVPQKEYSRDCVYSPYKAPELLLG----YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDES  230 (324)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  230 (324)
                      ..............+++.|+|||++..    ...++.++|+||||+++|+|++|+.||.............  .....  
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~--~~~~~--  247 (286)
T cd06638         172 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIP--RNPPP--  247 (286)
T ss_pred             eecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcc--ccCCC--
Confidence            776533333344468888999999853    2447889999999999999999999997654322111000  00000  


Q ss_pred             ccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          231 WAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                                           .......++..+.+++.+||+.||.+|||+.++++|+||
T Consensus       248 ---------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         248 ---------------------TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             ---------------------cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence                                 000111356789999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.1e-41  Score=289.57  Aligned_cols=254  Identities=29%  Similarity=0.456  Sum_probs=204.1

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccC----CCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQE----GVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   83 (324)
                      +|++.+.||.|++|.||++.+. +++.+++|.+.......    .....+.+|++++++++|+|++++++++.+....++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            5899999999999999999864 78899999887543221    123558889999999999999999999999999999


Q ss_pred             EEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC--
Q 045787           84 VFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP--  160 (324)
Q Consensus        84 v~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~--  160 (324)
                      ++||+.| +|.+++... .++++..+..++.+++.+|.+||+.|++|+||+|+||+++ .++.++|+|||.+......  
T Consensus        80 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~  157 (265)
T cd06631          80 FMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLM-PNGIIKLIDFGCARRLAWVGL  157 (265)
T ss_pred             EEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEEC-CCCeEEeccchhhHhhhhccc
Confidence            9999975 777777553 4688999999999999999999999999999999999999 8999999999988654211  


Q ss_pred             ----CCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhh
Q 045787          161 ----QKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY  236 (324)
Q Consensus       161 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (324)
                          ........++..|+|||++.+ ..++.++|+||||+++|+|++|..||...+..............          
T Consensus       158 ~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------  226 (265)
T cd06631         158 HGTHSNMLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL----------  226 (265)
T ss_pred             cccccccccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCC----------
Confidence                111223457788999999887 56789999999999999999999999765433221111100000          


Q ss_pred             hhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          237 ISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                                     .......++..+.++|++||+.||.+||++.++++||||
T Consensus       227 ---------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         227 ---------------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             ---------------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                           011123578899999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.6e-42  Score=295.55  Aligned_cols=266  Identities=26%  Similarity=0.416  Sum_probs=210.8

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF   82 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   82 (324)
                      ++..++|++++.||+|++|+||++.+..+++.+++|++..... ......+.+|+++++.++|||++++++.+......+
T Consensus         1 ~l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (284)
T cd06620           1 DLRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK-SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNIC   79 (284)
T ss_pred             CccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc-chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEE
Confidence            3567899999999999999999999999999999999875432 333567889999999999999999999999999999


Q ss_pred             EEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           83 LVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS-LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        83 iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      +|+||+++ +|.+++.. .+++++..+..++.+++.+|.+||+ .|++|+||+|+||+++ .++.++|+|||.+......
T Consensus        80 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~-~~~~~~l~d~gl~~~~~~~  157 (284)
T cd06620          80 MCMEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVN-SRGQIKLCDFGVSGELINS  157 (284)
T ss_pred             EEEecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEEC-CCCcEEEccCCcccchhhh
Confidence            99999985 66666554 4568999999999999999999997 6999999999999999 8899999999987654322


Q ss_pred             CCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHH-----HHHHHHcCCCCcccccchh
Q 045787          161 QKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHL-----SLIFSLLGTPTDESWAEST  235 (324)
Q Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-----~~~~~~~~~~~~~~~~~~~  235 (324)
                        ......++..|+|||++.+ ..++.++|+||||+++|++++|..||........     ......             
T Consensus       158 --~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-------------  221 (284)
T cd06620         158 --IADTFVGTSTYMSPERIQG-GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL-------------  221 (284)
T ss_pred             --ccCccccCcccCCHHHHcc-CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHH-------------
Confidence              1223467888999999876 5778999999999999999999999976553210     000000             


Q ss_pred             hhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCC
Q 045787          236 YISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVE  294 (324)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~  294 (324)
                       ........    .....  ...++..+.+++.+||+.||.+||++.++++|+||.+..
T Consensus       222 -~~~~~~~~----~~~~~--~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~  273 (284)
T cd06620         222 -LQQIVQEP----PPRLP--SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL  273 (284)
T ss_pred             -HHHHhhcc----CCCCC--chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence             00000000    00000  013677899999999999999999999999999997754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-44  Score=289.63  Aligned_cols=272  Identities=26%  Similarity=0.422  Sum_probs=215.3

Q ss_pred             EeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcC-CCCeeEEEeeeecCCeEEEEEEecC-C
Q 045787           13 KKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-HENIVRLLDVQSSRKDVFLVFEYLD-L   90 (324)
Q Consensus        13 ~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv~e~~~-g   90 (324)
                      +.||+|+++.|-.+....+|..||||++.+.....  ..++.+|++++.+.+ |+||+.++++|+++..+|+|||.+. |
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHs--R~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GG  161 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHS--RSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGG  161 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCchH--HHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCc
Confidence            57899999999999999999999999998774333  577889999999986 9999999999999999999999997 5


Q ss_pred             CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCC--CcEEEeeccceeeccC-------CC
Q 045787           91 DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKR--NTVKLADFGLARAIGV-------PQ  161 (324)
Q Consensus        91 ~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~--~~v~l~d~g~~~~~~~-------~~  161 (324)
                      ++++.+.++. .+++.++.+++++|+.||.+||.+||.|+|+||+|||....+  .-|||+||++..-...       ..
T Consensus       162 plLshI~~~~-~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spast  240 (463)
T KOG0607|consen  162 PLLSHIQKRK-HFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAST  240 (463)
T ss_pred             hHHHHHHHhh-hccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCC
Confidence            8898888854 599999999999999999999999999999999999997333  3589999987654321       12


Q ss_pred             CcccccccccccCCchhhc----CCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhh
Q 045787          162 KEYSRDCVYSPYKAPELLL----GYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYI  237 (324)
Q Consensus       162 ~~~~~~~~~~~y~aPE~~~----~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (324)
                      .....++|+-.|||||+..    ....|+.+.|.||||+++|-|+.|++||.+.-.+             +-.|++.+..
T Consensus       241 P~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~-------------dCGWdrGe~C  307 (463)
T KOG0607|consen  241 PELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGA-------------DCGWDRGEVC  307 (463)
T ss_pred             ccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCC-------------cCCccCCCcc
Confidence            2344456777799999974    2355899999999999999999999999664421             1122222111


Q ss_pred             hcccC----CCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchhhh
Q 045787          238 SEILP----LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVI  300 (324)
Q Consensus       238 ~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~~~  300 (324)
                      ..+..    .++.-......+.|..++.+..++|.++|.+|+.+|.++.++++|||++.....+.++
T Consensus       308 r~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ekalp  374 (463)
T KOG0607|consen  308 RVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEKALP  374 (463)
T ss_pred             HHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhccCC
Confidence            11100    0111112223345668999999999999999999999999999999999998776644

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.7e-41  Score=295.86  Aligned_cols=268  Identities=28%  Similarity=0.394  Sum_probs=218.2

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLV   84 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   84 (324)
                      ...|+..+.||+|++|.||++.+..++..+++|.+..... ..+....+.+|+.++++++||+++++++++.++...++|
T Consensus        24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  103 (317)
T cd06635          24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLV  103 (317)
T ss_pred             hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEE
Confidence            3558999999999999999999998999999999875432 222335688899999999999999999999999999999


Q ss_pred             EEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcc
Q 045787           85 FEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY  164 (324)
Q Consensus        85 ~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~  164 (324)
                      +||+.|++.+.+.....++++..+..++.+++.+|.+||+.|++|+||+|+||+++ .++.++|+|||.+.....    .
T Consensus       104 ~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~-~~~~~kl~dfg~~~~~~~----~  178 (317)
T cd06635         104 MEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT-EPGQVKLADFGSASIASP----A  178 (317)
T ss_pred             EeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEEC-CCCCEEEecCCCccccCC----c
Confidence            99999999988877777899999999999999999999999999999999999999 889999999998765432    2


Q ss_pred             cccccccccCCchhhcC--CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccC
Q 045787          165 SRDCVYSPYKAPELLLG--YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILP  242 (324)
Q Consensus       165 ~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (324)
                      ....+++.|+|||.+..  ....+.++|+||||+++|+|++|..||.................+..              
T Consensus       179 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------  244 (317)
T cd06635         179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL--------------  244 (317)
T ss_pred             ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCC--------------
Confidence            23457788999999742  24578899999999999999999999876543332222211111100              


Q ss_pred             CCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchhhhhhhh
Q 045787          243 LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLIN  304 (324)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~~~~~~~  304 (324)
                                  ....++..+.+++.+||+.+|.+||++.++++|+|+............+.
T Consensus       245 ------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~~~~~~~~  294 (317)
T cd06635         245 ------------QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPETVLIDLIQ  294 (317)
T ss_pred             ------------CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCcccchhhHHH
Confidence                        01246778999999999999999999999999999988877666544443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3.1e-42  Score=296.52  Aligned_cols=270  Identities=23%  Similarity=0.392  Sum_probs=211.1

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcC-CCCeeEEEeeeecCCeEEEE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-HENIVRLLDVQSSRKDVFLV   84 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv   84 (324)
                      ..+|+..+.||+|++|.||++.+..+++.+++|.+...... .....+.+|+..+.++. |+|++++++++..+...+++
T Consensus         3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~   81 (288)
T cd06616           3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC   81 (288)
T ss_pred             HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence            35788889999999999999999999999999998765433 22456788999999996 99999999999999999999


Q ss_pred             EEecCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCCCCceEeecCCCcEEEeeccceeeccC
Q 045787           85 FEYLDLDLHSFITR----HKNTLNLLVIKAILKQILLGLAYCHSL-KILHRDLKPNNLLIDLKRNTVKLADFGLARAIGV  159 (324)
Q Consensus        85 ~e~~~g~l~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~Lh~~-g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~  159 (324)
                      +|++++++.+....    ....+++..+..++.+++.||.|||+. |++|+||+|+||+++ .++.++|+|||.+.....
T Consensus        82 ~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          82 MELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLD-RNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             EecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEc-cCCcEEEeecchhHHhcc
Confidence            99998766554321    235699999999999999999999974 999999999999999 889999999998865542


Q ss_pred             CCCcccccccccccCCchhhcCC--CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhh
Q 045787          160 PQKEYSRDCVYSPYKAPELLLGY--TGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYI  237 (324)
Q Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (324)
                      .. ......+++.|+|||++.+.  ..++.++|+||||+++|+|++|+.||..... ............+.         
T Consensus       161 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-~~~~~~~~~~~~~~---------  229 (288)
T cd06616         161 SI-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-VFDQLTQVVKGDPP---------  229 (288)
T ss_pred             CC-ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-HHHHHhhhcCCCCC---------
Confidence            22 22233577889999999874  3689999999999999999999999965441 11111111110000         


Q ss_pred             hcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchhhh
Q 045787          238 SEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVI  300 (324)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~~~  300 (324)
                                  .........++.++.+|+.+||+.||.+|||++++++||||+.........
T Consensus       230 ------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~~~~~~  280 (288)
T cd06616         230 ------------ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEERNVDV  280 (288)
T ss_pred             ------------cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhhcchhH
Confidence                        000011135788999999999999999999999999999998866554433

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-44  Score=310.70  Aligned_cols=270  Identities=28%  Similarity=0.405  Sum_probs=229.3

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      ..|.-++.||.|+||.||.|++..+...||+|.+..+.. ..+....|.+|+.+|+++.|||.+.+-+.|..+...|+||
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM  105 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM  105 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence            357778899999999999999999999999999987763 3344567889999999999999999999999999999999


Q ss_pred             EecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccc
Q 045787           86 EYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYS  165 (324)
Q Consensus        86 e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~  165 (324)
                      |||-|+-.+.+.-..+++-+-.+..|+.+.+.||.|||+.+.+|+|||..|||++ +.|.|||+|||.+....+.    .
T Consensus       106 EYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLs-e~g~VKLaDFGSAsi~~PA----n  180 (948)
T KOG0577|consen  106 EYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLS-EPGLVKLADFGSASIMAPA----N  180 (948)
T ss_pred             HHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEec-CCCeeeeccccchhhcCch----h
Confidence            9999998888888888999999999999999999999999999999999999999 9999999999999876532    3


Q ss_pred             ccccccccCCchhhc--CCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCC
Q 045787          166 RDCVYSPYKAPELLL--GYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPL  243 (324)
Q Consensus       166 ~~~~~~~y~aPE~~~--~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (324)
                      ...|||.|||||++.  ....|+-++||||||+++.++.-.++|+-..+.-....-+.....|.-.              
T Consensus       181 sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLq--------------  246 (948)
T KOG0577|consen  181 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ--------------  246 (948)
T ss_pred             cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCC--------------
Confidence            347999999999985  3467899999999999999999999997555432222222222222111              


Q ss_pred             CCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchhhhhhhhccc
Q 045787          244 YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLINRKK  307 (324)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~~~~~~~~~~  307 (324)
                                  .+..+..+++||..||++-|.+|||.+++|.|+|...-+..-....++++.+
T Consensus       247 ------------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~tvi~dLIqRTK  298 (948)
T KOG0577|consen  247 ------------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERPPTVIMDLIQRTK  298 (948)
T ss_pred             ------------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCCchHHHHHHHHHH
Confidence                        1357888999999999999999999999999999998888777777777653

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=7.5e-42  Score=292.51  Aligned_cols=257  Identities=27%  Similarity=0.392  Sum_probs=206.4

Q ss_pred             ecccCceEEEEEEEccCCceEEEEEeeecccc-CCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEecCC-CH
Q 045787           15 IGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQ-EGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DL   92 (324)
Q Consensus        15 Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~g-~l   92 (324)
                      ||+|++|+||+|.+..+|+.+++|.+...... ......+.+|+.++++++||+++++++.+...+..|+|+||+++ +|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            68999999999999999999999998764322 22234567899999999999999999999999999999999984 88


Q ss_pred             HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccccccccc
Q 045787           93 HSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS  171 (324)
Q Consensus        93 ~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~  171 (324)
                      .+++.... ..+++..+..++.+++.+|.+||+.|++|+||+|+||+++ .++.++|+|||.+..... ........++.
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~-~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~  158 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLD-DHGNVRISDLGLAVELKG-GKKIKGRAGTP  158 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC-CCCCEEEccCcchhhhcc-CCccccccCCC
Confidence            87776644 3689999999999999999999999999999999999999 889999999998876542 22223345677


Q ss_pred             ccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcc
Q 045787          172 PYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPAN  251 (324)
Q Consensus       172 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (324)
                      .|+|||.+.+ ..++.++|+||||+++|+|++|+.||................                        ...
T Consensus       159 ~y~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------------------~~~  213 (277)
T cd05577         159 GYMAPEVLQG-EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRT------------------------LEM  213 (277)
T ss_pred             CcCCHHHhcC-CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcc------------------------ccc
Confidence            8999999877 458899999999999999999999997655321111100000                        000


Q ss_pred             hhhhCCCCChhHHHHHHHhhcCCCCCCC-----CHHHHhcCccccCCCCchh
Q 045787          252 LAEKFPNLEPAGVDLLSQMLCLNPKQRI-----TAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       252 ~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~~l~hp~~~~~~~~~~  298 (324)
                      .......+++.+.++|.+||+.||.+||     ++.++++||||...++...
T Consensus       214 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~  265 (277)
T cd05577         214 AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRL  265 (277)
T ss_pred             cccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChhhh
Confidence            1112235788999999999999999999     8899999999998886555

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.5e-41  Score=287.38  Aligned_cols=254  Identities=28%  Similarity=0.476  Sum_probs=208.0

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeecccc---CCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQ---EGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLV   84 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   84 (324)
                      +|+..+.||+|++|.||+|.+..++..+++|.+......   .+..+.+.+|+.+++.++|++++++++++.+....+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            688999999999999999999888999999998765422   22346688999999999999999999999999999999


Q ss_pred             EEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCc
Q 045787           85 FEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE  163 (324)
Q Consensus        85 ~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~  163 (324)
                      +||+++ +|.+++... .++++..+..++.+++.+|.+||+.|++|+||+|+||+++ .++.++|+|||.+....... .
T Consensus        81 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~-~~~~~kl~d~~~~~~~~~~~-~  157 (258)
T cd06632          81 LELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVD-TNGVVKLADFGMAKQVVEFS-F  157 (258)
T ss_pred             EEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC-CCCCEEEccCccceeccccc-c
Confidence            999985 787777654 4689999999999999999999999999999999999999 88999999999887654332 2


Q ss_pred             ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCC
Q 045787          164 YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPL  243 (324)
Q Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (324)
                      .....+++.|+|||.+.....++.++|+||||+++|++++|+.||.............  ...                 
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~--~~~-----------------  218 (258)
T cd06632         158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIG--RSK-----------------  218 (258)
T ss_pred             ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHH--hcc-----------------
Confidence            2344577889999998763447999999999999999999999997655222111111  000                 


Q ss_pred             CCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          244 YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                             ........+++.+.+++.+||+.||.+||++.++++|||+
T Consensus       219 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         219 -------ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             -------cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence                   0011123578899999999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.6e-41  Score=289.14  Aligned_cols=256  Identities=28%  Similarity=0.403  Sum_probs=203.6

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEe
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEY   87 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   87 (324)
                      .......||+|++|.||++.+..++..+++|.+......  ....+.+|+.++++++|+|++++++++..++..++|+||
T Consensus         9 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   86 (268)
T cd06624           9 ENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR--YVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQ   86 (268)
T ss_pred             cCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHH--HHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEec
Confidence            444557899999999999999988999999987654322  235688999999999999999999999999999999999


Q ss_pred             cC-CCHHHHHHhcCCCC--CHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcc
Q 045787           88 LD-LDLHSFITRHKNTL--NLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY  164 (324)
Q Consensus        88 ~~-g~l~~~~~~~~~~~--~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~  164 (324)
                      +. ++|.+++.....++  ++..+..++.+++.||.+||+.|++|+||+|+||+++..++.++|+|||.+..........
T Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~  166 (268)
T cd06624          87 VPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCT  166 (268)
T ss_pred             CCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCcc
Confidence            97 58888887654555  7888899999999999999999999999999999998457899999999887654333333


Q ss_pred             cccccccccCCchhhcCC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCC
Q 045787          165 SRDCVYSPYKAPELLLGY-TGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPL  243 (324)
Q Consensus       165 ~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (324)
                      ....+++.|+|||++.+. ..++.++|+||||+++|+|++|..||...............                    
T Consensus       167 ~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~--------------------  226 (268)
T cd06624         167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGM--------------------  226 (268)
T ss_pred             ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhh--------------------
Confidence            334577889999998652 34788999999999999999999999654322111100000                    


Q ss_pred             CCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          244 YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                           ..........+++++.+++.+||+.+|.+|||+.+++.||||
T Consensus       227 -----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         227 -----FKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             -----hccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence                 000011123577889999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1e-43  Score=306.01  Aligned_cols=254  Identities=30%  Similarity=0.468  Sum_probs=218.6

Q ss_pred             EeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEecCCCH
Q 045787           13 KKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDLDL   92 (324)
Q Consensus        13 ~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~g~l   92 (324)
                      +.||+|.||+||-+++..+|+.||+|++.+..........+++|+.+|+++.||+|+.+.-.++..+..++|||.+.|+.
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDM  649 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDM  649 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchH
Confidence            67999999999999999999999999999887666667889999999999999999999999999999999999999999


Q ss_pred             HHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCC--CcEEEeeccceeeccCCCCccccccc
Q 045787           93 HSFITRH-KNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKR--NTVKLADFGLARAIGVPQKEYSRDCV  169 (324)
Q Consensus        93 ~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~--~~v~l~d~g~~~~~~~~~~~~~~~~~  169 (324)
                      ++.+... .+.+++...+.++.||+.||+|||-+||+|+||||+|||+...+  -.+||+|||.++.++.. .-.....|
T Consensus       650 LEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-sFRrsVVG  728 (888)
T KOG4236|consen  650 LEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-SFRRSVVG  728 (888)
T ss_pred             HHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh-hhhhhhcC
Confidence            9888765 45799999999999999999999999999999999999997333  47999999999999844 33445689


Q ss_pred             ccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCC
Q 045787          170 YSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEP  249 (324)
Q Consensus       170 ~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (324)
                      ||.|+|||++++ ..|..+-|+||.|+|+|--+.|..||....+-.-...                          +-..
T Consensus       729 TPAYLaPEVLrn-kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQ--------------------------NAaF  781 (888)
T KOG4236|consen  729 TPAYLAPEVLRN-KGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQ--------------------------NAAF  781 (888)
T ss_pred             CccccCHHHHhh-ccccccccceeeeEEEEEEecccccCCCccchhHHhh--------------------------cccc
Confidence            999999999998 7789999999999999999999999954432111111                          1111


Q ss_pred             cchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCC
Q 045787          250 ANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVE  294 (324)
Q Consensus       250 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~  294 (324)
                      .....-|.++++.+.+||+.+|+..-.+|.|.+..+.|||+++..
T Consensus       782 MyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq  826 (888)
T KOG4236|consen  782 MYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQ  826 (888)
T ss_pred             ccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence            222233558999999999999999999999999999999999876

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.2e-41  Score=291.05  Aligned_cols=268  Identities=26%  Similarity=0.415  Sum_probs=208.5

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeec--CCeEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS--RKDVFLV   84 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv   84 (324)
                      ++|++.+.||.|++|.||++.+..+++.+++|.+...... .....+.+|++++++++||+|+++++++..  ...+++|
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   79 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP-DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA   79 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch-HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence            5799999999999999999999989999999998754332 334668899999999999999999998855  3478999


Q ss_pred             EEecCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           85 FEYLDL-DLHSFITR---HKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        85 ~e~~~g-~l~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      |||++| +|.+++..   ....+++..+..++.+++.+|.+||+.|++|+||+|+||+++ .++.++|+|||.+......
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~-~~~~~~l~dfg~~~~~~~~  158 (287)
T cd06621          80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLT-RKGQVKLCDFGVSGELVNS  158 (287)
T ss_pred             EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEe-cCCeEEEeecccccccccc
Confidence            999975 77766543   344688999999999999999999999999999999999999 8899999999988655422


Q ss_pred             CCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh---hHHHHHHHHcCCCCcccccchhhh
Q 045787          161 QKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH---DHLSLIFSLLGTPTDESWAESTYI  237 (324)
Q Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  237 (324)
                      ..  ....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.....   ............... .       
T Consensus       159 ~~--~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~-------  227 (287)
T cd06621         159 LA--GTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNP-E-------  227 (287)
T ss_pred             cc--ccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCch-h-------
Confidence            21  23346777999999877 6679999999999999999999999976532   111111110000000 0       


Q ss_pred             hcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchh
Q 045787          238 SEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~  298 (324)
                                 ...........++.+.++|.+||..||++|||+.+++.||||+.....+.
T Consensus       228 -----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~~~  277 (287)
T cd06621         228 -----------LKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKV  277 (287)
T ss_pred             -----------hccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccchh
Confidence                       00000000134678899999999999999999999999999988776653

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-42  Score=299.64  Aligned_cols=246  Identities=28%  Similarity=0.429  Sum_probs=204.0

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEe
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEY   87 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   87 (324)
                      .++.++.||+|.||.||.+.... ...+|+|.+.......   +.+.+|+.++++|+|++++++++++..++.+||||||
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~---~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~  282 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSP---EAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY  282 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccCh---hHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence            45678899999999999999763 2479999988654432   5577999999999999999999999999999999999


Q ss_pred             cC-CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccc
Q 045787           88 LD-LDLHSFITR-HKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYS  165 (324)
Q Consensus        88 ~~-g~l~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~  165 (324)
                      +. |+|++++.. .+..++......++.||+.|++||++++++||||...|||++ ++..+||+|||+++......-...
T Consensus       283 m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~-~~~~vKIsDFGLAr~~~d~~Y~~~  361 (468)
T KOG0197|consen  283 MPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVD-EDLVVKISDFGLARLIGDDEYTAS  361 (468)
T ss_pred             cccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeec-cCceEEEcccccccccCCCceeec
Confidence            97 899999997 455799999999999999999999999999999999999999 999999999999995432221111


Q ss_pred             ccc-cccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCC
Q 045787          166 RDC-VYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPL  243 (324)
Q Consensus       166 ~~~-~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (324)
                      ... -..-|.|||.+.- ..++.+|||||||++|+||+| |+.||.+.+..+...........+.               
T Consensus       362 ~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~---------------  425 (468)
T KOG0197|consen  362 EGGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPR---------------  425 (468)
T ss_pred             CCCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCC---------------
Confidence            111 1233999999987 678999999999999999999 8899988886666554443322221               


Q ss_pred             CCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          244 YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                  ....|+++.+++..|+..+|++|||.+.+..
T Consensus       426 ------------P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~  456 (468)
T KOG0197|consen  426 ------------PEGCPDEVYELMKSCWHEDPEDRPTFETLRE  456 (468)
T ss_pred             ------------CCCCCHHHHHHHHHHhhCCcccCCCHHHHHH
Confidence                        2368999999999999999999999987654

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-41  Score=285.13  Aligned_cols=253  Identities=31%  Similarity=0.494  Sum_probs=212.0

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEe
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEY   87 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   87 (324)
                      +|++.+.||+|++|.||++.+..+++.+++|.+..........+.+.+|++++++++|++++++++++.++...++++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            68999999999999999999998999999999987654334456789999999999999999999999999999999999


Q ss_pred             cCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcccc
Q 045787           88 LDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSR  166 (324)
Q Consensus        88 ~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~  166 (324)
                      +++ +|.+.+... ..+++..++.++.+++.+|.+||+.|++|+||+|+||+++ .++.++|+|||.+............
T Consensus        81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~~~~~~  158 (254)
T cd06627          81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTT-KDGVVKLADFGVATKLNDVSKDDAS  158 (254)
T ss_pred             CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEC-CCCCEEEeccccceecCCCcccccc
Confidence            985 777777654 5799999999999999999999999999999999999999 7899999999999877654443344


Q ss_pred             cccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCC
Q 045787          167 DCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPH  246 (324)
Q Consensus       167 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (324)
                      ..++..|+|||...+ ...+.++|+||+|+++++|++|..||...+............                      
T Consensus       159 ~~~~~~y~~pe~~~~-~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~----------------------  215 (254)
T cd06627         159 VVGTPYWMAPEVIEM-SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD----------------------  215 (254)
T ss_pred             cccchhhcCHhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccC----------------------
Confidence            567888999999877 447899999999999999999999997655221111110000                      


Q ss_pred             CCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          247 FEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       247 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                           .......++..+.+++.+||..+|++||++.+++.||||
T Consensus       216 -----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         216 -----HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             -----CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence                 001123568899999999999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-43  Score=280.20  Aligned_cols=262  Identities=24%  Similarity=0.398  Sum_probs=215.2

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcC-CCCeeEEEeeeecCCeEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-HENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      ++.+++..||+|..|+||++....+|...|||.+......++ .+++...+.+...-. +|+||+.+++|-.+...+|-|
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee-~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM  170 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEE-NKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM  170 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHH-HHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence            456778899999999999999999999999999987765544 466777788766554 899999999999999999999


Q ss_pred             EecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcc
Q 045787           86 EYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS-LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY  164 (324)
Q Consensus        86 e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~  164 (324)
                      |.+..-....+....+++++..+-.+...++.||.||.. +|++|+|+||+|||+| +.|.+||+|||.+-.+-.+ ...
T Consensus       171 elMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlD-e~GniKlCDFGIsGrlvdS-kAh  248 (391)
T KOG0983|consen  171 ELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDS-KAH  248 (391)
T ss_pred             HHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEc-cCCCEEeecccccceeecc-ccc
Confidence            999876666666667789999999999999999999994 6899999999999999 9999999999998666433 233


Q ss_pred             cccccccccCCchhhcC--CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChh--HHHHHHHHcCCCCcccccchhhhhcc
Q 045787          165 SRDCVYSPYKAPELLLG--YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD--HLSLIFSLLGTPTDESWAESTYISEI  240 (324)
Q Consensus       165 ~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (324)
                      +...|.+.|||||.+..  ...|+.++||||||+.++|+.||+.||.+.+.+  .+..+..  ..|+....         
T Consensus       249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln--~ePP~L~~---------  317 (391)
T KOG0983|consen  249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN--EEPPLLPG---------  317 (391)
T ss_pred             ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh--cCCCCCCc---------
Confidence            44568888999999864  466899999999999999999999999886533  2222222  22221110         


Q ss_pred             cCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCch
Q 045787          241 LPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP  297 (324)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~  297 (324)
                                     ...+++.+++|+..||.+|+.+||.-.++|+|||+...+.-.
T Consensus       318 ---------------~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a~  359 (391)
T KOG0983|consen  318 ---------------HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETAE  359 (391)
T ss_pred             ---------------ccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecchhh
Confidence                           114899999999999999999999999999999998776433

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.1e-41  Score=288.94  Aligned_cols=259  Identities=30%  Similarity=0.534  Sum_probs=206.1

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCC--------CchHHHHHHHHHHhcCCCCeeEEEeeeecCC
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEG--------VPSYIIREVSLLKELEHENIVRLLDVQSSRK   79 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~--------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   79 (324)
                      +|.+.+.||.|++|.||++.+..+|+.+++|.+........        ..+.+.+|+.+++.++|++++++++++....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            68899999999999999999998999999999865432111        1245778999999999999999999999999


Q ss_pred             eEEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeecc
Q 045787           80 DVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIG  158 (324)
Q Consensus        80 ~~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~  158 (324)
                      ..++|+||+. ++|.+.+... +++++..+..++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+....
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~-~~~~~~l~d~~~~~~~~  159 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVD-ADGICKISDFGISKKSD  159 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEc-CCCeEEEeecccccccc
Confidence            9999999997 4787777664 5789999999999999999999999999999999999999 89999999999887653


Q ss_pred             CCCC--cccccccccccCCchhhcCCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchh
Q 045787          159 VPQK--EYSRDCVYSPYKAPELLLGYT-GYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAEST  235 (324)
Q Consensus       159 ~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (324)
                      ....  ......++..|+|||.+.... .++.++|+||||++++++++|..||........  .........        
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~~--------  229 (272)
T cd06629         160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA--MFKLGNKRS--------  229 (272)
T ss_pred             ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH--HHHhhcccc--------
Confidence            2211  122235677899999987633 478999999999999999999999964442211  111110000        


Q ss_pred             hhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          236 YISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                                  ...........++..+.++|.+||..||.+||+++++++||||
T Consensus       230 ------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         230 ------------APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             ------------CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence                        0000111223578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-44  Score=330.60  Aligned_cols=269  Identities=25%  Similarity=0.388  Sum_probs=225.9

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF   82 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   82 (324)
                      +...+|+|++.||+|+||.|.+|+++.+++.||+|++.+-.. ......-|+.|..++..-+.+=|+.++..|+++.++|
T Consensus        72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY  151 (1317)
T KOG0612|consen   72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY  151 (1317)
T ss_pred             CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence            566899999999999999999999999999999999986432 2334567889999998888999999999999999999


Q ss_pred             EEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC
Q 045787           83 LVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        83 iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~  161 (324)
                      +||+|+. |+|...+.... ++++..++.++..|..||..+|+.|+|||||||+|||+| ..|+++|.|||.+..+...+
T Consensus       152 lVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld-~~GHikLADFGsClkm~~dG  229 (1317)
T KOG0612|consen  152 LVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLD-KSGHIKLADFGSCLKMDADG  229 (1317)
T ss_pred             EEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEec-ccCcEeeccchhHHhcCCCC
Confidence            9999997 59999998887 899999999999999999999999999999999999999 99999999999998887433


Q ss_pred             -CcccccccccccCCchhhcC----CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhH-HHHHHHHcCCCCcccccchh
Q 045787          162 -KEYSRDCVYSPYKAPELLLG----YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDH-LSLIFSLLGTPTDESWAEST  235 (324)
Q Consensus       162 -~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~  235 (324)
                       -......|||-|.+||++..    ...|++.+|.||+|+++|||+.|..||...+-.. +.++...             
T Consensus       230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h-------------  296 (1317)
T KOG0612|consen  230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH-------------  296 (1317)
T ss_pred             cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch-------------
Confidence             34556789999999999963    2568999999999999999999999997766322 2222111             


Q ss_pred             hhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCC---HHHHhcCccccCCCCchhhh
Q 045787          236 YISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRIT---AMDALKHEYLIGVENVPLVI  300 (324)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps---~~~~l~hp~~~~~~~~~~~~  300 (324)
                                 -....++ .-..+|+++++||.+++. +|..|..   +.++..||||.++.|..+-.
T Consensus       297 -----------k~~l~FP-~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~  351 (1317)
T KOG0612|consen  297 -----------KESLSFP-DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRE  351 (1317)
T ss_pred             -----------hhhcCCC-cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhh
Confidence                       0001111 012589999999999887 4888998   99999999999999977733

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=3.7e-41  Score=283.73  Aligned_cols=252  Identities=31%  Similarity=0.510  Sum_probs=210.0

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEe
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEY   87 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   87 (324)
                      +|++.+.||+|++|.||++.+..+++.+++|.+.....  .....+.+|++++++++|++++++++.+..+...++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~   78 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF   78 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence            58999999999999999999998999999999876544  2356788999999999999999999999999999999999


Q ss_pred             cC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcccc
Q 045787           88 LD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSR  166 (324)
Q Consensus        88 ~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~  166 (324)
                      ++ ++|.+++......+++..+..++.+++.+|.+||+.|++|+||+|+||+++ .++.++|+|||.+........ ...
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~~-~~~  156 (253)
T cd05122          79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLT-SDGEVKLIDFGLSAQLSDTKA-RNT  156 (253)
T ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEc-cCCeEEEeecccccccccccc-ccc
Confidence            99 588888777656799999999999999999999999999999999999999 889999999999877654332 334


Q ss_pred             cccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCC
Q 045787          167 DCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPH  246 (324)
Q Consensus       167 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (324)
                      ..++..|+|||.+.+ ...+.++|+||||+++|+|++|..||...+.............+..                  
T Consensus       157 ~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------------------  217 (253)
T cd05122         157 MVGTPYWMAPEVING-KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGL------------------  217 (253)
T ss_pred             eecCCcccCHHHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCc------------------
Confidence            567788999999987 5578999999999999999999999976643322222111100000                  


Q ss_pred             CCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCcc
Q 045787          247 FEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEY  289 (324)
Q Consensus       247 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~  289 (324)
                             .....++..+.++|.+||+.||++|||+.++++|||
T Consensus       218 -------~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         218 -------RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             -------CcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence                   000124788999999999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-43  Score=294.00  Aligned_cols=287  Identities=28%  Similarity=0.484  Sum_probs=226.9

Q ss_pred             CCcccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcC-C-C----CeeEEEee
Q 045787            1 MGKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-H-E----NIVRLLDV   74 (324)
Q Consensus         1 ~~~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~-~----~i~~~~~~   74 (324)
                      .|+.+.++|+++..||+|.||.|-.+.+...+..+|+|+++.-....   +.-+-|+++++++. + |    -++.+.++
T Consensus        83 ~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYr---eAa~iEi~vLqki~~~DP~g~~rcv~m~~w  159 (415)
T KOG0671|consen   83 VGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYR---EAALIEIEVLQKINESDPNGKFRCVQMRDW  159 (415)
T ss_pred             eccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHh---hHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence            37889999999999999999999999999889999999998654432   44567999999994 2 2    35677778


Q ss_pred             eecCCeEEEEEEecCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeec------------
Q 045787           75 QSSRKDVFLVFEYLDLDLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL------------  141 (324)
Q Consensus        75 ~~~~~~~~iv~e~~~g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~------------  141 (324)
                      |...++.|||+|.++.++.+++..++ .+++...++.+..|++.++.+||+.+++|.||||+||++-.            
T Consensus       160 FdyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~  239 (415)
T KOG0671|consen  160 FDYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKK  239 (415)
T ss_pred             hhccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCc
Confidence            99999999999999999999998854 47999999999999999999999999999999999999841            


Q ss_pred             -------CCCcEEEeeccceeeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-h
Q 045787          142 -------KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-H  213 (324)
Q Consensus       142 -------~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~  213 (324)
                             .+..|+++|||.++...   ...+....|.-|+|||++.+ -.++..+||||+||||+|+.+|...|.+.+ .
T Consensus       240 ~~~~r~~ks~~I~vIDFGsAtf~~---e~hs~iVsTRHYRAPEViLg-LGwS~pCDvWSiGCIL~ElytG~~LFqtHen~  315 (415)
T KOG0671|consen  240 VCFIRPLKSTAIKVIDFGSATFDH---EHHSTIVSTRHYRAPEVILG-LGWSQPCDVWSIGCILVELYTGETLFQTHENL  315 (415)
T ss_pred             cceeccCCCcceEEEecCCcceec---cCcceeeeccccCCchheec-cCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence                   12359999999998754   33355567788999999999 889999999999999999999999997766 6


Q ss_pred             hHHHHHHHHcCCCCcccccchhhhhcccC-CCCCCC--------------CcchhhhC---CCCChhHHHHHHHhhcCCC
Q 045787          214 DHLSLIFSLLGTPTDESWAESTYISEILP-LYPHFE--------------PANLAEKF---PNLEPAGVDLLSQMLCLNP  275 (324)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~--------------~~~~~~~~---~~~~~~l~~li~~~l~~dP  275 (324)
                      ++++.+..++++.|........ .++... ...++.              ........   ..-...+.+|+++||..||
T Consensus       316 EHLaMMerIlGp~P~~mi~r~~-~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP  394 (415)
T KOG0671|consen  316 EHLAMMERILGPIPSRMIKKTR-KEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP  394 (415)
T ss_pred             HHHHHHHHhhCCCcHHHhhhhh-hHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence            7788888888877765544431 111100 000000              01111111   1123457899999999999


Q ss_pred             CCCCCHHHHhcCccccCCCC
Q 045787          276 KQRITAMDALKHEYLIGVEN  295 (324)
Q Consensus       276 ~~Rps~~~~l~hp~~~~~~~  295 (324)
                      .+|+|+.|+|.||||+....
T Consensus       395 ~~RiTl~EAL~HpFF~~~~~  414 (415)
T KOG0671|consen  395 ARRITLREALSHPFFARLTP  414 (415)
T ss_pred             cccccHHHHhcCHHhhcCCC
Confidence            99999999999999998653

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=4.4e-41  Score=284.44  Aligned_cols=255  Identities=31%  Similarity=0.518  Sum_probs=212.2

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecC--CeEEEEE
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR--KDVFLVF   85 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~iv~   85 (324)
                      +|++.+.||.|++|.||++.+..++..+++|++..........+.+.+|+..+++++|++++++++.+...  ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            58899999999999999999998999999999887654444467789999999999999999999999888  8999999


Q ss_pred             EecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC--
Q 045787           86 EYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK--  162 (324)
Q Consensus        86 e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~--  162 (324)
                      |+++ ++|.+++.... .+++..++.++.+++.+|.+||+.|++|+||+|+||+++ .++.++|+|||.+........  
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~~~~  158 (260)
T cd06606          81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVD-SDGVVKLADFGCAKRLGDIETGE  158 (260)
T ss_pred             EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc-CCCCEEEcccccEEecccccccc
Confidence            9996 58888877654 799999999999999999999999999999999999999 789999999999887764432  


Q ss_pred             cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccC
Q 045787          163 EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILP  242 (324)
Q Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (324)
                      ......++..|+|||.+.+ ...+.++|+||||+++++|++|..||....... ........                  
T Consensus       159 ~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~------------------  218 (260)
T cd06606         159 GTGSVRGTPYWMAPEVIRG-EEYGRAADIWSLGCTVIEMATGKPPWSELGNPM-AALYKIGS------------------  218 (260)
T ss_pred             cccCCCCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-HHHHhccc------------------
Confidence            1344567788999999877 557999999999999999999999997765111 11111100                  


Q ss_pred             CCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          243 LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                            ..........++..+.++|.+||..||.+||++.+++.||||
T Consensus       219 ------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         219 ------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             ------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence                  000011222458899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.4e-41  Score=295.06  Aligned_cols=270  Identities=27%  Similarity=0.394  Sum_probs=217.9

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   83 (324)
                      -..+|+..+.||.|++|.||++.+..++..+++|.+..... .......+.+|+.+++.++|++++++.+++......++
T Consensus        13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   92 (308)
T cd06634          13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL   92 (308)
T ss_pred             cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence            34578899999999999999999999999999998875322 22223457789999999999999999999999999999


Q ss_pred             EEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCc
Q 045787           84 VFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE  163 (324)
Q Consensus        84 v~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~  163 (324)
                      |+||+.|++.+.+.....++++..+..++.+++.+|.+||+.|++|+||+|+||+++ .++.++|+|||.+......   
T Consensus        93 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~~---  168 (308)
T cd06634          93 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS-EPGLVKLGDFGSASIMAPA---  168 (308)
T ss_pred             EEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEEC-CCCcEEECCcccceeecCc---
Confidence            999999999888877667799999999999999999999999999999999999999 8899999999988765422   


Q ss_pred             ccccccccccCCchhhcC--CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhccc
Q 045787          164 YSRDCVYSPYKAPELLLG--YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEIL  241 (324)
Q Consensus       164 ~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (324)
                       ....+++.|+|||.+.+  ....+.++||||||+++|+|++|..||...+.............+.              
T Consensus       169 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------------  233 (308)
T cd06634         169 -NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA--------------  233 (308)
T ss_pred             -ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCC--------------
Confidence             23356778999999852  2456889999999999999999999986654322211111100000              


Q ss_pred             CCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchhhhhhhhc
Q 045787          242 PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLINR  305 (324)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~~~~~~~~  305 (324)
                                  .....++..+.++|++||+.+|.+||++.++++|||+.....+........+
T Consensus       234 ------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~~~~~~~~~~~  285 (308)
T cd06634         234 ------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQR  285 (308)
T ss_pred             ------------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccCChhHHHHHHHH
Confidence                        0012577889999999999999999999999999999998776655544443

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.3e-41  Score=287.87  Aligned_cols=252  Identities=26%  Similarity=0.393  Sum_probs=203.9

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      ++|++.+.||.|++|.||+|.+..++..+++|.+..... .......+.+|+.+++.++||+++++++++...+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            589999999999999999999999999999998865332 2222345788999999999999999999999999999999


Q ss_pred             EecCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC
Q 045787           86 EYLDL-DLHSFITR---HKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        86 e~~~g-~l~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~  161 (324)
                      ||+++ +|.+++..   ....+++..+..++.+++.||.+||++|++|+||+|+||+++ .++.++|+|||.+.......
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~-~~~~~~l~d~g~~~~~~~~~  160 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEc-CCCCEEECccccceeccchh
Confidence            99985 77777653   234588999999999999999999999999999999999999 88999999999887765333


Q ss_pred             CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHH--HHHHHHcCCCCcccccchhhhhc
Q 045787          162 KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHL--SLIFSLLGTPTDESWAESTYISE  239 (324)
Q Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
                      .......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|+.||........  .........++.           
T Consensus       161 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-----------  228 (267)
T cd08228         161 TAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPL-----------  228 (267)
T ss_pred             HHHhcCCCCccccChhhhcc-CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCC-----------
Confidence            33333467788999999877 5678999999999999999999999965543221  111111111100           


Q ss_pred             ccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                     ....++..+.+++.+||+.||++||++.++++
T Consensus       229 ---------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~  260 (267)
T cd08228         229 ---------------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ  260 (267)
T ss_pred             ---------------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence                           01146778999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.5e-41  Score=292.56  Aligned_cols=264  Identities=25%  Similarity=0.434  Sum_probs=212.9

Q ss_pred             cceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEec
Q 045787            9 YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYL   88 (324)
Q Consensus         9 y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   88 (324)
                      |+....||+|++|.||++....++..+++|.+.....  .....+.+|+.+++.++|++++++++.+..++..++|+||+
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   99 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL   99 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccch--hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence            3345679999999999999999999999998754332  22456888999999999999999999999999999999999


Q ss_pred             CC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccccc
Q 045787           89 DL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRD  167 (324)
Q Consensus        89 ~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~~  167 (324)
                      ++ ++.+++..  ..+++..+..++.+++.+|.+||+.|++|+||+|+||+++ .++.++|+|||.+.............
T Consensus       100 ~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~-~~~~~~l~dfg~~~~~~~~~~~~~~~  176 (292)
T cd06657         100 EGGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKSL  176 (292)
T ss_pred             CCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC-CCCCEEEcccccceeccccccccccc
Confidence            86 66665433  3589999999999999999999999999999999999999 88999999999887654333333445


Q ss_pred             ccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCC
Q 045787          168 CVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHF  247 (324)
Q Consensus       168 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (324)
                      .+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||.................+                     
T Consensus       177 ~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~---------------------  234 (292)
T cd06657         177 VGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP---------------------  234 (292)
T ss_pred             ccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCc---------------------
Confidence            67888999999876 56789999999999999999999999776544332222110000                     


Q ss_pred             CCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchhhhhhh
Q 045787          248 EPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLI  303 (324)
Q Consensus       248 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~~~~~~  303 (324)
                          .......++..+.+++.+||+.||.+||++.++++||||.....++....+.
T Consensus       235 ----~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~~~~~~~~~  286 (292)
T cd06657         235 ----KLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPSCIVPLM  286 (292)
T ss_pred             ----ccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCCCcccccHH
Confidence                0001135788899999999999999999999999999999999776655443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.8e-41  Score=288.45  Aligned_cols=253  Identities=19%  Similarity=0.229  Sum_probs=202.0

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEc---cCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCe
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNT---VTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKD   80 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~---~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   80 (324)
                      +..++|++.+.||+|+||.||++..+   ..+..+++|.+...... .....+.+|+..+++++|||++++++++..+..
T Consensus         2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   80 (266)
T cd05064           2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSD-KQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT   80 (266)
T ss_pred             CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCH-HHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence            56778999999999999999999765   34568999998754322 223567889999999999999999999999999


Q ss_pred             EEEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccC
Q 045787           81 VFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGV  159 (324)
Q Consensus        81 ~~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~  159 (324)
                      .++||||+++ +|.+++......+++..++.++.+++.||.+||+.|++|+||+|+||+++ .++.++++|||.+.....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~-~~~~~~l~dfg~~~~~~~  159 (266)
T cd05064          81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVN-SDLVCKISGFRRLQEDKS  159 (266)
T ss_pred             cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEc-CCCcEEECCCcccccccc
Confidence            9999999985 77777766556789999999999999999999999999999999999999 889999999997655422


Q ss_pred             CCCc-ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhh
Q 045787          160 PQKE-YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYI  237 (324)
Q Consensus       160 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (324)
                      .... .....++..|+|||.+.+ ..++.++||||||+++|++++ |..||...+.............+           
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~-----------  227 (266)
T cd05064         160 EAIYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL-----------  227 (266)
T ss_pred             cchhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC-----------
Confidence            2111 111234567999999877 678999999999999999875 99999776654433222110000           


Q ss_pred             hcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          238 SEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                      .....++..+.+++.+|++.+|.+||+++++++
T Consensus       228 ----------------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         228 ----------------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             ----------------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence                            012357888999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=8e-43  Score=305.00  Aligned_cols=255  Identities=24%  Similarity=0.347  Sum_probs=213.0

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   83 (324)
                      +..+...+...||+|.||+||++....   .||||++......++..+.|++|+..+++-+|.||+-+.|++..... .|
T Consensus       389 Ip~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AI  464 (678)
T KOG0193|consen  389 IPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AI  464 (678)
T ss_pred             cCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-ee
Confidence            345567788999999999999999763   69999999888777778999999999999999999999999998887 99


Q ss_pred             EEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccC--C
Q 045787           84 VFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGV--P  160 (324)
Q Consensus        84 v~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~--~  160 (324)
                      |+.+|+| +|+..+...+..+++...+.|+.||++|+.|||.++|+|+|||..||++. ++++|+|+|||++.....  .
T Consensus       465 iTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~-~~~kVkIgDFGLatvk~~w~g  543 (678)
T KOG0193|consen  465 ITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLH-EDLKVKIGDFGLATVKTRWSG  543 (678)
T ss_pred             eehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEc-cCCcEEEecccceeeeeeecc
Confidence            9999998 88898888778899999999999999999999999999999999999999 889999999999876532  2


Q ss_pred             CCcccccccccccCCchhhcC--CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhh
Q 045787          161 QKEYSRDCVYSPYKAPELLLG--YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYIS  238 (324)
Q Consensus       161 ~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (324)
                      ......+.+...|+|||+++.  ..++++.+||||||+++|||++|..||.....+++.-.             -     
T Consensus       544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifm-------------V-----  605 (678)
T KOG0193|consen  544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFM-------------V-----  605 (678)
T ss_pred             ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEE-------------e-----
Confidence            233445567788999999863  57789999999999999999999999985554432111             0     


Q ss_pred             cccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          239 EILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                           -+..............++++++|+..|+..++++||...+|+.
T Consensus       606 -----GrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  606 -----GRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             -----cccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence                 0011112223334467889999999999999999999999986

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=7.2e-41  Score=284.58  Aligned_cols=255  Identities=28%  Similarity=0.468  Sum_probs=203.6

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCC---CchHHHHHHHHHHhcCCCCeeEEEeeeecC--CeE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEG---VPSYIIREVSLLKELEHENIVRLLDVQSSR--KDV   81 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~   81 (324)
                      .+|++.+.||+|++|.||.+.+..++..|++|.+........   ....+.+|+.+++++.||+++++++.+.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            589999999999999999999999999999999865432221   234678899999999999999999988663  568


Q ss_pred             EEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           82 FLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        82 ~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      ++++||++| +|.+++... ..+++..+..++.+++.+|.+||+.|++|+||+|+||+++ .++.++|+|||.+......
T Consensus        82 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~-~~~~~~l~Dfg~~~~~~~~  159 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRD-SVGNVKLGDFGASKRLQTI  159 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEec-CCCCEEECcCccccccccc
Confidence            899999974 888877654 4588999999999999999999999999999999999999 8999999999988755321


Q ss_pred             C---CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhh
Q 045787          161 Q---KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYI  237 (324)
Q Consensus       161 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (324)
                      .   .......++..|+|||++.+ ...+.++|+||||+++|+|++|+.||.........  ......+..         
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~--~~~~~~~~~---------  227 (265)
T cd06652         160 CLSGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI--FKIATQPTN---------  227 (265)
T ss_pred             cccccccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHH--HHHhcCCCC---------
Confidence            1   12223457788999999977 66799999999999999999999999765422211  111111100         


Q ss_pred             hcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCcccc
Q 045787          238 SEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLI  291 (324)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~  291 (324)
                                     ......++..+.++|.+|+. +|.+||+++++++|||+.
T Consensus       228 ---------------~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         228 ---------------PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             ---------------CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence                           00122567788899999995 999999999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=4.3e-41  Score=289.43  Aligned_cols=262  Identities=23%  Similarity=0.354  Sum_probs=205.9

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEcc-----CCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecC
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTV-----TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR   78 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   78 (324)
                      +..++|++.+.||+|++|.||++..+.     .+..+++|.+...... .....+.+|+..++.++||+++++++++..+
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL-RERIEFLNEASVMKGFTCHHVVRLLGVVSKG   81 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            456899999999999999999987542     3457999987643321 1234567899999999999999999999999


Q ss_pred             CeEEEEEEecC-CCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEE
Q 045787           79 KDVFLVFEYLD-LDLHSFITRHK---------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKL  148 (324)
Q Consensus        79 ~~~~iv~e~~~-g~l~~~~~~~~---------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l  148 (324)
                      ...++||||+. |+|.+++....         ...+...+..++.+++.||.+||++|++|+||||+||+++ .++.++|
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~-~~~~~~L  160 (288)
T cd05061          82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVA-HDFTVKI  160 (288)
T ss_pred             CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEc-CCCcEEE
Confidence            99999999997 68988886532         2346678889999999999999999999999999999999 8999999


Q ss_pred             eeccceeeccCCCCc--ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCC
Q 045787          149 ADFGLARAIGVPQKE--YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGT  225 (324)
Q Consensus       149 ~d~g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~  225 (324)
                      +|||.+.........  .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||.................
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~  239 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY  239 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhcc-CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence            999988755322211  112234566999999877 567999999999999999998 7889977665443322211100


Q ss_pred             CCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc------CccccCCCC
Q 045787          226 PTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK------HEYLIGVEN  295 (324)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~------hp~~~~~~~  295 (324)
                      +                           ......++.+.+++.+||+.||.+|||+.++++      ||||.++.+
T Consensus       240 ~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~  288 (288)
T cd05061         240 L---------------------------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSF  288 (288)
T ss_pred             C---------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCCC
Confidence            0                           011245788999999999999999999999987      999998863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.7e-41  Score=291.21  Aligned_cols=254  Identities=27%  Similarity=0.383  Sum_probs=204.9

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCC-----ceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecC
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTG-----QKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR   78 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~-----~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   78 (324)
                      +...+|++++.||+|++|.||++.+...+     ..+++|.+..... ......+.+|+..+.+++||+++++++++...
T Consensus         2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~   80 (283)
T cd05048           2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE-PKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE   80 (283)
T ss_pred             CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCC-HHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence            44568999999999999999999976555     6789998764322 22235678999999999999999999999999


Q ss_pred             CeEEEEEEecC-CCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecC
Q 045787           79 KDVFLVFEYLD-LDLHSFITRHK---------------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK  142 (324)
Q Consensus        79 ~~~~iv~e~~~-g~l~~~~~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~  142 (324)
                      ...++++||++ ++|.+++....               ..+++..+..++.+++.||.+||+.|++|+||||+||+++ +
T Consensus        81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~-~  159 (283)
T cd05048          81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG-E  159 (283)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEc-C
Confidence            99999999997 58888886542               3578889999999999999999999999999999999999 8


Q ss_pred             CCcEEEeeccceeeccCCCC--cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 045787          143 RNTVKLADFGLARAIGVPQK--EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLI  219 (324)
Q Consensus       143 ~~~v~l~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~  219 (324)
                      ++.++|+|||.+........  ......+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||.+.........
T Consensus       160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05048         160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM  238 (283)
T ss_pred             CCcEEECCCcceeeccccccccccCCCcccccccCHHHhcc-CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            89999999999876542221  1223345677999999877 567999999999999999998 9999987665544333


Q ss_pred             HHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcC
Q 045787          220 FSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH  287 (324)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~h  287 (324)
                      ......+                           .....++.++.+++.+||+.||.+||++.+++++
T Consensus       239 i~~~~~~---------------------------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         239 IRSRQLL---------------------------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHcCCcC---------------------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            2211100                           0123578999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=3.4e-41  Score=284.95  Aligned_cols=252  Identities=28%  Similarity=0.440  Sum_probs=210.3

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEe
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEY   87 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   87 (324)
                      +|++.+.||.|++|.||++.+..+++.+++|.+............+.+|+.++++++|+|++++++.+......++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            68999999999999999999999999999999876554433345677899999999999999999999999999999999


Q ss_pred             cCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCc
Q 045787           88 LDL-DLHSFITRH---KNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE  163 (324)
Q Consensus        88 ~~g-~l~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~  163 (324)
                      +++ +|.+++...   ...+++..++.++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+......  .
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~-~~~~~kl~d~g~~~~~~~~--~  157 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLV-ANDLVKIGDLGISKVLKKN--M  157 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEe-cCCcEEEeeccchhhhccC--C
Confidence            975 788777652   34689999999999999999999999999999999999999 7899999999998776533  2


Q ss_pred             ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCC
Q 045787          164 YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPL  243 (324)
Q Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (324)
                      .....+++.|+|||.+.+ ..++.++|+||||+++++|++|+.||...+.............+                 
T Consensus       158 ~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------------  219 (256)
T cd08530         158 AKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYP-----------------  219 (256)
T ss_pred             cccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-----------------
Confidence            223457788999999977 66789999999999999999999999877654433322111000                 


Q ss_pred             CCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          244 YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                                .....++.++.+++.+||..+|.+||++.++++||++
T Consensus       220 ----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         220 ----------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             ----------CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence                      1112567889999999999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-42  Score=291.12  Aligned_cols=289  Identities=32%  Similarity=0.514  Sum_probs=227.7

Q ss_pred             CCcccC-cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcC--------CCCeeEE
Q 045787            1 MGKLKN-LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE--------HENIVRL   71 (324)
Q Consensus         1 ~~~~~~-~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~--------~~~i~~~   71 (324)
                      +|+... +||-++++||+|-|++||+|.|....+.||+|+.+...   .+.+....|+.+|++++        ..+||++
T Consensus        71 IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq---hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~L  147 (590)
T KOG1290|consen   71 IGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ---HYTEAALDEIKLLQQVREGDPNDPGKKCVVQL  147 (590)
T ss_pred             ccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh---HHHHHHHHHHHHHHHHHhcCCCCCCCceeeee
Confidence            366666 99999999999999999999999999999999987442   22455678999999984        2479999


Q ss_pred             Eeeeec----CCeEEEEEEecCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH-hCCCcccCCCCCceEeecCC--
Q 045787           72 LDVQSS----RKDVFLVFEYLDLDLHSFITRHKN-TLNLLVIKAILKQILLGLAYCH-SLKILHRDLKPNNLLIDLKR--  143 (324)
Q Consensus        72 ~~~~~~----~~~~~iv~e~~~g~l~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~Lh-~~g~~H~di~p~nIll~~~~--  143 (324)
                      ++.|..    ..++|+|+|+.+.+|+.++..... .++...++.|++||+.||.||| ..||+|.||||+|||+...+  
T Consensus       148 lD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~  227 (590)
T KOG1290|consen  148 LDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEID  227 (590)
T ss_pred             eccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccc
Confidence            999854    458999999999999999988764 5999999999999999999999 56999999999999985000  


Q ss_pred             --------------------------------------------------------------------------------
Q 045787          144 --------------------------------------------------------------------------------  143 (324)
Q Consensus       144 --------------------------------------------------------------------------------  143 (324)
                                                                                                      
T Consensus       228 ~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~  307 (590)
T KOG1290|consen  228 PAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEP  307 (590)
T ss_pred             hhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccccccccccc
Confidence                                                                                            


Q ss_pred             --------------------------------------------------------------------------------
Q 045787          144 --------------------------------------------------------------------------------  143 (324)
Q Consensus       144 --------------------------------------------------------------------------------  143 (324)
                                                                                                      
T Consensus       308 ~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~  387 (590)
T KOG1290|consen  308 RINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLP  387 (590)
T ss_pred             CCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCC
Confidence                                                                                            


Q ss_pred             ---CcEEEeeccceeeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCC-------CCh
Q 045787          144 ---NTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPS-------KKH  213 (324)
Q Consensus       144 ---~~v~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~-------~~~  213 (324)
                         -++||.|||-++...   ..+.....|..|+|||++.+ ..|+..+||||++|+++||+||...|..       .+.
T Consensus       388 ~~di~vKIaDlGNACW~~---khFT~DIQTRQYRapEVllG-sgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDE  463 (590)
T KOG1290|consen  388 ECDIRVKIADLGNACWVH---KHFTEDIQTRQYRAPEVLLG-SGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDE  463 (590)
T ss_pred             ccceeEEEeeccchhhhh---hhhchhhhhhhccCcceeec-CCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccH
Confidence               012333333322211   11222233445999999999 8899999999999999999999998854       347


Q ss_pred             hHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCC---------CCC----hhHHHHHHHhhcCCCCCCCC
Q 045787          214 DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFP---------NLE----PAGVDLLSQMLCLNPKQRIT  280 (324)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~----~~l~~li~~~l~~dP~~Rps  280 (324)
                      ++++.++..++..|...........+++............+.|+         .++    .++.+|+.-||+.+|.+|||
T Consensus       464 DHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~t  543 (590)
T KOG1290|consen  464 DHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPT  543 (590)
T ss_pred             HHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCcccccc
Confidence            89999999999999888777777777766555544333333332         233    35779999999999999999


Q ss_pred             HHHHhcCccccCCCCc
Q 045787          281 AMDALKHEYLIGVENV  296 (324)
Q Consensus       281 ~~~~l~hp~~~~~~~~  296 (324)
                      |.++|+|||+..+..+
T Consensus       544 A~~cl~hPwLn~~~~~  559 (590)
T KOG1290|consen  544 AAQCLKHPWLNPVAGP  559 (590)
T ss_pred             HHHHhcCccccCCCCC
Confidence            9999999999999886

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3.4e-41  Score=292.30  Aligned_cols=259  Identities=24%  Similarity=0.349  Sum_probs=199.0

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEcc----------------CCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCC
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTV----------------TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN   67 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~----------------~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~   67 (324)
                      +..++|++.+.||+|+||.||+|.+..                .+..||+|.+..... ......+.+|+.++.+++|||
T Consensus         2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~n   80 (304)
T cd05096           2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN-KNARNDFLKEVKILSRLKDPN   80 (304)
T ss_pred             CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC-HHHHHHHHHHHHHHhhcCCCC
Confidence            456899999999999999999998532                334799998875432 222356889999999999999


Q ss_pred             eeEEEeeeecCCeEEEEEEecC-CCHHHHHHhcC------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 045787           68 IVRLLDVQSSRKDVFLVFEYLD-LDLHSFITRHK------------------NTLNLLVIKAILKQILLGLAYCHSLKIL  128 (324)
Q Consensus        68 i~~~~~~~~~~~~~~iv~e~~~-g~l~~~~~~~~------------------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~  128 (324)
                      |+++++++.+.+..++||||+. |+|.+++....                  ..++...++.++.+++.||.+||+.|++
T Consensus        81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv  160 (304)
T cd05096          81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV  160 (304)
T ss_pred             eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            9999999999999999999997 58888775532                  2367788999999999999999999999


Q ss_pred             ccCCCCCceEeecCCCcEEEeeccceeeccCCCC--cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh--C
Q 045787          129 HRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK--EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT--G  204 (324)
Q Consensus       129 H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~--g  204 (324)
                      |+||||+||+++ .++.++|+|||.+........  ......++..|+|||++.+ ..++.++||||||+++|+|++  +
T Consensus       161 H~dlkp~Nill~-~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~  238 (304)
T cd05096         161 HRDLATRNCLVG-ENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM-GKFTTASDVWAFGVTLWEILMLCK  238 (304)
T ss_pred             ccCcchhheEEc-CCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-CCCCchhhhHHHHHHHHHHHHccC
Confidence            999999999999 889999999999876532221  1222344677999999877 668999999999999999987  5


Q ss_pred             CCCCCCCChhHHHHHHHH-cCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHH
Q 045787          205 KPLFPSKKHDHLSLIFSL-LGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMD  283 (324)
Q Consensus       205 ~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~  283 (324)
                      ..||...+.......... ......                     .......+..+..+.+++.+|++.||.+|||+.+
T Consensus       239 ~~p~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~  297 (304)
T cd05096         239 EQPYGELTDEQVIENAGEFFRDQGR---------------------QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSD  297 (304)
T ss_pred             CCCCCcCCHHHHHHHHHHHhhhccc---------------------cccccCCCCCCHHHHHHHHHHccCCchhCcCHHH
Confidence            678876554433222111 000000                     0000112356789999999999999999999999


Q ss_pred             Hhc
Q 045787          284 ALK  286 (324)
Q Consensus       284 ~l~  286 (324)
                      +.+
T Consensus       298 i~~  300 (304)
T cd05096         298 IHA  300 (304)
T ss_pred             HHH
Confidence            954

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2e-41  Score=287.62  Aligned_cols=252  Identities=31%  Similarity=0.524  Sum_probs=206.5

Q ss_pred             ecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEecCC-CH
Q 045787           15 IGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DL   92 (324)
Q Consensus        15 Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~g-~l   92 (324)
                      ||.|++|.||++.+..+|+.+++|.+..... .......+.+|+.++++++|||++++++.+......|+++||+.+ +|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999998899999999875542 223456788999999999999999999999999999999999975 88


Q ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC--------cc
Q 045787           93 HSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK--------EY  164 (324)
Q Consensus        93 ~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~--------~~  164 (324)
                      .+++.... .+++..+..++.|++.+|.+||+.|++|+||+|+||+++ .++.++|+|||.+........        ..
T Consensus        81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~  158 (265)
T cd05579          81 ASLLENVG-SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILID-SNGHLKLTDFGLSKVGLVRRQINLNDDEKED  158 (265)
T ss_pred             HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEc-CCCCEEEEecccchhcccCcccccccccccc
Confidence            77776644 789999999999999999999999999999999999999 899999999998876543311        22


Q ss_pred             cccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCC
Q 045787          165 SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLY  244 (324)
Q Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (324)
                      ....++..|+|||...+ ...+.++|+||||+++|++++|..||...................                 
T Consensus       159 ~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----------------  220 (265)
T cd05579         159 KRIVGTPDYIAPEVILG-QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEW-----------------  220 (265)
T ss_pred             cCcccCccccCHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCC-----------------
Confidence            33456778999999877 457899999999999999999999998776554332222100000                 


Q ss_pred             CCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCH---HHHhcCccccCCCC
Q 045787          245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITA---MDALKHEYLIGVEN  295 (324)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~---~~~l~hp~~~~~~~  295 (324)
                         .     . ...++..+.+++.+||+.+|.+||++   .++++||||.++++
T Consensus       221 ---~-----~-~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~  265 (265)
T cd05579         221 ---P-----E-DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW  265 (265)
T ss_pred             ---C-----c-cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence               0     0 01258899999999999999999999   99999999998764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-41  Score=285.32  Aligned_cols=252  Identities=29%  Similarity=0.443  Sum_probs=198.9

Q ss_pred             EeecccCceEEEEEEEccCCceEEEEEeeecccc-CCCchHHHHHHHHH-HhcCCCCeeEEEeeeecCCeEEEEEEecCC
Q 045787           13 KKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQ-EGVPSYIIREVSLL-KELEHENIVRLLDVQSSRKDVFLVFEYLDL   90 (324)
Q Consensus        13 ~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~-~~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~~~~~~iv~e~~~g   90 (324)
                      +.||.|++|.||+|.+..+++.+|+|++...... ......+..|..++ ...+|+|++++++.+..++..|+|+||++|
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            5799999999999999999999999998754321 11122334454443 445799999999999999999999999975


Q ss_pred             -CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccccccc
Q 045787           91 -DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCV  169 (324)
Q Consensus        91 -~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~~~~  169 (324)
                       +|.+++.. ..++++..+..++.|++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+.....    .....+
T Consensus        82 ~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~----~~~~~~  155 (260)
T cd05611          82 GDCASLIKT-LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLID-QTGHLKLTDFGLSRNGLE----NKKFVG  155 (260)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC-CCCcEEEeecccceeccc----cccCCC
Confidence             77777655 35689999999999999999999999999999999999999 889999999998875432    223356


Q ss_pred             ccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCC
Q 045787          170 YSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEP  249 (324)
Q Consensus       170 ~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (324)
                      ++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+..............                       
T Consensus       156 ~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------------------  211 (260)
T cd05611         156 TPDYLAPETILG-VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRIN-----------------------  211 (260)
T ss_pred             CcCccChhhhcC-CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccC-----------------------
Confidence            778999999887 44789999999999999999999999776654432222111000                       


Q ss_pred             cchhhhCCCCChhHHHHHHHhhcCCCCCCCC---HHHHhcCccccCCCC
Q 045787          250 ANLAEKFPNLEPAGVDLLSQMLCLNPKQRIT---AMDALKHEYLIGVEN  295 (324)
Q Consensus       250 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps---~~~~l~hp~~~~~~~  295 (324)
                       ........+++.+.+++.+||+.||.+||+   +.|++.||||+++++
T Consensus       212 -~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~  259 (260)
T cd05611         212 -WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINW  259 (260)
T ss_pred             -CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence             000111257889999999999999999995   579999999998775

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=7.6e-41  Score=284.66  Aligned_cols=248  Identities=26%  Similarity=0.406  Sum_probs=196.3

Q ss_pred             cCcceeEee--cccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEEE
Q 045787            7 LNYKKIKKI--GAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         7 ~~y~i~~~L--g~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~i   83 (324)
                      ++|++.+.+  |.|+||.||++.++.++..+++|.+.......       .|+.....+ +||+++++++.+..++..++
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~i   86 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVL   86 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence            467777776  99999999999999999999999987543221       122222222 69999999999999999999


Q ss_pred             EEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCC-cEEEeeccceeeccCCC
Q 045787           84 VFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN-TVKLADFGLARAIGVPQ  161 (324)
Q Consensus        84 v~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~-~v~l~d~g~~~~~~~~~  161 (324)
                      ||||++ ++|.+++.... ++++..++.++.|++.||.+||+.|++|+||+|+||+++ .++ .++|+|||.+...... 
T Consensus        87 v~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~-~~~~~~~l~dfg~~~~~~~~-  163 (267)
T PHA03390         87 IMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD-RAKDRIYLCDYGLCKIIGTP-  163 (267)
T ss_pred             EEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEe-CCCCeEEEecCccceecCCC-
Confidence            999997 58888887653 799999999999999999999999999999999999999 666 9999999988765422 


Q ss_pred             CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhccc
Q 045787          162 KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEIL  241 (324)
Q Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (324)
                         ....++..|+|||++.+ ..++.++|+||+|+++|+|++|..||..............               ... 
T Consensus       164 ---~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~---------------~~~-  223 (267)
T PHA03390        164 ---SCYDGTLDYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLL---------------KRQ-  223 (267)
T ss_pred             ---ccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHH---------------Hhh-
Confidence               22357788999999987 5678999999999999999999999975543321100000               000 


Q ss_pred             CCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCC-HHHHhcCccccC
Q 045787          242 PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRIT-AMDALKHEYLIG  292 (324)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-~~~~l~hp~~~~  292 (324)
                              .......+.+++.+.++|.+||+.||.+||+ .+++++||||++
T Consensus       224 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        224 --------QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             --------cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence                    0000112358899999999999999999996 599999999974

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=5.9e-41  Score=284.80  Aligned_cols=251  Identities=25%  Similarity=0.386  Sum_probs=204.6

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   83 (324)
                      +...+|++.+.||.|++|.||+|.+...+..+++|.+.....   ....+.+|+..+++++|++++++++++..+...++
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (263)
T cd05052           3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   79 (263)
T ss_pred             CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch---HHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEE
Confidence            456779999999999999999999998899999999864322   23567889999999999999999999999999999


Q ss_pred             EEEecC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC
Q 045787           84 VFEYLD-LDLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        84 v~e~~~-g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~  161 (324)
                      ++||++ ++|.+++.... ..+++..+..++.|++.+|.+||++|++|+||+|+||+++ +++.++|+|||.+.......
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~-~~~~~kl~df~~~~~~~~~~  158 (263)
T cd05052          80 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHLVKVADFGLSRLMTGDT  158 (263)
T ss_pred             EEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc-CCCcEEeCCCccccccccce
Confidence            999997 58888876543 3588999999999999999999999999999999999999 89999999999987654322


Q ss_pred             Ccc-cccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhc
Q 045787          162 KEY-SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISE  239 (324)
Q Consensus       162 ~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
                      ... .....++.|+|||.+.+ ..++.++||||||+++|+|++ |..||...+.............+             
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~-------------  224 (263)
T cd05052         159 YTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRM-------------  224 (263)
T ss_pred             eeccCCCCCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC-------------
Confidence            111 11223456999999877 667899999999999999998 89999876654433322110000             


Q ss_pred             ccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                    .....++.++.+++.+||+.||++||++.++++
T Consensus       225 --------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         225 --------------ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             --------------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                          111357889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=3.9e-41  Score=290.85  Aligned_cols=268  Identities=23%  Similarity=0.378  Sum_probs=211.3

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcC-CCCeeEEEeeeecCCeEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-HENIVRLLDVQSSRKDVF   82 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~   82 (324)
                      +..++|++.+.||+|++|.||+|.+..+++.+++|.+....... ....+..|+.++.+.. |++++++++++.+....|
T Consensus        12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~   90 (296)
T cd06618          12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE-ENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVF   90 (296)
T ss_pred             CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChH-HHHHHHHHHHHHHhccCCCchHhhheeeecCCeEE
Confidence            45688999999999999999999999889999999987543222 2344556777666664 999999999999999999


Q ss_pred             EEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC
Q 045787           83 LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS-LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        83 iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~  161 (324)
                      +++||+++++.+.+.....++++..+..++.+++.+|.|||+ .|++|+||+|+||+++ .++.++|+|||.+.......
T Consensus        91 ~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~-~~~~~kL~dfg~~~~~~~~~  169 (296)
T cd06618          91 ICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSK  169 (296)
T ss_pred             EEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEc-CCCCEEECccccchhccCCC
Confidence            999999988888887766789999999999999999999997 5999999999999999 89999999999887654222


Q ss_pred             CcccccccccccCCchhhcCC---CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhh
Q 045787          162 KEYSRDCVYSPYKAPELLLGY---TGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYIS  238 (324)
Q Consensus       162 ~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (324)
                       ......+++.|+|||.+.+.   ..++.++|+||||+++|+|++|+.||........ ............         
T Consensus       170 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~---------  238 (296)
T cd06618         170 -AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE-VLTKILQEEPPS---------  238 (296)
T ss_pred             -cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHH-HHHHHhcCCCCC---------
Confidence             22233467789999998753   3478899999999999999999999965432211 111111110000         


Q ss_pred             cccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchh
Q 045787          239 EILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~  298 (324)
                           .         .....++.++.+++.+||..||.+||++.++++||||+..+...-
T Consensus       239 -----~---------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~  284 (296)
T cd06618         239 -----L---------PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAEV  284 (296)
T ss_pred             -----C---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccchhHH
Confidence                 0         001146788999999999999999999999999999997665443

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=8.4e-41  Score=282.74  Aligned_cols=248  Identities=23%  Similarity=0.331  Sum_probs=200.4

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      .++|++.+.||+|++|.||++..+ ++..+++|.+......   ...+.+|+.++++++||+++++++++......++||
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   78 (256)
T cd05114           3 PSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT   78 (256)
T ss_pred             HHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence            467999999999999999999875 4568999987643222   356788999999999999999999999999999999


Q ss_pred             EecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCc-
Q 045787           86 EYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE-  163 (324)
Q Consensus        86 e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~-  163 (324)
                      ||++ |+|.+++......+++..+..++.+++.||.+||++|++|+||+|+||+++ .++.++|+|||.+......... 
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~-~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05114          79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVS-STGVVKVSDFGMTRYVLDDEYTS  157 (256)
T ss_pred             EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEc-CCCeEEECCCCCccccCCCceec
Confidence            9997 688888876656789999999999999999999999999999999999999 8899999999988765322211 


Q ss_pred             ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccC
Q 045787          164 YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILP  242 (324)
Q Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (324)
                      .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |+.||...+.............+.               
T Consensus       158 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~---------------  221 (256)
T cd05114         158 SSGAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLY---------------  221 (256)
T ss_pred             cCCCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCC---------------
Confidence            112233456999999876 567899999999999999999 899997776544333222111000               


Q ss_pred             CCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          243 LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                  .....+..+.+++.+|++.||.+||++.++++
T Consensus       222 ------------~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         222 ------------RPKLASMTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             ------------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                        01135678899999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.8e-44  Score=280.30  Aligned_cols=291  Identities=37%  Similarity=0.655  Sum_probs=239.9

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeec-------
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS-------   77 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-------   77 (324)
                      ..+.|+-+.++|+|.||.||+|+++..|+.|++|+...............+|+.+++.++|+|++.+++++..       
T Consensus        15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r   94 (376)
T KOG0669|consen   15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR   94 (376)
T ss_pred             cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence            4567888999999999999999999999999999887665555556667799999999999999999987643       


Q ss_pred             -CCeEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceee
Q 045787           78 -RKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARA  156 (324)
Q Consensus        78 -~~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~  156 (324)
                       ...+|+||.+|+.+|...+....-.++...+..++..+..||.|+|...++|+|+|+.|++++ .++.++|.|||.++.
T Consensus        95 ~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt-~dgilklADFGlar~  173 (376)
T KOG0669|consen   95 DRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLIT-KDGILKLADFGLARA  173 (376)
T ss_pred             ccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEc-CCceEEeeccccccc
Confidence             345999999999999999988777899999999999999999999999999999999999999 999999999999966


Q ss_pred             ccCCC----CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHHcCCCCcccc
Q 045787          157 IGVPQ----KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-HDHLSLIFSLLGTPTDESW  231 (324)
Q Consensus       157 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~  231 (324)
                      ...+.    ........|.+|++||.+.+...++++.|+|+-||++.+|+++.+.+.+++ ...+..+....+....+.|
T Consensus       174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW  253 (376)
T KOG0669|consen  174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW  253 (376)
T ss_pred             eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence            64332    234445679999999999999999999999999999999999999998888 5566677778888888888


Q ss_pred             cchhhhhcccCCCCC----CCCcchhhhCC--CCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCc
Q 045787          232 AESTYISEILPLYPH----FEPANLAEKFP--NLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENV  296 (324)
Q Consensus       232 ~~~~~~~~~~~~~~~----~~~~~~~~~~~--~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~  296 (324)
                      ..-....-.......    -..........  .-++++.+|+..||..||.+|+++++++.|.||..-..+
T Consensus       254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p  324 (376)
T KOG0669|consen  254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP  324 (376)
T ss_pred             CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence            775554433332111    11111111111  124578899999999999999999999999999876544

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=4.3e-41  Score=293.15  Aligned_cols=254  Identities=26%  Similarity=0.390  Sum_probs=204.2

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccCCce----EEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecC
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQK----VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR   78 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~----~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   78 (324)
                      .+...+|++.+.||+|+||.||+|.+..++..    +++|.+..... ......+.+|+.+++.++|||++++++++...
T Consensus         3 ~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~   81 (316)
T cd05108           3 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-PKANKEILDEAYVMASVDNPHVCRLLGICLTS   81 (316)
T ss_pred             ccchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence            46778999999999999999999987665554    89998864322 22345688899999999999999999998764


Q ss_pred             CeEEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeec
Q 045787           79 KDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAI  157 (324)
Q Consensus        79 ~~~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~  157 (324)
                       ..+++++|+. |++.+++......++...+..++.+++.||.|||+.|++|+||||+||+++ .++.++|+|||.+...
T Consensus        82 -~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~-~~~~~kl~DfG~a~~~  159 (316)
T cd05108          82 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVK-TPQHVKITDFGLAKLL  159 (316)
T ss_pred             -CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEec-CCCcEEEccccccccc
Confidence             5678899987 699999888766789999999999999999999999999999999999999 8899999999999876


Q ss_pred             cCCCCcc--cccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccch
Q 045787          158 GVPQKEY--SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAES  234 (324)
Q Consensus       158 ~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (324)
                      .......  .....+..|+|||.+.+ ..++.++||||||+++|+|++ |..||.+................+       
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-------  231 (316)
T cd05108         160 GADEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP-------  231 (316)
T ss_pred             cCCCcceeccCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCC-------
Confidence            5332211  11223567999999877 677999999999999999998 999998766554433322111110       


Q ss_pred             hhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcC
Q 045787          235 TYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH  287 (324)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~h  287 (324)
                                          ..+..+.++.+++.+|+..||.+||++.+++.+
T Consensus       232 --------------------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         232 --------------------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             --------------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                012456788999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1e-40  Score=285.53  Aligned_cols=258  Identities=24%  Similarity=0.383  Sum_probs=201.4

Q ss_pred             eecccCceEEEEEEEccCCceEEEEEeeeccccCCC-chHHHHHHH---HHHhcCCCCeeEEEeeeecCCeEEEEEEecC
Q 045787           14 KIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGV-PSYIIREVS---LLKELEHENIVRLLDVQSSRKDVFLVFEYLD   89 (324)
Q Consensus        14 ~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~---~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~   89 (324)
                      .||+|++|.||+|.+..+++.||+|.+......... ......|..   .++...||+++.+++.+...+..++|+||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            379999999999999989999999998765322111 122334433   3444579999999999999999999999998


Q ss_pred             C-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcccccc
Q 045787           90 L-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDC  168 (324)
Q Consensus        90 g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~~~  168 (324)
                      | +|..++.. .+.+++..++.++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+......  ......
T Consensus        81 g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~-~~~~~kl~dfg~~~~~~~~--~~~~~~  156 (278)
T cd05606          81 GGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKK--KPHASV  156 (278)
T ss_pred             CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEEC-CCCCEEEccCcCccccCcc--CCcCcC
Confidence            5 66666554 45799999999999999999999999999999999999999 8899999999988755322  223346


Q ss_pred             cccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCC
Q 045787          169 VYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFE  248 (324)
Q Consensus       169 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (324)
                      ++..|+|||.+.+...++.++|+||+|+++|+|++|..||..................                      
T Consensus       157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------------------  214 (278)
T cd05606         157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM----------------------  214 (278)
T ss_pred             CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhcc----------------------
Confidence            8888999999976456889999999999999999999999765322111111100000                      


Q ss_pred             CcchhhhCCCCChhHHHHHHHhhcCCCCCCC-----CHHHHhcCccccCCCCchhhh
Q 045787          249 PANLAEKFPNLEPAGVDLLSQMLCLNPKQRI-----TAMDALKHEYLIGVENVPLVI  300 (324)
Q Consensus       249 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~~l~hp~~~~~~~~~~~~  300 (324)
                         .......++..+.+++.+||..||.+||     ++.++++||||+.....+...
T Consensus       215 ---~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~~~  268 (278)
T cd05606         215 ---AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFL  268 (278)
T ss_pred             ---CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchHhhh
Confidence               0011224688999999999999999999     999999999999998777653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.1e-40  Score=285.67  Aligned_cols=255  Identities=24%  Similarity=0.364  Sum_probs=205.2

Q ss_pred             CCcccCcCcceeEeecccCceEEEEEEEccCCc----eEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeee
Q 045787            1 MGKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQ----KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQS   76 (324)
Q Consensus         1 ~~~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~----~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   76 (324)
                      |+-+...+|++++.||.|++|+||+|.+..++.    .||+|++...... .....+.+|+.+++.++|||++++++++.
T Consensus         1 ~~~l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   79 (279)
T cd05109           1 MRILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSP-KANKEILDEAYVMAGVGSPYVCRLLGICL   79 (279)
T ss_pred             CcccchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCH-HHHHHHHHHHHHHHhcCCCCCceEEEEEc
Confidence            667888999999999999999999999776666    4789988654322 22356788999999999999999999887


Q ss_pred             cCCeEEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeecccee
Q 045787           77 SRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLAR  155 (324)
Q Consensus        77 ~~~~~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~  155 (324)
                      .. ..+++++|++ |++.+.+......+++..+..++.+++.||.+||++|++|+||||+||+++ +++.++|+|||.+.
T Consensus        80 ~~-~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~-~~~~~kL~dfG~~~  157 (279)
T cd05109          80 TS-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVK-SPNHVKITDFGLAR  157 (279)
T ss_pred             CC-CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc-CCCcEEECCCCcee
Confidence            54 5678999997 699988877666799999999999999999999999999999999999998 88899999999988


Q ss_pred             eccCCCCcc--cccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCccccc
Q 045787          156 AIGVPQKEY--SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWA  232 (324)
Q Consensus       156 ~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  232 (324)
                      .........  ....+++.|+|||...+ ..++.++||||||+++|+|++ |..||.................++     
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-----  231 (279)
T cd05109         158 LLDIDETEYHADGGKVPIKWMALESILH-RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLP-----  231 (279)
T ss_pred             ecccccceeecCCCccchhhCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCC-----
Confidence            764322211  11233566999999877 668999999999999999998 899997766554433332111111     


Q ss_pred             chhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          233 ESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                            .....+.++.+++.+||..||++||++.+++.
T Consensus       232 ----------------------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         232 ----------------------QPPICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             ----------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                  01246788999999999999999999999995

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.2e-40  Score=281.83  Aligned_cols=250  Identities=24%  Similarity=0.328  Sum_probs=201.2

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLV   84 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   84 (324)
                      ...+|++.+.||+|++|.||.+.... +..+++|.+......   .+.+.+|+.++++++|||++++++++..+...+++
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   77 (256)
T cd05113           2 DPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV   77 (256)
T ss_pred             ChHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence            45689999999999999999998653 456999987643322   35688999999999999999999999998999999


Q ss_pred             EEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCc
Q 045787           85 FEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE  163 (324)
Q Consensus        85 ~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~  163 (324)
                      |||+. |+|.+++......+++..++.++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+.........
T Consensus        78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~-~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05113          78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVD-DQGCVKVSDFGLSRYVLDDEYT  156 (256)
T ss_pred             EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEc-CCCCEEECCCccceecCCCcee
Confidence            99997 588888877656789999999999999999999999999999999999999 8899999999988765432211


Q ss_pred             -ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhccc
Q 045787          164 -YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEIL  241 (324)
Q Consensus       164 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (324)
                       .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+.............+               
T Consensus       157 ~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---------------  220 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLY-SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL---------------  220 (256)
T ss_pred             ecCCCccChhhCCHHHHhc-CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC---------------
Confidence             111234456999999976 567899999999999999998 99999766644332222111000               


Q ss_pred             CCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcC
Q 045787          242 PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH  287 (324)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~h  287 (324)
                                  ......+..+.+++.+||+.||.+||++.+++++
T Consensus       221 ------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         221 ------------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             ------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence                        0011357889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=9.2e-41  Score=287.36  Aligned_cols=252  Identities=24%  Similarity=0.378  Sum_probs=202.1

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEc-----cCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecC
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNT-----VTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR   78 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   78 (324)
                      +...+|++.+.||.|++|.||++.+.     .++..+++|.+......  ....+.+|+.++++++||+++++++++...
T Consensus         2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (288)
T cd05093           2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDN--ARKDFHREAELLTNLQHEHIVKFYGVCVEG   79 (288)
T ss_pred             CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHH--HHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            56789999999999999999999853     34567899988654322  245688999999999999999999999999


Q ss_pred             CeEEEEEEecC-CCHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCc
Q 045787           79 KDVFLVFEYLD-LDLHSFITRHK------------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNT  145 (324)
Q Consensus        79 ~~~~iv~e~~~-g~l~~~~~~~~------------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~  145 (324)
                      ...++|+||++ ++|.+++....            ..+++..+..++.+++.||.+||++|++|+||||+||+++ +++.
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~-~~~~  158 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG-ENLL  158 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc-cCCc
Confidence            99999999997 58888876432            2489999999999999999999999999999999999999 8999


Q ss_pred             EEEeeccceeeccCCCC--cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHH
Q 045787          146 VKLADFGLARAIGVPQK--EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSL  222 (324)
Q Consensus       146 v~l~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~  222 (324)
                      ++|+|||.+........  ......+++.|+|||++.+ ..++.++|+||||+++|+|++ |..||..............
T Consensus       159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~  237 (288)
T cd05093         159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ  237 (288)
T ss_pred             EEeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            99999999876542221  1122334667999999887 667999999999999999998 8999977665443222221


Q ss_pred             cCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          223 LGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      ...+                           .....++.++.+++.+||+.||.+|||+.++++
T Consensus       238 ~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         238 GRVL---------------------------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             CCcC---------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            1000                           011246788999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-40  Score=283.56  Aligned_cols=253  Identities=22%  Similarity=0.354  Sum_probs=203.7

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccC---CceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVT---GQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV   81 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~---~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   81 (324)
                      ..++|++.+.||+|+||.||+|.....   ...+++|.+..... ......+.+|+..+++++|||++++++.+..++..
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (266)
T cd05033           2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS-DKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV   80 (266)
T ss_pred             ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCC-hHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence            457899999999999999999988644   45789998765432 22234577899999999999999999999999999


Q ss_pred             EEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           82 FLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        82 ~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      ++++||+. ++|.+++....+.++...+..++.+++.||.+||+.|++|+||+|+||+++ +++.++|+|||.+......
T Consensus        81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~-~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVN-SNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc-CCCCEEECccchhhccccc
Confidence            99999997 588888877666799999999999999999999999999999999999999 8999999999998876422


Q ss_pred             CCcc--cccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhh
Q 045787          161 QKEY--SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYI  237 (324)
Q Consensus       161 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (324)
                      ....  ....+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||..................+          
T Consensus       160 ~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~----------  228 (266)
T cd05033         160 EATYTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLP----------  228 (266)
T ss_pred             ccceeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC----------
Confidence            2211  11233467999999877 667999999999999999998 999997665444332222110000          


Q ss_pred             hcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcC
Q 045787          238 SEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH  287 (324)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~h  287 (324)
                                       .....+..+.+++.+|++.||.+||++.+++++
T Consensus       229 -----------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         229 -----------------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             -----------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                             012467889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=4.3e-41  Score=285.29  Aligned_cols=249  Identities=24%  Similarity=0.338  Sum_probs=204.6

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      ..+|++.+.||.|++|.||+|.+.. +..+++|.+......  ....+.+|+.+++.++|++++++++++......++||
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   81 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLL--KQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT   81 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchh--hHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence            4679999999999999999999987 889999998765432  2456888999999999999999999999999999999


Q ss_pred             EecC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCc
Q 045787           86 EYLD-LDLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE  163 (324)
Q Consensus        86 e~~~-g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~  163 (324)
                      ||++ ++|.+++.... ..++...+..++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+.........
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~-~~~~~kl~d~g~~~~~~~~~~~  160 (261)
T cd05148          82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVG-EDLVCKVADFGLARLIKEDVYL  160 (261)
T ss_pred             eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEc-CCceEEEccccchhhcCCcccc
Confidence            9997 48888887643 4689999999999999999999999999999999999999 8999999999998765433222


Q ss_pred             ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccC
Q 045787          164 YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILP  242 (324)
Q Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (324)
                      .....++..|+|||...+ ..++.++|+||||+++|+|++ |+.||...+.............+                
T Consensus       161 ~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----------------  223 (261)
T cd05148         161 SSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM----------------  223 (261)
T ss_pred             ccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC----------------
Confidence            223334567999999877 567899999999999999998 89999776644433322211000                


Q ss_pred             CCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          243 LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                 ......++.+.+++.+||+.||.+|||+.++++
T Consensus       224 -----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         224 -----------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             -----------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                       011357889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=8.9e-41  Score=281.91  Aligned_cols=244  Identities=23%  Similarity=0.363  Sum_probs=194.8

Q ss_pred             EeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEecC-CC
Q 045787           13 KKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD-LD   91 (324)
Q Consensus        13 ~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~-g~   91 (324)
                      +.||+|++|.||+|.+..+++.+++|.+..... .+....+.+|++++++++|||++++++++......++|+||+. ++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLP-PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD   79 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence            468999999999999998999999998764321 2223568899999999999999999999999999999999997 58


Q ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcc--ccccc
Q 045787           92 LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY--SRDCV  169 (324)
Q Consensus        92 l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~--~~~~~  169 (324)
                      |.+++......+++..++.++.+++.||.|||+.|++|+||+|+||+++ .++.++|+|||.+..........  .....
T Consensus        80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  158 (252)
T cd05084          80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVT-EKNVLKISDFGMSREEEDGVYASTGGMKQI  158 (252)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEc-CCCcEEECccccCcccccccccccCCCCCC
Confidence            8888776555689999999999999999999999999999999999999 88999999999887543211111  11122


Q ss_pred             ccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCC
Q 045787          170 YSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFE  248 (324)
Q Consensus       170 ~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (324)
                      +..|+|||.+.+ ..++.++|+||||+++|+|++ |..||..................                      
T Consensus       159 ~~~y~aPE~~~~-~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~----------------------  215 (252)
T cd05084         159 PVKWTAPEALNY-GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRL----------------------  215 (252)
T ss_pred             ceeecCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC----------------------
Confidence            345999999877 567999999999999999998 88888765544332222211000                      


Q ss_pred             CcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          249 PANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       249 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                           ......+..+.+++.+||+.||.+|||+.++++
T Consensus       216 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         216 -----PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             -----CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                 011246788999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.7e-40  Score=281.27  Aligned_cols=253  Identities=28%  Similarity=0.405  Sum_probs=204.6

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      ++|++.+.||.|++|.||+|.+..+|+.+++|.+..... .....+.+.+|++++++++|++++++++.+...+..++|+
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            689999999999999999999998999999999875432 2223567889999999999999999999999999999999


Q ss_pred             EecC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC
Q 045787           86 EYLD-LDLHSFITRH---KNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        86 e~~~-g~l~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~  161 (324)
                      ||++ ++|..++...   ...+++..+..++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+.......
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~-~~~~~~l~d~~~~~~~~~~~  160 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEEC-CCCcEEEeccceeeeccCCC
Confidence            9998 4888877542   34589999999999999999999999999999999999999 88999999999987654433


Q ss_pred             CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhccc
Q 045787          162 KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEIL  241 (324)
Q Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (324)
                      .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.................                
T Consensus       161 ~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------------  223 (267)
T cd08224         161 TAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC----------------  223 (267)
T ss_pred             cccceecCCccccCHHHhcc-CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcC----------------
Confidence            33334467788999999876 6678999999999999999999999965442211110000000                


Q ss_pred             CCCCCCCCcchhhh-CCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          242 PLYPHFEPANLAEK-FPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       242 ~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                               ..... ...++..+.++|.+||..+|++||++.++++
T Consensus       224 ---------~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         224 ---------DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             ---------CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                     00000 1246778999999999999999999999885

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.3e-41  Score=296.34  Aligned_cols=281  Identities=22%  Similarity=0.295  Sum_probs=204.5

Q ss_pred             Eeeccc--CceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEecC-
Q 045787           13 KKIGAG--GYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD-   89 (324)
Q Consensus        13 ~~Lg~g--~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~-   89 (324)
                      ..||.|  ++|+||+|.+..+|+.||+|++..........+.+.+|+.+++.++||||+++++++..++..++|+||+. 
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456666  99999999999999999999987654333334678899999999999999999999999999999999998 


Q ss_pred             CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCc-----
Q 045787           90 LDLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE-----  163 (324)
Q Consensus        90 g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~-----  163 (324)
                      +++.+++.... ..+++..+..++.|++.||.|||+.|++|+||||+||+++ .++.++++||+.+.........     
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILIS-GDGLVSLSGLSHLYSLVRNGQKAKVVY  162 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEe-CCCcEEEechHHHhhhhccCccccccc
Confidence            48888776543 3588999999999999999999999999999999999999 8899999999754332211111     


Q ss_pred             --ccccccccccCCchhhcCC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhh---
Q 045787          164 --YSRDCVYSPYKAPELLLGY-TGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYI---  237 (324)
Q Consensus       164 --~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  237 (324)
                        .....++..|+|||++.+. ..++.++|+|||||++|+|++|..||............  ...++...+......   
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~  240 (328)
T cd08226         163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQK--LKGPPYSPLDITTFPCEE  240 (328)
T ss_pred             cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHH--hcCCCCCCccccccchhh
Confidence              1112345569999998763 34789999999999999999999999776643322111  111111111000000   


Q ss_pred             hcccCC-----------CC-----CCC--CcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCc
Q 045787          238 SEILPL-----------YP-----HFE--PANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENV  296 (324)
Q Consensus       238 ~~~~~~-----------~~-----~~~--~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~  296 (324)
                      ......           ..     ...  ..........++..+.+|+++||+.||.+|||+.++++||||.++...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~  317 (328)
T cd08226         241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ  317 (328)
T ss_pred             hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence            000000           00     000  000011122467789999999999999999999999999999887764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=4.1e-41  Score=299.16  Aligned_cols=252  Identities=25%  Similarity=0.359  Sum_probs=197.6

Q ss_pred             CcCcceeEeecccCceEEEEEEEcc-----CCceEEEEEeeeccccCCCchHHHHHHHHHHhc-CCCCeeEEEeeeecCC
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTV-----TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRK   79 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   79 (324)
                      .++|++.+.||+|+||.||+|.+..     ++..||+|.+...... +....+.+|+.+++.+ +|+||+++++++....
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~  115 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT-DEREALMSELKILSHLGQHKNIVNLLGACTHGG  115 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH-HHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence            4579999999999999999998643     3357999998754322 2245678899999999 8999999999999999


Q ss_pred             eEEEEEEecC-CCHHHHHHhcC----------------------------------------------------------
Q 045787           80 DVFLVFEYLD-LDLHSFITRHK----------------------------------------------------------  100 (324)
Q Consensus        80 ~~~iv~e~~~-g~l~~~~~~~~----------------------------------------------------------  100 (324)
                      ..++||||+. |+|.+++....                                                          
T Consensus       116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (374)
T cd05106         116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS  195 (374)
T ss_pred             CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence            9999999997 58888775421                                                          


Q ss_pred             -----------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCc--cccc
Q 045787          101 -----------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE--YSRD  167 (324)
Q Consensus       101 -----------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~--~~~~  167 (324)
                                 .++++..++.++.+++.||.|||++|++|+||||+||+++ .++.++|+|||.+.........  ....
T Consensus       196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~-~~~~~kL~DfGla~~~~~~~~~~~~~~~  274 (374)
T cd05106         196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLT-DGRVAKICDFGLARDIMNDSNYVVKGNA  274 (374)
T ss_pred             cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEe-CCCeEEEeeceeeeeccCCcceeeccCC
Confidence                       2477888999999999999999999999999999999999 8899999999998765422211  1122


Q ss_pred             ccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCC
Q 045787          168 CVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPH  246 (324)
Q Consensus       168 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (324)
                      .+++.|+|||++.+ ..++.++||||||+++|+|++ |..||...............+...                   
T Consensus       275 ~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~-------------------  334 (374)
T cd05106         275 RLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQM-------------------  334 (374)
T ss_pred             CCccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCc-------------------
Confidence            34456999999876 668999999999999999997 999997655332111111100000                   


Q ss_pred             CCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          247 FEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       247 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                             .....+++++.+++.+||+.||.+||++.++++
T Consensus       335 -------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         335 -------SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             -------cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                   001236789999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=4.6e-41  Score=287.90  Aligned_cols=253  Identities=30%  Similarity=0.498  Sum_probs=209.3

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhcC-CCCeeEEEeeeecCCeEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKELE-HENIVRLLDVQSSRKDVFLV   84 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv   84 (324)
                      ++|++.+.||+|++|.||++.+..+++.+++|++..... .....+.+.+|+.++++++ |+|++++++.+...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            479999999999999999999999999999999876432 2222456788999999998 99999999999999999999


Q ss_pred             EEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC-
Q 045787           85 FEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK-  162 (324)
Q Consensus        85 ~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~-  162 (324)
                      ||++. ++|.+++... +.+++..++.++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+........ 
T Consensus        81 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~-~~~~~~l~df~~~~~~~~~~~~  158 (280)
T cd05581          81 LEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLD-KDMHIKITDFGTAKVLDPNSSP  158 (280)
T ss_pred             EcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC-CCCCEEecCCccccccCCcccc
Confidence            99995 6888888764 4699999999999999999999999999999999999999 889999999998876643321 


Q ss_pred             -------------------cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHc
Q 045787          163 -------------------EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLL  223 (324)
Q Consensus       163 -------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~  223 (324)
                                         ......++..|+|||+... ...+.++|+||||++++++++|..||...+...........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  237 (280)
T cd05581         159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL  237 (280)
T ss_pred             ccCCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc
Confidence                               1122345677999999877 55789999999999999999999999876643322211100


Q ss_pred             CCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCH----HHHhcCccc
Q 045787          224 GTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITA----MDALKHEYL  290 (324)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~----~~~l~hp~~  290 (324)
                      .                            ......+++.+.++|.+||+.||.+||++    .++++||||
T Consensus       238 ~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         238 E----------------------------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             C----------------------------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            0                            00112468899999999999999999999    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=5.8e-41  Score=285.41  Aligned_cols=254  Identities=26%  Similarity=0.397  Sum_probs=203.6

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      .+|++.+.||.|++|.||++.+..++..+++|.+..... .......+.+|+.+++.++|+|++++++.+..++..++++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            579999999999999999999998999999998875432 2222356788999999999999999999999999999999


Q ss_pred             EecCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC
Q 045787           86 EYLDL-DLHSFITR---HKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        86 e~~~g-~l~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~  161 (324)
                      ||+.| +|.+++..   ....+++..++.++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+.......
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~-~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc-CCCCEEECcchhhhccccCC
Confidence            99985 88777654   234589999999999999999999999999999999999999 88999999999887665433


Q ss_pred             CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhccc
Q 045787          162 KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEIL  241 (324)
Q Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (324)
                      .......++..|+|||.+.+ ...+.++|+||||+++|+|++|..||...................              
T Consensus       161 ~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------------  225 (267)
T cd08229         161 TAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY--------------  225 (267)
T ss_pred             cccccccCCcCccCHHHhcC-CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCC--------------
Confidence            33334467888999999977 567899999999999999999999996554322111111000000              


Q ss_pred             CCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          242 PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                         .       ......++..+.+++.+||+.||.+|||+.++++
T Consensus       226 ---~-------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         226 ---P-------PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             ---C-------CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence               0       0001247789999999999999999999998774

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=7.2e-41  Score=297.86  Aligned_cols=251  Identities=24%  Similarity=0.342  Sum_probs=197.2

Q ss_pred             CcCcceeEeecccCceEEEEEEE-----ccCCceEEEEEeeeccccCCCchHHHHHHHHHHhc-CCCCeeEEEeeeecCC
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRN-----TVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRK   79 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~-----~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   79 (324)
                      .++|++.+.||+|+||.||+|..     ..++..||+|++..... ....+.+.+|+.+++.+ +||||+++++++...+
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~  112 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGACTVGG  112 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence            45899999999999999999964     34566899999864432 22235678899999999 7999999999999999


Q ss_pred             eEEEEEEecC-CCHHHHHHhcC----------------------------------------------------------
Q 045787           80 DVFLVFEYLD-LDLHSFITRHK----------------------------------------------------------  100 (324)
Q Consensus        80 ~~~iv~e~~~-g~l~~~~~~~~----------------------------------------------------------  100 (324)
                      ..++||||++ |+|.+++....                                                          
T Consensus       113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (375)
T cd05104         113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG  192 (375)
T ss_pred             cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence            9999999997 58888876432                                                          


Q ss_pred             ----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCc-
Q 045787          101 ----------------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE-  163 (324)
Q Consensus       101 ----------------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~-  163 (324)
                                      ..+++..+..++.+|+.||.|||+.|++|+||||+||+++ .++.++|+|||.+......... 
T Consensus       193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~-~~~~~kl~DfG~a~~~~~~~~~~  271 (375)
T cd05104         193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLT-HGRITKICDFGLARDIRNDSNYV  271 (375)
T ss_pred             eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEE-CCCcEEEecCccceeccCccccc
Confidence                            1467888999999999999999999999999999999999 8899999999998765432211 


Q ss_pred             -ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHH-HHHHHHcCCCCcccccchhhhhcc
Q 045787          164 -YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHL-SLIFSLLGTPTDESWAESTYISEI  240 (324)
Q Consensus       164 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  240 (324)
                       .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||........ ...... +..              
T Consensus       272 ~~~~~~~~~~y~aPE~~~~-~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~-~~~--------------  335 (375)
T cd05104         272 VKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKE-GYR--------------  335 (375)
T ss_pred             ccCCCCCCcceeChhHhcC-CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHh-Ccc--------------
Confidence             112234556999999987 678999999999999999998 8889976543221 111110 000              


Q ss_pred             cCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          241 LPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                  .......+.++.+++.+||+.||++||++.++++
T Consensus       336 ------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  369 (375)
T cd05104         336 ------------MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ  369 (375)
T ss_pred             ------------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence                        0001235678999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.1e-40  Score=314.87  Aligned_cols=253  Identities=26%  Similarity=0.412  Sum_probs=200.2

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeecccc-CCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQ-EGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      ++|++.+.||+|++|.||+|.+..+|+.||+|++...... ....+.+.+|+.++++++|||++++++++.+++..|++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            6899999999999999999999999999999998754322 222456888999999999999999999999999999999


Q ss_pred             EecCC-CHHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccce
Q 045787           86 EYLDL-DLHSFITRH----------KNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLA  154 (324)
Q Consensus        86 e~~~g-~l~~~~~~~----------~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~  154 (324)
                      ||++| +|.+++...          ....+...+..++.+|+.||.+||+.|++||||||+||+++ .++.++|+|||.+
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd-~dg~vKLiDFGLA  160 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLG-LFGEVVILDWGAA  160 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEc-CCCCEEEEecCcc
Confidence            99985 888877542          12345667888999999999999999999999999999999 8999999999998


Q ss_pred             eeccCCC------------------CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHH
Q 045787          155 RAIGVPQ------------------KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHL  216 (324)
Q Consensus       155 ~~~~~~~------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~  216 (324)
                      .......                  .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||........
T Consensus       161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki  239 (932)
T PRK13184        161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLTLSFPYRRKKGRKI  239 (932)
T ss_pred             eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC-CCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence            7652110                  11122468999999999987 6679999999999999999999999976443222


Q ss_pred             HHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          217 SLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      ..... ...+.                        .......+++.+.+++.+||+.||.+|++..+.+.
T Consensus       240 ~~~~~-i~~P~------------------------~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl  284 (932)
T PRK13184        240 SYRDV-ILSPI------------------------EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK  284 (932)
T ss_pred             hhhhh-ccChh------------------------hccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            11100 00000                        00012367889999999999999999988766554

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.6e-40  Score=284.90  Aligned_cols=241  Identities=14%  Similarity=0.190  Sum_probs=194.9

Q ss_pred             EeecccCceEEEEEEEccCCceEEEEEeeeccccC-CCchHHHHHHHHHHhcCCCCeeEEEeeeec----CCeEEEEEEe
Q 045787           13 KKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQE-GVPSYIIREVSLLKELEHENIVRLLDVQSS----RKDVFLVFEY   87 (324)
Q Consensus        13 ~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~iv~e~   87 (324)
                      ..+|+|+++.||++..  +|+.||+|.+....... ...+.+.+|+.++++++||||+++++++.+    ....++|+||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            6789999999999987  58899999987654322 123567799999999999999999998866    3578999999


Q ss_pred             cCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccc
Q 045787           88 LDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSL-KILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYS  165 (324)
Q Consensus        88 ~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~  165 (324)
                      +.| +|.+++... ..++......++.+++.||.+||+. +++|+||+|+||+++ .++.++|+|||.+......   ..
T Consensus       104 ~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~-~~~~~kl~dfg~~~~~~~~---~~  178 (283)
T PHA02988        104 CTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVT-ENYKLKIICHGLEKILSSP---PF  178 (283)
T ss_pred             CCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEEC-CCCcEEEcccchHhhhccc---cc
Confidence            985 788877664 4688999999999999999999984 999999999999999 8999999999998765422   12


Q ss_pred             ccccccccCCchhhcC-CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCC
Q 045787          166 RDCVYSPYKAPELLLG-YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLY  244 (324)
Q Consensus       166 ~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (324)
                      ...+++.|+|||++.+ ...++.++||||||+++|+|++|..||...+...........+....                
T Consensus       179 ~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~----------------  242 (283)
T PHA02988        179 KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLK----------------  242 (283)
T ss_pred             cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC----------------
Confidence            3457788999999865 25689999999999999999999999987765544333221111100                


Q ss_pred             CCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                .....++.+.+++.+||+.||.+|||+.++++
T Consensus       243 ----------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        243 ----------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             ----------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence                      01146788999999999999999999999985

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-40  Score=281.15  Aligned_cols=245  Identities=29%  Similarity=0.447  Sum_probs=203.9

Q ss_pred             EeecccCceEEEEEEEccC---CceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEecC
Q 045787           13 KKIGAGGYGEVYKCRNTVT---GQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD   89 (324)
Q Consensus        13 ~~Lg~g~~~~v~~a~~~~~---~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~   89 (324)
                      +.||+|++|.||+|.+...   +..+++|.+....... ..+.+.+|+..++.++|++++++++++......++|+||+.
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME   79 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence            4689999999999999866   8899999987655433 35678899999999999999999999999999999999995


Q ss_pred             -CCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           90 -LDLHSFITRH--------KNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        90 -g~l~~~~~~~--------~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                       ++|.+++...        ...+++..++.++.+++.||.+||++|++|+||+|+||+++ .++.++|+|||.+......
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~-~~~~~~l~dfg~~~~~~~~  158 (262)
T cd00192          80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVG-EDLVVKISDFGLSRDVYDD  158 (262)
T ss_pred             CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEEC-CCCcEEEcccccccccccc
Confidence             6999988876        46799999999999999999999999999999999999999 8899999999999876543


Q ss_pred             C--CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhh
Q 045787          161 Q--KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYI  237 (324)
Q Consensus       161 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (324)
                      .  .......+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||................             
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-------------  224 (262)
T cd00192         159 DYYRKKTGGKLPIRWMAPESLKD-GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY-------------  224 (262)
T ss_pred             cccccccCCCcCccccCHHHhcc-CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-------------
Confidence            2  22333456778999999887 468999999999999999999 699998776544433322100             


Q ss_pred             hcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcC
Q 045787          238 SEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH  287 (324)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~h  287 (324)
                                    .......++.++.+++.+||..||.+|||+.+++++
T Consensus       225 --------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         225 --------------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             --------------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence                          001122468899999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.4e-40  Score=284.71  Aligned_cols=255  Identities=22%  Similarity=0.373  Sum_probs=202.6

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEcc-----CCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeec
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTV-----TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS   77 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   77 (324)
                      ++..++|++.+.||.|++|.||+|.+..     .+..+++|.+....... ....+.+|+.++++++|+|++++++++.+
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   80 (277)
T cd05036           2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQ-DESDFLMEALIMSKFNHQNIVRLIGVSFE   80 (277)
T ss_pred             CCCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence            4567889999999999999999999876     67789999876443221 12457889999999999999999999998


Q ss_pred             CCeEEEEEEecC-CCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCC---CcEE
Q 045787           78 RKDVFLVFEYLD-LDLHSFITRHK------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKR---NTVK  147 (324)
Q Consensus        78 ~~~~~iv~e~~~-g~l~~~~~~~~------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~---~~v~  147 (324)
                      ....++|+||+. ++|.+++....      ..+++..+..++.+|+.+|.+||++|++|+||+|+||+++ .+   ..++
T Consensus        81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~-~~~~~~~~k  159 (277)
T cd05036          81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLT-CKGPGRVAK  159 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEe-ccCCCcceE
Confidence            889999999996 58888887643      2488999999999999999999999999999999999998 44   3699


Q ss_pred             EeeccceeeccCCCCc--ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcC
Q 045787          148 LADFGLARAIGVPQKE--YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLG  224 (324)
Q Consensus       148 l~d~g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~  224 (324)
                      |+|||.+.........  ......+..|+|||++.+ ..++.++|||||||++|+|++ |..||...+............
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~  238 (277)
T cd05036         160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG  238 (277)
T ss_pred             eccCccccccCCccceecCCCCCccHhhCCHHHHhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence            9999998765322111  112223456999999977 668999999999999999997 999998766554433222111


Q ss_pred             CCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcC
Q 045787          225 TPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH  287 (324)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~h  287 (324)
                      .+                           .....++..+.+++.+||+.||.+||++.++++|
T Consensus       239 ~~---------------------------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         239 RL---------------------------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             cC---------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            00                           0113568899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-42  Score=310.91  Aligned_cols=251  Identities=27%  Similarity=0.415  Sum_probs=202.0

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcC-CCCeeEEEe-eeec---C--
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-HENIVRLLD-VQSS---R--   78 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~-~~~~---~--   78 (324)
                      ..+++|.+.|.+|||+.||+|++...|..||+|.+-..  ++...+.+.+|++++++|+ |+|||.+++ ....   +  
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~  113 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG  113 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence            46789999999999999999999888799999998766  3344688999999999997 999999999 3321   1  


Q ss_pred             -CeEEEEEEecC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--CcccCCCCCceEeecCCCcEEEeeccc
Q 045787           79 -KDVFLVFEYLD-LDLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLK--ILHRDLKPNNLLIDLKRNTVKLADFGL  153 (324)
Q Consensus        79 -~~~~iv~e~~~-g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~g--~~H~di~p~nIll~~~~~~v~l~d~g~  153 (324)
                       -.+.|+||||. |+|.+++.++- ..|++.++.+|+.++++|+.+||...  ++|||||-+|||++ .++..||||||.
T Consensus       114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls-~~g~~KLCDFGS  192 (738)
T KOG1989|consen  114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLS-ADGNYKLCDFGS  192 (738)
T ss_pred             eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEc-CCCCEEeCcccc
Confidence             24789999999 69999998653 35999999999999999999999988  99999999999999 999999999999


Q ss_pred             eeeccCCCCc---------ccccccccccCCchhhc--CCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHH
Q 045787          154 ARAIGVPQKE---------YSRDCVYSPYKAPELLL--GYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSL  222 (324)
Q Consensus       154 ~~~~~~~~~~---------~~~~~~~~~y~aPE~~~--~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~  222 (324)
                      ++........         .-....|+.|+|||.+.  +..+.++|+|||+|||+||.||....||+......+  +-..
T Consensus       193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laI--lng~  270 (738)
T KOG1989|consen  193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAI--LNGN  270 (738)
T ss_pred             cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeE--Eecc
Confidence            8755322211         01124578899999974  347789999999999999999999999966532110  0000


Q ss_pred             cCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCcc
Q 045787          223 LGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEY  289 (324)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~  289 (324)
                      ...|                            ..+.++..+.+||+.||+.||.+||++.+++.+-+
T Consensus       271 Y~~P----------------------------~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~  309 (738)
T KOG1989|consen  271 YSFP----------------------------PFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF  309 (738)
T ss_pred             ccCC----------------------------CCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence            0000                            11468899999999999999999999999987433

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=9.9e-41  Score=285.97  Aligned_cols=253  Identities=25%  Similarity=0.379  Sum_probs=203.5

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEcc-----CCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecC
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTV-----TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR   78 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   78 (324)
                      +...+|.+.+.||.|++|.||+|.+..     .+..+++|.+...... +..+.+.+|+++++.++|++++++++++...
T Consensus         2 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   80 (280)
T cd05049           2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN-DARKDFEREAELLTNFQHENIVKFYGVCTEG   80 (280)
T ss_pred             CChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCH-HHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence            456789999999999999999998743     3578999998654332 2246788999999999999999999999999


Q ss_pred             CeEEEEEEecC-CCHHHHHHhcC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCC
Q 045787           79 KDVFLVFEYLD-LDLHSFITRHK-------------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN  144 (324)
Q Consensus        79 ~~~~iv~e~~~-g~l~~~~~~~~-------------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~  144 (324)
                      ...++||||+. ++|.+++....             ..+++..+..++.+++.+|.+||++|++|+||+|+||+++ .++
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~-~~~  159 (280)
T cd05049          81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVG-YDL  159 (280)
T ss_pred             CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEc-CCC
Confidence            99999999997 58888876542             2478889999999999999999999999999999999999 889


Q ss_pred             cEEEeeccceeeccCCCC--cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHH
Q 045787          145 TVKLADFGLARAIGVPQK--EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFS  221 (324)
Q Consensus       145 ~v~l~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~  221 (324)
                      .++|+|||.+........  ......+++.|+|||++.+ ..++.++||||||+++|+|++ |..||...+.........
T Consensus       160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~  238 (280)
T cd05049         160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT  238 (280)
T ss_pred             eEEECCcccceecccCcceecCCCCcccceecChhhhcc-CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            999999999876532211  1223344677999999987 668999999999999999998 999997666544332222


Q ss_pred             HcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          222 LLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      ....                           ......++..+.+++.+||+.||.+||++.++++
T Consensus       239 ~~~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         239 QGRL---------------------------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             cCCc---------------------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            1000                           0011257889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.7e-40  Score=284.12  Aligned_cols=254  Identities=24%  Similarity=0.357  Sum_probs=200.3

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEc-----cCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecC
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNT-----VTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR   78 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   78 (324)
                      +..++|++.+.||.|++|.||++.+.     ..+..+++|++...... .....+.+|+.+++.++|||++++++++..+
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~   81 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASM-RERIEFLNEASVMKEFNCHHVVRLLGVVSQG   81 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            56789999999999999999999864     23567999987543221 1234577899999999999999999999999


Q ss_pred             CeEEEEEEecC-CCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEE
Q 045787           79 KDVFLVFEYLD-LDLHSFITRHK---------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKL  148 (324)
Q Consensus        79 ~~~~iv~e~~~-g~l~~~~~~~~---------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l  148 (324)
                      ...++|+||++ ++|.+++....         ..++...+..++.+++.||.+||+.|++|+||||+||+++ +++.++|
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~-~~~~~~l  160 (277)
T cd05062          82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA-EDFTVKI  160 (277)
T ss_pred             CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEc-CCCCEEE
Confidence            99999999998 58888776532         2356778889999999999999999999999999999999 8999999


Q ss_pred             eeccceeeccCCCC--cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCC
Q 045787          149 ADFGLARAIGVPQK--EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGT  225 (324)
Q Consensus       149 ~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~  225 (324)
                      +|||.+........  ......+++.|+|||++.+ ..++.++|+||||+++|+|++ |..||...+.............
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~  239 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGL  239 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc
Confidence            99998875532211  1112234567999999887 668999999999999999999 7889977665444332221111


Q ss_pred             CCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcC
Q 045787          226 PTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH  287 (324)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~h  287 (324)
                      +.                           .....+..+.+++.+||+.||.+|||+.+++++
T Consensus       240 ~~---------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         240 LD---------------------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             CC---------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            10                           112467789999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5e-40  Score=278.79  Aligned_cols=250  Identities=25%  Similarity=0.375  Sum_probs=202.6

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   83 (324)
                      +..++|++.+.||+|++|.||++.+. .+..+++|.+.....   ..+.+.+|+.++++++|+|++++++++...+..++
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05068           3 IDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM---DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI   78 (261)
T ss_pred             cchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc---cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeee
Confidence            45678999999999999999999975 456899999865432   23568889999999999999999999999999999


Q ss_pred             EEEecC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC
Q 045787           84 VFEYLD-LDLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        84 v~e~~~-g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~  161 (324)
                      ++||+. ++|.+++.... ..++...+..++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+.......
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~-~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05068          79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVG-ENNICKVADFGLARVIKEDI  157 (261)
T ss_pred             eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEc-CCCCEEECCcceEEEccCCc
Confidence            999995 68988887654 4689999999999999999999999999999999999999 89999999999988765221


Q ss_pred             Cc-ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhc
Q 045787          162 KE-YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISE  239 (324)
Q Consensus       162 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
                      .. ......+..|+|||+..+ ..++.++|+||||+++|+|++ |+.||.+.+..............             
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-------------  223 (261)
T cd05068         158 YEAREGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM-------------  223 (261)
T ss_pred             ccccCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-------------
Confidence            11 111122346999999877 667999999999999999999 99999876654433322211000             


Q ss_pred             ccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                    ......+..+.+++.+|++.||.+||++.++++
T Consensus       224 --------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         224 --------------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             --------------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence                          011246788999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.4e-40  Score=281.96  Aligned_cols=253  Identities=25%  Similarity=0.403  Sum_probs=202.1

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeecc---ccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQT---EQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLV   84 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   84 (324)
                      +|.+.+.||+|++|.||++.+...+..+++|+.....   ........+..|+.++++++|||++++++.+.++...++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            6999999999999999999988777767777665432   2222234566789999999999999999999999999999


Q ss_pred             EEecCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           85 FEYLDL-DLHSFITR---HKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        85 ~e~~~g-~l~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      +||+.+ ++.+.+..   ....+++..++.++.+++.||.+||+.|++|+||+|+||+++  ++.++|+|||.+......
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~--~~~~~l~d~g~~~~~~~~  158 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK--NNLLKIGDFGVSRLLMGS  158 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee--cCCEeecccCceeecCCC
Confidence            999985 77776653   234689999999999999999999999999999999999998  356999999998776544


Q ss_pred             CCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcc
Q 045787          161 QKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEI  240 (324)
Q Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (324)
                      ........+++.|+|||.+.+ ..++.++|+||||+++++|++|..||.............  .....            
T Consensus       159 ~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~--~~~~~------------  223 (260)
T cd08222         159 CDLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV--EGPTP------------  223 (260)
T ss_pred             cccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH--cCCCC------------
Confidence            333344567788999999876 567889999999999999999999997655332222111  11000            


Q ss_pred             cCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          241 LPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                                   .....++.++.++|.+||..||.+||++.++++||||
T Consensus       224 -------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         224 -------------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             -------------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence                         0112567899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=3.4e-40  Score=279.83  Aligned_cols=250  Identities=26%  Similarity=0.381  Sum_probs=202.0

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   83 (324)
                      +..++|+++++||+|++|.||+|... ++..+++|.+.....   ..+.+.+|+.++++++|++++++++.+...+..++
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05072           3 IPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYI   78 (261)
T ss_pred             CchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch---hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence            55689999999999999999999865 556799998764332   24678899999999999999999999999999999


Q ss_pred             EEEecC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC
Q 045787           84 VFEYLD-LDLHSFITRH-KNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        84 v~e~~~-g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~  161 (324)
                      ++||+. ++|.+++... ...++...+..++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+.......
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~-~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05072          79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVS-ESLMCKIADFGLARVIEDNE  157 (261)
T ss_pred             EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEec-CCCcEEECCCccceecCCCc
Confidence            999996 5888888654 34688889999999999999999999999999999999999 89999999999998764322


Q ss_pred             Cc-ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhc
Q 045787          162 KE-YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISE  239 (324)
Q Consensus       162 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
                      .. .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||.................              
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~--------------  222 (261)
T cd05072         158 YTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR--------------  222 (261)
T ss_pred             eeccCCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC--------------
Confidence            11 112234567999999877 567899999999999999998 9999977654433222211000              


Q ss_pred             ccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                   ......++.++.+++.+|+..||++||+++++++
T Consensus       223 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         223 -------------MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             -------------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                         0011257788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-41  Score=297.84  Aligned_cols=261  Identities=29%  Similarity=0.465  Sum_probs=227.7

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLV   84 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   84 (324)
                      ..+.|.+.+.||+|.|+.|.++.+..++..||+|.+.+..........+.+|+++++.++||||++++.+...+..+|+|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            45689999999999999999999999999999999988877766667789999999999999999999999999999999


Q ss_pred             EEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCc
Q 045787           85 FEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE  163 (324)
Q Consensus        85 ~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~  163 (324)
                      |||+. |.+.+++.+.+. ..+..++.++.|+..|++|+|+++++|+|||.+||+++ .+..++|+|||++.... ....
T Consensus       134 ~eya~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~-~~mnikIaDfgfS~~~~-~~~~  210 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLD-ENMNIKIADFGFSTFFD-YGLM  210 (596)
T ss_pred             EEeccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccc-cccceeeeccccceeec-cccc
Confidence            99986 699999988654 66699999999999999999999999999999999999 88889999999999887 5566


Q ss_pred             ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCC
Q 045787          164 YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPL  243 (324)
Q Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (324)
                      ....||++.|.|||++.+....++++|+||+|+++|.|+.|..||.+.+......-..                      
T Consensus       211 lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl----------------------  268 (596)
T KOG0586|consen  211 LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVL----------------------  268 (596)
T ss_pred             ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhe----------------------
Confidence            6778999999999999998888999999999999999999999998766432211100                      


Q ss_pred             CCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCc
Q 045787          244 YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENV  296 (324)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~  296 (324)
                            .......--++.+..++|+++|..+|.+|++.+++..|.|.......
T Consensus       269 ------~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  269 ------RGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             ------eeeecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence                  00011112467788999999999999999999999999999887766

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-40  Score=279.03  Aligned_cols=249  Identities=23%  Similarity=0.313  Sum_probs=200.5

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      ..+|++.+.||+|++|.||++.+. .+..+++|.+......   ...+.+|+.++++++||+++++++++...+..++|+
T Consensus         3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05059           3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT   78 (256)
T ss_pred             hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence            457999999999999999999876 4668999987643222   346778999999999999999999999999999999


Q ss_pred             EecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCc-
Q 045787           86 EYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE-  163 (324)
Q Consensus        86 e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~-  163 (324)
                      ||++ ++|.+++......+++..+..++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+......... 
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~-~~~~~kl~dfg~~~~~~~~~~~~  157 (256)
T cd05059          79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVG-EDNVVKVSDFGLARYVLDDQYTS  157 (256)
T ss_pred             ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEEC-CCCcEEECCcccceecccccccc
Confidence            9997 588888877666789999999999999999999999999999999999999 8999999999988765422111 


Q ss_pred             ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccC
Q 045787          164 YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILP  242 (324)
Q Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (324)
                      .....++..|+|||.+.+ ..++.++|+||||+++|++++ |..||...+........... ..                
T Consensus       158 ~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-~~----------------  219 (256)
T cd05059         158 SQGTKFPVKWAPPEVFDY-SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG-YR----------------  219 (256)
T ss_pred             cCCCCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcC-Cc----------------
Confidence            111123346999999887 667899999999999999999 89999766544332221100 00                


Q ss_pred             CCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcC
Q 045787          243 LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH  287 (324)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~h  287 (324)
                                .......+..+.+++.+||..+|.+|||+.++++.
T Consensus       220 ----------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         220 ----------LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             ----------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence                      00112468899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=4.1e-40  Score=279.49  Aligned_cols=249  Identities=27%  Similarity=0.385  Sum_probs=198.6

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   83 (324)
                      +..++|++.+.||+|++|.||+|.+..+ ..+++|.+.....   ..+.+.+|+.+++.++||+++++++.+.. ...++
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~l   77 (262)
T cd05071           3 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI   77 (262)
T ss_pred             CChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEE
Confidence            4467899999999999999999988655 4699999875332   23567889999999999999999998754 56899


Q ss_pred             EEEecC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC
Q 045787           84 VFEYLD-LDLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        84 v~e~~~-g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~  161 (324)
                      ||||++ |++.+++.... ..+++..+..++.+++.||.+||+.|++|+||+|+||+++ +++.++|+|||.+.......
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~-~~~~~~L~dfg~~~~~~~~~  156 (262)
T cd05071          78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIEDNE  156 (262)
T ss_pred             EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEc-CCCcEEeccCCceeeccccc
Confidence            999998 58888887643 3578999999999999999999999999999999999999 88999999999987664332


Q ss_pred             Ccc-cccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhc
Q 045787          162 KEY-SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISE  239 (324)
Q Consensus       162 ~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
                      ... ....++..|+|||+..+ ..++.++|+||||+++|+|++ |..||..................             
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~-------------  222 (262)
T cd05071         157 YTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-------------  222 (262)
T ss_pred             cccccCCcccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCC-------------
Confidence            211 12234567999999876 667999999999999999999 88899776544332221110000             


Q ss_pred             ccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                    .....++..+.+++.+|++.||.+||++.++++
T Consensus       223 --------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         223 --------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             --------------CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                          011257888999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2.8e-40  Score=287.82  Aligned_cols=274  Identities=20%  Similarity=0.256  Sum_probs=200.7

Q ss_pred             CceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEecC-CCHHHHHH
Q 045787           19 GYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD-LDLHSFIT   97 (324)
Q Consensus        19 ~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~-g~l~~~~~   97 (324)
                      +.+.||.+++..+++.||+|++..........+.+.+|+.+++.++|+|++++++++.+++..++++||++ |++.+++.
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~   91 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK   91 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence            44667777777789999999998764444456789999999999999999999999999999999999998 57777776


Q ss_pred             hc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC-------ccccccc
Q 045787           98 RH-KNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK-------EYSRDCV  169 (324)
Q Consensus        98 ~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~-------~~~~~~~  169 (324)
                      .. ...+++..+..++.+++.||.|||++|++|+||+|+||+++ .++.++|+||+.+........       ......+
T Consensus        92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~-~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (314)
T cd08216          92 THFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLS-GDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK  170 (314)
T ss_pred             HhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEe-cCCceEEecCccceeeccccccccccccccccccc
Confidence            53 34688999999999999999999999999999999999999 889999999998765532211       1122345


Q ss_pred             ccccCCchhhcCC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCC-----
Q 045787          170 YSPYKAPELLLGY-TGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPL-----  243 (324)
Q Consensus       170 ~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  243 (324)
                      +..|+|||++.+. ..++.++|+||+|+++++|++|..||........... ...+..+. .+............     
T Consensus       171 ~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~  248 (314)
T cd08216         171 NLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLE-KVRGTVPC-LLDKSTYPLYEDSMSQSRS  248 (314)
T ss_pred             cccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhccCcc-ccccCchhhhcCCcCcccc
Confidence            6679999998753 4578899999999999999999999987654332211 11111110 00000000000000     


Q ss_pred             ---CCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCC
Q 045787          244 ---YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVEN  295 (324)
Q Consensus       244 ---~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~  295 (324)
                         ...............++..+.+++.+||..||++|||+.++++||||+.+..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~  303 (314)
T cd08216         249 SNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKR  303 (314)
T ss_pred             cccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhcc
Confidence               0000000111111235678899999999999999999999999999998863

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2e-40  Score=287.26  Aligned_cols=254  Identities=26%  Similarity=0.341  Sum_probs=199.2

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccCCce--EEEEEeeeccccCCCchHHHHHHHHHHhc-CCCCeeEEEeeeecCC
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQK--VAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRK   79 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~--~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   79 (324)
                      .+.-++|++.+.||+|+||.||+|.+..++..  +++|.+.... .......+.+|+.++.++ +|+|++++++++..++
T Consensus         3 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~   81 (303)
T cd05088           3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   81 (303)
T ss_pred             ccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC-CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence            45668999999999999999999998877765  4666554321 122235678899999999 8999999999999999


Q ss_pred             eEEEEEEecC-CCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCC
Q 045787           80 DVFLVFEYLD-LDLHSFITRHK---------------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKR  143 (324)
Q Consensus        80 ~~~iv~e~~~-g~l~~~~~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~  143 (324)
                      ..++|+||+. ++|.+++....               ..+++..++.++.+++.||.+||+.|++|+||||+||+++ .+
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~-~~  160 (303)
T cd05088          82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG-EN  160 (303)
T ss_pred             CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEec-CC
Confidence            9999999997 58888886532               2478899999999999999999999999999999999999 88


Q ss_pred             CcEEEeeccceeeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHH
Q 045787          144 NTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSL  222 (324)
Q Consensus       144 ~~v~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~  222 (324)
                      +.++|+|||.+...... ........+..|+|||++.+ ..++.++||||||+++|+|++ |..||...+..........
T Consensus       161 ~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~  238 (303)
T cd05088         161 YVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ  238 (303)
T ss_pred             CcEEeCccccCcccchh-hhcccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc
Confidence            99999999988633211 11111223556999999876 567899999999999999998 9999976664433222110


Q ss_pred             cCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcC
Q 045787          223 LGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH  287 (324)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~h  287 (324)
                      ...                           ......++.++.+++.+||+.||.+||++.+++.+
T Consensus       239 ~~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         239 GYR---------------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             CCc---------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            000                           00112467889999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=7.1e-40  Score=277.69  Aligned_cols=249  Identities=26%  Similarity=0.398  Sum_probs=198.9

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   83 (324)
                      +..++|++++.||+|++|.||+|.+. .+..+++|.+......   .+.+.+|+.++++++|++++++++++.. ...++
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~l   77 (260)
T cd05070           3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYI   77 (260)
T ss_pred             CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEE
Confidence            45678999999999999999999876 5567999988754332   3568899999999999999999998754 56889


Q ss_pred             EEEecC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC
Q 045787           84 VFEYLD-LDLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        84 v~e~~~-g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~  161 (324)
                      +|||++ ++|.+++.... ..+++..+..++.+++.||.+||+.|++|+||+|+||+++ +++.++|+|||.+.......
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~-~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05070          78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVG-DGLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEe-CCceEEeCCceeeeeccCcc
Confidence            999997 58888876643 3589999999999999999999999999999999999999 88999999999987654322


Q ss_pred             Cc-ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhc
Q 045787          162 KE-YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISE  239 (324)
Q Consensus       162 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
                      .. .....++..|+|||...+ ..++.++|+||||+++|+|++ |..||...+.............+             
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-------------  222 (260)
T cd05070         157 YTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM-------------  222 (260)
T ss_pred             cccccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-------------
Confidence            11 111234456999999876 667899999999999999999 88999776544333322211000             


Q ss_pred             ccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                    ......+..+.+++.+||..||.+|||++++++
T Consensus       223 --------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         223 --------------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             --------------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence                          011256788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=5.6e-40  Score=278.31  Aligned_cols=250  Identities=26%  Similarity=0.389  Sum_probs=200.3

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF   82 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   82 (324)
                      ++..++|++++.||+|++|.||+|... +++.+++|.+......   ...+.+|+.++++++|++++++++++. .+..+
T Consensus         2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~   76 (260)
T cd05067           2 EVPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY   76 (260)
T ss_pred             ccchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence            356789999999999999999999865 5678999988644332   356889999999999999999999874 45689


Q ss_pred             EEEEecC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           83 LVFEYLD-LDLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        83 iv~e~~~-g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      +++||+. ++|.+.+.... ..++...+..++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05067          77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVS-ETLCCKIADFGLARLIEDN  155 (260)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEc-CCCCEEEccCcceeecCCC
Confidence            9999997 58888876543 4688999999999999999999999999999999999999 8999999999998765422


Q ss_pred             CC-cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhh
Q 045787          161 QK-EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYIS  238 (324)
Q Consensus       161 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (324)
                      .. ......++..|+|||++.. ..++.++|+||||+++|++++ |..||...+..............            
T Consensus       156 ~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~------------  222 (260)
T cd05067         156 EYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM------------  222 (260)
T ss_pred             CcccccCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC------------
Confidence            11 1122234567999999876 667899999999999999999 99999776644332222110000            


Q ss_pred             cccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          239 EILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                     ......+.++.+++.+||..||.+||+++++++
T Consensus       223 ---------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         223 ---------------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             ---------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                           011246788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.9e-40  Score=282.74  Aligned_cols=253  Identities=25%  Similarity=0.348  Sum_probs=200.9

Q ss_pred             cCcCcceeEeecccCceEEEEEEEc----cCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCe
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNT----VTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKD   80 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~----~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   80 (324)
                      .-.+|++.+.||+|+||.||+|...    .++..+++|.+...... .....+.+|+.++++++|||++++++++.....
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   81 (283)
T cd05090           3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNP-QQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP   81 (283)
T ss_pred             ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCH-HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence            3467999999999999999999853    45678999998743322 223567889999999999999999999999999


Q ss_pred             EEEEEEecC-CCHHHHHHhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCC
Q 045787           81 VFLVFEYLD-LDLHSFITRHK----------------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKR  143 (324)
Q Consensus        81 ~~iv~e~~~-g~l~~~~~~~~----------------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~  143 (324)
                      .|+||||++ ++|.+++....                ..+++..+..++.+++.||.|||++|++|+||+|+||+++ .+
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~-~~  160 (283)
T cd05090          82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG-EQ  160 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEc-CC
Confidence            999999998 58888875321                2467888999999999999999999999999999999999 88


Q ss_pred             CcEEEeeccceeeccCCCC--cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 045787          144 NTVKLADFGLARAIGVPQK--EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIF  220 (324)
Q Consensus       144 ~~v~l~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~  220 (324)
                      +.++|+|||.+........  ......++..|+|||++.+ ..++.++|+||||+++|+|++ |..||.+.+........
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~  239 (283)
T cd05090         161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY-GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV  239 (283)
T ss_pred             CcEEeccccccccccCCcceecccCCCccceecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            9999999999876542221  1222334567999999876 567999999999999999998 88999776654433332


Q ss_pred             HHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcC
Q 045787          221 SLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH  287 (324)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~h  287 (324)
                      .....++                           ....++..+.+++.+|++.||.+||++.+++++
T Consensus       240 ~~~~~~~---------------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         240 RKRQLLP---------------------------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HcCCcCC---------------------------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            2111100                           112467889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=4.4e-40  Score=284.34  Aligned_cols=249  Identities=25%  Similarity=0.330  Sum_probs=196.3

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCc--eEEEEEeeeccccCCCchHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQ--KVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~--~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~i   83 (324)
                      ++|++.+.||.|++|.||+|.++.++.  .+++|.+..... ....+.+.+|+.++.++ +|||++++++++...+..++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l   80 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFAS-ENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI   80 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCC-HHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence            579999999999999999999877665  467777653221 12235678899999999 69999999999999999999


Q ss_pred             EEEecC-CCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEE
Q 045787           84 VFEYLD-LDLHSFITRHK---------------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVK  147 (324)
Q Consensus        84 v~e~~~-g~l~~~~~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~  147 (324)
                      ++||+. ++|.+++....               ..+++..++.++.+++.||.+||+.|++|+||||+||+++ +++.++
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~-~~~~~k  159 (297)
T cd05089          81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVG-ENLASK  159 (297)
T ss_pred             EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEEC-CCCeEE
Confidence            999997 68888886532               2478889999999999999999999999999999999999 889999


Q ss_pred             EeeccceeeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCC
Q 045787          148 LADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTP  226 (324)
Q Consensus       148 l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~  226 (324)
                      |+|||.+...... ........+..|+|||+..+ ..++.++||||||+++|+|++ |..||................. 
T Consensus       160 l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~-  236 (297)
T cd05089         160 IADFGLSRGEEVY-VKKTMGRLPVRWMAIESLNY-SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR-  236 (297)
T ss_pred             ECCcCCCccccce-eccCCCCcCccccCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC-
Confidence            9999987643211 11111223456999999876 667999999999999999997 9999977665443222110000 


Q ss_pred             CcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          227 TDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                                ......++..+.+++.+||+.||.+||+++++++
T Consensus       237 --------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  270 (297)
T cd05089         237 --------------------------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISV  270 (297)
T ss_pred             --------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                      0011257889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-39  Score=276.43  Aligned_cols=250  Identities=28%  Similarity=0.398  Sum_probs=201.9

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   83 (324)
                      +..++|++.+.||+|++|.||+|.+. ++..+++|.+.....   ..+.+.+|+.++++++|++++++++++..+...++
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   78 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM---SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI   78 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc---CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence            45689999999999999999999976 457899998875432   23568899999999999999999999999899999


Q ss_pred             EEEecC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC
Q 045787           84 VFEYLD-LDLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        84 v~e~~~-g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~  161 (324)
                      |+||+. ++|.+++.... ..++...+..++.+++.|+.+||++|++|+||+|+||+++ +++.++|+|||.+.......
T Consensus        79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~-~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVG-ENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEc-CCCCEEECccccceeccchh
Confidence            999997 58888887654 4689999999999999999999999999999999999999 89999999999987654211


Q ss_pred             C-cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhc
Q 045787          162 K-EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISE  239 (324)
Q Consensus       162 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
                      . .......+..|+|||.+.+ ...+.++|+||||+++|++++ |+.||.+................             
T Consensus       158 ~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-------------  223 (261)
T cd05034         158 YTAREGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM-------------  223 (261)
T ss_pred             hhhhhccCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-------------
Confidence            1 1111223456999999887 667999999999999999998 99999776644333222110000             


Q ss_pred             ccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                    ......+..+.+++.+||+.||.+||+++++++
T Consensus       224 --------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         224 --------------PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             --------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                          001235778999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=9e-41  Score=282.94  Aligned_cols=247  Identities=30%  Similarity=0.453  Sum_probs=194.6

Q ss_pred             ceeEeecccCceEEEEEEEc----cCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787           10 KKIKKIGAGGYGEVYKCRNT----VTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus        10 ~i~~~Lg~g~~~~v~~a~~~----~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      .+.+.||.|.||.||+|...    ..+..|++|.+..... ....+.+.+|++.+++++||||+++++++...+..++|+
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~   80 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSS-EEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM   80 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSS-HHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccc-cccceeeeecccccccccccccccccccccccccccccc
Confidence            46789999999999999987    4566899999854322 222577899999999999999999999999888899999


Q ss_pred             EecC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC--
Q 045787           86 EYLD-LDLHSFITRH-KNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ--  161 (324)
Q Consensus        86 e~~~-g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~--  161 (324)
                      ||+. |+|.+++... ...+++..+..++.+++.||.|||+++++|++|+++||+++ .++.+||+|||.+.......  
T Consensus        81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~-~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLD-SNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEE-TTTEEEEESTTTGEETTTSSSE
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccc
Confidence            9998 6999999887 56799999999999999999999999999999999999999 89999999999988762211  


Q ss_pred             CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcc
Q 045787          162 KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEI  240 (324)
Q Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (324)
                      ...........|+|||.+.+ ..++.++||||||+++||+++ |+.||...+.............+              
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~-~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~--------------  224 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKD-GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRL--------------  224 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHH-SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEET--------------
T ss_pred             cccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccccc--------------
Confidence            11222345567999999977 457999999999999999999 68999877665544333211111              


Q ss_pred             cCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          241 LPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                   .....++..+.+++..||..||.+||++.++++
T Consensus       225 -------------~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  225 -------------PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             -------------TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             -------------eeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                         111257889999999999999999999999975

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.2e-40  Score=280.58  Aligned_cols=254  Identities=26%  Similarity=0.376  Sum_probs=203.5

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccC-----CceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeec
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVT-----GQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS   77 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~-----~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   77 (324)
                      ++..++|++.+.||.|++|.||++.+...     +..+++|.+...... .....+.+|+.+++.++||+++++++++..
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   80 (277)
T cd05032           2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASM-RERIEFLNEASVMKEFNCHHVVRLLGVVST   80 (277)
T ss_pred             ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCH-HHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence            35678999999999999999999987643     378999997644321 123457789999999999999999999999


Q ss_pred             CCeEEEEEEecC-CCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEE
Q 045787           78 RKDVFLVFEYLD-LDLHSFITRHK---------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVK  147 (324)
Q Consensus        78 ~~~~~iv~e~~~-g~l~~~~~~~~---------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~  147 (324)
                      ....++|+||+. |+|.+++....         ..+++..+..++.+++.||.|||+.|++|+||+|+||+++ .++.++
T Consensus        81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~-~~~~~k  159 (277)
T cd05032          81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVA-EDLTVK  159 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEc-CCCCEE
Confidence            999999999997 68888876532         2367888999999999999999999999999999999999 899999


Q ss_pred             EeeccceeeccCCCC--cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcC
Q 045787          148 LADFGLARAIGVPQK--EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLG  224 (324)
Q Consensus       148 l~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~  224 (324)
                      |+|||.+........  ......++..|+|||.+.+ ...+.++|+||||+++|++++ |..||...+............
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~  238 (277)
T cd05032         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGG  238 (277)
T ss_pred             ECCcccchhhccCcccccCCCCCccccccCHHHHhc-CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCC
Confidence            999998876542221  1222345677999999876 567999999999999999998 999998776555443332111


Q ss_pred             CCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          225 TPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      .+                           ......+..+.+++.+||+.+|++|||+.++++
T Consensus       239 ~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         239 HL---------------------------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             CC---------------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            00                           011245788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-39  Score=275.64  Aligned_cols=254  Identities=30%  Similarity=0.487  Sum_probs=203.5

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc---cCCCchHHHHHHHHHHhcCCCCeeEEEeeeecC--CeE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE---QEGVPSYIIREVSLLKELEHENIVRLLDVQSSR--KDV   81 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~   81 (324)
                      .+|++.+.||+|++|.||++.+..+++.+++|.+.....   .......+.+|+.++++++|++++++++.+.+.  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            579999999999999999999999999999998764321   122235688899999999999999999988664  468


Q ss_pred             EEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           82 FLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        82 ~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      ++++||+++ +|.+.+... ..+++..+..++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+......
T Consensus        82 ~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~~  159 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRD-SAGNVKLGDFGASKRIQTI  159 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc-CCCCEEECccccccccccc
Confidence            899999975 787777654 4588999999999999999999999999999999999999 8899999999998765321


Q ss_pred             C---CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhh
Q 045787          161 Q---KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYI  237 (324)
Q Consensus       161 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (324)
                      .   .......++..|+|||.+.+ ...+.++|+||||+++|++++|+.||.......  ........+...        
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~--------  228 (264)
T cd06653         160 CMSGTGIKSVTGTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA--AIFKIATQPTKP--------  228 (264)
T ss_pred             cccCccccccCCcccccCHhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccCHHH--HHHHHHcCCCCC--------
Confidence            1   11223457788999999987 567899999999999999999999997654222  112221111111        


Q ss_pred             hcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          238 SEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                                      .....+++.+.++|.+|+. +|.+||++.++++|||.
T Consensus       229 ----------------~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         229 ----------------MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             ----------------CCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence                            1123578899999999999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-40  Score=276.83  Aligned_cols=245  Identities=30%  Similarity=0.512  Sum_probs=203.9

Q ss_pred             ecccCceEEEEEEEccCCceEEEEEeeecccc-CCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEecC-CCH
Q 045787           15 IGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQ-EGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD-LDL   92 (324)
Q Consensus        15 Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~-g~l   92 (324)
                      ||.|++|.||++.+..+++.+++|.+...... ....+.+.+|+.++++++|++++++++.+..+...++||||++ ++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            68999999999999988999999998765432 2234678899999999999999999999999999999999995 688


Q ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcccccccccc
Q 045787           93 HSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP  172 (324)
Q Consensus        93 ~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~  172 (324)
                      .+++... ..+++..+..++.+++.+|.+||+.|++|+||+|+||+++ .++.++|+|||.+..............++..
T Consensus        81 ~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~  158 (250)
T cd05123          81 FSHLSKE-GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLD-ADGHIKLTDFGLAKELSSEGSRTNTFCGTPE  158 (250)
T ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEc-CCCcEEEeecCcceecccCCCcccCCcCCcc
Confidence            8887764 3689999999999999999999999999999999999999 8899999999998876543333444567788


Q ss_pred             cCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcch
Q 045787          173 YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANL  252 (324)
Q Consensus       173 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (324)
                      |+|||...+ ...+.++|+||||+++|++++|..||...+.......... ..                           
T Consensus       159 ~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~---------------------------  209 (250)
T cd05123         159 YLAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK-DP---------------------------  209 (250)
T ss_pred             ccChHHhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CC---------------------------
Confidence            999999877 5578899999999999999999999976664332222111 00                           


Q ss_pred             hhhCCCCChhHHHHHHHhhcCCCCCCCCH---HHHhcCccc
Q 045787          253 AEKFPNLEPAGVDLLSQMLCLNPKQRITA---MDALKHEYL  290 (324)
Q Consensus       253 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~---~~~l~hp~~  290 (324)
                      ......++..+.+++++||..||.+||++   +++++||||
T Consensus       210 ~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         210 LRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             CCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence            01112457889999999999999999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1e-39  Score=277.90  Aligned_cols=253  Identities=23%  Similarity=0.370  Sum_probs=203.1

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCc---eEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCe
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQ---KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKD   80 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~---~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   80 (324)
                      +..++|+..+.||+|++|.||+|.+..++.   .+++|....... ....+.+.+|+.++++++|+|++++.+++...+.
T Consensus         2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (268)
T cd05063           2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT-EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP   80 (268)
T ss_pred             CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC-HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence            456789999999999999999999876554   689998764422 1123567889999999999999999999999999


Q ss_pred             EEEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccC
Q 045787           81 VFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGV  159 (324)
Q Consensus        81 ~~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~  159 (324)
                      .++||||+++ +|.+++......+++..+..++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+.....
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~-~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVN-SNLECKVSDFGLSRVLED  159 (268)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEc-CCCcEEECCCccceeccc
Confidence            9999999985 88888776666789999999999999999999999999999999999999 889999999999876643


Q ss_pred             CCCccc---ccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchh
Q 045787          160 PQKEYS---RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAEST  235 (324)
Q Consensus       160 ~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (324)
                      ......   ....++.|+|||++.+ ..++.++|+||||+++|++++ |..||...+..............+.       
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~-------  231 (268)
T cd05063         160 DPEGTYTTSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPA-------  231 (268)
T ss_pred             ccccceeccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCC-------
Confidence            222111   1122346999999877 567999999999999999998 9999977665443333221111100       


Q ss_pred             hhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          236 YISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                          ....+..+.+++.+|++.||.+||++.++++
T Consensus       232 --------------------~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         232 --------------------PMDCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             --------------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                                1146788999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=4.1e-40  Score=284.03  Aligned_cols=254  Identities=27%  Similarity=0.387  Sum_probs=202.2

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccC-----CceEEEEEeeeccccCCCchHHHHHHHHHHhc-CCCCeeEEEeeeec
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVT-----GQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSS   77 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~-----~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   77 (324)
                      +..++|++.+.||+|++|.||++.....     ...+++|.+....... ....+.+|+.+++++ +|+|++++++++..
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   87 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEK-DLSDLVSEMEMMKMIGKHKNIINLLGVCTQ   87 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHH-HHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence            4567899999999999999999987633     3689999887543222 234577899999999 79999999999999


Q ss_pred             CCeEEEEEEecC-CCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeec
Q 045787           78 RKDVFLVFEYLD-LDLHSFITRH---------------KNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL  141 (324)
Q Consensus        78 ~~~~~iv~e~~~-g~l~~~~~~~---------------~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~  141 (324)
                      ++..+++|||+. |+|..++...               ...+++..+..++.|++.||.|||+.|++|+||+|+||+++ 
T Consensus        88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~-  166 (293)
T cd05053          88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT-  166 (293)
T ss_pred             CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc-
Confidence            999999999997 5888887642               24688999999999999999999999999999999999999 


Q ss_pred             CCCcEEEeeccceeeccCCCCc--ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 045787          142 KRNTVKLADFGLARAIGVPQKE--YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSL  218 (324)
Q Consensus       142 ~~~~v~l~d~g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~  218 (324)
                      .++.++|+|||.+.........  .....++..|+|||++.+ ..++.++||||||+++|++++ |..||..........
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  245 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK  245 (293)
T ss_pred             CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence            8999999999998765432211  111223456999999876 667999999999999999997 999997766544433


Q ss_pred             HHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcC
Q 045787          219 IFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH  287 (324)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~h  287 (324)
                      .......+                           ......+..+.+++.+|+..||.+|||+.+++++
T Consensus       246 ~~~~~~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         246 LLKEGYRM---------------------------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHcCCcC---------------------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            22211000                           0112467889999999999999999999999963

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=5.4e-40  Score=279.54  Aligned_cols=252  Identities=23%  Similarity=0.363  Sum_probs=201.9

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCc---eEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQ---KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV   81 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~---~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   81 (324)
                      ...+|++.+.||+|++|.||+|.+..++.   .+++|.+...... ...+.+.+|+.++++++|||++++++++..++..
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (267)
T cd05066           2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTE-KQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV   80 (267)
T ss_pred             CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            35789999999999999999998865443   6899988654321 2235688899999999999999999999999999


Q ss_pred             EEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           82 FLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        82 ~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      ++|+||++ ++|.+++......++...+..++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+......
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~-~~~~~~l~dfg~~~~~~~~  159 (267)
T cd05066          81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDD  159 (267)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEEC-CCCeEEeCCCCcccccccc
Confidence            99999997 588888877666789999999999999999999999999999999999999 8899999999998766433


Q ss_pred             CCcc---cccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhh
Q 045787          161 QKEY---SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY  236 (324)
Q Consensus       161 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (324)
                      ....   ....++..|+|||.+.+ ..++.++|+||||+++|++++ |..||...+.............+          
T Consensus       160 ~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~----------  228 (267)
T cd05066         160 PEAAYTTRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRL----------  228 (267)
T ss_pred             cceeeecCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcC----------
Confidence            2211   11122456999999987 567999999999999999886 99999766544332221100000          


Q ss_pred             hhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          237 ISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                       ......++.+.+++.+|++.+|.+||++.++++
T Consensus       229 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         229 -----------------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             -----------------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence                             001246788999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=6.8e-40  Score=280.85  Aligned_cols=252  Identities=27%  Similarity=0.404  Sum_probs=200.4

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEc-----cCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecC
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNT-----VTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR   78 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   78 (324)
                      ++..+|++.+.||.|++|.||+|...     .++..+++|.+......  ....+.+|++.++.++|+|++++++++...
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (280)
T cd05092           2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASES--ARQDFQREAELLTVLQHQHIVRFYGVCTEG   79 (280)
T ss_pred             CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHH--HHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence            45678999999999999999999743     34668899987644322  245688999999999999999999999999


Q ss_pred             CeEEEEEEecC-CCHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCC
Q 045787           79 KDVFLVFEYLD-LDLHSFITRHK--------------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKR  143 (324)
Q Consensus        79 ~~~~iv~e~~~-g~l~~~~~~~~--------------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~  143 (324)
                      +..++++||+. ++|.+++....              ..+++..+..++.+++.||.|||+.|++|+||+|+||+++ ++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~-~~  158 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG-QG  158 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEc-CC
Confidence            99999999997 58888876543              2478899999999999999999999999999999999999 89


Q ss_pred             CcEEEeeccceeeccCCCC--cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 045787          144 NTVKLADFGLARAIGVPQK--EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIF  220 (324)
Q Consensus       144 ~~v~l~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~  220 (324)
                      +.++|+|||.+........  ......+++.|+|||.+.+ ..++.++|+||||+++|+|++ |.+||............
T Consensus       159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  237 (280)
T cd05092         159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI  237 (280)
T ss_pred             CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence            9999999999875532211  1122234567999999877 667999999999999999998 89999765544332221


Q ss_pred             HHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          221 SLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      .....+                           .....+++.+.+++.+||+.||.+||++.++++
T Consensus       238 ~~~~~~---------------------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         238 TQGREL---------------------------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HcCccC---------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            111000                           111257889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=7.1e-40  Score=282.25  Aligned_cols=252  Identities=26%  Similarity=0.378  Sum_probs=201.2

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEc-----cCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecC
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNT-----VTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR   78 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   78 (324)
                      +...+|.+.+.||.|++|.||++.+.     .++..+++|.+.......  .+.+.+|+..+++++|+|++++++++...
T Consensus         2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (291)
T cd05094           2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA--RKDFQREAELLTNLQHEHIVKFYGVCGDG   79 (291)
T ss_pred             CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHH--HHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence            45678999999999999999999854     244568888876443221  35678899999999999999999999999


Q ss_pred             CeEEEEEEecC-CCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecC
Q 045787           79 KDVFLVFEYLD-LDLHSFITRHK---------------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK  142 (324)
Q Consensus        79 ~~~~iv~e~~~-g~l~~~~~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~  142 (324)
                      ...++||||++ ++|.+++....               ..+++..++.++.+++.||.+||++|++|+||+|+||+++ .
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~-~  158 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG-A  158 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc-c
Confidence            99999999997 58888886532               2478899999999999999999999999999999999999 8


Q ss_pred             CCcEEEeeccceeeccCCCC--cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 045787          143 RNTVKLADFGLARAIGVPQK--EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLI  219 (324)
Q Consensus       143 ~~~v~l~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~  219 (324)
                      ++.++|+|||.+........  ......+++.|+|||++.+ ..++.++||||||+++|+|++ |..||...+.......
T Consensus       159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~  237 (291)
T cd05094         159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC  237 (291)
T ss_pred             CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            89999999999876543221  1223345677999999887 667899999999999999999 9999977665443222


Q ss_pred             HHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          220 FSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      ..... .                          .......+..+.+++.+||+.||.+||++.++++
T Consensus       238 ~~~~~-~--------------------------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         238 ITQGR-V--------------------------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HhCCC-C--------------------------CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            11100 0                          0011246788999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-39  Score=274.46  Aligned_cols=246  Identities=24%  Similarity=0.374  Sum_probs=203.1

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   83 (324)
                      +..++|++.+.||.|++|.||++...  |+.+++|.+.....   ..+.+.+|+.++++++|++++++++++.+....++
T Consensus         3 ~~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   77 (256)
T cd05039           3 INSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI   77 (256)
T ss_pred             cChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence            45678999999999999999999865  78999999876543   34678899999999999999999999998999999


Q ss_pred             EEEecC-CCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC
Q 045787           84 VFEYLD-LDLHSFITRHKN-TLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        84 v~e~~~-g~l~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~  161 (324)
                      |+||++ ++|.+++..... .+++..+..++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+.......
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~-~~~~~~l~d~g~~~~~~~~~  156 (256)
T cd05039          78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVS-EDLVAKVSDFGLAKEASQGQ  156 (256)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEe-CCCCEEEccccccccccccc
Confidence            999998 589888876542 689999999999999999999999999999999999999 89999999999987663221


Q ss_pred             CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcc
Q 045787          162 KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEI  240 (324)
Q Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (324)
                      .   ....+..|+|||.+.+ ..++.++|+||||+++|++++ |..||.................               
T Consensus       157 ~---~~~~~~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---------------  217 (256)
T cd05039         157 D---SGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR---------------  217 (256)
T ss_pred             c---cCCCcccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC---------------
Confidence            1   2234556999999876 567889999999999999997 9999977665443222211000               


Q ss_pred             cCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          241 LPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                  ......+++.+.++|.+||..+|.+||++.+++.
T Consensus       218 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         218 ------------MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             ------------CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence                        0011256889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=6.9e-40  Score=284.45  Aligned_cols=252  Identities=26%  Similarity=0.378  Sum_probs=200.1

Q ss_pred             cCcCcceeEeecccCceEEEEEEEcc-------CCceEEEEEeeeccccCCCchHHHHHHHHHHhc-CCCCeeEEEeeee
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTV-------TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQS   76 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~-------~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~   76 (324)
                      ..++|.+.+.||+|+||.||+|.+..       ++..+|+|.+..... ......+.+|+.+++.+ +||+++++++++.
T Consensus        16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (307)
T cd05098          16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLGACT   94 (307)
T ss_pred             ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC-hHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence            44789999999999999999998643       234699999875432 22235677899999999 7999999999999


Q ss_pred             cCCeEEEEEEecC-CCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEee
Q 045787           77 SRKDVFLVFEYLD-LDLHSFITRHK---------------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLID  140 (324)
Q Consensus        77 ~~~~~~iv~e~~~-g~l~~~~~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~  140 (324)
                      .++..|+|+||++ |+|.+++....               ..++...+..++.+++.||.+||+.|++|+||+|+||+++
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~  174 (307)
T cd05098          95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT  174 (307)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEc
Confidence            9999999999997 58998887642               2478889999999999999999999999999999999999


Q ss_pred             cCCCcEEEeeccceeeccCCCCc--ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 045787          141 LKRNTVKLADFGLARAIGVPQKE--YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLS  217 (324)
Q Consensus       141 ~~~~~v~l~d~g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~  217 (324)
                       .++.++|+|||.+.........  .....+++.|+|||++.+ ..++.++|+||||+++|+|++ |..||.........
T Consensus       175 -~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~  252 (307)
T cd05098         175 -EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF  252 (307)
T ss_pred             -CCCcEEECCCcccccccccchhhccccCCCccceeChHHhcc-CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH
Confidence             8899999999988755321111  111223457999999887 667999999999999999998 88999776654443


Q ss_pred             HHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          218 LIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      ........                           .......+.++.+++.+||..+|.+||++.++++
T Consensus       253 ~~~~~~~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~  294 (307)
T cd05098         253 KLLKEGHR---------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  294 (307)
T ss_pred             HHHHcCCC---------------------------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            33221100                           0111256789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-41  Score=301.03  Aligned_cols=258  Identities=28%  Similarity=0.402  Sum_probs=215.4

Q ss_pred             eecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEecCC-CH
Q 045787           14 KIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DL   92 (324)
Q Consensus        14 ~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~g-~l   92 (324)
                      .||+|.+|+||.++|..+..+.|+|.++......  .+-+..|+...++++|.|||++.|.+..++.+-|.||.++| +|
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~--~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL  659 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSRE--VQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL  659 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchh--hccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence            6999999999999999999999999887544333  45688999999999999999999999999999999999985 67


Q ss_pred             HHHHHhcCCCC--CHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcccccccc
Q 045787           93 HSFITRHKNTL--NLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVY  170 (324)
Q Consensus        93 ~~~~~~~~~~~--~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~  170 (324)
                      -+.+...=+|+  +++.+..+.+||++||.|||.+.|+|+|||-+||+++.-.|.+||+|||.+.....-+.-.....||
T Consensus       660 SsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGT  739 (1226)
T KOG4279|consen  660 SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGT  739 (1226)
T ss_pred             HHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccc
Confidence            66666655677  8889999999999999999999999999999999999788999999999998887666667777899


Q ss_pred             cccCCchhhc-CCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCC
Q 045787          171 SPYKAPELLL-GYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEP  249 (324)
Q Consensus       171 ~~y~aPE~~~-~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (324)
                      ..|||||++. +...|+.++|||||||++.||.||++||......+.+.....                         ..
T Consensus       740 LQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVG-------------------------my  794 (1226)
T KOG4279|consen  740 LQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVG-------------------------MY  794 (1226)
T ss_pred             hhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhc-------------------------ce
Confidence            9999999996 445689999999999999999999999955443332221110                         11


Q ss_pred             cchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchh
Q 045787          250 ANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       250 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~  298 (324)
                      ...+.....++.+++.||.+|+..||.+||+|.++|..||++.-++.+-
T Consensus       795 KvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~kk~r  843 (1226)
T KOG4279|consen  795 KVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNNKKPR  843 (1226)
T ss_pred             ecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCCCCCC
Confidence            1111222367888999999999999999999999999999998854443

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.4e-39  Score=278.76  Aligned_cols=252  Identities=23%  Similarity=0.303  Sum_probs=199.5

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCce----EEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCC
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQK----VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK   79 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~----~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   79 (324)
                      +..++|++.+.||.|++|.||+|....++..    +++|.+..... ......+..|+..+.+++|||++++++++.. .
T Consensus         4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~   81 (279)
T cd05111           4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSG-RQTFQEITDHMLAMGSLDHAYIVRLLGICPG-A   81 (279)
T ss_pred             CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccc-hHHHHHHHHHHHHHhcCCCCCcceEEEEECC-C
Confidence            4567899999999999999999998776664    66676643221 1223456778888899999999999998754 4


Q ss_pred             eEEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeecc
Q 045787           80 DVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIG  158 (324)
Q Consensus        80 ~~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~  158 (324)
                      ..++++||+. |+|.+++......+++..+..++.|++.||.|||++|++|+||||+||+++ .++.++|+|||.+....
T Consensus        82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~-~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLK-SDSIVQIADFGVADLLY  160 (279)
T ss_pred             ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEc-CCCcEEEcCCccceecc
Confidence            5778899987 799999987777899999999999999999999999999999999999999 89999999999987654


Q ss_pred             CCCC--cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchh
Q 045787          159 VPQK--EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAEST  235 (324)
Q Consensus       159 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (324)
                      ....  ......++..|+|||.+.+ ..++.++|+||||+++|++++ |..||.+...............++.       
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~-------  232 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILF-GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQ-------  232 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCC-------
Confidence            2221  1222345667999999877 568999999999999999998 9999987775554443321111110       


Q ss_pred             hhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          236 YISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                          ....+.++.+++.+|+..||.+|||+.++++
T Consensus       233 --------------------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         233 --------------------PQICTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             --------------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                                0124567889999999999999999999976

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=4e-40  Score=282.69  Aligned_cols=253  Identities=23%  Similarity=0.320  Sum_probs=200.9

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEcc-----CCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecC
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTV-----TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR   78 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   78 (324)
                      +...+|++++.||.|++|.||++.+..     .+..+|+|++...... ...+.+.+|+.++..++||+|+++++++...
T Consensus         2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~   80 (283)
T cd05091           2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEG-PLREEFKHEAMMRSRLQHPNIVCLLGVVTKE   80 (283)
T ss_pred             CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCH-HHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence            445679999999999999999998754     3578999998754322 2235678899999999999999999999999


Q ss_pred             CeEEEEEEecC-CCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecC
Q 045787           79 KDVFLVFEYLD-LDLHSFITRH---------------KNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK  142 (324)
Q Consensus        79 ~~~~iv~e~~~-g~l~~~~~~~---------------~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~  142 (324)
                      +..++++||+. +++.+++...               ...+++..+..++.|++.||.+||+.|++|+||||+||+++ +
T Consensus        81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~-~  159 (283)
T cd05091          81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF-D  159 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEec-C
Confidence            99999999997 4777777532               13478888999999999999999999999999999999999 8


Q ss_pred             CCcEEEeeccceeeccCCCC--cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 045787          143 RNTVKLADFGLARAIGVPQK--EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLI  219 (324)
Q Consensus       143 ~~~v~l~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~  219 (324)
                      ++.++|+|||.+........  ......+++.|+|||++.+ ..++.++||||||+++|+|++ |..||.+.........
T Consensus       160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05091         160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM  238 (283)
T ss_pred             CCceEecccccccccccchheeeccCccCCccccCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            89999999998876532221  1223345677999999876 567999999999999999998 8889877665443332


Q ss_pred             HHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          220 FSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      .......                           ......+..+.+++..||+.||.+||+++++++
T Consensus       239 i~~~~~~---------------------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~  278 (283)
T cd05091         239 IRNRQVL---------------------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS  278 (283)
T ss_pred             HHcCCcC---------------------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            2211110                           011257888999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.9e-41  Score=296.74  Aligned_cols=254  Identities=26%  Similarity=0.390  Sum_probs=209.5

Q ss_pred             ceeEeecccCceEEEEEEEccCCceEEEEEeeecc--ccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCe--EEEEE
Q 045787           10 KKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQT--EQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKD--VFLVF   85 (324)
Q Consensus        10 ~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--~~iv~   85 (324)
                      +.-..||+|+|.+||+|.|...|..||--.++...  ..+...+++..|+++|+.|+||||+++++.+.+...  .-+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            44568999999999999999999988766555443  334445889999999999999999999999877554  78899


Q ss_pred             EecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcccCCCCCceEeecCCCcEEEeeccceeeccCCCC
Q 045787           86 EYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK--ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK  162 (324)
Q Consensus        86 e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g--~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~  162 (324)
                      |.+. |+|..|..+.+ ..+...++.|++||+.||.|||++.  |+|||||.+|||++...|.|||+|+|+|.....+..
T Consensus       123 EL~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a  201 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA  201 (632)
T ss_pred             ecccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcccc
Confidence            9997 79999988865 4999999999999999999999885  999999999999997779999999999998764333


Q ss_pred             cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHHcCCCCcccccchhhhhccc
Q 045787          163 EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-HDHLSLIFSLLGTPTDESWAESTYISEIL  241 (324)
Q Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (324)
                        ....|||.|||||.+.  ..|+...||||||++++||+|+..||.-=. +.++.+.......|...            
T Consensus       202 --ksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl------------  265 (632)
T KOG0584|consen  202 --KSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAAL------------  265 (632)
T ss_pred             --ceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHh------------
Confidence              2368999999999998  578999999999999999999999995433 44444443332222111            


Q ss_pred             CCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCC
Q 045787          242 PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVEN  295 (324)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~  295 (324)
                                    ..--.+++++||.+||.. .++|||+.|+|.||||+.-..
T Consensus       266 --------------~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d~g  304 (632)
T KOG0584|consen  266 --------------SKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDEDGG  304 (632)
T ss_pred             --------------hccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccccc
Confidence                          112367899999999999 999999999999999998643

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.1e-39  Score=280.98  Aligned_cols=263  Identities=22%  Similarity=0.397  Sum_probs=208.0

Q ss_pred             CcceeEeecccCceEEEEEEEc---cCCceEEEEEeeeccc--cCCCchHHHHHHHHHHhc-CCCCeeEEEeeeecCCeE
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNT---VTGQKVAIKMMTIQTE--QEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDV   81 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~---~~~~~~~~K~~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   81 (324)
                      +|++.+.||.|++|.||+|.+.   .+|..|++|++.....  .....+.+.+|+.+++++ +|++|+++++.+..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            5899999999999999999875   4788999999875432  222345678899999999 589999999999999999


Q ss_pred             EEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           82 FLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        82 ~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      |+|+||+.+ +|.+++... .++++..+..++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+......
T Consensus        81 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~~  158 (290)
T cd05613          81 HLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLD-SNGHVVLTDFGLSKEFHED  158 (290)
T ss_pred             EEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEC-CCCCEEEeeCccceecccc
Confidence            999999984 888887664 4688999999999999999999999999999999999999 8899999999988765432


Q ss_pred             CC-cccccccccccCCchhhcCC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHHcCCCCcccccchhhh
Q 045787          161 QK-EYSRDCVYSPYKAPELLLGY-TGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD-HLSLIFSLLGTPTDESWAESTYI  237 (324)
Q Consensus       161 ~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  237 (324)
                      .. ......++..|+|||.+.+. ...+.++|+||||+++|+|++|..||...... ............           
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-----------  227 (290)
T cd05613         159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-----------  227 (290)
T ss_pred             cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc-----------
Confidence            21 22234577889999998652 34678999999999999999999999643311 111111100000           


Q ss_pred             hcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCC-----CHHHHhcCccccCCCCch
Q 045787          238 SEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRI-----TAMDALKHEYLIGVENVP  297 (324)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~~l~hp~~~~~~~~~  297 (324)
                            .        ......++..+.+++.+||+.||.+||     ++.+++.||||+.+++.-
T Consensus       228 ------~--------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~  278 (290)
T cd05613         228 ------E--------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDD  278 (290)
T ss_pred             ------C--------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHH
Confidence                  0        001124678899999999999999997     899999999999998643

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.8e-39  Score=274.10  Aligned_cols=249  Identities=26%  Similarity=0.369  Sum_probs=198.3

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   83 (324)
                      +..++|++.+.||+|++|.||+|.+... ..+++|.+.....   ..+.+.+|+.++++++|++++++++++.. ...++
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   77 (260)
T cd05069           3 IPRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYI   77 (260)
T ss_pred             CChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEE
Confidence            4457899999999999999999987654 4689998764322   23567889999999999999999998754 56889


Q ss_pred             EEEecC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC
Q 045787           84 VFEYLD-LDLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        84 v~e~~~-g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~  161 (324)
                      +|||+. ++|.+++.... ..++...+..++.+++.||.+||+.|++|+||+|+||+++ +++.++|+|||.+.......
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~-~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05069          78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVG-DNLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc-CCCeEEECCCccceEccCCc
Confidence            999998 48998887643 3578999999999999999999999999999999999999 89999999999987654322


Q ss_pred             Cc-ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhc
Q 045787          162 KE-YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISE  239 (324)
Q Consensus       162 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
                      .. .....++..|+|||...+ ...+.++|+||||+++|+|++ |..||.................+             
T Consensus       157 ~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-------------  222 (260)
T cd05069         157 YTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM-------------  222 (260)
T ss_pred             ccccCCCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-------------
Confidence            11 112234567999998876 667999999999999999999 89999776644433222111000             


Q ss_pred             ccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                    .....++..+.+++.+||..||.+||+++++++
T Consensus       223 --------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         223 --------------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             --------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                          011246788999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=9.4e-40  Score=276.50  Aligned_cols=242  Identities=21%  Similarity=0.378  Sum_probs=192.6

Q ss_pred             eecccCceEEEEEEE--ccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEecC-C
Q 045787           14 KIGAGGYGEVYKCRN--TVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD-L   90 (324)
Q Consensus        14 ~Lg~g~~~~v~~a~~--~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~-g   90 (324)
                      .||+|++|.||++..  ..++..+++|++..........+.+.+|+.+++.++||+++++++++.. +..++|+||++ +
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            589999999999864  4567899999987554444445678889999999999999999998754 56789999998 5


Q ss_pred             CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCc---cccc
Q 045787           91 DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE---YSRD  167 (324)
Q Consensus        91 ~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~---~~~~  167 (324)
                      +|.+++.. ...+++..+..++.+++.||.+||++|++|+||+|.||+++ .++.++|+|||.+.........   ....
T Consensus        81 ~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05116          81 PLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLV-TQHYAKISDFGLSKALGADENYYKAKTHG  158 (257)
T ss_pred             cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEc-CCCeEEECCCccccccCCCCCeeeecCCC
Confidence            78777765 34689999999999999999999999999999999999999 8899999999998766433221   1112


Q ss_pred             ccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCC
Q 045787          168 CVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPH  246 (324)
Q Consensus       168 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (324)
                      .+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+.............+                    
T Consensus       159 ~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~--------------------  217 (257)
T cd05116         159 KWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERM--------------------  217 (257)
T ss_pred             CCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCC--------------------
Confidence            23467999999876 667889999999999999998 99999776654433322211000                    


Q ss_pred             CCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          247 FEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       247 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                             .....++.++.++|.+|++.||.+||++++|..
T Consensus       218 -------~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         218 -------ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             -------CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence                   011257889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-39  Score=274.41  Aligned_cols=243  Identities=24%  Similarity=0.371  Sum_probs=196.8

Q ss_pred             EeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEecC-CC
Q 045787           13 KKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD-LD   91 (324)
Q Consensus        13 ~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~-g~   91 (324)
                      +.||.|++|.||+|.+.. ++.+++|.+...... .....+.+|+.++++++|++++++++++......++|+||+. ++
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~   78 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS   78 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence            468999999999999877 999999988765433 234578899999999999999999999999999999999997 58


Q ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcc--ccccc
Q 045787           92 LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY--SRDCV  169 (324)
Q Consensus        92 l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~--~~~~~  169 (324)
                      +.+++......++...+..++.+++.+|.+||++|++|+||+|+||+++ .++.++|+|||.+..........  .....
T Consensus        79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVG-ENNVLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEc-CCCcEEEeeccccccccCCcceeccccCcc
Confidence            8888877666789999999999999999999999999999999999999 89999999999887554211111  11223


Q ss_pred             ccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCC
Q 045787          170 YSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFE  248 (324)
Q Consensus       170 ~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (324)
                      +..|+|||.+.+ ..++.++|+||||+++|+|++ |..||..................                      
T Consensus       158 ~~~y~~PE~~~~-~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~----------------------  214 (251)
T cd05041         158 PIKWTAPEALNY-GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRM----------------------  214 (251)
T ss_pred             eeccCChHhhcc-CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCC----------------------
Confidence            456999999877 568999999999999999999 88899776654433322211000                      


Q ss_pred             CcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          249 PANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       249 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                           ......+..+.+++.+||..+|.+||++.++++
T Consensus       215 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         215 -----PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             -----CCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence                 011246788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-39  Score=277.93  Aligned_cols=249  Identities=24%  Similarity=0.341  Sum_probs=195.7

Q ss_pred             cceeEeecccCceEEEEEEEccC---CceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCe-----
Q 045787            9 YKKIKKIGAGGYGEVYKCRNTVT---GQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKD-----   80 (324)
Q Consensus         9 y~i~~~Lg~g~~~~v~~a~~~~~---~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-----   80 (324)
                      |++.+.||+|+||.||.|....+   +..+|+|.+............+.+|+..++.++||+++++++.+.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            67899999999999999987643   4789999987654333334568899999999999999999998765443     


Q ss_pred             -EEEEEEecC-CCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccc
Q 045787           81 -VFLVFEYLD-LDLHSFITRH-----KNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGL  153 (324)
Q Consensus        81 -~~iv~e~~~-g~l~~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~  153 (324)
                       .++++||+. |++..++...     ...+++..+..++.+++.||.+||+.|++|+||||+||+++ +++.++|+|||.
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~-~~~~~kl~dfg~  159 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLR-EDMTVCVADFGL  159 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEEC-CCCeEEECCccc
Confidence             799999998 5887777443     23588999999999999999999999999999999999999 889999999999


Q ss_pred             eeeccCCCCc--ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCccc
Q 045787          154 ARAIGVPQKE--YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDES  230 (324)
Q Consensus       154 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  230 (324)
                      +.........  ......+..|+|||.+.+ ..++.++||||||+++|+|++ |..||............... ..    
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~----  233 (273)
T cd05035         160 SKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG-NR----  233 (273)
T ss_pred             eeeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CC----
Confidence            8766432211  111233567999999876 667999999999999999999 88999766543332211110 00    


Q ss_pred             ccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          231 WAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                            ......++..+.+++.+||+.||.+||++.++++
T Consensus       234 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~  267 (273)
T cd05035         234 ----------------------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLRE  267 (273)
T ss_pred             ----------------------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                  0112357889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-39  Score=277.71  Aligned_cols=254  Identities=26%  Similarity=0.389  Sum_probs=205.2

Q ss_pred             CcccCcCcceeEeecccCceEEEEEEEccCCc----eEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeec
Q 045787            2 GKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQ----KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS   77 (324)
Q Consensus         2 ~~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~----~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   77 (324)
                      ..+...+|++.+.||+|++|.||+|....+|.    .+++|....... ......+.+|+..+++++|||++++++++..
T Consensus         2 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   80 (279)
T cd05057           2 RILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS   80 (279)
T ss_pred             cccCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence            45677899999999999999999999876655    588888765433 2223567889999999999999999999887


Q ss_pred             CCeEEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceee
Q 045787           78 RKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARA  156 (324)
Q Consensus        78 ~~~~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~  156 (324)
                       ...++|+||+. |+|.+++......+++..+..++.+++.||.+||+.|++|+||+|+||+++ +++.++|+|||.+..
T Consensus        81 -~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~-~~~~~kL~dfg~~~~  158 (279)
T cd05057          81 -SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVK-TPQHVKITDFGLAKL  158 (279)
T ss_pred             -CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEc-CCCeEEECCCccccc
Confidence             78899999997 699998887667799999999999999999999999999999999999999 889999999999876


Q ss_pred             ccCCCCcccc--cccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccc
Q 045787          157 IGVPQKEYSR--DCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAE  233 (324)
Q Consensus       157 ~~~~~~~~~~--~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  233 (324)
                      ..........  ..++..|+|||.+.. ..++.++|+||||+++|++++ |..||...+..............+      
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~------  231 (279)
T cd05057         159 LDVDEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLP------  231 (279)
T ss_pred             ccCcccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCC------
Confidence            6432221111  123456999999876 667899999999999999998 999998877655444333111110      


Q ss_pred             hhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          234 STYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                           .....+..+.+++.+|+..||.+||++.++++
T Consensus       232 ---------------------~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         232 ---------------------QPPICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             ---------------------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                                 01235678899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-39  Score=273.99  Aligned_cols=242  Identities=24%  Similarity=0.378  Sum_probs=193.6

Q ss_pred             EeecccCceEEEEEEEccCC---ceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEecC
Q 045787           13 KKIGAGGYGEVYKCRNTVTG---QKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD   89 (324)
Q Consensus        13 ~~Lg~g~~~~v~~a~~~~~~---~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~   89 (324)
                      +.||.|++|.||+|.....+   ..+++|.+...... ...+.+.+|+.+++++.|++++++++++.. ...++|+||+.
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~   78 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAP   78 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCC
Confidence            46999999999999865544   78999998765443 234568889999999999999999998764 46899999997


Q ss_pred             -CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcccc--
Q 045787           90 -LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSR--  166 (324)
Q Consensus        90 -g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~--  166 (324)
                       |+|.+++.... .+++..+..++.+++.+|.+||..|++|+||+|+||+++ .++.++|+|||.+............  
T Consensus        79 ~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~-~~~~~kl~df~~~~~~~~~~~~~~~~~  156 (257)
T cd05060          79 LGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLV-NRHQAKISDFGMSRALGAGSDYYRATT  156 (257)
T ss_pred             CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEc-CCCcEEeccccccceeecCCccccccc
Confidence             58888887654 689999999999999999999999999999999999999 8999999999998766433322111  


Q ss_pred             -cccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCC
Q 045787          167 -DCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLY  244 (324)
Q Consensus       167 -~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (324)
                       ..++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+..............                  
T Consensus       157 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~------------------  217 (257)
T cd05060         157 AGRWPLKWYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERL------------------  217 (257)
T ss_pred             CccccccccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcC------------------
Confidence             112356999999876 668999999999999999998 99999776654433322211100                  


Q ss_pred             CCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                               .....++..+.+++.+||..||.+||++.++++
T Consensus       218 ---------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         218 ---------PRPEECPQEIYSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             ---------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                     111356789999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=7.8e-40  Score=287.22  Aligned_cols=254  Identities=24%  Similarity=0.388  Sum_probs=196.5

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEc-----cCCceEEEEEeeeccccCCCchHHHHHHHHHHhc-CCCCeeEEEeeeec
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNT-----VTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSS   77 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   77 (324)
                      +-.++|++++.||.|+||.||+|.+.     .+++.||+|++...... ...+.+.+|+.+++++ +|+||+++++++..
T Consensus         4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~-~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~   82 (337)
T cd05054           4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATA-SEYKALMTELKILIHIGHHLNVVNLLGACTK   82 (337)
T ss_pred             cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCH-HHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence            34578999999999999999999753     34578999998754322 2234577899999999 79999999998764


Q ss_pred             -CCeEEEEEEecC-CCHHHHHHhcC-------------------------------------------------------
Q 045787           78 -RKDVFLVFEYLD-LDLHSFITRHK-------------------------------------------------------  100 (324)
Q Consensus        78 -~~~~~iv~e~~~-g~l~~~~~~~~-------------------------------------------------------  100 (324)
                       +..+++++||+. ++|.+++....                                                       
T Consensus        83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (337)
T cd05054          83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG  162 (337)
T ss_pred             CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence             457889999998 48877775421                                                       


Q ss_pred             -----CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC--ccccccccccc
Q 045787          101 -----NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK--EYSRDCVYSPY  173 (324)
Q Consensus       101 -----~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~--~~~~~~~~~~y  173 (324)
                           .++++..+..++.+++.||.|||++|++|+||||+||+++ .++.++|+|||.+........  ......++..|
T Consensus       163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~-~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y  241 (337)
T cd05054         163 DELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW  241 (337)
T ss_pred             hHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEe-CCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence                 2578899999999999999999999999999999999999 889999999999876532211  12223345679


Q ss_pred             CCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhH-HHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcc
Q 045787          174 KAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDH-LSLIFSLLGTPTDESWAESTYISEILPLYPHFEPAN  251 (324)
Q Consensus       174 ~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (324)
                      +|||++.+ ..++.++|||||||++|+|++ |..||.+..... ....... +..                         
T Consensus       242 ~aPE~~~~-~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~-------------------------  294 (337)
T cd05054         242 MAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKE-GTR-------------------------  294 (337)
T ss_pred             cCcHHhcC-CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhc-cCC-------------------------
Confidence            99999987 678999999999999999998 999997644322 1111110 000                         


Q ss_pred             hhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcC
Q 045787          252 LAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH  287 (324)
Q Consensus       252 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~h  287 (324)
                       .......++++.+++.+||+.+|.+||++.++++|
T Consensus       295 -~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~  329 (337)
T cd05054         295 -MRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI  329 (337)
T ss_pred             -CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence             00112467889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.7e-39  Score=276.71  Aligned_cols=251  Identities=22%  Similarity=0.352  Sum_probs=201.0

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCc---eEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQ---KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF   82 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~---~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   82 (324)
                      ..+|++.+.||.|++|.||+|.+..++.   .|++|.+..... ......+..|+.++++++|||++++++++.++...+
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   81 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYT-EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM   81 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCC-HHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence            4579999999999999999999876665   599999865422 222456889999999999999999999999999999


Q ss_pred             EEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC
Q 045787           83 LVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        83 iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~  161 (324)
                      +|+||+++ +|.+++....+.+++..++.++.+++.||.+||++|++|+||+|+||+++ .++.++|+|||.+.......
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~-~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVN-SNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEc-CCCcEEECCCccccccccCc
Confidence            99999985 78888777666789999999999999999999999999999999999999 88999999999886554322


Q ss_pred             Ccc--cccc---cccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchh
Q 045787          162 KEY--SRDC---VYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAEST  235 (324)
Q Consensus       162 ~~~--~~~~---~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (324)
                      ...  ....   .+..|+|||.+.+ ..++.++||||||+++|++++ |..||...+..............         
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~---------  230 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRL---------  230 (269)
T ss_pred             cccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcC---------
Confidence            111  1111   1346999999876 667999999999999999886 99999776644332222110000         


Q ss_pred             hhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          236 YISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                        ......+..+.+++.+||..+|.+||++.+++.
T Consensus       231 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         231 ------------------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             ------------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                              001246788999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2.2e-39  Score=276.41  Aligned_cols=249  Identities=25%  Similarity=0.346  Sum_probs=194.4

Q ss_pred             cceeEeecccCceEEEEEEEccCCc--eEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeec------CCe
Q 045787            9 YKKIKKIGAGGYGEVYKCRNTVTGQ--KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS------RKD   80 (324)
Q Consensus         9 y~i~~~Lg~g~~~~v~~a~~~~~~~--~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~   80 (324)
                      |.+.+.||+|++|.||++....++.  .+++|.+..........+.+.+|+.+++.++|+|++++++++..      ...
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3567899999999999999876665  58999887654333334667889999999999999999997632      124


Q ss_pred             EEEEEEecC-CCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccce
Q 045787           81 VFLVFEYLD-LDLHSFITRH-----KNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLA  154 (324)
Q Consensus        81 ~~iv~e~~~-g~l~~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~  154 (324)
                      .++++||+. |++.+++...     ...+++..+..++.+++.||.|||++|++|+||||+||+++ .++.++|+|||.+
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~-~~~~~kl~Dfg~~  159 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLN-ENMNVCVADFGLS  159 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEc-CCCCEEECCCCcc
Confidence            789999997 5887776432     23478999999999999999999999999999999999999 8999999999998


Q ss_pred             eeccCCCC--cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccc
Q 045787          155 RAIGVPQK--EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESW  231 (324)
Q Consensus       155 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  231 (324)
                      ........  .......++.|+|||...+ ..++.++|+||||+++|+|++ |..||.................      
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~------  232 (272)
T cd05075         160 KKIYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR------  232 (272)
T ss_pred             cccCcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC------
Confidence            76543221  1122234567999999887 667999999999999999999 7899976654433222211000      


Q ss_pred             cchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          232 AESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                           ....+.++..+.+++.+||+.||.+|||+.++++
T Consensus       233 ---------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~  266 (272)
T cd05075         233 ---------------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRC  266 (272)
T ss_pred             ---------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                                 0011356788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=6.4e-39  Score=271.19  Aligned_cols=249  Identities=22%  Similarity=0.363  Sum_probs=200.4

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      ..+|++.+.||.|++|.||++.+. ++..+++|.+......   ...+.+|++++++++||+++++++++......++|+
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   78 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF   78 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence            457999999999999999999875 4678999987643322   356889999999999999999999999999999999


Q ss_pred             EecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCc-
Q 045787           86 EYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE-  163 (324)
Q Consensus        86 e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~-  163 (324)
                      ||+.+ +|.+++......+++..++.++.+++.++.+||+.|++|+||+|+||+++ .++.++|+|||.+......... 
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~~~~~~~  157 (256)
T cd05112          79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVG-ENQVVKVSDFGMTRFVLDDQYTS  157 (256)
T ss_pred             EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEc-CCCeEEECCCcceeecccCcccc
Confidence            99984 78888776666789999999999999999999999999999999999999 8899999999988765422111 


Q ss_pred             ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccC
Q 045787          164 YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILP  242 (324)
Q Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (324)
                      ......+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||.................                 
T Consensus       158 ~~~~~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-----------------  219 (256)
T cd05112         158 STGTKFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFR-----------------  219 (256)
T ss_pred             cCCCccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCC-----------------
Confidence            112234467999999876 567899999999999999998 8999976664433222110000                 


Q ss_pred             CCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcC
Q 045787          243 LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH  287 (324)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~h  287 (324)
                         ..       .....+..+.+++.+||+.+|.+||++.+++++
T Consensus       220 ---~~-------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         220 ---LY-------KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             ---CC-------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence               00       012357889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.3e-39  Score=273.11  Aligned_cols=242  Identities=23%  Similarity=0.362  Sum_probs=191.9

Q ss_pred             eecccCceEEEEEEEc--cCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEecC-C
Q 045787           14 KIGAGGYGEVYKCRNT--VTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD-L   90 (324)
Q Consensus        14 ~Lg~g~~~~v~~a~~~--~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~-g   90 (324)
                      .||+|++|.||++...  ..+..+++|++..... ....+.+.+|+.++++++||+++++++++.. ...++|+||++ +
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~   79 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE-KSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGG   79 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccC-hHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCC
Confidence            4899999999998765  3455799998865432 2234568899999999999999999998754 57899999997 5


Q ss_pred             CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCc---cccc
Q 045787           91 DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE---YSRD  167 (324)
Q Consensus        91 ~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~---~~~~  167 (324)
                      +|.+++......+++..+..++.+++.||.+||++|++|+||||+||+++ .++.++|+|||.+.........   ....
T Consensus        80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05115          80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLV-NQHYAKISDFGLSKALGADDSYYKARSAG  158 (257)
T ss_pred             CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEc-CCCcEEeccCCccccccCCccceeccCCC
Confidence            88888876667799999999999999999999999999999999999999 8899999999988755322211   1111


Q ss_pred             ccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCC
Q 045787          168 CVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPH  246 (324)
Q Consensus       168 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (324)
                      .+++.|+|||.+.+ ..++.++|+||||+++|++++ |..||.................+.                   
T Consensus       159 ~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-------------------  218 (257)
T cd05115         159 KWPLKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLD-------------------  218 (257)
T ss_pred             CCCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCC-------------------
Confidence            23467999999876 567999999999999999996 999997766544433322111110                   


Q ss_pred             CCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          247 FEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       247 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                              .....++++.+++.+|+..||.+||++.++++
T Consensus       219 --------~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         219 --------CPAECPPEMYALMKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             --------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                    11246889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.4e-39  Score=278.83  Aligned_cols=249  Identities=26%  Similarity=0.392  Sum_probs=197.2

Q ss_pred             CcceeEeecccCceEEEEEEEcc-----CCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTV-----TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF   82 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   82 (324)
                      +|++.+.||+|+||.||+|.+..     ....+++|.+....... ....+.+|+.+++.++|||++++++.+..++..+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSS-ELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL   79 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHH-HHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence            58899999999999999998753     22468888876443221 1356788999999999999999999999999999


Q ss_pred             EEEEecC-CCHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceE
Q 045787           83 LVFEYLD-LDLHSFITRHK-----------------------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLL  138 (324)
Q Consensus        83 iv~e~~~-g~l~~~~~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIl  138 (324)
                      +++||+. ++|.+++....                       .++++..+..++.+++.||.+||+.|++|+||+|+||+
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil  159 (290)
T cd05045          80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL  159 (290)
T ss_pred             EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence            9999998 58888775421                       24788899999999999999999999999999999999


Q ss_pred             eecCCCcEEEeeccceeeccCCCC--cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhH
Q 045787          139 IDLKRNTVKLADFGLARAIGVPQK--EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDH  215 (324)
Q Consensus       139 l~~~~~~v~l~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~  215 (324)
                      ++ +++.++|+|||.+........  ......++..|+|||.+.+ ..++.++||||||+++++|++ |..||.+.....
T Consensus       160 l~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         160 VA-EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             Ec-CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc-CCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            99 889999999999875532221  1122344567999999876 668999999999999999998 999997766554


Q ss_pred             HHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          216 LSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      ........-.                           ......++.++.+++.+||+.||.+||++.++++
T Consensus       238 ~~~~~~~~~~---------------------------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         238 LFNLLKTGYR---------------------------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             HHHHHhCCCC---------------------------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            3332211000                           0011256789999999999999999999999985

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=3.3e-39  Score=279.41  Aligned_cols=254  Identities=26%  Similarity=0.367  Sum_probs=200.2

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEc-----cCCceEEEEEeeeccccCCCchHHHHHHHHHHhc-CCCCeeEEEeeeec
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNT-----VTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSS   77 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   77 (324)
                      +..++|++.+.||.|++|.||++.+.     ..+..+|+|.+..... ....+.+.+|+.+++++ +|||++++++.+..
T Consensus        32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  110 (302)
T cd05055          32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-SSEREALMSELKIMSHLGNHENIVNLLGACTI  110 (302)
T ss_pred             ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-hHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence            45678999999999999999999753     3455799998765432 22235688999999999 79999999999999


Q ss_pred             CCeEEEEEEecC-CCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeecccee
Q 045787           78 RKDVFLVFEYLD-LDLHSFITRHKN-TLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLAR  155 (324)
Q Consensus        78 ~~~~~iv~e~~~-g~l~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~  155 (324)
                      .+..++++||+. |+|.+++..... .+++..+..++.+++.||.|||++|++|+||+|+||+++ .++.++|+|||.+.
T Consensus       111 ~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~-~~~~~~l~dfg~~~  189 (302)
T cd05055         111 GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLT-HGKIVKICDFGLAR  189 (302)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEc-CCCeEEECCCcccc
Confidence            999999999997 688888865433 489999999999999999999999999999999999999 88999999999987


Q ss_pred             eccCCCC--cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCccccc
Q 045787          156 AIGVPQK--EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWA  232 (324)
Q Consensus       156 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  232 (324)
                      .......  ......+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||...............+.+.     
T Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-----  263 (302)
T cd05055         190 DIMNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM-----  263 (302)
T ss_pred             cccCCCceeecCCCCcccccCCHhhhcc-CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC-----
Confidence            5542221  1122234567999999877 567999999999999999998 999997655332211111000000     


Q ss_pred             chhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          233 ESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                           ......+..+.+++.+||..+|.+||++.++++
T Consensus       264 ---------------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         264 ---------------------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             ---------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                                 011246788999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=3.1e-39  Score=278.95  Aligned_cols=260  Identities=25%  Similarity=0.355  Sum_probs=201.3

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCC----------------ceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCC
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTG----------------QKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN   67 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~----------------~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~   67 (324)
                      +..++|++++.||+|+||.||+|.+...+                ..+++|.+...... ...+.+.+|+.++++++|||
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~   80 (296)
T cd05051           2 FPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD-NAREDFLKEVKILSRLSDPN   80 (296)
T ss_pred             CchhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH-HHHHHHHHHHHHHHhcCCCC
Confidence            34578999999999999999999876533                45799988754322 22456788999999999999


Q ss_pred             eeEEEeeeecCCeEEEEEEecC-CCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 045787           68 IVRLLDVQSSRKDVFLVFEYLD-LDLHSFITRHK----------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNN  136 (324)
Q Consensus        68 i~~~~~~~~~~~~~~iv~e~~~-g~l~~~~~~~~----------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~n  136 (324)
                      ++++++++..++..++++|++. ++|.+++....          ..+++..++.++.+++.||.+||+.|++|+||||+|
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N  160 (296)
T cd05051          81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN  160 (296)
T ss_pred             EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence            9999999999999999999997 58888876643          268999999999999999999999999999999999


Q ss_pred             eEeecCCCcEEEeeccceeeccCCCC--cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh--CCCCCCCCC
Q 045787          137 LLIDLKRNTVKLADFGLARAIGVPQK--EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT--GKPLFPSKK  212 (324)
Q Consensus       137 Ill~~~~~~v~l~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~--g~~pf~~~~  212 (324)
                      |+++ .++.++|+|||.+........  ......+++.|+|||.+.+ ..++.++||||||+++|+|++  +..||...+
T Consensus       161 ili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05051         161 CLVG-KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWAFGVTLWEILTLCREQPYEHLT  238 (296)
T ss_pred             eeec-CCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc-CCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence            9999 889999999999876532221  1223345667999999877 568999999999999999998  678886655


Q ss_pred             hhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          213 HDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      ...........-.                    ...........+.++.++.+++.+||+.||.+|||+.+++.
T Consensus       239 ~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         239 DQQVIENAGHFFR--------------------DDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             hHHHHHHHHhccc--------------------cccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            3332221111000                    00000000112356789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=3.8e-39  Score=287.85  Aligned_cols=253  Identities=23%  Similarity=0.344  Sum_probs=197.1

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccC-----CceEEEEEeeeccccCCCchHHHHHHHHHHhcC-CCCeeEEEeeeecC
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVT-----GQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-HENIVRLLDVQSSR   78 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~-----~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~   78 (324)
                      ..++|++.+.||+|+||.||++.+...     +..||+|++..... ....+.+.+|+.+++++. ||||+++++++...
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~  113 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR-SSEKQALMSELKIMTHLGPHLNIVNLLGACTKS  113 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence            357888999999999999999986432     34699999865432 222356889999999996 99999999999999


Q ss_pred             CeEEEEEEecC-CCHHHHHHhcC---------------------------------------------------------
Q 045787           79 KDVFLVFEYLD-LDLHSFITRHK---------------------------------------------------------  100 (324)
Q Consensus        79 ~~~~iv~e~~~-g~l~~~~~~~~---------------------------------------------------------  100 (324)
                      +..|+||||+. |+|.+++....                                                         
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (400)
T cd05105         114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE  193 (400)
T ss_pred             CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence            99999999997 58888775421                                                         


Q ss_pred             --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecC
Q 045787          101 --------------------------------------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK  142 (324)
Q Consensus       101 --------------------------------------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~  142 (324)
                                                            ..+++..+..++.+++.||.|||+.|++|+||||+||+++ .
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~-~  272 (400)
T cd05105         194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA-Q  272 (400)
T ss_pred             hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEe-C
Confidence                                                  2367778889999999999999999999999999999999 8


Q ss_pred             CCcEEEeeccceeeccCCCC--cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 045787          143 RNTVKLADFGLARAIGVPQK--EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLI  219 (324)
Q Consensus       143 ~~~v~l~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~  219 (324)
                      ++.++|+|||.+........  ......+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||...........
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~  351 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD-NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN  351 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH
Confidence            89999999999876532221  1222345677999999877 667999999999999999997 8899976543221111


Q ss_pred             HHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          220 FSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      ....+..                          ......++..+.+++.+||+.||.+||++.++.+
T Consensus       352 ~~~~~~~--------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         352 KIKSGYR--------------------------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HHhcCCC--------------------------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            1100000                          0011257889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=4.9e-39  Score=271.99  Aligned_cols=248  Identities=27%  Similarity=0.427  Sum_probs=201.8

Q ss_pred             cceeEeecccCceEEEEEEEccCC----ceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 045787            9 YKKIKKIGAGGYGEVYKCRNTVTG----QKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLV   84 (324)
Q Consensus         9 y~i~~~Lg~g~~~~v~~a~~~~~~----~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   84 (324)
                      +++.+.||.|++|.||++.+...+    ..+++|.+...... .....+.+|+..++.++|++++++++.+.+.+..+++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i   79 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE-QQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV   79 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh-HHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence            467899999999999999998766    88999998654332 1346788999999999999999999999999999999


Q ss_pred             EEecC-CCHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC
Q 045787           85 FEYLD-LDLHSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK  162 (324)
Q Consensus        85 ~e~~~-g~l~~~~~~~~~~-~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~  162 (324)
                      +|++. +++.+++...... +++..+..++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+........
T Consensus        80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~-~~~~~~l~dfg~~~~~~~~~~  158 (258)
T smart00219       80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDDDY  158 (258)
T ss_pred             EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEc-cCCeEEEcccCCceecccccc
Confidence            99997 4888888765544 89999999999999999999999999999999999999 889999999999877653311


Q ss_pred             ccc-ccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcc
Q 045787          163 EYS-RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEI  240 (324)
Q Consensus       163 ~~~-~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (324)
                      ... ...+++.|+|||...+ ..++.++|+||||+++++|++ |..||...+.............+              
T Consensus       159 ~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--------------  223 (258)
T smart00219      159 YKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRL--------------  223 (258)
T ss_pred             cccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC--------------
Confidence            111 1235677999999865 667999999999999999998 78898776554443322211110              


Q ss_pred             cCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          241 LPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                   ......+..+.+++.+||..||.+|||+.++++
T Consensus       224 -------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      224 -------------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             -------------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence                         111247889999999999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3e-39  Score=277.42  Aligned_cols=267  Identities=27%  Similarity=0.413  Sum_probs=197.8

Q ss_pred             cCcCcceeEeecccCceEEEEEE----EccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeec--C
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCR----NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS--R   78 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~----~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~   78 (324)
                      ...+|++++.||+|++|.||++.    +..++..+++|.+......  ..+.+.+|+.++++++|||++++++++..  .
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   79 (284)
T cd05081           2 EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAE--HLRDFEREIEILKSLQHDNIVKYKGVCYSAGR   79 (284)
T ss_pred             ccccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHH--HHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence            35689999999999999999987    4457889999998654322  23568899999999999999999997643  4


Q ss_pred             CeEEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeec
Q 045787           79 KDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAI  157 (324)
Q Consensus        79 ~~~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~  157 (324)
                      ...++|+||++ ++|.+++......+++..+..++.+++.||.+||+.|++|+||||+||+++ .++.++|+|||.+...
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~-~~~~~~l~dfg~~~~~  158 (284)
T cd05081          80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVE-SENRVKIGDFGLTKVL  158 (284)
T ss_pred             CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEEC-CCCeEEECCCcccccc
Confidence            56899999997 689988877666789999999999999999999999999999999999999 8899999999998866


Q ss_pred             cCCCCcc---cccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccch
Q 045787          158 GVPQKEY---SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAES  234 (324)
Q Consensus       158 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (324)
                      .......   ....++..|+|||.+.+ ..++.++|+||||+++|+|++|..|+...........    +..........
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~  233 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMM----GNDKQGQMIVY  233 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhcc-CCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhc----ccccccccchH
Confidence            4322211   11122345999999877 5679999999999999999998876643332211100    00000000000


Q ss_pred             hhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          235 TYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      . ..+.....      ........++..+.+++.+||..+|++|||+.++++
T Consensus       234 ~-~~~~~~~~------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         234 H-LIELLKNN------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             H-HHHHHhcC------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            0 00000000      000112357889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=7.6e-39  Score=270.77  Aligned_cols=245  Identities=24%  Similarity=0.387  Sum_probs=197.3

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeee-ecCCeEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQ-SSRKDVF   82 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~   82 (324)
                      +...+|++.+.||+|++|.||++...  |..+++|......    ..+.+.+|+.++++++|++++++++++ ..++..+
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   76 (256)
T cd05082           3 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY   76 (256)
T ss_pred             ccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceE
Confidence            34568999999999999999999765  7789999875432    235688999999999999999999975 4556789


Q ss_pred             EEEEecC-CCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           83 LVFEYLD-LDLHSFITRHKN-TLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        83 iv~e~~~-g~l~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      +++||++ ++|.+++..... .+++..+..++.+++.+|.+||++|++|+||+|+||+++ .++.++|+|||.+......
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~-~~~~~kl~dfg~~~~~~~~  155 (256)
T cd05082          77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVS-EDNVAKVSDFGLTKEASST  155 (256)
T ss_pred             EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEc-CCCcEEecCCccceecccc
Confidence            9999997 589888876544 488999999999999999999999999999999999999 8999999999988765422


Q ss_pred             CCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhc
Q 045787          161 QKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISE  239 (324)
Q Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
                      .   .....+..|+|||++.+ ..++.++|+||||+++|+|++ |+.||.................              
T Consensus       156 ~---~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~--------------  217 (256)
T cd05082         156 Q---DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK--------------  217 (256)
T ss_pred             C---CCCccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC--------------
Confidence            2   22234456999999877 667899999999999999997 9999976554433222111000              


Q ss_pred             ccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                   ....+.+++.+.+++.+|++.||.+|||+.++++
T Consensus       218 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         218 -------------MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             -------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                         0112357889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.1e-39  Score=278.91  Aligned_cols=264  Identities=23%  Similarity=0.413  Sum_probs=206.5

Q ss_pred             CcceeEeecccCceEEEEEEEc---cCCceEEEEEeeeccc--cCCCchHHHHHHHHHHhc-CCCCeeEEEeeeecCCeE
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNT---VTGQKVAIKMMTIQTE--QEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDV   81 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~---~~~~~~~~K~~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   81 (324)
                      +|++.+.||.|++|.||++.+.   .++..+++|++.....  .....+.+.+|+.+++++ +||+++++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            5899999999999999999864   4678899999875432  222345678899999999 599999999999999999


Q ss_pred             EEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           82 FLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        82 ~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      ++|+||+.+ +|.+++... ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++ .++.++|+|||.+......
T Consensus        81 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~  158 (288)
T cd05583          81 HLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLD-SEGHVVLTDFGLSKEFLAE  158 (288)
T ss_pred             EEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC-CCCCEEEEECccccccccc
Confidence            999999974 888777653 4689999999999999999999999999999999999999 8899999999988765432


Q ss_pred             CC-cccccccccccCCchhhcCCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCChhH-HHHHHHHcCCCCcccccchhhh
Q 045787          161 QK-EYSRDCVYSPYKAPELLLGYT-GYSTPIDVWAVGCIFAEMITGKPLFPSKKHDH-LSLIFSLLGTPTDESWAESTYI  237 (324)
Q Consensus       161 ~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  237 (324)
                      .. ......+++.|+|||.+.+.. ..+.++|+||||+++|+|++|..||....... ........              
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~--------------  224 (288)
T cd05583         159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRI--------------  224 (288)
T ss_pred             cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHH--------------
Confidence            21 122235778899999987632 36889999999999999999999996433211 11110000              


Q ss_pred             hcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCC---HHHHhcCccccCCCCchh
Q 045787          238 SEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRIT---AMDALKHEYLIGVENVPL  298 (324)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps---~~~~l~hp~~~~~~~~~~  298 (324)
                         ....        ......++..+.+++.+||+.||++|||   +.++++||||+.+.+..+
T Consensus       225 ---~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~~  277 (288)
T cd05583         225 ---LKSK--------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDL  277 (288)
T ss_pred             ---HccC--------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHHH
Confidence               0000        0011246788999999999999999998   577799999999987544

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.5e-39  Score=276.19  Aligned_cols=264  Identities=29%  Similarity=0.351  Sum_probs=195.5

Q ss_pred             CcCc-ceeEeecccCceEEEEEE----EccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeec--C
Q 045787            6 NLNY-KKIKKIGAGGYGEVYKCR----NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS--R   78 (324)
Q Consensus         6 ~~~y-~i~~~Lg~g~~~~v~~a~----~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~   78 (324)
                      .++| ++++.||.|++|+||++.    ...++..+++|.+..... ......+.+|++++++++|||++++++++..  .
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (283)
T cd05080           2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG   80 (283)
T ss_pred             ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            3566 999999999999998764    345678999999875432 1224567889999999999999999998765  3


Q ss_pred             CeEEEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeec
Q 045787           79 KDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAI  157 (324)
Q Consensus        79 ~~~~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~  157 (324)
                      ...+++|||+.+ +|.+++..  ..+++..++.++.+++.||.+||++|++|+||||+||+++ .++.++|+|||.+...
T Consensus        81 ~~~~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~  157 (283)
T cd05080          81 KGLQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLD-NDRLVKIGDFGLAKAV  157 (283)
T ss_pred             ceEEEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEc-CCCcEEEeeccccccc
Confidence            468999999984 78777765  3599999999999999999999999999999999999999 8899999999998765


Q ss_pred             cCCCCc---ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccch
Q 045787          158 GVPQKE---YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAES  234 (324)
Q Consensus       158 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (324)
                      ......   .....++..|+|||.+.+ ...+.++||||||+++|+|++|..||...............+..     ...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-----~~~  231 (283)
T cd05080         158 PEGHEYYRVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQM-----TVV  231 (283)
T ss_pred             CCcchhhccCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhccccccc-----chh
Confidence            432211   111234456999999876 56799999999999999999999998654422111110000000     000


Q ss_pred             hhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          235 TYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                       ...+....      .........++..+.+++..|++.||++|||++++++
T Consensus       232 -~~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         232 -RLIELLER------GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             -hhhhhhhc------CCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence             00000000      0001112357889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-39  Score=279.61  Aligned_cols=260  Identities=24%  Similarity=0.350  Sum_probs=198.3

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccC--------------CceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCee
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVT--------------GQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIV   69 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~--------------~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~   69 (324)
                      +..++|++.+.||+|++|.||+|.+...              ...+++|.+..... ......+.+|++++++++|++++
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~   80 (295)
T cd05097           2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT-KTARNDFLKEIKIMSRLKNPNII   80 (295)
T ss_pred             CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCcC
Confidence            3467999999999999999999987532              23589998875322 22234678899999999999999


Q ss_pred             EEEeeeecCCeEEEEEEecC-CCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 045787           70 RLLDVQSSRKDVFLVFEYLD-LDLHSFITRHK-----------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL  137 (324)
Q Consensus        70 ~~~~~~~~~~~~~iv~e~~~-g~l~~~~~~~~-----------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nI  137 (324)
                      ++++++......++||||+. ++|.+++....           ..++...+..++.+++.||.+||+.|++|+||+|+||
T Consensus        81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni  160 (295)
T cd05097          81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC  160 (295)
T ss_pred             eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence            99999999999999999998 48888775432           1367888999999999999999999999999999999


Q ss_pred             EeecCCCcEEEeeccceeeccCCCC--cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh--CCCCCCCCCh
Q 045787          138 LIDLKRNTVKLADFGLARAIGVPQK--EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT--GKPLFPSKKH  213 (324)
Q Consensus       138 ll~~~~~~v~l~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~--g~~pf~~~~~  213 (324)
                      +++ .++.++|+|||.+........  ......+++.|+|||++.+ ..++.++|+||||+++|+|++  +..||...+.
T Consensus       161 ll~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~  238 (295)
T cd05097         161 LVG-NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD  238 (295)
T ss_pred             EEc-CCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc-CCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence            999 888999999998876532211  1122234567999999877 568999999999999999998  6678876664


Q ss_pred             hHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          214 DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      ..........-...                    .........+.+++.+.+++.+|++.||.+||+++++++
T Consensus       239 ~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         239 EQVIENTGEFFRNQ--------------------GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHHHHHHhhhhc--------------------cccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            44322211100000                    000000112246789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=5.1e-39  Score=273.96  Aligned_cols=253  Identities=24%  Similarity=0.364  Sum_probs=201.0

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccC---CceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCC
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVT---GQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK   79 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~---~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   79 (324)
                      ++..++|++.+.||.|++|.||+|.+...   ...+++|....... ....+.+.+|+.++++++|||++++++++.+ .
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~   79 (270)
T cd05056           2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS-PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-N   79 (270)
T ss_pred             eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-C
Confidence            35678899999999999999999987543   34689998765432 1224568899999999999999999998876 4


Q ss_pred             eEEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeecc
Q 045787           80 DVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIG  158 (324)
Q Consensus        80 ~~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~  158 (324)
                      ..++|+||+. ++|.+++......+++..+..++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+....
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~-~~~~~~l~d~g~~~~~~  158 (270)
T cd05056          80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVS-SPDCVKLGDFGLSRYLE  158 (270)
T ss_pred             CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEe-cCCCeEEccCceeeecc
Confidence            5789999997 589998877666789999999999999999999999999999999999999 88999999999987654


Q ss_pred             CCCCc-ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhh
Q 045787          159 VPQKE-YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY  236 (324)
Q Consensus       159 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (324)
                      ..... .....+++.|+|||.+.. ..++.++|+||||+++|++++ |..||...+.............+          
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~----------  227 (270)
T cd05056         159 DESYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL----------  227 (270)
T ss_pred             cccceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC----------
Confidence            33211 112223456999999876 567899999999999999986 99999776644332222110000          


Q ss_pred             hhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          237 ISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                       .....++..+.+++.+|+..+|.+|||+.+++.
T Consensus       228 -----------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~  260 (270)
T cd05056         228 -----------------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA  260 (270)
T ss_pred             -----------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                             012357889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=3.7e-39  Score=277.41  Aligned_cols=253  Identities=28%  Similarity=0.408  Sum_probs=200.2

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEcc-----CCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecC
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTV-----TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR   78 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   78 (324)
                      +..++|++.+.||.|++|.||+|.+..     .+..+++|.+...... .....+.+|+.++++++||+++++++++..+
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~   80 (288)
T cd05050           2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-DMQADFQREAALMAEFDHPNIVKLLGVCAVG   80 (288)
T ss_pred             CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCH-HHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence            456789999999999999999998743     5678999988754321 2235688899999999999999999999999


Q ss_pred             CeEEEEEEecC-CCHHHHHHhcC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 045787           79 KDVFLVFEYLD-LDLHSFITRHK---------------------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNN  136 (324)
Q Consensus        79 ~~~~iv~e~~~-g~l~~~~~~~~---------------------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~n  136 (324)
                      ...++++||++ |+|.+++....                     ..+++..++.++.+++.||.+||+.|++|+||+|+|
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n  160 (288)
T cd05050          81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN  160 (288)
T ss_pred             CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence            99999999998 58888886432                     246788889999999999999999999999999999


Q ss_pred             eEeecCCCcEEEeeccceeeccCCCC--cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCh
Q 045787          137 LLIDLKRNTVKLADFGLARAIGVPQK--EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKH  213 (324)
Q Consensus       137 Ill~~~~~~v~l~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~  213 (324)
                      |+++ .++.++|+|||.+........  .......+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||.+...
T Consensus       161 il~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~  238 (288)
T cd05050         161 CLVG-ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH  238 (288)
T ss_pred             eEec-CCCceEECccccceecccCccccccCCCccChhhcCHHHHhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            9999 899999999998875532211  1122234566999999877 568999999999999999998 8888876654


Q ss_pred             hHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          214 DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      ............                           .......+.++.+++.+||+.||.+|||+.|++.
T Consensus       239 ~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         239 EEVIYYVRDGNV---------------------------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHHHHHHhcCCC---------------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            433222111000                           0011246788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=4.1e-39  Score=279.27  Aligned_cols=253  Identities=24%  Similarity=0.375  Sum_probs=201.4

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEc-------cCCceEEEEEeeeccccCCCchHHHHHHHHHHhc-CCCCeeEEEeee
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNT-------VTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQ   75 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~-------~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~   75 (324)
                      +...+|++.+.||+|++|.||+|+..       ..+..+++|.+..... ......+.+|+.+++.+ +|||++++++.+
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   90 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGAC   90 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc-hHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence            55678999999999999999999742       2345789998864422 22245688999999999 799999999999


Q ss_pred             ecCCeEEEEEEecC-CCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEe
Q 045787           76 SSRKDVFLVFEYLD-LDLHSFITRHK---------------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLI  139 (324)
Q Consensus        76 ~~~~~~~iv~e~~~-g~l~~~~~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll  139 (324)
                      ......+++|||+. |+|.+++....               ..++...+..++.|++.||.|||++|++|+||||+||++
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili  170 (304)
T cd05101          91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV  170 (304)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEE
Confidence            99999999999997 58888887642               246778889999999999999999999999999999999


Q ss_pred             ecCCCcEEEeeccceeeccCCCCc--ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHH
Q 045787          140 DLKRNTVKLADFGLARAIGVPQKE--YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHL  216 (324)
Q Consensus       140 ~~~~~~v~l~d~g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~  216 (324)
                      + .++.++|+|||.+.........  .....+++.|+|||++.+ ..++.++||||||+++|++++ |..||...+....
T Consensus       171 ~-~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~  248 (304)
T cd05101         171 T-ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  248 (304)
T ss_pred             c-CCCcEEECCCccceecccccccccccCCCCCceeeCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence            9 8899999999998766432221  122234567999999977 667999999999999999998 7888877665544


Q ss_pred             HHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          217 SLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      ..........                           .....++..+.+++.+||..+|.+||++.++++
T Consensus       249 ~~~~~~~~~~---------------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~  291 (304)
T cd05101         249 FKLLKEGHRM---------------------------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE  291 (304)
T ss_pred             HHHHHcCCcC---------------------------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            3332210000                           011257889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=7.2e-39  Score=269.90  Aligned_cols=243  Identities=24%  Similarity=0.358  Sum_probs=194.7

Q ss_pred             EeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEecC-CC
Q 045787           13 KKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD-LD   91 (324)
Q Consensus        13 ~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~-g~   91 (324)
                      +.||.|++|.||++... ++..+++|.+...... .....+.+|+.+++.++|||++++++++......++||||++ ++
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   78 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQ-ELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD   78 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCH-HHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence            36899999999999864 6789999987654322 123457889999999999999999999999999999999997 58


Q ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCc-ccccccc
Q 045787           92 LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE-YSRDCVY  170 (324)
Q Consensus        92 l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~-~~~~~~~  170 (324)
                      +.+++......+++..+..++.+++.+|.++|+.|++|+||+|+||+++ .++.++|+|||.+......... .....++
T Consensus        79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (250)
T cd05085          79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVG-ENNVLKISDFGMSRQEDDGIYSSSGLKQIP  157 (250)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEc-CCCeEEECCCccceeccccccccCCCCCCc
Confidence            8888876666789999999999999999999999999999999999999 8999999999988654322111 1112334


Q ss_pred             cccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCC
Q 045787          171 SPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEP  249 (324)
Q Consensus       171 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (324)
                      +.|+|||++.+ ..++.++|+||||+++|++++ |..||................ .                       
T Consensus       158 ~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~-~-----------------------  212 (250)
T cd05085         158 IKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY-R-----------------------  212 (250)
T ss_pred             ccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC-C-----------------------
Confidence            66999999876 567899999999999999998 999997766544332221100 0                       


Q ss_pred             cchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          250 ANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       250 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                         ......++..+.+++.+|+..+|.+||++.++++
T Consensus       213 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         213 ---MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK  246 (250)
T ss_pred             ---CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence               0111256889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.1e-38  Score=270.39  Aligned_cols=250  Identities=24%  Similarity=0.365  Sum_probs=199.7

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF   82 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   82 (324)
                      ++..++|++.+.||+|++|.||++.+. .+..+++|.+.....   ..+.+.+|+.+++.++|++++++++.+.. ...+
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~   76 (260)
T cd05073           2 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY   76 (260)
T ss_pred             cccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChh---HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence            356789999999999999999999865 456799998764322   23567889999999999999999999887 7789


Q ss_pred             EEEEecC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           83 LVFEYLD-LDLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        83 iv~e~~~-g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      +++||++ +++.+++.... ..++...+..++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~  155 (260)
T cd05073          77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS-ASLVCKIADFGLARVIEDN  155 (260)
T ss_pred             EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEc-CCCcEEECCCcceeeccCC
Confidence            9999997 58998887643 3578888999999999999999999999999999999999 8999999999988765422


Q ss_pred             CC-cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhh
Q 045787          161 QK-EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYIS  238 (324)
Q Consensus       161 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (324)
                      .. ......++..|+|||++.. ..++.++|+||||+++|++++ |+.||...+...........  ..           
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~--~~-----------  221 (260)
T cd05073         156 EYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG--YR-----------  221 (260)
T ss_pred             CcccccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC--CC-----------
Confidence            11 1112234456999999876 667999999999999999999 89999876654433222110  00           


Q ss_pred             cccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          239 EILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                    ......++.++.+++.+|++.||.+||+++++++
T Consensus       222 --------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         222 --------------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             --------------CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence                          0011357889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=5.7e-39  Score=279.55  Aligned_cols=252  Identities=26%  Similarity=0.382  Sum_probs=199.1

Q ss_pred             cCcCcceeEeecccCceEEEEEEEc-------cCCceEEEEEeeeccccCCCchHHHHHHHHHHhc-CCCCeeEEEeeee
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNT-------VTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQS   76 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~-------~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~   76 (324)
                      -..+|.+.+.||+|++|.||+|.+.       .....+++|.+..... ......+.+|+.+++++ +||||+++++++.
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT-DKDLADLISEMELMKLIGKHKNIINLLGVCT   88 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC-hHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence            4568999999999999999999853       2345789998764322 22235678899999999 5999999999999


Q ss_pred             cCCeEEEEEEecC-CCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEee
Q 045787           77 SRKDVFLVFEYLD-LDLHSFITRHK---------------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLID  140 (324)
Q Consensus        77 ~~~~~~iv~e~~~-g~l~~~~~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~  140 (324)
                      .++..++++||+. |+|.+++....               ..++...+..++.+++.||.+||++|++|+||||+||+++
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~  168 (314)
T cd05099          89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT  168 (314)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc
Confidence            9999999999997 58888886632               3478888999999999999999999999999999999999


Q ss_pred             cCCCcEEEeeccceeeccCCCCc--ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 045787          141 LKRNTVKLADFGLARAIGVPQKE--YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLS  217 (324)
Q Consensus       141 ~~~~~v~l~d~g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~  217 (324)
                       .++.++|+|||.+.........  .....+++.|+|||++.+ ..++.++|+||||+++|+|++ |..||.........
T Consensus       169 -~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~  246 (314)
T cd05099         169 -EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF  246 (314)
T ss_pred             -CCCcEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence             8899999999998765422111  111223456999999877 668999999999999999999 88999776644433


Q ss_pred             HHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          218 LIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      ........                           ......++.++.+++.+||..||.+||++.++++
T Consensus       247 ~~~~~~~~---------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         247 KLLREGHR---------------------------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHHHcCCC---------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            32221000                           0112356788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=2.6e-41  Score=290.55  Aligned_cols=286  Identities=30%  Similarity=0.535  Sum_probs=227.4

Q ss_pred             CCcccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcC------CCCeeEEEee
Q 045787            1 MGKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE------HENIVRLLDV   74 (324)
Q Consensus         1 ~~~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~   74 (324)
                      +|.++.++|.+....|.|-||+|..|.++.-|..||||++.....-   .+.=..|+++|++|+      .-|+++++.+
T Consensus       426 igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M---~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~  502 (752)
T KOG0670|consen  426 IGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM---HKTGLKELEILKKLNDADPEDKFHCLRLFRH  502 (752)
T ss_pred             hhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH---hhhhhHHHHHHHHhhccCchhhhHHHHHHHH
Confidence            5889999999999999999999999999999999999999865422   233457999999996      3578999999


Q ss_pred             eecCCeEEEEEEecCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeecc
Q 045787           75 QSSRKDVFLVFEYLDLDLHSFITRHKN--TLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFG  152 (324)
Q Consensus        75 ~~~~~~~~iv~e~~~g~l~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g  152 (324)
                      |....++|+|||.+.-+|.+.+...+.  .+....++.++.|++.||..|-..|++|+||||+|||++.....+||||||
T Consensus       503 F~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfG  582 (752)
T KOG0670|consen  503 FKHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFG  582 (752)
T ss_pred             hhhcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCc
Confidence            999999999999999999999988654  478889999999999999999999999999999999999566889999999


Q ss_pred             ceeeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHc-CCCCcccc
Q 045787          153 LARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLL-GTPTDESW  231 (324)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~  231 (324)
                      .|...+..  .......+..|.|||++.+ .+|+...|+||.||+|||+.||+..|.+.+..+|..+...+ +..|....
T Consensus       583 SA~~~~en--eitPYLVSRFYRaPEIiLG-~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Kml  659 (752)
T KOG0670|consen  583 SASFASEN--EITPYLVSRFYRAPEIILG-LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKML  659 (752)
T ss_pred             cccccccc--cccHHHHHHhccCcceeec-CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHh
Confidence            99877532  2233345566999999999 88899999999999999999999999999977776665443 44444333


Q ss_pred             cchhhhhcccCCCCC--------------------CCC-cchhh----------hCCCCChhHHHHHHHhhcCCCCCCCC
Q 045787          232 AESTYISEILPLYPH--------------------FEP-ANLAE----------KFPNLEPAGVDLLSQMLCLNPKQRIT  280 (324)
Q Consensus       232 ~~~~~~~~~~~~~~~--------------------~~~-~~~~~----------~~~~~~~~l~~li~~~l~~dP~~Rps  280 (324)
                      ..+.+...-.+.-.+                    ..+ ..+..          .-+.+-..+++|+.+||..||.+|.|
T Consensus       660 RKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit  739 (752)
T KOG0670|consen  660 RKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRIT  739 (752)
T ss_pred             hhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCC
Confidence            333333222221111                    111 00000          11123456899999999999999999


Q ss_pred             HHHHhcCccccC
Q 045787          281 AMDALKHEYLIG  292 (324)
Q Consensus       281 ~~~~l~hp~~~~  292 (324)
                      +.++|.||||++
T Consensus       740 ~nqAL~HpFi~~  751 (752)
T KOG0670|consen  740 VNQALKHPFITE  751 (752)
T ss_pred             HHHHhcCCcccC
Confidence            999999999985

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=5.8e-39  Score=281.84  Aligned_cols=254  Identities=24%  Similarity=0.376  Sum_probs=200.0

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccC-------CceEEEEEeeeccccCCCchHHHHHHHHHHhc-CCCCeeEEEeee
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVT-------GQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQ   75 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~-------~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~   75 (324)
                      +...+|++.+.||+|+||.||+|.+...       +..+++|.+..... ....+.+.+|+.+++++ +||||+++++.+
T Consensus         9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (334)
T cd05100           9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDAT-DKDLSDLVSEMEMMKMIGKHKNIINLLGAC   87 (334)
T ss_pred             cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccC-HHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence            4567899999999999999999986432       23689998764322 22245688899999999 799999999999


Q ss_pred             ecCCeEEEEEEecC-CCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEe
Q 045787           76 SSRKDVFLVFEYLD-LDLHSFITRHK---------------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLI  139 (324)
Q Consensus        76 ~~~~~~~iv~e~~~-g~l~~~~~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll  139 (324)
                      ..++..++++||++ |+|.+++....               ..++...+..++.|++.||.+||++|++|+||+|+||++
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill  167 (334)
T cd05100          88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV  167 (334)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE
Confidence            99999999999997 58888886532               246778889999999999999999999999999999999


Q ss_pred             ecCCCcEEEeeccceeeccCCCCcc--cccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHH
Q 045787          140 DLKRNTVKLADFGLARAIGVPQKEY--SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHL  216 (324)
Q Consensus       140 ~~~~~~v~l~d~g~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~  216 (324)
                      + .++.++|+|||.+..........  ....++..|+|||++.+ ..++.++||||||+++|+|++ |..||...+....
T Consensus       168 ~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  245 (334)
T cd05100         168 T-EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL  245 (334)
T ss_pred             c-CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence            9 88999999999987654322111  11223456999999977 667899999999999999998 8899977664443


Q ss_pred             HHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcC
Q 045787          217 SLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH  287 (324)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~h  287 (324)
                      .........                           .......+..+.+++.+||+.+|.+||++.+++++
T Consensus       246 ~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         246 FKLLKEGHR---------------------------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HHHHHcCCC---------------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            332211000                           00112567889999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=9e-39  Score=270.42  Aligned_cols=244  Identities=25%  Similarity=0.364  Sum_probs=197.1

Q ss_pred             EeecccCceEEEEEEEcc-CCc--eEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEecC
Q 045787           13 KKIGAGGYGEVYKCRNTV-TGQ--KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD   89 (324)
Q Consensus        13 ~~Lg~g~~~~v~~a~~~~-~~~--~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~   89 (324)
                      +.||+|++|.||+|.+.. .+.  .+++|.+...... ...+.+.+|+..+++++|||++++++.+.. ...++|+||++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~   78 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP   78 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence            468999999999999865 333  5899998765543 345678899999999999999999999888 88999999997


Q ss_pred             -CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCc---c
Q 045787           90 -LDLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE---Y  164 (324)
Q Consensus        90 -g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~---~  164 (324)
                       ++|.+.+.... ..+++..++.++.+++.||.+||++|++|+||+|+||+++ .++.++|+|||.+.........   .
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~  157 (257)
T cd05040          79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLA-SDDKVKIGDFGLMRALPQNEDHYVME  157 (257)
T ss_pred             CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEe-cCCEEEeccccccccccccccceecc
Confidence             69999887765 5689999999999999999999999999999999999999 8899999999998776532221   1


Q ss_pred             cccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCC
Q 045787          165 SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPL  243 (324)
Q Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (324)
                      ....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+...............                
T Consensus       158 ~~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~----------------  220 (257)
T cd05040         158 EHLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERL----------------  220 (257)
T ss_pred             cCCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcC----------------
Confidence            12345667999999877 567999999999999999998 999997666544333222110000                


Q ss_pred             CCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          244 YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                .....++..+.+++.+||+.+|.+||++.++++
T Consensus       221 ----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         221 ----------ERPEACPQDIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             ----------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence                      011246788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5.3e-39  Score=275.87  Aligned_cols=266  Identities=26%  Similarity=0.402  Sum_probs=198.8

Q ss_pred             CcCcceeEeecccCceEEEEEEE----ccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecC--C
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRN----TVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR--K   79 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~----~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~   79 (324)
                      +..|++++.||+|++|.||+|..    ..++..+++|.+..... ......+.+|+.++++++|||++++++++...  .
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (284)
T cd05079           3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   81 (284)
T ss_pred             hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence            45689999999999999999974    45678999999865432 22346788999999999999999999988775  5


Q ss_pred             eEEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeecc
Q 045787           80 DVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIG  158 (324)
Q Consensus        80 ~~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~  158 (324)
                      ..++|+||++ ++|.+++......++...+..++.+++.||.+||++|++|+||+|+||+++ .++.++|+|||.+....
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~-~~~~~~l~dfg~~~~~~  160 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE-SEHQVKIGDFGLTKAIE  160 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEc-CCCCEEECCCccccccc
Confidence            6899999997 588888876555689999999999999999999999999999999999999 88999999999987664


Q ss_pred             CCCCc---ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchh
Q 045787          159 VPQKE---YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAEST  235 (324)
Q Consensus       159 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (324)
                      .....   .....++..|+|||.+.+ ..++.++||||||+++|+|+++..|.........    ...+.... ......
T Consensus       161 ~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~----~~~~~~~~-~~~~~~  234 (284)
T cd05079         161 TDKEYYTVKDDLDSPVFWYAPECLIQ-SKFYIASDVWSFGVTLYELLTYCDSESSPMTLFL----KMIGPTHG-QMTVTR  234 (284)
T ss_pred             cCccceeecCCCCCCccccCHHHhcc-CCCCccccchhhhhhhhhhhcCCCCCccccchhh----hhcccccc-cccHHH
Confidence            32221   122345566999999877 5678999999999999999998766533211110    00000000 000000


Q ss_pred             hhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          236 YISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      ..... ..      .........++..+.+|+.+||+.||.+||++.++++
T Consensus       235 ~~~~~-~~------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  278 (284)
T cd05079         235 LVRVL-EE------GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE  278 (284)
T ss_pred             HHHHH-Hc------CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            00000 00      0001122357889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7.3e-39  Score=271.76  Aligned_cols=239  Identities=19%  Similarity=0.295  Sum_probs=186.1

Q ss_pred             EeecccCceEEEEEEEcc------------CCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCe
Q 045787           13 KKIGAGGYGEVYKCRNTV------------TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKD   80 (324)
Q Consensus        13 ~~Lg~g~~~~v~~a~~~~------------~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   80 (324)
                      +.||.|++|.||++....            ....+++|++....  ......+.+|+.+++.++||||+++++++..+..
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~   78 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE   78 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            468999999999998532            22358888865432  2234567888999999999999999999999999


Q ss_pred             EEEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCc-------EEEeecc
Q 045787           81 VFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNT-------VKLADFG  152 (324)
Q Consensus        81 ~~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~-------v~l~d~g  152 (324)
                      .++|+||+++ ++..++......+++..++.++.||+.||.|||++|++|+||+|+||+++ .++.       ++++|||
T Consensus        79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~-~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLA-REGIDGECGPFIKLSDPG  157 (262)
T ss_pred             CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEe-cCCccCCCCceeEeCCCC
Confidence            9999999985 66666655556799999999999999999999999999999999999998 4443       8999999


Q ss_pred             ceeeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHH-hCCCCCCCCChhHHHHHHHHcCCCCcccc
Q 045787          153 LARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMI-TGKPLFPSKKHDHLSLIFSLLGTPTDESW  231 (324)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  231 (324)
                      .+......    ....++..|+|||.+.....++.++||||||+++|+|+ +|..||..............   .     
T Consensus       158 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~---~-----  225 (262)
T cd05077         158 IPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEG---Q-----  225 (262)
T ss_pred             CCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhc---C-----
Confidence            88654321    22346778999999875577899999999999999998 58888866543322211110   0     


Q ss_pred             cchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcC
Q 045787          232 AESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH  287 (324)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~h  287 (324)
                                  .         ......+.++.+++.+||+.||.+||++.+++++
T Consensus       226 ------------~---------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         226 ------------C---------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             ------------c---------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence                        0         0011245678999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.8e-40  Score=309.72  Aligned_cols=258  Identities=31%  Similarity=0.513  Sum_probs=197.8

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEee------------
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDV------------   74 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~------------   74 (324)
                      .+|+.++.||+||||.||+|+++-+|+.||+|+++... ......++.+|+..+.+|+||||++++..            
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e  557 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE  557 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence            57899999999999999999999999999999999876 55556889999999999999999998700            


Q ss_pred             ----------------------------------------------e--e------------------c-----------
Q 045787           75 ----------------------------------------------Q--S------------------S-----------   77 (324)
Q Consensus        75 ----------------------------------------------~--~------------------~-----------   77 (324)
                                                                    .  .                  +           
T Consensus       558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e  637 (1351)
T KOG1035|consen  558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE  637 (1351)
T ss_pred             ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence                                                          0  0                  0           


Q ss_pred             ----------------------C--------CeEEEEEEecCCCHHHHHHhcCCCC-CHHHHHHHHHHHHHHHHHHHhCC
Q 045787           78 ----------------------R--------KDVFLVFEYLDLDLHSFITRHKNTL-NLLVIKAILKQILLGLAYCHSLK  126 (324)
Q Consensus        78 ----------------------~--------~~~~iv~e~~~g~l~~~~~~~~~~~-~~~~~~~i~~~i~~~l~~Lh~~g  126 (324)
                                            +        ..+||-||||+.+++..+...+... ....+|+++++|+.||.|+|+.|
T Consensus       638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g  717 (1351)
T KOG1035|consen  638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG  717 (1351)
T ss_pred             CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence                                  0        2368999999988887777766544 47889999999999999999999


Q ss_pred             CcccCCCCCceEeecCCCcEEEeeccceeecc------------------CCCCcccccccccccCCchhhcCCC--CCC
Q 045787          127 ILHRDLKPNNLLIDLKRNTVKLADFGLARAIG------------------VPQKEYSRDCVYSPYKAPELLLGYT--GYS  186 (324)
Q Consensus       127 ~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~------------------~~~~~~~~~~~~~~y~aPE~~~~~~--~~~  186 (324)
                      ++||||||.||+++ +++.|||+|||++....                  ..........||-.|+|||++.+..  .++
T Consensus       718 iIHRDLKP~NIFLd-~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn  796 (1351)
T KOG1035|consen  718 IIHRDLKPRNIFLD-SRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN  796 (1351)
T ss_pred             eeeccCCcceeEEc-CCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence            99999999999999 99999999999997721                  0111233346788899999998755  699


Q ss_pred             CchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHH
Q 045787          187 TPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDL  266 (324)
Q Consensus       187 ~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  266 (324)
                      .|+|+||||++++||+.   ||...-.. ...+.. +..+..+..                     ...+..--+.-..+
T Consensus       797 ~KiDmYSLGIVlFEM~y---PF~TsMER-a~iL~~-LR~g~iP~~---------------------~~f~~~~~~~e~sl  850 (1351)
T KOG1035|consen  797 SKIDMYSLGIVLFEMLY---PFGTSMER-ASILTN-LRKGSIPEP---------------------ADFFDPEHPEEASL  850 (1351)
T ss_pred             chhhhHHHHHHHHHHhc---cCCchHHH-HHHHHh-cccCCCCCC---------------------cccccccchHHHHH
Confidence            99999999999999996   35332211 111111 111100000                     00111122233599


Q ss_pred             HHHhhcCCCCCCCCHHHHhcCccccC
Q 045787          267 LSQMLCLNPKQRITAMDALKHEYLIG  292 (324)
Q Consensus       267 i~~~l~~dP~~Rps~~~~l~hp~~~~  292 (324)
                      |+.||+.||++||||.|+|.+.||--
T Consensus       851 I~~Ll~hdP~kRPtA~eLL~s~llpp  876 (1351)
T KOG1035|consen  851 IRWLLSHDPSKRPTATELLNSELLPP  876 (1351)
T ss_pred             HHHHhcCCCccCCCHHHHhhccCCCc
Confidence            99999999999999999999999984

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-40  Score=288.32  Aligned_cols=240  Identities=23%  Similarity=0.334  Sum_probs=198.7

Q ss_pred             eEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEecC-C
Q 045787           12 IKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD-L   90 (324)
Q Consensus        12 ~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~-g   90 (324)
                      ++-||+|+.|.||+++.+  ++.||||+++..         -..++.-|++|+||||+.|.++|.....+|||||||. |
T Consensus       129 LeWlGSGaQGAVF~Grl~--netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G  197 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH--NETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG  197 (904)
T ss_pred             hhhhccCcccceeeeecc--CceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence            566899999999999865  789999987522         2367899999999999999999999999999999998 6


Q ss_pred             CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcccccccc
Q 045787           91 DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVY  170 (324)
Q Consensus        91 ~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~  170 (324)
                      -|...+.. +.+++......|..+|+.++.|||.+.|+|+|||.-|||+. .+..|||+|||.+...... ......+||
T Consensus       198 qL~~VLka-~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs-~~d~VKIsDFGTS~e~~~~-STkMSFaGT  274 (904)
T KOG4721|consen  198 QLYEVLKA-GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILIS-YDDVVKISDFGTSKELSDK-STKMSFAGT  274 (904)
T ss_pred             cHHHHHhc-cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEee-ccceEEeccccchHhhhhh-hhhhhhhhh
Confidence            77777665 56799999999999999999999999999999999999999 8999999999998876543 444556899


Q ss_pred             cccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCc
Q 045787          171 SPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPA  250 (324)
Q Consensus       171 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (324)
                      ..|||||++++ .+++.+.||||||++||||+||..||+.-+..  +.++......                        
T Consensus       275 VaWMAPEvIrn-ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss--AIIwGVGsNs------------------------  327 (904)
T KOG4721|consen  275 VAWMAPEVIRN-EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS--AIIWGVGSNS------------------------  327 (904)
T ss_pred             HhhhCHHHhhc-CCcccccceehhHHHHHHHHhcCCCccccchh--eeEEeccCCc------------------------
Confidence            99999999998 88999999999999999999999999654422  1111111100                        


Q ss_pred             chhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccC
Q 045787          251 NLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIG  292 (324)
Q Consensus       251 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~  292 (324)
                      -..-.....++.++-||+.||+..|.+||+.++++.|-=+.+
T Consensus       328 L~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~  369 (904)
T KOG4721|consen  328 LHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS  369 (904)
T ss_pred             ccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence            011122367889999999999999999999999999854443

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=6.9e-41  Score=260.69  Aligned_cols=282  Identities=32%  Similarity=0.566  Sum_probs=221.2

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcC-CCCeeEEEeeeecC--CeE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-HENIVRLLDVQSSR--KDV   81 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--~~~   81 (324)
                      ..++|++++++|+|-+|.||.+....+++.+++|+++....     +++.+|+.+|+.+. +|||++++++..+.  ...
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk-----kKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp  110 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK-----KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP  110 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH-----HHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence            46789999999999999999999999999999999875433     56999999999997 99999999998765  467


Q ss_pred             EEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           82 FLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        82 ~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      .+|+||++. +......    .++...++.++.+++.||.|+|+.||.|+|+||.|++++.....++|+|||++.... +
T Consensus       111 aLiFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH-p  185 (338)
T KOG0668|consen  111 SLIFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-P  185 (338)
T ss_pred             hhHhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcC-C
Confidence            899999986 4444333    388899999999999999999999999999999999999888899999999998876 4


Q ss_pred             CCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCC--CCChhHHHHHHHHcCCCCcccccc-----
Q 045787          161 QKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFP--SKKHDHLSLIFSLLGTPTDESWAE-----  233 (324)
Q Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~--~~~~~~~~~~~~~~~~~~~~~~~~-----  233 (324)
                      .........+..|.-||.+-....++.+-|+|||||++..|+..+.||-  ..+.+++-++...+|...-..+-.     
T Consensus       186 ~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~  265 (338)
T KOG0668|consen  186 GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID  265 (338)
T ss_pred             CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence            4445555666778999999888889999999999999999999998873  333666767776666543211111     


Q ss_pred             -hhhhhcccCCCCCCCCcch--hhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCc
Q 045787          234 -STYISEILPLYPHFEPANL--AEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENV  296 (324)
Q Consensus       234 -~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~  296 (324)
                       ..................+  .+.-.-.++++.+|+.++|..|-.+|+||+|++.||||..+...
T Consensus       266 Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~  331 (338)
T KOG0668|consen  266 LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREA  331 (338)
T ss_pred             CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHH
Confidence             1111121112221111111  11122357999999999999999999999999999999876543

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-41  Score=317.62  Aligned_cols=262  Identities=31%  Similarity=0.500  Sum_probs=218.1

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      .-+|+...++|.|.||.||.|.+..+|...|+|-+............+.+|..++..++|||+++++++-...+..+|.|
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence            35788889999999999999999999999999999877766777788999999999999999999999999999999999


Q ss_pred             EecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCc-
Q 045787           86 EYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE-  163 (324)
Q Consensus        86 e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~-  163 (324)
                      |||.| +|.+.+ ++++-.++.....+..|++.|+.|||++||||+||||+||+++ .+|.+|++|||.+..+...... 
T Consensus      1314 EyC~~GsLa~ll-~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld-~~g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1314 EYCEGGSLASLL-EHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLD-FNGLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred             HHhccCcHHHHH-HhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeee-cCCcEEeecccceeEecCchhcC
Confidence            99985 555554 4455677888888999999999999999999999999999999 9999999999999888655422 


Q ss_pred             ---ccccccccccCCchhhcCCC--CCCCchhhHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHHcCCCCcccccchhhh
Q 045787          164 ---YSRDCVYSPYKAPELLLGYT--GYSTPIDVWAVGCIFAEMITGKPLFPSKKHD-HLSLIFSLLGTPTDESWAESTYI  237 (324)
Q Consensus       164 ---~~~~~~~~~y~aPE~~~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  237 (324)
                         .....||+.|||||++.+..  ....++|||||||++.||+||+.||...+.+ .+.......-.|+          
T Consensus      1392 ~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq---------- 1461 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQ---------- 1461 (1509)
T ss_pred             CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCC----------
Confidence               22357999999999997633  3467999999999999999999999765522 2222222222221          


Q ss_pred             hcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCc
Q 045787          238 SEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENV  296 (324)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~  296 (324)
                                       ....++.+.++||..||..||.+|+++.|+++|-|-+.-.+.
T Consensus      1462 -----------------~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d~ 1503 (1509)
T KOG4645|consen 1462 -----------------IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTDE 1503 (1509)
T ss_pred             -----------------CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccccccc
Confidence                             112488899999999999999999999999999998766554

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=7.5e-39  Score=277.43  Aligned_cols=254  Identities=24%  Similarity=0.351  Sum_probs=201.5

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccCCc----eEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecC
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQ----KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR   78 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~----~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   78 (324)
                      .+..++|++.+.||+|++|.||++.+..+|.    .+++|.+..... ......+.+|+.+++.++|||++++++.+...
T Consensus         3 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~   81 (303)
T cd05110           3 ILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG-PKANVEFMDEALIMASMDHPHLVRLLGVCLSP   81 (303)
T ss_pred             ccchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC
Confidence            3567899999999999999999999877776    468887754322 12223577899999999999999999988654


Q ss_pred             CeEEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeec
Q 045787           79 KDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAI  157 (324)
Q Consensus        79 ~~~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~  157 (324)
                       ..+++++|+. |++.+++......+++..+..++.+++.||.|||++|++|+||||+||+++ .++.++|+|||.+...
T Consensus        82 -~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~-~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          82 -TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVK-SPNHVKITDFGLARLL  159 (303)
T ss_pred             -CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeec-CCCceEEccccccccc
Confidence             4678999997 689998887666789999999999999999999999999999999999998 8899999999999765


Q ss_pred             cCCCCc--ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccch
Q 045787          158 GVPQKE--YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAES  234 (324)
Q Consensus       158 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (324)
                      ......  .....++..|+|||.+.+ ..++.++||||||+++|++++ |+.||.+...............++       
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-------  231 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLP-------  231 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCC-------
Confidence            432221  112234567999999876 668999999999999999997 899997766544433322111110       


Q ss_pred             hhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcC
Q 045787          235 TYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH  287 (324)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~h  287 (324)
                                          ..+..+..+.+++.+|+..||.+||+++++++.
T Consensus       232 --------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         232 --------------------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             --------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                012356788999999999999999999999873

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9e-40  Score=288.35  Aligned_cols=249  Identities=26%  Similarity=0.447  Sum_probs=202.0

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEEEE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDVFLV   84 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv   84 (324)
                      ...|++...+|.|+|+.|-.+.+..+++.+++|++.......      .+|+.++... +|||+++..+.+.++...|+|
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~------~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v  394 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDN------QDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV  394 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccccccc------ccccchhhhhcCCCcceeecceecCCceeeee
Confidence            467889999999999999999999999999999998763222      3566555444 699999999999999999999


Q ss_pred             EEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCc
Q 045787           85 FEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE  163 (324)
Q Consensus        85 ~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~  163 (324)
                      ||.+.| .+++.+... ..+. ..+..|+.+|+.|+.+||.+|++|||+||+|||++.+.++++|+|||.+......   
T Consensus       395 ~e~l~g~ell~ri~~~-~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~---  469 (612)
T KOG0603|consen  395 MELLDGGELLRRIRSK-PEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS---  469 (612)
T ss_pred             ehhccccHHHHHHHhc-chhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh---
Confidence            999986 555544442 2233 7788899999999999999999999999999999437899999999999865433   


Q ss_pred             ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCC
Q 045787          164 YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPL  243 (324)
Q Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (324)
                      ...++-|..|.|||+... ..+++++|+||||++||+|++|+.||.......  .+..-.+.+...              
T Consensus       470 ~~tp~~t~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~--ei~~~i~~~~~s--------------  532 (612)
T KOG0603|consen  470 CDTPALTLQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI--EIHTRIQMPKFS--------------  532 (612)
T ss_pred             hcccchhhcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCccccCCchH--HHHHhhcCCccc--------------
Confidence            334466677999999985 889999999999999999999999997777551  111111111111              


Q ss_pred             CCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCC
Q 045787          244 YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVEN  295 (324)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~  295 (324)
                                   ..+|..+++||+.||+.||.+||++.++..||||-+...
T Consensus       533 -------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~~~~t  571 (612)
T KOG0603|consen  533 -------------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFLSHPT  571 (612)
T ss_pred             -------------cccCHHHHHHHHHhccCChhhCcChhhhccCcchhcCCC
Confidence                         368999999999999999999999999999999944443

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2e-39  Score=274.71  Aligned_cols=239  Identities=17%  Similarity=0.283  Sum_probs=187.8

Q ss_pred             EeecccCceEEEEEEEccCCc-------eEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787           13 KKIGAGGYGEVYKCRNTVTGQ-------KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus        13 ~~Lg~g~~~~v~~a~~~~~~~-------~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      +.||.|+||.||++.+...+.       .+++|.+....  ....+.+.+|+.+++.++|||++++++++......++||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   78 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ   78 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence            368999999999998765443       47888775432  222456788999999999999999999999988999999


Q ss_pred             EecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCc--------EEEeeccceee
Q 045787           86 EYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNT--------VKLADFGLARA  156 (324)
Q Consensus        86 e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~--------v~l~d~g~~~~  156 (324)
                      ||++ |+|.+++......+++..+..++.|++.||.|||++|++|+||||+||+++ .++.        ++++|||.+..
T Consensus        79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~-~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLI-REEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEe-cccccccCCCceEEecccccccc
Confidence            9998 578888877666789999999999999999999999999999999999998 4443        79999998765


Q ss_pred             ccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCC-CCCCCCChhHHHHHHHHcCCCCcccccchh
Q 045787          157 IGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGK-PLFPSKKHDHLSLIFSLLGTPTDESWAEST  235 (324)
Q Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (324)
                      ...    .....+++.|+|||++.+...++.++|+||||+++|+|++|. .||...+...........            
T Consensus       158 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~------------  221 (258)
T cd05078         158 VLP----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDR------------  221 (258)
T ss_pred             cCC----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHcc------------
Confidence            432    223456778999999987566789999999999999999984 666554433222111100            


Q ss_pred             hhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcC
Q 045787          236 YISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH  287 (324)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~h  287 (324)
                                       .......+..+.+++.+||+.||.+|||++++++.
T Consensus       222 -----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         222 -----------------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             -----------------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence                             00112345678999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=8e-39  Score=276.39  Aligned_cols=259  Identities=24%  Similarity=0.349  Sum_probs=197.0

Q ss_pred             cCcCcceeEeecccCceEEEEEEEcc----------------CCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCe
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTV----------------TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI   68 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~----------------~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i   68 (324)
                      -.++|++.+.||+|++|.||+|.+..                ++..+++|.+..... ......+.+|+.+++.++|+++
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~E~~~l~~l~~~~i   81 (296)
T cd05095           3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN-KNARNDFLKEIKIMSRLKDPNI   81 (296)
T ss_pred             ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCc
Confidence            45789999999999999999986432                344689998865422 2223568899999999999999


Q ss_pred             eEEEeeeecCCeEEEEEEecC-CCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 045787           69 VRLLDVQSSRKDVFLVFEYLD-LDLHSFITRHK----------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL  137 (324)
Q Consensus        69 ~~~~~~~~~~~~~~iv~e~~~-g~l~~~~~~~~----------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nI  137 (324)
                      +++++++..++..++++||+. ++|.+++....          ..++...+..++.+++.||.+||+.|++|+||||+||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni  161 (296)
T cd05095          82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC  161 (296)
T ss_pred             ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence            999999999999999999997 58888887643          1366778999999999999999999999999999999


Q ss_pred             EeecCCCcEEEeeccceeeccCCCC--cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh--CCCCCCCCCh
Q 045787          138 LIDLKRNTVKLADFGLARAIGVPQK--EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT--GKPLFPSKKH  213 (324)
Q Consensus       138 ll~~~~~~v~l~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~--g~~pf~~~~~  213 (324)
                      +++ .++.++|+|||.+........  .......++.|+|||...+ ..++.++|+||||+++|+|++  |..||...+.
T Consensus       162 li~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05095         162 LVG-KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL-GKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD  239 (296)
T ss_pred             EEc-CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc-CCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence            999 899999999999876532221  1122233567999998876 568999999999999999998  6788876554


Q ss_pred             hHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          214 DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      ..........-            .......        ........+..+.+++.+||+.||.+||++.++++
T Consensus       240 ~~~~~~~~~~~------------~~~~~~~--------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         240 EQVIENTGEFF------------RDQGRQV--------YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             HHHHHHHHHHH------------hhccccc--------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            33221110000            0000000        00011246788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=9.7e-39  Score=272.75  Aligned_cols=238  Identities=19%  Similarity=0.284  Sum_probs=185.0

Q ss_pred             eecccCceEEEEEEEcc------------------------CCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCee
Q 045787           14 KIGAGGYGEVYKCRNTV------------------------TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIV   69 (324)
Q Consensus        14 ~Lg~g~~~~v~~a~~~~------------------------~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~   69 (324)
                      .||+|+||.||++....                        ....+++|.+.....  .....+.+|+.+++.++|||++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~~~~~~~~~l~h~niv   79 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR--DIALAFFETASLMSQVSHIHLA   79 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH--HHHHHHHHHHHHHhcCCCCCee
Confidence            68999999999987432                        123578888764322  2235677889999999999999


Q ss_pred             EEEeeeecCCeEEEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCC-----
Q 045787           70 RLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKR-----  143 (324)
Q Consensus        70 ~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~-----  143 (324)
                      ++++++..+...++||||+++ +|..++....+.+++..+..++.|++.||.|||++|++|+||||+||+++ ..     
T Consensus        80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~-~~~~~~~  158 (274)
T cd05076          80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLA-RLGLAEG  158 (274)
T ss_pred             eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEe-ccCcccC
Confidence            999999999999999999985 66666665566789999999999999999999999999999999999997 33     


Q ss_pred             --CcEEEeeccceeeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHH-hCCCCCCCCChhHHHHHH
Q 045787          144 --NTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMI-TGKPLFPSKKHDHLSLIF  220 (324)
Q Consensus       144 --~~v~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~-~g~~pf~~~~~~~~~~~~  220 (324)
                        ..++++|||.+......    ....++..|+|||.+.+...++.++|+||||+++|+++ +|..||............
T Consensus       159 ~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~  234 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFY  234 (274)
T ss_pred             ccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHH
Confidence              24899999987543211    22346677999999876567899999999999999995 689999766544332221


Q ss_pred             HHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcC
Q 045787          221 SLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH  287 (324)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~h  287 (324)
                      .....                             .....++.+.+++.+||+.+|.+||++.+++++
T Consensus       235 ~~~~~-----------------------------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         235 EKKHR-----------------------------LPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HhccC-----------------------------CCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            10000                             001245678999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.3e-38  Score=273.00  Aligned_cols=253  Identities=20%  Similarity=0.299  Sum_probs=200.1

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEcc----CCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeec-C
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTV----TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS-R   78 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~----~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~   78 (324)
                      +..++|++.+.||+|++|.||++.+..    .+..+++|.+.... .......+.+|+.++++++|+|++++++++.. +
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~   81 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA-SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG   81 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            567899999999999999999999875    35788999876332 22224567889999999999999999998765 5


Q ss_pred             CeEEEEEEecC-CCHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEee
Q 045787           79 KDVFLVFEYLD-LDLHSFITRHK-------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLAD  150 (324)
Q Consensus        79 ~~~~iv~e~~~-g~l~~~~~~~~-------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d  150 (324)
                      ...+++++|+. +++.+++....       ..+++..+..++.+++.||.|||+.|++|+||+|+||+++ +++.++|+|
T Consensus        82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~-~~~~~kl~d  160 (280)
T cd05043          82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVID-EELQVKITD  160 (280)
T ss_pred             CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEc-CCCcEEECC
Confidence            67899999987 68888876542       3588999999999999999999999999999999999999 889999999


Q ss_pred             ccceeeccCCCCc--ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCC
Q 045787          151 FGLARAIGVPQKE--YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPT  227 (324)
Q Consensus       151 ~g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~  227 (324)
                      ||.+.........  .....++..|+|||++.+ ..++.++||||||+++|++++ |..||...+.............+ 
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-  238 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRL-  238 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhc-CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCC-
Confidence            9998755322111  112234566999999977 667999999999999999999 99999776544332222110000 


Q ss_pred             cccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          228 DESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                                .....++.++.+++.+|+..||++|||+.++++
T Consensus       239 --------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         239 --------------------------AQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             --------------------------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                                      011246788999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-39  Score=282.23  Aligned_cols=260  Identities=29%  Similarity=0.384  Sum_probs=198.4

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCC-eEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK-DVFLVF   85 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~iv~   85 (324)
                      ++|.--+.||.|+||.||++.-.. |..+|||.+.......  ...+.+|+.++.+++|||+++++|+|.+.+ ..++|+
T Consensus        75 ~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVY  151 (361)
T KOG1187|consen   75 NNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVY  151 (361)
T ss_pred             hCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEE
Confidence            567778899999999999998754 4899999777655432  345999999999999999999999999988 599999


Q ss_pred             EecC-CCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---CcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           86 EYLD-LDLHSFITRHKN-TLNLLVIKAILKQILLGLAYCHSLK---ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        86 e~~~-g~l~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~g---~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      ||+. |+|.+.+..... ++++....+|+.+++.||+|||...   ++|+||||+|||+| ++..+||+|||++......
T Consensus       152 Eym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD-~~~~aKlsDFGLa~~~~~~  230 (361)
T KOG1187|consen  152 EYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD-EDFNAKLSDFGLAKLGPEG  230 (361)
T ss_pred             EccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC-CCCCEEccCccCcccCCcc
Confidence            9997 799999888776 8999999999999999999999854   99999999999999 9999999999999655431


Q ss_pred             CCccccc-ccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhH---HHHH-HHHcCCCCcccccchh
Q 045787          161 QKEYSRD-CVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDH---LSLI-FSLLGTPTDESWAEST  235 (324)
Q Consensus       161 ~~~~~~~-~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~-~~~~~~~~~~~~~~~~  235 (324)
                      ....... .||.+|+|||+... ...+.++||||||+++.|+++|+.+........   .... .......         
T Consensus       231 ~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~---------  300 (361)
T KOG1187|consen  231 DTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG---------  300 (361)
T ss_pred             ccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc---------
Confidence            1222222 78999999999987 678999999999999999999998886543111   1110 0111110         


Q ss_pred             hhhcccCCCCCCCCcchhhhCC--CCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          236 YISEILPLYPHFEPANLAEKFP--NLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      ...++++.....      ....  ..-..+..+..+|++.+|.+||++.++++
T Consensus       301 ~~~eiiD~~l~~------~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  301 KLREIVDPRLKE------GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             chhheeCCCccC------CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence            111111111000      0000  11123567889999999999999999764

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-38  Score=271.26  Aligned_cols=243  Identities=27%  Similarity=0.356  Sum_probs=189.9

Q ss_pred             EeecccCceEEEEEEEccCCc--eEEEEEeeeccccCCCchHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEEEEEEecC
Q 045787           13 KKIGAGGYGEVYKCRNTVTGQ--KVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDVFLVFEYLD   89 (324)
Q Consensus        13 ~~Lg~g~~~~v~~a~~~~~~~--~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~   89 (324)
                      +.||+|++|.||++.+..++.  .+++|.+.... .......+.+|+.+++++ +|||++++++++...+..+++|||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~   79 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP   79 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC-CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence            368999999999999887765  45778776322 122235678899999999 79999999999999999999999997


Q ss_pred             -CCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccc
Q 045787           90 -LDLHSFITRHK---------------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGL  153 (324)
Q Consensus        90 -g~l~~~~~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~  153 (324)
                       |+|.+++....               ..+++..+..++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.
T Consensus        80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~-~~~~~kl~dfgl  158 (270)
T cd05047          80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG-ENYVAKIADFGL  158 (270)
T ss_pred             CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEc-CCCeEEECCCCC
Confidence             68988886532               2478899999999999999999999999999999999999 899999999998


Q ss_pred             eeeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCccccc
Q 045787          154 ARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWA  232 (324)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  232 (324)
                      +...... ........+..|+|||++.. ..++.++|+||||+++|+|++ |..||...+............        
T Consensus       159 ~~~~~~~-~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~--------  228 (270)
T cd05047         159 SRGQEVY-VKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY--------  228 (270)
T ss_pred             ccccchh-hhccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC--------
Confidence            7532211 11111223456999999876 667999999999999999997 999997665443322211000        


Q ss_pred             chhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          233 ESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                         ........+.++.+++.+|+..||.+|||+.+++.
T Consensus       229 -------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         229 -------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             -------------------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence                               00011246788999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2.7e-38  Score=269.33  Aligned_cols=251  Identities=26%  Similarity=0.421  Sum_probs=199.5

Q ss_pred             CcceeEeecccCceEEEEEEEcc-CCceEEEEEeeecccc--------CCCchHHHHHHHHHHh-cCCCCeeEEEeeeec
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTV-TGQKVAIKMMTIQTEQ--------EGVPSYIIREVSLLKE-LEHENIVRLLDVQSS   77 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~-~~~~~~~K~~~~~~~~--------~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~   77 (324)
                      +|++.+.||+|++|.||++.+.. .++.+++|.+......        ......+.+|+.++.+ ++|||++++++.+..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            58999999999999999999887 6788999988643321        1122446678887764 789999999999999


Q ss_pred             CCeEEEEEEecCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCceEeecCCCcEEEeecc
Q 045787           78 RKDVFLVFEYLDL-DLHSFITR---HKNTLNLLVIKAILKQILLGLAYCHS-LKILHRDLKPNNLLIDLKRNTVKLADFG  152 (324)
Q Consensus        78 ~~~~~iv~e~~~g-~l~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~-~g~~H~di~p~nIll~~~~~~v~l~d~g  152 (324)
                      ++..++++||+.| ++.+.+..   ....+++..++.++.+++.+|.+||+ .|++|+||+|+||+++ .++.++|+|||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~-~~~~~~l~dfg  159 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLG-EDDKVTITDFG  159 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEEC-CCCcEEEeccc
Confidence            9999999999975 77776643   34568999999999999999999996 7899999999999999 89999999999


Q ss_pred             ceeeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCccccc
Q 045787          153 LARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWA  232 (324)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  232 (324)
                      .+....... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||..................+     
T Consensus       160 ~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----  232 (269)
T cd08528         160 LAKQKQPES-KLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP-----  232 (269)
T ss_pred             ceeeccccc-ccccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc-----
Confidence            988765332 3344567888999999987 567999999999999999999999997665443322211100000     


Q ss_pred             chhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcC
Q 045787          233 ESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH  287 (324)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~h  287 (324)
                                           .....+++.+.+++.+||+.||.+||++.++.++
T Consensus       233 ---------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         233 ---------------------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             ---------------------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence                                 0011467889999999999999999999999763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.4e-38  Score=280.25  Aligned_cols=255  Identities=25%  Similarity=0.374  Sum_probs=194.9

Q ss_pred             ccCcCcceeEeecccCceEEEEEEE-----ccCCceEEEEEeeeccccCCCchHHHHHHHHHHhc-CCCCeeEEEeeeec
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRN-----TVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSS   77 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~-----~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   77 (324)
                      +..++|++.+.||.|+||.||+|.+     ..+++.||+|.+...... .....+.+|+.++.++ +|||++++++++..
T Consensus         4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (343)
T cd05103           4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGHHLNVVNLLGACTK   82 (343)
T ss_pred             cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCCh-HHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence            3457899999999999999999984     356789999998754322 2235678899999999 58999999998765


Q ss_pred             C-CeEEEEEEecC-CCHHHHHHhcC-------------------------------------------------------
Q 045787           78 R-KDVFLVFEYLD-LDLHSFITRHK-------------------------------------------------------  100 (324)
Q Consensus        78 ~-~~~~iv~e~~~-g~l~~~~~~~~-------------------------------------------------------  100 (324)
                      . ...++++||++ |+|.+++....                                                       
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (343)
T cd05103          83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE  162 (343)
T ss_pred             CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence            4 56899999998 58888876432                                                       


Q ss_pred             -----------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC--ccccc
Q 045787          101 -----------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK--EYSRD  167 (324)
Q Consensus       101 -----------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~--~~~~~  167 (324)
                                 ..++...+..++.+++.||.|||+.|++|+||||+||+++ .++.++|+|||.+........  .....
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~  241 (343)
T cd05103         163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGDA  241 (343)
T ss_pred             hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEc-CCCcEEEEecccccccccCcchhhcCCC
Confidence                       1357778888999999999999999999999999999999 889999999998876532211  11222


Q ss_pred             ccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCC
Q 045787          168 CVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPH  246 (324)
Q Consensus       168 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (324)
                      .+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||...............+..                    
T Consensus       242 ~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--------------------  300 (343)
T cd05103         242 RLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR--------------------  300 (343)
T ss_pred             CCCcceECcHHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCC--------------------
Confidence            34566999999877 667999999999999999997 89998664422111110000000                    


Q ss_pred             CCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcC
Q 045787          247 FEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH  287 (324)
Q Consensus       247 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~h  287 (324)
                            .......++.+.+++.+|++.||.+||++.++++|
T Consensus       301 ------~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         301 ------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             ------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                  00011356788999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.8e-38  Score=282.14  Aligned_cols=253  Identities=24%  Similarity=0.344  Sum_probs=198.2

Q ss_pred             cCcCcceeEeecccCceEEEEEEEc-----cCCceEEEEEeeeccccCCCchHHHHHHHHHHhcC-CCCeeEEEeeeecC
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNT-----VTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-HENIVRLLDVQSSR   78 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~   78 (324)
                      ..++|.+.+.||+|+||.||+|.+.     ..+..||+|++....... ..+.+.+|+.++.++. ||||+++++++..+
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~-~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~  113 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSS-EKQALMSELKIMSHLGPHLNIVNLLGACTKG  113 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChh-HHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence            3467888999999999999999854     345689999997543222 2346889999999997 99999999999999


Q ss_pred             CeEEEEEEecC-CCHHHHHHhcC---------------------------------------------------------
Q 045787           79 KDVFLVFEYLD-LDLHSFITRHK---------------------------------------------------------  100 (324)
Q Consensus        79 ~~~~iv~e~~~-g~l~~~~~~~~---------------------------------------------------------  100 (324)
                      +..++|+||+. |+|.+++....                                                         
T Consensus       114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (401)
T cd05107         114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ  193 (401)
T ss_pred             CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence            99999999998 58888886532                                                         


Q ss_pred             ----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEee
Q 045787          101 ----------------------------------------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLID  140 (324)
Q Consensus       101 ----------------------------------------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~  140 (324)
                                                              ..++...+..++.+++.||.|||+.|++|+||||+||+++
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~  273 (401)
T cd05107         194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC  273 (401)
T ss_pred             cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEe
Confidence                                                    1256677888999999999999999999999999999999


Q ss_pred             cCCCcEEEeeccceeeccCCCC--cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 045787          141 LKRNTVKLADFGLARAIGVPQK--EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLS  217 (324)
Q Consensus       141 ~~~~~v~l~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~  217 (324)
                       .++.++|+|||.+........  ......+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||.........
T Consensus       274 -~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~  351 (401)
T cd05107         274 -EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN-NLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF  351 (401)
T ss_pred             -CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC-CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence             889999999999876532211  1222345677999999977 567999999999999999998 88999665433221


Q ss_pred             HHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          218 LIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      ......+..+                          .....++..+.+++.+|+..||.+||+++++++
T Consensus       352 ~~~~~~~~~~--------------------------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~  394 (401)
T cd05107         352 YNAIKRGYRM--------------------------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVH  394 (401)
T ss_pred             HHHHHcCCCC--------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            1111111000                          011246789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.9e-38  Score=266.90  Aligned_cols=243  Identities=24%  Similarity=0.387  Sum_probs=196.1

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLV   84 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   84 (324)
                      ..++|++.+.||.|++|.||++.  ..++.+++|.......    ...+.+|+.++++++||+++++++.+..+ ..+++
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~~----~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v   76 (254)
T cd05083           4 NLQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDVT----AQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIV   76 (254)
T ss_pred             cHHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcch----HHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEE
Confidence            34689999999999999999986  4678899998865322    35678999999999999999999988664 47999


Q ss_pred             EEecC-CCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC
Q 045787           85 FEYLD-LDLHSFITRHKN-TLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK  162 (324)
Q Consensus        85 ~e~~~-g~l~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~  162 (324)
                      +||+. ++|.+++..... .++...+..++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+......  
T Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~-~~~~~kl~Dfg~~~~~~~~--  153 (254)
T cd05083          77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVS-EDGVAKVSDFGLARVGSMG--  153 (254)
T ss_pred             EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEc-CCCcEEECCCccceecccc--
Confidence            99997 599888876543 578999999999999999999999999999999999999 8899999999988764321  


Q ss_pred             cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhccc
Q 045787          163 EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEIL  241 (324)
Q Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (324)
                       ......+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+.............                
T Consensus       154 -~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~----------------  215 (254)
T cd05083         154 -VDNSKLPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYR----------------  215 (254)
T ss_pred             -CCCCCCCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCC----------------
Confidence             122233466999999876 668899999999999999998 9999977665443322211000                


Q ss_pred             CCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          242 PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                 ......++..+.+++.+||+.+|.+||++++++.
T Consensus       216 -----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         216 -----------MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             -----------CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                       0011257889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=3e-38  Score=298.75  Aligned_cols=148  Identities=29%  Similarity=0.447  Sum_probs=131.0

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLV   84 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   84 (324)
                      -++|++++.||+|+||.||+|.+..+++.||+|++..... .......+..|+.++..++||+|+++++.+......|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            3689999999999999999999999999999999875432 222235678899999999999999999999999999999


Q ss_pred             EEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeecccee
Q 045787           85 FEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLAR  155 (324)
Q Consensus        85 ~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~  155 (324)
                      |||+. ++|.+++... +.+++..++.++.+|+.||.|||+.|++|+||||+|||++ .++.++|+|||++.
T Consensus        83 mEy~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~-~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLIS-NEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEc-CCCCEEEEeCCCCc
Confidence            99996 5888877654 4689999999999999999999999999999999999999 88999999999764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=8.8e-39  Score=267.23  Aligned_cols=228  Identities=26%  Similarity=0.321  Sum_probs=184.7

Q ss_pred             cCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEecC-CCHHHHH
Q 045787           18 GGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD-LDLHSFI   96 (324)
Q Consensus        18 g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~-g~l~~~~   96 (324)
                      |.++.||+|.+..+++.||+|.+.....       ..+|...+....|||++++++++.+....++||||++ |+|.+++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l   76 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI   76 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh-------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence            8899999999999999999999876532       2345555556679999999999999999999999998 4888887


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcccccccccccCCc
Q 045787           97 TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAP  176 (324)
Q Consensus        97 ~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~y~aP  176 (324)
                      ... ..+++..+..++.+++.||.+||+.|++|+||||+||+++ .++.++++|||.+......   .....++..|+||
T Consensus        77 ~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~-~~~~~~l~df~~~~~~~~~---~~~~~~~~~y~aP  151 (237)
T cd05576          77 SKF-LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLD-DRGHIQLTYFSRWSEVEDS---CDGEAVENMYCAP  151 (237)
T ss_pred             HHh-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEc-CCCCEEEecccchhccccc---cccCCcCccccCC
Confidence            664 4589999999999999999999999999999999999999 8899999999977654422   1223456679999


Q ss_pred             hhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhC
Q 045787          177 ELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKF  256 (324)
Q Consensus       177 E~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (324)
                      |...+ ..++.++|+||+|+++|+|++|..|+.......                      ..    .      ......
T Consensus       152 E~~~~-~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~----------------------~~----~------~~~~~~  198 (237)
T cd05576         152 EVGGI-SEETEACDWWSLGAILFELLTGKTLVECHPSGI----------------------NT----H------TTLNIP  198 (237)
T ss_pred             cccCC-CCCCchhhHHHHHHHHHHHHHCcchhhcCchhc----------------------cc----c------cccCCc
Confidence            99876 567899999999999999999998774321100                      00    0      000112


Q ss_pred             CCCChhHHHHHHHhhcCCCCCCCCH-----HHHhcCccc
Q 045787          257 PNLEPAGVDLLSQMLCLNPKQRITA-----MDALKHEYL  290 (324)
Q Consensus       257 ~~~~~~l~~li~~~l~~dP~~Rps~-----~~~l~hp~~  290 (324)
                      ..++..+.++|.+||+.||.+||++     .++++||||
T Consensus       199 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         199 EWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             ccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence            3578899999999999999999986     999999998

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=4.8e-38  Score=268.67  Aligned_cols=255  Identities=24%  Similarity=0.373  Sum_probs=201.5

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEcc-----CCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecC
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTV-----TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR   78 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   78 (324)
                      +...+|++++.||.|++|.||+|+.+.     ....+++|.+..... ....+.+.+|+.++++++|++++++++++.+.
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   80 (275)
T cd05046           2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD-ENLQSEFRRELDMFRKLSHKNVVRLLGLCREA   80 (275)
T ss_pred             CChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc-hHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence            345789999999999999999999653     345789998764332 22345688999999999999999999999999


Q ss_pred             CeEEEEEEecC-CCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEe
Q 045787           79 KDVFLVFEYLD-LDLHSFITRHK--------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLA  149 (324)
Q Consensus        79 ~~~~iv~e~~~-g~l~~~~~~~~--------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~  149 (324)
                      ...++|+||++ |+|.+++....        ..+++..+..++.+++.+|.|||+.|++|+||+|+||+++ .++.++++
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~-~~~~~~l~  159 (275)
T cd05046          81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVS-SQREVKVS  159 (275)
T ss_pred             CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEe-CCCcEEEc
Confidence            99999999998 58888887644        1589999999999999999999999999999999999999 88999999


Q ss_pred             eccceeeccCCC-CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCC
Q 045787          150 DFGLARAIGVPQ-KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPT  227 (324)
Q Consensus       150 d~g~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~  227 (324)
                      |||.+....... .......++..|+|||.+.+ ...+.++||||||+++|++++ |..||.................. 
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~-  237 (275)
T cd05046         160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQE-DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLE-  237 (275)
T ss_pred             ccccccccCcccccccCCceeEEeecChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcC-
Confidence            999876443221 12223345667999999876 557899999999999999999 78899765544332221100000 


Q ss_pred             cccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcC
Q 045787          228 DESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH  287 (324)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~h  287 (324)
                                               ......++..+.+++.+||+.||.+||++.+++..
T Consensus       238 -------------------------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         238 -------------------------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             -------------------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence                                     00112577899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.5e-38  Score=269.50  Aligned_cols=244  Identities=26%  Similarity=0.422  Sum_probs=192.1

Q ss_pred             EeecccCceEEEEEEEccCC------ceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEE
Q 045787           13 KKIGAGGYGEVYKCRNTVTG------QKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE   86 (324)
Q Consensus        13 ~~Lg~g~~~~v~~a~~~~~~------~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   86 (324)
                      +.||.|++|.||++.+....      ..+++|.+..... ......+.+|+.+++.++||+|+++++++..++..++|+|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME   79 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccc-hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence            36899999999999876433      6899998765432 2224568889999999999999999999999999999999


Q ss_pred             ecC-CCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCC-----cEEEeeccce
Q 045787           87 YLD-LDLHSFITRH------KNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN-----TVKLADFGLA  154 (324)
Q Consensus        87 ~~~-g~l~~~~~~~------~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~-----~v~l~d~g~~  154 (324)
                      |++ ++|.+++...      ...+++..+..++.+++.||.+||+.|++|+||+|+||+++ .++     .++|+|||.+
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~-~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVS-EKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEe-cCCCCCCcceEECCcccc
Confidence            997 5888888652      23478889999999999999999999999999999999999 655     8999999988


Q ss_pred             eeccCCCC--cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccc
Q 045787          155 RAIGVPQK--EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESW  231 (324)
Q Consensus       155 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  231 (324)
                      ........  .......+..|+|||++.+ ..++.++||||||+++|+|++ |..||...+.............      
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~------  231 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGR------  231 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHcc-CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCc------
Confidence            75532211  1122234567999999987 667999999999999999998 9999976654433222211000      


Q ss_pred             cchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          232 AESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                           ......++..+.+++.+||..+|.+||+++++++
T Consensus       232 ---------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         232 ---------------------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             ---------------------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                                 0111356788999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.7e-38  Score=271.34  Aligned_cols=266  Identities=29%  Similarity=0.444  Sum_probs=200.7

Q ss_pred             CcCcceeEeecccCceEEEEEEEc----cCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeec--CC
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNT----VTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS--RK   79 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~----~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~   79 (324)
                      ...|++.+.||+|++|.||+|...    .++..+|+|.+...... .....+.+|+..++.++|++++++++++..  ..
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~   81 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR   81 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence            567899999999999999999854    34789999998765443 234678999999999999999999998877  55


Q ss_pred             eEEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeecc
Q 045787           80 DVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIG  158 (324)
Q Consensus        80 ~~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~  158 (324)
                      ..++++||++ +++.+++......++...+..++.+++.||.+||++|++|+||+|+||+++ .++.++|+|||.+....
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVE-SEDLVKISDFGLAKVLP  160 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEc-CCCCEEEcccccccccc
Confidence            7999999997 599998887666799999999999999999999999999999999999999 88999999999988765


Q ss_pred             CCCCcc---cccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchh
Q 045787          159 VPQKEY---SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAEST  235 (324)
Q Consensus       159 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (324)
                      ......   ....++..|+|||.+.+ ..++.++|+||||+++++|++|..|+..........    .+.... ......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~----~~~~~~-~~~~~~  234 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRT-SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRM----IGIAQG-QMIVTR  234 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHcc-CCCCcccchHHHhhhhheeeccCCCcccccchhccc----cccccc-cccHHH
Confidence            222211   11233455999999877 567899999999999999999999885543221110    000000 000000


Q ss_pred             hhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          236 YISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                       ..+.......      .......+.++.+++.+||+.||.+||++.++++
T Consensus       235 -~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         235 -LLELLKEGER------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             -HHHHHHcCCc------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence             0000000000      0011245688999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=4.7e-38  Score=266.81  Aligned_cols=244  Identities=24%  Similarity=0.336  Sum_probs=186.5

Q ss_pred             EeecccCceEEEEEEEcc---CCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeee-cCCeEEEEEEec
Q 045787           13 KKIGAGGYGEVYKCRNTV---TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQS-SRKDVFLVFEYL   88 (324)
Q Consensus        13 ~~Lg~g~~~~v~~a~~~~---~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~iv~e~~   88 (324)
                      +.||+|++|.||+|.+..   .+..+++|.+..... ....+.+.+|+.+++.++||+++++++++. .++..++++||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~   79 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITD-LEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM   79 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCC-HHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence            468999999999998643   345789998753221 112356778999999999999999999765 456689999999


Q ss_pred             C-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC----Cc
Q 045787           89 D-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ----KE  163 (324)
Q Consensus        89 ~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~----~~  163 (324)
                      . |+|.+++.......+...+..++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+.......    ..
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~  158 (262)
T cd05058          80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLD-ESFTVKVADFGLARDIYDKEYYSVHN  158 (262)
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEc-CCCcEEECCccccccccCCcceeecc
Confidence            7 689888877655677888889999999999999999999999999999999 88999999999887543211    11


Q ss_pred             ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhC-CCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccC
Q 045787          164 YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITG-KPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILP  242 (324)
Q Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (324)
                      .....++..|+|||.+.+ ..++.++||||||+++|+|++| .+||...+.............+                
T Consensus       159 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~----------------  221 (262)
T cd05058         159 HTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRL----------------  221 (262)
T ss_pred             cccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCC----------------
Confidence            112234567999999877 6689999999999999999995 5667554433222211100000                


Q ss_pred             CCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          243 LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                 .....++..+.+++.+||..+|++||++.+++.
T Consensus       222 -----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~  254 (262)
T cd05058         222 -----------LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS  254 (262)
T ss_pred             -----------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                       001245778999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.7e-38  Score=265.71  Aligned_cols=236  Identities=21%  Similarity=0.326  Sum_probs=186.7

Q ss_pred             EeecccCceEEEEEEEccCC----------ceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 045787           13 KKIGAGGYGEVYKCRNTVTG----------QKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF   82 (324)
Q Consensus        13 ~~Lg~g~~~~v~~a~~~~~~----------~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   82 (324)
                      +.||.|++|.||++.+..++          ..+++|.+......   ...+.+|+.+++.++|||++++++++.. ...+
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   76 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---SLAFFETASLMSQLSHKHLVKLYGVCVR-DENI   76 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh---HHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence            46899999999999998766          34777776544322   4678899999999999999999999887 7789


Q ss_pred             EEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCC-------cEEEeeccce
Q 045787           83 LVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN-------TVKLADFGLA  154 (324)
Q Consensus        83 iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~-------~v~l~d~g~~  154 (324)
                      +|+||++ |+|.+++......++...+..++.+++.||.|||+.|++|+||||+||+++ .++       .++|+|||.+
T Consensus        77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~-~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVA-RYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEe-cCccccCCceeEEeCCCCcc
Confidence            9999998 578887777655789999999999999999999999999999999999999 665       7999999998


Q ss_pred             eeccCCCCcccccccccccCCchhhcCC-CCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCccccc
Q 045787          155 RAIGVPQKEYSRDCVYSPYKAPELLLGY-TGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWA  232 (324)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  232 (324)
                      .....    .....++..|+|||++.+. ..++.++|+||||+++|++++ |..||...+.............       
T Consensus       156 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~-------  224 (259)
T cd05037         156 ITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHR-------  224 (259)
T ss_pred             ccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCC-------
Confidence            76543    2233456679999999874 468999999999999999999 5777866543222111110000       


Q ss_pred             chhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          233 ESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                 .           .......+.+++.+||..||.+||++.++++
T Consensus       225 -----------~-----------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         225 -----------L-----------PMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             -----------C-----------CCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence                       0           0011268889999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-39  Score=272.21  Aligned_cols=266  Identities=24%  Similarity=0.367  Sum_probs=222.4

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhcC-CCCeeEEEeeeecCCeE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKELE-HENIVRLLDVQSSRKDV   81 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~   81 (324)
                      +...+|..+..||+|+||.|.+|..+.+.+.||+|+++++-- +.+..+--..|-++|.... -|.+++++..|+.-+.+
T Consensus       346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL  425 (683)
T KOG0696|consen  346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL  425 (683)
T ss_pred             eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence            455689999999999999999999999999999999987652 2223333456666766554 57889999999999999


Q ss_pred             EEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           82 FLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        82 ~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      |+||||+.| +|--.+++ -+.+.+..+..++..|+.||-+||++||+++|||.+|||++ .+|++||+|||.+..--..
T Consensus       426 yFVMEyvnGGDLMyhiQQ-~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd-~eGHiKi~DFGmcKEni~~  503 (683)
T KOG0696|consen  426 YFVMEYVNGGDLMYHIQQ-VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD-SEGHIKIADFGMCKENIFD  503 (683)
T ss_pred             eeEEEEecCchhhhHHHH-hcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEec-cCCceEeeecccccccccC
Confidence            999999986 55544444 55699999999999999999999999999999999999999 9999999999999765555


Q ss_pred             CCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcc
Q 045787          161 QKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEI  240 (324)
Q Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (324)
                      .......||||.|+|||++.- .+|+.++|.||+|+++|||+.|++||.+.+.+.+...+..-..               
T Consensus       504 ~~TTkTFCGTPdYiAPEIi~Y-qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv---------------  567 (683)
T KOG0696|consen  504 GVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV---------------  567 (683)
T ss_pred             CcceeeecCCCcccccceEEe-cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC---------------
Confidence            556666799999999999877 8899999999999999999999999999998776554432111               


Q ss_pred             cCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCC-----HHHHhcCccccCCCCchhhh
Q 045787          241 LPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRIT-----AMDALKHEYLIGVENVPLVI  300 (324)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~~~l~hp~~~~~~~~~~~~  300 (324)
                                   .....+|.++.++.+..|.+.|++|+.     -+++-.||||+.+.+.++..
T Consensus       568 -------------syPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~  619 (683)
T KOG0696|consen  568 -------------SYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLER  619 (683)
T ss_pred             -------------cCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhh
Confidence                         112368899999999999999999984     46788899999999988743

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.4e-37  Score=268.25  Aligned_cols=260  Identities=20%  Similarity=0.233  Sum_probs=191.1

Q ss_pred             CCcccCcCcceeEeecccCceEEEEEEEccC---CceEEEEEeeeccccCCC---------chHHHHHHHHHHhcCCCCe
Q 045787            1 MGKLKNLNYKKIKKIGAGGYGEVYKCRNTVT---GQKVAIKMMTIQTEQEGV---------PSYIIREVSLLKELEHENI   68 (324)
Q Consensus         1 ~~~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~---~~~~~~K~~~~~~~~~~~---------~~~~~~e~~~l~~l~~~~i   68 (324)
                      +.++.+++|++.+.||+|+||.||+|.+..+   +..+++|+..........         ......+...+..+.|+++
T Consensus         6 ~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i   85 (294)
T PHA02882          6 LIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGI   85 (294)
T ss_pred             eeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCC
Confidence            3577889999999999999999999998776   667777764432211100         0111223344556689999


Q ss_pred             eEEEeeeecCC----eEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCC
Q 045787           69 VRLLDVQSSRK----DVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN  144 (324)
Q Consensus        69 ~~~~~~~~~~~----~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~  144 (324)
                      +++++......    ..+++++++..++.+.+... ...++..++.++.|++.||.+||+.|++||||||+||+++ .++
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~-~~~  163 (294)
T PHA02882         86 PKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVD-GNN  163 (294)
T ss_pred             CcEEEeeeEecCCceEEEEEEehhccCHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc-CCC
Confidence            99998765433    45788888877777766553 3467888999999999999999999999999999999999 889


Q ss_pred             cEEEeeccceeeccCCCC-------cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh-hHH
Q 045787          145 TVKLADFGLARAIGVPQK-------EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHL  216 (324)
Q Consensus       145 ~v~l~d~g~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~  216 (324)
                      .++|+|||.+........       ......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||..... ...
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~  242 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL  242 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence            999999999876532211       1122368899999999887 6689999999999999999999999977642 211


Q ss_pred             HHHHH--HcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          217 SLIFS--LLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       217 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      .....  .......                       .....+..++.+.++++.|+..+|.+||+..++++
T Consensus       243 ~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        243 IHAAKCDFIKRLHE-----------------------GKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHHhHHHHHHHhhh-----------------------hhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            11100  0000000                       00012356788999999999999999999999875

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-40  Score=283.90  Aligned_cols=268  Identities=26%  Similarity=0.416  Sum_probs=225.4

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeecc-ccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeE
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQT-EQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV   81 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   81 (324)
                      ++.-.+.+++..||-|+||.|-++..+++...+|+|++++.. -.....+.+..|-.++...+.|+|+++|..|.++...
T Consensus       416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv  495 (732)
T KOG0614|consen  416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV  495 (732)
T ss_pred             ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence            445567889999999999999999988777679999987654 2333356788999999999999999999999999999


Q ss_pred             EEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           82 FLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        82 ~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      |++||.|- |.+...+.. ++.+++..++.++..+++|+.|||++||+++||||+|.+++ .+|-+||.|||++..++ .
T Consensus       496 YmLmEaClGGElWTiLrd-Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd-~~Gy~KLVDFGFAKki~-~  572 (732)
T KOG0614|consen  496 YMLMEACLGGELWTILRD-RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLD-NRGYLKLVDFGFAKKIG-S  572 (732)
T ss_pred             hhhHHhhcCchhhhhhhh-cCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeec-cCCceEEeehhhHHHhc-c
Confidence            99999986 566666665 56799999999999999999999999999999999999999 99999999999999988 4


Q ss_pred             CCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcc
Q 045787          161 QKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEI  240 (324)
Q Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (324)
                      .......||||.|.|||++.+ ...+.++|.|+||+++||+++|.+||.+.++-....++...                 
T Consensus       573 g~KTwTFcGTpEYVAPEIILn-KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkG-----------------  634 (732)
T KOG0614|consen  573 GRKTWTFCGTPEYVAPEIILN-KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKG-----------------  634 (732)
T ss_pred             CCceeeecCCcccccchhhhc-cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhh-----------------
Confidence            455566799999999999988 55699999999999999999999999888744333222110                 


Q ss_pred             cCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCC-----HHHHhcCccccCCCCchhhh
Q 045787          241 LPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRIT-----AMDALKHEYLIGVENVPLVI  300 (324)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~~~l~hp~~~~~~~~~~~~  300 (324)
                               .+..+....++..+.++|+++...+|.+|+.     +.+|-.|-||.+.++..+-.
T Consensus       635 ---------id~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~  690 (732)
T KOG0614|consen  635 ---------IDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRS  690 (732)
T ss_pred             ---------hhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhh
Confidence                     0011122368899999999999999999986     99999999999999877743

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-38  Score=279.82  Aligned_cols=254  Identities=25%  Similarity=0.341  Sum_probs=208.2

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCc---e-EEEEEeeecc-ccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCC
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQ---K-VAIKMMTIQT-EQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK   79 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~---~-~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   79 (324)
                      .+.+-.+.++||+|+||.||++.-+..+.   . ||+|...... ...+....+.+|++++++++||||++++|+...+.
T Consensus       155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~  234 (474)
T KOG0194|consen  155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE  234 (474)
T ss_pred             eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence            45566677999999999999998764322   3 8999887533 44445677999999999999999999999999999


Q ss_pred             eEEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeecc
Q 045787           80 DVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIG  158 (324)
Q Consensus        80 ~~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~  158 (324)
                      .++||||+|. |+|.+++...++.++..+...++.+.+.||+|||+++++||||-..|+|++ .++.+||+|||++....
T Consensus       235 Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~-~~~~vKISDFGLs~~~~  313 (474)
T KOG0194|consen  235 PLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYS-KKGVVKISDFGLSRAGS  313 (474)
T ss_pred             ccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheec-CCCeEEeCccccccCCc
Confidence            9999999998 599999999887899999999999999999999999999999999999999 88889999999987543


Q ss_pred             CCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhh
Q 045787          159 VPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYI  237 (324)
Q Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (324)
                      .-............|+|||.+.. ..++.++||||||+++||+.+ |..||.+.........+...+.+...        
T Consensus       314 ~~~~~~~~~klPirWLAPEtl~~-~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~--------  384 (474)
T KOG0194|consen  314 QYVMKKFLKKLPIRWLAPETLNT-GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPI--------  384 (474)
T ss_pred             ceeeccccccCcceecChhhhcc-CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCC--------
Confidence            11111111124456999999988 588999999999999999999 78899998877666555332222211        


Q ss_pred             hcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          238 SEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                        ...-+..+..++..|+..||++||++.++.+
T Consensus       385 ------------------~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  385 ------------------PSKTPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             ------------------CCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence                              1145778889999999999999999999886

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.3e-37  Score=265.73  Aligned_cols=249  Identities=24%  Similarity=0.363  Sum_probs=193.5

Q ss_pred             cceeEeecccCceEEEEEEEc---cCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCC------
Q 045787            9 YKKIKKIGAGGYGEVYKCRNT---VTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------   79 (324)
Q Consensus         9 y~i~~~Lg~g~~~~v~~a~~~---~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------   79 (324)
                      |++.+.||+|++|.||+|...   .++..+++|.+..........+.+.+|+.++++++||+++++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            678899999999999999864   35688999998765444434566889999999999999999999875432      


Q ss_pred             eEEEEEEecC-CCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccc
Q 045787           80 DVFLVFEYLD-LDLHSFITRHK-----NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGL  153 (324)
Q Consensus        80 ~~~iv~e~~~-g~l~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~  153 (324)
                      ..+++++|+. |++..++....     ..++...+..++.+++.||.|||++|++|+||+|+||+++ .++.++|+|||.
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~-~~~~~kl~dfg~  159 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLN-ENMTVCVADFGL  159 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEc-CCCCEEECcccc
Confidence            3478889987 57776664321     2478889999999999999999999999999999999999 899999999998


Q ss_pred             eeeccCCCC--cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCccc
Q 045787          154 ARAIGVPQK--EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDES  230 (324)
Q Consensus       154 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  230 (324)
                      +........  ......+++.|++||.+.+ ..++.++||||||+++|+|++ |..||...+..............    
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~----  234 (273)
T cd05074         160 SKKIYSGDYYRQGCASKLPVKWLALESLAD-NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRL----  234 (273)
T ss_pred             cccccCCcceecCCCccCchhhcCHhHHhc-CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcC----
Confidence            876542211  1112234566999999877 567889999999999999999 88999766544332222111000    


Q ss_pred             ccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          231 WAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                             ......+..+.+++.+||+.+|++||++.+++.
T Consensus       235 -----------------------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~  267 (273)
T cd05074         235 -----------------------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD  267 (273)
T ss_pred             -----------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                   011246788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=3.7e-37  Score=262.35  Aligned_cols=249  Identities=21%  Similarity=0.276  Sum_probs=187.4

Q ss_pred             EeecccCceEEEEEEEc--cCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEecC-
Q 045787           13 KKIGAGGYGEVYKCRNT--VTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD-   89 (324)
Q Consensus        13 ~~Lg~g~~~~v~~a~~~--~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~-   89 (324)
                      +.||+|+||.||++...  .++..+++|.+....... ....+.+|+.++++++|||++++++.+.+....++||||++ 
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQ-EQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL   79 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChH-HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence            36899999999999754  345678999876544321 23467889999999999999999999999899999999998 


Q ss_pred             CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC--c
Q 045787           90 LDLHSFITRHK----NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK--E  163 (324)
Q Consensus        90 g~l~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~--~  163 (324)
                      |+|.+++....    ...+...+..++.+++.||.+||+.|++|+||||+||+++ .++.++|+|||.+........  .
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~-~~~~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLT-ADLTVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEc-CCCcEEECCccccccccCcceeec
Confidence            58888876532    2456778888999999999999999999999999999999 889999999998865432211  1


Q ss_pred             ccccccccccCCchhhcCC------CCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhh
Q 045787          164 YSRDCVYSPYKAPELLLGY------TGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY  236 (324)
Q Consensus       164 ~~~~~~~~~y~aPE~~~~~------~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (324)
                      .....+++.|+|||++.+.      ..++.++|+||||+++|+|++ |..||............. .....         
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~---------  228 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTV-REQQL---------  228 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHh-hcccC---------
Confidence            1223456779999998642      235789999999999999996 999997665443221111 00000         


Q ss_pred             hhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          237 ISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                            ..      .........++.+.++++.|+ .+|.+|||+++++.
T Consensus       229 ------~~------~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         229 ------KL------PKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             ------CC------CCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence                  00      000111245678889999998 68999999999984

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3e-37  Score=262.92  Aligned_cols=249  Identities=19%  Similarity=0.270  Sum_probs=185.8

Q ss_pred             EeecccCceEEEEEEEcc--CCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEecC-
Q 045787           13 KKIGAGGYGEVYKCRNTV--TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD-   89 (324)
Q Consensus        13 ~~Lg~g~~~~v~~a~~~~--~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~-   89 (324)
                      +.||+|+||.||++....  ....+++|.+..... ......+.+|+..++.++|+||+++++.+......++||||+. 
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASAT-PDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL   79 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCC-hHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence            368999999999996432  345688887654322 2223457789999999999999999999999999999999998 


Q ss_pred             CCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC--Cc
Q 045787           90 LDLHSFITRHKN----TLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ--KE  163 (324)
Q Consensus        90 g~l~~~~~~~~~----~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~--~~  163 (324)
                      |+|.+++.....    ..++..+..++.|++.||.|||++|++|+||||+||+++ .++.++|+|||.+.......  ..
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~-~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLT-ADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEec-CCCcEEEeccccccccccchheec
Confidence            588888876432    245778889999999999999999999999999999999 89999999999886542211  11


Q ss_pred             ccccccccccCCchhhcC------CCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhh
Q 045787          164 YSRDCVYSPYKAPELLLG------YTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY  236 (324)
Q Consensus       164 ~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (324)
                      .....+++.|+|||++..      ...++.++||||||+++|+|++ |..||....................        
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~--------  230 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKL--------  230 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccC--------
Confidence            122334567999999753      2456889999999999999999 7888876654332222111111000        


Q ss_pred             hhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          237 ISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                 .   .......++..+.+++..|+ .||.+||+++++++
T Consensus       231 -----------~---~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         231 -----------P---KPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             -----------C---CCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence                       0   00112257788889999998 59999999999986

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-38  Score=260.28  Aligned_cols=263  Identities=24%  Similarity=0.369  Sum_probs=221.0

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeecc-ccCCCchHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEEE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQT-EQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~i   83 (324)
                      -++|+.++.||+|++..|.+|+.+.+.+.||+|++++.- ...+..+..+.|-.++.+- +||.++-++..|+.+..+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            468999999999999999999999999999999998765 3445567788899988887 48999999999999999999


Q ss_pred             EEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCc
Q 045787           84 VFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE  163 (324)
Q Consensus        84 v~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~  163 (324)
                      |.||++|.-+-+..++...++++.++.+...|..||.|||+.||+++|+|.+||+++ ..|++||+|+|.+..--.+...
T Consensus       329 vieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlld-aeghikltdygmcke~l~~gd~  407 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLD-AEGHIKLTDYGMCKEGLGPGDT  407 (593)
T ss_pred             EEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEc-cCCceeecccchhhcCCCCCcc
Confidence            999998644444444456799999999999999999999999999999999999999 9999999999999877667777


Q ss_pred             ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC--------hhHHHHHHHHcCCCCcccccchh
Q 045787          164 YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK--------HDHLSLIFSLLGTPTDESWAEST  235 (324)
Q Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--------~~~~~~~~~~~~~~~~~~~~~~~  235 (324)
                      .+..||||.|.|||++++ ..|+.+.|.|+||++++||+.|+.||.--.        .+.+.+++..             
T Consensus       408 tstfcgtpnyiapeilrg-eeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvile-------------  473 (593)
T KOG0695|consen  408 TSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE-------------  473 (593)
T ss_pred             cccccCCCcccchhhhcc-cccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh-------------
Confidence            888899999999999999 889999999999999999999999994211        2222222110             


Q ss_pred             hhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCC------HHHHhcCccccCCCCchh
Q 045787          236 YISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRIT------AMDALKHEYLIGVENVPL  298 (324)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps------~~~~l~hp~~~~~~~~~~  298 (324)
                                     ......+.++..+..+++.-|.+||.+|..      .+++..|+||..+.+..+
T Consensus       474 ---------------kqiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~l  527 (593)
T KOG0695|consen  474 ---------------KQIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLL  527 (593)
T ss_pred             ---------------hcccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHH
Confidence                           011122345666779999999999999974      789999999999998776

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-37  Score=293.26  Aligned_cols=253  Identities=26%  Similarity=0.403  Sum_probs=210.6

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccC-C----ceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecC
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVT-G----QKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR   78 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~-~----~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   78 (324)
                      +...+-+..+.||+|.||.||.+.-... |    ..||+|.+......++ ...+.+|..+++.++||||++++|++.+.
T Consensus       689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~-~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~  767 (1025)
T KOG1095|consen  689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQE-VSDFLKEALLMSKFDHPNIVSLIGVCLDS  767 (1025)
T ss_pred             CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHH-HHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence            4456778899999999999999975432 2    3489998876654433 46788999999999999999999999999


Q ss_pred             CeEEEEEEecC-CCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeec
Q 045787           79 KDVFLVFEYLD-LDLHSFITRH------KNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADF  151 (324)
Q Consensus        79 ~~~~iv~e~~~-g~l~~~~~~~------~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~  151 (324)
                      ...+|++||+. |+|+.++.+.      ...++......++.+|+.|+.||++++++|+||...|+|++ ....|||+||
T Consensus       768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~-~~r~VKIaDF  846 (1025)
T KOG1095|consen  768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLD-ERRVVKIADF  846 (1025)
T ss_pred             CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeec-ccCcEEEccc
Confidence            99999999997 6999999988      66799999999999999999999999999999999999999 8899999999


Q ss_pred             cceeeccCCCC-cc-cccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCc
Q 045787          152 GLARAIGVPQK-EY-SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTD  228 (324)
Q Consensus       152 g~~~~~~~~~~-~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  228 (324)
                      |+++.+....- .. ....-...|||||.+.. .-++.++||||||+++||+++ |..||...+..++.......+.-+.
T Consensus       847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~  925 (1025)
T KOG1095|consen  847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDP  925 (1025)
T ss_pred             chhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCC
Confidence            99985532211 11 11122345999999998 778999999999999999999 8899998887776654443332222


Q ss_pred             ccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          229 ESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                                 .+..+..+.+++..|++.+|.+||+...+++
T Consensus       926 ---------------------------P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  926 ---------------------------PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             ---------------------------CCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence                                       2368889999999999999999999999997

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=1e-38  Score=259.78  Aligned_cols=281  Identities=36%  Similarity=0.543  Sum_probs=230.2

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCC----
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK----   79 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----   79 (324)
                      +...||.-+..+|.|.. .|..|.|...++++++|....+.......++..+|...+..++|+|+++++.++.-+.    
T Consensus        14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~   92 (369)
T KOG0665|consen   14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE   92 (369)
T ss_pred             eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence            34578888999999999 8889999999999999998877655556677889999999999999999999986543    


Q ss_pred             --eEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeec
Q 045787           80 --DVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAI  157 (324)
Q Consensus        80 --~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~  157 (324)
                        ..|+|||++..++.+.+..   .++-..+..++.|++.|+++||+.|++||||||+||++. .+..+||.|||.+...
T Consensus        93 ~~e~y~v~e~m~~nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~-~~~~lKi~dfg~ar~e  168 (369)
T KOG0665|consen   93 FQEVYLVMELMDANLCQVILM---ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVN-SDCTLKILDFGLARTE  168 (369)
T ss_pred             HHhHHHHHHhhhhHHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceec-chhheeeccchhhccc
Confidence              5899999999999998884   377888999999999999999999999999999999999 9999999999999887


Q ss_pred             cCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHHcCCCCcccccchhh
Q 045787          158 GVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-HDHLSLIFSLLGTPTDESWAESTY  236 (324)
Q Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  236 (324)
                      +.. -..+....+..|.|||+..+.. +...+||||+||++.||++|+..|.+.+ .++..++....+.|......+-..
T Consensus       169 ~~~-~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~  246 (369)
T KOG0665|consen  169 DTD-FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP  246 (369)
T ss_pred             Ccc-cccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence            644 4555567788899999999844 8999999999999999999999998877 778888889999988766554222


Q ss_pred             hhc----ccCCC---------CCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCcccc
Q 045787          237 ISE----ILPLY---------PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLI  291 (324)
Q Consensus       237 ~~~----~~~~~---------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~  291 (324)
                      ..+    ..+.+         ++.......+..+.-...+++++.+||..||++|.|++++|+|||++
T Consensus       247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence            211    11111         11111111122222345678999999999999999999999999997

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-39  Score=273.02  Aligned_cols=267  Identities=25%  Similarity=0.396  Sum_probs=214.2

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeecc-----ccCCCchHHHHHHHHHHhcCCCCeeEEEeeee-
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQT-----EQEGVPSYIIREVSLLKELEHENIVRLLDVQS-   76 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~-----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-   76 (324)
                      .+++++|-.++.||+|+|+.||+|.|...++.+|+|+-....     ......+...+|.++.+.|.||.||++++++. 
T Consensus       459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl  538 (775)
T KOG1151|consen  459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL  538 (775)
T ss_pred             cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence            467899999999999999999999999999999999976443     22233455678999999999999999999986 


Q ss_pred             cCCeEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--CCcccCCCCCceEeecC--CCcEEEeecc
Q 045787           77 SRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSL--KILHRDLKPNNLLIDLK--RNTVKLADFG  152 (324)
Q Consensus        77 ~~~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~--g~~H~di~p~nIll~~~--~~~v~l~d~g  152 (324)
                      +.+.+|-|+|||+|+-+++..+....+++.+++.|+.||..||.||...  .|+|.||||.|||+-..  -|.+||+|||
T Consensus       539 DtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG  618 (775)
T KOG1151|consen  539 DTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG  618 (775)
T ss_pred             ccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence            4567999999999988888888778899999999999999999999976  49999999999999622  2789999999


Q ss_pred             ceeeccCCCC-------cccccccccccCCchhhcC---CCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHH
Q 045787          153 LARAIGVPQK-------EYSRDCVYSPYKAPELLLG---YTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-HDHLSLIFS  221 (324)
Q Consensus       153 ~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~  221 (324)
                      ++..+.....       ..+...||.+|++||.+--   .+..+.+.||||+|+|+|+++.|+.||..+- ...+...-.
T Consensus       619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT  698 (775)
T KOG1151|consen  619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT  698 (775)
T ss_pred             hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc
Confidence            9988854332       2444578999999999842   3456889999999999999999999996554 222222111


Q ss_pred             HcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccC
Q 045787          222 LLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIG  292 (324)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~  292 (324)
                      ++....-                 .+      ..-+-++.++++||++||+..-.+|.++-++..||+|.-
T Consensus       699 IlkAtEV-----------------qF------P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  699 ILKATEV-----------------QF------PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP  746 (775)
T ss_pred             hhcceec-----------------cC------CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence            1111000                 00      011358889999999999999999999999999999975

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=5.4e-38  Score=285.47  Aligned_cols=251  Identities=28%  Similarity=0.399  Sum_probs=210.2

Q ss_pred             CcCcceeEeecccCceEEEEEEEc-----cCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCe
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNT-----VTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKD   80 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   80 (324)
                      -.+-+..+.||+|+||.||+|+-.     .....||||.++.....+ ....|++|++++..|+|||||+++|++...+.
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~-~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P  563 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQ-ARQDFRREAELLAELQHPNIVRLLGVCREGDP  563 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHH-HHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence            345677899999999999999753     234589999988665442 25779999999999999999999999999999


Q ss_pred             EEEEEEecC-CCHHHHHHhcC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcE
Q 045787           81 VFLVFEYLD-LDLHSFITRHK-------------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTV  146 (324)
Q Consensus        81 ~~iv~e~~~-g~l~~~~~~~~-------------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v  146 (324)
                      +|+||||+. |+|.+++..+.             .+++..+...|+.||+.|+.||-++.+||+||-..|+|++ ++-.|
T Consensus       564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVg-e~l~V  642 (774)
T KOG1026|consen  564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVG-ENLVV  642 (774)
T ss_pred             eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceec-cceEE
Confidence            999999998 89999997653             2388899999999999999999999999999999999999 99999


Q ss_pred             EEeeccceeeccCCC--CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHc
Q 045787          147 KLADFGLARAIGVPQ--KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLL  223 (324)
Q Consensus       147 ~l~d~g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~  223 (324)
                      ||+|||+++.+....  ...+...-..+|||||.+.- ..++.+|||||+|+++||+++ |..||.+.+.+++...+...
T Consensus       643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly-~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g  721 (774)
T KOG1026|consen  643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY-GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAG  721 (774)
T ss_pred             EecccccchhhhhhhhhcccCCceeeeecCCHHHhhc-CcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcC
Confidence            999999998775322  12223345577999999987 778999999999999999998 88999998877765554432


Q ss_pred             CCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          224 GTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      ..                           .....+.|.++.+|+..|++..|.+||+..||-+
T Consensus       722 ~l---------------------------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~  757 (774)
T KOG1026|consen  722 QL---------------------------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHS  757 (774)
T ss_pred             Cc---------------------------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            22                           2223478999999999999999999999999864

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=3.9e-37  Score=284.58  Aligned_cols=278  Identities=23%  Similarity=0.277  Sum_probs=179.7

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccC----CceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEee------
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVT----GQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDV------   74 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~----~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~------   74 (324)
                      ..++|++.+.||+|+||.||+|.+..+    +..||+|.+......    +...++  .+++..+..+..+...      
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~----e~~~~e--~l~~~~~~~~~~~~~~~~~~~~  203 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV----EIWMNE--RVRRACPNSCADFVYGFLEPVS  203 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh----HHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence            457899999999999999999999888    899999986532211    111111  1112122222222111      


Q ss_pred             eecCCeEEEEEEecC-CCHHHHHHhcCCC-------------------CCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 045787           75 QSSRKDVFLVFEYLD-LDLHSFITRHKNT-------------------LNLLVIKAILKQILLGLAYCHSLKILHRDLKP  134 (324)
Q Consensus        75 ~~~~~~~~iv~e~~~-g~l~~~~~~~~~~-------------------~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p  134 (324)
                      ...+...++|+||++ ++|.+++.....+                   .....+..++.|++.||.|||+.|++|+||||
T Consensus       204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP  283 (566)
T PLN03225        204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKP  283 (566)
T ss_pred             cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCH
Confidence            245667999999998 4788877654321                   12344678999999999999999999999999


Q ss_pred             CceEeecCCCcEEEeeccceeeccCC-CCcccccccccccCCchhhcCCC---------------------CCCCchhhH
Q 045787          135 NNLLIDLKRNTVKLADFGLARAIGVP-QKEYSRDCVYSPYKAPELLLGYT---------------------GYSTPIDVW  192 (324)
Q Consensus       135 ~nIll~~~~~~v~l~d~g~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~---------------------~~~~~~Diw  192 (324)
                      +|||++.+++.+||+|||.+...... ........+++.|+|||.+....                     .++.++|||
T Consensus       284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw  363 (566)
T PLN03225        284 QNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY  363 (566)
T ss_pred             HHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence            99999944689999999999765322 12233456788999999764211                     234467999


Q ss_pred             HHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhc
Q 045787          193 AVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLC  272 (324)
Q Consensus       193 slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  272 (324)
                      ||||++|+|+++..|+... ...........+.. ...|      ................+.........++||.+||+
T Consensus       364 SlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~-~~~~------~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~  435 (566)
T PLN03225        364 SAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYD-LVAW------RKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR  435 (566)
T ss_pred             HHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCc-HHHH------HHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence            9999999999976554321 11111111111110 0000      00000000000011111222334566799999999


Q ss_pred             CCCCCCCCHHHHhcCccccCCCCc
Q 045787          273 LNPKQRITAMDALKHEYLIGVENV  296 (324)
Q Consensus       273 ~dP~~Rps~~~~l~hp~~~~~~~~  296 (324)
                      .||.+|||++++|+||||++....
T Consensus       436 ~dP~kR~ta~e~L~Hpff~~~~~~  459 (566)
T PLN03225        436 FKGRQRISAKAALAHPYFDREGLL  459 (566)
T ss_pred             CCcccCCCHHHHhCCcCcCCCCcc
Confidence            999999999999999999987654

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=258.95  Aligned_cols=269  Identities=23%  Similarity=0.354  Sum_probs=212.3

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhc-CCCCeeEEEeeeecCCeE
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDV   81 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   81 (324)
                      ++...+.+-+..||.|+||+|.+..++.+|+..|||.++....+. ...++..|.+...+- +.|+||+++|....++..
T Consensus        60 ~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~k-eq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdc  138 (361)
T KOG1006|consen   60 TFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEK-EQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDC  138 (361)
T ss_pred             ccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchH-HHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCce
Confidence            345666777889999999999999999999999999998765432 245566777765554 589999999999999999


Q ss_pred             EEEEEecCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCceEeecCCCcEEEeeccceee
Q 045787           82 FLVFEYLDLDLHSFITR----HKNTLNLLVIKAILKQILLGLAYCHS-LKILHRDLKPNNLLIDLKRNTVKLADFGLARA  156 (324)
Q Consensus        82 ~iv~e~~~g~l~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~Lh~-~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~  156 (324)
                      ||-||.++-++..+...    ....++++.+..|......||.||.. ..++|||+||+|||++ ..|.|||||||.+-.
T Consensus       139 WiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILld-r~G~vKLCDFGIcGq  217 (361)
T KOG1006|consen  139 WICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLD-RHGDVKLCDFGICGQ  217 (361)
T ss_pred             eeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEe-cCCCEeeecccchHh
Confidence            99999999776655432    23468999999999999999999984 5899999999999999 999999999998865


Q ss_pred             ccCCCCcccccccccccCCchhhcCCCC-CCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchh
Q 045787          157 IGVPQKEYSRDCVYSPYKAPELLLGYTG-YSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAEST  235 (324)
Q Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (324)
                      +..+ -......|..+|+|||.+..... ++.+||+||||+++||+.||..||...+..-........+.|+.-..+   
T Consensus       218 Lv~S-iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~---  293 (361)
T KOG1006|consen  218 LVDS-IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFD---  293 (361)
T ss_pred             HHHH-HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCc---
Confidence            5322 22334467778999999976555 899999999999999999999999766642222222333333332211   


Q ss_pred             hhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCC
Q 045787          236 YISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVEN  295 (324)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~  295 (324)
                                        ..--+++..+..+|+.||.+|-+.||...+++.+||+.....
T Consensus       294 ------------------~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~  335 (361)
T KOG1006|consen  294 ------------------KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAV  335 (361)
T ss_pred             ------------------ccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhh
Confidence                              111258899999999999999999999999999999986553

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.4e-37  Score=271.73  Aligned_cols=269  Identities=25%  Similarity=0.407  Sum_probs=214.0

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeecc-ccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQT-EQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF   82 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   82 (324)
                      +...-|..++.||-|+||.|.+|...++...||+|.+.+.+ .........+.|..||..-.++-||+++..|++.+.+|
T Consensus       626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY  705 (1034)
T KOG0608|consen  626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY  705 (1034)
T ss_pred             ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence            34556888999999999999999998889999999998765 22333456788999999999999999999999999999


Q ss_pred             EEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeec----
Q 045787           83 LVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAI----  157 (324)
Q Consensus        83 iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~----  157 (324)
                      +||+|+. |++-..+.+.+ -|.++.++.++..+..|+++.|..|++|+||||+|||+| .+|++||+|||+++-.    
T Consensus       706 FVMdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILID-rdGHIKLTDFGLCTGfRWTH  783 (1034)
T KOG0608|consen  706 FVMDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTH  783 (1034)
T ss_pred             EEEeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEc-cCCceeeeeccccccceecc
Confidence            9999997 58888888764 599999999999999999999999999999999999999 9999999999998432    


Q ss_pred             -----cCCC----------C-----------------------cccccccccccCCchhhcCCCCCCCchhhHHHHHHHH
Q 045787          158 -----GVPQ----------K-----------------------EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFA  199 (324)
Q Consensus       158 -----~~~~----------~-----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~  199 (324)
                           ....          .                       ......||+.|+|||++.. ..++..+|.||.|+|||
T Consensus       784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~cdwws~gvil~  862 (1034)
T KOG0608|consen  784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQLCDWWSVGVILY  862 (1034)
T ss_pred             ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCccccchhhHhhHHHH
Confidence                 0000          0                       0112367888999999987 66799999999999999


Q ss_pred             HHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCC
Q 045787          200 EMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRI  279 (324)
Q Consensus       200 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp  279 (324)
                      +|+.|++||....+..-..                        ...+|...-....-.+++++..++|.++. .+++.|+
T Consensus       863 em~~g~~pf~~~tp~~tq~------------------------kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RL  917 (1034)
T KOG0608|consen  863 EMLVGQPPFLADTPGETQY------------------------KVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRL  917 (1034)
T ss_pred             HHhhCCCCccCCCCCccee------------------------eeeehhhccccccccccCHHHHHHHHHHh-cChhhhh
Confidence            9999999997655332110                        11111111111112368999999998865 5688888


Q ss_pred             C---HHHHhcCccccCCCCchhhh
Q 045787          280 T---AMDALKHEYLIGVENVPLVI  300 (324)
Q Consensus       280 s---~~~~l~hp~~~~~~~~~~~~  300 (324)
                      .   ++++..||||+++....+-+
T Consensus       918 Gkng~d~vKaHpfFkgIDfsslRk  941 (1034)
T KOG0608|consen  918 GKNGADQVKAHPFFKGIDFSSLRK  941 (1034)
T ss_pred             cccchhhhhcCccccccchHhhhh
Confidence            4   78899999999999776533

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=5e-36  Score=255.23  Aligned_cols=248  Identities=21%  Similarity=0.304  Sum_probs=183.6

Q ss_pred             eecccCceEEEEEEEccC--CceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEecC-C
Q 045787           14 KIGAGGYGEVYKCRNTVT--GQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD-L   90 (324)
Q Consensus        14 ~Lg~g~~~~v~~a~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~-g   90 (324)
                      .||+|+||.||++.....  ...+++|.+...... ...+.+.+|+..++.++|||++++++.+......|+||||+. |
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASS-KEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCCh-HHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            689999999999975433  235667766543321 224678899999999999999999999999999999999998 5


Q ss_pred             CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC--Cccc
Q 045787           91 DLHSFITRHK---NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ--KEYS  165 (324)
Q Consensus        91 ~l~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~--~~~~  165 (324)
                      +|.+++....   ...+...++.++.+++.||.|||+.+++|+||||+||+++ .++.++|+|||.+.......  ....
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~-~~~~~~l~Dfg~~~~~~~~~~~~~~~  159 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLT-SDLTVKVGDYGIGPSRYKEDYIETED  159 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEc-CCccEEecccccccccCcchhhhccc
Confidence            8888887643   2456677889999999999999999999999999999999 88999999999875432111  1122


Q ss_pred             ccccccccCCchhhcC------CCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhh
Q 045787          166 RDCVYSPYKAPELLLG------YTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYIS  238 (324)
Q Consensus       166 ~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (324)
                      ...++..|+|||++..      ....+.++||||||+++|+|++ +..||...+...............  .        
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~--~--------  229 (268)
T cd05086         160 DKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK--L--------  229 (268)
T ss_pred             CCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccc--c--------
Confidence            3456788999999753      1235789999999999999997 567886655432222111000000  0        


Q ss_pred             cccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          239 EILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                  ........+++.+.+++..|+ .+|.+||++.++++
T Consensus       230 ------------~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         230 ------------FKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             ------------CCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence                        001111246788899999999 67999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=3.9e-36  Score=251.51  Aligned_cols=242  Identities=39%  Similarity=0.633  Sum_probs=198.0

Q ss_pred             CceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEecCC-CHHHHHH
Q 045787           19 GYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFIT   97 (324)
Q Consensus        19 ~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~   97 (324)
                      ++|.||++.+..+|+.+++|++........ .+.+.+|+..+++++|++++++++.+......++++|++++ +|.+++.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~   79 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK   79 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence            578999999998899999999876543322 46788999999999999999999999998999999999986 8888877


Q ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcccccccccccCCch
Q 045787           98 RHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPE  177 (324)
Q Consensus        98 ~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE  177 (324)
                      ... .++...++.++.+++.++.+||+.|++|+||+|+||+++ .++.++|+|||.+....... ......++..|+|||
T Consensus        80 ~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~-~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pE  156 (244)
T smart00220       80 KRG-RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLD-EDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAPE  156 (244)
T ss_pred             hcc-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEEC-CCCcEEEccccceeeecccc-ccccccCCcCCCCHH
Confidence            644 389999999999999999999999999999999999999 88999999999998775432 333445777899999


Q ss_pred             hhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCC-CChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhC
Q 045787          178 LLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPS-KKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKF  256 (324)
Q Consensus       178 ~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (324)
                      ...+ ...+.++|+||||++++++++|..||.. .................                         ....
T Consensus       157 ~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~  210 (244)
T smart00220      157 VLLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF-------------------------PPPE  210 (244)
T ss_pred             HHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC-------------------------cccc
Confidence            9876 5678899999999999999999999976 33332222211100000                         0000


Q ss_pred             CCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          257 PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       257 ~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                      ..++..+.+++.+|+..||.+||++.++++||||
T Consensus       211 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      211 WKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             ccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence            1177889999999999999999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=277.70  Aligned_cols=205  Identities=29%  Similarity=0.485  Sum_probs=177.1

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecC------C
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR------K   79 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~   79 (324)
                      ...|..-+.||.|+||.||+++++.+|+.+|+|.+..... ....+..-+|++++++++|+|||+.+++-+..      .
T Consensus        12 ~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~-~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~   90 (732)
T KOG4250|consen   12 NYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS-LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR   90 (732)
T ss_pred             CcceeehhhhcCCccceeeeecccccccchhHHhhhhhcc-cchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence            4567888999999999999999999999999999987653 33356778999999999999999999876543      3


Q ss_pred             eEEEEEEecC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCC-C--cEEEeeccc
Q 045787           80 DVFLVFEYLD-LDLHSFITRHKN--TLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKR-N--TVKLADFGL  153 (324)
Q Consensus        80 ~~~iv~e~~~-g~l~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~-~--~v~l~d~g~  153 (324)
                      ...+|||||. |+|+..+..-..  .+++.+...++.++..||.|||++||+||||||.||++.... |  ..||+|||.
T Consensus        91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            5789999997 588888876433  599999999999999999999999999999999999985222 3  579999999


Q ss_pred             eeeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 045787          154 ARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK  212 (324)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  212 (324)
                      |+... .+.......||+.|++||.+....+++...|.|||||++|++.||..||....
T Consensus       171 Arel~-d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~  228 (732)
T KOG4250|consen  171 ARELD-DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG  228 (732)
T ss_pred             cccCC-CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence            99887 44467777899999999999866889999999999999999999999996655

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-36  Score=273.27  Aligned_cols=260  Identities=28%  Similarity=0.407  Sum_probs=218.2

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcC-CCCeeEEEeeee-----cCC
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-HENIVRLLDVQS-----SRK   79 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~-----~~~   79 (324)
                      .+.|++.+.+|.|.+|.||++.+..+++..|+|+.......+   +.+..|.++++... |||++.+++++.     .++
T Consensus        18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d---eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D   94 (953)
T KOG0587|consen   18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE---EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD   94 (953)
T ss_pred             CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc---HHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence            467999999999999999999999999999999988765543   56888999998885 899999999873     356


Q ss_pred             eEEEEEEecC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeec
Q 045787           80 DVFLVFEYLD-LDLHSFITRH-KNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAI  157 (324)
Q Consensus        80 ~~~iv~e~~~-g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~  157 (324)
                      .+|+|||+|+ |+.-+.+... +..+.+..+..|++.++.||.+||.+.++|+|||-.|||+. .++.|||+|||.+...
T Consensus        95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT-~e~~VKLvDFGvSaQl  173 (953)
T KOG0587|consen   95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQL  173 (953)
T ss_pred             eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEe-ccCcEEEeeeeeeeee
Confidence            8999999998 5776666554 34689999999999999999999999999999999999999 9999999999999988


Q ss_pred             cCCCCcccccccccccCCchhhcC----CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccc
Q 045787          158 GVPQKEYSRDCVYSPYKAPELLLG----YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAE  233 (324)
Q Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  233 (324)
                      .....+.....|||.|||||++..    ...++.++|+||||++..||.-|.+|+....+..  .++.+...|+...   
T Consensus       174 dsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr--aLF~IpRNPPPkL---  248 (953)
T KOG0587|consen  174 DSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR--ALFLIPRNPPPKL---  248 (953)
T ss_pred             ecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh--hhccCCCCCCccc---
Confidence            877777777889999999999853    3457889999999999999999999997665432  2223223332221   


Q ss_pred             hhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCC
Q 045787          234 STYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVE  294 (324)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~  294 (324)
                                          ..+...++++.+||..||.+|..+||+..++|.|||+.+..
T Consensus       249 --------------------krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~  289 (953)
T KOG0587|consen  249 --------------------KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQP  289 (953)
T ss_pred             --------------------cchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccccc
Confidence                                11235678899999999999999999999999999999665

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-38  Score=253.32  Aligned_cols=286  Identities=33%  Similarity=0.577  Sum_probs=225.0

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCC-----eE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK-----DV   81 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~   81 (324)
                      .+.+.-+.||.|+||.||.+.|..+|+.+++|.+......-...+++.+|+.++.-++|.|++...++.+-..     .+
T Consensus        53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi  132 (449)
T KOG0664|consen   53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL  132 (449)
T ss_pred             ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence            4556678999999999999999999999999998866554444577889999999999999999888765432     36


Q ss_pred             EEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccC-C
Q 045787           82 FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGV-P  160 (324)
Q Consensus        82 ~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~-~  160 (324)
                      |+++|.+..+|...+-. +.+++...++-+++||+.||.|||+.||.|+||||.|.+++ .+..+||+|||+++.-.. .
T Consensus       133 YV~TELmQSDLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVN-SNCvLKICDFGLARvee~d~  210 (449)
T KOG0664|consen  133 YVLTELMQSDLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVN-SNCILKICDFGLARTWDQRD  210 (449)
T ss_pred             HHHHHHHHhhhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEec-cCceEEecccccccccchhh
Confidence            78888888787776655 56799999999999999999999999999999999999999 999999999999986542 2


Q ss_pred             CCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHHcCCCCcccccchhhh-h
Q 045787          161 QKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-HDHLSLIFSLLGTPTDESWAESTYI-S  238 (324)
Q Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~-~  238 (324)
                      .........|..|+|||++.+...|+.+.||||.|||+.|++..+..|...+ .+++..+...++.|..+.....-.. .
T Consensus       211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk  290 (449)
T KOG0664|consen  211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK  290 (449)
T ss_pred             hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence            3345556778889999999998899999999999999999999999996655 6677778888888875433221000 0


Q ss_pred             -cccC-CCCCCCCcchhhhC--CCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCC
Q 045787          239 -EILP-LYPHFEPANLAEKF--PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVE  294 (324)
Q Consensus       239 -~~~~-~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~  294 (324)
                       .+.. .....+........  .....+...++..+|..||.+|.+.++.+.|+++.+.+
T Consensus       291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R  350 (449)
T KOG0664|consen  291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR  350 (449)
T ss_pred             HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence             0000 01111111111111  13455677999999999999999999999999999887

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-36  Score=263.30  Aligned_cols=245  Identities=27%  Similarity=0.403  Sum_probs=199.9

Q ss_pred             ceeEeecccCceEEEEEEEcc----CCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787           10 KKIKKIGAGGYGEVYKCRNTV----TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus        10 ~i~~~Lg~g~~~~v~~a~~~~----~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      +.-+.||.|.||.||.+.-..    ..-.||+|+++.+... +..+.|..|..++++++||||++++|++.++ ..+|||
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~-d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wivm  469 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP-DDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVM  469 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh-hhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEE
Confidence            445689999999999987542    2336899998765433 3378899999999999999999999999875 479999


Q ss_pred             EecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcc
Q 045787           86 EYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY  164 (324)
Q Consensus        86 e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~  164 (324)
                      |.+. |.|+.+++.+...++......++.||..||.|||++.++||||-..|||+. ...-|||+|||+++.+..+.--.
T Consensus       470 EL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVs-Sp~CVKLaDFGLSR~~ed~~yYk  548 (974)
T KOG4257|consen  470 ELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVS-SPQCVKLADFGLSRYLEDDAYYK  548 (974)
T ss_pred             ecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeec-Ccceeeecccchhhhccccchhh
Confidence            9998 899999999999999999999999999999999999999999999999999 88999999999999876443222


Q ss_pred             ccccc--ccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhccc
Q 045787          165 SRDCV--YSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEIL  241 (324)
Q Consensus       165 ~~~~~--~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (324)
                      +. .+  ..-|+|||.+.- ..++.++|||.||+++||++. |..||.+-....+.                        
T Consensus       549 aS-~~kLPIKWmaPESINf-RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI------------------------  602 (974)
T KOG4257|consen  549 AS-RGKLPIKWMAPESINF-RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI------------------------  602 (974)
T ss_pred             cc-ccccceeecCccccch-hcccchhhHHHHHHHHHHHHHhcCCccccccccceE------------------------
Confidence            22 22  233999999865 668999999999999999887 88999665533221                        


Q ss_pred             CCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          242 PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                         ............++.|+.+..++.+|++.||.+||...++..
T Consensus       603 ---~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~  644 (974)
T KOG4257|consen  603 ---GHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKA  644 (974)
T ss_pred             ---EEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence               111222223334578999999999999999999999888875

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.1e-34  Score=262.09  Aligned_cols=273  Identities=19%  Similarity=0.315  Sum_probs=185.1

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEc----------------cCCceEEEEEeeeccccC------------CCchHHHH
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNT----------------VTGQKVAIKMMTIQTEQE------------GVPSYIIR   55 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~----------------~~~~~~~~K~~~~~~~~~------------~~~~~~~~   55 (324)
                      ...++|++.++||+|+||+||++...                ..++.||+|.+.......            ...+....
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            45679999999999999999998642                345679999986543211            01122334


Q ss_pred             HHHHHHhcCCCCe-----eEEEeeeec--------CCeEEEEEEecC-CCHHHHHHhcCC--------------------
Q 045787           56 EVSLLKELEHENI-----VRLLDVQSS--------RKDVFLVFEYLD-LDLHSFITRHKN--------------------  101 (324)
Q Consensus        56 e~~~l~~l~~~~i-----~~~~~~~~~--------~~~~~iv~e~~~-g~l~~~~~~~~~--------------------  101 (324)
                      |+.++.+++|.++     +++++++..        .+..++|+||++ ++|.+++....+                    
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            6777777766543     566666542        356899999998 588777754211                    


Q ss_pred             ---CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC-cccccccccccCCch
Q 045787          102 ---TLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK-EYSRDCVYSPYKAPE  177 (324)
Q Consensus       102 ---~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~-~~~~~~~~~~y~aPE  177 (324)
                         .++...++.++.+++.+|.+||+.|++|+||||+||+++ .++.++|+|||.+........ .......++.|+|||
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE  380 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVT-VDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE  380 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEEC-CCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence               235677889999999999999999999999999999999 889999999999876542221 112233478899999


Q ss_pred             hhcCCCC---------------------CCCchhhHHHHHHHHHHHhCCC-CCCCCChhHHHHHHHHcCCCCcccccchh
Q 045787          178 LLLGYTG---------------------YSTPIDVWAVGCIFAEMITGKP-LFPSKKHDHLSLIFSLLGTPTDESWAEST  235 (324)
Q Consensus       178 ~~~~~~~---------------------~~~~~DiwslG~il~~l~~g~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (324)
                      .+.....                     ...+.|+||+||++|+|+++.. ||.....-..  ....... ....|    
T Consensus       381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~--~~~~~~~-~~~~~----  453 (507)
T PLN03224        381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNT--ELRQYDN-DLNRW----  453 (507)
T ss_pred             hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhh--HHhhccc-hHHHH----
Confidence            9854211                     1234799999999999999875 6643221100  0000000 00000    


Q ss_pred             hhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCC---CCCCCHHHHhcCccccC
Q 045787          236 YISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNP---KQRITAMDALKHEYLIG  292 (324)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP---~~Rps~~~~l~hp~~~~  292 (324)
                        ...    ..  .......+...++..++++.+||..+|   .+|+|+.|+|+||||..
T Consensus       454 --r~~----~~--~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        454 --RMY----KG--QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             --Hhh----cc--cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence              000    00  000111345678999999999999876   68999999999999953

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=2.1e-35  Score=248.71  Aligned_cols=285  Identities=30%  Similarity=0.482  Sum_probs=214.1

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEcc---CCceEEEEEeeeccccCCCchHHHHHHHHHHhcC-CCCeeEEEeeeecCC
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTV---TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-HENIVRLLDVQSSRK   79 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~---~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~   79 (324)
                      .+.+.|++++++|.|.|++||++.+..   ..+.||+|.+...+.    ..++.+|++++..+. +.||+++.+.+..++
T Consensus        33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----PSRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            356789999999999999999999887   778999999876543    356899999999996 899999999999999


Q ss_pred             eEEEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeecc
Q 045787           80 DVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIG  158 (324)
Q Consensus        80 ~~~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~  158 (324)
                      ...+|+||++. ...++...    ++...++.+++.++.||.++|++||+|+||||.|++++...+.-.|+|||++....
T Consensus       109 ~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d  184 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD  184 (418)
T ss_pred             eeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHH
Confidence            99999999995 66665554    77889999999999999999999999999999999999788999999999985110


Q ss_pred             ----------------CC----------------------------CCcccccccccccCCchhhcCCCCCCCchhhHHH
Q 045787          159 ----------------VP----------------------------QKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAV  194 (324)
Q Consensus       159 ----------------~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl  194 (324)
                                      .+                            ........||++|+|||++.....-+.+.||||.
T Consensus       185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~  264 (418)
T KOG1167|consen  185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA  264 (418)
T ss_pred             hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence                            00                            0011123678999999999988888999999999


Q ss_pred             HHHHHHHHhCCCCCCCCC--hhHHHHHHHHcCCCCc--------c--cccchh--hhhcccCCCCCC--------CC-cc
Q 045787          195 GCIFAEMITGKPLFPSKK--HDHLSLIFSLLGTPTD--------E--SWAEST--YISEILPLYPHF--------EP-AN  251 (324)
Q Consensus       195 G~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~--------~--~~~~~~--~~~~~~~~~~~~--------~~-~~  251 (324)
                      |+|++.++++..||-...  .+.+..+..+++...-        .  .|..+.  ...+....+...        +. ..
T Consensus       265 GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~  344 (418)
T KOG1167|consen  265 GVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNT  344 (418)
T ss_pred             cceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccce
Confidence            999999999999984433  3333333333332211        1  111110  001111111111        00 01


Q ss_pred             hhhhC-CCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCc
Q 045787          252 LAEKF-PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENV  296 (324)
Q Consensus       252 ~~~~~-~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~  296 (324)
                      ..+.+ ..++..+.+++.+||..||.+|.|++++|.||||.+....
T Consensus       345 ~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~~  390 (418)
T KOG1167|consen  345 EREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADRT  390 (418)
T ss_pred             eeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhhh
Confidence            12222 2355688999999999999999999999999999977643

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-35  Score=255.21  Aligned_cols=247  Identities=24%  Similarity=0.390  Sum_probs=207.7

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      -.+.++.++||.|.+|.||.+..+...-.+|||.++-+...   .+.|..|+.+++.++|||+|+++++|..+..+|||+
T Consensus       266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe---veEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiT  342 (1157)
T KOG4278|consen  266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIIT  342 (1157)
T ss_pred             chheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh---HHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEE
Confidence            34567889999999999999999988889999998765544   467999999999999999999999999999999999


Q ss_pred             EecC-CCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCc
Q 045787           86 EYLD-LDLHSFITRHKN-TLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE  163 (324)
Q Consensus        86 e~~~-g~l~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~  163 (324)
                      ||+. |+|++++...+. .++.-...+++.||..|+.||..++++|+||-..|.|+. ++..||+.|||+++.+....  
T Consensus       343 EfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVg-EnhiVKvADFGLsRlMtgDT--  419 (1157)
T KOG4278|consen  343 EFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHIVKVADFGLSRLMTGDT--  419 (1157)
T ss_pred             ecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccc-ccceEEeeccchhhhhcCCc--
Confidence            9986 899999998765 477778889999999999999999999999999999999 99999999999998875322  


Q ss_pred             cccccc---ccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhc
Q 045787          164 YSRDCV---YSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISE  239 (324)
Q Consensus       164 ~~~~~~---~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
                      +....|   ..-|.|||-+-- +.++.++|||+||++|||+.| |..||.+-+..++..+....-.              
T Consensus       420 YTAHAGAKFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyR--------------  484 (1157)
T KOG4278|consen  420 YTAHAGAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYR--------------  484 (1157)
T ss_pred             eecccCccCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcccc--------------
Confidence            111112   233999999866 678999999999999999999 8899998887666554432111              


Q ss_pred             ccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                   .+.....++.+.+|++.|++++|.+||+.+++-+
T Consensus       485 -------------M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHq  518 (1157)
T KOG4278|consen  485 -------------MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQ  518 (1157)
T ss_pred             -------------ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHH
Confidence                         1122378999999999999999999999988753

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-35  Score=254.92  Aligned_cols=256  Identities=25%  Similarity=0.366  Sum_probs=207.1

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE   86 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   86 (324)
                      ....++++||+|-||.|.++.-. .+..||+|+++...... ....+.+|+++|.+++||||+.++++|..++.+++|+|
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~-~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E  615 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKN-ARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE  615 (807)
T ss_pred             hheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchh-HHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence            45678999999999999999864 36899999988665433 25679999999999999999999999999999999999


Q ss_pred             ecC-CCHHHHHHhcCCCC-CHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC--CC
Q 045787           87 YLD-LDLHSFITRHKNTL-NLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP--QK  162 (324)
Q Consensus        87 ~~~-g~l~~~~~~~~~~~-~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~--~~  162 (324)
                      |++ |+|.+++.++..+. ......+++.||+.|++||.+.+++|||+.+.|+|++ .++++||+|||.++.+...  ..
T Consensus       616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~-~e~~iKiadfgmsR~lysg~yy~  694 (807)
T KOG1094|consen  616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVD-GEFTIKIADFGMSRNLYSGDYYR  694 (807)
T ss_pred             HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeec-CcccEEecCcccccccccCCcee
Confidence            998 89999999986554 5566778999999999999999999999999999999 9999999999999855322  12


Q ss_pred             cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh--CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcc
Q 045787          163 EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT--GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEI  240 (324)
Q Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (324)
                      ..+...-...|+|+|.+.. .+++.++|+|++|+++||+++  ...||.....++.-.....+                 
T Consensus       695 vqgr~vlpiRwmawEsill-gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~-----------------  756 (807)
T KOG1094|consen  695 VQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEF-----------------  756 (807)
T ss_pred             eecceeeeeeehhHHHHHh-ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhh-----------------
Confidence            2333344577999999987 788999999999999999876  67899877765543322211                 


Q ss_pred             cCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          241 LPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                         ...-.........+..+..+.+++.+|+..|-.+||+.+++-.
T Consensus       757 ---~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  757 ---FRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             ---cCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence               1111222233334568889999999999999999999999854

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1e-35  Score=268.95  Aligned_cols=249  Identities=29%  Similarity=0.454  Sum_probs=191.2

Q ss_pred             eeEeecccCceE-EEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcC-CCCeeEEEeeeecCCeEEEEEEec
Q 045787           11 KIKKIGAGGYGE-VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-HENIVRLLDVQSSRKDVFLVFEYL   88 (324)
Q Consensus        11 i~~~Lg~g~~~~-v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv~e~~   88 (324)
                      -.+.+|.|+.|+ ||++.  -.|+.||||.+-..     ..+...+|+..|+.-+ ||||+++++.-.++...||..|.|
T Consensus       513 ~~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~e-----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC  585 (903)
T KOG1027|consen  513 PKEILGYGSNGTVVFRGV--YEGREVAVKRLLEE-----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC  585 (903)
T ss_pred             cHHHcccCCCCcEEEEEe--eCCceehHHHHhhH-----hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence            345678888876 46665  45889999987533     2355789999998885 999999999999999999999999


Q ss_pred             CCCHHHHHHhcCC--C-CCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecC----CCcEEEeeccceeeccCCC
Q 045787           89 DLDLHSFITRHKN--T-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK----RNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        89 ~g~l~~~~~~~~~--~-~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~----~~~v~l~d~g~~~~~~~~~  161 (324)
                      .++|.+++.....  . ......+.++.|++.||++||+.+++||||||.|||++..    ..+++|+|||++.......
T Consensus       586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~  665 (903)
T KOG1027|consen  586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK  665 (903)
T ss_pred             hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence            9999999988411  1 1124567889999999999999999999999999999842    2579999999998886443


Q ss_pred             C---cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhC-CCCCCCCChhHHHHHHHHcCCCCcccccchhhh
Q 045787          162 K---EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITG-KPLFPSKKHDHLSLIFSLLGTPTDESWAESTYI  237 (324)
Q Consensus       162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (324)
                      .   +.+...||.+|+|||++.. ..-+.++|||||||++|+.++| .+||...-..+...+..                
T Consensus       666 sS~~r~s~~sGt~GW~APE~L~~-~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~----------------  728 (903)
T KOG1027|consen  666 SSFSRLSGGSGTSGWQAPEQLRE-DRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTG----------------  728 (903)
T ss_pred             chhhcccCCCCcccccCHHHHhc-cccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcC----------------
Confidence            3   3444578899999999987 4447799999999999999996 89996654332211100                


Q ss_pred             hcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCC
Q 045787          238 SEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVE  294 (324)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~  294 (324)
                                 ........+.-..++.+||.+|+..||..||+|.++|.||||=.-+
T Consensus       729 -----------~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~e  774 (903)
T KOG1027|consen  729 -----------NYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSE  774 (903)
T ss_pred             -----------ccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCChH
Confidence                       0000011111122788999999999999999999999999985544

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=260.46  Aligned_cols=252  Identities=25%  Similarity=0.406  Sum_probs=214.2

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCc---eEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCe
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQ---KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKD   80 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~---~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   80 (324)
                      +....-+|.+.||.|.||.|+.++.+..|+   .||+|.++....+ .....|..|+.++-+++||||+++.++......
T Consensus       626 Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyte-kqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~P  704 (996)
T KOG0196|consen  626 IDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTE-KQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKP  704 (996)
T ss_pred             cChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccH-HHHhhhhhhhhhcccCCCCcEEEEEEEEecCce
Confidence            344556889999999999999999876654   6899998765433 335678999999999999999999999999999


Q ss_pred             EEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccC
Q 045787           81 VFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGV  159 (324)
Q Consensus        81 ~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~  159 (324)
                      .-||+||++ |+|..++..+.+.++..++.-+++.|+.|+.||-+.|+|||||-..|||++ .+-..|++|||+++.+..
T Consensus       705 vMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVN-snLvCKVsDFGLSRvled  783 (996)
T KOG0196|consen  705 VMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVN-SNLVCKVSDFGLSRVLED  783 (996)
T ss_pred             eEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeec-cceEEEeccccceeeccc
Confidence            999999997 899999999999999999999999999999999999999999999999999 999999999999998754


Q ss_pred             CCCc-cccccc--ccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCC-hhHHHHHHHHcCCCCcccccch
Q 045787          160 PQKE-YSRDCV--YSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKK-HDHLSLIFSLLGTPTDESWAES  234 (324)
Q Consensus       160 ~~~~-~~~~~~--~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~  234 (324)
                      ..+. .....|  ..+|.|||.+.- .+++.++||||+|++|||.|+ |..||-..+ ++.++.+......|++-     
T Consensus       784 d~~~~ytt~GGKIPiRWTAPEAIa~-RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPm-----  857 (996)
T KOG0196|consen  784 DPEAAYTTLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPM-----  857 (996)
T ss_pred             CCCccccccCCccceeecChhHhhh-cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCC-----
Confidence            4422 222222  355999999977 778999999999999999887 899986666 55666666655555442     


Q ss_pred             hhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          235 TYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                             +.|..|.+|+..|+++|-.+||...+|++
T Consensus       858 -----------------------DCP~aL~qLMldCWqkdR~~RP~F~qiV~  886 (996)
T KOG0196|consen  858 -----------------------DCPAALYQLMLDCWQKDRNRRPKFAQIVS  886 (996)
T ss_pred             -----------------------CCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence                                   57889999999999999999999999986

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=7.1e-34  Score=281.83  Aligned_cols=249  Identities=21%  Similarity=0.271  Sum_probs=182.1

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEe
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEY   87 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   87 (324)
                      .|+..+.||+|++|.||+|.+..++..||+|.+......      ...|++.+++++||||+++++++.++...++||||
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey  764 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY  764 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence            466678899999999999999889999999988643221      23568899999999999999999999999999999


Q ss_pred             cC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCc
Q 045787           88 LD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCH---SLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE  163 (324)
Q Consensus        88 ~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~  163 (324)
                      ++ |+|.+++..    +++..+..++.+++.||+|||   +.+++|+||||+||+++ .++..++. ++.......    
T Consensus       765 ~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~-~~~~~~~~-~~~~~~~~~----  834 (968)
T PLN00113        765 IEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID-GKDEPHLR-LSLPGLLCT----  834 (968)
T ss_pred             CCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEEC-CCCceEEE-ecccccccc----
Confidence            97 588887753    788999999999999999999   66999999999999999 77766664 444332211    


Q ss_pred             ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChh--HHHHHHHH-cCCCCcccccchhhhhcc
Q 045787          164 YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD--HLSLIFSL-LGTPTDESWAESTYISEI  240 (324)
Q Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~-~~~~~~~~~~~~~~~~~~  240 (324)
                      .....+++.|+|||++.+ ..++.++||||||+++|||++|+.||......  ........ ......         ...
T Consensus       835 ~~~~~~t~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~~~  904 (968)
T PLN00113        835 DTKCFISSAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHL---------DMW  904 (968)
T ss_pred             CCCccccccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccch---------hhe
Confidence            112256788999999887 67899999999999999999999998533211  11111000 000000         000


Q ss_pred             cCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          241 LPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      .+.......    ........++.+++.+|++.||.+||++.++++
T Consensus       905 ~~~~~~~~~----~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~  946 (968)
T PLN00113        905 IDPSIRGDV----SVNQNEIVEVMNLALHCTATDPTARPCANDVLK  946 (968)
T ss_pred             eCccccCCC----CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHH
Confidence            000000000    000012235678999999999999999999986

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4e-34  Score=254.01  Aligned_cols=257  Identities=25%  Similarity=0.325  Sum_probs=210.8

Q ss_pred             cCcceeEeecccCceEEEEEEEcc-CCc--eEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTV-TGQ--KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~-~~~--~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   83 (324)
                      +..+..++||+|.||.|+++.... +|+  .||||.+....... ..+.|.+|+.++.+|+|+|++++||+..+ .-.-+
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM  187 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM  187 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence            345677899999999999998663 444  57999988766544 35778999999999999999999999987 55678


Q ss_pred             EEEecC-CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC
Q 045787           84 VFEYLD-LDLHSFITR-HKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        84 v~e~~~-g~l~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~  161 (324)
                      |||.+. |+|++.+.+ ....+-....-.++.||+.|+.||.+++++|+|+-..|+++- ....|||+|||+.+.++...
T Consensus       188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNllla-sprtVKI~DFGLmRaLg~ne  266 (1039)
T KOG0199|consen  188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLA-SPRTVKICDFGLMRALGENE  266 (1039)
T ss_pred             HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheec-ccceeeeecccceeccCCCC
Confidence            999998 799999888 445688889999999999999999999999999999999999 78999999999999887554


Q ss_pred             Ccccc---cccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhh
Q 045787          162 KEYSR---DCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYI  237 (324)
Q Consensus       162 ~~~~~---~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (324)
                      ..+..   ......|+|||.++. ..++.++|||++|++||||++ |..||.+-+...+.+.++....-           
T Consensus       267 d~Yvm~p~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erL-----------  334 (1039)
T KOG0199|consen  267 DMYVMAPQRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERL-----------  334 (1039)
T ss_pred             cceEecCCCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccC-----------
Confidence            43321   223455999999988 778999999999999999999 78999988876665554422111           


Q ss_pred             hcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCC
Q 045787          238 SEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVE  294 (324)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~  294 (324)
                                      ...+..++++.++++.|+..+|.+||+...|.+.-++++..
T Consensus       335 ----------------pRPk~csedIY~imk~cWah~paDRptFsair~~~~l~eaq  375 (1039)
T KOG0199|consen  335 ----------------PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEAQ  375 (1039)
T ss_pred             ----------------CCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHhcC
Confidence                            11236788999999999999999999999998766666554

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-35  Score=256.74  Aligned_cols=279  Identities=25%  Similarity=0.383  Sum_probs=231.1

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      .++|+.+..+|+|.+|.||+|+++.+++..|+|+++......  ...+++|+-+++..+||||+.+++.+.....++|.|
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd--~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM   91 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD--FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM   91 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc--ccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence            468999999999999999999999999999999998765433  567889999999999999999999999999999999


Q ss_pred             EecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccc
Q 045787           86 EYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYS  165 (324)
Q Consensus        86 e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~  165 (324)
                      |||+|+.++.+-..-+++++.++...++..+.+|.|||+.|-+|||||-.||+++ +.|.+++.|||.+..+...-....
T Consensus        92 EycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanillt-d~gDvklaDfgvsaqitati~Krk  170 (829)
T KOG0576|consen   92 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLT-DEGDVKLADFGVSAQITATIAKRK  170 (829)
T ss_pred             EecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeec-ccCceeecccCchhhhhhhhhhhh
Confidence            9999644444455567899999999999999999999999999999999999999 999999999999887765555666


Q ss_pred             ccccccccCCchhhc--CCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCC
Q 045787          166 RDCVYSPYKAPELLL--GYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPL  243 (324)
Q Consensus       166 ~~~~~~~y~aPE~~~--~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (324)
                      ...|||.|+|||+-.  ....+...+|+|++|+...|+---++|.-...+-....+...-+.-+..              
T Consensus       171 sfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~--------------  236 (829)
T KOG0576|consen  171 SFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPT--------------  236 (829)
T ss_pred             cccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCc--------------
Confidence            678999999999952  3466899999999999999999888776544443333332211111110              


Q ss_pred             CCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchhhhhhhhcccCCC
Q 045787          244 YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLINRKKKLG  310 (324)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~  310 (324)
                               .+.....++.+.+|++.+|.++|.+||+++.+|.|||........+...++++.++=+
T Consensus       237 ---------lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~l~~rl~~eLLdK~n~P~  294 (829)
T KOG0576|consen  237 ---------LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQTLSRRLAIELLDKVNNPN  294 (829)
T ss_pred             ---------ccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccchhhHHHHHHHHHccCCC
Confidence                     1112356788899999999999999999999999999999988888888888775544

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=1.1e-31  Score=219.51  Aligned_cols=213  Identities=39%  Similarity=0.654  Sum_probs=185.1

Q ss_pred             ecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEecC-CCHH
Q 045787           15 IGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD-LDLH   93 (324)
Q Consensus        15 Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~-g~l~   93 (324)
                      ||+|++|.||++.+..+++.+++|++....... ..+.+.+|+..++.++|++++++++++......++++|+++ +++.
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~   79 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK   79 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence            689999999999998889999999988654432 24678899999999999999999999999999999999999 5888


Q ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecC-CCcEEEeeccceeeccCCCCcccccccccc
Q 045787           94 SFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK-RNTVKLADFGLARAIGVPQKEYSRDCVYSP  172 (324)
Q Consensus        94 ~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~-~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~  172 (324)
                      +++......++...++.++.+++.++.+||+.|++|+||+|.||+++ . ++.++|+|||.+..............+...
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~-~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~  158 (215)
T cd00180          80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLD-SDNGKVKLADFGLSKLLTSDKSLLKTIVGTPA  158 (215)
T ss_pred             HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEe-CCCCcEEEecCCceEEccCCcchhhcccCCCC
Confidence            88776545689999999999999999999999999999999999999 6 799999999999876544322333456777


Q ss_pred             cCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcch
Q 045787          173 YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANL  252 (324)
Q Consensus       173 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (324)
                      |++||........+.++|+|++|++++++                                                   
T Consensus       159 ~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------------  187 (215)
T cd00180         159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------------  187 (215)
T ss_pred             ccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------------
Confidence            99999987743778999999999999998                                                   


Q ss_pred             hhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCc
Q 045787          253 AEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHE  288 (324)
Q Consensus       253 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp  288 (324)
                              ..+.+++.+|++.||.+||+++++++|+
T Consensus       188 --------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 --------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             --------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                    2456999999999999999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-34  Score=246.82  Aligned_cols=199  Identities=29%  Similarity=0.440  Sum_probs=176.2

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc------cCCCchHHHHHHHHHHhcC---CCCeeEEEeeeec
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE------QEGVPSYIIREVSLLKELE---HENIVRLLDVQSS   77 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~------~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~   77 (324)
                      .+|+.++.||.|+||.|++|.++.+...|++|.+.+..-      +....-.+-.|+.+|..++   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            469999999999999999999999999999999987642      1222334667999999997   9999999999999


Q ss_pred             CCeEEEEEEecC-C-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeecccee
Q 045787           78 RKDVFLVFEYLD-L-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLAR  155 (324)
Q Consensus        78 ~~~~~iv~e~~~-g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~  155 (324)
                      ++++||++|..+ | +|.++++..+ .+++.+++.|++|+..|+.+||+.||+|||||-+||.++ .+|-+||+|||.+.
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd-~~g~~klidfgsaa  718 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVD-SNGFVKLIDFGSAA  718 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhccC-ccchHHHHHHHHHHHhccccccccCceecccccccEEEe-cCCeEEEeeccchh
Confidence            999999999987 5 8999988754 599999999999999999999999999999999999999 99999999999987


Q ss_pred             eccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCC
Q 045787          156 AIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFP  209 (324)
Q Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~  209 (324)
                      ....  .......||..|.|||++.+....+..-|||+||+++|.++....||.
T Consensus       719 ~~ks--gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  719 YTKS--GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             hhcC--CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            6542  334455799999999999998888999999999999999999999984

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-33  Score=212.36  Aligned_cols=203  Identities=26%  Similarity=0.436  Sum_probs=169.2

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      +.......||+|++|.|-+.++..+|...|+|.+...-..+. .+++..|+.+..+- .+|+++.+++.+......+|-|
T Consensus        46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~-q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM  124 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQE-QKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM  124 (282)
T ss_pred             hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHH-HHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence            344556789999999999999999999999999876554332 35566788877666 5899999999999999999999


Q ss_pred             EecCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCCCCceEeecCCCcEEEeeccceeeccCCC
Q 045787           86 EYLDLDLHSFIT---RHKNTLNLLVIKAILKQILLGLAYCHSL-KILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        86 e~~~g~l~~~~~---~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~  161 (324)
                      |.++.++..+..   ..+..+++..+-+++.++..||.|||++ .++|||+||+|||++ .+|+||+||||.+-.+..+-
T Consensus       125 E~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn-~~GqVKiCDFGIsG~L~dSi  203 (282)
T KOG0984|consen  125 ELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILIN-YDGQVKICDFGISGYLVDSI  203 (282)
T ss_pred             HHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEc-cCCcEEEcccccceeehhhh
Confidence            999987766654   3466799999999999999999999965 899999999999999 99999999999987664332


Q ss_pred             CcccccccccccCCchhhcC---CCCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 045787          162 KEYSRDCVYSPYKAPELLLG---YTGYSTPIDVWAVGCIFAEMITGKPLFPSKK  212 (324)
Q Consensus       162 ~~~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  212 (324)
                       ..+...|...|+|||.+..   ...|+.++||||||+.++||.+++.||....
T Consensus       204 -Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~  256 (282)
T KOG0984|consen  204 -AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG  256 (282)
T ss_pred             -HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence             2233457777999999853   3468999999999999999999999997655

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-33  Score=249.02  Aligned_cols=250  Identities=25%  Similarity=0.349  Sum_probs=210.5

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCc----eEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQ----KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV   81 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~----~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   81 (324)
                      ....+-.+.||+|+||+||++..-..|+    +||+|++..... ......+.+|+.++.++.|||++++++++.... .
T Consensus       695 Etelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~-~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~  772 (1177)
T KOG1025|consen  695 ETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS-PKASIELLDEALRMASLDHPNLLRLLGVCMLST-L  772 (1177)
T ss_pred             hhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC-chhhHHHHHHHHHHhcCCCchHHHHhhhcccch-H
Confidence            3445667899999999999998765555    678888764433 333577889999999999999999999987655 6


Q ss_pred             EEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           82 FLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        82 ~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      -||++|++ |+|++++..+++.+-......|..||++|+.|||.++++||||-..|||+. .-+.+|++|||++......
T Consensus       773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVk-sP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVK-SPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeec-CCCeEEEEecchhhccCcc
Confidence            78999998 799999999999999999999999999999999999999999999999999 8999999999999988766


Q ss_pred             CCcccccccc--cccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhh
Q 045787          161 QKEYSRDCVY--SPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYI  237 (324)
Q Consensus       161 ~~~~~~~~~~--~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (324)
                      ........+.  +.|+|-|.++. ..++.++||||+|+.+||++| |..|+.+...+++.........            
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR------------  918 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER------------  918 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc------------
Confidence            6665555443  34899998887 788999999999999999999 9999999887777665543322            


Q ss_pred             hcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          238 SEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                     ....+..+.++..++.+||..|+..||+++++..
T Consensus       919 ---------------LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  919 ---------------LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             ---------------CCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence                           2223467889999999999999999999998864

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-31  Score=249.33  Aligned_cols=250  Identities=28%  Similarity=0.402  Sum_probs=200.6

Q ss_pred             cCcceeEeecccCceEEEEEEEc----c---CCceEEEEEeeeccccCCCchHHHHHHHHHHhcC-CCCeeEEEeeeecC
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNT----V---TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-HENIVRLLDVQSSR   78 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~----~---~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~   78 (324)
                      ++..+.+.||+|.||.|+++.-.    .   ....||+|.+...... ...+.+..|+.+++.+. |+|++.+++.+...
T Consensus       296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~~  374 (609)
T KOG0200|consen  296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQD  374 (609)
T ss_pred             hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence            34466779999999999999733    1   1457899998876655 45678999999999995 99999999999999


Q ss_pred             CeEEEEEEecC-CCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecC
Q 045787           79 KDVFLVFEYLD-LDLHSFITRHK---------------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK  142 (324)
Q Consensus        79 ~~~~iv~e~~~-g~l~~~~~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~  142 (324)
                      +..++|.||+. |+|+.++...+               ..++......+..||+.|++||++..++|||+-..|||+. .
T Consensus       375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~-~  453 (609)
T KOG0200|consen  375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT-K  453 (609)
T ss_pred             CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec-C
Confidence            99999999998 89999999877               3488999999999999999999999999999999999999 8


Q ss_pred             CCcEEEeeccceeeccCCCCcc-ccccc--ccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCC-hhHHH
Q 045787          143 RNTVKLADFGLARAIGVPQKEY-SRDCV--YSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKK-HDHLS  217 (324)
Q Consensus       143 ~~~v~l~d~g~~~~~~~~~~~~-~~~~~--~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~-~~~~~  217 (324)
                      +..+||+|||+++.......-. ....+  ...|+|||.+.. ..++.++||||+|+++||+++ |..||.+-. ...+.
T Consensus       454 ~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~  532 (609)
T KOG0200|consen  454 NKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELL  532 (609)
T ss_pred             CCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHH
Confidence            8999999999998654322211 11122  233999999998 889999999999999999999 789997633 22222


Q ss_pred             HHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          218 LIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      ......                           ...+.....++++.++++.|++.+|.+||+..++..
T Consensus       533 ~~l~~G---------------------------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  533 EFLKEG---------------------------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             HHHhcC---------------------------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            211111                           111122356889999999999999999999999985

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.98  E-value=3e-32  Score=232.53  Aligned_cols=258  Identities=23%  Similarity=0.309  Sum_probs=190.3

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhc--CCCCeeEEEeeeecCC----eE
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL--EHENIVRLLDVQSSRK----DV   81 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l--~~~~i~~~~~~~~~~~----~~   81 (324)
                      ..+..+.+|+|.||.||+|+-.  ++.||||+|+....     +.+.+|-+++...  +|+||++++++-....    .+
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~k-----qs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey  283 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQEK-----QSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY  283 (534)
T ss_pred             chhhHHHhhcCccceeehhhcc--CceeEEEecCHHHH-----HHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence            4566788999999999999865  68999999985543     3467777777654  7999999998865544    79


Q ss_pred             EEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCcccCCCCCceEeecCCCcEEEeec
Q 045787           82 FLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSL---------KILHRDLKPNNLLIDLKRNTVKLADF  151 (324)
Q Consensus        82 ~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---------g~~H~di~p~nIll~~~~~~v~l~d~  151 (324)
                      ++|++|.+ |+|.+++..+  .+++....+++..++.||+|||+-         +|+|||||..|||+. .+.+..|+||
T Consensus       284 wLVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK-~DlTccIaDF  360 (534)
T KOG3653|consen  284 WLVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVK-NDLTCCIADF  360 (534)
T ss_pred             eEEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEc-cCCcEEeecc
Confidence            99999997 8999999874  699999999999999999999963         499999999999999 9999999999


Q ss_pred             cceeeccCCCC--cccccccccccCCchhhcCCCCCC-----CchhhHHHHHHHHHHHhCCCCCC-CCChh-HHHHHHHH
Q 045787          152 GLARAIGVPQK--EYSRDCVYSPYKAPELLLGYTGYS-----TPIDVWAVGCIFAEMITGKPLFP-SKKHD-HLSLIFSL  222 (324)
Q Consensus       152 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~-----~~~DiwslG~il~~l~~g~~pf~-~~~~~-~~~~~~~~  222 (324)
                      |++........  ......||.+|||||++.+..++.     .+.||||+|.++|||++.-..+. +..++ ++.....+
T Consensus       361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev  440 (534)
T KOG3653|consen  361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV  440 (534)
T ss_pred             ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence            99988863222  233368999999999998755555     36899999999999999765543 22222 22222233


Q ss_pred             cCCCCcccccchhhhhcccCCCCCCCCcchhhhCC--CCChhHHHHHHHhhcCCCCCCCCHHH
Q 045787          223 LGTPTDESWAESTYISEILPLYPHFEPANLAEKFP--NLEPAGVDLLSQMLCLNPKQRITAMD  283 (324)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~dP~~Rps~~~  283 (324)
                      ...|..+.....--..     .   .+..+.+.|.  .-...+.+.+..|++.||+-|.|+.=
T Consensus       441 G~hPt~e~mq~~VV~k-----K---~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~C  495 (534)
T KOG3653|consen  441 GNHPTLEEMQELVVRK-----K---QRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGC  495 (534)
T ss_pred             cCCCCHHHHHHHHHhh-----c---cCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHH
Confidence            3333322221111111     1   1111122222  23456789999999999999999653

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=6.5e-33  Score=221.29  Aligned_cols=258  Identities=24%  Similarity=0.341  Sum_probs=195.4

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcC-CCCeeEEEe-eeecCCeEE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-HENIVRLLD-VQSSRKDVF   82 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~-~~~~~~~~~   82 (324)
                      +.+.|.|.+.||.|.||.+-+|.++.++.++++|.++.+...   .+.+.+|...--.|+ |.||+..++ .|+..+.++
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt---~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv   98 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT---QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV   98 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh---HHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence            457899999999999999999999999999999999876544   356777777555554 889998887 477788899


Q ss_pred             EEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeec-CCCcEEEeeccceeeccCC
Q 045787           83 LVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL-KRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        83 iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~-~~~~v~l~d~g~~~~~~~~  160 (324)
                      +++||++ |+|.+-+..  ..+-+...+.++.|+++|+.|+|+++++|||||.+|||+-. +..+|||||||..+..+..
T Consensus        99 F~qE~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t  176 (378)
T KOG1345|consen   99 FVQEFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT  176 (378)
T ss_pred             EeeccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce
Confidence            9999998 799887766  34889999999999999999999999999999999999953 3468999999998876533


Q ss_pred             CCcccccccccccCCchhhcC----CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhh
Q 045787          161 QKEYSRDCVYSPYKAPELLLG----YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY  236 (324)
Q Consensus       161 ~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (324)
                      -...   -....|.+||....    .-...+.+|+|.||+++|.++||..||....          ...++...|..+..
T Consensus       177 V~~~---~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~----------~~d~~Y~~~~~w~~  243 (378)
T KOG1345|consen  177 VKYL---EYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS----------IMDKPYWEWEQWLK  243 (378)
T ss_pred             ehhh---hhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh----------ccCchHHHHHHHhc
Confidence            2221   23345999998753    2235788999999999999999999995222          01111111111110


Q ss_pred             hhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCC---CCHHHHhcCccc
Q 045787          237 ISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQR---ITAMDALKHEYL  290 (324)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R---ps~~~~l~hp~~  290 (324)
                               . .....+..+..+++.+.+++++-|..+|++|   .+++.-...-|.
T Consensus       244 ---------r-k~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~  290 (378)
T KOG1345|consen  244 ---------R-KNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK  290 (378)
T ss_pred             ---------c-cCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence                     0 1124455667799999999999999999999   555544444443

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=1.1e-29  Score=210.26  Aligned_cols=200  Identities=39%  Similarity=0.625  Sum_probs=172.5

Q ss_pred             cceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEec
Q 045787            9 YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYL   88 (324)
Q Consensus         9 y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   88 (324)
                      |++.+.||.|+++.||++.+..+++.+++|.+...... ...+.+.+|++.+++++|++++++++.+......++++|++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   79 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC   79 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence            67889999999999999999888899999998865433 13567889999999999999999999999989999999999


Q ss_pred             CC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC-Ccccc
Q 045787           89 DL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ-KEYSR  166 (324)
Q Consensus        89 ~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~-~~~~~  166 (324)
                      ++ +|.+++......+++..+..++.+++.++.+||+.|++|+|++|.||+++ .++.++|+|||.+....... .....
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~-~~~~~~l~d~g~~~~~~~~~~~~~~~  158 (225)
T smart00221       80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLG-MDGLVKLADFGLARFIHRDLAALLKT  158 (225)
T ss_pred             CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc-CCCCEEEeeCceeeEecCcccccccc
Confidence            87 88888876543388999999999999999999999999999999999999 78999999999988765432 12233


Q ss_pred             cccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 045787          167 DCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPS  210 (324)
Q Consensus       167 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  210 (324)
                      ..++..|++||.+.+...++.++|+|+||+++++|++|+.||..
T Consensus       159 ~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      159 VKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             eeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            45667799999984436678899999999999999999999976

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.6e-30  Score=218.40  Aligned_cols=254  Identities=25%  Similarity=0.340  Sum_probs=185.2

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHh--cCCCCeeEEEeeeecC---
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKE--LEHENIVRLLDVQSSR---   78 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~~~---   78 (324)
                      +...+.++++.+|+|.||.||++...  |+.||||+|.....     +...+|.++++.  |+|+||+.+++.-..+   
T Consensus       208 TiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE-----~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs  280 (513)
T KOG2052|consen  208 TIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDE-----RSWFRETEIYQTVMLRHENILGFIAADNKDNGS  280 (513)
T ss_pred             hhhheeEEEEEecCccccceeecccc--CCceEEEEecccch-----hhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence            34567789999999999999999875  88999999975433     345677777766  4899999999875433   


Q ss_pred             -CeEEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCcccCCCCCceEeecCCCcEEE
Q 045787           79 -KDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSL--------KILHRDLKPNNLLIDLKRNTVKL  148 (324)
Q Consensus        79 -~~~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~--------g~~H~di~p~nIll~~~~~~v~l  148 (324)
                       .++++|++|.+ |+|.+++..  ..++.+...+++.+++.||++||..        .|.|||||..|||+. .++..-|
T Consensus       281 ~TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK-kn~~C~I  357 (513)
T KOG2052|consen  281 WTQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCI  357 (513)
T ss_pred             eEEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc-cCCcEEE
Confidence             26899999998 899999988  5799999999999999999999953        399999999999999 9999999


Q ss_pred             eeccceeeccCCC----CcccccccccccCCchhhcCCCCC-----CCchhhHHHHHHHHHHHhC----------CCCCC
Q 045787          149 ADFGLARAIGVPQ----KEYSRDCVYSPYKAPELLLGYTGY-----STPIDVWAVGCIFAEMITG----------KPLFP  209 (324)
Q Consensus       149 ~d~g~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~-----~~~~DiwslG~il~~l~~g----------~~pf~  209 (324)
                      +|+|++.......    ......+||.+|||||++......     -..+||||||.++||++..          ++||.
T Consensus       358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy  437 (513)
T KOG2052|consen  358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY  437 (513)
T ss_pred             eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence            9999998775442    234456899999999998642221     2358999999999999864          25653


Q ss_pred             CCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCC-CCCcchhhhCCCC--ChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          210 SKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPH-FEPANLAEKFPNL--EPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~--~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      +--                   +.....+++.+...- ......+..|...  =..+.++++.|+..||.-|.|+..+..
T Consensus       438 d~V-------------------p~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  438 DVV-------------------PSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             cCC-------------------CCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence            221                   111111111110000 0000011111111  124568999999999999999887763

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=4.9e-31  Score=255.36  Aligned_cols=202  Identities=17%  Similarity=0.230  Sum_probs=145.1

Q ss_pred             hcCC-CCeeEEEeee-------ecCCeEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 045787           62 ELEH-ENIVRLLDVQ-------SSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLK  133 (324)
Q Consensus        62 ~l~~-~~i~~~~~~~-------~~~~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~  133 (324)
                      .++| +||.++++.+       ...+.++.++|+++++|.+++......+++..++.++.||+.||.|||++||+|+|||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK  107 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR  107 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence            3444 4666666665       2234678889999999999998766679999999999999999999999999999999


Q ss_pred             CCceEeecCC-------------------CcEEEeeccceeeccCCC----------------CcccccccccccCCchh
Q 045787          134 PNNLLIDLKR-------------------NTVKLADFGLARAIGVPQ----------------KEYSRDCVYSPYKAPEL  178 (324)
Q Consensus       134 p~nIll~~~~-------------------~~v~l~d~g~~~~~~~~~----------------~~~~~~~~~~~y~aPE~  178 (324)
                      |+|||++ ..                   +.++++|||.+.......                .......+|+.|+|||+
T Consensus       108 P~NiLl~-~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~  186 (793)
T PLN00181        108 PSCFVMS-SFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE  186 (793)
T ss_pred             chhEEEc-ccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence            9999996 43                   445566666554321000                00011357888999999


Q ss_pred             hcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCC
Q 045787          179 LLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPN  258 (324)
Q Consensus       179 ~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (324)
                      +.+ ..++.++|||||||++|||++|..|+...... +...... ..++.                           ...
T Consensus       187 ~~~-~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~-~~~~~~~-~~~~~---------------------------~~~  236 (793)
T PLN00181        187 DNG-SSSNCASDVYRLGVLLFELFCPVSSREEKSRT-MSSLRHR-VLPPQ---------------------------ILL  236 (793)
T ss_pred             hcc-CCCCchhhhhhHHHHHHHHhhCCCchhhHHHH-HHHHHHh-hcChh---------------------------hhh
Confidence            887 66799999999999999999988876432211 1111000 00000                           001


Q ss_pred             CChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCC
Q 045787          259 LEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVE  294 (324)
Q Consensus       259 ~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~  294 (324)
                      ......+++.+||+.||.+||++.++++||||.+..
T Consensus       237 ~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~~  272 (793)
T PLN00181        237 NWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEPR  272 (793)
T ss_pred             cCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhhh
Confidence            133456889999999999999999999999998753

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=6.9e-29  Score=197.86  Aligned_cols=166  Identities=19%  Similarity=0.217  Sum_probs=127.6

Q ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccccccc
Q 045787           90 LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCV  169 (324)
Q Consensus        90 g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~~~~  169 (324)
                      |+|.+++...+.++++..++.++.|++.||.|||+.+      ||+||+++ .++.+++  ||.+.......     ..+
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~-~~~~~~~--fG~~~~~~~~~-----~~g   66 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLT-WDGLLKL--DGSVAFKTPEQ-----SRV   66 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEc-Cccceee--ccceEeecccc-----CCC
Confidence            6888888876778999999999999999999999998      99999999 8899998  99887654322     257


Q ss_pred             ccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChh--HHHHHHHHcCCCCcccccchhhhhcccCCCCCC
Q 045787          170 YSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD--HLSLIFSLLGTPTDESWAESTYISEILPLYPHF  247 (324)
Q Consensus       170 ~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (324)
                      ++.|+|||++.+ ..++.++|||||||++|+|++|..||......  ............   ....              
T Consensus        67 ~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~--------------  128 (176)
T smart00750       67 DPYFMAPEVIQG-QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPAD---DPRD--------------  128 (176)
T ss_pred             cccccChHHhcC-CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccC---Cccc--------------
Confidence            889999999987 67899999999999999999999999654421  111111111000   0000              


Q ss_pred             CCcchhhhCCCCCh--hHHHHHHHhhcCCCCCCCCHHHHhcCccccC
Q 045787          248 EPANLAEKFPNLEP--AGVDLLSQMLCLNPKQRITAMDALKHEYLIG  292 (324)
Q Consensus       248 ~~~~~~~~~~~~~~--~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~  292 (324)
                       ..    ....++.  .+.+++.+||..||.+||++.++++|+|+..
T Consensus       129 -~~----~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      129 -RS----NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             -cc----cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence             00    0012233  6899999999999999999999999999864

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=5.8e-29  Score=208.04  Aligned_cols=253  Identities=19%  Similarity=0.266  Sum_probs=198.4

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEcc-----CCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeee-ec
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTV-----TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQ-SS   77 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~   77 (324)
                      +...|++..-.+-+|.||.||.++...     +.+.+.+|++...... -....+..|--.+..+.|||+..+.++. ++
T Consensus       281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~-iQv~~~L~es~lly~~sH~nll~V~~V~ie~  359 (563)
T KOG1024|consen  281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQ-IQVNLLLQESMLLYGASHPNLLSVLGVSIED  359 (563)
T ss_pred             hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccH-HHHHHHHHHHHHHhcCcCCCccceeEEEeec
Confidence            345677888889999999999996542     2345666666533322 1245677888888888999999999976 45


Q ss_pred             CCeEEEEEEecC-CCHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEe
Q 045787           78 RKDVFLVFEYLD-LDLHSFITRHK-------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLA  149 (324)
Q Consensus        78 ~~~~~iv~e~~~-g~l~~~~~~~~-------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~  149 (324)
                      ....++++++.+ |+|..++...+       ..++..+...++.|++.|+.|||+.|++|.||-..|.+++ +.-+|||+
T Consensus       360 ~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvId-d~LqVklt  438 (563)
T KOG1024|consen  360 YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVID-DQLQVKLT  438 (563)
T ss_pred             cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceeh-hheeEEec
Confidence            567899999998 89999998443       2366677888999999999999999999999999999999 88999999


Q ss_pred             eccceeeccCCCCc-cc-ccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCC
Q 045787          150 DFGLARAIGVPQKE-YS-RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTP  226 (324)
Q Consensus       150 d~g~~~~~~~~~~~-~~-~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~  226 (324)
                      |=.+++...+..-. .+ ..-....||+||.+.+ ..++.++|+||||+++|||+| |+.|+..-++.++..........
T Consensus       439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRl  517 (563)
T KOG1024|consen  439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRL  517 (563)
T ss_pred             cchhccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcccee
Confidence            99988876533221 11 1112344999999988 788999999999999999999 89999888877776554433222


Q ss_pred             CcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          227 TDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      ..                           .-+.|+++..++.-|+..+|++||+..|+..
T Consensus       518 aQ---------------------------P~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  518 AQ---------------------------PFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             cC---------------------------CCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            21                           2278999999999999999999999999875

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=9.7e-26  Score=196.34  Aligned_cols=253  Identities=23%  Similarity=0.225  Sum_probs=194.6

Q ss_pred             CcceeEeecccCceEEEEEEEccCC-ceEEEEEeeeccccCCCchHHHHHHHHHHhcC----CCCeeEEEeee-ecCCeE
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTG-QKVAIKMMTIQTEQEGVPSYIIREVSLLKELE----HENIVRLLDVQ-SSRKDV   81 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~-~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~----~~~i~~~~~~~-~~~~~~   81 (324)
                      +|++.+.||+|+||.||.|.+...+ ..+|+|.-........  ..+..|..++..+.    .+++..+++.. ..+...
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~   96 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN   96 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence            8999999999999999999988764 5788888765533321  25778899888887    26899999999 578889


Q ss_pred             EEEEEecCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCC----CcEEEeecccee-
Q 045787           82 FLVFEYLDLDLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKR----NTVKLADFGLAR-  155 (324)
Q Consensus        82 ~iv~e~~~g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~----~~v~l~d~g~~~-  155 (324)
                      |+||+.++.+|.+...... +.++...+..++.|++.+|.+||+.|++||||||+|++++...    ..++|.|||+++ 
T Consensus        97 ~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~  176 (322)
T KOG1164|consen   97 FIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR  176 (322)
T ss_pred             EEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence            9999999999999887665 6899999999999999999999999999999999999998443    579999999998 


Q ss_pred             -eccCCCC---c-----ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHHcCC
Q 045787          156 -AIGVPQK---E-----YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD-HLSLIFSLLGT  225 (324)
Q Consensus       156 -~~~~~~~---~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~  225 (324)
                       .......   .     .....||..|+++....+ ...+.+.|+||++.++.++..|..||...... ...........
T Consensus       177 ~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~-~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~  255 (322)
T KOG1164|consen  177 FKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG-IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRK  255 (322)
T ss_pred             ccccCCCCcccccCCCCccCCCCccccccHHHhCC-CccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhh
Confidence             3211111   1     122348999999999988 77799999999999999999999999665522 11111111000


Q ss_pred             CCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcC
Q 045787          226 PTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH  287 (324)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~h  287 (324)
                      .....                        .....+..+..+...+-..+...+|....+...
T Consensus       256 ~~~~~------------------------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  256 LLTDR------------------------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             hcccc------------------------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            00000                        112345677788887778999999998887754

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=3.4e-28  Score=224.66  Aligned_cols=265  Identities=27%  Similarity=0.385  Sum_probs=202.7

Q ss_pred             ceeEeecccCceEEEEEEEccCCceEEEEEeee----ccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787           10 KKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTI----QTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus        10 ~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~----~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      ...+.+|.|++|.|+.+......+.+..|.+..    ..........+-.|+.+-..+.|++++.....+.+.....-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            567889999999999888877777777776552    2222222222666777778889999988877776655555559


Q ss_pred             EecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCc--
Q 045787           86 EYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE--  163 (324)
Q Consensus        86 e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~--  163 (324)
                      ||++++|...+... ..++...+..++.|++.|+.|+|+.|+.|+|+||+|+++. .++.+||+|||.+.....+.+.  
T Consensus       401 E~~~~Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~-~~g~lki~Dfg~~~vf~~~~e~~~  478 (601)
T KOG0590|consen  401 EYCPYDLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVT-ENGILKIIDFGAASVFRYPWEKNI  478 (601)
T ss_pred             hcccHHHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEe-cCCceEEeecCcceeeccCcchhh
Confidence            99999777776663 4699999999999999999999999999999999999999 9999999999998877655543  


Q ss_pred             --ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhccc
Q 045787          164 --YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEIL  241 (324)
Q Consensus       164 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (324)
                        ....+|+.+|+|||++.+........||||.|+++..|.+|+.||.......-..                   ....
T Consensus       479 ~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-------------------~~~~  539 (601)
T KOG0590|consen  479 HESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-------------------KTNN  539 (601)
T ss_pred             hhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-------------------hhhc
Confidence              3445788899999999986666778999999999999999999996555332110                   0000


Q ss_pred             CCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCC
Q 045787          242 PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVEN  295 (324)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~  295 (324)
                      .....-........+..++...+.+|.+||+.||.+|.|+.+|++.+||+++.-
T Consensus       540 ~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~  593 (601)
T KOG0590|consen  540 YSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC  593 (601)
T ss_pred             cccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence            000001122223344568888999999999999999999999999999999864

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=4.5e-25  Score=173.80  Aligned_cols=206  Identities=24%  Similarity=0.377  Sum_probs=175.2

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCC-CCeeEEEeeeecCCeEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEH-ENIVRLLDVQSSRKDVF   82 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~   82 (324)
                      +..+.|+++++||+|+||.+|++....+|..||+|+-+.....    ..+..|..+++.+++ ..++.+..+..+..+-.
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynv   87 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNV   87 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhccccccce
Confidence            4678999999999999999999999999999999986654443    346789999999985 78888888888889999


Q ss_pred             EEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecC--CCcEEEeeccceeeccCC
Q 045787           83 LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK--RNTVKLADFGLARAIGVP  160 (324)
Q Consensus        83 iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~--~~~v~l~d~g~~~~~~~~  160 (324)
                      +||+..+.+|.+.+.-+...++...+.-++-|++.-++|+|.++++|+||||+|+|..-.  ...+.|+|||++...-..
T Consensus        88 lVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~  167 (341)
T KOG1163|consen   88 LVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDI  167 (341)
T ss_pred             eeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccc
Confidence            999999999999999988899999999999999999999999999999999999998622  367999999999776433


Q ss_pred             CC-------cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChh
Q 045787          161 QK-------EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD  214 (324)
Q Consensus       161 ~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~  214 (324)
                      ..       ......||-.|.+--...+ ..-+.+.|+-|+|.++.++..|..||.+....
T Consensus       168 ~t~~HIpyre~r~ltGTaRYASinAh~g-~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~  227 (341)
T KOG1163|consen  168 RTRQHIPYREDRNLTGTARYASINAHLG-IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA  227 (341)
T ss_pred             cccccCccccCCccceeeeehhhhhhhh-hhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence            22       2233467878888776666 44588899999999999999999999776633

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.93  E-value=2.7e-25  Score=185.38  Aligned_cols=235  Identities=20%  Similarity=0.309  Sum_probs=151.5

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeecccc-CCCchHHHHHHHHHHhcCC----------CCeeEEEeee-
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQ-EGVPSYIIREVSLLKELEH----------ENIVRLLDVQ-   75 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~-~~~~~~~~~e~~~l~~l~~----------~~i~~~~~~~-   75 (324)
                      .....+.||.|+++.||.|.+..+|+.+++|++...... ....+.+++|.-....+.+          -.++..++.. 
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            456778999999999999999999999999999876522 2234555555544444322          1222222221 


Q ss_pred             --------ec---CC-----eEEEEEEecCCCHHHHHHh---cCCC---CCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 045787           76 --------SS---RK-----DVFLVFEYLDLDLHSFITR---HKNT---LNLLVIKAILKQILLGLAYCHSLKILHRDLK  133 (324)
Q Consensus        76 --------~~---~~-----~~~iv~e~~~g~l~~~~~~---~~~~---~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~  133 (324)
                              ..   ..     ..+++|+-+.++|.+.+..   ....   ........+..|++..+++||..|++|+||+
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~  172 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK  172 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence                    11   11     2478899988888777653   2211   2223344556889999999999999999999


Q ss_pred             CCceEeecCCCcEEEeeccceeeccCCCCcccccccccccCCchhhcC-------CCCCCCchhhHHHHHHHHHHHhCCC
Q 045787          134 PNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLG-------YTGYSTPIDVWAVGCIFAEMITGKP  206 (324)
Q Consensus       134 p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~~g~~  206 (324)
                      |+|++++ .+|.++|+||+.....+...   .....+..|.|||....       ...++.+.|.|+||+++|.|+++..
T Consensus       173 ~~nfll~-~~G~v~Lg~F~~~~r~g~~~---~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l  248 (288)
T PF14531_consen  173 PENFLLD-QDGGVFLGDFSSLVRAGTRY---RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL  248 (288)
T ss_dssp             GGGEEE--TTS-EEE--GGGEEETTEEE---EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred             eeeEEEc-CCCCEEEcChHHHeecCcee---eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence            9999999 89999999999887655322   11334466899998743       2346889999999999999999999


Q ss_pred             CCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCC
Q 045787          207 LFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQR  278 (324)
Q Consensus       207 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R  278 (324)
                      ||........                ..               ..+.... ++|+.+++||..+|+.||.+|
T Consensus       249 Pf~~~~~~~~----------------~~---------------~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  249 PFGLSSPEAD----------------PE---------------WDFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             STCCCGGGST----------------SG---------------GGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCcccc----------------cc---------------ccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            9965443210                00               0122222 789999999999999999988

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.93  E-value=2.1e-23  Score=182.30  Aligned_cols=264  Identities=35%  Similarity=0.576  Sum_probs=205.6

Q ss_pred             cceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCC-CchHHHHHHHHHHhcCCC-CeeEEEeeeecCCeEEEEEE
Q 045787            9 YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEG-VPSYIIREVSLLKELEHE-NIVRLLDVQSSRKDVFLVFE   86 (324)
Q Consensus         9 y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~-~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~iv~e   86 (324)
                      |++...||.|+++.||.+.+.   ..+++|.+........ ....+.+|...+..+.|+ +++++.+.+......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            789999999999999999987   7889999887665543 467788999999999988 79999999987778899999


Q ss_pred             ecCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCC-cEEEeeccceeeccCCCC
Q 045787           87 YLDL-DLHSFITRHK--NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN-TVKLADFGLARAIGVPQK  162 (324)
Q Consensus        87 ~~~g-~l~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~-~v~l~d~g~~~~~~~~~~  162 (324)
                      ++.+ ++.+.+....  ..++......++.+++.++.++|+.|++|+|+||+||+++ ..+ .++++|||.+........
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~-~~~~~~~l~dfg~~~~~~~~~~  157 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLD-RDGRVVKLIDFGLAKLLPDPGS  157 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec-CCCCeEEEeccCcceecCCCCc
Confidence            9985 6664554433  2699999999999999999999999999999999999999 666 799999999876543332


Q ss_pred             ------cccccccccccCCchhhcCC--CCCCCchhhHHHHHHHHHHHhCCCCCCCCCh----hHHHHHHHHcCCC-Ccc
Q 045787          163 ------EYSRDCVYSPYKAPELLLGY--TGYSTPIDVWAVGCIFAEMITGKPLFPSKKH----DHLSLIFSLLGTP-TDE  229 (324)
Q Consensus       163 ------~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~~~~~~~~~~-~~~  229 (324)
                            ......++..|+|||...+.  .......|+|++|++++++++|..||.....    ............+ ...
T Consensus       158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (384)
T COG0515         158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS  237 (384)
T ss_pred             cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccccc
Confidence                  23556789999999999874  5779999999999999999999999876663    2322222222221 000


Q ss_pred             cccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCc
Q 045787          230 SWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENV  296 (324)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~  296 (324)
                      ..                .....    ......+.+++..++..+|..|.+..+...++|.......
T Consensus       238 ~~----------------~~~~~----~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~  284 (384)
T COG0515         238 PL----------------SPSNP----ELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLK  284 (384)
T ss_pred             cc----------------Ccccc----chhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcccc
Confidence            00                00000    1233578899999999999999999999988666555433

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.92  E-value=8.1e-26  Score=210.45  Aligned_cols=248  Identities=23%  Similarity=0.386  Sum_probs=184.0

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHH--HHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSL--LKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~--l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      +|..++-||++.|=.|.+|++. .| .+++|+|-+....... +.+.+.++-  ...+++||++++.-+...+...|+|-
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~-eG-~vVvKVFvk~~p~~sL-~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvR  100 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR-EG-LVVVKVFVKQDPTISL-RPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVR  100 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC-Cc-eEEEEEEeccCCCCCc-hHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHH
Confidence            6888999999999999999875 34 4999999876644332 223333322  44557999999998888888999999


Q ss_pred             EecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccc
Q 045787           86 EYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYS  165 (324)
Q Consensus        86 e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~  165 (324)
                      +|...+|.+.+..++ -+..-+.++|+.|++.||..+|..|++|||||.+|||+. .-+-+.|+||..-....-+..+++
T Consensus       101 qyvkhnLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiT-SWNW~~LtDFAsFKPtYLPeDNPa  178 (1431)
T KOG1240|consen  101 QYVKHNLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILIT-SWNWLYLTDFASFKPTYLPEDNPA  178 (1431)
T ss_pred             HHHhhhhhhhhccch-HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEe-eechhhhhcccccCCccCCCCCcc
Confidence            999999999888754 377888999999999999999999999999999999999 888899999986544432222222


Q ss_pred             c---c----ccccccCCchhhcC---------CCC-CCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCC
Q 045787          166 R---D----CVYSPYKAPELLLG---------YTG-YSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPT  227 (324)
Q Consensus       166 ~---~----~~~~~y~aPE~~~~---------~~~-~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~  227 (324)
                      .   .    ..-.+|.|||.+-.         ..+ .+++.||||+||+++|+++ |.+||...      ++....... 
T Consensus       179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~aYr~~~-  251 (1431)
T KOG1240|consen  179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLAYRSGN-  251 (1431)
T ss_pred             cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHhHhccC-
Confidence            1   1    22345999999853         122 6889999999999999998 68888321      111111000 


Q ss_pred             cccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcC
Q 045787          228 DESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH  287 (324)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~h  287 (324)
                                        +..+....+.+  -+..++.+|..|++.||++|.+|++.|+.
T Consensus       252 ------------------~~~~e~~Le~I--ed~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  252 ------------------ADDPEQLLEKI--EDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             ------------------ccCHHHHHHhC--cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence                              11112222222  24478999999999999999999999974

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.92  E-value=4.8e-26  Score=201.76  Aligned_cols=245  Identities=25%  Similarity=0.395  Sum_probs=197.3

Q ss_pred             ecccCceEEEEEEE---ccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcC-CCCeeEEEeeeecCCeEEEEEEecCC
Q 045787           15 IGAGGYGEVYKCRN---TVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-HENIVRLLDVQSSRKDVFLVFEYLDL   90 (324)
Q Consensus        15 Lg~g~~~~v~~a~~---~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv~e~~~g   90 (324)
                      +|.|++|.|+++..   ...|..|++|+..+..........-..|..++...+ ||++++++..++.+...+++.++..|
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg   81 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG   81 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence            78999999998763   356788999998876644333335556888888887 99999999999999999999999986


Q ss_pred             -CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccccccc
Q 045787           91 -DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCV  169 (324)
Q Consensus        91 -~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~~~~  169 (324)
                       .+...... ...+++...+.+...++.++.++|+.|++|+|+|++||+++ .+|++++.|||.+...-..    ...||
T Consensus        82 g~lft~l~~-~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld-~~Ghi~~tdfglske~v~~----~~~cg  155 (612)
T KOG0603|consen   82 GDLFTRLSK-EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLL-LEGHIKLTDFGLSKEAVKE----KIACG  155 (612)
T ss_pred             chhhhcccc-CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeec-ccCccccCCchhhhHhHhh----hhccc
Confidence             66655544 34588888889999999999999999999999999999999 9999999999998765322    22289


Q ss_pred             ccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCC
Q 045787          170 YSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEP  249 (324)
Q Consensus       170 ~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (324)
                      +..|+|||+..+   ...++|.||+|+++++|++|..||..   +.+..+... ..                        
T Consensus       156 t~eymApEI~~g---h~~a~D~ws~gvl~felltg~~pf~~---~~~~~Il~~-~~------------------------  204 (612)
T KOG0603|consen  156 TYEYRAPEIING---HLSAADWWSFGVLAFELLTGTLPFGG---DTMKRILKA-EL------------------------  204 (612)
T ss_pred             chhhhhhHhhhc---cCCcccchhhhhhHHHHhhCCCCCch---HHHHHHhhh-cc------------------------
Confidence            999999999983   47889999999999999999999977   222222110 00                        


Q ss_pred             cchhhhCCCCChhHHHHHHHhhcCCCCCCCC-----HHHHhcCccccCCCCchhhh
Q 045787          250 ANLAEKFPNLEPAGVDLLSQMLCLNPKQRIT-----AMDALKHEYLIGVENVPLVI  300 (324)
Q Consensus       250 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~~~l~hp~~~~~~~~~~~~  300 (324)
                          .....++..+++++..++..+|.+|..     +.++++|+||+.+.++.+..
T Consensus       205 ----~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~  256 (612)
T KOG0603|consen  205 ----EMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEA  256 (612)
T ss_pred             ----CCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhh
Confidence                011256778899999999999999985     58999999999999986643

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=3.2e-24  Score=186.55  Aligned_cols=177  Identities=19%  Similarity=0.172  Sum_probs=130.8

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEcc-CCceEEEEEeeeccc---cCCCchHHHHHHHHHHhcCCCCeeE-EEeeeecC
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTV-TGQKVAIKMMTIQTE---QEGVPSYIIREVSLLKELEHENIVR-LLDVQSSR   78 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~-~~~~~~~K~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~-~~~~~~~~   78 (324)
                      .+.++|++.+.||+|+||+||+|++.. +++.+|+|.......   .......+.+|++++++++|+++++ +++.    
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----   90 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----   90 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence            456889999999999999999999875 677789998653211   1122456899999999999999885 4432    


Q ss_pred             CeEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC-CCCceEeecCCCcEEEeeccceeec
Q 045787           79 KDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDL-KPNNLLIDLKRNTVKLADFGLARAI  157 (324)
Q Consensus        79 ~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di-~p~nIll~~~~~~v~l~d~g~~~~~  157 (324)
                      +..|+||||++|..+.....    ..   ...++.+++.+|.+||+.|++|||| ||+||+++ .++.++|+|||++...
T Consensus        91 ~~~~LVmE~~~G~~L~~~~~----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~-~~~~ikLiDFGlA~~~  162 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHLARP----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMG-PDGEAAVIDFQLASVF  162 (365)
T ss_pred             CCcEEEEEccCCCCHHHhCc----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEc-CCCCEEEEECccceec
Confidence            45799999998744432211    11   1467889999999999999999999 99999998 7889999999999876


Q ss_pred             cCCCCcc--------cccccccccCCchhhcC-----CCCCCCchhhH
Q 045787          158 GVPQKEY--------SRDCVYSPYKAPELLLG-----YTGYSTPIDVW  192 (324)
Q Consensus       158 ~~~~~~~--------~~~~~~~~y~aPE~~~~-----~~~~~~~~Diw  192 (324)
                      .......        ....+++.|+|||.+..     ....+..+|-|
T Consensus       163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             ccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            5432111        12356677899998753     12234456665

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=4.2e-23  Score=169.85  Aligned_cols=216  Identities=25%  Similarity=0.373  Sum_probs=183.8

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcC-CCCeeEEEeeeecCCeEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-HENIVRLLDVQSSRKDVF   82 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~   82 (324)
                      +.+-.|++.++||.|+||.++.+...-+++.||+|.-+..+..    ..++.|.+.++.|. .++|..++.+.+..-+-.
T Consensus        25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A----PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni  100 (449)
T KOG1165|consen   25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA----PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI  100 (449)
T ss_pred             EecccceeccccccCcceeeecccccccCceEEEEeccccCCc----chHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence            5667899999999999999999999999999999976654443    45788999999996 699999998888888889


Q ss_pred             EEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeec----CCCcEEEeeccceeecc
Q 045787           83 LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL----KRNTVKLADFGLARAIG  158 (324)
Q Consensus        83 iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~----~~~~v~l~d~g~~~~~~  158 (324)
                      +|++..+.+|.+.+.-++..|+...+..++.|++.-++++|++.++.+||||+|+||..    ..+.+.++|||.+....
T Consensus       101 LVidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr  180 (449)
T KOG1165|consen  101 LVIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR  180 (449)
T ss_pred             hhhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence            99999999999999999999999999999999999999999999999999999999962    33569999999997764


Q ss_pred             CCC-------CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcC
Q 045787          159 VPQ-------KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLG  224 (324)
Q Consensus       159 ~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  224 (324)
                      .+.       .+.....||-.||+=-...+ .+-+.+.|+-|||-++.+++.|..||.+...+..+.....++
T Consensus       181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlG-rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIG  252 (449)
T KOG1165|consen  181 DPKTKQHIPYREHKSLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIG  252 (449)
T ss_pred             CccccccCccccccccccceeeeEeecccc-chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhc
Confidence            332       23444578888999888888 556899999999999999999999998877665555444333

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.91  E-value=2.3e-24  Score=172.86  Aligned_cols=241  Identities=17%  Similarity=0.258  Sum_probs=187.4

Q ss_pred             cceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEec
Q 045787            9 YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYL   88 (324)
Q Consensus         9 y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   88 (324)
                      .....+|.....|..|+++.+  |..+++|++..........+.+..|.-.++-+.||||+.+++.+.....+.++..|+
T Consensus       192 lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m  269 (448)
T KOG0195|consen  192 LNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM  269 (448)
T ss_pred             hhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence            345567888999999999875  567888888776666666677889999999999999999999999999999999999


Q ss_pred             C-CCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC--CcccCCCCCceEeecCCCcEEEe--eccceeeccCCCC
Q 045787           89 D-LDLHSFITRHKN-TLNLLVIKAILKQILLGLAYCHSLK--ILHRDLKPNNLLIDLKRNTVKLA--DFGLARAIGVPQK  162 (324)
Q Consensus        89 ~-g~l~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~g--~~H~di~p~nIll~~~~~~v~l~--d~g~~~~~~~~~~  162 (324)
                      + |+|...+....+ -.+..++.+++.+++.++.|||+..  +.-..++...+++| ++-+.+|.  |--++..  ... 
T Consensus       270 p~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmid-edltarismad~kfsfq--e~g-  345 (448)
T KOG0195|consen  270 PFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMID-EDLTARISMADTKFSFQ--EVG-  345 (448)
T ss_pred             cchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEec-chhhhheecccceeeee--ccc-
Confidence            8 899999887654 3677889999999999999999875  44446888999999 77666554  3222221  111 


Q ss_pred             cccccccccccCCchhhcCCCCC--CCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcc
Q 045787          163 EYSRDCVYSPYKAPELLLGYTGY--STPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEI  240 (324)
Q Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~--~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (324)
                          ..-.|.|++||.+...+..  -.++|+|||+++++|+.|...||...++-+....+...+..              
T Consensus       346 ----r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglr--------------  407 (448)
T KOG0195|consen  346 ----RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLR--------------  407 (448)
T ss_pred             ----cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcccc--------------
Confidence                1235779999999863332  35799999999999999999999776654443333332221              


Q ss_pred             cCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHh
Q 045787          241 LPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDAL  285 (324)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l  285 (324)
                                  ....++++..+..+++-|+..||.+||..+.++
T Consensus       408 ------------v~ippgis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  408 ------------VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             ------------ccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence                        234468899999999999999999999988776

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=1.4e-23  Score=170.18  Aligned_cols=174  Identities=14%  Similarity=0.188  Sum_probs=131.3

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCC-Cc------hHHHHHHHHHHhcCCCCeeEEEeee
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEG-VP------SYIIREVSLLKELEHENIVRLLDVQ   75 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~-~~------~~~~~e~~~l~~l~~~~i~~~~~~~   75 (324)
                      +++.++|++++.||.|+||.||++.+  ++..+|+|++........ ..      +.+.+|+..+.++.|+++..+.+++
T Consensus        27 ~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~  104 (232)
T PRK10359         27 DFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY  104 (232)
T ss_pred             HHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence            46789999999999999999999765  466899999975543221 11      1257899999999999999998876


Q ss_pred             ecC--------CeEEEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcE
Q 045787           76 SSR--------KDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTV  146 (324)
Q Consensus        76 ~~~--------~~~~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v  146 (324)
                      ...        +..+++|||++| +|.+..     .+++.    ...++..++..+|+.|++|+|++|+||+++ .++ +
T Consensus       105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~-----~~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~-~~g-i  173 (232)
T PRK10359        105 LLAERKTLRYAHTYIMLIEYIEGVELNDMP-----EISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVS-KNG-L  173 (232)
T ss_pred             eecccccccccCCeEEEEEEECCccHHHhh-----hccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEe-CCC-E
Confidence            533        358899999998 665542     13332    456899999999999999999999999999 677 9


Q ss_pred             EEeeccceeeccCCCCcccccccccccCCch-hhcCCCCCCCchhhHHHHHHHHHHHh
Q 045787          147 KLADFGLARAIGVPQKEYSRDCVYSPYKAPE-LLLGYTGYSTPIDVWAVGCIFAEMIT  203 (324)
Q Consensus       147 ~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~~~DiwslG~il~~l~~  203 (324)
                      +|+|||.........             |-+ +... ..+..++|+|+||+++..+..
T Consensus       174 ~liDfg~~~~~~e~~-------------a~d~~vle-r~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        174 RIIDLSGKRCTAQRK-------------AKDRIDLE-RHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             EEEECCCcccccchh-------------hHHHHHHH-hHhcccccccceeEeehHHHH
Confidence            999999776432110             111 2223 345689999999999877654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.90  E-value=5.5e-23  Score=164.77  Aligned_cols=141  Identities=18%  Similarity=0.193  Sum_probs=107.9

Q ss_pred             eEeecccCceEEEEEEEccCCceEEEEEeeeccccCCC-------c-----------------hHHHHHHHHHHhcCCCC
Q 045787           12 IKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGV-------P-----------------SYIIREVSLLKELEHEN   67 (324)
Q Consensus        12 ~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~-------~-----------------~~~~~e~~~l~~l~~~~   67 (324)
                      ...||+|++|.||+|.+. +|+.||+|++.........       .                 .....|+..+.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            468999999999999987 8999999999765321111       1                 12235999999998777


Q ss_pred             eeEEEeeeecCCeEEEEEEecCCCHH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HhCCCcccCCCCCceEeecCCCc
Q 045787           68 IVRLLDVQSSRKDVFLVFEYLDLDLH-SFITRHKNTLNLLVIKAILKQILLGLAYC-HSLKILHRDLKPNNLLIDLKRNT  145 (324)
Q Consensus        68 i~~~~~~~~~~~~~~iv~e~~~g~l~-~~~~~~~~~~~~~~~~~i~~~i~~~l~~L-h~~g~~H~di~p~nIll~~~~~~  145 (324)
                      +.....+...  ..++||||++|+.+ ..... ..+++...+..++.+++.+|.++ |+.|++|+||||+||+++  ++.
T Consensus        81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~--~~~  155 (190)
T cd05147          81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH--DGK  155 (190)
T ss_pred             CCCCcEEEec--CCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE--CCc
Confidence            6433322222  23899999997433 33233 35789999999999999999999 799999999999999998  378


Q ss_pred             EEEeeccceeecc
Q 045787          146 VKLADFGLARAIG  158 (324)
Q Consensus       146 v~l~d~g~~~~~~  158 (324)
                      ++|+|||++....
T Consensus       156 v~LiDFG~a~~~~  168 (190)
T cd05147         156 LYIIDVSQSVEHD  168 (190)
T ss_pred             EEEEEccccccCC
Confidence            9999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.89  E-value=7.3e-23  Score=190.57  Aligned_cols=240  Identities=29%  Similarity=0.449  Sum_probs=174.7

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLV   84 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   84 (324)
                      ...+|..++.+..|++|.||+++|+.+.+++|+|+ .+...      -+++   ++..-.+|.++               
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l------ilRn---ilt~a~npfvv---------------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL------ILRN---ILTFAGNPFVV---------------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhcc-cccch------hhhc---cccccCCccee---------------
Confidence            35789999999999999999999999999999954 22111      1111   22222344444               


Q ss_pred             EEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC--
Q 045787           85 FEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK--  162 (324)
Q Consensus        85 ~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~--  162 (324)
                           |+-...+.. .++++...        +.+++|||+.|++|+|+||+|.++. .-|++|++|||++........  
T Consensus       136 -----gDc~tllk~-~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT-~mGhiKlTDfgLsk~GLms~atn  200 (1205)
T KOG0606|consen  136 -----GDCATLLKN-IGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLIT-SMGHIKLTDFGLSKKGLMSLATN  200 (1205)
T ss_pred             -----chhhhhccc-CCCCcchh--------hHHhHhhccCCeecCCCCCCcceee-ecccccccchhhhhhhhhhccch
Confidence                 322222222 22343333        7789999999999999999999999 999999999998754421110  


Q ss_pred             -------------cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcc
Q 045787          163 -------------EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDE  229 (324)
Q Consensus       163 -------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  229 (324)
                                   .....++||.|.|||+... ..|+..+|.|+||+|+|+++.|..||.+.+++.+........     
T Consensus       201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~-----  274 (1205)
T KOG0606|consen  201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD-----  274 (1205)
T ss_pred             hhhcchHHHHHHhhhccccCCccccChhhhhh-hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhh-----
Confidence                         1223489999999999987 668999999999999999999999999988776544332111     


Q ss_pred             cccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCC---CHHHHhcCccccCCCCchhhh---hhh
Q 045787          230 SWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRI---TAMDALKHEYLIGVENVPLVI---LLI  303 (324)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp---s~~~~l~hp~~~~~~~~~~~~---~~~  303 (324)
                                          ..+.+.-..+++++++++..+|+.+|..|.   .+.++.+|+||+.+.+..++.   +++
T Consensus       275 --------------------i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~llRqkaefv  334 (1205)
T KOG0606|consen  275 --------------------IEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKSLLRQKAEFV  334 (1205)
T ss_pred             --------------------ccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccchhhhhhcccc
Confidence                                111112236889999999999999999996   578888999999999997755   555


Q ss_pred             hcccCCC
Q 045787          304 NRKKKLG  310 (324)
Q Consensus       304 ~~~~~~~  310 (324)
                      ++.+..+
T Consensus       335 pql~~ed  341 (1205)
T KOG0606|consen  335 PQLESED  341 (1205)
T ss_pred             ccccccc
Confidence            5554443

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=2.8e-22  Score=168.79  Aligned_cols=195  Identities=23%  Similarity=0.348  Sum_probs=140.2

Q ss_pred             CCCCeeEEEeeee---------------------------cCCeEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHH
Q 045787           64 EHENIVRLLDVQS---------------------------SRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQIL  116 (324)
Q Consensus        64 ~~~~i~~~~~~~~---------------------------~~~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~  116 (324)
                      .||||+++...|.                           ....+|+||..+..+|.+++-.+  ..+....+-++.|++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~--~~s~r~~~~~laQlL  351 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTR--HRSYRTGRVILAQLL  351 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcC--CCchHHHHHHHHHHH
Confidence            4999999876542                           23358999999999999998764  467777888999999


Q ss_pred             HHHHHHHhCCCcccCCCCCceEeecCCC---cEEEeeccceeeccCCCCcc------cccccccccCCchhhcCCCC---
Q 045787          117 LGLAYCHSLKILHRDLKPNNLLIDLKRN---TVKLADFGLARAIGVPQKEY------SRDCVYSPYKAPELLLGYTG---  184 (324)
Q Consensus       117 ~~l~~Lh~~g~~H~di~p~nIll~~~~~---~v~l~d~g~~~~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~---  184 (324)
                      +|+.|||++|+.|+|+|.+||++..++.   .+++.|||++-.........      -...|.-.-+|||+......   
T Consensus       352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a  431 (598)
T KOG4158|consen  352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA  431 (598)
T ss_pred             HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence            9999999999999999999999953332   57999999886543321111      11234455899999864111   


Q ss_pred             --CCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChh
Q 045787          185 --YSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPA  262 (324)
Q Consensus       185 --~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (324)
                        --.++|.|+.|.+.||++....||.....-.+..               .           .......+.....+++.
T Consensus       432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~---------------r-----------~Yqe~qLPalp~~vpp~  485 (598)
T KOG4158|consen  432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT---------------R-----------TYQESQLPALPSRVPPV  485 (598)
T ss_pred             eeccchhhhhhhhhhHHHHhccCCcccccchheech---------------h-----------hhhhhhCCCCcccCChH
Confidence              1347999999999999999999997633211100               0           00111222233468899


Q ss_pred             HHHHHHHhhcCCCCCCCCH---HHHhc
Q 045787          263 GVDLLSQMLCLNPKQRITA---MDALK  286 (324)
Q Consensus       263 l~~li~~~l~~dP~~Rps~---~~~l~  286 (324)
                      +++++..+|+.||++|+++   +.+++
T Consensus       486 ~rqlV~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  486 ARQLVFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHHHHHHHhcCCccccCCccHHHhHHH
Confidence            9999999999999999984   44554

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.88  E-value=1.2e-21  Score=157.55  Aligned_cols=142  Identities=18%  Similarity=0.190  Sum_probs=110.5

Q ss_pred             eeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCC------------------------chHHHHHHHHHHhcCCC
Q 045787           11 KIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGV------------------------PSYIIREVSLLKELEHE   66 (324)
Q Consensus        11 i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~------------------------~~~~~~e~~~l~~l~~~   66 (324)
                      +.+.||+|++|.||+|.+. +|+.||+|++.........                        ......|...+.++.++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            4578999999999999987 8999999999865321100                        11235788999999988


Q ss_pred             CeeEEEeeeecCCeEEEEEEecCCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCceEeecCCC
Q 045787           67 NIVRLLDVQSSRKDVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHS-LKILHRDLKPNNLLIDLKRN  144 (324)
Q Consensus        67 ~i~~~~~~~~~~~~~~iv~e~~~g~-l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~g~~H~di~p~nIll~~~~~  144 (324)
                      ++.....+....  .++||||++|. +...... ..+++...+..++.+++.++.++|+ .|++|+||||+||+++  ++
T Consensus        80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~--~~  154 (190)
T cd05145          80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH--DG  154 (190)
T ss_pred             CCCCceEEEecC--CEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE--CC
Confidence            875444333322  48999999874 3333222 3467888999999999999999999 9999999999999998  68


Q ss_pred             cEEEeeccceeecc
Q 045787          145 TVKLADFGLARAIG  158 (324)
Q Consensus       145 ~v~l~d~g~~~~~~  158 (324)
                      .++|+|||.+....
T Consensus       155 ~~~liDFG~a~~~~  168 (190)
T cd05145         155 KPYIIDVSQAVELD  168 (190)
T ss_pred             CEEEEEcccceecC
Confidence            89999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=3.3e-21  Score=153.03  Aligned_cols=190  Identities=17%  Similarity=0.056  Sum_probs=137.6

Q ss_pred             cceeEeecccCceEEEEEEEccCCceEEEEEeeecccc--CCCchHHHHHHHHHHhcC-CCCeeEEEeeeecCCeEEEEE
Q 045787            9 YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQ--EGVPSYIIREVSLLKELE-HENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         9 y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      +-+...|++|+||+|+++..  .+..++.+.+.....-  .-....+.+|++++++++ ++++++++++    ...+++|
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm   77 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR   77 (218)
T ss_pred             cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence            45778999999999998875  5677887776644431  111235789999999996 5789999886    3469999


Q ss_pred             EecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC-CCCceEeecCCCcEEEeeccceeeccCCCCc-
Q 045787           86 EYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDL-KPNNLLIDLKRNTVKLADFGLARAIGVPQKE-  163 (324)
Q Consensus        86 e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di-~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~-  163 (324)
                      +|+.|..+.....    .  . ...++.+++.+|.++|+.|++|+|| ||+||+++ .++.++|+|||.+......... 
T Consensus        78 eyI~G~~L~~~~~----~--~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~-~~g~i~LIDFG~A~~~~~~~~~~  149 (218)
T PRK12274         78 SYLAGAAMYQRPP----R--G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQ-EDGSPAVIDFQLAVRGNPRARWM  149 (218)
T ss_pred             eeecCccHHhhhh----h--h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEc-CCCCEEEEECCCceecCCcchHH
Confidence            9998844432111    1  1 1357789999999999999999999 79999999 8899999999999865432211 


Q ss_pred             ------------ccccccccccCCchhhcCCCCCC-CchhhHHHHHHHHHHHhCCCCCCCCC
Q 045787          164 ------------YSRDCVYSPYKAPELLLGYTGYS-TPIDVWAVGCIFAEMITGKPLFPSKK  212 (324)
Q Consensus       164 ------------~~~~~~~~~y~aPE~~~~~~~~~-~~~DiwslG~il~~l~~g~~pf~~~~  212 (324)
                                  ......++.+++|+...--...+ .+.+.++.|+.+|.++|+..|+-+.+
T Consensus       150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence                        00112356677776654322233 57788999999999999998875443

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=1.8e-20  Score=177.36  Aligned_cols=194  Identities=21%  Similarity=0.321  Sum_probs=155.9

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcC---CCCeeEEEeeeecCCeE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE---HENIVRLLDVQSSRKDV   81 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~   81 (324)
                      -+..|.|-+.+|.|++|.||.|.+.. |+.+|+|+-..+..     ..+.--.+++.+|+   -+.|..+...+.-++..
T Consensus       696 ~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~-----WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S  769 (974)
T KOG1166|consen  696 GGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP-----WEFYICLQVMERLKPQMLPSIMHISSAHVFQNAS  769 (974)
T ss_pred             cceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc-----eeeeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence            45679999999999999999999876 99999998654431     11122233444554   34566666666777888


Q ss_pred             EEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEee------cCCCcEEEeeccce
Q 045787           82 FLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLID------LKRNTVKLADFGLA  154 (324)
Q Consensus        82 ~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~------~~~~~v~l~d~g~~  154 (324)
                      ++|++|.+ |+|++++.. .+-.++..+..+..+++..+.+||..||+||||||+|+++.      .+.--++|+|||.+
T Consensus       770 ~lv~ey~~~Gtlld~~N~-~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s  848 (974)
T KOG1166|consen  770 VLVSEYSPYGTLLDLINT-NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS  848 (974)
T ss_pred             eeeeeccccccHHHhhcc-CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccc
Confidence            99999999 899999884 45699999999999999999999999999999999999994      23346899999998


Q ss_pred             eeccC--CCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCC
Q 045787          155 RAIGV--PQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKP  206 (324)
Q Consensus       155 ~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~  206 (324)
                      ..+..  ........++|-.+-.+|...| .+++...|.|+|+.+++-|+.|+.
T Consensus       849 iDm~lfp~~~~F~~~~~td~f~C~EM~~g-rpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  849 IDMKLFPDGTKFKAVWHTDLFDCIEMREG-RPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             eeeeEcCCCcEEeeeeccccchhHHHhcC-CCCchhhhhHHHHHHHHHHHHHHH
Confidence            77642  2234555677888999999888 889999999999999999999973

>smart00090 RIO RIO-like kinase

Probab=99.82  E-value=1.7e-19  Score=149.50  Aligned_cols=144  Identities=17%  Similarity=0.147  Sum_probs=111.1

Q ss_pred             CcceeEeecccCceEEEEEE-EccCCceEEEEEeeeccccCC----------------------CchHHHHHHHHHHhcC
Q 045787            8 NYKKIKKIGAGGYGEVYKCR-NTVTGQKVAIKMMTIQTEQEG----------------------VPSYIIREVSLLKELE   64 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~-~~~~~~~~~~K~~~~~~~~~~----------------------~~~~~~~e~~~l~~l~   64 (324)
                      -|++.+.||.|++|.||+|. +..+|+.||+|++........                      ....+..|+..+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            48999999999999999998 667899999999875432100                      0123568999999997


Q ss_pred             C--CCeeEEEeeeecCCeEEEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-CcccCCCCCceEee
Q 045787           65 H--ENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK-ILHRDLKPNNLLID  140 (324)
Q Consensus        65 ~--~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g-~~H~di~p~nIll~  140 (324)
                      +  ..++++++.    ...++||||++| ++...... ........+..++.+++.++.+||+.| ++|+||+|+||+++
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~  183 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH  183 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence            5  334455543    234899999998 44443322 335666777899999999999999999 99999999999998


Q ss_pred             cCCCcEEEeeccceeecc
Q 045787          141 LKRNTVKLADFGLARAIG  158 (324)
Q Consensus       141 ~~~~~v~l~d~g~~~~~~  158 (324)
                        ++.++|+|||.+...+
T Consensus       184 --~~~i~LiDFg~a~~~~  199 (237)
T smart00090      184 --DGKVVIIDVSQSVELD  199 (237)
T ss_pred             --CCCEEEEEChhhhccC
Confidence              6789999999877543

>PRK10345 hypothetical protein; Provisional

Probab=99.81  E-value=6.4e-19  Score=142.55  Aligned_cols=134  Identities=20%  Similarity=0.249  Sum_probs=103.8

Q ss_pred             ceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhc-----CCCCeeEEEeeeecCC---e-
Q 045787           10 KKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-----EHENIVRLLDVQSSRK---D-   80 (324)
Q Consensus        10 ~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~---~-   80 (324)
                      .-.+.||+|+++.||.  +..++.. ++|+.......  ..+.+.+|+.+++.+     .||||++++++++++.   . 
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~--~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v   79 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDG--GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV   79 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccc--hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence            3457899999999995  6656555 79988764322  246789999999999     5799999999998874   3 


Q ss_pred             EEEEEEecC---CCHHHHHHhcCCCCCHHHHHHHHHHHHHHH-HHHHhCCCcccCCCCCceEeec---CCCcEEEeecc
Q 045787           81 VFLVFEYLD---LDLHSFITRHKNTLNLLVIKAILKQILLGL-AYCHSLKILHRDLKPNNLLIDL---KRNTVKLADFG  152 (324)
Q Consensus        81 ~~iv~e~~~---g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l-~~Lh~~g~~H~di~p~nIll~~---~~~~v~l~d~g  152 (324)
                      +.+|+||.+   |+|.+++.+.  .+++.  ..++.+++.++ .|||+++++|+||||+||+++.   .+..++|+|++
T Consensus        80 ~~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         80 YDVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             EEEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            337899955   5898888653  36555  35678888777 9999999999999999999972   22379999954

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.81  E-value=2.7e-19  Score=158.76  Aligned_cols=207  Identities=24%  Similarity=0.373  Sum_probs=155.3

Q ss_pred             HHhcCCCCeeEEEeeeecCCeEEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCC-cccCCCCCce
Q 045787           60 LKELEHENIVRLLDVQSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI-LHRDLKPNNL  137 (324)
Q Consensus        60 l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~-~H~di~p~nI  137 (324)
                      ++.+.|.|+.++++.+.++...++|.+||. |+|++.+....-.++......++++|+.||.|||...+ .|+.++..|.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            356889999999999999999999999998 89999999877789999999999999999999998765 9999999999


Q ss_pred             EeecCCCcEEEeeccceeeccCCC--CcccccccccccCCchhhcCC--C----CCCCchhhHHHHHHHHHHHhCCCCCC
Q 045787          138 LIDLKRNTVKLADFGLARAIGVPQ--KEYSRDCVYSPYKAPELLLGY--T----GYSTPIDVWAVGCIFAEMITGKPLFP  209 (324)
Q Consensus       138 ll~~~~~~v~l~d~g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~--~----~~~~~~DiwslG~il~~l~~g~~pf~  209 (324)
                      +++ ....+||+|||+........  ..........-|.|||.++..  .    ..+.+.|+||+|++++|+++.+.||.
T Consensus        81 lvd-~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~  159 (484)
T KOG1023|consen   81 LVD-SRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFD  159 (484)
T ss_pred             eee-eeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccc
Confidence            999 99999999999887664211  111111223349999998762  1    14778999999999999999999997


Q ss_pred             CCC--hhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          210 SKK--HDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       210 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      ...  .+....+..+......                 ...+.....  ...++.+..+++.|+..+|.+||+++++-.
T Consensus       160 ~~~~~~~~~eii~~~~~~~~~-----------------~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  160 LRNLVEDPDEIILRVKKGGSN-----------------PFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             cccccCChHHHHHHHHhcCCC-----------------CcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            644  2211111111110000                 000111111  145668899999999999999999999875

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.76  E-value=2.2e-19  Score=156.76  Aligned_cols=177  Identities=25%  Similarity=0.463  Sum_probs=131.8

Q ss_pred             CeEEEEEEecC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeecccee
Q 045787           79 KDVFLVFEYLD-LDLHSFITRHK--NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLAR  155 (324)
Q Consensus        79 ~~~~iv~e~~~-g~l~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~  155 (324)
                      .++||.|++|. .+|.+++...+  ...+......++.|++.++.|   +|.+|+|++|.||++. .+..++|+|||+..
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~-~d~q~kIgDFgl~t  404 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFS-DDDQLKIGDFGLVT  404 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccc-cchhhhhhhhhhee
Confidence            35789999998 68999886543  357778889999999999999   9999999999999998 78899999999987


Q ss_pred             eccCCC------CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhC-CCCCCCCChhHHHHHHHHcCCCCc
Q 045787          156 AIGVPQ------KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITG-KPLFPSKKHDHLSLIFSLLGTPTD  228 (324)
Q Consensus       156 ~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~  228 (324)
                      ......      .......+|..|++||.+.+ ..++.++|||+||++++|++.. .-++.    ... -          
T Consensus       405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-~~y~~kvdIyaLGlil~EL~~~f~T~~e----r~~-t----------  468 (516)
T KOG1033|consen  405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRG-QQYSEKVDIYALGLILAELLIQFSTQFE----RIA-T----------  468 (516)
T ss_pred             ecccCCcccchhhhhhhcccccccCCHHHHhh-hhhhhhcchhhHHHHHHHHHHHhccHHH----HHH-h----------
Confidence            764322      24555688999999999998 7789999999999999999982 21110    000 0          


Q ss_pred             ccccchhhhhcccCCCCCCCCcchh-hhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCcccc
Q 045787          229 ESWAESTYISEILPLYPHFEPANLA-EKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLI  291 (324)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~  291 (324)
                                     ........++ ..+.+++ .-..|+..||...|.+||++.+.-.|+|.+
T Consensus       469 ---------------~~d~r~g~ip~~~~~d~p-~e~~ll~~lls~~p~~RP~~~~~~~~~~~~  516 (516)
T KOG1033|consen  469 ---------------LTDIRDGIIPPEFLQDYP-EEYTLLQQLLSPSPEERPSAIEVALHEFLQ  516 (516)
T ss_pred             ---------------hhhhhcCCCChHHhhcCc-HHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence                           0000011111 1111222 334999999999999999888888888764

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.76  E-value=4.8e-20  Score=170.77  Aligned_cols=263  Identities=28%  Similarity=0.414  Sum_probs=205.2

Q ss_pred             CcCcceeEeecccCceEEEEEEEcc-CCceEEEEEeeeccccCCCchHHHHHHHHHHhcC-CCCeeEEEeeeecCCeEEE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTV-TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-HENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~-~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~i   83 (324)
                      ...|.+.+.||.|+++.|-.+.... ....++.|.+............+..|..+-+.+. |+|++.+++...+.+..++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            4678999999999999999988743 3445666666655444444566777888888887 9999999999999999999


Q ss_pred             EEEecCC-CHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCCcccCCCCCceEeecCCC-cEEEeeccceeeccC
Q 045787           84 VFEYLDL-DLHSFI-TRHKNTLNLLVIKAILKQILLGLAYCH-SLKILHRDLKPNNLLIDLKRN-TVKLADFGLARAIGV  159 (324)
Q Consensus        84 v~e~~~g-~l~~~~-~~~~~~~~~~~~~~i~~~i~~~l~~Lh-~~g~~H~di~p~nIll~~~~~-~v~l~d~g~~~~~~~  159 (324)
                      ++++..| ++...+ .......+...+..++.++..++.|+| ..+++|+|++|+|.+++ ..+ ..++.|||.+.....
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~-~s~~~l~~~df~~At~~~~  177 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLD-ESGSALKIADFGLATAYRN  177 (601)
T ss_pred             ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhc-cCCCcccCCCchhhccccc
Confidence            9999775 666666 333325777788889999999999999 99999999999999999 777 999999999987765


Q ss_pred             -CCC--ccccccc-ccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchh
Q 045787          160 -PQK--EYSRDCV-YSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAEST  235 (324)
Q Consensus       160 -~~~--~~~~~~~-~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (324)
                       ...  .....+| ++.|.|||...+.+...+..|+||.|+++..+++|..|+........          ....|.   
T Consensus       178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~----------~~~~~~---  244 (601)
T KOG0590|consen  178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG----------RYSSWK---  244 (601)
T ss_pred             cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc----------cceeec---
Confidence             222  2334577 89999999998866778899999999999999999999854442210          000000   


Q ss_pred             hhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccC
Q 045787          236 YISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIG  292 (324)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~  292 (324)
                                ..........+..++....+++.+++..+|.+|.+.+++-.+||+..
T Consensus       245 ----------~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  245 ----------SNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             ----------ccccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence                      00011112334578889999999999999999999999999999999

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.76  E-value=1.6e-17  Score=136.25  Aligned_cols=136  Identities=22%  Similarity=0.282  Sum_probs=109.3

Q ss_pred             eEeecccCceEEEEEEEccCCceEEEEEeeeccccCC------CchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787           12 IKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEG------VPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus        12 ~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      ++.||+|++|.||++..  .|..+++|..........      ....+.+|+.++..+.++++.....++...+..+++|
T Consensus         1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~   78 (211)
T PRK14879          1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM   78 (211)
T ss_pred             CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence            36799999999999986  577899998654332111      1134678999999999988877776766777889999


Q ss_pred             EecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceee
Q 045787           86 EYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARA  156 (324)
Q Consensus        86 e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~  156 (324)
                      ||++| +|.+.+....    . ....++.+++.+|.++|+.|++|+|++|.||+++  ++.++|+|||.+..
T Consensus        79 e~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~--~~~~~liDf~~a~~  143 (211)
T PRK14879         79 EYIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS--GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE--CCCEEEEECCcccC
Confidence            99986 7777665422    2 7788999999999999999999999999999998  67899999998764

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.74  E-value=2.4e-17  Score=133.69  Aligned_cols=138  Identities=22%  Similarity=0.259  Sum_probs=104.8

Q ss_pred             cceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCC--------------------CchHHHHHHHHHHhcCCC--
Q 045787            9 YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEG--------------------VPSYIIREVSLLKELEHE--   66 (324)
Q Consensus         9 y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~--------------------~~~~~~~e~~~l~~l~~~--   66 (324)
                      |.+.+.||.|++|.||++... +|+.+++|++........                    .......|+.++..+.++  
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            888999999999999999875 799999999765431100                    011256788888888776  


Q ss_pred             CeeEEEeeeecCCeEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcE
Q 045787           67 NIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTV  146 (324)
Q Consensus        67 ~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v  146 (324)
                      .++..++    ....++||||++|..+..+..      ......++.+++.++.++|+.|++|+||+|+||+++ .++.+
T Consensus        96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~-~~~~~  164 (198)
T cd05144          96 PVPKPID----WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVD-DDEKI  164 (198)
T ss_pred             CCCceee----cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEc-CCCcE
Confidence            4444443    234589999998743332221      134567889999999999999999999999999999 89999


Q ss_pred             EEeeccceeecc
Q 045787          147 KLADFGLARAIG  158 (324)
Q Consensus       147 ~l~d~g~~~~~~  158 (324)
                      +|+|||.+....
T Consensus       165 ~liDfg~~~~~~  176 (198)
T cd05144         165 YIIDWPQMVSTD  176 (198)
T ss_pred             EEEECCccccCC
Confidence            999999886554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.73  E-value=5.5e-17  Score=131.76  Aligned_cols=131  Identities=21%  Similarity=0.286  Sum_probs=101.2

Q ss_pred             eecccCceEEEEEEEccCCceEEEEEeeeccccCC------CchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEe
Q 045787           14 KIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEG------VPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEY   87 (324)
Q Consensus        14 ~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   87 (324)
                      .||+|++|.||++..  .+..+++|..........      ....+.+|+.+++.+.++++.....++......++||||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            379999999999984  577899998654321111      124567899999999887655444444556667899999


Q ss_pred             cCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceee
Q 045787           88 LDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARA  156 (324)
Q Consensus        88 ~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~  156 (324)
                      ++| ++.+.+.... .       .++.+++.+|.+||+.|++|+|++|.||+++  ++.++++|||.+..
T Consensus        79 ~~g~~l~~~~~~~~-~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~--~~~~~liDfg~a~~  138 (199)
T TIGR03724        79 IEGKPLKDVIEEGN-D-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR--DDKLYLIDFGLGKY  138 (199)
T ss_pred             ECCccHHHHHhhcH-H-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE--CCcEEEEECCCCcC
Confidence            986 6666554321 1       7889999999999999999999999999998  68899999998764

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.71  E-value=1.6e-17  Score=147.74  Aligned_cols=258  Identities=25%  Similarity=0.242  Sum_probs=203.2

Q ss_pred             cCcCcceeEeecc--cCceEEEEEEE--ccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcC-CCCeeEEEeeeecCC
Q 045787            5 KNLNYKKIKKIGA--GGYGEVYKCRN--TVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-HENIVRLLDVQSSRK   79 (324)
Q Consensus         5 ~~~~y~i~~~Lg~--g~~~~v~~a~~--~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~   79 (324)
                      ....+.+.+.+|.  |.+|.+|.+..  ..++..+++|.-............-.+|+.....+. |++.++.+..+...+
T Consensus       112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~  191 (524)
T KOG0601|consen  112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG  191 (524)
T ss_pred             hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCC
Confidence            3567788899999  99999999998  788899999986555443333333446777777775 899999899999999


Q ss_pred             eEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHH----HHHHHHhCCCcccCCCCCceEeecCC-CcEEEeeccce
Q 045787           80 DVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILL----GLAYCHSLKILHRDLKPNNLLIDLKR-NTVKLADFGLA  154 (324)
Q Consensus        80 ~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~----~l~~Lh~~g~~H~di~p~nIll~~~~-~~v~l~d~g~~  154 (324)
                      ..|+-+|.++.++++++..-...+++..++..+.+...    ||.++|+.+++|-|++|+||+.. .+ ...+++|||..
T Consensus       192 ~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~-~~~~s~~~~df~~v  270 (524)
T KOG0601|consen  192 ILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTT-SDWTSCKLTDFGLV  270 (524)
T ss_pred             cceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecc-cccceeecCCccee
Confidence            99999999999999999887777889999999999999    99999999999999999999999 66 78899999999


Q ss_pred             eeccCCCCccccc-----ccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcc
Q 045787          155 RAIGVPQKEYSRD-----CVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDE  229 (324)
Q Consensus       155 ~~~~~~~~~~~~~-----~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  229 (324)
                      ..++.........     .+...|++||...+  -++.+.|+|+||.++.+..++..++........             
T Consensus       271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W-------------  335 (524)
T KOG0601|consen  271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSW-------------  335 (524)
T ss_pred             EEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCc-------------
Confidence            8887655332222     45566999999876  568999999999999999998766543311110             


Q ss_pred             cccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccC
Q 045787          230 SWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIG  292 (324)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~  292 (324)
                        .      ..-.      .....+.....+.++...+..|++.||..|+++..+.+|++..+
T Consensus       336 --~------~~r~------~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s  384 (524)
T KOG0601|consen  336 --S------QLRQ------GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS  384 (524)
T ss_pred             --c------cccc------ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence              0      0000      01112233356677778999999999999999999999999883

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.70  E-value=1.8e-16  Score=127.41  Aligned_cols=137  Identities=23%  Similarity=0.281  Sum_probs=97.7

Q ss_pred             eEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchH----------------------HHHHHHHHHhcCCCC--
Q 045787           12 IKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSY----------------------IIREVSLLKELEHEN--   67 (324)
Q Consensus        12 ~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~----------------------~~~e~~~l~~l~~~~--   67 (324)
                      .+.||+|++|+||+|.+. +++.||+|++............                      ...|...+.++.+.+  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            567999999999999986 7899999998754322111111                      135666666665432  


Q ss_pred             eeEEEeeeecCCeEEEEEEecCC-CHHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCceEeecCCC
Q 045787           68 IVRLLDVQSSRKDVFLVFEYLDL-DLHS-FITRHKNTLNLLVIKAILKQILLGLAYCHS-LKILHRDLKPNNLLIDLKRN  144 (324)
Q Consensus        68 i~~~~~~~~~~~~~~iv~e~~~g-~l~~-~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~g~~H~di~p~nIll~~~~~  144 (324)
                      +.+.++.    ...++||||++| ++.. .+....  . ...+..++.+++.++.++|. .|++|+||+|+||+++  ++
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~--~~  151 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD--DG  151 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhhh--h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE--CC
Confidence            4444443    235899999987 2211 111111  1 16678899999999999999 9999999999999999  78


Q ss_pred             cEEEeeccceeecc
Q 045787          145 TVKLADFGLARAIG  158 (324)
Q Consensus       145 ~v~l~d~g~~~~~~  158 (324)
                      .++|+|||.+....
T Consensus       152 ~~~liDfg~a~~~~  165 (187)
T cd05119         152 KVYIIDVPQAVEID  165 (187)
T ss_pred             cEEEEECccccccc
Confidence            89999999887543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.69  E-value=3.4e-16  Score=145.48  Aligned_cols=137  Identities=20%  Similarity=0.231  Sum_probs=106.7

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeecc-ccC-----CCchHHHHHHHHHHhcCCCCeeEEEeeeecCCe
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQT-EQE-----GVPSYIIREVSLLKELEHENIVRLLDVQSSRKD   80 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~-~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   80 (324)
                      ..|...+.||+|++|+||++....  ..+++|+..... ...     ...+.+.+|+++++.++|++++....+..+...
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            345678899999999999988653  344554432211 111     112457889999999999998887777777777


Q ss_pred             EEEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceee
Q 045787           81 VFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARA  156 (324)
Q Consensus        81 ~~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~  156 (324)
                      .++||||++| +|.+.+.         ....++.+++.+|.+||+.|++|+|+||+||+++  ++.++|+|||.+..
T Consensus       411 ~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~--~~~~~liDFGla~~  476 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR--DDRLYLIDFGLGKY  476 (535)
T ss_pred             CEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE--CCcEEEEeCccccc
Confidence            8999999986 7766654         3467899999999999999999999999999995  67899999998875

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.67  E-value=1.7e-15  Score=125.79  Aligned_cols=135  Identities=20%  Similarity=0.247  Sum_probs=101.5

Q ss_pred             Eeec-ccCceEEEEEEEccCCceEEEEEeeeccc-----------cCCCchHHHHHHHHHHhcCCCCe--eEEEeeeecC
Q 045787           13 KKIG-AGGYGEVYKCRNTVTGQKVAIKMMTIQTE-----------QEGVPSYIIREVSLLKELEHENI--VRLLDVQSSR   78 (324)
Q Consensus        13 ~~Lg-~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-----------~~~~~~~~~~e~~~l~~l~~~~i--~~~~~~~~~~   78 (324)
                      ..|| .|+.|+||.+...  +..+++|.+.....           ......++.+|+.++.++.++++  +..+++....
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4576 8999999999864  77899998864210           01223567889999999988774  6666654332


Q ss_pred             -Ce---EEEEEEecCC--CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeecc
Q 045787           79 -KD---VFLVFEYLDL--DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFG  152 (324)
Q Consensus        79 -~~---~~iv~e~~~g--~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g  152 (324)
                       ..   .++|+|+++|  ++.+.+..  .++++..    +.+++.+|.+||+.|++|+||||.|||++ .++.++|+|||
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~-~~~~v~LIDfg  187 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE--APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLD-PDGKFWLIDFD  187 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc--CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEc-CCCCEEEEECC
Confidence             22   3599999985  66666544  3455543    56899999999999999999999999999 77899999999


Q ss_pred             ceee
Q 045787          153 LARA  156 (324)
Q Consensus       153 ~~~~  156 (324)
                      .+..
T Consensus       188 ~~~~  191 (239)
T PRK01723        188 RGEL  191 (239)
T ss_pred             Cccc
Confidence            8764

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.66  E-value=7.4e-16  Score=119.21  Aligned_cols=132  Identities=23%  Similarity=0.281  Sum_probs=108.9

Q ss_pred             eeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCC--CCeeEEEeeeecCCeEEEEEEec
Q 045787           11 KIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEH--ENIVRLLDVQSSRKDVFLVFEYL   88 (324)
Q Consensus        11 i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~iv~e~~   88 (324)
                      +++.||.|.++.||++....  ..+++|.......    ...+.+|+..++.+++  .++++++.....++..++++||+
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~   75 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWI   75 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEec
Confidence            57889999999999999753  7899998765433    3568899999999976  58999998888888899999999


Q ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcccCCCCCceEeecCCCcEEEeeccceee
Q 045787           89 DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSL---KILHRDLKPNNLLIDLKRNTVKLADFGLARA  156 (324)
Q Consensus        89 ~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---g~~H~di~p~nIll~~~~~~v~l~d~g~~~~  156 (324)
                      +|.....+       +......++.+++.++..+|..   +++|+|++|+||+++ ..+.++++||+.+..
T Consensus        76 ~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~-~~~~~~l~Df~~~~~  138 (155)
T cd05120          76 EGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD-DGKILGIIDWEYAGY  138 (155)
T ss_pred             CCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE-CCcEEEEEecccccC
Confidence            87433221       4456667889999999999984   799999999999999 688999999997753

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.63  E-value=1.2e-14  Score=131.04  Aligned_cols=169  Identities=21%  Similarity=0.344  Sum_probs=129.9

Q ss_pred             EEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEecCCCHHHHHHhcCCCCC
Q 045787           25 KCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLN  104 (324)
Q Consensus        25 ~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~~~  104 (324)
                      .+..+.++.++.+........  .......+.++.++.++||+|+++++.++.+++.|||+|.+.. +-.++.+    +.
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P-l~~~lk~----l~  102 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP-LETVLKE----LG  102 (690)
T ss_pred             ccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc-HHHHHHH----hH
Confidence            355667888888888776554  4456788899999999999999999999999999999999863 2222333    33


Q ss_pred             HHHHHHHHHHHHHHHHHHH-hCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcccccccccccCCchhhcCCC
Q 045787          105 LLVIKAILKQILLGLAYCH-SLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYT  183 (324)
Q Consensus       105 ~~~~~~i~~~i~~~l~~Lh-~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  183 (324)
                      ...+...+.||+.||.+|| ..+++|++++-+.|+++ ..|..+|++|..+...............-..|..|+.... .
T Consensus       103 ~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn-~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~-s  180 (690)
T KOG1243|consen  103 KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVN-ESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP-S  180 (690)
T ss_pred             HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEc-CCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCc-c
Confidence            6677788999999999998 67899999999999999 9999999999988765432221111111122677766543 1


Q ss_pred             CCCCchhhHHHHHHHHHHHhC
Q 045787          184 GYSTPIDVWAVGCIFAEMITG  204 (324)
Q Consensus       184 ~~~~~~DiwslG~il~~l~~g  204 (324)
                        +-..|.|.|||++++++.|
T Consensus       181 --~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  181 --EWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             --ccchhhhhHHHHHHHHhCc
Confidence              2457999999999999998

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.53  E-value=2.1e-14  Score=118.84  Aligned_cols=209  Identities=23%  Similarity=0.269  Sum_probs=146.5

Q ss_pred             HHHHHHhcCCCCeeEEEeeeecC-----CeEEEEEEecC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 045787           56 EVSLLKELEHENIVRLLDVQSSR-----KDVFLVFEYLD-LDLHSFITRHK---NTLNLLVIKAILKQILLGLAYCHSLK  126 (324)
Q Consensus        56 e~~~l~~l~~~~i~~~~~~~~~~-----~~~~iv~e~~~-g~l~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~Lh~~g  126 (324)
                      -+..+.++-|.|+++++.++.+.     ....++.||+. |++.+++.+..   ..+.....++|+-||+.||.|||+..
T Consensus       117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~  196 (458)
T KOG1266|consen  117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence            34455566799999999887543     35788899998 78888776643   35788888999999999999999875


Q ss_pred             --CcccCCCCCceEeecCCCcEEEeeccceeeccC----CCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHH
Q 045787          127 --ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGV----PQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAE  200 (324)
Q Consensus       127 --~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~  200 (324)
                        ++|+++..+.|++. .++.+|++--........    -........+.++|.+||.=.. ...+-++|||++|....+
T Consensus       197 PpiihgnlTc~tifiq-~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~-tn~~~a~dIy~fgmcAle  274 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQ-HNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTT-TNTTGASDIYKFGMCALE  274 (458)
T ss_pred             CccccCCcchhheeec-CCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcc-cccccchhhhhhhHHHHH
Confidence              99999999999999 888888765433221110    0112333456677999987443 445778999999999999


Q ss_pred             HHhCCCC-CCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChh-HHHHHHHhhcCCCCCC
Q 045787          201 MITGKPL-FPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPA-GVDLLSQMLCLNPKQR  278 (324)
Q Consensus       201 l~~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-l~~li~~~l~~dP~~R  278 (324)
                      |..+..- -.+.+.......                                .....-..... -+.++.+|++-.|..|
T Consensus       275 mailEiq~tnseS~~~~ee~--------------------------------ia~~i~~len~lqr~~i~kcl~~eP~~r  322 (458)
T KOG1266|consen  275 MAILEIQSTNSESKVEVEEN--------------------------------IANVIIGLENGLQRGSITKCLEGEPNGR  322 (458)
T ss_pred             HHHheeccCCCcceeehhhh--------------------------------hhhheeeccCccccCcCcccccCCCCCC
Confidence            9987632 111111110000                                00000111122 2488999999999999


Q ss_pred             CCHHHHhcCccccCCCCchh
Q 045787          279 ITAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       279 ps~~~~l~hp~~~~~~~~~~  298 (324)
                      |+++.++.||-+-++...++
T Consensus       323 p~ar~llfHpllfeVhslkl  342 (458)
T KOG1266|consen  323 PDARLLLFHPLLFEVHSLKL  342 (458)
T ss_pred             cchhhhhcCceeeecchHHH
Confidence            99999999999999886665

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.52  E-value=2.7e-13  Score=107.89  Aligned_cols=140  Identities=19%  Similarity=0.178  Sum_probs=101.3

Q ss_pred             eEeecccCceEEEEEEEcc------CCceEEEEEeeecccc-----------C---------CCchHHH----HHHHHHH
Q 045787           12 IKKIGAGGYGEVYKCRNTV------TGQKVAIKMMTIQTEQ-----------E---------GVPSYII----REVSLLK   61 (324)
Q Consensus        12 ~~~Lg~g~~~~v~~a~~~~------~~~~~~~K~~~~~~~~-----------~---------~~~~~~~----~e~~~l~   61 (324)
                      ...||.|--+.||.|....      .+..+|+|+++.....           .         .....+.    +|+..|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3578999999999998653      3579999998643210           0         0112233    7999999


Q ss_pred             hcCC--CCeeEEEeeeecCCeEEEEEEecCCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HhCCCcccCCCCCce
Q 045787           62 ELEH--ENIVRLLDVQSSRKDVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAILKQILLGLAYC-HSLKILHRDLKPNNL  137 (324)
Q Consensus        62 ~l~~--~~i~~~~~~~~~~~~~~iv~e~~~g~-l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~L-h~~g~~H~di~p~nI  137 (324)
                      ++..  -.+++++++    ...++||||++++ +...... ...++......+..+++.+|..| |+.|++|||+++.||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-d~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI  156 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-DAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM  156 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-ccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence            9864  456666654    4457999999863 2221111 12355666778889999999988 899999999999999


Q ss_pred             EeecCCCcEEEeeccceeecc
Q 045787          138 LIDLKRNTVKLADFGLARAIG  158 (324)
Q Consensus       138 ll~~~~~~v~l~d~g~~~~~~  158 (324)
                      +++  ++.++|+|||.+....
T Consensus       157 L~~--~~~v~iIDF~qav~~~  175 (197)
T cd05146         157 LWH--DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             EEE--CCcEEEEECCCceeCC
Confidence            998  4779999999887654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.51  E-value=9.3e-15  Score=137.25  Aligned_cols=268  Identities=22%  Similarity=0.273  Sum_probs=197.0

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCC-CchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEG-VPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   83 (324)
                      ..+.+.+.+-+.+|+++.++.+.-..+|...+.|+......-.. ..+.+..+-.++..-.+|.++.....+......++
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            45678888899999999999998888886666666544332111 12223333333333345666666655666778899


Q ss_pred             EEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC--
Q 045787           84 VFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP--  160 (324)
Q Consensus        84 v~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~--  160 (324)
                      +++|.+| ++...+... ++.+++.++..+..+..++++||...+.|+|++|.|.+.. .++..++.+++.....+.-  
T Consensus       882 ~~~~~~~~~~~Skl~~~-~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~-~~gh~~l~~~~t~~~vg~~~p  959 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNS-GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIA-YDGHRPLTDFGTLSKVGLIPP  959 (1205)
T ss_pred             hhHHhccCCchhhhhcC-CCcccccccchhHHHHhhhhccccchhhcccccccchhhc-ccCCcccCccccccccccccC
Confidence            9999975 777666654 4688888889999999999999999999999999999999 8899999998733222100  


Q ss_pred             -----------------------------CCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 045787          161 -----------------------------QKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSK  211 (324)
Q Consensus       161 -----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  211 (324)
                                                   ........+|+.|.+||...+ .....++|.|+.|+++++.++|.+||...
T Consensus       960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg-~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen  960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG-RRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred             cCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc-ccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence                                         011222357788999999988 55688899999999999999999999887


Q ss_pred             ChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHH---HHhcCc
Q 045787          212 KHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAM---DALKHE  288 (324)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~---~~l~hp  288 (324)
                      ........+....                         ..+.......+..+++++..++..+|.+|..+.   ++-.|+
T Consensus      1039 tpq~~f~ni~~~~-------------------------~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~ 1093 (1205)
T KOG0606|consen 1039 TPQQIFENILNRD-------------------------IPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHP 1093 (1205)
T ss_pred             chhhhhhccccCC-------------------------CCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCC
Confidence            7665432222111                         112222336788999999999999999999888   888999


Q ss_pred             cccCCCCchhhh
Q 045787          289 YLIGVENVPLVI  300 (324)
Q Consensus       289 ~~~~~~~~~~~~  300 (324)
                      ||+.+.+..+..
T Consensus      1094 ~~~~~~~~~l~~ 1105 (1205)
T KOG0606|consen 1094 FFQDVDWENLAL 1105 (1205)
T ss_pred             ccCCCCcccccc
Confidence            999999887754

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.42  E-value=1.5e-12  Score=102.76  Aligned_cols=128  Identities=20%  Similarity=0.166  Sum_probs=93.5

Q ss_pred             eeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCC-eeEEEeeeecCCeEEEEEEecC
Q 045787           11 KIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN-IVRLLDVQSSRKDVFLVFEYLD   89 (324)
Q Consensus        11 i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~iv~e~~~   89 (324)
                      .++.|+.|..+.||++...  +..|++|........   ...+..|+.+++.+.+.+ +++++....  ...++||||++
T Consensus         2 ~~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~---~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~   74 (170)
T cd05151           2 HISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTEL---LINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE   74 (170)
T ss_pred             ceeecCCcccCceEEEEEC--CeEEEEEeCCCCccc---ccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence            3678999999999999864  778999987644321   234578999999886544 345555433  23579999999


Q ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCC-----cccCCCCCceEeecCCCcEEEeecccee
Q 045787           90 LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI-----LHRDLKPNNLLIDLKRNTVKLADFGLAR  155 (324)
Q Consensus        90 g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~-----~H~di~p~nIll~~~~~~v~l~d~g~~~  155 (324)
                      |......        ......++.+++.+|..||+.++     +|+|++|.||+++  ++.++++||+.+.
T Consensus        75 G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~--~~~~~liDf~~a~  135 (170)
T cd05151          75 GSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD--DGRLWLIDWEYAG  135 (170)
T ss_pred             CCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE--CCeEEEEeccccc
Confidence            7433211        01113456789999999999885     9999999999998  5679999999775

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.41  E-value=3.3e-12  Score=115.27  Aligned_cols=141  Identities=23%  Similarity=0.334  Sum_probs=92.7

Q ss_pred             EeecccCceEEEEEEEccCCceEEEEEeeeccccC--------------------C----Cc--------------hHHH
Q 045787           13 KKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQE--------------------G----VP--------------SYII   54 (324)
Q Consensus        13 ~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~--------------------~----~~--------------~~~~   54 (324)
                      +.||+|+.|.||+|..+ +|+.||||+........                    .    ..              -.+.
T Consensus       123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            57999999999999865 78999999985431100                    0    00              0134


Q ss_pred             HHHHHHHhcC----CCCeeEEEeee-ecCCeEEEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHH-HHHHHHhCCC
Q 045787           55 REVSLLKELE----HENIVRLLDVQ-SSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILL-GLAYCHSLKI  127 (324)
Q Consensus        55 ~e~~~l~~l~----~~~i~~~~~~~-~~~~~~~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~-~l~~Lh~~g~  127 (324)
                      +|+..+.++.    +..-+.+-.++ ...+..++||||++| ++.+.........+   ...++..++. .+..+|..|+
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~  278 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF  278 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence            4555555552    22223332222 223456899999987 55554433222222   2334455554 4678999999


Q ss_pred             cccCCCCCceEeecCCCcEEEeeccceeecc
Q 045787          128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIG  158 (324)
Q Consensus       128 ~H~di~p~nIll~~~~~~v~l~d~g~~~~~~  158 (324)
                      +|+|++|.||+++ .++.++++|||.+...+
T Consensus       279 ~H~D~hPgNilv~-~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       279 FHADLHPGNIFVL-KDGKIIALDFGIVGRLS  308 (437)
T ss_pred             eeCCCCcccEEEC-CCCcEEEEeCCCeeECC
Confidence            9999999999998 88999999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.38  E-value=2.8e-11  Score=106.47  Aligned_cols=221  Identities=17%  Similarity=0.219  Sum_probs=158.7

Q ss_pred             CceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeec----CCeEEEEEEecCC--CH
Q 045787           19 GYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS----RKDVFLVFEYLDL--DL   92 (324)
Q Consensus        19 ~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~iv~e~~~g--~l   92 (324)
                      ...+.|++....+|..|++|.+.......  ..+...-+++++++.|.|++++.+++..    +..+++|++|+++  +|
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~--~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL  365 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQS--TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL  365 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccC--cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence            45789999999999999999984332211  2234466899999999999999998863    4568999999984  77


Q ss_pred             HHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeecc
Q 045787           93 HSFITRH--------------KNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIG  158 (324)
Q Consensus        93 ~~~~~~~--------------~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~  158 (324)
                      .+..-..              +...++..+|.++.|++.||.++|+.|+..+-+.|.+|++. .+-+++|...|......
T Consensus       366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~-G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVT-GKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEee-CcceEEEecccceeeec
Confidence            7765432              12367899999999999999999999999999999999999 66689998888766554


Q ss_pred             CCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhh
Q 045787          159 VPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYIS  238 (324)
Q Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (324)
                      ...            .+|  +..    ..+-|.=.||.+++.+.||..--...+...                       
T Consensus       445 ~d~------------~~~--le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~-----------------------  483 (655)
T KOG3741|consen  445 EDP------------TEP--LES----QQQNDLRDLGLLLLALATGTENSNRTDSTQ-----------------------  483 (655)
T ss_pred             CCC------------Ccc--hhH----HhhhhHHHHHHHHHHHhhcccccccccchH-----------------------
Confidence            221            011  111    335699999999999999863211111110                       


Q ss_pred             cccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc---CccccCCC
Q 045787          239 EILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK---HEYLIGVE  294 (324)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~---hp~~~~~~  294 (324)
                                ........+.++.+++++|.-+...++++ -++.+++.   .-||...+
T Consensus       484 ----------~s~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~~~~ff~vme  531 (655)
T KOG3741|consen  484 ----------SSHLTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMIGSRFFTVME  531 (655)
T ss_pred             ----------HHHHHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHHHHHHHHHHH
Confidence                      01112233468889999999999999987 67777765   34444443

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.37  E-value=1.5e-11  Score=94.39  Aligned_cols=145  Identities=19%  Similarity=0.189  Sum_probs=106.6

Q ss_pred             eeEeecccCceEEEEEEEccCCceEEEEEeeec-cccC-----CCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 045787           11 KIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQ-TEQE-----GVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLV   84 (324)
Q Consensus        11 i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~-~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   84 (324)
                      .+..+-+|+-+.|+++..  +|+.+++|.-... ...+     -...+.++|++.+.++.--+|.-..=++.+...-+|+
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            678888999999998875  5888888764322 2222     1235577899999888744443333344445555699


Q ss_pred             EEecCC--CHHHHHHhcCCCC-CHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcE--EEeeccceeec
Q 045787           85 FEYLDL--DLHSFITRHKNTL-NLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTV--KLADFGLARAI  157 (324)
Q Consensus        85 ~e~~~g--~l~~~~~~~~~~~-~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v--~l~d~g~~~~~  157 (324)
                      |||++|  ++.+++......- ++.....++..|-..+.-||..+++||||..+||++.+.++.+  .++|||++...
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            999998  8888887754433 3334478889999999999999999999999999998555554  99999998754

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.36  E-value=6.2e-13  Score=118.75  Aligned_cols=254  Identities=23%  Similarity=0.216  Sum_probs=177.1

Q ss_pred             cCcCcceeEeecccCceEEEEEEEc-cCCceEEEEEeeeccccCCCchHHHHHHHHHHhcC-CCCeeEEEeeeecCCeEE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNT-VTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-HENIVRLLDVQSSRKDVF   82 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~-~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~   82 (324)
                      ...+|-.+..||.|.++.|+.+... ..+..|++|..............-..|+.+...+. |.+++..+..+...+..|
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~  342 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY  342 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence            4567899999999999999987755 56778999987655433322222334666666664 888999888888888888


Q ss_pred             EEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC
Q 045787           83 LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK  162 (324)
Q Consensus        83 iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~  162 (324)
                      +-.||+.+............+++...+++..+++.++.++|+..++|+|++|+||++...++.-+++||+....+.-   
T Consensus       343 ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~---  419 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF---  419 (524)
T ss_pred             CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce---
Confidence            99999975322222222335788889999999999999999999999999999999983347789999998764211   


Q ss_pred             cccccccccccC-CchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhccc
Q 045787          163 EYSRDCVYSPYK-APELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEIL  241 (324)
Q Consensus       163 ~~~~~~~~~~y~-aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (324)
                      ........-++. .+|++....++..+.|++|||..+.+..++...-.......                       .+ 
T Consensus       420 ~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~-----------------------~i-  475 (524)
T KOG0601|consen  420 SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL-----------------------TI-  475 (524)
T ss_pred             ecccccccccccccchhhccccccccccccccccccccccccCcccCcccccce-----------------------ee-
Confidence            111112223344 36666655778999999999999999998864321111110                       00 


Q ss_pred             CCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccC
Q 045787          242 PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIG  292 (324)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~  292 (324)
                             ........+....+++.+.+.++..|+..||.+.++..|+-|..
T Consensus       476 -------~~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  476 -------RSGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             -------ecccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence                   00001111234467788999999999999999999988776543

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.34  E-value=2e-12  Score=118.08  Aligned_cols=142  Identities=15%  Similarity=0.259  Sum_probs=91.4

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeecccc--------------------C------------CCchH---
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQ--------------------E------------GVPSY---   52 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~--------------------~------------~~~~~---   52 (324)
                      .|.. +.||+|+.|.||+|..+.+|+.||+|+....-..                    .            +..+.   
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            4666 7899999999999999888999999999754210                    0            00111   


Q ss_pred             ---HHHHHHHHHhcC----CCCeeEEEeeeec-CCeEEEEEEecCC-CHHHH--HHhcCC---CCCHHHHHHHHHHHHHH
Q 045787           53 ---IIREVSLLKELE----HENIVRLLDVQSS-RKDVFLVFEYLDL-DLHSF--ITRHKN---TLNLLVIKAILKQILLG  118 (324)
Q Consensus        53 ---~~~e~~~l~~l~----~~~i~~~~~~~~~-~~~~~iv~e~~~g-~l~~~--~~~~~~---~~~~~~~~~i~~~i~~~  118 (324)
                         +.+|+..+.++.    +...+.+-.++.+ .+..++||||+.| .+.+.  +...+.   .+.+..+..++.|    
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q----  275 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ----  275 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH----
Confidence               334444444442    3333333333332 4456899999987 55442  222111   1223333333333    


Q ss_pred             HHHHHhCCCcccCCCCCceEeecCCC----cEEEeeccceeecc
Q 045787          119 LAYCHSLKILHRDLKPNNLLIDLKRN----TVKLADFGLARAIG  158 (324)
Q Consensus       119 l~~Lh~~g~~H~di~p~nIll~~~~~----~v~l~d~g~~~~~~  158 (324)
                         +...|++|+|++|.||+++ .++    .++++|||.....+
T Consensus       276 ---if~~GffHaDpHPGNIlv~-~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        276 ---VFRDGFFHADMHPGNIFVS-YDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             ---HHhCCeeeCCCChHHeEEe-cCCCCCCeEEEEecceEEECC
Confidence               4468999999999999999 666    99999999987664

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.29  E-value=6.3e-11  Score=91.34  Aligned_cols=132  Identities=17%  Similarity=0.268  Sum_probs=92.6

Q ss_pred             EeecccCceEEEEEEEccCCceEEEEEeeec-cccCCC-----chHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEE
Q 045787           13 KKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQ-TEQEGV-----PSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE   86 (324)
Q Consensus        13 ~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~-~~~~~~-----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   86 (324)
                      ..++.|+-+.++.+..  -|..+++|.-... ...+..     ..+..+|+.++.++.--.|....=+..+.....|+||
T Consensus         2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            3577899999999854  3555677764322 222221     2345678999988875555444444555666779999


Q ss_pred             ecCCCHHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceee
Q 045787           87 YLDLDLHS-FITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARA  156 (324)
Q Consensus        87 ~~~g~l~~-~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~  156 (324)
                      |++|.++. .+...    .    ..++..+-.-+.-||..|++|||++++||.++  ++.+.++|||++..
T Consensus        80 ~I~G~~lkd~l~~~----~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~--~~~i~~IDfGLg~~  140 (204)
T COG3642          80 YIEGELLKDALEEA----R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILS--GGRIYFIDFGLGEF  140 (204)
T ss_pred             EeCChhHHHHHHhc----c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEe--CCcEEEEECCcccc
Confidence            99995555 55543    2    34556666667779999999999999999998  44499999998874

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.29  E-value=1.3e-12  Score=118.37  Aligned_cols=158  Identities=22%  Similarity=0.270  Sum_probs=115.8

Q ss_pred             HHHHHHHHHHh-CCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccccc----------ccccccCCchhhcCC
Q 045787          114 QILLGLAYCHS-LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRD----------CVYSPYKAPELLLGY  182 (324)
Q Consensus       114 ~i~~~l~~Lh~-~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~~----------~~~~~y~aPE~~~~~  182 (324)
                      ++..|+.++|. -+++|++|.|++|.++ .++.+||+.|+.+.....+.. ....          .....|.|||++.+ 
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~n-a~~~wkl~Gf~f~v~~~~~~~-~p~~~yd~~lp~~~~~~~~f~apE~~~~-  183 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVN-ANGDWKLAGFSFCVNANGPTE-YPFSEYDPPLPLLLQPHLNFLAPEYLLG-  183 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeec-cCcceeeccchhhhccCCCCc-cccccCCCCCChhhccCcccccchhhcc-
Confidence            34489999995 5899999999999999 999999999998876654222 1111          12334999999988 


Q ss_pred             CCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCCh
Q 045787          183 TGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEP  261 (324)
Q Consensus       183 ~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (324)
                      ...+.++|+||+|+++|.+.. |+..+.................                        ........+++.
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~------------------------~~~~~~s~~~p~  239 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLN------------------------AGAFGYSNNLPS  239 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccc------------------------cccccccccCcH
Confidence            777999999999999999995 5544544432222221111111                        011111147999


Q ss_pred             hHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchh
Q 045787          262 AGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       262 ~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~  298 (324)
                      ++++=+.+++..|+..||++.+++..|||.+..-.-+
T Consensus       240 el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~~~aL  276 (700)
T KOG2137|consen  240 ELRESLKKLLNGDSAVRPTLDLLLSIPFFSDPGLKAL  276 (700)
T ss_pred             HHHHHHHHHhcCCcccCcchhhhhcccccCCchhhhh
Confidence            9999999999999999999999999999999876554

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.24  E-value=1.6e-10  Score=99.50  Aligned_cols=258  Identities=13%  Similarity=0.089  Sum_probs=158.5

Q ss_pred             cceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhc-CCCCeeEEEee------eecC-Ce
Q 045787            9 YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDV------QSSR-KD   80 (324)
Q Consensus         9 y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~------~~~~-~~   80 (324)
                      ....+.||+|+-+.+|-+-.-   .--+.|++..+....     -.+.+..+... .||-+..-+.+      ..+. ..
T Consensus        13 i~~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~-----~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~   84 (637)
T COG4248          13 IPPGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAA-----QAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKV   84 (637)
T ss_pred             cCCCccccCCccceeeecchh---hchhheeecCCCchH-----HHHHHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence            344577899999999976533   234667776554321     11223333332 45544331111      1122 23


Q ss_pred             EEEEEEecCC--CHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccc
Q 045787           81 VFLVFEYLDL--DLHSFITRH-----KNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGL  153 (324)
Q Consensus        81 ~~iv~e~~~g--~l~~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~  153 (324)
                      .-++|+.+.|  ....++.-.     -...++....+..+.++.+...||..|.+-||++++|+|++ +++.|.|+|=+.
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVs-d~~~V~LVdsDs  163 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVS-DDSKVVLVDSDS  163 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeee-cCceEEEEcccc
Confidence            6788888875  343333211     12377889999999999999999999999999999999999 999999999775


Q ss_pred             eeeccCCCCcccccccccccCCchhhc-C---CCCCCCchhhHHHHHHHHHHHhC-CCCCCCCChhHHHHHHHHcCCCCc
Q 045787          154 ARAIGVPQKEYSRDCVYSPYKAPELLL-G---YTGYSTPIDVWAVGCIFAEMITG-KPLFPSKKHDHLSLIFSLLGTPTD  228 (324)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-~---~~~~~~~~DiwslG~il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~  228 (324)
                      -... ........+.+.+.|.+||.-. +   ...-+..+|.|.||+++++++.| .+||.+-....       ...++.
T Consensus       164 fqi~-~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~-------~ap~p~  235 (637)
T COG4248         164 FQIN-ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLIS-------DAPNPL  235 (637)
T ss_pred             eeec-cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccC-------CCCCcc
Confidence            5544 2444556677888899999864 1   23357789999999999999997 89997643110       000000


Q ss_pred             ccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcC--CCCCCCCHHH
Q 045787          229 ESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCL--NPKQRITAMD  283 (324)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~--dP~~Rps~~~  283 (324)
                      +.-..........+......+....--+..++++++.++..|+..  +|.-|||++.
T Consensus       236 E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         236 ETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             hhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence            000000000000000111111111112235789999999999985  3668999754

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.21  E-value=1.7e-10  Score=95.14  Aligned_cols=141  Identities=20%  Similarity=0.260  Sum_probs=99.0

Q ss_pred             eEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCC--CeeEEEeeeecC---CeEEEEEE
Q 045787           12 IKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHE--NIVRLLDVQSSR---KDVFLVFE   86 (324)
Q Consensus        12 ~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~~~~~---~~~~iv~e   86 (324)
                      ++.|+.|..+.+|++... +|..+++|........ .....+..|..+++.+.+.  .+++++.+....   +..++|||
T Consensus         3 ~~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e   80 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME   80 (223)
T ss_pred             ceecCCCccceEEEEEec-CCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence            467899999999999874 3689999997654332 2345688999999999753  456677766553   36789999


Q ss_pred             ecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 045787           87 YLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS-----------------------------------------  124 (324)
Q Consensus        87 ~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-----------------------------------------  124 (324)
                      |++| ++...+..  ..+++.....++.+++.+|..||+                                         
T Consensus        81 ~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          81 RVDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             EeCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            9987 34332211  235555555556666666666653                                         


Q ss_pred             ---------------CCCcccCCCCCceEeecC-CCcEEEeeccceee
Q 045787          125 ---------------LKILHRDLKPNNLLIDLK-RNTVKLADFGLARA  156 (324)
Q Consensus       125 ---------------~g~~H~di~p~nIll~~~-~~~v~l~d~g~~~~  156 (324)
                                     ..++|+|+.|.||+++.. ++.+.|+||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                           246999999999999932 56789999987753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.21  E-value=1.5e-10  Score=91.84  Aligned_cols=127  Identities=25%  Similarity=0.336  Sum_probs=82.2

Q ss_pred             EEEEEEccCCceEEEEEeeecccc-----------CC-------------CchHHHHHHHHHHhcCCC--CeeEEEeeee
Q 045787           23 VYKCRNTVTGQKVAIKMMTIQTEQ-----------EG-------------VPSYIIREVSLLKELEHE--NIVRLLDVQS   76 (324)
Q Consensus        23 v~~a~~~~~~~~~~~K~~~~~~~~-----------~~-------------~~~~~~~e~~~l~~l~~~--~i~~~~~~~~   76 (324)
                      ||.|... +|..+|+|........           ..             ......+|.+.|.++..-  ++++++++. 
T Consensus         2 Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    2 VYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             EEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            7888864 5779999998643211           00             012367899999999865  466666553 


Q ss_pred             cCCeEEEEEEecC--CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH-HHhCCCcccCCCCCceEeecCCCcEEEeeccc
Q 045787           77 SRKDVFLVFEYLD--LDLHSFITRHKNTLNLLVIKAILKQILLGLAY-CHSLKILHRDLKPNNLLIDLKRNTVKLADFGL  153 (324)
Q Consensus        77 ~~~~~~iv~e~~~--g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~-Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~  153 (324)
                         ..+|||||++  |..+..+....  ++.+....++.+++..+.. +|..|++|||+++.||+++ ++ .+.++|||.
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~-~~-~~~iIDf~q  152 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVD-DG-KVYIIDFGQ  152 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEE-TT-CEEE--GTT
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEee-cc-eEEEEecCc
Confidence               2369999999  75555455432  2244456677777775554 6799999999999999999 44 999999998


Q ss_pred             eeecc
Q 045787          154 ARAIG  158 (324)
Q Consensus       154 ~~~~~  158 (324)
                      +....
T Consensus       153 av~~~  157 (188)
T PF01163_consen  153 AVDSS  157 (188)
T ss_dssp             EEETT
T ss_pred             ceecC
Confidence            88654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.18  E-value=8e-10  Score=92.97  Aligned_cols=132  Identities=16%  Similarity=0.167  Sum_probs=93.1

Q ss_pred             EEEEEEEccCCceEEEEEeeeccccC---------CCchHHHHHHHHHHhcCCCCe--eEEEeeeec-----CCeEEEEE
Q 045787           22 EVYKCRNTVTGQKVAIKMMTIQTEQE---------GVPSYIIREVSLLKELEHENI--VRLLDVQSS-----RKDVFLVF   85 (324)
Q Consensus        22 ~v~~a~~~~~~~~~~~K~~~~~~~~~---------~~~~~~~~e~~~l~~l~~~~i--~~~~~~~~~-----~~~~~iv~   85 (324)
                      .|+.+.  -.|+.|.+|.........         .-.....+|...+.++...+|  +..+.+...     ....++|+
T Consensus        37 rvvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt  114 (268)
T PRK15123         37 RTLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT  114 (268)
T ss_pred             eEEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence            355553  357789999764332110         001246789998888853333  334444432     23578999


Q ss_pred             EecCC--CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeec------CCCcEEEeecccee
Q 045787           86 EYLDL--DLHSFITRH-KNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL------KRNTVKLADFGLAR  155 (324)
Q Consensus        86 e~~~g--~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~------~~~~v~l~d~g~~~  155 (324)
                      |++++  ++.+++... ..+.+......++.+++..+..||..|++|+|+++.|||++.      .+..+.|+||+.+.
T Consensus       115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            99997  677776542 245667778899999999999999999999999999999983      24689999999775

>PRK09902 hypothetical protein; Provisional

Probab=99.12  E-value=2.6e-09  Score=85.34  Aligned_cols=137  Identities=21%  Similarity=0.269  Sum_probs=101.8

Q ss_pred             cccCceEEEEEEEccCCceEEEEEeeecc----ccCCCchHHHHHHHHHHhcCCCC--eeEEEeeee---c--CCeEEEE
Q 045787           16 GAGGYGEVYKCRNTVTGQKVAIKMMTIQT----EQEGVPSYIIREVSLLKELEHEN--IVRLLDVQS---S--RKDVFLV   84 (324)
Q Consensus        16 g~g~~~~v~~a~~~~~~~~~~~K~~~~~~----~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~---~--~~~~~iv   84 (324)
                      |+||-|.|+.....  |..|-+|......    ..+-....+.+|+..++++..-+  +++++ ++.   .  .-..+||
T Consensus        27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            45889999987754  4578888765211    11335577999999999996322  44444 222   1  1247899


Q ss_pred             EEecCC--CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCc--EEEeeccceee
Q 045787           85 FEYLDL--DLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNT--VKLADFGLARA  156 (324)
Q Consensus        85 ~e~~~g--~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~--v~l~d~g~~~~  156 (324)
                      +|-++|  +|.+++.+.. .+.+......++.+++.++.-||+.|+.|+|+.+.||+++ .++.  +.++||..++.
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~-~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVK-TEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeec-CCCCeeEEEEEhhccch
Confidence            999985  8887776532 3567888889999999999999999999999999999998 4555  99999987654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.05  E-value=8.5e-09  Score=83.90  Aligned_cols=125  Identities=22%  Similarity=0.265  Sum_probs=89.5

Q ss_pred             cCCceEEEEEeeecccc-----CCCchHHHHHHHHHHhcCCCC--eeEEEeeeecC----CeEEEEEEecCC--CHHHHH
Q 045787           30 VTGQKVAIKMMTIQTEQ-----EGVPSYIIREVSLLKELEHEN--IVRLLDVQSSR----KDVFLVFEYLDL--DLHSFI   96 (324)
Q Consensus        30 ~~~~~~~~K~~~~~~~~-----~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~----~~~~iv~e~~~g--~l~~~~   96 (324)
                      ..++.|.+|........     .-...+..+|...+..+...+  .++.+++....    ...++|+|+++|  +|.+.+
T Consensus        30 ~~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~  109 (206)
T PF06293_consen   30 LVGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLL  109 (206)
T ss_pred             ccceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHH
Confidence            34556666654322111     122356788998888886433  34455554432    246899999986  677777


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCC---cEEEeeccceee
Q 045787           97 TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN---TVKLADFGLARA  156 (324)
Q Consensus        97 ~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~---~v~l~d~g~~~~  156 (324)
                      ..... .+......++.+++..+.-||..|++|+|+++.|||++ .++   .+.++||+.+..
T Consensus       110 ~~~~~-~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~-~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  110 QQWEQ-LDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVD-PDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             Hhhcc-cchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEe-CCCCceeEEEEcchhcee
Confidence            66433 67777889999999999999999999999999999999 555   899999997764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.04  E-value=2e-09  Score=88.17  Aligned_cols=138  Identities=24%  Similarity=0.265  Sum_probs=102.2

Q ss_pred             cceeEeecccCceEEEEEEEccCCceEEEEEeeecccc----------------C----CCchHHHHHHHHHHhcCCC--
Q 045787            9 YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQ----------------E----GVPSYIIREVSLLKELEHE--   66 (324)
Q Consensus         9 y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~----------------~----~~~~~~~~e~~~l~~l~~~--   66 (324)
                      +.+...||-|--|.||.|.+. +|..+++|.-+.....                .    -.....++|.++|++|...  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            346678999999999999986 6889999975432110                0    0113367899999999755  


Q ss_pred             CeeEEEeeeecCCeEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcE
Q 045787           67 NIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTV  146 (324)
Q Consensus        67 ~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v  146 (324)
                      .+++.+++    +..++|||+++|..+.-+     +++.+....++..|+.-+..+-..|++|||+++=||+++ ++|.+
T Consensus       172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~-~dg~~  241 (304)
T COG0478         172 KVPKPIAW----NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVT-EDGDI  241 (304)
T ss_pred             CCCCcccc----ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEe-cCCCE
Confidence            56666543    445799999998433211     224555667777888888888899999999999999999 99999


Q ss_pred             EEeeccceeec
Q 045787          147 KLADFGLARAI  157 (324)
Q Consensus       147 ~l~d~g~~~~~  157 (324)
                      +++||-.+...
T Consensus       242 ~vIDwPQ~v~~  252 (304)
T COG0478         242 VVIDWPQAVPI  252 (304)
T ss_pred             EEEeCcccccC
Confidence            99999876644

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.85  E-value=7e-08  Score=77.50  Aligned_cols=140  Identities=19%  Similarity=0.227  Sum_probs=91.0

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCC-------chHHHHHHHHHHhcCC---CCeeEEE
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGV-------PSYIIREVSLLKELEH---ENIVRLL   72 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~-------~~~~~~e~~~l~~l~~---~~i~~~~   72 (324)
                      .++.++|.+.+.+-......|.++.  .+|..+++|.+.........       -....+.+..+.++..   ...+.++
T Consensus        27 ~i~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~y  104 (229)
T PF06176_consen   27 KILDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPY  104 (229)
T ss_pred             HHHhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccce
Confidence            3578899999999999988888876  45789999998754322100       0112233333334432   2222222


Q ss_pred             ee-----eecCCeEEEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcE
Q 045787           73 DV-----QSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTV  146 (324)
Q Consensus        73 ~~-----~~~~~~~~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v  146 (324)
                      -+     +......++++||++| .+.+. ..    +++.    +...+.+++..+|+.|+.|||.+|.|++++  ++.+
T Consensus       105 l~~ekk~~~~~~~~~ll~EYIeG~~l~d~-~~----i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~--~~~i  173 (229)
T PF06176_consen  105 LAAEKKIFRYTSSYVLLMEYIEGVELNDI-ED----IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVS--NNGI  173 (229)
T ss_pred             eeeeeeeccceeEEEEEEEEecCeecccc-hh----cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEE--CCcE
Confidence            22     2223456789999998 44332 11    2332    345577788999999999999999999998  4559


Q ss_pred             EEeecccee
Q 045787          147 KLADFGLAR  155 (324)
Q Consensus       147 ~l~d~g~~~  155 (324)
                      +++|++...
T Consensus       174 ~iID~~~k~  182 (229)
T PF06176_consen  174 RIIDTQGKR  182 (229)
T ss_pred             EEEECcccc
Confidence            999997554

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.70  E-value=2.3e-07  Score=75.37  Aligned_cols=138  Identities=19%  Similarity=0.250  Sum_probs=94.9

Q ss_pred             eEeecccCceEEEEEEEccCCceEEEEEeeeccccCC-----------------Cc-----hHHHHHHHHHHhcCCC--C
Q 045787           12 IKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEG-----------------VP-----SYIIREVSLLKELEHE--N   67 (324)
Q Consensus        12 ~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~-----------------~~-----~~~~~e~~~l~~l~~~--~   67 (324)
                      ...|++|--+.||+|.. .++..+|+|++........                 ..     ....+|+..|.++...  .
T Consensus        53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr  131 (268)
T COG1718          53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR  131 (268)
T ss_pred             EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence            34566788899999885 4678999999975432211                 00     1145677778777543  3


Q ss_pred             eeEEEeeeecCCeEEEEEEecCCC--HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCceEeecCCC
Q 045787           68 IVRLLDVQSSRKDVFLVFEYLDLD--LHSFITRHKNTLNLLVIKAILKQILLGLAYCHS-LKILHRDLKPNNLLIDLKRN  144 (324)
Q Consensus        68 i~~~~~~~~~~~~~~iv~e~~~g~--l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~g~~H~di~p~nIll~~~~~  144 (324)
                      +++.+.+..+    .+|||+++..  ..-.+..  -++....+..+..+++..+.-|-. .|++|+||+.=|||+.  ++
T Consensus       132 vP~Pi~~~~n----VLvMEfIg~~g~pAP~LkD--v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~--~~  203 (268)
T COG1718         132 VPEPIAFRNN----VLVMEFIGDDGLPAPRLKD--VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH--DG  203 (268)
T ss_pred             CCCceeecCC----eEEEEeccCCCCCCCCccc--CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE--CC
Confidence            4444544433    4999999743  1111111  123444677778888888888887 8999999999999999  88


Q ss_pred             cEEEeeccceeecc
Q 045787          145 TVKLADFGLARAIG  158 (324)
Q Consensus       145 ~v~l~d~g~~~~~~  158 (324)
                      .+.++|++.+....
T Consensus       204 ~p~iID~~QaV~~~  217 (268)
T COG1718         204 EPYIIDVSQAVTID  217 (268)
T ss_pred             eEEEEECccccccC
Confidence            99999999887654

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.70  E-value=3.9e-07  Score=75.11  Aligned_cols=71  Identities=20%  Similarity=0.219  Sum_probs=54.1

Q ss_pred             EeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCC--CeeEEEeeeecCCeEEEEEEecCC
Q 045787           13 KKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHE--NIVRLLDVQSSRKDVFLVFEYLDL   90 (324)
Q Consensus        13 ~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~~~~~~~~~iv~e~~~g   90 (324)
                      ..+|+|..+.||+.    .+..+++|......    ....+.+|.++++.+..-  .+.+++++....+...+||++++|
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G   78 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVG   78 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCC
Confidence            57899999999974    25578899876432    234578999999998643  357778887777788899999998


Q ss_pred             C
Q 045787           91 D   91 (324)
Q Consensus        91 ~   91 (324)
                      .
T Consensus        79 ~   79 (226)
T TIGR02172        79 K   79 (226)
T ss_pred             c
Confidence            4

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.57  E-value=7.3e-07  Score=74.01  Aligned_cols=74  Identities=19%  Similarity=0.332  Sum_probs=52.7

Q ss_pred             eEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCC--CeeEEEeee---ecCCeEEEEEE
Q 045787           12 IKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHE--NIVRLLDVQ---SSRKDVFLVFE   86 (324)
Q Consensus        12 ~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~~---~~~~~~~iv~e   86 (324)
                      ++.|+.|..+.||++....  ..+++|.....    .....+.+|..+++.+...  .+++++...   ......+++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~   75 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLME   75 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEE
Confidence            6789999999999999764  59999987654    1235677899998888533  355666533   23345799999


Q ss_pred             ecCCC
Q 045787           87 YLDLD   91 (324)
Q Consensus        87 ~~~g~   91 (324)
                      +++|.
T Consensus        76 ~i~g~   80 (239)
T PF01636_consen   76 YIPGR   80 (239)
T ss_dssp             EESSE
T ss_pred             Eeccc
Confidence            99884

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.46  E-value=1.1e-06  Score=80.26  Aligned_cols=142  Identities=18%  Similarity=0.272  Sum_probs=88.9

Q ss_pred             EeecccCceEEEEEEEccCCceEEEEEeeeccccC--------------------C------------CchH------HH
Q 045787           13 KKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQE--------------------G------------VPSY------II   54 (324)
Q Consensus        13 ~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~--------------------~------------~~~~------~~   54 (324)
                      +.+++++-|.||.|.-++ |+.||||+..+.-...                    .            ..+.      +.
T Consensus       131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            578899999999999764 9999999986432110                    0            0011      34


Q ss_pred             HHHHHHHhcC----CCCeeEEEeee-ecCCeEEEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 045787           55 REVSLLKELE----HENIVRLLDVQ-SSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKIL  128 (324)
Q Consensus        55 ~e~~~l~~l~----~~~i~~~~~~~-~~~~~~~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~  128 (324)
                      +|...+.++.    ...-+.+=.++ +..+.-.++|||++| .+.+...-.....+...+...+.++.  +..+-..|++
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgff  287 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGFF  287 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCcc
Confidence            4555554442    22222222232 234456799999998 44444322223466444433333322  3334458999


Q ss_pred             ccCCCCCceEeecCCCcEEEeeccceeecc
Q 045787          129 HRDLKPNNLLIDLKRNTVKLADFGLARAIG  158 (324)
Q Consensus       129 H~di~p~nIll~~~~~~v~l~d~g~~~~~~  158 (324)
                      |+|..|.||+++ .++++.+.|||.....+
T Consensus       288 HaDpHpGNi~v~-~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         288 HADPHPGNILVR-SDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             ccCCCccceEEe-cCCcEEEEcCcceecCC
Confidence            999999999999 88999999999876554

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.46  E-value=1.5e-06  Score=84.27  Aligned_cols=209  Identities=20%  Similarity=0.268  Sum_probs=138.7

Q ss_pred             HHHHHHHHHhcCCCCeeEEEeeeecCCe----EEEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 045787           53 IIREVSLLKELEHENIVRLLDVQSSRKD----VFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI  127 (324)
Q Consensus        53 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~----~~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~  127 (324)
                      ...|+..+.+..|+|+..++.+-.....    ..+..+++.+ ++...+.. -...+.+..+.+..++..+|.++|+...
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~-v~~i~~~~~r~~~~~~~~GL~~~h~~~l  307 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS-VGSIPLETLRILHQKLLEGLAYLHSLSL  307 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh-ccccCHHHHHHHHHHHhhhHHHHHHhcc
Confidence            4456778888899999999887654322    2344566765 55554444 5678999999999999999999999866


Q ss_pred             cccCCCCC---ceEeecCCCcEEEe--eccceeeccCCCCcccccccccccCCchhhcC-CCCCCCchhhHHHHHHHHHH
Q 045787          128 LHRDLKPN---NLLIDLKRNTVKLA--DFGLARAIGVPQKEYSRDCVYSPYKAPELLLG-YTGYSTPIDVWAVGCIFAEM  201 (324)
Q Consensus       128 ~H~di~p~---nIll~~~~~~v~l~--d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~il~~l  201 (324)
                      .|.-+...   +.-.+ ..+.+.++  ||+.+............. .+..+.+||.... ..+.....|+|++|.....+
T Consensus       308 ~~v~L~~s~~~~~~~~-~e~~~~~sl~~~~ss~~l~d~~~~~~~~-~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~  385 (1351)
T KOG1035|consen  308 EHVVLSASSSKESTVD-GEGVVAISLSDFDSSKPLPDNEKSFSDL-LAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQL  385 (1351)
T ss_pred             ceeEEecccccccccC-ccceeecchhhhcccccCCCcccchhhc-CccccccccccccccchhhhhhHHHHHHHHHhhh
Confidence            66555444   22233 44555555  888777665433333222 2334667777654 23334457999999999999


Q ss_pred             HhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCC-ChhHHHHHHHhhcCCCCCCCC
Q 045787          202 ITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNL-EPAGVDLLSQMLCLNPKQRIT  280 (324)
Q Consensus       202 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~~l~~dP~~Rps  280 (324)
                      ..|..+-....                                      ......+.. ...+.+.+.+|+..|+++|++
T Consensus       386 ~~~~~i~~~~~--------------------------------------~~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~  427 (1351)
T KOG1035|consen  386 SQGEDISEKSA--------------------------------------VPVSLLDVLSTSELLDALPKCLDEDSEERLS  427 (1351)
T ss_pred             hhcCccccccc--------------------------------------chhhhhccccchhhhhhhhhhcchhhhhccc
Confidence            98764321100                                      000011111 126679999999999999999


Q ss_pred             HHHHhcCccccCCCCchhhhhh
Q 045787          281 AMDALKHEYLIGVENVPLVILL  302 (324)
Q Consensus       281 ~~~~l~hp~~~~~~~~~~~~~~  302 (324)
                      +.+++.|+|...-......+..
T Consensus       428 ~~~ll~~~f~~~~~~~~~~~~~  449 (1351)
T KOG1035|consen  428 ALELLTHPFLRFPTDNESSEFA  449 (1351)
T ss_pred             hhhhhhchhccccccccccccc
Confidence            9999999999887777665544

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.45  E-value=2.1e-06  Score=66.16  Aligned_cols=130  Identities=21%  Similarity=0.238  Sum_probs=92.5

Q ss_pred             cceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCee-EEEeeeecCCeEEEEEEe
Q 045787            9 YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIV-RLLDVQSSRKDVFLVFEY   87 (324)
Q Consensus         9 y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~iv~e~   87 (324)
                      -++.+.|++|..|.||++...  |..+++|+-..++..    ..+..|+++++.+...++. +++.+..+.    +.|||
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds~r----~~l~kEakiLeil~g~~~~p~vy~yg~~~----i~me~   93 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDSPR----RNLEKEAKILEILAGEGVTPEVYFYGEDF----IRMEY   93 (201)
T ss_pred             hhhhhhhhcccccEEEEeecc--CceEEEEEecCCcch----hhHHHHHHHHHHhhhcCCCceEEEechhh----hhhhh
Confidence            356788999999999999865  668999987665543    4588999999999876654 455554443    56999


Q ss_pred             cCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC-CCceEeecCCCcEEEeeccceeec
Q 045787           88 LDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLK-PNNLLIDLKRNTVKLADFGLARAI  157 (324)
Q Consensus        88 ~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~-p~nIll~~~~~~v~l~d~g~~~~~  157 (324)
                      +.| .|.......    +    ++-+..+++.-.-|-..||-|+.|+ |..+++- .++.+.|+||+.++..
T Consensus        94 i~G~~L~~~~~~~----~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv-~~~~~~iIDFd~At~k  156 (201)
T COG2112          94 IDGRPLGKLEIGG----D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLV-NDRDVYIIDFDSATFK  156 (201)
T ss_pred             hcCcchhhhhhcc----c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEe-cCCcEEEEEccchhhc
Confidence            998 666544431    2    2334556666666888899999986 4444444 3559999999988743

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.45  E-value=4.2e-06  Score=70.10  Aligned_cols=71  Identities=15%  Similarity=0.188  Sum_probs=50.8

Q ss_pred             eecccCc-eEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcC-CCCeeEEEeeeecCCeEEEEEEecCCC
Q 045787           14 KIGAGGY-GEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-HENIVRLLDVQSSRKDVFLVFEYLDLD   91 (324)
Q Consensus        14 ~Lg~g~~-~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv~e~~~g~   91 (324)
                      .|..|.+ +.||++...  +..+++|......     ...+.+|+++++.+. +-.+++++++...++..++||++++|.
T Consensus         5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~   77 (244)
T cd05150           5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV   77 (244)
T ss_pred             ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence            4445555 888998753  4688899876443     234678999988885 344667788777767789999999873

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PLN02876 acyl-CoA dehydrogenase

Probab=98.33  E-value=1.2e-05  Score=78.90  Aligned_cols=80  Identities=16%  Similarity=0.301  Sum_probs=57.2

Q ss_pred             eeEeecccCceEEEEEEEccCC--ceEEEEEeeeccccCCCchHHHHHHHHHHhcC-CCCe--eEEEeeeecC---CeEE
Q 045787           11 KIKKIGAGGYGEVYKCRNTVTG--QKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-HENI--VRLLDVQSSR---KDVF   82 (324)
Q Consensus        11 i~~~Lg~g~~~~v~~a~~~~~~--~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i--~~~~~~~~~~---~~~~   82 (324)
                      -++.++.|.+..+|++.....+  ..+++|+.+...... ....+.+|+.+++.+. |.++  ++++.++.+.   +..|
T Consensus        42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~-~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f  120 (822)
T PLN02876         42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ-SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF  120 (822)
T ss_pred             eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc-cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence            4678899999999998765432  478888765432211 2346789999999995 5554  7777777654   4678


Q ss_pred             EEEEecCCC
Q 045787           83 LVFEYLDLD   91 (324)
Q Consensus        83 iv~e~~~g~   91 (324)
                      +||||++|.
T Consensus       121 lVME~v~G~  129 (822)
T PLN02876        121 YIMEYLEGR  129 (822)
T ss_pred             EEEEecCCc
Confidence            999999874

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.28  E-value=4.6e-05  Score=61.12  Aligned_cols=131  Identities=21%  Similarity=0.274  Sum_probs=93.0

Q ss_pred             eEeecccCceEEEEEEEccCCceEEEEEeeecc--------------ccCCCchHHHHHHHHHHhcC------CCCeeEE
Q 045787           12 IKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQT--------------EQEGVPSYIIREVSLLKELE------HENIVRL   71 (324)
Q Consensus        12 ~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~--------------~~~~~~~~~~~e~~~l~~l~------~~~i~~~   71 (324)
                      ...||+|+.-.||.-   .+....++|+.....              ......+...+|+..+..+.      +.+|.++
T Consensus         6 ~~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            357899999999953   234568999987665              11122455677877777776      7899999


Q ss_pred             EeeeecCCeEEEEEEecC---C----CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCC-
Q 045787           72 LDVQSSRKDVFLVFEYLD---L----DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKR-  143 (324)
Q Consensus        72 ~~~~~~~~~~~iv~e~~~---g----~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~-  143 (324)
                      +|..+++...-+|+|.+.   |    +|.+++.+  +.+++ .....   +-.-..+|-..+|+.+|++|.||++...+ 
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~--~~~~~-~~~~~---L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~  156 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE--GGLTE-ELRQA---LDEFKRYLLDHHIVIRDLNPHNIVVQRRDS  156 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc--CCccH-HHHHH---HHHHHHHHHHcCCeecCCCcccEEEEecCC
Confidence            999999999999999872   3    67777643  34666 33333   34445667889999999999999996322 


Q ss_pred             -C-cEEEeec
Q 045787          144 -N-TVKLADF  151 (324)
Q Consensus       144 -~-~v~l~d~  151 (324)
                       . .+.|+|-
T Consensus       157 ~~~~lvlIDG  166 (199)
T PF10707_consen  157 GEFRLVLIDG  166 (199)
T ss_pred             CceEEEEEeC
Confidence             2 5677774

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.28  E-value=5.2e-08  Score=88.41  Aligned_cols=243  Identities=18%  Similarity=0.111  Sum_probs=160.6

Q ss_pred             cceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCC-eeEEEeeeecCCeEEEEEEe
Q 045787            9 YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN-IVRLLDVQSSRKDVFLVFEY   87 (324)
Q Consensus         9 y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~iv~e~   87 (324)
                      |...+.+++++.+.+++.+........ .+.+...       ..+.-++++|.+.+||+ .+..++-++-+...++.+++
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i  315 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI  315 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence            344566778888889988765443333 5544433       23456899999999999 56666666777889999999


Q ss_pred             cCCC--HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccc
Q 045787           88 LDLD--LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYS  165 (324)
Q Consensus        88 ~~g~--l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~  165 (324)
                      +++.  ....+....-.+...+...+.+.-+.+++++|+.--+|+|    ||+..  ++.++..+++....+.... ...
T Consensus       316 ~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s--~~~~~~~~~~v~~~L~~~~-~~~  388 (829)
T KOG0576|consen  316 CSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS--EEEVKLLDFAVPPQLTRTM-KPR  388 (829)
T ss_pred             hcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc--ccccccccccCCcccCccc-ccc
Confidence            9843  4433333333455556667778888899999988667887    77655  5788999999876654222 334


Q ss_pred             ccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCC-cccccchhhhhcccCCC
Q 045787          166 RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPT-DESWAESTYISEILPLY  244 (324)
Q Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  244 (324)
                      ...+++.++|||+... ..+....|+|++|.-..++.-|-+|-.......    .. .+..+ ...+.+           
T Consensus       389 t~~~~~~~~~pev~~~-~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~~~----~~-~g~~p~s~~L~~-----------  451 (829)
T KOG0576|consen  389 TAIGTPEPLAPEVIQE-NTIDGCPDSGSLAVSAIQMAPGLPPRSSPPAVL----PM-IGNGPNSPMLTD-----------  451 (829)
T ss_pred             cCCCCCCCCCchhhcc-cccccCCCccCCCcchhhcCCCCCCCCCCcccc----CC-CCCCCCccccch-----------
Confidence            4567888999998877 667888999999988888888877764411100    00 00000 000000           


Q ss_pred             CCCCCcchhhhCCCCChhHH-HHHHHhhcCCCCCCCCHHHHhcCccccCCC
Q 045787          245 PHFEPANLAEKFPNLEPAGV-DLLSQMLCLNPKQRITAMDALKHEYLIGVE  294 (324)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~l~-~li~~~l~~dP~~Rps~~~~l~hp~~~~~~  294 (324)
                              ...   .+.... ++...|+..-|..|+....++-|.+|.+-+
T Consensus       452 --------~~a---w~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCp  491 (829)
T KOG0576|consen  452 --------KSA---WSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCP  491 (829)
T ss_pred             --------hhh---cCcccccCCcccccCCCCCCCcchhhHHHHHHhccCc
Confidence                    000   111111 467788899999999999999888887755

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.17  E-value=5.7e-05  Score=60.23  Aligned_cols=127  Identities=24%  Similarity=0.312  Sum_probs=89.2

Q ss_pred             cCcceeEeecccCc-eEEEEEEEccCCceEEEEEeee---cccc---------C-------CCchHHHHHHHHHHhcC--
Q 045787            7 LNYKKIKKIGAGGY-GEVYKCRNTVTGQKVAIKMMTI---QTEQ---------E-------GVPSYIIREVSLLKELE--   64 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~-~~v~~a~~~~~~~~~~~K~~~~---~~~~---------~-------~~~~~~~~e~~~l~~l~--   64 (324)
                      .+++.++.||.|.- |.||++...  |+.||+|++..   ....         .       ...+-+..|.+.+-+|+  
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            68999999999999 999999864  77999999421   1110         0       12345778888888775  


Q ss_pred             -CCCe--eEEEeeeecC------------------CeEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Q 045787           65 -HENI--VRLLDVQSSR------------------KDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCH  123 (324)
Q Consensus        65 -~~~i--~~~~~~~~~~------------------~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh  123 (324)
                       +.+.  ++++|+..-.                  ....||.||....-         .++...    +.++..-+..+|
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~----~~~~~~dl~~~~  181 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRD----IPQMLRDLKILH  181 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhH----HHHHHHHHHHHH
Confidence             3344  8898876211                  12467888776432         233333    355666677799


Q ss_pred             hCCCcccCCCCCceEeecCCCcEEEeeccce
Q 045787          124 SLKILHRDLKPNNLLIDLKRNTVKLADFGLA  154 (324)
Q Consensus       124 ~~g~~H~di~p~nIll~~~~~~v~l~d~g~~  154 (324)
                      +.||+-+|+++.|..    +|  +|+|||.+
T Consensus       182 k~gI~~~Dv~~~ny~----~G--~lvDfs~~  206 (207)
T PF13095_consen  182 KLGIVPRDVKPRNYR----GG--KLVDFSSS  206 (207)
T ss_pred             HCCeeeccCcccccc----CC--EEEecccC
Confidence            999999999999986    33  78999854

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.08  E-value=8.6e-05  Score=61.75  Aligned_cols=72  Identities=19%  Similarity=0.217  Sum_probs=47.2

Q ss_pred             eEeecccCceEEEEEEEcc-CCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCC-eeEEEeeeecCCeEEEEEEecC
Q 045787           12 IKKIGAGGYGEVYKCRNTV-TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN-IVRLLDVQSSRKDVFLVFEYLD   89 (324)
Q Consensus        12 ~~~Lg~g~~~~v~~a~~~~-~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~iv~e~~~   89 (324)
                      ++.|..|-...+|++.... ++..|++|+.......   .-...+|+.+++.+...+ .++++....  +  .+++||++
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~---~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~   75 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL---IIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIP   75 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc---eecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeC
Confidence            5678889999999997543 3568999976533211   122457888998886433 344544332  2  37999998


Q ss_pred             C
Q 045787           90 L   90 (324)
Q Consensus        90 g   90 (324)
                      |
T Consensus        76 G   76 (235)
T cd05157          76 G   76 (235)
T ss_pred             C
Confidence            7

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.08  E-value=2.8e-05  Score=64.70  Aligned_cols=70  Identities=13%  Similarity=0.257  Sum_probs=44.6

Q ss_pred             eEeecccCce-EEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCC---CeeEEEeeeecC---CeEEEE
Q 045787           12 IKKIGAGGYG-EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHE---NIVRLLDVQSSR---KDVFLV   84 (324)
Q Consensus        12 ~~~Lg~g~~~-~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~i~~~~~~~~~~---~~~~iv   84 (324)
                      ++.++.|+.+ .||++.     ..+++|......    ....+.+|.++++.+...   .+.++++.....   ...+++
T Consensus         2 ~~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l   72 (235)
T cd05155           2 IEPVDSGGTDNATFRLG-----DDMSVRLPSAAG----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV   72 (235)
T ss_pred             ceeccCCCcccceEEcC-----CceEEEcCCccc----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence            4667877766 589762     358888755321    134688999999888632   344445443332   245889


Q ss_pred             EEecCC
Q 045787           85 FEYLDL   90 (324)
Q Consensus        85 ~e~~~g   90 (324)
                      |++++|
T Consensus        73 ~~~i~G   78 (235)
T cd05155          73 YRWLEG   78 (235)
T ss_pred             EEeecC
Confidence            999987

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=98.04  E-value=0.00029  Score=62.75  Aligned_cols=78  Identities=18%  Similarity=0.178  Sum_probs=55.0

Q ss_pred             eeEeecccCceEEEEEEEccCCceEEEEEeeeccc---c--CCCchHHHHHHHHHHhcC---CCCeeEEEeeeecCCeEE
Q 045787           11 KIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE---Q--EGVPSYIIREVSLLKELE---HENIVRLLDVQSSRKDVF   82 (324)
Q Consensus        11 i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~---~--~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~   82 (324)
                      -.+.||.|....||++.+...++.+++|.-.....   .  +...++...|.+.|+.+.   ..++++++.+  +.+..+
T Consensus        30 ~~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~  107 (401)
T PRK09550         30 TAREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAV  107 (401)
T ss_pred             eeeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCE
Confidence            45789999999999999864435899998542211   1  123466778888888874   2456777766  345678


Q ss_pred             EEEEecCC
Q 045787           83 LVFEYLDL   90 (324)
Q Consensus        83 iv~e~~~g   90 (324)
                      +|||++++
T Consensus       108 lVME~L~~  115 (401)
T PRK09550        108 TVMEDLSD  115 (401)
T ss_pred             EEEecCCC
Confidence            99999875

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.03  E-value=3.4e-05  Score=65.13  Aligned_cols=133  Identities=21%  Similarity=0.253  Sum_probs=75.8

Q ss_pred             eecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCe-eEEEeeeecCCeEEEEEEecCCCH
Q 045787           14 KIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI-VRLLDVQSSRKDVFLVFEYLDLDL   92 (324)
Q Consensus        14 ~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~iv~e~~~g~l   92 (324)
                      .+..|-...+|++.  .++..+++|..........  -...+|..+++.+....+ .+++....    -++|++|++|..
T Consensus         3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~--~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~   74 (256)
T TIGR02721         3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKALG--VDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEV   74 (256)
T ss_pred             cCCCcCcCCeEEEE--eCCccEEEeeCCccccccc--CcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcc
Confidence            45678888999887  4567899997654322211  125789999999864333 34444332    258999998732


Q ss_pred             HH-----------HHH-------hcC---CCCCHH-HHHHHHHHH---------HHHHHHHHh--------CCCcccCCC
Q 045787           93 HS-----------FIT-------RHK---NTLNLL-VIKAILKQI---------LLGLAYCHS--------LKILHRDLK  133 (324)
Q Consensus        93 ~~-----------~~~-------~~~---~~~~~~-~~~~i~~~i---------~~~l~~Lh~--------~g~~H~di~  133 (324)
                      ..           .+.       ..+   .+++.. .+..+..++         ...+..+-.        ..++|+|+.
T Consensus        75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~  154 (256)
T TIGR02721        75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH  154 (256)
T ss_pred             cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence            21           011       000   111211 111111111         111222211        248999999


Q ss_pred             CCceEeecCCCcEEEeeccceee
Q 045787          134 PNNLLIDLKRNTVKLADFGLARA  156 (324)
Q Consensus       134 p~nIll~~~~~~v~l~d~g~~~~  156 (324)
                      |.||+++ +++ +.++||+.+..
T Consensus       155 ~~Nil~~-~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       155 AYNLVVT-PQG-LKLIDWEYASD  175 (256)
T ss_pred             cCcEEEe-CCC-CEEEeccccCc
Confidence            9999999 555 78999987754

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.99  E-value=7.4e-05  Score=64.50  Aligned_cols=138  Identities=16%  Similarity=0.134  Sum_probs=81.8

Q ss_pred             ceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCC--eeEEEee------eecCCeE
Q 045787           10 KKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN--IVRLLDV------QSSRKDV   81 (324)
Q Consensus        10 ~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~------~~~~~~~   81 (324)
                      .-++.+..|....+|++..  .+..+++|++...     ....+..|+.+++.+...+  +++++..      ...++..
T Consensus        17 ~~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~-----~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~   89 (296)
T cd05153          17 LSFEGISAGIENTNYFVTT--DSGRYVLTLFEKV-----SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKP   89 (296)
T ss_pred             hheecccCccccceEEEEe--CCCcEEEEEcCCC-----ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCce
Confidence            3467788888899999864  3457999987641     1245677888888885322  4444432      2334567


Q ss_pred             EEEEEecCCCHHH-----HHHh----------cCCCC----------CH--HHHH--------HHHHHHHHHHHHHHh--
Q 045787           82 FLVFEYLDLDLHS-----FITR----------HKNTL----------NL--LVIK--------AILKQILLGLAYCHS--  124 (324)
Q Consensus        82 ~iv~e~~~g~l~~-----~~~~----------~~~~~----------~~--~~~~--------~i~~~i~~~l~~Lh~--  124 (324)
                      ++|+++++|....     ....          ....+          ..  ....        .....+..++..+.+  
T Consensus        90 ~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~  169 (296)
T cd05153          90 AALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD  169 (296)
T ss_pred             EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh
Confidence            8999999873211     1110          00000          00  0000        011112233344432  


Q ss_pred             -----CCCcccCCCCCceEeecCCCcEEEeecccee
Q 045787          125 -----LKILHRDLKPNNLLIDLKRNTVKLADFGLAR  155 (324)
Q Consensus       125 -----~g~~H~di~p~nIll~~~~~~v~l~d~g~~~  155 (324)
                           .+++|+|+.|.||+++ .++.+.|+||+.+.
T Consensus       170 ~~~~~~~l~HgD~~~~Nil~~-~~~~~~iIDfe~a~  204 (296)
T cd05153         170 PSDLPRGVIHADLFRDNVLFD-GDELSGVIDFYFAC  204 (296)
T ss_pred             hhcCCCcCCccCcCcccEEEe-CCceEEEeehhhhc
Confidence                 4799999999999999 66667899998765

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.98  E-value=0.00011  Score=67.38  Aligned_cols=139  Identities=20%  Similarity=0.247  Sum_probs=87.2

Q ss_pred             EeecccCceEEEEEEEccCCceEEEEEeeeccccC-----------------------------CCchH------HHHHH
Q 045787           13 KKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQE-----------------------------GVPSY------IIREV   57 (324)
Q Consensus        13 ~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~-----------------------------~~~~~------~~~e~   57 (324)
                      +.||..+.+.|++|+-+. |+.||+|+-+..-...                             +..+.      +.+|+
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            578999999999999875 9999999975432110                             00011      22333


Q ss_pred             HHHHhc----CCCC------eeEEEeeeecCCeEEEEEEecCC---CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 045787           58 SLLKEL----EHEN------IVRLLDVQSSRKDVFLVFEYLDL---DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS  124 (324)
Q Consensus        58 ~~l~~l----~~~~------i~~~~~~~~~~~~~~iv~e~~~g---~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~  124 (324)
                      +..+++    .|-.      |++++-.+  ...-.++|||++|   +-++.+.+.  .++...+..-+.+..  +.-+=.
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~--gi~~~~i~~~l~~~~--~~qIf~  319 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKR--GISPHDILNKLVEAY--LEQIFK  319 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHc--CCCHHHHHHHHHHHH--HHHHHh
Confidence            333332    2333      33333222  3346799999997   455555554  366664433333322  223446


Q ss_pred             CCCcccCCCCCceEeec---CCCcEEEeeccceeecc
Q 045787          125 LKILHRDLKPNNLLIDL---KRNTVKLADFGLARAIG  158 (324)
Q Consensus       125 ~g~~H~di~p~nIll~~---~~~~v~l~d~g~~~~~~  158 (324)
                      .|++|+|=.|.||++++   .+..+.+-|+|......
T Consensus       320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            78999999999999983   36789999999877654

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.91  E-value=0.00025  Score=56.61  Aligned_cols=98  Identities=22%  Similarity=0.183  Sum_probs=77.3

Q ss_pred             HHHHHHHHhcCC-CCeeEEEeeeecCCeEEEEEEecC-CCHHHH---HHhcCCCCCHHHHHHHHHHHHHHHHHHHh---C
Q 045787           54 IREVSLLKELEH-ENIVRLLDVQSSRKDVFLVFEYLD-LDLHSF---ITRHKNTLNLLVIKAILKQILLGLAYCHS---L  125 (324)
Q Consensus        54 ~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~iv~e~~~-g~l~~~---~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~---~  125 (324)
                      .+|.-+++.+++ +++++++|++..    +++.||.+ +++...   +.+. ...++..+..++.+++..+.+|+.   .
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~-~~~~w~~R~~iA~~lL~~l~~l~~~~~~   81 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQF-LQSPWEQRAKIALQLLELLEELDHGPLG   81 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccc-cccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            358888889975 699999999954    47889988 455421   1111 236788899999999999999997   3


Q ss_pred             CCcccCCCCCceEeecCCCcEEEeeccceeec
Q 045787          126 KILHRDLKPNNLLIDLKRNTVKLADFGLARAI  157 (324)
Q Consensus       126 g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~  157 (324)
                      .+..+|++|+|+-++ ++++++++|.+.....
T Consensus        82 ~~~lcDv~~~nfgv~-~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   82 FFYLCDVSPDNFGVN-DDGRLKLIDLDDVFVE  112 (188)
T ss_pred             cEEEeecchHHeEEe-CCCcEEEEechhcchh
Confidence            478889999999999 8899999999876554

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.85  E-value=0.00015  Score=62.59  Aligned_cols=142  Identities=20%  Similarity=0.220  Sum_probs=95.1

Q ss_pred             eeEeecccCceEEEEEEEccCCceEEEEEeeecccc-------------------CCCch-----HHHHHHHHHHhcCCC
Q 045787           11 KIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQ-------------------EGVPS-----YIIREVSLLKELEHE   66 (324)
Q Consensus        11 i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~-------------------~~~~~-----~~~~e~~~l~~l~~~   66 (324)
                      +-..|..|--+.||.|.. .+|..+|+|++.-+-..                   ....+     ....|++.|.++...
T Consensus       148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            445677888999999985 47888999998532110                   00111     145678888888765


Q ss_pred             CeeEEEeeeecCCeEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCCcccCCCCCceEeecCCCc
Q 045787           67 NIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCH-SLKILHRDLKPNNLLIDLKRNT  145 (324)
Q Consensus        67 ~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh-~~g~~H~di~p~nIll~~~~~~  145 (324)
                      +|.-.--+..  ....+||++++++-...-.-....++...+..+-.+++.-+.-|. ..++||.||+-=|+|+.  +|.
T Consensus       227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh--dG~  302 (520)
T KOG2270|consen  227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH--DGK  302 (520)
T ss_pred             CCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE--CCE
Confidence            5433222221  224699999984211111111235777778888888888887766 56899999999999998  899


Q ss_pred             EEEeeccceeec
Q 045787          146 VKLADFGLARAI  157 (324)
Q Consensus       146 v~l~d~g~~~~~  157 (324)
                      ++++|.+.+...
T Consensus       303 lyiIDVSQSVE~  314 (520)
T KOG2270|consen  303 LYIIDVSQSVEH  314 (520)
T ss_pred             EEEEEccccccC
Confidence            999999877643

>PRK10593 hypothetical protein; Provisional

Probab=97.83  E-value=0.00068  Score=58.46  Aligned_cols=77  Identities=16%  Similarity=0.166  Sum_probs=55.7

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCC---CCeeEEEeeeec---CCeE
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEH---ENIVRLLDVQSS---RKDV   81 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~---~~i~~~~~~~~~---~~~~   81 (324)
                      .-.-++.||.|..+.||.+.... + .+++|..+. ..   ....+..|...++.+..   -.++++++++..   .+..
T Consensus        15 ~~~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~-~~---~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~   88 (297)
T PRK10593         15 KLSRVECISEQPYAALWALYDSQ-G-NPMPLMARS-FS---TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPD   88 (297)
T ss_pred             hhheeeecCCccceeEEEEEcCC-C-CEEEEEecc-cc---cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCe
Confidence            44557789999999999987532 3 577787432 11   12468899999998863   467888887654   3668


Q ss_pred             EEEEEecCC
Q 045787           82 FLVFEYLDL   90 (324)
Q Consensus        82 ~iv~e~~~g   90 (324)
                      ++|||+++|
T Consensus        89 ~LVmE~i~G   97 (297)
T PRK10593         89 VLLLERLRG   97 (297)
T ss_pred             EEEEeccCC
Confidence            999999986

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.67  E-value=0.00062  Score=59.11  Aligned_cols=139  Identities=16%  Similarity=0.152  Sum_probs=80.2

Q ss_pred             ceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCC--eeEEEee------eecCCeE
Q 045787           10 KKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN--IVRLLDV------QSSRKDV   81 (324)
Q Consensus        10 ~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~------~~~~~~~   81 (324)
                      ..++.++.|....+|++...  +..+++|.......    .+.+..|.++++.|...+  +++++..      ...++..
T Consensus        25 ~~i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~~----~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~   98 (307)
T TIGR00938        25 LSLKGIAEGVENSNYLLTTD--VGRYILTLYEKRVK----AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKP   98 (307)
T ss_pred             eeccccCCccccceEEEEeC--CCcEEEEEecCCCC----HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeE
Confidence            34667778888899998743  44688997654211    234567788887775322  3444432      1234567


Q ss_pred             EEEEEecCCCH-----HHHHH----------hcCCCC--------CHHH-----HH----------HHHHHHHHHHHHHH
Q 045787           82 FLVFEYLDLDL-----HSFIT----------RHKNTL--------NLLV-----IK----------AILKQILLGLAYCH  123 (324)
Q Consensus        82 ~iv~e~~~g~l-----~~~~~----------~~~~~~--------~~~~-----~~----------~i~~~i~~~l~~Lh  123 (324)
                      +++++|++|..     ...+.          .....+        ....     ..          .....+...+.++.
T Consensus        99 ~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~  178 (307)
T TIGR00938        99 ACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLD  178 (307)
T ss_pred             EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHH
Confidence            89999998621     11111          000000        0000     00          00111223344443


Q ss_pred             -------hCCCcccCCCCCceEeecCCCcEEEeecccee
Q 045787          124 -------SLKILHRDLKPNNLLIDLKRNTVKLADFGLAR  155 (324)
Q Consensus       124 -------~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~  155 (324)
                             ..+++|+|+++.||+++ .++.+.++||+.+.
T Consensus       179 ~~~~~~~~~~l~HgD~~~~Nvl~~-~~~~~~vIDfd~~~  216 (307)
T TIGR00938       179 KFWPRDLPRGVIHADLFPDNVLFD-GDSVKGVIDFYFAC  216 (307)
T ss_pred             hhhhhcCCCccCCCCCCcCcEEEE-CCceEEEeeccccc
Confidence                   26899999999999999 66667899998764

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.67  E-value=0.00077  Score=58.00  Aligned_cols=140  Identities=20%  Similarity=0.256  Sum_probs=87.0

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCC--CCeeEEEeeeecCC--eEEE
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEH--ENIVRLLDVQSSRK--DVFL   83 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~--~~~i   83 (324)
                      ...+++...+|....+|.+.+.  ++.++++ .+.............+|+..++.+..  -.+...++.+.++.  ..|.
T Consensus        26 ~~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~  102 (321)
T COG3173          26 GLLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFY  102 (321)
T ss_pred             CCceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceE
Confidence            4556777766777777777765  7889999 33222222334567788888888853  33445566665554  6799


Q ss_pred             EEEecCCC-HHHHHHhcCCCCCHHHHHHHH-HHHHHHHHHHHh-------------------------------------
Q 045787           84 VFEYLDLD-LHSFITRHKNTLNLLVIKAIL-KQILLGLAYCHS-------------------------------------  124 (324)
Q Consensus        84 v~e~~~g~-l~~~~~~~~~~~~~~~~~~i~-~~i~~~l~~Lh~-------------------------------------  124 (324)
                      ||+|+.|. ..+....      .....+++ ..+...|..||+                                     
T Consensus       103 v~~~veGe~~~~~~~~------~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~  176 (321)
T COG3173         103 VMEWVEGEVVWSALPP------ESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGR  176 (321)
T ss_pred             EEEEecceeccCcCCc------ccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCC
Confidence            99999872 1111100      00001111 244444444443                                     


Q ss_pred             ---------------------CCCcccCCCCCceEeecCCCcEEEeeccceeec
Q 045787          125 ---------------------LKILHRDLKPNNLLIDLKRNTVKLADFGLARAI  157 (324)
Q Consensus       125 ---------------------~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~  157 (324)
                                           ..++|||+++.|++++ .++.+=+.||+.+..-
T Consensus       177 ~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~-~~~~~gVlDwe~~~lG  229 (321)
T COG3173         177 IPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIID-PGRPTGVLDWELATLG  229 (321)
T ss_pred             CchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEe-CCCeeEEEeccccccC
Confidence                                 2379999999999999 6666999999988653

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.65  E-value=0.00063  Score=58.87  Aligned_cols=72  Identities=21%  Similarity=0.206  Sum_probs=47.4

Q ss_pred             eEeecccCceEEEEEEEcc------CCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCC-eeEEEeeeecCCeEEEE
Q 045787           12 IKKIGAGGYGEVYKCRNTV------TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN-IVRLLDVQSSRKDVFLV   84 (324)
Q Consensus        12 ~~~Lg~g~~~~v~~a~~~~------~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~iv   84 (324)
                      ++.|..|-...+|++....      .++.+++|++......   .....+|..+++.+...+ .++++..+..    ..|
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~---~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v   75 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL---LIDRERELVVFARLSERNLGPKLYGIFPN----GRI   75 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc---eechHHHHHHHHHHHhCCCCCceEEEeCC----Cch
Confidence            4667778888999987543      2578999997654322   234578888888886433 3455555432    257


Q ss_pred             EEecCC
Q 045787           85 FEYLDL   90 (324)
Q Consensus        85 ~e~~~g   90 (324)
                      ++|++|
T Consensus        76 ~e~i~G   81 (302)
T cd05156          76 EEFIPS   81 (302)
T ss_pred             hheeCC
Confidence            888876

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=97.65  E-value=0.002  Score=56.17  Aligned_cols=136  Identities=15%  Similarity=0.205  Sum_probs=74.8

Q ss_pred             eEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCC--eeEEEe------eeecCCeEEE
Q 045787           12 IKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN--IVRLLD------VQSSRKDVFL   83 (324)
Q Consensus        12 ~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~------~~~~~~~~~i   83 (324)
                      ++.++.|....+|++...  +..+++|++. . ..   .+.+..+...++.|...+  +++++.      +....+..++
T Consensus        27 ~~~l~~G~~n~~y~v~t~--~g~~vLK~~~-~-~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~   99 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTT--QGEYVLTLFE-R-LT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAA   99 (319)
T ss_pred             cchhccccccceEEEEeC--CCcEEEEEec-c-CC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEE
Confidence            456777888899998753  3379999875 1 11   233445666666664212  333332      1233556789


Q ss_pred             EEEecCCCHH------------HHHHh---cCCCC--------C---H-HHHH-----------HHHHH-HHHHHHHHH-
Q 045787           84 VFEYLDLDLH------------SFITR---HKNTL--------N---L-LVIK-----------AILKQ-ILLGLAYCH-  123 (324)
Q Consensus        84 v~e~~~g~l~------------~~~~~---~~~~~--------~---~-~~~~-----------~i~~~-i~~~l~~Lh-  123 (324)
                      +++|++|...            ..+.+   ....+        .   . ....           ..+.+ +...+..+. 
T Consensus       100 l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  179 (319)
T PRK05231        100 IVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLAS  179 (319)
T ss_pred             EEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhc
Confidence            9999987311            11110   00000        0   0 0000           01111 111122222 


Q ss_pred             ------hCCCcccCCCCCceEeecCCCcEEEeecccee
Q 045787          124 ------SLKILHRDLKPNNLLIDLKRNTVKLADFGLAR  155 (324)
Q Consensus       124 ------~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~  155 (324)
                            ..|++|+|+.|.||+++ .+...-++||+.+.
T Consensus       180 ~~~~~lp~~liHgD~~~~Nil~~-~~~~~~iIDf~~~~  216 (319)
T PRK05231        180 AAWPALPRGVIHADLFRDNVLFE-GDRLSGFIDFYFAC  216 (319)
T ss_pred             cccccCCcccCCCCCCCCcEEEE-CCceEEEEeccccc
Confidence                  24899999999999999 66656899998775

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.59  E-value=0.00025  Score=63.86  Aligned_cols=174  Identities=22%  Similarity=0.255  Sum_probs=109.5

Q ss_pred             hHHHHHHHHHHhcCCCCeeEEEeeeec-CCeEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 045787           51 SYIIREVSLLKELEHENIVRLLDVQSS-RKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILH  129 (324)
Q Consensus        51 ~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H  129 (324)
                      ..+.-...+++.+.|++....+++... .....+|+|+++-++.+....+.  +......                  .|
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~Sled~~~~~~--l~~~s~~------------------~~   86 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTMSLEDILKTGN--LKDESLL------------------AH   86 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhccchHHHHHhcc--cchhhhc------------------cc
Confidence            456677888999999999999988743 45689999999999999877643  2111110                  23


Q ss_pred             cCCCCCceEeecCCCcEEEeeccceeeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCC
Q 045787          130 RDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFP  209 (324)
Q Consensus       130 ~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~  209 (324)
                      + +.+-|++.        .+| ..+.                 |. |      .+..+++||||+|.++.++..|...+.
T Consensus        87 ~-~~~~~~~~--------~td-~~~t-----------------~~-~------~~~~pKsdVwsl~~i~~el~L~~~l~~  132 (725)
T KOG1093|consen   87 G-VLHLNIIY--------ITD-HFLT-----------------KY-P------SPIGPKSDVWSLGFIILELYLGISLEA  132 (725)
T ss_pred             c-cceehhhh--------ccc-cccc-----------------cC-C------CCCCcchhhhhHHHHHHHHHHhhHHHH
Confidence            2 22223332        233 0000                 00 1      112259999999999999999987776


Q ss_pred             CCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCcc
Q 045787          210 SKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEY  289 (324)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~  289 (324)
                      ................-+.....-                .......-..+....++.++|+-..|..||...++..++-
T Consensus       133 ~~~~s~~l~~i~k~~~~d~~~~~~----------------a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i  196 (725)
T KOG1093|consen  133 ELTESEYLEILLKYYTDDQELLST----------------AMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCS  196 (725)
T ss_pred             HHHHHHHHHHHHHhccCchhHHHH----------------HHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCcc
Confidence            555443333333222222111000                0000111245677789999999999999999999999999


Q ss_pred             ccCCC
Q 045787          290 LIGVE  294 (324)
Q Consensus       290 ~~~~~  294 (324)
                      |.++-
T Consensus       197 ~~ev~  201 (725)
T KOG1093|consen  197 FTEVY  201 (725)
T ss_pred             HHHHH
Confidence            99983

>PLN02236 choline kinase

Probab=97.58  E-value=0.0014  Score=57.69  Aligned_cols=142  Identities=17%  Similarity=0.203  Sum_probs=81.7

Q ss_pred             CcceeEeecccCceEEEEEEEcc----CCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCe-eEEEeeeecCCeEE
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTV----TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI-VRLLDVQSSRKDVF   82 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~----~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~   82 (324)
                      ...-+..|..|-...+|++....    .++.+++|+.....  ....+ ..+|..+++.+...++ +++++.+...    
T Consensus        37 ~~~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----  109 (344)
T PLN02236         37 EALQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----  109 (344)
T ss_pred             CcEEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--Ceeec-hHHHHHHHHHHHHcCCCCceEEEECCc----
Confidence            34455667678889999987432    34689999876543  22222 3689999999875444 4556655332    


Q ss_pred             EEEEecCC-CHHH----------HH-------HhcCCC----CC-HHHHHHHHHHH-----------------HHHHHHH
Q 045787           83 LVFEYLDL-DLHS----------FI-------TRHKNT----LN-LLVIKAILKQI-----------------LLGLAYC  122 (324)
Q Consensus        83 iv~e~~~g-~l~~----------~~-------~~~~~~----~~-~~~~~~i~~~i-----------------~~~l~~L  122 (324)
                      .|.+|++| ++..          .+       ++...+    .+ ...+..+..++                 ...+..|
T Consensus       110 ~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L  189 (344)
T PLN02236        110 RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLL  189 (344)
T ss_pred             eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHH
Confidence            57888876 2211          01       000100    11 12222222111                 1111112


Q ss_pred             ----H----hCCCcccCCCCCceEeecCCCcEEEeeccceee
Q 045787          123 ----H----SLKILHRDLKPNNLLIDLKRNTVKLADFGLARA  156 (324)
Q Consensus       123 ----h----~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~  156 (324)
                          .    ...++|+|+++.||+++..++.+.++||+.+..
T Consensus       190 ~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        190 EKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             HHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence                1    235899999999999983457899999987753

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.55  E-value=0.003  Score=56.28  Aligned_cols=76  Identities=18%  Similarity=0.236  Sum_probs=53.2

Q ss_pred             eeEeecccCceEEEEEEEccCCceEEEEEeeeccc--c---CCCchHHHHHHHHHHhcC---CCCeeEEEeeeecCCeEE
Q 045787           11 KIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE--Q---EGVPSYIIREVSLLKELE---HENIVRLLDVQSSRKDVF   82 (324)
Q Consensus        11 i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~--~---~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~   82 (324)
                      ..+.+|.|....||++.+.  +..++||.-.....  .   +....+...|.+.|+.+.   ..++++++.+..  +..+
T Consensus        36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v  111 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL  111 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence            5788999999999999873  45699998652221  0   113455566777777764   247788887776  4467


Q ss_pred             EEEEecCC
Q 045787           83 LVFEYLDL   90 (324)
Q Consensus        83 iv~e~~~g   90 (324)
                      ++||++++
T Consensus       112 lvME~L~~  119 (418)
T PLN02756        112 IGMRYLEP  119 (418)
T ss_pred             EEEeecCC
Confidence            88999965

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.53  E-value=0.0011  Score=58.16  Aligned_cols=73  Identities=16%  Similarity=0.241  Sum_probs=46.2

Q ss_pred             eeEeecccCceEEEEEEEccC---CceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCe-eEEEeeeecCCeEEEEEE
Q 045787           11 KIKKIGAGGYGEVYKCRNTVT---GQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI-VRLLDVQSSRKDVFLVFE   86 (324)
Q Consensus        11 i~~~Lg~g~~~~v~~a~~~~~---~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~iv~e   86 (324)
                      .++.|..|-...+|++.....   +..|++|+.......   .-...+|..+++.+..-++ +++++++. ++   +|.+
T Consensus        18 ~i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~---~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~   90 (330)
T PLN02421         18 SVERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY---VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQS   90 (330)
T ss_pred             EEEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe---EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeeh
Confidence            345555588888999875432   348999987653321   2224678999999875544 45565553 22   5888


Q ss_pred             ecCC
Q 045787           87 YLDL   90 (324)
Q Consensus        87 ~~~g   90 (324)
                      |++|
T Consensus        91 fi~g   94 (330)
T PLN02421         91 FINA   94 (330)
T ss_pred             hhcC
Confidence            8876

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.52  E-value=7.6e-05  Score=63.34  Aligned_cols=137  Identities=14%  Similarity=0.243  Sum_probs=92.8

Q ss_pred             cceeEeecccCceEEEEEEEccCCceEEEEEeeecccc-------CC---------C----chHHHHHHHHHHhcCC-C-
Q 045787            9 YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQ-------EG---------V----PSYIIREVSLLKELEH-E-   66 (324)
Q Consensus         9 y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~-------~~---------~----~~~~~~e~~~l~~l~~-~-   66 (324)
                      +-+.+.||-|--|-+|.+-+. .|+.+++|.-+.....       .+         +    .-...+|+..++.|.. - 
T Consensus        94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            456788999999999999875 6788898875432110       00         0    0114457777777753 2 


Q ss_pred             CeeEEEeeeecCCeEEEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCc
Q 045787           67 NIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNT  145 (324)
Q Consensus        67 ~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~  145 (324)
                      .+++.++    ....++||+.+.| .+.+. .+..      .+..+...+...+.-|..+|++|||++-=||++. +++.
T Consensus       173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v-~~v~------d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~-dd~~  240 (465)
T KOG2268|consen  173 PVPKPID----HNRHCVVMELVDGYPLRQV-RHVE------DPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVK-DDDK  240 (465)
T ss_pred             CCCCccc----ccceeeHHHhhcccceeee-eecC------ChHHHHHHHHHHHHHHHHcCceecccchheeEEe-cCCC
Confidence            2344443    3456899999987 44443 2211      1234556666677789999999999999999999 8999


Q ss_pred             EEEeeccceeecc
Q 045787          146 VKLADFGLARAIG  158 (324)
Q Consensus       146 v~l~d~g~~~~~~  158 (324)
                      ++++||-.....+
T Consensus       241 i~vIDFPQmvS~s  253 (465)
T KOG2268|consen  241 IVVIDFPQMVSTS  253 (465)
T ss_pred             EEEeechHhhccC
Confidence            9999997665443

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.36  E-value=0.0033  Score=55.01  Aligned_cols=83  Identities=13%  Similarity=0.055  Sum_probs=53.0

Q ss_pred             eecccCceEEEEEEEccCCceEEEEEeeeccc-----cCCCchHHHHHHHHHHhcC--CC-CeeEEEeeeecCCeEEEEE
Q 045787           14 KIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-----QEGVPSYIIREVSLLKELE--HE-NIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus        14 ~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-----~~~~~~~~~~e~~~l~~l~--~~-~i~~~~~~~~~~~~~~iv~   85 (324)
                      .+|.|....||++.+...++.++||.-.....     -+-..++..-|.+.|+...  .| .+++++.+  +++...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            57999999999999754346899997642221     1334456677888887764  34 34455433  345566899


Q ss_pred             EecCC--CHHHHHHh
Q 045787           86 EYLDL--DLHSFITR   98 (324)
Q Consensus        86 e~~~g--~l~~~~~~   98 (324)
                      |+++.  .++..+.+
T Consensus        80 EdL~~~~ilR~~Li~   94 (370)
T TIGR01767        80 EDLSHHKIARKGLIE   94 (370)
T ss_pred             hhCccchHHHHHHHc
Confidence            99863  44444443

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PRK12396 5-methylribose kinase; Reviewed

Probab=97.18  E-value=0.0054  Score=54.41  Aligned_cols=84  Identities=18%  Similarity=0.112  Sum_probs=54.5

Q ss_pred             eEeecccCceEEEEEEEccCCceEEEEEeeeccc----cCCCchHHHHHHHHHHhcC--CC-CeeEEEeeeecCCeEEEE
Q 045787           12 IKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE----QEGVPSYIIREVSLLKELE--HE-NIVRLLDVQSSRKDVFLV   84 (324)
Q Consensus        12 ~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~----~~~~~~~~~~e~~~l~~l~--~~-~i~~~~~~~~~~~~~~iv   84 (324)
                      ++.||.|....||++.+...++.++||.-.....    -+-..++..-|.+.|+...  .| ++++++.+  +.....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            7889999999999999854456799987542221    1233466777888888775  34 45555543  34455678


Q ss_pred             EEecCC--CHHHHHH
Q 045787           85 FEYLDL--DLHSFIT   97 (324)
Q Consensus        85 ~e~~~g--~l~~~~~   97 (324)
                      ||+++.  .++..+.
T Consensus       112 MEdL~~~~ilR~~Li  126 (409)
T PRK12396        112 MEDLSDHTILRTALI  126 (409)
T ss_pred             HHhCcccHHHHHHHH
Confidence            887753  3444443

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=97.09  E-value=0.0018  Score=52.90  Aligned_cols=31  Identities=45%  Similarity=0.629  Sum_probs=21.2

Q ss_pred             CCcccCCCCCceEeecCCCcEEEeeccceee
Q 045787          126 KILHRDLKPNNLLIDLKRNTVKLADFGLARA  156 (324)
Q Consensus       126 g~~H~di~p~nIll~~~~~~v~l~d~g~~~~  156 (324)
                      .++|+|+.|.||+++..++.++++||..+..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            4899999999999943889999999997753

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.07  E-value=0.0093  Score=50.99  Aligned_cols=74  Identities=20%  Similarity=0.329  Sum_probs=49.6

Q ss_pred             cceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcC---CCCeeEEEeeeecCCeEEEEE
Q 045787            9 YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE---HENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         9 y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      -+-.+.++.|....+|.+.  .+++.+.+|+-...     ....+..|.+-|+.|.   .-.+++++.+...++..++|+
T Consensus        19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~-----~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll   91 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSES-----GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL   91 (288)
T ss_dssp             --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGG-----GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred             eeeeEecCCCChhheEEEE--CCCccEEEEecChh-----hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence            4556788999999999988  66889999986621     1246788999888884   455788888888777789999


Q ss_pred             EecC
Q 045787           86 EYLD   89 (324)
Q Consensus        86 e~~~   89 (324)
                      ||++
T Consensus        92 e~l~   95 (288)
T PF03881_consen   92 EFLE   95 (288)
T ss_dssp             E---
T ss_pred             Eeec
Confidence            9986

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.06  E-value=0.0059  Score=52.06  Aligned_cols=30  Identities=33%  Similarity=0.601  Sum_probs=24.6

Q ss_pred             CCcccCCCCCceEeecCCCc-EEEeeccceee
Q 045787          126 KILHRDLKPNNLLIDLKRNT-VKLADFGLARA  156 (324)
Q Consensus       126 g~~H~di~p~nIll~~~~~~-v~l~d~g~~~~  156 (324)
                      .++|+|++|.||+++ +++. .-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~-~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILID-EDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEe-CCCCEEEEECcHhccc
Confidence            489999999999999 5454 56999997763

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.96  E-value=0.012  Score=51.22  Aligned_cols=30  Identities=20%  Similarity=0.274  Sum_probs=26.8

Q ss_pred             CCcccCCCCCceEeecCCCcEEEeeccceee
Q 045787          126 KILHRDLKPNNLLIDLKRNTVKLADFGLARA  156 (324)
Q Consensus       126 g~~H~di~p~nIll~~~~~~v~l~d~g~~~~  156 (324)
                      +++|+|+.++||+++ .++.+.++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~-~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYD-ETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEc-CCCCEEEEEhhhccc
Confidence            799999999999998 778899999987763

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.95  E-value=0.015  Score=50.51  Aligned_cols=29  Identities=28%  Similarity=0.445  Sum_probs=25.0

Q ss_pred             CCCcccCCCCCceEeecCCCcEEEeecccee
Q 045787          125 LKILHRDLKPNNLLIDLKRNTVKLADFGLAR  155 (324)
Q Consensus       125 ~g~~H~di~p~nIll~~~~~~v~l~d~g~~~  155 (324)
                      .+++|||+.+.||+++ . +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~-~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLK-D-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEe-C-CcEEEEECcccc
Confidence            5789999999999999 5 678999998654

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PTZ00384 choline kinase; Provisional

Probab=96.79  E-value=0.018  Score=51.36  Aligned_cols=74  Identities=19%  Similarity=0.196  Sum_probs=44.4

Q ss_pred             ceeEeecccCceEEEEEEEccC-Cce-----EEEEEeeeccccCCCchHHHHHHHHHHhcCCCC-eeEEEeeeecCCeEE
Q 045787           10 KKIKKIGAGGYGEVYKCRNTVT-GQK-----VAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN-IVRLLDVQSSRKDVF   82 (324)
Q Consensus        10 ~i~~~Lg~g~~~~v~~a~~~~~-~~~-----~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~   82 (324)
                      ..++.|..|-...+|++..... +..     |+++...   ......-...+|+.+++.+...+ -+++++.+..    +
T Consensus        53 i~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g---~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g  125 (383)
T PTZ00384         53 IEIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSS---TYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----F  125 (383)
T ss_pred             EEEEEeCCcccceEEEEEecCCCCCccccceEEEEecc---CCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----E
Confidence            3455666688999999975432 223     3444321   11111122357899999997554 4566666643    4


Q ss_pred             EEEEecCC
Q 045787           83 LVFEYLDL   90 (324)
Q Consensus        83 iv~e~~~g   90 (324)
                      +|.||++|
T Consensus       126 ~l~efIeG  133 (383)
T PTZ00384        126 TIQEWVEG  133 (383)
T ss_pred             EEEEEecc
Confidence            89999987

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.73  E-value=0.00017  Score=72.54  Aligned_cols=211  Identities=14%  Similarity=-0.003  Sum_probs=134.4

Q ss_pred             HHHHHHHhcCCCCeeEEEeeee--cCCeEEEEEEecC-CCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC-C-
Q 045787           55 REVSLLKELEHENIVRLLDVQS--SRKDVFLVFEYLD-LDLHSFITRHKN---TLNLLVIKAILKQILLGLAYCHSL-K-  126 (324)
Q Consensus        55 ~e~~~l~~l~~~~i~~~~~~~~--~~~~~~iv~e~~~-g~l~~~~~~~~~---~~~~~~~~~i~~~i~~~l~~Lh~~-g-  126 (324)
                      .|..-++...|+++.....-..  .....++.++++. |.+.+.+.+.-.   +++...+.....+......-.|+. + 
T Consensus      1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred             hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence            3444445556777666554332  2334678888886 688888876533   233444444333335555555533 2 


Q ss_pred             ---CcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh
Q 045787          127 ---ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT  203 (324)
Q Consensus       127 ---~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~  203 (324)
                         -+|.++++.|.++. .+..++++++|+.+.........+...+++-|++|++... ..++.++|+|..|+.+|....
T Consensus      1358 g~T~v~~~Lkf~lpmIV-tny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~-ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIV-TNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE-IKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred             Cccchhhhhhhhcccee-cCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHH-HhhhhHHHHHHHHHHHHHHhc
Confidence               58899999999999 8899999999999855444445555566777888888766 667888999999999999998


Q ss_pred             CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHH
Q 045787          204 GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMD  283 (324)
Q Consensus       204 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~  283 (324)
                      |..+|-...       .........                    .....+.....|.++......+|-+.-..||.-..
T Consensus      1436 ~n~~fi~fl-------q~~Lkgiid--------------------n~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~i 1488 (2724)
T KOG1826|consen 1436 GNAYFIFFL-------QPALKGIID--------------------NHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYI 1488 (2724)
T ss_pred             ccHHHHHHH-------HHHHcCccc--------------------ccccccccccCCCcccHHHHHHHHHHhhhcchhhh
Confidence            887762111       111111110                    00000111123455556666677777788999888


Q ss_pred             HhcCccccCCC
Q 045787          284 ALKHEYLIGVE  294 (324)
Q Consensus       284 ~l~hp~~~~~~  294 (324)
                      .++-+.|.-..
T Consensus      1489 sls~d~~a~~~ 1499 (2724)
T KOG1826|consen 1489 SLSRDHFAVGL 1499 (2724)
T ss_pred             hcccccccccc
Confidence            88877776544

>PTZ00296 choline kinase; Provisional

Probab=96.58  E-value=0.041  Score=50.14  Aligned_cols=74  Identities=18%  Similarity=0.211  Sum_probs=47.6

Q ss_pred             eeEeecccCceEEEEEEEccC--------CceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCe-eEEEeeeecCCeE
Q 045787           11 KIKKIGAGGYGEVYKCRNTVT--------GQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI-VRLLDVQSSRKDV   81 (324)
Q Consensus        11 i~~~Lg~g~~~~v~~a~~~~~--------~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~   81 (324)
                      -++.|..|-.-.+|++.....        ++.|++|++......-  . ...+|..+++.+...++ .++++.+..    
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~l--I-dR~~E~~v~~~ls~~gi~P~l~~~f~g----  181 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDEL--Y-NPISEFEVYKTMSKYRIAPQLLNTFSG----  181 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccce--e-CHHHHHHHHHHHHHCCCCCceEEEeCC----
Confidence            567777788889999875421        4689999876543221  1 24578888888865444 345555532    


Q ss_pred             EEEEEecCCC
Q 045787           82 FLVFEYLDLD   91 (324)
Q Consensus        82 ~iv~e~~~g~   91 (324)
                      ..|.+|++|.
T Consensus       182 g~I~efi~g~  191 (442)
T PTZ00296        182 GRIEEWLYGD  191 (442)
T ss_pred             CEEEEeeCCc
Confidence            3578888763

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.03  E-value=0.049  Score=47.48  Aligned_cols=134  Identities=19%  Similarity=0.215  Sum_probs=76.0

Q ss_pred             eecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCC---eeE---EEee--eecC--CeEEE
Q 045787           14 KIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN---IVR---LLDV--QSSR--KDVFL   83 (324)
Q Consensus        14 ~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~---i~~---~~~~--~~~~--~~~~i   83 (324)
                      .|.+ ....+|++...  +..+++|+.... ..   ...+..|...++.+....   .++   .-|-  ..-.  ...+.
T Consensus        33 ~l~s-~eN~~f~~~~~--~g~~iLki~~~~-~~---~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~  105 (331)
T COG2334          33 GLNS-EENSNFRVQTE--DGRYILKIYRPG-WT---RAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAA  105 (331)
T ss_pred             cccc-ccCceEEEEec--CCCeEEEEecCC-CC---HHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEE
Confidence            3444 56678888764  334599988765 22   356778899998885222   122   1111  1123  37888


Q ss_pred             EEEecCCCHHHH------HH----------hc----C--CC-----CCHH----H---------HHHHHHHHHHHHHHHH
Q 045787           84 VFEYLDLDLHSF------IT----------RH----K--NT-----LNLL----V---------IKAILKQILLGLAYCH  123 (324)
Q Consensus        84 v~e~~~g~l~~~------~~----------~~----~--~~-----~~~~----~---------~~~i~~~i~~~l~~Lh  123 (324)
                      +++|++|.....      +.          ..    .  .+     ..+.    .         .......+...+..+.
T Consensus       106 lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~  185 (331)
T COG2334         106 LFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLL  185 (331)
T ss_pred             EEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHH
Confidence            999998844331      11          00    0  00     0111    0         0012233333344433


Q ss_pred             h--------CC--CcccCCCCCceEeecCCC-cEEEeecccee
Q 045787          124 S--------LK--ILHRDLKPNNLLIDLKRN-TVKLADFGLAR  155 (324)
Q Consensus       124 ~--------~g--~~H~di~p~nIll~~~~~-~v~l~d~g~~~  155 (324)
                      +        .+  ++|+|+.|+||+++ .+. .+-++||+.+.
T Consensus       186 ~~~~~~lp~~~~~iIH~D~~~~NVl~d-~~~~~~g~iDFdDa~  227 (331)
T COG2334         186 ARLPAHLPALGDQIIHGDLHPDNVLFD-DDTDVSGFIDFDDAG  227 (331)
T ss_pred             hhchhhCCcccceeeecCCCccceeEc-CCCCeeeEEEccccc
Confidence            2        24  89999999999999 555 48899999764

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.98  E-value=0.15  Score=44.60  Aligned_cols=69  Identities=20%  Similarity=0.219  Sum_probs=42.3

Q ss_pred             cCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCe--eEEE---e--eeecCCeEEEEEEecCC
Q 045787           18 GGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI--VRLL---D--VQSSRKDVFLVFEYLDL   90 (324)
Q Consensus        18 g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i--~~~~---~--~~~~~~~~~iv~e~~~g   90 (324)
                      +....||++.. .++..+++|+.....   .....+..|.+.+..+....+  +...   +  ....++..+.++++++|
T Consensus        36 s~eN~vy~v~~-~~~~~~vlKv~r~~~---~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G  111 (325)
T PRK11768         36 SYENRVYQFGD-EDGRRVVAKFYRPER---WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGG  111 (325)
T ss_pred             cccceEEEEec-CCCCEEEEEEcCccc---CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCC
Confidence            34567888875 346689999875332   124567788888887743221  2111   1  12335667889999876

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.91  E-value=0.094  Score=45.88  Aligned_cols=108  Identities=18%  Similarity=0.159  Sum_probs=72.9

Q ss_pred             cCCeEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCCCCceEeecCCCcEEEeecccee
Q 045787           77 SRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSL-KILHRDLKPNNLLIDLKRNTVKLADFGLAR  155 (324)
Q Consensus        77 ~~~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-g~~H~di~p~nIll~~~~~~v~l~d~g~~~  155 (324)
                      +..+.|++|++.++++...     .....+++..++.+.+..+.-+..+ .+-|+|+...||+++  +|.|.|+||.+++
T Consensus       297 e~~y~yl~~kdhgt~is~i-----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId--~GnvtLIDfklsR  369 (488)
T COG5072         297 ETLYLYLHFKDHGTPISII-----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID--EGNVTLIDFKLSR  369 (488)
T ss_pred             CceEEEEEEecCCceeeee-----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee--cCceEEEEeeeee
Confidence            3446788888887765532     2245677788889988888877754 689999999999999  8999999999988


Q ss_pred             eccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHH
Q 045787          156 AIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIF  198 (324)
Q Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il  198 (324)
                      ....++.....     .+--|-.+.|  ..+...+||-+.-.+
T Consensus       370 l~~~q~~isy~-----rldhp~lF~G--~dd~QFeIYrlMr~l  405 (488)
T COG5072         370 LSYSQGIISYN-----RLDHPDLFNG--VDDYQFEIYRLMRRL  405 (488)
T ss_pred             cccCCceeecc-----ccCchhhhcC--ccceeeeHHHHHHHH
Confidence            43322221111     1223444554  226777888865444

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.91  E-value=0.059  Score=43.76  Aligned_cols=116  Identities=18%  Similarity=0.196  Sum_probs=66.8

Q ss_pred             cCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEecCCCHHHHHH
Q 045787           18 GGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDLDLHSFIT   97 (324)
Q Consensus        18 g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~   97 (324)
                      ++.++.-.+..+. | ...+|+++...-.- ....++++.+++.++.  +|+++..-  +.-.+-++.|+|-.       
T Consensus        73 ~gNsTl~~~kt~i-G-~L~lKKi~slp~~~-~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~-------  138 (308)
T PF07387_consen   73 NGNSTLLIGKTKI-G-PLFLKKIRSLPCCI-NDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYK-------  138 (308)
T ss_pred             CCceEEEEecccc-c-hhhhhhccCCCccc-chhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccC-------
Confidence            3444444444333 3 34455444322211 1244577788887764  35665521  33356788898752       


Q ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHHHh--CCCcccCCCCCceEeecCCCcEEEeeccce
Q 045787           98 RHKNTLNLLVIKAILKQILLGLAYCHS--LKILHRDLKPNNLLIDLKRNTVKLADFGLA  154 (324)
Q Consensus        98 ~~~~~~~~~~~~~i~~~i~~~l~~Lh~--~g~~H~di~p~nIll~~~~~~v~l~d~g~~  154 (324)
                           +.....-.+. -=+.+|...|+  .+..|||.+|+|||.| ..|-+||.|-+..
T Consensus       139 -----~~i~~~N~i~-agi~~L~~fH~~~~~~lHGD~np~NiM~D-~~G~lKlVDP~~L  190 (308)
T PF07387_consen  139 -----IKINFSNFIT-AGIKDLMDFHSENQHCLHGDCNPDNIMCD-KFGYLKLVDPVCL  190 (308)
T ss_pred             -----cccchhHHHH-HhHHHHHHhhccCCCeecCCCChhheeec-CCCCEEecChhhh
Confidence                 1111111111 11345677883  4699999999999999 9999999998754

The function of this family is unknown.

>PRK06148 hypothetical protein; Provisional

Probab=95.73  E-value=0.17  Score=51.26  Aligned_cols=31  Identities=32%  Similarity=0.589  Sum_probs=25.1

Q ss_pred             CCCcccCCCCCceEeecCCC--cEE-Eeeccceee
Q 045787          125 LKILHRDLKPNNLLIDLKRN--TVK-LADFGLARA  156 (324)
Q Consensus       125 ~g~~H~di~p~nIll~~~~~--~v~-l~d~g~~~~  156 (324)
                      .+++|+|+++.||+++ .++  .+. |+|||.+..
T Consensus       203 ~~vIHgDln~~NiLv~-~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVD-ADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEc-CCCCcceEEEEECccccc
Confidence            4799999999999999 443  555 999997753

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=95.10  E-value=0.15  Score=43.86  Aligned_cols=73  Identities=19%  Similarity=0.231  Sum_probs=45.2

Q ss_pred             cccCceEEEEEEEcc----CC----ceEEEEEeeeccccC---CCchHHHHHHHHHHhcC-------------CCCeeEE
Q 045787           16 GAGGYGEVYKCRNTV----TG----QKVAIKMMTIQTEQE---GVPSYIIREVSLLKELE-------------HENIVRL   71 (324)
Q Consensus        16 g~g~~~~v~~a~~~~----~~----~~~~~K~~~~~~~~~---~~~~~~~~e~~~l~~l~-------------~~~i~~~   71 (324)
                      |.|-.|.+|++.-..    ++    ..+++|.........   .....+.+|+.+++.+-             ....+++
T Consensus         2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~   81 (294)
T PF02958_consen    2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC   81 (294)
T ss_pred             CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence            667788888887533    22    368889876222211   12355778888887662             1234666


Q ss_pred             EeeeecCCeEEEEEEec
Q 045787           72 LDVQSSRKDVFLVFEYL   88 (324)
Q Consensus        72 ~~~~~~~~~~~iv~e~~   88 (324)
                      +....+.+..+||+|-+
T Consensus        82 ~~~~~~~~~~~lvlEDL   98 (294)
T PF02958_consen   82 YYADEDPGDEVLVLEDL   98 (294)
T ss_pred             EEeccCCCceeeehhhh
Confidence            66665555678888866

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	324
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		5e-67
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		5e-67
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		5e-67
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		9e-67
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-66
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-66
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-66
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-66
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-66
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-66
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-66
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-66
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-66
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-66
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-66
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-66
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-66
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-66
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-66
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-66
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-66
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-66
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-66
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-66
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-66
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		4e-66
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-66
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		4e-66
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-66
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-66
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-66
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-66
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-66
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		5e-66
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-66
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-66
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-65
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-65
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		9e-65
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		9e-65
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-63
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-61
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-61
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-58
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-53
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-49
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-49
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-49
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-47
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		4e-46
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-45
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-44
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-44
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		5e-44
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		6e-44
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		5e-43
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		5e-43
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		5e-43
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		6e-43
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		8e-40
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-39
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-39
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-39
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-39
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-39
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-39
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-39
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-39
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-39
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-39
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-39
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-39
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-39
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-39
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-39
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-39
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-39
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-39
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-39
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-39
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-39
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-39
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-39
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-39
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-39
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-39
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-39
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-39
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-39
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-39
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-39
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-39
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-39
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-39
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-39
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-39
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-39
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-39
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-39
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-39
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-39
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-39
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-39
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-39
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-39
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-39
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-39
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-39
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-39
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-39
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		4e-39
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-39
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		8e-39
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-38
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-38
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-38
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-38
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-38
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		7e-38
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-37
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-37
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-37
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-37
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-37
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-37
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-37
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-37
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		3e-37
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		5e-37
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		5e-37
4exu_A	371	Mapk13, Inactive Form Length = 371		6e-37
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		6e-37
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-37
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		6e-37
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		6e-37
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		6e-37
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		7e-37
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		7e-37
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-37
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		7e-37
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		7e-37
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-36
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-36
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-36
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-36
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-36
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-36
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-36
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-36
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-36
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-36
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		4e-36
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		9e-36
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		9e-36
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		3e-35
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		4e-35
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-34
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-34
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-34
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-34
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-34
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-34
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-34
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-34
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-34
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-34
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-34
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-34
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-34
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-34
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-34
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-34
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-34
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-34
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-34
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-34
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		3e-34
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		8e-34
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		3e-33
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		5e-33
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		6e-33
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		8e-33
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-32
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-32
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-32
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-32
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-32
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-32
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		3e-32
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-32
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-32
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		4e-32
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		4e-32
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		4e-32
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		4e-32
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		6e-32
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		1e-31
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-31
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-31
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-31
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-31
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-31
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-31
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		5e-31
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-31
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		7e-31
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-31
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		9e-31
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-30
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		5e-30
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		9e-30
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-29
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-29
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-29
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-27
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-27
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		3e-26
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		7e-26
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-25
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		4e-25
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-25
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-25
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-25
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		7e-25
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		7e-25
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-24
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-24
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-24
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-24
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		4e-24
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		5e-24
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		6e-24
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		6e-24
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		7e-24
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		8e-24
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-23
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-23
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		1e-23
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		1e-23
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-23
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		1e-23
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		1e-23
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		1e-23
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		1e-23
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		1e-23
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-23
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		1e-23
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-23
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-23
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-23
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-23
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-23
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-23
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-23
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-23
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-23
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-23
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-23
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-23
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-23
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-23
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		2e-23
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-23
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		4e-23
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		4e-23
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		4e-23
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		4e-23
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		4e-23
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		4e-23
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		4e-23
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		4e-23
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		4e-23
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		4e-23
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		5e-23
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		5e-23
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		7e-23
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		8e-23
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		9e-23
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-23
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-23
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-22
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-22
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-22
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-22
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-22
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-22
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-22
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-22
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-22
3soa_A	444	Full-Length Human Camkii Length = 444		2e-22
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-22
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-22
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-22
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		4e-22
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		4e-22
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		4e-22
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		5e-22
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		6e-22
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		7e-22
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		8e-22
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		8e-22
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-22
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-21
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-21
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-21
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		3e-21
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-21
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-21
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-21
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-21
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-21
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		5e-21
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		5e-21
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		7e-21
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		8e-21
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		8e-21
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-20
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-20
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-20
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-20
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-20
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		4e-20
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		4e-20
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		4e-20
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-20
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-20
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-20
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-20
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-20
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		4e-20
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-20
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		4e-20
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		5e-20
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		5e-20
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		5e-20
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		5e-20
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		5e-20
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		5e-20
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		7e-20
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		7e-20
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		8e-20
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-19
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-19
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-19
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-19
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-19
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-19
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-19
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-19
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-19
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-19
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-19
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-19
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-19
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-19
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-19
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-19
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-19
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-19
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-19
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-19
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		5e-19
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		5e-19
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		5e-19
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		5e-19
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		5e-19
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		5e-19
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		6e-19
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		6e-19
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		6e-19
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		6e-19
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		6e-19
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		7e-19
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		7e-19
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		7e-19
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		8e-19
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		8e-19
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		8e-19
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-18
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-18
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-18
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-18
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-18
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-18
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-18
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-18
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-18
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-18
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-18
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-18
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		5e-18
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-18
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-18
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		5e-18
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		5e-18
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		6e-18
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		6e-18
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		7e-18
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		8e-18
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-17
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-17
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-17
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-17
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		5e-17
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		5e-17
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		5e-17
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		6e-17
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		6e-17
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		8e-17
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		9e-17
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-16
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		1e-16
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		1e-16
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-16
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-16
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-16
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-16
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		3e-16
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-16
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		4e-16
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		5e-16
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		5e-16
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		6e-16
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		6e-16
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		7e-16
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		7e-16
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		7e-16
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-16
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		7e-16
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		7e-16
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		7e-16
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		8e-16
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		8e-16
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		8e-16
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		8e-16
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		9e-16
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		9e-16
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		9e-16
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		1e-15
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-15
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-15
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-15
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-15
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-15
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-15
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-15
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		1e-15
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-15
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-15
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-15
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-15
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-15
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-15
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-15
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-15
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-15
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-15
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		3e-15
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-15
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-15
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-15
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		3e-15
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-15
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-15
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-15
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		4e-15
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		4e-15
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		4e-15
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		5e-15
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		5e-15
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		5e-15
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		5e-15
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		5e-15
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-15
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		5e-15
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		6e-15
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		6e-15
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		6e-15
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		6e-15
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		7e-15
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		7e-15
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		7e-15
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		8e-15
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-14
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-14
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-14
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-14
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-14
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-14
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-14
2oza_A	356	Structure Of P38alpha Complex Length = 356		1e-14
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-14
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-14
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-14
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-14
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-14
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-14
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-14
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-14
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-14
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-14
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-14
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-14
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-14
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-14
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-14
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		4e-14
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-14
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-14
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		4e-14
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		4e-14
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		4e-14
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		5e-14
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		5e-14
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		6e-14
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		7e-14
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		8e-14
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		8e-14
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		8e-14
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		9e-14
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		9e-14
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		9e-14
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-13
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-13
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-13
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-13
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-13
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-13
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-13
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-13
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-13
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-13
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-13
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-13
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-13
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-13
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-13
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-13
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-13
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-13
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-13
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		3e-13
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-13
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-13
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-13
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-13
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-13
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-13
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-13
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-13
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-13
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-13
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		4e-13
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-13
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		4e-13
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		4e-13
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-13
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		4e-13
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		4e-13
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-13
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		4e-13
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-13
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-13
2pl0_A	289	Lck Bound To Imatinib Length = 289		4e-13
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		4e-13
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-13
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-13
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		4e-13
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-13
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-13
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		4e-13
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-13
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		4e-13
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		5e-13
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		5e-13
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		5e-13
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		5e-13
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		5e-13
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		5e-13
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		5e-13
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		5e-13
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		5e-13
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		5e-13
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		5e-13
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		6e-13
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		6e-13
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		6e-13
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		6e-13
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		7e-13
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		7e-13
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		7e-13
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		7e-13
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		7e-13
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		7e-13
4ae9_A	343	Structure And Function Of The Human Sperm-specific		7e-13
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		7e-13
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		7e-13
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		7e-13
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		7e-13
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		7e-13
4ae6_A	343	Structure And Function Of The Human Sperm-specific		7e-13
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		7e-13
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		7e-13
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		7e-13
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		7e-13
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		7e-13
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		7e-13
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-13
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		8e-13
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		8e-13
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-13
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		8e-13
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-13
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		8e-13
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		8e-13
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		8e-13
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		8e-13
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		8e-13
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		8e-13
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		8e-13
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		8e-13
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		8e-13
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		8e-13
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		8e-13
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		8e-13
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		8e-13
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		8e-13
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		8e-13
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		8e-13
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		8e-13
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		8e-13
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		9e-13
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		9e-13
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		9e-13
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		9e-13
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		9e-13
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		9e-13
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		9e-13
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		9e-13
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		9e-13
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		9e-13
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		9e-13
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		9e-13
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-12
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-12
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-12
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-12
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-12
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-12
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-12
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-12
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-12
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-12
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-12
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		1e-12
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-12
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-12
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-12
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-12
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-12
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-12
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-12
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-12
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-12
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-12
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-12
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-12
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		1e-12
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-12
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-12
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-12
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-12
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-12
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-12
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-12
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-12
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-12
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-12
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-12
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-12
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-12
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		1e-12
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-12
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-12
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-12
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-12
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-12
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-12
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-12
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		2e-12
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-12
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-12
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-12
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-12
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-12
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-12
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-12
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-12
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-12
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-12
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-12
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-12
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-12
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-12
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-12
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-12
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-12
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		4e-12
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		4e-12
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		4e-12
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		5e-12
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		5e-12
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		5e-12
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		5e-12
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		6e-12
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		6e-12
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		6e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		6e-12
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		6e-12
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		7e-12
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-12
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		7e-12
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-12
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		7e-12
3a7f_A	303	Human Mst3 Kinase Length = 303		8e-12
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		8e-12
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		8e-12
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		8e-12
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		8e-12
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		9e-12
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		9e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		9e-12
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		9e-12
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		9e-12
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		9e-12
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		9e-12
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-11
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-11
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-11
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-11
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-11
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-11
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-11
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-11
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-11
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-11
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-11
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-11
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-11
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-11
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-11
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-11
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-11
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-11
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-11
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-11
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-11
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-11
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-11
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-11
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-11
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-11
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-11
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-11
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-11
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-11
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-11
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-11
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-11
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-11
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		4e-11
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		4e-11
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		4e-11
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-11
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		5e-11
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		5e-11
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		5e-11
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		5e-11
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		5e-11
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		5e-11
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		5e-11
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		5e-11
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		5e-11
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-11
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		5e-11
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		6e-11
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		6e-11
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		6e-11
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		6e-11
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		6e-11
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		6e-11
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		7e-11
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		7e-11
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		7e-11
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-11
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		8e-11
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		8e-11
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		8e-11
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-11
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-11
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-11
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		9e-11
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-10
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-10
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-10
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-10
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-10
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-10
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-10
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		1e-10
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-10
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-10
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-10
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-10
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-10
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-10
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-10
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-10
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-10
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-10
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-10
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-10
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-10
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-10
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-10
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-10
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-10
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-10
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-10
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-10
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-10
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-10
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-10
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-10
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-10
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-10
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-10
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-10
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-10
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-10
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-10
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-10
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-10
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-10
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-10
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-10
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-10
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-10
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-10
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-10
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-10
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-10
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-10
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-10
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-10
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-10
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-10
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		3e-10
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-10
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-10
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-10
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-10
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-10
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-10
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-10
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-10
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-10
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-10
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-10
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-10
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-10
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-10
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-10
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		4e-10
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		4e-10
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-10
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-10
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-10
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		5e-10
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		5e-10
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		5e-10
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		5e-10
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-10
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-10
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		5e-10
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		5e-10
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		5e-10
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		6e-10
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		6e-10
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		6e-10
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		6e-10
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		6e-10
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		6e-10
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-10
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		7e-10
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		7e-10
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-10
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		7e-10
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		7e-10
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		7e-10
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-10
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		8e-10
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		8e-10
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		9e-10
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-09
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-09
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-09
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-09
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-09
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-09
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-09
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-09
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-09
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-09
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-09
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-09
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-09
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-09
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-09
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-09
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-09
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-09
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-09
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		4e-09
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		4e-09
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		5e-09
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-09
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		5e-09
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		5e-09
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		5e-09
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		5e-09
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		6e-09
3b2t_A	311	Structure Of Phosphotransferase Length = 311		6e-09
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-09
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		6e-09
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		6e-09
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-09
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-09
4fl3_A	635	Structural And Biophysical Characterization Of The		8e-09
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		8e-09
4fl2_A	636	Structural And Biophysical Characterization Of The		8e-09
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		8e-09
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		9e-09
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		9e-09
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		9e-09
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		9e-09
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		9e-09
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		9e-09
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-08
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-08
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-08
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-08
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-08
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-08
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-08
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-08
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-08
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-08
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-08
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-08
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-08
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-08
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-08
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-08
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-08
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		3e-08
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-08
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-08
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-08
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-08
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-08
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-08
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-08
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-08
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-08
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		4e-08
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		4e-08
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		4e-08
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		4e-08
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-08
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		4e-08
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		4e-08
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		4e-08
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-08
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		4e-08
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		4e-08
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		4e-08
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		4e-08
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-08
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-08
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		5e-08
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-08

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  251 bits (640), Expect = 5e-67,   Method: Compositional matrix adjust.
 Identities = 126/269 (46%), Positives = 179/269 (66%), Gaps = 3/269 (1%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           VYK +N   G+  A+K + ++ E EG+PS  IRE+S+LKEL+H NIV+L DV  ++K + 
Sbjct: 18  VYKAQNNY-GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLV 76
Query: 83  LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK 142
           LVFE+LD DL   +   +  L  +  K+ L Q+L G+AYCH  ++LHRDLKP NLLI+ +
Sbjct: 77  LVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN-R 135
Query: 143 RNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMI 202
              +K+ADFGLARA G+P ++Y+ + V   Y+AP++L+G   YST ID+W+VGCIFAEM+
Sbjct: 136 EGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMV 195
Query: 203 TGKPLFPS-KKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEP 261
            G PLFP   + D L  IF +LGTP  ++W   T + +  P +  +EP         L+ 
Sbjct: 196 NGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDE 255
Query: 262 AGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           +G+DLLS+ML L+P QRITA  AL+H Y 
Sbjct: 256 SGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  251 bits (640), Expect = 5e-67,   Method: Compositional matrix adjust.
 Identities = 126/269 (46%), Positives = 179/269 (66%), Gaps = 3/269 (1%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           VYK +N   G+  A+K + ++ E EG+PS  IRE+S+LKEL+H NIV+L DV  ++K + 
Sbjct: 18  VYKAQNNY-GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLV 76
Query: 83  LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK 142
           LVFE+LD DL   +   +  L  +  K+ L Q+L G+AYCH  ++LHRDLKP NLLI+ +
Sbjct: 77  LVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN-R 135
Query: 143 RNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMI 202
              +K+ADFGLARA G+P ++Y+ + V   Y+AP++L+G   YST ID+W+VGCIFAEM+
Sbjct: 136 EGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMV 195
Query: 203 TGKPLFPS-KKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEP 261
            G PLFP   + D L  IF +LGTP  ++W   T + +  P +  +EP         L+ 
Sbjct: 196 NGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDE 255
Query: 262 AGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           +G+DLLS+ML L+P QRITA  AL+H Y 
Sbjct: 256 SGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  251 bits (640), Expect = 5e-67,   Method: Compositional matrix adjust.
 Identities = 126/269 (46%), Positives = 179/269 (66%), Gaps = 3/269 (1%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           VYK +N   G+  A+K + ++ E EG+PS  IRE+S+LKEL+H NIV+L DV  ++K + 
Sbjct: 18  VYKAQNNY-GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLV 76
Query: 83  LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK 142
           LVFE+LD DL   +   +  L  +  K+ L Q+L G+AYCH  ++LHRDLKP NLLI+ +
Sbjct: 77  LVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN-R 135
Query: 143 RNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMI 202
              +K+ADFGLARA G+P ++Y+ + V   Y+AP++L+G   YST ID+W+VGCIFAEM+
Sbjct: 136 EGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMV 195
Query: 203 TGKPLFPS-KKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEP 261
            G PLFP   + D L  IF +LGTP  ++W   T + +  P +  +EP         L+ 
Sbjct: 196 NGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDE 255
Query: 262 AGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           +G+DLLS+ML L+P QRITA  AL+H Y 
Sbjct: 256 SGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  250 bits (638), Expect = 9e-67,   Method: Compositional matrix adjust.
 Identities = 133/273 (48%), Positives = 179/273 (65%), Gaps = 3/273 (1%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           VYK RN +TG+ VA+K + + TE EGVPS  IRE+SLLKEL H NIV+LLDV  +   ++
Sbjct: 22  VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY 81
Query: 83  LVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           LVFE+L +DL  F+     T + L +IK+ L Q+L GLA+CHS ++LHRDLKP NLLI+ 
Sbjct: 82  LVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 141
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +KLADFGLARA GVP + Y  + V   Y+APE+LLG   YST +D+W++GCIFAEM
Sbjct: 142 E-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 200
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
           +T + LFP     D L  IF  LGTP +  W   T + +  P +P +   + ++  P L+
Sbjct: 201 VTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 260
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
             G  LLSQML  +P +RI+A  AL H +   V
Sbjct: 261 EDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 293

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  250 bits (638), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 133/273 (48%), Positives = 179/273 (65%), Gaps = 3/273 (1%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           VYK RN +TG+ VA+K + + TE EGVPS  IRE+SLLKEL H NIV+LLDV  +   ++
Sbjct: 21  VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY 80
Query: 83  LVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           LVFE+L +DL  F+     T + L +IK+ L Q+L GLA+CHS ++LHRDLKP NLLI+ 
Sbjct: 81  LVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 140
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +KLADFGLARA GVP + Y  + V   Y+APE+LLG   YST +D+W++GCIFAEM
Sbjct: 141 E-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 199
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
           +T + LFP     D L  IF  LGTP +  W   T + +  P +P +   + ++  P L+
Sbjct: 200 VTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 259
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
             G  LLSQML  +P +RI+A  AL H +   V
Sbjct: 260 EDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 292

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  249 bits (637), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 133/273 (48%), Positives = 179/273 (65%), Gaps = 3/273 (1%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           VYK RN +TG+ VA+K + + TE EGVPS  IRE+SLLKEL H NIV+LLDV  +   ++
Sbjct: 20  VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY 79
Query: 83  LVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           LVFE+L +DL  F+     T + L +IK+ L Q+L GLA+CHS ++LHRDLKP NLLI+ 
Sbjct: 80  LVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINT 139
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +KLADFGLARA GVP + Y  + V   Y+APE+LLG   YST +D+W++GCIFAEM
Sbjct: 140 E-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 198
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
           +T + LFP     D L  IF  LGTP +  W   T + +  P +P +   + ++  P L+
Sbjct: 199 VTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 258
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
             G  LLSQML  +P +RI+A  AL H +   V
Sbjct: 259 EDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 291

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  249 bits (637), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 133/273 (48%), Positives = 179/273 (65%), Gaps = 3/273 (1%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           VYK RN +TG+ VA+K + + TE EGVPS  IRE+SLLKEL H NIV+LLDV  +   ++
Sbjct: 19  VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY 78
Query: 83  LVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           LVFE+L  DL  F+     T + L +IK+ L Q+L GLA+CHS ++LHRDLKP NLLI+ 
Sbjct: 79  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 138
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +KLADFGLARA GVP + Y+ + V   Y+APE+LLG   YST +D+W++GCIFAEM
Sbjct: 139 E-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEM 197
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
           +T + LFP     D L  IF  LGTP +  W   T + +  P +P +   + ++  P L+
Sbjct: 198 VTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 257
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
             G  LLSQML  +P +RI+A  AL H +   V
Sbjct: 258 EDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  249 bits (637), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 133/273 (48%), Positives = 179/273 (65%), Gaps = 3/273 (1%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           VYK RN +TG+ VA+K + + TE EGVPS  IRE+SLLKEL H NIV+LLDV  +   ++
Sbjct: 22  VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY 81
Query: 83  LVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           LVFE+L +DL  F+     T + L +IK+ L Q+L GLA+CHS ++LHRDLKP NLLI+ 
Sbjct: 82  LVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINT 141
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +KLADFGLARA GVP + Y  + V   Y+APE+LLG   YST +D+W++GCIFAEM
Sbjct: 142 E-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 200
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
           +T + LFP     D L  IF  LGTP +  W   T + +  P +P +   + ++  P L+
Sbjct: 201 VTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 260
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
             G  LLSQML  +P +RI+A  AL H +   V
Sbjct: 261 EDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 293

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  249 bits (637), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 133/273 (48%), Positives = 179/273 (65%), Gaps = 3/273 (1%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           VYK RN +TG+ VA+K + + TE EGVPS  IRE+SLLKEL H NIV+LLDV  +   ++
Sbjct: 26  VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY 85
Query: 83  LVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           LVFE+L  DL  F+     T + L +IK+ L Q+L GLA+CHS ++LHRDLKP NLLI+ 
Sbjct: 86  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 145
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +KLADFGLARA GVP + Y+ + V   Y+APE+LLG   YST +D+W++GCIFAEM
Sbjct: 146 E-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEM 204
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
           +T + LFP     D L  IF  LGTP +  W   T + +  P +P +   + ++  P L+
Sbjct: 205 VTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 264
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
             G  LLSQML  +P +RI+A  AL H +   V
Sbjct: 265 EDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 297

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  249 bits (635), Expect = 2e-66,   Method: Compositional matrix adjust.
 Identities = 133/273 (48%), Positives = 179/273 (65%), Gaps = 3/273 (1%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           VYK RN +TG+ VA+K + + TE EGVPS  IRE+SLLKEL H NIV+LLDV  +   ++
Sbjct: 18  VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY 77
Query: 83  LVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           LVFE+L  DL  F+     T + L +IK+ L Q+L GLA+CHS ++LHRDLKP NLLI+ 
Sbjct: 78  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 137
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +KLADFGLARA GVP + Y+ + V   Y+APE+LLG   YST +D+W++GCIFAEM
Sbjct: 138 E-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 196
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
           +T + LFP     D L  IF  LGTP +  W   T + +  P +P +   + ++  P L+
Sbjct: 197 VTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 256
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
             G  LLSQML  +P +RI+A  AL H +   V
Sbjct: 257 EDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  249 bits (635), Expect = 2e-66,   Method: Compositional matrix adjust.
 Identities = 133/273 (48%), Positives = 179/273 (65%), Gaps = 3/273 (1%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           VYK RN +TG+ VA+K + + TE EGVPS  IRE+SLLKEL H NIV+LLDV  +   ++
Sbjct: 19  VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY 78
Query: 83  LVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           LVFE+L  DL  F+     T + L +IK+ L Q+L GLA+CHS ++LHRDLKP NLLI+ 
Sbjct: 79  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 138
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +KLADFGLARA GVP + Y+ + V   Y+APE+LLG   YST +D+W++GCIFAEM
Sbjct: 139 E-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 197
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
           +T + LFP     D L  IF  LGTP +  W   T + +  P +P +   + ++  P L+
Sbjct: 198 VTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 257
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
             G  LLSQML  +P +RI+A  AL H +   V
Sbjct: 258 EDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  249 bits (635), Expect = 2e-66,   Method: Compositional matrix adjust.
 Identities = 133/273 (48%), Positives = 179/273 (65%), Gaps = 3/273 (1%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           VYK RN +TG+ VA+K + + TE EGVPS  IRE+SLLKEL H NIV+LLDV  +   ++
Sbjct: 22  VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY 81
Query: 83  LVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           LVFE++D DL  F+     T + L +IK+ L Q+L GLA+CHS ++LHRDLKP NLLI+ 
Sbjct: 82  LVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 141
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +KLADFGLARA GVP + Y  + V   Y+APE+LLG   YST +D+W++GCIFAEM
Sbjct: 142 E-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 200
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
           +T + LFP     D L  IF  LGTP +  W   T + +  P +P +   + ++  P L+
Sbjct: 201 VTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 260
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
             G  LLSQML  +P +RI+A  AL H +   V
Sbjct: 261 EDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 293

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  249 bits (635), Expect = 2e-66,   Method: Compositional matrix adjust.
 Identities = 133/273 (48%), Positives = 179/273 (65%), Gaps = 3/273 (1%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           VYK RN +TG+ VA+K + + TE EGVPS  IRE+SLLKEL H NIV+LLDV  +   ++
Sbjct: 20  VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY 79
Query: 83  LVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           LVFE+L  DL  F+     T + L +IK+ L Q+L GLA+CHS ++LHRDLKP NLLI+ 
Sbjct: 80  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 139
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +KLADFGLARA GVP + Y+ + V   Y+APE+LLG   YST +D+W++GCIFAEM
Sbjct: 140 E-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 198
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
           +T + LFP     D L  IF  LGTP +  W   T + +  P +P +   + ++  P L+
Sbjct: 199 VTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 258
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
             G  LLSQML  +P +RI+A  AL H +   V
Sbjct: 259 EDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 291

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  249 bits (635), Expect = 2e-66,   Method: Compositional matrix adjust.
 Identities = 133/273 (48%), Positives = 179/273 (65%), Gaps = 3/273 (1%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           VYK RN +TG+ VA+K + + TE EGVPS  IRE+SLLKEL H NIV+LLDV  +   ++
Sbjct: 26  VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY 85
Query: 83  LVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           LVFE+L  DL  F+     T + L +IK+ L Q+L GLA+CHS ++LHRDLKP NLLI+ 
Sbjct: 86  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 145
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +KLADFGLARA GVP + Y+ + V   Y+APE+LLG   YST +D+W++GCIFAEM
Sbjct: 146 E-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 204
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
           +T + LFP     D L  IF  LGTP +  W   T + +  P +P +   + ++  P L+
Sbjct: 205 VTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 264
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
             G  LLSQML  +P +RI+A  AL H +   V
Sbjct: 265 EDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 297

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  248 bits (634), Expect = 2e-66,   Method: Compositional matrix adjust.
 Identities = 133/273 (48%), Positives = 179/273 (65%), Gaps = 3/273 (1%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           VYK RN +TG+ VA+K + + TE EGVPS  IRE+SLLKEL H NIV+LLDV  +   ++
Sbjct: 19  VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY 78
Query: 83  LVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           LVFE+L  DL  F+     T + L +IK+ L Q+L GLA+CHS ++LHRDLKP NLLI+ 
Sbjct: 79  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 138
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +KLADFGLARA GVP + Y+ + V   Y+APE+LLG   YST +D+W++GCIFAEM
Sbjct: 139 E-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 197
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
           +T + LFP     D L  IF  LGTP +  W   T + +  P +P +   + ++  P L+
Sbjct: 198 VTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 257
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
             G  LLSQML  +P +RI+A  AL H +   V
Sbjct: 258 EDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  248 bits (634), Expect = 2e-66,   Method: Compositional matrix adjust.
 Identities = 133/273 (48%), Positives = 179/273 (65%), Gaps = 3/273 (1%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           VYK RN +TG+ VA+K + + TE EGVPS  IRE+SLLKEL H NIV+LLDV  +   ++
Sbjct: 18  VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY 77
Query: 83  LVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           LVFE+L  DL  F+     T + L +IK+ L Q+L GLA+CHS ++LHRDLKP NLLI+ 
Sbjct: 78  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 137
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +KLADFGLARA GVP + Y+ + V   Y+APE+LLG   YST +D+W++GCIFAEM
Sbjct: 138 E-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 196
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
           +T + LFP     D L  IF  LGTP +  W   T + +  P +P +   + ++  P L+
Sbjct: 197 VTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 256
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
             G  LLSQML  +P +RI+A  AL H +   V
Sbjct: 257 EDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  248 bits (634), Expect = 2e-66,   Method: Compositional matrix adjust.
 Identities = 133/273 (48%), Positives = 179/273 (65%), Gaps = 3/273 (1%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           VYK RN +TG+ VA+K + + TE EGVPS  IRE+SLLKEL H NIV+LLDV  +   ++
Sbjct: 23  VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY 82
Query: 83  LVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           LVFE+L  DL  F+     T + L +IK+ L Q+L GLA+CHS ++LHRDLKP NLLI+ 
Sbjct: 83  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 142
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +KLADFGLARA GVP + Y+ + V   Y+APE+LLG   YST +D+W++GCIFAEM
Sbjct: 143 E-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 201
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
           +T + LFP     D L  IF  LGTP +  W   T + +  P +P +   + ++  P L+
Sbjct: 202 VTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 261
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
             G  LLSQML  +P +RI+A  AL H +   V
Sbjct: 262 EDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 294

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  248 bits (634), Expect = 3e-66,   Method: Compositional matrix adjust.
 Identities = 133/273 (48%), Positives = 179/273 (65%), Gaps = 3/273 (1%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           VYK RN +TG+ VA+K + + TE EGVPS  IRE+SLLKEL H NIV+LLDV  +   ++
Sbjct: 22  VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY 81
Query: 83  LVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           LVFE+L  DL +F+     T + L +IK+ L Q+L GLA+CHS ++LHRDLKP NLLI+ 
Sbjct: 82  LVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 141
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +KLADFGLARA GVP + Y  + V   Y+APE+LLG   YST +D+W++GCIFAEM
Sbjct: 142 E-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 200
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
           +T + LFP     D L  IF  LGTP +  W   T + +  P +P +   + ++  P L+
Sbjct: 201 VTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 260
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
             G  LLSQML  +P +RI+A  AL H +   V
Sbjct: 261 EDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 293

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  248 bits (633), Expect = 3e-66,   Method: Compositional matrix adjust.
 Identities = 133/273 (48%), Positives = 178/273 (65%), Gaps = 3/273 (1%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           VYK RN +TG+ VA+K + + TE EGVPS  IRE+SLLKEL H NIV+LLDV  +   ++
Sbjct: 19  VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY 78
Query: 83  LVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           LVFE+L  DL  F+     T + L +IK+ L Q+L GLA+CHS ++LHRDLKP NLLI+ 
Sbjct: 79  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 138
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +KLADFGLARA GVP + Y  + V   Y+APE+LLG   YST +D+W++GCIFAEM
Sbjct: 139 E-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 197
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
           +T + LFP     D L  IF  LGTP +  W   T + +  P +P +   + ++  P L+
Sbjct: 198 VTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 257
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
             G  LLSQML  +P +RI+A  AL H +   V
Sbjct: 258 EDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  248 bits (633), Expect = 3e-66,   Method: Compositional matrix adjust.
 Identities = 132/270 (48%), Positives = 177/270 (65%), Gaps = 3/270 (1%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           VYK RN +TG+ VA+K + + TE EGVPS  IRE+SLLKEL H NIV+LLDV  +   ++
Sbjct: 19  VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY 78
Query: 83  LVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           LVFE+L  DL  F+     T + L +IK+ L Q+L GLA+CHS ++LHRDLKP NLLI+ 
Sbjct: 79  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 138
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +KLADFGLARA GVP + Y  + V   Y+APE+LLG   YST +D+W++GCIFAEM
Sbjct: 139 E-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 197
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
           +T + LFP     D L  IF  LGTP +  W   T + +  P +P +   + ++  P L+
Sbjct: 198 VTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 257
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
             G  LLSQML  +P +RI+A  AL H + 
Sbjct: 258 EDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  248 bits (633), Expect = 3e-66,   Method: Compositional matrix adjust.
 Identities = 133/273 (48%), Positives = 178/273 (65%), Gaps = 3/273 (1%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           VYK RN +TG+ VA+K + + TE EGVPS  IRE+SLLKEL H NIV+LLDV  +   ++
Sbjct: 22  VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY 81
Query: 83  LVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           LVFE+L  DL  F+     T + L +IK+ L Q+L GLA+CHS ++LHRDLKP NLLI+ 
Sbjct: 82  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 141
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +KLADFGLARA GVP + Y  + V   Y+APE+LLG   YST +D+W++GCIFAEM
Sbjct: 142 E-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 200
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
           +T + LFP     D L  IF  LGTP +  W   T + +  P +P +   + ++  P L+
Sbjct: 201 VTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 260
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
             G  LLSQML  +P +RI+A  AL H +   V
Sbjct: 261 EDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 293

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  248 bits (633), Expect = 3e-66,   Method: Compositional matrix adjust.
 Identities = 133/273 (48%), Positives = 178/273 (65%), Gaps = 3/273 (1%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           VYK RN +TG+ VA+K + + TE EGVPS  IRE+SLLKEL H NIV+LLDV  +   ++
Sbjct: 21  VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY 80
Query: 83  LVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           LVFE+L  DL  F+     T + L +IK+ L Q+L GLA+CHS ++LHRDLKP NLLI+ 
Sbjct: 81  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 140
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +KLADFGLARA GVP + Y  + V   Y+APE+LLG   YST +D+W++GCIFAEM
Sbjct: 141 E-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 199
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
           +T + LFP     D L  IF  LGTP +  W   T + +  P +P +   + ++  P L+
Sbjct: 200 VTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 259
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
             G  LLSQML  +P +RI+A  AL H +   V
Sbjct: 260 EDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 292

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  248 bits (633), Expect = 3e-66,   Method: Compositional matrix adjust.
 Identities = 133/273 (48%), Positives = 178/273 (65%), Gaps = 3/273 (1%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           VYK RN +TG+ VA+K + + TE EGVPS  IRE+SLLKEL H NIV+LLDV  +   ++
Sbjct: 20  VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY 79
Query: 83  LVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           LVFE+L  DL  F+     T + L +IK+ L Q+L GLA+CHS ++LHRDLKP NLLI+ 
Sbjct: 80  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 139
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +KLADFGLARA GVP + Y  + V   Y+APE+LLG   YST +D+W++GCIFAEM
Sbjct: 140 E-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 198
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
           +T + LFP     D L  IF  LGTP +  W   T + +  P +P +   + ++  P L+
Sbjct: 199 VTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 258
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
             G  LLSQML  +P +RI+A  AL H +   V
Sbjct: 259 EDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 291

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  248 bits (633), Expect = 4e-66,   Method: Compositional matrix adjust.
 Identities = 133/273 (48%), Positives = 178/273 (65%), Gaps = 3/273 (1%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           VYK RN +TG+ VA+K + + TE EGVPS  IRE+SLLKEL H NIV+LLDV  +   ++
Sbjct: 19  VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY 78
Query: 83  LVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           LVFE+L  DL  F+     T + L +IK+ L Q+L GLA+CHS ++LHRDLKP NLLI+ 
Sbjct: 79  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 138
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +KLADFGLARA GVP + Y  + V   Y+APE+LLG   YST +D+W++GCIFAEM
Sbjct: 139 E-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 197
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
           +T + LFP     D L  IF  LGTP +  W   T + +  P +P +   + ++  P L+
Sbjct: 198 VTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 257
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
             G  LLSQML  +P +RI+A  AL H +   V
Sbjct: 258 EDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  248 bits (632), Expect = 4e-66,   Method: Compositional matrix adjust.
 Identities = 133/273 (48%), Positives = 178/273 (65%), Gaps = 3/273 (1%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           VYK RN +TG+ VA+K + + TE EGVPS  IRE+SLLKEL H NIV+LLDV  +   ++
Sbjct: 18  VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY 77
Query: 83  LVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           LVFE+L  DL  F+     T + L +IK+ L Q+L GLA+CHS ++LHRDLKP NLLI+ 
Sbjct: 78  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 137
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +KLADFGLARA GVP + Y  + V   Y+APE+LLG   YST +D+W++GCIFAEM
Sbjct: 138 E-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 196
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
           +T + LFP     D L  IF  LGTP +  W   T + +  P +P +   + ++  P L+
Sbjct: 197 VTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 256
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
             G  LLSQML  +P +RI+A  AL H +   V
Sbjct: 257 EDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  248 bits (632), Expect = 4e-66,   Method: Compositional matrix adjust.
 Identities = 133/273 (48%), Positives = 178/273 (65%), Gaps = 3/273 (1%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           VYK RN +TG+ VA+K + + TE EGVPS  IRE+SLLKEL H NIV+LLDV  +   ++
Sbjct: 22  VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY 81
Query: 83  LVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           LVFE+L  DL  F+     T + L +IK+ L Q+L GLA+CHS ++LHRDLKP NLLI+ 
Sbjct: 82  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 141
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +KLADFGLARA GVP + Y  + V   Y+APE+LLG   YST +D+W++GCIFAEM
Sbjct: 142 E-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 200
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
           +T + LFP     D L  IF  LGTP +  W   T + +  P +P +   + ++  P L+
Sbjct: 201 VTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 260
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
             G  LLSQML  +P +RI+A  AL H +   V
Sbjct: 261 EDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 293

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  248 bits (632), Expect = 4e-66,   Method: Compositional matrix adjust.
 Identities = 133/273 (48%), Positives = 178/273 (65%), Gaps = 3/273 (1%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           VYK RN +TG+ VA+K + + TE EGVPS  IRE+SLLKEL H NIV+LLDV  +   ++
Sbjct: 19  VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY 78
Query: 83  LVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           LVFE+L  DL  F+     T + L +IK+ L Q+L GLA+CHS ++LHRDLKP NLLI+ 
Sbjct: 79  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 138
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +KLADFGLARA GVP + Y  + V   Y+APE+LLG   YST +D+W++GCIFAEM
Sbjct: 139 E-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 197
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
           +T + LFP     D L  IF  LGTP +  W   T + +  P +P +   + ++  P L+
Sbjct: 198 VTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 257
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
             G  LLSQML  +P +RI+A  AL H +   V
Sbjct: 258 EDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  248 bits (632), Expect = 4e-66,   Method: Compositional matrix adjust.
 Identities = 132/273 (48%), Positives = 180/273 (65%), Gaps = 3/273 (1%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           VYK RN +TG+ VA+K + + TE EGVPS  IRE+SLLKEL H NIV+LLDV  +   ++
Sbjct: 18  VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY 77
Query: 83  LVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           LVFE++  DL +F+     T + L +IK+ L Q+L GLA+CHS ++LHRDLKP NLLI+ 
Sbjct: 78  LVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 137
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +KLADFGLARA GVP + Y+ + V   Y+APE+LLG   YST +D+W++GCIFAEM
Sbjct: 138 E-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 196
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
           +T + LFP     D L  IF  LGTP +  W   T + +  P +P +   + ++  P L+
Sbjct: 197 VTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 256
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
             G  LLSQML  +P +RI+A  AL H +   V
Sbjct: 257 EDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  248 bits (632), Expect = 4e-66,   Method: Compositional matrix adjust.
 Identities = 133/273 (48%), Positives = 178/273 (65%), Gaps = 3/273 (1%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           VYK RN +TG+ VA+K + + TE EGVPS  IRE+SLLKEL H NIV+LLDV  +   ++
Sbjct: 18  VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY 77
Query: 83  LVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           LVFE+L  DL  F+     T + L +IK+ L Q+L GLA+CHS ++LHRDLKP NLLI+ 
Sbjct: 78  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 137
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +KLADFGLARA GVP + Y  + V   Y+APE+LLG   YST +D+W++GCIFAEM
Sbjct: 138 E-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 196
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
           +T + LFP     D L  IF  LGTP +  W   T + +  P +P +   + ++  P L+
Sbjct: 197 VTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 256
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
             G  LLSQML  +P +RI+A  AL H +   V
Sbjct: 257 EDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  248 bits (632), Expect = 4e-66,   Method: Compositional matrix adjust.
 Identities = 133/273 (48%), Positives = 178/273 (65%), Gaps = 3/273 (1%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           VYK RN +TG+ VA+K + + TE EGVPS  IRE+SLLKEL H NIV+LLDV  +   ++
Sbjct: 21  VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY 80
Query: 83  LVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           LVFE+L  DL  F+     T + L +IK+ L Q+L GLA+CHS ++LHRDLKP NLLI+ 
Sbjct: 81  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 140
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +KLADFGLARA GVP + Y  + V   Y+APE+LLG   YST +D+W++GCIFAEM
Sbjct: 141 E-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 199
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
           +T + LFP     D L  IF  LGTP +  W   T + +  P +P +   + ++  P L+
Sbjct: 200 VTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 259
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
             G  LLSQML  +P +RI+A  AL H +   V
Sbjct: 260 EDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 292

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  248 bits (632), Expect = 4e-66,   Method: Compositional matrix adjust.
 Identities = 133/273 (48%), Positives = 178/273 (65%), Gaps = 3/273 (1%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           VYK RN +TG+ VA+K + + TE EGVPS  IRE+SLLKEL H NIV+LLDV  +   ++
Sbjct: 20  VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY 79
Query: 83  LVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           LVFE+L  DL  F+     T + L +IK+ L Q+L GLA+CHS ++LHRDLKP NLLI+ 
Sbjct: 80  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 139
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +KLADFGLARA GVP + Y  + V   Y+APE+LLG   YST +D+W++GCIFAEM
Sbjct: 140 E-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 198
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
           +T + LFP     D L  IF  LGTP +  W   T + +  P +P +   + ++  P L+
Sbjct: 199 VTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 258
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
             G  LLSQML  +P +RI+A  AL H +   V
Sbjct: 259 EDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 291

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  248 bits (632), Expect = 4e-66,   Method: Compositional matrix adjust.
 Identities = 133/273 (48%), Positives = 178/273 (65%), Gaps = 3/273 (1%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           VYK RN +TG+ VA+K + + TE EGVPS  IRE+SLLKEL H NIV+LLDV  +   ++
Sbjct: 19  VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY 78
Query: 83  LVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           LVFE+L  DL  F+     T + L +IK+ L Q+L GLA+CHS ++LHRDLKP NLLI+ 
Sbjct: 79  LVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINT 138
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +KLADFGLARA GVP + Y  + V   Y+APE+LLG   YST +D+W++GCIFAEM
Sbjct: 139 E-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 197
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
           +T + LFP     D L  IF  LGTP +  W   T + +  P +P +   + ++  P L+
Sbjct: 198 VTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 257
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
             G  LLSQML  +P +RI+A  AL H +   V
Sbjct: 258 EDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  248 bits (632), Expect = 5e-66,   Method: Compositional matrix adjust.
 Identities = 133/273 (48%), Positives = 178/273 (65%), Gaps = 3/273 (1%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           VYK RN +TG+ VA+K + + TE EGVPS  IRE+SLLKEL H NIV+LLDV  +   ++
Sbjct: 20  VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY 79
Query: 83  LVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           LVFE+L  DL  F+     T + L +IK+ L Q+L GLA+CHS ++LHRDLKP NLLI+ 
Sbjct: 80  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINT 139
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +KLADFGLARA GVP + Y  + V   Y+APE+LLG   YST +D+W++GCIFAEM
Sbjct: 140 E-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 198
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
           +T + LFP     D L  IF  LGTP +  W   T + +  P +P +   + ++  P L+
Sbjct: 199 VTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 258
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
             G  LLSQML  +P +RI+A  AL H +   V
Sbjct: 259 EDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 291

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  248 bits (632), Expect = 5e-66,   Method: Compositional matrix adjust.
 Identities = 133/273 (48%), Positives = 178/273 (65%), Gaps = 3/273 (1%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           VYK RN +TG+ VA+K + + TE EGVPS  IRE+SLLKEL H NIV+LLDV  +   ++
Sbjct: 23  VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY 82
Query: 83  LVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           LVFE+L  DL  F+     T + L +IK+ L Q+L GLA+CHS ++LHRDLKP NLLI+ 
Sbjct: 83  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 142
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +KLADFGLARA GVP + Y  + V   Y+APE+LLG   YST +D+W++GCIFAEM
Sbjct: 143 E-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 201
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
           +T + LFP     D L  IF  LGTP +  W   T + +  P +P +   + ++  P L+
Sbjct: 202 VTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 261
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
             G  LLSQML  +P +RI+A  AL H +   V
Sbjct: 262 EDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 294

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  248 bits (632), Expect = 5e-66,   Method: Compositional matrix adjust.
 Identities = 133/273 (48%), Positives = 178/273 (65%), Gaps = 3/273 (1%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           VYK RN +TG+ VA+K + + TE EGVPS  IRE+SLLKEL H NIV+LLDV  +   ++
Sbjct: 21  VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY 80
Query: 83  LVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           LVFE+L  DL  F+     T + L +IK+ L Q+L GLA+CHS ++LHRDLKP NLLI+ 
Sbjct: 81  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINT 140
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +KLADFGLARA GVP + Y  + V   Y+APE+LLG   YST +D+W++GCIFAEM
Sbjct: 141 E-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 199
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
           +T + LFP     D L  IF  LGTP +  W   T + +  P +P +   + ++  P L+
Sbjct: 200 VTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 259
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
             G  LLSQML  +P +RI+A  AL H +   V
Sbjct: 260 EDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 292

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  247 bits (631), Expect = 6e-66,   Method: Compositional matrix adjust.
 Identities = 132/273 (48%), Positives = 179/273 (65%), Gaps = 3/273 (1%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           VYK RN +TG+ VA+K + + TE EGVPS  IRE+SLLKEL H NIV+LLDV  +   ++
Sbjct: 19  VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY 78
Query: 83  LVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           LVFE+L  DL  F+     T + L +IK+ L Q+L GL++CHS ++LHRDLKP NLLI+ 
Sbjct: 79  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSHRVLHRDLKPQNLLINT 138
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +KLADFGLARA GVP + Y+ + V   Y+APE+LLG   YST +D+W++GCIFAEM
Sbjct: 139 E-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 197
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
           +T + LFP     D L  IF  LGTP +  W   T + +  P +P +   + ++  P L+
Sbjct: 198 VTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 257
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
             G  LLSQML  +P +RI+A  AL H +   V
Sbjct: 258 EDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  246 bits (629), Expect = 1e-65,   Method: Compositional matrix adjust.
 Identities = 132/273 (48%), Positives = 178/273 (65%), Gaps = 3/273 (1%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           VYK RN +TG+ VA+  + + TE EGVPS  IRE+SLLKEL H NIV+LLDV  +   ++
Sbjct: 19  VYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY 78
Query: 83  LVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           LVFE+L  DL  F+     T + L +IK+ L Q+L GLA+CHS ++LHRDLKP NLLI+ 
Sbjct: 79  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 138
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +KLADFGLARA GVP + Y+ + V   Y+APE+LLG   YST +D+W++GCIFAEM
Sbjct: 139 E-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 197
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
           +T + LFP     D L  IF  LGTP +  W   T + +  P +P +   + ++  P L+
Sbjct: 198 VTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 257
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
             G  LLSQML  +P +RI+A  AL H +   V
Sbjct: 258 EDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  246 bits (629), Expect = 1e-65,   Method: Compositional matrix adjust.
 Identities = 132/273 (48%), Positives = 178/273 (65%), Gaps = 3/273 (1%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           VYK RN +TG+ VA+  + + TE EGVPS  IRE+SLLKEL H NIV+LLDV  +   ++
Sbjct: 18  VYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY 77
Query: 83  LVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           LVFE+L  DL  F+     T + L +IK+ L Q+L GLA+CHS ++LHRDLKP NLLI+ 
Sbjct: 78  LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 137
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +KLADFGLARA GVP + Y+ + V   Y+APE+LLG   YST +D+W++GCIFAEM
Sbjct: 138 E-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 196
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
           +T + LFP     D L  IF  LGTP +  W   T + +  P +P +   + ++  P L+
Sbjct: 197 VTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 256
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
             G  LLSQML  +P +RI+A  AL H +   V
Sbjct: 257 EDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  243 bits (621), Expect = 9e-65,   Method: Compositional matrix adjust.
 Identities = 129/274 (47%), Positives = 174/274 (63%), Gaps = 12/274 (4%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           VYK +++  G+ VA+K + +  E EG+PS  IRE+SLLKEL H NIV L+DV  S + + 
Sbjct: 37  VYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLT 95
Query: 83  LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK 142
           LVFE+++ DL   +  +K  L    IK  L Q+L G+A+CH  +ILHRDLKP NLLI+  
Sbjct: 96  LVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLIN-S 154
Query: 143 RNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMI 202
              +KLADFGLARA G+P + Y+ + V   Y+AP++L+G   YST +D+W++GCIFAEMI
Sbjct: 155 DGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMI 214
Query: 203 TGKPLFPS-KKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPH-----FEPANLAEKF 256
           TGKPLFP     D L  IFS+LGTP    W +     + LPL+       FE    +   
Sbjct: 215 TGKPLFPGVTDDDQLPKIFSILGTPNPREWPQ----VQELPLWKQRTFQVFEKKPWSSII 270
Query: 257 PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           P     G+DLLS MLC +P +RI+A DA+ H Y 
Sbjct: 271 PGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF 304

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  243 bits (620), Expect = 9e-65,   Method: Compositional matrix adjust.
 Identities = 129/274 (47%), Positives = 174/274 (63%), Gaps = 12/274 (4%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           VYK +++  G+ VA+K + +  E EG+PS  IRE+SLLKEL H NIV L+DV  S + + 
Sbjct: 37  VYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLT 95
Query: 83  LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK 142
           LVFE+++ DL   +  +K  L    IK  L Q+L G+A+CH  +ILHRDLKP NLLI+  
Sbjct: 96  LVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLIN-S 154
Query: 143 RNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMI 202
              +KLADFGLARA G+P + Y+ + V   Y+AP++L+G   YST +D+W++GCIFAEMI
Sbjct: 155 DGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMI 214
Query: 203 TGKPLFPS-KKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPH-----FEPANLAEKF 256
           TGKPLFP     D L  IFS+LGTP    W +     + LPL+       FE    +   
Sbjct: 215 TGKPLFPGVTDDDQLPKIFSILGTPNPREWPQ----VQELPLWKQRTFQVFEKKPWSSII 270
Query: 257 PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           P     G+DLLS MLC +P +RI+A DA+ H Y 
Sbjct: 271 PGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF 304

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  239 bits (609), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 129/273 (47%), Positives = 173/273 (63%), Gaps = 4/273 (1%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           VYK ++ +T   VA+K + ++ E EG P   IREVSLLK+L+H NIV L D+  + K + 
Sbjct: 18  VYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLT 76
Query: 83  LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK 142
           LVFEYLD DL  ++    N +N+  +K  L Q+L GLAYCH  K+LHRDLKP NLLI+ +
Sbjct: 77  LVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLIN-E 135
Query: 143 RNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMI 202
           R  +KLADFGLARA  +P K Y  + V   Y+ P++LLG T YST ID+W VGCIF EM 
Sbjct: 136 RGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMA 195
Query: 203 TGKPLFP-SKKHDHLSLIFSLLGTPTDESWAESTYISEILPL-YPHFEPANLAEKFPNLE 260
           TG+PLFP S   + L  IF +LGTPT+E+W       E     YP +    L    P L+
Sbjct: 196 TGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLD 255
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
             G DLL+++L    + RI+A DA+KH + + +
Sbjct: 256 SDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  232 bits (591), Expect = 2e-61,   Method: Compositional matrix adjust.
 Identities = 128/272 (47%), Positives = 172/272 (63%), Gaps = 7/272 (2%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           V+K +N  T + VA+K + +  + EGVPS  +RE+ LLKEL+H+NIVRL DV  S K + 
Sbjct: 18  VFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLT 77
Query: 83  LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK 142
           LVFE+ D DL  +       L+  ++K+ L Q+L GL +CHS  +LHRDLKP NLLI+ +
Sbjct: 78  LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN-R 136
Query: 143 RNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMI 202
              +KLA+FGLARA G+P + YS + V   Y+ P++L G   YST ID+W+ GCIFAE+ 
Sbjct: 137 NGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELA 196
Query: 203 T-GKPLFPSKK-HDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPA--NLAEKFPN 258
             G+PLFP     D L  IF LLGTPT+E W   T + +  P YP + PA  +L    P 
Sbjct: 197 NAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP-YPMY-PATTSLVNVVPK 254
Query: 259 LEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           L   G DLL  +L  NP QRI+A +AL+H Y 
Sbjct: 255 LNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  231 bits (590), Expect = 3e-61,   Method: Compositional matrix adjust.
 Identities = 128/272 (47%), Positives = 171/272 (62%), Gaps = 7/272 (2%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           V+K +N  T + VA+K + +  + EGVPS  +RE+ LLKEL+H+NIVRL DV  S K + 
Sbjct: 18  VFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLT 77
Query: 83  LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK 142
           LVFE+ D DL  +       L+  ++K+ L Q+L GL +CHS  +LHRDLKP NLLI+ +
Sbjct: 78  LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN-R 136
Query: 143 RNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMI 202
              +KLADFGLARA G+P + YS + V   Y+ P++L G   YST ID+W+ GCIFAE+ 
Sbjct: 137 NGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELA 196
Query: 203 T-GKPLFPSKK-HDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPA--NLAEKFPN 258
              +PLFP     D L  IF LLGTPT+E W   T + +  P YP + PA  +L    P 
Sbjct: 197 NAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP-YPMY-PATTSLVNVVPK 254
Query: 259 LEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           L   G DLL  +L  NP QRI+A +AL+H Y 
Sbjct: 255 LNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  223 bits (568), Expect = 1e-58,   Method: Compositional matrix adjust.
 Identities = 129/280 (46%), Positives = 172/280 (61%), Gaps = 15/280 (5%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           VYK  N  TG  VA+K + + +E EG PS  IRE+SL+KEL+HENIVRL DV  +   + 
Sbjct: 21  VYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLT 79
Query: 83  LVFEYLDLDLHSFITRHK--NT---LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
           LVFE++D DL  ++      NT   L L ++K    Q+L GLA+CH  KILHRDLKP NL
Sbjct: 80  LVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNL 139
Query: 138 LIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCI 197
           LI+ KR  +KL DFGLARA G+P   +S + V   Y+AP++L+G   YST ID+W+ GCI
Sbjct: 140 LIN-KRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCI 198
Query: 198 FAEMITGKPLFP-SKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAE-- 254
            AEMITGKPLFP +   + L LIF ++GTP +  W   T + +  P      P +L +  
Sbjct: 199 LAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVL 258
Query: 255 ----KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
               K P L+   +D L  +L LNP  R++A  AL H + 
Sbjct: 259 QPHTKEP-LDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF 297

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  206 bits (524), Expect = 1e-53,   Method: Compositional matrix adjust.
 Identities = 114/275 (41%), Positives = 173/275 (62%), Gaps = 7/275 (2%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           EVYK  +TVT + VAIK + ++ E+EGVP   IREVSLLKEL+H NI+ L  V      +
Sbjct: 49  EVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL 108
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
            L+FEY + DL  ++ ++ + +++ VIK+ L Q++ G+ +CHS + LHRDLKP NLL+ +
Sbjct: 109 HLIFEYAENDLKKYMDKNPD-VSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSV 167
Query: 142 KRNT----VKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCI 197
              +    +K+ DFGLARA G+P ++++ + +   Y+ PE+LLG   YST +D+W++ CI
Sbjct: 168 SDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACI 227
Query: 198 FAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKF 256
           +AEM+   PLFP     D L  IF +LG P D +W   T + +    +P F    L    
Sbjct: 228 WAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVL 287
Query: 257 -PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
              L+  G+DLL+ ML ++P +RI+A +AL+H Y 
Sbjct: 288 GALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYF 322

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  193 bits (490), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 121/291 (41%), Positives = 169/291 (58%), Gaps = 27/291 (9%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE---HENIVRLLDV-QSSR 78
           VYK R+  +G  VA+K + +   +EG+P   +REV+LL+ LE   H N+VRL+DV  +SR
Sbjct: 20  VYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 79
Query: 79  KD----VFLVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLK 133
            D    V LVFE++D DL +++ +     L    IK +++Q L GL + H+  I+HRDLK
Sbjct: 80  TDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLK 139
Query: 134 PNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP------YKAPELLLGYTGYST 187
           P N+L+     TVKLADFGLAR        YS     +P      Y+APE+LL  T Y+T
Sbjct: 140 PENILV-TSGGTVKLADFGLARI-------YSYQMALAPVVVTLWYRAPEVLLQST-YAT 190
Query: 188 PIDVWAVGCIFAEMITGKPLF-PSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPH 246
           P+D+W+VGCIFAEM   KPLF  + + D L  IF L+G P ++ W     +S     +P 
Sbjct: 191 PVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD--VSLPRGAFPP 248
Query: 247 FEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
             P  +    P +E +G  LL +ML  NP +RI+A  AL+H YL   E  P
Sbjct: 249 RGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGNP 299

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  192 bits (489), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 121/291 (41%), Positives = 168/291 (57%), Gaps = 27/291 (9%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE---HENIVRLLDV-QSSR 78
           VYK R+  +G  VA+K + +   +EG+P   +REV+LL+ LE   H N+VRL+DV  +SR
Sbjct: 20  VYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 79
Query: 79  KD----VFLVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLK 133
            D    V LVFE++D DL +++ +     L    IK +++Q L GL + H+  I+HRDLK
Sbjct: 80  TDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLK 139
Query: 134 PNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP------YKAPELLLGYTGYST 187
           P N+L+     TVKLADFGLAR        YS      P      Y+APE+LL  T Y+T
Sbjct: 140 PENILV-TSGGTVKLADFGLARI-------YSYQMALDPVVVTLWYRAPEVLLQST-YAT 190
Query: 188 PIDVWAVGCIFAEMITGKPLF-PSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPH 246
           P+D+W+VGCIFAEM   KPLF  + + D L  IF L+G P ++ W     +S     +P 
Sbjct: 191 PVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD--VSLPRGAFPP 248
Query: 247 FEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
             P  +    P +E +G  LL +ML  NP +RI+A  AL+H YL   E  P
Sbjct: 249 RGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGNP 299

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  191 bits (486), Expect = 3e-49,   Method: Compositional matrix adjust.
 Identities = 121/291 (41%), Positives = 168/291 (57%), Gaps = 27/291 (9%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE---HENIVRLLDV-QSSR 78
           VYK R+  +G  VA+K + +   +EG+P   +REV+LL+ LE   H N+VRL+DV  +SR
Sbjct: 20  VYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 79
Query: 79  KD----VFLVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLK 133
            D    V LVFE++D DL +++ +     L    IK +++Q L GL + H+  I+HRDLK
Sbjct: 80  TDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLK 139
Query: 134 PNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP------YKAPELLLGYTGYST 187
           P N+L+     TVKLADFGLAR        YS      P      Y+APE+LL  T Y+T
Sbjct: 140 PENILV-TSGGTVKLADFGLARI-------YSYQMALFPVVVTLWYRAPEVLLQST-YAT 190
Query: 188 PIDVWAVGCIFAEMITGKPLF-PSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPH 246
           P+D+W+VGCIFAEM   KPLF  + + D L  IF L+G P ++ W     +S     +P 
Sbjct: 191 PVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD--VSLPRGAFPP 248
Query: 247 FEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
             P  +    P +E +G  LL +ML  NP +RI+A  AL+H YL   E  P
Sbjct: 249 RGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGNP 299

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  186 bits (471), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 109/272 (40%), Positives = 148/272 (54%), Gaps = 6/272 (2%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQE---GVPSYIIREVSLLKELEHENIVRLLDVQSSRK 79
           VYK R+  T Q VAIK + +    E   G+    +RE+ LL+EL H NI+ LLD    + 
Sbjct: 26  VYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85
Query: 80  DVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLI 139
           ++ LVF++++ DL   I  +   L    IKA +   L GL Y H   ILHRDLKPNNLL+
Sbjct: 86  NISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL 145
Query: 140 DLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFA 199
           D +   +KLADFGLA++ G P + Y    V   Y+APELL G   Y   +D+WAVGCI A
Sbjct: 146 D-ENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILA 204
Query: 200 EMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPN 258
           E++   P  P     D L+ IF  LGTPT+E W +   + + +  +  F    L   F  
Sbjct: 205 ELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV-TFKSFPGIPLHHIFSA 263
Query: 259 LEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                +DL+  +   NP  RITA  ALK +Y 
Sbjct: 264 AGDDLLDLIQGLFLFNPCARITATQALKMKYF 295

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  181 bits (460), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 119/294 (40%), Positives = 166/294 (56%), Gaps = 30/294 (10%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEG---VPSYIIREVSLLKELE---HENIVRLLDV-Q 75
           VYK R+  +G  VA+K + +     G   +P   +REV+LL+ LE   H N+VRL+DV  
Sbjct: 25  VYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84
Query: 76  SSRKD----VFLVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHR 130
           +SR D    V LVFE++D DL +++ +     L    IK +++Q L GL + H+  I+HR
Sbjct: 85  TSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHR 144
Query: 131 DLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP------YKAPELLLGYTG 184
           DLKP N+L+     TVKLADFGLAR        YS     +P      Y+APE+LL  T 
Sbjct: 145 DLKPENILV-TSGGTVKLADFGLARI-------YSYQMALTPVVVTLWYRAPEVLLQST- 195
Query: 185 YSTPIDVWAVGCIFAEMITGKPLF-PSKKHDHLSLIFSLLGTPTDESWAESTYISEILPL 243
           Y+TP+D+W+VGCIFAEM   KPLF  + + D L  IF L+G P ++ W     +      
Sbjct: 196 YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRG--A 253
Query: 244 YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
           +P   P  +    P +E +G  LL +ML  NP +RI+A  AL+H YL   E  P
Sbjct: 254 FPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGNP 307

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  179 bits (454), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 103/279 (36%), Positives = 157/279 (56%), Gaps = 8/279 (2%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           V+KCRN  TGQ VAIK      +   +    +RE+ +LK+L+H N+V LL+V   ++ + 
Sbjct: 19  VFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLH 78
Query: 83  LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK 142
           LVFEY D  +   + R++  +   ++K+I  Q L  + +CH    +HRD+KP N+LI  K
Sbjct: 79  LVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILI-TK 137
Query: 143 RNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMI 202
            + +KL DFG AR +  P   Y  +     Y++PELL+G T Y  P+DVWA+GC+FAE++
Sbjct: 138 HSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELL 197
Query: 203 TGKPLFPSKKH-DHLSLIFSLLGT--PTDES-WAESTYISEI-LPLYPHFEPANLAEKFP 257
           +G PL+P K   D L LI   LG   P  +  ++ + Y S + +P     EP  L  KFP
Sbjct: 198 SGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLEL--KFP 255
Query: 258 NLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENV 296
           N+    + LL   L ++P +R+T    L H Y   +  +
Sbjct: 256 NISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI 294

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  175 bits (444), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 116/287 (40%), Positives = 168/287 (58%), Gaps = 20/287 (6%)
Query: 22  EVYKCRNTVTGQK-VAIKMMTIQTEQEGVPSYIIREVSLLKELE---HENIVRLLDVQS- 76
           +V+K R+   G + VA+K + +QT +EG+P   IREV++L+ LE   H N+VRL DV + 
Sbjct: 26  KVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 85
Query: 77  SRKD----VFLVFEYLDLDLHSFITR-HKNTLNLLVIKAILKQILLGLAYCHSLKILHRD 131
           SR D    + LVFE++D DL +++ +  +  +    IK ++ Q+L GL + HS +++HRD
Sbjct: 86  SRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRD 145
Query: 132 LKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDV 191
           LKP N+L+      +KLADFGLAR     Q   +   V   Y+APE+LL  + Y+TP+D+
Sbjct: 146 LKPQNILV-TSSGQIKLADFGLARIYSF-QMALTSVVVTLWYRAPEVLL-QSSYATPVDL 202
Query: 192 WAVGCIFAEMITGKPLF-PSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYP-HFEP 249
           W+VGCIFAEM   KPLF  S   D L  I  ++G P +E W         LP    H + 
Sbjct: 203 WSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV----ALPRQAFHSKS 258
Query: 250 ANLAEKF-PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVEN 295
           A   EKF  +++  G DLL + L  NP +RI+A  AL H Y   +E 
Sbjct: 259 AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  175 bits (444), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 116/287 (40%), Positives = 168/287 (58%), Gaps = 20/287 (6%)
Query: 22  EVYKCRNTVTGQK-VAIKMMTIQTEQEGVPSYIIREVSLLKELE---HENIVRLLDVQS- 76
           +V+K R+   G + VA+K + +QT +EG+P   IREV++L+ LE   H N+VRL DV + 
Sbjct: 26  KVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 85
Query: 77  SRKD----VFLVFEYLDLDLHSFITR-HKNTLNLLVIKAILKQILLGLAYCHSLKILHRD 131
           SR D    + LVFE++D DL +++ +  +  +    IK ++ Q+L GL + HS +++HRD
Sbjct: 86  SRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRD 145
Query: 132 LKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDV 191
           LKP N+L+      +KLADFGLAR     Q   +   V   Y+APE+LL  + Y+TP+D+
Sbjct: 146 LKPQNILV-TSSGQIKLADFGLARIYSF-QMALTSVVVTLWYRAPEVLL-QSSYATPVDL 202
Query: 192 WAVGCIFAEMITGKPLF-PSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYP-HFEP 249
           W+VGCIFAEM   KPLF  S   D L  I  ++G P +E W         LP    H + 
Sbjct: 203 WSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV----ALPRQAFHSKS 258
Query: 250 ANLAEKF-PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVEN 295
           A   EKF  +++  G DLL + L  NP +RI+A  AL H Y   +E 
Sbjct: 259 AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  174 bits (442), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 115/282 (40%), Positives = 166/282 (58%), Gaps = 20/282 (7%)
Query: 22  EVYKCRNTVTGQK-VAIKMMTIQTEQEGVPSYIIREVSLLKELE---HENIVRLLDVQS- 76
           +V+K R+   G + VA+K + +QT +EG+P   IREV++L+ LE   H N+VRL DV + 
Sbjct: 26  KVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 85
Query: 77  SRKD----VFLVFEYLDLDLHSFITR-HKNTLNLLVIKAILKQILLGLAYCHSLKILHRD 131
           SR D    + LVFE++D DL +++ +  +  +    IK ++ Q+L GL + HS +++HRD
Sbjct: 86  SRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRD 145
Query: 132 LKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDV 191
           LKP N+L+      +KLADFGLAR     Q   +   V   Y+APE+LL  + Y+TP+D+
Sbjct: 146 LKPQNILV-TSSGQIKLADFGLARIYSF-QMALTSVVVTLWYRAPEVLL-QSSYATPVDL 202
Query: 192 WAVGCIFAEMITGKPLF-PSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYP-HFEP 249
           W+VGCIFAEM   KPLF  S   D L  I  ++G P +E W         LP    H + 
Sbjct: 203 WSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV----ALPRQAFHSKS 258
Query: 250 ANLAEKF-PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           A   EKF  +++  G DLL + L  NP +RI+A  AL H Y 
Sbjct: 259 AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  174 bits (441), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 100/273 (36%), Positives = 146/273 (53%), Gaps = 8/273 (2%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           V KCRN  TG+ VAIK      + + V    +RE+ LLK+L HEN+V LL+V   +K  +
Sbjct: 41  VMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWY 100
Query: 83  LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK 142
           LVFE++D  +   +    N L+  V++  L QI+ G+ +CHS  I+HRD+KP N+L+  +
Sbjct: 101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVS-Q 159
Query: 143 RNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMI 202
              VKL DFG AR +  P + Y  +     Y+APELL+G   Y   +DVWA+GC+  EM 
Sbjct: 160 SGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMF 219
Query: 203 TGKPLFPSKKH-DHLSLIFSLLGT--PTDESWAEST--YISEILPLYPHFEPANLAEKFP 257
            G+PLFP     D L  I   LG   P  +        +    LP     EP  L  ++P
Sbjct: 220 MGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREP--LERRYP 277
Query: 258 NLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            L    +DL  + L ++P +R    + L H++ 
Sbjct: 278 KLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF 310

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score =  171 bits (433), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 104/286 (36%), Positives = 159/286 (55%), Gaps = 19/286 (6%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDV------- 74
           EV+K R+  TGQKVA+K + ++ E+EG P   +RE+ +L+ L+HEN+V L+++       
Sbjct: 33  EVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASP 92
Query: 75  -QSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLK 133
               +  ++LVF++ + DL   ++       L  IK +++ +L GL Y H  KILHRD+K
Sbjct: 93  YNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMK 152
Query: 134 PNNLLIDLKRNTVKLADFGLARAIGVPQ----KEYSRDCVYSPYKAPELLLGYTGYSTPI 189
             N+LI  +   +KLADFGLARA  + +      Y    V   Y+ PELLLG   Y  PI
Sbjct: 153 AANVLI-TRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPI 211
Query: 190 DVWAVGCIFAEMITGKPLFPSKKHDH-LSLIFSLLGTPTDESW--AESTYISEILPLYPH 246
           D+W  GCI AEM T  P+       H L+LI  L G+ T E W   ++  + E L L   
Sbjct: 212 DLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKG 271
Query: 247 FEPANLAEKFPNL--EPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            +   + ++      +P  +DL+ ++L L+P QRI + DAL H++ 
Sbjct: 272 -QKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 316

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score =  171 bits (433), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 104/286 (36%), Positives = 159/286 (55%), Gaps = 19/286 (6%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDV------- 74
           EV+K R+  TGQKVA+K + ++ E+EG P   +RE+ +L+ L+HEN+V L+++       
Sbjct: 33  EVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASP 92
Query: 75  -QSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLK 133
               +  ++LVF++ + DL   ++       L  IK +++ +L GL Y H  KILHRD+K
Sbjct: 93  YNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMK 152
Query: 134 PNNLLIDLKRNTVKLADFGLARAIGVPQ----KEYSRDCVYSPYKAPELLLGYTGYSTPI 189
             N+LI  +   +KLADFGLARA  + +      Y    V   Y+ PELLLG   Y  PI
Sbjct: 153 AANVLI-TRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPI 211
Query: 190 DVWAVGCIFAEMITGKPLFPSKKHDH-LSLIFSLLGTPTDESW--AESTYISEILPLYPH 246
           D+W  GCI AEM T  P+       H L+LI  L G+ T E W   ++  + E L L   
Sbjct: 212 DLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKG 271
Query: 247 FEPANLAEKFPNL--EPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            +   + ++      +P  +DL+ ++L L+P QRI + DAL H++ 
Sbjct: 272 -QKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 316

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score =  171 bits (433), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 104/286 (36%), Positives = 159/286 (55%), Gaps = 19/286 (6%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDV------- 74
           EV+K R+  TGQKVA+K + ++ E+EG P   +RE+ +L+ L+HEN+V L+++       
Sbjct: 32  EVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASP 91
Query: 75  -QSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLK 133
               +  ++LVF++ + DL   ++       L  IK +++ +L GL Y H  KILHRD+K
Sbjct: 92  YNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMK 151
Query: 134 PNNLLIDLKRNTVKLADFGLARAIGVPQ----KEYSRDCVYSPYKAPELLLGYTGYSTPI 189
             N+LI  +   +KLADFGLARA  + +      Y    V   Y+ PELLLG   Y  PI
Sbjct: 152 AANVLI-TRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPI 210
Query: 190 DVWAVGCIFAEMITGKPLFPSKKHDH-LSLIFSLLGTPTDESW--AESTYISEILPLYPH 246
           D+W  GCI AEM T  P+       H L+LI  L G+ T E W   ++  + E L L   
Sbjct: 211 DLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKG 270
Query: 247 FEPANLAEKFPNL--EPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            +   + ++      +P  +DL+ ++L L+P QRI + DAL H++ 
Sbjct: 271 -QKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 315

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score =  171 bits (432), Expect = 6e-43,   Method: Compositional matrix adjust.
 Identities = 104/286 (36%), Positives = 159/286 (55%), Gaps = 19/286 (6%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDV------- 74
           EV+K R+  TGQKVA+K + ++ E+EG P   +RE+ +L+ L+HEN+V L+++       
Sbjct: 33  EVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASP 92
Query: 75  -QSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLK 133
               +  ++LVF++ + DL   ++       L  IK +++ +L GL Y H  KILHRD+K
Sbjct: 93  YNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMK 152
Query: 134 PNNLLIDLKRNTVKLADFGLARAIGVPQ----KEYSRDCVYSPYKAPELLLGYTGYSTPI 189
             N+LI  +   +KLADFGLARA  + +      Y    V   Y+ PELLLG   Y  PI
Sbjct: 153 AANVLI-TRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPI 211
Query: 190 DVWAVGCIFAEMITGKPLFPSKKHDH-LSLIFSLLGTPTDESW--AESTYISEILPLYPH 246
           D+W  GCI AEM T  P+       H L+LI  L G+ T E W   ++  + E L L   
Sbjct: 212 DLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKG 271
Query: 247 FEPANLAEKFPNL--EPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            +   + ++      +P  +DL+ ++L L+P QRI + DAL H++ 
Sbjct: 272 -QKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 316

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  160 bits (405), Expect = 8e-40,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 150/276 (54%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 43  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 102
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 103 YLVTHLMGADLNNIVKXQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 159
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ DFGLAR        Y        Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 160 EDXELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM----PKMNFAN 272
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 273 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 151/276 (54%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 45  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 104
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 105 YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 161
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           + + +K+ DFGLAR        Y        Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 162 EDSELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 218
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 219 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM----PKMNFAN 274
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 275 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 310

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 151/276 (54%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 49  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 108
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 109 YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 165
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           + + +K+ DFGLAR        Y        Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 166 EDSELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 222
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 223 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM----PKMNFAN 278
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 279 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 314

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 150/276 (54%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 63  DTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 122
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 123 YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 179
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ DFGLAR       E         Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 180 EDCELKILDFGLARHT---DDEMXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 236
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 237 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQM----PKMNFAN 292
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 293 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 328

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 150/276 (54%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 39  DTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 98
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 99  YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 155
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ DFGLAR        Y        Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 156 EDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 212
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 213 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQM----PKMNFAN 268
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 269 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 150/276 (54%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 53  DTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 112
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 113 YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 169
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ DFGLAR        Y        Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 170 EDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 226
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 227 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQM----PKMNFAN 282
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 283 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 318

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 149/276 (53%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 43  DTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 102
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 103 YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 159
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ DFGLAR        Y        Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 160 EDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +          N A 
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL----AQMPKMNFAN 272
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 273 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 150/276 (54%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 63  DTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 122
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 123 YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 179
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ DFGLAR        Y        Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 180 EDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 236
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 237 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQM----PKMNFAN 292
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 293 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 328

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 150/276 (54%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 62  DTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 121
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 122 YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 178
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ DFGLAR        Y        Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 179 EDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 235
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 236 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQM----PKMNFAN 291
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 292 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 327

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 151/276 (54%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 39  DTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 98
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 99  YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 155
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ DFGLAR       E +       Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 156 EDCELKILDFGLARHT---DDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 212
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 213 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQM----PKMNFAN 268
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 269 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 151/276 (54%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 43  DTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 102
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 103 YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 159
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ DFGLAR       E +       Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 160 EDCELKILDFGLARHT---DDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM----PKMNFAN 272
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 273 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  159 bits (403), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 150/276 (54%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 49  DTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 108
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 109 YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 165
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ DFGLAR        Y        Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 166 EDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 222
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 223 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQM----PKMNFAN 278
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 279 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 314

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  159 bits (403), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 150/276 (54%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 43  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 102
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 103 YLVTHLMGADLNNIVKXQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 159
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ DFGLAR        Y        Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 160 EDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM----PKMNFAN 272
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 273 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  159 bits (403), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 151/276 (54%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 43  DTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 102
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 103 YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 159
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ DFGLAR       E +       Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 160 EDCELKILDFGLARHT---DDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQM----PKMNFAN 272
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 273 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 150/276 (54%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 54  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 113
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 114 YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 170
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ DFGLAR        Y        Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 171 EDXELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 227
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 228 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM----PKMNFAN 283
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 284 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 319

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 150/276 (54%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 50  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 109
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 110 YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 166
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ DFGLAR        Y        Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 167 EDCELKILDFGLARHTADEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 223
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 224 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM----PKMNFAN 279
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 280 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 150/276 (54%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 48  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 107
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 108 YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 164
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ DFGLAR        Y        Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 165 EDXELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 221
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 222 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM----PKMNFAN 277
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 278 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 313

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 101/276 (36%), Positives = 150/276 (54%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 43  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 102
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 103 YLVTHLMGADLNNIVKSQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 159
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           + + +K+ DFGL R        Y        Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 160 EDSELKILDFGLCRHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM----PKMNFAN 272
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 273 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 150/276 (54%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 50  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 109
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 110 YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 166
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ DFGLAR        Y        Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 167 EDCELKILDFGLARHTADEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 223
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 224 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM----PKMNFAN 279
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 280 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 151/276 (54%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 43  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 102
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 103 YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 159
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ DFGLAR       E +       Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 160 EDCELKILDFGLARHT---DDEMTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM----PKMNFAN 272
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 273 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 150/276 (54%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 48  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 107
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 108 YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 164
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ DFGLAR        Y        Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 165 EDXELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 221
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 222 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM----PKMNFAN 277
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 278 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 313

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 150/276 (54%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 39  DTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 98
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 99  YLVTHLMGADLNNIVKCAKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 155
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ DFGLAR        Y        Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 156 EDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 212
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 213 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQM----PKMNFAN 268
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 269 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 150/276 (54%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 50  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 109
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 110 YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 166
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ DFGLAR        Y        Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 167 EDCELKILDFGLARHTADEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 223
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 224 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM----PKMNFAN 279
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 280 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 150/276 (54%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 54  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 113
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 114 YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 170
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ DFGLAR        Y        Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 171 EDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 227
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 228 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM----PKMNFAN 283
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 284 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 319

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 150/276 (54%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 41  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 100
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 101 YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 157
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ DFGLAR        Y        Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 158 EDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 214
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 215 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM----PKMNFAN 270
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 271 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 306

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 150/276 (54%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 49  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 108
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 109 YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 165
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ DFGLAR        Y        Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 166 EDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 222
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 223 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM----PKMNFAN 278
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 279 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 314

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 150/276 (54%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 55  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 114
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 115 YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 171
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ DFGLAR        Y        Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 172 EDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 228
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 229 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM----PKMNFAN 284
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 285 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 320

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 150/276 (54%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 63  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 122
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 123 YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 179
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ DFGLAR        Y        Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 180 EDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 236
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 237 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM----PKMNFAN 292
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 293 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 328

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 150/276 (54%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 55  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 114
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 115 YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 171
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ DFGLAR        Y        Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 172 EDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 228
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 229 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM----PKMNFAN 284
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 285 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 320

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 101/269 (37%), Positives = 142/269 (52%), Gaps = 15/269 (5%)
Query: 31  TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DVFLV 84
           TG KVAIK +    + E       RE+ LLK + HEN++ LLDV +  +      D +LV
Sbjct: 49  TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV 108
Query: 85  FEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN 144
             ++  DL   +   K  L    I+ ++ Q+L GL Y H+  I+HRDLKP NL ++ +  
Sbjct: 109 MPFMGTDLGKLMKHEK--LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN-EDC 165
Query: 145 TVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITG 204
            +K+ DFGLAR       E     V   Y+APE++L +  Y+  +D+W+VGCI AEMITG
Sbjct: 166 ELKILDFGLARQA---DSEMXGXVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 222
Query: 205 KPLFPSKKH-DHLSLIFSLLGTPTDE--SWAESTYISEILPLYPHFEPANLAEKFPNLEP 261
           K LF    H D L  I  + GTP  E     +S      +   P  E  + A    N  P
Sbjct: 223 KTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASP 282
Query: 262 AGVDLLSQMLCLNPKQRITAMDALKHEYL 290
             V+LL +ML L+ +QR+TA +AL H Y 
Sbjct: 283 LAVNLLEKMLVLDAEQRVTAGEALAHPYF 311

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 150/276 (54%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 43  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 102
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 103 YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 159
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ DFGLAR        Y        Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 160 EDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM----PKMNFAN 272
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 273 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 150/276 (54%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 43  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 102
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 103 YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 159
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ DFGLAR        Y        Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 160 EDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM----PKMNFAN 272
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 273 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 150/276 (54%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 43  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 102
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 103 YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 159
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ DFGLAR        Y        Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 160 EDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM----PKMNFAN 272
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 273 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 150/276 (54%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 55  DTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 114
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 115 YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 171
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ DFGLAR        Y        Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 172 EDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 228
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 229 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM----PKMNFAN 284
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 285 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 320

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 150/276 (54%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 43  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 102
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 103 YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 159
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ DFGLAR        Y        Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 160 EDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM----PKMNFAN 272
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 273 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 150/276 (54%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 48  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 107
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 108 YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 164
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ DFGLAR        Y        Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 165 EDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 221
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 222 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM----PKMNFAN 277
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 278 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 313

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 150/276 (54%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 48  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 107
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 108 YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 164
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ DFGLAR        Y        Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 165 EDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 221
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 222 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM----PKMNFAN 277
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 278 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 313

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 150/276 (54%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 42  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 101
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 102 YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 158
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ DFGLAR        Y        Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 159 EDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 215
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 216 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM----PKMNFAN 271
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 272 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 307

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 150/276 (54%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 62  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 121
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 122 YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 178
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ DFGLAR        Y        Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 179 EDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 235
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 236 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM----PKMNFAN 291
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 292 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 327

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 150/276 (54%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 43  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 102
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 103 YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 159
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ DFGLAR        Y        Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 160 EDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM----PKMNFAN 272
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 273 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 150/276 (54%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 50  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 109
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 110 YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 166
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ DFGLAR        Y        Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 167 EDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 223
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 224 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM----PKMNFAN 279
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 280 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 150/276 (54%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 43  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 102
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 103 YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 159
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ DFGLAR        Y        Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 160 EDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM----PKMNFAN 272
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 273 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 150/276 (54%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 45  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 104
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 105 YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 161
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ DFGLAR        Y        Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 162 EDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 218
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 219 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM----PKMNFAN 274
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 275 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 310

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 150/276 (54%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 39  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 98
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 99  YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 155
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ DFGLAR        Y        Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 156 EDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 212
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 213 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM----PKMNFAN 268
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 269 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  158 bits (400), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 150/276 (54%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 66  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 125
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 126 YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 182
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ DFGLAR        Y        Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 183 EDCELKILDFGLARHTDDEMXGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 239
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 240 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM----PKMNFAN 295
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 296 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 331

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  158 bits (400), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 151/276 (54%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 66  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 125
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 126 YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 182
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ DFGLAR       E +       Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 183 EDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 239
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 240 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM----PKMNFAN 295
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 296 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 331

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  158 bits (400), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 150/276 (54%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 43  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 102
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 103 YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 159
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ DFGLAR        Y        Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 160 EDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM----PKMNFAN 272
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 273 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  158 bits (400), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 150/276 (54%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 40  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 99
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 100 YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 156
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ DFGLAR        Y        Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 157 EDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 213
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 214 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM----PKMNFAN 269
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 270 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 305

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  158 bits (400), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 150/276 (54%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 45  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 104
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 105 YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 161
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ DFGLAR        Y        Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 162 EDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 218
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 219 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM----PKMNFAN 274
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 275 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 310

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  158 bits (400), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 150/276 (54%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 40  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 99
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 100 YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 156
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ DFGLAR        Y        Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 157 EDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 213
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 214 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM----PKMNFAN 269
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 270 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 305

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  158 bits (400), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 150/276 (54%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 45  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 104
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 105 YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 161
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ DFGLAR        Y        Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 162 EDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 218
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 219 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM----PKMNFAN 274
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 275 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 310

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  158 bits (400), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 150/276 (54%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 49  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 108
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 109 YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 165
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ DFGLAR        Y        Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 166 EDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 222
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 223 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM----PKMNFAN 278
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 279 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 314

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  157 bits (398), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 101/276 (36%), Positives = 150/276 (54%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 43  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 102
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 103 YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 159
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ D+GLAR        Y        Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 160 EDCELKILDYGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM----PKMNFAN 272
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 273 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  157 bits (397), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 149/276 (53%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 43  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 102
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 103 YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 159
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ DFGLAR        Y        Y+APE++L    Y+  +D+W+VGCI AE+
Sbjct: 160 EDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAEL 216
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM----PKMNFAN 272
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 273 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 101/276 (36%), Positives = 149/276 (53%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 43  DTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 102
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 103 YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 159
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ DF LAR        Y        Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 160 EDCELKILDFYLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM----PKMNFAN 272
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 273 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 101/276 (36%), Positives = 149/276 (53%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 43  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 102
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 103 YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 159
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+  FGLAR        Y        Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 160 EDCELKILGFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM----PKMNFAN 272
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 273 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  155 bits (392), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 101/276 (36%), Positives = 149/276 (53%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 43  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 102
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 103 YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 159
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ D GLAR        Y        Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 160 EDCELKILDAGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM----PKMNFAN 272
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 273 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  155 bits (392), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 101/276 (36%), Positives = 149/276 (53%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 43  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 102
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 103 YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 159
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ D GLAR        Y        Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 160 EDCELKILDRGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM----PKMNFAN 272
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 273 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  155 bits (391), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 101/276 (36%), Positives = 149/276 (53%), Gaps = 23/276 (8%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +T TG +VA+K ++   +         RE+ LLK ++HEN++ LLDV +  +      DV
Sbjct: 43  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 102
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV   +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ 
Sbjct: 103 YLVTHLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN- 159
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           +   +K+ D GLAR        Y        Y+APE++L +  Y+  +D+W+VGCI AE+
Sbjct: 160 EDCELKILDGGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAE 254
           +TG+ LFP   H D L LI  L+GTP  E      S +   YI  +  +       N A 
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM----PKMNFAN 272
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 273 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  154 bits (389), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 98/284 (34%), Positives = 155/284 (54%), Gaps = 25/284 (8%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR---- 78
           V    + V   +VAIK ++   E +      +RE+ +L    HEN++ + D+  +     
Sbjct: 59  VSSAYDHVRKTRVAIKKIS-PFEHQTYCQRTLREIQILLRFRHENVIGIRDILRASTLEA 117
Query: 79  -KDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
            +DV++V + ++ DL+  +   +  L+   I   L QIL GL Y HS  +LHRDLKP+NL
Sbjct: 118 MRDVYIVQDLMETDLYKLLKSQQ--LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNL 175
Query: 138 LIDLKRNTVKLADFGLARAIGVPQKEYS----RDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           LI+   + +K+ DFGLAR I  P+ +++           Y+APE++L   GY+  ID+W+
Sbjct: 176 LINTTCD-LKICDFGLAR-IADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWS 233
Query: 194 VGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPH 246
           VGCI AEM++ +P+FP K + D L+ I  +LG+P+ E      +     Y+  +    P 
Sbjct: 234 VGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINMKARNYLQSL----PS 289
Query: 247 FEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                 A+ FP  +   +DLL +ML  NP +RIT  +AL H YL
Sbjct: 290 KTKVAWAKLFPKSDSKALDLLDRMLTFNPNKRITVEEALAHPYL 333

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 101/282 (35%), Positives = 152/282 (53%), Gaps = 29/282 (10%)
Query: 31  TGQKVAIKMMTIQTEQEGVPSY---IIREVSLLKELEHENIVRLLDVQ-----SSRKDVF 82
           TG+ VAIK    + E    P +    +RE+ +LK  +HENI+ + ++Q      +  +V+
Sbjct: 35  TGEIVAIK----KIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY 90
Query: 83  LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK 142
           ++ E +  DLH  I+     L+   I+  + Q L  +   H   ++HRDLKP+NLLI+  
Sbjct: 91  IIQELMQTDLHRVIS--TQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLIN-S 147
Query: 143 RNTVKLADFGLARAI-------GVPQKEYSRDCVYSP---YKAPELLLGYTGYSTPIDVW 192
              +K+ DFGLAR I         P  + S    Y     Y+APE++L    YS  +DVW
Sbjct: 148 NCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVW 207
Query: 193 AVGCIFAEMITGKPLFPSKKHDH-LSLIFSLLGTP---TDESWAESTYISEILPLYPHFE 248
           + GCI AE+   +P+FP + + H L LIF ++GTP    D    ES    E +   P + 
Sbjct: 208 SCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYP 267
Query: 249 PANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            A L + FP + P G+DLL +ML  +P +RITA +AL+H YL
Sbjct: 268 AAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  153 bits (386), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 99/282 (35%), Positives = 150/282 (53%), Gaps = 29/282 (10%)
Query: 31  TGQKVAIKMMTIQTEQEGVPSY---IIREVSLLKELEHENIVRLLDVQ-----SSRKDVF 82
           TG+ VAIK    + E    P +    +RE+ +LK  +HENI+ + ++Q      +  +V+
Sbjct: 35  TGEIVAIK----KIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY 90
Query: 83  LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK 142
           ++ E +  DLH  I+     L+   I+  + Q L  +   H   ++HRDLKP+NLLI+  
Sbjct: 91  IIQELMQTDLHRVIS--TQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLIN-S 147
Query: 143 RNTVKLADFGLARAIGVP----------QKEYSRDCVYSPYKAPELLLGYTGYSTPIDVW 192
              +K+ DFGLAR I             Q   +       Y+APE++L    YS  +DVW
Sbjct: 148 NCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVW 207
Query: 193 AVGCIFAEMITGKPLFPSKKHDH-LSLIFSLLGTP---TDESWAESTYISEILPLYPHFE 248
           + GCI AE+   +P+FP + + H L LIF ++GTP    D    ES    E +   P + 
Sbjct: 208 SCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYP 267
Query: 249 PANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            A L + FP + P G+DLL +ML  +P +RITA +AL+H YL
Sbjct: 268 AAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 99/282 (35%), Positives = 150/282 (53%), Gaps = 29/282 (10%)
Query: 31  TGQKVAIKMMTIQTEQEGVPSY---IIREVSLLKELEHENIVRLLDVQ-----SSRKDVF 82
           TG+ VAIK    + E    P +    +RE+ +LK  +HENI+ + ++Q      +  +V+
Sbjct: 35  TGEIVAIK----KIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY 90
Query: 83  LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK 142
           ++ E +  DLH  I+     L+   I+  + Q L  +   H   ++HRDLKP+NLLI+  
Sbjct: 91  IIQELMQTDLHRVIS--TQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLIN-S 147
Query: 143 RNTVKLADFGLARAIGVPQKEYSRDCVYSP----------YKAPELLLGYTGYSTPIDVW 192
              +K+ DFGLAR I     + S                 Y+APE++L    YS  +DVW
Sbjct: 148 NCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVW 207
Query: 193 AVGCIFAEMITGKPLFPSKKHDH-LSLIFSLLGTP---TDESWAESTYISEILPLYPHFE 248
           + GCI AE+   +P+FP + + H L LIF ++GTP    D    ES    E +   P + 
Sbjct: 208 SCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYP 267
Query: 249 PANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            A L + FP + P G+DLL +ML  +P +RITA +AL+H YL
Sbjct: 268 AAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 94/281 (33%), Positives = 148/281 (52%), Gaps = 15/281 (5%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDV------QS 76
           V   R  +TGQ+VAIK +    +        +RE+ +LK  +H+NI+ + D+        
Sbjct: 70  VSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYG 129
Query: 77  SRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNN 136
             K V++V + ++ DLH  I      L L  ++  L Q+L GL Y HS +++HRDLKP+N
Sbjct: 130 EFKSVYVVLDLMESDLHQII-HSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSN 188
Query: 137 LLIDLKRNTVKLADFGLARAIGVPQKEY----SRDCVYSPYKAPELLLGYTGYSTPIDVW 192
           LL++ +   +K+ DFG+AR +     E+    +       Y+APEL+L    Y+  ID+W
Sbjct: 189 LLVN-ENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLW 247
Query: 193 AVGCIFAEMITGKPLFPSKKHDH-LSLIFSLLGTPTDE--SWAESTYISEILPLYPHFEP 249
           +VGCIF EM+  + LFP K + H L LI  +LGTP+        +  +   +   P  +P
Sbjct: 248 SVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQP 307
Query: 250 ANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                 +P  +   + LL +ML   P  RI+A  AL+H +L
Sbjct: 308 VPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFL 348

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  152 bits (384), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 97/276 (35%), Positives = 151/276 (54%), Gaps = 19/276 (6%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS-----RKDVF 82
           + V   +VAIK ++   E +      +RE+ +L    HENI+ + D+  +      KDV+
Sbjct: 44  DNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 102
Query: 83  LVFEYLDLDLHSFI-TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +V + ++ DL+  + T+H +  ++      L QIL GL Y HS  +LHRDLKP+NLL++ 
Sbjct: 103 IVQDLMETDLYKLLKTQHLSNDHICYF---LYQILRGLKYIHSANVLHRDLKPSNLLLNT 159
Query: 142 KRNTVKLADFGLARAIGVPQKEYS----RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCI 197
             + +K+ DFGLAR +  P  +++           Y+APE++L   GY+  ID+W+VGCI
Sbjct: 160 TXD-LKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCI 217
Query: 198 FAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAE--STYISEILPLYPHFEPANLAE 254
            AEM++ +P+FP K + D L+ I  +LG+P+ E      +      L   PH        
Sbjct: 218 LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKARNYLLSLPHKNKVPWNR 277
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            FPN +   +DLL +ML  NP +RI    AL H YL
Sbjct: 278 LFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 313

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  152 bits (384), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 97/276 (35%), Positives = 152/276 (55%), Gaps = 19/276 (6%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS-----RKDVF 82
           + V   +VAIK ++   E +      +RE+ +L    HENI+ + D+  +      KDV+
Sbjct: 46  DNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILLAFRHENIIGINDIIRAPTIEQMKDVY 104
Query: 83  LVFEYLDLDLHSFI-TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +V + ++ DL+  + T+H +  ++      L QIL GL Y HS  +LHRDLKP+NLL++ 
Sbjct: 105 IVQDLMETDLYKLLKTQHLSNDHICYF---LYQILRGLKYIHSANVLHRDLKPSNLLLNT 161
Query: 142 KRNTVKLADFGLARAIGVPQKEYS----RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCI 197
             + +K+ DFGLAR +  P  +++           Y+APE++L   GY+  ID+W+VGCI
Sbjct: 162 TSD-LKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCI 219
Query: 198 FAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDE--SWAESTYISEILPLYPHFEPANLAE 254
            AEM++ +P+FP K + D L+ I  +LG+P+ E  +   +      L   PH        
Sbjct: 220 LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCGINLKARNYLLSLPHKNKVPWNR 279
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            FPN +   +DLL +ML  NP +RI    AL H YL
Sbjct: 280 LFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 315

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  152 bits (384), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 97/276 (35%), Positives = 151/276 (54%), Gaps = 19/276 (6%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS-----RKDVF 82
           + V   +VAIK ++   E +      +RE+ +L    HENI+ + D+  +      KDV+
Sbjct: 44  DNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 102
Query: 83  LVFEYLDLDLHSFI-TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +V + ++ DL+  + T+H +  ++      L QIL GL Y HS  +LHRDLKP+NLL++ 
Sbjct: 103 IVQDLMETDLYKLLKTQHLSNDHICYF---LYQILRGLKYIHSANVLHRDLKPSNLLLNT 159
Query: 142 KRNTVKLADFGLARAIGVPQKEYS----RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCI 197
             + +K+ DFGLAR +  P  +++           Y+APE++L   GY+  ID+W+VGCI
Sbjct: 160 TXD-LKIXDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCI 217
Query: 198 FAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAE--STYISEILPLYPHFEPANLAE 254
            AEM++ +P+FP K + D L+ I  +LG+P+ E      +      L   PH        
Sbjct: 218 LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKARNYLLSLPHKNKVPWNR 277
Query: 255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            FPN +   +DLL +ML  NP +RI    AL H YL
Sbjct: 278 LFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 313

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 94/281 (33%), Positives = 148/281 (52%), Gaps = 15/281 (5%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDV------QS 76
           V   R  +TGQ+VAIK +    +        +RE+ +LK  +H+NI+ + D+        
Sbjct: 71  VSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYG 130
Query: 77  SRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNN 136
             K V++V + ++ DLH  I      L L  ++  L Q+L GL Y HS +++HRDLKP+N
Sbjct: 131 EFKSVYVVLDLMESDLHQII-HSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSN 189
Query: 137 LLIDLKRNTVKLADFGLARAIGVPQKEY----SRDCVYSPYKAPELLLGYTGYSTPIDVW 192
           LL++ +   +K+ DFG+AR +     E+    +       Y+APEL+L    Y+  ID+W
Sbjct: 190 LLVN-ENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLW 248
Query: 193 AVGCIFAEMITGKPLFPSKKHDH-LSLIFSLLGTPTDE--SWAESTYISEILPLYPHFEP 249
           +VGCIF EM+  + LFP K + H L LI  +LGTP+        +  +   +   P  +P
Sbjct: 249 SVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQP 308
Query: 250 ANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                 +P  +   + LL +ML   P  RI+A  AL+H +L
Sbjct: 309 VPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFL 349

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  152 bits (383), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 97/280 (34%), Positives = 153/280 (54%), Gaps = 27/280 (9%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS-----RKDVF 82
           + V   +VAIK ++   E +      +RE+ +L    HENI+ + D+  +      KDV+
Sbjct: 44  DNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 102
Query: 83  LVFEYLDLDLHSFI-TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +V + ++ DL+  + T+H +  ++      L QIL GL Y HS  +LHRDLKP+NLL++ 
Sbjct: 103 IVQDLMETDLYKLLKTQHLSNDHICYF---LYQILRGLKYIHSANVLHRDLKPSNLLLNT 159
Query: 142 KRNTVKLADFGLARAIGVPQKEYS----RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCI 197
             + +K+ DFGLAR +  P  +++           Y+APE++L   GY+  ID+W+VGCI
Sbjct: 160 TXD-LKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCI 217
Query: 198 FAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPA 250
            AEM++ +P+FP K + D L+ I  +LG+P+ E      +     Y+  +    PH    
Sbjct: 218 LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL----PHKNKV 273
Query: 251 NLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                FPN +   +DLL +ML  NP +RI    AL H YL
Sbjct: 274 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 313

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 99/280 (35%), Positives = 151/280 (53%), Gaps = 27/280 (9%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS-----RKDVF 82
           + V   +VAIK ++   E +      +RE+ +L    HENI+ + D+  +      KDV+
Sbjct: 64  DNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 122
Query: 83  LVFEYLDLDLHSFI-TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           LV   +  DL+  + T+H +  +   I   L QIL GL Y HS  +LHRDLKP+NLL++ 
Sbjct: 123 LVTHLMGADLYKLLKTQHLSNDH---ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 179
Query: 142 KRNTVKLADFGLARAIGVPQKEYS----RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCI 197
             + +K+ DFGLAR +  P  +++           Y+APE++L   GY+  ID+W+VGCI
Sbjct: 180 TXD-LKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCI 237
Query: 198 FAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPA 250
            AEM++ +P+FP K + D L+ I  +LG+P+ E      +     Y+  +    PH    
Sbjct: 238 LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL----PHKNKV 293
Query: 251 NLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                FPN +   +DLL +ML  NP +RI    AL H YL
Sbjct: 294 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 333

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  151 bits (381), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 98/274 (35%), Positives = 151/274 (55%), Gaps = 27/274 (9%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS-----RKDVFLVFEYL 88
           +VAIK ++   E +      +RE+ +L    HENI+ + D+  +      KDV++V + +
Sbjct: 54  RVAIKKIS-PFEHQTYXQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 112
Query: 89  DLDLHSFI-TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVK 147
           + DL+  + T+H   L+   I   L QIL GL Y HS  +LHRDLKP+NLL++   + +K
Sbjct: 113 ETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXD-LK 168
Query: 148 LADFGLARAIGVPQKEYS----RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           + DFGLAR +  P  +++           Y+APE++L   GY+  ID+W+VGCI AEM++
Sbjct: 169 ICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 227
Query: 204 GKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAEKF 256
            +P+FP K + D L+ I  +LG+P+ E      +     Y+  +    PH         F
Sbjct: 228 NRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL----PHKNKVPWNRLF 283
Query: 257 PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           PN +   +DLL +ML  NP +RI    AL H YL
Sbjct: 284 PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  151 bits (381), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 99/273 (36%), Positives = 147/273 (53%), Gaps = 24/273 (8%)
Query: 31  TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDV---QSSRK---DVFLV 84
           +G+KVAIK ++   + E       RE+ LLK ++HEN++ LLDV    SS +   D +LV
Sbjct: 66  SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLV 125
Query: 85  FEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN 144
             ++  DL   +       +   I+ ++ Q+L GL Y HS  ++HRDLKP NL ++ +  
Sbjct: 126 MPFMQTDLQKIMGME---FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN-EDC 181
Query: 145 TVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITG 204
            +K+ DFGLAR        Y    V   Y+APE++L +  Y+  +D+W+VGCI AEM+TG
Sbjct: 182 ELKILDFGLARHADAEMTGY---VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 238
Query: 205 KPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAEKFP 257
           K LF  K + D L+ I  + G P  E        A  +YI + LP  P     +  + FP
Sbjct: 239 KTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYI-QSLPQTPR---KDFTQLFP 294
Query: 258 NLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
              P   DLL +ML L+  +R+TA  AL H + 
Sbjct: 295 RASPQAADLLEKMLELDVDKRLTAAQALTHPFF 327

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  151 bits (381), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 97/280 (34%), Positives = 153/280 (54%), Gaps = 27/280 (9%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS-----RKDVF 82
           + V   +VAIK ++   E +      +RE+ +L    HENI+ + D+  +      KDV+
Sbjct: 44  DNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 102
Query: 83  LVFEYLDLDLHSFI-TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +V + ++ DL+  + T+H +  ++      L QIL GL Y HS  +LHRDLKP+NLL++ 
Sbjct: 103 IVQDLMETDLYKLLKTQHLSNDHICYF---LYQILRGLKYIHSANVLHRDLKPSNLLLNT 159
Query: 142 KRNTVKLADFGLARAIGVPQKEYS----RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCI 197
             + +K+ DFGLAR +  P  +++           Y+APE++L   GY+  ID+W+VGCI
Sbjct: 160 TCD-LKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCI 217
Query: 198 FAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPA 250
            AEM++ +P+FP K + D L+ I  +LG+P+ E      +     Y+  +    PH    
Sbjct: 218 LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL----PHKNKV 273
Query: 251 NLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                FPN +   +DLL +ML  NP +RI    AL H YL
Sbjct: 274 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 313

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  150 bits (380), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 97/280 (34%), Positives = 153/280 (54%), Gaps = 27/280 (9%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS-----RKDVF 82
           + V   +VAIK ++   E +      +RE+ +L    HENI+ + D+  +      KDV+
Sbjct: 46  DNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 104
Query: 83  LVFEYLDLDLHSFI-TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +V + ++ DL+  + T+H +  ++      L QIL GL Y HS  +LHRDLKP+NLL++ 
Sbjct: 105 IVQDLMETDLYKLLKTQHLSNDHICYF---LYQILRGLKYIHSANVLHRDLKPSNLLLNT 161
Query: 142 KRNTVKLADFGLARAIGVPQKEYS----RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCI 197
             + +K+ DFGLAR +  P  +++           Y+APE++L   GY+  ID+W+VGCI
Sbjct: 162 TCD-LKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCI 219
Query: 198 FAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPA 250
            AEM++ +P+FP K + D L+ I  +LG+P+ E      +     Y+  +    PH    
Sbjct: 220 LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL----PHKNKV 275
Query: 251 NLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                FPN +   +DLL +ML  NP +RI    AL H YL
Sbjct: 276 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 315

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  150 bits (380), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 97/280 (34%), Positives = 153/280 (54%), Gaps = 27/280 (9%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS-----RKDVF 82
           + V   +VAIK ++   E +      +RE+ +L    HENI+ + D+  +      KDV+
Sbjct: 64  DNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 122
Query: 83  LVFEYLDLDLHSFI-TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +V + ++ DL+  + T+H +  ++      L QIL GL Y HS  +LHRDLKP+NLL++ 
Sbjct: 123 IVQDLMETDLYKLLKTQHLSNDHICYF---LYQILRGLKYIHSANVLHRDLKPSNLLLNT 179
Query: 142 KRNTVKLADFGLARAIGVPQKEYS----RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCI 197
             + +K+ DFGLAR +  P  +++           Y+APE++L   GY+  ID+W+VGCI
Sbjct: 180 TCD-LKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCI 237
Query: 198 FAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPA 250
            AEM++ +P+FP K + D L+ I  +LG+P+ E      +     Y+  +    PH    
Sbjct: 238 LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL----PHKNKV 293
Query: 251 NLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                FPN +   +DLL +ML  NP +RI    AL H YL
Sbjct: 294 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 333

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  150 bits (380), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 98/280 (35%), Positives = 153/280 (54%), Gaps = 27/280 (9%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS-----RKDVF 82
           + V   +VAIK ++   E +      +RE+ +L    HENI+ + D+  +      KDV+
Sbjct: 52  DNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 110
Query: 83  LVFEYLDLDLHSFI-TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +V + ++ DL+  + T+H +  +   I   L QIL GL Y HS  +LHRDLKP+NLL++ 
Sbjct: 111 IVQDLMETDLYKLLKTQHLSNDH---ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 167
Query: 142 KRNTVKLADFGLARAIGVPQKEYS----RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCI 197
             + +K+ DFGLAR +  P  +++           Y+APE++L   GY+  ID+W+VGCI
Sbjct: 168 TCD-LKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCI 225
Query: 198 FAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPA 250
            AEM++ +P+FP K + D L+ I  +LG+P+ E      +     Y+  +    PH    
Sbjct: 226 LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL----PHKNKV 281
Query: 251 NLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                FPN +   +DLL +ML  NP +RI    AL H YL
Sbjct: 282 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 321

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  150 bits (380), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 98/280 (35%), Positives = 153/280 (54%), Gaps = 27/280 (9%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS-----RKDVF 82
           + V   +VAIK ++   E +      +RE+ +L    HENI+ + D+  +      KDV+
Sbjct: 44  DNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 102
Query: 83  LVFEYLDLDLHSFI-TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +V + ++ DL+  + T+H +  +   I   L QIL GL Y HS  +LHRDLKP+NLL++ 
Sbjct: 103 IVQDLMETDLYKLLKTQHLSNDH---ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 159
Query: 142 KRNTVKLADFGLARAIGVPQKEYS----RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCI 197
             + +K+ DFGLAR +  P  +++           Y+APE++L   GY+  ID+W+VGCI
Sbjct: 160 TCD-LKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCI 217
Query: 198 FAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPA 250
            AEM++ +P+FP K + D L+ I  +LG+P+ E      +     Y+  +    PH    
Sbjct: 218 LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL----PHKNKV 273
Query: 251 NLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                FPN +   +DLL +ML  NP +RI    AL H YL
Sbjct: 274 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 313

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  150 bits (380), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 98/274 (35%), Positives = 151/274 (55%), Gaps = 27/274 (9%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS-----RKDVFLVFEYL 88
           +VAIK ++   E +      +RE+ +L    HENI+ + D+  +      KDV++V + +
Sbjct: 54  RVAIKKIS-PFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 112
Query: 89  DLDLHSFI-TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVK 147
           + DL+  + T+H   L+   I   L QIL GL Y HS  +LHRDLKP+NLL++   + +K
Sbjct: 113 ETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXD-LK 168
Query: 148 LADFGLARAIGVPQKEYS----RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           + DFGLAR +  P  +++           Y+APE++L   GY+  ID+W+VGCI AEM++
Sbjct: 169 ICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 227
Query: 204 GKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAEKF 256
            +P+FP K + D L+ I  +LG+P+ E      +     Y+  +    PH         F
Sbjct: 228 NRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL----PHKNKVPWNRLF 283
Query: 257 PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           PN +   +DLL +ML  NP +RI    AL H YL
Sbjct: 284 PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  150 bits (380), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 98/273 (35%), Positives = 146/273 (53%), Gaps = 23/273 (8%)
Query: 31  TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR------KDVFLV 84
           +G K+A+K ++   +         RE+ LLK ++HEN++ LLDV +         DV+LV
Sbjct: 75  SGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLV 134
Query: 85  FEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN 144
              +  DL++ +   K T +   ++ ++ QIL GL Y HS  I+HRDLKP+NL ++ +  
Sbjct: 135 THLMGADLNNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDC 191
Query: 145 TVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITG 204
            +K+ DFGLAR        Y        Y+APE++L +  Y+  +D+W+VGCI AE++TG
Sbjct: 192 ELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTG 248
Query: 205 KPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAEKFP 257
           + LFP   H + L  I  L GTP         S     YI+ +    P     N A+ F 
Sbjct: 249 RTLFPGTDHINQLQQIMRLTGTPPASVISRMPSHEARNYINSL----PQMPKRNFADVFI 304
Query: 258 NLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
              P  VDLL +ML L+  +RITA +AL H Y 
Sbjct: 305 GANPLAVDLLEKMLVLDTDKRITASEALAHPYF 337

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  150 bits (380), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 97/280 (34%), Positives = 153/280 (54%), Gaps = 27/280 (9%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS-----RKDVF 82
           + V   +VAIK ++   E +      +RE+ +L    HENI+ + D+  +      KDV+
Sbjct: 46  DNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILLAFRHENIIGINDIIRAPTIEQMKDVY 104
Query: 83  LVFEYLDLDLHSFI-TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +V + ++ DL+  + T+H +  ++      L QIL GL Y HS  +LHRDLKP+NLL++ 
Sbjct: 105 IVQDLMETDLYKLLKTQHLSNDHICYF---LYQILRGLKYIHSANVLHRDLKPSNLLLNT 161
Query: 142 KRNTVKLADFGLARAIGVPQKEYS----RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCI 197
             + +K+ DFGLAR +  P  +++           Y+APE++L   GY+  ID+W+VGCI
Sbjct: 162 TCD-LKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCI 219
Query: 198 FAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPA 250
            AEM++ +P+FP K + D L+ I  +LG+P+ E      +     Y+  +    PH    
Sbjct: 220 LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL----PHKNKV 275
Query: 251 NLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                FPN +   +DLL +ML  NP +RI    AL H YL
Sbjct: 276 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 315

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  150 bits (380), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 96/274 (35%), Positives = 151/274 (55%), Gaps = 27/274 (9%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS-----RKDVFLVFEYL 88
           +VAIK ++   E +      +RE+ +L    HENI+ + D+  +      KDV++V + +
Sbjct: 54  RVAIKKIS-PFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 112
Query: 89  DLDLHSFI-TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVK 147
           + DL+  + T+H +  ++      L QIL GL Y HS  +LHRDLKP+NLL++   + +K
Sbjct: 113 ETDLYKLLKTQHLSNDHICYF---LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD-LK 168
Query: 148 LADFGLARAIGVPQKEYS----RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           + DFGLAR +  P  +++           Y+APE++L   GY+  ID+W+VGCI AEM++
Sbjct: 169 ICDFGLAR-VADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 227
Query: 204 GKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAEKF 256
            +P+FP K + D L+ I  +LG+P+ E      +     Y+  +    PH         F
Sbjct: 228 NRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL----PHKNKVPWNRLF 283
Query: 257 PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           PN +   +DLL +ML  NP +RI    AL H YL
Sbjct: 284 PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  150 bits (380), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 96/274 (35%), Positives = 151/274 (55%), Gaps = 27/274 (9%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS-----RKDVFLVFEYL 88
           +VAIK ++   E +      +RE+ +L    HENI+ + D+  +      KDV++V + +
Sbjct: 55  RVAIKKIS-PFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 113
Query: 89  DLDLHSFI-TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVK 147
           + DL+  + T+H +  ++      L QIL GL Y HS  +LHRDLKP+NLL++   + +K
Sbjct: 114 ETDLYKLLKTQHLSNDHICYF---LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD-LK 169
Query: 148 LADFGLARAIGVPQKEYS----RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           + DFGLAR +  P  +++           Y+APE++L   GY+  ID+W+VGCI AEM++
Sbjct: 170 ICDFGLAR-VADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 228
Query: 204 GKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAEKF 256
            +P+FP K + D L+ I  +LG+P+ E      +     Y+  +    PH         F
Sbjct: 229 NRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL----PHKNKVPWNRLF 284
Query: 257 PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           PN +   +DLL +ML  NP +RI    AL H YL
Sbjct: 285 PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 318

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 99/273 (36%), Positives = 147/273 (53%), Gaps = 24/273 (8%)
Query: 31  TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDV---QSSRK---DVFLV 84
           +G+KVAIK ++   + E       RE+ LLK ++HEN++ LLDV    SS +   D +LV
Sbjct: 48  SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLV 107
Query: 85  FEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN 144
             ++  DL   +       +   I+ ++ Q+L GL Y HS  ++HRDLKP NL ++ +  
Sbjct: 108 MPFMQTDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN-EDC 163
Query: 145 TVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITG 204
            +K+ DFGLAR        Y    V   Y+APE++L +  Y+  +D+W+VGCI AEM+TG
Sbjct: 164 ELKILDFGLARHADAEMTGY---VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 220
Query: 205 KPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAEKFP 257
           K LF  K + D L+ I  + G P  E        A  +YI + LP  P     +  + FP
Sbjct: 221 KTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYI-QSLPQTPR---KDFTQLFP 276
Query: 258 NLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
              P   DLL +ML L+  +R+TA  AL H + 
Sbjct: 277 RASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 96/271 (35%), Positives = 154/271 (56%), Gaps = 23/271 (8%)
Query: 33  QKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDV---QSSRKD---VFLVFE 86
           QKVA+K ++   +         RE+ LLK L+HEN++ LLDV    +S +D   V+LV  
Sbjct: 54  QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTT 113
Query: 87  YLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTV 146
            +  DL++ +      L+   ++ ++ Q+L GL Y HS  I+HRDLKP+N+ ++ + + +
Sbjct: 114 LMGADLNNIVK--SQALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVN-EDSEL 170
Query: 147 KLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKP 206
           ++ DFGLAR      +E +       Y+APE++L +  Y+  +D+W+VGCI AE++ GK 
Sbjct: 171 RILDFGLARQA---DEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKA 227
Query: 207 LFPSKKH-DHLSLIFSLLGTPTDESWAE------STYISEILPLYPHFEPANLAEKFPNL 259
           LFP   + D L  I  ++GTP+ E  A+       TYI  + P+ P     +L+  F   
Sbjct: 228 LFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLPPM-PQ---KDLSSIFRGA 283
Query: 260 EPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            P  +DLL +ML L+  QR++A +AL H Y 
Sbjct: 284 NPLAIDLLGRMLVLDSDQRVSAAEALAHAYF 314

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  150 bits (378), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 98/274 (35%), Positives = 151/274 (55%), Gaps = 27/274 (9%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS-----RKDVFLVFEYL 88
           +VAIK ++   E +      +RE+ +L    HENI+ + D+  +      KDV++V + +
Sbjct: 55  RVAIKKIS-PFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 113
Query: 89  DLDLHSFI-TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVK 147
           + DL+  + T+H   L+   I   L QIL GL Y HS  +LHRDLKP+NLL++   + +K
Sbjct: 114 ETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD-LK 169
Query: 148 LADFGLARAIGVPQKEYS----RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           + DFGLAR +  P  +++           Y+APE++L   GY+  ID+W+VGCI AEM++
Sbjct: 170 ICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 228
Query: 204 GKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAEKF 256
            +P+FP K + D L+ I  +LG+P+ E      +     Y+  +    PH         F
Sbjct: 229 NRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL----PHKNKVPWNRLF 284
Query: 257 PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           PN +   +DLL +ML  NP +RI    AL H YL
Sbjct: 285 PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 318

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  150 bits (378), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 98/274 (35%), Positives = 151/274 (55%), Gaps = 27/274 (9%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS-----RKDVFLVFEYL 88
           +VAIK ++   E +      +RE+ +L    HENI+ + D+  +      KDV++V + +
Sbjct: 56  RVAIKKIS-PFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 114
Query: 89  DLDLHSFI-TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVK 147
           + DL+  + T+H   L+   I   L QIL GL Y HS  +LHRDLKP+NLL++   + +K
Sbjct: 115 ETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD-LK 170
Query: 148 LADFGLARAIGVPQKEYS----RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           + DFGLAR +  P  +++           Y+APE++L   GY+  ID+W+VGCI AEM++
Sbjct: 171 ICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 229
Query: 204 GKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAEKF 256
            +P+FP K + D L+ I  +LG+P+ E      +     Y+  +    PH         F
Sbjct: 230 NRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL----PHKNKVPWNRLF 285
Query: 257 PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           PN +   +DLL +ML  NP +RI    AL H YL
Sbjct: 286 PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 319

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  150 bits (378), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 98/274 (35%), Positives = 151/274 (55%), Gaps = 27/274 (9%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS-----RKDVFLVFEYL 88
           +VAIK ++   E +      +RE+ +L    HENI+ + D+  +      KDV++V + +
Sbjct: 47  RVAIKKIS-PFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 105
Query: 89  DLDLHSFI-TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVK 147
           + DL+  + T+H   L+   I   L QIL GL Y HS  +LHRDLKP+NLL++   + +K
Sbjct: 106 ETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD-LK 161
Query: 148 LADFGLARAIGVPQKEYS----RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           + DFGLAR +  P  +++           Y+APE++L   GY+  ID+W+VGCI AEM++
Sbjct: 162 ICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 220
Query: 204 GKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAEKF 256
            +P+FP K + D L+ I  +LG+P+ E      +     Y+  +    PH         F
Sbjct: 221 NRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL----PHKNKVPWNRLF 276
Query: 257 PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           PN +   +DLL +ML  NP +RI    AL H YL
Sbjct: 277 PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 310

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  150 bits (378), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 98/274 (35%), Positives = 151/274 (55%), Gaps = 27/274 (9%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS-----RKDVFLVFEYL 88
           +VAIK ++   E +      +RE+ +L    HENI+ + D+  +      KDV++V + +
Sbjct: 54  RVAIKKIS-PFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 112
Query: 89  DLDLHSFI-TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVK 147
           + DL+  + T+H   L+   I   L QIL GL Y HS  +LHRDLKP+NLL++   + +K
Sbjct: 113 ETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD-LK 168
Query: 148 LADFGLARAIGVPQKEYS----RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           + DFGLAR +  P  +++           Y+APE++L   GY+  ID+W+VGCI AEM++
Sbjct: 169 ICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 227
Query: 204 GKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAEKF 256
            +P+FP K + D L+ I  +LG+P+ E      +     Y+  +    PH         F
Sbjct: 228 NRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL----PHKNKVPWNRLF 283
Query: 257 PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           PN +   +DLL +ML  NP +RI    AL H YL
Sbjct: 284 PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  150 bits (378), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 97/274 (35%), Positives = 151/274 (55%), Gaps = 27/274 (9%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS-----RKDVFLVFEYL 88
           +VAIK ++   E +      +RE+ +L    HENI+ + D+  +      KDV++V + +
Sbjct: 48  RVAIKKIS-PFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 106
Query: 89  DLDLHSFI-TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVK 147
           + DL+  + T+H +  +   I   L QIL GL Y HS  +LHRDLKP+NLL++   + +K
Sbjct: 107 ETDLYKLLKTQHLSNDH---ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD-LK 162
Query: 148 LADFGLARAIGVPQKEYS----RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           + DFGLAR +  P  +++           Y+APE++L   GY+  ID+W+VGCI AEM++
Sbjct: 163 ICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 221
Query: 204 GKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAEKF 256
            +P+FP K + D L+ I  +LG+P+ E      +     Y+  +    PH         F
Sbjct: 222 NRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL----PHKNKVPWNRLF 277
Query: 257 PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           PN +   +DLL +ML  NP +RI    AL H YL
Sbjct: 278 PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 311

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  149 bits (376), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 95/274 (34%), Positives = 151/274 (55%), Gaps = 27/274 (9%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS-----RKDVFLVFEYL 88
           +VAI+ ++   E +      +RE+ +L    HENI+ + D+  +      KDV++V + +
Sbjct: 54  RVAIRKIS-PFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 112
Query: 89  DLDLHSFI-TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVK 147
           + DL+  + T+H +  ++      L QIL GL Y HS  +LHRDLKP+NLL++   + +K
Sbjct: 113 ETDLYKLLKTQHLSNDHICYF---LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD-LK 168
Query: 148 LADFGLARAIGVPQKEYS----RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           + DFGLAR +  P  +++           Y+APE++L   GY+  ID+W+VGCI AEM++
Sbjct: 169 ICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 227
Query: 204 GKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAEKF 256
            +P+FP K + D L+ I  +LG+P+ E      +     Y+  +    PH         F
Sbjct: 228 NRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL----PHKNKVPWNRLF 283
Query: 257 PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           PN +   +DLL +ML  NP +RI    AL H YL
Sbjct: 284 PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  149 bits (375), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 97/274 (35%), Positives = 150/274 (54%), Gaps = 27/274 (9%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS-----RKDVFLVFEYL 88
           +VAIK ++   E +      +RE+ +L    HENI+ + D+  +      KDV++V + +
Sbjct: 48  RVAIKKIS-PFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 106
Query: 89  DLDLHSFI-TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVK 147
           + DL+  + T+H +  +   I   L QIL GL Y HS  +LHRDLKP+NLL++   + +K
Sbjct: 107 ETDLYKLLKTQHLSNDH---ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD-LK 162
Query: 148 LADFGLARAIGVPQKEYS----RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           + DFGLAR +  P  +++           Y+APE++L   GY+  ID+W+VGCI AEM++
Sbjct: 163 ICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 221
Query: 204 GKPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAEKF 256
            +P+FP K + D L+ I  +LG+P  E      +     Y+  +    PH         F
Sbjct: 222 NRPIFPGKHYLDQLNHILGILGSPEQEDLNCIINLKARNYLLSL----PHKNKVPWNRLF 277
Query: 257 PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           PN +   +DLL +ML  NP +RI    AL H YL
Sbjct: 278 PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 311

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  149 bits (375), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 96/271 (35%), Positives = 154/271 (56%), Gaps = 23/271 (8%)
Query: 33  QKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDV---QSSRKD---VFLVFE 86
           QKVA+K ++   +         RE+ LLK L+HEN++ LLDV    +S +D   V+LV  
Sbjct: 54  QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTT 113
Query: 87  YLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTV 146
            +  DL++ +      L+   ++ ++ Q+L GL Y HS  I+HRDLKP+N+ ++ + + +
Sbjct: 114 LMGADLNNIVK--CQALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVN-EDSEL 170
Query: 147 KLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKP 206
           ++ DFGLAR      +E +       Y+APE++L +  Y+  +D+W+VGCI AE++ GK 
Sbjct: 171 RILDFGLARQA---DEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKA 227
Query: 207 LFPSKKH-DHLSLIFSLLGTPTDESWAE------STYISEILPLYPHFEPANLAEKFPNL 259
           LFP   + D L  I  ++GTP+ E  A+       TYI  + P+ P     +L+  F   
Sbjct: 228 LFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLPPM-PQ---KDLSSIFRGA 283
Query: 260 EPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            P  +DLL +ML L+  QR++A +AL H Y 
Sbjct: 284 NPLAIDLLGRMLVLDSDQRVSAAEALAHAYF 314

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  148 bits (373), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 96/273 (35%), Positives = 148/273 (54%), Gaps = 25/273 (9%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS-----RKDVFLVFEYL 88
           +VAIK ++   E +      +RE+ +L    HENI+ + D+  +      KDV++V + +
Sbjct: 54  RVAIKKIS-PFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 112
Query: 89  DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKL 148
           + DL+  +      L+   I   L QIL GL Y HS  +LHRDLKP+NLL++   + +K+
Sbjct: 113 ETDLYKLLKCQH--LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD-LKI 169
Query: 149 ADFGLARAIGVPQKEYS----RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITG 204
            DFGLAR +  P  +++           Y+APE++L   GY+  ID+W+VGCI AEM++ 
Sbjct: 170 CDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228
Query: 205 KPLFPSKKH-DHLSLIFSLLGTPTDE------SWAESTYISEILPLYPHFEPANLAEKFP 257
           +P+FP K + D L+ I  +LG+P+ E      +     Y+  +    PH         FP
Sbjct: 229 RPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL----PHKNKVPWNRLFP 284
Query: 258 NLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           N +   +DLL +ML  NP +RI    AL H YL
Sbjct: 285 NADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  147 bits (370), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 96/271 (35%), Positives = 153/271 (56%), Gaps = 23/271 (8%)
Query: 33  QKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDV---QSSRKD---VFLVFE 86
           QKVA+K ++   +         RE+ LLK L+HEN++ LLDV    +S +D   V+LV  
Sbjct: 46  QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTT 105
Query: 87  YLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTV 146
            +  DL++ +      L+   ++ ++ Q+L GL Y HS  I+HRDLKP+N+ ++ +   +
Sbjct: 106 LMGADLNNIVK--CQALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVN-EDCEL 162
Query: 147 KLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKP 206
           ++ DFGLAR      +E +       Y+APE++L +  Y+  +D+W+VGCI AE++ GK 
Sbjct: 163 RILDFGLARQA---DEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKA 219
Query: 207 LFPSKKH-DHLSLIFSLLGTPTDESWAE------STYISEILPLYPHFEPANLAEKFPNL 259
           LFP   + D L  I  ++GTP+ E  A+       TYI  + P+ P     +L+  F   
Sbjct: 220 LFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLPPM-PQ---KDLSSIFRGA 275
Query: 260 EPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            P  +DLL +ML L+  QR++A +AL H Y 
Sbjct: 276 NPLAIDLLGRMLVLDSDQRVSAAEALAHAYF 306

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  147 bits (370), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 92/250 (36%), Positives = 139/250 (55%), Gaps = 19/250 (7%)
Query: 55  REVSLLKELEHENIVRLLDVQSSRKD----VFL--VFEYLDLDLHSFITRH----KNTLN 104
           RE+ +++ ++H N+V L     S  D    VFL  V EY+   ++   +RH    K T+ 
Sbjct: 81  RELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYR-ASRHYAKLKQTMP 139
Query: 105 LLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY 164
           +L+IK  + Q+L  LAY HS+ I HRD+KP NLL+D     +KL DFG A+ +   +   
Sbjct: 140 MLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNV 199
Query: 165 SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLL 223
           S  C    Y+APEL+ G T Y+T ID+W+ GC+ AE++ G+PLFP +   D L  I  +L
Sbjct: 200 SXICSRY-YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVL 258
Query: 224 GTPTDES--WAESTYISEILPLYPHFEPANLAEKF-PNLEPAGVDLLSQMLCLNPKQRIT 280
           GTP+ E        Y+      +P   P   ++ F P   P  +DL+S++L   P  R+T
Sbjct: 259 GTPSREQIKTMNPNYMEH---KFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLT 315
Query: 281 AMDALKHEYL 290
           A++AL H + 
Sbjct: 316 AIEALCHPFF 325

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score =  145 bits (366), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 97/284 (34%), Positives = 148/284 (52%), Gaps = 35/284 (12%)
Query: 43  QTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKD--VFLVFEYLDLDLHSFITRHK 100
           Q E  G+     RE++LL+EL+H N++ L  V  S  D  V+L+F+Y + DL   I  H+
Sbjct: 55  QIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHR 114
Query: 101 NT--------LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLI---DLKRNTVKLA 149
            +        L   ++K++L QIL G+ Y H+  +LHRDLKP N+L+     +R  VK+A
Sbjct: 115 ASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 174
Query: 150 DFGLARAIGVPQK---EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKP 206
           D G AR    P K   +     V   Y+APELLLG   Y+  ID+WA+GCIFAE++T +P
Sbjct: 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 234
Query: 207 LFPSKK----------HDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLA--- 253
           +F  ++          HD L  IF+++G P D+ W +   + E   L   F         
Sbjct: 235 IFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCS 294
Query: 254 -----EKFP-NLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLI 291
                EK     +     LL ++L ++P +RIT+  A++  Y +
Sbjct: 295 LIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFL 338

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  145 bits (365), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 98/284 (34%), Positives = 151/284 (53%), Gaps = 29/284 (10%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRL---LDVQSSRK 79
           VY+ +   +G+ VAIK + +Q ++     +  RE+ ++++L+H NIVRL         +K
Sbjct: 36  VYQAKLCDSGELVAIKKV-LQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK 89
Query: 80  DVF---LVFEYLDLDLHSFI---TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLK 133
           DV    LV +Y+   ++      +R K TL ++ +K  + Q+   LAY HS  I HRD+K
Sbjct: 90  DVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIK 149
Query: 134 PNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           P NLL+D     +KL DFG A+ +   +   S  C    Y+APEL+ G T Y++ IDVW+
Sbjct: 150 PQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGATDYTSSIDVWS 208
Query: 194 VGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFE-PAN 251
            GC+ AE++ G+P+FP     D L  I  +LGTPT E       I E+ P Y  F+ P  
Sbjct: 209 AGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ------IREMNPNYTEFKFPQI 262
Query: 252 LAEKF-----PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            A  +     P   P  + L S++L   P  R+T ++A  H + 
Sbjct: 263 KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  143 bits (361), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 97/284 (34%), Positives = 151/284 (53%), Gaps = 29/284 (10%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRL---LDVQSSRK 79
           VY+ +   +G+ VAIK + +Q ++     +  RE+ ++++L+H NIVRL         +K
Sbjct: 70  VYQAKLCDSGELVAIKKV-LQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK 123
Query: 80  D---VFLVFEYLDLDLHSFI---TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLK 133
           D   + LV +Y+   ++      +R K TL ++ +K  + Q+   LAY HS  I HRD+K
Sbjct: 124 DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIK 183
Query: 134 PNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           P NLL+D     +KL DFG A+ +   +   S  C    Y+APEL+ G T Y++ IDVW+
Sbjct: 184 PQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGATDYTSSIDVWS 242
Query: 194 VGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFE-PAN 251
            GC+ AE++ G+P+FP     D L  I  +LGTPT E       I E+ P Y  F+ P  
Sbjct: 243 AGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ------IREMNPNYTEFKFPQI 296
Query: 252 LAEKF-----PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            A  +     P   P  + L S++L   P  R+T ++A  H + 
Sbjct: 297 KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 340

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  143 bits (360), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 97/284 (34%), Positives = 151/284 (53%), Gaps = 29/284 (10%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRL---LDVQSSRK 79
           VY+ +   +G+ VAIK + +Q ++     +  RE+ ++++L+H NIVRL         +K
Sbjct: 48  VYQAKLCDSGELVAIKKV-LQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK 101
Query: 80  D---VFLVFEYLDLDLHSFI---TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLK 133
           D   + LV +Y+   ++      +R K TL ++ +K  + Q+   LAY HS  I HRD+K
Sbjct: 102 DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIK 161
Query: 134 PNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           P NLL+D     +KL DFG A+ +   +   S  C    Y+APEL+ G T Y++ IDVW+
Sbjct: 162 PQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGATDYTSSIDVWS 220
Query: 194 VGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFE-PAN 251
            GC+ AE++ G+P+FP     D L  I  +LGTPT E       I E+ P Y  F+ P  
Sbjct: 221 AGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ------IREMNPNYTEFKFPQI 274
Query: 252 LAEKF-----PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            A  +     P   P  + L S++L   P  R+T ++A  H + 
Sbjct: 275 KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 318

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  143 bits (360), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 97/284 (34%), Positives = 151/284 (53%), Gaps = 29/284 (10%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRL---LDVQSSRK 79
           VY+ +   +G+ VAIK + +Q ++     +  RE+ ++++L+H NIVRL         +K
Sbjct: 48  VYQAKLCDSGELVAIKKV-LQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK 101
Query: 80  D---VFLVFEYLDLDLHSFI---TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLK 133
           D   + LV +Y+   ++      +R K TL ++ +K  + Q+   LAY HS  I HRD+K
Sbjct: 102 DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIK 161
Query: 134 PNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           P NLL+D     +KL DFG A+ +   +   S  C    Y+APEL+ G T Y++ IDVW+
Sbjct: 162 PQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGATDYTSSIDVWS 220
Query: 194 VGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFE-PAN 251
            GC+ AE++ G+P+FP     D L  I  +LGTPT E       I E+ P Y  F+ P  
Sbjct: 221 AGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ------IREMNPNYTEFKFPQI 274
Query: 252 LAEKF-----PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            A  +     P   P  + L S++L   P  R+T ++A  H + 
Sbjct: 275 KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 318

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  143 bits (360), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 97/284 (34%), Positives = 151/284 (53%), Gaps = 29/284 (10%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRL---LDVQSSRK 79
           VY+ +   +G+ VAIK + +Q ++     +  RE+ ++++L+H NIVRL         +K
Sbjct: 44  VYQAKLCDSGELVAIKKV-LQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK 97
Query: 80  D---VFLVFEYLDLDLHSFI---TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLK 133
           D   + LV +Y+   ++      +R K TL ++ +K  + Q+   LAY HS  I HRD+K
Sbjct: 98  DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIK 157
Query: 134 PNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           P NLL+D     +KL DFG A+ +   +   S  C    Y+APEL+ G T Y++ IDVW+
Sbjct: 158 PQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGATDYTSSIDVWS 216
Query: 194 VGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFE-PAN 251
            GC+ AE++ G+P+FP     D L  I  +LGTPT E       I E+ P Y  F+ P  
Sbjct: 217 AGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ------IREMNPNYTEFKFPQI 270
Query: 252 LAEKF-----PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            A  +     P   P  + L S++L   P  R+T ++A  H + 
Sbjct: 271 KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 314

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  143 bits (360), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 97/284 (34%), Positives = 151/284 (53%), Gaps = 29/284 (10%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRL---LDVQSSRK 79
           VY+ +   +G+ VAIK + +Q ++     +  RE+ ++++L+H NIVRL         +K
Sbjct: 55  VYQAKLCDSGELVAIKKV-LQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK 108
Query: 80  D---VFLVFEYLDLDLHSFI---TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLK 133
           D   + LV +Y+   ++      +R K TL ++ +K  + Q+   LAY HS  I HRD+K
Sbjct: 109 DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIK 168
Query: 134 PNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           P NLL+D     +KL DFG A+ +   +   S  C    Y+APEL+ G T Y++ IDVW+
Sbjct: 169 PQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGATDYTSSIDVWS 227
Query: 194 VGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFE-PAN 251
            GC+ AE++ G+P+FP     D L  I  +LGTPT E       I E+ P Y  F+ P  
Sbjct: 228 AGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ------IREMNPNYTEFKFPQI 281
Query: 252 LAEKF-----PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            A  +     P   P  + L S++L   P  R+T ++A  H + 
Sbjct: 282 KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 325

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  143 bits (360), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 97/284 (34%), Positives = 151/284 (53%), Gaps = 29/284 (10%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRL---LDVQSSRK 79
           VY+ +   +G+ VAIK + +Q ++     +  RE+ ++++L+H NIVRL         +K
Sbjct: 41  VYQAKLCDSGELVAIKKV-LQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK 94
Query: 80  D---VFLVFEYLDLDLHSFI---TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLK 133
           D   + LV +Y+   ++      +R K TL ++ +K  + Q+   LAY HS  I HRD+K
Sbjct: 95  DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIK 154
Query: 134 PNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           P NLL+D     +KL DFG A+ +   +   S  C    Y+APEL+ G T Y++ IDVW+
Sbjct: 155 PQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIFGATDYTSSIDVWS 213
Query: 194 VGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFE-PAN 251
            GC+ AE++ G+P+FP     D L  I  +LGTPT E       I E+ P Y  F+ P  
Sbjct: 214 AGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ------IREMNPNYTEFKFPQI 267
Query: 252 LAEKF-----PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            A  +     P   P  + L S++L   P  R+T ++A  H + 
Sbjct: 268 KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 311

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  143 bits (360), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 97/284 (34%), Positives = 151/284 (53%), Gaps = 29/284 (10%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRL---LDVQSSRK 79
           VY+ +   +G+ VAIK + +Q ++     +  RE+ ++++L+H NIVRL         +K
Sbjct: 74  VYQAKLCDSGELVAIKKV-LQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK 127
Query: 80  D---VFLVFEYLDLDLHSFI---TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLK 133
           D   + LV +Y+   ++      +R K TL ++ +K  + Q+   LAY HS  I HRD+K
Sbjct: 128 DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIK 187
Query: 134 PNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           P NLL+D     +KL DFG A+ +   +   S  C    Y+APEL+ G T Y++ IDVW+
Sbjct: 188 PQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIFGATDYTSSIDVWS 246
Query: 194 VGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFE-PAN 251
            GC+ AE++ G+P+FP     D L  I  +LGTPT E       I E+ P Y  F+ P  
Sbjct: 247 AGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ------IREMNPNYTEFKFPQI 300
Query: 252 LAEKF-----PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            A  +     P   P  + L S++L   P  R+T ++A  H + 
Sbjct: 301 KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 344

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  143 bits (360), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 97/284 (34%), Positives = 151/284 (53%), Gaps = 29/284 (10%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRL---LDVQSSRK 79
           VY+ +   +G+ VAIK + +Q ++     +  RE+ ++++L+H NIVRL         +K
Sbjct: 40  VYQAKLCDSGELVAIKKV-LQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK 93
Query: 80  D---VFLVFEYLDLDLHSFI---TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLK 133
           D   + LV +Y+   ++      +R K TL ++ +K  + Q+   LAY HS  I HRD+K
Sbjct: 94  DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIK 153
Query: 134 PNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           P NLL+D     +KL DFG A+ +   +   S  C    Y+APEL+ G T Y++ IDVW+
Sbjct: 154 PQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGATDYTSSIDVWS 212
Query: 194 VGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFE-PAN 251
            GC+ AE++ G+P+FP     D L  I  +LGTPT E       I E+ P Y  F+ P  
Sbjct: 213 AGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ------IREMNPNYTEFKFPQI 266
Query: 252 LAEKF-----PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            A  +     P   P  + L S++L   P  R+T ++A  H + 
Sbjct: 267 KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 310

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  143 bits (360), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 97/284 (34%), Positives = 151/284 (53%), Gaps = 29/284 (10%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRL---LDVQSSRK 79
           VY+ +   +G+ VAIK + +Q ++     +  RE+ ++++L+H NIVRL         +K
Sbjct: 64  VYQAKLCDSGELVAIKKV-LQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK 117
Query: 80  D---VFLVFEYLDLDLHSFI---TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLK 133
           D   + LV +Y+   ++      +R K TL ++ +K  + Q+   LAY HS  I HRD+K
Sbjct: 118 DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIK 177
Query: 134 PNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           P NLL+D     +KL DFG A+ +   +   S  C    Y+APEL+ G T Y++ IDVW+
Sbjct: 178 PQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIFGATDYTSSIDVWS 236
Query: 194 VGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFE-PAN 251
            GC+ AE++ G+P+FP     D L  I  +LGTPT E       I E+ P Y  F+ P  
Sbjct: 237 AGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ------IREMNPNYTEFKFPQI 290
Query: 252 LAEKF-----PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            A  +     P   P  + L S++L   P  R+T ++A  H + 
Sbjct: 291 KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 334

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  143 bits (360), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 97/284 (34%), Positives = 150/284 (52%), Gaps = 29/284 (10%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRL---LDVQSSRK 79
           VY+ +   +G+ VAIK + +Q +     ++  RE+ ++++L+H NIVRL         +K
Sbjct: 36  VYQAKLCDSGELVAIKKV-LQGK-----AFKNRELQIMRKLDHCNIVRLRYFFYSSGEKK 89
Query: 80  D---VFLVFEYLDLDLHSFI---TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLK 133
           D   + LV +Y+   ++      +R K TL ++ +K  + Q+   LAY HS  I HRD+K
Sbjct: 90  DEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIK 149
Query: 134 PNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           P NLL+D     +KL DFG A+ +   +   S  C    Y+APEL+ G T Y++ IDVW+
Sbjct: 150 PQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGATDYTSSIDVWS 208
Query: 194 VGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFE-PAN 251
            GC+ AE++ G+P+FP     D L  I  +LGTPT E       I E+ P Y  F  P  
Sbjct: 209 AGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ------IREMNPNYTEFAFPQI 262
Query: 252 LAEKF-----PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            A  +     P   P  + L S++L   P  R+T ++A  H + 
Sbjct: 263 KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  143 bits (360), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 97/284 (34%), Positives = 151/284 (53%), Gaps = 29/284 (10%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRL---LDVQSSRK 79
           VY+ +   +G+ VAIK + +Q ++     +  RE+ ++++L+H NIVRL         +K
Sbjct: 36  VYQAKLCDSGELVAIKKV-LQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK 89
Query: 80  D---VFLVFEYLDLDLHSFI---TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLK 133
           D   + LV +Y+   ++      +R K TL ++ +K  + Q+   LAY HS  I HRD+K
Sbjct: 90  DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIK 149
Query: 134 PNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           P NLL+D     +KL DFG A+ +   +   S  C    Y+APEL+ G T Y++ IDVW+
Sbjct: 150 PQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGATDYTSSIDVWS 208
Query: 194 VGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFE-PAN 251
            GC+ AE++ G+P+FP     D L  I  +LGTPT E       I E+ P Y  F+ P  
Sbjct: 209 AGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ------IREMNPNYTEFKFPQI 262
Query: 252 LAEKF-----PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            A  +     P   P  + L S++L   P  R+T ++A  H + 
Sbjct: 263 KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 97/284 (34%), Positives = 151/284 (53%), Gaps = 29/284 (10%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRL---LDVQSSRK 79
           VY+ +   +G+ VAIK + +Q ++     +  RE+ ++++L+H NIVRL         +K
Sbjct: 37  VYQAKLCDSGELVAIKKV-LQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK 90
Query: 80  D---VFLVFEYLDLDLHSFI---TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLK 133
           D   + LV +Y+   ++      +R K TL ++ +K  + Q+   LAY HS  I HRD+K
Sbjct: 91  DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIK 150
Query: 134 PNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           P NLL+D     +KL DFG A+ +   +   S  C    Y+APEL+ G T Y++ IDVW+
Sbjct: 151 PQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGATDYTSSIDVWS 209
Query: 194 VGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFE-PAN 251
            GC+ AE++ G+P+FP     D L  I  +LGTPT E       I E+ P Y  F+ P  
Sbjct: 210 AGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ------IREMNPNYTEFKFPQI 263
Query: 252 LAEKF-----PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            A  +     P   P  + L S++L   P  R+T ++A  H + 
Sbjct: 264 KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 307

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 97/284 (34%), Positives = 151/284 (53%), Gaps = 29/284 (10%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRL---LDVQSSRK 79
           VY+ +   +G+ VAIK + +Q ++     +  RE+ ++++L+H NIVRL         +K
Sbjct: 70  VYQAKLCDSGELVAIKKV-LQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK 123
Query: 80  D---VFLVFEYLDLDLHSFI---TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLK 133
           D   + LV +Y+   ++      +R K TL ++ +K  + Q+   LAY HS  I HRD+K
Sbjct: 124 DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIK 183
Query: 134 PNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           P NLL+D     +KL DFG A+ +   +   S  C    Y+APEL+ G T Y++ IDVW+
Sbjct: 184 PQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIFGATDYTSSIDVWS 242
Query: 194 VGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFE-PAN 251
            GC+ AE++ G+P+FP     D L  I  +LGTPT E       I E+ P Y  F+ P  
Sbjct: 243 AGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ------IREMNPNYTEFKFPQI 296
Query: 252 LAEKF-----PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            A  +     P   P  + L S++L   P  R+T ++A  H + 
Sbjct: 297 KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 340

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 97/284 (34%), Positives = 151/284 (53%), Gaps = 29/284 (10%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRL---LDVQSSRK 79
           VY+ +   +G+ VAIK + +Q ++     +  RE+ ++++L+H NIVRL         +K
Sbjct: 36  VYQAKLCDSGELVAIKKV-LQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK 89
Query: 80  D---VFLVFEYLDLDLHSFI---TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLK 133
           D   + LV +Y+   ++      +R K TL ++ +K  + Q+   LAY HS  I HRD+K
Sbjct: 90  DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIK 149
Query: 134 PNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           P NLL+D     +KL DFG A+ +   +   S  C    Y+APEL+ G T Y++ IDVW+
Sbjct: 150 PQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGATDYTSSIDVWS 208
Query: 194 VGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFE-PAN 251
            GC+ AE++ G+P+FP     D L  I  +LGTPT E       I E+ P Y  F+ P  
Sbjct: 209 AGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ------IREMNPNYTEFKFPQI 262
Query: 252 LAEKF-----PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            A  +     P   P  + L S++L   P  R+T ++A  H + 
Sbjct: 263 KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 97/284 (34%), Positives = 151/284 (53%), Gaps = 29/284 (10%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRL---LDVQSSRK 79
           VY+ +   +G+ VAIK + +Q ++     +  RE+ ++++L+H NIVRL         +K
Sbjct: 115 VYQAKLCDSGELVAIKKV-LQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK 168
Query: 80  D---VFLVFEYLDLDLHSFI---TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLK 133
           D   + LV +Y+   ++      +R K TL ++ +K  + Q+   LAY HS  I HRD+K
Sbjct: 169 DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIK 228
Query: 134 PNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           P NLL+D     +KL DFG A+ +   +   S  C    Y+APEL+ G T Y++ IDVW+
Sbjct: 229 PQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIFGATDYTSSIDVWS 287
Query: 194 VGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFE-PAN 251
            GC+ AE++ G+P+FP     D L  I  +LGTPT E       I E+ P Y  F+ P  
Sbjct: 288 AGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ------IREMNPNYTEFKFPQI 341
Query: 252 LAEKF-----PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            A  +     P   P  + L S++L   P  R+T ++A  H + 
Sbjct: 342 KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 385

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 97/284 (34%), Positives = 151/284 (53%), Gaps = 29/284 (10%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRL---LDVQSSRK 79
           VY+ +   +G+ VAIK + +Q ++     +  RE+ ++++L+H NIVRL         +K
Sbjct: 72  VYQAKLCDSGELVAIKKV-LQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK 125
Query: 80  D---VFLVFEYLDLDLHSFI---TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLK 133
           D   + LV +Y+   ++      +R K TL ++ +K  + Q+   LAY HS  I HRD+K
Sbjct: 126 DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIK 185
Query: 134 PNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           P NLL+D     +KL DFG A+ +   +   S  C    Y+APEL+ G T Y++ IDVW+
Sbjct: 186 PQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIFGATDYTSSIDVWS 244
Query: 194 VGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFE-PAN 251
            GC+ AE++ G+P+FP     D L  I  +LGTPT E       I E+ P Y  F+ P  
Sbjct: 245 AGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ------IREMNPNYTEFKFPQI 298
Query: 252 LAEKF-----PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            A  +     P   P  + L S++L   P  R+T ++A  H + 
Sbjct: 299 KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 342

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 97/284 (34%), Positives = 151/284 (53%), Gaps = 29/284 (10%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRL---LDVQSSRK 79
           VY+ +   +G+ VAIK + +Q ++     +  RE+ ++++L+H NIVRL         +K
Sbjct: 49  VYQAKLCDSGELVAIKKV-LQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK 102
Query: 80  D---VFLVFEYLDLDLHSFI---TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLK 133
           D   + LV +Y+   ++      +R K TL ++ +K  + Q+   LAY HS  I HRD+K
Sbjct: 103 DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIK 162
Query: 134 PNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           P NLL+D     +KL DFG A+ +   +   S  C    Y+APEL+ G T Y++ IDVW+
Sbjct: 163 PQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIFGATDYTSSIDVWS 221
Query: 194 VGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFE-PAN 251
            GC+ AE++ G+P+FP     D L  I  +LGTPT E       I E+ P Y  F+ P  
Sbjct: 222 AGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ------IREMNPNYTEFKFPQI 275
Query: 252 LAEKF-----PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            A  +     P   P  + L S++L   P  R+T ++A  H + 
Sbjct: 276 KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 319

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 97/284 (34%), Positives = 151/284 (53%), Gaps = 29/284 (10%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRL---LDVQSSRK 79
           VY+ +   +G+ VAIK + +Q +     ++  RE+ ++++L+H NIVRL         +K
Sbjct: 36  VYQAKLCDSGELVAIKKV-LQGK-----AFKNRELQIMRKLDHCNIVRLRYFFYSSGEKK 89
Query: 80  D---VFLVFEYLDLDLHSFI---TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLK 133
           D   + LV +Y+   ++      +R K TL ++ +K  + Q+   LAY HS  I HRD+K
Sbjct: 90  DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIK 149
Query: 134 PNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           P NLL+D     +KL DFG A+ +   +   S  C    Y+APEL+ G T Y++ IDVW+
Sbjct: 150 PQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIFGATDYTSSIDVWS 208
Query: 194 VGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFE-PAN 251
            GC+ AE++ G+P+FP     D L  I  +LGTPT E       I E+ P Y  F+ P  
Sbjct: 209 AGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ------IREMNPNYTEFKFPQI 262
Query: 252 LAEKF-----PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            A  +     P   P  + L S++L   P  R+T ++A  H + 
Sbjct: 263 KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 97/284 (34%), Positives = 151/284 (53%), Gaps = 29/284 (10%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRL---LDVQSSRK 79
           VY+ +   +G+ VAIK + +Q ++     +  RE+ ++++L+H NIVRL         +K
Sbjct: 36  VYQAKLCDSGELVAIKKV-LQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK 89
Query: 80  D---VFLVFEYLDLDLHSFI---TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLK 133
           D   + LV +Y+   ++      +R K TL ++ +K  + Q+   LAY HS  I HRD+K
Sbjct: 90  DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIK 149
Query: 134 PNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           P NLL+D     +KL DFG A+ +   +   S  C    Y+APEL+ G T Y++ IDVW+
Sbjct: 150 PQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIFGATDYTSSIDVWS 208
Query: 194 VGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFE-PAN 251
            GC+ AE++ G+P+FP     D L  I  +LGTPT E       I E+ P Y  F+ P  
Sbjct: 209 AGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ------IREMNPNYTEFKFPQI 262
Query: 252 LAEKF-----PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            A  +     P   P  + L S++L   P  R+T ++A  H + 
Sbjct: 263 KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  142 bits (358), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 97/284 (34%), Positives = 150/284 (52%), Gaps = 29/284 (10%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRL---LDVQSSRK 79
           VY+ +   +G+ VAIK + +Q +     ++  RE+ ++++L+H NIVRL         +K
Sbjct: 36  VYQAKLCDSGELVAIKKV-LQGK-----AFKNRELQIMRKLDHCNIVRLRYFFYSSGEKK 89
Query: 80  D---VFLVFEYLDLDLHSFI---TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLK 133
           D   + LV +Y+   ++      +R K TL ++ +K  + Q+   LAY HS  I HRD+K
Sbjct: 90  DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIK 149
Query: 134 PNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           P NLL+D     +KL DFG A+ +   +   S  C    Y+APEL+ G T Y++ IDVW+
Sbjct: 150 PQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIFGATDYTSSIDVWS 208
Query: 194 VGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFE-PAN 251
            GC+ AE++ G+P+FP     D L  I  +LGTPT E       I E+ P Y  F  P  
Sbjct: 209 AGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ------IREMNPNYTEFAFPQI 262
Query: 252 LAEKF-----PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            A  +     P   P  + L S++L   P  R+T ++A  H + 
Sbjct: 263 KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 113/351 (32%), Positives = 167/351 (47%), Gaps = 83/351 (23%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK--- 79
           VY   +  T + VAIK +    E       I+RE+++L  L+ + I+RL D+        
Sbjct: 42  VYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLK 101
Query: 80  --DVFLVFEYLDLDLHS------FITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRD 131
             ++++V E  D DL        F+T          IK IL  +LLG  + H   I+HRD
Sbjct: 102 FDELYIVLEIADSDLKKLFKTPIFLTEEH-------IKTILYNLLLGENFIHESGIIHRD 154
Query: 132 LKPNNLLIDLKRNTVKLADFGLARAIGVPQ----------------------KEYSRDCV 169
           LKP N L++ +  +VK+ DFGLAR I   +                      K+ +   V
Sbjct: 155 LKPANCLLN-QDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVV 213
Query: 170 YSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMI----------TGK-PLFP--------- 209
              Y+APEL+L    Y+  ID+W+ GCIFAE++          T + PLFP         
Sbjct: 214 TRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSP 273
Query: 210 ---SKK------HDHLSLIFSLLGTPTDESWAE--STYISEILPLYPHFEPANLAEKFPN 258
              SKK       D L++IF+++GTPT++         + + + L+PH +P NL +K+P+
Sbjct: 274 DRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPS 333
Query: 259 LEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLINRKKKL 309
           +   G++LL  ML  NP +RIT   AL H YL  V           RKKKL
Sbjct: 334 ISDDGINLLESMLKFNPNKRITIDQALDHPYLKDV-----------RKKKL 373

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  140 bits (353), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 100/311 (32%), Positives = 162/311 (52%), Gaps = 46/311 (14%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-HENIVRLLDV--QSSRK 79
           V+K  +  TG+ VA+K +    +         RE+ +L EL  HENIV LL+V    + +
Sbjct: 25  VWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84
Query: 80  DVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLI 139
           DV+LVF+Y++ DLH+ I    N L  +  + ++ Q++  + Y HS  +LHRD+KP+N+L+
Sbjct: 85  DVYLVFDYMETDLHAVI--RANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL 142
Query: 140 DLKRNTVKLADFGLARA--------------IGVPQKEYSRD-------CVYSPYKAPEL 178
           + + + VK+ADFGL+R+              I    + +  D            Y+APE+
Sbjct: 143 NAECH-VKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEI 201
Query: 179 LLGYTGYSTPIDVWAVGCIFAEMITGKPLFP-SKKHDHLSLIFSLLGTPTDESWAE---- 233
           LLG T Y+  ID+W++GCI  E++ GKP+FP S   + L  I  ++  P++E        
Sbjct: 202 LLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSP 261
Query: 234 -STYISEILPLYPHFEPANLAE---KFPNL----------EPAGVDLLSQMLCLNPKQRI 279
            +  + E L        +N  +   K+ NL              +DLL ++L  NP +RI
Sbjct: 262 FAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRI 321
Query: 280 TAMDALKHEYL 290
           +A DALKH ++
Sbjct: 322 SANDALKHPFV 332

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score =  138 bits (348), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 96/307 (31%), Positives = 147/307 (47%), Gaps = 68/307 (22%)
Query: 53  IIREVSLLKELEHENIVRLLDVQSSRK-----DVFLVFEYLDLDLHSFITRHKNTLNLLV 107
           I+RE+++L  L H+++V++LD+   +      ++++V E  D D      R    L  L 
Sbjct: 99  ILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLF-RTPVYLTELH 157
Query: 108 IKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ------ 161
           IK +L  +L+G+ Y HS  ILHRDLKP N L++ +  +VK+ DFGLAR +  P+      
Sbjct: 158 IKTLLYNLLVGVKYVHSAGILHRDLKPANCLVN-QDCSVKVCDFGLARTVDYPENGNSQL 216
Query: 162 ----KEYSRDCVYSP-----------------YKAPELLLGYTGYSTPIDVWAVGCIFAE 200
               +E   + V  P                 Y+APEL+L    Y+  IDVW++GCIFAE
Sbjct: 217 PISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAE 276
Query: 201 MIT-----------GKPLFPSK---------------------KHDHLSLIFSLLGTPTD 228
           ++              PLFP                         D L++IF++LGTP++
Sbjct: 277 LLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSE 336
Query: 229 ESWA--ESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK 286
           E     E       + ++P  E  +LAE+FP      + LL +ML  NP +RIT  + L 
Sbjct: 337 EDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLA 396
Query: 287 HEYLIGV 293
           H +   V
Sbjct: 397 HPFFKEV 403

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score =  138 bits (347), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 96/289 (33%), Positives = 151/289 (52%), Gaps = 38/289 (13%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           + V  + VAIK ++   + +       RE+ L+K + H+NI+ LL+V + +K      DV
Sbjct: 45  DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDV 104
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV E +D +L   I   +  L+   +  +L Q+L G+ + HS  I+HRDLKP+N+++  
Sbjct: 105 YLVMELMDANLXQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK- 160
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
              T+K+ DFGLAR  G      +   V   Y+APE++LG  GY   +D+W+VGCI  EM
Sbjct: 161 SDXTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEM 218
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPL---YPHFEPANLAEKFP 257
           +  K LFP + + D  + +   LGTP  E      ++ ++ P    Y    P      FP
Sbjct: 219 VRHKILFPGRDYIDQWNKVIEQLGTPCPE------FMKKLQPTVRNYVENRPKYAGLTFP 272
Query: 258 NLEPAGV----------------DLLSQMLCLNPKQRITAMDALKHEYL 290
            L P  +                DLLS+ML ++P +RI+  DAL+H Y+
Sbjct: 273 KLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score =  137 bits (346), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 96/289 (33%), Positives = 151/289 (52%), Gaps = 38/289 (13%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           + V  + VAIK ++   + +       RE+ L+K + H+NI+ LL+V + +K      DV
Sbjct: 45  DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDV 104
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV E +D +L   I   +  L+   +  +L Q+L G+ + HS  I+HRDLKP+N+++  
Sbjct: 105 YLVMELMDANLXQVI---QMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVK- 160
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
              T+K+ DFGLAR  G      +   V   Y+APE++LG  GY   +D+W+VGCI  EM
Sbjct: 161 SDXTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEM 218
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPL---YPHFEPANLAEKFP 257
           +  K LFP + + D  + +   LGTP  E      ++ ++ P    Y    P      FP
Sbjct: 219 VRHKILFPGRDYIDQWNKVIEQLGTPCPE------FMKKLQPTVRNYVENRPKYAGLTFP 272
Query: 258 NLEPAGV----------------DLLSQMLCLNPKQRITAMDALKHEYL 290
            L P  +                DLLS+ML ++P +RI+  DAL+H Y+
Sbjct: 273 KLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score =  137 bits (345), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 96/289 (33%), Positives = 151/289 (52%), Gaps = 38/289 (13%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           + V  + VAIK ++   + +       RE+ L+K + H+NI+ LL+V + +K      DV
Sbjct: 45  DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDV 104
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV E +D +L   I   +  L+   +  +L Q+L G+ + HS  I+HRDLKP+N+++  
Sbjct: 105 YLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK- 160
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
              T+K+ DFGLAR  G      +   V   Y+APE++LG  GY   +D+W+VGCI  EM
Sbjct: 161 SDXTLKILDFGLARTAGTSFM-MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEM 218
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPL---YPHFEPANLAEKFP 257
           +  K LFP + + D  + +   LGTP  E      ++ ++ P    Y    P      FP
Sbjct: 219 VRHKILFPGRDYIDQWNKVIEQLGTPCPE------FMKKLQPTVRNYVENRPKYAGLTFP 272
Query: 258 NLEPAGV----------------DLLSQMLCLNPKQRITAMDALKHEYL 290
            L P  +                DLLS+ML ++P +RI+  DAL+H Y+
Sbjct: 273 KLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score =  136 bits (343), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 96/289 (33%), Positives = 151/289 (52%), Gaps = 38/289 (13%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           + V  + VAIK ++   + +       RE+ L+K + H+NI+ LL+V + +K      DV
Sbjct: 45  DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 104
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV E +D +L   I   +  L+   +  +L Q+L G+ + HS  I+HRDLKP+N+++  
Sbjct: 105 YLVMELMDANLXQVI---QMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVK- 160
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
              T+K+ DFGLAR  G      +   V   Y+APE++LG  GY   +D+W+VGCI  EM
Sbjct: 161 SDXTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEM 218
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPL---YPHFEPANLAEKFP 257
           +  K LFP + + D  + +   LGTP  E      ++ ++ P    Y    P      FP
Sbjct: 219 VRHKILFPGRDYIDQWNKVIEQLGTPCPE------FMKKLQPTVRNYVENRPKYAGLTFP 272
Query: 258 NLEPAGV----------------DLLSQMLCLNPKQRITAMDALKHEYL 290
            L P  +                DLLS+ML ++P +RI+  DAL+H Y+
Sbjct: 273 KLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score =  136 bits (343), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 96/289 (33%), Positives = 151/289 (52%), Gaps = 38/289 (13%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           + V  + VAIK ++   + +       RE+ L+K + H+NI+ LL+V + +K      DV
Sbjct: 38  DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 97
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV E +D +L   I   +  L+   +  +L Q+L G+ + HS  I+HRDLKP+N+++  
Sbjct: 98  YLVMELMDANLXQVI---QMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVK- 153
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
              T+K+ DFGLAR  G      +   V   Y+APE++LG  GY   +D+W+VGCI  EM
Sbjct: 154 SDXTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEM 211
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPL---YPHFEPANLAEKFP 257
           +  K LFP + + D  + +   LGTP  E      ++ ++ P    Y    P      FP
Sbjct: 212 VRHKILFPGRDYIDQWNKVIEQLGTPCPE------FMKKLQPTVRNYVENRPKYAGLTFP 265
Query: 258 NLEPAGV----------------DLLSQMLCLNPKQRITAMDALKHEYL 290
            L P  +                DLLS+ML ++P +RI+  DAL+H Y+
Sbjct: 266 KLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 314

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 92/293 (31%), Positives = 150/293 (51%), Gaps = 35/293 (11%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQ------- 75
           V+   +    ++VAIK + + T+ + V  + +RE+ +++ L+H+NIV++ ++        
Sbjct: 27  VFSAVDNDCDKRVAIKKIVL-TDPQSV-KHALREIKIIRRLDHDNIVKVFEILGPSGSQL 84
Query: 76  -------SSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKIL 128
                  +    V++V EY++ DL + +   +  L     +  + Q+L GL Y HS  +L
Sbjct: 85  TDDVGSLTELNSVYIVQEYMETDLANVL--EQGPLLEEHARLFMYQLLRGLKYIHSANVL 142
Query: 129 HRDLKPNNLLIDLKRNTVKLADFGLARAIG---VPQKEYSRDCVYSPYKAPELLLGYTGY 185
           HRDLKP NL I+ +   +K+ DFGLAR +      +   S   V   Y++P LLL    Y
Sbjct: 143 HRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNY 202
Query: 186 STPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLY 244
           +  ID+WA GCIFAEM+TGK LF      + + LI   +    +E   E   +  ++P+Y
Sbjct: 203 TKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQE---LLSVIPVY 259
Query: 245 -------PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                  PH     L +  P +    VD L Q+L  +P  R+TA +AL H Y+
Sbjct: 260 IRNDMTEPH---KPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM 309

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score =  135 bits (340), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 96/289 (33%), Positives = 151/289 (52%), Gaps = 38/289 (13%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           + V  + VAIK ++   + +       RE+ L+K + H+NI+ LL+V + +K      DV
Sbjct: 46  DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 105
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV E +D +L   I   +  L+   +  +L Q+L G+ + HS  I+HRDLKP+N+++  
Sbjct: 106 YLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK- 161
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
              T+K+ DFGLAR  G      +   V   Y+APE++LG  GY   +D+W+VGCI  EM
Sbjct: 162 SDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEM 219
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPL---YPHFEPANLAEKFP 257
           +  K LFP + + D  + +   LGTP  E      ++ ++ P    Y    P      FP
Sbjct: 220 VRHKILFPGRDYIDQWNKVIEQLGTPCPE------FMKKLQPTVRNYVENRPKYAGLTFP 273
Query: 258 NLEPAGV----------------DLLSQMLCLNPKQRITAMDALKHEYL 290
            L P  +                DLLS+ML ++P +RI+  DAL+H Y+
Sbjct: 274 KLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 322

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score =  135 bits (340), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 96/289 (33%), Positives = 151/289 (52%), Gaps = 38/289 (13%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           + V  + VAIK ++   + +       RE+ L+K + H+NI+ LL+V + +K      DV
Sbjct: 44  DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 103
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV E +D +L   I   +  L+   +  +L Q+L G+ + HS  I+HRDLKP+N+++  
Sbjct: 104 YLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK- 159
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
              T+K+ DFGLAR  G      +   V   Y+APE++LG  GY   +D+W+VGCI  EM
Sbjct: 160 SDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEM 217
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPL---YPHFEPANLAEKFP 257
           +  K LFP + + D  + +   LGTP  E      ++ ++ P    Y    P      FP
Sbjct: 218 VRHKILFPGRDYIDQWNKVIEQLGTPCPE------FMKKLQPTVRNYVENRPKYAGLTFP 271
Query: 258 NLEPAGV----------------DLLSQMLCLNPKQRITAMDALKHEYL 290
            L P  +                DLLS+ML ++P +RI+  DAL+H Y+
Sbjct: 272 KLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 320

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score =  135 bits (340), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 96/289 (33%), Positives = 151/289 (52%), Gaps = 38/289 (13%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           + V  + VAIK ++   + +       RE+ L+K + H+NI+ LL+V + +K      DV
Sbjct: 45  DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 104
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV E +D +L   I   +  L+   +  +L Q+L G+ + HS  I+HRDLKP+N+++  
Sbjct: 105 YLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK- 160
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
              T+K+ DFGLAR  G      +   V   Y+APE++LG  GY   +D+W+VGCI  EM
Sbjct: 161 SDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEM 218
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPL---YPHFEPANLAEKFP 257
           +  K LFP + + D  + +   LGTP  E      ++ ++ P    Y    P      FP
Sbjct: 219 VRHKILFPGRDYIDQWNKVIEQLGTPCPE------FMKKLQPTVRNYVENRPKYAGLTFP 272
Query: 258 NLEPAGV----------------DLLSQMLCLNPKQRITAMDALKHEYL 290
            L P  +                DLLS+ML ++P +RI+  DAL+H Y+
Sbjct: 273 KLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score =  135 bits (340), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 96/289 (33%), Positives = 151/289 (52%), Gaps = 38/289 (13%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           + V  + VAIK ++   + +       RE+ L+K + H+NI+ LL+V + +K      DV
Sbjct: 39  DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 98
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV E +D +L   I   +  L+   +  +L Q+L G+ + HS  I+HRDLKP+N+++  
Sbjct: 99  YLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK- 154
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
              T+K+ DFGLAR  G      +   V   Y+APE++LG  GY   +D+W+VGCI  EM
Sbjct: 155 SDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEM 212
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPL---YPHFEPANLAEKFP 257
           +  K LFP + + D  + +   LGTP  E      ++ ++ P    Y    P      FP
Sbjct: 213 VRHKILFPGRDYIDQWNKVIEQLGTPCPE------FMKKLQPTVRNYVENRPKYAGLTFP 266
Query: 258 NLEPAGV----------------DLLSQMLCLNPKQRITAMDALKHEYL 290
            L P  +                DLLS+ML ++P +RI+  DAL+H Y+
Sbjct: 267 KLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 315

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score =  135 bits (340), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 96/289 (33%), Positives = 151/289 (52%), Gaps = 38/289 (13%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           + V  + VAIK ++   + +       RE+ L+K + H+NI+ LL+V + +K      DV
Sbjct: 83  DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 142
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV E +D +L   I   +  L+   +  +L Q+L G+ + HS  I+HRDLKP+N+++  
Sbjct: 143 YLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK- 198
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
              T+K+ DFGLAR  G      +   V   Y+APE++LG  GY   +D+W+VGCI  EM
Sbjct: 199 SDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEM 256
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPL---YPHFEPANLAEKFP 257
           +  K LFP + + D  + +   LGTP  E      ++ ++ P    Y    P      FP
Sbjct: 257 VRHKILFPGRDYIDQWNKVIEQLGTPCPE------FMKKLQPTVRNYVENRPKYAGLTFP 310
Query: 258 NLEPAGV----------------DLLSQMLCLNPKQRITAMDALKHEYL 290
            L P  +                DLLS+ML ++P +RI+  DAL+H Y+
Sbjct: 311 KLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score =  135 bits (340), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 96/289 (33%), Positives = 151/289 (52%), Gaps = 38/289 (13%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           + V  + VAIK ++   + +       RE+ L+K + H+NI+ LL+V + +K      DV
Sbjct: 46  DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 105
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV E +D +L   I   +  L+   +  +L Q+L G+ + HS  I+HRDLKP+N+++  
Sbjct: 106 YLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK- 161
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
              T+K+ DFGLAR  G      +   V   Y+APE++LG  GY   +D+W+VGCI  EM
Sbjct: 162 SDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEM 219
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPL---YPHFEPANLAEKFP 257
           +  K LFP + + D  + +   LGTP  E      ++ ++ P    Y    P      FP
Sbjct: 220 VRHKILFPGRDYIDQWNKVIEQLGTPCPE------FMKKLQPTVRNYVENRPKYAGLTFP 273
Query: 258 NLEPAGV----------------DLLSQMLCLNPKQRITAMDALKHEYL 290
            L P  +                DLLS+ML ++P +RI+  DAL+H Y+
Sbjct: 274 KLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 322

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score =  135 bits (339), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 96/289 (33%), Positives = 151/289 (52%), Gaps = 38/289 (13%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           + V  + VAIK ++   + +       RE+ L+K + H+NI+ LL+V + +K      DV
Sbjct: 39  DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 98
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV E +D +L   I   +  L+   +  +L Q+L G+ + HS  I+HRDLKP+N+++  
Sbjct: 99  YLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK- 154
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
              T+K+ DFGLAR  G      +   V   Y+APE++LG  GY   +D+W+VGCI  EM
Sbjct: 155 SDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEM 212
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPL---YPHFEPANLAEKFP 257
           +  K LFP + + D  + +   LGTP  E      ++ ++ P    Y    P      FP
Sbjct: 213 VRHKILFPGRDYIDQWNKVIEQLGTPCPE------FMKKLQPTVRNYVENRPKYAGLTFP 266
Query: 258 NLEPAGV----------------DLLSQMLCLNPKQRITAMDALKHEYL 290
            L P  +                DLLS+ML ++P +RI+  DAL+H Y+
Sbjct: 267 KLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 315

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score =  135 bits (339), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 96/289 (33%), Positives = 151/289 (52%), Gaps = 38/289 (13%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           + V  + VAIK ++   + +       RE+ L+K + H+NI+ LL+V + +K      DV
Sbjct: 45  DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 104
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV E +D +L   I   +  L+   +  +L Q+L G+ + HS  I+HRDLKP+N+++  
Sbjct: 105 YLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK- 160
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
              T+K+ DFGLAR  G      +   V   Y+APE++LG  GY   +D+W+VGCI  EM
Sbjct: 161 SDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEM 218
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPL---YPHFEPANLAEKFP 257
           +  K LFP + + D  + +   LGTP  E      ++ ++ P    Y    P      FP
Sbjct: 219 VRHKILFPGRDYIDQWNKVIEQLGTPCPE------FMKKLQPTVRNYVENRPKYAGLTFP 272
Query: 258 NLEPAGV----------------DLLSQMLCLNPKQRITAMDALKHEYL 290
            L P  +                DLLS+ML ++P +RI+  DAL+H Y+
Sbjct: 273 KLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score =  135 bits (339), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 96/289 (33%), Positives = 151/289 (52%), Gaps = 38/289 (13%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           + V  + VAIK ++   + +       RE+ L+K + H+NI+ LL+V + +K      DV
Sbjct: 38  DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 97
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV E +D +L   I   +  L+   +  +L Q+L G+ + HS  I+HRDLKP+N+++  
Sbjct: 98  YLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK- 153
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
              T+K+ DFGLAR  G      +   V   Y+APE++LG  GY   +D+W+VGCI  EM
Sbjct: 154 SDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEM 211
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPL---YPHFEPANLAEKFP 257
           +  K LFP + + D  + +   LGTP  E      ++ ++ P    Y    P      FP
Sbjct: 212 VRHKILFPGRDYIDQWNKVIEQLGTPCPE------FMKKLQPTVRNYVENRPKYAGLTFP 265
Query: 258 NLEPAGV----------------DLLSQMLCLNPKQRITAMDALKHEYL 290
            L P  +                DLLS+ML ++P +RI+  DAL+H Y+
Sbjct: 266 KLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 314

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score =  135 bits (339), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 96/289 (33%), Positives = 151/289 (52%), Gaps = 38/289 (13%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           + V  + VAIK ++   + +       RE+ L+K + H+NI+ LL+V + +K      DV
Sbjct: 83  DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 142
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV E +D +L   I   +  L+   +  +L Q+L G+ + HS  I+HRDLKP+N+++  
Sbjct: 143 YLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK- 198
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
              T+K+ DFGLAR  G      +   V   Y+APE++LG  GY   +D+W+VGCI  EM
Sbjct: 199 SDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEM 256
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPL---YPHFEPANLAEKFP 257
           +  K LFP + + D  + +   LGTP  E      ++ ++ P    Y    P      FP
Sbjct: 257 VRHKILFPGRDYIDQWNKVIEQLGTPCPE------FMKKLQPTVRNYVENRPKYAGLTFP 310
Query: 258 NLEPAGV----------------DLLSQMLCLNPKQRITAMDALKHEYL 290
            L P  +                DLLS+ML ++P +RI+  DAL+H Y+
Sbjct: 311 KLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  134 bits (338), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 95/287 (33%), Positives = 153/287 (53%), Gaps = 34/287 (11%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           + +  + VAIK ++   + +       RE+ L+K + H+NI+ LL+V + +K      DV
Sbjct: 45  DAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDV 104
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           ++V E +D +L   I   +  L+   +  +L Q+L+G+ + HS  I+HRDLKP+N+++  
Sbjct: 105 YIVMELMDANLSQVI---QMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVK- 160
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
              T+K+ DFGLAR  G      +   V   Y+APE++LG  GY   +D+W+VGCI  EM
Sbjct: 161 SDATLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEM 218
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAE-----STYISEILPLYPHFEPANLAEK 255
           I G  LFP   H D  + +   LGTP+ E   +      TY+       P +   +  + 
Sbjct: 219 IKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVEN----RPKYAGYSFEKL 274
Query: 256 FPN-LEPA-----------GVDLLSQMLCLNPKQRITAMDALKHEYL 290
           FP+ L PA             DLLS+ML ++  +RI+  +AL+H Y+
Sbjct: 275 FPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 94/310 (30%), Positives = 152/310 (49%), Gaps = 55/310 (17%)
Query: 31  TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLD----------------- 73
           +G++ A+K +         P Y  RE+ ++K L+H NI++L+D                 
Sbjct: 31  SGKRFALKKVLQD------PRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPD 84
Query: 74  -----------VQSSRKDVFL----------VFEYLDLDLH----SFITRHKNTLNLLVI 108
                      V +  K V +          + EY+   LH    SFI R   ++ + +I
Sbjct: 85  DHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFI-RSGRSIPMNLI 143
Query: 109 KAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDC 168
              + Q+   + + HSL I HRD+KP NLL++ K NT+KL DFG A+ + +P +      
Sbjct: 144 SIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKL-IPSEPSVAXI 202
Query: 169 VYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPT 227
               Y+APEL+LG T Y+  ID+W++GC+F E+I GKPLF  +   D L  I  ++GTPT
Sbjct: 203 CSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPT 262
Query: 228 DESWAE-STYISEILPLYPHFEPANLAEKFPNLEPA-GVDLLSQMLCLNPKQRITAMDAL 285
            E     + + +E+   +P  +  +  +  P   P+  +DLL Q+L   P  RI   +A+
Sbjct: 263 KEQMIRMNPHYTEV--RFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAM 320
Query: 286 KHEYLIGVEN 295
            H +   + N
Sbjct: 321 AHPFFDHLRN 330

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 95/287 (33%), Positives = 152/287 (52%), Gaps = 34/287 (11%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           + +  + VAIK ++   + +       RE+ L+K + H+NI+ LL+V + +K      DV
Sbjct: 45  DAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDV 104
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           ++V E +D +L   I   +  L+   +  +L Q+L G+ + HS  I+HRDLKP+N+++  
Sbjct: 105 YIVMELMDANLSQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK- 160
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
              T+K+ DFGLAR  G      +   V   Y+APE++LG  GY   +D+W+VGCI  EM
Sbjct: 161 SDATLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEM 218
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAE-----STYISEILPLYPHFEPANLAEK 255
           I G  LFP   H D  + +   LGTP+ E   +      TY+       P +   +  + 
Sbjct: 219 IKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVEN----RPKYAGYSFEKL 274
Query: 256 FPN-LEPA-----------GVDLLSQMLCLNPKQRITAMDALKHEYL 290
           FP+ L PA             DLLS+ML ++  +RI+  +AL+H Y+
Sbjct: 275 FPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 95/287 (33%), Positives = 152/287 (52%), Gaps = 34/287 (11%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           + +  + VAIK ++   + +       RE+ L+K + H+NI+ LL+V + +K      DV
Sbjct: 45  DAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 104
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           ++V E +D +L   I   +  L+   +  +L Q+L G+ + HS  I+HRDLKP+N+++  
Sbjct: 105 YIVMELMDANLSQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK- 160
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
              T+K+ DFGLAR  G      +   V   Y+APE++LG  GY   +D+W+VGCI  EM
Sbjct: 161 SDATLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEM 218
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAE-----STYISEILPLYPHFEPANLAEK 255
           I G  LFP   H D  + +   LGTP+ E   +      TY+       P +   +  + 
Sbjct: 219 IKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVEN----RPKYAGYSFEKL 274
Query: 256 FPN-LEPA-----------GVDLLSQMLCLNPKQRITAMDALKHEYL 290
           FP+ L PA             DLLS+ML ++  +RI+  +AL+H Y+
Sbjct: 275 FPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  132 bits (332), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 97/293 (33%), Positives = 151/293 (51%), Gaps = 46/293 (15%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +TV G  VA+K ++   + +       RE+ LLK + H+NI+ LL+V + +K      DV
Sbjct: 43  DTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDV 102
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV E +D +L   I      L+   +  +L Q+L G+ + HS  I+HRDLKP+N+++  
Sbjct: 103 YLVMELMDANLCQVIHME---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK- 158
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSP------YKAPELLLGYTGYSTPIDVWAVG 195
              T+K+ DFGLAR         S + + +P      Y+APE++LG  GY   +D+W+VG
Sbjct: 159 SDCTLKILDFGLARTA-------STNFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVG 210
Query: 196 CIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAE-----STYISEILPLYPHFEP 249
           CI  E++ G  +F    H D  + +   LGTP+ E  A        Y+ E  P YP    
Sbjct: 211 CIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYV-ENRPAYPGIA- 268
Query: 250 ANLAEKFPNL------------EPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
               E FP+                  DLLS+ML ++P +RI+  +AL+H Y+
Sbjct: 269 --FEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 319

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score =  132 bits (332), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 95/287 (33%), Positives = 152/287 (52%), Gaps = 34/287 (11%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           + +  + VAIK ++   + +       RE+ L+K + H+NI+ LL+V + +K      DV
Sbjct: 45  DAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 104
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           ++V E +D +L   I   +  L+   +  +L Q+L G+ + HS  I+HRDLKP+N+++  
Sbjct: 105 YIVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK- 160
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
              T+K+ DFGLAR  G      + + V   Y+APE++LG  GY   +D+W+VGCI  EM
Sbjct: 161 SDCTLKILDFGLARTAGT-SFMMTPEVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEM 218
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAE-----STYISEILPLYPHFEPANLAEK 255
           I G  LFP   H D  + +   LGTP  E   +      TY+       P +   +  + 
Sbjct: 219 IKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVEN----RPKYAGYSFEKL 274
Query: 256 FPN-LEPA-----------GVDLLSQMLCLNPKQRITAMDALKHEYL 290
           FP+ L PA             DLLS+ML ++  +RI+  +AL+H Y+
Sbjct: 275 FPDVLFPADSEHNALKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 95/287 (33%), Positives = 152/287 (52%), Gaps = 34/287 (11%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           + +  + VAIK ++   + +       RE+ L+K + H+NI+ LL+V + +K      DV
Sbjct: 45  DAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 104
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           ++V E +D +L   I   +  L+   +  +L Q+L G+ + HS  I+HRDLKP+N+++  
Sbjct: 105 YIVMELMDANLSQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK- 160
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
              T+K+ DFGLAR  G      +   V   Y+APE++LG  GY   +D+W+VGCI  EM
Sbjct: 161 SDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEM 218
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAE-----STYISEILPLYPHFEPANLAEK 255
           I G  LFP   H D  + +   LGTP+ E   +      TY+       P +   +  + 
Sbjct: 219 IKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVEN----RPKYAGYSFEKL 274
Query: 256 FPN-LEPA-----------GVDLLSQMLCLNPKQRITAMDALKHEYL 290
           FP+ L PA             DLLS+ML ++  +RI+  +AL+H Y+
Sbjct: 275 FPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  132 bits (331), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 96/287 (33%), Positives = 150/287 (52%), Gaps = 34/287 (11%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           +TV G  VA+K ++   + +       RE+ LLK + H+NI+ LL+V + +K      DV
Sbjct: 45  DTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDV 104
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV E +D +L   I      L+   +  +L Q+L G+ + HS  I+HRDLKP+N+++  
Sbjct: 105 YLVMELMDANLCQVIHME---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK- 160
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
              T+K+ DFGLAR         +   V   Y+APE++LG  GY+  +D+W+VGCI  E+
Sbjct: 161 SDCTLKILDFGLART-ACTNFMMTPYVVTRYYRAPEVILG-MGYAANVDIWSVGCIMGEL 218
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAE-----STYISEILPLYPHFEPANLAEK 255
           + G  +F    H D  + +   LGTP+ E  A        Y+ E  P YP  +     E 
Sbjct: 219 VKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYV-ENRPKYPGIK---FEEL 274
Query: 256 FPNL------------EPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           FP+                  DLLS+ML ++P +RI+  +AL+H Y+
Sbjct: 275 FPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 321

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  131 bits (329), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 95/292 (32%), Positives = 153/292 (52%), Gaps = 34/292 (11%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK--- 79
           V    + +  + VAIK ++   + +       RE+ L+K + H+NI+ LL+V + +K   
Sbjct: 40  VVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLE 99
Query: 80  ---DVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNN 136
              DV++V E +D +L   I   +  L+   +  +L Q+L+G+ + HS  I+HRDLKP+N
Sbjct: 100 EFQDVYIVMELMDANLSQVI---QMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSN 156
Query: 137 LLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGC 196
           +++     T+K+ DFGLAR  G      +   V   Y+APE++LG  GY   +D+W+VG 
Sbjct: 157 IVVK-SDATLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGV 213
Query: 197 IFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAE-----STYISEILPLYPHFEPA 250
           I  EMI G  LFP   H D  + +   LGTP+ E   +      TY+       P +   
Sbjct: 214 IMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVEN----RPKYAGY 269
Query: 251 NLAEKFPN-LEPA-----------GVDLLSQMLCLNPKQRITAMDALKHEYL 290
           +  + FP+ L PA             DLLS+ML ++  +RI+  +AL+H Y+
Sbjct: 270 SFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  131 bits (329), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 95/287 (33%), Positives = 152/287 (52%), Gaps = 34/287 (11%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           + +  + VAIK ++   + +       RE+ L+K + H+NI+ LL+V + +K      DV
Sbjct: 45  DAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 104
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           ++V E +D +L   I   +  L+   +  +L Q+L G+ + HS  I+HRDLKP+N+++  
Sbjct: 105 YIVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK- 160
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
              T+K+ DFGLAR  G      +   V   Y+APE++LG  GY   +D+W+VGCI  EM
Sbjct: 161 SDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEM 218
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAE-----STYISEILPLYPHFEPANLAEK 255
           I G  LFP   H D  + +   LGTP+ E   +      TY+       P +   +  + 
Sbjct: 219 IKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVEN----RPKYAGYSFEKL 274
Query: 256 FPN-LEPA-----------GVDLLSQMLCLNPKQRITAMDALKHEYL 290
           FP+ L PA             DLLS+ML ++  +RI+  +AL+H Y+
Sbjct: 275 FPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score =  130 bits (328), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 95/287 (33%), Positives = 151/287 (52%), Gaps = 34/287 (11%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           + +  + VAIK ++   + +       RE+ L+K + H+NI+ LL+V + +K      DV
Sbjct: 45  DAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 104
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           ++V E +D +L   I   +  L+   +  +L Q+L G+ + HS  I+HRDLKP+N+++  
Sbjct: 105 YIVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK- 160
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
              T+K+ DFGLAR  G      +   V   Y+APE++LG  GY   +D+W+VGCI  EM
Sbjct: 161 SDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEM 218
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAE-----STYISEILPLYPHFEPANLAEK 255
           I G  LFP   H D  + +   LGTP  E   +      TY+       P +   +  + 
Sbjct: 219 IKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVEN----RPKYAGYSFEKL 274
Query: 256 FPN-LEPA-----------GVDLLSQMLCLNPKQRITAMDALKHEYL 290
           FP+ L PA             DLLS+ML ++  +RI+  +AL+H Y+
Sbjct: 275 FPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  130 bits (328), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 94/287 (32%), Positives = 152/287 (52%), Gaps = 34/287 (11%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           + +  + VAIK ++   + +       RE+ L+K + H+NI+ LL+V + +K      DV
Sbjct: 45  DAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDV 104
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           ++V E +D +L   I   +  L+   +  +L Q+L+G+ + HS  I+HRDLKP+N+++  
Sbjct: 105 YIVMELMDANLSQVI---QMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVK- 160
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
              T+K+ DFGLAR  G      +   V   Y+APE++LG  GY   +D+W+VG I  EM
Sbjct: 161 SDATLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGVIMGEM 218
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAE-----STYISEILPLYPHFEPANLAEK 255
           I G  LFP   H D  + +   LGTP+ E   +      TY+       P +   +  + 
Sbjct: 219 IKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVEN----RPKYAGYSFEKL 274
Query: 256 FPN-LEPA-----------GVDLLSQMLCLNPKQRITAMDALKHEYL 290
           FP+ L PA             DLLS+ML ++  +RI+  +AL+H Y+
Sbjct: 275 FPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score =  130 bits (327), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 95/287 (33%), Positives = 151/287 (52%), Gaps = 34/287 (11%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           + +  + VAIK ++   + +       RE+ L+K + H+NI+ LL+V + +K      DV
Sbjct: 46  DAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 105
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           ++V E +D +L   I   +  L+   +  +L Q+L G+ + HS  I+HRDLKP+N+++  
Sbjct: 106 YIVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK- 161
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
              T+K+ DFGLAR  G      +   V   Y+APE++LG  GY   +D+W+VGCI  EM
Sbjct: 162 SDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEM 219
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAE-----STYISEILPLYPHFEPANLAEK 255
           I G  LFP   H D  + +   LGTP  E   +      TY+       P +   +  + 
Sbjct: 220 IKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVEN----RPKYAGYSFEKL 275
Query: 256 FPN-LEPA-----------GVDLLSQMLCLNPKQRITAMDALKHEYL 290
           FP+ L PA             DLLS+ML ++  +RI+  +AL+H Y+
Sbjct: 276 FPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 322

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 97/292 (33%), Positives = 152/292 (52%), Gaps = 44/292 (15%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           + +  + VAIK ++   + +       RE+ L+K + H+NI+ LL+V + +K      DV
Sbjct: 47  DAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 106
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           ++V E +D +L   I   +  L+   +  +L Q+L G+ + HS  I+HRDLKP+N+++  
Sbjct: 107 YIVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK- 162
Query: 142 KRNTVKLADFGLARAIG-----VPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGC 196
              T+K+ DFGLAR  G     VP        V   Y+APE++LG  GY   +D+W+VGC
Sbjct: 163 SDCTLKILDFGLARTAGTSFMMVPF------VVTRYYRAPEVILG-MGYKENVDIWSVGC 215
Query: 197 IFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAE-----STYISEILPLYPHFEPA 250
           I  EMI G  LFP   H D  + +   LGTP  E   +      TY+       P +   
Sbjct: 216 IMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVEN----RPKYAGY 271
Query: 251 NLAEKFPN-LEPA-----------GVDLLSQMLCLNPKQRITAMDALKHEYL 290
           +  + FP+ L PA             DLLS+ML ++  +RI+  +AL+H Y+
Sbjct: 272 SFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 323

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score =  128 bits (321), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 93/287 (32%), Positives = 152/287 (52%), Gaps = 34/287 (11%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           + +  + VAIK ++   + +       RE+ L+K + H+NI+ LL+V + +K      DV
Sbjct: 45  DAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 104
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           ++V E +D +L   I   +  L+   +  +L Q+L G+ + HS  I+HRDLKP+N+++  
Sbjct: 105 YIVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK- 160
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
              T+K+ DFGLAR  G        + V   Y+APE++LG  GY   +D+W+VGCI  EM
Sbjct: 161 SDCTLKILDFGLARTAGTSFM-MEPEVVTRYYRAPEVILG-MGYKENVDLWSVGCIMGEM 218
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAE-----STYISEILPLYPHFEPANLAEK 255
           +  K LFP + + D  + +   LGTP  E   +      TY+       P +   +  + 
Sbjct: 219 VCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVEN----RPKYAGYSFEKL 274
Query: 256 FPN-LEPA-----------GVDLLSQMLCLNPKQRITAMDALKHEYL 290
           FP+ L PA             DLLS+ML ++  +RI+  +AL+H Y+
Sbjct: 275 FPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score =  127 bits (319), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 93/287 (32%), Positives = 152/287 (52%), Gaps = 34/287 (11%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           + +  + VAIK ++   + +       RE+ L+K + H+NI+ LL+V + +K      DV
Sbjct: 50  DAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 109
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           ++V E +D +L   I   +  L+   +  +L Q+L G+ + HS  I+HRDLKP+N+++  
Sbjct: 110 YIVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK- 165
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
              T+K+ DFGLAR  G      +   V   Y+APE++LG  GY   +D+W+VGCI  EM
Sbjct: 166 SDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG-MGYKENVDLWSVGCIMGEM 223
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAE-----STYISEILPLYPHFEPANLAEK 255
           +  K LFP + + D  + +   LGTP  E   +      TY+       P +   +  + 
Sbjct: 224 VCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVEN----RPKYAGYSFEKL 279
Query: 256 FPN-LEPA-----------GVDLLSQMLCLNPKQRITAMDALKHEYL 290
           FP+ L PA             DLLS+ML ++  +RI+  +AL+H Y+
Sbjct: 280 FPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 326

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 93/287 (32%), Positives = 152/287 (52%), Gaps = 34/287 (11%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           + +  + VAIK ++   + +       RE+ L+K + H+NI+ LL+V + +K      DV
Sbjct: 39  DAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 98
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           ++V E +D +L   I   +  L+   +  +L Q+L G+ + HS  I+HRDLKP+N+++  
Sbjct: 99  YIVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK- 154
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
              T+K+ DFGLAR  G      +   V   Y+APE++LG  GY   +D+W+VGCI  EM
Sbjct: 155 SDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG-MGYKENVDLWSVGCIMGEM 212
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAE-----STYISEILPLYPHFEPANLAEK 255
           +  K LFP + + D  + +   LGTP  E   +      TY+       P +   +  + 
Sbjct: 213 VCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVEN----RPKYAGYSFEKL 268
Query: 256 FPN-LEPA-----------GVDLLSQMLCLNPKQRITAMDALKHEYL 290
           FP+ L PA             DLLS+ML ++  +RI+  +AL+H Y+
Sbjct: 269 FPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 315

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 103/338 (30%), Positives = 159/338 (47%), Gaps = 75/338 (22%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK--- 79
           VY   +    + VAIK +    E       I+RE+++L  L+ + I+RL D+        
Sbjct: 44  VYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLHDLIIPEDLLK 103
Query: 80  --DVFLVFEYLDLDLHS------FITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRD 131
             ++++V E  D DL        F+T          +K IL  +LLG  + H   I+HRD
Sbjct: 104 FDELYIVLEIADSDLKKLFKTPIFLTEQH-------VKTILYNLLLGEKFIHESGIIHRD 156
Query: 132 LKPNNLLIDLKRNTVKLADFGLARAIGVP-------------------------QKEYSR 166
           LKP N L++ +  +VK+ DFGLAR I                            +K+ + 
Sbjct: 157 LKPANCLLN-QDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPHNKNLKKQLTS 215
Query: 167 DCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMI----------TGK-PLFP------ 209
             V   Y+APEL+L    Y+  ID+W+ GCIFAE++          T + PLFP      
Sbjct: 216 HVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHINNPTNRFPLFPGSSCFP 275
Query: 210 ------SKK------HDHLSLIFSLLGTPTDESWAESTY--ISEILPLYPHFEPANLAEK 255
                 SKK       D L++IF+++GTP +E     T   + + + L+P  +  +L++K
Sbjct: 276 LSPDHNSKKVHEKSNRDQLNIIFNVIGTPPEEDLKCITKQEVIKYIKLFPTRDGIDLSKK 335
Query: 256 FPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
           + ++   G+DLL  ML  N ++RIT   AL H YL  V
Sbjct: 336 YSSISKEGIDLLESMLRFNAQKRITIDKALSHPYLKDV 373

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score =  126 bits (317), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 90/283 (31%), Positives = 150/283 (53%), Gaps = 26/283 (9%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------DV 81
           + +  + VAIK ++   + +       RE+ L+K + H+NI+ LL+V + +K      DV
Sbjct: 45  DAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 104
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           ++V E +D +L   I   +  L+   +  +L Q+L G+ + HS  I+HRDLKP+N+++  
Sbjct: 105 YIVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK- 160
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
              T+K+ DFGLAR  G        + V   Y+APE++LG  GY   +D+W+VGCI  EM
Sbjct: 161 SDCTLKILDFGLARTAGT-SFMMEPEVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEM 218
Query: 202 ITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAE-STYISEILPLYPHFEPANLAEKFPN- 258
           +  K LFP + + D  + +   LGTP      +    +   +   P +   +  + FP+ 
Sbjct: 219 VCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKKLQPTVRNYVENRPKYAGYSFEKLFPDV 278
Query: 259 LEPA-----------GVDLLSQMLCLNPKQRITAMDALKHEYL 290
           L PA             DLLS+ML ++  +RI+  +AL+H Y+
Sbjct: 279 LFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 76/250 (30%), Positives = 125/250 (50%), Gaps = 17/250 (6%)
Query: 53  IIREVSLLKELEHENIVRLLDV-----QSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLV 107
           ++RE+ LL    H NI+ L D+     + +   ++LV E +  DL   I   +  ++   
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQH 135
Query: 108 IKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRD 167
           I+  +  ILLGL   H   ++HRDL P N+L+    N + + DF LAR         +  
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILL-ADNNDITICDFNLARE-DTADANKTHY 193
Query: 168 CVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF-PSKKHDHLSLIFSLLGTP 226
             +  Y+APEL++ + G++  +D+W+ GC+ AEM   K LF  S  ++ L+ I  ++GTP
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253
Query: 227 TDE------SWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRIT 280
             E      S +   Y+   L   P           P  +P  +DL+++ML  NP++RI+
Sbjct: 254 KIEDVVMFSSPSARDYLRNSLSNVP---ARAWTAVVPTADPVALDLIAKMLEFNPQRRIS 310
Query: 281 AMDALKHEYL 290
              AL+H Y 
Sbjct: 311 TEQALRHPYF 320

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 76/250 (30%), Positives = 125/250 (50%), Gaps = 17/250 (6%)
Query: 53  IIREVSLLKELEHENIVRLLDV-----QSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLV 107
           ++RE+ LL    H NI+ L D+     + +   ++LV E +  DL   I   +  ++   
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQH 135
Query: 108 IKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRD 167
           I+  +  ILLGL   H   ++HRDL P N+L+    N + + DF LAR         +  
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILL-ADNNDITICDFNLARE-DTADANKTHY 193
Query: 168 CVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF-PSKKHDHLSLIFSLLGTP 226
             +  Y+APEL++ + G++  +D+W+ GC+ AEM   K LF  S  ++ L+ I  ++GTP
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253
Query: 227 TDE------SWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRIT 280
             E      S +   Y+   L   P           P  +P  +DL+++ML  NP++RI+
Sbjct: 254 KIEDVVMFSSPSARDYLRNSLSNVP---ARAWTAVVPTADPVALDLIAKMLEFNPQRRIS 310
Query: 281 AMDALKHEYL 290
              AL+H Y 
Sbjct: 311 TEQALRHPYF 320

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  115 bits (288), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 90/284 (31%), Positives = 142/284 (50%), Gaps = 36/284 (12%)
Query: 31  TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL---EHENIVRLLDV-----QSSRKDVF 82
           TG  VAIK + IQ      P +  RE+ ++++L    H NIV+L        +  R+D++
Sbjct: 47  TGMSVAIKKV-IQD-----PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY 100
Query: 83  L--VFEYLDLDLHSFIT---RHKNTLNLLVIKAILKQILLGLAYCH--SLKILHRDLKPN 135
           L  V EY+   LH       R +     ++IK  L Q++  +   H  S+ + HRD+KP+
Sbjct: 101 LNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPH 160
Query: 136 NLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVG 195
           N+L++    T+KL DFG A+ +   +   +  C    Y+APEL+ G   Y+T +D+W+VG
Sbjct: 161 NVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY-YRAPELIFGNQHYTTAVDIWSVG 219
Query: 196 CIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAE--------STYISEILPLYPH 246
           CIFAEM+ G+P+F        L  I  +LG P+ E   +          Y S+ +P    
Sbjct: 220 CIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNV 279
Query: 247 FEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           F   +L +          DLLS +L   P++R+   +AL H Y 
Sbjct: 280 FSDHSLKDA-----KEAYDLLSALLQYLPEERMKPYEALCHPYF 318

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  114 bits (285), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 86/272 (31%), Positives = 136/272 (50%), Gaps = 31/272 (11%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           EV  CR+ VT  + AIK++   +      S ++ EV++LK L+H NI++L D    +++ 
Sbjct: 52  EVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNY 111
Query: 82  FLVFE-YLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLID 140
           +LV E Y   +L   I  H+   N +    I+KQ+L G+ Y H   I+HRDLKP NLL++
Sbjct: 112 YLVMECYKGGELFDEII-HRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLE 170
Query: 141 LKRNT--VKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIF 198
            K     +K+ DFGL+ A+   QK+       + Y APE+L     Y    DVW++G I 
Sbjct: 171 SKEKDALIKIVDFGLS-AVFENQKKMKERLGTAYYIAPEVL--RKKYDEKCDVWSIGVIL 227
Query: 199 AEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPN 258
             ++ G P F               G  TD+         EIL      +    + ++ N
Sbjct: 228 FILLAGYPPF---------------GGQTDQ---------EILRKVEKGKYTFDSPEWKN 263
Query: 259 LEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           +     DL+ QML  + ++RI+A  AL+H ++
Sbjct: 264 VSEGAKDLIKQMLQFDSQRRISAQQALEHPWI 295

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 86/286 (30%), Positives = 145/286 (50%), Gaps = 24/286 (8%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEH-ENIVRLLDVQSS--R 78
           EV++  N    +KV +K++    + +     I RE+ +L+ L    NI+ L D+      
Sbjct: 52  EVFEAINITNNEKVVVKILKPVKKNK-----IKREIKILENLRGGPNIITLADIVKDPVS 106
Query: 79  KDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLL 138
           +   LVFE+++   ++   +   TL    I+  + +IL  L YCHS+ I+HRD+KP+N++
Sbjct: 107 RTPALVFEHVN---NTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM 163
Query: 139 IDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIF 198
           ID +   ++L D+GLA     P +EY+       +K PELL+ Y  Y   +D+W++GC+ 
Sbjct: 164 IDHEHRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCML 222
Query: 199 AEMITGK-PLFPS-KKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHF---EPANLA 253
           A MI  K P F     +D L  I  +LGT     + +  Y  E+ P +            
Sbjct: 223 ASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK-YNIELDPRFNDILGRHSRKRW 281
Query: 254 EKFPNLE------PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
           E+F + E      P  +D L ++L  + + R+TA +A++H Y   V
Sbjct: 282 ERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 327

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 86/275 (31%), Positives = 143/275 (52%), Gaps = 36/275 (13%)
Query: 22  EVYKCRNTVTGQKVAIKMMTI-QTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKD 80
           EV  C++ +TGQ+ A+K+++  Q +Q+     ++REV LLK+L+H NI++L +    +  
Sbjct: 47  EVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGY 106
Query: 81  VFLVFE-YLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLI 139
            +LV E Y   +L   I   K    +   + I++Q+L G+ Y H  KI+HRDLKP NLL+
Sbjct: 107 FYLVGEVYTGGELFDEIISRKRFSEVDAAR-IIRQVLSGITYMHKNKIVHRDLKPENLLL 165
Query: 140 DLKRN--TVKLADFGLARAIGVPQKEYSRDCVYSPYK-APELLLGYTGYSTPIDVWAVGC 196
           + K     +++ DFGL+      +K   +D + + Y  APE+L G   Y    DVW+ G 
Sbjct: 166 ESKSKDANIRIIDFGLSTHFEASKK--MKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGV 221
Query: 197 IFAEMITGKPLF-PSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEK 255
           I   +++G P F  + ++D L  +             +  Y  E+    P ++  + + K
Sbjct: 222 ILYILLSGCPPFNGANEYDILKKV------------EKGKYTFEL----PQWKKVSESAK 265
Query: 256 FPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                    DL+ +ML   P  RI+A DAL HE++
Sbjct: 266 ---------DLIRKMLTYVPSMRISARDALDHEWI 291

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 86/275 (31%), Positives = 143/275 (52%), Gaps = 36/275 (13%)
Query: 22  EVYKCRNTVTGQKVAIKMMTI-QTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKD 80
           EV  C++ +TGQ+ A+K+++  Q +Q+     ++REV LLK+L+H NI++L +    +  
Sbjct: 64  EVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGY 123
Query: 81  VFLVFE-YLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLI 139
            +LV E Y   +L   I   K    +   + I++Q+L G+ Y H  KI+HRDLKP NLL+
Sbjct: 124 FYLVGEVYTGGELFDEIISRKRFSEVDAAR-IIRQVLSGITYMHKNKIVHRDLKPENLLL 182
Query: 140 DLKRN--TVKLADFGLARAIGVPQKEYSRDCVYSPYK-APELLLGYTGYSTPIDVWAVGC 196
           + K     +++ DFGL+      +K   +D + + Y  APE+L G   Y    DVW+ G 
Sbjct: 183 ESKSKDANIRIIDFGLSTHFEASKK--MKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGV 238
Query: 197 IFAEMITGKPLF-PSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEK 255
           I   +++G P F  + ++D L  +             +  Y  E+    P ++  + + K
Sbjct: 239 ILYILLSGCPPFNGANEYDILKKV------------EKGKYTFEL----PQWKKVSESAK 282
Query: 256 FPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                    DL+ +ML   P  RI+A DAL HE++
Sbjct: 283 ---------DLIRKMLTYVPSMRISARDALDHEWI 308

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 86/275 (31%), Positives = 143/275 (52%), Gaps = 36/275 (13%)
Query: 22  EVYKCRNTVTGQKVAIKMMTI-QTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKD 80
           EV  C++ +TGQ+ A+K+++  Q +Q+     ++REV LLK+L+H NI++L +    +  
Sbjct: 65  EVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGY 124
Query: 81  VFLVFE-YLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLI 139
            +LV E Y   +L   I   K    +   + I++Q+L G+ Y H  KI+HRDLKP NLL+
Sbjct: 125 FYLVGEVYTGGELFDEIISRKRFSEVDAAR-IIRQVLSGITYMHKNKIVHRDLKPENLLL 183
Query: 140 DLKRN--TVKLADFGLARAIGVPQKEYSRDCVYSPYK-APELLLGYTGYSTPIDVWAVGC 196
           + K     +++ DFGL+      +K   +D + + Y  APE+L G   Y    DVW+ G 
Sbjct: 184 ESKSKDANIRIIDFGLSTHFEASKK--MKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGV 239
Query: 197 IFAEMITGKPLF-PSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEK 255
           I   +++G P F  + ++D L  +             +  Y  E+    P ++  + + K
Sbjct: 240 ILYILLSGCPPFNGANEYDILKKV------------EKGKYTFEL----PQWKKVSESAK 283
Query: 256 FPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                    DL+ +ML   P  RI+A DAL HE++
Sbjct: 284 ---------DLIRKMLTYVPSMRISARDALDHEWI 309

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  111 bits (278), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 86/275 (31%), Positives = 143/275 (52%), Gaps = 36/275 (13%)
Query: 22  EVYKCRNTVTGQKVAIKMMTI-QTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKD 80
           EV  C++ +TGQ+ A+K+++  Q +Q+     ++REV LLK+L+H NI++L +    +  
Sbjct: 41  EVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGY 100
Query: 81  VFLVFE-YLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLI 139
            +LV E Y   +L   I   K    +   + I++Q+L G+ Y H  KI+HRDLKP NLL+
Sbjct: 101 FYLVGEVYTGGELFDEIISRKRFSEVDAAR-IIRQVLSGITYMHKNKIVHRDLKPENLLL 159
Query: 140 DLKRN--TVKLADFGLARAIGVPQKEYSRDCVYSPYK-APELLLGYTGYSTPIDVWAVGC 196
           + K     +++ DFGL+      +K   +D + + Y  APE+L G   Y    DVW+ G 
Sbjct: 160 ESKSKDANIRIIDFGLSTHFEASKK--MKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGV 215
Query: 197 IFAEMITGKPLF-PSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEK 255
           I   +++G P F  + ++D L  +             +  Y  E+    P ++  + + K
Sbjct: 216 ILYILLSGCPPFNGANEYDILKKV------------EKGKYTFEL----PQWKKVSESAK 259
Query: 256 FPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                    DL+ +ML   P  RI+A DAL HE++
Sbjct: 260 ---------DLIRKMLTYVPSMRISARDALDHEWI 285

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score =  111 bits (277), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 78/243 (32%), Positives = 126/243 (51%), Gaps = 24/243 (9%)
Query: 67  NIVRLLDVQSS--RKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
           NI++L+D       K   LVFEY++   ++   +    L    I+  + ++L  L YCHS
Sbjct: 99  NIIKLIDTVKDPVSKTPALVFEYIN---NTDFKQLYQILTDFDIRFYMYELLKALDYCHS 155
Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTG 184
             I+HRD+KP+N++ID ++  ++L D+GLA     P +EY+       +K PELL+ Y  
Sbjct: 156 KGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYH-PAQEYNVRVASRYFKGPELLVDYQM 214
Query: 185 YSTPIDVWAVGCIFAEMITGK-PLFPSK-KHDHLSLIFSLLGTPTDESWAESTYISEILP 242
           Y   +D+W++GC+ A MI  + P F  +  +D L  I  +LGT     + +  +I     
Sbjct: 215 YDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHID---- 270
Query: 243 LYPHF------EPANLAEKFPNLE------PAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           L PHF            E F + E      P  +DLL ++L  + +QR+TA +A++H Y 
Sbjct: 271 LDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYF 330
Query: 291 IGV 293
             V
Sbjct: 331 YPV 333

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score =  111 bits (277), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 78/243 (32%), Positives = 126/243 (51%), Gaps = 24/243 (9%)
Query: 67  NIVRLLDVQSS--RKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
           NI++L+D       K   LVFEY++   ++   +    L    I+  + ++L  L YCHS
Sbjct: 94  NIIKLIDTVKDPVSKTPALVFEYIN---NTDFKQLYQILTDFDIRFYMYELLKALDYCHS 150
Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTG 184
             I+HRD+KP+N++ID ++  ++L D+GLA     P +EY+       +K PELL+ Y  
Sbjct: 151 KGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYH-PAQEYNVRVASRYFKGPELLVDYQM 209
Query: 185 YSTPIDVWAVGCIFAEMITGK-PLFPSK-KHDHLSLIFSLLGTPTDESWAESTYISEILP 242
           Y   +D+W++GC+ A MI  + P F  +  +D L  I  +LGT     + +  +I     
Sbjct: 210 YDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHID---- 265
Query: 243 LYPHF------EPANLAEKFPNLE------PAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           L PHF            E F + E      P  +DLL ++L  + +QR+TA +A++H Y 
Sbjct: 266 LDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYF 325
Query: 291 IGV 293
             V
Sbjct: 326 YPV 328

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 81/267 (30%), Positives = 132/267 (49%), Gaps = 35/267 (13%)
Query: 27  RNTVTGQKVAIKMMTIQTEQE-GVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF 85
           ++ +TG KVA+K++  Q  +   V   I RE+  LK   H +I++L  V S+  D+F+V 
Sbjct: 36  KHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95
Query: 86  EYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN 144
           EY+   +L  +I ++   L+    + + +QIL G+ YCH   ++HRDLKP N+L+D   N
Sbjct: 96  EYVSGGELFDYICKN-GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMN 154
Query: 145 TVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
             K+ADFGL+  +     E+ R    SP Y APE++ G       +D+W+ G I   ++ 
Sbjct: 155 A-KIADFGLSNMMS--DGEFLRXSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLC 211
Query: 204 GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAG 263
           G   F     DH+  +F                I + +   P +           L P+ 
Sbjct: 212 GTLPFDD---DHVPTLFK--------------KICDGIFYTPQY-----------LNPSV 243
Query: 264 VDLLSQMLCLNPKQRITAMDALKHEYL 290
           + LL  ML ++P +R T  D  +HE+ 
Sbjct: 244 ISLLKHMLQVDPMKRATIKDIREHEWF 270

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 85/275 (30%), Positives = 141/275 (51%), Gaps = 36/275 (13%)
Query: 22  EVYKCRNTVTGQKVAIKMMTI-QTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKD 80
           EV  C++ +TGQ+ A+K+++  Q +Q+     ++REV LLK+L+H NI +L +    +  
Sbjct: 41  EVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLYEFFEDKGY 100
Query: 81  VFLVFE-YLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLI 139
            +LV E Y   +L   I   K    +   + I++Q+L G+ Y H  KI+HRDLKP NLL+
Sbjct: 101 FYLVGEVYTGGELFDEIISRKRFSEVDAAR-IIRQVLSGITYXHKNKIVHRDLKPENLLL 159
Query: 140 DLKRN--TVKLADFGLARAIGVPQKEYSRDCVYSPYK-APELLLGYTGYSTPIDVWAVGC 196
           + K     +++ DFGL+      +K   +D + + Y  APE+L G   Y    DVW+ G 
Sbjct: 160 ESKSKDANIRIIDFGLSTHFEASKK--XKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGV 215
Query: 197 IFAEMITGKPLF-PSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEK 255
           I   +++G P F  + ++D L  +             +  Y  E+    P ++  + + K
Sbjct: 216 ILYILLSGCPPFNGANEYDILKKV------------EKGKYTFEL----PQWKKVSESAK 259
Query: 256 FPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                    DL+ + L   P  RI+A DAL HE++
Sbjct: 260 ---------DLIRKXLTYVPSXRISARDALDHEWI 285

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 82/274 (29%), Positives = 135/274 (49%), Gaps = 35/274 (12%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           EV KC++ +T Q+ A+K++   + +    S I+REV LLK+L+H NI++L ++       
Sbjct: 37  EVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96
Query: 82  FLVFE-YLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLID 140
           ++V E Y   +L   I + K        + I+KQ+  G+ Y H   I+HRDLKP N+L++
Sbjct: 97  YIVGELYTGGELFDEIIKRKRFSEHDAAR-IIKQVFSGITYMHKHNIVHRDLKPENILLE 155
Query: 141 LKRN--TVKLADFGLARAIGVPQKEYSRDCVYSPYK-APELLLGYTGYSTPIDVWAVGCI 197
            K     +K+ DFGL+      Q    +D + + Y  APE+L G   Y    DVW+ G I
Sbjct: 156 SKEKDCDIKIIDFGLSTCF--QQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVI 211
Query: 198 FAEMITGKPLFPSK-KHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKF 256
              +++G P F  K ++D L  +             E+   +  LP            ++
Sbjct: 212 LYILLSGTPPFYGKNEYDILKRV-------------ETGKYAFDLP------------QW 246
Query: 257 PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
             +     DL+ +ML  +P  RITA   L+H ++
Sbjct: 247 RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 82/274 (29%), Positives = 135/274 (49%), Gaps = 35/274 (12%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           EV KC++ +T Q+ A+K++   + +    S I+REV LLK+L+H NI++L ++       
Sbjct: 37  EVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96
Query: 82  FLVFE-YLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLID 140
           ++V E Y   +L   I + K        + I+KQ+  G+ Y H   I+HRDLKP N+L++
Sbjct: 97  YIVGELYTGGELFDEIIKRKRFSEHDAAR-IIKQVFSGITYMHKHNIVHRDLKPENILLE 155
Query: 141 LKRN--TVKLADFGLARAIGVPQKEYSRDCVYSPYK-APELLLGYTGYSTPIDVWAVGCI 197
            K     +K+ DFGL+      Q    +D + + Y  APE+L G   Y    DVW+ G I
Sbjct: 156 SKEKDCDIKIIDFGLSTCF--QQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVI 211
Query: 198 FAEMITGKPLFPSK-KHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKF 256
              +++G P F  K ++D L  +             E+   +  LP            ++
Sbjct: 212 LYILLSGTPPFYGKNEYDILKRV-------------ETGKYAFDLP------------QW 246
Query: 257 PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
             +     DL+ +ML  +P  RITA   L+H ++
Sbjct: 247 RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 82/274 (29%), Positives = 135/274 (49%), Gaps = 35/274 (12%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           EV KC++ +T Q+ A+K++   + +    S I+REV LLK+L+H NI++L ++       
Sbjct: 37  EVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96
Query: 82  FLVFE-YLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLID 140
           ++V E Y   +L   I + K        + I+KQ+  G+ Y H   I+HRDLKP N+L++
Sbjct: 97  YIVGELYTGGELFDEIIKRKRFSEHDAAR-IIKQVFSGITYMHKHNIVHRDLKPENILLE 155
Query: 141 LKRN--TVKLADFGLARAIGVPQKEYSRDCVYSPYK-APELLLGYTGYSTPIDVWAVGCI 197
            K     +K+ DFGL+      Q    +D + + Y  APE+L G   Y    DVW+ G I
Sbjct: 156 SKEKDCDIKIIDFGLSTCF--QQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVI 211
Query: 198 FAEMITGKPLFPSK-KHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKF 256
              +++G P F  K ++D L  +             E+   +  LP            ++
Sbjct: 212 LYILLSGTPPFYGKNEYDILKRV-------------ETGKYAFDLP------------QW 246
Query: 257 PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
             +     DL+ +ML  +P  RITA   L+H ++
Sbjct: 247 RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  108 bits (269), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 129/264 (48%), Gaps = 32/264 (12%)
Query: 28  NTVTGQKVAIKMMTIQT-EQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE 86
           +T TGQKVA+K++  +   +  +   I RE+S L+ L H +I++L DV  S+ ++ +V E
Sbjct: 35  HTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE 94
Query: 87  YLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTV 146
           Y   +L  +I + ++ ++    +   +QI+  + YCH  KI+HRDLKP NLL+D   N V
Sbjct: 95  YAGNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLN-V 152
Query: 147 KLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKP 206
           K+ADFGL+  I          C    Y APE++ G       +DVW+ G I   M+  + 
Sbjct: 153 KIADFGLSN-IMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRL 211
Query: 207 LFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDL 266
            F     + + ++F                IS  +   P F           L P    L
Sbjct: 212 PFDD---ESIPVLFK--------------NISNGVYTLPKF-----------LSPGAAGL 243
Query: 267 LSQMLCLNPKQRITAMDALKHEYL 290
           + +ML +NP  RI+  + ++ ++ 
Sbjct: 244 IKRMLIVNPLNRISIHEIMQDDWF 267

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 129/264 (48%), Gaps = 32/264 (12%)
Query: 28  NTVTGQKVAIKMMTIQT-EQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE 86
           +T TGQKVA+K++  +   +  +   I RE+S L+ L H +I++L DV  S+ ++ +V E
Sbjct: 34  HTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE 93
Query: 87  YLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTV 146
           Y   +L  +I + ++ ++    +   +QI+  + YCH  KI+HRDLKP NLL+D   N V
Sbjct: 94  YAGNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLN-V 151
Query: 147 KLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKP 206
           K+ADFGL+  I          C    Y APE++ G       +DVW+ G I   M+  + 
Sbjct: 152 KIADFGLSN-IMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRL 210
Query: 207 LFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDL 266
            F     + + ++F                IS  +   P F           L P    L
Sbjct: 211 PFDD---ESIPVLFK--------------NISNGVYTLPKF-----------LSPGAAGL 242
Query: 267 LSQMLCLNPKQRITAMDALKHEYL 290
           + +ML +NP  RI+  + ++ ++ 
Sbjct: 243 IKRMLIVNPLNRISIHEIMQDDWF 266

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  107 bits (268), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 129/264 (48%), Gaps = 32/264 (12%)
Query: 28  NTVTGQKVAIKMMTIQT-EQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE 86
           +T TGQKVA+K++  +   +  +   I RE+S L+ L H +I++L DV  S+ ++ +V E
Sbjct: 25  HTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE 84
Query: 87  YLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTV 146
           Y   +L  +I + ++ ++    +   +QI+  + YCH  KI+HRDLKP NLL+D   N V
Sbjct: 85  YAGNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLN-V 142
Query: 147 KLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKP 206
           K+ADFGL+  I          C    Y APE++ G       +DVW+ G I   M+  + 
Sbjct: 143 KIADFGLSN-IMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRL 201
Query: 207 LFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDL 266
            F     + + ++F                IS  +   P F           L P    L
Sbjct: 202 PFDD---ESIPVLFK--------------NISNGVYTLPKF-----------LSPGAAGL 233
Query: 267 LSQMLCLNPKQRITAMDALKHEYL 290
           + +ML +NP  RI+  + ++ ++ 
Sbjct: 234 IKRMLIVNPLNRISIHEIMQDDWF 257

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  107 bits (268), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 129/264 (48%), Gaps = 32/264 (12%)
Query: 28  NTVTGQKVAIKMMTIQT-EQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE 86
           +T TGQKVA+K++  +   +  +   I RE+S L+ L H +I++L DV  S+ ++ +V E
Sbjct: 29  HTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE 88
Query: 87  YLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTV 146
           Y   +L  +I + ++ ++    +   +QI+  + YCH  KI+HRDLKP NLL+D   N V
Sbjct: 89  YAGNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLN-V 146
Query: 147 KLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKP 206
           K+ADFGL+  I          C    Y APE++ G       +DVW+ G I   M+  + 
Sbjct: 147 KIADFGLSN-IMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRL 205
Query: 207 LFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDL 266
            F  +    + ++F                IS  +   P F           L P    L
Sbjct: 206 PFDDES---IPVLFK--------------NISNGVYTLPKF-----------LSPGAAGL 237
Query: 267 LSQMLCLNPKQRITAMDALKHEYL 290
           + +ML +NP  RI+  + ++ ++ 
Sbjct: 238 IKRMLIVNPLNRISIHEIMQDDWF 261

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 80/241 (33%), Positives = 124/241 (51%), Gaps = 20/241 (8%)
Query: 67  NIVRLLDV--QSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCH 123
           NIV+LLD+      K   L+FEY++  D          TL    I+  + ++L  L YCH
Sbjct: 108 NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP----TLTDYDIRYYIYELLKALDYCH 163
Query: 124 SLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYT 183
           S  I+HRD+KP+N++ID +   ++L D+GLA     P KEY+       +K PELL+   
Sbjct: 164 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQ 222
Query: 184 GYSTPIDVWAVGCIFAEMITGK-PLF-PSKKHDHLSLIFSLLGTPTDESWAESTYISEIL 241
            Y   +D+W++GC+FA MI  K P F     HD L  I  +LGT    ++  + Y  E+ 
Sbjct: 223 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNAYL-NKYRIELD 281
Query: 242 PLYPHFEPANLAE---KFPNLE------PAGVDLLSQMLCLNPKQRITAMDALKHEYLIG 292
           P        +  +   KF N +      P  +D L ++L  + ++R+TA++A+ H Y   
Sbjct: 282 PQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 341
Query: 293 V 293
           V
Sbjct: 342 V 342

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 83/282 (29%), Positives = 129/282 (45%), Gaps = 51/282 (18%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           V +C   + GQ+ A K++  +         + RE  + + L+H NIVRL D  S     +
Sbjct: 38  VRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY 97
Query: 83  LVFE-------YLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPN 135
           L+F+       + D+    + +    +         ++QIL  + +CH + ++HRDLKP 
Sbjct: 98  LIFDLVTGGELFEDIVAREYYSEADAS-------HCIQQILEAVLHCHQMGVVHRDLKPE 150
Query: 136 NLLI--DLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           NLL+   LK   VKLADFGLA  +   Q+ +        Y +PE+L     Y  P+D+WA
Sbjct: 151 NLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWA 209
Query: 194 VGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLA 253
            G I   ++ G P F                      W E  +      LY   +    A
Sbjct: 210 CGVILYILLVGYPPF----------------------WDEDQH-----RLYQQIKAG--A 240
Query: 254 EKFPNLE-----PAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
             FP+ E     P   DL+++ML +NP +RITA +ALKH ++
Sbjct: 241 YDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWI 282

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 85/277 (30%), Positives = 131/277 (47%), Gaps = 35/277 (12%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQ--TEQEGVPSY-IIREVSLLKELEHENIVRLLDVQSSRK 79
           V +C N  TGQ+ A+K++ +   T   G+ +  + RE S+   L+H +IV LL+  SS  
Sbjct: 40  VRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDG 99
Query: 80  DVFLVFEYLD-LDLHSFITRHKNT---LNLLVIKAILKQILLGLAYCHSLKILHRDLKPN 135
            +++VFE++D  DL   I +  +     +  V    ++QIL  L YCH   I+HRD+KP 
Sbjct: 100 MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPE 159
Query: 136 NLLIDLKRNT--VKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           N+L+  K N+  VKL DFG+A  +G              + APE ++    Y  P+DVW 
Sbjct: 160 NVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPE-VVKREPYGKPVDVWG 218
Query: 194 VGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLA 253
            G I   +++G   F   K      I           W   ++ISE              
Sbjct: 219 CGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQW---SHISE-------------- 261
Query: 254 EKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                   +  DL+ +ML L+P +RIT  +AL H +L
Sbjct: 262 --------SAKDLVRRMLMLDPAERITVYEALNHPWL 290

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 81/245 (33%), Positives = 124/245 (50%), Gaps = 28/245 (11%)
Query: 67  NIVRLLDV--QSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCH 123
           NIV+LLD+      K   L+FEY++  D          TL    I+  + ++L  L YCH
Sbjct: 88  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP----TLTDYDIRYYIYELLKALDYCH 143
Query: 124 SLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYT 183
           S  I+HRD+KP+N++ID +   ++L D+GLA     P KEY+       +K PELL+   
Sbjct: 144 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQ 202
Query: 184 GYSTPIDVWAVGCIFAEMITGK-PLF-PSKKHDHLSLIFSLLGTPTDESWAESTYISEI- 240
            Y   +D+W++GC+FA MI  K P F     HD L  I  +LGT        + Y+++  
Sbjct: 203 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD-----GLNVYLNKYR 257
Query: 241 LPLYPHFEPANLAE------KFPNLE------PAGVDLLSQMLCLNPKQRITAMDALKHE 288
           + L P  E            KF N +      P  +D L ++L  + ++R+TA++A+ H 
Sbjct: 258 IELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHP 317
Query: 289 YLIGV 293
           Y   V
Sbjct: 318 YFQQV 322

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 81/245 (33%), Positives = 124/245 (50%), Gaps = 28/245 (11%)
Query: 67  NIVRLLDV--QSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCH 123
           NIV+LLD+      K   L+FEY++  D          TL    I+  + ++L  L YCH
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP----TLTDYDIRYYIYELLKALDYCH 142
Query: 124 SLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYT 183
           S  I+HRD+KP+N++ID +   ++L D+GLA     P KEY+       +K PELL+   
Sbjct: 143 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQ 201
Query: 184 GYSTPIDVWAVGCIFAEMITGK-PLF-PSKKHDHLSLIFSLLGTPTDESWAESTYISEI- 240
            Y   +D+W++GC+FA MI  K P F     HD L  I  +LGT        + Y+++  
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD-----GLNVYLNKYR 256
Query: 241 LPLYPHFEPANLAE------KFPNLE------PAGVDLLSQMLCLNPKQRITAMDALKHE 288
           + L P  E            KF N +      P  +D L ++L  + ++R+TA++A+ H 
Sbjct: 257 IELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHP 316
Query: 289 YLIGV 293
           Y   V
Sbjct: 317 YFQQV 321

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 81/245 (33%), Positives = 124/245 (50%), Gaps = 28/245 (11%)
Query: 67  NIVRLLDV--QSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCH 123
           NIV+LLD+      K   L+FEY++  D          TL    I+  + ++L  L YCH
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP----TLTDYDIRYYIYELLKALDYCH 142
Query: 124 SLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYT 183
           S  I+HRD+KP+N++ID +   ++L D+GLA     P KEY+       +K PELL+   
Sbjct: 143 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQ 201
Query: 184 GYSTPIDVWAVGCIFAEMITGK-PLF-PSKKHDHLSLIFSLLGTPTDESWAESTYISEI- 240
            Y   +D+W++GC+FA MI  K P F     HD L  I  +LGT        + Y+++  
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD-----GLNVYLNKYR 256
Query: 241 LPLYPHFEPANLAE------KFPNLE------PAGVDLLSQMLCLNPKQRITAMDALKHE 288
           + L P  E            KF N +      P  +D L ++L  + ++R+TA++A+ H 
Sbjct: 257 IELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHP 316
Query: 289 YLIGV 293
           Y   V
Sbjct: 317 YFQQV 321

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 81/245 (33%), Positives = 124/245 (50%), Gaps = 28/245 (11%)
Query: 67  NIVRLLDV--QSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCH 123
           NIV+LLD+      K   L+FEY++  D          TL    I+  + ++L  L YCH
Sbjct: 88  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP----TLTDYDIRYYIYELLKALDYCH 143
Query: 124 SLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYT 183
           S  I+HRD+KP+N++ID +   ++L D+GLA     P KEY+       +K PELL+   
Sbjct: 144 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQ 202
Query: 184 GYSTPIDVWAVGCIFAEMITGK-PLF-PSKKHDHLSLIFSLLGTPTDESWAESTYISEI- 240
            Y   +D+W++GC+FA MI  K P F     HD L  I  +LGT        + Y+++  
Sbjct: 203 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD-----GLNVYLNKYR 257
Query: 241 LPLYPHFEPANLAE------KFPNLE------PAGVDLLSQMLCLNPKQRITAMDALKHE 288
           + L P  E            KF N +      P  +D L ++L  + ++R+TA++A+ H 
Sbjct: 258 IELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHP 317
Query: 289 YLIGV 293
           Y   V
Sbjct: 318 YFQQV 322

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 75/240 (31%), Positives = 124/240 (51%), Gaps = 18/240 (7%)
Query: 67  NIVRLLDVQSS--RKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
           NI+ L D+      +   LVFE+++   ++   + + TL    I+  + +IL  L YCHS
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVN---NTDFKQLRQTLTDYDIRFYMYEILKALDYCHS 149
Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTG 184
           + I+HRD+KP+N++ID +   ++L D+GLA     P +EY+       +K PELL+ Y  
Sbjct: 150 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLVDYQM 208
Query: 185 YSTPIDVWAVGCIFAEMITGK-PLFPS-KKHDHLSLIFSLLGTPTDESWAESTYISEILP 242
           Y   +D+W++GC+ A MI  K P F     +D L  I  +LGT     + +  Y  E+ P
Sbjct: 209 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK-YNIELDP 267
Query: 243 LYPHF---EPANLAEKFPNLE------PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
            +            E+F + E      P  +D L ++L  + + R+TA +A++H Y   V
Sbjct: 268 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 327

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 81/245 (33%), Positives = 124/245 (50%), Gaps = 28/245 (11%)
Query: 67  NIVRLLDV--QSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCH 123
           NIV+LLD+      K   L+FEY++  D          TL    I+  + ++L  L YCH
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP----TLTDYDIRYYIYELLKALDYCH 142
Query: 124 SLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYT 183
           S  I+HRD+KP+N++ID +   ++L D+GLA     P KEY+       +K PELL+   
Sbjct: 143 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQ 201
Query: 184 GYSTPIDVWAVGCIFAEMITGK-PLF-PSKKHDHLSLIFSLLGTPTDESWAESTYISEI- 240
            Y   +D+W++GC+FA MI  K P F     HD L  I  +LGT        + Y+++  
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD-----GLNVYLNKYR 256
Query: 241 LPLYPHFEPANLAE------KFPNLE------PAGVDLLSQMLCLNPKQRITAMDALKHE 288
           + L P  E            KF N +      P  +D L ++L  + ++R+TA++A+ H 
Sbjct: 257 IELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHP 316
Query: 289 YLIGV 293
           Y   V
Sbjct: 317 YFQQV 321

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 81/245 (33%), Positives = 124/245 (50%), Gaps = 28/245 (11%)
Query: 67  NIVRLLDV--QSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCH 123
           NIV+LLD+      K   L+FEY++  D          TL    I+  + ++L  L YCH
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP----TLTDYDIRYYIYELLKALDYCH 142
Query: 124 SLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYT 183
           S  I+HRD+KP+N++ID +   ++L D+GLA     P KEY+       +K PELL+   
Sbjct: 143 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQ 201
Query: 184 GYSTPIDVWAVGCIFAEMITGK-PLF-PSKKHDHLSLIFSLLGTPTDESWAESTYISEI- 240
            Y   +D+W++GC+FA MI  K P F     HD L  I  +LGT        + Y+++  
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD-----GLNVYLNKYR 256
Query: 241 LPLYPHFEPANLAE------KFPNLE------PAGVDLLSQMLCLNPKQRITAMDALKHE 288
           + L P  E            KF N +      P  +D L ++L  + ++R+TA++A+ H 
Sbjct: 257 IELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHP 316
Query: 289 YLIGV 293
           Y   V
Sbjct: 317 YFQQV 321

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 81/245 (33%), Positives = 124/245 (50%), Gaps = 28/245 (11%)
Query: 67  NIVRLLDV--QSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCH 123
           NIV+LLD+      K   L+FEY++  D          TL    I+  + ++L  L YCH
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP----TLTDYDIRYYIYELLKALDYCH 142
Query: 124 SLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYT 183
           S  I+HRD+KP+N++ID +   ++L D+GLA     P KEY+       +K PELL+   
Sbjct: 143 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQ 201
Query: 184 GYSTPIDVWAVGCIFAEMITGK-PLF-PSKKHDHLSLIFSLLGTPTDESWAESTYISEI- 240
            Y   +D+W++GC+FA MI  K P F     HD L  I  +LGT        + Y+++  
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD-----GLNVYLNKYR 256
Query: 241 LPLYPHFEPANLAE------KFPNLE------PAGVDLLSQMLCLNPKQRITAMDALKHE 288
           + L P  E            KF N +      P  +D L ++L  + ++R+TA++A+ H 
Sbjct: 257 IELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHP 316
Query: 289 YLIGV 293
           Y   V
Sbjct: 317 YFQQV 321

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 81/245 (33%), Positives = 124/245 (50%), Gaps = 28/245 (11%)
Query: 67  NIVRLLDV--QSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCH 123
           NIV+LLD+      K   L+FEY++  D          TL    I+  + ++L  L YCH
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP----TLTDYDIRYYIYELLKALDYCH 142
Query: 124 SLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYT 183
           S  I+HRD+KP+N++ID +   ++L D+GLA     P KEY+       +K PELL+   
Sbjct: 143 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQ 201
Query: 184 GYSTPIDVWAVGCIFAEMITGK-PLF-PSKKHDHLSLIFSLLGTPTDESWAESTYISEI- 240
            Y   +D+W++GC+FA MI  K P F     HD L  I  +LGT        + Y+++  
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD-----GLNVYLNKYR 256
Query: 241 LPLYPHFEPANLAE------KFPNLE------PAGVDLLSQMLCLNPKQRITAMDALKHE 288
           + L P  E            KF N +      P  +D L ++L  + ++R+TA++A+ H 
Sbjct: 257 IELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHP 316
Query: 289 YLIGV 293
           Y   V
Sbjct: 317 YFQQV 321

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 81/245 (33%), Positives = 124/245 (50%), Gaps = 28/245 (11%)
Query: 67  NIVRLLDV--QSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCH 123
           NIV+LLD+      K   L+FEY++  D          TL    I+  + ++L  L YCH
Sbjct: 89  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP----TLTDYDIRYYIYELLKALDYCH 144
Query: 124 SLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYT 183
           S  I+HRD+KP+N++ID +   ++L D+GLA     P KEY+       +K PELL+   
Sbjct: 145 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQ 203
Query: 184 GYSTPIDVWAVGCIFAEMITGK-PLF-PSKKHDHLSLIFSLLGTPTDESWAESTYISEI- 240
            Y   +D+W++GC+FA MI  K P F     HD L  I  +LGT        + Y+++  
Sbjct: 204 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD-----GLNVYLNKYR 258
Query: 241 LPLYPHFEPANLAE------KFPNLE------PAGVDLLSQMLCLNPKQRITAMDALKHE 288
           + L P  E            KF N +      P  +D L ++L  + ++R+TA++A+ H 
Sbjct: 259 IELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHP 318
Query: 289 YLIGV 293
           Y   V
Sbjct: 319 YFQQV 323

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 87/277 (31%), Positives = 135/277 (48%), Gaps = 37/277 (13%)
Query: 23  VYKCRNTVTGQKVA---IKMMTIQTEQEGVPSYII-REVSLLKELEHENIVRLLDVQSSR 78
           V KCR   TG + A   IK    ++ + GV    I REVS+LKE++H N++ L +V  ++
Sbjct: 27  VKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 86
Query: 79  KDVFLVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
            DV L+ E +   +L  F+   K +L        LKQIL G+ Y HSL+I H DLKP N+
Sbjct: 87  TDVILILELVAGGELFDFLA-EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENI 145
Query: 138 LIDLKRNT----VKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           ++ L RN     +K+ DFGLA  I     E+        + APE ++ Y       D+W+
Sbjct: 146 ML-LDRNVPKPRIKIIDFGLAHKIDFGN-EFKNIFGTPAFVAPE-IVNYEPLGLEADMWS 202
Query: 194 VGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLA 253
           +G I   +++G   F              LG    E+ A  + ++        FE     
Sbjct: 203 IGVITYILLSGASPF--------------LGDTKQETLANVSAVN------YEFED---- 238
Query: 254 EKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           E F N      D + ++L  +PK+R+T  D+L+H ++
Sbjct: 239 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 87/277 (31%), Positives = 135/277 (48%), Gaps = 37/277 (13%)
Query: 23  VYKCRNTVTGQKVA---IKMMTIQTEQEGVPSYII-REVSLLKELEHENIVRLLDVQSSR 78
           V KCR   TG + A   IK    ++ + GV    I REVS+LKE++H N++ L +V  ++
Sbjct: 27  VKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 86
Query: 79  KDVFLVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
            DV L+ E +   +L  F+   K +L        LKQIL G+ Y HSL+I H DLKP N+
Sbjct: 87  TDVILILELVAGGELFDFLA-EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENI 145
Query: 138 LIDLKRNT----VKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           ++ L RN     +K+ DFGLA  I     E+        + APE ++ Y       D+W+
Sbjct: 146 ML-LDRNVPKPRIKIIDFGLAHKIDFGN-EFKNIFGTPEFVAPE-IVNYEPLGLEADMWS 202
Query: 194 VGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLA 253
           +G I   +++G   F              LG    E+ A  + ++        FE     
Sbjct: 203 IGVITYILLSGASPF--------------LGDTKQETLANVSAVN------YEFED---- 238
Query: 254 EKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           E F N      D + ++L  +PK+R+T  D+L+H ++
Sbjct: 239 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 87/277 (31%), Positives = 135/277 (48%), Gaps = 37/277 (13%)
Query: 23  VYKCRNTVTGQKVA---IKMMTIQTEQEGVPSYII-REVSLLKELEHENIVRLLDVQSSR 78
           V KCR   TG + A   IK    ++ + GV    I REVS+LKE++H N++ L +V  ++
Sbjct: 27  VKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 86
Query: 79  KDVFLVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
            DV L+ E +   +L  F+   K +L        LKQIL G+ Y HSL+I H DLKP N+
Sbjct: 87  TDVILILELVAGGELFDFLA-EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENI 145
Query: 138 LIDLKRNT----VKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           ++ L RN     +K+ DFGLA  I     E+        + APE ++ Y       D+W+
Sbjct: 146 ML-LDRNVPKPRIKIIDFGLAHKIDFGN-EFKNIFGTPEFVAPE-IVNYEPLGLEADMWS 202
Query: 194 VGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLA 253
           +G I   +++G   F              LG    E+ A  + ++        FE     
Sbjct: 203 IGVITYILLSGASPF--------------LGDTKQETLANVSAVN------YEFED---- 238
Query: 254 EKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           E F N      D + ++L  +PK+R+T  D+L+H ++
Sbjct: 239 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 87/277 (31%), Positives = 135/277 (48%), Gaps = 37/277 (13%)
Query: 23  VYKCRNTVTGQKVA---IKMMTIQTEQEGVPSYII-REVSLLKELEHENIVRLLDVQSSR 78
           V KCR   TG + A   IK    ++ + GV    I REVS+LKE++H N++ L +V  ++
Sbjct: 27  VKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 86
Query: 79  KDVFLVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
            DV L+ E +   +L  F+   K +L        LKQIL G+ Y HSL+I H DLKP N+
Sbjct: 87  TDVILILELVAGGELFDFLA-EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENI 145
Query: 138 LIDLKRNT----VKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           ++ L RN     +K+ DFGLA  I     E+        + APE ++ Y       D+W+
Sbjct: 146 ML-LDRNVPKPRIKIIDFGLAHKIDFGN-EFKNIFGTPEFVAPE-IVNYEPLGLEADMWS 202
Query: 194 VGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLA 253
           +G I   +++G   F              LG    E+ A  + ++        FE     
Sbjct: 203 IGVITYILLSGASPF--------------LGDTKQETLANVSAVN------YEFED---- 238
Query: 254 EKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           E F N      D + ++L  +PK+R+T  D+L+H ++
Sbjct: 239 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 87/277 (31%), Positives = 135/277 (48%), Gaps = 37/277 (13%)
Query: 23  VYKCRNTVTGQKVA---IKMMTIQTEQEGVPSYII-REVSLLKELEHENIVRLLDVQSSR 78
           V KCR   TG + A   IK    ++ + GV    I REVS+LKE++H N++ L +V  ++
Sbjct: 27  VKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 86
Query: 79  KDVFLVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
            DV L+ E +   +L  F+   K +L        LKQIL G+ Y HSL+I H DLKP N+
Sbjct: 87  TDVILILELVAGGELFDFLA-EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENI 145
Query: 138 LIDLKRNT----VKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           ++ L RN     +K+ DFGLA  I     E+        + APE ++ Y       D+W+
Sbjct: 146 ML-LDRNVPKPRIKIIDFGLAHKIDFGN-EFKNIFGTPEFVAPE-IVNYEPLGLEADMWS 202
Query: 194 VGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLA 253
           +G I   +++G   F              LG    E+ A  + ++        FE     
Sbjct: 203 IGVITYILLSGASPF--------------LGDTKQETLANVSAVNY------EFED---- 238
Query: 254 EKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           E F N      D + ++L  +PK+R+T  D+L+H ++
Sbjct: 239 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 87/277 (31%), Positives = 135/277 (48%), Gaps = 37/277 (13%)
Query: 23  VYKCRNTVTGQKVA---IKMMTIQTEQEGVPSYII-REVSLLKELEHENIVRLLDVQSSR 78
           V KCR   TG + A   IK    ++ + GV    I REVS+LKE++H N++ L +V  ++
Sbjct: 27  VKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 86
Query: 79  KDVFLVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
            DV L+ E +   +L  F+   K +L        LKQIL G+ Y HSL+I H DLKP N+
Sbjct: 87  TDVILILELVAGGELFDFLA-EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENI 145
Query: 138 LIDLKRNT----VKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           ++ L RN     +K+ DFGLA  I     E+        + APE ++ Y       D+W+
Sbjct: 146 ML-LDRNVPKPRIKIIDFGLAHKIDFGN-EFKNIFGTPEFVAPE-IVNYEPLGLEADMWS 202
Query: 194 VGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLA 253
           +G I   +++G   F              LG    E+ A  + ++        FE     
Sbjct: 203 IGVITYILLSGASPF--------------LGDTKQETLANVSAVNY------EFED---- 238
Query: 254 EKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           E F N      D + ++L  +PK+R+T  D+L+H ++
Sbjct: 239 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 87/277 (31%), Positives = 135/277 (48%), Gaps = 37/277 (13%)
Query: 23  VYKCRNTVTGQKVA---IKMMTIQTEQEGVPSYII-REVSLLKELEHENIVRLLDVQSSR 78
           V KCR   TG + A   IK    ++ + GV    I REVS+LKE++H N++ L +V  ++
Sbjct: 27  VKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 86
Query: 79  KDVFLVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
            DV L+ E +   +L  F+   K +L        LKQIL G+ Y HSL+I H DLKP N+
Sbjct: 87  TDVILILELVAGGELFDFLA-EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENI 145
Query: 138 LIDLKRNT----VKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           ++ L RN     +K+ DFGLA  I     E+        + APE ++ Y       D+W+
Sbjct: 146 ML-LDRNVPKPRIKIIDFGLAHKIDFGN-EFKNIFGTPEFVAPE-IVNYEPLGLEADMWS 202
Query: 194 VGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLA 253
           +G I   +++G   F              LG    E+ A  + ++        FE     
Sbjct: 203 IGVITYILLSGASPF--------------LGDTKQETLANVSAVNY------EFED---- 238
Query: 254 EKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           E F N      D + ++L  +PK+R+T  D+L+H ++
Sbjct: 239 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 87/277 (31%), Positives = 135/277 (48%), Gaps = 37/277 (13%)
Query: 23  VYKCRNTVTGQKVA---IKMMTIQTEQEGVPSYII-REVSLLKELEHENIVRLLDVQSSR 78
           V KCR   TG + A   IK    ++ + GV    I REVS+LKE++H N++ L +V  ++
Sbjct: 27  VKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 86
Query: 79  KDVFLVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
            DV L+ E +   +L  F+   K +L        LKQIL G+ Y HSL+I H DLKP N+
Sbjct: 87  TDVILILELVAGGELFDFLA-EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENI 145
Query: 138 LIDLKRNT----VKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           ++ L RN     +K+ DFGLA  I     E+        + APE ++ Y       D+W+
Sbjct: 146 ML-LDRNVPKPRIKIIDFGLAHKIDFGN-EFKNIFGTPEFVAPE-IVNYEPLGLEADMWS 202
Query: 194 VGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLA 253
           +G I   +++G   F              LG    E+ A  + ++        FE     
Sbjct: 203 IGVITYILLSGASPF--------------LGDTKQETLANVSAVN------YEFED---- 238
Query: 254 EKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           E F N      D + ++L  +PK+R+T  D+L+H ++
Sbjct: 239 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 87/277 (31%), Positives = 135/277 (48%), Gaps = 37/277 (13%)
Query: 23  VYKCRNTVTGQKVA---IKMMTIQTEQEGVPSYII-REVSLLKELEHENIVRLLDVQSSR 78
           V KCR   TG + A   IK    ++ + GV    I REVS+LKE++H N++ L +V  ++
Sbjct: 27  VKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 86
Query: 79  KDVFLVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
            DV L+ E +   +L  F+   K +L        LKQIL G+ Y HSL+I H DLKP N+
Sbjct: 87  TDVILILELVAGGELFDFLA-EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENI 145
Query: 138 LIDLKRNT----VKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           ++ L RN     +K+ DFGLA  I     E+        + APE ++ Y       D+W+
Sbjct: 146 ML-LDRNVPKPRIKIIDFGLAHKIDFGN-EFKNIFGTPEFVAPE-IVNYEPLGLEADMWS 202
Query: 194 VGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLA 253
           +G I   +++G   F              LG    E+ A  + ++        FE     
Sbjct: 203 IGVITYILLSGASPF--------------LGDTKQETLANVSAVNY------EFED---- 238
Query: 254 EKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           E F N      D + ++L  +PK+R+T  D+L+H ++
Sbjct: 239 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 87/277 (31%), Positives = 135/277 (48%), Gaps = 37/277 (13%)
Query: 23  VYKCRNTVTGQKVA---IKMMTIQTEQEGVPSYII-REVSLLKELEHENIVRLLDVQSSR 78
           V KCR   TG + A   IK    ++ + GV    I REVS+LKE++H N++ L +V  ++
Sbjct: 27  VKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 86
Query: 79  KDVFLVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
            DV L+ E +   +L  F+   K +L        LKQIL G+ Y HSL+I H DLKP N+
Sbjct: 87  TDVILILELVAGGELFDFLA-EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENI 145
Query: 138 LIDLKRNT----VKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           ++ L RN     +K+ DFGLA  I     E+        + APE ++ Y       D+W+
Sbjct: 146 ML-LDRNVPKPRIKIIDFGLAHKIDFGN-EFKNIFGTPEFVAPE-IVNYEPLGLEADMWS 202
Query: 194 VGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLA 253
           +G I   +++G   F              LG    E+ A  + ++        FE     
Sbjct: 203 IGVITYILLSGASPF--------------LGDTKQETLANVSAVNY------EFED---- 238
Query: 254 EKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           E F N      D + ++L  +PK+R+T  D+L+H ++
Sbjct: 239 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 87/277 (31%), Positives = 135/277 (48%), Gaps = 37/277 (13%)
Query: 23  VYKCRNTVTGQKVA---IKMMTIQTEQEGVPSYII-REVSLLKELEHENIVRLLDVQSSR 78
           V KCR   TG + A   IK    ++ + GV    I REVS+LKE++H N++ L +V  ++
Sbjct: 26  VKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 85
Query: 79  KDVFLVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
            DV L+ E +   +L  F+   K +L        LKQIL G+ Y HSL+I H DLKP N+
Sbjct: 86  TDVILILELVAGGELFDFLA-EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENI 144
Query: 138 LIDLKRNT----VKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           ++ L RN     +K+ DFGLA  I     E+        + APE ++ Y       D+W+
Sbjct: 145 ML-LDRNVPKPRIKIIDFGLAHKIDFGN-EFKNIFGTPEFVAPE-IVNYEPLGLEADMWS 201
Query: 194 VGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLA 253
           +G I   +++G   F              LG    E+ A  + ++        FE     
Sbjct: 202 IGVITYILLSGASPF--------------LGDTKQETLANVSAVNY------EFED---- 237
Query: 254 EKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           E F N      D + ++L  +PK+R+T  D+L+H ++
Sbjct: 238 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 87/277 (31%), Positives = 135/277 (48%), Gaps = 37/277 (13%)
Query: 23  VYKCRNTVTGQKVA---IKMMTIQTEQEGVPSYII-REVSLLKELEHENIVRLLDVQSSR 78
           V KCR   TG + A   IK    ++ + GV    I REVS+LKE++H N++ L +V  ++
Sbjct: 27  VKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 86
Query: 79  KDVFLVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
            DV L+ E +   +L  F+   K +L        LKQIL G+ Y HSL+I H DLKP N+
Sbjct: 87  TDVILILELVAGGELFDFLA-EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENI 145
Query: 138 LIDLKRNT----VKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           ++ L RN     +K+ DFGLA  I     E+        + APE ++ Y       D+W+
Sbjct: 146 ML-LDRNVPKPRIKIIDFGLAHKIDFGN-EFKNIFGTPEFVAPE-IVNYEPLGLEADMWS 202
Query: 194 VGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLA 253
           +G I   +++G   F              LG    E+ A  + ++        FE     
Sbjct: 203 IGVITYILLSGASPF--------------LGDTKQETLANVSAVNY------EFED---- 238
Query: 254 EKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           E F N      D + ++L  +PK+R+T  D+L+H ++
Sbjct: 239 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  105 bits (263), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 83/282 (29%), Positives = 127/282 (45%), Gaps = 51/282 (18%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           V +C    TG + A K++  +         + RE  + + L+H NIVRL D  S     +
Sbjct: 20  VRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDSISEEGFHY 79
Query: 83  LVFE-------YLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPN 135
           LVF+       + D+    + +    +         ++QIL  + +CH + ++HRDLKP 
Sbjct: 80  LVFDLVTGGELFEDIVAREYYSEADAS-------HCIQQILEAVLHCHQMGVVHRDLKPE 132
Query: 136 NLLI--DLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           NLL+    K   VKLADFGLA  +   Q+ +        Y +PE+L     Y  P+D+WA
Sbjct: 133 NLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRK-EAYGKPVDIWA 191
Query: 194 VGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLA 253
            G I   ++ G P F                      W E  +      LY   +    A
Sbjct: 192 CGVILYILLVGYPPF----------------------WDEDQH-----KLYQQIKAG--A 222
Query: 254 EKFPNLE-----PAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
             FP+ E     P   +L++QML +NP +RITA +ALKH ++
Sbjct: 223 YDFPSPEWDTVTPEAKNLINQMLTINPAKRITAHEALKHPWV 264

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  105 bits (263), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 87/277 (31%), Positives = 135/277 (48%), Gaps = 37/277 (13%)
Query: 23  VYKCRNTVTGQKVA---IKMMTIQTEQEGVPSYII-REVSLLKELEHENIVRLLDVQSSR 78
           V KCR   TG + A   IK    ++ + GV    I REVS+LKE++H N++ L +V  ++
Sbjct: 26  VKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 85
Query: 79  KDVFLVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
            DV L+ E +   +L  F+   K +L        LKQIL G+ Y HSL+I H DLKP N+
Sbjct: 86  TDVILILELVAGGELFDFLA-EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENI 144
Query: 138 LIDLKRNT----VKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           ++ L RN     +K+ DFGLA  I     E+        + APE ++ Y       D+W+
Sbjct: 145 ML-LDRNVPKPRIKIIDFGLAHKIDFGN-EFKNIFGTPEFVAPE-IVNYEPLGLEADMWS 201
Query: 194 VGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLA 253
           +G I   +++G   F              LG    E+ A  + ++        FE     
Sbjct: 202 IGVITYILLSGASPF--------------LGDTKQETLANVSAVNY------EFED---- 237
Query: 254 EKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           E F N      D + ++L  +PK+R+T  D+L+H ++
Sbjct: 238 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score =  105 bits (263), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 76/240 (31%), Positives = 123/240 (51%), Gaps = 18/240 (7%)
Query: 67  NIVRLLDVQSS--RKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
           NI+ L D+      +   LVFE+++   ++   +   TL    I+  + +IL  L YCHS
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVN---NTDFKQLYQTLTDYDIRFYMYEILKALDYCHS 149
Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTG 184
           + I+HRD+KP+N+LID +   ++L D+GLA     P +EY+       +K PELL+ Y  
Sbjct: 150 MGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLVDYQM 208
Query: 185 YSTPIDVWAVGCIFAEMITGK-PLFPS-KKHDHLSLIFSLLGTPTDESWAESTYISEILP 242
           Y   +D+W++GC+ A MI  K P F     +D L  I  +LGT     + +  Y  E+ P
Sbjct: 209 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK-YNIELDP 267
Query: 243 LYPHF---EPANLAEKFPNLE------PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
            +            E+F + E      P  +D L ++L  + + R+TA +A++H Y   V
Sbjct: 268 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 327

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 82/271 (30%), Positives = 134/271 (49%), Gaps = 30/271 (11%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           +V+KC  T TG K+A K+  I+T        +  E+S++ +L+H N+++L D   S+ D+
Sbjct: 104 QVHKCEETATGLKLAAKI--IKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDI 161
Query: 82  FLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLL-I 139
            LV EY+D  +L   I      L  L     +KQI  G+ + H + ILH DLKP N+L +
Sbjct: 162 VLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCV 221
Query: 140 DLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFA 199
           +     +K+ DFGLAR    P+++   +     + APE ++ Y   S P D+W+VG I  
Sbjct: 222 NRDAKQIKIIDFGLARRYK-PREKLKVNFGTPEFLAPE-VVNYDFVSFPTDMWSVGVIAY 279
Query: 200 EMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNL 259
            +++G   F              LG    E+      ++ IL      E     E+F ++
Sbjct: 280 MLLSGLSPF--------------LGDNDAET------LNNILACRWDLED----EEFQDI 315
Query: 260 EPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                + +S++L      RI+A +ALKH +L
Sbjct: 316 SEEAKEFISKLLIKEKSWRISASEALKHPWL 346

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 75/240 (31%), Positives = 123/240 (51%), Gaps = 18/240 (7%)
Query: 67  NIVRLLDVQSS--RKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
           NI+ L D+      +   LVFE+++   ++   +   TL    I+  + +IL  L YCHS
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVN---NTDFKQLYQTLTDYDIRFYMYEILKALDYCHS 149
Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTG 184
           + I+HRD+KP+N++ID +   ++L D+GLA     P +EY+       +K PELL+ Y  
Sbjct: 150 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLVDYQM 208
Query: 185 YSTPIDVWAVGCIFAEMITGK-PLFPS-KKHDHLSLIFSLLGTPTDESWAESTYISEILP 242
           Y   +D+W++GC+ A MI  K P F     +D L  I  +LGT     + +  Y  E+ P
Sbjct: 209 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK-YNIELDP 267
Query: 243 LYPHF---EPANLAEKFPNLE------PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
            +            E+F + E      P  +D L ++L  + + R+TA +A++H Y   V
Sbjct: 268 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 327

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  105 bits (261), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 87/277 (31%), Positives = 135/277 (48%), Gaps = 37/277 (13%)
Query: 23  VYKCRNTVTGQKVA---IKMMTIQTEQEGVPSYII-REVSLLKELEHENIVRLLDVQSSR 78
           V KCR   TG + A   IK    ++ + GV    I REVS+LKE++H N++ L +V  ++
Sbjct: 27  VKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 86
Query: 79  KDVFLVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
            DV L+ E +   +L  F+   K +L        LKQIL G+ Y HSL+I H DLKP N+
Sbjct: 87  TDVILIGELVAGGELFDFLA-EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENI 145
Query: 138 LIDLKRNT----VKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           ++ L RN     +K+ DFGLA  I     E+        + APE ++ Y       D+W+
Sbjct: 146 ML-LDRNVPKPRIKIIDFGLAHKIDFGN-EFKNIFGTPEFVAPE-IVNYEPLGLEADMWS 202
Query: 194 VGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLA 253
           +G I   +++G   F              LG    E+ A  + ++        FE     
Sbjct: 203 IGVITYILLSGASPF--------------LGDTKQETLANVSAVNY------EFED---- 238
Query: 254 EKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           E F N      D + ++L  +PK+R+T  D+L+H ++
Sbjct: 239 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  105 bits (261), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 75/240 (31%), Positives = 123/240 (51%), Gaps = 18/240 (7%)
Query: 67  NIVRLLDVQSS--RKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
           NI+ L D+      +   LVFE+++   ++   +   TL    I+  + +IL  L YCHS
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVN---NTDFKQLYQTLTDYDIRFYMYEILKALDYCHS 149
Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTG 184
           + I+HRD+KP+N++ID +   ++L D+GLA     P +EY+       +K PELL+ Y  
Sbjct: 150 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLVDYQM 208
Query: 185 YSTPIDVWAVGCIFAEMITGK-PLFPS-KKHDHLSLIFSLLGTPTDESWAESTYISEILP 242
           Y   +D+W++GC+ A MI  K P F     +D L  I  +LGT     + +  Y  E+ P
Sbjct: 209 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK-YNIELDP 267
Query: 243 LYPHF---EPANLAEKFPNLE------PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
            +            E+F + E      P  +D L ++L  + + R+TA +A++H Y   V
Sbjct: 268 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 327

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  105 bits (261), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 75/240 (31%), Positives = 123/240 (51%), Gaps = 18/240 (7%)
Query: 67  NIVRLLDVQSS--RKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
           NI+ L D+      +   LVFE+++   ++   +   TL    I+  + +IL  L YCHS
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVN---NTDFKQLYQTLTDYDIRFYMYEILKALDYCHS 149
Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTG 184
           + I+HRD+KP+N++ID +   ++L D+GLA     P +EY+       +K PELL+ Y  
Sbjct: 150 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLVDYQM 208
Query: 185 YSTPIDVWAVGCIFAEMITGK-PLFPS-KKHDHLSLIFSLLGTPTDESWAESTYISEILP 242
           Y   +D+W++GC+ A MI  K P F     +D L  I  +LGT     + +  Y  E+ P
Sbjct: 209 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK-YNIELDP 267
Query: 243 LYPHF---EPANLAEKFPNLE------PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
            +            E+F + E      P  +D L ++L  + + R+TA +A++H Y   V
Sbjct: 268 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 327

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score =  105 bits (261), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 75/240 (31%), Positives = 123/240 (51%), Gaps = 18/240 (7%)
Query: 67  NIVRLLDVQSS--RKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
           NI+ L D+      +   LVFE+++   ++   +   TL    I+  + +IL  L YCHS
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVN---NTDFKQLYQTLTDYDIRFYMYEILKALDYCHS 149
Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTG 184
           + I+HRD+KP+N++ID +   ++L D+GLA     P +EY+       +K PELL+ Y  
Sbjct: 150 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLVDYQM 208
Query: 185 YSTPIDVWAVGCIFAEMITGK-PLFPS-KKHDHLSLIFSLLGTPTDESWAESTYISEILP 242
           Y   +D+W++GC+ A MI  K P F     +D L  I  +LGT     + +  Y  E+ P
Sbjct: 209 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK-YNIELDP 267
Query: 243 LYPHF---EPANLAEKFPNLE------PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
            +            E+F + E      P  +D L ++L  + + R+TA +A++H Y   V
Sbjct: 268 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 327

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score =  105 bits (261), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 75/240 (31%), Positives = 123/240 (51%), Gaps = 18/240 (7%)
Query: 67  NIVRLLDVQSS--RKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
           NI+ L D+      +   LVFE+++   ++   +   TL    I+  + +IL  L YCHS
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVN---NTDFKQLYQTLTDYDIRFYMYEILKALDYCHS 149
Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTG 184
           + I+HRD+KP+N++ID +   ++L D+GLA     P +EY+       +K PELL+ Y  
Sbjct: 150 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLVDYQM 208
Query: 185 YSTPIDVWAVGCIFAEMITGK-PLFPS-KKHDHLSLIFSLLGTPTDESWAESTYISEILP 242
           Y   +D+W++GC+ A MI  K P F     +D L  I  +LGT     + +  Y  E+ P
Sbjct: 209 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK-YNIELDP 267
Query: 243 LYPHF---EPANLAEKFPNLE------PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
            +            E+F + E      P  +D L ++L  + + R+TA +A++H Y   V
Sbjct: 268 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 327

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score =  105 bits (261), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 75/240 (31%), Positives = 123/240 (51%), Gaps = 18/240 (7%)
Query: 67  NIVRLLDVQSS--RKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
           NI+ L D+      +   LVFE+++   ++   +   TL    I+  + +IL  L YCHS
Sbjct: 92  NIITLADIVKDPVSRTPALVFEHVN---NTDFKQLYQTLTDYDIRFYMYEILKALDYCHS 148
Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTG 184
           + I+HRD+KP+N++ID +   ++L D+GLA     P +EY+       +K PELL+ Y  
Sbjct: 149 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLVDYQM 207
Query: 185 YSTPIDVWAVGCIFAEMITGK-PLFPS-KKHDHLSLIFSLLGTPTDESWAESTYISEILP 242
           Y   +D+W++GC+ A MI  K P F     +D L  I  +LGT     + +  Y  E+ P
Sbjct: 208 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK-YNIELDP 266
Query: 243 LYPHF---EPANLAEKFPNLE------PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
            +            E+F + E      P  +D L ++L  + + R+TA +A++H Y   V
Sbjct: 267 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score =  105 bits (261), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 75/240 (31%), Positives = 123/240 (51%), Gaps = 18/240 (7%)
Query: 67  NIVRLLDVQSS--RKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
           NI+ L D+      +   LVFE+++   ++   +   TL    I+  + +IL  L YCHS
Sbjct: 91  NIITLADIVKDPVSRTPALVFEHVN---NTDFKQLYQTLTDYDIRFYMYEILKALDYCHS 147
Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTG 184
           + I+HRD+KP+N++ID +   ++L D+GLA     P +EY+       +K PELL+ Y  
Sbjct: 148 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLVDYQM 206
Query: 185 YSTPIDVWAVGCIFAEMITGK-PLFPS-KKHDHLSLIFSLLGTPTDESWAESTYISEILP 242
           Y   +D+W++GC+ A MI  K P F     +D L  I  +LGT     + +  Y  E+ P
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK-YNIELDP 265
Query: 243 LYPHF---EPANLAEKFPNLE------PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
            +            E+F + E      P  +D L ++L  + + R+TA +A++H Y   V
Sbjct: 266 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score =  105 bits (261), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 75/240 (31%), Positives = 123/240 (51%), Gaps = 18/240 (7%)
Query: 67  NIVRLLDVQSS--RKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
           NI+ L D+      +   LVFE+++   ++   +   TL    I+  + +IL  L YCHS
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVN---NTDFKQLYQTLTDYDIRFYMYEILKALDYCHS 149
Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTG 184
           + I+HRD+KP+N++ID +   ++L D+GLA     P +EY+       +K PELL+ Y  
Sbjct: 150 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLVDYQM 208
Query: 185 YSTPIDVWAVGCIFAEMITGK-PLFPS-KKHDHLSLIFSLLGTPTDESWAESTYISEILP 242
           Y   +D+W++GC+ A MI  K P F     +D L  I  +LGT     + +  Y  E+ P
Sbjct: 209 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK-YNIELDP 267
Query: 243 LYPHF---EPANLAEKFPNLE------PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
            +            E+F + E      P  +D L ++L  + + R+TA +A++H Y   V
Sbjct: 268 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 327

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score =  105 bits (261), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 75/240 (31%), Positives = 123/240 (51%), Gaps = 18/240 (7%)
Query: 67  NIVRLLDVQSS--RKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
           NI+ L D+      +   LVFE+++   ++   +   TL    I+  + +IL  L YCHS
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVN---NTDFKQLYQTLTDYDIRFYMYEILKALDYCHS 149
Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTG 184
           + I+HRD+KP+N++ID +   ++L D+GLA     P +EY+       +K PELL+ Y  
Sbjct: 150 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLVDYQM 208
Query: 185 YSTPIDVWAVGCIFAEMITGK-PLFPS-KKHDHLSLIFSLLGTPTDESWAESTYISEILP 242
           Y   +D+W++GC+ A MI  K P F     +D L  I  +LGT     + +  Y  E+ P
Sbjct: 209 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK-YNIELDP 267
Query: 243 LYPHF---EPANLAEKFPNLE------PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
            +            E+F + E      P  +D L ++L  + + R+TA +A++H Y   V
Sbjct: 268 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 327

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 75/240 (31%), Positives = 123/240 (51%), Gaps = 18/240 (7%)
Query: 67  NIVRLLDVQSS--RKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
           NI+ L D+      +   LVFE+++   ++   +   TL    I+  + +IL  L YCHS
Sbjct: 92  NIITLADIVKDPVSRTPALVFEHVN---NTDFKQLYQTLTDYDIRFYMYEILKALDYCHS 148
Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTG 184
           + I+HRD+KP+N++ID +   ++L D+GLA     P +EY+       +K PELL+ Y  
Sbjct: 149 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLVDYQM 207
Query: 185 YSTPIDVWAVGCIFAEMITGK-PLFPS-KKHDHLSLIFSLLGTPTDESWAESTYISEILP 242
           Y   +D+W++GC+ A MI  K P F     +D L  I  +LGT     + +  Y  E+ P
Sbjct: 208 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK-YNIELDP 266
Query: 243 LYPHF---EPANLAEKFPNLE------PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
            +            E+F + E      P  +D L ++L  + + R+TA +A++H Y   V
Sbjct: 267 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 75/240 (31%), Positives = 123/240 (51%), Gaps = 18/240 (7%)
Query: 67  NIVRLLDVQSS--RKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
           NI+ L D+      +   LVFE+++   ++   +   TL    I+  + +IL  L YCHS
Sbjct: 98  NIITLADIVKDPVSRTPALVFEHVN---NTDFKQLYQTLTDYDIRFYMYEILKALDYCHS 154
Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTG 184
           + I+HRD+KP+N++ID +   ++L D+GLA     P +EY+       +K PELL+ Y  
Sbjct: 155 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLVDYQM 213
Query: 185 YSTPIDVWAVGCIFAEMITGK-PLFPS-KKHDHLSLIFSLLGTPTDESWAESTYISEILP 242
           Y   +D+W++GC+ A MI  K P F     +D L  I  +LGT     + +  Y  E+ P
Sbjct: 214 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK-YNIELDP 272
Query: 243 LYPHF---EPANLAEKFPNLE------PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
            +            E+F + E      P  +D L ++L  + + R+TA +A++H Y   V
Sbjct: 273 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 332

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score =  104 bits (259), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 75/240 (31%), Positives = 123/240 (51%), Gaps = 18/240 (7%)
Query: 67  NIVRLLDVQSS--RKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
           NI+ L D+      +   LVFE+++   ++   +   TL    I+  + +IL  L YCHS
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVN---NTDFKQLYQTLTDYDIRFYMYEILKALDYCHS 149
Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTG 184
           + I+HRD+KP+N++ID +   ++L D+GLA     P +EY+       +K PELL+ Y  
Sbjct: 150 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLVDYQM 208
Query: 185 YSTPIDVWAVGCIFAEMITGK-PLFPS-KKHDHLSLIFSLLGTPTDESWAESTYISEILP 242
           Y   +D+W++GC+ A MI  K P F     +D L  I  +LGT     + +  Y  E+ P
Sbjct: 209 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK-YNIELDP 267
Query: 243 LYPHF---EPANLAEKFPNLE------PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
            +            E+F + E      P  +D L ++L  + + R+TA +A++H Y   V
Sbjct: 268 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYPV 327

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 80/266 (30%), Positives = 127/266 (47%), Gaps = 35/266 (13%)
Query: 28  NTVTGQKVAIKMMTIQTEQE-GVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE 86
           + +TG KVA+K++  Q  +   V   I RE+  LK   H +I++L  V S+  D F+V E
Sbjct: 32  HQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVME 91
Query: 87  YLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNT 145
           Y+   +L  +I +H   +  +  + + +QIL  + YCH   ++HRDLKP N+L+D   N 
Sbjct: 92  YVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNA 150
Query: 146 VKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGYTGYSTPIDVWAVGCIFAEMITG 204
            K+ADFGL+  +     E+ RD   SP Y APE++ G       +D+W+ G I   ++ G
Sbjct: 151 -KIADFGLSNMMS--DGEFLRDSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCG 207
Query: 205 KPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGV 264
              F     +H+  +F  +            YI E                   L  +  
Sbjct: 208 TLPFDD---EHVPTLFKKI-------RGGVFYIPEY------------------LNRSVA 239
Query: 265 DLLSQMLCLNPKQRITAMDALKHEYL 290
            LL  ML ++P +R T  D  +HE+ 
Sbjct: 240 TLLMHMLQVDPLKRATIKDIREHEWF 265

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  103 bits (258), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 74/247 (29%), Positives = 116/247 (46%), Gaps = 18/247 (7%)
Query: 26  CRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF 85
            R+ +TG++VA+K++            + REV ++K L H NIV+L +V  + K ++LV 
Sbjct: 33  ARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVM 92
Query: 86  EYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN 144
           EY    ++  ++  H   +     +A  +QI+  + YCH   I+HRDLK  NLL+D   N
Sbjct: 93  EYASGGEVFDYLVAH-GRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMN 151
Query: 145 TVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITG 204
            +K+ADFG +       K     C   PY APEL  G       +DVW++G I   +++G
Sbjct: 152 -IKIADFGFSNEFTFGNK-LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209
Query: 205 KPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGV 264
              F  +    L            E      Y    +P Y   +  NL +KF  L P+  
Sbjct: 210 SLPFDGQNLKELR-----------ERVLRGKY---RIPFYMSTDCENLLKKFLILNPSKR 255
Query: 265 DLLSQML 271
             L Q++
Sbjct: 256 GTLEQIM 262

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  103 bits (258), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 74/247 (29%), Positives = 116/247 (46%), Gaps = 18/247 (7%)
Query: 26  CRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF 85
            R+ +TG++VA+K++            + REV ++K L H NIV+L +V  + K ++LV 
Sbjct: 33  ARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVM 92
Query: 86  EYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN 144
           EY    ++  ++  H   +     +A  +QI+  + YCH   I+HRDLK  NLL+D   N
Sbjct: 93  EYASGGEVFDYLVAH-GRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMN 151
Query: 145 TVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITG 204
            +K+ADFG +       K     C   PY APEL  G       +DVW++G I   +++G
Sbjct: 152 -IKIADFGFSNEFTFGNK-LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209
Query: 205 KPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGV 264
              F  +    L            E      Y    +P Y   +  NL +KF  L P+  
Sbjct: 210 SLPFDGQNLKELR-----------ERVLRGKY---RIPFYMSTDCENLLKKFLILNPSKR 255
Query: 265 DLLSQML 271
             L Q++
Sbjct: 256 GTLEQIM 262

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  103 bits (258), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 74/247 (29%), Positives = 116/247 (46%), Gaps = 18/247 (7%)
Query: 26  CRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF 85
            R+ +TG++VA+K++            + REV ++K L H NIV+L +V  + K ++LV 
Sbjct: 33  ARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVM 92
Query: 86  EYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN 144
           EY    ++  ++  H   +     +A  +QI+  + YCH   I+HRDLK  NLL+D   N
Sbjct: 93  EYASGGEVFDYLVAH-GRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMN 151
Query: 145 TVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITG 204
            +K+ADFG +       K     C   PY APEL  G       +DVW++G I   +++G
Sbjct: 152 -IKIADFGFSNEFTFGNK-LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209
Query: 205 KPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGV 264
              F  +    L            E      Y    +P Y   +  NL +KF  L P+  
Sbjct: 210 SLPFDGQNLKELR-----------ERVLRGKY---RIPFYMSTDCENLLKKFLILNPSKR 255
Query: 265 DLLSQML 271
             L Q++
Sbjct: 256 GTLEQIM 262

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 76/253 (30%), Positives = 121/253 (47%), Gaps = 36/253 (14%)
Query: 31  TGQKVAIKMMTIQT-EQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD 89
           T QKVA+K ++ Q  ++  +   + RE+S LK L H +I++L DV ++  D+ +V EY  
Sbjct: 33  TQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYAG 92
Query: 90  LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLA 149
            +L  +I   K  +     +   +QI+  + YCH  KI+HRDLKP NLL+D   N VK+A
Sbjct: 93  GELFDYIV-EKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLN-VKIA 150
Query: 150 DFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFP 209
           DFGL+  I          C    Y APE++ G       +DVW+ G +   M+ G+    
Sbjct: 151 DFGLSN-IMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR---- 205
Query: 210 SKKHDHLSLIFSLLGTPTDESWAESTY--ISEILPLYPHFEPANLAEKFPNLEPAGVDLL 267
                           P D+ +  + +  ++  + + P F           L P    L+
Sbjct: 206 ---------------LPFDDEFIPNLFKKVNSCVYVMPDF-----------LSPGAQSLI 239
Query: 268 SQMLCLNPKQRIT 280
            +M+  +P QRIT
Sbjct: 240 RRMIVADPMQRIT 252

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 90/288 (31%), Positives = 129/288 (44%), Gaps = 44/288 (15%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           V +C +  TG + A K++  +         + RE  + ++L+H NIVRL D        +
Sbjct: 22  VRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 81
Query: 83  LVFE-------YLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPN 135
           LVF+       + D+    F +    +         ++QIL  +AYCHS  I+HR+LKP 
Sbjct: 82  LVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQILESIAYCHSNGIVHRNLKPE 134
Query: 136 NLLI--DLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGYTGYSTPIDVW 192
           NLL+    K   VKLADFGLA  I V   E       +P Y +PE+L     YS P+D+W
Sbjct: 135 NLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLSPEVL-KKDPYSKPVDIW 191
Query: 193 AVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANL 252
           A G I   ++ G P F  +  D   L   +     D               YP  E    
Sbjct: 192 ACGVILYILLVGYPPFWDE--DQHRLYAQIKAGAYD---------------YPSPE---- 230
Query: 253 AEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVI 300
              +  + P    L+  ML +NPK+RITA  ALK  ++   E V   I
Sbjct: 231 ---WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAI 275

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 90/288 (31%), Positives = 129/288 (44%), Gaps = 44/288 (15%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           V +C +  TG + A K++  +         + RE  + ++L+H NIVRL D        +
Sbjct: 21  VRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 80
Query: 83  LVFE-------YLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPN 135
           LVF+       + D+    F +    +         ++QIL  +AYCHS  I+HR+LKP 
Sbjct: 81  LVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQILESIAYCHSNGIVHRNLKPE 133
Query: 136 NLLI--DLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGYTGYSTPIDVW 192
           NLL+    K   VKLADFGLA  I V   E       +P Y +PE+L     YS P+D+W
Sbjct: 134 NLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLSPEVL-KKDPYSKPVDIW 190
Query: 193 AVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANL 252
           A G I   ++ G P F  +  D   L   +     D               YP  E    
Sbjct: 191 ACGVILYILLVGYPPFWDE--DQHRLYAQIKAGAYD---------------YPSPE---- 229
Query: 253 AEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVI 300
              +  + P    L+  ML +NPK+RITA  ALK  ++   E V   I
Sbjct: 230 ---WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAI 274

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 91/293 (31%), Positives = 130/293 (44%), Gaps = 54/293 (18%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           V +C +  TG + A K++  +         + RE  + ++L+H NIVRL D        +
Sbjct: 45  VRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 104
Query: 83  LVFE-------YLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPN 135
           LVF+       + D+    F +    +         ++QIL  +AYCHS  I+HR+LKP 
Sbjct: 105 LVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQILESIAYCHSNGIVHRNLKPE 157
Query: 136 NLLI--DLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGYTGYSTPIDVW 192
           NLL+    K   VKLADFGLA  I V   E       +P Y +PE+L     YS P+D+W
Sbjct: 158 NLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLSPEVL-KKDPYSKPVDIW 214
Query: 193 AVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANL 252
           A G I   ++ G P F                      W E  +      LY   +    
Sbjct: 215 ACGVILYILLVGYPPF----------------------WDEDQH-----RLYAQIKAG-- 245
Query: 253 AEKFPNLE-----PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVI 300
           A  +P+ E     P    L+  ML +NPK+RITA  ALK  ++   E V   I
Sbjct: 246 AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAI 298

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 116/247 (46%), Gaps = 18/247 (7%)
Query: 26  CRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF 85
            R+ +TG++VA++++            + REV ++K L H NIV+L +V  + K ++LV 
Sbjct: 33  ARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVM 92
Query: 86  EYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN 144
           EY    ++  ++  H   +     +A  +QI+  + YCH   I+HRDLK  NLL+D   N
Sbjct: 93  EYASGGEVFDYLVAH-GRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMN 151
Query: 145 TVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITG 204
            +K+ADFG +       K     C   PY APEL  G       +DVW++G I   +++G
Sbjct: 152 -IKIADFGFSNEFTFGNK-LDEFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209
Query: 205 KPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGV 264
              F  +    L            E      Y    +P Y   +  NL +KF  L P+  
Sbjct: 210 SLPFDGQNLKELR-----------ERVLRGKY---RIPFYMSTDCENLLKKFLILNPSKR 255
Query: 265 DLLSQML 271
             L Q++
Sbjct: 256 GTLEQIM 262

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 74/247 (29%), Positives = 116/247 (46%), Gaps = 18/247 (7%)
Query: 26  CRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF 85
            R+ +TG++VA+K++            + REV ++K L H NIV+L +V  + K ++LV 
Sbjct: 26  ARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVM 85
Query: 86  EYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN 144
           EY    ++  ++  H   +     +A  +QI+  + YCH   I+HRDLK  NLL+D   N
Sbjct: 86  EYASGGEVFDYLVAH-GWMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMN 144
Query: 145 TVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITG 204
            +K+ADFG +       K     C   PY APEL  G       +DVW++G I   +++G
Sbjct: 145 -IKIADFGFSNEFTFGNK-LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 202
Query: 205 KPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGV 264
              F  +    L            E      Y    +P Y   +  NL +KF  L P+  
Sbjct: 203 SLPFDGQNLKELR-----------ERVLRGKY---RIPFYMSTDCENLLKKFLILNPSKR 248
Query: 265 DLLSQML 271
             L Q++
Sbjct: 249 GTLEQIM 255

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 117/247 (47%), Gaps = 18/247 (7%)
Query: 26  CRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF 85
            R+ +TG++VAIK++            + REV ++K L H NIV+L +V  + K ++L+ 
Sbjct: 34  ARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93
Query: 86  EYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN 144
           EY    ++  ++  H   +     ++  +QI+  + YCH  +I+HRDLK  NLL+D   N
Sbjct: 94  EYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMN 152
Query: 145 TVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITG 204
            +K+ADFG +    V  K     C   PY APEL  G       +DVW++G I   +++G
Sbjct: 153 -IKIADFGFSNEFTVGGK-LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210
Query: 205 KPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGV 264
              F  +    L            E      Y    +P Y   +  NL ++F  L P   
Sbjct: 211 SLPFDGQNLKELR-----------ERVLRGKY---RIPFYMSTDCENLLKRFLVLNPIKR 256
Query: 265 DLLSQML 271
             L Q++
Sbjct: 257 GTLEQIM 263

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 116/247 (46%), Gaps = 18/247 (7%)
Query: 26  CRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF 85
            R+ +TG++VA++++            + REV ++K L H NIV+L +V  + K ++LV 
Sbjct: 33  ARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVM 92
Query: 86  EYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN 144
           EY    ++  ++  H   +     +A  +QI+  + YCH   I+HRDLK  NLL+D   N
Sbjct: 93  EYASGGEVFDYLVAH-GRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMN 151
Query: 145 TVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITG 204
            +K+ADFG +       K     C   PY APEL  G       +DVW++G I   +++G
Sbjct: 152 -IKIADFGFSNEFTFGNK-LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209
Query: 205 KPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGV 264
              F  +    L            E      Y    +P Y   +  NL +KF  L P+  
Sbjct: 210 SLPFDGQNLKELR-----------ERVLRGKY---RIPFYMSTDCENLLKKFLILNPSKR 255
Query: 265 DLLSQML 271
             L Q++
Sbjct: 256 GTLEQIM 262

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 117/247 (47%), Gaps = 18/247 (7%)
Query: 26  CRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF 85
            R+ +TG++VAIK++            + REV ++K L H NIV+L +V  + K ++L+ 
Sbjct: 31  ARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 90
Query: 86  EYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN 144
           EY    ++  ++  H   +     ++  +QI+  + YCH  +I+HRDLK  NLL+D   N
Sbjct: 91  EYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMN 149
Query: 145 TVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITG 204
            +K+ADFG +    V  K     C   PY APEL  G       +DVW++G I   +++G
Sbjct: 150 -IKIADFGFSNEFTVGGK-LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 207
Query: 205 KPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGV 264
              F  +    L            E      Y    +P Y   +  NL ++F  L P   
Sbjct: 208 SLPFDGQNLKELR-----------ERVLRGKY---RIPFYMSTDCENLLKRFLVLNPIKR 253
Query: 265 DLLSQML 271
             L Q++
Sbjct: 254 GTLEQIM 260

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 81/282 (28%), Positives = 128/282 (45%), Gaps = 51/282 (18%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           V +C   + GQ+ A  ++  +         + RE  + + L+H NIVRL D  S     +
Sbjct: 27  VRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY 86
Query: 83  LVFE-------YLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPN 135
           L+F+       + D+    + +    +         ++QIL  + +CH + ++HR+LKP 
Sbjct: 87  LIFDLVTGGELFEDIVAREYYSEADAS-------HCIQQILEAVLHCHQMGVVHRNLKPE 139
Query: 136 NLLI--DLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           NLL+   LK   VKLADFGLA  +   Q+ +        Y +PE+L     Y  P+D+WA
Sbjct: 140 NLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWA 198
Query: 194 VGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLA 253
            G I   ++ G P F                      W E  +      LY   +    A
Sbjct: 199 CGVILYILLVGYPPF----------------------WDEDQH-----RLYQQIKAG--A 229
Query: 254 EKFPNLE-----PAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
             FP+ E     P   DL+++ML +NP +RITA +ALKH ++
Sbjct: 230 YDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWI 271

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 85/282 (30%), Positives = 127/282 (45%), Gaps = 51/282 (18%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           V +C    TGQ+ A K++  +         + RE  + + L+H NIVRL D  S     +
Sbjct: 20  VRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHY 79
Query: 83  LVFE-------YLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPN 135
           LVF+       + D+    + +    +         ++QIL  + +CH   I+HRDLKP 
Sbjct: 80  LVFDLVTGGELFEDIVAREYYSEADAS-------HCIQQILESVNHCHLNGIVHRDLKPE 132
Query: 136 NLLIDLKRN--TVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           NLL+  K     VKLADFGLA  +   Q+ +        Y +PE+L     Y  P+D+WA
Sbjct: 133 NLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRK-DPYGKPVDMWA 191
Query: 194 VGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLA 253
            G I   ++ G P F                      W E  +      LY   +    A
Sbjct: 192 CGVILYILLVGYPPF----------------------WDEDQH-----RLYQQIKAG--A 222
Query: 254 EKFPNLE-----PAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
             FP+ E     P   DL+++ML +NP +RITA +ALKH ++
Sbjct: 223 YDFPSPEWDTVTPEAKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 85/282 (30%), Positives = 127/282 (45%), Gaps = 51/282 (18%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           V +C    TGQ+ A K++  +         + RE  + + L+H NIVRL D  S     +
Sbjct: 20  VRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHY 79
Query: 83  LVFE-------YLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPN 135
           LVF+       + D+    + +    +         ++QIL  + +CH   I+HRDLKP 
Sbjct: 80  LVFDLVTGGELFEDIVAREYYSEADAS-------HCIQQILESVNHCHLNGIVHRDLKPE 132
Query: 136 NLLIDLKRN--TVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           NLL+  K     VKLADFGLA  +   Q+ +        Y +PE+L     Y  P+D+WA
Sbjct: 133 NLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRK-DPYGKPVDMWA 191
Query: 194 VGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLA 253
            G I   ++ G P F                      W E  +      LY   +    A
Sbjct: 192 CGVILYILLVGYPPF----------------------WDEDQH-----RLYQQIKAG--A 222
Query: 254 EKFPNLE-----PAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
             FP+ E     P   DL+++ML +NP +RITA +ALKH ++
Sbjct: 223 YDFPSPEWDTVTPEAKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 61/180 (33%), Positives = 96/180 (53%), Gaps = 4/180 (2%)
Query: 26  CRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF 85
            R+ +TG++VA+K++            + REV ++K L H NIV+L +V  + K ++LV 
Sbjct: 34  ARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLVM 93
Query: 86  EYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN 144
           EY    ++  ++  H   +     +A  +QI+  + YCH   I+HRDLK  NLL+D   N
Sbjct: 94  EYASGGEVFDYLVAH-GRMKEKEARAKFRQIVSAVQYCHQKYIVHRDLKAENLLLDGDMN 152
Query: 145 TVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITG 204
            +K+ADFG +    V  K     C   PY APEL  G       +DVW++G I   +++G
Sbjct: 153 -IKIADFGFSNEFTVGNK-LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  101 bits (252), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 83/277 (29%), Positives = 130/277 (46%), Gaps = 35/277 (12%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQ--TEQEGVPSY-IIREVSLLKELEHENIVRLLDVQSSRK 79
           V +C N  TGQ+ A+K++ +   T   G+ +  + RE S+   L+H +IV LL+  SS  
Sbjct: 42  VRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDG 101
Query: 80  DVFLVFEYLD-LDLHSFITRHKNT---LNLLVIKAILKQILLGLAYCHSLKILHRDLKPN 135
            +++VFE++D  DL   I +  +     +  V    ++QIL  L YCH   I+HRD+KP+
Sbjct: 102 MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPH 161
Query: 136 NLLIDLKRNT--VKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
            +L+  K N+  VKL  FG+A  +G              + APE ++    Y  P+DVW 
Sbjct: 162 CVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPE-VVKREPYGKPVDVWG 220
Query: 194 VGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLA 253
            G I   +++G   F   K      I           W   ++ISE              
Sbjct: 221 CGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQW---SHISE-------------- 263
Query: 254 EKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                   +  DL+ +ML L+P +RIT  +AL H +L
Sbjct: 264 --------SAKDLVRRMLMLDPAERITVYEALNHPWL 292

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  101 bits (252), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 83/277 (29%), Positives = 130/277 (46%), Gaps = 35/277 (12%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQ--TEQEGVPSY-IIREVSLLKELEHENIVRLLDVQSSRK 79
           V +C N  TGQ+ A+K++ +   T   G+ +  + RE S+   L+H +IV LL+  SS  
Sbjct: 40  VRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDG 99
Query: 80  DVFLVFEYLD-LDLHSFITRHKNT---LNLLVIKAILKQILLGLAYCHSLKILHRDLKPN 135
            +++VFE++D  DL   I +  +     +  V    ++QIL  L YCH   I+HRD+KP+
Sbjct: 100 MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPH 159
Query: 136 NLLIDLKRNT--VKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
            +L+  K N+  VKL  FG+A  +G              + APE ++    Y  P+DVW 
Sbjct: 160 CVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPE-VVKREPYGKPVDVWG 218
Query: 194 VGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLA 253
            G I   +++G   F   K      I           W   ++ISE              
Sbjct: 219 CGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQW---SHISE-------------- 261
Query: 254 EKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                   +  DL+ +ML L+P +RIT  +AL H +L
Sbjct: 262 --------SAKDLVRRMLMLDPAERITVYEALNHPWL 290

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 88/282 (31%), Positives = 127/282 (45%), Gaps = 44/282 (15%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           V +C +  TG + A K++  +         + RE  + ++L+H NIVRL D        +
Sbjct: 22  VRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 81
Query: 83  LVFE-------YLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPN 135
           LVF+       + D+    F +    +         ++QIL  +AYCHS  I+HR+LKP 
Sbjct: 82  LVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQILESIAYCHSNGIVHRNLKPE 134
Query: 136 NLLI--DLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGYTGYSTPIDVW 192
           NLL+    K   VKLADFGLA  I V   E       +P Y +PE+L     YS P+D+W
Sbjct: 135 NLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLSPEVL-KKDPYSKPVDIW 191
Query: 193 AVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANL 252
           A G I   ++ G P F  +  D   L   +     D               YP  E    
Sbjct: 192 ACGVILYILLVGYPPFWDE--DQHRLYAQIKAGAYD---------------YPSPE---- 230
Query: 253 AEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVE 294
              +  + P    L+  ML +NPK+RITA  ALK  ++   E
Sbjct: 231 ---WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRE 269

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  101 bits (251), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 79/266 (29%), Positives = 126/266 (47%), Gaps = 35/266 (13%)
Query: 28  NTVTGQKVAIKMMTIQTEQE-GVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE 86
           + +TG KVA+K++  Q  +   V   I RE+  LK   H +I++L  V S+  D F+V E
Sbjct: 32  HQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVME 91
Query: 87  YLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNT 145
           Y+   +L  +I +H   +  +  + + +QIL  + YCH   ++HRDLKP N+L+D   N 
Sbjct: 92  YVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNA 150
Query: 146 VKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGYTGYSTPIDVWAVGCIFAEMITG 204
            K+ADFGL+  +     E+ R    SP Y APE++ G       +D+W+ G I   ++ G
Sbjct: 151 -KIADFGLSNMMS--DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCG 207
Query: 205 KPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGV 264
              F     +H+  +F  +            YI E                   L  +  
Sbjct: 208 TLPFDD---EHVPTLFKKI-------RGGVFYIPEY------------------LNRSVA 239
Query: 265 DLLSQMLCLNPKQRITAMDALKHEYL 290
            LL  ML ++P +R T  D  +HE+ 
Sbjct: 240 TLLMHMLQVDPLKRATIKDIREHEWF 265

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 87/312 (27%), Positives = 146/312 (46%), Gaps = 54/312 (17%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN---IVRLLDVQSSR 78
           +V K  +    Q VA+KM+  +       +  IR +  L++ + +N   ++ +L+  + R
Sbjct: 112 QVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171
Query: 79  KDVFLVFEYLDLDLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
             + + FE L ++L+  I ++K    +L +++     IL  L   H  +I+H DLKP N+
Sbjct: 172 NHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENI 231
Query: 138 LIDLK-RNTVKLADFGLARAIGVPQKEYSRDCVYSP-----YKAPELLLGYTGYSTPIDV 191
           L+  + R+ +K+ DFG +         Y    VY+      Y+APE++LG   Y  PID+
Sbjct: 232 LLKQQGRSGIKVIDFGSS--------CYEHQRVYTXIQSRFYRAPEVILG-ARYGMPIDM 282
Query: 192 WAVGCIFAEMITGKPLFPSK-KHDHLSLIFSLLGTPT----DESWAESTYISEILPLYPH 246
           W++GCI AE++TG PL P + + D L+ +  LLG P+    D S     ++S     YP 
Sbjct: 283 WSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVS--XKGYPR 340
Query: 247 F------------------------EPANLAEKFPNL----EPAGVDLLSQMLCLNPKQR 278
           +                         P    E    L    +P  +D L Q L  +P  R
Sbjct: 341 YCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVR 400
Query: 279 ITAMDALKHEYL 290
           +T   AL+H +L
Sbjct: 401 MTPGQALRHPWL 412

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score =  100 bits (250), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 87/312 (27%), Positives = 146/312 (46%), Gaps = 54/312 (17%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN---IVRLLDVQSSR 78
           +V K  +    Q VA+KM+  +       +  IR +  L++ + +N   ++ +L+  + R
Sbjct: 112 QVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171
Query: 79  KDVFLVFEYLDLDLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
             + + FE L ++L+  I ++K    +L +++     IL  L   H  +I+H DLKP N+
Sbjct: 172 NHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENI 231
Query: 138 LIDLK-RNTVKLADFGLARAIGVPQKEYSRDCVYSP-----YKAPELLLGYTGYSTPIDV 191
           L+  + R+ +K+ DFG +         Y    VY+      Y+APE++LG   Y  PID+
Sbjct: 232 LLKQQGRSGIKVIDFGSS--------CYEHQRVYTXIQSRFYRAPEVILG-ARYGMPIDM 282
Query: 192 WAVGCIFAEMITGKPLFPSK-KHDHLSLIFSLLGTPT----DESWAESTYISEILPLYPH 246
           W++GCI AE++TG PL P + + D L+ +  LLG P+    D S     ++S     YP 
Sbjct: 283 WSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVS--XKGYPR 340
Query: 247 F------------------------EPANLAEKFPNL----EPAGVDLLSQMLCLNPKQR 278
           +                         P    E    L    +P  +D L Q L  +P  R
Sbjct: 341 YCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVR 400
Query: 279 ITAMDALKHEYL 290
           +T   AL+H +L
Sbjct: 401 MTPGQALRHPWL 412

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  100 bits (250), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 88/302 (29%), Positives = 139/302 (46%), Gaps = 49/302 (16%)
Query: 23  VYKCRNTVTGQKVA---IKMMTIQTEQEGVP-SYIIREVSLLKELEHENIVRLLDVQSSR 78
           V KCR   TG++ A   IK   + + + GV    I REV++L+E+ H NI+ L D+  ++
Sbjct: 21  VRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK 80
Query: 79  KDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
            DV L+ E +   +L  F+   K +L        LKQIL G+ Y HS +I H DLKP N+
Sbjct: 81  TDVVLILELVSGGELFDFLA-EKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENI 139
Query: 138 LIDLKRNT----VKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           ++ L +N     +KL DFG+A  I     E+        + APE ++ Y       D+W+
Sbjct: 140 ML-LDKNVPNPRIKLIDFGIAHKIEAGN-EFKNIFGTPEFVAPE-IVNYEPLGLEADMWS 196
Query: 194 VGCIFAEMITG-KPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANL 252
           +G I   +++G  P     K + L+ I S +    DE +                     
Sbjct: 197 IGVITYILLSGASPFLGETKQETLTNI-SAVNYDFDEEY--------------------- 234
Query: 253 AEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLINRKKKLGVD 312
              F N      D + ++L  +PK+R+T   +L+H +          I  I R+   G D
Sbjct: 235 ---FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSW----------IKAIRRRNVRGED 281
Query: 313 NG 314
           +G
Sbjct: 282 SG 283

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  100 bits (250), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 74/246 (30%), Positives = 113/246 (45%), Gaps = 18/246 (7%)
Query: 26  CRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF 85
            R+ +TG++VA+K++            + REV + K L H NIV+L +V  + K ++LV 
Sbjct: 33  ARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEVIETEKTLYLVX 92
Query: 86  EYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN 144
           EY    ++  ++  H         +A  +QI+  + YCH   I+HRDLK  NLL+D   N
Sbjct: 93  EYASGGEVFDYLVAHGRXKEKEA-RAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADXN 151
Query: 145 TVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITG 204
            +K+ADFG +       K     C   PY APEL  G       +DVW++G I   +++G
Sbjct: 152 -IKIADFGFSNEFTFGNK-LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209
Query: 205 KPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGV 264
              F  +    L            E      Y    +P Y   +  NL +KF  L P+  
Sbjct: 210 SLPFDGQNLKELR-----------ERVLRGKY---RIPFYXSTDCENLLKKFLILNPSKR 255
Query: 265 DLLSQM 270
             L Q+
Sbjct: 256 GTLEQI 261

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 87/312 (27%), Positives = 144/312 (46%), Gaps = 54/312 (17%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN---IVRLLDVQSSR 78
           +V K  +    Q VA+KM+  +       +  IR +  L++ + +N   ++ +L+  + R
Sbjct: 112 QVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171
Query: 79  KDVFLVFEYLDLDLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
             + + FE L ++L+  I ++K    +L +++     IL  L   H  +I+H DLKP N+
Sbjct: 172 NHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENI 231
Query: 138 LIDLK-RNTVKLADFGLARAIGVPQKEYSRDCVYSP-----YKAPELLLGYTGYSTPIDV 191
           L+  + R+ +K+ DFG +         Y    VY       Y+APE++LG   Y  PID+
Sbjct: 232 LLKQQGRSGIKVIDFGSS--------CYEHQRVYXXIQSRFYRAPEVILG-ARYGMPIDM 282
Query: 192 WAVGCIFAEMITGKPLFPSK-KHDHLSLIFSLLGTPT----DESWAESTYISEILPLYPH 246
           W++GCI AE++TG PL P + + D L+ +  LLG P     D S     ++S     YP 
Sbjct: 283 WSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPXQKLLDASKRAKNFVS--XKGYPR 340
Query: 247 F------------------------EPANLAEKFPNL----EPAGVDLLSQMLCLNPKQR 278
           +                         P    E    L    +P  +D L Q L  +P  R
Sbjct: 341 YCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVR 400
Query: 279 ITAMDALKHEYL 290
           +T   AL+H +L
Sbjct: 401 MTPGQALRHPWL 412

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 88/284 (30%), Positives = 138/284 (48%), Gaps = 41/284 (14%)
Query: 23  VYKCRNTVTGQKVA---IKMMTIQTEQEGVP-SYIIREVSLLKELEHENIVRLLDVQSSR 78
           V KCR   TG + A   IK    +  + GV    I REVS+L+++ H N++ L DV  +R
Sbjct: 28  VKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR 87
Query: 79  KDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
            DV L+ E +   +L  F+ + K +L+     + +KQIL G+ Y H+ KI H DLKP N+
Sbjct: 88  TDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENI 146
Query: 138 LIDLKRNT----VKLADFGLARAI--GVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDV 191
           ++ L +N     +KL DFGLA  I  GV   E+        + APE ++ Y       D+
Sbjct: 147 ML-LDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPE-IVNYEPLGLEADM 201
Query: 192 WAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPAN 251
           W++G I   +++G   F              LG    E+ A  T +S     Y   E   
Sbjct: 202 WSIGVITYILLSGASPF--------------LGDTKQETLANITSVS-----YDFDE--- 239
Query: 252 LAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVEN 295
             E F +      D + ++L    ++R+T  +AL+H ++  V+N
Sbjct: 240 --EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDN 281

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 124/268 (46%), Gaps = 39/268 (14%)
Query: 34  KVAIKMMT-IQTEQEGVPSYII-------REVSLLKELEHENIVRLLDVQSSRKDVFLVF 85
           K+A++  T I+   + +P Y +       +E+ ++K L+H NI+RL +      D++LV 
Sbjct: 43  KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 102
Query: 86  EYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLI--DLKR 143
           E            HK          I+K +L  +AYCH L + HRDLKP N L   D   
Sbjct: 103 ELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPD 162
Query: 144 NTVKLADFGLARAIGVPQKEYSRDCVYSPYK-APELLLGYTGYSTPIDVWAVGCIFAEMI 202
           + +KL DFGLA A   P K   R  V +PY  +P++L G   Y    D W+ G +   ++
Sbjct: 163 SPLKLIDFGLA-ARFKPGK-MMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLL 218
Query: 203 TGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPA 262
            G P F +               PTD        I E    +P        + + N+ P 
Sbjct: 219 CGYPPFSA---------------PTDXEVM--LKIREGTFTFPE-------KDWLNVSPQ 254
Query: 263 GVDLLSQMLCLNPKQRITAMDALKHEYL 290
              L+ ++L  +PKQRIT++ AL+HE+ 
Sbjct: 255 AESLIRRLLTKSPKQRITSLQALEHEWF 282

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 88/284 (30%), Positives = 138/284 (48%), Gaps = 41/284 (14%)
Query: 23  VYKCRNTVTGQKVA---IKMMTIQTEQEGVP-SYIIREVSLLKELEHENIVRLLDVQSSR 78
           V KCR   TG + A   IK    +  + GV    I REVS+L+++ H N++ L DV  +R
Sbjct: 28  VKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR 87
Query: 79  KDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
            DV L+ E +   +L  F+ + K +L+     + +KQIL G+ Y H+ KI H DLKP N+
Sbjct: 88  TDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENI 146
Query: 138 LIDLKRNT----VKLADFGLARAI--GVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDV 191
           ++ L +N     +KL DFGLA  I  GV   E+        + APE ++ Y       D+
Sbjct: 147 ML-LDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPE-IVNYEPLGLEADM 201
Query: 192 WAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPAN 251
           W++G I   +++G   F              LG    E+ A  T +S     Y   E   
Sbjct: 202 WSIGVITYILLSGASPF--------------LGDTKQETLANITSVS-----YDFDE--- 239
Query: 252 LAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVEN 295
             E F +      D + ++L    ++R+T  +AL+H ++  V+N
Sbjct: 240 --EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDN 281

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 88/284 (30%), Positives = 138/284 (48%), Gaps = 41/284 (14%)
Query: 23  VYKCRNTVTGQKVA---IKMMTIQTEQEGVP-SYIIREVSLLKELEHENIVRLLDVQSSR 78
           V KCR   TG + A   IK    +  + GV    I REVS+L+++ H N++ L DV  +R
Sbjct: 28  VKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR 87
Query: 79  KDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
            DV L+ E +   +L  F+ + K +L+     + +KQIL G+ Y H+ KI H DLKP N+
Sbjct: 88  TDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENI 146
Query: 138 LIDLKRNT----VKLADFGLARAI--GVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDV 191
           ++ L +N     +KL DFGLA  I  GV   E+        + APE ++ Y       D+
Sbjct: 147 ML-LDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPE-IVNYEPLGLEADM 201
Query: 192 WAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPAN 251
           W++G I   +++G   F              LG    E+ A  T +S     Y   E   
Sbjct: 202 WSIGVITYILLSGASPF--------------LGDTKQETLANITSVS-----YDFDE--- 239
Query: 252 LAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVEN 295
             E F +      D + ++L    ++R+T  +AL+H ++  V+N
Sbjct: 240 --EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDN 281

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 123/268 (45%), Gaps = 39/268 (14%)
Query: 34  KVAIKMMT-IQTEQEGVPSYII-------REVSLLKELEHENIVRLLDVQSSRKDVFLVF 85
           K+A++  T I+   + +P Y +       +E+ ++K L+H NI+RL +      D++LV 
Sbjct: 26  KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85
Query: 86  EYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLI--DLKR 143
           E            HK          I+K +L  +AYCH L + HRDLKP N L   D   
Sbjct: 86  ELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPD 145
Query: 144 NTVKLADFGLARAIGVPQKEYSRDCVYSPYK-APELLLGYTGYSTPIDVWAVGCIFAEMI 202
           + +KL DFGLA A   P K   R  V +PY  +P++L G   Y    D W+ G +   ++
Sbjct: 146 SPLKLIDFGLA-ARFKPGK-MMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLL 201
Query: 203 TGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPA 262
            G P F                 PTD        I E    +P        + + N+ P 
Sbjct: 202 CGYPPF---------------SAPTDXEVM--LKIREGTFTFPE-------KDWLNVSPQ 237
Query: 263 GVDLLSQMLCLNPKQRITAMDALKHEYL 290
              L+ ++L  +PKQRIT++ AL+HE+ 
Sbjct: 238 AESLIRRLLTKSPKQRITSLQALEHEWF 265

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 88/284 (30%), Positives = 137/284 (48%), Gaps = 41/284 (14%)
Query: 23  VYKCRNTVTGQKVA---IKMMTIQTEQEGVP-SYIIREVSLLKELEHENIVRLLDVQSSR 78
           V KCR   TG + A   IK    +  + GV    I REVS+L+++ H N++ L DV  +R
Sbjct: 28  VKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR 87
Query: 79  KDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
            DV L+ E +   +L  F+ + K +L+     + +KQIL G+ Y H+ KI H DLKP N+
Sbjct: 88  TDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENI 146
Query: 138 LIDLKRNT----VKLADFGLARAI--GVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDV 191
           ++ L +N     +KL DFGLA  I  GV   E+        + APE ++ Y       D+
Sbjct: 147 ML-LDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPE-IVNYEPLGLEADM 201
Query: 192 WAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPAN 251
           W++G I   +++G   F              LG    E+ A  T +S     Y   E   
Sbjct: 202 WSIGVITYILLSGASPF--------------LGDTKQETLANITAVS-----YDFDE--- 239
Query: 252 LAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVEN 295
             E F        D + ++L    ++R+T  +AL+H ++  V+N
Sbjct: 240 --EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDN 281

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 138/270 (51%), Gaps = 34/270 (12%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           VY   +  TGQ+VAI+ M +Q  Q+     II E+ +++E ++ NIV  LD      +++
Sbjct: 36  VYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELW 93
Query: 83  LVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +V EYL    L   +T  +  ++   I A+ ++ L  L + HS +++HRD+K +N+L+ +
Sbjct: 94  VVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM 151
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPY-KAPELLLGYTGYSTPIDVWAVGCIFAE 200
              +VKL DFG    I  P++    + V +PY  APE++     Y   +D+W++G +  E
Sbjct: 152 D-GSVKLTDFGFCAQI-TPEQSKRSEMVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIE 208
Query: 201 MITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
           MI G+P + ++       + +  GTP  ++                  P  L+  F    
Sbjct: 209 MIEGEPPYLNENPLRALYLIATNGTPELQN------------------PEKLSAIFR--- 247
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
               D L++ L ++ ++R +A + L+H++L
Sbjct: 248 ----DFLNRCLDMDVEKRGSAKELLQHQFL 273

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 88/284 (30%), Positives = 137/284 (48%), Gaps = 41/284 (14%)
Query: 23  VYKCRNTVTGQKVA---IKMMTIQTEQEGVP-SYIIREVSLLKELEHENIVRLLDVQSSR 78
           V KCR   TG + A   IK    +  + GV    I REVS+L+++ H N++ L DV  +R
Sbjct: 28  VKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR 87
Query: 79  KDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
            DV L+ E +   +L  F+ + K +L+     + +KQIL G+ Y H+ KI H DLKP N+
Sbjct: 88  TDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENI 146
Query: 138 LIDLKRNT----VKLADFGLARAI--GVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDV 191
           ++ L +N     +KL DFGLA  I  GV   E+        + APE ++ Y       D+
Sbjct: 147 ML-LDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPE-IVNYEPLGLEADM 201
Query: 192 WAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPAN 251
           W++G I   +++G   F              LG    E+ A  T +S     Y   E   
Sbjct: 202 WSIGVITYILLSGASPF--------------LGDTKQETLANITAVS-----YDFDE--- 239
Query: 252 LAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVEN 295
             E F        D + ++L    ++R+T  +AL+H ++  V+N
Sbjct: 240 --EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDN 281

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 87/302 (28%), Positives = 138/302 (45%), Gaps = 49/302 (16%)
Query: 23  VYKCRNTVTGQKVA---IKMMTIQTEQEGVP-SYIIREVSLLKELEHENIVRLLDVQSSR 78
           V KCR   TG++ A   IK   + + + GV    I REV++L+E+ H NI+ L D+  ++
Sbjct: 42  VRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK 101
Query: 79  KDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
            DV L+ E +   +L  F+   K +L        LKQIL G+ Y HS +I H DLKP N+
Sbjct: 102 TDVVLILELVSGGELFDFLA-EKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENI 160
Query: 138 LIDLKRNT----VKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           ++ L +N     +KL DFG+A  I     E+        + APE ++ Y       D+W+
Sbjct: 161 ML-LDKNVPNPRIKLIDFGIAHKIEAGN-EFKNIFGTPEFVAPE-IVNYEPLGLEADMWS 217
Query: 194 VGCIFAEMITG-KPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANL 252
           +G I   +++G  P     K + L+ I S +    DE +                     
Sbjct: 218 IGVITYILLSGASPFLGETKQETLTNI-SAVNYDFDEEY--------------------- 255
Query: 253 AEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLINRKKKLGVD 312
              F N      D + ++L  +PK+R+    +L+H +          I  I R+   G D
Sbjct: 256 ---FSNTSELAKDFIRRLLVKDPKRRMXIAQSLEHSW----------IKAIRRRNVRGED 302
Query: 313 NG 314
           +G
Sbjct: 303 SG 304

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 98.2 bits (243), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 138/285 (48%), Gaps = 36/285 (12%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           VYK  +  TGQ VAIK + ++++ QE     II+E+S++++ +  ++V+         D+
Sbjct: 45  VYKAIHKETGQIVAIKQVPVESDLQE-----IIKEISIMQQCDSPHVVKYYGSYFKNTDL 99
Query: 82  FLVFEYLDLDLHSFITRHKN-TLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLID 140
           ++V EY      S I R +N TL    I  IL+  L GL Y H ++ +HRD+K  N+L++
Sbjct: 100 WIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLN 159
Query: 141 LKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAE 200
            + +  KLADFG+A  +     + +       + APE ++   GY+   D+W++G    E
Sbjct: 160 TEGH-AKLADFGVAGQLTDXMAKRNXVIGTPFWMAPE-VIQEIGYNCVADIWSLGITAIE 217
Query: 201 MITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHF-EPANLAEKFPNL 259
           M  GKP  P      +  IF +   P                  P F +P   ++ F   
Sbjct: 218 MAEGKP--PYADIHPMRAIFMIPTNPP-----------------PTFRKPELWSDNF--- 255
Query: 260 EPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLIN 304
                D + Q L  +P+QR TA   L+H ++   + V ++  LIN
Sbjct: 256 ----TDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSILRDLIN 296

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 97.8 bits (242), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 137/270 (50%), Gaps = 34/270 (12%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           VY   +  TGQ+VAI+ M +Q  Q+     II E+ +++E ++ NIV  LD      +++
Sbjct: 36  VYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELW 93
Query: 83  LVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +V EYL    L   +T  +  ++   I A+ ++ L  L + HS +++HRD+K +N+L+ +
Sbjct: 94  VVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM 151
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPY-KAPELLLGYTGYSTPIDVWAVGCIFAE 200
              +VKL DFG    I  P++      V +PY  APE++     Y   +D+W++G +  E
Sbjct: 152 D-GSVKLTDFGFCAQI-TPEQSKRSTMVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIE 208
Query: 201 MITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
           MI G+P + ++       + +  GTP  ++                  P  L+  F    
Sbjct: 209 MIEGEPPYLNENPLRALYLIATNGTPELQN------------------PEKLSAIFR--- 247
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
               D L++ L ++ ++R +A + L+H++L
Sbjct: 248 ----DFLNRCLDMDVEKRGSAKELLQHQFL 273

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 97.4 bits (241), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 137/270 (50%), Gaps = 34/270 (12%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           VY   +  TGQ+VAI+ M +Q  Q+     II E+ +++E ++ NIV  LD      +++
Sbjct: 36  VYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELW 93
Query: 83  LVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +V EYL    L   +T  +  ++   I A+ ++ L  L + HS +++HRD+K +N+L+ +
Sbjct: 94  VVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM 151
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPY-KAPELLLGYTGYSTPIDVWAVGCIFAE 200
              +VKL DFG    I  P++      V +PY  APE++     Y   +D+W++G +  E
Sbjct: 152 D-GSVKLTDFGFCAQI-TPEQSKRSXMVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIE 208
Query: 201 MITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
           MI G+P + ++       + +  GTP  ++                  P  L+  F    
Sbjct: 209 MIEGEPPYLNENPLRALYLIATNGTPELQN------------------PEKLSAIFR--- 247
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
               D L++ L ++ ++R +A + L+H++L
Sbjct: 248 ----DFLNRCLEMDVEKRGSAKELLQHQFL 273

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 97.4 bits (241), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 131/278 (47%), Gaps = 39/278 (14%)
Query: 23  VYKCRNTVTGQKVA---IKMMTIQTEQEGVP-SYIIREVSLLKELEHENIVRLLDVQSSR 78
           V KCR   TG++ A   IK   + + + GV    I REV++L+E+ H NI+ L D+  ++
Sbjct: 28  VRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK 87
Query: 79  KDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
            DV L+ E +   +L  F+   K +L        LKQIL G+ Y HS +I H DLKP N+
Sbjct: 88  TDVVLILELVSGGELFDFLA-EKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENI 146
Query: 138 LIDLKRNT----VKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           ++ L +N     +KL DFG+A  I     E+        + APE ++ Y       D+W+
Sbjct: 147 ML-LDKNVPNPRIKLIDFGIAHKIEAGN-EFKNIFGTPEFVAPE-IVNYEPLGLEADMWS 203
Query: 194 VGCIFAEMITG-KPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANL 252
           +G I   +++G  P     K + L+ I S +    DE +                     
Sbjct: 204 IGVITYILLSGASPFLGETKQETLTNI-SAVNYDFDEEY--------------------- 241
Query: 253 AEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
              F N      D + ++L  +PK+R+    +L+H ++
Sbjct: 242 ---FSNTSELAKDFIRRLLVKDPKRRMXIAQSLEHSWI 276

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 137/270 (50%), Gaps = 34/270 (12%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           VY   +  TGQ+VAI+ M +Q  Q+     II E+ +++E ++ NIV  LD      +++
Sbjct: 37  VYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELW 94
Query: 83  LVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +V EYL    L   +T  +  ++   I A+ ++ L  L + HS +++HRD+K +N+L+ +
Sbjct: 95  VVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM 152
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPY-KAPELLLGYTGYSTPIDVWAVGCIFAE 200
              +VKL DFG    I  P++      V +PY  APE++     Y   +D+W++G +  E
Sbjct: 153 D-GSVKLTDFGFCAQI-TPEQSKRSXMVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIE 209
Query: 201 MITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
           MI G+P + ++       + +  GTP  ++                  P  L+  F    
Sbjct: 210 MIEGEPPYLNENPLRALYLIATNGTPELQN------------------PEKLSAIFR--- 248
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
               D L++ L ++ ++R +A + ++H++L
Sbjct: 249 ----DFLNRCLEMDVEKRGSAKELIQHQFL 274

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 106/204 (51%), Gaps = 13/204 (6%)
Query: 25  KCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLD--VQSSRKDVF 82
           K R    G+ +  K +   +  E     ++ EV+LL+EL+H NIVR  D  +  +   ++
Sbjct: 24  KIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83
Query: 83  LVFEYLD-LDLHSFI---TRHKNTLNLLVIKAILKQILLGLAYCHSLK-----ILHRDLK 133
           +V EY +  DL S I   T+ +  L+   +  ++ Q+ L L  CH        +LHRDLK
Sbjct: 84  IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLK 143
Query: 134 PNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           P N+ +D K+N VKL DFGLAR +    ++++++ V +PY      +    Y+   D+W+
Sbjct: 144 PANVFLDGKQN-VKLGDFGLARILN-HDEDFAKEFVGTPYYMSPEQMNRMSYNEKSDIWS 201
Query: 194 VGCIFAEMITGKPLFPSKKHDHLS 217
           +GC+  E+    P F +     L+
Sbjct: 202 LGCLLYELCALMPPFTAFSQKELA 225

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 138/281 (49%), Gaps = 40/281 (14%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQ------EGVPSYIIREVSLLKELE-HENIVRLLDVQ 75
           V +C +  TG + A+K+M +  E+      E V     RE  +L+++  H +I+ L+D  
Sbjct: 110 VRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169
Query: 76  SSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKP 134
            S   +FLVF+ +   +L  ++T  K  L+    ++I++ +L  +++ H+  I+HRDLKP
Sbjct: 170 ESSSFMFLVFDLMRKGELFDYLT-EKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKP 228
Query: 135 NNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLL-----GYTGYSTPI 189
            N+L+D     ++L+DFG +  +  P ++    C    Y APE+L       + GY   +
Sbjct: 229 ENILLD-DNMQIRLSDFGFSCHLE-PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEV 286
Query: 190 DVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEP 249
           D+WA G I   ++ G P F    H    L+  ++         E  Y          F  
Sbjct: 287 DLWACGVILFTLLAGSPPF---WHRRQILMLRMI--------MEGQY---------QFSS 326
Query: 250 ANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
               ++   ++    DL+S++L ++P+ R+TA  AL+H + 
Sbjct: 327 PEWDDRSSTVK----DLISRLLQVDPEARLTAEQALQHPFF 363

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 82/278 (29%), Positives = 131/278 (47%), Gaps = 40/278 (14%)
Query: 22  EVYKCRNTVTGQKVAIKMM----TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS 77
           EV  C++ +TG + AIK++       T   G    ++ EV++LK+L+H NI++L +    
Sbjct: 36  EVLLCKDKLTGAERAIKIIKKSSVTTTSNSGA---LLDEVAVLKQLDHPNIMKLYEFFED 92
Query: 78  RKDVFLVFE-YLDLDL-HSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPN 135
           +++ +LV E Y   +L    I R K   + +    I+KQ+L G  Y H   I+HRDLKP 
Sbjct: 93  KRNYYLVMEVYRGGELFDEIILRQK--FSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPE 150
Query: 136 NLLIDLKRNT--VKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           NLL++ K     +K+ DFGL+    V  K   R    + Y APE+L     Y    DVW+
Sbjct: 151 NLLLESKSRDALIKIVDFGLSAHFEVGGKMKER-LGTAYYIAPEVLR--KKYDEKCDVWS 207
Query: 194 VGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLA 253
            G I   ++ G P F               G  TD+   +     +       F+P +  
Sbjct: 208 CGVILYILLCGYPPF---------------GGQTDQEILKRVEKGKF-----SFDPPD-- 245
Query: 254 EKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLI 291
             +  +      L+  ML   P +RI+A +AL H +++
Sbjct: 246 --WTQVSDEAKQLVKLMLTYEPSKRISAEEALNHPWIV 281

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 88/283 (31%), Positives = 136/283 (48%), Gaps = 41/283 (14%)
Query: 23  VYKCRNTVTGQKVA---IKMMTIQTEQEGV-PSYIIREVSLLKELEHENIVRLLDVQSSR 78
           V KCR   TG + A   IK    +  + GV    I REVS+L+++ H NI+ L DV  +R
Sbjct: 28  VKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR 87
Query: 79  KDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
            DV L+ E +   +L  F+ + K +L+     + +KQIL G+ Y H+ KI H DLKP N+
Sbjct: 88  TDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENI 146
Query: 138 LIDLKRNT----VKLADFGLARAI--GVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDV 191
           ++ L +N     +KL DFGLA  I  GV   E+        + APE ++ Y       D+
Sbjct: 147 ML-LDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPE-IVNYEPLGLEADM 201
Query: 192 WAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPAN 251
           W++G I   +++G   F              LG    E+ A  T +S     Y   E   
Sbjct: 202 WSIGVITYILLSGASPF--------------LGDTKQETLANITAVS-----YDFDE--- 239
Query: 252 LAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVE 294
             E F        D + ++L    ++R+T  +AL+H ++  V+
Sbjct: 240 --EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 125/272 (45%), Gaps = 33/272 (12%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           EV    N VT + VA+K++ ++   +  P  I +E+ + K L HEN+V+    +      
Sbjct: 21  EVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVKFYGHRREGNIQ 79
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKA--ILKQILLGLAYCHSLKILHRDLKPNNLLI 139
           +L  EY          R +  + +    A     Q++ G+ Y H + I HRD+KP NLL+
Sbjct: 80  YLFLEYCSGG--ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL 137
Query: 140 DLKRNTVKLADFGLARAIGVPQKEY--SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCI 197
           D +R+ +K++DFGLA       +E   ++ C   PY APELL     ++ P+DVW+ G +
Sbjct: 138 D-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV 196
Query: 198 FAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFP 257
              M+ G+   P  +             P+D     S +  +   L P          + 
Sbjct: 197 LTAMLAGE--LPWDQ-------------PSDSCQEYSDWKEKKTYLNP----------WK 231
Query: 258 NLEPAGVDLLSQMLCLNPKQRITAMDALKHEY 289
            ++ A + LL ++L  NP  RIT  D  K  +
Sbjct: 232 KIDSAPLALLHKILVENPSARITIPDIKKDRW 263

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 95.1 bits (235), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 125/272 (45%), Gaps = 33/272 (12%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           EV    N VT + VA+K++ ++   +  P  I +E+ + K L HEN+V+    +      
Sbjct: 21  EVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVKFYGHRREGNIQ 79
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKA--ILKQILLGLAYCHSLKILHRDLKPNNLLI 139
           +L  EY          R +  + +    A     Q++ G+ Y H + I HRD+KP NLL+
Sbjct: 80  YLFLEYCSGG--ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL 137
Query: 140 DLKRNTVKLADFGLARAIGVPQKEY--SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCI 197
           D +R+ +K++DFGLA       +E   ++ C   PY APELL     ++ P+DVW+ G +
Sbjct: 138 D-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV 196
Query: 198 FAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFP 257
              M+ G+   P  +             P+D     S +  +   L P          + 
Sbjct: 197 LTAMLAGE--LPWDQ-------------PSDSCQEYSDWKEKKTYLNP----------WK 231
Query: 258 NLEPAGVDLLSQMLCLNPKQRITAMDALKHEY 289
            ++ A + LL ++L  NP  RIT  D  K  +
Sbjct: 232 KIDSAPLALLHKILVENPSARITIPDIKKDRW 263

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 95.1 bits (235), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 125/272 (45%), Gaps = 33/272 (12%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           EV    N VT + VA+K++ ++   +  P  I +E+ + K L HEN+V+    +      
Sbjct: 22  EVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVKFYGHRREGNIQ 80
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKA--ILKQILLGLAYCHSLKILHRDLKPNNLLI 139
           +L  EY          R +  + +    A     Q++ G+ Y H + I HRD+KP NLL+
Sbjct: 81  YLFLEYCSGG--ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL 138
Query: 140 DLKRNTVKLADFGLARAIGVPQKEY--SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCI 197
           D +R+ +K++DFGLA       +E   ++ C   PY APELL     ++ P+DVW+ G +
Sbjct: 139 D-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV 197
Query: 198 FAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFP 257
              M+ G+   P  +             P+D     S +  +   L P          + 
Sbjct: 198 LTAMLAGE--LPWDQ-------------PSDSCQEYSDWKEKKTYLNP----------WK 232
Query: 258 NLEPAGVDLLSQMLCLNPKQRITAMDALKHEY 289
            ++ A + LL ++L  NP  RIT  D  K  +
Sbjct: 233 KIDSAPLALLHKILVENPSARITIPDIKKDRW 264

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 95.1 bits (235), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 82/278 (29%), Positives = 131/278 (47%), Gaps = 40/278 (14%)
Query: 22  EVYKCRNTVTGQKVAIKMM----TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS 77
           EV  C++ +TG + AIK++       T   G    ++ EV++LK+L+H NI++L +    
Sbjct: 19  EVLLCKDKLTGAERAIKIIKKSSVTTTSNSGA---LLDEVAVLKQLDHPNIMKLYEFFED 75
Query: 78  RKDVFLVFE-YLDLDL-HSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPN 135
           +++ +LV E Y   +L    I R K   + +    I+KQ+L G  Y H   I+HRDLKP 
Sbjct: 76  KRNYYLVMEVYRGGELFDEIILRQK--FSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPE 133
Query: 136 NLLIDLKRNT--VKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           NLL++ K     +K+ DFGL+    V  K   R    + Y APE+L     Y    DVW+
Sbjct: 134 NLLLESKSRDALIKIVDFGLSAHFEVGGKMKER-LGTAYYIAPEVL--RKKYDEKCDVWS 190
Query: 194 VGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLA 253
            G I   ++ G P F               G  TD+       +  +      F+P +  
Sbjct: 191 CGVILYILLCGYPPF---------------GGQTDQE-----ILKRVEKGKFSFDPPD-- 228
Query: 254 EKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLI 291
             +  +      L+  ML   P +RI+A +AL H +++
Sbjct: 229 --WTQVSDEAKQLVKLMLTYEPSKRISAEEALNHPWIV 264

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 95.1 bits (235), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 125/272 (45%), Gaps = 33/272 (12%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           EV    N VT + VA+K++ ++   +  P  I +E+ + K L HEN+V+    +      
Sbjct: 21  EVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEIXINKMLNHENVVKFYGHRREGNIQ 79
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKA--ILKQILLGLAYCHSLKILHRDLKPNNLLI 139
           +L  EY          R +  + +    A     Q++ G+ Y H + I HRD+KP NLL+
Sbjct: 80  YLFLEYCSGG--ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL 137
Query: 140 DLKRNTVKLADFGLARAIGVPQKEY--SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCI 197
           D +R+ +K++DFGLA       +E   ++ C   PY APELL     ++ P+DVW+ G +
Sbjct: 138 D-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV 196
Query: 198 FAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFP 257
              M+ G+   P  +             P+D     S +  +   L P          + 
Sbjct: 197 LTAMLAGE--LPWDQ-------------PSDSCQEYSDWKEKKTYLNP----------WK 231
Query: 258 NLEPAGVDLLSQMLCLNPKQRITAMDALKHEY 289
            ++ A + LL ++L  NP  RIT  D  K  +
Sbjct: 232 KIDSAPLALLHKILVENPSARITIPDIKKDRW 263

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 95.1 bits (235), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 125/272 (45%), Gaps = 33/272 (12%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           EV    N VT + VA+K++ ++   +  P  I +E+ + K L HEN+V+    +      
Sbjct: 22  EVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVKFYGHRREGNIQ 80
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKA--ILKQILLGLAYCHSLKILHRDLKPNNLLI 139
           +L  EY          R +  + +    A     Q++ G+ Y H + I HRD+KP NLL+
Sbjct: 81  YLFLEYCSGG--ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL 138
Query: 140 DLKRNTVKLADFGLARAIGVPQKEY--SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCI 197
           D +R+ +K++DFGLA       +E   ++ C   PY APELL     ++ P+DVW+ G +
Sbjct: 139 D-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV 197
Query: 198 FAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFP 257
              M+ G+   P  +             P+D     S +  +   L P          + 
Sbjct: 198 LTAMLAGE--LPWDQ-------------PSDSCQEYSDWKEKKTYLNP----------WK 232
Query: 258 NLEPAGVDLLSQMLCLNPKQRITAMDALKHEY 289
            ++ A + LL ++L  NP  RIT  D  K  +
Sbjct: 233 KIDSAPLALLHKILVENPSARITIPDIKKDRW 264

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 95.1 bits (235), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 125/272 (45%), Gaps = 33/272 (12%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           EV    N VT + VA+K++ ++   +  P  I +E+ + K L HEN+V+    +      
Sbjct: 22  EVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVKFYGHRREGNIQ 80
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKA--ILKQILLGLAYCHSLKILHRDLKPNNLLI 139
           +L  EY          R +  + +    A     Q++ G+ Y H + I HRD+KP NLL+
Sbjct: 81  YLFLEYCSGG--ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL 138
Query: 140 DLKRNTVKLADFGLARAIGVPQKEY--SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCI 197
           D +R+ +K++DFGLA       +E   ++ C   PY APELL     ++ P+DVW+ G +
Sbjct: 139 D-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV 197
Query: 198 FAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFP 257
              M+ G+   P  +             P+D     S +  +   L P          + 
Sbjct: 198 LTAMLAGE--LPWDQ-------------PSDSCQEYSDWKEKKTYLNP----------WK 232
Query: 258 NLEPAGVDLLSQMLCLNPKQRITAMDALKHEY 289
            ++ A + LL ++L  NP  RIT  D  K  +
Sbjct: 233 KIDSAPLALLHKILVENPSARITIPDIKKDRW 264

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 95.1 bits (235), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 125/272 (45%), Gaps = 33/272 (12%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           EV    N VT + VA+K++ ++   +  P  I +E+ + K L HEN+V+    +      
Sbjct: 22  EVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVKFYGHRREGNIQ 80
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKA--ILKQILLGLAYCHSLKILHRDLKPNNLLI 139
           +L  EY          R +  + +    A     Q++ G+ Y H + I HRD+KP NLL+
Sbjct: 81  YLFLEYCSGG--ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL 138
Query: 140 DLKRNTVKLADFGLARAIGVPQKEY--SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCI 197
           D +R+ +K++DFGLA       +E   ++ C   PY APELL     ++ P+DVW+ G +
Sbjct: 139 D-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV 197
Query: 198 FAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFP 257
              M+ G+   P  +             P+D     S +  +   L P          + 
Sbjct: 198 LTAMLAGE--LPWDQ-------------PSDSCQEYSDWKEKKTYLNP----------WK 232
Query: 258 NLEPAGVDLLSQMLCLNPKQRITAMDALKHEY 289
            ++ A + LL ++L  NP  RIT  D  K  +
Sbjct: 233 KIDSAPLALLHKILVENPSARITIPDIKKDRW 264

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 95.1 bits (235), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 137/270 (50%), Gaps = 34/270 (12%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           VY   +  TGQ+VAI+ M +Q  Q+     II E+ +++E ++ NIV  LD      +++
Sbjct: 37  VYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELW 94
Query: 83  LVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +V EYL    L   +T  +  ++   I A+ ++ L  L + HS +++HR++K +N+L+ +
Sbjct: 95  VVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQVIHRNIKSDNILLGM 152
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPY-KAPELLLGYTGYSTPIDVWAVGCIFAE 200
              +VKL DFG    I  P++      V +PY  APE++     Y   +D+W++G +  E
Sbjct: 153 D-GSVKLTDFGFCAQI-TPEQSKRSTMVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIE 209
Query: 201 MITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
           MI G+P + ++       + +  GTP  ++                  P  L+  F    
Sbjct: 210 MIEGEPPYLNENPLRALYLIATNGTPELQN------------------PEKLSAIFR--- 248
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
               D L++ L ++ ++R +A + ++H++L
Sbjct: 249 ----DFLNRCLEMDVEKRGSAKELIQHQFL 274

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 95.1 bits (235), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 125/272 (45%), Gaps = 33/272 (12%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           EV    N VT + VA+K++ ++   +  P  I +E+ + K L HEN+V+    +      
Sbjct: 21  EVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVKFYGHRREGNIQ 79
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKA--ILKQILLGLAYCHSLKILHRDLKPNNLLI 139
           +L  EY          R +  + +    A     Q++ G+ Y H + I HRD+KP NLL+
Sbjct: 80  YLFLEYCSGG--ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL 137
Query: 140 DLKRNTVKLADFGLARAIGVPQKEY--SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCI 197
           D +R+ +K++DFGLA       +E   ++ C   PY APELL     ++ P+DVW+ G +
Sbjct: 138 D-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV 196
Query: 198 FAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFP 257
              M+ G+   P  +             P+D     S +  +   L P          + 
Sbjct: 197 LTAMLAGE--LPWDQ-------------PSDSCQEYSDWKEKKTYLNP----------WK 231
Query: 258 NLEPAGVDLLSQMLCLNPKQRITAMDALKHEY 289
            ++ A + LL ++L  NP  RIT  D  K  +
Sbjct: 232 KIDSAPLALLHKILVENPSARITIPDIKKDRW 263

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 95.1 bits (235), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 125/272 (45%), Gaps = 33/272 (12%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           EV    N VT + VA+K++ ++   +  P  I +E+ + K L HEN+V+    +      
Sbjct: 21  EVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVKFYGHRREGNIQ 79
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKA--ILKQILLGLAYCHSLKILHRDLKPNNLLI 139
           +L  EY          R +  + +    A     Q++ G+ Y H + I HRD+KP NLL+
Sbjct: 80  YLFLEYCSGG--ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL 137
Query: 140 DLKRNTVKLADFGLARAIGVPQKEY--SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCI 197
           D +R+ +K++DFGLA       +E   ++ C   PY APELL     ++ P+DVW+ G +
Sbjct: 138 D-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV 196
Query: 198 FAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFP 257
              M+ G+   P  +             P+D     S +  +   L P          + 
Sbjct: 197 LTAMLAGE--LPWDQ-------------PSDSCQEYSDWKEKKTYLNP----------WK 231
Query: 258 NLEPAGVDLLSQMLCLNPKQRITAMDALKHEY 289
            ++ A + LL ++L  NP  RIT  D  K  +
Sbjct: 232 KIDSAPLALLHKILVENPSARITIPDIKKDRW 263

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 125/272 (45%), Gaps = 33/272 (12%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           EV    N VT + VA+K++ ++   +  P  I +E+ + K L HEN+V+    +      
Sbjct: 21  EVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVKFYGHRREGNIQ 79
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKA--ILKQILLGLAYCHSLKILHRDLKPNNLLI 139
           +L  EY          R +  + +    A     Q++ G+ Y H + I HRD+KP NLL+
Sbjct: 80  YLFLEYCSGG--ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL 137
Query: 140 DLKRNTVKLADFGLARAIGVPQKEY--SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCI 197
           D +R+ +K++DFGLA       +E   ++ C   PY APELL     ++ P+DVW+ G +
Sbjct: 138 D-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV 196
Query: 198 FAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFP 257
              M+ G+   P  +             P+D     S +  +   L P          + 
Sbjct: 197 LTAMLAGE--LPWDQ-------------PSDSCQEYSDWKEKKTYLNP----------WK 231
Query: 258 NLEPAGVDLLSQMLCLNPKQRITAMDALKHEY 289
            ++ A + LL ++L  NP  RIT  D  K  +
Sbjct: 232 KIDSAPLALLHKILVENPSARITIPDIKKDRW 263

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 125/272 (45%), Gaps = 33/272 (12%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           EV    N VT + VA+K++ ++   +  P  I +E+ + K L HEN+V+    +      
Sbjct: 22  EVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVKFYGHRREGNIQ 80
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKA--ILKQILLGLAYCHSLKILHRDLKPNNLLI 139
           +L  EY          R +  + +    A     Q++ G+ Y H + I HRD+KP NLL+
Sbjct: 81  YLFLEYCSGG--ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL 138
Query: 140 DLKRNTVKLADFGLARAIGVPQKEY--SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCI 197
           D +R+ +K++DFGLA       +E   ++ C   PY APELL     ++ P+DVW+ G +
Sbjct: 139 D-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV 197
Query: 198 FAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFP 257
              M+ G+   P  +             P+D     S +  +   L P          + 
Sbjct: 198 LTAMLAGE--LPWDQ-------------PSDSCQEYSDWKEKKTYLNP----------WK 232
Query: 258 NLEPAGVDLLSQMLCLNPKQRITAMDALKHEY 289
            ++ A + LL ++L  NP  RIT  D  K  +
Sbjct: 233 KIDSAPLALLHKILVENPSARITIPDIKKDRW 264

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 125/272 (45%), Gaps = 33/272 (12%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           EV    N VT + VA+K++ ++   +  P  I +E+ + K L HEN+V+    +      
Sbjct: 22  EVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVKFYGHRREGNIQ 80
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKA--ILKQILLGLAYCHSLKILHRDLKPNNLLI 139
           +L  EY          R +  + +    A     Q++ G+ Y H + I HRD+KP NLL+
Sbjct: 81  YLFLEYCSGG--ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL 138
Query: 140 DLKRNTVKLADFGLARAIGVPQKEY--SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCI 197
           D +R+ +K++DFGLA       +E   ++ C   PY APELL     ++ P+DVW+ G +
Sbjct: 139 D-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV 197
Query: 198 FAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFP 257
              M+ G+   P  +             P+D     S +  +   L P          + 
Sbjct: 198 LTAMLAGE--LPWDQ-------------PSDSCQEYSDWKEKKTYLNP----------WK 232
Query: 258 NLEPAGVDLLSQMLCLNPKQRITAMDALKHEY 289
            ++ A + LL ++L  NP  RIT  D  K  +
Sbjct: 233 KIDSAPLALLHKILVENPSARITIPDIKKDRW 264

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 125/272 (45%), Gaps = 33/272 (12%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           EV    N VT + VA+K++ ++   +  P  I +E+ + K L HEN+V+    +      
Sbjct: 21  EVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVKFYGHRREGNIQ 79
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKA--ILKQILLGLAYCHSLKILHRDLKPNNLLI 139
           +L  EY          R +  + +    A     Q++ G+ Y H + I HRD+KP NLL+
Sbjct: 80  YLFLEYCSGG--ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL 137
Query: 140 DLKRNTVKLADFGLARAIGVPQKEY--SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCI 197
           D +R+ +K++DFGLA       +E   ++ C   PY APELL     ++ P+DVW+ G +
Sbjct: 138 D-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV 196
Query: 198 FAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFP 257
              M+ G+   P  +             P+D     S +  +   L P          + 
Sbjct: 197 LTAMLAGE--LPWDQ-------------PSDSCQEYSDWKEKKTYLNP----------WK 231
Query: 258 NLEPAGVDLLSQMLCLNPKQRITAMDALKHEY 289
            ++ A + LL ++L  NP  RIT  D  K  +
Sbjct: 232 KIDSAPLALLHKILVENPSARITIPDIKKDRW 263

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 125/272 (45%), Gaps = 33/272 (12%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           EV    N VT + VA+K++ ++   +  P  I +E+ + K L HEN+V+    +      
Sbjct: 20  EVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVKFYGHRREGNIQ 78
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKA--ILKQILLGLAYCHSLKILHRDLKPNNLLI 139
           +L  EY          R +  + +    A     Q++ G+ Y H + I HRD+KP NLL+
Sbjct: 79  YLFLEYCSGG--ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL 136
Query: 140 DLKRNTVKLADFGLARAIGVPQKEY--SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCI 197
           D +R+ +K++DFGLA       +E   ++ C   PY APELL     ++ P+DVW+ G +
Sbjct: 137 D-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV 195
Query: 198 FAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFP 257
              M+ G+   P  +             P+D     S +  +   L P          + 
Sbjct: 196 LTAMLAGE--LPWDQ-------------PSDSCQEYSDWKEKKTYLNP----------WK 230
Query: 258 NLEPAGVDLLSQMLCLNPKQRITAMDALKHEY 289
            ++ A + LL ++L  NP  RIT  D  K  +
Sbjct: 231 KIDSAPLALLHKILVENPSARITIPDIKKDRW 262

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 94.7 bits (234), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 125/272 (45%), Gaps = 33/272 (12%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           EV    N VT + VA+K++ ++   +  P  I +E+ + K L HEN+V+    +      
Sbjct: 21  EVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVKFYGHRREGNIQ 79
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKA--ILKQILLGLAYCHSLKILHRDLKPNNLLI 139
           +L  EY          R +  + +    A     Q++ G+ Y H + I HRD+KP NLL+
Sbjct: 80  YLFLEYCSGG--ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL 137
Query: 140 DLKRNTVKLADFGLARAIGVPQKEY--SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCI 197
           D +R+ +K++DFGLA       +E   ++ C   PY APELL     ++ P+DVW+ G +
Sbjct: 138 D-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV 196
Query: 198 FAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFP 257
              M+ G+   P  +             P+D     S +  +   L P          + 
Sbjct: 197 LTAMLAGE--LPWDQ-------------PSDSCQEYSDWKEKKTYLNP----------WK 231
Query: 258 NLEPAGVDLLSQMLCLNPKQRITAMDALKHEY 289
            ++ A + LL ++L  NP  RIT  D  K  +
Sbjct: 232 KIDSAPLALLHKILVENPSARITIPDIKKDRW 263

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 94.4 bits (233), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 123/271 (45%), Gaps = 37/271 (13%)
Query: 23  VYKCRNTVTGQKVAIKMM-TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           VY  R       +A+K++   Q E+EGV   + RE+ +   L H NI+R+ +    RK +
Sbjct: 31  VYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI 90
Query: 82  FLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLID 140
           +L+ E+    +L+  + +H    +       ++++   L YCH  K++HRD+KP NLL+ 
Sbjct: 91  YLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMG 149
Query: 141 LKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAE 200
            K   +K+ADFG   ++  P       C    Y  PE++ G T +   +D+W  G +  E
Sbjct: 150 YK-GELKIADFGW--SVHAPSLRRRXMCGTLDYLPPEMIEGKT-HDEKVDLWCAGVLCYE 205
Query: 201 MITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPN-L 259
            + G P F S  H           T T                  H    N+  KFP  L
Sbjct: 206 FLVGMPPFDSPSH-----------TET------------------HRRIVNVDLKFPPFL 236
Query: 260 EPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                DL+S++L  +P QR+     ++H ++
Sbjct: 237 SDGSKDLISKLLRYHPPQRLPLKGVMEHPWV 267

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 123/271 (45%), Gaps = 37/271 (13%)
Query: 23  VYKCRNTVTGQKVAIKMM-TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           VY  R       +A+K++   Q E+EGV   + RE+ +   L H NI+R+ +    RK +
Sbjct: 30  VYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI 89
Query: 82  FLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLID 140
           +L+ E+    +L+  + +H    +       ++++   L YCH  K++HRD+KP NLL+ 
Sbjct: 90  YLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMG 148
Query: 141 LKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAE 200
            K   +K+ADFG   ++  P       C    Y  PE++ G T +   +D+W  G +  E
Sbjct: 149 YK-GELKIADFGW--SVHAPSLRRRXMCGTLDYLPPEMIEGKT-HDEKVDLWCAGVLCYE 204
Query: 201 MITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPN-L 259
            + G P F S  H           T T                  H    N+  KFP  L
Sbjct: 205 FLVGMPPFDSPSH-----------TET------------------HRRIVNVDLKFPPFL 235
Query: 260 EPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                DL+S++L  +P QR+     ++H ++
Sbjct: 236 SDGSKDLISKLLRYHPPQRLPLKGVMEHPWV 266

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 122/282 (43%), Gaps = 51/282 (18%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           V +C      Q+ A K++  +         + RE  + + L+H NIVRL D  S     +
Sbjct: 47  VRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHY 106
Query: 83  LVFE-------YLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPN 135
           LVF+       + D+    + +    +         + QIL  + + H   I+HRDLKP 
Sbjct: 107 LVFDLVTGGELFEDIVAREYYSEADAS-------HCIHQILESVNHIHQHDIVHRDLKPE 159
Query: 136 NLLI--DLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           NLL+    K   VKLADFGLA  +   Q+ +        Y +PE+L     Y  P+D+WA
Sbjct: 160 NLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRK-DPYGKPVDIWA 218
Query: 194 VGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLA 253
            G I   ++ G P F                      W E  +      LY   +    A
Sbjct: 219 CGVILYILLVGYPPF----------------------WDEDQH-----KLYQQIKAG--A 249
Query: 254 EKFPNLE-----PAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
             FP+ E     P   +L++QML +NP +RITA  ALKH ++
Sbjct: 250 YDFPSPEWDTVTPEAKNLINQMLTINPAKRITADQALKHPWV 291

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 13/204 (6%)
Query: 25  KCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLD--VQSSRKDVF 82
           K R    G+ +  K +   +  E     ++ EV+LL+EL+H NIVR  D  +  +   ++
Sbjct: 24  KIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83
Query: 83  LVFEYLD-LDLHSFI---TRHKNTLNLLVIKAILKQILLGLAYCHSLK-----ILHRDLK 133
           +V EY +  DL S I   T+ +  L+   +  ++ Q+ L L  CH        +LHRDLK
Sbjct: 84  IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLK 143
Query: 134 PNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           P N+ +D K+N VKL DFGLAR +      +++  V +PY      +    Y+   D+W+
Sbjct: 144 PANVFLDGKQN-VKLGDFGLARILN-HDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWS 201
Query: 194 VGCIFAEMITGKPLFPSKKHDHLS 217
           +GC+  E+    P F +     L+
Sbjct: 202 LGCLLYELCALMPPFTAFSQKELA 225

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 127/272 (46%), Gaps = 36/272 (13%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQT-EQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           VY+  +  TG +VAIKM+  +   + G+   +  EV +  +L+H +I+ L +       V
Sbjct: 27  VYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYV 86
Query: 82  FLVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLID 140
           +LV E   + +++ ++       +    +  + QI+ G+ Y HS  ILHRDL  +NLL+ 
Sbjct: 87  YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLT 146
Query: 141 LKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAE 200
              N +K+ADFGLA  + +P +++   C    Y +PE+    + +    DVW++GC+F  
Sbjct: 147 RNMN-IKIADFGLATQLKMPHEKHYTLCGTPNYISPEIAT-RSAHGLESDVWSLGCMFYT 204
Query: 201 MITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLY--PHFEPANLAEKFPN 258
           ++ G+P                   P D    ++T    +L  Y  P F           
Sbjct: 205 LLIGRP-------------------PFDTDTVKNTLNKVVLADYEMPSF----------- 234
Query: 259 LEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           L     DL+ Q+L  NP  R++    L H ++
Sbjct: 235 LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFM 266

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 13/204 (6%)
Query: 25  KCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLD--VQSSRKDVF 82
           K R    G+ +  K +   +  E     ++ EV+LL+EL+H NIVR  D  +  +   ++
Sbjct: 24  KIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83
Query: 83  LVFEYLD-LDLHSFI---TRHKNTLNLLVIKAILKQILLGLAYCHSLK-----ILHRDLK 133
           +V EY +  DL S I   T+ +  L+   +  ++ Q+ L L  CH        +LHRDLK
Sbjct: 84  IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLK 143
Query: 134 PNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           P N+ +D K+N VKL DFGLAR +      +++  V +PY      +    Y+   D+W+
Sbjct: 144 PANVFLDGKQN-VKLGDFGLARILN-HDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWS 201
Query: 194 VGCIFAEMITGKPLFPSKKHDHLS 217
           +GC+  E+    P F +     L+
Sbjct: 202 LGCLLYELCALMPPFTAFSQKELA 225

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 124/272 (45%), Gaps = 33/272 (12%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           EV    N VT + VA+K++ ++   +  P  I +E+ +   L HEN+V+    +      
Sbjct: 22  EVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINAMLNHENVVKFYGHRREGNIQ 80
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKA--ILKQILLGLAYCHSLKILHRDLKPNNLLI 139
           +L  EY          R +  + +    A     Q++ G+ Y H + I HRD+KP NLL+
Sbjct: 81  YLFLEYCSGG--ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL 138
Query: 140 DLKRNTVKLADFGLARAIGVPQKEY--SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCI 197
           D +R+ +K++DFGLA       +E   ++ C   PY APELL     ++ P+DVW+ G +
Sbjct: 139 D-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV 197
Query: 198 FAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFP 257
              M+ G+   P  +             P+D     S +  +   L P          + 
Sbjct: 198 LTAMLAGE--LPWDQ-------------PSDSCQEYSDWKEKKTYLNP----------WK 232
Query: 258 NLEPAGVDLLSQMLCLNPKQRITAMDALKHEY 289
            ++ A + LL ++L  NP  RIT  D  K  +
Sbjct: 233 KIDSAPLALLHKILVENPSARITIPDIKKDRW 264

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 123/278 (44%), Gaps = 37/278 (13%)
Query: 23  VYKCRNTVTGQKVAIKMM-TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           VY  R   +   +A+K++   Q E+ GV   + REV +   L H NI+RL         V
Sbjct: 24  VYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDSTRV 83
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +L+ EY  L       +  +  +       + ++   L+YCHS K++HRD+KP NLL+  
Sbjct: 84  YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKKVIHRDIKPENLLLG- 142
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
               +K+ADFG   ++  P    +  C    Y  PE++ G   +   +D+W++G +  E 
Sbjct: 143 SAGELKIADFGW--SVHAPSSRRAALCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEF 199
Query: 202 ITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY--ISEILPLYPHFEPANLAEKFPNL 259
           + GKP F +  +                   + TY  IS +   +P F           +
Sbjct: 200 LVGKPPFEANTY-------------------QDTYKRISRVEFTFPDF-----------V 229
Query: 260 EPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
                DL+S++L  NP QR    + L+H ++    + P
Sbjct: 230 TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 123/278 (44%), Gaps = 37/278 (13%)
Query: 23  VYKCRNTVTGQKVAIKMM-TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           VY  R   +   +A+K++   Q E+ GV   + REV +   L H NI+RL         V
Sbjct: 24  VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 83
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +L+ EY  L       +  +  +       + ++   L+YCHS +++HRD+KP NLL+  
Sbjct: 84  YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG- 142
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
               +K+ADFG   ++  P    +  C    Y  PE++ G   +   +D+W++G +  E 
Sbjct: 143 SAGELKIADFGW--SVHAPSSRRTELCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEF 199
Query: 202 ITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY--ISEILPLYPHFEPANLAEKFPNL 259
           + GKP F +  +                   + TY  IS +   +P F           +
Sbjct: 200 LVGKPPFEANTY-------------------QETYKRISRVEFTFPDF-----------V 229
Query: 260 EPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
                DL+S++L  NP QR    + L+H ++    + P
Sbjct: 230 TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 123/278 (44%), Gaps = 37/278 (13%)
Query: 23  VYKCRNTVTGQKVAIKMM-TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           VY  R   +   +A+K++   Q E+ GV   + REV +   L H NI+RL         V
Sbjct: 28  VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 87
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +L+ EY  L       +  +  +       + ++   L+YCHS +++HRD+KP NLL+  
Sbjct: 88  YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG- 146
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
               +K+ADFG   ++  P    +  C    Y  PE++ G   +   +D+W++G +  E 
Sbjct: 147 SAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEF 203
Query: 202 ITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY--ISEILPLYPHFEPANLAEKFPNL 259
           + GKP F +  +                   + TY  IS +   +P F           +
Sbjct: 204 LVGKPPFEANTY-------------------QETYKRISRVEFTFPDF-----------V 233
Query: 260 EPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
                DL+S++L  NP QR    + L+H ++    + P
Sbjct: 234 TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 271

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 123/278 (44%), Gaps = 37/278 (13%)
Query: 23  VYKCRNTVTGQKVAIKMM-TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           VY  R   +   +A+K++   Q E+ GV   + REV +   L H NI+RL         V
Sbjct: 27  VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 86
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +L+ EY  L       +  +  +       + ++   L+YCHS +++HRD+KP NLL+  
Sbjct: 87  YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG- 145
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
               +K+ADFG   ++  P    +  C    Y  PE++ G   +   +D+W++G +  E 
Sbjct: 146 SAGELKIADFGW--SVHAPSSRRAALCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEF 202
Query: 202 ITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY--ISEILPLYPHFEPANLAEKFPNL 259
           + GKP F +  +                   + TY  IS +   +P F           +
Sbjct: 203 LVGKPPFEANTY-------------------QETYKRISRVEFTFPDF-----------V 232
Query: 260 EPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
                DL+S++L  NP QR    + L+H ++    + P
Sbjct: 233 TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 270

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 123/278 (44%), Gaps = 37/278 (13%)
Query: 23  VYKCRNTVTGQKVAIKMM-TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           VY  R   +   +A+K++   Q E+ GV   + REV +   L H NI+RL         V
Sbjct: 24  VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 83
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +L+ EY  L       +  +  +       + ++   L+YCHS +++HRD+KP NLL+  
Sbjct: 84  YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG- 142
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
               +K+ADFG   ++  P    +  C    Y  PE++ G   +   +D+W++G +  E 
Sbjct: 143 SAGELKIADFGW--SVHAPSSRRTXLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEF 199
Query: 202 ITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY--ISEILPLYPHFEPANLAEKFPNL 259
           + GKP F +  +                   + TY  IS +   +P F           +
Sbjct: 200 LVGKPPFEANTY-------------------QETYKRISRVEFTFPDF-----------V 229
Query: 260 EPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
                DL+S++L  NP QR    + L+H ++    + P
Sbjct: 230 TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 123/278 (44%), Gaps = 37/278 (13%)
Query: 23  VYKCRNTVTGQKVAIKMM-TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           VY  R   +   +A+K++   Q E+ GV   + REV +   L H NI+RL         V
Sbjct: 24  VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 83
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +L+ EY  L       +  +  +       + ++   L+YCHS +++HRD+KP NLL+  
Sbjct: 84  YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG- 142
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
               +K+ADFG   ++  P    +  C    Y  PE++ G   +   +D+W++G +  E 
Sbjct: 143 SAGELKIADFGW--SVHAPSSRRTDLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEF 199
Query: 202 ITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY--ISEILPLYPHFEPANLAEKFPNL 259
           + GKP F +  +                   + TY  IS +   +P F           +
Sbjct: 200 LVGKPPFEANTY-------------------QETYKRISRVEFTFPDF-----------V 229
Query: 260 EPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
                DL+S++L  NP QR    + L+H ++    + P
Sbjct: 230 TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 123/278 (44%), Gaps = 37/278 (13%)
Query: 23  VYKCRNTVTGQKVAIKMM-TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           VY  R   +   +A+K++   Q E+ GV   + REV +   L H NI+RL         V
Sbjct: 23  VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 82
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +L+ EY  L       +  +  +       + ++   L+YCHS +++HRD+KP NLL+  
Sbjct: 83  YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG- 141
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
               +K+ADFG   ++  P    +  C    Y  PE++ G   +   +D+W++G +  E 
Sbjct: 142 SAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEF 198
Query: 202 ITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY--ISEILPLYPHFEPANLAEKFPNL 259
           + GKP F +  +                   + TY  IS +   +P F           +
Sbjct: 199 LVGKPPFEANTY-------------------QETYKRISRVEFTFPDF-----------V 228
Query: 260 EPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
                DL+S++L  NP QR    + L+H ++    + P
Sbjct: 229 TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 266

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 123/278 (44%), Gaps = 37/278 (13%)
Query: 23  VYKCRNTVTGQKVAIKMM-TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           VY  R   +   +A+K++   Q E+ GV   + REV +   L H NI+RL         V
Sbjct: 27  VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 86
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +L+ EY  L       +  +  +       + ++   L+YCHS +++HRD+KP NLL+  
Sbjct: 87  YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG- 145
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
               +K+ADFG   ++  P    +  C    Y  PE++ G   +   +D+W++G +  E 
Sbjct: 146 SAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEF 202
Query: 202 ITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY--ISEILPLYPHFEPANLAEKFPNL 259
           + GKP F +  +                   + TY  IS +   +P F           +
Sbjct: 203 LVGKPPFEANTY-------------------QETYKRISRVEFTFPDF-----------V 232
Query: 260 EPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
                DL+S++L  NP QR    + L+H ++    + P
Sbjct: 233 TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 270

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 123/278 (44%), Gaps = 37/278 (13%)
Query: 23  VYKCRNTVTGQKVAIKMM-TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           VY  R   +   +A+K++   Q E+ GV   + REV +   L H NI+RL         V
Sbjct: 29  VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 88
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +L+ EY  L       +  +  +       + ++   L+YCHS +++HRD+KP NLL+  
Sbjct: 89  YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG- 147
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
               +K+ADFG   ++  P    +  C    Y  PE++ G   +   +D+W++G +  E 
Sbjct: 148 SAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEF 204
Query: 202 ITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY--ISEILPLYPHFEPANLAEKFPNL 259
           + GKP F +  +                   + TY  IS +   +P F           +
Sbjct: 205 LVGKPPFEANTY-------------------QETYKRISRVEFTFPDF-----------V 234
Query: 260 EPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
                DL+S++L  NP QR    + L+H ++    + P
Sbjct: 235 TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 272

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 123/278 (44%), Gaps = 37/278 (13%)
Query: 23  VYKCRNTVTGQKVAIKMM-TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           VY  R   +   +A+K++   Q E+ GV   + REV +   L H NI+RL         V
Sbjct: 24  VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 83
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +L+ EY  L       +  +  +       + ++   L+YCHS +++HRD+KP NLL+  
Sbjct: 84  YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG- 142
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
               +K+ADFG   ++  P    +  C    Y  PE++ G   +   +D+W++G +  E 
Sbjct: 143 SAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEF 199
Query: 202 ITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY--ISEILPLYPHFEPANLAEKFPNL 259
           + GKP F +  +                   + TY  IS +   +P F           +
Sbjct: 200 LVGKPPFEANTY-------------------QETYKRISRVEFTFPDF-----------V 229
Query: 260 EPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
                DL+S++L  NP QR    + L+H ++    + P
Sbjct: 230 TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 123/278 (44%), Gaps = 37/278 (13%)
Query: 23  VYKCRNTVTGQKVAIKMM-TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           VY  R   +   +A+K++   Q E+ GV   + REV +   L H NI+RL         V
Sbjct: 25  VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 84
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +L+ EY  L       +  +  +       + ++   L+YCHS +++HRD+KP NLL+  
Sbjct: 85  YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG- 143
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
               +K+ADFG   ++  P    +  C    Y  PE++ G   +   +D+W++G +  E 
Sbjct: 144 SAGELKIADFGW--SVHAPSSRRTDLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEF 200
Query: 202 ITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY--ISEILPLYPHFEPANLAEKFPNL 259
           + GKP F +  +                   + TY  IS +   +P F           +
Sbjct: 201 LVGKPPFEANTY-------------------QETYKRISRVEFTFPDF-----------V 230
Query: 260 EPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
                DL+S++L  NP QR    + L+H ++    + P
Sbjct: 231 TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 268

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 123/278 (44%), Gaps = 37/278 (13%)
Query: 23  VYKCRNTVTGQKVAIKMM-TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           VY  R   +   +A+K++   Q E+ GV   + REV +   L H NI+RL         V
Sbjct: 41  VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 100
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +L+ EY  L       +  +  +       + ++   L+YCHS +++HRD+KP NLL+  
Sbjct: 101 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG- 159
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
               +K+ADFG   ++  P    +  C    Y  PE++ G   +   +D+W++G +  E 
Sbjct: 160 SAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEF 216
Query: 202 ITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY--ISEILPLYPHFEPANLAEKFPNL 259
           + GKP F +  +                   + TY  IS +   +P F           +
Sbjct: 217 LVGKPPFEANTY-------------------QETYKRISRVEFTFPDF-----------V 246
Query: 260 EPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
                DL+S++L  NP QR    + L+H ++    + P
Sbjct: 247 TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 284

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 123/278 (44%), Gaps = 37/278 (13%)
Query: 23  VYKCRNTVTGQKVAIKMM-TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           VY  R   +   +A+K++   Q E+ GV   + REV +   L H NI+RL         V
Sbjct: 24  VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 83
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +L+ EY  L       +  +  +       + ++   L+YCHS +++HRD+KP NLL+  
Sbjct: 84  YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG- 142
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
               +K+ADFG   ++  P    +  C    Y  PE++ G   +   +D+W++G +  E 
Sbjct: 143 SAGELKIADFGW--SVHAPSSRRAALCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEF 199
Query: 202 ITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY--ISEILPLYPHFEPANLAEKFPNL 259
           + GKP F +  +                   + TY  IS +   +P F           +
Sbjct: 200 LVGKPPFEANTY-------------------QETYKRISRVEFTFPDF-----------V 229
Query: 260 EPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
                DL+S++L  NP QR    + L+H ++    + P
Sbjct: 230 TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 123/278 (44%), Gaps = 37/278 (13%)
Query: 23  VYKCRNTVTGQKVAIKMM-TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           VY  R   +   +A+K++   Q E+ GV   + REV +   L H NI+RL         V
Sbjct: 24  VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 83
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +L+ EY  L       +  +  +       + ++   L+YCHS +++HRD+KP NLL+  
Sbjct: 84  YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG- 142
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
               +K+ADFG   ++  P    +  C    Y  PE++ G   +   +D+W++G +  E 
Sbjct: 143 SAGELKIADFGW--SVHAPSSRRTDLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEF 199
Query: 202 ITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY--ISEILPLYPHFEPANLAEKFPNL 259
           + GKP F +  +                   + TY  IS +   +P F           +
Sbjct: 200 LVGKPPFEANTY-------------------QETYKRISRVEFTFPDF-----------V 229
Query: 260 EPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
                DL+S++L  NP QR    + L+H ++    + P
Sbjct: 230 TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 91.7 bits (226), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 123/278 (44%), Gaps = 37/278 (13%)
Query: 23  VYKCRNTVTGQKVAIKMM-TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           VY  R   +   +A+K++   Q E+ GV   + REV +   L H NI+RL         V
Sbjct: 29  VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 88
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +L+ EY  L       +  +  +       + ++   L+YCHS +++HRD+KP NLL+  
Sbjct: 89  YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG- 147
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
               +K+ADFG   ++  P    +  C    Y  PE++ G   +   +D+W++G +  E 
Sbjct: 148 SAGELKIADFGW--SVHAPSSRRTDLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEF 204
Query: 202 ITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY--ISEILPLYPHFEPANLAEKFPNL 259
           + GKP F +  +                   + TY  IS +   +P F           +
Sbjct: 205 LVGKPPFEANTY-------------------QETYKRISRVEFTFPDF-----------V 234
Query: 260 EPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
                DL+S++L  NP QR    + L+H ++    + P
Sbjct: 235 TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 272

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 124/272 (45%), Gaps = 33/272 (12%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           EV    N VT + VA+K++ ++   +  P  I +E+ + K L HEN+V+    +      
Sbjct: 22  EVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEIXINKMLNHENVVKFYGHRREGNIQ 80
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKA--ILKQILLGLAYCHSLKILHRDLKPNNLLI 139
           +L  EY          R +  + +    A     Q++ G+ Y H + I HRD+KP NLL+
Sbjct: 81  YLFLEYCSGG--ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL 138
Query: 140 DLKRNTVKLADFGLARAIGVPQKEYSRDCVYS--PYKAPELLLGYTGYSTPIDVWAVGCI 197
           D +R+ +K++DFGLA       +E   + +    PY APELL     ++ P+DVW+ G +
Sbjct: 139 D-ERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIV 197
Query: 198 FAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFP 257
              M+ G+   P  +             P+D     S +  +   L P          + 
Sbjct: 198 LTAMLAGE--LPWDQ-------------PSDSCQEYSDWKEKKTYLNP----------WK 232
Query: 258 NLEPAGVDLLSQMLCLNPKQRITAMDALKHEY 289
            ++ A + LL ++L  NP  RIT  D  K  +
Sbjct: 233 KIDSAPLALLHKILVENPSARITIPDIKKDRW 264

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 124/272 (45%), Gaps = 33/272 (12%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           EV    N VT + VA+K++ ++   +  P  I +E+ + K L HEN+V+    +      
Sbjct: 21  EVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVKFYGHRREGNIQ 79
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKA--ILKQILLGLAYCHSLKILHRDLKPNNLLI 139
           +L  EY          R +  + +    A     Q++ G+ Y H + I HRD+KP NLL+
Sbjct: 80  YLFLEYCSGG--ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL 137
Query: 140 DLKRNTVKLADFGLARAIGVPQKEYSRDCVYS--PYKAPELLLGYTGYSTPIDVWAVGCI 197
           D +R+ +K++DFGLA       +E   + +    PY APELL     ++ P+DVW+ G +
Sbjct: 138 D-ERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIV 196
Query: 198 FAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFP 257
              M+ G+   P  +             P+D     S +  +   L P          + 
Sbjct: 197 LTAMLAGE--LPWDQ-------------PSDSXQEYSDWKEKKTYLNP----------WK 231
Query: 258 NLEPAGVDLLSQMLCLNPKQRITAMDALKHEY 289
            ++ A + LL ++L  NP  RIT  D  K  +
Sbjct: 232 KIDSAPLALLHKILVENPSARITIPDIKKDRW 263

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 124/272 (45%), Gaps = 33/272 (12%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           EV    N VT + VA+K++ ++   +  P  I +E+ + K L HEN+V+    +      
Sbjct: 21  EVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEIXINKMLNHENVVKFYGHRREGNIQ 79
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKA--ILKQILLGLAYCHSLKILHRDLKPNNLLI 139
           +L  EY          R +  + +    A     Q++ G+ Y H + I HRD+KP NLL+
Sbjct: 80  YLFLEYCSGG--ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL 137
Query: 140 DLKRNTVKLADFGLARAIGVPQKEYSRDCVYS--PYKAPELLLGYTGYSTPIDVWAVGCI 197
           D +R+ +K++DFGLA       +E   + +    PY APELL     ++ P+DVW+ G +
Sbjct: 138 D-ERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIV 196
Query: 198 FAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFP 257
              M+ G+   P  +             P+D     S +  +   L P          + 
Sbjct: 197 LTAMLAGE--LPWDQ-------------PSDSCQEYSDWKEKKTYLNP----------WK 231
Query: 258 NLEPAGVDLLSQMLCLNPKQRITAMDALKHEY 289
            ++ A + LL ++L  NP  RIT  D  K  +
Sbjct: 232 KIDSAPLALLHKILVENPSARITIPDIKKDRW 263

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 123/278 (44%), Gaps = 37/278 (13%)
Query: 23  VYKCRNTVTGQKVAIKMM-TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           VY  R   +   +A+K++   Q E+ GV   + REV +   L H NI+RL         V
Sbjct: 50  VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 109
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +L+ EY  L       +  +  +       + ++   L+YCHS +++HRD+KP NLL+  
Sbjct: 110 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG- 168
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
               +K+ADFG   ++  P    +  C    Y  PE++ G   +   +D+W++G +  E 
Sbjct: 169 SAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEF 225
Query: 202 ITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY--ISEILPLYPHFEPANLAEKFPNL 259
           + GKP F +  +                   + TY  IS +   +P F           +
Sbjct: 226 LVGKPPFEANTY-------------------QETYKRISRVEFTFPDF-----------V 255
Query: 260 EPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
                DL+S++L  NP QR    + L+H ++    + P
Sbjct: 256 TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 293

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 124/272 (45%), Gaps = 33/272 (12%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           EV    N VT + VA+K++ ++   +  P  I +E+ + K L HEN+V+    +      
Sbjct: 21  EVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVKFYGHRREGNIQ 79
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKA--ILKQILLGLAYCHSLKILHRDLKPNNLLI 139
           +L  EY          R +  + +    A     Q++ G+ Y H + I HRD+KP NLL+
Sbjct: 80  YLFLEYCSGG--ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL 137
Query: 140 DLKRNTVKLADFGLARAIGVPQKEYSRDCVYS--PYKAPELLLGYTGYSTPIDVWAVGCI 197
           D +R+ +K++DFGLA       +E   + +    PY APELL     ++ P+DVW+ G +
Sbjct: 138 D-ERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIV 196
Query: 198 FAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFP 257
              M+ G+   P  +             P+D     S +  +   L P          + 
Sbjct: 197 LTAMLAGE--LPWDQ-------------PSDSCQEYSDWKEKKTYLNP----------WK 231
Query: 258 NLEPAGVDLLSQMLCLNPKQRITAMDALKHEY 289
            ++ A + LL ++L  NP  RIT  D  K  +
Sbjct: 232 KIDSAPLALLHKILVENPSARITIPDIKKDRW 263

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 71/269 (26%), Positives = 132/269 (49%), Gaps = 36/269 (13%)
Query: 26  CRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF 85
            R   +G++VA+KMM ++ +Q      +  EV ++++ +H N+V +       ++++++ 
Sbjct: 64  AREKHSGRQVAVKMMDLRKQQRR--ELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLM 121
Query: 86  EYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNT 145
           E+L     + I      LN   I  + + +L  LAY H+  ++HRD+K +++L+ L    
Sbjct: 122 EFLQGGALTDIVSQVR-LNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLD-GR 179
Query: 146 VKLADFGLARAIG--VPQKEYSRDCVYSPY-KAPELLLGYTGYSTPIDVWAVGCIFAEMI 202
           VKL+DFG    I   VP++   +  V +PY  APE ++  + Y+T +D+W++G +  EM+
Sbjct: 180 VKLSDFGFCAQISKDVPKR---KXLVGTPYWMAPE-VISRSLYATEVDIWSLGIMVIEMV 235
Query: 203 TGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPA 262
            G+P  P      +  +  L  +P                      P  L      + P 
Sbjct: 236 DGEP--PYFSDSPVQAMKRLRDSP----------------------PPKLKNSH-KVSPV 270
Query: 263 GVDLLSQMLCLNPKQRITAMDALKHEYLI 291
             D L +ML  +P++R TA + L H +L+
Sbjct: 271 LRDFLERMLVRDPQERATAQELLDHPFLL 299

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 122/278 (43%), Gaps = 37/278 (13%)
Query: 23  VYKCRNTVTGQKVAIKMM-TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           VY  R   +   +A+K++   Q E+ GV   + REV +   L H NI+RL         V
Sbjct: 25  VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 84
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +L+ EY  L       +  +  +       + ++   L+YCHS +++HRD+KP NLL+  
Sbjct: 85  YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG- 143
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
               +K+ADFG   ++  P       C    Y  PE++ G   +   +D+W++G +  E 
Sbjct: 144 SAGELKIADFGW--SVHAPSSRRDTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEF 200
Query: 202 ITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY--ISEILPLYPHFEPANLAEKFPNL 259
           + GKP F +  +                   + TY  IS +   +P F           +
Sbjct: 201 LVGKPPFEANTY-------------------QETYKRISRVEFTFPDF-----------V 230
Query: 260 EPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
                DL+S++L  NP QR    + L+H ++    + P
Sbjct: 231 TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 268

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 124/272 (45%), Gaps = 33/272 (12%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           EV    N VT + VA+K++ ++   +  P  I +E+ + K L HEN+V+    +      
Sbjct: 21  EVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVKFYGHRREGNIQ 79
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKA--ILKQILLGLAYCHSLKILHRDLKPNNLLI 139
           +L  EY          R +  + +    A     Q++ G+ Y H + I HRD+KP NLL+
Sbjct: 80  YLFLEYCSGG--ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL 137
Query: 140 DLKRNTVKLADFGLARAIGVPQKEYSRDCVYS--PYKAPELLLGYTGYSTPIDVWAVGCI 197
           D +R+ +K++DFGLA       +E   + +    PY APELL     ++ P+DVW+ G +
Sbjct: 138 D-ERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIV 196
Query: 198 FAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFP 257
              M+ G+   P  +             P+D     S +  +   L P          + 
Sbjct: 197 LTAMLAGE--LPWDQ-------------PSDSCQEYSDWKEKKTYLNP----------WK 231
Query: 258 NLEPAGVDLLSQMLCLNPKQRITAMDALKHEY 289
            ++ A + LL ++L  NP  RIT  D  K  +
Sbjct: 232 KIDSAPLALLHKILVENPSARITIPDIKKDRW 263

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 122/278 (43%), Gaps = 37/278 (13%)
Query: 23  VYKCRNTVTGQKVAIKMM-TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           VY  R   +   +A+K++   Q E+ GV   + REV +   L H NI+RL         V
Sbjct: 26  VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 85
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +L+ EY  L       +  +  +       + ++   L+YCHS +++HRD+KP NLL+  
Sbjct: 86  YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG- 144
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
               +K+ADFG   ++  P       C    Y  PE++ G   +   +D+W++G +  E 
Sbjct: 145 SAGELKIADFGW--SVHAPSSRRXXLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEF 201
Query: 202 ITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY--ISEILPLYPHFEPANLAEKFPNL 259
           + GKP F +  +                   + TY  IS +   +P F           +
Sbjct: 202 LVGKPPFEANTY-------------------QETYKRISRVEFTFPDF-----------V 231
Query: 260 EPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
                DL+S++L  NP QR    + L+H ++    + P
Sbjct: 232 TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 269

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 122/278 (43%), Gaps = 37/278 (13%)
Query: 23  VYKCRNTVTGQKVAIKMM-TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           VY  R   +   +A+K++   Q E+ GV   + REV +   L H NI+RL         V
Sbjct: 24  VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 83
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +L+ EY  L       +  +  +       + ++   L+YCHS +++HRD+KP NLL+  
Sbjct: 84  YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG- 142
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
               +K+ADFG   ++  P       C    Y  PE++ G   +   +D+W++G +  E 
Sbjct: 143 SAGELKIADFGW--SVHAPSSRRXXLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEF 199
Query: 202 ITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY--ISEILPLYPHFEPANLAEKFPNL 259
           + GKP F +  +                   + TY  IS +   +P F           +
Sbjct: 200 LVGKPPFEANTY-------------------QETYKRISRVEFTFPDF-----------V 229
Query: 260 EPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
                DL+S++L  NP QR    + L+H ++    + P
Sbjct: 230 TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 91.3 bits (225), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 122/278 (43%), Gaps = 37/278 (13%)
Query: 23  VYKCRNTVTGQKVAIKMM-TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           VY  R   +   +A+K++   Q E+ GV   + REV +   L H NI+RL         V
Sbjct: 27  VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 86
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +L+ EY  L       +  +  +       + ++   L+YCHS +++HRD+KP NLL+  
Sbjct: 87  YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG- 145
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
               +K+ADFG   ++  P       C    Y  PE++ G   +   +D+W++G +  E 
Sbjct: 146 SAGELKIADFGW--SVHAPSSRRDDLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEF 202
Query: 202 ITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY--ISEILPLYPHFEPANLAEKFPNL 259
           + GKP F +  +                   + TY  IS +   +P F           +
Sbjct: 203 LVGKPPFEANTY-------------------QETYKRISRVEFTFPDF-----------V 232
Query: 260 EPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
                DL+S++L  NP QR    + L+H ++    + P
Sbjct: 233 TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 270

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 62/189 (32%), Positives = 100/189 (52%), Gaps = 6/189 (3%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQ-TEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           VY   +T+   KVAIK + I   E+E       REV    +L H+NIV ++DV       
Sbjct: 27  VYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY 86
Query: 82  FLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLID 140
           +LV EY++   L  +I  H   L++        QIL G+ + H ++I+HRD+KP N+LID
Sbjct: 87  YLVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILID 145
Query: 141 LKRNTVKLADFGLARAIGVPQKEYSRDCVYS-PYKAPELLLGYTGYSTPIDVWAVGCIFA 199
             + T+K+ DFG+A+A+       +   + +  Y +PE   G        D++++G +  
Sbjct: 146 SNK-TLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG-EATDECTDIYSIGIVLY 203
Query: 200 EMITGKPLF 208
           EM+ G+P F
Sbjct: 204 EMLVGEPPF 212

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 122/278 (43%), Gaps = 37/278 (13%)
Query: 23  VYKCRNTVTGQKVAIKMM-TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           VY  R   +   +A+K++   Q E+ GV   + REV +   L H NI+RL         V
Sbjct: 29  VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 88
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +L+ EY  L       +  +  +       + ++   L+YCHS +++HRD+KP NLL+  
Sbjct: 89  YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG- 147
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
               +K+ADFG   ++  P    +  C    Y  PE + G   +   +D+W++G +  E 
Sbjct: 148 SAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEXIEGRX-HDEKVDLWSLGVLCYEF 204
Query: 202 ITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY--ISEILPLYPHFEPANLAEKFPNL 259
           + GKP F +  +                   + TY  IS +   +P F           +
Sbjct: 205 LVGKPPFEANTY-------------------QETYKRISRVEFTFPDF-----------V 234
Query: 260 EPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
                DL+S++L  NP QR    + L+H ++    + P
Sbjct: 235 TEGARDLISRLLKHNPSQRPXLREVLEHPWITANSSKP 272

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 75/244 (30%), Positives = 114/244 (46%), Gaps = 37/244 (15%)
Query: 53  IIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDLD--LHSFITRHKNTLNLLVIKA 110
           I  E+SLLK L+H NI++L DV   +K  +LV E+ +        I RHK   +      
Sbjct: 93  IYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK--FDECDAAN 150
Query: 111 ILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN--TVKLADFGLARAIGVPQKEYS-RD 167
           I+KQIL G+ Y H   I+HRD+KP N+L++ K +   +K+ DFGL+       K+Y  RD
Sbjct: 151 IMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF---SKDYKLRD 207
Query: 168 CVYSPYK-APELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTP 226
            + + Y  APE+L     Y+   DVW+ G I   ++ G P F               G  
Sbjct: 208 RLGTAYYIAPEVLK--KKYNEKCDVWSCGVIMYILLCGYPPF---------------GGQ 250
Query: 227 TDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK 286
            D+   +     E    Y  F        + N+     +L+  ML  +  +R TA +AL 
Sbjct: 251 NDQDIIKKV---EKGKYYFDFND------WKNISDEAKELIKLMLTYDYNKRCTAEEALN 301
Query: 287 HEYL 290
             ++
Sbjct: 302 SRWI 305

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 90.9 bits (224), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 136/286 (47%), Gaps = 49/286 (17%)
Query: 23  VYKCRNTVTGQKVAIKMMTI-------QTEQEGVPSYIIREVSLLKELE-HENIVRLLDV 74
           V +C +  T ++ A+K++ +         E + +    ++EV +L+++  H NI++L D 
Sbjct: 20  VRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT 79
Query: 75  QSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLK 133
             +    FLVF+ +   +L  ++T  K TL+    + I++ +L  +   H L I+HRDLK
Sbjct: 80  YETNTFFFLVFDLMKKGELFDYLT-EKVTLSEKETRKIMRALLEVICALHKLNIVHRDLK 138
Query: 134 PNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLL-----GYTGYSTP 188
           P N+L+D   N +KL DFG +  +  P ++    C    Y APE++       + GY   
Sbjct: 139 PENILLDDDMN-IKLTDFGFSCQLD-PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKE 196
Query: 189 IDVWAVGCIFAEMITGKPLFPSKKHD-HLSLIFS---LLGTPTDESWAESTYISEILPLY 244
           +D+W+ G I   ++ G P F  +K    L +I S     G+P  + ++++          
Sbjct: 197 VDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTV--------- 247
Query: 245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                               DL+S+ L + P++R TA +AL H + 
Sbjct: 248 -------------------KDLVSRFLVVQPQKRYTAEEALAHPFF 274

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 90.9 bits (224), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 122/278 (43%), Gaps = 37/278 (13%)
Query: 23  VYKCRNTVTGQKVAIKMM-TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           VY  R   +   +A+K++   Q E+ GV   + REV +   L H NI+RL         V
Sbjct: 50  VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 109
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +L+ EY  L       +  +  +       + ++   L+YCHS +++HRD+KP NLL+  
Sbjct: 110 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG- 168
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
               +K+ADFG   ++  P       C    Y  PE++ G   +   +D+W++G +  E 
Sbjct: 169 SAGELKIADFGW--SVHAPSSRRDDLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEF 225
Query: 202 ITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY--ISEILPLYPHFEPANLAEKFPNL 259
           + GKP F +  +                   + TY  IS +   +P F           +
Sbjct: 226 LVGKPPFEANTY-------------------QETYKRISRVEFTFPDF-----------V 255
Query: 260 EPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
                DL+S++L  NP QR    + L+H ++    + P
Sbjct: 256 TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 293

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 90.9 bits (224), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 136/286 (47%), Gaps = 49/286 (17%)
Query: 23  VYKCRNTVTGQKVAIKMMTI-------QTEQEGVPSYIIREVSLLKELE-HENIVRLLDV 74
           V +C +  T ++ A+K++ +         E + +    ++EV +L+++  H NI++L D 
Sbjct: 33  VRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT 92
Query: 75  QSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLK 133
             +    FLVF+ +   +L  ++T  K TL+    + I++ +L  +   H L I+HRDLK
Sbjct: 93  YETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLK 151
Query: 134 PNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLL-----GYTGYSTP 188
           P N+L+D   N +KL DFG +  +  P ++    C    Y APE++       + GY   
Sbjct: 152 PENILLDDDMN-IKLTDFGFSCQLD-PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKE 209
Query: 189 IDVWAVGCIFAEMITGKPLFPSKKHD-HLSLIFS---LLGTPTDESWAESTYISEILPLY 244
           +D+W+ G I   ++ G P F  +K    L +I S     G+P  + ++++          
Sbjct: 210 VDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVK-------- 261
Query: 245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                               DL+S+ L + P++R TA +AL H + 
Sbjct: 262 --------------------DLVSRFLVVQPQKRYTAEEALAHPFF 287

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 136/286 (47%), Gaps = 49/286 (17%)
Query: 23  VYKCRNTVTGQKVAIKMMTI-------QTEQEGVPSYIIREVSLLKELE-HENIVRLLDV 74
           V +C +  T ++ A+K++ +         E + +    ++EV +L+++  H NI++L D 
Sbjct: 33  VRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT 92
Query: 75  QSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLK 133
             +    FLVF+ +   +L  ++T  K TL+    + I++ +L  +   H L I+HRDLK
Sbjct: 93  YETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLK 151
Query: 134 PNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLL-----GYTGYSTP 188
           P N+L+D   N +KL DFG +  +  P ++    C    Y APE++       + GY   
Sbjct: 152 PENILLDDDMN-IKLTDFGFSCQLD-PGEKLRSVCGTPSYLAPEIIECSMNDNHPGYGKE 209
Query: 189 IDVWAVGCIFAEMITGKPLFPSKKHD-HLSLIFS---LLGTPTDESWAESTYISEILPLY 244
           +D+W+ G I   ++ G P F  +K    L +I S     G+P  + ++++          
Sbjct: 210 VDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVK-------- 261
Query: 245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                               DL+S+ L + P++R TA +AL H + 
Sbjct: 262 --------------------DLVSRFLVVQPQKRYTAEEALAHPFF 287

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 121/273 (44%), Gaps = 37/273 (13%)
Query: 23  VYKCRNTVTGQKVAIKMM-TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           VY  R   +   +A+K++   Q E+ GV   + REV +   L H NI+RL         V
Sbjct: 27  VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 86
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +L+ EY  L       +  +  +       + ++   L+YCHS +++HRD+KP NLL+  
Sbjct: 87  YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG- 145
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
               +K+ADFG   ++  P    +  C    Y  PE++ G   +   +D+W++G +  E 
Sbjct: 146 SAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEF 202
Query: 202 ITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY--ISEILPLYPHFEPANLAEKFPNL 259
           + GKP F +  +                   + TY  IS +   +P F           +
Sbjct: 203 LVGKPPFEANTY-------------------QETYKRISRVEFTFPDF-----------V 232
Query: 260 EPAGVDLLSQMLCLNPKQRITAMDALKHEYLIG 292
                DL+S++L  NP QR    + L+H ++  
Sbjct: 233 TEGARDLISRLLKHNPSQRPMLREVLEHPWITA 265

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 89/291 (30%), Positives = 133/291 (45%), Gaps = 40/291 (13%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVP-SYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           VY  R+    + VAIK M+   +Q       II+EV  L++L H N ++           
Sbjct: 70  VYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTA 129
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV EY        +  HK  L  + I A+    L GLAY HS  ++HRD+K  N+L+  
Sbjct: 130 WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS- 188
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPY-KAPELLLGYT--GYSTPIDVWAVGCIF 198
           +   VKL DFG A +I  P   +    V +PY  APE++L      Y   +DVW++G   
Sbjct: 189 EPGLVKLGDFGSA-SIMAPANXF----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 243
Query: 199 AEMITGK-PLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFP 257
            E+   K PLF      +++ + +L     +ES              P  +  + +E F 
Sbjct: 244 IELAERKPPLF------NMNAMSALYHIAQNES--------------PALQSGHWSEYFR 283
Query: 258 NLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVIL-LINRKK 307
           N     VD   Q +   P+ R T+   LKH +++  E  P VI+ LI R K
Sbjct: 284 NF----VDSCLQKI---PQDRPTSEVLLKHRFVL-RERPPTVIMDLIQRTK 326

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 89/291 (30%), Positives = 133/291 (45%), Gaps = 40/291 (13%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVP-SYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           VY  R+    + VAIK M+   +Q       II+EV  L++L H N ++           
Sbjct: 31  VYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTA 90
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +LV EY        +  HK  L  + I A+    L GLAY HS  ++HRD+K  N+L+  
Sbjct: 91  WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS- 149
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPY-KAPELLLGYT--GYSTPIDVWAVGCIF 198
           +   VKL DFG A +I  P   +    V +PY  APE++L      Y   +DVW++G   
Sbjct: 150 EPGLVKLGDFGSA-SIMAPANXF----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 204
Query: 199 AEMITGK-PLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFP 257
            E+   K PLF      +++ + +L     +ES              P  +  + +E F 
Sbjct: 205 IELAERKPPLF------NMNAMSALYHIAQNES--------------PALQSGHWSEYFR 244
Query: 258 NLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVIL-LINRKK 307
           N     VD   Q +   P+ R T+   LKH +++  E  P VI+ LI R K
Sbjct: 245 NF----VDSCLQKI---PQDRPTSEVLLKHRFVLR-ERPPTVIMDLIQRTK 287

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/278 (25%), Positives = 123/278 (44%), Gaps = 37/278 (13%)
Query: 23  VYKCRNTVTGQKVAIKMM-TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           VY  R   +   +A+K++   Q E+ GV   + REV +   L H NI+RL         V
Sbjct: 27  VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 86
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +L+ EY  L       +  +  +       + ++   L+YCHS +++HRD+KP NLL+  
Sbjct: 87  YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG- 145
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
               +K+A+FG   ++  P    +  C    Y  PE++ G   +   +D+W++G +  E 
Sbjct: 146 SAGELKIANFGW--SVHAPSSRRTTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEF 202
Query: 202 ITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY--ISEILPLYPHFEPANLAEKFPNL 259
           + GKP F +  +                   + TY  IS +   +P F           +
Sbjct: 203 LVGKPPFEANTY-------------------QETYKRISRVEFTFPDF-----------V 232
Query: 260 EPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
                DL+S++L  NP QR    + L+H ++    + P
Sbjct: 233 TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 270

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/278 (25%), Positives = 123/278 (44%), Gaps = 37/278 (13%)
Query: 23  VYKCRNTVTGQKVAIKMM-TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           VY  R   +   +A+K++   Q E+ GV   + REV +   L H NI+RL         V
Sbjct: 26  VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 85
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +L+ EY  L       +  +  +       + ++   L+YCHS +++HRD+KP NLL+  
Sbjct: 86  YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG- 144
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
               +K+A+FG   ++  P    +  C    Y  PE++ G   +   +D+W++G +  E 
Sbjct: 145 SAGELKIANFGW--SVHAPSSRRTTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEF 201
Query: 202 ITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY--ISEILPLYPHFEPANLAEKFPNL 259
           + GKP F +  +                   + TY  IS +   +P F           +
Sbjct: 202 LVGKPPFEANTY-------------------QETYKRISRVEFTFPDF-----------V 231
Query: 260 EPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
                DL+S++L  NP QR    + L+H ++    + P
Sbjct: 232 TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 269

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 120/273 (43%), Gaps = 37/273 (13%)
Query: 23  VYKCRNTVTGQKVAIKMM-TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           VY  R   +   +A+K++   Q E+ GV   + REV +   L H NI+RL         V
Sbjct: 27  VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 86
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +L+ EY  L       +  +  +       + ++   L+YCHS +++HRD+KP NLL+  
Sbjct: 87  YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG- 145
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
               +K+ADFG   ++  P       C    Y  PE++ G   +   +D+W++G +  E 
Sbjct: 146 SAGELKIADFGW--SVHAPSSRRXXLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEF 202
Query: 202 ITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY--ISEILPLYPHFEPANLAEKFPNL 259
           + GKP F +  +                   + TY  IS +   +P F           +
Sbjct: 203 LVGKPPFEANTY-------------------QETYKRISRVEFTFPDF-----------V 232
Query: 260 EPAGVDLLSQMLCLNPKQRITAMDALKHEYLIG 292
                DL+S++L  NP QR    + L+H ++  
Sbjct: 233 TEGARDLISRLLKHNPSQRPMLREVLEHPWITA 265

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/278 (25%), Positives = 123/278 (44%), Gaps = 37/278 (13%)
Query: 23  VYKCRNTVTGQKVAIKMM-TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           VY  R   +   +A+K++   Q E+ GV   + REV +   L H NI+RL         V
Sbjct: 28  VYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 87
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +L+ EY  L       +  +  +       + ++   L+YCHS +++HRD+KP NLL+  
Sbjct: 88  YLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG- 146
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
               +K+ADFG   ++  P    +  C    Y  PE++ G   +   +D+W++G +  E 
Sbjct: 147 SNGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEF 203
Query: 202 ITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY--ISEILPLYPHFEPANLAEKFPNL 259
           + G P F +  +                   + TY  IS +   +P F           +
Sbjct: 204 LVGMPPFEAHTY-------------------QETYRRISRVEFTFPDF-----------V 233
Query: 260 EPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
                DL+S++L  N  QR+T  + L+H ++    + P
Sbjct: 234 TEGARDLISRLLKHNASQRLTLAEVLEHPWIKANSSKP 271

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 120/273 (43%), Gaps = 37/273 (13%)
Query: 23  VYKCRNTVTGQKVAIKMM-TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           VY  R       +A+K++   Q E+ GV   + REV +   L H NI+RL         V
Sbjct: 21  VYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 80
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +L+ EY  L       +  +  +       + ++   L+YCHS +++HRD+KP NLL+  
Sbjct: 81  YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG- 139
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
               +K+ADFG   ++  P    +  C    Y  PE++ G   +   +D+W++G +  E 
Sbjct: 140 SAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEF 196
Query: 202 ITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY--ISEILPLYPHFEPANLAEKFPNL 259
           + GKP F +  +                   + TY  IS +   +P F           +
Sbjct: 197 LVGKPPFEANTY-------------------QETYKRISRVEFTFPDF-----------V 226
Query: 260 EPAGVDLLSQMLCLNPKQRITAMDALKHEYLIG 292
                DL+S++L  NP QR    + L+H ++  
Sbjct: 227 TEGARDLISRLLKHNPSQRPMLREVLEHPWITA 259

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 71/278 (25%), Positives = 122/278 (43%), Gaps = 37/278 (13%)
Query: 23  VYKCRNTVTGQKVAIKMM-TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           VY  R   +   +A+K++   Q E+ GV   + REV +   L H NI+RL         V
Sbjct: 28  VYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 87
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +L+ EY  L       +  +  +       + ++   L+YCHS +++HRD+KP NLL+  
Sbjct: 88  YLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG- 146
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
               +K+ADFG   ++  P       C    Y  PE++ G   +   +D+W++G +  E 
Sbjct: 147 SNGELKIADFGW--SVHAPSSRRDTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEF 203
Query: 202 ITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY--ISEILPLYPHFEPANLAEKFPNL 259
           + G P F +  +                   + TY  IS +   +P F           +
Sbjct: 204 LVGMPPFEAHTY-------------------QETYRRISRVEFTFPDF-----------V 233
Query: 260 EPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
                DL+S++L  N  QR+T  + L+H ++    + P
Sbjct: 234 TEGARDLISRLLKHNASQRLTLAEVLEHPWIKANSSKP 271

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 71/278 (25%), Positives = 122/278 (43%), Gaps = 37/278 (13%)
Query: 23  VYKCRNTVTGQKVAIKMM-TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           VY  R   +   +A+K++   Q E+ GV   + REV +   L H NI+RL         V
Sbjct: 29  VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 88
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +L+ EY          +  +  +       + ++   L+YCHS +++HRD+KP NLL+  
Sbjct: 89  YLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG- 147
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
               +K+ADFG   ++  P    +  C    Y  PE++ G   +   +D+W++G +  E 
Sbjct: 148 SAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEF 204
Query: 202 ITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY--ISEILPLYPHFEPANLAEKFPNL 259
           + GKP F +  +                   + TY  IS +   +P F           +
Sbjct: 205 LVGKPPFEANTY-------------------QETYKRISRVEFTFPDF-----------V 234
Query: 260 EPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
                DL+S++L  NP QR    + L+H ++    + P
Sbjct: 235 TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 272

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 140/272 (51%), Gaps = 39/272 (14%)
Query: 31  TGQKVAIKMMT-----IQTEQEGVPSYIIR-EVSLLKELEHENIVRLLDVQSSRKDVFLV 84
           T +KVAIK+++     I + +E  P+  +  E+ +LK+L H  I+++ +   + +D ++V
Sbjct: 33  TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-EDYYIV 91
Query: 85  FEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKR 143
            E ++  +L   +  +K  L     K    Q+LL + Y H   I+HRDLKP N+L+  + 
Sbjct: 92  LELMEGGELFDKVVGNKR-LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE 150
Query: 144 NT--VKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELL--LGYTGYSTPIDVWAVGCIF 198
               +K+ DFG ++ +G  +    R    +P Y APE+L  +G  GY+  +D W++G I 
Sbjct: 151 EDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 208
Query: 199 AEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPN 258
              ++G P F S+    +SL   +       +  +  +I E+         A ++EK   
Sbjct: 209 FICLSGYPPF-SEHRTQVSLKDQI-------TSGKYNFIPEVW--------AEVSEK--- 249
Query: 259 LEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                +DL+ ++L ++PK R T  +AL+H +L
Sbjct: 250 ----ALDLVKKLLVVDPKARFTTEEALRHPWL 277

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 140/272 (51%), Gaps = 39/272 (14%)
Query: 31  TGQKVAIKMMT-----IQTEQEGVPSYIIR-EVSLLKELEHENIVRLLDVQSSRKDVFLV 84
           T +KVAIK+++     I + +E  P+  +  E+ +LK+L H  I+++ +   + +D ++V
Sbjct: 34  TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-EDYYIV 92
Query: 85  FEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKR 143
            E ++  +L   +  +K  L     K    Q+LL + Y H   I+HRDLKP N+L+  + 
Sbjct: 93  LELMEGGELFDKVVGNKR-LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE 151
Query: 144 NT--VKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELL--LGYTGYSTPIDVWAVGCIF 198
               +K+ DFG ++ +G  +    R    +P Y APE+L  +G  GY+  +D W++G I 
Sbjct: 152 EDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
Query: 199 AEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPN 258
              ++G P F S+    +SL   +       +  +  +I E+         A ++EK   
Sbjct: 210 FICLSGYPPF-SEHRTQVSLKDQI-------TSGKYNFIPEVW--------AEVSEK--- 250
Query: 259 LEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                +DL+ ++L ++PK R T  +AL+H +L
Sbjct: 251 ----ALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 140/272 (51%), Gaps = 39/272 (14%)
Query: 31  TGQKVAIKMMT-----IQTEQEGVPSYIIR-EVSLLKELEHENIVRLLDVQSSRKDVFLV 84
           T +KVAIK+++     I + +E  P+  +  E+ +LK+L H  I+++ +   + +D ++V
Sbjct: 34  TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-EDYYIV 92
Query: 85  FEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKR 143
            E ++  +L   +  +K  L     K    Q+LL + Y H   I+HRDLKP N+L+  + 
Sbjct: 93  LELMEGGELFDKVVGNKR-LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE 151
Query: 144 NT--VKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELL--LGYTGYSTPIDVWAVGCIF 198
               +K+ DFG ++ +G  +    R    +P Y APE+L  +G  GY+  +D W++G I 
Sbjct: 152 EDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
Query: 199 AEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPN 258
              ++G P F S+    +SL   +       +  +  +I E+         A ++EK   
Sbjct: 210 FICLSGYPPF-SEHRTQVSLKDQI-------TSGKYNFIPEVW--------AEVSEK--- 250
Query: 259 LEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                +DL+ ++L ++PK R T  +AL+H +L
Sbjct: 251 ----ALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 140/272 (51%), Gaps = 39/272 (14%)
Query: 31  TGQKVAIKMMT-----IQTEQEGVPSYIIR-EVSLLKELEHENIVRLLDVQSSRKDVFLV 84
           T +KVAIK+++     I + +E  P+  +  E+ +LK+L H  I+++ +   + +D ++V
Sbjct: 34  TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-EDYYIV 92
Query: 85  FEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKR 143
            E ++  +L   +  +K  L     K    Q+LL + Y H   I+HRDLKP N+L+  + 
Sbjct: 93  LELMEGGELFDKVVGNKR-LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE 151
Query: 144 NT--VKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELL--LGYTGYSTPIDVWAVGCIF 198
               +K+ DFG ++ +G  +    R    +P Y APE+L  +G  GY+  +D W++G I 
Sbjct: 152 EDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
Query: 199 AEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPN 258
              ++G P F S+    +SL   +       +  +  +I E+         A ++EK   
Sbjct: 210 FICLSGYPPF-SEHRTQVSLKDQI-------TSGKYNFIPEVW--------AEVSEK--- 250
Query: 259 LEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                +DL+ ++L ++PK R T  +AL+H +L
Sbjct: 251 ----ALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 126/277 (45%), Gaps = 39/277 (14%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVP-SYIIREVSLLKELEHENIVRLLDVQSSRKD 80
           +V+      +G +  IK  TI  ++  VP   I  E+ +LK L+H NI+++ +V     +
Sbjct: 37  DVHLVEERSSGLERVIK--TINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHN 94
Query: 81  VFLVFEYLD----LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNN 136
           +++V E  +    L+           L+   +  ++KQ++  LAY HS  ++H+DLKP N
Sbjct: 95  MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPEN 154
Query: 137 LLID--LKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGYTGYSTPIDVWA 193
           +L       + +K+ DFGLA        E+S +   +  Y APE+      +    D+W+
Sbjct: 155 ILFQDTSPHSPIKIIDFGLAELF--KSDEHSTNAAGTALYMAPEVFKRDVTFKC--DIWS 210
Query: 194 VGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLA 253
            G +   ++TG                   GT  +E   ++TY           EP    
Sbjct: 211 AGVVMYFLLTG--------------CLPFTGTSLEEVQQKATYK----------EPNYAV 246
Query: 254 EKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           E  P L P  VDLL QML  +P++R +A   L HE+ 
Sbjct: 247 ECRP-LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWF 282

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 140/272 (51%), Gaps = 39/272 (14%)
Query: 31  TGQKVAIKMMT-----IQTEQEGVPSYIIR-EVSLLKELEHENIVRLLDVQSSRKDVFLV 84
           T +KVAIK+++     I + +E  P+  +  E+ +LK+L H  I+++ +   + +D ++V
Sbjct: 40  TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-EDYYIV 98
Query: 85  FEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKR 143
            E ++  +L   +  +K  L     K    Q+LL + Y H   I+HRDLKP N+L+  + 
Sbjct: 99  LELMEGGELFDKVVGNKR-LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE 157
Query: 144 NT--VKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELL--LGYTGYSTPIDVWAVGCIF 198
               +K+ DFG ++ +G  +    R    +P Y APE+L  +G  GY+  +D W++G I 
Sbjct: 158 EDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 215
Query: 199 AEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPN 258
              ++G P F S+    +SL   +       +  +  +I E+         A ++EK   
Sbjct: 216 FICLSGYPPF-SEHRTQVSLKDQI-------TSGKYNFIPEVW--------AEVSEK--- 256
Query: 259 LEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                +DL+ ++L ++PK R T  +AL+H +L
Sbjct: 257 ----ALDLVKKLLVVDPKARFTTEEALRHPWL 284

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 76/271 (28%), Positives = 127/271 (46%), Gaps = 37/271 (13%)
Query: 23  VYKCRNTVTGQKVAIKMM-TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           VY  R   +   VA+K++   Q E+EGV   + RE+ +   L H NI+RL +    R+ +
Sbjct: 39  VYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYNYFYDRRRI 98
Query: 82  FLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLID 140
           +L+ EY    +L+  + +   T +      I++++   L YCH  K++HRD+KP NLL+ 
Sbjct: 99  YLILEYAPRGELYKELQK-SCTFDEQRTATIMEELADALMYCHGKKVIHRDIKPENLLLG 157
Query: 141 LKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAE 200
           LK   +K+ADFG   ++  P       C    Y  PE++ G   ++  +D+W +G +  E
Sbjct: 158 LK-GELKIADFGW--SVHAPSLRRKTMCGTLDYLPPEMIEGRM-HNEKVDLWCIGVLCYE 213
Query: 201 MITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
           ++ G P F S  H+                    TY   +           +  KFP   
Sbjct: 214 LLVGNPPFESASHN-------------------ETYRRIV----------KVDLKFPASV 244
Query: 261 PAGV-DLLSQMLCLNPKQRITAMDALKHEYL 290
           P G  DL+S++L  NP +R+       H ++
Sbjct: 245 PTGAQDLISKLLRHNPSERLPLAQVSAHPWV 275

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 87.8 bits (216), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 80/274 (29%), Positives = 132/274 (48%), Gaps = 35/274 (12%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIR-EVSLLKELEHENIVRLLDVQSSRKDV 81
           VY+C+   T +  A+K++     ++ V   I+R E+ +L  L H NI++L ++  +  ++
Sbjct: 69  VYRCKQKGTQKPYALKVL-----KKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEI 123
Query: 82  FLVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLL-- 138
            LV E +   +L   I             A+ KQIL  +AY H   I+HRDLKP NLL  
Sbjct: 124 SLVLELVTGGELFDRIVEKGYYSERDAADAV-KQILEAVAYLHENGIVHRDLKPENLLYA 182
Query: 139 IDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIF 198
                  +K+ADFGL++ +   Q      C    Y APE+L G   Y   +D+W+VG I 
Sbjct: 183 TPAPDAPLKIADFGLSKIVE-HQVLMKTVCGTPGYCAPEILRG-CAYGPEVDMWSVGIIT 240
Query: 199 AEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPN 258
             ++ G   F  ++ D   +   +L         E  +IS      P ++  +L  K   
Sbjct: 241 YILLCGFEPFYDERGDQF-MFRRILN-------CEYYFIS------PWWDEVSLNAK--- 283
Query: 259 LEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIG 292
                 DL+ +++ L+PK+R+T   AL+H ++ G
Sbjct: 284 ------DLVRKLIVLDPKKRLTTFQALQHPWVTG 311

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 139/272 (51%), Gaps = 39/272 (14%)
Query: 31  TGQKVAIKMMT-----IQTEQEGVPSYIIR-EVSLLKELEHENIVRLLDVQSSRKDVFLV 84
           T +KVAI++++     I + +E  P+  +  E+ +LK+L H  I+++ +   + +D ++V
Sbjct: 159 TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-EDYYIV 217
Query: 85  FEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKR 143
            E ++  +L   +  +K  L     K    Q+LL + Y H   I+HRDLKP N+L+  + 
Sbjct: 218 LELMEGGELFDKVVGNKR-LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE 276
Query: 144 NT--VKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELL--LGYTGYSTPIDVWAVGCIF 198
               +K+ DFG ++ +G  +    R    +P Y APE+L  +G  GY+  +D W++G I 
Sbjct: 277 EDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
Query: 199 AEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPN 258
              ++G P F S+    +SL   +          +  +I E+         A ++EK   
Sbjct: 335 FICLSGYPPF-SEHRTQVSLKDQITS-------GKYNFIPEVW--------AEVSEK--- 375
Query: 259 LEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                +DL+ ++L ++PK R T  +AL+H +L
Sbjct: 376 ----ALDLVKKLLVVDPKARFTTEEALRHPWL 403

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 139/272 (51%), Gaps = 39/272 (14%)
Query: 31  TGQKVAIKMMT-----IQTEQEGVPSYIIR-EVSLLKELEHENIVRLLDVQSSRKDVFLV 84
           T +KVAI++++     I + +E  P+  +  E+ +LK+L H  I+++ +   + +D ++V
Sbjct: 173 TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-EDYYIV 231
Query: 85  FEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKR 143
            E ++  +L   +  +K  L     K    Q+LL + Y H   I+HRDLKP N+L+  + 
Sbjct: 232 LELMEGGELFDKVVGNKR-LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE 290
Query: 144 NT--VKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELL--LGYTGYSTPIDVWAVGCIF 198
               +K+ DFG ++ +G  +    R    +P Y APE+L  +G  GY+  +D W++G I 
Sbjct: 291 EDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 348
Query: 199 AEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPN 258
              ++G P F S+    +SL   +          +  +I E+         A ++EK   
Sbjct: 349 FICLSGYPPF-SEHRTQVSLKDQITS-------GKYNFIPEVW--------AEVSEK--- 389
Query: 259 LEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                +DL+ ++L ++PK R T  +AL+H +L
Sbjct: 390 ----ALDLVKKLLVVDPKARFTTEEALRHPWL 417

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/192 (33%), Positives = 98/192 (51%), Gaps = 10/192 (5%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           VY  R+     ++AIK +  +  +   P +   E++L K L+H+NIV+ L   S    + 
Sbjct: 24  VYAGRDLSNQVRIAIKEIPERDSRYSQPLH--EEIALHKHLKHKNIVQYLGSFSENGFIK 81
Query: 83  LVFEYLDLDLHSFITRHKNTL---NLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLI 139
           +  E +     S + R K      N   I    KQIL GL Y H  +I+HRD+K +N+LI
Sbjct: 82  IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLI 141
Query: 140 DLKRNTVKLADFGLA-RAIGV-PQKEYSRDCVYSPYKAPELL-LGYTGYSTPIDVWAVGC 196
           +     +K++DFG + R  G+ P  E     +   Y APE++  G  GY    D+W++GC
Sbjct: 142 NTYSGVLKISDFGTSKRLAGINPCTETFTGTL--QYMAPEIIDKGPRGYGKAADIWSLGC 199
Query: 197 IFAEMITGKPLF 208
              EM TGKP F
Sbjct: 200 TIIEMATGKPPF 211

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/192 (33%), Positives = 98/192 (51%), Gaps = 10/192 (5%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           VY  R+     ++AIK +  +  +   P  +  E++L K L+H+NIV+ L   S    + 
Sbjct: 38  VYAGRDLSNQVRIAIKEIPERDSRYSQP--LHEEIALHKHLKHKNIVQYLGSFSENGFIK 95
Query: 83  LVFEYLDLDLHSFITRHKNTL---NLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLI 139
           +  E +     S + R K      N   I    KQIL GL Y H  +I+HRD+K +N+LI
Sbjct: 96  IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLI 155
Query: 140 DLKRNTVKLADFGLA-RAIGV-PQKEYSRDCVYSPYKAPELL-LGYTGYSTPIDVWAVGC 196
           +     +K++DFG + R  G+ P  E     +   Y APE++  G  GY    D+W++GC
Sbjct: 156 NTYSGVLKISDFGTSKRLAGINPCTETFTGTLQ--YMAPEIIDKGPRGYGKAADIWSLGC 213
Query: 197 IFAEMITGKPLF 208
              EM TGKP F
Sbjct: 214 TIIEMATGKPPF 225

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/278 (25%), Positives = 121/278 (43%), Gaps = 37/278 (13%)
Query: 23  VYKCRNTVTGQKVAIKMM-TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           VY  R   +   +A+K++   Q E+ GV   + REV +   L H NI+RL         V
Sbjct: 25  VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 84
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +L+ EY  L       +  +  +       + ++   L+YCHS +++HRD+KP NLL+  
Sbjct: 85  YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG- 143
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
               +K+ADFG   +   P    +       Y  PE++ G   +   +D+W++G +  E 
Sbjct: 144 SAGELKIADFGW--SCHAPSSRRTTLSGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEF 200
Query: 202 ITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY--ISEILPLYPHFEPANLAEKFPNL 259
           + GKP F +  +                   + TY  IS +   +P F           +
Sbjct: 201 LVGKPPFEANTY-------------------QETYKRISRVEFTFPDF-----------V 230
Query: 260 EPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
                DL+S++L  NP QR    + L+H ++    + P
Sbjct: 231 TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 268

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 94/194 (48%), Gaps = 4/194 (2%)
Query: 27  RNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE 86
           ++T  G++  IK + I            REV++L  ++H NIV+  +       +++V +
Sbjct: 44  KSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103
Query: 87  YLDL-DLHSFITRHKNTL-NLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN 144
           Y +  DL   I   K  L     I     QI L L + H  KILHRD+K  N+ +  K  
Sbjct: 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL-TKDG 162
Query: 145 TVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITG 204
           TV+L DFG+AR +     E +R C+ +PY     +     Y+   D+WA+GC+  E+ T 
Sbjct: 163 TVQLGDFGIARVLN-STVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTL 221
Query: 205 KPLFPSKKHDHLSL 218
           K  F +    +L L
Sbjct: 222 KHAFEAGSMKNLVL 235

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 135/270 (50%), Gaps = 38/270 (14%)
Query: 26  CRNTV--TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL 83
           C  TV  +G+ VA+K M ++ +Q      +  EV ++++ +HEN+V + +      ++++
Sbjct: 37  CIATVRSSGKLVAVKKMDLRKQQRR--ELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV 94
Query: 84  VFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKR 143
           V E+L+    + I  H   +N   I A+   +L  L+  H+  ++HRD+K +++L+    
Sbjct: 95  VMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT-HD 152
Query: 144 NTVKLADFGLARAIG--VPQKEYSRDCVYSPY-KAPELLLGYTGYSTPIDVWAVGCIFAE 200
             VKL+DFG    +   VP++   +  V +PY  APEL+     Y   +D+W++G +  E
Sbjct: 153 GRVKLSDFGFCAQVSKEVPRR---KXLVGTPYWMAPELI-SRLPYGPEVDIWSLGIMVIE 208
Query: 201 MITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
           M+ G+P +                 P  ++      I + LP  P  +  NL +  P+L+
Sbjct: 209 MVDGEPPY--------------FNEPPLKAM---KMIRDNLP--PRLK--NLHKVSPSLK 247
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                 L ++L  +P QR TA + LKH +L
Sbjct: 248 ----GFLDRLLVRDPAQRATAAELLKHPFL 273

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 135/270 (50%), Gaps = 38/270 (14%)
Query: 26  CRNTV--TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL 83
           C  TV  +G+ VA+K M ++ +Q      +  EV ++++ +HEN+V + +      ++++
Sbjct: 46  CIATVRSSGKLVAVKKMDLRKQQRR--ELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV 103
Query: 84  VFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKR 143
           V E+L+    + I  H   +N   I A+   +L  L+  H+  ++HRD+K +++L+    
Sbjct: 104 VMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL-THD 161
Query: 144 NTVKLADFGLARAIG--VPQKEYSRDCVYSPY-KAPELLLGYTGYSTPIDVWAVGCIFAE 200
             VKL+DFG    +   VP++   +  V +PY  APEL+     Y   +D+W++G +  E
Sbjct: 162 GRVKLSDFGFCAQVSKEVPRR---KXLVGTPYWMAPELI-SRLPYGPEVDIWSLGIMVIE 217
Query: 201 MITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
           M+ G+P +                 P  ++      I + LP  P  +  NL +  P+L+
Sbjct: 218 MVDGEPPY--------------FNEPPLKAM---KMIRDNLP--PRLK--NLHKVSPSLK 256
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                 L ++L  +P QR TA + LKH +L
Sbjct: 257 ----GFLDRLLVRDPAQRATAAELLKHPFL 282

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 135/270 (50%), Gaps = 38/270 (14%)
Query: 26  CRNTV--TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL 83
           C  TV  +G+ VA+K M ++ +Q      +  EV ++++ +HEN+V + +      ++++
Sbjct: 41  CIATVRSSGKLVAVKKMDLRKQQRR--ELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV 98
Query: 84  VFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKR 143
           V E+L+    + I  H   +N   I A+   +L  L+  H+  ++HRD+K +++L+    
Sbjct: 99  VMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT-HD 156
Query: 144 NTVKLADFGLARAIG--VPQKEYSRDCVYSPY-KAPELLLGYTGYSTPIDVWAVGCIFAE 200
             VKL+DFG    +   VP++   +  V +PY  APEL+     Y   +D+W++G +  E
Sbjct: 157 GRVKLSDFGFCAQVSKEVPRR---KXLVGTPYWMAPELI-SRLPYGPEVDIWSLGIMVIE 212
Query: 201 MITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
           M+ G+P +                 P  ++      I + LP  P  +  NL +  P+L+
Sbjct: 213 MVDGEPPY--------------FNEPPLKAM---KMIRDNLP--PRLK--NLHKVSPSLK 251
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                 L ++L  +P QR TA + LKH +L
Sbjct: 252 ----GFLDRLLVRDPAQRATAAELLKHPFL 277

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 135/270 (50%), Gaps = 38/270 (14%)
Query: 26  CRNTV--TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL 83
           C  TV  +G+ VA+K M ++ +Q      +  EV ++++ +HEN+V + +      ++++
Sbjct: 48  CIATVRSSGKLVAVKKMDLRKQQRR--ELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV 105
Query: 84  VFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKR 143
           V E+L+    + I  H   +N   I A+   +L  L+  H+  ++HRD+K +++L+    
Sbjct: 106 VMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL-THD 163
Query: 144 NTVKLADFGLARAIG--VPQKEYSRDCVYSPY-KAPELLLGYTGYSTPIDVWAVGCIFAE 200
             VKL+DFG    +   VP++   +  V +PY  APEL+     Y   +D+W++G +  E
Sbjct: 164 GRVKLSDFGFCAQVSKEVPRR---KXLVGTPYWMAPELI-SRLPYGPEVDIWSLGIMVIE 219
Query: 201 MITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
           M+ G+P +                 P  ++      I + LP  P  +  NL +  P+L+
Sbjct: 220 MVDGEPPY--------------FNEPPLKAM---KMIRDNLP--PRLK--NLHKVSPSLK 258
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                 L ++L  +P QR TA + LKH +L
Sbjct: 259 ----GFLDRLLVRDPAQRATAAELLKHPFL 284

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 135/270 (50%), Gaps = 38/270 (14%)
Query: 26  CRNTV--TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL 83
           C  TV  +G+ VA+K M ++ +Q      +  EV ++++ +HEN+V + +      ++++
Sbjct: 91  CIATVRSSGKLVAVKKMDLRKQQRR--ELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV 148
Query: 84  VFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKR 143
           V E+L+    + I  H   +N   I A+   +L  L+  H+  ++HRD+K +++L+    
Sbjct: 149 VMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL-THD 206
Query: 144 NTVKLADFGLARAIG--VPQKEYSRDCVYSPY-KAPELLLGYTGYSTPIDVWAVGCIFAE 200
             VKL+DFG    +   VP++   +  V +PY  APEL+     Y   +D+W++G +  E
Sbjct: 207 GRVKLSDFGFCAQVSKEVPRR---KXLVGTPYWMAPELI-SRLPYGPEVDIWSLGIMVIE 262
Query: 201 MITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
           M+ G+P +           F+      +        I + LP  P  +  NL +  P+L+
Sbjct: 263 MVDGEPPY-----------FN------EPPLKAMKMIRDNLP--PRLK--NLHKVSPSLK 301
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                 L ++L  +P QR TA + LKH +L
Sbjct: 302 ----GFLDRLLVRDPAQRATAAELLKHPFL 327

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 120/278 (43%), Gaps = 37/278 (13%)
Query: 23  VYKCRNTVTGQKVAIKMM-TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           VY  R   +   +A+K++   Q E+ GV   + REV +   L H NI+RL         V
Sbjct: 29  VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 88
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +L+ EY          +  +  +       + ++   L+YCHS +++HRD+KP NLL+  
Sbjct: 89  YLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG- 147
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
               +K+ADFG   ++  P            Y  PE++ G   +   +D+W++G +  E 
Sbjct: 148 SAGELKIADFGW--SVHAPSSRRXXLXGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEF 204
Query: 202 ITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY--ISEILPLYPHFEPANLAEKFPNL 259
           + GKP F +  +                   + TY  IS +   +P F           +
Sbjct: 205 LVGKPPFEANTY-------------------QETYKRISRVEFTFPDF-----------V 234
Query: 260 EPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
                DL+S++L  NP QR    + L+H ++    + P
Sbjct: 235 TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 272

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 133/296 (44%), Gaps = 47/296 (15%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-HENIVRLLDVQSSRKDV 81
           V  C N +T Q+ A+K+  I+ +   + S + REV +L + + H N++ L++        
Sbjct: 29  VQTCINLITSQEYAVKI--IEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRF 86
Query: 82  FLVFEYL---DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLL 138
           +LVFE +    +  H    RH N L   V+   ++ +   L + H+  I HRDLKP N+L
Sbjct: 87  YLVFEKMRGGSILSHIHKRRHFNELEASVV---VQDVASALDFLHNKGIAHRDLKPENIL 143
Query: 139 IDLKRNT--VKLADFGLARAIG-------VPQKEYSRDCVYSPYKAPELLLGYTG----Y 185
            +       VK+ DFGL   I        +   E    C  + Y APE++  ++     Y
Sbjct: 144 CEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIY 203
Query: 186 STPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYP 245
               D+W++G I   +++G P F  +               +D  W       E  P   
Sbjct: 204 DKRCDLWSLGVILYILLSGYPPFVGR-------------CGSDCGWDR----GEACPACQ 246
Query: 246 HFEPANLAE---KFPN-----LEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
           +    ++ E   +FP+     +  A  DL+S++L  + KQR++A   L+H ++ G 
Sbjct: 247 NMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 135/270 (50%), Gaps = 38/270 (14%)
Query: 26  CRNTV--TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL 83
           C  TV  +G+ VA+K M ++ +Q      +  EV ++++ +HEN+V + +      ++++
Sbjct: 168 CIATVRSSGKLVAVKKMDLRKQQRR--ELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV 225
Query: 84  VFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKR 143
           V E+L+    + I  H   +N   I A+   +L  L+  H+  ++HRD+K +++L+    
Sbjct: 226 VMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL-THD 283
Query: 144 NTVKLADFGLARAIG--VPQKEYSRDCVYSPY-KAPELLLGYTGYSTPIDVWAVGCIFAE 200
             VKL+DFG    +   VP++   +  V +PY  APEL+     Y   +D+W++G +  E
Sbjct: 284 GRVKLSDFGFCAQVSKEVPRR---KXLVGTPYWMAPELI-SRLPYGPEVDIWSLGIMVIE 339
Query: 201 MITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
           M+ G+P +           F+      +        I + LP  P  +  NL +  P+L+
Sbjct: 340 MVDGEPPY-----------FN------EPPLKAMKMIRDNLP--PRLK--NLHKVSPSLK 378
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                 L ++L  +P QR TA + LKH +L
Sbjct: 379 ----GFLDRLLVRDPAQRATAAELLKHPFL 404

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/246 (30%), Positives = 123/246 (50%), Gaps = 34/246 (13%)
Query: 81  VFLVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILLGLAYCHS-LKILHRDLKPNNLL 138
           V +VFE L  +L + I ++++  + L+ +K I KQ+LLGL Y H    I+H D+KP N+L
Sbjct: 105 VVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVL 164
Query: 139 IDLKRN-----TVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           +++  +      +K+AD G A       + Y+       Y++PE+LLG   +    D+W+
Sbjct: 165 MEIVDSPENLIQIKIADLGNACWY---DEHYTNSIQTREYRSPEVLLG-APWGCGADIWS 220
Query: 194 VGCIFAEMITGKPLF-PSKKH------DHLSLIFSLLGT-PT----DESWAESTYISE-- 239
             C+  E+ITG  LF P + H      DH++ I  LLG  P+    +  +  + + S   
Sbjct: 221 TACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGL 280
Query: 240 -----ILPLYPHFEPANLAEKFPNLEPAGV-DLLSQMLCLNPKQRITAMDALKHEYL--- 290
                 L  +P  +      KF   E   + D LS ML L+P++R  A   + H +L   
Sbjct: 281 LRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT 340
Query: 291 IGVENV 296
           +G+E +
Sbjct: 341 LGMEEI 346

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/246 (30%), Positives = 123/246 (50%), Gaps = 34/246 (13%)
Query: 81  VFLVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILLGLAYCHS-LKILHRDLKPNNLL 138
           V +VFE L  +L + I ++++  + L+ +K I KQ+LLGL Y H    I+H D+KP N+L
Sbjct: 105 VVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVL 164
Query: 139 IDLKRN-----TVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           +++  +      +K+AD G A       + Y+       Y++PE+LLG   +    D+W+
Sbjct: 165 MEIVDSPENLIQIKIADLGNACWY---DEHYTNSIQTREYRSPEVLLG-APWGCGADIWS 220
Query: 194 VGCIFAEMITGKPLF-PSKKH------DHLSLIFSLLGT-PT----DESWAESTYISE-- 239
             C+  E+ITG  LF P + H      DH++ I  LLG  P+    +  +  + + S   
Sbjct: 221 TACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGL 280
Query: 240 -----ILPLYPHFEPANLAEKFPNLEPAGV-DLLSQMLCLNPKQRITAMDALKHEYL--- 290
                 L  +P  +      KF   E   + D LS ML L+P++R  A   + H +L   
Sbjct: 281 LRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT 340
Query: 291 IGVENV 296
           +G+E +
Sbjct: 341 LGMEEI 346

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 128/270 (47%), Gaps = 28/270 (10%)
Query: 25  KCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-HENIVRLLDVQSSRKDVFL 83
           KC +  + Q  A+K+++ + E     +   +E++ LK  E H NIV+L +V   +   FL
Sbjct: 29  KCVHKKSNQAFAVKIISKRME-----ANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFL 83
Query: 84  VFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK 142
           V E L+  +L   I + K+  +      I+++++  +++ H + ++HRDLKP NLL   +
Sbjct: 84  VMELLNGGELFERIKKKKH-FSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDE 142
Query: 143 RNT--VKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAE 200
            +   +K+ DFG AR      +     C    Y APE LL   GY    D+W++G I   
Sbjct: 143 NDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE-LLNQNGYDESCDLWSLGVILYT 201
Query: 201 MITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
           M++G+   P + HD  SL                T   EI+      + +   E + N+ 
Sbjct: 202 MLSGQ--VPFQSHDR-SLT--------------CTSAVEIMKKIKKGDFSFEGEAWKNVS 244
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
               DL+  +L ++P +R+       +E+L
Sbjct: 245 QEAKDLIQGLLTVDPNKRLKMSGLRYNEWL 274

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 116/244 (47%), Gaps = 29/244 (11%)
Query: 59  LLKELEHENIVRLLDVQSSRKDVFLVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQILL 117
           LL+  +H NI+ L DV    K V++V E +   +L   I R K   +     A+L  I  
Sbjct: 69  LLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK-FFSEREASAVLFTITK 127
Query: 118 GLAYCHSLKILHRDLKPNNLL-IDLKRN--TVKLADFGLARAIGVPQKEYSRDCVYSPYK 174
            + Y H+  ++HRDLKP+N+L +D   N  ++++ DFG A+ +          C  + + 
Sbjct: 128 TVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFV 187
Query: 175 APELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAES 234
           APE +L   GY    D+W++G +   M+TG   F +   D    I + +G+         
Sbjct: 188 APE-VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGK------- 239
Query: 235 TYISEILPLYPHFEPANLAEKFPN-LEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
                           +L+  + N +     DL+S+ML ++P QR+TA   L+H +++  
Sbjct: 240 ---------------FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284
Query: 294 ENVP 297
           + +P
Sbjct: 285 DQLP 288

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 135/287 (47%), Gaps = 54/287 (18%)
Query: 27  RNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-HENIVRLLDVQSSRKDVFLVF 85
           + +  G+ VA+K M I           + E+ LL E + H N++R    +++ + +++  
Sbjct: 52  QGSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIAL 106
Query: 86  EYLDLDLHSFI-TRHKNTLNLLVIK-----AILKQILLGLAYCHSLKILHRDLKPNNLLI 139
           E  +L+L   + +++ +  NL + K     ++L+QI  G+A+ HSLKI+HRDLKP N+L+
Sbjct: 107 ELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILV 166
Query: 140 DLKRN------------TVKLADFGLARAIGVPQKEYSRD----CVYSPYKAPELLLGYT 183
                             + ++DFGL + +   Q  +  +       S ++APELL   T
Sbjct: 167 STSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEEST 226
Query: 184 GY--STPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEI 240
               +  ID++++GC+F  +++ GK  F  K     ++I  +      +   + + I+E 
Sbjct: 227 KRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAE- 285
Query: 241 LPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH 287
                                   DL+SQM+  +P +R TAM  L+H
Sbjct: 286 ----------------------ATDLISQMIDHDPLKRPTAMKVLRH 310

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 135/287 (47%), Gaps = 54/287 (18%)
Query: 27  RNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-HENIVRLLDVQSSRKDVFLVF 85
           + +  G+ VA+K M I           + E+ LL E + H N++R    +++ + +++  
Sbjct: 52  QGSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIAL 106
Query: 86  EYLDLDLHSFI-TRHKNTLNLLVIK-----AILKQILLGLAYCHSLKILHRDLKPNNLLI 139
           E  +L+L   + +++ +  NL + K     ++L+QI  G+A+ HSLKI+HRDLKP N+L+
Sbjct: 107 ELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILV 166
Query: 140 DLKRN------------TVKLADFGLARAIGVPQKEYSRD----CVYSPYKAPELLLGYT 183
                             + ++DFGL + +   Q  +  +       S ++APELL   T
Sbjct: 167 STSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEEST 226
Query: 184 GY--STPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEI 240
               +  ID++++GC+F  +++ GK  F  K     ++I  +      +   + + I+E 
Sbjct: 227 KRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAE- 285
Query: 241 LPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH 287
                                   DL+SQM+  +P +R TAM  L+H
Sbjct: 286 ----------------------ATDLISQMIDHDPLKRPTAMKVLRH 310

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 134/291 (46%), Gaps = 58/291 (19%)
Query: 27  RNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-HENIVRLLDVQSSRKDVFLVF 85
           + +  G+ VA+K M I           + E+ LL E + H N++R    +++ + +++  
Sbjct: 34  QGSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIAL 88
Query: 86  EYLDLDLHSFI-TRHKNTLNLLVIK-----AILKQILLGLAYCHSLKILHRDLKPNNLLI 139
           E  +L+L   + +++ +  NL + K     ++L+QI  G+A+ HSLKI+HRDLKP N+L+
Sbjct: 89  ELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILV 148
Query: 140 DLKRN------------TVKLADFGLARAIGVPQKEYSRD----CVYSPYKAPELLLGYT 183
                             + ++DFGL + +   Q  +  +       S ++APELL    
Sbjct: 149 STSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESN 208
Query: 184 GYST------PIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY 236
              T       ID++++GC+F  +++ GK  F  K     ++I  +      +   + + 
Sbjct: 209 NLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSL 268
Query: 237 ISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH 287
           I+E                         DL+SQM+  +P +R TAM  L+H
Sbjct: 269 IAE-----------------------ATDLISQMIDHDPLKRPTAMKVLRH 296

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 126/279 (45%), Gaps = 41/279 (14%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           EV       TG+  A+K +  +   +G  S I  E+++L++++HENIV L D+  S   +
Sbjct: 37  EVVLAEEKATGKLFAVKCIP-KKALKGKESSIENEIAVLRKIKHENIVALEDIYESPNHL 95
Query: 82  FLVF------EYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPN 135
           +LV       E  D  +       K+   L+      +Q+L  + Y H + I+HRDLKP 
Sbjct: 96  YLVMQLVSGGELFDRIVEKGFYTEKDASTLI------RQVLDAVYYLHRMGIVHRDLKPE 149
Query: 136 NLLI--DLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           NLL     + + + ++DFGL++  G      S  C    Y APE +L    YS  +D W+
Sbjct: 150 NLLYYSQDEESKIMISDFGLSKMEG-KGDVMSTACGTPGYVAPE-VLAQKPYSKAVDCWS 207
Query: 194 VGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLA 253
           +G I   ++ G P F                   DE+  +S    +IL     F+    +
Sbjct: 208 IGVIAYILLCGYPPF------------------YDEN--DSKLFEQILKAEYEFD----S 243
Query: 254 EKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIG 292
             + ++  +  D +  ++  +P +R T   A +H ++ G
Sbjct: 244 PYWDDISDSAKDFIRNLMEKDPNKRYTCEQAARHPWIAG 282

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 134/291 (46%), Gaps = 58/291 (19%)
Query: 27  RNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-HENIVRLLDVQSSRKDVFLVF 85
           + +  G+ VA+K M I           + E+ LL E + H N++R    +++ + +++  
Sbjct: 34  QGSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIAL 88
Query: 86  EYLDLDLHSFI-TRHKNTLNLLVIK-----AILKQILLGLAYCHSLKILHRDLKPNNLLI 139
           E  +L+L   + +++ +  NL + K     ++L+QI  G+A+ HSLKI+HRDLKP N+L+
Sbjct: 89  ELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILV 148
Query: 140 DLKRN------------TVKLADFGLARAIGVPQKEYSRD----CVYSPYKAPELLLGYT 183
                             + ++DFGL + +   Q  +  +       S ++APELL    
Sbjct: 149 STSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESN 208
Query: 184 GYST------PIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY 236
              T       ID++++GC+F  +++ GK  F  K     ++I  +      +   + + 
Sbjct: 209 NLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSL 268
Query: 237 ISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH 287
           I+E                         DL+SQM+  +P +R TAM  L+H
Sbjct: 269 IAE-----------------------ATDLISQMIDHDPLKRPTAMKVLRH 296

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 82/308 (26%), Positives = 130/308 (42%), Gaps = 64/308 (20%)
Query: 32  GQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI---------VRLLDVQSSRKDVF 82
           G+ VA+K++      + V  Y     S ++ LEH N          V++L+       + 
Sbjct: 40  GRHVAVKIV------KNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHIC 93
Query: 83  LVFEYLDLDLHSFITRHKN-TLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLI-- 139
           +VFE L L  + FI  +      L  I+ +  QI   + + HS K+ H DLKP N+L   
Sbjct: 94  IVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQ 153
Query: 140 ---------DLKRN-------TVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYT 183
                     +KR+        +K+ DFG A       + +S       Y+APE++L   
Sbjct: 154 SDYTEAYNPKIKRDERTLINPDIKVVDFGSA---TYDDEHHSTLVXXRHYRAPEVILA-L 209
Query: 184 GYSTPIDVWAVGCIFAEMITGKPLFPS-KKHDHLSLIFSLLGT----------------- 225
           G+S P DVW++GCI  E   G  +FP+    +HL+++  +LG                  
Sbjct: 210 GWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHH 269
Query: 226 ---PTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAM 282
                DE  +   Y+S        F  +   E          DL+ +ML  +P +RIT  
Sbjct: 270 DRLDWDEHSSAGRYVSRACKPLKEFMLSQDVE-----HERLFDLIQKMLEYDPAKRITLR 324
Query: 283 DALKHEYL 290
           +ALKH + 
Sbjct: 325 EALKHPFF 332

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/181 (32%), Positives = 99/181 (54%), Gaps = 14/181 (7%)
Query: 31  TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDV--QSSRKDVFLVFEYL 88
           TG+ VA+K +   TE+        RE+ +LK L+H+NIV+   V   + R+++ L+ EYL
Sbjct: 38  TGEVVAVKKLQHSTEEH--LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 95
Query: 89  DL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVK 147
               L  ++ +HK  ++ + +     QI  G+ Y  + + +HRDL   N+L++   N VK
Sbjct: 96  PYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE-NENRVK 154
Query: 148 LADFGLARAIGVPQ-KEY--SRDCVYSP--YKAPELLLGYTGYSTPIDVWAVGCIFAEMI 202
           + DFGL + +  PQ KE+   ++   SP  + APE L   + +S   DVW+ G +  E+ 
Sbjct: 155 IGDFGLTKVL--PQDKEFFKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELF 211
Query: 203 T 203
           T
Sbjct: 212 T 212

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 82/308 (26%), Positives = 130/308 (42%), Gaps = 64/308 (20%)
Query: 32  GQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI---------VRLLDVQSSRKDVF 82
           G+ VA+K++      + V  Y     S ++ LEH N          V++L+       + 
Sbjct: 40  GRHVAVKIV------KNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHIC 93
Query: 83  LVFEYLDLDLHSFITRHKN-TLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLI-- 139
           +VFE L L  + FI  +      L  I+ +  QI   + + HS K+ H DLKP N+L   
Sbjct: 94  IVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQ 153
Query: 140 ---------DLKRN-------TVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYT 183
                     +KR+        +K+ DFG A       + +S       Y+APE++L   
Sbjct: 154 SDYTEAYNPKIKRDERTLINPDIKVVDFGSA---TYDDEHHSTLVSTRHYRAPEVILA-L 209
Query: 184 GYSTPIDVWAVGCIFAEMITGKPLFPS-KKHDHLSLIFSLLGT----------------- 225
           G+S P DVW++GCI  E   G  +FP+    +HL+++  +LG                  
Sbjct: 210 GWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHH 269
Query: 226 ---PTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAM 282
                DE  +   Y+S        F  +   E          DL+ +ML  +P +RIT  
Sbjct: 270 DRLDWDEHSSAGRYVSRACKPLKEFMLSQDVE-----HERLFDLIQKMLEYDPAKRITLR 324
Query: 283 DALKHEYL 290
           +ALKH + 
Sbjct: 325 EALKHPFF 332

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/181 (32%), Positives = 99/181 (54%), Gaps = 14/181 (7%)
Query: 31  TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDV--QSSRKDVFLVFEYL 88
           TG+ VA+K +   TE+        RE+ +LK L+H+NIV+   V   + R+++ L+ EYL
Sbjct: 39  TGEVVAVKKLQHSTEEH--LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 96
Query: 89  DL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVK 147
               L  ++ +HK  ++ + +     QI  G+ Y  + + +HR+L   N+L++   N VK
Sbjct: 97  PYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRNLATRNILVE-NENRVK 155
Query: 148 LADFGLARAIGVPQ-KEYS--RDCVYSP--YKAPELLLGYTGYSTPIDVWAVGCIFAEMI 202
           + DFGL + +  PQ KEY   ++   SP  + APE L   + +S   DVW+ G +  E+ 
Sbjct: 156 IGDFGLTKVL--PQDKEYYKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELF 212
Query: 203 T 203
           T
Sbjct: 213 T 213

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 54/159 (33%), Positives = 82/159 (51%), Gaps = 14/159 (8%)
Query: 56  EVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD----LDLHSFITRHKNTLNLLVIKAI 111
           E+S+ + L H+++V           VF+V E       L+LH    + +  L     +  
Sbjct: 71  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEARYY 126
Query: 112 LKQILLGLAYCHSLKILHRDLKPNNLLI--DLKRNTVKLADFGLARAIGVPQKEYSRDCV 169
           L+QI+LG  Y H  +++HRDLK  NL +  DL+   VK+ DFGLA  +    +     C 
Sbjct: 127 LRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE---VKIGDFGLATKVEYDGERKKTLCG 183
Query: 170 YSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
              Y APE+L    G+S  +DVW++GCI   ++ GKP F
Sbjct: 184 TPNYIAPEVL-SKKGHSFEVDVWSIGCIMYTLLVGKPPF 221

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 132/296 (44%), Gaps = 47/296 (15%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-HENIVRLLDVQSSRKDV 81
           V  C N +T Q+ A+K+  I+ +   + S + REV +L + + H N++ L++        
Sbjct: 29  VQTCINLITSQEYAVKI--IEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRF 86
Query: 82  FLVFEYL---DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLL 138
           +LVFE +    +  H    RH N L   V+   ++ +   L + H+  I HRDLKP N+L
Sbjct: 87  YLVFEKMRGGSILSHIHKRRHFNELEASVV---VQDVASALDFLHNKGIAHRDLKPENIL 143
Query: 139 IDLKRNT--VKLADFGLARAIG-------VPQKEYSRDCVYSPYKAPELLLGYTG----Y 185
            +       VK+ DF L   I        +   E    C  + Y APE++  ++     Y
Sbjct: 144 CEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIY 203
Query: 186 STPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYP 245
               D+W++G I   +++G P F  +               +D  W       E  P   
Sbjct: 204 DKRCDLWSLGVILYILLSGYPPFVGR-------------CGSDCGWDR----GEACPACQ 246
Query: 246 HFEPANLAE---KFPN-----LEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
           +    ++ E   +FP+     +  A  DL+S++L  + KQR++A   L+H ++ G 
Sbjct: 247 NMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 54/159 (33%), Positives = 82/159 (51%), Gaps = 14/159 (8%)
Query: 56  EVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD----LDLHSFITRHKNTLNLLVIKAI 111
           E+S+ + L H+++V           VF+V E       L+LH    + +  L     +  
Sbjct: 67  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEARYY 122
Query: 112 LKQILLGLAYCHSLKILHRDLKPNNLLI--DLKRNTVKLADFGLARAIGVPQKEYSRDCV 169
           L+QI+LG  Y H  +++HRDLK  NL +  DL+   VK+ DFGLA  +    +     C 
Sbjct: 123 LRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE---VKIGDFGLATKVEYDGERKKTLCG 179
Query: 170 YSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
              Y APE+L    G+S  +DVW++GCI   ++ GKP F
Sbjct: 180 TPNYIAPEVL-SKKGHSFEVDVWSIGCIMYTLLVGKPPF 217

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 124/281 (44%), Gaps = 47/281 (16%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           EV+  +  +TG+  A+K   I+       S +  E+++LK+++HENIV L D+  S    
Sbjct: 24  EVFLVKQRLTGKLFALK--CIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHY 81
Query: 82  FLVF------EYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPN 135
           +LV       E  D  L   +   K+         +++Q+L  + Y H   I+HRDLKP 
Sbjct: 82  YLVMQLVSGGELFDRILERGVYTEKDA------SLVIQQVLSAVKYLHENGIVHRDLKPE 135
Query: 136 NL--LIDLKRNTVKLADFGLAR--AIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDV 191
           NL  L   + + + + DFGL++    G+     S  C    Y APE +L    YS  +D 
Sbjct: 136 NLLYLTPEENSKIMITDFGLSKMEQNGI----MSTACGTPGYVAPE-VLAQKPYSKAVDC 190
Query: 192 WAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPAN 251
           W++G I   ++ G P F  +                     ES    +I   Y  FE   
Sbjct: 191 WSIGVITYILLCGYPPFYEE--------------------TESKLFEKIKEGYYEFE--- 227
Query: 252 LAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIG 292
            +  + ++  +  D +  +L  +P +R T   AL H ++ G
Sbjct: 228 -SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDG 267

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 54/159 (33%), Positives = 82/159 (51%), Gaps = 14/159 (8%)
Query: 56  EVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD----LDLHSFITRHKNTLNLLVIKAI 111
           E+S+ + L H+++V           VF+V E       L+LH    + +  L     +  
Sbjct: 67  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEARYY 122
Query: 112 LKQILLGLAYCHSLKILHRDLKPNNLLI--DLKRNTVKLADFGLARAIGVPQKEYSRDCV 169
           L+QI+LG  Y H  +++HRDLK  NL +  DL+   VK+ DFGLA  +    +     C 
Sbjct: 123 LRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE---VKIGDFGLATKVEYDGERKKTLCG 179
Query: 170 YSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
              Y APE+L    G+S  +DVW++GCI   ++ GKP F
Sbjct: 180 TPNYIAPEVL-SKKGHSFEVDVWSIGCIMYTLLVGKPPF 217

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 126/284 (44%), Gaps = 40/284 (14%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           E  +C +  T  + A+K++         PS  I    LL+  +H NI+ L DV    K V
Sbjct: 42  ECKRCVHKATNMEYAVKVIDKSKRD---PSEEIE--ILLRYGQHPNIITLKDVYDDGKHV 96
Query: 82  FLVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLL-I 139
           +LV E +   +L   I R K   +      +L  I   + Y HS  ++HRDLKP+N+L +
Sbjct: 97  YLVTELMRGGELLDKILRQK-FFSEREASFVLHTIGKTVEYLHSQGVVHRDLKPSNILYV 155
Query: 140 DLKRN--TVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCI 197
           D   N   +++ DFG A+ +          C  + + APE+L    GY    D+W++G +
Sbjct: 156 DESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVL-KRQGYDEGCDIWSLGIL 214
Query: 198 FAEMITGKPLFPSKKHDHLSLIFSLLG----TPTDESWAESTYISEILPLYPHFEPANLA 253
              M+ G   F +   D    I + +G    T +  +W     +SE              
Sbjct: 215 LYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNW---NTVSE-------------- 257
Query: 254 EKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
                      DL+S+ML ++P QR+TA   L+H ++   + +P
Sbjct: 258 --------TAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQKDKLP 293

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 100/181 (55%), Gaps = 11/181 (6%)
Query: 31  TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL 90
           TG++VA+K M ++ +Q      +  EV ++++  H+N+V +        ++++V E+L+ 
Sbjct: 69  TGKQVAVKKMDLRKQQRR--ELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEG 126
Query: 91  DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLAD 150
              + I  H   +N   I  +   +L  L+Y H+  ++HRD+K +++L+      +KL+D
Sbjct: 127 GALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLT-SDGRIKLSD 184
Query: 151 FGLARAIG--VPQKEYSRDCVYSPY-KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPL 207
           FG    +   VP++   +  V +PY  APE++     Y T +D+W++G +  EMI G+P 
Sbjct: 185 FGFCAQVSKEVPKR---KXLVGTPYWMAPEVI-SRLPYGTEVDIWSLGIMVIEMIDGEPP 240
Query: 208 F 208
           +
Sbjct: 241 Y 241

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 57/181 (31%), Positives = 97/181 (53%), Gaps = 14/181 (7%)
Query: 31  TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDV--QSSRKDVFLVFEYL 88
           TG+ VA+K +   TE+        RE+ +LK L+H+NIV+   V   + R+++ L+ EYL
Sbjct: 45  TGEVVAVKKLQHSTEEH--LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 102
Query: 89  DL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVK 147
               L  ++ +HK  ++ + +     QI  G+ Y  + + +HRDL   N+L++   N VK
Sbjct: 103 PYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE-NENRVK 161
Query: 148 LADFGLARAIGVPQKEYS---RDCVYSP--YKAPELLLGYTGYSTPIDVWAVGCIFAEMI 202
           + DFGL + +  PQ +     ++   SP  + APE L   + +S   DVW+ G +  E+ 
Sbjct: 162 IGDFGLTKVL--PQDKEXXKVKEPGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELF 218
Query: 203 T 203
           T
Sbjct: 219 T 219

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 126/284 (44%), Gaps = 40/284 (14%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           E  +C +  T  + A+K++         PS  I    LL+  +H NI+ L DV    K V
Sbjct: 42  ECKRCVHKATNMEYAVKVIDKSKRD---PSEEIE--ILLRYGQHPNIITLKDVYDDGKHV 96
Query: 82  FLVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLL-I 139
           +LV E +   +L   I R K   +      +L  I   + Y HS  ++HRDLKP+N+L +
Sbjct: 97  YLVTELMRGGELLDKILRQK-FFSEREASFVLHTIGKTVEYLHSQGVVHRDLKPSNILYV 155
Query: 140 DLKRN--TVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCI 197
           D   N   +++ DFG A+ +          C  + + APE+L    GY    D+W++G +
Sbjct: 156 DESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVL-KRQGYDEGCDIWSLGIL 214
Query: 198 FAEMITGKPLFPSKKHDHLSLIFSLLG----TPTDESWAESTYISEILPLYPHFEPANLA 253
              M+ G   F +   D    I + +G    T +  +W     +SE              
Sbjct: 215 LYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNW---NTVSE-------------- 257
Query: 254 EKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
                      DL+S+ML ++P QR+TA   L+H ++   + +P
Sbjct: 258 --------TAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQKDKLP 293

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 57/181 (31%), Positives = 97/181 (53%), Gaps = 14/181 (7%)
Query: 31  TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDV--QSSRKDVFLVFEYL 88
           TG+ VA+K +   TE+        RE+ +LK L+H+NIV+   V   + R+++ L+ EYL
Sbjct: 56  TGEVVAVKKLQHSTEEH--LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 113
Query: 89  DL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVK 147
               L  ++ +HK  ++ + +     QI  G+ Y  + + +HRDL   N+L++   N VK
Sbjct: 114 PYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE-NENRVK 172
Query: 148 LADFGLARAIGVPQKEYS---RDCVYSP--YKAPELLLGYTGYSTPIDVWAVGCIFAEMI 202
           + DFGL + +  PQ +     ++   SP  + APE L   + +S   DVW+ G +  E+ 
Sbjct: 173 IGDFGLTKVL--PQDKEXXKVKEPGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELF 229
Query: 203 T 203
           T
Sbjct: 230 T 230

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 57/181 (31%), Positives = 97/181 (53%), Gaps = 14/181 (7%)
Query: 31  TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDV--QSSRKDVFLVFEYL 88
           TG+ VA+K +   TE+        RE+ +LK L+H+NIV+   V   + R+++ L+ EYL
Sbjct: 69  TGEVVAVKKLQHSTEEH--LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 126
Query: 89  DL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVK 147
               L  ++ +HK  ++ + +     QI  G+ Y  + + +HRDL   N+L++   N VK
Sbjct: 127 PYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE-NENRVK 185
Query: 148 LADFGLARAIGVPQKEYS---RDCVYSP--YKAPELLLGYTGYSTPIDVWAVGCIFAEMI 202
           + DFGL + +  PQ +     ++   SP  + APE L   + +S   DVW+ G +  E+ 
Sbjct: 186 IGDFGLTKVL--PQDKEXXKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELF 242
Query: 203 T 203
           T
Sbjct: 243 T 243

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 57/181 (31%), Positives = 97/181 (53%), Gaps = 14/181 (7%)
Query: 31  TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDV--QSSRKDVFLVFEYL 88
           TG+ VA+K +   TE+        RE+ +LK L+H+NIV+   V   + R+++ L+ EYL
Sbjct: 56  TGEVVAVKKLQHSTEEH--LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 113
Query: 89  DL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVK 147
               L  ++ +HK  ++ + +     QI  G+ Y  + + +HRDL   N+L++   N VK
Sbjct: 114 PYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE-NENRVK 172
Query: 148 LADFGLARAIGVPQKEYS---RDCVYSP--YKAPELLLGYTGYSTPIDVWAVGCIFAEMI 202
           + DFGL + +  PQ +     ++   SP  + APE L   + +S   DVW+ G +  E+ 
Sbjct: 173 IGDFGLTKVL--PQDKEXXKVKEPGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELF 229
Query: 203 T 203
           T
Sbjct: 230 T 230

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 57/181 (31%), Positives = 97/181 (53%), Gaps = 14/181 (7%)
Query: 31  TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDV--QSSRKDVFLVFEYL 88
           TG+ VA+K +   TE+        RE+ +LK L+H+NIV+   V   + R+++ L+ EYL
Sbjct: 38  TGEVVAVKKLQHSTEEH--LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 95
Query: 89  DL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVK 147
               L  ++ +HK  ++ + +     QI  G+ Y  + + +HRDL   N+L++   N VK
Sbjct: 96  PYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE-NENRVK 154
Query: 148 LADFGLARAIGVPQKEYS---RDCVYSP--YKAPELLLGYTGYSTPIDVWAVGCIFAEMI 202
           + DFGL + +  PQ +     ++   SP  + APE L   + +S   DVW+ G +  E+ 
Sbjct: 155 IGDFGLTKVL--PQDKEXXKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELF 211
Query: 203 T 203
           T
Sbjct: 212 T 212

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 57/181 (31%), Positives = 97/181 (53%), Gaps = 14/181 (7%)
Query: 31  TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDV--QSSRKDVFLVFEYL 88
           TG+ VA+K +   TE+        RE+ +LK L+H+NIV+   V   + R+++ L+ EYL
Sbjct: 41  TGEVVAVKKLQHSTEEH--LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 98
Query: 89  DL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVK 147
               L  ++ +HK  ++ + +     QI  G+ Y  + + +HRDL   N+L++   N VK
Sbjct: 99  PYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE-NENRVK 157
Query: 148 LADFGLARAIGVPQKEYS---RDCVYSP--YKAPELLLGYTGYSTPIDVWAVGCIFAEMI 202
           + DFGL + +  PQ +     ++   SP  + APE L   + +S   DVW+ G +  E+ 
Sbjct: 158 IGDFGLTKVL--PQDKEXXKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELF 214
Query: 203 T 203
           T
Sbjct: 215 T 215

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 89/343 (25%), Positives = 142/343 (41%), Gaps = 88/343 (25%)
Query: 30  VTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEH--------ENIVRLLD----VQSS 77
           + G+K     M +    E      + E+ LLK + +        E +V+LLD       +
Sbjct: 43  IQGKKFV--AMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVN 100
Query: 78  RKDVFLVFEYLDLDLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHS-LKILHRDLKPN 135
              + +VFE L   L  +I +     L L  +K I++Q+L GL Y H+  +I+H D+KP 
Sbjct: 101 GTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPE 160
Query: 136 NLLIDLKRN------------------------------------------------TVK 147
           N+L+ +                                                    VK
Sbjct: 161 NILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVK 220
Query: 148 LADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPL 207
           +AD G A  +    K ++ D     Y++ E+L+G +GY+TP D+W+  C+  E+ TG  L
Sbjct: 221 IADLGNACWV---HKHFTEDIQTRQYRSLEVLIG-SGYNTPADIWSTACMAFELATGDYL 276
Query: 208 FP-------SKKHDHLSLIFSLLGTP----------TDESWAESTYISEILPLYPHFEPA 250
           F        ++  DH++LI  LLG            + E + +   +  I  L P     
Sbjct: 277 FEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFE 336
Query: 251 NLAEKF--PNLEPAG-VDLLSQMLCLNPKQRITAMDALKHEYL 290
            L EK+     E AG  D L  ML L P++R TA + L+H +L
Sbjct: 337 VLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWL 379

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/181 (31%), Positives = 97/181 (53%), Gaps = 14/181 (7%)
Query: 31  TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDV--QSSRKDVFLVFEYL 88
           TG+ VA+K +   TE+        RE+ +LK L+H+NIV+   V   + R+++ L+ EYL
Sbjct: 42  TGEVVAVKKLQHSTEEH--LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 99
Query: 89  DL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVK 147
               L  ++ +HK  ++ + +     QI  G+ Y  + + +HRDL   N+L++   N VK
Sbjct: 100 PYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE-NENRVK 158
Query: 148 LADFGLARAIGVPQKEYS---RDCVYSP--YKAPELLLGYTGYSTPIDVWAVGCIFAEMI 202
           + DFGL + +  PQ +     ++   SP  + APE L   + +S   DVW+ G +  E+ 
Sbjct: 159 IGDFGLTKVL--PQDKEXXKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELF 215
Query: 203 T 203
           T
Sbjct: 216 T 216

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/181 (31%), Positives = 97/181 (53%), Gaps = 14/181 (7%)
Query: 31  TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDV--QSSRKDVFLVFEYL 88
           TG+ VA+K +   TE+        RE+ +LK L+H+NIV+   V   + R+++ L+ EYL
Sbjct: 43  TGEVVAVKKLQHSTEEH--LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 100
Query: 89  DL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVK 147
               L  ++ +HK  ++ + +     QI  G+ Y  + + +HRDL   N+L++   N VK
Sbjct: 101 PYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE-NENRVK 159
Query: 148 LADFGLARAIGVPQKEYS---RDCVYSP--YKAPELLLGYTGYSTPIDVWAVGCIFAEMI 202
           + DFGL + +  PQ +     ++   SP  + APE L   + +S   DVW+ G +  E+ 
Sbjct: 160 IGDFGLTKVL--PQDKEXXKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELF 216
Query: 203 T 203
           T
Sbjct: 217 T 217

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/181 (31%), Positives = 97/181 (53%), Gaps = 14/181 (7%)
Query: 31  TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDV--QSSRKDVFLVFEYL 88
           TG+ VA+K +   TE+        RE+ +LK L+H+NIV+   V   + R+++ L+ EYL
Sbjct: 44  TGEVVAVKKLQHSTEEH--LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 101
Query: 89  DL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVK 147
               L  ++ +HK  ++ + +     QI  G+ Y  + + +HRDL   N+L++   N VK
Sbjct: 102 PYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE-NENRVK 160
Query: 148 LADFGLARAIGVPQKEYS---RDCVYSP--YKAPELLLGYTGYSTPIDVWAVGCIFAEMI 202
           + DFGL + +  PQ +     ++   SP  + APE L   + +S   DVW+ G +  E+ 
Sbjct: 161 IGDFGLTKVL--PQDKEXXKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELF 217
Query: 203 T 203
           T
Sbjct: 218 T 218

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/181 (31%), Positives = 97/181 (53%), Gaps = 14/181 (7%)
Query: 31  TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDV--QSSRKDVFLVFEYL 88
           TG+ VA+K +   TE+        RE+ +LK L+H+NIV+   V   + R+++ L+ EYL
Sbjct: 38  TGEVVAVKKLQHSTEEH--LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 95
Query: 89  DL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVK 147
               L  ++ +HK  ++ + +     QI  G+ Y  + + +HRDL   N+L++   N VK
Sbjct: 96  PYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE-NENRVK 154
Query: 148 LADFGLARAIGVPQKEYS---RDCVYSP--YKAPELLLGYTGYSTPIDVWAVGCIFAEMI 202
           + DFGL + +  PQ +     ++   SP  + APE L   + +S   DVW+ G +  E+ 
Sbjct: 155 IGDFGLTKVL--PQDKEXXKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELF 211
Query: 203 T 203
           T
Sbjct: 212 T 212

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/181 (31%), Positives = 97/181 (53%), Gaps = 14/181 (7%)
Query: 31  TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDV--QSSRKDVFLVFEYL 88
           TG+ VA+K +   TE+        RE+ +LK L+H+NIV+   V   + R+++ L+ EYL
Sbjct: 36  TGEVVAVKKLQHSTEEH--LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 93
Query: 89  DL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVK 147
               L  ++ +HK  ++ + +     QI  G+ Y  + + +HRDL   N+L++   N VK
Sbjct: 94  PYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE-NENRVK 152
Query: 148 LADFGLARAIGVPQKEYS---RDCVYSP--YKAPELLLGYTGYSTPIDVWAVGCIFAEMI 202
           + DFGL + +  PQ +     ++   SP  + APE L   + +S   DVW+ G +  E+ 
Sbjct: 153 IGDFGLTKVL--PQDKEXXKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELF 209
Query: 203 T 203
           T
Sbjct: 210 T 210

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 81/157 (51%), Gaps = 10/157 (6%)
Query: 56  EVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD----LDLHSFITRHKNTLNLLVIKAI 111
           E+S+ + L H+++V           VF+V E       L+LH    + +  L     +  
Sbjct: 65  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEARYY 120
Query: 112 LKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS 171
           L+QI+LG  Y H  +++HRDLK  NL ++ +   VK+ DFGLA  +    +     C   
Sbjct: 121 LRQIVLGCQYLHRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTP 179
Query: 172 PYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
            Y APE+L    G+S  +DVW++GCI   ++ GKP F
Sbjct: 180 NYIAPEVL-SKKGHSFEVDVWSIGCIMYTLLVGKPPF 215

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/181 (31%), Positives = 97/181 (53%), Gaps = 14/181 (7%)
Query: 31  TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDV--QSSRKDVFLVFEYL 88
           TG+ VA+K +   TE+        RE+ +LK L+H+NIV+   V   + R+++ L+ EYL
Sbjct: 37  TGEVVAVKKLQHSTEEH--LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 94
Query: 89  DL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVK 147
               L  ++ +HK  ++ + +     QI  G+ Y  + + +HRDL   N+L++   N VK
Sbjct: 95  PYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE-NENRVK 153
Query: 148 LADFGLARAIGVPQKEYS---RDCVYSP--YKAPELLLGYTGYSTPIDVWAVGCIFAEMI 202
           + DFGL + +  PQ +     ++   SP  + APE L   + +S   DVW+ G +  E+ 
Sbjct: 154 IGDFGLTKVL--PQDKEXXKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELF 210
Query: 203 T 203
           T
Sbjct: 211 T 211

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 89/343 (25%), Positives = 142/343 (41%), Gaps = 88/343 (25%)
Query: 30  VTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEH--------ENIVRLLD----VQSS 77
           + G+K     M +    E      + E+ LLK + +        E +V+LLD       +
Sbjct: 59  IQGKKFV--AMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVN 116
Query: 78  RKDVFLVFEYLDLDLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHS-LKILHRDLKPN 135
              + +VFE L   L  +I +     L L  +K I++Q+L GL Y H+  +I+H D+KP 
Sbjct: 117 GTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPE 176
Query: 136 NLLIDLKRN------------------------------------------------TVK 147
           N+L+ +                                                    VK
Sbjct: 177 NILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVK 236
Query: 148 LADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPL 207
           +AD G A  +    K ++ D     Y++ E+L+G +GY+TP D+W+  C+  E+ TG  L
Sbjct: 237 IADLGNACWV---HKHFTEDIQTRQYRSLEVLIG-SGYNTPADIWSTACMAFELATGDYL 292
Query: 208 FP-------SKKHDHLSLIFSLLGTP----------TDESWAESTYISEILPLYPHFEPA 250
           F        ++  DH++LI  LLG            + E + +   +  I  L P     
Sbjct: 293 FEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFE 352
Query: 251 NLAEKF--PNLEPAG-VDLLSQMLCLNPKQRITAMDALKHEYL 290
            L EK+     E AG  D L  ML L P++R TA + L+H +L
Sbjct: 353 VLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWL 395

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/159 (33%), Positives = 82/159 (51%), Gaps = 14/159 (8%)
Query: 56  EVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD----LDLHSFITRHKNTLNLLVIKAI 111
           E+S+ + L H+++V           VF+V E       L+LH    + +  L     +  
Sbjct: 91  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEARYY 146
Query: 112 LKQILLGLAYCHSLKILHRDLKPNNLLI--DLKRNTVKLADFGLARAIGVPQKEYSRDCV 169
           L+QI+LG  Y H  +++HRDLK  NL +  DL+   VK+ DFGLA  +    +     C 
Sbjct: 147 LRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE---VKIGDFGLATKVEYDGERKKVLCG 203
Query: 170 YSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
              Y APE+L    G+S  +DVW++GCI   ++ GKP F
Sbjct: 204 TPNYIAPEVL-SKKGHSFEVDVWSIGCIMYTLLVGKPPF 241

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/159 (33%), Positives = 82/159 (51%), Gaps = 14/159 (8%)
Query: 56  EVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD----LDLHSFITRHKNTLNLLVIKAI 111
           E+S+ + L H+++V           VF+V E       L+LH    + +  L     +  
Sbjct: 89  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEARYY 144
Query: 112 LKQILLGLAYCHSLKILHRDLKPNNLLI--DLKRNTVKLADFGLARAIGVPQKEYSRDCV 169
           L+QI+LG  Y H  +++HRDLK  NL +  DL+   VK+ DFGLA  +    +     C 
Sbjct: 145 LRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE---VKIGDFGLATKVEYDGERKKVLCG 201
Query: 170 YSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
              Y APE+L    G+S  +DVW++GCI   ++ GKP F
Sbjct: 202 TPNYIAPEVL-SKKGHSFEVDVWSIGCIMYTLLVGKPPF 239

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 102/192 (53%), Gaps = 12/192 (6%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           +VYK +N  T    A K++  ++E+E +  Y++ E+ +L   +H NIV+LLD      ++
Sbjct: 52  KVYKAQNKETSVLAAAKVIDTKSEEE-LEDYMV-EIDILASCDHPNIVKLLDAFYYENNL 109
Query: 82  FLVFEY-LDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLID 140
           +++ E+     + + +   +  L    I+ + KQ L  L Y H  KI+HRDLK  N+L  
Sbjct: 110 WILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFT 169
Query: 141 LKRNTVKLADFGL-ARAIGVPQKEYSRDCVYSPY-KAPELLLGYTGYSTP----IDVWAV 194
           L  + +KLADFG+ A+     Q+  S   + +PY  APE+++  T    P     DVW++
Sbjct: 170 LDGD-IKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCETSKDRPYDYKADVWSL 226
Query: 195 GCIFAEMITGKP 206
           G    EM   +P
Sbjct: 227 GITLIEMAEIEP 238

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/211 (34%), Positives = 106/211 (50%), Gaps = 36/211 (17%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKD- 80
           +V K RN +  +  AIK +   TE++   S I+ EV LL  L H+ +VR       R++ 
Sbjct: 21  QVVKARNALDSRYYAIKKIR-HTEEK--LSTILSEVMLLASLNHQYVVRYYAAWLERRNF 77
Query: 81  ------------VFLVFEYLD-LDLHSFITRHKNTLNLLVIK--AILKQILLGLAYCHSL 125
                       +F+  EY +   L+  I  H   LN    +   + +QIL  L+Y HS 
Sbjct: 78  VKPMTAVKKKSTLFIQMEYCENRTLYDLI--HSENLNQQRDEYWRLFRQILEALSYIHSQ 135
Query: 126 KILHRDLKPNNLLIDLKRNTVKLADFGLA----RAIGVPQKEY-----SRDCVYSP---- 172
            I+HRDLKP N+ ID  RN VK+ DFGLA    R++ + + +      S D + S     
Sbjct: 136 GIIHRDLKPMNIFIDESRN-VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTA 194
Query: 173 -YKAPELLLGYTGYSTPIDVWAVGCIFAEMI 202
            Y A E+L G   Y+  ID++++G IF EMI
Sbjct: 195 MYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/186 (33%), Positives = 96/186 (51%), Gaps = 11/186 (5%)
Query: 24  YKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDV--QSSRKDV 81
           Y   N  TG+ VA+K +      +    +  +E+ +L+ L HE+I++       +    +
Sbjct: 52  YDPTNDGTGEMVAVKALKADAGPQHRSGWK-QEIDILRTLYHEHIIKYKGCCEDAGAASL 110
Query: 82  FLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLID 140
            LV EY+ L  L  ++ RH   L  L++ A  +QI  G+AY H+   +HRDL   N+L+D
Sbjct: 111 QLVMEYVPLGSLRDYLPRHSIGLAQLLLFA--QQICEGMAYLHAQHYIHRDLAARNVLLD 168
Query: 141 LKRNTVKLADFGLARAIGVPQKEYS-RDCVYSP--YKAPELLLGYTGYSTPIDVWAVGCI 197
             R  VK+ DFGLA+A+    + Y  R+   SP  + APE L  Y  Y    DVW+ G  
Sbjct: 169 NDR-LVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYAS-DVWSFGVT 226
Query: 198 FAEMIT 203
             E++T
Sbjct: 227 LYELLT 232

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/187 (33%), Positives = 96/187 (51%), Gaps = 11/187 (5%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDV--QSSRKD 80
            Y   N  TG+ VA+K +      +    +  +E+ +L+ L HE+I++          K 
Sbjct: 34  CYDPTNDGTGEMVAVKALKADCGPQHRSGWK-QEIDILRTLYHEHIIKYKGCCEDQGEKS 92
Query: 81  VFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLI 139
           + LV EY+ L  L  ++ RH   L  L++ A  +QI  G+AY HS   +HR+L   N+L+
Sbjct: 93  LQLVMEYVPLGSLRDYLPRHSIGLAQLLLFA--QQICEGMAYLHSQHYIHRNLAARNVLL 150
Query: 140 DLKRNTVKLADFGLARAIGVPQKEYS-RDCVYSP--YKAPELLLGYTGYSTPIDVWAVGC 196
           D  R  VK+ DFGLA+A+    + Y  R+   SP  + APE L  Y  Y    DVW+ G 
Sbjct: 151 DNDR-LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYAS-DVWSFGV 208
Query: 197 IFAEMIT 203
              E++T
Sbjct: 209 TLYELLT 215

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/211 (34%), Positives = 106/211 (50%), Gaps = 36/211 (17%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKD- 80
           +V K RN +  +  AIK +   TE++   S I+ EV LL  L H+ +VR       R++ 
Sbjct: 21  QVVKARNALDSRYYAIKKIR-HTEEK--LSTILSEVMLLASLNHQYVVRYYAAWLERRNF 77
Query: 81  ------------VFLVFEYLDLD-LHSFITRHKNTLNLLVIK--AILKQILLGLAYCHSL 125
                       +F+  EY +   L+  I  H   LN    +   + +QIL  L+Y HS 
Sbjct: 78  VKPMTAVKKKSTLFIQMEYCENGTLYDLI--HSENLNQQRDEYWRLFRQILEALSYIHSQ 135
Query: 126 KILHRDLKPNNLLIDLKRNTVKLADFGLA----RAIGVPQKEY-----SRDCVYSP---- 172
            I+HRDLKP N+ ID  RN VK+ DFGLA    R++ + + +      S D + S     
Sbjct: 136 GIIHRDLKPMNIFIDESRN-VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTA 194
Query: 173 -YKAPELLLGYTGYSTPIDVWAVGCIFAEMI 202
            Y A E+L G   Y+  ID++++G IF EMI
Sbjct: 195 MYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 102/192 (53%), Gaps = 12/192 (6%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           +VYK +N  T    A K++  ++E+E +  Y++ E+ +L   +H NIV+LLD      ++
Sbjct: 52  KVYKAQNKETSVLAAAKVIDTKSEEE-LEDYMV-EIDILASCDHPNIVKLLDAFYYENNL 109
Query: 82  FLVFEY-LDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLID 140
           +++ E+     + + +   +  L    I+ + KQ L  L Y H  KI+HRDLK  N+L  
Sbjct: 110 WILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFT 169
Query: 141 LKRNTVKLADFGL-ARAIGVPQKEYSRDCVYSPY-KAPELLLGYTGYSTP----IDVWAV 194
           L  + +KLADFG+ A+     Q+  S   + +PY  APE+++  T    P     DVW++
Sbjct: 170 LDGD-IKLADFGVSAKNTRXIQRRDS--FIGTPYWMAPEVVMCETSKDRPYDYKADVWSL 226
Query: 195 GCIFAEMITGKP 206
           G    EM   +P
Sbjct: 227 GITLIEMAEIEP 238

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 95/174 (54%), Gaps = 9/174 (5%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD-LDLH 93
           VAIK + +   ++    ++  E S++ + +H NI+RL  V +  K V +V EY++   L 
Sbjct: 76  VAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 94  SFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTV-KLADFG 152
           SF+ +H     ++ +  +L+ I  G+ Y   +  +HRDL   N+LI+   N V K++DFG
Sbjct: 135 SFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN--SNLVCKVSDFG 192
Query: 153 LARAI-GVPQKEYSRDCVYSP--YKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           LAR +   P+  Y+      P  + +PE  + Y  +++  DVW+ G +  E+++
Sbjct: 193 LARVLEDDPEAAYTTRGGKIPIRWTSPE-AIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 113/214 (52%), Gaps = 14/214 (6%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHE---NIVRLLDVQSSR 78
           +V K  + V  + VAIK++  +          +R + L+ + + E    IV L      R
Sbjct: 69  QVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128
Query: 79  KDVFLVFEYLDLDLHSFITRHKN--TLNLLVIKAILKQILLGLAYCHS--LKILHRDLKP 134
             + LVFE L  +L+  + R+ N   ++L + +   +Q+   L +  +  L I+H DLKP
Sbjct: 129 NHLCLVFEMLSYNLYDLL-RNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKP 187
Query: 135 NNLLI-DLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
            N+L+ + KR+ +K+ DFG +  +G  Q+ Y +      Y++PE+LLG   Y   ID+W+
Sbjct: 188 ENILLCNPKRSAIKIVDFGSSCQLG--QRIY-QXIQSRFYRSPEVLLGMP-YDLAIDMWS 243
Query: 194 VGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTP 226
           +GCI  EM TG+PLF      D ++ I  +LG P
Sbjct: 244 LGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP 277

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 97/181 (53%), Gaps = 14/181 (7%)
Query: 31  TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDV--QSSRKDVFLVFEYL 88
           TG+ VA+K +   TE+        RE+ +LK L+H+NIV+   V   + R+++ L+ E+L
Sbjct: 41  TGEVVAVKKLQHSTEEH--LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFL 98
Query: 89  DL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVK 147
               L  ++ +HK  ++ + +     QI  G+ Y  + + +HRDL   N+L++   N VK
Sbjct: 99  PYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE-NENRVK 157
Query: 148 LADFGLARAIGVPQKEYS---RDCVYSP--YKAPELLLGYTGYSTPIDVWAVGCIFAEMI 202
           + DFGL + +  PQ +     ++   SP  + APE L   + +S   DVW+ G +  E+ 
Sbjct: 158 IGDFGLTKVL--PQDKEXXKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELF 214
Query: 203 T 203
           T
Sbjct: 215 T 215

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 100/191 (52%), Gaps = 10/191 (5%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           +VYK +N  T    A K++  ++E+E +  Y++ E+ +L   +H NIV+LLD      ++
Sbjct: 52  KVYKAQNKETSVLAAAKVIDTKSEEE-LEDYMV-EIDILASCDHPNIVKLLDAFYYENNL 109
Query: 82  FLVFEYLDLD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLID 140
           +++ E+     + + +   +  L    I+ + KQ L  L Y H  KI+HRDLK  N+L  
Sbjct: 110 WILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFT 169
Query: 141 LKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY-KAPELLLGYTGYSTP----IDVWAVG 195
           L  + +KLADFG++ A      +     + +PY  APE+++  T    P     DVW++G
Sbjct: 170 LDGD-IKLADFGVS-AKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLG 227
Query: 196 CIFAEMITGKP 206
               EM   +P
Sbjct: 228 ITLIEMAEIEP 238

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 111/218 (50%), Gaps = 17/218 (7%)
Query: 22  EVYKCR-NTVTGQK---VAIKMMTIQ-TEQEGVPSYIIREVSLLKELEHENIVRLLDVQS 76
           EVYK    T +G+K   VAIK +    TE++ V    + E  ++ +  H NI+RL  V S
Sbjct: 59  EVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD--FLGEAGIMGQFSHHNIIRLEGVIS 116
Query: 77  SRKDVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPN 135
             K + ++ EY++   L  F+       ++L +  +L+ I  G+ Y  ++  +HRDL   
Sbjct: 117 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAAR 176
Query: 136 NLLIDLKRNTV-KLADFGLARAI-GVPQKEYSRDCVYSP--YKAPELLLGYTGYSTPIDV 191
           N+L++   N V K++DFGL+R +   P+  Y+      P  + APE  + Y  +++  DV
Sbjct: 177 NILVN--SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE-AISYRKFTSASDV 233
Query: 192 WAVGCIFAEMIT--GKPLFPSKKHDHLSLIFSLLGTPT 227
           W+ G +  E++T   +P +    H+ +  I      PT
Sbjct: 234 WSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT 271

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 113/214 (52%), Gaps = 14/214 (6%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHE---NIVRLLDVQSSR 78
           +V K  + V  + VAIK++  +          +R + L+ + + E    IV L      R
Sbjct: 50  QVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 109
Query: 79  KDVFLVFEYLDLDLHSFITRHKN--TLNLLVIKAILKQILLGLAYCHS--LKILHRDLKP 134
             + LVFE L  +L+  + R+ N   ++L + +   +Q+   L +  +  L I+H DLKP
Sbjct: 110 NHLCLVFEMLSYNLYDLL-RNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKP 168
Query: 135 NNLLI-DLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
            N+L+ + KR+ +K+ DFG +  +G  Q+ Y +      Y++PE+LLG   Y   ID+W+
Sbjct: 169 ENILLCNPKRSAIKIVDFGSSCQLG--QRIY-QXIQSRFYRSPEVLLGMP-YDLAIDMWS 224
Query: 194 VGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTP 226
           +GCI  EM TG+PLF      D ++ I  +LG P
Sbjct: 225 LGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP 258

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 95/174 (54%), Gaps = 9/174 (5%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD-LDLH 93
           VAIK + +   ++    ++  E S++ + +H NI+RL  V +  K V +V EY++   L 
Sbjct: 76  VAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 94  SFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTV-KLADFG 152
           SF+ +H     ++ +  +L+ I  G+ Y   +  +HRDL   N+LI+   N V K++DFG
Sbjct: 135 SFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGFVHRDLAARNILIN--SNLVCKVSDFG 192
Query: 153 LARAI-GVPQKEYSRDCVYSP--YKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           L+R +   P+  Y+      P  + +PE  + Y  +++  DVW+ G +  E+++
Sbjct: 193 LSRVLEDDPEAAYTTRGGKIPIRWTSPE-AIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/192 (30%), Positives = 105/192 (54%), Gaps = 12/192 (6%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           +VYK +N  TG   A K++  ++E+E +  YI+ E+ +L   +H  IV+LL        +
Sbjct: 26  KVYKAKNKETGALAAAKVIETKSEEE-LEDYIV-EIEILATCDHPYIVKLLGAYYHDGKL 83
Query: 82  FLVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLID 140
           +++ E+     + + +      L    I+ + +Q+L  L + HS +I+HRDLK  N+L+ 
Sbjct: 84  WIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMT 143
Query: 141 LKRNTVKLADFGL-ARAIGVPQKEYSRDCVYSPY-KAPELLLGYTGYSTP----IDVWAV 194
           L+ + ++LADFG+ A+ +   QK  S   + +PY  APE+++  T   TP     D+W++
Sbjct: 144 LEGD-IRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCETMKDTPYDYKADIWSL 200
Query: 195 GCIFAEMITGKP 206
           G    EM   +P
Sbjct: 201 GITLIEMAQIEP 212

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/187 (33%), Positives = 96/187 (51%), Gaps = 11/187 (5%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDV--QSSRKD 80
            Y   N  TG+ VA+K +      +    +  +E+ +L+ L HE+I++          K 
Sbjct: 34  CYDPTNDGTGEMVAVKALKADCGPQHRSGWK-QEIDILRTLYHEHIIKYKGCCEDQGEKS 92
Query: 81  VFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLI 139
           + LV EY+ L  L  ++ RH   L  L++ A  +QI  G+AY H+   +HR+L   N+L+
Sbjct: 93  LQLVMEYVPLGSLRDYLPRHSIGLAQLLLFA--QQICEGMAYLHAQHYIHRNLAARNVLL 150
Query: 140 DLKRNTVKLADFGLARAIGVPQKEYS-RDCVYSP--YKAPELLLGYTGYSTPIDVWAVGC 196
           D  R  VK+ DFGLA+A+    + Y  R+   SP  + APE L  Y  Y    DVW+ G 
Sbjct: 151 DNDR-LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYAS-DVWSFGV 208
Query: 197 IFAEMIT 203
              E++T
Sbjct: 209 TLYELLT 215

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 122/278 (43%), Gaps = 72/278 (25%)
Query: 81  VFLVFEYLDLDLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHS-LKILHRDLKPNNLL 138
           V +VFE L   L  +I +     L +  +K+I++Q+L GL Y HS  KI+H D+KP N+L
Sbjct: 114 VCMVFEVLGHHLLKWIIKSNYQGLPVRCVKSIIRQVLQGLDYLHSKCKIIHTDIKPENIL 173
Query: 139 I------------------------------------DL------KRNT----VKLADFG 152
           +                                    DL       RN     VK+AD G
Sbjct: 174 MCVDDAYVRRMAAEATEWQKAGAPPPSGSAVSTAPAADLLVNPLDPRNADKIRVKIADLG 233
Query: 153 LARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFP--- 209
            A  +    K ++ D     Y++ E+L+G  GYSTP D+W+  C+  E+ TG  LF    
Sbjct: 234 NACWV---HKHFTEDIQTRQYRSIEVLIG-AGYSTPADIWSTACMAFELATGDYLFEPHS 289
Query: 210 ----SKKHDHLSLI----------FSLLGTPTDESWAESTYISEILPLYPHFEPANLAEK 255
               S+  DH++ I          F+L G  + E +     +  I  L P      L EK
Sbjct: 290 GEDYSRDEDHIAHIIELLGSIPRHFALSGKYSREFFNRRGELRHITKLKPWSLFDVLVEK 349
Query: 256 F--PNLEPAG-VDLLSQMLCLNPKQRITAMDALKHEYL 290
           +  P+ + A   D L  ML + P++R +A + L+H +L
Sbjct: 350 YGWPHEDAAQFTDFLIPMLEMVPEKRASAGECLRHPWL 387

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/192 (30%), Positives = 105/192 (54%), Gaps = 12/192 (6%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           +VYK +N  TG   A K++  ++E+E +  YI+ E+ +L   +H  IV+LL        +
Sbjct: 34  KVYKAKNKETGALAAAKVIETKSEEE-LEDYIV-EIEILATCDHPYIVKLLGAYYHDGKL 91
Query: 82  FLVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLID 140
           +++ E+     + + +      L    I+ + +Q+L  L + HS +I+HRDLK  N+L+ 
Sbjct: 92  WIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMT 151
Query: 141 LKRNTVKLADFGL-ARAIGVPQKEYSRDCVYSPY-KAPELLLGYTGYSTP----IDVWAV 194
           L+ + ++LADFG+ A+ +   QK  S   + +PY  APE+++  T   TP     D+W++
Sbjct: 152 LEGD-IRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCETMKDTPYDYKADIWSL 208
Query: 195 GCIFAEMITGKP 206
           G    EM   +P
Sbjct: 209 GITLIEMAQIEP 220

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 112/216 (51%), Gaps = 18/216 (8%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHE---NIVRLLDVQSSR 78
           +V K  + V  + VAIK++  +          +R + L+ + + E    IV L      R
Sbjct: 69  QVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128
Query: 79  KDVFLVFEYLDLDLHSFITRHKN--TLNLLVIKAILKQILLGLAYCHS--LKILHRDLKP 134
             + LVFE L  +L+  + R+ N   ++L + +   +Q+   L +  +  L I+H DLKP
Sbjct: 129 NHLCLVFEMLSYNLYDLL-RNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKP 187
Query: 135 NNLLI-DLKRNTVKLADFGLARAIG--VPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDV 191
            N+L+ + KR  +K+ DFG +  +G  + Q   SR      Y++PE+LLG   Y   ID+
Sbjct: 188 ENILLCNPKRXAIKIVDFGSSCQLGQRIYQXIQSR-----FYRSPEVLLGMP-YDLAIDM 241
Query: 192 WAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTP 226
           W++GCI  EM TG+PLF      D ++ I  +LG P
Sbjct: 242 WSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP 277

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 95/174 (54%), Gaps = 9/174 (5%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD-LDLH 93
           VAIK + +   ++    ++  E S++ + +H NI+RL  V +  K V +V EY++   L 
Sbjct: 64  VAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 122
Query: 94  SFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTV-KLADFG 152
           SF+ +H     ++ +  +L+ I  G+ Y   +  +HRDL   N+LI+   N V K++DFG
Sbjct: 123 SFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN--SNLVCKVSDFG 180
Query: 153 LARAI-GVPQKEYSRDCVYSP--YKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           L+R +   P+  Y+      P  + +PE  + Y  +++  DVW+ G +  E+++
Sbjct: 181 LSRVLEDDPEAAYTTRGGKIPIRWTSPE-AIAYRKFTSASDVWSYGIVLWEVMS 233

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 71/249 (28%), Positives = 125/249 (50%), Gaps = 29/249 (11%)
Query: 56  EVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDLDL-----HSFITRHKNTLNLL---V 107
           E+ ++ ++++E  +    + ++  +V++++EY++ D        F    KN    +   V
Sbjct: 93  ELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQV 152
Query: 108 IKAILKQILLGLAYCHSLK-ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSR 166
           IK I+K +L   +Y H+ K I HRD+KP+N+L+D K   VKL+DFG +  +   + + SR
Sbjct: 153 IKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD-KNGRVKLSDFGESEYMVDKKIKGSR 211
Query: 167 DCVYSPYKAPELLLGYTGYS-TPIDVWAVG-CIFAEMITGKPLFPSKKHDHLSLI--FSL 222
                 +  PE     + Y+   +D+W++G C++       P F  K    +SL+  F+ 
Sbjct: 212 GTY--EFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP-FSLK----ISLVELFNN 264
Query: 223 LGTPTDESWAESTYISEILPLYP-HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITA 281
           + T   E   +  +      LYP   + +  +  F  L    +D L   L  NP +RIT+
Sbjct: 265 IRTKNIEYPLDRNHF-----LYPLTNKKSTCSNNF--LSNEDIDFLKLFLRKNPAERITS 317
Query: 282 MDALKHEYL 290
            DALKHE+L
Sbjct: 318 EDALKHEWL 326

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 95/174 (54%), Gaps = 9/174 (5%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD-LDLH 93
           VAIK + +   ++    ++  E S++ + +H NI+RL  V +  K V +V EY++   L 
Sbjct: 47  VAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 105
Query: 94  SFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTV-KLADFG 152
           SF+ +H     ++ +  +L+ I  G+ Y   +  +HRDL   N+LI+   N V K++DFG
Sbjct: 106 SFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN--SNLVCKVSDFG 163
Query: 153 LARAI-GVPQKEYSRDCVYSP--YKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           L+R +   P+  Y+      P  + +PE  + Y  +++  DVW+ G +  E+++
Sbjct: 164 LSRVLEDDPEAAYTTRGGKIPIRWTSPE-AIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 95/174 (54%), Gaps = 9/174 (5%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD-LDLH 93
           VAIK + +   ++    ++  E S++ + +H NI+RL  V +  K V +V EY++   L 
Sbjct: 76  VAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 94  SFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTV-KLADFG 152
           SF+ +H     ++ +  +L+ I  G+ Y   +  +HRDL   N+LI+   N V K++DFG
Sbjct: 135 SFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN--SNLVCKVSDFG 192
Query: 153 LARAI-GVPQKEYSRDCVYSP--YKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           L+R +   P+  Y+      P  + +PE  + Y  +++  DVW+ G +  E+++
Sbjct: 193 LSRVLEDDPEAAYTTRGGKIPIRWTSPE-AIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 95/174 (54%), Gaps = 9/174 (5%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD-LDLH 93
           VAIK + +   ++    ++  E S++ + +H NI+RL  V +  K V +V EY++   L 
Sbjct: 76  VAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 94  SFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTV-KLADFG 152
           SF+ +H     ++ +  +L+ I  G+ Y   +  +HRDL   N+LI+   N V K++DFG
Sbjct: 135 SFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN--SNLVCKVSDFG 192
Query: 153 LARAI-GVPQKEYSRDCVYSP--YKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           L+R +   P+  Y+      P  + +PE  + Y  +++  DVW+ G +  E+++
Sbjct: 193 LSRVLEDDPEAAYTTRGGKIPIRWTSPE-AIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 95/174 (54%), Gaps = 9/174 (5%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD-LDLH 93
           VAIK + +   ++    ++  E S++ + +H NI+RL  V +  K V +V EY++   L 
Sbjct: 76  VAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 94  SFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTV-KLADFG 152
           SF+ +H     ++ +  +L+ I  G+ Y   +  +HRDL   N+LI+   N V K++DFG
Sbjct: 135 SFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN--SNLVCKVSDFG 192
Query: 153 LARAI-GVPQKEYSRDCVYSP--YKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           L+R +   P+  Y+      P  + +PE  + Y  +++  DVW+ G +  E+++
Sbjct: 193 LSRVLEDDPEAAYTTRGGKIPIRWTSPE-AIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 95/174 (54%), Gaps = 9/174 (5%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD-LDLH 93
           VAIK + +   ++    ++  E S++ + +H NI+RL  V +  K V +V EY++   L 
Sbjct: 76  VAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 94  SFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTV-KLADFG 152
           SF+ +H     ++ +  +L+ I  G+ Y   +  +HRDL   N+LI+   N V K++DFG
Sbjct: 135 SFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN--SNLVCKVSDFG 192
Query: 153 LARAI-GVPQKEYSRDCVYSP--YKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           L+R +   P+  Y+      P  + +PE  + Y  +++  DVW+ G +  E+++
Sbjct: 193 LSRVLEDDPEAAYTTRGGKIPIRWTSPE-AIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 94/174 (54%), Gaps = 9/174 (5%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD-LDLH 93
           VAIK + +   ++    ++  E S++ + +H NI+RL  V +  K V +V EY++   L 
Sbjct: 76  VAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 94  SFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTV-KLADFG 152
           SF+ +H     ++ +  +L+ I  G+ Y   +  +HRDL   N+LI+   N V K++DFG
Sbjct: 135 SFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN--SNLVCKVSDFG 192
Query: 153 LARAI-GVPQKEYSRDCVYSP--YKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           L R +   P+  Y+      P  + +PE  + Y  +++  DVW+ G +  E+++
Sbjct: 193 LGRVLEDDPEAAYTTRGGKIPIRWTSPE-AIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 81/156 (51%), Gaps = 11/156 (7%)
Query: 56  EVSLLKELE----HENIVRLLDVQSSRKDVFLVFEYL--DLDLHSFITRHKNTLNLLVIK 109
           EV+LL ++     H  ++RLLD   +++   LV E      DL  +IT  K  L     +
Sbjct: 84  EVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYIT-EKGPLGEGPSR 142
Query: 110 AILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAI-GVPQKEYSRDC 168
               Q++  + +CHS  ++HRD+K  N+LIDL+R   KL DFG    +   P  ++    
Sbjct: 143 CFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTR 202
Query: 169 VYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITG 204
           VYSP   PE +  +  ++ P  VW++G +  +M+ G
Sbjct: 203 VYSP---PEWISRHQYHALPATVWSLGILLYDMVCG 235

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 95/174 (54%), Gaps = 9/174 (5%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD-LDLH 93
           VAIK + +   ++    ++  E S++ + +H NI+RL  V +  K V +V EY++   L 
Sbjct: 74  VAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 132
Query: 94  SFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTV-KLADFG 152
           SF+ +H     ++ +  +L+ I  G+ Y   +  +HRDL   N+LI+   N V K++DFG
Sbjct: 133 SFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN--SNLVCKVSDFG 190
Query: 153 LARAI-GVPQKEYSRDCVYSP--YKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           L+R +   P+  Y+      P  + +PE  + Y  +++  DVW+ G +  E+++
Sbjct: 191 LSRVLEDDPEAAYTTRGGKIPIRWTSPE-AIAYRKFTSASDVWSYGIVLWEVMS 243

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 127/279 (45%), Gaps = 41/279 (14%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           EV    +  T + VAIK +  +   EG    +  E+++L +++H NIV L D+  S   +
Sbjct: 33  EVILAEDKRTQKLVAIKCIAKEA-LEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHL 91
Query: 82  FLVF------EYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPN 135
           +L+       E  D  +       ++   L+       Q+L  + Y H L I+HRDLKP 
Sbjct: 92  YLIMQLVSGGELFDRIVEKGFYTERDASRLIF------QVLDAVKYLHDLGIVHRDLKPE 145
Query: 136 NLL-IDLKRNT-VKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           NLL   L  ++ + ++DFGL++ +  P    S  C    Y APE +L    YS  +D W+
Sbjct: 146 NLLYYSLDEDSKIMISDFGLSK-MEDPGSVLSTACGTPGYVAPE-VLAQKPYSKAVDCWS 203
Query: 194 VGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLA 253
           +G I   ++ G P F                   DE+  ++    +IL     F+    +
Sbjct: 204 IGVIAYILLCGYPPF------------------YDEN--DAKLFEQILKAEYEFD----S 239
Query: 254 EKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIG 292
             + ++  +  D +  ++  +P++R T   AL+H ++ G
Sbjct: 240 PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 278

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 128/280 (45%), Gaps = 43/280 (15%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           EV    +  T + VAIK +  +   EG    +  E+++L +++H NIV L D+  S   +
Sbjct: 33  EVILAEDKRTQKLVAIKCIAKEA-LEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHL 91
Query: 82  FLVF------EYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPN 135
           +L+       E  D  +       ++   L+       Q+L  + Y H L I+HRDLKP 
Sbjct: 92  YLIMQLVSGGELFDRIVEKGFYTERDASRLIF------QVLDAVKYLHDLGIVHRDLKPE 145
Query: 136 NLL---IDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVW 192
           NLL   +D + + + ++DFGL++ +  P    S  C    Y APE +L    YS  +D W
Sbjct: 146 NLLYYSLD-EDSKIMISDFGLSK-MEDPGSVLSTACGTPGYVAPE-VLAQKPYSKAVDCW 202
Query: 193 AVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANL 252
           ++G I   ++ G P F                   DE+  ++    +IL     F+    
Sbjct: 203 SIGVIAYILLCGYPPF------------------YDEN--DAKLFEQILKAEYEFD---- 238
Query: 253 AEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIG 292
           +  + ++  +  D +  ++  +P++R T   AL+H ++ G
Sbjct: 239 SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 278

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 113/244 (46%), Gaps = 29/244 (11%)
Query: 59  LLKELEHENIVRLLDVQSSRKDVFLVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQILL 117
           LL+  +H NI+ L DV    K V++V E     +L   I R K   +     A+L  I  
Sbjct: 69  LLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQK-FFSEREASAVLFTITK 127
Query: 118 GLAYCHSLKILHRDLKPNNLL-IDLKRN--TVKLADFGLARAIGVPQKEYSRDCVYSPYK 174
            + Y H+  ++HRDLKP+N+L +D   N  ++++ DFG A+ +          C  + + 
Sbjct: 128 TVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFV 187
Query: 175 APELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAES 234
           APE +L   GY    D+W++G +    +TG   F +   D    I + +G+         
Sbjct: 188 APE-VLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILARIGSGK------- 239
Query: 235 TYISEILPLYPHFEPANLAEKFPN-LEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
                           +L+  + N +     DL+S+ L ++P QR+TA   L+H +++  
Sbjct: 240 ---------------FSLSGGYWNSVSDTAKDLVSKXLHVDPHQRLTAALVLRHPWIVHW 284
Query: 294 ENVP 297
           + +P
Sbjct: 285 DQLP 288

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 128/280 (45%), Gaps = 43/280 (15%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           EV    +  T + VAIK +  +   EG    +  E+++L +++H NIV L D+  S   +
Sbjct: 33  EVILAEDKRTQKLVAIKCIAKEA-LEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHL 91
Query: 82  FLVF------EYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPN 135
           +L+       E  D  +       ++   L+       Q+L  + Y H L I+HRDLKP 
Sbjct: 92  YLIMQLVSGGELFDRIVEKGFYTERDASRLIF------QVLDAVKYLHDLGIVHRDLKPE 145
Query: 136 NLL---IDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVW 192
           NLL   +D + + + ++DFGL++ +  P    S  C    Y APE +L    YS  +D W
Sbjct: 146 NLLYYSLD-EDSKIMISDFGLSK-MEDPGSVLSTACGTPGYVAPE-VLAQKPYSKAVDCW 202
Query: 193 AVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANL 252
           ++G I   ++ G P F                   DE+  ++    +IL     F+    
Sbjct: 203 SIGVIAYILLCGYPPF------------------YDEN--DAKLFEQILKAEYEFD---- 238
Query: 253 AEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIG 292
           +  + ++  +  D +  ++  +P++R T   AL+H ++ G
Sbjct: 239 SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 278

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 127/279 (45%), Gaps = 41/279 (14%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           EV    +  T + VAIK +  +   EG    +  E+++L +++H NIV L D+  S   +
Sbjct: 33  EVILAEDKRTQKLVAIKCIA-KKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHL 91
Query: 82  FLVF------EYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPN 135
           +L+       E  D  +       ++   L+       Q+L  + Y H L I+HRDLKP 
Sbjct: 92  YLIMQLVSGGELFDRIVEKGFYTERDASRLIF------QVLDAVKYLHDLGIVHRDLKPE 145
Query: 136 NLL-IDLKRNT-VKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           NLL   L  ++ + ++DFGL++ +  P    S  C    Y APE +L    YS  +D W+
Sbjct: 146 NLLYYSLDEDSKIMISDFGLSK-MEDPGSVLSTACGTPGYVAPE-VLAQKPYSKAVDCWS 203
Query: 194 VGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLA 253
           +G I   ++ G P F                   DE+  ++    +IL     F+    +
Sbjct: 204 IGVIAYILLCGYPPF------------------YDEN--DAKLFEQILKAEYEFD----S 239
Query: 254 EKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIG 292
             + ++  +  D +  ++  +P++R T   AL+H ++ G
Sbjct: 240 PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 278

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 126/287 (43%), Gaps = 38/287 (13%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSL-LKELEHENIVRLLDVQ----SSRKDVF 82
           N  T +K A+KM+      +  P    REV L  +  +  +IVR++DV     + RK + 
Sbjct: 37  NKRTQEKFALKML------QDCPK-ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 89
Query: 83  LVFEYLDL-DLHSFIT-RHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLID 140
           +V E LD  +L S I  R            I+K I   + Y HS+ I HRD+KP NLL  
Sbjct: 90  IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYT 149
Query: 141 LKRNT--VKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIF 198
            KR    +KL DFG A+         +  C Y+PY     +LG   Y    D+W++G I 
Sbjct: 150 SKRPNAILKLTDFGFAKET-TSHNSLTEPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 207
Query: 199 AEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPN 258
             ++ G P F S   +H   I   + T       E          +P+ E + ++E+   
Sbjct: 208 YILLCGYPPFYS---NHGLAISPGMKTRIRMGQYE----------FPNPEWSEVSEEVKM 254
Query: 259 LEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLINR 305
                  L+  +L   P QR+T  + + H +++    VP   L  +R
Sbjct: 255 -------LIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSR 294

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 126/287 (43%), Gaps = 38/287 (13%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSL-LKELEHENIVRLLDVQ----SSRKDVF 82
           N  T +K A+KM+      +  P    REV L  +  +  +IVR++DV     + RK + 
Sbjct: 53  NKRTQEKFALKML------QDCPK-ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 105
Query: 83  LVFEYLDL-DLHSFIT-RHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLID 140
           +V E LD  +L S I  R            I+K I   + Y HS+ I HRD+KP NLL  
Sbjct: 106 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYT 165
Query: 141 LKRNT--VKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIF 198
            KR    +KL DFG A+         +  C Y+PY     +LG   Y    D+W++G I 
Sbjct: 166 SKRPNAILKLTDFGFAKET-TSHNSLTTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 223
Query: 199 AEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPN 258
             ++ G P F S   +H   I   + T       E          +P+ E + ++E+   
Sbjct: 224 YILLCGYPPFYS---NHGLAISPGMKTRIRMGQYE----------FPNPEWSEVSEEVKM 270
Query: 259 LEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLINR 305
                  L+  +L   P QR+T  + + H +++    VP   L  +R
Sbjct: 271 -------LIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSR 310

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 95/181 (52%), Gaps = 14/181 (7%)
Query: 31  TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDV--QSSRKDVFLVFEYL 88
           TG+ VA+K +   TE+        RE+ +LK L+H+NIV+   V   + R+++ L+ EYL
Sbjct: 41  TGEVVAVKKLQHSTEEH--LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 98
Query: 89  DL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVK 147
               L  ++  H   ++ + +     QI  G+ Y  + + +HRDL   N+L++   N VK
Sbjct: 99  PYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE-NENRVK 157
Query: 148 LADFGLARAIGVPQKEYS---RDCVYSP--YKAPELLLGYTGYSTPIDVWAVGCIFAEMI 202
           + DFGL + +  PQ +     ++   SP  + APE L   + +S   DVW+ G +  E+ 
Sbjct: 158 IGDFGLTKVL--PQDKEXXKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELF 214
Query: 203 T 203
           T
Sbjct: 215 T 215

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 126/287 (43%), Gaps = 38/287 (13%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSL-LKELEHENIVRLLDVQ----SSRKDVF 82
           N  T +K A+KM+      +  P    REV L  +  +  +IVR++DV     + RK + 
Sbjct: 45  NKRTQEKFALKML------QDCPK-ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 97
Query: 83  LVFEYLDL-DLHSFIT-RHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLID 140
           +V E LD  +L S I  R            I+K I   + Y HS+ I HRD+KP NLL  
Sbjct: 98  IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYT 157
Query: 141 LKRNT--VKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIF 198
            KR    +KL DFG A+         +  C Y+PY     +LG   Y    D+W++G I 
Sbjct: 158 SKRPNAILKLTDFGFAKET-TSHNSLTTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 215
Query: 199 AEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPN 258
             ++ G P F S   +H   I   + T       E          +P+ E + ++E+   
Sbjct: 216 YILLCGYPPFYS---NHGLAISPGMKTRIRMGQYE----------FPNPEWSEVSEEVKM 262
Query: 259 LEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLINR 305
                  L+  +L   P QR+T  + + H +++    VP   L  +R
Sbjct: 263 -------LIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSR 302

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 120/256 (46%), Gaps = 36/256 (14%)
Query: 51  SYIIREVSLLKEL-EHENIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIK 109
           S+  REV LL+E  EH N++R    +  R+  ++  E     L  ++ +       L   
Sbjct: 62  SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPI 121
Query: 110 AILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVK----LADFGLARAIGVPQKEYS 165
            +L+Q   GLA+ HSL I+HRDLKP+N+LI +     K    ++DFGL + + V +  +S
Sbjct: 122 TLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFS 181
Query: 166 RDCVY---SPYKAPELLLG--YTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLI 219
           R         + APE+L        +  +D+++ GC+F  +I+ G   F        ++ 
Sbjct: 182 RRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI- 240
Query: 220 FSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRI 279
             LLG  + +             L+P        EK  ++     +L+ +M+ ++P++R 
Sbjct: 241 --LLGACSLDC------------LHP--------EKHEDV--IARELIEKMIAMDPQKRP 276
Query: 280 TAMDALKHEYLIGVEN 295
           +A   LKH +   +E 
Sbjct: 277 SAKHVLKHPFFWSLEK 292

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 126/287 (43%), Gaps = 38/287 (13%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSL-LKELEHENIVRLLDVQ----SSRKDVF 82
           N  T +K A+KM+      +  P    REV L  +  +  +IVR++DV     + RK + 
Sbjct: 43  NKRTQEKFALKML------QDCPK-ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 95
Query: 83  LVFEYLDL-DLHSFIT-RHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLID 140
           +V E LD  +L S I  R            I+K I   + Y HS+ I HRD+KP NLL  
Sbjct: 96  IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYT 155
Query: 141 LKRNT--VKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIF 198
            KR    +KL DFG A+         +  C Y+PY     +LG   Y    D+W++G I 
Sbjct: 156 SKRPNAILKLTDFGFAKET-TSHNSLTTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 213
Query: 199 AEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPN 258
             ++ G P F S   +H   I   + T       E          +P+ E + ++E+   
Sbjct: 214 YILLCGYPPFYS---NHGLAISPGMKTRIRMGQYE----------FPNPEWSEVSEEVKM 260
Query: 259 LEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLINR 305
                  L+  +L   P QR+T  + + H +++    VP   L  +R
Sbjct: 261 -------LIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSR 300

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 126/287 (43%), Gaps = 38/287 (13%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSL-LKELEHENIVRLLDVQ----SSRKDVF 82
           N  T +K A+KM+      +  P    REV L  +  +  +IVR++DV     + RK + 
Sbjct: 39  NKRTQEKFALKML------QDCPK-ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91
Query: 83  LVFEYLDL-DLHSFIT-RHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLID 140
           +V E LD  +L S I  R            I+K I   + Y HS+ I HRD+KP NLL  
Sbjct: 92  IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYT 151
Query: 141 LKRNT--VKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIF 198
            KR    +KL DFG A+         +  C Y+PY     +LG   Y    D+W++G I 
Sbjct: 152 SKRPNAILKLTDFGFAKET-TSHNSLTTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 209
Query: 199 AEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPN 258
             ++ G P F S   +H   I   + T       E          +P+ E + ++E+   
Sbjct: 210 YILLCGYPPFYS---NHGLAISPGMKTRIRMGQYE----------FPNPEWSEVSEEVKM 256
Query: 259 LEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLINR 305
                  L+  +L   P QR+T  + + H +++    VP   L  +R
Sbjct: 257 -------LIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSR 296

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 126/287 (43%), Gaps = 38/287 (13%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSL-LKELEHENIVRLLDVQ----SSRKDVF 82
           N  T +K A+KM+      +  P    REV L  +  +  +IVR++DV     + RK + 
Sbjct: 39  NKRTQEKFALKML------QDCPK-ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91
Query: 83  LVFEYLDL-DLHSFIT-RHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLID 140
           +V E LD  +L S I  R            I+K I   + Y HS+ I HRD+KP NLL  
Sbjct: 92  IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYT 151
Query: 141 LKRNT--VKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIF 198
            KR    +KL DFG A+         +  C Y+PY     +LG   Y    D+W++G I 
Sbjct: 152 SKRPNAILKLTDFGFAKET-TSHNSLTTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 209
Query: 199 AEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPN 258
             ++ G P F S   +H   I   + T       E          +P+ E + ++E+   
Sbjct: 210 YILLCGYPPFYS---NHGLAISPGMKTRIRMGQYE----------FPNPEWSEVSEEVKM 256
Query: 259 LEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLINR 305
                  L+  +L   P QR+T  + + H +++    VP   L  +R
Sbjct: 257 -------LIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSR 296

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 126/287 (43%), Gaps = 38/287 (13%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSL-LKELEHENIVRLLDVQ----SSRKDVF 82
           N  T +K A+KM+      +  P    REV L  +  +  +IVR++DV     + RK + 
Sbjct: 44  NKRTQEKFALKML------QDCPK-ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 96
Query: 83  LVFEYLDL-DLHSFIT-RHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLID 140
           +V E LD  +L S I  R            I+K I   + Y HS+ I HRD+KP NLL  
Sbjct: 97  IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYT 156
Query: 141 LKRNT--VKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIF 198
            KR    +KL DFG A+         +  C Y+PY     +LG   Y    D+W++G I 
Sbjct: 157 SKRPNAILKLTDFGFAKET-TSHNSLTTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 214
Query: 199 AEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPN 258
             ++ G P F S   +H   I   + T       E          +P+ E + ++E+   
Sbjct: 215 YILLCGYPPFYS---NHGLAISPGMKTRIRMGQYE----------FPNPEWSEVSEEVKM 261
Query: 259 LEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLINR 305
                  L+  +L   P QR+T  + + H +++    VP   L  +R
Sbjct: 262 -------LIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSR 301

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 126/287 (43%), Gaps = 38/287 (13%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSL-LKELEHENIVRLLDVQ----SSRKDVF 82
           N  T +K A+KM+      +  P    REV L  +  +  +IVR++DV     + RK + 
Sbjct: 37  NKRTQEKFALKML------QDCPK-ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 89
Query: 83  LVFEYLDL-DLHSFIT-RHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLID 140
           +V E LD  +L S I  R            I+K I   + Y HS+ I HRD+KP NLL  
Sbjct: 90  IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYT 149
Query: 141 LKRNT--VKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIF 198
            KR    +KL DFG A+         +  C Y+PY     +LG   Y    D+W++G I 
Sbjct: 150 SKRPNAILKLTDFGFAKET-TSHNSLTTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 207
Query: 199 AEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPN 258
             ++ G P F S   +H   I   + T       E          +P+ E + ++E+   
Sbjct: 208 YILLCGYPPFYS---NHGLAISPGMKTRIRMGQYE----------FPNPEWSEVSEEVKM 254
Query: 259 LEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLINR 305
                  L+  +L   P QR+T  + + H +++    VP   L  +R
Sbjct: 255 -------LIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSR 294

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 126/287 (43%), Gaps = 38/287 (13%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSL-LKELEHENIVRLLDVQ----SSRKDVF 82
           N  T +K A+KM+      +  P    REV L  +  +  +IVR++DV     + RK + 
Sbjct: 38  NKRTQEKFALKML------QDCPK-ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 90
Query: 83  LVFEYLDL-DLHSFIT-RHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLID 140
           +V E LD  +L S I  R            I+K I   + Y HS+ I HRD+KP NLL  
Sbjct: 91  IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYT 150
Query: 141 LKRNT--VKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIF 198
            KR    +KL DFG A+         +  C Y+PY     +LG   Y    D+W++G I 
Sbjct: 151 SKRPNAILKLTDFGFAKET-TSHNSLTTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 208
Query: 199 AEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPN 258
             ++ G P F S   +H   I   + T       E          +P+ E + ++E+   
Sbjct: 209 YILLCGYPPFYS---NHGLAISPGMKTRIRMGQYE----------FPNPEWSEVSEEVKM 255
Query: 259 LEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLINR 305
                  L+  +L   P QR+T  + + H +++    VP   L  +R
Sbjct: 256 -------LIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSR 295

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 7/202 (3%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEG-VPSYIIREVSLLKELEHENIVRLLDVQSSRKD 80
           EVY+    + G  VA+K + I    +    +  I+E+ LLK+L H N+++         +
Sbjct: 47  EVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE 106
Query: 81  VFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILK---QILLGLAYCHSLKILHRDLKPNN 136
           + +V E  D  DL   I   K    L+  + + K   Q+   L + HS +++HRD+KP N
Sbjct: 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPAN 166
Query: 137 LLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGC 196
           + I      VKL D GL R     +   +   V +PY      +   GY+   D+W++GC
Sbjct: 167 VFI-TATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGC 224
Query: 197 IFAEMITGKPLFPSKKHDHLSL 218
           +  EM   +  F   K +  SL
Sbjct: 225 LLYEMAALQSPFYGDKMNLYSL 246

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 126/287 (43%), Gaps = 38/287 (13%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSL-LKELEHENIVRLLDVQ----SSRKDVF 82
           N  T +K A+KM+      +  P    REV L  +  +  +IVR++DV     + RK + 
Sbjct: 89  NKRTQEKFALKML------QDCPK-ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 141
Query: 83  LVFEYLDL-DLHSFIT-RHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLID 140
           +V E LD  +L S I  R            I+K I   + Y HS+ I HRD+KP NLL  
Sbjct: 142 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYT 201
Query: 141 LKRNT--VKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIF 198
            KR    +KL DFG A+         +  C Y+PY     +LG   Y    D+W++G I 
Sbjct: 202 SKRPNAILKLTDFGFAKET-TSHNSLTTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 259
Query: 199 AEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPN 258
             ++ G P F S   +H   I   + T       E          +P+ E + ++E+   
Sbjct: 260 YILLCGYPPFYS---NHGLAISPGMKTRIRMGQYE----------FPNPEWSEVSEEVKM 306
Query: 259 LEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLINR 305
                  L+  +L   P QR+T  + + H +++    VP   L  +R
Sbjct: 307 -------LIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSR 346

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 103/210 (49%), Gaps = 13/210 (6%)
Query: 31  TGQKVAIKMMT--IQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYL 88
           T Q  AIK +   +    + V   ++ +  L    EH  +  +     +++++F V EYL
Sbjct: 42  TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYL 101
Query: 89  ---DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNT 145
              DL ++   + HK  L+     A   +I+LGL + HS  I++RDLK +N+L+D K   
Sbjct: 102 NGGDL-MYHIQSCHKFDLSRATFYAA--EIILGLQFLHSKGIVYRDLKLDNILLD-KDGH 157
Query: 146 VKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGK 205
           +K+ADFG+ +   +   + +  C    Y APE+LLG   Y+  +D W+ G +  EM+ G+
Sbjct: 158 IKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQ 216
Query: 206 PLFPSKKHDHLSLIFSL-LGTPTDESWAES 234
              P    D   L  S+ +  P    W E 
Sbjct: 217 S--PFHGQDEEELFHSIRMDNPFYPRWLEK 244

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 126/287 (43%), Gaps = 38/287 (13%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSL-LKELEHENIVRLLDVQ----SSRKDVF 82
           N  T +K A+KM+      +  P    REV L  +  +  +IVR++DV     + RK + 
Sbjct: 83  NKRTQEKFALKML------QDCPK-ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135
Query: 83  LVFEYLDL-DLHSFIT-RHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLID 140
           +V E LD  +L S I  R            I+K I   + Y HS+ I HRD+KP NLL  
Sbjct: 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYT 195
Query: 141 LKRNT--VKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIF 198
            KR    +KL DFG A+         +  C Y+PY     +LG   Y    D+W++G I 
Sbjct: 196 SKRPNAILKLTDFGFAKET-TSHNSLTTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
Query: 199 AEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPN 258
             ++ G P F S   +H   I   + T       E          +P+ E + ++E+   
Sbjct: 254 YILLCGYPPFYS---NHGLAISPGMKTRIRMGQYE----------FPNPEWSEVSEEVKM 300
Query: 259 LEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLINR 305
                  L+  +L   P QR+T  + + H +++    VP   L  +R
Sbjct: 301 -------LIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSR 340

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 103/210 (49%), Gaps = 13/210 (6%)
Query: 31  TGQKVAIKMMT--IQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYL 88
           T Q  AIK +   +    + V   ++ +  L    EH  +  +     +++++F V EYL
Sbjct: 41  TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYL 100
Query: 89  ---DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNT 145
              DL ++   + HK  L+     A   +I+LGL + HS  I++RDLK +N+L+D K   
Sbjct: 101 NGGDL-MYHIQSCHKFDLSRATFYAA--EIILGLQFLHSKGIVYRDLKLDNILLD-KDGH 156
Query: 146 VKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGK 205
           +K+ADFG+ +   +   + +  C    Y APE+LLG   Y+  +D W+ G +  EM+ G+
Sbjct: 157 IKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQ 215
Query: 206 PLFPSKKHDHLSLIFSL-LGTPTDESWAES 234
              P    D   L  S+ +  P    W E 
Sbjct: 216 S--PFHGQDEEELFHSIRMDNPFYPRWLEK 243

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/175 (33%), Positives = 98/175 (56%), Gaps = 8/175 (4%)
Query: 56  EVSLLKELEHENIVRLLDVQSSRKDVFLVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQ 114
           E  +L ++ H  +V+L     +   ++L+ ++L   DL + +++ +       +K  L +
Sbjct: 80  ERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAE 138
Query: 115 ILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLAR-AIGVPQKEYSRDCVYSPY 173
           + LGL + HSL I++RDLKP N+L+D +   +KL DFGL++ AI   +K YS  C    Y
Sbjct: 139 LALGLDHLHSLGIIYRDLKPENILLD-EEGHIKLTDFGLSKEAIDHEKKAYSF-CGTVEY 196
Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSK-KHDHLSLIF-SLLGTP 226
            APE ++   G+S   D W+ G +  EM+TG   F  K + + ++LI  + LG P
Sbjct: 197 MAPE-VVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMP 250

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/274 (23%), Positives = 125/274 (45%), Gaps = 34/274 (12%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIR-EVSLLKELEHENIVRLLDVQSSRKDV 81
           V++C    TG+    K +        +  Y ++ E+S++ +L H  ++ L D    + ++
Sbjct: 67  VHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM 123
Query: 82  FLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLID 140
            L+ E+L   +L   I      ++   +   ++Q   GL + H   I+H D+KP N++ +
Sbjct: 124 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCE 183
Query: 141 LKR-NTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELL-LGYTGYSTPIDVWAVGCIF 198
            K+ ++VK+ DFGLA  +  P +        + + APE++     G+ T  D+WA+G + 
Sbjct: 184 TKKASSVKIIDFGLATKLN-PDEIVKVTTATAEFAAPEIVDREPVGFYT--DMWAIGVLG 240
Query: 199 AEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPN 258
             +++G  L P    D L  + ++     D  + E                      F +
Sbjct: 241 YVLLSG--LSPFAGEDDLETLQNV--KRCDWEFDEDA--------------------FSS 276
Query: 259 LEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIG 292
           + P   D +  +L   P++R+T  DAL+H +L G
Sbjct: 277 VSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 310

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/191 (35%), Positives = 97/191 (50%), Gaps = 19/191 (9%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEG----VPSYIIREVSLLKELEHENIVRLLDV--QS 76
            Y   N  TG+ VA+K +     +EG    + S   RE+ +L+ L HE+IV+        
Sbjct: 29  CYDPTNDGTGEMVAVKAL-----KEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQ 83
Query: 77  SRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPN 135
             K V LV EY+ L  L  ++ RH   L  L++ A  +QI  G+AY H+   +HR L   
Sbjct: 84  GEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFA--QQICEGMAYLHAQHYIHRALAAR 141
Query: 136 NLLIDLKRNTVKLADFGLARAIGVPQKEYS-RDCVYSP--YKAPELLLGYTGYSTPIDVW 192
           N+L+D  R  VK+ DFGLA+A+    + Y  R+   SP  + APE L     Y    DVW
Sbjct: 142 NVLLDNDR-LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYAS-DVW 199
Query: 193 AVGCIFAEMIT 203
           + G    E++T
Sbjct: 200 SFGVTLYELLT 210

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 97/197 (49%), Gaps = 32/197 (16%)
Query: 26  CRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHE----------NIVRLLDVQ 75
            ++  TG   A+K++  Q            +V  LK++EH           N   L+ ++
Sbjct: 60  VKHMETGNHYAMKILDKQ------------KVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 76  SSRKD---VFLVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRD 131
            S KD   +++V EY+   D+ S + R     +    +    QI+L   Y HSL +++RD
Sbjct: 108 FSFKDNSNLYMVMEYMPGGDMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 132 LKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDV 191
           LKP NLLID ++  +K+ADFG A+ +   +      C    Y APE++L   GY+  +D 
Sbjct: 167 LKPENLLID-QQGYIKVADFGFAKRV---KGRTWXLCGTPEYLAPEIILS-KGYNKAVDW 221
Query: 192 WAVGCIFAEMITGKPLF 208
           WA+G +  EM  G P F
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/191 (35%), Positives = 97/191 (50%), Gaps = 19/191 (9%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEG----VPSYIIREVSLLKELEHENIVRLLDV--QS 76
            Y   N  TG+ VA+K +     +EG    + S   RE+ +L+ L HE+IV+        
Sbjct: 28  CYDPTNDGTGEMVAVKAL-----KEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQ 82
Query: 77  SRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPN 135
             K V LV EY+ L  L  ++ RH   L  L++ A  +QI  G+AY H+   +HR L   
Sbjct: 83  GEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFA--QQICEGMAYLHAQHYIHRALAAR 140
Query: 136 NLLIDLKRNTVKLADFGLARAIGVPQKEYS-RDCVYSP--YKAPELLLGYTGYSTPIDVW 192
           N+L+D  R  VK+ DFGLA+A+    + Y  R+   SP  + APE L     Y    DVW
Sbjct: 141 NVLLDNDR-LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYAS-DVW 198
Query: 193 AVGCIFAEMIT 203
           + G    E++T
Sbjct: 199 SFGVTLYELLT 209

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/211 (33%), Positives = 104/211 (49%), Gaps = 36/211 (17%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKD- 80
           +V K RN +  +  AIK +   TE++   S I+ EV LL  L H+ +VR       R++ 
Sbjct: 21  QVVKARNALDSRYYAIKKIR-HTEEK--LSTILSEVXLLASLNHQYVVRYYAAWLERRNF 77
Query: 81  ------------VFLVFEYLD-LDLHSFITRHKNTLNLLVIK--AILKQILLGLAYCHSL 125
                       +F+  EY +   L+  I  H   LN    +   + +QIL  L+Y HS 
Sbjct: 78  VKPXTAVKKKSTLFIQXEYCENRTLYDLI--HSENLNQQRDEYWRLFRQILEALSYIHSQ 135
Query: 126 KILHRDLKPNNLLIDLKRNTVKLADFGLA----RAIGVPQKEY-----SRDCVYSP---- 172
            I+HR+LKP N+ ID  RN VK+ DFGLA    R++ + + +      S D + S     
Sbjct: 136 GIIHRNLKPXNIFIDESRN-VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTA 194
Query: 173 -YKAPELLLGYTGYSTPIDVWAVGCIFAEMI 202
            Y A E+L G   Y+  ID +++G IF E I
Sbjct: 195 XYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 97/197 (49%), Gaps = 32/197 (16%)
Query: 26  CRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHE----------NIVRLLDVQ 75
            ++  TG   A+K++  Q            +V  LK++EH           N   L+ ++
Sbjct: 60  VKHMETGNHYAMKILDKQ------------KVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 76  SSRKD---VFLVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRD 131
            S KD   +++V EY+   D+ S + R     +    +    QI+L   Y HSL +++RD
Sbjct: 108 FSFKDNSNLYMVMEYMPGGDMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 132 LKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDV 191
           LKP NLLID ++  +K+ADFG A+ +   +      C    Y APE++L   GY+  +D 
Sbjct: 167 LKPENLLID-QQGYIKVADFGFAKRV---KGRTWXLCGTPEYLAPEIILS-KGYNKAVDW 221
Query: 192 WAVGCIFAEMITGKPLF 208
           WA+G +  EM  G P F
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 125/271 (46%), Gaps = 33/271 (12%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIR-EVSLLKELEHENIVRLLDVQSSRKDV 81
           V++C  T + +    K + ++    G    +++ E+S+L    H NI+ L +   S +++
Sbjct: 21  VHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIARHRNILHLHESFESMEEL 76
Query: 82  FLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLID 140
            ++FE++  LD+   I      LN   I + + Q+   L + HS  I H D++P N++  
Sbjct: 77  VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQ 136
Query: 141 LKR-NTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFA 199
            +R +T+K+ +FG AR +  P   +        Y APE +  +   ST  D+W++G +  
Sbjct: 137 TRRSSTIKIIEFGQARQLK-PGDNFRLLFTAPEYYAPE-VHQHDVVSTATDMWSLGTLVY 194
Query: 200 EMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNL 259
            +++G   F ++ +  +                    I  I+     F+     E F  +
Sbjct: 195 VLLSGINPFLAETNQQI--------------------IENIMNAEYTFDE----EAFKEI 230
Query: 260 EPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
               +D + ++L    K R+TA +AL+H +L
Sbjct: 231 SIEAMDFVDRLLVKERKSRMTASEALQHPWL 261

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 96/190 (50%), Gaps = 12/190 (6%)
Query: 22  EVYKCRNTVTGQK---VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR 78
           EV   R  V GQ+   VAIK +     +     ++  E S++ + +H NI+RL  V +  
Sbjct: 64  EVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFL-SEASIMGQFDHPNIIRLEGVVTRG 122
Query: 79  KDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
           +   +V EY++   L +F+  H     ++ +  +L+ +  G+ Y   L  +HRDL   N+
Sbjct: 123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNV 182
Query: 138 LIDLKRNTV-KLADFGLARAI-GVPQKEYSRDCVYSP--YKAPELLLGYTGYSTPIDVWA 193
           L+D   N V K++DFGL+R +   P   Y+      P  + APE  + +  +S+  DVW+
Sbjct: 183 LVD--SNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPE-AIAFRTFSSASDVWS 239
Query: 194 VGCIFAEMIT 203
            G +  E++ 
Sbjct: 240 FGVVMWEVLA 249

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 94/174 (54%), Gaps = 9/174 (5%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD-LDLH 93
           VAIK + +   ++    ++  E S++ + +H NI+RL  V +  K V +V E ++   L 
Sbjct: 76  VAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLD 134
Query: 94  SFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTV-KLADFG 152
           SF+ +H     ++ +  +L+ I  G+ Y   +  +HRDL   N+LI+   N V K++DFG
Sbjct: 135 SFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGAVHRDLAARNILIN--SNLVCKVSDFG 192
Query: 153 LARAI-GVPQKEYSRDCVYSP--YKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           L+R +   P+  Y+      P  + +PE  + Y  +++  DVW+ G +  E+++
Sbjct: 193 LSRVLEDDPEAAYTTRGGKIPIRWTSPE-AIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 96/179 (53%), Gaps = 9/179 (5%)
Query: 31  TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDV--QSSRKDVFLVFEYL 88
           TG++VA+K +  ++    +   + +E+ +L+ L HENIV+   +  +     + L+ E+L
Sbjct: 49  TGEQVAVKSLKPESGGNHIAD-LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFL 107
Query: 89  -DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVK 147
               L  ++ ++KN +NL        QI  G+ Y  S + +HRDL   N+L++   + VK
Sbjct: 108 PSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE-SEHQVK 166
Query: 148 LADFGLARAIGVPQKEYS-RDCVYSP--YKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           + DFGL +AI   ++  + +D   SP  + APE L+  + +    DVW+ G    E++T
Sbjct: 167 IGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM-QSKFYIASDVWSFGVTLHELLT 224

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 125/282 (44%), Gaps = 49/282 (17%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHE--NIVRLLDVQSSRKD 80
           V +C +  TGQ+ A K +  +   +   + I+ E+++L EL      ++ L +V  +  +
Sbjct: 45  VRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVL-ELAKSCPRVINLHEVYENTSE 103
Query: 81  VFLVFEYLDL---------DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRD 131
           + L+ EY            +L   ++ +       VI+ ++KQIL G+ Y H   I+H D
Sbjct: 104 IILILEYAAGGEIFSLCLPELAEMVSEND------VIR-LIKQILEGVYYLHQNNIVHLD 156
Query: 132 LKPNNLLID--LKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGYTGYSTP 188
           LKP N+L+        +K+ DFG++R IG   +   R+ + +P Y APE +L Y   +T 
Sbjct: 157 LKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE--LREIMGTPEYLAPE-ILNYDPITTA 213
Query: 189 IDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFE 248
            D+W +G I   ++T    F  + +    L  S +     E                   
Sbjct: 214 TDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE------------------- 254
Query: 249 PANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                E F ++     D +  +L  NP++R TA   L H +L
Sbjct: 255 -----ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWL 291

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 94/174 (54%), Gaps = 9/174 (5%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD-LDLH 93
           VAIK + +   ++    ++  E S++ + +H NI+RL  V +  K V +V E ++   L 
Sbjct: 47  VAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLD 105
Query: 94  SFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTV-KLADFG 152
           SF+ +H     ++ +  +L+ I  G+ Y   +  +HRDL   N+LI+   N V K++DFG
Sbjct: 106 SFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN--SNLVCKVSDFG 163
Query: 153 LARAI-GVPQKEYSRDCVYSP--YKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           L+R +   P+  Y+      P  + +PE  + Y  +++  DVW+ G +  E+++
Sbjct: 164 LSRVLEDDPEAAYTTRGGKIPIRWTSPE-AIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 96/179 (53%), Gaps = 9/179 (5%)
Query: 31  TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDV--QSSRKDVFLVFEYL 88
           TG++VA+K +  ++    +   + +E+ +L+ L HENIV+   +  +     + L+ E+L
Sbjct: 37  TGEQVAVKSLKPESGGNHIAD-LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFL 95
Query: 89  -DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVK 147
               L  ++ ++KN +NL        QI  G+ Y  S + +HRDL   N+L++   + VK
Sbjct: 96  PSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE-SEHQVK 154
Query: 148 LADFGLARAIGVPQKEYS-RDCVYSP--YKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           + DFGL +AI   ++  + +D   SP  + APE L+  + +    DVW+ G    E++T
Sbjct: 155 IGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM-QSKFYIASDVWSFGVTLHELLT 212

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 94/174 (54%), Gaps = 9/174 (5%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD-LDLH 93
           VAIK + +   ++    ++  E S++ + +H NI+RL  V +  K V +V E ++   L 
Sbjct: 76  VAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLD 134
Query: 94  SFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTV-KLADFG 152
           SF+ +H     ++ +  +L+ I  G+ Y   +  +HRDL   N+LI+   N V K++DFG
Sbjct: 135 SFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN--SNLVCKVSDFG 192
Query: 153 LARAI-GVPQKEYSRDCVYSP--YKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           L+R +   P+  Y+      P  + +PE  + Y  +++  DVW+ G +  E+++
Sbjct: 193 LSRVLEDDPEAAYTTRGGKIPIRWTSPE-AIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/271 (23%), Positives = 112/271 (41%), Gaps = 32/271 (11%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           V++     TG   A K   + T  E     + +E+  +  L H  +V L D      ++ 
Sbjct: 173 VHRVTERATGNNFAAKF--VMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 230
Query: 83  LVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +++E++   +L   +    N ++       ++Q+  GL + H    +H DLKP N++   
Sbjct: 231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT 290
Query: 142 KR-NTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGY-TGYSTPIDVWAVGCIFA 199
           KR N +KL DFGL   +  P++        + + APE+  G   GY T  D+W+VG +  
Sbjct: 291 KRSNELKLIDFGLTAHLD-PKQSVKVTTGTAEFAAPEVAEGKPVGYYT--DMWSVGVLSY 347
Query: 200 EMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNL 259
            +++G   F  +  D             D+S                         F  +
Sbjct: 348 ILLSGLSPFGGENDDETLRNVKSCDWNMDDS------------------------AFSGI 383
Query: 260 EPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
              G D + ++L  +P  R+T   AL+H +L
Sbjct: 384 SEDGKDFIRKLLLADPNTRMTIHQALEHPWL 414

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 20/197 (10%)
Query: 25  KCRNTVTGQ-KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL 83
           +C N +  Q K+ + +  ++   E       RE  LL  L+H++IVR   V +  + + +
Sbjct: 61  ECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120
Query: 84  VFEYL-DLDLHSFITRHKNTLNLLV--------------IKAILKQILLGLAYCHSLKIL 128
           VFEY+   DL+ F+  H     LL               + A+  Q+  G+ Y   L  +
Sbjct: 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFV 180
Query: 129 HRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ--KEYSRDCVYSPYKAPELLLGYTGYS 186
           HRDL   N L+  +   VK+ DFG++R I      +   R  +   +  PE +L Y  ++
Sbjct: 181 HRDLATRNCLVG-QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL-YRKFT 238
Query: 187 TPIDVWAVGCIFAEMIT 203
           T  DVW+ G +  E+ T
Sbjct: 239 TESDVWSFGVVLWEIFT 255

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 107/208 (51%), Gaps = 14/208 (6%)
Query: 22  EVYKCRNTVTGQK---VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR 78
           EV   R  + G++   VAIK + +   ++    ++  E S++ + +H N+V L  V +  
Sbjct: 58  EVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLC-EASIMGQFDHPNVVHLEGVVTRG 116
Query: 79  KDVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
           K V +V E+++   L +F+ +H     ++ +  +L+ I  G+ Y   +  +HRDL   N+
Sbjct: 117 KPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMGYVHRDLAARNI 176
Query: 138 LIDLKRNTV-KLADFGLARAI-GVPQKEYSRDCVYSP--YKAPELLLGYTGYSTPIDVWA 193
           L++   N V K++DFGL+R I   P+  Y+      P  + APE +  Y  +++  DVW+
Sbjct: 177 LVN--SNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQ-YRKFTSASDVWS 233
Query: 194 VGCIFAEMIT--GKPLFPSKKHDHLSLI 219
            G +  E+++   +P +     D +  I
Sbjct: 234 YGIVMWEVMSYGERPYWDMSNQDVIKAI 261

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/271 (23%), Positives = 112/271 (41%), Gaps = 32/271 (11%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           V++     TG   A K   + T  E     + +E+  +  L H  +V L D      ++ 
Sbjct: 67  VHRVTERATGNNFAAKF--VMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 124
Query: 83  LVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           +++E++   +L   +    N ++       ++Q+  GL + H    +H DLKP N++   
Sbjct: 125 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT 184
Query: 142 KR-NTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGY-TGYSTPIDVWAVGCIFA 199
           KR N +KL DFGL   +  P++        + + APE+  G   GY T  D+W+VG +  
Sbjct: 185 KRSNELKLIDFGLTAHLD-PKQSVKVTTGTAEFAAPEVAEGKPVGYYT--DMWSVGVLSY 241
Query: 200 EMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNL 259
            +++G   F  +  D             D+S                         F  +
Sbjct: 242 ILLSGLSPFGGENDDETLRNVKSCDWNMDDS------------------------AFSGI 277
Query: 260 EPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
              G D + ++L  +P  R+T   AL+H +L
Sbjct: 278 SEDGKDFIRKLLLADPNTRMTIHQALEHPWL 308

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 20/197 (10%)
Query: 25  KCRNTVTGQ-KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL 83
           +C N +  Q K+ + +  ++   E       RE  LL  L+H++IVR   V +  + + +
Sbjct: 32  ECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 91
Query: 84  VFEYL-DLDLHSFITRHKNTLNLLV--------------IKAILKQILLGLAYCHSLKIL 128
           VFEY+   DL+ F+  H     LL               + A+  Q+  G+ Y   L  +
Sbjct: 92  VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFV 151
Query: 129 HRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ--KEYSRDCVYSPYKAPELLLGYTGYS 186
           HRDL   N L+  +   VK+ DFG++R I      +   R  +   +  PE +L Y  ++
Sbjct: 152 HRDLATRNCLVG-QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL-YRKFT 209
Query: 187 TPIDVWAVGCIFAEMIT 203
           T  DVW+ G +  E+ T
Sbjct: 210 TESDVWSFGVVLWEIFT 226

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 95/193 (49%), Gaps = 7/193 (3%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           EV+  R       VA+K    +T    + +  ++E  +LK+  H NIVRL+ V + ++ +
Sbjct: 129 EVFSGRLRADNTLVAVKSCR-ETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI 187
Query: 82  FLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLID 140
           ++V E +   D  +F+      L +  +  ++     G+ Y  S   +HRDL   N L+ 
Sbjct: 188 YIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVT 247
Query: 141 LKRNTVKLADFGLAR--AIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIF 198
            ++N +K++DFG++R  A GV         V   + APE  L Y  YS+  DVW+ G + 
Sbjct: 248 -EKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPE-ALNYGRYSSESDVWSFGILL 305
Query: 199 AEMIT-GKPLFPS 210
            E  + G   +P+
Sbjct: 306 WETFSLGASPYPN 318

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 20/197 (10%)
Query: 25  KCRNTVTGQ-KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL 83
           +C N +  Q K+ + +  ++   E       RE  LL  L+H++IVR   V +  + + +
Sbjct: 38  ECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 97
Query: 84  VFEYL-DLDLHSFITRHKNTLNLLV--------------IKAILKQILLGLAYCHSLKIL 128
           VFEY+   DL+ F+  H     LL               + A+  Q+  G+ Y   L  +
Sbjct: 98  VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFV 157
Query: 129 HRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ--KEYSRDCVYSPYKAPELLLGYTGYS 186
           HRDL   N L+  +   VK+ DFG++R I      +   R  +   +  PE +L Y  ++
Sbjct: 158 HRDLATRNCLVG-QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL-YRKFT 215
Query: 187 TPIDVWAVGCIFAEMIT 203
           T  DVW+ G +  E+ T
Sbjct: 216 TESDVWSFGVVLWEIFT 232

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 40/95 (42%), Positives = 57/95 (60%), Gaps = 5/95 (5%)
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           QI+L   Y HSL +++RDLKP NLLID ++  +K+ADFG A+ +   +      C    Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIKVADFGFAKRV---KGRTWXLCGTPEY 204
Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
            APE++L   GY+  +D WA+G +  EM  G P F
Sbjct: 205 LAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 40/95 (42%), Positives = 57/95 (60%), Gaps = 5/95 (5%)
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           QI+L   Y HSL +++RDLKP NLLID ++  +K+ADFG A+ +   +      C    Y
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIKVADFGFAKRV---KGRTWXLCGTPEY 205
Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
            APE++L   GY+  +D WA+G +  EM  G P F
Sbjct: 206 LAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 91/183 (49%), Gaps = 13/183 (7%)
Query: 30  VTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD 89
           V   KV  K M ++  Q+     +  E+++ K L++ ++V           V++V E   
Sbjct: 69  VFAGKVVPKSMLLKPHQK---EKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICR 125
Query: 90  ----LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNT 145
               L+LH    + +  +     +  ++Q + G+ Y H+ +++HRDLK  NL ++   + 
Sbjct: 126 RRSLLELH----KRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMD- 180
Query: 146 VKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGK 205
           VK+ DFGLA  I    +     C    Y APE+L    G+S  +D+W++GCI   ++ GK
Sbjct: 181 VKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCK-KGHSFEVDIWSLGCILYTLLVGK 239
Query: 206 PLF 208
           P F
Sbjct: 240 PPF 242

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 91/183 (49%), Gaps = 13/183 (7%)
Query: 30  VTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD 89
           V   KV  K M ++  Q+     +  E+++ K L++ ++V           V++V E   
Sbjct: 69  VFAGKVVPKSMLLKPHQK---EKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICR 125
Query: 90  ----LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNT 145
               L+LH    + +  +     +  ++Q + G+ Y H+ +++HRDLK  NL ++   + 
Sbjct: 126 RRSLLELH----KRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMD- 180
Query: 146 VKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGK 205
           VK+ DFGLA  I    +     C    Y APE+L    G+S  +D+W++GCI   ++ GK
Sbjct: 181 VKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCK-KGHSFEVDIWSLGCILYTLLVGK 239
Query: 206 PLF 208
           P F
Sbjct: 240 PPF 242

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 133/294 (45%), Gaps = 44/294 (14%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           EV+K  +  T Q VAIK++ ++  ++     I +E+++L + +   + +          +
Sbjct: 38  EVFKGIDNRTQQVVAIKIIDLEEAED-EIEDIQQEITVLSQCDSSYVTKYYGSYLKGSKL 96
Query: 82  FLVFEYLD----LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
           +++ EYL     LDL           +   I  +LK+IL GL Y HS K +HRD+K  N+
Sbjct: 97  WIIMEYLGGGSALDL-----LRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANV 151
Query: 138 LIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCI 197
           L+  ++  VKLADFG+A  +   Q + +       + APE++   + Y +  D+W++G  
Sbjct: 152 LLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQ-QSAYDSKADIWSLGIT 209
Query: 198 FAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFP 257
             E+  G+P  P+     + ++F                      L P   P  L   F 
Sbjct: 210 AIELAKGEP--PNSDMHPMRVLF----------------------LIPKNNPPTLVGDFT 245
Query: 258 NLEPAGVDLLSQMLCLN--PKQRITAMDALKHEYLI-GVENVPLVILLINRKKK 308
                 +D      CLN  P  R TA + LKH++++   +    +  LI+R K+
Sbjct: 246 KSFKEFID-----ACLNKDPSFRPTAKELLKHKFIVKNSKKTSYLTELIDRFKR 294

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 130/277 (46%), Gaps = 35/277 (12%)
Query: 33  QKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD--- 89
           +KVAIK + ++  Q  +   +++E+  + +  H NIV        + +++LV + L    
Sbjct: 41  EKVAIKRINLEKCQTSMDE-LLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGS 99
Query: 90  -LDLHSFIT---RHKN-TLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN 144
            LD+   I     HK+  L+   I  IL+++L GL Y H    +HRD+K  N+L+  +  
Sbjct: 100 VLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLG-EDG 158
Query: 145 TVKLADFG----LARAIGVPQKEYSRDCVYSP-YKAPELLLGYTGYSTPIDVWAVGCIFA 199
           +V++ADFG    LA    + + +  +  V +P + APE++    GY    D+W+ G    
Sbjct: 159 SVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAI 218
Query: 200 EMITGKPLFPSKKHDHLS-LIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPN 258
           E+ TG    P  K+  +  L+ +L   P   S        E+L  Y         + F  
Sbjct: 219 ELATGAA--PYHKYPPMKVLMLTLQNDPP--SLETGVQDKEMLKKY--------GKSFRK 266
Query: 259 LEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVEN 295
                  ++S  L  +P++R TA + L+H++    +N
Sbjct: 267 -------MISLCLQKDPEKRPTAAELLRHKFFQKAKN 296

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 106/227 (46%), Gaps = 15/227 (6%)
Query: 30  VTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD 89
           V   KV  K M ++  Q+     +  E+++ K L++ ++V           V++V E   
Sbjct: 53  VFAGKVVPKSMLLKPHQK---EKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICR 109
Query: 90  ----LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNT 145
               L+LH    + +  +     +  ++Q + G+ Y H+ +++HRDLK  NL ++   + 
Sbjct: 110 RRSLLELH----KRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMD- 164
Query: 146 VKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGK 205
           VK+ DFGLA  I    +     C    Y APE+L    G+S  +D+W++GCI   ++ GK
Sbjct: 165 VKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCK-KGHSFEVDIWSLGCILYTLLVGK 223
Query: 206 PLFPSK--KHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPA 250
           P F +   K  ++ +  +    P   +   S  I  +L   P   P+
Sbjct: 224 PPFETSCLKETYIRIKKNEYSVPRHINPVASALIRRMLHADPTLRPS 270

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 91/183 (49%), Gaps = 13/183 (7%)
Query: 30  VTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD 89
           V   KV  K M ++  Q+     +  E+++ K L++ ++V           V++V E   
Sbjct: 69  VFAGKVVPKSMLLKPHQK---EKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICR 125
Query: 90  ----LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNT 145
               L+LH    + +  +     +  ++Q + G+ Y H+ +++HRDLK  NL ++   + 
Sbjct: 126 RRSLLELH----KRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMD- 180
Query: 146 VKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGK 205
           VK+ DFGLA  I    +     C    Y APE+L    G+S  +D+W++GCI   ++ GK
Sbjct: 181 VKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCK-KGHSFEVDIWSLGCILYTLLVGK 239
Query: 206 PLF 208
           P F
Sbjct: 240 PPF 242

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 95/193 (49%), Gaps = 7/193 (3%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           EV+  R       VA+K    +T    + +  ++E  +LK+  H NIVRL+ V + ++ +
Sbjct: 129 EVFSGRLRADNTLVAVKSCR-ETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI 187
Query: 82  FLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLID 140
           ++V E +   D  +F+      L +  +  ++     G+ Y  S   +HRDL   N L+ 
Sbjct: 188 YIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVT 247
Query: 141 LKRNTVKLADFGLAR--AIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIF 198
            ++N +K++DFG++R  A GV         V   + APE  L Y  YS+  DVW+ G + 
Sbjct: 248 -EKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPE-ALNYGRYSSESDVWSFGILL 305
Query: 199 AEMIT-GKPLFPS 210
            E  + G   +P+
Sbjct: 306 WETFSLGASPYPN 318

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 96/185 (51%), Gaps = 10/185 (5%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           VY+ R       VAIK++   TE+      ++RE  ++ +L++  IVRL+ V  + + + 
Sbjct: 30  VYRMRKKQI--DVAIKVLKQGTEKADTEE-MMREAQIMHQLDNPYIVRLIGVCQA-EALM 85
Query: 83  LVFEYLDLD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           LV E      LH F+   +  + +  +  +L Q+ +G+ Y      +HRDL   N+L+ +
Sbjct: 86  LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL-V 144
Query: 142 KRNTVKLADFGLARAIGVPQKEY-SRDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIF 198
            R+  K++DFGL++A+G     Y +R     P K  APE  + +  +S+  DVW+ G   
Sbjct: 145 NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE-CINFRKFSSRSDVWSYGVTM 203
Query: 199 AEMIT 203
            E ++
Sbjct: 204 WEALS 208

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 126/277 (45%), Gaps = 27/277 (9%)
Query: 31  TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-HENIVRLLDVQSSRKDVFLVFEYLD 89
            G++ A+K++  Q       S + REV  L + + ++NI+ L++        +LVFE L 
Sbjct: 37  NGKEYAVKIIEKQAGHS--RSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQ 94
Query: 90  L-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL--KRNTV 146
              + + I + K+  N      +++ +   L + H+  I HRDLKP N+L +   K + V
Sbjct: 95  GGSILAHIQKQKH-FNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPV 153
Query: 147 KLADFGLARAIG-------VPQKEYSRDCVYSPYKAPELLLGYTG----YSTPIDVWAVG 195
           K+ DF L   +        +   E +  C  + Y APE++  +T     Y    D+W++G
Sbjct: 154 KICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLG 213
Query: 196 CIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEK 255
            +   M++G P F              +         ES  I E    +P  + A+++ +
Sbjct: 214 VVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES--IQEGKYEFPDKDWAHISSE 271
Query: 256 FPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIG 292
                    DL+S++L  + KQR++A   L+H ++ G
Sbjct: 272 -------AKDLISKLLVRDAKQRLSAAQVLQHPWVQG 301

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 101/190 (53%), Gaps = 12/190 (6%)
Query: 22  EVYKCRNTVTGQK---VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR 78
           EV   R  + G++   VAIK + +   ++    ++  E S++ + +H NI+ L  V +  
Sbjct: 37  EVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPNIIHLEGVVTKS 95
Query: 79  KDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
           K V +V EY++   L +F+ ++     ++ +  +L+ I  G+ Y   +  +HRDL   N+
Sbjct: 96  KPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGYVHRDLAARNI 155
Query: 138 LIDLKRNTV-KLADFGLARAI-GVPQKEYSRDCVYSP--YKAPELLLGYTGYSTPIDVWA 193
           LI+   N V K++DFGL+R +   P+  Y+      P  + APE  + +  +++  DVW+
Sbjct: 156 LIN--SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE-AIAFRKFTSASDVWS 212
Query: 194 VGCIFAEMIT 203
            G +  E+++
Sbjct: 213 YGIVMWEVVS 222

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 88/170 (51%), Gaps = 5/170 (2%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYL-DLDLH 93
           VAIKM+   +  E      I E  ++  L HE +V+L  V + ++ +F++ EY+ +  L 
Sbjct: 36  VAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 92
Query: 94  SFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGL 153
           +++   ++      +  + K +   + Y  S + LHRDL   N L++  +  VK++DFGL
Sbjct: 93  NYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN-DQGVVKVSDFGL 151
Query: 154 ARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           +R +   +   SR   +    +P  +L Y+ +S+  D+WA G +  E+ +
Sbjct: 152 SRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 92/196 (46%), Gaps = 30/196 (15%)
Query: 26  CRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHE----------NIVRLLDVQ 75
            ++  TG   A+K++  Q            +V  LKE+EH           N   L+ ++
Sbjct: 60  VKHMETGNHYAMKILDKQ------------KVVKLKEIEHTLNEKRILQAVNFPFLVKLE 107
Query: 76  SSRKD---VFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDL 132
            S KD   +++V EY          R     +    +    QI+L   Y HSL +++RDL
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 133 KPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVW 192
           KP NL+ID ++  +K+ DFGLA+ +   +      C    Y APE++L   GY+  +D W
Sbjct: 168 KPENLMID-QQGYIKVTDFGLAKRV---KGRTWXLCGTPEYLAPEIILS-KGYNKAVDWW 222
Query: 193 AVGCIFAEMITGKPLF 208
           A+G +  EM  G P F
Sbjct: 223 ALGVLIYEMAAGYPPF 238

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 94/195 (48%), Gaps = 29/195 (14%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DLH 93
           VA+KM+  +   + + +   RE +L+ E ++ NIV+LL V +  K + L+FEY+   DL+
Sbjct: 80  VAVKMLKEEASAD-MQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLN 138
Query: 94  SFI-----------------TRHKNT------LNLLVIKAILKQILLGLAYCHSLKILHR 130
            F+                 TR + +      L+      I +Q+  G+AY    K +HR
Sbjct: 139 EFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 198
Query: 131 DLKPNNLLIDLKRNTVKLADFGLARAIGVPQ--KEYSRDCVYSPYKAPELLLGYTGYSTP 188
           DL   N L+  +   VK+ADFGL+R I      K    D +   +  PE +  Y  Y+T 
Sbjct: 199 DLATRNCLVG-ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF-YNRYTTE 256
Query: 189 IDVWAVGCIFAEMIT 203
            DVWA G +  E+ +
Sbjct: 257 SDVWAYGVVLWEIFS 271

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 103/202 (50%), Gaps = 14/202 (6%)
Query: 26  CRNTVTGQKVAIKMMTIQ--TEQEGVPSYIIREVSLLKELEHENIVRL-LDVQSSRKDVF 82
            R   T ++ AIK++  +   ++  VP Y+ RE  ++  L+H   V+L    Q   K  F
Sbjct: 51  ARELATSREYAIKILEKRHIIKENKVP-YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109
Query: 83  LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK 142
            +    + +L  +I R   + +    +    +I+  L Y H   I+HRDLKP N+L++  
Sbjct: 110 GLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 168
Query: 143 RNTVKLADFGLARAIGVPQKEYSRDCVY---SPYKAPELLLGYTGYSTPIDVWAVGCIFA 199
            + +++ DFG A+ +  P+ + +R   +   + Y +PELL   +   +  D+WA+GCI  
Sbjct: 169 MH-IQITDFGTAKVLS-PESKQARANXFVGTAQYVSPELLTEKSAXKSS-DLWALGCIIY 225
Query: 200 EMITGKPLFPSKKHDHLSLIFS 221
           +++ G P F   +  +  LIF+
Sbjct: 226 QLVAGLPPF---RAGNEGLIFA 244

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 128/272 (47%), Gaps = 35/272 (12%)
Query: 33  QKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD--- 89
           +KVAIK + ++  Q  +   +++E+  + +  H NIV        + +++LV + L    
Sbjct: 36  EKVAIKRINLEKCQTSMDE-LLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGS 94
Query: 90  -LDLHSFIT---RHKN-TLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN 144
            LD+   I     HK+  L+   I  IL+++L GL Y H    +HRD+K  N+L+  +  
Sbjct: 95  VLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLG-EDG 153
Query: 145 TVKLADFG----LARAIGVPQKEYSRDCVYSP-YKAPELLLGYTGYSTPIDVWAVGCIFA 199
           +V++ADFG    LA    + + +  +  V +P + APE++    GY    D+W+ G    
Sbjct: 154 SVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAI 213
Query: 200 EMITGKPLFPSKKHDHLS-LIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPN 258
           E+ TG    P  K+  +  L+ +L   P   S        E+L  Y         + F  
Sbjct: 214 ELATGAA--PYHKYPPMKVLMLTLQNDPP--SLETGVQDKEMLKKY--------GKSFRK 261
Query: 259 LEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                  ++S  L  +P++R TA + L+H++ 
Sbjct: 262 -------MISLCLQKDPEKRPTAAELLRHKFF 286

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 97/189 (51%), Gaps = 11/189 (5%)
Query: 26  CRNTVTGQKVAIKMMTIQ--TEQEGVPSYIIREVSLLKELEHENIVRL-LDVQSSRKDVF 82
            R   T ++ AIK++  +   ++  VP Y+ RE  ++  L+H   V+L    Q   K  F
Sbjct: 49  ARELATSREYAIKILEKRHIIKENKVP-YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 107
Query: 83  LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK 142
            +    + +L  +I R   + +    +    +I+  L Y H   I+HRDLKP N+L++  
Sbjct: 108 GLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 166
Query: 143 RNTVKLADFGLARAIGVPQKEYSRDCVY---SPYKAPELLLGYTGYSTPIDVWAVGCIFA 199
            + +++ DFG A+ +  P+ + +R   +   + Y +PELL   +   +  D+WA+GCI  
Sbjct: 167 MH-IQITDFGTAKVLS-PESKQARANAFVGTAQYVSPELLTEKSACKSS-DLWALGCIIY 223
Query: 200 EMITGKPLF 208
           +++ G P F
Sbjct: 224 QLVAGLPPF 232

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 97/196 (49%), Gaps = 23/196 (11%)
Query: 31  TGQKVAIKMMTIQTEQEGVPSYIIR---EVSLLKELEHENIVRLLDVQSSRKDV------ 81
           TG++VAIK    Q  QE  P    R   E+ ++K+L H N+V   +V    + +      
Sbjct: 39  TGEQVAIK----QCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 94
Query: 82  FLVFEYLDL-DLHSFITRHKNTLNLLV--IKAILKQILLGLAYCHSLKILHRDLKPNNLL 138
            L  EY +  DL  ++ + +N   L    I+ +L  I   L Y H  +I+HRDLKP N++
Sbjct: 95  LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIV 154
Query: 139 ID--LKRNTVKLADFGLARAIGVPQKEYSRDCVYS-PYKAPELLLGYTGYSTPIDVWAVG 195
           +    +R   K+ D G A+ +   Q E   + V +  Y APE LL    Y+  +D W+ G
Sbjct: 155 LQPGPQRLIHKIIDLGYAKELD--QGELCTEFVGTLQYLAPE-LLEQKKYTVTVDYWSFG 211
Query: 196 CIFAEMITG-KPLFPS 210
            +  E ITG +P  P+
Sbjct: 212 TLAFECITGFRPFLPN 227

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/175 (32%), Positives = 97/175 (55%), Gaps = 8/175 (4%)
Query: 56  EVSLLKELEHENIVRLLDVQSSRKDVFLVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQ 114
           E  +L E+ H  IV+L     +   ++L+ ++L   DL + +++ +       +K  L +
Sbjct: 77  ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAE 135
Query: 115 ILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLAR-AIGVPQKEYSRDCVYSPY 173
           + L L + HSL I++RDLKP N+L+D +   +KL DFGL++ +I   +K YS  C    Y
Sbjct: 136 LALALDHLHSLGIIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSF-CGTVEY 193
Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSK-KHDHLSLIF-SLLGTP 226
            APE ++   G++   D W+ G +  EM+TG   F  K + + +++I  + LG P
Sbjct: 194 MAPE-VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 247

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 82/169 (48%), Gaps = 22/169 (13%)
Query: 56  EVSLLKELEH--ENIVRLLDVQSSRKDVFLVFEYLD--LDLHSFITRHKNTLNLLVIKAI 111
           EV LLK++      ++RLLD         L+ E ++   DL  FIT  +  L   + ++ 
Sbjct: 61  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITE-RGALQEELARSF 119
Query: 112 LKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS 171
             Q+L  + +CH+  +LHRD+K  N+LIDL R  +KL DFG    +        +D VY+
Sbjct: 120 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--------KDTVYT 171
Query: 172 P------YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD 214
                  Y  PE +  +  +     VW++G +  +M+ G   F   +HD
Sbjct: 172 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHD 217

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 95/190 (50%), Gaps = 12/190 (6%)
Query: 22  EVYKCRNTVTGQK---VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR 78
           EV   R  V GQ+   VAIK +     +     ++  E S++ + +H NI+RL  V +  
Sbjct: 64  EVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFL-SEASIMGQFDHPNIIRLEGVVTRG 122
Query: 79  KDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
           +   +V EY++   L +F+  H     ++ +  +L+ +  G+ Y   L  +HRDL   N+
Sbjct: 123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNV 182
Query: 138 LIDLKRNTV-KLADFGLARAI-GVPQKEYSRDCVYSP--YKAPELLLGYTGYSTPIDVWA 193
           L+D   N V K++DFGL+R +   P    +      P  + APE  + +  +S+  DVW+
Sbjct: 183 LVD--SNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPE-AIAFRTFSSASDVWS 239
Query: 194 VGCIFAEMIT 203
            G +  E++ 
Sbjct: 240 FGVVMWEVLA 249

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 92/188 (48%), Gaps = 9/188 (4%)
Query: 26  CRNTVTGQKVAIKMMTIQ--TEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL 83
            R   T ++ AIK++  +   ++  VP Y+ RE  ++  L+H   V+L       + ++ 
Sbjct: 51  ARELATSREYAIKILEKRHIIKENKVP-YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109
Query: 84  VFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKR 143
              Y          R   + +    +    +I+  L Y H   I+HRDLKP N+L++   
Sbjct: 110 GLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM 169
Query: 144 NTVKLADFGLARAIGVPQKEYSRDCVY---SPYKAPELLLGYTGYSTPIDVWAVGCIFAE 200
           + +++ DFG A+ +  P+ + +R   +   + Y +PELL   +  S   D+WA+GCI  +
Sbjct: 170 H-IQITDFGTAKVLS-PESKQARANSFVGTAQYVSPELLTEKSA-SKSSDLWALGCIIYQ 226
Query: 201 MITGKPLF 208
           ++ G P F
Sbjct: 227 LVAGLPPF 234

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/175 (32%), Positives = 97/175 (55%), Gaps = 8/175 (4%)
Query: 56  EVSLLKELEHENIVRLLDVQSSRKDVFLVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQ 114
           E  +L E+ H  IV+L     +   ++L+ ++L   DL + +++ +       +K  L +
Sbjct: 76  ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAE 134
Query: 115 ILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLAR-AIGVPQKEYSRDCVYSPY 173
           + L L + HSL I++RDLKP N+L+D +   +KL DFGL++ +I   +K YS  C    Y
Sbjct: 135 LALALDHLHSLGIIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSF-CGTVEY 192
Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSK-KHDHLSLIF-SLLGTP 226
            APE ++   G++   D W+ G +  EM+TG   F  K + + +++I  + LG P
Sbjct: 193 MAPE-VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 246

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/175 (32%), Positives = 97/175 (55%), Gaps = 8/175 (4%)
Query: 56  EVSLLKELEHENIVRLLDVQSSRKDVFLVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQ 114
           E  +L E+ H  IV+L     +   ++L+ ++L   DL + +++ +       +K  L +
Sbjct: 76  ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAE 134
Query: 115 ILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLAR-AIGVPQKEYSRDCVYSPY 173
           + L L + HSL I++RDLKP N+L+D +   +KL DFGL++ +I   +K YS  C    Y
Sbjct: 135 LALALDHLHSLGIIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSF-CGTVEY 192
Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSK-KHDHLSLIF-SLLGTP 226
            APE ++   G++   D W+ G +  EM+TG   F  K + + +++I  + LG P
Sbjct: 193 MAPE-VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 246

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 130/289 (44%), Gaps = 30/289 (10%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           V+K  +  +G  +A K++ ++  +  + + IIRE+ +L E     IV       S  ++ 
Sbjct: 22  VFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80
Query: 83  LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSL-KILHRDLKPNNLLIDL 141
           +  E++D      + +    +   ++  +   ++ GL Y     KI+HRD+KP+N+L++ 
Sbjct: 81  ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN- 139
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
            R  +KL DFG++  + +     S     S Y +PE L G T YS   D+W++G    EM
Sbjct: 140 SRGEIKLCDFGVSGQL-IDSMANSFVGTRS-YMSPERLQG-THYSVQSDIWSMGLSLVEM 196
Query: 202 ITGKPLFPSKKHDHLSLIFSLLGTPTDESWAE------------STYISEILPLYPHFEP 249
             G+   P      L L+F   G   +   AE            S+Y  +  P    FE 
Sbjct: 197 AVGRYPIPPPDAKELELMF---GCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFEL 253
Query: 250 AN--LAEKFPNLEPAGV------DLLSQMLCLNPKQRITAMDALKHEYL 290
            +  + E  P L P+GV      D +++ L  NP +R      + H ++
Sbjct: 254 LDYIVNEPPPKL-PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 130/289 (44%), Gaps = 30/289 (10%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           V+K  +  +G  +A K++ ++  +  + + IIRE+ +L E     IV       S  ++ 
Sbjct: 22  VFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80
Query: 83  LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSL-KILHRDLKPNNLLIDL 141
           +  E++D      + +    +   ++  +   ++ GL Y     KI+HRD+KP+N+L++ 
Sbjct: 81  ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN- 139
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
            R  +KL DFG++  + +     S     S Y +PE L G T YS   D+W++G    EM
Sbjct: 140 SRGEIKLCDFGVSGQL-IDSMANSFVGTRS-YMSPERLQG-THYSVQSDIWSMGLSLVEM 196
Query: 202 ITGKPLFPSKKHDHLSLIFSLLGTPTDESWAE------------STYISEILPLYPHFEP 249
             G+   P      L L+F   G   +   AE            S+Y  +  P    FE 
Sbjct: 197 AVGRYPIPPPDAKELELMF---GCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFEL 253
Query: 250 AN--LAEKFPNLEPAGV------DLLSQMLCLNPKQRITAMDALKHEYL 290
            +  + E  P L P+GV      D +++ L  NP +R      + H ++
Sbjct: 254 LDYIVNEPPPKL-PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 97/189 (51%), Gaps = 11/189 (5%)
Query: 26  CRNTVTGQKVAIKMMTIQ--TEQEGVPSYIIREVSLLKELEHENIVRL-LDVQSSRKDVF 82
            R   T ++ AIK++  +   ++  VP Y+ RE  ++  L+H   V+L    Q   K  F
Sbjct: 49  ARELATSREYAIKILEKRHIIKENKVP-YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 107
Query: 83  LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK 142
            +    + +L  +I R   + +    +    +I+  L Y H   I+HRDLKP N+L++  
Sbjct: 108 GLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 166
Query: 143 RNTVKLADFGLARAIGVPQKEYSRDCVY---SPYKAPELLLGYTGYSTPIDVWAVGCIFA 199
            + +++ DFG A+ +  P+ + +R   +   + Y +PELL   +   +  D+WA+GCI  
Sbjct: 167 MH-IQITDFGTAKVLS-PESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIY 223
Query: 200 EMITGKPLF 208
           +++ G P F
Sbjct: 224 QLVAGLPPF 232

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 97/189 (51%), Gaps = 11/189 (5%)
Query: 26  CRNTVTGQKVAIKMMTIQ--TEQEGVPSYIIREVSLLKELEHENIVRL-LDVQSSRKDVF 82
            R   T ++ AIK++  +   ++  VP Y+ RE  ++  L+H   V+L    Q   K  F
Sbjct: 52  ARELATSREYAIKILEKRHIIKENKVP-YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 110
Query: 83  LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK 142
            +    + +L  +I R   + +    +    +I+  L Y H   I+HRDLKP N+L++  
Sbjct: 111 GLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 169
Query: 143 RNTVKLADFGLARAIGVPQKEYSRDCVY---SPYKAPELLLGYTGYSTPIDVWAVGCIFA 199
            + +++ DFG A+ +  P+ + +R   +   + Y +PELL   +   +  D+WA+GCI  
Sbjct: 170 MH-IQITDFGTAKVLS-PESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIY 226
Query: 200 EMITGKPLF 208
           +++ G P F
Sbjct: 227 QLVAGLPPF 235

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 97/189 (51%), Gaps = 11/189 (5%)
Query: 26  CRNTVTGQKVAIKMMTIQ--TEQEGVPSYIIREVSLLKELEHENIVRL-LDVQSSRKDVF 82
            R   T ++ AIK++  +   ++  VP Y+ RE  ++  L+H   V+L    Q   K  F
Sbjct: 51  ARELATSREYAIKILEKRHIIKENKVP-YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109
Query: 83  LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK 142
            +    + +L  +I R   + +    +    +I+  L Y H   I+HRDLKP N+L++  
Sbjct: 110 GLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 168
Query: 143 RNTVKLADFGLARAIGVPQKEYSRDCVY---SPYKAPELLLGYTGYSTPIDVWAVGCIFA 199
            + +++ DFG A+ +  P+ + +R   +   + Y +PELL   +   +  D+WA+GCI  
Sbjct: 169 MH-IQITDFGTAKVLS-PESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIY 225
Query: 200 EMITGKPLF 208
           +++ G P F
Sbjct: 226 QLVAGLPPF 234

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 14/206 (6%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIR---EVSLLKELEHENIVRLLDVQSSR 78
           EV+  R+    + VA+K++     ++  PS+ +R   E      L H  IV + D   + 
Sbjct: 27  EVHLARDLRDHRDVAVKVLRADLARD--PSFYLRFRREAQNAAALNHPAIVAVYDTGEAE 84
Query: 79  KDV----FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKP 134
                  ++V EY+D      I   +  +       ++      L + H   I+HRD+KP
Sbjct: 85  TPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKP 144
Query: 135 NNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVY---SPYKAPELLLGYTGYSTPIDV 191
            N++I    N VK+ DFG+ARAI       ++       + Y +PE   G +      DV
Sbjct: 145 ANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDV 202
Query: 192 WAVGCIFAEMITGKPLFPSKKHDHLS 217
           +++GC+  E++TG+P F     D ++
Sbjct: 203 YSLGCVLYEVLTGEPPFTGDSPDSVA 228

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 97/196 (49%), Gaps = 23/196 (11%)
Query: 31  TGQKVAIKMMTIQTEQEGVPSYIIR---EVSLLKELEHENIVRLLDVQSSRKDV------ 81
           TG++VAIK    Q  QE  P    R   E+ ++K+L H N+V   +V    + +      
Sbjct: 38  TGEQVAIK----QCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93
Query: 82  FLVFEYLDL-DLHSFITRHKNTLNLLV--IKAILKQILLGLAYCHSLKILHRDLKPNNLL 138
            L  EY +  DL  ++ + +N   L    I+ +L  I   L Y H  +I+HRDLKP N++
Sbjct: 94  LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIV 153
Query: 139 ID--LKRNTVKLADFGLARAIGVPQKEYSRDCVYS-PYKAPELLLGYTGYSTPIDVWAVG 195
           +    +R   K+ D G A+ +   Q E   + V +  Y APE LL    Y+  +D W+ G
Sbjct: 154 LQPGPQRLIHKIIDLGYAKELD--QGELCTEFVGTLQYLAPE-LLEQKKYTVTVDYWSFG 210
Query: 196 CIFAEMITG-KPLFPS 210
            +  E ITG +P  P+
Sbjct: 211 TLAFECITGFRPFLPN 226

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 130/289 (44%), Gaps = 30/289 (10%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           V+K  +  +G  +A K++ ++  +  + + IIRE+ +L E     IV       S  ++ 
Sbjct: 22  VFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80
Query: 83  LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSL-KILHRDLKPNNLLIDL 141
           +  E++D      + +    +   ++  +   ++ GL Y     KI+HRD+KP+N+L++ 
Sbjct: 81  ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN- 139
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
            R  +KL DFG++  + +     S     S Y +PE L G T YS   D+W++G    EM
Sbjct: 140 SRGEIKLCDFGVSGQL-IDSMANSFVGTRS-YMSPERLQG-THYSVQSDIWSMGLSLVEM 196
Query: 202 ITGKPLFPSKKHDHLSLIFSLLGTPTDESWAE------------STYISEILPLYPHFEP 249
             G+   P      L L+F   G   +   AE            S+Y  +  P    FE 
Sbjct: 197 AVGRYPIPPPDAKELELMF---GCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFEL 253
Query: 250 AN--LAEKFPNLEPAGV------DLLSQMLCLNPKQRITAMDALKHEYL 290
            +  + E  P L P+GV      D +++ L  NP +R      + H ++
Sbjct: 254 LDYIVNEPPPKL-PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 103/202 (50%), Gaps = 14/202 (6%)
Query: 26  CRNTVTGQKVAIKMMTIQ--TEQEGVPSYIIREVSLLKELEHENIVRL-LDVQSSRKDVF 82
            R   T ++ AIK++  +   ++  VP Y+ RE  ++  L+H   V+L    Q   K  F
Sbjct: 51  ARELATSREYAIKILEKRHIIKENKVP-YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109
Query: 83  LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK 142
            +    + +L  +I R   + +    +    +I+  L Y H   I+HRDLKP N+L++  
Sbjct: 110 GLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 168
Query: 143 RNTVKLADFGLARAIGVPQKEYSRDCVY---SPYKAPELLLGYTGYSTPIDVWAVGCIFA 199
            + +++ DFG A+ +  P+ + +R   +   + Y +PELL   +   +  D+WA+GCI  
Sbjct: 169 MH-IQITDFGTAKVLS-PESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIY 225
Query: 200 EMITGKPLFPSKKHDHLSLIFS 221
           +++ G P F   +  +  LIF+
Sbjct: 226 QLVAGLPPF---RAGNEGLIFA 244

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 97/189 (51%), Gaps = 11/189 (5%)
Query: 26  CRNTVTGQKVAIKMMTIQ--TEQEGVPSYIIREVSLLKELEHENIVRL-LDVQSSRKDVF 82
            R   T ++ AIK++  +   ++  VP Y+ RE  ++  L+H   V+L    Q   K  F
Sbjct: 51  ARELATSREYAIKILEKRHIIKENKVP-YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109
Query: 83  LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK 142
            +    + +L  +I R   + +    +    +I+  L Y H   I+HRDLKP N+L++  
Sbjct: 110 GLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 168
Query: 143 RNTVKLADFGLARAIGVPQKEYSRDCVY---SPYKAPELLLGYTGYSTPIDVWAVGCIFA 199
            + +++ DFG A+ +  P+ + +R   +   + Y +PELL   +   +  D+WA+GCI  
Sbjct: 169 MH-IQITDFGTAKVLS-PESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIY 225
Query: 200 EMITGKPLF 208
           +++ G P F
Sbjct: 226 QLVAGLPPF 234

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 97/189 (51%), Gaps = 11/189 (5%)
Query: 26  CRNTVTGQKVAIKMMTIQ--TEQEGVPSYIIREVSLLKELEHENIVRL-LDVQSSRKDVF 82
            R   T ++ AIK++  +   ++  VP Y+ RE  ++  L+H   V+L    Q   K  F
Sbjct: 49  ARELATSREYAIKILEKRHIIKENKVP-YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 107
Query: 83  LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK 142
            +    + +L  +I R   + +    +    +I+  L Y H   I+HRDLKP N+L++  
Sbjct: 108 GLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 166
Query: 143 RNTVKLADFGLARAIGVPQKEYSRDCVY---SPYKAPELLLGYTGYSTPIDVWAVGCIFA 199
            + +++ DFG A+ +  P+ + +R   +   + Y +PELL   +   +  D+WA+GCI  
Sbjct: 167 MH-IQITDFGTAKVLS-PESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIY 223
Query: 200 EMITGKPLF 208
           +++ G P F
Sbjct: 224 QLVAGLPPF 232

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 97/189 (51%), Gaps = 11/189 (5%)
Query: 26  CRNTVTGQKVAIKMMTIQ--TEQEGVPSYIIREVSLLKELEHENIVRL-LDVQSSRKDVF 82
            R   T ++ AIK++  +   ++  VP Y+ RE  ++  L+H   V+L    Q   K  F
Sbjct: 51  ARELATSREYAIKILEKRHIIKENKVP-YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109
Query: 83  LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK 142
            +    + +L  +I R   + +    +    +I+  L Y H   I+HRDLKP N+L++  
Sbjct: 110 GLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 168
Query: 143 RNTVKLADFGLARAIGVPQKEYSRDCVY---SPYKAPELLLGYTGYSTPIDVWAVGCIFA 199
            + +++ DFG A+ +  P+ + +R   +   + Y +PELL   +   +  D+WA+GCI  
Sbjct: 169 MH-IQITDFGTAKVLS-PESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIY 225
Query: 200 EMITGKPLF 208
           +++ G P F
Sbjct: 226 QLVAGLPPF 234

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 97/189 (51%), Gaps = 11/189 (5%)
Query: 26  CRNTVTGQKVAIKMMTIQ--TEQEGVPSYIIREVSLLKELEHENIVRL-LDVQSSRKDVF 82
            R   T ++ AIK++  +   ++  VP Y+ RE  ++  L+H   V+L    Q   K  F
Sbjct: 54  ARELATSREYAIKILEKRHIIKENKVP-YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 112
Query: 83  LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK 142
            +    + +L  +I R   + +    +    +I+  L Y H   I+HRDLKP N+L++  
Sbjct: 113 GLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 171
Query: 143 RNTVKLADFGLARAIGVPQKEYSRDCVY---SPYKAPELLLGYTGYSTPIDVWAVGCIFA 199
            + +++ DFG A+ +  P+ + +R   +   + Y +PELL   +   +  D+WA+GCI  
Sbjct: 172 MH-IQITDFGTAKVLS-PESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIY 228
Query: 200 EMITGKPLF 208
           +++ G P F
Sbjct: 229 QLVAGLPPF 237

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 97/189 (51%), Gaps = 11/189 (5%)
Query: 26  CRNTVTGQKVAIKMMTIQ--TEQEGVPSYIIREVSLLKELEHENIVRL-LDVQSSRKDVF 82
            R   T ++ AIK++  +   ++  VP Y+ RE  ++  L+H   V+L    Q   K  F
Sbjct: 49  ARELATSREYAIKILEKRHIIKENKVP-YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 107
Query: 83  LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK 142
            +    + +L  +I R   + +    +    +I+  L Y H   I+HRDLKP N+L++  
Sbjct: 108 GLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 166
Query: 143 RNTVKLADFGLARAIGVPQKEYSRDCVY---SPYKAPELLLGYTGYSTPIDVWAVGCIFA 199
            + +++ DFG A+ +  P+ + +R   +   + Y +PELL   +   +  D+WA+GCI  
Sbjct: 167 MH-IQITDFGTAKVLS-PESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIY 223
Query: 200 EMITGKPLF 208
           +++ G P F
Sbjct: 224 QLVAGLPPF 232

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/185 (31%), Positives = 100/185 (54%), Gaps = 18/185 (9%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD---- 89
           KVA+K +    +    P   + E +L+K+L+H+ +VRL  V  +++ ++++ EY++    
Sbjct: 45  KVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAV-VTQEPIYIITEYMENGSL 100
Query: 90  LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLA 149
           +D     +  K T+N L+  A   QI  G+A+      +HRDL+  N+L+     + K+A
Sbjct: 101 VDFLKTPSGIKLTINKLLDMA--AQIAEGMAFIEERNYIHRDLRAANILVS-DTLSCKIA 157
Query: 150 DFGLARAIGVPQKEYS-RDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT-GK 205
           DFGLAR I     EY+ R+    P K  APE  + Y  ++   DVW+ G +  E++T G+
Sbjct: 158 DFGLARLI--EDNEYTAREGAKFPIKWTAPE-AINYGTFTIKSDVWSFGILLTEIVTHGR 214
Query: 206 PLFPS 210
             +P 
Sbjct: 215 IPYPG 219

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 130/289 (44%), Gaps = 30/289 (10%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           V+K  +  +G  +A K++ ++  +  + + IIRE+ +L E     IV       S  ++ 
Sbjct: 22  VFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80
Query: 83  LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSL-KILHRDLKPNNLLIDL 141
           +  E++D      + +    +   ++  +   ++ GL Y     KI+HRD+KP+N+L++ 
Sbjct: 81  ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN- 139
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
            R  +KL DFG++  + +     S     S Y +PE L G T YS   D+W++G    EM
Sbjct: 140 SRGEIKLCDFGVSGQL-IDSMANSFVGTRS-YMSPERLQG-THYSVQSDIWSMGLSLVEM 196
Query: 202 ITGKPLFPSKKHDHLSLIFSLLGTPTDESWAE------------STYISEILPLYPHFEP 249
             G+   P      L L+F   G   +   AE            S+Y  +  P    FE 
Sbjct: 197 AVGRYPIPPPDAKELELMF---GCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFEL 253
Query: 250 AN--LAEKFPNLEPAGV------DLLSQMLCLNPKQRITAMDALKHEYL 290
            +  + E  P L P+GV      D +++ L  NP +R      + H ++
Sbjct: 254 LDYIVNEPPPKL-PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 97/189 (51%), Gaps = 11/189 (5%)
Query: 26  CRNTVTGQKVAIKMMTIQ--TEQEGVPSYIIREVSLLKELEHENIVRL-LDVQSSRKDVF 82
            R   T ++ AIK++  +   ++  VP Y+ RE  ++  L+H   V+L    Q   K  F
Sbjct: 52  ARELATSREYAIKILEKRHIIKENKVP-YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 110
Query: 83  LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK 142
            +    + +L  +I R   + +    +    +I+  L Y H   I+HRDLKP N+L++  
Sbjct: 111 GLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 169
Query: 143 RNTVKLADFGLARAIGVPQKEYSRDCVY---SPYKAPELLLGYTGYSTPIDVWAVGCIFA 199
            + +++ DFG A+ +  P+ + +R   +   + Y +PELL   +   +  D+WA+GCI  
Sbjct: 170 MH-IQITDFGTAKVLS-PESKQARANSFVGTAQYVSPELLTEKSACKSS-DLWALGCIIY 226
Query: 200 EMITGKPLF 208
           +++ G P F
Sbjct: 227 QLVAGLPPF 235

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/185 (31%), Positives = 100/185 (54%), Gaps = 18/185 (9%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD---- 89
           KVA+K +    +    P   + E +L+K+L+H+ +VRL  V  +++ ++++ EY++    
Sbjct: 49  KVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAV-VTQEPIYIITEYMENGSL 104
Query: 90  LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLA 149
           +D     +  K T+N L+  A   QI  G+A+      +HRDL+  N+L+     + K+A
Sbjct: 105 VDFLKTPSGIKLTINKLLDMA--AQIAEGMAFIEERNYIHRDLRAANILVS-DTLSCKIA 161
Query: 150 DFGLARAIGVPQKEYS-RDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT-GK 205
           DFGLAR I     EY+ R+    P K  APE  + Y  ++   DVW+ G +  E++T G+
Sbjct: 162 DFGLARLI--EDNEYTAREGAKFPIKWTAPE-AINYGTFTIKSDVWSFGILLTEIVTHGR 218
Query: 206 PLFPS 210
             +P 
Sbjct: 219 IPYPG 223

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/185 (31%), Positives = 100/185 (54%), Gaps = 18/185 (9%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD---- 89
           KVA+K +    +    P   + E +L+K+L+H+ +VRL  V  +++ ++++ EY++    
Sbjct: 34  KVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAV-VTQEPIYIITEYMENGSL 89
Query: 90  LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLA 149
           +D     +  K T+N L+  A   QI  G+A+      +HRDL+  N+L+     + K+A
Sbjct: 90  VDFLKTPSGIKLTINKLLDMA--AQIAEGMAFIEERNYIHRDLRAANILVS-DTLSCKIA 146
Query: 150 DFGLARAIGVPQKEYS-RDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT-GK 205
           DFGLAR I     EY+ R+    P K  APE  + Y  ++   DVW+ G +  E++T G+
Sbjct: 147 DFGLARLI--EDNEYTAREGAKFPIKWTAPE-AINYGTFTIKSDVWSFGILLTEIVTHGR 203
Query: 206 PLFPS 210
             +P 
Sbjct: 204 IPYPG 208

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 97/189 (51%), Gaps = 11/189 (5%)
Query: 26  CRNTVTGQKVAIKMMTIQ--TEQEGVPSYIIREVSLLKELEHENIVRL-LDVQSSRKDVF 82
            R   T ++ AIK++  +   ++  VP Y+ RE  ++  L+H   V+L    Q   K  F
Sbjct: 29  ARELATSREYAIKILEKRHIIKENKVP-YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 87
Query: 83  LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK 142
            +    + +L  +I R   + +    +    +I+  L Y H   I+HRDLKP N+L++  
Sbjct: 88  GLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 146
Query: 143 RNTVKLADFGLARAIGVPQKEYSRDCVY---SPYKAPELLLGYTGYSTPIDVWAVGCIFA 199
            + +++ DFG A+ +  P+ + +R   +   + Y +PELL   +   +  D+WA+GCI  
Sbjct: 147 MH-IQITDFGTAKVLS-PESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIY 203
Query: 200 EMITGKPLF 208
           +++ G P F
Sbjct: 204 QLVAGLPPF 212

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 97/189 (51%), Gaps = 11/189 (5%)
Query: 26  CRNTVTGQKVAIKMMTIQ--TEQEGVPSYIIREVSLLKELEHENIVRL-LDVQSSRKDVF 82
            R   T ++ AIK++  +   ++  VP Y+ RE  ++  L+H   V+L    Q   K  F
Sbjct: 28  ARELATSREYAIKILEKRHIIKENKVP-YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 86
Query: 83  LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK 142
            +    + +L  +I R   + +    +    +I+  L Y H   I+HRDLKP N+L++  
Sbjct: 87  GLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 145
Query: 143 RNTVKLADFGLARAIGVPQKEYSRDCVY---SPYKAPELLLGYTGYSTPIDVWAVGCIFA 199
            + +++ DFG A+ +  P+ + +R   +   + Y +PELL   +   +  D+WA+GCI  
Sbjct: 146 MH-IQITDFGTAKVLS-PESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIY 202
Query: 200 EMITGKPLF 208
           +++ G P F
Sbjct: 203 QLVAGLPPF 211

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 97/189 (51%), Gaps = 11/189 (5%)
Query: 26  CRNTVTGQKVAIKMMTIQ--TEQEGVPSYIIREVSLLKELEHENIVRL-LDVQSSRKDVF 82
            R   T ++ AIK++  +   ++  VP Y+ RE  ++  L+H   V+L    Q   K  F
Sbjct: 33  ARELATSREYAIKILEKRHIIKENKVP-YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 91
Query: 83  LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK 142
            +    + +L  +I R   + +    +    +I+  L Y H   I+HRDLKP N+L++  
Sbjct: 92  GLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 150
Query: 143 RNTVKLADFGLARAIGVPQKEYSRDCVY---SPYKAPELLLGYTGYSTPIDVWAVGCIFA 199
            + +++ DFG A+ +  P+ + +R   +   + Y +PELL   +   +  D+WA+GCI  
Sbjct: 151 MH-IQITDFGTAKVLS-PESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIY 207
Query: 200 EMITGKPLF 208
           +++ G P F
Sbjct: 208 QLVAGLPPF 216

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/185 (31%), Positives = 100/185 (54%), Gaps = 18/185 (9%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD---- 89
           KVA+K +    +    P   + E +L+K+L+H+ +VRL  V  +++ ++++ EY++    
Sbjct: 44  KVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAV-VTQEPIYIITEYMENGSL 99
Query: 90  LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLA 149
           +D     +  K T+N L+  A   QI  G+A+      +HRDL+  N+L+     + K+A
Sbjct: 100 VDFLKTPSGIKLTINKLLDMA--AQIAEGMAFIEERNYIHRDLRAANILVS-DTLSCKIA 156
Query: 150 DFGLARAIGVPQKEYS-RDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT-GK 205
           DFGLAR I     EY+ R+    P K  APE  + Y  ++   DVW+ G +  E++T G+
Sbjct: 157 DFGLARLI--EDNEYTAREGAKFPIKWTAPE-AINYGTFTIKSDVWSFGILLTEIVTHGR 213
Query: 206 PLFPS 210
             +P 
Sbjct: 214 IPYPG 218

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/185 (31%), Positives = 100/185 (54%), Gaps = 18/185 (9%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD---- 89
           KVA+K +    +    P   + E +L+K+L+H+ +VRL  V  +++ ++++ EY++    
Sbjct: 39  KVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAV-VTQEPIYIITEYMENGSL 94
Query: 90  LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLA 149
           +D     +  K T+N L+  A   QI  G+A+      +HRDL+  N+L+     + K+A
Sbjct: 95  VDFLKTPSGIKLTINKLLDMA--AQIAEGMAFIEERNYIHRDLRAANILVS-DTLSCKIA 151
Query: 150 DFGLARAIGVPQKEYS-RDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT-GK 205
           DFGLAR I     EY+ R+    P K  APE  + Y  ++   DVW+ G +  E++T G+
Sbjct: 152 DFGLARLI--EDNEYTAREGAKFPIKWTAPE-AINYGTFTIKSDVWSFGILLTEIVTHGR 208
Query: 206 PLFPS 210
             +P 
Sbjct: 209 IPYPG 213

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 97/189 (51%), Gaps = 11/189 (5%)
Query: 26  CRNTVTGQKVAIKMMTIQ--TEQEGVPSYIIREVSLLKELEHENIVRL-LDVQSSRKDVF 82
            R   T ++ AIK++  +   ++  VP Y+ RE  ++  L+H   V+L    Q   K  F
Sbjct: 48  ARELATSREYAIKILEKRHIIKENKVP-YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 106
Query: 83  LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK 142
            +    + +L  +I R   + +    +    +I+  L Y H   I+HRDLKP N+L++  
Sbjct: 107 GLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 165
Query: 143 RNTVKLADFGLARAIGVPQKEYSRDCVY---SPYKAPELLLGYTGYSTPIDVWAVGCIFA 199
            + +++ DFG A+ +  P+ + +R   +   + Y +PELL   +   +  D+WA+GCI  
Sbjct: 166 MH-IQITDFGTAKVLS-PESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIY 222
Query: 200 EMITGKPLF 208
           +++ G P F
Sbjct: 223 QLVAGLPPF 231

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 97/189 (51%), Gaps = 11/189 (5%)
Query: 26  CRNTVTGQKVAIKMMTIQ--TEQEGVPSYIIREVSLLKELEHENIVRL-LDVQSSRKDVF 82
            R   T ++ AIK++  +   ++  VP Y+ RE  ++  L+H   V+L    Q   K  F
Sbjct: 26  ARELATSREYAIKILEKRHIIKENKVP-YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 84
Query: 83  LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK 142
            +    + +L  +I R   + +    +    +I+  L Y H   I+HRDLKP N+L++  
Sbjct: 85  GLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 143
Query: 143 RNTVKLADFGLARAIGVPQKEYSRDCVY---SPYKAPELLLGYTGYSTPIDVWAVGCIFA 199
            + +++ DFG A+ +  P+ + +R   +   + Y +PELL   +   +  D+WA+GCI  
Sbjct: 144 MH-IQITDFGTAKVLS-PESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIY 200
Query: 200 EMITGKPLF 208
           +++ G P F
Sbjct: 201 QLVAGLPPF 209

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 38/95 (40%), Positives = 56/95 (58%), Gaps = 5/95 (5%)
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           QI+L   Y HSL +++RDLKP NL+ID ++  +K+ DFG A+ +   +      C    Y
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLMID-QQGYIKVTDFGFAKRV---KGRTWXLCGTPEY 205
Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
            APE++L   GY+  +D WA+G +  EM  G P F
Sbjct: 206 LAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 38/95 (40%), Positives = 56/95 (58%), Gaps = 5/95 (5%)
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           QI+L   Y HSL +++RDLKP NL+ID ++  +K+ DFG A+ +   +      C    Y
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLMID-QQGYIKVTDFGFAKRV---KGRTWXLCGTPEY 205
Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
            APE++L   GY+  +D WA+G +  EM  G P F
Sbjct: 206 LAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 38/95 (40%), Positives = 56/95 (58%), Gaps = 5/95 (5%)
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           QI+L   Y HSL +++RDLKP NL+ID ++  +K+ DFG A+ +   +      C    Y
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLMID-QQGYIKVTDFGFAKRV---KGRTWXLCGTPEY 205
Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
            APE++L   GY+  +D WA+G +  EM  G P F
Sbjct: 206 LAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 38/95 (40%), Positives = 56/95 (58%), Gaps = 5/95 (5%)
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           QI+L   Y HSL +++RDLKP NL+ID ++  +K+ DFG A+ +   +      C    Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLMID-QQGYIKVTDFGFAKRV---KGRTWXLCGTPEY 204
Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
            APE++L   GY+  +D WA+G +  EM  G P F
Sbjct: 205 LAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 97/189 (51%), Gaps = 11/189 (5%)
Query: 26  CRNTVTGQKVAIKMMTIQ--TEQEGVPSYIIREVSLLKELEHENIVRL-LDVQSSRKDVF 82
            R   T ++ AIK++  +   ++  VP Y+ RE  ++  L+H   V+L    Q   K  F
Sbjct: 27  ARELATSREYAIKILEKRHIIKENKVP-YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 85
Query: 83  LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK 142
            +    + +L  +I R   + +    +    +I+  L Y H   I+HRDLKP N+L++  
Sbjct: 86  GLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 144
Query: 143 RNTVKLADFGLARAIGVPQKEYSRDCVY---SPYKAPELLLGYTGYSTPIDVWAVGCIFA 199
            + +++ DFG A+ +  P+ + +R   +   + Y +PELL   +   +  D+WA+GCI  
Sbjct: 145 MH-IQITDFGTAKVLS-PESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIY 201
Query: 200 EMITGKPLF 208
           +++ G P F
Sbjct: 202 QLVAGLPPF 210

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 97/187 (51%), Gaps = 19/187 (10%)
Query: 31  TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL 90
           TG+ + +K + I+ ++E   +++ +EV +++ LEH N+++ + V    K +  + EY+  
Sbjct: 34  TGEVMVMKEL-IRFDEETQRTFL-KEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKG 91
Query: 91  D-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLA 149
             L   I    +        +  K I  G+AY HS+ I+HRDL  +N L+   +N V +A
Sbjct: 92  GTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVV-VA 150
Query: 150 DFGLA-------------RAIGVPQKEYSRDCVYSPY-KAPELLLGYTGYSTPIDVWAVG 195
           DFGLA             R++  P ++     V +PY  APE++ G + Y   +DV++ G
Sbjct: 151 DFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRS-YDEKVDVFSFG 209
Query: 196 CIFAEMI 202
            +  E+I
Sbjct: 210 IVLCEII 216

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 38/95 (40%), Positives = 56/95 (58%), Gaps = 5/95 (5%)
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           QI+L   Y HSL +++RDLKP NL+ID ++  +K+ DFG A+ +   +      C    Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLMID-QQGYIKVTDFGFAKRV---KGRTWXLCGTPEY 204
Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
            APE++L   GY+  +D WA+G +  EM  G P F
Sbjct: 205 LAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 38/95 (40%), Positives = 56/95 (58%), Gaps = 5/95 (5%)
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           QI+L   Y HSL +++RDLKP NL+ID ++  +K+ DFG A+ +   +      C    Y
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLMID-QQGYIKVTDFGFAKRV---KGRTWXLCGTPEY 205
Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
            APE++L   GY+  +D WA+G +  EM  G P F
Sbjct: 206 LAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 97/189 (51%), Gaps = 11/189 (5%)
Query: 26  CRNTVTGQKVAIKMMTIQ--TEQEGVPSYIIREVSLLKELEHENIVRL-LDVQSSRKDVF 82
            R   T ++ AIK++  +   ++  VP Y+ RE  ++  L+H   V+L    Q   K  F
Sbjct: 48  ARELATSREYAIKILEKRHIIKENKVP-YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 106
Query: 83  LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK 142
            +    + +L  +I R   + +    +    +I+  L Y H   I+HRDLKP N+L++  
Sbjct: 107 GLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 165
Query: 143 RNTVKLADFGLARAIGVPQKEYSRDCVY---SPYKAPELLLGYTGYSTPIDVWAVGCIFA 199
            + +++ DFG A+ +  P+ + +R   +   + Y +PELL   +   +  D+WA+GCI  
Sbjct: 166 MH-IQITDFGTAKVLS-PESKQARANSFVGTAQYVSPELLTEKSACKSS-DLWALGCIIY 222
Query: 200 EMITGKPLF 208
           +++ G P F
Sbjct: 223 QLVAGLPPF 231

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 115/263 (43%), Gaps = 71/263 (26%)
Query: 83  LVFEYLDLDLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLID- 140
           L+FE L   L+  ITR+  N  ++  IK    +IL  L Y   + + H DLKP N+L+D 
Sbjct: 113 LIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDD 172
Query: 141 -----------------------LKRNTVKLADFGLARAIGVPQKEYSRDCVYS-PYKAP 176
                                   K   +KL DFG A      + +Y    + +  Y+AP
Sbjct: 173 PYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA----TFKSDYHGSIINTRQYRAP 228
Query: 177 ELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLL----------GT 225
           E++L   G+    D+W+ GC+ AE+ TG  LF + +H +HL+++ S++           T
Sbjct: 229 EVILN-LGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEAT 287
Query: 226 PTDES-----------WAEST-------YISEILPLYPHFEPANLAEKFPNLEPAGVDLL 267
            T+ S           W E+        ++ + LPLY   +     E F        D L
Sbjct: 288 KTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIK----HELF-------CDFL 336
Query: 268 SQMLCLNPKQRITAMDALKHEYL 290
             +L ++P  R +  + LKH++L
Sbjct: 337 YSILQIDPTLRPSPAELLKHKFL 359

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 90/197 (45%), Gaps = 14/197 (7%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIR---EVSLLKELEHENIVRLLDVQSSR 78
           EV+  R+    + VA+K++     ++  PS+ +R   E      L H  IV + D   + 
Sbjct: 27  EVHLARDLRDHRDVAVKVLRADLARD--PSFYLRFRREAQNAAALNHPAIVAVYDTGEAE 84
Query: 79  KDV----FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKP 134
                  ++V EY+D      I   +  +       ++      L + H   I+HRD+KP
Sbjct: 85  TPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKP 144
Query: 135 NNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVY---SPYKAPELLLGYTGYSTPIDV 191
            N+LI    N VK+ DFG+ARAI        +       + Y +PE   G +      DV
Sbjct: 145 ANILISAT-NAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDS-VDARSDV 202
Query: 192 WAVGCIFAEMITGKPLF 208
           +++GC+  E++TG+P F
Sbjct: 203 YSLGCVLYEVLTGEPPF 219

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 51/189 (26%), Positives = 97/189 (51%), Gaps = 11/189 (5%)
Query: 26  CRNTVTGQKVAIKMMTIQ--TEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL 83
            R   T ++ AIK++  +   ++  VP Y+ RE  ++  L+H   V+L       + ++ 
Sbjct: 56  ARELATSREYAIKILEKRHIIKENKVP-YVTRERDVMSRLDHPFFVKLYFCFQDDEKLYF 114
Query: 84  VFEYL-DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK 142
              Y  + +L  +I R   + +    +    +I+  L Y H   I+HRDLKP N+L++  
Sbjct: 115 GLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 173
Query: 143 RNTVKLADFGLARAIGVPQKEYSRDCVY---SPYKAPELLLGYTGYSTPIDVWAVGCIFA 199
            + +++ DFG A+ +  P+ + +R   +   + Y +PELL   +   +  D+WA+GCI  
Sbjct: 174 MH-IQITDFGTAKVLS-PESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIY 230
Query: 200 EMITGKPLF 208
           +++ G P F
Sbjct: 231 QLVAGLPPF 239

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 92/196 (46%), Gaps = 30/196 (15%)
Query: 26  CRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHE----------NIVRLLDVQ 75
            ++  TG   A+K++  Q            +V  LKE+EH           N   L+ ++
Sbjct: 60  VKHMETGNHYAMKILDKQ------------KVVKLKEIEHTLNEKRILQAVNFPFLVKLE 107
Query: 76  SSRKD---VFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDL 132
            S KD   +++V EY          R     +    +    QI+L   Y HSL +++RDL
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 133 KPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVW 192
           KP NL+ID ++  +++ DFGLA+ +   +      C    Y APE++L   GY+  +D W
Sbjct: 168 KPENLMID-QQGYIQVTDFGLAKRV---KGRTWXLCGTPEYLAPEIILS-KGYNKAVDWW 222
Query: 193 AVGCIFAEMITGKPLF 208
           A+G +  EM  G P F
Sbjct: 223 ALGVLIYEMAAGYPPF 238

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 91/197 (46%), Gaps = 14/197 (7%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIR---EVSLLKELEHENIVRLLDVQSSR 78
           EV+  R+    + VA+K++     ++  PS+ +R   E      L H  IV + D   + 
Sbjct: 27  EVHLARDLRDHRDVAVKVLRADLARD--PSFYLRFRREAQNAAALNHPAIVAVYDTGEAE 84
Query: 79  KDV----FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKP 134
                  ++V EY+D      I   +  +       ++      L + H   I+HRD+KP
Sbjct: 85  TPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKP 144
Query: 135 NNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVY---SPYKAPELLLGYTGYSTPIDV 191
            N++I    N VK+ DFG+ARAI       ++       + Y +PE   G +      DV
Sbjct: 145 ANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDV 202
Query: 192 WAVGCIFAEMITGKPLF 208
           +++GC+  E++TG+P F
Sbjct: 203 YSLGCVLYEVLTGEPPF 219

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 81/304 (26%), Positives = 120/304 (39%), Gaps = 73/304 (24%)
Query: 36  AIKMMTIQTEQEGVPSYIIR---EVSLLKELEHENIVRLLDVQSSRKDVFLVFE-----Y 87
           AIK+M     ++  P  + R   EV L+K+L H NI RL +V    + + LV E     +
Sbjct: 55  AIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGH 114
Query: 88  LDLDLHSFITRHKNTLNLLVIKA-----------------------------------IL 112
           L   L+ FI        + V+K                                    I+
Sbjct: 115 LLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIM 174
Query: 113 KQILLGLAYCHSLKILHRDLKPNNLLIDLKRN-TVKLADFGLARAI-GVPQKEY--SRDC 168
           +QI   L Y H+  I HRD+KP N L    ++  +KL DFGL++    +   EY      
Sbjct: 175 RQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTK 234
Query: 169 VYSPY-KAPELL-LGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTP 226
             +PY  APE+L      Y    D W+ G +   ++ G   FP                 
Sbjct: 235 AGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVN-------------- 280
Query: 227 TDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK 286
                 ++  IS++L     FE  N    +  L P   DLLS +L  N  +R  AM AL+
Sbjct: 281 ------DADTISQVLNKKLCFENPN----YNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330
Query: 287 HEYL 290
           H ++
Sbjct: 331 HPWI 334

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 75/317 (23%), Positives = 140/317 (44%), Gaps = 55/317 (17%)
Query: 22  EVYKCRNTVTGQ-KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN---IVRLLDVQSS 77
           +V +C +   G+ +VA+K++    +        I  +  +KE + EN    V + D  + 
Sbjct: 34  KVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF 93
Query: 78  RKDVFLVFEYLDLDLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNN 136
              + + FE L  +   F+  +      L  ++ +  Q+   L + H  ++ H DLKP N
Sbjct: 94  HGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPEN 153
Query: 137 LLI------------------DLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPEL 178
           +L                    +K  ++++ADFG A       + ++       Y+ PE+
Sbjct: 154 ILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA---TFDHEHHTTIVATRHYRPPEV 210
Query: 179 LLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLG-TPT--------- 227
           +L   G++ P DVW++GCI  E   G  LF + ++ +HL ++  +LG  P+         
Sbjct: 211 ILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQ 269
Query: 228 ----------DESWAESTYISE-ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPK 276
                     DE+ ++  Y+ E   PL  +     L +   +++    DL+ +ML  +P 
Sbjct: 270 KYFYKGGLVWDENSSDGRYVKENCKPLKSYM----LQDSLEHVQL--FDLMRRMLEFDPA 323
Query: 277 QRITAMDALKHEYLIGV 293
           QRIT  +AL H +  G+
Sbjct: 324 QRITLAEALLHPFFAGL 340

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 92/196 (46%), Gaps = 30/196 (15%)
Query: 26  CRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHE----------NIVRLLDVQ 75
            ++  TG   A+K++  Q            +V  LK++EH           N   L+ ++
Sbjct: 60  VKHKETGNHFAMKILDKQ------------KVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 76  SSRKD---VFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDL 132
            S KD   +++V EY+         R     +    +    QI+L   Y HSL +++RDL
Sbjct: 108 YSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 133 KPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVW 192
           KP NLLID ++  +++ DFG A+ +   +      C    Y APE++L   GY+  +D W
Sbjct: 168 KPENLLID-QQGYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILS-KGYNKAVDWW 222
Query: 193 AVGCIFAEMITGKPLF 208
           A+G +  EM  G P F
Sbjct: 223 ALGVLIYEMAAGYPPF 238

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/184 (33%), Positives = 94/184 (51%), Gaps = 16/184 (8%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DL 92
           +VAIK +   T     P   ++E  ++K+L HE +V+L  V  S + +++V EY+    L
Sbjct: 293 RVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSL 348
Query: 93  HSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTV-KLAD 150
             F+       L L  +  +  QI  G+AY   +  +HRDL+  N+L+    N V K+AD
Sbjct: 349 LDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG--ENLVCKVAD 406
Query: 151 FGLARAIGVPQKEYS-RDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT-GKP 206
           FGLAR I     EY+ R     P K  APE  L Y  ++   DVW+ G +  E+ T G+ 
Sbjct: 407 FGLARLI--EDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRV 463
Query: 207 LFPS 210
            +P 
Sbjct: 464 PYPG 467

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 39/95 (41%), Positives = 58/95 (61%), Gaps = 5/95 (5%)
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           QI+L   Y HSL +++RDLKP NLLID ++  +++ DFG A+   V  + ++  C    Y
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKR--VKGRTWTL-CGTPEY 205
Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
            APE++L   GY+  +D WA+G +  EM  G P F
Sbjct: 206 LAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 96/185 (51%), Gaps = 10/185 (5%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           VY+ R       VAIK++   TE+      ++RE  ++ +L++  IVRL+ V  + + + 
Sbjct: 356 VYRMRKKQI--DVAIKVLKQGTEKADTEE-MMREAQIMHQLDNPYIVRLIGVCQA-EALM 411
Query: 83  LVFEYLDLD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
           LV E      LH F+   +  + +  +  +L Q+ +G+ Y      +HR+L   N+L+ +
Sbjct: 412 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLL-V 470
Query: 142 KRNTVKLADFGLARAIGVPQKEY-SRDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIF 198
            R+  K++DFGL++A+G     Y +R     P K  APE  + +  +S+  DVW+ G   
Sbjct: 471 NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE-CINFRKFSSRSDVWSYGVTM 529
Query: 199 AEMIT 203
            E ++
Sbjct: 530 WEALS 534

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/183 (32%), Positives = 94/183 (51%), Gaps = 14/183 (7%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DL 92
           +VAIK +   T     P   ++E  ++K+L HE +V+L  V  S + +++V EY++   L
Sbjct: 41  RVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVTEYMNKGSL 96
Query: 93  HSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADF 151
             F+       L L  +  +  QI  G+AY   +  +HRDL+  N+L+  +    K+ADF
Sbjct: 97  LDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADF 155
Query: 152 GLARAIGVPQKEYS-RDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPL 207
           GLAR I     EY+ R     P K  APE  L Y  ++   DVW+ G +  E+ T G+  
Sbjct: 156 GLARLI--EDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVP 212
Query: 208 FPS 210
           +P 
Sbjct: 213 YPG 215

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 39/95 (41%), Positives = 58/95 (61%), Gaps = 5/95 (5%)
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           QI+L   Y HSL +++RDLKP NLLID ++  +++ DFG A+   V  + ++  C    Y
Sbjct: 135 QIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKR--VKGRTWTL-CGTPEY 190
Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
            APE++L   GY+  +D WA+G +  EM  G P F
Sbjct: 191 LAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPF 224

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 38/95 (40%), Positives = 56/95 (58%), Gaps = 5/95 (5%)
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           QI+L   Y HSL +++RDLKP NLLID ++  +++ DFG A+ +   +      C    Y
Sbjct: 142 QIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRV---KGRTWXLCGTPEY 197
Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
            APE++L   GY+  +D WA+G +  EM  G P F
Sbjct: 198 LAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/183 (32%), Positives = 93/183 (50%), Gaps = 14/183 (7%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DL 92
           +VAIK +   T     P   ++E  ++K+L HE +V+L  V  S + +++V EY+    L
Sbjct: 44  RVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVIEYMSKGSL 99
Query: 93  HSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADF 151
             F+       L L  +  +  QI  G+AY   +  +HRDL+  N+L+  +    K+ADF
Sbjct: 100 LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADF 158
Query: 152 GLARAIGVPQKEY-SRDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPL 207
           GLAR I     EY +R     P K  APE  L Y  ++   DVW+ G +  E+ T G+  
Sbjct: 159 GLARLI--EDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVP 215
Query: 208 FPS 210
           +P 
Sbjct: 216 YPG 218

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 92/196 (46%), Gaps = 30/196 (15%)
Query: 26  CRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHE----------NIVRLLDVQ 75
            ++  TG   A+K++  Q            +V  LK++EH           N   L+ ++
Sbjct: 60  VKHKETGNHFAMKILDKQ------------KVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 76  SSRKD---VFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDL 132
            S KD   +++V EY+         R     +    +    QI+L   Y HSL +++RDL
Sbjct: 108 YSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 133 KPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVW 192
           KP NLLID ++  +++ DFG A+ +   +      C    Y APE++L   GY+  +D W
Sbjct: 168 KPENLLID-QQGYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILS-KGYNKAVDWW 222
Query: 193 AVGCIFAEMITGKPLF 208
           A+G +  EM  G P F
Sbjct: 223 ALGVLIYEMAAGYPPF 238

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 38/95 (40%), Positives = 56/95 (58%), Gaps = 5/95 (5%)
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           QI+L   Y HSL +++RDLKP NLLID ++  +++ DFG A+ +   +      C    Y
Sbjct: 144 QIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRV---KGRTWXLCGTPEY 199
Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
            APE++L   GY+  +D WA+G +  EM  G P F
Sbjct: 200 LAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPF 233

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/179 (32%), Positives = 90/179 (50%), Gaps = 10/179 (5%)
Query: 31  TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQ--SSRKDVFLVFEYL 88
           TG  VA+K +  Q           RE+ +LK L  + IV+   V     R+ + LV EYL
Sbjct: 38  TGALVAVKQL--QHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYL 95
Query: 89  DLD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVK 147
               L  F+ RH+  L+   +     QI  G+ Y  S + +HRDL   N+L++ + + VK
Sbjct: 96  PSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAH-VK 154
Query: 148 LADFGLARAIGVPQKEY-SRDCVYSP--YKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           +ADFGLA+ + + +  Y  R+   SP  + APE L     +S   DVW+ G +  E+ T
Sbjct: 155 IADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI-FSRQSDVWSFGVVLYELFT 212

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/183 (32%), Positives = 93/183 (50%), Gaps = 14/183 (7%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDLD-L 92
           +VAIK +   T     P   ++E  ++K+L HE +V+L  V  S + +++V EY+    L
Sbjct: 44  RVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVMEYMSKGCL 99
Query: 93  HSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADF 151
             F+       L L  +  +  QI  G+AY   +  +HRDL+  N+L+  +    K+ADF
Sbjct: 100 LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADF 158
Query: 152 GLARAIGVPQKEY-SRDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPL 207
           GLAR I     EY +R     P K  APE  L Y  ++   DVW+ G +  E+ T G+  
Sbjct: 159 GLARLI--EDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVP 215
Query: 208 FPS 210
           +P 
Sbjct: 216 YPG 218

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 38/95 (40%), Positives = 56/95 (58%), Gaps = 5/95 (5%)
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           QI+L   Y HSL +++RDLKP NLLID ++  +++ DFG A+ +   +      C    Y
Sbjct: 142 QIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRV---KGRTWXLCGTPEY 197
Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
            APE++L   GY+  +D WA+G +  EM  G P F
Sbjct: 198 LAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 38/95 (40%), Positives = 56/95 (58%), Gaps = 5/95 (5%)
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           QI+L   Y HSL +++RDLKP NLLID ++  +++ DFG A+ +   +      C    Y
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRV---KGRTWXLCGTPEY 205
Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
            APE++L   GY+  +D WA+G +  EM  G P F
Sbjct: 206 LAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 75/317 (23%), Positives = 140/317 (44%), Gaps = 55/317 (17%)
Query: 22  EVYKCRNTVTGQ-KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN---IVRLLDVQSS 77
           +V +C +   G+ +VA+K++    +        I  +  +KE + EN    V + D  + 
Sbjct: 43  KVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF 102
Query: 78  RKDVFLVFEYLDLDLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNN 136
              + + FE L  +   F+  +      L  ++ +  Q+   L + H  ++ H DLKP N
Sbjct: 103 HGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPEN 162
Query: 137 LLI------------------DLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPEL 178
           +L                    +K  ++++ADFG A       + ++       Y+ PE+
Sbjct: 163 ILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA---TFDHEHHTTIVATRHYRPPEV 219
Query: 179 LLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLG-TPT--------- 227
           +L   G++ P DVW++GCI  E   G  LF + ++ +HL ++  +LG  P+         
Sbjct: 220 ILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQ 278
Query: 228 ----------DESWAESTYISE-ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPK 276
                     DE+ ++  Y+ E   PL  +     L +   +++    DL+ +ML  +P 
Sbjct: 279 KYFYKGGLVWDENSSDGRYVKENCKPLKSYM----LQDSLEHVQL--FDLMRRMLEFDPA 332
Query: 277 QRITAMDALKHEYLIGV 293
           QRIT  +AL H +  G+
Sbjct: 333 QRITLAEALLHPFFAGL 349

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 38/95 (40%), Positives = 56/95 (58%), Gaps = 5/95 (5%)
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           QI+L   Y HSL +++RDLKP NLLID ++  +++ DFG A+ +   +      C    Y
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRV---KGRTWXLCGTPEY 205
Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
            APE++L   GY+  +D WA+G +  EM  G P F
Sbjct: 206 LAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 38/95 (40%), Positives = 56/95 (58%), Gaps = 5/95 (5%)
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           QI+L   Y HSL +++RDLKP NLLID ++  +++ DFG A+ +   +      C    Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRV---KGRTWXLCGTPEY 204
Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
            APE++L   GY+  +D WA+G +  EM  G P F
Sbjct: 205 LAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 38/95 (40%), Positives = 56/95 (58%), Gaps = 5/95 (5%)
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           QI+L   Y HSL +++RDLKP NLLID ++  +++ DFG A+ +   +      C    Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRV---KGRTWXLCGTPEY 204
Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
            APE++L   GY+  +D WA+G +  EM  G P F
Sbjct: 205 LAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 38/95 (40%), Positives = 56/95 (58%), Gaps = 5/95 (5%)
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           QI+L   Y HSL +++RDLKP NLLID ++  +++ DFG A+ +   +      C    Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRV---KGRTWXLCGTPEY 204
Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
            APE++L   GY+  +D WA+G +  EM  G P F
Sbjct: 205 LAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 38/95 (40%), Positives = 56/95 (58%), Gaps = 5/95 (5%)
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           QI+L   Y HSL +++RDLKP NLLID ++  +++ DFG A+ +   +      C    Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRV---KGRTWXLCGTPEY 204
Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
            APE++L   GY+  +D WA+G +  EM  G P F
Sbjct: 205 LAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 38/95 (40%), Positives = 56/95 (58%), Gaps = 5/95 (5%)
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           QI+L   Y HSL +++RDLKP NLLID ++  +++ DFG A+ +   +      C    Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRV---KGRTWXLCGTPEY 204
Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
            APE++L   GY+  +D WA+G +  EM  G P F
Sbjct: 205 LAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 38/95 (40%), Positives = 56/95 (58%), Gaps = 5/95 (5%)
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           QI+L   Y HSL +++RDLKP NLLID ++  +++ DFG A+ +   +      C    Y
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRV---KGRTWXLCGTPEY 205
Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
            APE++L   GY+  +D WA+G +  EM  G P F
Sbjct: 206 LAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 38/95 (40%), Positives = 56/95 (58%), Gaps = 5/95 (5%)
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           QI+L   Y HSL +++RDLKP NLLID ++  +++ DFG A+ +   +      C    Y
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRV---KGRTWXLCGTPEY 205
Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
            APE++L   GY+  +D WA+G +  EM  G P F
Sbjct: 206 LAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 38/95 (40%), Positives = 56/95 (58%), Gaps = 5/95 (5%)
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           QI+L   Y HSL +++RDLKP NLLID ++  +++ DFG A+ +   +      C    Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRV---KGRTWXLCGTPEY 204
Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
            APE++L   GY+  +D WA+G +  EM  G P F
Sbjct: 205 LAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 38/95 (40%), Positives = 56/95 (58%), Gaps = 5/95 (5%)
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           QI+L   Y HSL +++RDLKP NLLID ++  +++ DFG A+ +   +      C    Y
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRV---KGRTWXLCGTPEY 205
Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
            APE++L   GY+  +D WA+G +  EM  G P F
Sbjct: 206 LAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 38/95 (40%), Positives = 56/95 (58%), Gaps = 5/95 (5%)
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           QI+L   Y HSL +++RDLKP NLLID ++  +++ DFG A+ +   +      C    Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRV---KGRTWXLCGTPEY 204
Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
            APE++L   GY+  +D WA+G +  EM  G P F
Sbjct: 205 LAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 38/95 (40%), Positives = 56/95 (58%), Gaps = 5/95 (5%)
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           QI+L   Y HSL +++RDLKP NLLID ++  +++ DFG A+ +   +      C    Y
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRV---KGRTWXLCGTPEY 205
Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
            APE++L   GY+  +D WA+G +  EM  G P F
Sbjct: 206 LAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 38/95 (40%), Positives = 56/95 (58%), Gaps = 5/95 (5%)
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           QI+L   Y HSL +++RDLKP NLLID ++  +++ DFG A+ +   +      C    Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRV---KGRTWXLCGTPEY 204
Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
            APE++L   GY+  +D WA+G +  EM  G P F
Sbjct: 205 LAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/179 (32%), Positives = 90/179 (50%), Gaps = 10/179 (5%)
Query: 31  TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQ--SSRKDVFLVFEYL 88
           TG  VA+K +  Q           RE+ +LK L  + IV+   V     R+ + LV EYL
Sbjct: 51  TGALVAVKQL--QHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYL 108
Query: 89  DLD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVK 147
               L  F+ RH+  L+   +     QI  G+ Y  S + +HRDL   N+L++ + + VK
Sbjct: 109 PSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAH-VK 167
Query: 148 LADFGLARAIGVPQKEY-SRDCVYSP--YKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           +ADFGLA+ + + +  Y  R+   SP  + APE L     +S   DVW+ G +  E+ T
Sbjct: 168 IADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI-FSRQSDVWSFGVVLYELFT 225

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 38/95 (40%), Positives = 56/95 (58%), Gaps = 5/95 (5%)
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           QI+L   Y HSL +++RDLKP NLLID ++  +++ DFG A+ +   +      C    Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRV---KGRTWXLCGTPEY 204
Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
            APE++L   GY+  +D WA+G +  EM  G P F
Sbjct: 205 LAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 38/95 (40%), Positives = 56/95 (58%), Gaps = 5/95 (5%)
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           QI+L   Y HSL +++RDLKP NLLID ++  +++ DFG A+ +   +      C    Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRV---KGRTWXLCGTPEY 204
Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
            APE++L   GY+  +D WA+G +  EM  G P F
Sbjct: 205 LAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 92/196 (46%), Gaps = 30/196 (15%)
Query: 26  CRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHE----------NIVRLLDVQ 75
            ++  TG   A+K++  Q            +V  LK++EH           N   L+ ++
Sbjct: 60  VKHKETGNHFAMKILDKQ------------KVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 76  SSRKD---VFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDL 132
            S KD   +++V EY+         R     +    +    QI+L   Y HSL +++RDL
Sbjct: 108 YSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 133 KPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVW 192
           KP NLLID ++  +++ DFG A+ +   +      C    Y APE++L   GY+  +D W
Sbjct: 168 KPENLLID-QQGYIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILS-KGYNKAVDWW 222
Query: 193 AVGCIFAEMITGKPLF 208
           A+G +  EM  G P F
Sbjct: 223 ALGVLIYEMAAGYPPF 238

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 38/95 (40%), Positives = 56/95 (58%), Gaps = 5/95 (5%)
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           QI+L   Y HSL +++RDLKP NLLID ++  +++ DFG A+ +   +      C    Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRV---KGRTWXLCGTPEY 204
Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
            APE++L   GY+  +D WA+G +  EM  G P F
Sbjct: 205 LAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 38/95 (40%), Positives = 56/95 (58%), Gaps = 5/95 (5%)
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           QI+L   Y HSL +++RDLKP NLLID ++  +++ DFG A+ +   +      C    Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRV---KGRTWXLCGTPEY 204
Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
            APE++L   GY+  +D WA+G +  EM  G P F
Sbjct: 205 LAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/179 (32%), Positives = 90/179 (50%), Gaps = 10/179 (5%)
Query: 31  TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQ--SSRKDVFLVFEYL 88
           TG  VA+K +  Q           RE+ +LK L  + IV+   V     R+ + LV EYL
Sbjct: 39  TGALVAVKQL--QHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYL 96
Query: 89  DLD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVK 147
               L  F+ RH+  L+   +     QI  G+ Y  S + +HRDL   N+L++ + + VK
Sbjct: 97  PSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAH-VK 155
Query: 148 LADFGLARAIGVPQKEY-SRDCVYSP--YKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           +ADFGLA+ + + +  Y  R+   SP  + APE L     +S   DVW+ G +  E+ T
Sbjct: 156 IADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI-FSRQSDVWSFGVVLYELFT 213

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 38/95 (40%), Positives = 56/95 (58%), Gaps = 5/95 (5%)
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           QI+L   Y HSL +++RDLKP NLLID ++  +++ DFG A+ +   +      C    Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRV---KGRTWXLCGTPEY 204
Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
            APE++L   GY+  +D WA+G +  EM  G P F
Sbjct: 205 LAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 99/184 (53%), Gaps = 16/184 (8%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD---- 89
           KVA+K +    +    P   + E +L+K+L+H+ +VRL  V  +++ ++++ EY++    
Sbjct: 47  KVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAV-VTQEPIYIITEYMENGSL 102
Query: 90  LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLA 149
           +D     +  K T+N L+  A   QI  G+A+      +HRDL+  N+L+     + K+A
Sbjct: 103 VDFLKTPSGIKLTINKLLDMA--AQIAEGMAFIEERNYIHRDLRAANILVS-DTLSCKIA 159
Query: 150 DFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT-GKP 206
           DFGLAR I    +  +R+    P K  APE  + Y  ++   DVW+ G +  E++T G+ 
Sbjct: 160 DFGLARLI-EDNEXTAREGAKFPIKWTAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRI 217
Query: 207 LFPS 210
            +P 
Sbjct: 218 PYPG 221

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 38/95 (40%), Positives = 56/95 (58%), Gaps = 5/95 (5%)
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           QI+L   Y HSL +++RDLKP NLLID ++  +++ DFG A+ +   +      C    Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRV---KGRTWXLCGTPEY 204
Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
            APE++L   GY+  +D WA+G +  EM  G P F
Sbjct: 205 LAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 88/170 (51%), Gaps = 5/170 (2%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYL-DLDLH 93
           VAIKM+   +  E      I E  ++  L HE +V+L  V + ++ +F++ EY+ +  L 
Sbjct: 51  VAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 107
Query: 94  SFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGL 153
           +++   ++      +  + K +   + Y  S + LHRDL   N L++  +  VK++DFGL
Sbjct: 108 NYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN-DQGVVKVSDFGL 166
Query: 154 ARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           +R +   ++  S    +    +P  +L Y+ +S+  D+WA G +  E+ +
Sbjct: 167 SRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 38/95 (40%), Positives = 56/95 (58%), Gaps = 5/95 (5%)
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           QI+L   Y HSL +++RDLKP NLLID ++  +++ DFG A+ +   +      C    Y
Sbjct: 170 QIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRV---KGRTWXLCGTPEY 225
Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
            APE++L   GY+  +D WA+G +  EM  G P F
Sbjct: 226 LAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 99/184 (53%), Gaps = 16/184 (8%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD---- 89
           KVA+K +    +    P   + E +L+K+L+H+ +VRL  V  +++ ++++ EY++    
Sbjct: 40  KVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAV-VTQEPIYIITEYMENGSL 95
Query: 90  LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLA 149
           +D     +  K T+N L+  A   QI  G+A+      +HRDL+  N+L+     + K+A
Sbjct: 96  VDFLKTPSGIKLTINKLLDMA--AQIAEGMAFIEERNYIHRDLRAANILVS-DTLSCKIA 152
Query: 150 DFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT-GKP 206
           DFGLAR I    +  +R+    P K  APE  + Y  ++   DVW+ G +  E++T G+ 
Sbjct: 153 DFGLARLIE-DNEXTAREGAKFPIKWTAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRI 210
Query: 207 LFPS 210
            +P 
Sbjct: 211 PYPG 214

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 99/184 (53%), Gaps = 16/184 (8%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD---- 89
           KVA+K +    +    P   + E +L+K+L+H+ +VRL  V  +++ ++++ EY++    
Sbjct: 48  KVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAV-VTQEPIYIITEYMENGSL 103
Query: 90  LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLA 149
           +D     +  K T+N L+  A   QI  G+A+      +HRDL+  N+L+     + K+A
Sbjct: 104 VDFLKTPSGIKLTINKLLDMA--AQIAEGMAFIEERNYIHRDLRAANILVS-DTLSCKIA 160
Query: 150 DFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT-GKP 206
           DFGLAR I    +  +R+    P K  APE  + Y  ++   DVW+ G +  E++T G+ 
Sbjct: 161 DFGLARLIE-DNEXTAREGAKFPIKWTAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRI 218
Query: 207 LFPS 210
            +P 
Sbjct: 219 PYPG 222

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 75/317 (23%), Positives = 140/317 (44%), Gaps = 55/317 (17%)
Query: 22  EVYKCRNTVTGQ-KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN---IVRLLDVQSS 77
           +V +C +   G+ +VA+K++    +        I  +  +KE + EN    V + D  + 
Sbjct: 66  KVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF 125
Query: 78  RKDVFLVFEYLDLDLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNN 136
              + + FE L  +   F+  +      L  ++ +  Q+   L + H  ++ H DLKP N
Sbjct: 126 HGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPEN 185
Query: 137 LLI------------------DLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPEL 178
           +L                    +K  ++++ADFG A       + ++       Y+ PE+
Sbjct: 186 ILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA---TFDHEHHTTIVATRHYRPPEV 242
Query: 179 LLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLG-TPT--------- 227
           +L   G++ P DVW++GCI  E   G  LF + ++ +HL ++  +LG  P+         
Sbjct: 243 ILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQ 301
Query: 228 ----------DESWAESTYISE-ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPK 276
                     DE+ ++  Y+ E   PL  +     L +   +++    DL+ +ML  +P 
Sbjct: 302 KYFYKGGLVWDENSSDGRYVKENCKPLKSYM----LQDSLEHVQL--FDLMRRMLEFDPA 355
Query: 277 QRITAMDALKHEYLIGV 293
           QRIT  +AL H +  G+
Sbjct: 356 QRITLAEALLHPFFAGL 372

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 38/95 (40%), Positives = 56/95 (58%), Gaps = 5/95 (5%)
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           QI+L   Y HSL +++RDLKP NLLID ++  +++ DFG A+ +   +      C    Y
Sbjct: 170 QIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRV---KGRTWXLCGTPEY 225
Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
            APE++L   GY+  +D WA+G +  EM  G P F
Sbjct: 226 LAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 99/184 (53%), Gaps = 16/184 (8%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD---- 89
           KVA+K +    +    P   + E +L+K+L+H+ +VRL  V  +++ ++++ EY++    
Sbjct: 39  KVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAV-VTQEPIYIITEYMENGSL 94
Query: 90  LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLA 149
           +D     +  K T+N L+  A   QI  G+A+      +HRDL+  N+L+     + K+A
Sbjct: 95  VDFLKTPSGIKLTINKLLDMA--AQIAEGMAFIEERNYIHRDLRAANILVS-DTLSCKIA 151
Query: 150 DFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT-GKP 206
           DFGLAR I   +   +R+    P K  APE  + Y  ++   DVW+ G +  E++T G+ 
Sbjct: 152 DFGLARLIEDAEXT-AREGAKFPIKWTAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRI 209
Query: 207 LFPS 210
            +P 
Sbjct: 210 PYPG 213

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/183 (32%), Positives = 93/183 (50%), Gaps = 14/183 (7%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DL 92
           +VAIK +   T     P   ++E  ++K+L HE +V+L  V  S + +++V EY+    L
Sbjct: 210 RVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVGEYMSKGSL 265
Query: 93  HSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADF 151
             F+       L L  +  +  QI  G+AY   +  +HRDL+  N+L+  +    K+ADF
Sbjct: 266 LDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADF 324
Query: 152 GLARAIGVPQKEYS-RDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPL 207
           GLAR I     EY+ R     P K  APE  L Y  ++   DVW+ G +  E+ T G+  
Sbjct: 325 GLARLI--EDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVP 381
Query: 208 FPS 210
           +P 
Sbjct: 382 YPG 384

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/183 (32%), Positives = 93/183 (50%), Gaps = 14/183 (7%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DL 92
           +VAIK +   T     P   ++E  ++K+L HE +V+L  V  S + +++V EY+    L
Sbjct: 210 RVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSL 265
Query: 93  HSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADF 151
             F+       L L  +  +  QI  G+AY   +  +HRDL+  N+L+  +    K+ADF
Sbjct: 266 LDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADF 324
Query: 152 GLARAIGVPQKEYS-RDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPL 207
           GLAR I     EY+ R     P K  APE  L Y  ++   DVW+ G +  E+ T G+  
Sbjct: 325 GLARLI--EDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVP 381
Query: 208 FPS 210
           +P 
Sbjct: 382 YPG 384

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 99/184 (53%), Gaps = 16/184 (8%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD---- 89
           KVA+K +    +    P   + E +L+K+L+H+ +VRL  V  +++ ++++ EY++    
Sbjct: 45  KVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAV-VTQEPIYIITEYMENGSL 100
Query: 90  LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLA 149
           +D     +  K T+N L+  A   QI  G+A+      +HRDL+  N+L+     + K+A
Sbjct: 101 VDFLKTPSGIKLTINKLLDMA--AQIAEGMAFIEERNYIHRDLRAANILVS-DTLSCKIA 157
Query: 150 DFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT-GKP 206
           DFGLAR I    +  +R+    P K  APE  + Y  ++   DVW+ G +  E++T G+ 
Sbjct: 158 DFGLARLI-EDNEXTAREGAKFPIKWTAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRI 215
Query: 207 LFPS 210
            +P 
Sbjct: 216 PYPG 219

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 99/184 (53%), Gaps = 16/184 (8%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD---- 89
           KVA+K +    +    P   + E +L+K+L+H+ +VRL  V  +++ ++++ EY++    
Sbjct: 41  KVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAV-VTQEPIYIITEYMENGSL 96
Query: 90  LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLA 149
           +D     +  K T+N L+  A   QI  G+A+      +HRDL+  N+L+     + K+A
Sbjct: 97  VDFLKTPSGIKLTINKLLDMA--AQIAEGMAFIEERNYIHRDLRAANILVS-DTLSCKIA 153
Query: 150 DFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT-GKP 206
           DFGLAR I    +  +R+    P K  APE  + Y  ++   DVW+ G +  E++T G+ 
Sbjct: 154 DFGLARLIE-DNEXTAREGAKFPIKWTAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRI 211
Query: 207 LFPS 210
            +P 
Sbjct: 212 PYPG 215

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 99/184 (53%), Gaps = 16/184 (8%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD---- 89
           KVA+K +    +    P   + E +L+K+L+H+ +VRL  V  +++ ++++ EY++    
Sbjct: 39  KVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAV-VTQEPIYIITEYMENGSL 94
Query: 90  LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLA 149
           +D     +  K T+N L+  A   QI  G+A+      +HRDL+  N+L+     + K+A
Sbjct: 95  VDFLKTPSGIKLTINKLLDMA--AQIAEGMAFIEERNYIHRDLRAANILVS-DTLSCKIA 151
Query: 150 DFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT-GKP 206
           DFGLAR I    +  +R+    P K  APE  + Y  ++   DVW+ G +  E++T G+ 
Sbjct: 152 DFGLARLIE-DNEXTAREGAKFPIKWTAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRI 209
Query: 207 LFPS 210
            +P 
Sbjct: 210 PYPG 213

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 99/184 (53%), Gaps = 16/184 (8%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD---- 89
           KVA+K +    +    P   + E +L+K+L+H+ +VRL  V  +++ ++++ EY++    
Sbjct: 39  KVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAV-VTQEPIYIITEYMENGSL 94
Query: 90  LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLA 149
           +D     +  K T+N L+  A   QI  G+A+      +HRDL+  N+L+     + K+A
Sbjct: 95  VDFLKTPSGIKLTINKLLDMA--AQIAEGMAFIEERNYIHRDLRAANILVS-DTLSCKIA 151
Query: 150 DFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT-GKP 206
           DFGLAR I    +  +R+    P K  APE  + Y  ++   DVW+ G +  E++T G+ 
Sbjct: 152 DFGLARLIE-DNEXTAREGAKFPIKWTAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRI 209
Query: 207 LFPS 210
            +P 
Sbjct: 210 PYPG 213

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 38/95 (40%), Positives = 56/95 (58%), Gaps = 5/95 (5%)
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           QI+L   Y HSL +++RDLKP NLLID ++  +++ DFG A+ +   +      C    Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRV---KGRTWXLCGTPEY 204
Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
            APE++L   GY+  +D WA+G +  EM  G P F
Sbjct: 205 LAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 38/95 (40%), Positives = 56/95 (58%), Gaps = 5/95 (5%)
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           QI+L   Y HSL +++RDLKP NLLID ++  +++ DFG A+ +   +      C    Y
Sbjct: 136 QIVLTFEYLHSLDLIYRDLKPENLLID-EQGYIQVTDFGFAKRV---KGRTWXLCGTPEY 191
Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
            APE++L   GY+  +D WA+G +  EM  G P F
Sbjct: 192 LAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPF 225

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/183 (32%), Positives = 93/183 (50%), Gaps = 14/183 (7%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DL 92
           +VAIK +   T     P   ++E  ++K+L HE +V+L  V  S + +++V EY+    L
Sbjct: 37  RVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSL 92
Query: 93  HSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADF 151
             F+       L L  +  +  QI  G+AY   +  +HRDL+  N+L+  +    K+ADF
Sbjct: 93  LDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADF 151
Query: 152 GLARAIGVPQKEY-SRDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPL 207
           GLAR I     EY +R     P K  APE  L Y  ++   DVW+ G +  E+ T G+  
Sbjct: 152 GLARLI--EDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVP 208
Query: 208 FPS 210
           +P 
Sbjct: 209 YPG 211

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/183 (32%), Positives = 93/183 (50%), Gaps = 14/183 (7%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DL 92
           +VAIK +   T     P   ++E  ++K+L HE +V+L  V  S + +++V EY+    L
Sbjct: 210 RVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSL 265
Query: 93  HSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADF 151
             F+       L L  +  +  QI  G+AY   +  +HRDL+  N+L+  +    K+ADF
Sbjct: 266 LDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADF 324
Query: 152 GLARAIGVPQKEYS-RDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPL 207
           GLAR I     EY+ R     P K  APE  L Y  ++   DVW+ G +  E+ T G+  
Sbjct: 325 GLARLI--EDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVP 381
Query: 208 FPS 210
           +P 
Sbjct: 382 YPG 384

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 91/197 (46%), Gaps = 14/197 (7%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIR---EVSLLKELEHENIVRLLDVQSSR 78
           EV+  R+    + VA+K++     ++  PS+ +R   E      L H  IV + D   + 
Sbjct: 44  EVHLARDLRLHRDVAVKVLRADLARD--PSFYLRFRREAQNAAALNHPAIVAVYDTGEAE 101
Query: 79  KDV----FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKP 134
                  ++V EY+D      I   +  +       ++      L + H   I+HRD+KP
Sbjct: 102 TPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKP 161
Query: 135 NNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVY---SPYKAPELLLGYTGYSTPIDV 191
            N++I    N VK+ DFG+ARAI       ++       + Y +PE   G +      DV
Sbjct: 162 ANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDV 219
Query: 192 WAVGCIFAEMITGKPLF 208
           +++GC+  E++TG+P F
Sbjct: 220 YSLGCVLYEVLTGEPPF 236

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 91/197 (46%), Gaps = 14/197 (7%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIR---EVSLLKELEHENIVRLLDVQSSR 78
           EV+  R+    + VA+K++     ++  PS+ +R   E      L H  IV + D   + 
Sbjct: 27  EVHLARDLRLHRDVAVKVLRADLARD--PSFYLRFRREAQNAAALNHPAIVAVYDTGEAE 84
Query: 79  KDV----FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKP 134
                  ++V EY+D      I   +  +       ++      L + H   I+HRD+KP
Sbjct: 85  TPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKP 144
Query: 135 NNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVY---SPYKAPELLLGYTGYSTPIDV 191
            N++I    N VK+ DFG+ARAI       ++       + Y +PE   G +      DV
Sbjct: 145 ANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDV 202
Query: 192 WAVGCIFAEMITGKPLF 208
           +++GC+  E++TG+P F
Sbjct: 203 YSLGCVLYEVLTGEPPF 219

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 84/169 (49%), Gaps = 21/169 (12%)
Query: 57  VSLLKELEHEN-------------IVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNT 102
           V  LK++EH N             I+R+       + +F++ +Y++  +L S + + +  
Sbjct: 44  VVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF 103
Query: 103 LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK 162
            N  V K    ++ L L Y HS  I++RDLKP N+L+D K   +K+ DFG A+   VP  
Sbjct: 104 PNP-VAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD-KNGHIKITDFGFAKY--VPDV 159
Query: 163 EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITG-KPLFPS 210
            Y   C    Y APE ++    Y+  ID W+ G +  EM+ G  P + S
Sbjct: 160 TYXL-CGTPDYIAPE-VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS 206

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 39/96 (40%), Positives = 58/96 (60%), Gaps = 7/96 (7%)
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP- 172
           QI+L   Y HSL +++RDLKP NLLID ++  +++ DFG A+ +    K  +     +P 
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRV----KGRTWXLAGTPE 203
Query: 173 YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
           Y APE++L   GY+  +D WA+G +  EM  G P F
Sbjct: 204 YLAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/183 (32%), Positives = 93/183 (50%), Gaps = 14/183 (7%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DL 92
           +VAIK +   T     P   ++E  ++K+L HE +V+L  V  S + +++V EY+    L
Sbjct: 44  RVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSL 99
Query: 93  HSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADF 151
             F+       L L  +  +  QI  G+AY   +  +HRDL+  N+L+  +    K+ADF
Sbjct: 100 LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADF 158
Query: 152 GLARAIGVPQKEY-SRDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPL 207
           GLAR I     EY +R     P K  APE  L Y  ++   DVW+ G +  E+ T G+  
Sbjct: 159 GLARLI--EDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVP 215
Query: 208 FPS 210
           +P 
Sbjct: 216 YPG 218

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 81/169 (47%), Gaps = 22/169 (13%)
Query: 56  EVSLLKELEH--ENIVRLLDVQSSRKDVFLVFEYLD--LDLHSFITRHKNTLNLLVIKAI 111
           EV LLK++      ++RLLD         L+ E  +   DL  FIT  +  L   + ++ 
Sbjct: 62  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSF 120
Query: 112 LKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS 171
             Q+L  + +CH+  +LHRD+K  N+LIDL R  +KL DFG    +        +D VY+
Sbjct: 121 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--------KDTVYT 172
Query: 172 P------YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD 214
                  Y  PE +  +  +     VW++G +  +M+ G   F   +HD
Sbjct: 173 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHD 218

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 38/95 (40%), Positives = 56/95 (58%), Gaps = 5/95 (5%)
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           QI+L   Y HSL +++RDLKP NLLID ++  +++ DFG A+ +   +      C    Y
Sbjct: 170 QIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRV---KGATWTLCGTPEY 225
Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
            APE++L   GY+  +D WA+G +  EM  G P F
Sbjct: 226 LAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/183 (32%), Positives = 93/183 (50%), Gaps = 14/183 (7%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DL 92
           +VAIK +   T     P   ++E  ++K+L HE +V+L  V  S + +++V EY+    L
Sbjct: 44  RVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVCEYMSKGSL 99
Query: 93  HSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADF 151
             F+       L L  +  +  QI  G+AY   +  +HRDL+  N+L+  +    K+ADF
Sbjct: 100 LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADF 158
Query: 152 GLARAIGVPQKEY-SRDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPL 207
           GLAR I     EY +R     P K  APE  L Y  ++   DVW+ G +  E+ T G+  
Sbjct: 159 GLARLI--EDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVP 215
Query: 208 FPS 210
           +P 
Sbjct: 216 YPG 218

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 81/169 (47%), Gaps = 22/169 (13%)
Query: 56  EVSLLKELEH--ENIVRLLDVQSSRKDVFLVFEYLD--LDLHSFITRHKNTLNLLVIKAI 111
           EV LLK++      ++RLLD         L+ E  +   DL  FIT  +  L   + ++ 
Sbjct: 84  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSF 142
Query: 112 LKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS 171
             Q+L  + +CH+  +LHRD+K  N+LIDL R  +KL DFG    +        +D VY+
Sbjct: 143 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--------KDTVYT 194
Query: 172 P------YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD 214
                  Y  PE +  +  +     VW++G +  +M+ G   F   +HD
Sbjct: 195 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHD 240

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 37/95 (38%), Positives = 56/95 (58%), Gaps = 5/95 (5%)
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           QI+L   Y HSL +++RDLKP NL+ID ++  +++ DFG A+ +   +      C    Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLMID-QQGYIQVTDFGFAKRV---KGRTWXLCGTPEY 204
Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
            APE++L   GY+  +D WA+G +  EM  G P F
Sbjct: 205 LAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 81/169 (47%), Gaps = 22/169 (13%)
Query: 56  EVSLLKELEH--ENIVRLLDVQSSRKDVFLVFEYLD--LDLHSFITRHKNTLNLLVIKAI 111
           EV LLK++      ++RLLD         L+ E  +   DL  FIT  +  L   + ++ 
Sbjct: 96  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSF 154
Query: 112 LKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS 171
             Q+L  + +CH+  +LHRD+K  N+LIDL R  +KL DFG    +        +D VY+
Sbjct: 155 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--------KDTVYT 206
Query: 172 P------YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD 214
                  Y  PE +  +  +     VW++G +  +M+ G   F   +HD
Sbjct: 207 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHD 252

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/183 (32%), Positives = 93/183 (50%), Gaps = 14/183 (7%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DL 92
           +VAIK +   T     P   ++E  ++K+L HE +V+L  V  S + +++V EY+    L
Sbjct: 33  RVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSL 88
Query: 93  HSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADF 151
             F+       L L  +  +  QI  G+AY   +  +HRDL+  N+L+  +    K+ADF
Sbjct: 89  LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADF 147
Query: 152 GLARAIGVPQKEY-SRDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPL 207
           GLAR I     EY +R     P K  APE  L Y  ++   DVW+ G +  E+ T G+  
Sbjct: 148 GLARLI--EDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVP 204
Query: 208 FPS 210
           +P 
Sbjct: 205 YPG 207

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 81/169 (47%), Gaps = 22/169 (13%)
Query: 56  EVSLLKELEH--ENIVRLLDVQSSRKDVFLVFEYLD--LDLHSFITRHKNTLNLLVIKAI 111
           EV LLK++      ++RLLD         L+ E  +   DL  FIT  +  L   + ++ 
Sbjct: 77  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSF 135
Query: 112 LKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS 171
             Q+L  + +CH+  +LHRD+K  N+LIDL R  +KL DFG    +        +D VY+
Sbjct: 136 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--------KDTVYT 187
Query: 172 P------YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD 214
                  Y  PE +  +  +     VW++G +  +M+ G   F   +HD
Sbjct: 188 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHD 233

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/183 (32%), Positives = 93/183 (50%), Gaps = 14/183 (7%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DL 92
           +VAIK +   T     P   ++E  ++K+L HE +V+L  V  S + +++V EY+    L
Sbjct: 35  RVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSL 90
Query: 93  HSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADF 151
             F+       L L  +  +  QI  G+AY   +  +HRDL+  N+L+  +    K+ADF
Sbjct: 91  LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADF 149
Query: 152 GLARAIGVPQKEY-SRDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPL 207
           GLAR I     EY +R     P K  APE  L Y  ++   DVW+ G +  E+ T G+  
Sbjct: 150 GLARLI--EDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVP 206
Query: 208 FPS 210
           +P 
Sbjct: 207 YPG 209

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 81/169 (47%), Gaps = 22/169 (13%)
Query: 56  EVSLLKELEH--ENIVRLLDVQSSRKDVFLVFEYLD--LDLHSFITRHKNTLNLLVIKAI 111
           EV LLK++      ++RLLD         L+ E  +   DL  FIT  +  L   + ++ 
Sbjct: 61  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSF 119
Query: 112 LKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS 171
             Q+L  + +CH+  +LHRD+K  N+LIDL R  +KL DFG    +        +D VY+
Sbjct: 120 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--------KDTVYT 171
Query: 172 P------YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD 214
                  Y  PE +  +  +     VW++G +  +M+ G   F   +HD
Sbjct: 172 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHD 217

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 81/169 (47%), Gaps = 22/169 (13%)
Query: 56  EVSLLKELEH--ENIVRLLDVQSSRKDVFLVFEYLD--LDLHSFITRHKNTLNLLVIKAI 111
           EV LLK++      ++RLLD         L+ E  +   DL  FIT  +  L   + ++ 
Sbjct: 62  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSF 120
Query: 112 LKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS 171
             Q+L  + +CH+  +LHRD+K  N+LIDL R  +KL DFG    +        +D VY+
Sbjct: 121 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--------KDTVYT 172
Query: 172 P------YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD 214
                  Y  PE +  +  +     VW++G +  +M+ G   F   +HD
Sbjct: 173 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHD 218

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/183 (32%), Positives = 93/183 (50%), Gaps = 14/183 (7%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDLD-L 92
           +VAIK +   T     P   ++E  ++K+L HE +V+L  V  S + +++V EY+    L
Sbjct: 44  RVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGCL 99
Query: 93  HSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADF 151
             F+       L L  +  +  QI  G+AY   +  +HRDL+  N+L+  +    K+ADF
Sbjct: 100 LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADF 158
Query: 152 GLARAIGVPQKEY-SRDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPL 207
           GLAR I     EY +R     P K  APE  L Y  ++   DVW+ G +  E+ T G+  
Sbjct: 159 GLARLI--EDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVP 215
Query: 208 FPS 210
           +P 
Sbjct: 216 YPG 218

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 81/169 (47%), Gaps = 22/169 (13%)
Query: 56  EVSLLKELEH--ENIVRLLDVQSSRKDVFLVFEYLD--LDLHSFITRHKNTLNLLVIKAI 111
           EV LLK++      ++RLLD         L+ E  +   DL  FIT  +  L   + ++ 
Sbjct: 62  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSF 120
Query: 112 LKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS 171
             Q+L  + +CH+  +LHRD+K  N+LIDL R  +KL DFG    +        +D VY+
Sbjct: 121 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--------KDTVYT 172
Query: 172 P------YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD 214
                  Y  PE +  +  +     VW++G +  +M+ G   F   +HD
Sbjct: 173 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHD 218

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 81/169 (47%), Gaps = 22/169 (13%)
Query: 56  EVSLLKELEH--ENIVRLLDVQSSRKDVFLVFEYLD--LDLHSFITRHKNTLNLLVIKAI 111
           EV LLK++      ++RLLD         L+ E  +   DL  FIT  +  L   + ++ 
Sbjct: 104 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSF 162
Query: 112 LKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS 171
             Q+L  + +CH+  +LHRD+K  N+LIDL R  +KL DFG    +        +D VY+
Sbjct: 163 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--------KDTVYT 214
Query: 172 P------YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD 214
                  Y  PE +  +  +     VW++G +  +M+ G   F   +HD
Sbjct: 215 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHD 260

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 81/169 (47%), Gaps = 22/169 (13%)
Query: 56  EVSLLKELEH--ENIVRLLDVQSSRKDVFLVFEYLD--LDLHSFITRHKNTLNLLVIKAI 111
           EV LLK++      ++RLLD         L+ E  +   DL  FIT  +  L   + ++ 
Sbjct: 89  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSF 147
Query: 112 LKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS 171
             Q+L  + +CH+  +LHRD+K  N+LIDL R  +KL DFG    +        +D VY+
Sbjct: 148 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--------KDTVYT 199
Query: 172 P------YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD 214
                  Y  PE +  +  +     VW++G +  +M+ G   F   +HD
Sbjct: 200 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHD 245

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 81/169 (47%), Gaps = 22/169 (13%)
Query: 56  EVSLLKELEH--ENIVRLLDVQSSRKDVFLVFEYLD--LDLHSFITRHKNTLNLLVIKAI 111
           EV LLK++      ++RLLD         L+ E  +   DL  FIT  +  L   + ++ 
Sbjct: 90  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSF 148
Query: 112 LKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS 171
             Q+L  + +CH+  +LHRD+K  N+LIDL R  +KL DFG    +        +D VY+
Sbjct: 149 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--------KDTVYT 200
Query: 172 P------YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD 214
                  Y  PE +  +  +     VW++G +  +M+ G   F   +HD
Sbjct: 201 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHD 246

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 94/182 (51%), Gaps = 12/182 (6%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DL 92
           KVAIK +   T     P   + E  ++K+L+H+ +V+L  V  S + +++V EY++   L
Sbjct: 35  KVAIKTLKPGTMS---PESFLEEAQIMKKLKHDKLVQLYAV-VSEEPIYIVTEYMNKGSL 90
Query: 93  HSFITRHKN-TLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADF 151
             F+   +   L L  +  +  Q+  G+AY   +  +HRDL+  N+L+       K+ADF
Sbjct: 91  LDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVG-NGLICKIADF 149
Query: 152 GLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLF 208
           GLAR I    +  +R     P K  APE  L Y  ++   DVW+ G +  E++T G+  +
Sbjct: 150 GLARLI-EDNEXTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELVTKGRVPY 207
Query: 209 PS 210
           P 
Sbjct: 208 PG 209

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 81/169 (47%), Gaps = 22/169 (13%)
Query: 56  EVSLLKELEH--ENIVRLLDVQSSRKDVFLVFEYLD--LDLHSFITRHKNTLNLLVIKAI 111
           EV LLK++      ++RLLD         L+ E  +   DL  FIT  +  L   + ++ 
Sbjct: 77  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSF 135
Query: 112 LKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS 171
             Q+L  + +CH+  +LHRD+K  N+LIDL R  +KL DFG    +        +D VY+
Sbjct: 136 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--------KDTVYT 187
Query: 172 P------YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD 214
                  Y  PE +  +  +     VW++G +  +M+ G   F   +HD
Sbjct: 188 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHD 233

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 39/96 (40%), Positives = 58/96 (60%), Gaps = 7/96 (7%)
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP- 172
           QI+L   Y HSL +++RDLKP NLLID ++  +++ DFG A+ +    K  +     +P 
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRV----KGRTWXLXGTPE 203
Query: 173 YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
           Y APE++L   GY+  +D WA+G +  EM  G P F
Sbjct: 204 YLAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 81/169 (47%), Gaps = 22/169 (13%)
Query: 56  EVSLLKELEH--ENIVRLLDVQSSRKDVFLVFEYLD--LDLHSFITRHKNTLNLLVIKAI 111
           EV LLK++      ++RLLD         L+ E  +   DL  FIT  +  L   + ++ 
Sbjct: 104 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSF 162
Query: 112 LKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS 171
             Q+L  + +CH+  +LHRD+K  N+LIDL R  +KL DFG    +        +D VY+
Sbjct: 163 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--------KDTVYT 214
Query: 172 P------YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD 214
                  Y  PE +  +  +     VW++G +  +M+ G   F   +HD
Sbjct: 215 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHD 260

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 81/169 (47%), Gaps = 22/169 (13%)
Query: 56  EVSLLKELEH--ENIVRLLDVQSSRKDVFLVFEYLD--LDLHSFITRHKNTLNLLVIKAI 111
           EV LLK++      ++RLLD         L+ E  +   DL  FIT  +  L   + ++ 
Sbjct: 76  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSF 134
Query: 112 LKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS 171
             Q+L  + +CH+  +LHRD+K  N+LIDL R  +KL DFG    +        +D VY+
Sbjct: 135 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--------KDTVYT 186
Query: 172 P------YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD 214
                  Y  PE +  +  +     VW++G +  +M+ G   F   +HD
Sbjct: 187 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHD 232

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/185 (30%), Positives = 100/185 (54%), Gaps = 18/185 (9%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD---- 89
           KVA+K +    +    P   + E +L+K+L+H+ +VRL  V  +++ ++++ EY++    
Sbjct: 35  KVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAV-VTQEPIYIITEYMENGSL 90
Query: 90  LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLA 149
           +D     +  K T+N L+  A   QI  G+A+      +HR+L+  N+L+     + K+A
Sbjct: 91  VDFLKTPSGIKLTINKLLDMA--AQIAEGMAFIEERNYIHRNLRAANILVS-DTLSCKIA 147
Query: 150 DFGLARAIGVPQKEYS-RDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT-GK 205
           DFGLAR I     EY+ R+    P K  APE  + Y  ++   DVW+ G +  E++T G+
Sbjct: 148 DFGLARLI--EDNEYTAREGAKFPIKWTAPE-AINYGTFTIKSDVWSFGILLTEIVTHGR 204
Query: 206 PLFPS 210
             +P 
Sbjct: 205 IPYPG 209

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 81/169 (47%), Gaps = 22/169 (13%)
Query: 56  EVSLLKELEH--ENIVRLLDVQSSRKDVFLVFEYLD--LDLHSFITRHKNTLNLLVIKAI 111
           EV LLK++      ++RLLD         L+ E  +   DL  FIT  +  L   + ++ 
Sbjct: 90  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSF 148
Query: 112 LKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS 171
             Q+L  + +CH+  +LHRD+K  N+LIDL R  +KL DFG    +        +D VY+
Sbjct: 149 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--------KDTVYT 200
Query: 172 P------YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD 214
                  Y  PE +  +  +     VW++G +  +M+ G   F   +HD
Sbjct: 201 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHD 246

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 81/169 (47%), Gaps = 22/169 (13%)
Query: 56  EVSLLKELEH--ENIVRLLDVQSSRKDVFLVFEYLD--LDLHSFITRHKNTLNLLVIKAI 111
           EV LLK++      ++RLLD         L+ E  +   DL  FIT  +  L   + ++ 
Sbjct: 76  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSF 134
Query: 112 LKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS 171
             Q+L  + +CH+  +LHRD+K  N+LIDL R  +KL DFG    +        +D VY+
Sbjct: 135 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--------KDTVYT 186
Query: 172 P------YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD 214
                  Y  PE +  +  +     VW++G +  +M+ G   F   +HD
Sbjct: 187 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHD 232

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 81/169 (47%), Gaps = 22/169 (13%)
Query: 56  EVSLLKELEH--ENIVRLLDVQSSRKDVFLVFEYLD--LDLHSFITRHKNTLNLLVIKAI 111
           EV LLK++      ++RLLD         L+ E  +   DL  FIT  +  L   + ++ 
Sbjct: 90  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSF 148
Query: 112 LKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS 171
             Q+L  + +CH+  +LHRD+K  N+LIDL R  +KL DFG    +        +D VY+
Sbjct: 149 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--------KDTVYT 200
Query: 172 P------YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD 214
                  Y  PE +  +  +     VW++G +  +M+ G   F   +HD
Sbjct: 201 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHD 246

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 81/164 (49%), Gaps = 12/164 (7%)
Query: 56  EVSLLKELEH--ENIVRLLDVQSSRKDVFLVFEYLD--LDLHSFITRHKNTLNLLVIKAI 111
           EV LLK++      ++RLLD         L+ E  +   DL  FIT  +  L   + ++ 
Sbjct: 57  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSF 115
Query: 112 LKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAI-GVPQKEYSRDCVY 170
             Q+L  + +CH+  +LHRD+K  N+LIDL R  +KL DFG    +      ++    VY
Sbjct: 116 FWQVLEAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVY 175
Query: 171 SPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD 214
           SP   PE +  +  +     VW++G +  +M+ G   F   +HD
Sbjct: 176 SP---PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHD 213

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 81/164 (49%), Gaps = 12/164 (7%)
Query: 56  EVSLLKELEH--ENIVRLLDVQSSRKDVFLVFEYLD--LDLHSFITRHKNTLNLLVIKAI 111
           EV LLK++      ++RLLD         L+ E  +   DL  FIT  +  L   + ++ 
Sbjct: 60  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSF 118
Query: 112 LKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAI-GVPQKEYSRDCVY 170
             Q+L  + +CH+  +LHRD+K  N+LIDL R  +KL DFG    +      ++    VY
Sbjct: 119 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVY 178
Query: 171 SPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD 214
           SP   PE +  +  +     VW++G +  +M+ G   F   +HD
Sbjct: 179 SP---PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHD 216

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 81/169 (47%), Gaps = 22/169 (13%)
Query: 56  EVSLLKELEH--ENIVRLLDVQSSRKDVFLVFEYLD--LDLHSFITRHKNTLNLLVIKAI 111
           EV LLK++      ++RLLD         L+ E  +   DL  FIT  +  L   + ++ 
Sbjct: 90  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSF 148
Query: 112 LKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS 171
             Q+L  + +CH+  +LHRD+K  N+LIDL R  +KL DFG    +        +D VY+
Sbjct: 149 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--------KDTVYT 200
Query: 172 P------YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD 214
                  Y  PE +  +  +     VW++G +  +M+ G   F   +HD
Sbjct: 201 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHD 246

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 81/164 (49%), Gaps = 12/164 (7%)
Query: 56  EVSLLKELEH--ENIVRLLDVQSSRKDVFLVFEYLD--LDLHSFITRHKNTLNLLVIKAI 111
           EV LLK++      ++RLLD         L+ E  +   DL  FIT  +  L   + ++ 
Sbjct: 57  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSF 115
Query: 112 LKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAI-GVPQKEYSRDCVY 170
             Q+L  + +CH+  +LHRD+K  N+LIDL R  +KL DFG    +      ++    VY
Sbjct: 116 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVY 175
Query: 171 SPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD 214
           SP   PE +  +  +     VW++G +  +M+ G   F   +HD
Sbjct: 176 SP---PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHD 213

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 81/169 (47%), Gaps = 22/169 (13%)
Query: 56  EVSLLKELEH--ENIVRLLDVQSSRKDVFLVFEYLD--LDLHSFITRHKNTLNLLVIKAI 111
           EV LLK++      ++RLLD         L+ E  +   DL  FIT  +  L   + ++ 
Sbjct: 89  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSF 147
Query: 112 LKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS 171
             Q+L  + +CH+  +LHRD+K  N+LIDL R  +KL DFG    +        +D VY+
Sbjct: 148 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--------KDTVYT 199
Query: 172 P------YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD 214
                  Y  PE +  +  +     VW++G +  +M+ G   F   +HD
Sbjct: 200 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHD 245

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 81/164 (49%), Gaps = 12/164 (7%)
Query: 56  EVSLLKELEH--ENIVRLLDVQSSRKDVFLVFEYLD--LDLHSFITRHKNTLNLLVIKAI 111
           EV LLK++      ++RLLD         L+ E  +   DL  FIT  +  L   + ++ 
Sbjct: 57  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSF 115
Query: 112 LKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAI-GVPQKEYSRDCVY 170
             Q+L  + +CH+  +LHRD+K  N+LIDL R  +KL DFG    +      ++    VY
Sbjct: 116 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVY 175
Query: 171 SPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD 214
           SP   PE +  +  +     VW++G +  +M+ G   F   +HD
Sbjct: 176 SP---PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHD 213

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 81/169 (47%), Gaps = 22/169 (13%)
Query: 56  EVSLLKELEH--ENIVRLLDVQSSRKDVFLVFEYLD--LDLHSFITRHKNTLNLLVIKAI 111
           EV LLK++      ++RLLD         L+ E  +   DL  FIT  +  L   + ++ 
Sbjct: 77  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSF 135
Query: 112 LKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS 171
             Q+L  + +CH+  +LHRD+K  N+LIDL R  +KL DFG    +        +D VY+
Sbjct: 136 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--------KDTVYT 187
Query: 172 P------YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD 214
                  Y  PE +  +  +     VW++G +  +M+ G   F   +HD
Sbjct: 188 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHD 233

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 81/169 (47%), Gaps = 22/169 (13%)
Query: 56  EVSLLKELEH--ENIVRLLDVQSSRKDVFLVFEYLD--LDLHSFITRHKNTLNLLVIKAI 111
           EV LLK++      ++RLLD         L+ E  +   DL  FIT  +  L   + ++ 
Sbjct: 89  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSF 147
Query: 112 LKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS 171
             Q+L  + +CH+  +LHRD+K  N+LIDL R  +KL DFG    +        +D VY+
Sbjct: 148 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--------KDTVYT 199
Query: 172 P------YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD 214
                  Y  PE +  +  +     VW++G +  +M+ G   F   +HD
Sbjct: 200 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHD 245

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/182 (31%), Positives = 92/182 (50%), Gaps = 12/182 (6%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DL 92
           +VAIK +   T     P   ++E  ++K+L HE +V+L  V  S + +++V EY+    L
Sbjct: 44  RVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVIEYMSKGSL 99
Query: 93  HSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADF 151
             F+       L L  +  +  QI  G+AY   +  +HRDL+  N+L+  +    K+ADF
Sbjct: 100 LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADF 158
Query: 152 GLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLF 208
           GLAR I    +  +R     P K  APE  L Y  ++   DVW+ G +  E+ T G+  +
Sbjct: 159 GLARLI-EDNEXTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPY 216
Query: 209 PS 210
           P 
Sbjct: 217 PG 218

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/260 (28%), Positives = 109/260 (41%), Gaps = 31/260 (11%)
Query: 55  REVSL-LKELEHENIVRLLDVQ----SSRKDVFLVFEYLDL-DLHSFIT-RHKNTLNLLV 107
           REV L  +  +  +IVR++DV     + RK + +V E LD  +L S I  R         
Sbjct: 103 REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTERE 162
Query: 108 IKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNT--VKLADFGLARAIGVPQKEYS 165
              I K I   + Y HS+ I HRD+KP NLL   KR    +KL DFG A+         +
Sbjct: 163 ASEIXKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-TSHNSLT 221
Query: 166 RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGT 225
             C Y+PY     +LG   Y    D W++G I   ++ G P F S           L  +
Sbjct: 222 TPC-YTPYYVAPEVLGPEKYDKSCDXWSLGVIXYILLCGYPPFYSN--------HGLAIS 272
Query: 226 PTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDAL 285
           P        T I      +P+ E + ++E+          L+  +L   P QR T  +  
Sbjct: 273 P-----GXKTRIRXGQYEFPNPEWSEVSEEVKX-------LIRNLLKTEPTQRXTITEFX 320
Query: 286 KHEYLIGVENVPLVILLINR 305
            H ++     VP   L  +R
Sbjct: 321 NHPWIXQSTKVPQTPLHTSR 340

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 81/169 (47%), Gaps = 22/169 (13%)
Query: 56  EVSLLKELEH--ENIVRLLDVQSSRKDVFLVFEYLD--LDLHSFITRHKNTLNLLVIKAI 111
           EV LLK++      ++RLLD         L+ E  +   DL  FIT  +  L   + ++ 
Sbjct: 109 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSF 167
Query: 112 LKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS 171
             Q+L  + +CH+  +LHRD+K  N+LIDL R  +KL DFG    +        +D VY+
Sbjct: 168 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--------KDTVYT 219
Query: 172 P------YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD 214
                  Y  PE +  +  +     VW++G +  +M+ G   F   +HD
Sbjct: 220 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHD 265

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 81/169 (47%), Gaps = 22/169 (13%)
Query: 56  EVSLLKELEH--ENIVRLLDVQSSRKDVFLVFEYLD--LDLHSFITRHKNTLNLLVIKAI 111
           EV LLK++      ++RLLD         L+ E  +   DL  FIT  +  L   + ++ 
Sbjct: 89  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSF 147
Query: 112 LKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS 171
             Q+L  + +CH+  +LHRD+K  N+LIDL R  +KL DFG    +        +D VY+
Sbjct: 148 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--------KDTVYT 199
Query: 172 P------YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD 214
                  Y  PE +  +  +     VW++G +  +M+ G   F   +HD
Sbjct: 200 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHD 245

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 81/169 (47%), Gaps = 22/169 (13%)
Query: 56  EVSLLKELEH--ENIVRLLDVQSSRKDVFLVFEYLD--LDLHSFITRHKNTLNLLVIKAI 111
           EV LLK++      ++RLLD         L+ E  +   DL  FIT  +  L   + ++ 
Sbjct: 104 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSF 162
Query: 112 LKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS 171
             Q+L  + +CH+  +LHRD+K  N+LIDL R  +KL DFG    +        +D VY+
Sbjct: 163 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--------KDTVYT 214
Query: 172 P------YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD 214
                  Y  PE +  +  +     VW++G +  +M+ G   F   +HD
Sbjct: 215 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHD 260

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 105/208 (50%), Gaps = 14/208 (6%)
Query: 22  EVYKCRNTVTGQK---VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR 78
           EV   R  V G++   VAIK +      +    ++  E S++ + +H NI+ L  V +  
Sbjct: 44  EVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFL-SEASIMGQFDHPNIIHLEGVVTKC 102
Query: 79  KDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
           K V ++ EY++   L +F+ ++     ++ +  +L+ I  G+ Y   +  +HRDL   N+
Sbjct: 103 KPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSAVHRDLAARNI 162
Query: 138 LIDLKRNTV-KLADFGLARAI-GVPQKEYSRDCVYSP--YKAPELLLGYTGYSTPIDVWA 193
           L++   N V K++DFG++R +   P+  Y+      P  + APE  + Y  +++  DVW+
Sbjct: 163 LVN--SNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPE-AIAYRKFTSASDVWS 219
Query: 194 VGCIFAEMIT--GKPLFPSKKHDHLSLI 219
            G +  E+++   +P +     D +  I
Sbjct: 220 YGIVMWEVMSYGERPYWDMSNQDVIKAI 247

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 93/178 (52%), Gaps = 10/178 (5%)
Query: 53  IIREVSLLKELEHENIVRLLDV--QSSRKDVFLVFEYLDLDLHSFI-TRHKNTLNLLVIK 109
           + +E+ LL+ L H+N+++L+DV     ++ +++V EY    +   + +  +    +    
Sbjct: 53  VKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAH 112
Query: 110 AILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAI-GVPQKEYSRDC 168
               Q++ GL Y HS  I+H+D+KP NLL+     T+K++  G+A A+      +  R  
Sbjct: 113 GYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTG-GTLKISALGVAEALHPFAADDTCRTS 171
Query: 169 VYSP-YKAPELLLGYTGYST-PIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLG 224
             SP ++ PE+  G   +S   +D+W+ G     + TG  L+P +  D++  +F  +G
Sbjct: 172 QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG--LYPFEG-DNIYKLFENIG 226

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 134/296 (45%), Gaps = 48/296 (16%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           EVYK  +  T + VAIK++ ++  ++ +   I +E+++L + +   I R          +
Sbjct: 34  EVYKGIDNHTKEVVAIKIIDLEEAEDEI-EDIQQEITVLSQCDSPYITRYFGSYLKSTKL 92
Query: 82  FLVFEYLD----LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
           +++ EYL     LDL          L    I  IL++IL GL Y HS + +HRD+K  N+
Sbjct: 93  WIIMEYLGGGSALDLLK-----PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANV 147
Query: 138 LIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCI 197
           L+  ++  VKLADFG+A  +   Q + +       + APE ++  + Y    D+W++G  
Sbjct: 148 LLS-EQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE-VIKQSAYDFKADIWSLGIT 205
Query: 198 FAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFP 257
             E+  G+P  P+     + ++F                      L P   P       P
Sbjct: 206 AIELAKGEP--PNSDLHPMRVLF----------------------LIPKNSP-------P 234
Query: 258 NLEPAGVDLLSQML--CLN--PKQRITAMDALKHEYLIG-VENVPLVILLINRKKK 308
            LE        + +  CLN  P+ R TA + LKH+++    +    +  LI+R K+
Sbjct: 235 TLEGQHSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTKKTSFLTELIDRYKR 290

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 105/208 (50%), Gaps = 14/208 (6%)
Query: 22  EVYKCRNTVTGQK---VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR 78
           EV   R  V G++   VAIK +      +    ++  E S++ + +H NI+ L  V +  
Sbjct: 23  EVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFL-SEASIMGQFDHPNIIHLEGVVTKC 81
Query: 79  KDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
           K V ++ EY++   L +F+ ++     ++ +  +L+ I  G+ Y   +  +HRDL   N+
Sbjct: 82  KPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYVHRDLAARNI 141
Query: 138 LIDLKRNTV-KLADFGLARAI-GVPQKEYSRDCVYSP--YKAPELLLGYTGYSTPIDVWA 193
           L++   N V K++DFG++R +   P+  Y+      P  + APE  + Y  +++  DVW+
Sbjct: 142 LVN--SNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPE-AIAYRKFTSASDVWS 198
Query: 194 VGCIFAEMIT--GKPLFPSKKHDHLSLI 219
            G +  E+++   +P +     D +  I
Sbjct: 199 YGIVMWEVMSYGERPYWDMSNQDVIKAI 226

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 97/200 (48%), Gaps = 6/200 (3%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           V+K  +  +G  +A K++ ++  +  + + IIRE+ +L E     IV       S  ++ 
Sbjct: 84  VFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 142
Query: 83  LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSL-KILHRDLKPNNLLIDL 141
           +  E++D      + +    +   ++  +   ++ GL Y     KI+HRD+KP+N+L++ 
Sbjct: 143 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN- 201
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
            R  +KL DFG++  + +     S     S Y +PE L G T YS   D+W++G    EM
Sbjct: 202 SRGEIKLCDFGVSGQL-IDSMANSFVGTRS-YMSPERLQG-THYSVQSDIWSMGLSLVEM 258
Query: 202 ITGKPLFPSKKHDHLSLIFS 221
             G+   P      L L+F 
Sbjct: 259 AVGRYPIPPPDAKELELMFG 278

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 76/311 (24%), Positives = 133/311 (42%), Gaps = 56/311 (18%)
Query: 32  GQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN---IVRLLDVQSSRKDVFLVFEYL 88
           G +VA+K++    + +      I  +  + E + +N    V++ D       + + FE L
Sbjct: 59  GARVALKIIKNVEKYKEAARLEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELL 118
Query: 89  DLDLHSFITRHKNTLNLLV--IKAILKQILLGLAYCHSLKILHRDLKPNNLLI------- 139
            L    F+ +  N L   +  ++ +  Q+   + + H  K+ H DLKP N+L        
Sbjct: 119 GLSTFDFL-KDNNYLPYPIHQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYEL 177
Query: 140 -----------DLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTP 188
                       +K   V++ DFG A       + +S       Y+APE++L   G+S P
Sbjct: 178 TYNLEKKRDERSVKSTAVRVVDFGSA---TFDHEHHSTIVSTRHYRAPEVILE-LGWSQP 233
Query: 189 IDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLG-TPT------------------- 227
            DVW++GCI  E   G  LF +  + +HL+++  +LG  P+                   
Sbjct: 234 CDVWSIGCIIFEYYVGFTLFQTHDNREHLAMMERILGPIPSRMIRKTRKQKYFYRGRLDW 293
Query: 228 DESWAESTYISE-ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK 286
           DE+ +   Y+ E   PL  +    + AE+   L     DL+  ML   P +R+T  +AL+
Sbjct: 294 DENTSAGRYVRENCKPLRRYL--TSEAEEHHQL----FDLIESMLEYEPAKRLTLGEALQ 347
Query: 287 HEYLIGVENVP 297
           H +   +   P
Sbjct: 348 HPFFARLRAEP 358

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 97/192 (50%), Gaps = 10/192 (5%)
Query: 22  EVYKCRNTVTGQ----KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS 77
           +V K     TG+    KV  K M ++  ++   ++   E ++L+E++H  IV L+    +
Sbjct: 35  QVRKVTGANTGKIFAMKVLKKAMIVRNAKD--TAHTKAERNILEEVKHPFIVDLIYAFQT 92
Query: 78  RKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAI-LKQILLGLAYCHSLKILHRDLKPNN 136
              ++L+ EYL      F+   +  + +       L +I + L + H   I++RDLKP N
Sbjct: 93  GGKLYLILEYLSGG-ELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPEN 151
Query: 137 LLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGC 196
           ++++  +  VKL DFGL +            C    Y APE+L+  +G++  +D W++G 
Sbjct: 152 IMLN-HQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILM-RSGHNRAVDWWSLGA 209
Query: 197 IFAEMITGKPLF 208
           +  +M+TG P F
Sbjct: 210 LMYDMLTGAPPF 221

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/183 (32%), Positives = 94/183 (51%), Gaps = 14/183 (7%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DL 92
           +VAIK +   T     P   ++E  ++K+L HE +V+L  V  S + +++V EY++   L
Sbjct: 41  RVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVTEYMNKGSL 96
Query: 93  HSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADF 151
             F+       L L  +  +  QI  G+AY   +  +HRDL+  N+L+  +    K+ADF
Sbjct: 97  LDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADF 155
Query: 152 GLARAIGVPQKEYS-RDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPL 207
           GLAR I     E++ R     P K  APE  L Y  ++   DVW+ G +  E+ T G+  
Sbjct: 156 GLARLI--EDNEWTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVP 212
Query: 208 FPS 210
           +P 
Sbjct: 213 YPG 215

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 105/208 (50%), Gaps = 14/208 (6%)
Query: 22  EVYKCRNTVTGQK---VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR 78
           EV   R  V G++   VAIK +      +    ++  E S++ + +H NI+ L  V +  
Sbjct: 29  EVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFL-SEASIMGQFDHPNIIHLEGVVTKC 87
Query: 79  KDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
           K V ++ EY++   L +F+ ++     ++ +  +L+ I  G+ Y   +  +HRDL   N+
Sbjct: 88  KPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYVHRDLAARNI 147
Query: 138 LIDLKRNTV-KLADFGLARAI-GVPQKEYSRDCVYSP--YKAPELLLGYTGYSTPIDVWA 193
           L++   N V K++DFG++R +   P+  Y+      P  + APE  + Y  +++  DVW+
Sbjct: 148 LVN--SNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPE-AIAYRKFTSASDVWS 204
Query: 194 VGCIFAEMIT--GKPLFPSKKHDHLSLI 219
            G +  E+++   +P +     D +  I
Sbjct: 205 YGIVMWEVMSYGERPYWDMSNQDVIKAI 232

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 27/203 (13%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKD- 80
           +VYK R+  TGQ  AIK+M +  ++E     I +E+++LK+  H   +        +K+ 
Sbjct: 39  QVYKGRHVKTGQLAAIKVMDVTGDEE---EEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95
Query: 81  ------VFLVFEYLDLDLHSFITRHK--NTLNLLVIKAILKQILLGLAYCHSLKILHRDL 132
                 ++LV E+      + + ++   NTL    I  I ++IL GL++ H  K++HRD+
Sbjct: 96  PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDI 155
Query: 133 KPNNLLIDLKRNTVKLADFG----LARAIGVPQKEYSRDCVYSPY-KAPELLLGYTG--- 184
           K  N+L+  +   VKL DFG    L R +G          + +PY  APE++        
Sbjct: 156 KGQNVLL-TENAEVKLVDFGVSAQLDRTVG-----RRNTFIGTPYWMAPEVIACDENPDA 209
Query: 185 -YSTPIDVWAVGCIFAEMITGKP 206
            Y    D+W++G    EM  G P
Sbjct: 210 TYDFKSDLWSLGITAIEMAEGAP 232

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 37/95 (38%), Positives = 56/95 (58%), Gaps = 5/95 (5%)
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           QI+L   Y HSL +++RDLKP NLLID ++  +++ DFG A+ +   +      C    Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRV---KGRTWXLCGTPEY 204
Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
            APE++L   GY+  +D WA+G +  +M  G P F
Sbjct: 205 LAPEIILS-KGYNKAVDWWALGVLIYQMAAGYPPF 238

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 97/192 (50%), Gaps = 10/192 (5%)
Query: 22  EVYKCRNTVTGQ----KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS 77
           +V K     TG+    KV  K M ++  ++   ++   E ++L+E++H  IV L+    +
Sbjct: 35  QVRKVTGANTGKIFAMKVLKKAMIVRNAKD--TAHTKAERNILEEVKHPFIVDLIYAFQT 92
Query: 78  RKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAI-LKQILLGLAYCHSLKILHRDLKPNN 136
              ++L+ EYL      F+   +  + +       L +I + L + H   I++RDLKP N
Sbjct: 93  GGKLYLILEYLSGG-ELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPEN 151
Query: 137 LLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGC 196
           ++++  +  VKL DFGL +            C    Y APE+L+  +G++  +D W++G 
Sbjct: 152 IMLN-HQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILM-RSGHNRAVDWWSLGA 209
Query: 197 IFAEMITGKPLF 208
           +  +M+TG P F
Sbjct: 210 LMYDMLTGAPPF 221

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 87/170 (51%), Gaps = 5/170 (2%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYL-DLDLH 93
           VAIKM+   +  E      I E  ++  L HE +V+L  V + ++ +F++ EY+ +  L 
Sbjct: 51  VAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 107
Query: 94  SFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGL 153
           +++   ++      +  + K +   + Y  S + LHRDL   N L++  +  VK++DFGL
Sbjct: 108 NYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN-DQGVVKVSDFGL 166
Query: 154 ARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           +R +   +   S    +    +P  +L Y+ +S+  D+WA G +  E+ +
Sbjct: 167 SRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/183 (32%), Positives = 93/183 (50%), Gaps = 14/183 (7%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DL 92
           +VAIK +   T     P   ++E  ++K++ HE +V+L  V  S + +++V EY+    L
Sbjct: 44  RVAIKTLKPGTMS---PEAFLQEAQVMKKIRHEKLVQLYAV-VSEEPIYIVTEYMSKGSL 99
Query: 93  HSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADF 151
             F+       L L  +  +  QI  G+AY   +  +HRDL+  N+L+  +    K+ADF
Sbjct: 100 LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADF 158
Query: 152 GLARAIGVPQKEY-SRDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPL 207
           GLAR I     EY +R     P K  APE  L Y  ++   DVW+ G +  E+ T G+  
Sbjct: 159 GLARLI--EDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVP 215
Query: 208 FPS 210
           +P 
Sbjct: 216 YPG 218

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/183 (32%), Positives = 92/183 (50%), Gaps = 14/183 (7%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DL 92
           +VAIK +   T     P   ++E  ++K+L HE +V+L  V  S + +++V EY+    L
Sbjct: 44  RVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSL 99
Query: 93  HSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADF 151
             F+       L L  +  +  QI  G+AY   +  +HRDL   N+L+  +    K+ADF
Sbjct: 100 LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLAAANILVG-ENLVCKVADF 158
Query: 152 GLARAIGVPQKEY-SRDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPL 207
           GLAR I     EY +R     P K  APE  L Y  ++   DVW+ G +  E+ T G+  
Sbjct: 159 GLARLI--EDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVP 215
Query: 208 FPS 210
           +P 
Sbjct: 216 YPG 218

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 87/170 (51%), Gaps = 5/170 (2%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYL-DLDLH 93
           VAIKM+   +  E      I E  ++  L HE +V+L  V + ++ +F++ EY+ +  L 
Sbjct: 42  VAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 98
Query: 94  SFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGL 153
           +++   ++      +  + K +   + Y  S + LHRDL   N L++  +  VK++DFGL
Sbjct: 99  NYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN-DQGVVKVSDFGL 157
Query: 154 ARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           +R +   +   S    +    +P  +L Y+ +S+  D+WA G +  E+ +
Sbjct: 158 SRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 207

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 87/170 (51%), Gaps = 5/170 (2%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYL-DLDLH 93
           VAIKM+   +  E      I E  ++  L HE +V+L  V + ++ +F++ EY+ +  L 
Sbjct: 36  VAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 92
Query: 94  SFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGL 153
           +++   ++      +  + K +   + Y  S + LHRDL   N L++  +  VK++DFGL
Sbjct: 93  NYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN-DQGVVKVSDFGL 151
Query: 154 ARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           +R +   +   S    +    +P  +L Y+ +S+  D+WA G +  E+ +
Sbjct: 152 SRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 97/200 (48%), Gaps = 6/200 (3%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           V+K  +  +G  +A K++ ++  +  + + IIRE+ +L E     IV       S  ++ 
Sbjct: 49  VFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 107
Query: 83  LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSL-KILHRDLKPNNLLIDL 141
           +  E++D      + +    +   ++  +   ++ GL Y     KI+HRD+KP+N+L++ 
Sbjct: 108 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN- 166
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
            R  +KL DFG++  + +     S     S Y +PE L G T YS   D+W++G    EM
Sbjct: 167 SRGEIKLCDFGVSGQL-IDSMANSFVGTRS-YMSPERLQG-THYSVQSDIWSMGLSLVEM 223
Query: 202 ITGKPLFPSKKHDHLSLIFS 221
             G+   P      L L+F 
Sbjct: 224 AVGRYPIPPPDAKELELMFG 243

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 56/95 (58%), Gaps = 5/95 (5%)
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           QI+L   Y HSL +++RDLKP NL+ID ++  +++ DFG A+ +   +      C    Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLIID-QQGYIQVTDFGFAKRV---KGRTWXLCGTPEY 204
Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
            APE+++   GY+  +D WA+G +  EM  G P F
Sbjct: 205 LAPEIIIS-KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 89/172 (51%), Gaps = 9/172 (5%)
Query: 35  VAIKMMTIQTEQEGVPSY--IIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYL-DLD 91
           VAIKM+     +EG  S    I E  ++  L HE +V+L  V + ++ +F++ EY+ +  
Sbjct: 31  VAIKMI-----KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC 85
Query: 92  LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADF 151
           L +++   ++      +  + K +   + Y  S + LHRDL   N L++  +  VK++DF
Sbjct: 86  LLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN-DQGVVKVSDF 144
Query: 152 GLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           GL+R +   +   S    +    +P  +L Y+ +S+  D+WA G +  E+ +
Sbjct: 145 GLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 196

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 89/172 (51%), Gaps = 9/172 (5%)
Query: 35  VAIKMMTIQTEQEGVPSY--IIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYL-DLD 91
           VAIKM+     +EG  S    I E  ++  L HE +V+L  V + ++ +F++ EY+ +  
Sbjct: 35  VAIKMI-----KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC 89
Query: 92  LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADF 151
           L +++   ++      +  + K +   + Y  S + LHRDL   N L++  +  VK++DF
Sbjct: 90  LLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN-DQGVVKVSDF 148
Query: 152 GLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           GL+R +   +   S    +    +P  +L Y+ +S+  D+WA G +  E+ +
Sbjct: 149 GLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 200

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 89/187 (47%), Gaps = 10/187 (5%)
Query: 31  TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL 90
           +GQ +A+K +    +++     ++    +++  +   IV+         D ++  E +  
Sbjct: 46  SGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST 105
Query: 91  DLHSFITRHKNTLNLLVIKAILKQILLGLAYC-----HSLKILHRDLKPNNLLIDLKRNT 145
               F     + L+ ++ + IL +I L           +LKI+HRD+KP+N+L+D   N 
Sbjct: 106 SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGN- 164
Query: 146 VKLADFGLARAIGVPQKEYSRDCVYSPYKAPELL---LGYTGYSTPIDVWAVGCIFAEMI 202
           +KL DFG++  + V     +RD    PY APE +       GY    DVW++G    E+ 
Sbjct: 165 IKLCDFGISGQL-VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELA 223
Query: 203 TGKPLFP 209
           TG+  +P
Sbjct: 224 TGRFPYP 230

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/186 (31%), Positives = 99/186 (53%), Gaps = 13/186 (6%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYL-DLDL 92
           KVA+K  T++     V +++  E +L+K L+H+ +VRL  V +  + ++++ EY+    L
Sbjct: 39  KVAVK--TLKPGTMSVQAFL-EEANLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSL 95
Query: 93  HSFITRHKNTLNLL-VIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADF 151
             F+   +    LL  +     QI  G+AY      +HRDL+  N+L+  +    K+ADF
Sbjct: 96  LDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVS-ESLMCKIADF 154
Query: 152 GLARAIGVPQKEY-SRDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPL 207
           GLAR I     EY +R+    P K  APE  + +  ++   DVW+ G +  E++T GK  
Sbjct: 155 GLARVI--EDNEYTAREGAKFPIKWTAPE-AINFGCFTIKSDVWSFGILLYEIVTYGKIP 211
Query: 208 FPSKKH 213
           +P + +
Sbjct: 212 YPGRTN 217

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 97/200 (48%), Gaps = 6/200 (3%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           V K ++  +G  +A K++ ++  +  + + IIRE+ +L E     IV       S  ++ 
Sbjct: 32  VTKVQHRPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 90
Query: 83  LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSL-KILHRDLKPNNLLIDL 141
           +  E++D      + +    +   ++  +   +L GLAY     +I+HRD+KP+N+L++ 
Sbjct: 91  ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVN- 149
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
            R  +KL DFG++  + +     S     S Y APE L G T YS   D+W++G    E+
Sbjct: 150 SRGEIKLCDFGVSGQL-IDSMANSFVGTRS-YMAPERLQG-THYSVQSDIWSMGLSLVEL 206
Query: 202 ITGKPLFPSKKHDHLSLIFS 221
             G+   P      L  IF 
Sbjct: 207 AVGRYPIPPPDAKELEAIFG 226

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 37/95 (38%), Positives = 55/95 (57%), Gaps = 5/95 (5%)
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           QI+L   Y HSL +++RDLKP NLLID ++  +++ DFG A+ +   +      C    Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRV---KGRTWXLCGTPEY 204
Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
            AP ++L   GY+  +D WA+G +  EM  G P F
Sbjct: 205 LAPAIILS-KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 22  EVYKCRNTVTGQK---VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR 78
           EV + R    G+K   VAIK +     +     ++  E S++ + EH NI+RL  V ++ 
Sbjct: 29  EVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFL-SEASIMGQFEHPNIIRLEGVVTNS 87
Query: 79  KDVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
             V ++ E+++   L SF+  +     ++ +  +L+ I  G+ Y   +  +HRDL   N+
Sbjct: 88  MPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVHRDLAARNI 147
Query: 138 LIDLKRNTV-KLADFGLARAIGVPQKEYSRDCVYSP---------YKAPELLLGYTGYST 187
           L++   N V K++DFGL+R +    +E S D  Y+          + APE  + +  +++
Sbjct: 148 LVN--SNLVCKVSDFGLSRFL----EENSSDPTYTSSLGGKIPIRWTAPE-AIAFRKFTS 200
Query: 188 PIDVWAVGCIFAEMIT--GKPLFPSKKHDHLSLI 219
             D W+ G +  E+++   +P +     D ++ I
Sbjct: 201 ASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAI 234

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 93/182 (51%), Gaps = 13/182 (7%)
Query: 31  TGQKVAIKMMTIQ--TEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYL 88
           T +  A+K M  Q   E+  V + + +E+ +++ LEH  +V L       +D+F+V + L
Sbjct: 39  TKKMYAMKYMNKQKCVERNEVRN-VFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLL 97
Query: 89  ---DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNT 145
              DL  H     H        +K  + ++++ L Y  + +I+HRD+KP+N+L+D +   
Sbjct: 98  LGGDLRYHLQQNVH---FKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLD-EHGH 153
Query: 146 VKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGY--TGYSTPIDVWAVGCIFAEMIT 203
           V + DF +A A+   + + +      PY APE+       GYS  +D W++G    E++ 
Sbjct: 154 VHITDFNIA-AMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLR 212
Query: 204 GK 205
           G+
Sbjct: 213 GR 214

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/142 (32%), Positives = 79/142 (55%), Gaps = 5/142 (3%)
Query: 56  EVSLLKELEHENIVRLLDVQSSRKDVFLVFEY--LDLDLHSFITRHKNTLNLLVIKAILK 113
           E+++L  +EH NI+++LD+  ++    LV E     LDL +FI RH   L+  +   I +
Sbjct: 79  EIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR-LDEPLASYIFR 137
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           Q++  + Y     I+HRD+K  N++I  +  T+KL DFG A  +   +  Y+  C    Y
Sbjct: 138 QLVSAVGYLRLKDIIHRDIKDENIVI-AEDFTIKLIDFGSAAYLERGKLFYTF-CGTIEY 195
Query: 174 KAPELLLGYTGYSTPIDVWAVG 195
            APE+L+G       +++W++G
Sbjct: 196 CAPEVLMGNPYRGPELEMWSLG 217

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 105/209 (50%), Gaps = 18/209 (8%)
Query: 22  EVYKCRNTVTGQKVAIKMM---TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR 78
           EVY+         VA+K +   T++ E+       ++E +++KE++H N+V+LL V +  
Sbjct: 29  EVYEGVWKKYSLTVAVKTLKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGVCTRE 82
Query: 79  KDVFLVFEYLDL-DLHSFITR-HKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNN 136
              +++ E++   +L  ++   ++  +N +V+  +  QI   + Y      +HRDL   N
Sbjct: 83  PPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARN 142
Query: 137 LLIDLKRNTVKLADFGLARAI-GVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVG 195
            L+  + + VK+ADFGL+R + G     ++       + APE  L Y  +S   DVWA G
Sbjct: 143 CLVG-ENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFG 200
Query: 196 CIFAEMIT-GKPLFPSKKHDHLSLIFSLL 223
            +  E+ T G   +P      LS ++ LL
Sbjct: 201 VLLWEIATYGMSPYPGID---LSQVYELL 226

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 94/185 (50%), Gaps = 8/185 (4%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           V+K  +  +G  +A K++ ++  +  + + IIRE+ +L E     IV       S  ++ 
Sbjct: 25  VFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 83
Query: 83  LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSL-KILHRDLKPNNLLIDL 141
           +  E++D      + +    +   ++  +   ++ GL Y     KI+HRD+KP+N+L++ 
Sbjct: 84  ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN- 142
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYS-PYKAPELLLGYTGYSTPIDVWAVGCIFAE 200
            R  +KL DFG++   G    E + + V +  Y +PE L G T YS   D+W++G    E
Sbjct: 143 SRGEIKLCDFGVS---GQLIDEMANEFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVE 198
Query: 201 MITGK 205
           M  G+
Sbjct: 199 MAVGR 203

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/182 (31%), Positives = 91/182 (50%), Gaps = 12/182 (6%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DL 92
           +VAIK +   T     P   ++E  ++K+L HE +V+L  V  S + + +V EY+    L
Sbjct: 34  RVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIXIVTEYMSKGSL 89
Query: 93  HSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADF 151
             F+       L L  +  +  QI  G+AY   +  +HRDL+  N+L+  +    K+ADF
Sbjct: 90  LDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADF 148
Query: 152 GLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLF 208
           GLAR I    +  +R     P K  APE  L Y  ++   DVW+ G +  E+ T G+  +
Sbjct: 149 GLARLI-EDNEXTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPY 206
Query: 209 PS 210
           P 
Sbjct: 207 PG 208

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/179 (32%), Positives = 89/179 (49%), Gaps = 10/179 (5%)
Query: 31  TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQ--SSRKDVFLVFEYL 88
           TG  VA+K +  Q           RE+ +LK L  + IV+   V     R ++ LV EYL
Sbjct: 35  TGALVAVKQL--QHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYL 92
Query: 89  DLD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVK 147
               L  F+ RH+  L+   +     QI  G+ Y  S + +HRDL   N+L++ + + VK
Sbjct: 93  PSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAH-VK 151
Query: 148 LADFGLARAIGVPQKEY-SRDCVYSP--YKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           +ADFGLA+ + + +     R+   SP  + APE L     +S   DVW+ G +  E+ T
Sbjct: 152 IADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNI-FSRQSDVWSFGVVLYELFT 209

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 125/284 (44%), Gaps = 39/284 (13%)
Query: 27  RNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE 86
           R+  + + VA+K +      E + + + RE+   + L H NIVR  +V  +   + +V E
Sbjct: 39  RDKQSNELVAVKYIE---RGEKIAANVKREIINHRSLRHPNIVRFKEVILTPTHLAIVME 95
Query: 87  YLDLDLHSFITRHKNTLNLLVIKA--ILKQILLGLAYCHSLKILHRDLKPNNLLIDLK-R 143
           Y          R  N       +A    +Q++ G++YCH++++ HRDLK  N L+D    
Sbjct: 96  YASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 153
Query: 144 NTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGYTGYSTPIDVWAVGCIFAEMI 202
             +K+ DFG +++  +  +  S   V +P Y APE+LL         DVW+ G     M+
Sbjct: 154 PRLKICDFGYSKSSVLHSQPKS--TVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVML 211
Query: 203 TGKPLF--PSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
            G   F  P +  +    I  +L             +   +P Y H            + 
Sbjct: 212 VGAYPFEDPEEPKNFRKTIHRILN------------VQYAIPDYVH------------IS 247
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLIN 304
           P    L+S++   +P +RI+  +   HE+ +  +N+P  ++  N
Sbjct: 248 PECRHLISRIFVADPAKRISIPEIRNHEWFL--KNLPADLMNDN 289

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/176 (32%), Positives = 82/176 (46%), Gaps = 26/176 (14%)
Query: 55  REVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRH-------------- 99
           RE  LL  L+HE+IV+   V      + +VFEY+   DL+ F+  H              
Sbjct: 66  REAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 100 -KNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIG 158
            K  L L  +  I  QI  G+ Y  S   +HRDL   N L+      VK+ DFG++R   
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL-LVKIGDFGMSRD-- 182
Query: 159 VPQKEYSRDCVYS----PYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GK-PLF 208
           V   +Y R   ++     +  PE ++ Y  ++T  DVW+ G I  E+ T GK P F
Sbjct: 183 VYSTDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVILWEIFTYGKQPWF 237

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 100/200 (50%), Gaps = 29/200 (14%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRL--------LD 73
           +V+K ++ + G+   IK +    E+        REV  L +L+H NIV           D
Sbjct: 26  QVFKAKHRIDGKTYVIKRVKYNNEK------AEREVKALAKLDHVNIVHYNGCWDGFDYD 79
Query: 74  VQSSRKD--------VFLVFEYLDLD-LHSFI-TRHKNTLNLLVIKAILKQILLGLAYCH 123
            ++S K+        +F+  E+ D   L  +I  R    L+ ++   + +QI  G+ Y H
Sbjct: 80  PETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH 139
Query: 124 SLKILHRDLKPNNL-LIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGY 182
           S K+++RDLKP+N+ L+D K+  VK+ DFGL  ++    K   R      Y +PE  +  
Sbjct: 140 SKKLINRDLKPSNIFLVDTKQ--VKIGDFGLVTSLKNDGKR-XRSKGTLRYMSPE-QISS 195
Query: 183 TGYSTPIDVWAVGCIFAEMI 202
             Y   +D++A+G I AE++
Sbjct: 196 QDYGKEVDLYALGLILAELL 215

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 92/197 (46%), Gaps = 22/197 (11%)
Query: 25  KCRNTVTGQ-KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL 83
           +C N    Q K+ + + T++   +       RE  LL  L+HE+IV+   V      + +
Sbjct: 33  ECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92
Query: 84  VFEYLDL-DLHSFITRHKNTLNLLV------------IKAILKQILLGLAYCHSLKILHR 130
           VFEY+   DL+ F+  H     L+             +  I +QI  G+ Y  S   +HR
Sbjct: 93  VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHR 152
Query: 131 DLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS----PYKAPELLLGYTGYS 186
           DL   N L+  +   VK+ DFG++R   V   +Y R   ++     +  PE ++ Y  ++
Sbjct: 153 DLATRNCLVG-ENLLVKIGDFGMSR--DVYSTDYYRVGGHTMLPIRWMPPESIM-YRKFT 208
Query: 187 TPIDVWAVGCIFAEMIT 203
           T  DVW++G +  E+ T
Sbjct: 209 TESDVWSLGVVLWEIFT 225

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 118/273 (43%), Gaps = 44/273 (16%)
Query: 33  QKVAIKMMTIQTEQEGVPSYIIREVSLLKELEH--ENIVRLLDVQSSRKDVFLVFEYLDL 90
           Q  AIK + ++            E++ L +L+   + I+RL D + + + +++V E  ++
Sbjct: 53  QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNI 112
Query: 91  DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLAD 150
           DL+S++ + K +++    K+  K +L  +   H   I+H DLKP N LI      +KL D
Sbjct: 113 DLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI--VDGMLKLID 169
Query: 151 FGLARAIGVPQKEYSRDCVYSP--YKAPELLLGYTG----------YSTPIDVWAVGCIF 198
           FG+A  +        +D       Y  PE +   +            S   DVW++GCI 
Sbjct: 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 229
Query: 199 AEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPN 258
             M  GK  F                            I++I  L+   +P +  E FP+
Sbjct: 230 YYMTYGKTPF-------------------------QQIINQISKLHAIIDPNHEIE-FPD 263
Query: 259 L-EPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           + E    D+L   L  +PKQRI+  + L H Y+
Sbjct: 264 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 136/296 (45%), Gaps = 48/296 (16%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           EV+K  +  T + VAIK++ ++  ++ +   I +E+++L + +   + +          +
Sbjct: 22  EVFKGIDNRTQKVVAIKIIDLEEAEDEI-EDIQQEITVLSQCDSPYVTKYYGSYLKDTKL 80
Query: 82  FLVFEYLD----LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
           +++ EYL     LDL          L+   I  IL++IL GL Y HS K +HRD+K  N+
Sbjct: 81  WIIMEYLGGGSALDL-----LEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANV 135
Query: 138 LIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCI 197
           L+  +   VKLADFG+A  +   Q + +       + APE ++  + Y +  D+W++G  
Sbjct: 136 LLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIKQSAYDSKADIWSLGIT 193
Query: 198 FAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFP 257
             E+  G+P      H  L  +                   ++L L P   P       P
Sbjct: 194 AIELARGEP-----PHSELHPM-------------------KVLFLIPKNNP-------P 222
Query: 258 NLEPAGVDLLSQML--CLN--PKQRITAMDALKHEYLI-GVENVPLVILLINRKKK 308
            LE      L + +  CLN  P  R TA + LKH++++   +    +  LI+R K+
Sbjct: 223 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRYKR 278

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 105/209 (50%), Gaps = 18/209 (8%)
Query: 22  EVYKCRNTVTGQKVAIKMM---TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR 78
           EVY+         VA+K +   T++ E+       ++E +++KE++H N+V+LL V +  
Sbjct: 33  EVYEGVWKKYSLTVAVKTLKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGVCTRE 86
Query: 79  KDVFLVFEYLDL-DLHSFITR-HKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNN 136
              +++ E++   +L  ++   ++  +N +V+  +  QI   + Y      +HRDL   N
Sbjct: 87  PPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARN 146
Query: 137 LLIDLKRNTVKLADFGLARAI-GVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVG 195
            L+  + + VK+ADFGL+R + G     ++       + APE  L Y  +S   DVWA G
Sbjct: 147 CLVG-ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFG 204
Query: 196 CIFAEMIT-GKPLFPSKKHDHLSLIFSLL 223
            +  E+ T G   +P      LS ++ LL
Sbjct: 205 VLLWEIATYGMSPYPGID---LSQVYELL 230

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 136/296 (45%), Gaps = 48/296 (16%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           EV+K  +  T + VAIK++ ++  ++ +   I +E+++L + +   + +          +
Sbjct: 22  EVFKGIDNRTQKVVAIKIIDLEEAEDEI-EDIQQEITVLSQCDSPYVTKYYGSYLKDTKL 80
Query: 82  FLVFEYLD----LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
           +++ EYL     LDL          L+   I  IL++IL GL Y HS K +HRD+K  N+
Sbjct: 81  WIIMEYLGGGSALDL-----LEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANV 135
Query: 138 LIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCI 197
           L+  +   VKLADFG+A  +   Q + +       + APE ++  + Y +  D+W++G  
Sbjct: 136 LLS-EHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE-VIKQSAYDSKADIWSLGIT 193
Query: 198 FAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFP 257
             E+  G+P      H  L  +                   ++L L P   P       P
Sbjct: 194 AIELARGEP-----PHSELHPM-------------------KVLFLIPKNNP-------P 222
Query: 258 NLEPAGVDLLSQML--CLN--PKQRITAMDALKHEYLI-GVENVPLVILLINRKKK 308
            LE      L + +  CLN  P  R TA + LKH++++   +    +  LI+R K+
Sbjct: 223 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRYKR 278

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 105/209 (50%), Gaps = 18/209 (8%)
Query: 22  EVYKCRNTVTGQKVAIKMM---TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR 78
           EVY+         VA+K +   T++ E+       ++E +++KE++H N+V+LL V +  
Sbjct: 33  EVYEGVWKKYSLTVAVKTLKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGVCTRE 86
Query: 79  KDVFLVFEYLDL-DLHSFITR-HKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNN 136
              +++ E++   +L  ++   ++  +N +V+  +  QI   + Y      +HRDL   N
Sbjct: 87  PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARN 146
Query: 137 LLIDLKRNTVKLADFGLARAI-GVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVG 195
            L+  + + VK+ADFGL+R + G     ++       + APE  L Y  +S   DVWA G
Sbjct: 147 CLVG-ENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFG 204
Query: 196 CIFAEMIT-GKPLFPSKKHDHLSLIFSLL 223
            +  E+ T G   +P      LS ++ LL
Sbjct: 205 VLLWEIATYGMSPYPGID---LSQVYELL 230

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 136/296 (45%), Gaps = 48/296 (16%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           EV+K  +  T + VAIK++ ++  ++ +   I +E+++L + +   + +          +
Sbjct: 37  EVFKGIDNRTQKVVAIKIIDLEEAEDEI-EDIQQEITVLSQCDSPYVTKYYGSYLKDTKL 95
Query: 82  FLVFEYLD----LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
           +++ EYL     LDL          L+   I  IL++IL GL Y HS K +HRD+K  N+
Sbjct: 96  WIIMEYLGGGSALDL-----LEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANV 150
Query: 138 LIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCI 197
           L+  +   VKLADFG+A  +   Q + +       + APE ++  + Y +  D+W++G  
Sbjct: 151 LLS-EHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE-VIKQSAYDSKADIWSLGIT 208
Query: 198 FAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFP 257
             E+  G+P      H  L  +                   ++L L P   P       P
Sbjct: 209 AIELARGEP-----PHSELHPM-------------------KVLFLIPKNNP-------P 237
Query: 258 NLEPAGVDLLSQML--CLN--PKQRITAMDALKHEYLI-GVENVPLVILLINRKKK 308
            LE      L + +  CLN  P  R TA + LKH++++   +    +  LI+R K+
Sbjct: 238 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRYKR 293

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 118/273 (43%), Gaps = 44/273 (16%)
Query: 33  QKVAIKMMTIQTEQEGVPSYIIREVSLLKELEH--ENIVRLLDVQSSRKDVFLVFEYLDL 90
           Q  AIK + ++            E++ L +L+   + I+RL D + + + +++V E  ++
Sbjct: 81  QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNI 140
Query: 91  DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLAD 150
           DL+S++ + K +++    K+  K +L  +   H   I+H DLKP N LI      +KL D
Sbjct: 141 DLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI--VDGMLKLID 197
Query: 151 FGLARAIGVPQKEYSRDCVYSP--YKAPELLLGYTG----------YSTPIDVWAVGCIF 198
           FG+A  +        +D       Y  PE +   +            S   DVW++GCI 
Sbjct: 198 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 257
Query: 199 AEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPN 258
             M  GK  F                            I++I  L+   +P +  E FP+
Sbjct: 258 YYMTYGKTPF-------------------------QQIINQISKLHAIIDPNHEIE-FPD 291
Query: 259 L-EPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           + E    D+L   L  +PKQRI+  + L H Y+
Sbjct: 292 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 37/95 (38%), Positives = 55/95 (57%), Gaps = 5/95 (5%)
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           QI+L   Y HSL +++RDLKP NLLID ++  +++ DFG A+ +   +      C     
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRV---KGRTWXLCGTPEA 204
Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF 208
            APE++L   GY+  +D WA+G +  EM  G P F
Sbjct: 205 LAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 85/167 (50%), Gaps = 11/167 (6%)
Query: 50  PSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNT-LNLLV 107
           P   ++E  ++K+L HE +V+L  V  S + +++V EY+    L  F+       L L  
Sbjct: 224 PEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQ 282
Query: 108 IKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYS-R 166
           +  +  QI  G+AY   +  +HRDL+  N+L+  +    K+ADFGL R I     EY+ R
Sbjct: 283 LVDMAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLGRLI--EDNEYTAR 339
Query: 167 DCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPS 210
                P K  APE  L Y  ++   DVW+ G +  E+ T G+  +P 
Sbjct: 340 QGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPG 385

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 118/273 (43%), Gaps = 44/273 (16%)
Query: 33  QKVAIKMMTIQTEQEGVPSYIIREVSLLKELEH--ENIVRLLDVQSSRKDVFLVFEYLDL 90
           Q  AIK + ++            E++ L +L+   + I+RL D + + + +++V E  ++
Sbjct: 33  QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNI 92
Query: 91  DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLAD 150
           DL+S++ + K +++    K+  K +L  +   H   I+H DLKP N LI      +KL D
Sbjct: 93  DLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI--VDGMLKLID 149
Query: 151 FGLARAIGVPQKEYSRDCVYSP--YKAPELLLGYTG----------YSTPIDVWAVGCIF 198
           FG+A  +        +D       Y  PE +   +            S   DVW++GCI 
Sbjct: 150 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 209
Query: 199 AEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPN 258
             M  GK  F                            I++I  L+   +P +  E FP+
Sbjct: 210 YYMTYGKTPF-------------------------QQIINQISKLHAIIDPNHEIE-FPD 243
Query: 259 L-EPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           + E    D+L   L  +PKQRI+  + L H Y+
Sbjct: 244 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 276

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 124/284 (43%), Gaps = 39/284 (13%)
Query: 27  RNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE 86
           R+  + + VA+K +      E +   + RE+   + L H NIVR  +V  +   + +V E
Sbjct: 38  RDKQSNELVAVKYIE---RGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVME 94
Query: 87  YLDLDLHSFITRHKNTLNLLVIKA--ILKQILLGLAYCHSLKILHRDLKPNNLLIDLK-R 143
           Y          R  N       +A    +Q++ G++YCH++++ HRDLK  N L+D    
Sbjct: 95  YASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 152
Query: 144 NTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGYTGYSTPIDVWAVGCIFAEMI 202
             +K+ DFG +++  +  +  S   V +P Y APE+LL         DVW+ G     M+
Sbjct: 153 PRLKICDFGYSKSSVLHSQPKS--TVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVML 210
Query: 203 TGKPLF--PSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
            G   F  P +  +    I  +L             +   +P Y H            + 
Sbjct: 211 VGAYPFEDPEEPKNFRKTIHRILN------------VQYAIPDYVH------------IS 246
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLIN 304
           P    L+S++   +P +RI+  +   HE+ +  +N+P  ++  N
Sbjct: 247 PECRHLISRIFVADPAKRISIPEIRNHEWFL--KNLPADLMNDN 288

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 118/273 (43%), Gaps = 44/273 (16%)
Query: 33  QKVAIKMMTIQTEQEGVPSYIIREVSLLKELEH--ENIVRLLDVQSSRKDVFLVFEYLDL 90
           Q  AIK + ++            E++ L +L+   + I+RL D + + + +++V E  ++
Sbjct: 37  QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNI 96
Query: 91  DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLAD 150
           DL+S++ + K +++    K+  K +L  +   H   I+H DLKP N LI      +KL D
Sbjct: 97  DLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI--VDGMLKLID 153
Query: 151 FGLARAIGVPQKEYSRDCVYSP--YKAPELLLGYTG----------YSTPIDVWAVGCIF 198
           FG+A  +        +D       Y  PE +   +            S   DVW++GCI 
Sbjct: 154 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 213
Query: 199 AEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPN 258
             M  GK  F                            I++I  L+   +P +  E FP+
Sbjct: 214 YYMTYGKTPF-------------------------QQIINQISKLHAIIDPNHEIE-FPD 247
Query: 259 L-EPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           + E    D+L   L  +PKQRI+  + L H Y+
Sbjct: 248 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 280

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 90/197 (45%), Gaps = 14/197 (7%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIR---EVSLLKELEHENIVRLLDVQSSR 78
           EV+  R+    + VA+K++     ++  PS+ +R   E      L H  IV +     + 
Sbjct: 27  EVHLARDLRLHRDVAVKVLRADLARD--PSFYLRFRREAQNAAALNHPAIVAVYATGEAE 84
Query: 79  KDV----FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKP 134
                  ++V EY+D      I   +  +       ++      L + H   I+HRD+KP
Sbjct: 85  TPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKP 144
Query: 135 NNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVY---SPYKAPELLLGYTGYSTPIDV 191
            N++I    N VK+ DFG+ARAI       ++       + Y +PE   G +      DV
Sbjct: 145 ANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDV 202
Query: 192 WAVGCIFAEMITGKPLF 208
           +++GC+  E++TG+P F
Sbjct: 203 YSLGCVLYEVLTGEPPF 219

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 118/273 (43%), Gaps = 44/273 (16%)
Query: 33  QKVAIKMMTIQTEQEGVPSYIIREVSLLKELEH--ENIVRLLDVQSSRKDVFLVFEYLDL 90
           Q  AIK + ++            E++ L +L+   + I+RL D + + + +++V E  ++
Sbjct: 53  QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNI 112
Query: 91  DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLAD 150
           DL+S++ + K +++    K+  K +L  +   H   I+H DLKP N LI      +KL D
Sbjct: 113 DLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI--VDGMLKLID 169
Query: 151 FGLARAIGVPQKEYSRDCVYSP--YKAPELLLGYTG----------YSTPIDVWAVGCIF 198
           FG+A  +        +D       Y  PE +   +            S   DVW++GCI 
Sbjct: 170 FGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 229
Query: 199 AEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPN 258
             M  GK  F                            I++I  L+   +P +  E FP+
Sbjct: 230 YYMTYGKTPF-------------------------QQIINQISKLHAIIDPNHEIE-FPD 263
Query: 259 L-EPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           + E    D+L   L  +PKQRI+  + L H Y+
Sbjct: 264 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 105/209 (50%), Gaps = 18/209 (8%)
Query: 22  EVYKCRNTVTGQKVAIKMM---TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR 78
           EVY+         VA+K +   T++ E+       ++E +++KE++H N+V+LL V +  
Sbjct: 33  EVYEGVWKKYSLTVAVKTLKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGVCTRE 86
Query: 79  KDVFLVFEYLDL-DLHSFITR-HKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNN 136
              +++ E++   +L  ++   ++  +N +V+  +  QI   + Y      +HRDL   N
Sbjct: 87  PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARN 146
Query: 137 LLIDLKRNTVKLADFGLARAI-GVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVG 195
            L+  + + VK+ADFGL+R + G     ++       + APE  L Y  +S   DVWA G
Sbjct: 147 CLVG-ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFG 204
Query: 196 CIFAEMIT-GKPLFPSKKHDHLSLIFSLL 223
            +  E+ T G   +P      LS ++ LL
Sbjct: 205 VLLWEIATYGMSPYPGID---LSQVYELL 230

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 105/209 (50%), Gaps = 18/209 (8%)
Query: 22  EVYKCRNTVTGQKVAIKMM---TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR 78
           EVY+         VA+K +   T++ E+       ++E +++KE++H N+V+LL V +  
Sbjct: 32  EVYEGVWKKYSLTVAVKTLKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGVCTRE 85
Query: 79  KDVFLVFEYLDL-DLHSFITR-HKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNN 136
              +++ E++   +L  ++   ++  +N +V+  +  QI   + Y      +HRDL   N
Sbjct: 86  PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARN 145
Query: 137 LLIDLKRNTVKLADFGLARAI-GVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVG 195
            L+  + + VK+ADFGL+R + G     ++       + APE  L Y  +S   DVWA G
Sbjct: 146 CLVG-ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFG 203
Query: 196 CIFAEMIT-GKPLFPSKKHDHLSLIFSLL 223
            +  E+ T G   +P      LS ++ LL
Sbjct: 204 VLLWEIATYGMSPYPGID---LSQVYELL 229

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 106/216 (49%), Gaps = 32/216 (14%)
Query: 22  EVYKCRNTVTGQKVAIKMM---TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR 78
           EVY+         VA+K +   T++ E+       ++E +++KE++H N+V+LL V +  
Sbjct: 29  EVYEGVWKKYSLTVAVKTLKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGVCTRE 82
Query: 79  KDVFLVFEYLDL-DLHSFITR-HKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNN 136
              +++ E++   +L  ++   ++  +N +V+  +  QI   + Y      +HRDL   N
Sbjct: 83  PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARN 142
Query: 137 LLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP--------YKAPELLLGYTGYSTP 188
            L+  + + VK+ADFGL+R +       + D   +P        + APE  L Y  +S  
Sbjct: 143 CLVG-ENHLVKVADFGLSRLM-------TGDTYTAPAGAKFPIKWTAPE-SLAYNKFSIK 193
Query: 189 IDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLL 223
            DVWA G +  E+ T G   +P      LS ++ LL
Sbjct: 194 SDVWAFGVLLWEIATYGMSPYPGI---DLSQVYELL 226

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 118/273 (43%), Gaps = 44/273 (16%)
Query: 33  QKVAIKMMTIQTEQEGVPSYIIREVSLLKELEH--ENIVRLLDVQSSRKDVFLVFEYLDL 90
           Q  AIK + ++            E++ L +L+   + I+RL D + + + +++V E  ++
Sbjct: 34  QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNI 93
Query: 91  DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLAD 150
           DL+S++ + K +++    K+  K +L  +   H   I+H DLKP N LI      +KL D
Sbjct: 94  DLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI--VDGMLKLID 150
Query: 151 FGLARAIGVPQKEYSRDCVYSP--YKAPELLLGYTG----------YSTPIDVWAVGCIF 198
           FG+A  +        +D       Y  PE +   +            S   DVW++GCI 
Sbjct: 151 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 210
Query: 199 AEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPN 258
             M  GK  F                            I++I  L+   +P +  E FP+
Sbjct: 211 YYMTYGKTPF-------------------------QQIINQISKLHAIIDPNHEIE-FPD 244
Query: 259 L-EPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           + E    D+L   L  +PKQRI+  + L H Y+
Sbjct: 245 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 277

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 105/209 (50%), Gaps = 18/209 (8%)
Query: 22  EVYKCRNTVTGQKVAIKMM---TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR 78
           EVY+         VA+K +   T++ E+       ++E +++KE++H N+V+LL V +  
Sbjct: 30  EVYEGVWKKYSLTVAVKTLKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGVCTRE 83
Query: 79  KDVFLVFEYLDL-DLHSFITR-HKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNN 136
              +++ E++   +L  ++   ++  +N +V+  +  QI   + Y      +HRDL   N
Sbjct: 84  PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARN 143
Query: 137 LLIDLKRNTVKLADFGLARAI-GVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVG 195
            L+  + + VK+ADFGL+R + G     ++       + APE  L Y  +S   DVWA G
Sbjct: 144 CLVG-ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFG 201
Query: 196 CIFAEMIT-GKPLFPSKKHDHLSLIFSLL 223
            +  E+ T G   +P      LS ++ LL
Sbjct: 202 VLLWEIATYGMSPYPGID---LSQVYELL 227

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 105/209 (50%), Gaps = 18/209 (8%)
Query: 22  EVYKCRNTVTGQKVAIKMM---TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR 78
           EVY+         VA+K +   T++ E+       ++E +++KE++H N+V+LL V +  
Sbjct: 30  EVYEGVWKKYSLTVAVKTLKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGVCTRE 83
Query: 79  KDVFLVFEYLDL-DLHSFITR-HKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNN 136
              +++ E++   +L  ++   ++  +N +V+  +  QI   + Y      +HRDL   N
Sbjct: 84  PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARN 143
Query: 137 LLIDLKRNTVKLADFGLARAI-GVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVG 195
            L+  + + VK+ADFGL+R + G     ++       + APE  L Y  +S   DVWA G
Sbjct: 144 CLVG-ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFG 201
Query: 196 CIFAEMIT-GKPLFPSKKHDHLSLIFSLL 223
            +  E+ T G   +P      LS ++ LL
Sbjct: 202 VLLWEIATYGMSPYPGID---LSQVYELL 227

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 118/273 (43%), Gaps = 44/273 (16%)
Query: 33  QKVAIKMMTIQTEQEGVPSYIIREVSLLKELEH--ENIVRLLDVQSSRKDVFLVFEYLDL 90
           Q  AIK + ++            E++ L +L+   + I+RL D + + + +++V E  ++
Sbjct: 81  QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNI 140
Query: 91  DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLAD 150
           DL+S++ + K +++    K+  K +L  +   H   I+H DLKP N LI      +KL D
Sbjct: 141 DLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI--VDGMLKLID 197
Query: 151 FGLARAIGVPQKEYSRDCVYSP--YKAPELLLGYTG----------YSTPIDVWAVGCIF 198
           FG+A  +        +D       Y  PE +   +            S   DVW++GCI 
Sbjct: 198 FGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 257
Query: 199 AEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPN 258
             M  GK  F                            I++I  L+   +P +  E FP+
Sbjct: 258 YYMTYGKTPF-------------------------QQIINQISKLHAIIDPNHEIE-FPD 291
Query: 259 L-EPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           + E    D+L   L  +PKQRI+  + L H Y+
Sbjct: 292 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 106/216 (49%), Gaps = 32/216 (14%)
Query: 22  EVYKCRNTVTGQKVAIKMM---TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR 78
           EVY+         VA+K +   T++ E+       ++E +++KE++H N+V+LL V +  
Sbjct: 30  EVYEGVWKKYSLTVAVKTLKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGVCTRE 83
Query: 79  KDVFLVFEYLDL-DLHSFITR-HKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNN 136
              +++ E++   +L  ++   ++  +N +V+  +  QI   + Y      +HRDL   N
Sbjct: 84  PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARN 143
Query: 137 LLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP--------YKAPELLLGYTGYSTP 188
            L+  + + VK+ADFGL+R +       + D   +P        + APE  L Y  +S  
Sbjct: 144 CLVG-ENHLVKVADFGLSRLM-------TGDTYTAPAGAKFPIKWTAPE-SLAYNKFSIK 194
Query: 189 IDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLL 223
            DVWA G +  E+ T G   +P      LS ++ LL
Sbjct: 195 SDVWAFGVLLWEIATYGMSPYPGID---LSQVYELL 227

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 105/209 (50%), Gaps = 18/209 (8%)
Query: 22  EVYKCRNTVTGQKVAIKMM---TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR 78
           EVY+         VA+K +   T++ E+       ++E +++KE++H N+V+LL V +  
Sbjct: 28  EVYEGVWKKYSLTVAVKTLKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGVCTRE 81
Query: 79  KDVFLVFEYLDL-DLHSFITR-HKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNN 136
              +++ E++   +L  ++   ++  +N +V+  +  QI   + Y      +HRDL   N
Sbjct: 82  PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARN 141
Query: 137 LLIDLKRNTVKLADFGLARAI-GVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVG 195
            L+  + + VK+ADFGL+R + G     ++       + APE  L Y  +S   DVWA G
Sbjct: 142 CLVG-ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFG 199
Query: 196 CIFAEMIT-GKPLFPSKKHDHLSLIFSLL 223
            +  E+ T G   +P      LS ++ LL
Sbjct: 200 VLLWEIATYGMSPYPGID---LSQVYELL 225

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 105/209 (50%), Gaps = 18/209 (8%)
Query: 22  EVYKCRNTVTGQKVAIKMM---TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR 78
           EVY+         VA+K +   T++ E+       ++E +++KE++H N+V+LL V +  
Sbjct: 28  EVYEGVWKKYSLTVAVKTLKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGVCTRE 81
Query: 79  KDVFLVFEYLDL-DLHSFITR-HKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNN 136
              +++ E++   +L  ++   ++  +N +V+  +  QI   + Y      +HRDL   N
Sbjct: 82  PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARN 141
Query: 137 LLIDLKRNTVKLADFGLARAI-GVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVG 195
            L+  + + VK+ADFGL+R + G     ++       + APE  L Y  +S   DVWA G
Sbjct: 142 CLVG-ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFG 199
Query: 196 CIFAEMIT-GKPLFPSKKHDHLSLIFSLL 223
            +  E+ T G   +P      LS ++ LL
Sbjct: 200 VLLWEIATYGMSPYPGID---LSQVYELL 225

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 101/196 (51%), Gaps = 18/196 (9%)
Query: 35  VAIKMM---TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL- 90
           VA+K +   T++ E+       ++E +++KE++H N+V+LL V +     +++ E++   
Sbjct: 46  VAVKTLKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG 99
Query: 91  DLHSFITR-HKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLA 149
           +L  ++   ++  +N +V+  +  QI   + Y      +HRDL   N L+  + + VK+A
Sbjct: 100 NLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHLVKVA 158
Query: 150 DFGLARAI-GVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPL 207
           DFGL+R + G     ++       + APE  L Y  +S   DVWA G +  E+ T G   
Sbjct: 159 DFGLSRLMTGDTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFGVLLWEIATYGMSP 217
Query: 208 FPSKKHDHLSLIFSLL 223
           +P      LS ++ LL
Sbjct: 218 YPGID---LSQVYELL 230

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 90/176 (51%), Gaps = 7/176 (3%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDLD-LH 93
           VAIK++   T  +    ++  E  ++  ++H ++VRLL V  S   + LV + +    L 
Sbjct: 70  VAIKILNETTGPKANVEFM-DEALIMASMDHPHLVRLLGVCLS-PTIQLVTQLMPHGCLL 127
Query: 94  SFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGL 153
            ++  HK+ +   ++     QI  G+ Y    +++HRDL   N+L+    N VK+ DFGL
Sbjct: 128 EYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVK-SPNHVKITDFGL 186
Query: 154 ARAIGVPQKEYSRDCVYSPYKAPEL-LLGYTGYSTPIDVWAVGCIFAEMIT--GKP 206
           AR +   +KEY+ D    P K   L  + Y  ++   DVW+ G    E++T  GKP
Sbjct: 187 ARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 242

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 118/273 (43%), Gaps = 44/273 (16%)
Query: 33  QKVAIKMMTIQTEQEGVPSYIIREVSLLKELEH--ENIVRLLDVQSSRKDVFLVFEYLDL 90
           Q  AIK + ++            E++ L +L+   + I+RL D + + + +++V E  ++
Sbjct: 81  QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNI 140
Query: 91  DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLAD 150
           DL+S++ + K +++    K+  K +L  +   H   I+H DLKP N LI      +KL D
Sbjct: 141 DLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI--VDGMLKLID 197
Query: 151 FGLARAIGVPQKEYSRDCVYSP--YKAPELLLGYTG----------YSTPIDVWAVGCIF 198
           FG+A  +        +D       Y  PE +   +            S   DVW++GCI 
Sbjct: 198 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 257
Query: 199 AEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPN 258
             M  GK  F                            I++I  L+   +P +  E FP+
Sbjct: 258 YYMTYGKTPF-------------------------QQIINQISKLHAIIDPNHEIE-FPD 291
Query: 259 L-EPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           + E    D+L   L  +PKQRI+  + L H Y+
Sbjct: 292 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 105/209 (50%), Gaps = 18/209 (8%)
Query: 22  EVYKCRNTVTGQKVAIKMM---TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR 78
           EVY+         VA+K +   T++ E+       ++E +++KE++H N+V+LL V +  
Sbjct: 41  EVYEGVWKKYSLTVAVKTLKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGVCTRE 94
Query: 79  KDVFLVFEYLDL-DLHSFITR-HKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNN 136
              +++ E++   +L  ++   ++  +N +V+  +  QI   + Y      +HRDL   N
Sbjct: 95  PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARN 154
Query: 137 LLIDLKRNTVKLADFGLARAI-GVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVG 195
            L+  + + VK+ADFGL+R + G     ++       + APE  L Y  +S   DVWA G
Sbjct: 155 CLVG-ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFG 212
Query: 196 CIFAEMIT-GKPLFPSKKHDHLSLIFSLL 223
            +  E+ T G   +P      LS ++ LL
Sbjct: 213 VLLWEIATYGMSPYPGID---LSQVYELL 238

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 11/203 (5%)
Query: 27  RNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE 86
           R+ +T + VA+K +        +   + RE+   + L H NIVR  +V  +   + ++ E
Sbjct: 40  RDKLTKELVAVKYIE---RGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96
Query: 87  YLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK-RN 144
           Y    +L+  I  +    +    +   +Q+L G++YCHS++I HRDLK  N L+D     
Sbjct: 97  YASGGELYERIC-NAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAP 155
Query: 145 TVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
            +K+ DFG +++  +  +  S   V +P Y APE+LL         DVW+ G     M+ 
Sbjct: 156 RLKICDFGYSKSSVLHSQPKS--TVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLV 213
Query: 204 GKPLF--PSKKHDHLSLIFSLLG 224
           G   F  P +  D+   I  +L 
Sbjct: 214 GAYPFEDPEEPRDYRKTIQRILS 236

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 90/176 (51%), Gaps = 7/176 (3%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDLD-LH 93
           VAIK++   T  +    ++  E  ++  ++H ++VRLL V  S   + LV + +    L 
Sbjct: 47  VAIKILNETTGPKANVEFM-DEALIMASMDHPHLVRLLGVCLS-PTIQLVTQLMPHGCLL 104
Query: 94  SFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGL 153
            ++  HK+ +   ++     QI  G+ Y    +++HRDL   N+L+    N VK+ DFGL
Sbjct: 105 EYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVK-SPNHVKITDFGL 163
Query: 154 ARAIGVPQKEYSRDCVYSPYKAPEL-LLGYTGYSTPIDVWAVGCIFAEMIT--GKP 206
           AR +   +KEY+ D    P K   L  + Y  ++   DVW+ G    E++T  GKP
Sbjct: 164 ARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 219

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 59/106 (55%), Gaps = 8/106 (7%)
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARA---IGVPQKEYSRDCVY 170
           +I +GL + H   I++RDLK +N+++D     +K+ADFG+ +     GV  +E+   C  
Sbjct: 128 EISIGLFFLHKRGIIYRDLKLDNVMLD-SEGHIKIADFGMCKEHMMDGVTTREF---CGT 183
Query: 171 SPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHL 216
             Y APE++  Y  Y   +D WA G +  EM+ G+P F  +  D L
Sbjct: 184 PDYIAPEII-AYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL 228

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 98/198 (49%), Gaps = 22/198 (11%)
Query: 35  VAIKMM---TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD-- 89
           VA+K +   T++ E+       ++E +++KE++H N+V+LL V +     ++V EY+   
Sbjct: 60  VAVKTLKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYG 113
Query: 90  --LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVK 147
             LD      R + T  +L+  A   QI   + Y      +HRDL   N L+  + + VK
Sbjct: 114 NLLDYLRECNREEVTAVVLLYMAT--QISSAMEYLEKKNFIHRDLAARNCLVG-ENHVVK 170
Query: 148 LADFGLARAI-GVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GK 205
           +ADFGL+R + G     ++       + APE  L Y  +S   DVWA G +  E+ T G 
Sbjct: 171 VADFGLSRLMTGDTYTAHAGAKFPIKWTAPE-SLAYNTFSIKSDVWAFGVLLWEIATYGM 229
Query: 206 PLFPSKKHDHLSLIFSLL 223
             +P      LS ++ LL
Sbjct: 230 SPYPGID---LSQVYDLL 244

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 124/284 (43%), Gaps = 39/284 (13%)
Query: 27  RNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE 86
           R+  + + VA+K +      E +   + RE+   + L H NIVR  +V  +   + +V E
Sbjct: 39  RDKQSNELVAVKYIE---RGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVME 95
Query: 87  YLDLDLHSFITRHKNTLNLLVIKA--ILKQILLGLAYCHSLKILHRDLKPNNLLIDLK-R 143
           Y          R  N       +A    +Q++ G++YCH++++ HRDLK  N L+D    
Sbjct: 96  YASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 153
Query: 144 NTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGYTGYSTPIDVWAVGCIFAEMI 202
             +K+  FG +++  +  +   +D V +P Y APE+LL         DVW+ G     M+
Sbjct: 154 PRLKICAFGYSKSSVLHSQ--PKDTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVML 211
Query: 203 TGKPLF--PSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
            G   F  P +  +    I  +L             +   +P Y H            + 
Sbjct: 212 VGAYPFEDPEEPKNFRKTIHRILN------------VQYAIPDYVH------------IS 247
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLIN 304
           P    L+S++   +P +RI+  +   HE+ +  +N+P  ++  N
Sbjct: 248 PECRHLISRIFVADPAKRISIPEIRNHEWFL--KNLPADLMNDN 289

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 98/189 (51%), Gaps = 12/189 (6%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           EV+K  +  T + VAIK++ ++  ++ +   I +E+++L + +   + +          +
Sbjct: 42  EVFKGIDNRTQKVVAIKIIDLEEAEDEI-EDIQQEITVLSQCDSPYVTKYYGSYLKDTKL 100
Query: 82  FLVFEYLD----LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
           +++ EYL     LDL          L+   I  IL++IL GL Y HS K +HRD+K  N+
Sbjct: 101 WIIMEYLGGGSALDL-----LEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANV 155
Query: 138 LIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCI 197
           L+  +   VKLADFG+A  +   Q + +       + APE ++  + Y +  D+W++G  
Sbjct: 156 LLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIKQSAYDSKADIWSLGIT 213
Query: 198 FAEMITGKP 206
             E+  G+P
Sbjct: 214 AIELARGEP 222

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/284 (25%), Positives = 123/284 (43%), Gaps = 39/284 (13%)
Query: 27  RNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE 86
           R+    + VA+K +      E +   + RE+   + L H NIVR  +V  +   + +V E
Sbjct: 39  RDKQANELVAVKYIE---RGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVME 95
Query: 87  YLDLDLHSFITRHKNTLNLLVIKA--ILKQILLGLAYCHSLKILHRDLKPNNLLIDLK-R 143
           Y          R  N       +A    +Q++ G++Y H++++ HRDLK  N L+D    
Sbjct: 96  YASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYAHAMQVAHRDLKLENTLLDGSPA 153
Query: 144 NTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGYTGYSTPIDVWAVGCIFAEMI 202
             +K+ADFG ++A  +  +  S   V +P Y APE+LL         DVW+ G     M+
Sbjct: 154 PRLKIADFGYSKASVLHSQPKS--AVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVML 211
Query: 203 TGKPLF--PSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
            G   F  P +  +    I  +L             +   +P Y H            + 
Sbjct: 212 VGAYPFEDPEEPKNFRKTIHRILN------------VQYAIPDYVH------------IS 247
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLIN 304
           P    L+S++   +P +RI+  +   HE+ +  +N+P  ++  N
Sbjct: 248 PECRHLISRIFVADPAKRISIPEIRNHEWFL--KNLPADLMNDN 289

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 96/192 (50%), Gaps = 14/192 (7%)
Query: 23  VYK--CRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKD 80
           VYK    NT    K    M+ I TE+  +     +E+ ++ + +HEN+V LL   S   D
Sbjct: 47  VYKGYVNNTTVAVKKLAAMVDITTEE--LKQQFDQEIKVMAKCQHENLVELLGFSSDGDD 104
Query: 81  VFLVFEYL-DLDLHSFITRHKNT--LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
           + LV+ Y+ +  L   ++    T  L+  +   I +    G+ + H    +HRD+K  N+
Sbjct: 105 LCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANI 164
Query: 138 LIDLKRNTVKLADFGLARAIGVPQKE--YSRDCVYSPYKAPELLLGYTGYSTP-IDVWAV 194
           L+D +  T K++DFGLARA     +    SR    + Y APE L G     TP  D+++ 
Sbjct: 165 LLD-EAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEALRGEI---TPKSDIYSF 220
Query: 195 GCIFAEMITGKP 206
           G +  E+ITG P
Sbjct: 221 GVVLLEIITGLP 232

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 117/275 (42%), Gaps = 34/275 (12%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           V K R+  +GQ +A+K +      +     ++     ++ ++    V          DV+
Sbjct: 67  VEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW 126
Query: 83  LVFEYLDLDLHSF---ITRHKNTLNLLVIKAILKQILLGLAYCHS-LKILHRDLKPNNLL 138
           +  E +D  L  F   +     T+   ++  I   I+  L + HS L ++HRD+KP+N+L
Sbjct: 127 ICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVL 186
Query: 139 IDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELL---LGYTGYSTPIDVWAVG 195
           I+     VK+ DFG++  + V     + D    PY APE +   L   GYS   D+W++G
Sbjct: 187 INA-LGQVKMCDFGISGYL-VDSVAKTIDAGCKPYMAPERINPELNQKGYSVKSDIWSLG 244
Query: 196 CIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEK 255
               E+                   ++L  P D SW   T   ++  +     P   A+K
Sbjct: 245 ITMIEL-------------------AILRFPYD-SWG--TPFQQLKQVVEEPSPQLPADK 282
Query: 256 FPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           F       VD  SQ L  N K+R T  + ++H + 
Sbjct: 283 F---SAEFVDFTSQCLKKNSKERPTYPELMQHPFF 314

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 98/202 (48%), Gaps = 8/202 (3%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           V+K  +  +G  +A K++ ++  +  + + IIRE+ +L E     IV       S  ++ 
Sbjct: 41  VFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 99
Query: 83  LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSL-KILHRDLKPNNLLIDL 141
           +  E++D      + +    +   ++  +   ++ GL Y     KI+HRD+KP+N+L++ 
Sbjct: 100 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN- 158
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
            R  +KL DFG++  + +     S     S Y +PE L G T YS   D+W++G    EM
Sbjct: 159 SRGEIKLCDFGVSGQL-IDSMANSFVGTRS-YMSPERLQG-THYSVQSDIWSMGLSLVEM 215
Query: 202 ITGKPLFPSKKHDHLSLIFSLL 223
             G+  +P         IF LL
Sbjct: 216 AVGR--YPIGSGSGSMAIFELL 235

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 99/186 (53%), Gaps = 13/186 (6%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYL-DLDL 92
           KVA+K  T++     V +++  E +L+K L+H+ +VRL  V +  + ++++ E++    L
Sbjct: 38  KVAVK--TLKPGTMSVQAFL-EEANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSL 94
Query: 93  HSFITRHKNTLNLL-VIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADF 151
             F+   +    LL  +     QI  G+AY      +HRDL+  N+L+  +    K+ADF
Sbjct: 95  LDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVS-ESLMCKIADF 153
Query: 152 GLARAIGVPQKEY-SRDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPL 207
           GLAR I     EY +R+    P K  APE  + +  ++   +VW+ G +  E++T GK  
Sbjct: 154 GLARVI--EDNEYTAREGAKFPIKWTAPE-AINFGCFTIKSNVWSFGILLYEIVTYGKIP 210
Query: 208 FPSKKH 213
           +P + +
Sbjct: 211 YPGRTN 216

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 95/189 (50%), Gaps = 7/189 (3%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           V+K  +  +G  +A K++ ++  +  + + IIRE+ +L E     IV       S  ++ 
Sbjct: 22  VFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80
Query: 83  LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSL-KILHRDLKPNNLLIDL 141
           +  E++D      + +    +   ++  +   ++ GL Y     KI+HRD+KP+N+L++ 
Sbjct: 81  ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN- 139
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
            R  +KL DFG++  + +     S     S Y +PE L G T YS   D+W++G    EM
Sbjct: 140 SRGEIKLCDFGVSGQL-IDSMANSFVGTRS-YMSPERLQG-THYSVQSDIWSMGLSLVEM 196
Query: 202 ITGK-PLFP 209
             G+ P+ P
Sbjct: 197 AVGRYPIPP 205

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 105/209 (50%), Gaps = 18/209 (8%)
Query: 22  EVYKCRNTVTGQKVAIKMM---TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR 78
           EVY+         VA+K +   T++ E+       ++E +++KE++H N+V+LL V +  
Sbjct: 28  EVYEGVWKKYSLTVAVKTLKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGVCTRE 81
Query: 79  KDVFLVFEYLDL-DLHSFITR-HKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNN 136
              +++ E++   +L  ++   ++  ++ +V+  +  QI   + Y      +HRDL   N
Sbjct: 82  PPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARN 141
Query: 137 LLIDLKRNTVKLADFGLARAI-GVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVG 195
            L+  + + VK+ADFGL+R + G     ++       + APE  L Y  +S   DVWA G
Sbjct: 142 CLVG-ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFG 199
Query: 196 CIFAEMIT-GKPLFPSKKHDHLSLIFSLL 223
            +  E+ T G   +P      LS ++ LL
Sbjct: 200 VLLWEIATYGMSPYPGID---LSQVYELL 225

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 88/178 (49%), Gaps = 11/178 (6%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD-LDLH 93
           VA+KM+ +             EV +L++  H NI+  +   S++  + +V ++ +   L+
Sbjct: 37  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLY 95
Query: 94  SFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGL 153
             +   +    +  +  I +Q   G+ Y H+  I+HRDLK NN+ +  + NTVK+ DFGL
Sbjct: 96  HHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLH-EDNTVKIGDFGL 154
Query: 154 A----RAIGVPQKEYSRDCVYSPYKAPEL--LLGYTGYSTPIDVWAVGCIFAEMITGK 205
           A    R  G  Q E     +   + APE+  +     YS   DV+A G +  E++TG+
Sbjct: 155 ATVKSRWSGSHQFEQLSGSIL--WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 210

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 88/189 (46%), Gaps = 16/189 (8%)
Query: 26  CRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF 85
           C+     + VAIK +  ++E++      I E+  L  + H NIV+L    +    V LV 
Sbjct: 25  CKAKWRAKDVAIKQIESESERKA----FIVELRQLSRVNHPNIVKLYG--ACLNPVCLVM 78
Query: 86  EYLDLDLHSFITRHKNTLNLLVIKAILK---QILLGLAYCHSLK---ILHRDLKPNNLLI 139
           EY +      +      L        +    Q   G+AY HS++   ++HRDLKP NLL+
Sbjct: 79  EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLL 138
Query: 140 DLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFA 199
                 +K+ DFG A  I   Q   + +   + + APE+  G + YS   DV++ G I  
Sbjct: 139 VAGGTVLKICDFGTACDI---QTHMTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILW 194
Query: 200 EMITGKPLF 208
           E+IT +  F
Sbjct: 195 EVITRRKPF 203

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 88/189 (46%), Gaps = 16/189 (8%)
Query: 26  CRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF 85
           C+     + VAIK +  ++E++      I E+  L  + H NIV+L    +    V LV 
Sbjct: 26  CKAKWRAKDVAIKQIESESERKA----FIVELRQLSRVNHPNIVKLYG--ACLNPVCLVM 79
Query: 86  EYLDLDLHSFITRHKNTLNLLVIKAILK---QILLGLAYCHSLK---ILHRDLKPNNLLI 139
           EY +      +      L        +    Q   G+AY HS++   ++HRDLKP NLL+
Sbjct: 80  EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLL 139
Query: 140 DLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFA 199
                 +K+ DFG A  I   Q   + +   + + APE+  G + YS   DV++ G I  
Sbjct: 140 VAGGTVLKICDFGTACDI---QTHMTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILW 195
Query: 200 EMITGKPLF 208
           E+IT +  F
Sbjct: 196 EVITRRKPF 204

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 116/271 (42%), Gaps = 32/271 (11%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGV-PSYIIREVSLLKELEHENIVRLLDVQSSRKD 80
           EV  C+   TG+  A K +  +  ++    +  + E  +L+++    +V L     ++  
Sbjct: 199 EVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA 258
Query: 81  VFLVFEYLDLDLHSFITRHKNTLNLLVIKAIL--KQILLGLAYCHSLKILHRDLKPNNLL 138
           + LV   ++     F   H         +A+    +I  GL   H  +I++RDLKP N+L
Sbjct: 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENIL 318
Query: 139 IDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS-PYKAPELLLGYTGYSTPIDVWAVGCI 197
           +D     ++++D GL  A+ VP+ +  +  V +  Y APE++     Y+   D WA+GC+
Sbjct: 319 LD-DHGHIRISDLGL--AVHVPEGQTIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCL 374
Query: 198 FAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFP 257
             EMI G+  F  +K          L             + E+        P   +E+F 
Sbjct: 375 LYEMIAGQSPFQQRKKKIKREEVERL-------------VKEV--------PEEYSERF- 412
Query: 258 NLEPAGVDLLSQMLCLNPKQRITAMDALKHE 288
              P    L SQ+LC +P +R+        E
Sbjct: 413 --SPQARSLCSQLLCKDPAERLGCRGGSARE 441

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 88/178 (49%), Gaps = 11/178 (6%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD-LDLH 93
           VA+KM+ +             EV +L++  H NI+  +   S++  + +V ++ +   L+
Sbjct: 49  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLY 107
Query: 94  SFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGL 153
             +   +    +  +  I +Q   G+ Y H+  I+HRDLK NN+ +  + NTVK+ DFGL
Sbjct: 108 HHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLH-EDNTVKIGDFGL 166
Query: 154 A----RAIGVPQKEYSRDCVYSPYKAPEL--LLGYTGYSTPIDVWAVGCIFAEMITGK 205
           A    R  G  Q E     +   + APE+  +     YS   DV+A G +  E++TG+
Sbjct: 167 ATEKSRWSGSHQFEQLSGSIL--WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 116/271 (42%), Gaps = 32/271 (11%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGV-PSYIIREVSLLKELEHENIVRLLDVQSSRKD 80
           EV  C+   TG+  A K +  +  ++    +  + E  +L+++    +V L     ++  
Sbjct: 199 EVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA 258
Query: 81  VFLVFEYLDLDLHSFITRHKNTLNLLVIKAIL--KQILLGLAYCHSLKILHRDLKPNNLL 138
           + LV   ++     F   H         +A+    +I  GL   H  +I++RDLKP N+L
Sbjct: 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENIL 318
Query: 139 IDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS-PYKAPELLLGYTGYSTPIDVWAVGCI 197
           +D     ++++D GL  A+ VP+ +  +  V +  Y APE++     Y+   D WA+GC+
Sbjct: 319 LD-DHGHIRISDLGL--AVHVPEGQTIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCL 374
Query: 198 FAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFP 257
             EMI G+  F  +K          L             + E+        P   +E+F 
Sbjct: 375 LYEMIAGQSPFQQRKKKIKREEVERL-------------VKEV--------PEEYSERF- 412
Query: 258 NLEPAGVDLLSQMLCLNPKQRITAMDALKHE 288
              P    L SQ+LC +P +R+        E
Sbjct: 413 --SPQARSLCSQLLCKDPAERLGCRGGSARE 441

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 101/196 (51%), Gaps = 18/196 (9%)
Query: 35  VAIKMM---TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL- 90
           VA+K +   T++ E+       ++E +++KE++H N+V+LL V +     +++ E++   
Sbjct: 41  VAVKTLKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYG 94
Query: 91  DLHSFITR-HKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLA 149
           +L  ++   ++  ++ +V+  +  QI   + Y      +HRDL   N L+  + + VK+A
Sbjct: 95  NLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHLVKVA 153
Query: 150 DFGLARAI-GVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPL 207
           DFGL+R + G     ++       + APE  L Y  +S   DVWA G +  E+ T G   
Sbjct: 154 DFGLSRLMTGDTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212
Query: 208 FPSKKHDHLSLIFSLL 223
           +P      LS ++ LL
Sbjct: 213 YPGID---LSQVYELL 225

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 89/195 (45%), Gaps = 9/195 (4%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV 81
           +V+K R   TG  +A+K M     +E     ++    +LK  +   IV+      +  DV
Sbjct: 40  QVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDV 99
Query: 82  FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYC-HSLKILHRDLKPNNLLID 140
           F+  E +         R +  +   ++  +   I+  L Y      ++HRD+KP+N+L+D
Sbjct: 100 FIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD 159
Query: 141 LKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELL----LGYTGYSTPIDVWAVGC 196
            +R  +KL DFG++  + V  K   R    + Y APE +         Y    DVW++G 
Sbjct: 160 -ERGQIKLCDFGISGRL-VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGI 217
Query: 197 IFAEMITGKPLFPSK 211
              E+ TG+  FP K
Sbjct: 218 SLVELATGQ--FPYK 230

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 116/275 (42%), Gaps = 34/275 (12%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF 82
           V K R+  +GQ +A+K +      +     ++     ++ ++    V          DV+
Sbjct: 23  VEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW 82
Query: 83  LVFEYLDLDLHSF---ITRHKNTLNLLVIKAILKQILLGLAYCHS-LKILHRDLKPNNLL 138
           +  E +D  L  F   +     T+   ++  I   I+  L + HS L ++HRD+KP+N+L
Sbjct: 83  ICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVL 142
Query: 139 IDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELL---LGYTGYSTPIDVWAVG 195
           I+     VK+ DFG++  + V       D    PY APE +   L   GYS   D+W++G
Sbjct: 143 IN-ALGQVKMCDFGISGYL-VDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLG 200
Query: 196 CIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEK 255
               E+                   ++L  P D SW   T   ++  +     P   A+K
Sbjct: 201 ITMIEL-------------------AILRFPYD-SWG--TPFQQLKQVVEEPSPQLPADK 238
Query: 256 FPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           F       VD  SQ L  N K+R T  + ++H + 
Sbjct: 239 F---SAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 96/188 (51%), Gaps = 14/188 (7%)
Query: 22  EVYKCRNTVTGQKVAIKMM---TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR 78
           EVY+         VA+K +   T++ E+       ++E +++KE++H N+V+LL V +  
Sbjct: 26  EVYEGVWKKYSLTVAVKTLKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGVCTRE 79
Query: 79  KDVFLVFEYLDL-DLHSFITR-HKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNN 136
              +++ E++   +L  ++   ++  ++ +V+  +  QI   + Y      +HRDL   N
Sbjct: 80  PPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARN 139
Query: 137 LLIDLKRNTVKLADFGLARAI-GVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVG 195
            L+  + + VK+ADFGL+R + G     ++       + APE  L Y  +S   DVWA G
Sbjct: 140 CLVG-ENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFG 197
Query: 196 CIFAEMIT 203
            +  E+ T
Sbjct: 198 VLLWEIAT 205

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 85/162 (52%), Gaps = 18/162 (11%)
Query: 53  IIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAI 111
            + E S++ + +H N++ L  V +    V ++ E+++   L SF+ ++     ++ +  +
Sbjct: 81  FLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGM 140
Query: 112 LKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTV-KLADFGLARAIGVPQKEYSRDCVY 170
           L+ I  G+ Y   +  +HRDL   N+L++   N V K++DFGL+R +    ++ + D  Y
Sbjct: 141 LRGIAAGMKYLADMNYVHRDLAARNILVN--SNLVCKVSDFGLSRFL----EDDTSDPTY 194
Query: 171 SP---------YKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           +          + APE +  Y  +++  DVW+ G +  E+++
Sbjct: 195 TSALGGKIPIRWTAPEAIQ-YRKFTSASDVWSYGIVMWEVMS 235

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 105/209 (50%), Gaps = 18/209 (8%)
Query: 22  EVYKCRNTVTGQKVAIKMM---TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR 78
           EVY+         VA+K +   T++ E+       ++E +++KE++H N+V+LL V +  
Sbjct: 28  EVYEGVWKKYSLTVAVKTLKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGVCTRE 81
Query: 79  KDVFLVFEYLDL-DLHSFITR-HKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNN 136
              +++ E++   +L  ++   ++  ++ +V+  +  QI   + Y      +HRDL   N
Sbjct: 82  PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARN 141
Query: 137 LLIDLKRNTVKLADFGLARAI-GVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVG 195
            L+  + + VK+ADFGL+R + G     ++       + APE  L Y  +S   DVWA G
Sbjct: 142 CLVG-ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFG 199
Query: 196 CIFAEMIT-GKPLFPSKKHDHLSLIFSLL 223
            +  E+ T G   +P      LS ++ LL
Sbjct: 200 VLLWEIATYGMSPYPGID---LSQVYELL 225

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 101/196 (51%), Gaps = 18/196 (9%)
Query: 35  VAIKMM---TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL- 90
           VA+K +   T++ E+       ++E +++KE++H N+V+LL V +     +++ E++   
Sbjct: 287 VAVKTLKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG 340
Query: 91  DLHSFITR-HKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLA 149
           +L  ++   ++  +N +V+  +  QI   + Y      +HR+L   N L+  + + VK+A
Sbjct: 341 NLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVG-ENHLVKVA 399
Query: 150 DFGLARAI-GVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPL 207
           DFGL+R + G     ++       + APE  L Y  +S   DVWA G +  E+ T G   
Sbjct: 400 DFGLSRLMTGDTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFGVLLWEIATYGMSP 458
Query: 208 FPSKKHDHLSLIFSLL 223
           +P      LS ++ LL
Sbjct: 459 YPGID---LSQVYELL 471

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 119/278 (42%), Gaps = 46/278 (16%)
Query: 27  RNTVTGQKVAIKMMTIQT--EQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLV 84
           R   TG+  A+K++  +    ++ V ++ + E  +L+   H  +  L     +   +  V
Sbjct: 30  REKATGRYYAMKILRKEVIIAKDEV-AHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 88
Query: 85  FEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN 144
            EY +     F    +        +    +I+  L Y HS  +++RD+K  NL++D K  
Sbjct: 89  MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD-KDG 147
Query: 145 TVKLADFGLAR---AIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
            +K+ DFGL +   + G   K +   C    Y APE+L     Y   +D W +G +  EM
Sbjct: 148 HIKITDFGLCKEGISDGATMKXF---CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEM 203
Query: 202 ITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPN-LE 260
           + G+  F ++ H+ L   F L+             + EI              +FP  L 
Sbjct: 204 MCGRLPFYNQDHERL---FELI------------LMEEI--------------RFPRTLS 234
Query: 261 PAGVDLLSQMLCLNPKQRI-----TAMDALKHEYLIGV 293
           P    LL+ +L  +PKQR+      A + ++H + + +
Sbjct: 235 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 272

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 119/278 (42%), Gaps = 46/278 (16%)
Query: 27  RNTVTGQKVAIKMMTIQT--EQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLV 84
           R   TG+  A+K++  +    ++ V ++ + E  +L+   H  +  L     +   +  V
Sbjct: 25  REKATGRYYAMKILRKEVIIAKDEV-AHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83
Query: 85  FEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN 144
            EY +     F    +        +    +I+  L Y HS  +++RD+K  NL++D K  
Sbjct: 84  MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD-KDG 142
Query: 145 TVKLADFGLAR---AIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
            +K+ DFGL +   + G   K +   C    Y APE+L     Y   +D W +G +  EM
Sbjct: 143 HIKITDFGLCKEGISDGATMKXF---CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEM 198
Query: 202 ITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPN-LE 260
           + G+  F ++ H+ L   F L+             + EI              +FP  L 
Sbjct: 199 MCGRLPFYNQDHERL---FELI------------LMEEI--------------RFPRTLS 229
Query: 261 PAGVDLLSQMLCLNPKQRI-----TAMDALKHEYLIGV 293
           P    LL+ +L  +PKQR+      A + ++H + + +
Sbjct: 230 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 22  EVYKCRNTVTGQK---VAIKMMTIQ-TEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS 77
           EV + R    G+K   VAIK +    TE++      + E S++ + EH NI+RL  V ++
Sbjct: 31  EVCRGRLKAPGKKESCVAIKTLKGGYTERQ--RREFLSEASIMGQFEHPNIIRLEGVVTN 88
Query: 78  RKDVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNN 136
              V ++ E+++   L SF+  +     ++ +  +L+ I  G+ Y   +  +HRDL   N
Sbjct: 89  SMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVHRDLAARN 148
Query: 137 LLIDLKRNTV-KLADFGLARAIGVPQKEYSRDCVYSP---------YKAPELLLGYTGYS 186
           +L++   N V K++DFGL+R +    +E S D   +          + APE  + +  ++
Sbjct: 149 ILVN--SNLVCKVSDFGLSRFL----EENSSDPTETSSLGGKIPIRWTAPE-AIAFRKFT 201
Query: 187 TPIDVWAVGCIFAEMIT--GKPLFPSKKHDHLSLI 219
           +  D W+ G +  E+++   +P +     D ++ I
Sbjct: 202 SASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAI 236

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 92/199 (46%), Gaps = 28/199 (14%)
Query: 23  VYK--CRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKD 80
           VYK    NT    K    M+ I TE+  +     +E+ +  + +HEN+V LL   S   D
Sbjct: 38  VYKGYVNNTTVAVKKLAAMVDITTEE--LKQQFDQEIKVXAKCQHENLVELLGFSSDGDD 95
Query: 81  VFLVFEY------LD----LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHR 130
           + LV+ Y      LD    LD    ++ H           I +    G+ + H    +HR
Sbjct: 96  LCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRC-------KIAQGAANGINFLHENHHIHR 148
Query: 131 DLKPNNLLIDLKRNTVKLADFGLARAIG--VPQKEYSRDCVYSPYKAPELLLGYTGYSTP 188
           D+K  N+L+D +  T K++DFGLARA          SR    + Y APE L G     TP
Sbjct: 149 DIKSANILLD-EAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEALRGEI---TP 204
Query: 189 -IDVWAVGCIFAEMITGKP 206
             D+++ G +  E+ITG P
Sbjct: 205 KSDIYSFGVVLLEIITGLP 223

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 119/278 (42%), Gaps = 46/278 (16%)
Query: 27  RNTVTGQKVAIKMMTIQT--EQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLV 84
           R   TG+  A+K++  +    ++ V ++ + E  +L+   H  +  L     +   +  V
Sbjct: 25  REKATGRYYAMKILRKEVIIAKDEV-AHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83
Query: 85  FEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN 144
            EY +     F    +        +    +I+  L Y HS  +++RD+K  NL++D K  
Sbjct: 84  MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD-KDG 142
Query: 145 TVKLADFGLAR---AIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
            +K+ DFGL +   + G   K +   C    Y APE+L     Y   +D W +G +  EM
Sbjct: 143 HIKITDFGLCKEGISDGATMKXF---CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEM 198
Query: 202 ITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPN-LE 260
           + G+  F ++ H+ L   F L+             + EI              +FP  L 
Sbjct: 199 MCGRLPFYNQDHERL---FELI------------LMEEI--------------RFPRTLS 229
Query: 261 PAGVDLLSQMLCLNPKQRI-----TAMDALKHEYLIGV 293
           P    LL+ +L  +PKQR+      A + ++H + + +
Sbjct: 230 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 101/196 (51%), Gaps = 18/196 (9%)
Query: 35  VAIKMM---TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL- 90
           VA+K +   T++ E+       ++E +++KE++H N+V+LL V +     +++ E++   
Sbjct: 41  VAVKTLKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG 94
Query: 91  DLHSFITR-HKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLA 149
           +L  ++   ++  ++ +V+  +  QI   + Y      +HRDL   N L+  + + VK+A
Sbjct: 95  NLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHLVKVA 153
Query: 150 DFGLARAI-GVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPL 207
           DFGL+R + G     ++       + APE  L Y  +S   DVWA G +  E+ T G   
Sbjct: 154 DFGLSRLMTGDTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212
Query: 208 FPSKKHDHLSLIFSLL 223
           +P      LS ++ LL
Sbjct: 213 YPGID---LSQVYELL 225

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 99/196 (50%), Gaps = 22/196 (11%)
Query: 23  VYK--CRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKD 80
           VYK    NT    K    M+ I TE+  +     +E+ ++ + +HEN+V LL   S   D
Sbjct: 47  VYKGYVNNTTVAVKKLAAMVDITTEE--LKQQFDQEIKVMAKCQHENLVELLGFSSDGDD 104
Query: 81  VFLVFEYL-DLDLHSFITRHKNT--LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
           + LV+ Y+ +  L   ++    T  L+  +   I +    G+ + H    +HRD+K  N+
Sbjct: 105 LCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANI 164
Query: 138 LIDLKRNTVKLADFGLARAIGVPQKEYSRDCVY------SPYKAPELLLGYTGYSTP-ID 190
           L+D +  T K++DFGLARA     +++++  +       + Y APE L G     TP  D
Sbjct: 165 LLD-EAFTAKISDFGLARA----SEKFAQTVMXXRIVGTTAYMAPEALRGEI---TPKSD 216
Query: 191 VWAVGCIFAEMITGKP 206
           +++ G +  E+ITG P
Sbjct: 217 IYSFGVVLLEIITGLP 232

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 119/278 (42%), Gaps = 46/278 (16%)
Query: 27  RNTVTGQKVAIKMMTIQT--EQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLV 84
           R   TG+  A+K++  +    ++ V ++ + E  +L+   H  +  L     +   +  V
Sbjct: 25  REKATGRYYAMKILRKEVIIAKDEV-AHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83
Query: 85  FEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN 144
            EY +     F    +        +    +I+  L Y HS  +++RD+K  NL++D K  
Sbjct: 84  MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD-KDG 142
Query: 145 TVKLADFGLAR---AIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
            +K+ DFGL +   + G   K +   C    Y APE+L     Y   +D W +G +  EM
Sbjct: 143 HIKITDFGLCKEGISDGATMKTF---CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEM 198
Query: 202 ITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFP-NLE 260
           + G+  F ++ H+ L   F L+             + EI              +FP  L 
Sbjct: 199 MCGRLPFYNQDHERL---FELI------------LMEEI--------------RFPRTLS 229
Query: 261 PAGVDLLSQMLCLNPKQRI-----TAMDALKHEYLIGV 293
           P    LL+ +L  +PKQR+      A + ++H + + +
Sbjct: 230 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 101/196 (51%), Gaps = 18/196 (9%)
Query: 35  VAIKMM---TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL- 90
           VA+K +   T++ E+       ++E +++KE++H N+V+LL V +     +++ E++   
Sbjct: 46  VAVKTLKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG 99
Query: 91  DLHSFITR-HKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLA 149
           +L  ++   ++  ++ +V+  +  QI   + Y      +HRDL   N L+  + + VK+A
Sbjct: 100 NLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHLVKVA 158
Query: 150 DFGLARAI-GVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPL 207
           DFGL+R + G     ++       + APE  L Y  +S   DVWA G +  E+ T G   
Sbjct: 159 DFGLSRLMTGDTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFGVLLWEIATYGMSP 217
Query: 208 FPSKKHDHLSLIFSLL 223
           +P      LS ++ LL
Sbjct: 218 YPGID---LSQVYELL 230

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 96/188 (51%), Gaps = 14/188 (7%)
Query: 22  EVYKCRNTVTGQKVAIKMM---TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR 78
           EVY+         VA+K +   T++ E+       ++E +++KE++H N+V+LL V +  
Sbjct: 26  EVYEGVWKKYSLTVAVKTLKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGVCTRE 79
Query: 79  KDVFLVFEYLDL-DLHSFITR-HKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNN 136
              +++ E++   +L  ++   ++  ++ +V+  +  QI   + Y      +HRDL   N
Sbjct: 80  PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARN 139
Query: 137 LLIDLKRNTVKLADFGLARAI-GVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVG 195
            L+  + + VK+ADFGL+R + G     ++       + APE  L Y  +S   DVWA G
Sbjct: 140 CLVG-ENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFG 197
Query: 196 CIFAEMIT 203
            +  E+ T
Sbjct: 198 VLLWEIAT 205

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 91/190 (47%), Gaps = 8/190 (4%)
Query: 24  YKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVS-LLKELEHENIVRLLDVQSSRKDVF 82
           +K        KV  K   ++ ++E    +I+ E + LLK ++H  +V L     +   ++
Sbjct: 59  HKAEEVFYAVKVLQKKAILKKKEE---KHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115
Query: 83  LVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
            V +Y++  +L   + R +  L     +    +I   L Y HSL I++RDLKP N+L+D 
Sbjct: 116 FVLDYINGGELFYHLQRERCFLEPRA-RFYAAEIASALGYLHSLNIVYRDLKPENILLDS 174
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
           + + V L DFGL +         S  C    Y APE +L    Y   +D W +G +  EM
Sbjct: 175 QGHIV-LTDFGLCKENIEHNSTTSTFCGTPEYLAPE-VLHKQPYDRTVDWWCLGAVLYEM 232
Query: 202 ITGKPLFPSK 211
           + G P F S+
Sbjct: 233 LYGLPPFYSR 242

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 119/278 (42%), Gaps = 46/278 (16%)
Query: 27  RNTVTGQKVAIKMMTIQT--EQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLV 84
           R   TG+  A+K++  +    ++ V ++ + E  +L+   H  +  L     +   +  V
Sbjct: 25  REKATGRYYAMKILRKEVIIAKDEV-AHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83
Query: 85  FEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN 144
            EY +     F    +        +    +I+  L Y HS  +++RD+K  NL++D K  
Sbjct: 84  MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD-KDG 142
Query: 145 TVKLADFGLAR---AIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
            +K+ DFGL +   + G   K +   C    Y APE+L     Y   +D W +G +  EM
Sbjct: 143 HIKITDFGLCKEGISDGATMKXF---CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEM 198
Query: 202 ITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPN-LE 260
           + G+  F ++ H+ L   F L+             + EI              +FP  L 
Sbjct: 199 MCGRLPFYNQDHERL---FELI------------LMEEI--------------RFPRTLS 229
Query: 261 PAGVDLLSQMLCLNPKQRI-----TAMDALKHEYLIGV 293
           P    LL+ +L  +PKQR+      A + ++H + + +
Sbjct: 230 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 119/278 (42%), Gaps = 46/278 (16%)
Query: 27  RNTVTGQKVAIKMMTIQT--EQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLV 84
           R   TG+  A+K++  +    ++ V ++ + E  +L+   H  +  L     +   +  V
Sbjct: 28  REKATGRYYAMKILRKEVIIAKDEV-AHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 86
Query: 85  FEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN 144
            EY +     F    +        +    +I+  L Y HS  +++RD+K  NL++D K  
Sbjct: 87  MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD-KDG 145
Query: 145 TVKLADFGLAR---AIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
            +K+ DFGL +   + G   K +   C    Y APE+L     Y   +D W +G +  EM
Sbjct: 146 HIKITDFGLCKEGISDGATMKTF---CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEM 201
Query: 202 ITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPN-LE 260
           + G+  F ++ H+ L   F L+             + EI              +FP  L 
Sbjct: 202 MCGRLPFYNQDHERL---FELI------------LMEEI--------------RFPRTLS 232
Query: 261 PAGVDLLSQMLCLNPKQRI-----TAMDALKHEYLIGV 293
           P    LL+ +L  +PKQR+      A + ++H + + +
Sbjct: 233 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 270

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 99/196 (50%), Gaps = 22/196 (11%)
Query: 23  VYK--CRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKD 80
           VYK    NT    K    M+ I TE+  +     +E+ ++ + +HEN+V LL   S   D
Sbjct: 41  VYKGYVNNTTVAVKKLAAMVDITTEE--LKQQFDQEIKVMAKCQHENLVELLGFSSDGDD 98
Query: 81  VFLVFEYL-DLDLHSFITRHKNT--LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
           + LV+ Y+ +  L   ++    T  L+  +   I +    G+ + H    +HRD+K  N+
Sbjct: 99  LCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANI 158
Query: 138 LIDLKRNTVKLADFGLARAIGVPQKEYSRDCVY------SPYKAPELLLGYTGYSTP-ID 190
           L+D +  T K++DFGLARA     +++++  +       + Y APE L G     TP  D
Sbjct: 159 LLD-EAFTAKISDFGLARA----SEKFAQXVMXXRIVGTTAYMAPEALRGEI---TPKSD 210
Query: 191 VWAVGCIFAEMITGKP 206
           +++ G +  E+ITG P
Sbjct: 211 IYSFGVVLLEIITGLP 226

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/180 (31%), Positives = 90/180 (50%), Gaps = 13/180 (7%)
Query: 32  GQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDLD 91
           G  VA+K++  Q       +  +REV+++K L H NIV  +   +   ++ +V EYL   
Sbjct: 60  GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRG 119
Query: 92  -----LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK--ILHRDLKPNNLLIDLKRN 144
                LH    R +  L+     ++   +  G+ Y H+    I+HRDLK  NLL+D K+ 
Sbjct: 120 SLYRLLHKSGAREQ--LDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVD-KKY 176
Query: 145 TVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           TVK+ DFGL+R +       S+    +P + APE+L      +   DV++ G I  E+ T
Sbjct: 177 TVKVCDFGLSR-LKASXFLXSKXAAGTPEWMAPEVLRDEPS-NEKSDVYSFGVILWELAT 234

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 104/209 (49%), Gaps = 15/209 (7%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSY---IIREVSLLKELEHENIVRLLDVQSSRK 79
           VYK      G+KV I +  ++  +   P     I+ E  ++  +++ ++ RLL +  +  
Sbjct: 65  VYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-S 123
Query: 80  DVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLL 138
            V L+ + +    L  ++  HK+ +    +     QI  G+ Y    +++HRDL   N+L
Sbjct: 124 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL 183
Query: 139 IDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGC 196
           +   ++ VK+ DFGLA+ +G  +KEY  +    P K  A E +L +  Y+   DVW+ G 
Sbjct: 184 VKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGV 241
Query: 197 IFAEMITGKPLFPSKKHDHL--SLIFSLL 223
              E++T    F SK +D +  S I S+L
Sbjct: 242 TVWELMT----FGSKPYDGIPASEISSIL 266

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 119/278 (42%), Gaps = 46/278 (16%)
Query: 27  RNTVTGQKVAIKMMTIQT--EQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLV 84
           R   TG+  A+K++  +    ++ V ++ + E  +L+   H  +  L     +   +  V
Sbjct: 25  REKATGRYYAMKILRKEVIIAKDEV-AHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83
Query: 85  FEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN 144
            EY +     F    +        +    +I+  L Y HS  +++RD+K  NL++D K  
Sbjct: 84  MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD-KDG 142
Query: 145 TVKLADFGLAR---AIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEM 201
            +K+ DFGL +   + G   K +   C    Y APE+L     Y   +D W +G +  EM
Sbjct: 143 HIKITDFGLCKEGISDGATMKTF---CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEM 198
Query: 202 ITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPN-LE 260
           + G+  F ++ H+ L   F L+             + EI              +FP  L 
Sbjct: 199 MCGRLPFYNQDHERL---FELI------------LMEEI--------------RFPRTLS 229
Query: 261 PAGVDLLSQMLCLNPKQRI-----TAMDALKHEYLIGV 293
           P    LL+ +L  +PKQR+      A + ++H + + +
Sbjct: 230 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 42/213 (19%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRL---------- 71
           +V+K ++ + G+   I+ +    E+        REV  L +L+H NIV            
Sbjct: 27  QVFKAKHRIDGKTYVIRRVKYNNEK------AEREVKALAKLDHVNIVHYNGCWDGFDYD 80
Query: 72  ------------LDVQSSR-------KDVFLVFEYLDLD-LHSFI-TRHKNTLNLLVIKA 110
                        D ++S+       K +F+  E+ D   L  +I  R    L+ ++   
Sbjct: 81  PETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 140
Query: 111 ILKQILLGLAYCHSLKILHRDLKPNNL-LIDLKRNTVKLADFGLARAIGVPQKEYSRDCV 169
           + +QI  G+ Y HS K++HRDLKP+N+ L+D K+  VK+ DFGL  ++    K  +R   
Sbjct: 141 LFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQ--VKIGDFGLVTSLKNDGKR-TRSKG 197
Query: 170 YSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMI 202
              Y +PE  +    Y   +D++A+G I AE++
Sbjct: 198 TLRYMSPE-QISSQDYGKEVDLYALGLILAELL 229

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 15/209 (7%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSY---IIREVSLLKELEHENIVRLLDVQSSRK 79
           VYK      G+KV I +   +  +   P     I+ E  ++  +++ ++ RLL +  +  
Sbjct: 35  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-S 93
Query: 80  DVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLL 138
            V L+ + +    L  ++  HK+ +    +     QI  G+ Y    +++HRDL   N+L
Sbjct: 94  TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL 153
Query: 139 IDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGC 196
           +   ++ VK+ DFGLA+ +G  +KEY  +    P K  A E +L +  Y+   DVW+ G 
Sbjct: 154 VKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGV 211
Query: 197 IFAEMITGKPLFPSKKHDHL--SLIFSLL 223
              E++T    F SK +D +  S I S+L
Sbjct: 212 TVWELMT----FGSKPYDGIPASEISSIL 236

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 15/209 (7%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSY---IIREVSLLKELEHENIVRLLDVQSSRK 79
           VYK      G+KV I +   +  +   P     I+ E  ++  +++ ++ RLL +  +  
Sbjct: 38  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-S 96
Query: 80  DVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLL 138
            V L+ + +    L  ++  HK+ +    +     QI  G+ Y    +++HRDL   N+L
Sbjct: 97  TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL 156
Query: 139 IDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGC 196
           +   ++ VK+ DFGLA+ +G  +KEY  +    P K  A E +L +  Y+   DVW+ G 
Sbjct: 157 VKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGV 214
Query: 197 IFAEMITGKPLFPSKKHDHL--SLIFSLL 223
              E++T    F SK +D +  S I S+L
Sbjct: 215 TVWELMT----FGSKPYDGIPASEISSIL 239

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 87/178 (48%), Gaps = 11/178 (6%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD-LDLH 93
           VA+KM+ +             EV +L++  H NI+  +   S+   + +V ++ +   L+
Sbjct: 49  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STAPQLAIVTQWCEGSSLY 107
Query: 94  SFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGL 153
             +   +    +  +  I +Q   G+ Y H+  I+HRDLK NN+ +  + NTVK+ DFGL
Sbjct: 108 HHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLH-EDNTVKIGDFGL 166
Query: 154 A----RAIGVPQKEYSRDCVYSPYKAPEL--LLGYTGYSTPIDVWAVGCIFAEMITGK 205
           A    R  G  Q E     +   + APE+  +     YS   DV+A G +  E++TG+
Sbjct: 167 ATEKSRWSGSHQFEQLSGSIL--WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 15/209 (7%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSY---IIREVSLLKELEHENIVRLLDVQSSRK 79
           VYK      G+KV I +   +  +   P     I+ E  ++  +++ ++ RLL +  +  
Sbjct: 34  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-S 92
Query: 80  DVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLL 138
            V L+ + +    L  ++  HK+ +    +     QI  G+ Y    +++HRDL   N+L
Sbjct: 93  TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL 152
Query: 139 IDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGC 196
           +   ++ VK+ DFGLA+ +G  +KEY  +    P K  A E +L +  Y+   DVW+ G 
Sbjct: 153 VKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGV 210
Query: 197 IFAEMITGKPLFPSKKHDHL--SLIFSLL 223
              E++T    F SK +D +  S I S+L
Sbjct: 211 TVWELMT----FGSKPYDGIPASEISSIL 235

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 15/209 (7%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSY---IIREVSLLKELEHENIVRLLDVQSSRK 79
           VYK      G+KV I +   +  +   P     I+ E  ++  +++ ++ RLL +  +  
Sbjct: 33  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-S 91
Query: 80  DVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLL 138
            V L+ + +    L  ++  HK+ +    +     QI  G+ Y    +++HRDL   N+L
Sbjct: 92  TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL 151
Query: 139 IDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGC 196
           +   ++ VK+ DFGLA+ +G  +KEY  +    P K  A E +L +  Y+   DVW+ G 
Sbjct: 152 VKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGV 209
Query: 197 IFAEMITGKPLFPSKKHDHL--SLIFSLL 223
              E++T    F SK +D +  S I S+L
Sbjct: 210 TVWELMT----FGSKPYDGIPASEISSIL 234

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 68/144 (47%), Gaps = 2/144 (1%)
Query: 65  HENIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
           H  +V L     +   +F V EY++     F  + +  L     +    +I L L Y H 
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 171
Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTG 184
             I++RDLK +N+L+D     +KL D+G+ +    P    S  C    Y APE+L G   
Sbjct: 172 RGIIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-ED 229
Query: 185 YSTPIDVWAVGCIFAEMITGKPLF 208
           Y   +D WA+G +  EM+ G+  F
Sbjct: 230 YGFSVDWWALGVLMFEMMAGRSPF 253

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 15/209 (7%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSY---IIREVSLLKELEHENIVRLLDVQSSRK 79
           VYK      G+KV I +   +  +   P     I+ E  ++  +++ ++ RLL +  +  
Sbjct: 32  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-S 90
Query: 80  DVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLL 138
            V L+ + +    L  ++  HK+ +    +     QI  G+ Y    +++HRDL   N+L
Sbjct: 91  TVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL 150
Query: 139 IDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGC 196
           +   ++ VK+ DFGLA+ +G  +KEY  +    P K  A E +L +  Y+   DVW+ G 
Sbjct: 151 VKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGV 208
Query: 197 IFAEMITGKPLFPSKKHDHL--SLIFSLL 223
              E++T    F SK +D +  S I S+L
Sbjct: 209 TVWELMT----FGSKPYDGIPASEISSIL 233

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 15/209 (7%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSY---IIREVSLLKELEHENIVRLLDVQSSRK 79
           VYK      G+KV I +   +  +   P     I+ E  ++  +++ ++ RLL +  +  
Sbjct: 32  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-S 90
Query: 80  DVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLL 138
            V L+ + +    L  ++  HK+ +    +     QI  G+ Y    +++HRDL   N+L
Sbjct: 91  TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL 150
Query: 139 IDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGC 196
           +   ++ VK+ DFGLA+ +G  +KEY  +    P K  A E +L +  Y+   DVW+ G 
Sbjct: 151 VKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGV 208
Query: 197 IFAEMITGKPLFPSKKHDHL--SLIFSLL 223
              E++T    F SK +D +  S I S+L
Sbjct: 209 TVWELMT----FGSKPYDGIPASEISSIL 233

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 15/209 (7%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSY---IIREVSLLKELEHENIVRLLDVQSSRK 79
           VYK      G+KV I +   +  +   P     I+ E  ++  +++ ++ RLL +  +  
Sbjct: 31  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-S 89
Query: 80  DVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLL 138
            V L+ + +    L  ++  HK+ +    +     QI  G+ Y    +++HRDL   N+L
Sbjct: 90  TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL 149
Query: 139 IDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGC 196
           +   ++ VK+ DFGLA+ +G  +KEY  +    P K  A E +L +  Y+   DVW+ G 
Sbjct: 150 VKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGV 207
Query: 197 IFAEMITGKPLFPSKKHDHL--SLIFSLL 223
              E++T    F SK +D +  S I S+L
Sbjct: 208 TVWELMT----FGSKPYDGIPASEISSIL 232

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 123/284 (43%), Gaps = 39/284 (13%)
Query: 27  RNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE 86
           R+  + + VA+K +      E +   + RE+   + L H NIVR  +V  +   + +V E
Sbjct: 39  RDKQSNELVAVKYIE---RGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVME 95
Query: 87  YLDLDLHSFITRHKNTLNLLVIKA--ILKQILLGLAYCHSLKILHRDLKPNNLLIDLK-R 143
           Y          R  N       +A    +Q++ G++YCH++++ HRDLK  N L+D    
Sbjct: 96  YASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 153
Query: 144 NTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGYTGYSTPIDVWAVGCIFAEMI 202
             +K+  FG +++  +  +  S   V +P Y APE+LL         DVW+ G     M+
Sbjct: 154 PRLKICAFGYSKSSVLHSQPKS--TVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVML 211
Query: 203 TGKPLF--PSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLE 260
            G   F  P +  +    I  +L             +   +P Y H            + 
Sbjct: 212 VGAYPFEDPEEPKNFRKTIHRILN------------VQYAIPDYVH------------IS 247
Query: 261 PAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLIN 304
           P    L+S++   +P +RI+  +   HE+ +  +N+P  ++  N
Sbjct: 248 PECRHLISRIFVADPAKRISIPEIRNHEWFL--KNLPADLMNDN 289

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/167 (24%), Positives = 79/167 (47%), Gaps = 4/167 (2%)
Query: 40  MTIQTEQEGVPSY--IIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDLD-LHSFI 96
           + I+T +EG  S    I E  ++ +L H  +V+L  V   +  + LVFE+++   L  ++
Sbjct: 34  VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL 93
Query: 97  TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARA 156
              +       +  +   +  G+AY     ++HRDL   N L+  +   +K++DFG+ R 
Sbjct: 94  RTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHRDLAARNCLVG-ENQVIKVSDFGMTRF 152
Query: 157 IGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           +   Q   S    +    A   +  ++ YS+  DVW+ G +  E+ +
Sbjct: 153 VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 199

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 68/144 (47%), Gaps = 2/144 (1%)
Query: 65  HENIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
           H  +V L     +   +F V EY++     F  + +  L     +    +I L L Y H 
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 128
Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTG 184
             I++RDLK +N+L+D     +KL D+G+ +    P    S  C    Y APE+L G   
Sbjct: 129 RGIIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRG-ED 186
Query: 185 YSTPIDVWAVGCIFAEMITGKPLF 208
           Y   +D WA+G +  EM+ G+  F
Sbjct: 187 YGFSVDWWALGVLMFEMMAGRSPF 210

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 68/144 (47%), Gaps = 2/144 (1%)
Query: 65  HENIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
           H  +V L     +   +F V EY++     F  + +  L     +    +I L L Y H 
Sbjct: 80  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 139
Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTG 184
             I++RDLK +N+L+D     +KL D+G+ +    P    S  C    Y APE+L G   
Sbjct: 140 RGIIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRG-ED 197
Query: 185 YSTPIDVWAVGCIFAEMITGKPLF 208
           Y   +D WA+G +  EM+ G+  F
Sbjct: 198 YGFSVDWWALGVLMFEMMAGRSPF 221

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 96/188 (51%), Gaps = 14/188 (7%)
Query: 22  EVYKCRNTVTGQKVAIKMM---TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR 78
           EVY+         VA+K +   T++ E+       ++E +++KE++H N+V+LL V +  
Sbjct: 26  EVYEGVWKKYSLTVAVKTLKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGVCTRE 79
Query: 79  KDVFLVFEYLDL-DLHSFITR-HKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNN 136
              +++ E++   +L  ++   ++  ++ +V+  +  QI   + Y      +HRDL   N
Sbjct: 80  PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARN 139
Query: 137 LLIDLKRNTVKLADFGLARAI-GVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVG 195
            L+  + + VK+ADFGL+R + G     ++       + APE  L Y  +S   DVWA G
Sbjct: 140 CLVG-ENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFG 197
Query: 196 CIFAEMIT 203
            +  E+ T
Sbjct: 198 VLLWEIAT 205

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 68/144 (47%), Gaps = 2/144 (1%)
Query: 65  HENIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
           H  +V L     +   +F V EY++     F  + +  L     +    +I L L Y H 
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 124
Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTG 184
             I++RDLK +N+L+D     +KL D+G+ +    P    S  C    Y APE+L G   
Sbjct: 125 RGIIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRG-ED 182
Query: 185 YSTPIDVWAVGCIFAEMITGKPLF 208
           Y   +D WA+G +  EM+ G+  F
Sbjct: 183 YGFSVDWWALGVLMFEMMAGRSPF 206

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 102/204 (50%), Gaps = 20/204 (9%)
Query: 32  GQKVAIKMMTIQTEQEGVPSY--IIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD 89
           G +VA+K      +++   +   + +E  L   L+H NI+ L  V     ++ LV E+  
Sbjct: 30  GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFAR 89
Query: 90  LD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHS---LKILHRDLKPNNLLI------ 139
              L+  ++  +   ++LV  A+  QI  G+ Y H    + I+HRDLK +N+LI      
Sbjct: 90  GGPLNRVLSGKRIPPDILVNWAV--QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVEN 147
Query: 140 -DLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIF 198
            DL    +K+ DFGLAR      K  S    Y+ + APE++   + +S   DVW+ G + 
Sbjct: 148 GDLSNKILKITDFGLAREWHRTTK-MSAAGAYA-WMAPEVIRA-SMFSKGSDVWSYGVLL 204
Query: 199 AEMITGKPLFPSKKHDHLSLIFSL 222
            E++TG+   P +  D L++ + +
Sbjct: 205 WELLTGE--VPFRGIDGLAVAYGV 226

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 15/209 (7%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSY---IIREVSLLKELEHENIVRLLDVQSSRK 79
           VYK      G+KV I +   +  +   P     I+ E  ++  +++ ++ RLL +  +  
Sbjct: 33  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-S 91
Query: 80  DVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLL 138
            V L+ + +    L  ++  HK+ +    +     QI  G+ Y    +++HRDL   N+L
Sbjct: 92  TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL 151
Query: 139 IDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGC 196
           +   ++ VK+ DFGLA+ +G  +KEY  +    P K  A E +L +  Y+   DVW+ G 
Sbjct: 152 VKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGV 209
Query: 197 IFAEMITGKPLFPSKKHDHL--SLIFSLL 223
              E++T    F SK +D +  S I S+L
Sbjct: 210 TVWELMT----FGSKPYDGIPASEISSIL 234

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 121/287 (42%), Gaps = 59/287 (20%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSL-LKELEHENIVRLLDVQ----SSRKDVF 82
           N  T +K A+KM+      +  P    REV L  +  +  +IVR++DV     + RK + 
Sbjct: 39  NKRTQEKFALKML------QDCPK-ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91
Query: 83  LVFEYLDL-DLHSFIT-RHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLID 140
           +V E LD  +L S I  R            I+K I   + Y HS+ I HRD+KP NLL  
Sbjct: 92  IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYT 151
Query: 141 LKRNT--VKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIF 198
            KR    +KL DFG A+      ++Y + C                     D+W++G I 
Sbjct: 152 SKRPNAILKLTDFGFAKE--TTGEKYDKSC---------------------DMWSLGVIM 188
Query: 199 AEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPN 258
             ++ G P F S   +H   I   + T       E          +P+ E + ++E+   
Sbjct: 189 YILLCGYPPFYS---NHGLAISPGMKTRIRMGQYE----------FPNPEWSEVSEEVKM 235
Query: 259 LEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLINR 305
                  L+  +L   P QR+T  + + H +++    VP   L  +R
Sbjct: 236 -------LIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSR 275

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 15/209 (7%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSY---IIREVSLLKELEHENIVRLLDVQSSRK 79
           VYK      G+KV I +   +  +   P     I+ E  ++  +++ ++ RLL +  +  
Sbjct: 56  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-S 114
Query: 80  DVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLL 138
            V L+ + +    L  ++  HK+ +    +     QI  G+ Y    +++HRDL   N+L
Sbjct: 115 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL 174
Query: 139 IDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGC 196
           +   ++ VK+ DFGLA+ +G  +KEY  +    P K  A E +L +  Y+   DVW+ G 
Sbjct: 175 VKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGV 232
Query: 197 IFAEMITGKPLFPSKKHDHL--SLIFSLL 223
              E++T    F SK +D +  S I S+L
Sbjct: 233 TVWELMT----FGSKPYDGIPASEISSIL 257

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 95/197 (48%), Gaps = 24/197 (12%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DLH 93
           VAIK     T  + V    ++E   +++ +H +IV+L+ V  +   V+++ E   L +L 
Sbjct: 69  VAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELR 126
Query: 94  SFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGL 153
           SF+   K +L+L  +     Q+   LAY  S + +HRD+   N+L+    + VKL DFGL
Sbjct: 127 SFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS-SNDCVKLGDFGL 185
Query: 154 ARAIGVPQKEYSRDCVYS---------PYKAPELLLGYTGYSTPIDVWAVG-CIFAEMIT 203
           +R        Y  D  Y           + APE  + +  +++  DVW  G C++  ++ 
Sbjct: 186 SR--------YMEDSTYYKASKGKLPIKWMAPE-SINFRRFTSASDVWMFGVCMWEILMH 236
Query: 204 G-KPLFPSKKHDHLSLI 219
           G KP    K +D +  I
Sbjct: 237 GVKPFQGVKNNDVIGRI 253

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 15/209 (7%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSY---IIREVSLLKELEHENIVRLLDVQSSRK 79
           VYK      G+KV I +   +  +   P     I+ E  ++  +++ ++ RLL +  +  
Sbjct: 38  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-S 96
Query: 80  DVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLL 138
            V L+ + +    L  ++  HK+ +    +     QI  G+ Y    +++HRDL   N+L
Sbjct: 97  TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL 156
Query: 139 IDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGC 196
           +   ++ VK+ DFGLA+ +G  +KEY  +    P K  A E +L +  Y+   DVW+ G 
Sbjct: 157 VKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGV 214
Query: 197 IFAEMITGKPLFPSKKHDHL--SLIFSLL 223
              E++T    F SK +D +  S I S+L
Sbjct: 215 TVWELMT----FGSKPYDGIPASEISSIL 239

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 15/209 (7%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSY---IIREVSLLKELEHENIVRLLDVQSSRK 79
           VYK      G+KV I +   +  +   P     I+ E  ++  +++ ++ RLL +  +  
Sbjct: 34  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-S 92
Query: 80  DVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLL 138
            V L+ + +    L  ++  HK+ +    +     QI  G+ Y    +++HRDL   N+L
Sbjct: 93  TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL 152
Query: 139 IDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGC 196
           +   ++ VK+ DFGLA+ +G  +KEY  +    P K  A E +L +  Y+   DVW+ G 
Sbjct: 153 VKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGV 210
Query: 197 IFAEMITGKPLFPSKKHDHL--SLIFSLL 223
              E++T    F SK +D +  S I S+L
Sbjct: 211 TVWELMT----FGSKPYDGIPASEISSIL 235

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 15/209 (7%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSY---IIREVSLLKELEHENIVRLLDVQSSRK 79
           VYK      G+KV I +   +  +   P     I+ E  ++  +++ ++ RLL +  +  
Sbjct: 34  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-S 92
Query: 80  DVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLL 138
            V L+ + +    L  ++  HK+ +    +     QI  G+ Y    +++HRDL   N+L
Sbjct: 93  TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL 152
Query: 139 IDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGC 196
           +   ++ VK+ DFGLA+ +G  +KEY  +    P K  A E +L +  Y+   DVW+ G 
Sbjct: 153 VKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGV 210
Query: 197 IFAEMITGKPLFPSKKHDHL--SLIFSLL 223
              E++T    F SK +D +  S I S+L
Sbjct: 211 TVWELMT----FGSKPYDGIPASEISSIL 235

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 95/197 (48%), Gaps = 24/197 (12%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DLH 93
           VAIK     T  + V    ++E   +++ +H +IV+L+ V  +   V+++ E   L +L 
Sbjct: 44  VAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELR 101
Query: 94  SFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGL 153
           SF+   K +L+L  +     Q+   LAY  S + +HRD+   N+L+    + VKL DFGL
Sbjct: 102 SFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS-SNDCVKLGDFGL 160
Query: 154 ARAIGVPQKEYSRDCVYS---------PYKAPELLLGYTGYSTPIDVWAVG-CIFAEMIT 203
           +R        Y  D  Y           + APE  + +  +++  DVW  G C++  ++ 
Sbjct: 161 SR--------YMEDSTYYKASKGKLPIKWMAPE-SINFRRFTSASDVWMFGVCMWEILMH 211
Query: 204 G-KPLFPSKKHDHLSLI 219
           G KP    K +D +  I
Sbjct: 212 GVKPFQGVKNNDVIGRI 228

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 15/209 (7%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSY---IIREVSLLKELEHENIVRLLDVQSSRK 79
           VYK      G+KV I +   +  +   P     I+ E  ++  +++ ++ RLL +  +  
Sbjct: 31  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-S 89
Query: 80  DVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLL 138
            V L+ + +    L  ++  HK+ +    +     QI  G+ Y    +++HRDL   N+L
Sbjct: 90  TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL 149
Query: 139 IDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGC 196
           +   ++ VK+ DFGLA+ +G  +KEY  +    P K  A E +L +  Y+   DVW+ G 
Sbjct: 150 VKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGV 207
Query: 197 IFAEMITGKPLFPSKKHDHL--SLIFSLL 223
              E++T    F SK +D +  S I S+L
Sbjct: 208 TVWELMT----FGSKPYDGIPASEISSIL 232

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 97/189 (51%), Gaps = 8/189 (4%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DLH 93
           VAIK     T  + V    ++E   +++ +H +IV+L+ V  +   V+++ E   L +L 
Sbjct: 41  VAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELR 98
Query: 94  SFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGL 153
           SF+   K +L+L  +     Q+   LAY  S + +HRD+   N+L+    + VKL DFGL
Sbjct: 99  SFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS-SNDCVKLGDFGL 157
Query: 154 ARAI-GVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVG-CIFAEMITG-KPLFPS 210
           +R +      + S+  +   + APE  + +  +++  DVW  G C++  ++ G KP    
Sbjct: 158 SRYMEDSTXXKASKGKLPIKWMAPE-SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 216
Query: 211 KKHDHLSLI 219
           K +D +  I
Sbjct: 217 KNNDVIGRI 225

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 15/209 (7%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSY---IIREVSLLKELEHENIVRLLDVQSSRK 79
           VYK      G+KV I +   +  +   P     I+ E  ++  +++ ++ RLL +  +  
Sbjct: 37  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-S 95
Query: 80  DVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLL 138
            V L+ + +    L  ++  HK+ +    +     QI  G+ Y    +++HRDL   N+L
Sbjct: 96  TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL 155
Query: 139 IDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGC 196
           +   ++ VK+ DFGLA+ +G  +KEY  +    P K  A E +L +  Y+   DVW+ G 
Sbjct: 156 VKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGV 213
Query: 197 IFAEMITGKPLFPSKKHDHL--SLIFSLL 223
              E++T    F SK +D +  S I S+L
Sbjct: 214 TVWELMT----FGSKPYDGIPASEISSIL 238

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 15/209 (7%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSY---IIREVSLLKELEHENIVRLLDVQSSRK 79
           VYK      G+KV I +   +  +   P     I+ E  ++  +++ ++ RLL +  +  
Sbjct: 34  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-S 92
Query: 80  DVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLL 138
            V L+ + +    L  ++  HK+ +    +     QI  G+ Y    +++HRDL   N+L
Sbjct: 93  TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL 152
Query: 139 IDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGC 196
           +   ++ VK+ DFGLA+ +G  +KEY  +    P K  A E +L +  Y+   DVW+ G 
Sbjct: 153 VKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGV 210
Query: 197 IFAEMITGKPLFPSKKHDHL--SLIFSLL 223
              E++T    F SK +D +  S I S+L
Sbjct: 211 TVWELMT----FGSKPYDGIPASEISSIL 235

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 15/209 (7%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSY---IIREVSLLKELEHENIVRLLDVQSSRK 79
           VYK      G+KV I +   +  +   P     I+ E  ++  +++ ++ RLL +  +  
Sbjct: 31  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-S 89
Query: 80  DVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLL 138
            V L+ + +    L  ++  HK+ +    +     QI  G+ Y    +++HRDL   N+L
Sbjct: 90  TVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL 149
Query: 139 IDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGC 196
           +   ++ VK+ DFGLA+ +G  +KEY  +    P K  A E +L +  Y+   DVW+ G 
Sbjct: 150 VKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGV 207
Query: 197 IFAEMITGKPLFPSKKHDHL--SLIFSLL 223
              E++T    F SK +D +  S I S+L
Sbjct: 208 TVWELMT----FGSKPYDGIPASEISSIL 232

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 95/197 (48%), Gaps = 24/197 (12%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DLH 93
           VAIK     T  + V    ++E   +++ +H +IV+L+ V  +   V+++ E   L +L 
Sbjct: 41  VAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELR 98
Query: 94  SFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGL 153
           SF+   K +L+L  +     Q+   LAY  S + +HRD+   N+L+    + VKL DFGL
Sbjct: 99  SFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS-SNDCVKLGDFGL 157
Query: 154 ARAIGVPQKEYSRDCVYS---------PYKAPELLLGYTGYSTPIDVWAVG-CIFAEMIT 203
           +R        Y  D  Y           + APE  + +  +++  DVW  G C++  ++ 
Sbjct: 158 SR--------YMEDSTYYKASKGKLPIKWMAPE-SINFRRFTSASDVWMFGVCMWEILMH 208
Query: 204 G-KPLFPSKKHDHLSLI 219
           G KP    K +D +  I
Sbjct: 209 GVKPFQGVKNNDVIGRI 225

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 95/197 (48%), Gaps = 24/197 (12%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DLH 93
           VAIK     T  + V    ++E   +++ +H +IV+L+ V  +   V+++ E   L +L 
Sbjct: 38  VAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELR 95
Query: 94  SFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGL 153
           SF+   K +L+L  +     Q+   LAY  S + +HRD+   N+L+    + VKL DFGL
Sbjct: 96  SFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS-SNDCVKLGDFGL 154
Query: 154 ARAIGVPQKEYSRDCVYS---------PYKAPELLLGYTGYSTPIDVWAVG-CIFAEMIT 203
           +R        Y  D  Y           + APE  + +  +++  DVW  G C++  ++ 
Sbjct: 155 SR--------YMEDSTYYKASKGKLPIKWMAPE-SINFRRFTSASDVWMFGVCMWEILMH 205
Query: 204 G-KPLFPSKKHDHLSLI 219
           G KP    K +D +  I
Sbjct: 206 GVKPFQGVKNNDVIGRI 222

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 95/197 (48%), Gaps = 24/197 (12%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DLH 93
           VAIK     T  + V    ++E   +++ +H +IV+L+ V  +   V+++ E   L +L 
Sbjct: 43  VAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELR 100
Query: 94  SFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGL 153
           SF+   K +L+L  +     Q+   LAY  S + +HRD+   N+L+    + VKL DFGL
Sbjct: 101 SFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS-SNDCVKLGDFGL 159
Query: 154 ARAIGVPQKEYSRDCVYS---------PYKAPELLLGYTGYSTPIDVWAVG-CIFAEMIT 203
           +R        Y  D  Y           + APE  + +  +++  DVW  G C++  ++ 
Sbjct: 160 SR--------YMEDSTYYKASKGKLPIKWMAPE-SINFRRFTSASDVWMFGVCMWEILMH 210
Query: 204 G-KPLFPSKKHDHLSLI 219
           G KP    K +D +  I
Sbjct: 211 GVKPFQGVKNNDVIGRI 227

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 95/197 (48%), Gaps = 24/197 (12%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DLH 93
           VAIK     T  + V    ++E   +++ +H +IV+L+ V  +   V+++ E   L +L 
Sbjct: 46  VAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELR 103
Query: 94  SFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGL 153
           SF+   K +L+L  +     Q+   LAY  S + +HRD+   N+L+    + VKL DFGL
Sbjct: 104 SFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS-SNDCVKLGDFGL 162
Query: 154 ARAIGVPQKEYSRDCVYS---------PYKAPELLLGYTGYSTPIDVWAVG-CIFAEMIT 203
           +R        Y  D  Y           + APE  + +  +++  DVW  G C++  ++ 
Sbjct: 163 SR--------YMEDSTYYKASKGKLPIKWMAPE-SINFRRFTSASDVWMFGVCMWEILMH 213
Query: 204 G-KPLFPSKKHDHLSLI 219
           G KP    K +D +  I
Sbjct: 214 GVKPFQGVKNNDVIGRI 230

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 15/209 (7%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSY---IIREVSLLKELEHENIVRLLDVQSSRK 79
           VYK      G+KV I +   +  +   P     I+ E  ++  +++ ++ RLL +  +  
Sbjct: 31  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-S 89
Query: 80  DVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLL 138
            V L+ + +    L  ++  HK+ +    +     QI  G+ Y    +++HRDL   N+L
Sbjct: 90  TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL 149
Query: 139 IDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGC 196
           +   ++ VK+ DFGLA+ +G  +KEY  +    P K  A E +L +  Y+   DVW+ G 
Sbjct: 150 VKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGV 207
Query: 197 IFAEMITGKPLFPSKKHDHL--SLIFSLL 223
              E++T    F SK +D +  S I S+L
Sbjct: 208 TVWELMT----FGSKPYDGIPASEISSIL 232

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 15/209 (7%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSY---IIREVSLLKELEHENIVRLLDVQSSRK 79
           VYK      G+KV I +   +  +   P     I+ E  ++  +++ ++ RLL +  +  
Sbjct: 38  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-S 96
Query: 80  DVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLL 138
            V L+ + +    L  ++  HK+ +    +     QI  G+ Y    +++HRDL   N+L
Sbjct: 97  TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL 156
Query: 139 IDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGC 196
           +   ++ VK+ DFGLA+ +G  +KEY  +    P K  A E +L +  Y+   DVW+ G 
Sbjct: 157 VKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGV 214
Query: 197 IFAEMITGKPLFPSKKHDHL--SLIFSLL 223
              E++T    F SK +D +  S I S+L
Sbjct: 215 TVWELMT----FGSKPYDGIPASEISSIL 239

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 15/209 (7%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSY---IIREVSLLKELEHENIVRLLDVQSSRK 79
           VYK      G+KV I +   +  +   P     I+ E  ++  +++ ++ RLL +  +  
Sbjct: 31  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-S 89
Query: 80  DVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLL 138
            V L+ + +    L  ++  HK+ +    +     QI  G+ Y    +++HRDL   N+L
Sbjct: 90  TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL 149
Query: 139 IDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGC 196
           +   ++ VK+ DFGLA+ +G  +KEY  +    P K  A E +L +  Y+   DVW+ G 
Sbjct: 150 VKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGV 207
Query: 197 IFAEMITGKPLFPSKKHDHL--SLIFSLL 223
              E++T    F SK +D +  S I S+L
Sbjct: 208 TVWELMT----FGSKPYDGIPASEISSIL 232

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 95/197 (48%), Gaps = 24/197 (12%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DLH 93
           VAIK     T  + V    ++E   +++ +H +IV+L+ V  +   V+++ E   L +L 
Sbjct: 41  VAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELR 98
Query: 94  SFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGL 153
           SF+   K +L+L  +     Q+   LAY  S + +HRD+   N+L+    + VKL DFGL
Sbjct: 99  SFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS-SNDCVKLGDFGL 157
Query: 154 ARAIGVPQKEYSRDCVYS---------PYKAPELLLGYTGYSTPIDVWAVG-CIFAEMIT 203
           +R        Y  D  Y           + APE  + +  +++  DVW  G C++  ++ 
Sbjct: 158 SR--------YMEDSTYYKASKGKLPIKWMAPE-SINFRRFTSASDVWMFGVCMWEILMH 208
Query: 204 G-KPLFPSKKHDHLSLI 219
           G KP    K +D +  I
Sbjct: 209 GVKPFQGVKNNDVIGRI 225

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 87/184 (47%), Gaps = 12/184 (6%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYI---IREVSLLKELEHENIVRLLDVQSSRKDVFLV 84
           +  +G+ V++ +  ++ +    P  +   IREV+ +  L+H N++RL  V  +   + +V
Sbjct: 40  DAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMV 98
Query: 85  FEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKR 143
            E   L  L   + +H+    L  +     Q+  G+ Y  S + +HRDL   NLL+   R
Sbjct: 99  TELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL-ATR 157
Query: 144 NTVKLADFGLARAIGVPQKEY----SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFA 199
           + VK+ DFGL RA+      Y     R   ++ + APE L   T +S   D W  G    
Sbjct: 158 DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA-WCAPESLKTRT-FSHASDTWMFGVTLW 215
Query: 200 EMIT 203
           EM T
Sbjct: 216 EMFT 219

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 15/209 (7%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSY---IIREVSLLKELEHENIVRLLDVQSSRK 79
           VYK      G+KV I +   +  +   P     I+ E  ++  +++ ++ RLL +  +  
Sbjct: 28  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-S 86
Query: 80  DVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLL 138
            V L+ + +    L  ++  HK+ +    +     QI  G+ Y    +++HRDL   N+L
Sbjct: 87  TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYLEDRRLVHRDLAARNVL 146
Query: 139 IDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGC 196
           +   ++ VK+ DFGLA+ +G  +KEY  +    P K  A E +L +  Y+   DVW+ G 
Sbjct: 147 VKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGV 204
Query: 197 IFAEMITGKPLFPSKKHDHL--SLIFSLL 223
              E++T    F SK +D +  S I S+L
Sbjct: 205 TVWELMT----FGSKPYDGIPASEISSIL 229

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 101/196 (51%), Gaps = 18/196 (9%)
Query: 35  VAIKMM---TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL- 90
           VA+K +   T++ E+       ++E +++KE++H N+V+LL V +     +++ E++   
Sbjct: 248 VAVKTLKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG 301
Query: 91  DLHSFITR-HKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLA 149
           +L  ++   ++  ++ +V+  +  QI   + Y      +HR+L   N L+  + + VK+A
Sbjct: 302 NLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVG-ENHLVKVA 360
Query: 150 DFGLARAI-GVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPL 207
           DFGL+R + G     ++       + APE  L Y  +S   DVWA G +  E+ T G   
Sbjct: 361 DFGLSRLMTGDTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFGVLLWEIATYGMSP 419
Query: 208 FPSKKHDHLSLIFSLL 223
           +P      LS ++ LL
Sbjct: 420 YPGID---LSQVYELL 432

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 90/180 (50%), Gaps = 13/180 (7%)
Query: 32  GQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDLD 91
           G  VA+K++  Q       +  +REV+++K L H NIV  +   +   ++ +V EYL   
Sbjct: 60  GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRG 119
Query: 92  -----LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK--ILHRDLKPNNLLIDLKRN 144
                LH    R +  L+     ++   +  G+ Y H+    I+HR+LK  NLL+D K+ 
Sbjct: 120 SLYRLLHKSGAREQ--LDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD-KKY 176
Query: 145 TVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           TVK+ DFGL+R +       S+    +P + APE+L      +   DV++ G I  E+ T
Sbjct: 177 TVKVCDFGLSR-LKASTFLSSKSAAGTPEWMAPEVLRDEPS-NEKSDVYSFGVILWELAT 234

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 15/209 (7%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSY---IIREVSLLKELEHENIVRLLDVQSSRK 79
           VYK      G+KV I +   +  +   P     I+ E  ++  +++ ++ RLL +  +  
Sbjct: 41  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-S 99
Query: 80  DVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLL 138
            V L+ + +    L  ++  HK+ +    +     QI  G+ Y    +++HRDL   N+L
Sbjct: 100 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL 159
Query: 139 IDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGC 196
           +   ++ VK+ DFGLA+ +G  +KEY  +    P K  A E +L +  Y+   DVW+ G 
Sbjct: 160 VKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGV 217
Query: 197 IFAEMITGKPLFPSKKHDHL--SLIFSLL 223
              E++T    F SK +D +  S I S+L
Sbjct: 218 TVWELMT----FGSKPYDGIPASEISSIL 242

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 84/170 (49%), Gaps = 11/170 (6%)
Query: 48  GVPSYIIREVSLLKELEHENIVRLLDV-QSSRKDVFLVFEYLDL-DLHSFITRHKNTLNL 105
           G  S  + E  ++K+  H N++ LL +   S     +V  Y+   DL +FI    +   +
Sbjct: 91  GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV 150
Query: 106 LVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY- 164
             +     Q+  G+ Y  S K +HRDL   N ++D ++ TVK+ADFGLAR +    KEY 
Sbjct: 151 KDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDM--YDKEYY 207
Query: 165 ---SRDCVYSPYKAPEL-LLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFP 209
              ++     P K   L  L    ++T  DVW+ G +  E++T G P +P
Sbjct: 208 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 257

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 84/170 (49%), Gaps = 11/170 (6%)
Query: 48  GVPSYIIREVSLLKELEHENIVRLLDV-QSSRKDVFLVFEYLDL-DLHSFITRHKNTLNL 105
           G  S  + E  ++K+  H N++ LL +   S     +V  Y+   DL +FI    +   +
Sbjct: 92  GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV 151
Query: 106 LVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY- 164
             +     Q+  G+ Y  S K +HRDL   N ++D ++ TVK+ADFGLAR +    KEY 
Sbjct: 152 KDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMY--DKEYY 208
Query: 165 ---SRDCVYSPYKAPEL-LLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFP 209
              ++     P K   L  L    ++T  DVW+ G +  E++T G P +P
Sbjct: 209 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 258

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 87/184 (47%), Gaps = 12/184 (6%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYI---IREVSLLKELEHENIVRLLDVQSSRKDVFLV 84
           +  +G+ V++ +  ++ +    P  +   IREV+ +  L+H N++RL  V  +   + +V
Sbjct: 30  DAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMV 88
Query: 85  FEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKR 143
            E   L  L   + +H+    L  +     Q+  G+ Y  S + +HRDL   NLL+   R
Sbjct: 89  TELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL-ATR 147
Query: 144 NTVKLADFGLARAIGVPQKEY----SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFA 199
           + VK+ DFGL RA+      Y     R   ++ + APE L   T +S   D W  G    
Sbjct: 148 DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA-WCAPESLKTRT-FSHASDTWMFGVTLW 205
Query: 200 EMIT 203
           EM T
Sbjct: 206 EMFT 209

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 84/170 (49%), Gaps = 11/170 (6%)
Query: 48  GVPSYIIREVSLLKELEHENIVRLLDV-QSSRKDVFLVFEYLDL-DLHSFITRHKNTLNL 105
           G  S  + E  ++K+  H N++ LL +   S     +V  Y+   DL +FI    +   +
Sbjct: 73  GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV 132
Query: 106 LVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY- 164
             +     Q+  G+ Y  S K +HRDL   N ++D ++ TVK+ADFGLAR +    KEY 
Sbjct: 133 KDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDM--YDKEYY 189
Query: 165 ---SRDCVYSPYKAPEL-LLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFP 209
              ++     P K   L  L    ++T  DVW+ G +  E++T G P +P
Sbjct: 190 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 86/181 (47%), Gaps = 12/181 (6%)
Query: 31  TGQKVAIKMMTIQTEQEGVPSYI---IREVSLLKELEHENIVRLLDVQSSRKDVFLVFEY 87
           +G+ V++ +  ++ +    P  +   IREV+ +  L+H N++RL  V  +   + +V E 
Sbjct: 37  SGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTEL 95
Query: 88  LDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTV 146
             L  L   + +H+    L  +     Q+  G+ Y  S + +HRDL   NLL+   R+ V
Sbjct: 96  APLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL-ATRDLV 154
Query: 147 KLADFGLARAIGVPQKEY----SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMI 202
           K+ DFGL RA+      Y     R   ++ + APE L   T +S   D W  G    EM 
Sbjct: 155 KIGDFGLMRALPQNDDHYVMQEHRKVPFA-WCAPESLKTRT-FSHASDTWMFGVTLWEMF 212
Query: 203 T 203
           T
Sbjct: 213 T 213

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 86/162 (53%), Gaps = 10/162 (6%)
Query: 53  IIREVSLLKELEHENIVRLLDV--QSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKA 110
           + +E+++LK+L+H N+V+L++V    +   +++VFE ++      +   K  L+    + 
Sbjct: 83  VYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK-PLSEDQARF 141
Query: 111 ILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVY 170
             + ++ G+ Y H  KI+HRD+KP+NLL+  +   +K+ADFG++          S     
Sbjct: 142 YFQDLIKGIEYLHYQKIIHRDIKPSNLLVG-EDGHIKIADFGVSNEFKGSDALLSNTVGT 200
Query: 171 SPYKAPELLLG----YTGYSTPIDVWAVGCIFAEMITGKPLF 208
             + APE L      ++G +  +DVWA+G      + G+  F
Sbjct: 201 PAFMAPESLSETRKIFSGKA--LDVWAMGVTLYCFVFGQCPF 240

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 86/181 (47%), Gaps = 12/181 (6%)
Query: 31  TGQKVAIKMMTIQTEQEGVPSYI---IREVSLLKELEHENIVRLLDVQSSRKDVFLVFEY 87
           +G+ V++ +  ++ +    P  +   IREV+ +  L+H N++RL  V  +   + +V E 
Sbjct: 37  SGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTEL 95
Query: 88  LDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTV 146
             L  L   + +H+    L  +     Q+  G+ Y  S + +HRDL   NLL+   R+ V
Sbjct: 96  APLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL-ATRDLV 154
Query: 147 KLADFGLARAIGVPQKEY----SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMI 202
           K+ DFGL RA+      Y     R   ++ + APE L   T +S   D W  G    EM 
Sbjct: 155 KIGDFGLMRALPQNDDHYVMQEHRKVPFA-WCAPESLKTRT-FSHASDTWMFGVTLWEMF 212
Query: 203 T 203
           T
Sbjct: 213 T 213

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/188 (30%), Positives = 94/188 (50%), Gaps = 14/188 (7%)
Query: 32  GQKV--AIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDV-QSSRKDVFLVFEYL 88
           G+K+  A+K +   T+  G  S  + E  ++K+  H N++ LL +   S     +V  Y+
Sbjct: 48  GKKIHCAVKSLNRITDI-GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 106
Query: 89  DL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVK 147
              DL +FI    +   +  +     Q+  G+ Y  S K +HRDL   N ++D ++ TVK
Sbjct: 107 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD-EKFTVK 165
Query: 148 LADFGLARAIGVPQKEY----SRDCVYSPYKAPEL-LLGYTGYSTPIDVWAVGCIFAEMI 202
           +ADFGLAR +    KEY    ++     P K   L  L    ++T  DVW+ G +  E++
Sbjct: 166 VADFGLARDM--YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 223
Query: 203 T-GKPLFP 209
           T G P +P
Sbjct: 224 TRGAPPYP 231

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 87/185 (47%), Gaps = 14/185 (7%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYI---IREVSLLKELEHENIVRLLDVQSSRKDVFLV 84
           +  +G+ V++ +  ++ +    P  +   IREV+ +  L+H N++RL  V  +   + +V
Sbjct: 40  DAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMV 98
Query: 85  FEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKR 143
            E   L  L   + +H+    L  +     Q+  G+ Y  S + +HRDL   NLL+   R
Sbjct: 99  TELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL-ATR 157
Query: 144 NTVKLADFGLARAIGVPQKE-----YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIF 198
           + VK+ DFGL RA+  PQ +          V   + APE L   T +S   D W  G   
Sbjct: 158 DLVKIGDFGLMRAL--PQNDDHXVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTL 214
Query: 199 AEMIT 203
            EM T
Sbjct: 215 WEMFT 219

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 84/170 (49%), Gaps = 11/170 (6%)
Query: 48  GVPSYIIREVSLLKELEHENIVRLLDV-QSSRKDVFLVFEYLDL-DLHSFITRHKNTLNL 105
           G  S  + E  ++K+  H N++ LL +   S     +V  Y+   DL +FI    +   +
Sbjct: 71  GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV 130
Query: 106 LVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY- 164
             +     Q+  G+ Y  S K +HRDL   N ++D ++ TVK+ADFGLAR +    KEY 
Sbjct: 131 KDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDM--YDKEYY 187
Query: 165 ---SRDCVYSPYKAPEL-LLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFP 209
              ++     P K   L  L    ++T  DVW+ G +  E++T G P +P
Sbjct: 188 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 237

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/188 (30%), Positives = 94/188 (50%), Gaps = 14/188 (7%)
Query: 32  GQKV--AIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDV-QSSRKDVFLVFEYL 88
           G+K+  A+K +   T+  G  S  + E  ++K+  H N++ LL +   S     +V  Y+
Sbjct: 51  GKKIHCAVKSLNRITDI-GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 109
Query: 89  DL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVK 147
              DL +FI    +   +  +     Q+  G+ Y  S K +HRDL   N ++D ++ TVK
Sbjct: 110 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD-EKFTVK 168
Query: 148 LADFGLARAIGVPQKEY----SRDCVYSPYKAPEL-LLGYTGYSTPIDVWAVGCIFAEMI 202
           +ADFGLAR +    KEY    ++     P K   L  L    ++T  DVW+ G +  E++
Sbjct: 169 VADFGLARDM--YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 226
Query: 203 T-GKPLFP 209
           T G P +P
Sbjct: 227 TRGAPPYP 234

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 15/209 (7%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSY---IIREVSLLKELEHENIVRLLDVQSSRK 79
           VYK      G+KV I +   +  +   P     I+ E  ++  +++ ++ RLL +  +  
Sbjct: 25  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-S 83
Query: 80  DVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLL 138
            V L+ + +    L  ++  HK+ +    +     QI  G+ Y    +++HRDL   N+L
Sbjct: 84  TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL 143
Query: 139 IDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGC 196
           +   ++ VK+ DFGLA+ +G  +KEY  +    P K  A E +L +  Y+   DVW+ G 
Sbjct: 144 VKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGV 201
Query: 197 IFAEMITGKPLFPSKKHDHL--SLIFSLL 223
              E++T    F SK +D +  S I S+L
Sbjct: 202 TVWELMT----FGSKPYDGIPASEISSIL 226

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 81/173 (46%), Gaps = 9/173 (5%)
Query: 34  KVAIKMMTIQTEQEGVPSY--IIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDLD 91
           KVAIK     T +EG  S    I E  ++ +L H  +V+L  V   +  + LVFE+++  
Sbjct: 33  KVAIK-----TIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHG 87
Query: 92  -LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLAD 150
            L  ++   +       +  +   +  G+AY     ++HRDL   N L+  +   +K++D
Sbjct: 88  CLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG-ENQVIKVSD 146
Query: 151 FGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           FG+ R +   Q   S    +    A   +  ++ YS+  DVW+ G +  E+ +
Sbjct: 147 FGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 199

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 87/190 (45%), Gaps = 44/190 (23%)
Query: 114 QILLGLAYCHSLK-ILHRDLKPNNLLIDLKRNTVKLADFGLAR---AIGVPQKEYSRDCV 169
           +I+  L Y HS K +++RDLK  NL++D K   +K+ DFGL +     G   K +   C 
Sbjct: 259 EIVSALDYLHSEKNVVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMKTF---CG 314
Query: 170 YSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDE 229
              Y APE+L     Y   +D W +G +  EM+ G+  F ++ H+ L   F L+      
Sbjct: 315 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---FELI------ 364
Query: 230 SWAESTYISEILPLYPHFEPANLAEKFPN-LEPAGVDLLSQMLCLNPKQRI-----TAMD 283
                  + EI              +FP  L P    LLS +L  +PKQR+      A +
Sbjct: 365 ------LMEEI--------------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKE 404
Query: 284 ALKHEYLIGV 293
            ++H +  G+
Sbjct: 405 IMQHRFFAGI 414

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 84/170 (49%), Gaps = 11/170 (6%)
Query: 48  GVPSYIIREVSLLKELEHENIVRLLDV-QSSRKDVFLVFEYLDL-DLHSFITRHKNTLNL 105
           G  S  + E  ++K+  H N++ LL +   S     +V  Y+   DL +FI    +   +
Sbjct: 70  GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV 129
Query: 106 LVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY- 164
             +     Q+  G+ Y  S K +HRDL   N ++D ++ TVK+ADFGLAR +    KEY 
Sbjct: 130 KDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDM--YDKEYY 186
Query: 165 ---SRDCVYSPYKAPEL-LLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFP 209
              ++     P K   L  L    ++T  DVW+ G +  E++T G P +P
Sbjct: 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 236

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 84/170 (49%), Gaps = 11/170 (6%)
Query: 48  GVPSYIIREVSLLKELEHENIVRLLDV-QSSRKDVFLVFEYLDL-DLHSFITRHKNTLNL 105
           G  S  + E  ++K+  H N++ LL +   S     +V  Y+   DL +FI    +   +
Sbjct: 73  GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV 132
Query: 106 LVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY- 164
             +     Q+  G+ Y  S K +HRDL   N ++D ++ TVK+ADFGLAR +    KEY 
Sbjct: 133 KDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDM--YDKEYY 189
Query: 165 ---SRDCVYSPYKAPEL-LLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFP 209
              ++     P K   L  L    ++T  DVW+ G +  E++T G P +P
Sbjct: 190 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 86/181 (47%), Gaps = 12/181 (6%)
Query: 31  TGQKVAIKMMTIQTEQEGVPSYI---IREVSLLKELEHENIVRLLDVQSSRKDVFLVFEY 87
           +G+ V++ +  ++ +    P  +   IREV+ +  L+H N++RL  V  +   + +V E 
Sbjct: 33  SGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTEL 91
Query: 88  LDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTV 146
             L  L   + +H+    L  +     Q+  G+ Y  S + +HRDL   NLL+   R+ V
Sbjct: 92  APLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL-ATRDLV 150
Query: 147 KLADFGLARAIGVPQKEY----SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMI 202
           K+ DFGL RA+      Y     R   ++ + APE L   T +S   D W  G    EM 
Sbjct: 151 KIGDFGLMRALPQNDDHYVMQEHRKVPFA-WCAPESLKTRT-FSHASDTWMFGVTLWEMF 208
Query: 203 T 203
           T
Sbjct: 209 T 209

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 81/173 (46%), Gaps = 9/173 (5%)
Query: 34  KVAIKMMTIQTEQEGVPSY--IIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDLD 91
           KVAIK     T +EG  S    I E  ++ +L H  +V+L  V   +  + LVFE+++  
Sbjct: 31  KVAIK-----TIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHG 85
Query: 92  -LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLAD 150
            L  ++   +       +  +   +  G+AY     ++HRDL   N L+  +   +K++D
Sbjct: 86  CLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG-ENQVIKVSD 144
Query: 151 FGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           FG+ R +   Q   S    +    A   +  ++ YS+  DVW+ G +  E+ +
Sbjct: 145 FGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 197

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 81/173 (46%), Gaps = 9/173 (5%)
Query: 34  KVAIKMMTIQTEQEGVPSY--IIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDLD 91
           KVAIK     T +EG  S    I E  ++ +L H  +V+L  V   +  + LVFE+++  
Sbjct: 36  KVAIK-----TIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHG 90
Query: 92  -LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLAD 150
            L  ++   +       +  +   +  G+AY     ++HRDL   N L+  +   +K++D
Sbjct: 91  CLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG-ENQVIKVSD 149
Query: 151 FGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           FG+ R +   Q   S    +    A   +  ++ YS+  DVW+ G +  E+ +
Sbjct: 150 FGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 202

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 95/197 (48%), Gaps = 24/197 (12%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DLH 93
           VAIK     T  + V    ++E   +++ +H +IV+L+ V  +   V+++ E   L +L 
Sbjct: 41  VAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELR 98
Query: 94  SFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGL 153
           SF+   K +L+L  +     Q+   LAY  S + +HRD+   N+L+    + VKL DFGL
Sbjct: 99  SFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSAT-DCVKLGDFGL 157
Query: 154 ARAIGVPQKEYSRDCVYS---------PYKAPELLLGYTGYSTPIDVWAVG-CIFAEMIT 203
           +R        Y  D  Y           + APE  + +  +++  DVW  G C++  ++ 
Sbjct: 158 SR--------YMEDSTYYKASKGKLPIKWMAPE-SINFRRFTSASDVWMFGVCMWEILMH 208
Query: 204 G-KPLFPSKKHDHLSLI 219
           G KP    K +D +  I
Sbjct: 209 GVKPFQGVKNNDVIGRI 225

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 87/190 (45%), Gaps = 44/190 (23%)
Query: 114 QILLGLAYCHSLK-ILHRDLKPNNLLIDLKRNTVKLADFGLAR---AIGVPQKEYSRDCV 169
           +I+  L Y HS K +++RDLK  NL++D K   +K+ DFGL +     G   K +   C 
Sbjct: 256 EIVSALDYLHSEKNVVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMKTF---CG 311
Query: 170 YSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDE 229
              Y APE+L     Y   +D W +G +  EM+ G+  F ++ H+ L   F L+      
Sbjct: 312 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---FELI------ 361
Query: 230 SWAESTYISEILPLYPHFEPANLAEKFPN-LEPAGVDLLSQMLCLNPKQRI-----TAMD 283
                  + EI              +FP  L P    LLS +L  +PKQR+      A +
Sbjct: 362 ------LMEEI--------------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKE 401
Query: 284 ALKHEYLIGV 293
            ++H +  G+
Sbjct: 402 IMQHRFFAGI 411

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 84/170 (49%), Gaps = 11/170 (6%)
Query: 48  GVPSYIIREVSLLKELEHENIVRLLDV-QSSRKDVFLVFEYLDL-DLHSFITRHKNTLNL 105
           G  S  + E  ++K+  H N++ LL +   S     +V  Y+   DL +FI    +   +
Sbjct: 72  GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV 131
Query: 106 LVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY- 164
             +     Q+  G+ Y  S K +HRDL   N ++D ++ TVK+ADFGLAR +    KEY 
Sbjct: 132 KDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDM--YDKEYY 188
Query: 165 ---SRDCVYSPYKAPEL-LLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFP 209
              ++     P K   L  L    ++T  DVW+ G +  E++T G P +P
Sbjct: 189 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 238

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 87/177 (49%), Gaps = 33/177 (18%)
Query: 108 IKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRD 167
           ++  + +I+L L + H L I++RD+K  N+L+D   + V L DFGL++     + E + D
Sbjct: 161 VQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVV-LTDFGLSKEFVADETERAYD 219
Query: 168 -CVYSPYKAPELLLGY-TGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGT 225
            C    Y AP+++ G  +G+   +D W++G +  E++TG   F                T
Sbjct: 220 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF----------------T 263
Query: 226 PTDESWAESTYISEIL---PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRI 279
              E  +++     IL   P YP  E + LA+          DL+ ++L  +PK+R+
Sbjct: 264 VDGEKNSQAEISRRILKSEPPYPQ-EMSALAK----------DLIQRLLMKDPKKRL 309

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 87/185 (47%), Gaps = 14/185 (7%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYI---IREVSLLKELEHENIVRLLDVQSSRKDVFLV 84
           +  +G+ V++ +  ++ +    P  +   IREV+ +  L+H N++RL  V  +   + +V
Sbjct: 30  DAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMV 88
Query: 85  FEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKR 143
            E   L  L   + +H+    L  +     Q+  G+ Y  S + +HRDL   NLL+   R
Sbjct: 89  TELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL-ATR 147
Query: 144 NTVKLADFGLARAIGVPQKE-----YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIF 198
           + VK+ DFGL RA+  PQ +          V   + APE L   T +S   D W  G   
Sbjct: 148 DLVKIGDFGLMRAL--PQNDDHXVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTL 204
Query: 199 AEMIT 203
            EM T
Sbjct: 205 WEMFT 209

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 95/197 (48%), Gaps = 24/197 (12%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DLH 93
           VAIK     T  + V    ++E   +++ +H +IV+L+ V  +   V+++ E   L +L 
Sbjct: 421 VAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELR 478
Query: 94  SFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGL 153
           SF+   K +L+L  +     Q+   LAY  S + +HRD+   N+L+    + VKL DFGL
Sbjct: 479 SFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS-SNDCVKLGDFGL 537
Query: 154 ARAIGVPQKEYSRDCVYS---------PYKAPELLLGYTGYSTPIDVWAVG-CIFAEMIT 203
           +R        Y  D  Y           + APE  + +  +++  DVW  G C++  ++ 
Sbjct: 538 SR--------YMEDSTYYKASKGKLPIKWMAPE-SINFRRFTSASDVWMFGVCMWEILMH 588
Query: 204 G-KPLFPSKKHDHLSLI 219
           G KP    K +D +  I
Sbjct: 589 GVKPFQGVKNNDVIGRI 605

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 82/171 (47%), Gaps = 7/171 (4%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDLD-LH 93
           VA+KM+   +  E       +E   + +L H  +V+   V S    +++V EY+    L 
Sbjct: 35  VAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLL 91
Query: 94  SFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGL 153
           +++  H   L    +  +   +  G+A+  S + +HRDL   N L+D +   VK++DFG+
Sbjct: 92  NYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVD-RDLCVKVSDFGM 150
Query: 154 ARAIGVPQKEYSRDCVYS-PYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
            R +   Q   S    +   + APE +  Y  YS+  DVWA G +  E+ +
Sbjct: 151 TRYVLDDQYVSSVGTKFPVKWSAPE-VFHYFKYSSKSDVWAFGILMWEVFS 200

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 87/172 (50%), Gaps = 9/172 (5%)
Query: 53  IIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAIL 112
            + E  ++K L+H +IV+L+ +        ++  Y   +L  ++ R+KN+L +L +    
Sbjct: 60  FMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYS 119
Query: 113 KQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS- 171
            QI   +AY  S+  +HRD+   N+L+      VKL DFGL+R I    ++Y +  V   
Sbjct: 120 LQICKAMAYLESINCVHRDIAVRNILV-ASPECVKLGDFGLSRYI--EDEDYYKASVTRL 176
Query: 172 --PYKAPELLLGYTGYSTPIDVWAVG-CIFAEMITGK-PLFPSKKHDHLSLI 219
              + +PE  + +  ++T  DVW    C++  +  GK P F  +  D + ++
Sbjct: 177 PIKWMSPE-SINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL 227

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 91/191 (47%), Gaps = 14/191 (7%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS----R 78
           VYK  +T T  +VA   +  +   +        E   LK L+H NIVR  D   S    +
Sbjct: 42  VYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDSWESTVKGK 101
Query: 79  KDVFLVFE-YLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK--ILHRDLKPN 135
           K + LV E      L +++ R K    + V+++  +QIL GL + H+    I+HRDLK +
Sbjct: 102 KCIVLVTELXTSGTLKTYLKRFK-VXKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCD 160
Query: 136 NLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGYTGYSTPIDVWAV 194
           N+ I     +VK+ D GLA    + +  +++  + +P + APE       Y   +DV+A 
Sbjct: 161 NIFITGPTGSVKIGDLGLA---TLKRASFAKAVIGTPEFXAPEXY--EEKYDESVDVYAF 215
Query: 195 GCIFAEMITGK 205
           G    E  T +
Sbjct: 216 GXCXLEXATSE 226

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 87/172 (50%), Gaps = 9/172 (5%)
Query: 53  IIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAIL 112
            + E  ++K L+H +IV+L+ +        ++  Y   +L  ++ R+KN+L +L +    
Sbjct: 72  FMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYS 131
Query: 113 KQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS- 171
            QI   +AY  S+  +HRD+   N+L+      VKL DFGL+R I    ++Y +  V   
Sbjct: 132 LQICKAMAYLESINCVHRDIAVRNILV-ASPECVKLGDFGLSRYI--EDEDYYKASVTRL 188
Query: 172 --PYKAPELLLGYTGYSTPIDVWAVG-CIFAEMITGK-PLFPSKKHDHLSLI 219
              + +PE  + +  ++T  DVW    C++  +  GK P F  +  D + ++
Sbjct: 189 PIKWMSPE-SINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL 239

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQE--GVPSYIIREVSLLKELEHENIVRLLDVQSSRK 79
           EV+ C+   TG+  A K +  +  ++  G    ++ E  +L ++    IV L     ++ 
Sbjct: 200 EVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMV-EKKILAKVHSRFIVSLAYAFETKT 258
Query: 80  DVFLVFEYL---DLDLHSFITRHKNTLNLLVIKAIL--KQILLGLAYCHSLKILHRDLKP 134
           D+ LV   +   D+  H +     N       +AI    QI+ GL + H   I++RDLKP
Sbjct: 259 DLCLVMTIMNGGDIRYHIYNVDEDNP-GFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKP 317
Query: 135 NNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAV 194
            N+L+D   N V+++D GLA  +   Q +         + APELLLG   Y   +D +A+
Sbjct: 318 ENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEE-YDFSVDYFAL 375
Query: 195 GCIFAEMITGKPLFPSK 211
           G    EMI  +  F ++
Sbjct: 376 GVTLYEMIAARGPFRAR 392

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQE--GVPSYIIREVSLLKELEHENIVRLLDVQSSRK 79
           EV+ C+   TG+  A K +  +  ++  G    ++ E  +L ++    IV L     ++ 
Sbjct: 200 EVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMV-EKKILAKVHSRFIVSLAYAFETKT 258
Query: 80  DVFLVFEYL---DLDLHSFITRHKNTLNLLVIKAIL--KQILLGLAYCHSLKILHRDLKP 134
           D+ LV   +   D+  H +     N       +AI    QI+ GL + H   I++RDLKP
Sbjct: 259 DLCLVMTIMNGGDIRYHIYNVDEDNP-GFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKP 317
Query: 135 NNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAV 194
            N+L+D   N V+++D GLA  +   Q +         + APELLLG   Y   +D +A+
Sbjct: 318 ENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEE-YDFSVDYFAL 375
Query: 195 GCIFAEMITGKPLFPSK 211
           G    EMI  +  F ++
Sbjct: 376 GVTLYEMIAARGPFRAR 392

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 85/171 (49%), Gaps = 7/171 (4%)
Query: 53  IIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAIL 112
            + E  ++K L+H +IV+L+ +        ++  Y   +L  ++ R+KN+L +L +    
Sbjct: 56  FMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYS 115
Query: 113 KQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP 172
            QI   +AY  S+  +HRD+   N+L+      VKL DFGL+R I   +  Y       P
Sbjct: 116 LQICKAMAYLESINCVHRDIAVRNILV-ASPECVKLGDFGLSRYIE-DEDYYKASVTRLP 173
Query: 173 YK--APELLLGYTGYSTPIDVWAVG-CIFAEMITGK-PLFPSKKHDHLSLI 219
            K  +PE  + +  ++T  DVW    C++  +  GK P F  +  D + ++
Sbjct: 174 IKWMSPE-SINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL 223

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 87/190 (45%), Gaps = 44/190 (23%)
Query: 114 QILLGLAYCHSLK-ILHRDLKPNNLLIDLKRNTVKLADFGLARA---IGVPQKEYSRDCV 169
           +I+  L Y HS K +++RDLK  NL++D K   +K+ DFGL +     G   K +   C 
Sbjct: 116 EIVSALDYLHSEKNVVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMKXF---CG 171
Query: 170 YSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDE 229
              Y APE+L     Y   +D W +G +  EM+ G+  F ++ H+ L   F L+      
Sbjct: 172 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---FELI------ 221
Query: 230 SWAESTYISEILPLYPHFEPANLAEKFPN-LEPAGVDLLSQMLCLNPKQRI-----TAMD 283
                  + EI              +FP  L P    LLS +L  +PKQR+      A +
Sbjct: 222 ------LMEEI--------------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKE 261
Query: 284 ALKHEYLIGV 293
            ++H +  G+
Sbjct: 262 IMQHRFFAGI 271

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQE--GVPSYIIREVSLLKELEHENIVRLLDVQSSRK 79
           EV+ C+   TG+  A K +  +  ++  G    ++ E  +L ++    IV L     ++ 
Sbjct: 200 EVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMV-EKKILAKVHSRFIVSLAYAFETKT 258
Query: 80  DVFLVFEYL---DLDLHSFITRHKNTLNLLVIKAIL--KQILLGLAYCHSLKILHRDLKP 134
           D+ LV   +   D+  H +     N       +AI    QI+ GL + H   I++RDLKP
Sbjct: 259 DLCLVMTIMNGGDIRYHIYNVDEDNP-GFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKP 317
Query: 135 NNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAV 194
            N+L+D   N V+++D GLA  +   Q +         + APELLLG   Y   +D +A+
Sbjct: 318 ENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEE-YDFSVDYFAL 375
Query: 195 GCIFAEMITGKPLFPSK 211
           G    EMI  +  F ++
Sbjct: 376 GVTLYEMIAARGPFRAR 392

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 81/173 (46%), Gaps = 9/173 (5%)
Query: 34  KVAIKMMTIQTEQEGVPSY--IIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDLD 91
           KVAIK     T +EG  S    I E  ++ +L H  +V+L  V   +  + LVFE+++  
Sbjct: 53  KVAIK-----TIKEGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHG 107
Query: 92  -LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLAD 150
            L  ++   +       +  +   +  G+AY     ++HRDL   N L+  +   +K++D
Sbjct: 108 CLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG-ENQVIKVSD 166
Query: 151 FGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           FG+ R +   Q   S    +    A   +  ++ YS+  DVW+ G +  E+ +
Sbjct: 167 FGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 219

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQE--GVPSYIIREVSLLKELEHENIVRLLDVQSSRK 79
           EV+ C+   TG+  A K +  +  ++  G    ++ E  +L ++    IV L     ++ 
Sbjct: 200 EVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMV-EKKILAKVHSRFIVSLAYAFETKT 258
Query: 80  DVFLVFEYL---DLDLHSFITRHKNTLNLLVIKAIL--KQILLGLAYCHSLKILHRDLKP 134
           D+ LV   +   D+  H +     N       +AI    QI+ GL + H   I++RDLKP
Sbjct: 259 DLCLVMTIMNGGDIRYHIYNVDEDNP-GFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKP 317
Query: 135 NNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAV 194
            N+L+D   N V+++D GLA  +   Q +         + APELLLG   Y   +D +A+
Sbjct: 318 ENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEE-YDFSVDYFAL 375
Query: 195 GCIFAEMITGKPLFPSK 211
           G    EMI  +  F ++
Sbjct: 376 GVTLYEMIAARGPFRAR 392

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 95/197 (48%), Gaps = 24/197 (12%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DLH 93
           VAIK     T  + V    ++E   +++ +H +IV+L+ V  +   V+++ E   L +L 
Sbjct: 421 VAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELR 478
Query: 94  SFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGL 153
           SF+   K +L+L  +     Q+   LAY  S + +HRD+   N+L+    + VKL DFGL
Sbjct: 479 SFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSAT-DCVKLGDFGL 537
Query: 154 ARAIGVPQKEYSRDCVYS---------PYKAPELLLGYTGYSTPIDVWAVG-CIFAEMIT 203
           +R        Y  D  Y           + APE  + +  +++  DVW  G C++  ++ 
Sbjct: 538 SR--------YMEDSTYYKASKGKLPIKWMAPE-SINFRRFTSASDVWMFGVCMWEILMH 588
Query: 204 G-KPLFPSKKHDHLSLI 219
           G KP    K +D +  I
Sbjct: 589 GVKPFQGVKNNDVIGRI 605

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 95/184 (51%), Gaps = 14/184 (7%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV-FLVFEYL-DLD 91
           + AIK ++  TE + V +++ RE  L++ L H N++ L+ +    + +  ++  Y+   D
Sbjct: 51  QCAIKSLSRITEMQQVEAFL-REGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGD 109
Query: 92  LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADF 151
           L  FI   +    +  + +   Q+  G+ Y    K +HRDL   N ++D +  TVK+ADF
Sbjct: 110 LLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLD-ESFTVKVADF 168
Query: 152 GLARAI------GVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-G 204
           GLAR I       V Q  ++R  V   + A E L  Y  ++T  DVW+ G +  E++T G
Sbjct: 169 GLARDILDREYYSVQQHRHARLPV--KWTALESLQTYR-FTTKSDVWSFGVLLWELLTRG 225
Query: 205 KPLF 208
            P +
Sbjct: 226 APPY 229

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 102/209 (48%), Gaps = 15/209 (7%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSY---IIREVSLLKELEHENIVRLLDVQSSRK 79
           VYK      G+KV I +   +  +   P     I+ E  ++  +++ ++ RLL +  +  
Sbjct: 33  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-S 91
Query: 80  DVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLL 138
            V L+ + +    L  ++  HK+ +    +     QI  G+ Y    +++HRDL   N+L
Sbjct: 92  TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL 151
Query: 139 IDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGC 196
           +   ++ VK+ DFG A+ +G  +KEY  +    P K  A E +L +  Y+   DVW+ G 
Sbjct: 152 VKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGV 209
Query: 197 IFAEMITGKPLFPSKKHDHL--SLIFSLL 223
              E++T    F SK +D +  S I S+L
Sbjct: 210 TVWELMT----FGSKPYDGIPASEISSIL 234

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 87/190 (45%), Gaps = 44/190 (23%)
Query: 114 QILLGLAYCHSLK-ILHRDLKPNNLLIDLKRNTVKLADFGLARA---IGVPQKEYSRDCV 169
           +I+  L Y HS K +++RDLK  NL++D K   +K+ DFGL +     G   K +   C 
Sbjct: 117 EIVSALDYLHSEKNVVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMKXF---CG 172
Query: 170 YSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDE 229
              Y APE+L     Y   +D W +G +  EM+ G+  F ++ H+ L   F L+      
Sbjct: 173 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---FELI------ 222
Query: 230 SWAESTYISEILPLYPHFEPANLAEKFP-NLEPAGVDLLSQMLCLNPKQRI-----TAMD 283
                  + EI              +FP  L P    LLS +L  +PKQR+      A +
Sbjct: 223 ------LMEEI--------------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKE 262
Query: 284 ALKHEYLIGV 293
            ++H +  G+
Sbjct: 263 IMQHRFFAGI 272

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 102/209 (48%), Gaps = 15/209 (7%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSY---IIREVSLLKELEHENIVRLLDVQSSRK 79
           VYK      G+KV I +   +  +   P     I+ E  ++  +++ ++ RLL +  +  
Sbjct: 33  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-S 91
Query: 80  DVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLL 138
            V L+ + +    L  ++  HK+ +    +     QI  G+ Y    +++HRDL   N+L
Sbjct: 92  TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL 151
Query: 139 IDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGC 196
           +   ++ VK+ DFG A+ +G  +KEY  +    P K  A E +L +  Y+   DVW+ G 
Sbjct: 152 VKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGV 209
Query: 197 IFAEMITGKPLFPSKKHDHL--SLIFSLL 223
              E++T    F SK +D +  S I S+L
Sbjct: 210 TVWELMT----FGSKPYDGIPASEISSIL 234

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 87/190 (45%), Gaps = 44/190 (23%)
Query: 114 QILLGLAYCHSLK-ILHRDLKPNNLLIDLKRNTVKLADFGLARA---IGVPQKEYSRDCV 169
           +I+  L Y HS K +++RDLK  NL++D K   +K+ DFGL +     G   K +   C 
Sbjct: 118 EIVSALDYLHSEKNVVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMKXF---CG 173
Query: 170 YSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDE 229
              Y APE+L     Y   +D W +G +  EM+ G+  F ++ H+ L   F L+      
Sbjct: 174 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---FELI------ 223
Query: 230 SWAESTYISEILPLYPHFEPANLAEKFPN-LEPAGVDLLSQMLCLNPKQRI-----TAMD 283
                  + EI              +FP  L P    LLS +L  +PKQR+      A +
Sbjct: 224 ------LMEEI--------------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKE 263
Query: 284 ALKHEYLIGV 293
            ++H +  G+
Sbjct: 264 IMQHRFFAGI 273

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 102/209 (48%), Gaps = 15/209 (7%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSY---IIREVSLLKELEHENIVRLLDVQSSRK 79
           VYK      G+KV I +   +  +   P     I+ E  ++  +++ ++ RLL +  +  
Sbjct: 35  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-S 93
Query: 80  DVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLL 138
            V L+ + +    L  ++  HK+ +    +     QI  G+ Y    +++HRDL   N+L
Sbjct: 94  TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL 153
Query: 139 IDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGC 196
           +   ++ VK+ DFG A+ +G  +KEY  +    P K  A E +L +  Y+   DVW+ G 
Sbjct: 154 VKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGV 211
Query: 197 IFAEMITGKPLFPSKKHDHL--SLIFSLL 223
              E++T    F SK +D +  S I S+L
Sbjct: 212 TVWELMT----FGSKPYDGIPASEISSIL 236

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/180 (23%), Positives = 91/180 (50%), Gaps = 20/180 (11%)
Query: 53  IIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAI 111
            + E S++ + +H N++ L  V +    V ++ E+++   L SF+ ++     ++ +  +
Sbjct: 55  FLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGM 114
Query: 112 LKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTV-KLADFGLARAIGVPQKEYSRDCVY 170
           L+ I  G+ Y   +  +HR L   N+L++   N V K++DFGL+R +    ++ + D  Y
Sbjct: 115 LRGIAAGMKYLADMNYVHRALAARNILVN--SNLVCKVSDFGLSRFL----EDDTSDPTY 168
Query: 171 SP---------YKAPELLLGYTGYSTPIDVWAVGCIFAEMIT--GKPLFPSKKHDHLSLI 219
           +          + APE +  Y  +++  DVW+ G +  E+++   +P +     D ++ I
Sbjct: 169 TSALGGKIPIRWTAPEAIQ-YRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI 227

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 89/180 (49%), Gaps = 15/180 (8%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD-LDLH 93
           VA+KM+ +             EV +L++  H NI+  +   S++  + +V ++ +   L+
Sbjct: 33  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLY 91
Query: 94  SFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLI--DLKRNTVKLADF 151
             +   +    ++ +  I +Q   G+ Y H+  I+HRDLK NN+ +  DL   TVK+ DF
Sbjct: 92  HHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL---TVKIGDF 148
Query: 152 GLA----RAIGVPQKEYSRDCVYSPYKAPEL--LLGYTGYSTPIDVWAVGCIFAEMITGK 205
           GLA    R  G  Q E     +   + APE+  +     YS   DV+A G +  E++TG+
Sbjct: 149 GLATEKSRWSGSHQFEQLSGSIL--WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 89/180 (49%), Gaps = 15/180 (8%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD-LDLH 93
           VA+KM+ +             EV +L++  H NI+  +   S++  + +V ++ +   L+
Sbjct: 33  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLY 91
Query: 94  SFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLI--DLKRNTVKLADF 151
             +   +    ++ +  I +Q   G+ Y H+  I+HRDLK NN+ +  DL   TVK+ DF
Sbjct: 92  HHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL---TVKIGDF 148
Query: 152 GLA----RAIGVPQKEYSRDCVYSPYKAPEL--LLGYTGYSTPIDVWAVGCIFAEMITGK 205
           GLA    R  G  Q E     +   + APE+  +     YS   DV+A G +  E++TG+
Sbjct: 149 GLATVKSRWSGSHQFEQLSGSIL--WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 89/180 (49%), Gaps = 15/180 (8%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD-LDLH 93
           VA+KM+ +             EV +L++  H NI+  +   S++  + +V ++ +   L+
Sbjct: 35  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLY 93
Query: 94  SFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLI--DLKRNTVKLADF 151
             +   +    ++ +  I +Q   G+ Y H+  I+HRDLK NN+ +  DL   TVK+ DF
Sbjct: 94  HHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL---TVKIGDF 150
Query: 152 GLA----RAIGVPQKEYSRDCVYSPYKAPEL--LLGYTGYSTPIDVWAVGCIFAEMITGK 205
           GLA    R  G  Q E     +   + APE+  +     YS   DV+A G +  E++TG+
Sbjct: 151 GLATVKSRWSGSHQFEQLSGSIL--WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 208

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 89/180 (49%), Gaps = 15/180 (8%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD-LDLH 93
           VA+KM+ +             EV +L++  H NI+  +   S++  + +V ++ +   L+
Sbjct: 38  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLY 96
Query: 94  SFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLI--DLKRNTVKLADF 151
             +   +    ++ +  I +Q   G+ Y H+  I+HRDLK NN+ +  DL   TVK+ DF
Sbjct: 97  HHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL---TVKIGDF 153
Query: 152 GLA----RAIGVPQKEYSRDCVYSPYKAPEL--LLGYTGYSTPIDVWAVGCIFAEMITGK 205
           GLA    R  G  Q E     +   + APE+  +     YS   DV+A G +  E++TG+
Sbjct: 154 GLATVKSRWSGSHQFEQLSGSIL--WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 89/180 (49%), Gaps = 15/180 (8%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD-LDLH 93
           VA+KM+ +             EV +L++  H NI+  +   S++  + +V ++ +   L+
Sbjct: 38  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLY 96
Query: 94  SFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLI--DLKRNTVKLADF 151
             +   +    ++ +  I +Q   G+ Y H+  I+HRDLK NN+ +  DL   TVK+ DF
Sbjct: 97  HHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL---TVKIGDF 153
Query: 152 GLA----RAIGVPQKEYSRDCVYSPYKAPEL--LLGYTGYSTPIDVWAVGCIFAEMITGK 205
           GLA    R  G  Q E     +   + APE+  +     YS   DV+A G +  E++TG+
Sbjct: 154 GLATVKSRWSGSHQFEQLSGSIL--WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 7/168 (4%)
Query: 48  GVPSYIIREVSLLKELEHENIVRLLDV-QSSRKDVFLVFEYLDL-DLHSFITRHKNTLNL 105
           G  S  + E  ++K+  H N++ LL +   S     +V  Y+   DL +FI    +   +
Sbjct: 72  GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV 131
Query: 106 LVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE-- 163
             +     Q+  G+ Y  S K +HRDL   N ++D ++ TVK+ADFGLAR +   +    
Sbjct: 132 KDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEXXSV 190
Query: 164 YSRDCVYSPYKAPEL-LLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFP 209
           +++     P K   L  L    ++T  DVW+ G +  E++T G P +P
Sbjct: 191 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 238

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 57/106 (53%), Gaps = 8/106 (7%)
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARA---IGVPQKEYSRDCVY 170
           +I +GL +  S  I++RDLK +N+++D     +K+ADFG+ +     GV  K +   C  
Sbjct: 129 EIAIGLFFLQSKGIIYRDLKLDNVMLD-SEGHIKIADFGMCKENIWDGVTTKXF---CGT 184
Query: 171 SPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHL 216
             Y APE++  Y  Y   +D WA G +  EM+ G+  F  +  D L
Sbjct: 185 PDYIAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 229

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 98/200 (49%), Gaps = 26/200 (13%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDVFLVFE 86
           N VT  KVA+KM+     ++ + S +I E+ ++K + +H+NI+ LL   +    ++++ E
Sbjct: 58  NRVT--KVAVKMLKSDATEKDL-SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVE 114
Query: 87  YLDL-DLHSFITRHK------------NTLNLLVIKAILK---QILLGLAYCHSLKILHR 130
           Y    +L  ++   +            N    L  K ++    Q+  G+ Y  S K +HR
Sbjct: 115 YASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHR 174
Query: 131 DLKPNNLLIDLKRNTVKLADFGLARAIG--VPQKEYSRDCVYSPYKAPELLLGYTGYSTP 188
           DL   N+L+  + N +K+ADFGLAR I      K+ +   +   + APE L     Y+  
Sbjct: 175 DLAARNVLV-TEDNVMKIADFGLARDIHHIDXXKKTTNGRLPVKWMAPEALFDRI-YTHQ 232
Query: 189 IDVWAVGCIFAEMIT--GKP 206
            DVW+ G +  E+ T  G P
Sbjct: 233 SDVWSFGVLLWEIFTLGGSP 252

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 89/180 (49%), Gaps = 15/180 (8%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD-LDLH 93
           VA+KM+ +             EV +L++  H NI+  +   S++  + +V ++ +   L+
Sbjct: 53  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLY 111
Query: 94  SFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLI--DLKRNTVKLADF 151
             +   +    ++ +  I +Q   G+ Y H+  I+HRDLK NN+ +  DL   TVK+ DF
Sbjct: 112 HHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL---TVKIGDF 168
Query: 152 GLA----RAIGVPQKEYSRDCVYSPYKAPEL--LLGYTGYSTPIDVWAVGCIFAEMITGK 205
           GLA    R  G  Q E     +   + APE+  +     YS   DV+A G +  E++TG+
Sbjct: 169 GLATEKSRWSGSHQFEQLSGSIL--WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 226

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 89/180 (49%), Gaps = 15/180 (8%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD-LDLH 93
           VA+KM+ +             EV +L++  H NI+  +   S++  + +V ++ +   L+
Sbjct: 60  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLY 118
Query: 94  SFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLI--DLKRNTVKLADF 151
             +   +    ++ +  I +Q   G+ Y H+  I+HRDLK NN+ +  DL   TVK+ DF
Sbjct: 119 HHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL---TVKIGDF 175
Query: 152 GLA----RAIGVPQKEYSRDCVYSPYKAPEL--LLGYTGYSTPIDVWAVGCIFAEMITGK 205
           GLA    R  G  Q E     +   + APE+  +     YS   DV+A G +  E++TG+
Sbjct: 176 GLATVKSRWSGSHQFEQLSGSIL--WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 233

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 89/180 (49%), Gaps = 15/180 (8%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD-LDLH 93
           VA+KM+ +             EV +L++  H NI+  +   S++  + +V ++ +   L+
Sbjct: 61  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLY 119
Query: 94  SFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLI--DLKRNTVKLADF 151
             +   +    ++ +  I +Q   G+ Y H+  I+HRDLK NN+ +  DL   TVK+ DF
Sbjct: 120 HHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL---TVKIGDF 176
Query: 152 GLA----RAIGVPQKEYSRDCVYSPYKAPEL--LLGYTGYSTPIDVWAVGCIFAEMITGK 205
           GLA    R  G  Q E     +   + APE+  +     YS   DV+A G +  E++TG+
Sbjct: 177 GLATEKSRWSGSHQFEQLSGSIL--WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 89/180 (49%), Gaps = 15/180 (8%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD-LDLH 93
           VA+KM+ +             EV +L++  H NI+  +   S++  + +V ++ +   L+
Sbjct: 61  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLY 119
Query: 94  SFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLI--DLKRNTVKLADF 151
             +   +    ++ +  I +Q   G+ Y H+  I+HRDLK NN+ +  DL   TVK+ DF
Sbjct: 120 HHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL---TVKIGDF 176
Query: 152 GLA----RAIGVPQKEYSRDCVYSPYKAPEL--LLGYTGYSTPIDVWAVGCIFAEMITGK 205
           GLA    R  G  Q E     +   + APE+  +     YS   DV+A G +  E++TG+
Sbjct: 177 GLATVKSRWSGSHQFEQLSGSIL--WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 36/206 (17%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-HENIVRLLDVQS----- 76
           VY+ ++  +G++ A+K +    E++     II+EV  +K+L  H NIV+     S     
Sbjct: 44  VYEAQDVGSGREYALKRLLSNEEEKN--RAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE 101
Query: 77  ---SRKDVFLVFEYLDLDLHSFITR--HKNTLNLLVIKAILKQILLGLAYCHSLK--ILH 129
               + +  L+ E     L  F+ +   +  L+   +  I  Q    + + H  K  I+H
Sbjct: 102 SDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIH 161
Query: 130 RDLKPNNLLIDLKRNTVKLADFGLARAI-------------GVPQKEYSRDCVYSPYKAP 176
           RDLK  NLL+   + T+KL DFG A  I              + ++E +R+     Y+ P
Sbjct: 162 RDLKVENLLLS-NQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT-PMYRTP 219
Query: 177 ELLLGYTGYSTPI----DVWAVGCIF 198
           E++  Y+ +  PI    D+WA+GCI 
Sbjct: 220 EIIDLYSNF--PIGEKQDIWALGCIL 243

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 102/209 (48%), Gaps = 15/209 (7%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSY---IIREVSLLKELEHENIVRLLDVQSSRK 79
           VYK      G+KV I +   +  +   P     I+ E  ++  +++ ++ RLL +  +  
Sbjct: 33  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-S 91
Query: 80  DVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLL 138
            V L+ + +    L  ++  HK+ +    +     QI  G+ Y    +++HRDL   N+L
Sbjct: 92  TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL 151
Query: 139 IDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGC 196
           +   ++ VK+ DFG A+ +G  +KEY  +    P K  A E +L +  Y+   DVW+ G 
Sbjct: 152 VKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGV 209
Query: 197 IFAEMITGKPLFPSKKHDHL--SLIFSLL 223
              E++T    F SK +D +  S I S+L
Sbjct: 210 TVWELMT----FGSKPYDGIPASEISSIL 234

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 102/209 (48%), Gaps = 15/209 (7%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSY---IIREVSLLKELEHENIVRLLDVQSSRK 79
           VYK      G+KV I +   +  +   P     I+ E  ++  +++ ++ RLL +  +  
Sbjct: 38  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-S 96
Query: 80  DVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLL 138
            V L+ + +    L  ++  HK+ +    +     QI  G+ Y    +++HRDL   N+L
Sbjct: 97  TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL 156
Query: 139 IDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGC 196
           +   ++ VK+ DFG A+ +G  +KEY  +    P K  A E +L +  Y+   DVW+ G 
Sbjct: 157 VKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGV 214
Query: 197 IFAEMITGKPLFPSKKHDHL--SLIFSLL 223
              E++T    F SK +D +  S I S+L
Sbjct: 215 TVWELMT----FGSKPYDGIPASEISSIL 239

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 92/193 (47%), Gaps = 9/193 (4%)
Query: 22  EVYKCRNTVTGQKVAIKMMT-IQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKD 80
           EV   R+  + +  A+K+++  +  +    ++   E  ++       +V+L       K 
Sbjct: 90  EVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 149
Query: 81  VFLVFEYL-DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLI 139
           +++V EY+   DL + ++ +   +     K    +++L L   HS+ ++HRD+KP+N+L+
Sbjct: 150 LYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLL 207
Query: 140 DLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGYTG---YSTPIDVWAVG 195
           D K   +KLADFG    +      +    V +P Y +PE+L    G   Y    D W+VG
Sbjct: 208 D-KHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG 266
Query: 196 CIFAEMITGKPLF 208
               EM+ G   F
Sbjct: 267 VFLFEMLVGDTPF 279

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 99/233 (42%), Gaps = 38/233 (16%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHE-------NIVRLLDV 74
           +V +C +  TGQK A+K++    +               +E++H        +IV +LDV
Sbjct: 44  KVLECFHRRTGQKCALKLLYDSPKAR-------------QEVDHHWQASGGPHIVCILDV 90
Query: 75  ----QSSRKDVFLVFEYLDL-DLHSFIT-RHKNTLNLLVIKAILKQILLGLAYCHSLKIL 128
                  ++ + ++ E ++  +L S I  R            I++ I   + + HS  I 
Sbjct: 91  YENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIA 150
Query: 129 HRDLKPNNLLIDLKRN--TVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYS 186
           HRD+KP NLL   K     +KL DFG A+     Q      C Y+PY     +LG   Y 
Sbjct: 151 HRDVKPENLLYTSKEKDAVLKLTDFGFAKE--TTQNALQTPC-YTPYYVAPEVLGPEKYD 207
Query: 187 TPIDVWAVGCIFAEMITGKPLFPSKKHDHLS------LIFSLLGTPTDESWAE 233
              D+W++G I   ++ G P F S     +S      +     G P  E W+E
Sbjct: 208 KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPE-WSE 259

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 96/190 (50%), Gaps = 18/190 (9%)
Query: 32  GQKV--AIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDV-QSSRKDVFLVFEYL 88
           G+K+  A+K +   T+  G  S  + E  ++K+  H N++ LL +   S     +V  Y+
Sbjct: 57  GKKIHCAVKSLNRITDI-GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 115
Query: 89  DL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVK 147
              DL +FI    +   +  +     Q+  G+ +  S K +HRDL   N ++D ++ TVK
Sbjct: 116 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD-EKFTVK 174
Query: 148 LADFGLARAIGVPQKEYSRDCVYS------PYKAPEL-LLGYTGYSTPIDVWAVGCIFAE 200
           +ADFGLAR +    KE+  D V++      P K   L  L    ++T  DVW+ G +  E
Sbjct: 175 VADFGLARDM--YDKEF--DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 230
Query: 201 MIT-GKPLFP 209
           ++T G P +P
Sbjct: 231 LMTRGAPPYP 240

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 96/190 (50%), Gaps = 18/190 (9%)
Query: 32  GQKV--AIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDV-QSSRKDVFLVFEYL 88
           G+K+  A+K +   T+   V  ++   + ++K+  H N++ LL +   S     +V  Y+
Sbjct: 115 GKKIHCAVKSLNRITDIGEVSQFLTEGI-IMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 173
Query: 89  DL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVK 147
              DL +FI    +   +  +     Q+  G+ +  S K +HRDL   N ++D ++ TVK
Sbjct: 174 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD-EKFTVK 232
Query: 148 LADFGLARAIGVPQKEYSRDCVYS------PYKAPEL-LLGYTGYSTPIDVWAVGCIFAE 200
           +ADFGLAR +    KE+  D V++      P K   L  L    ++T  DVW+ G +  E
Sbjct: 233 VADFGLARDM--YDKEF--DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 288
Query: 201 MIT-GKPLFP 209
           ++T G P +P
Sbjct: 289 LMTRGAPPYP 298

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 96/190 (50%), Gaps = 18/190 (9%)
Query: 32  GQKV--AIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDV-QSSRKDVFLVFEYL 88
           G+K+  A+K +   T+   V  ++   + ++K+  H N++ LL +   S     +V  Y+
Sbjct: 61  GKKIHCAVKSLNRITDIGEVSQFLTEGI-IMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 119
Query: 89  DL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVK 147
              DL +FI    +   +  +     Q+  G+ +  S K +HRDL   N ++D ++ TVK
Sbjct: 120 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD-EKFTVK 178
Query: 148 LADFGLARAIGVPQKEYSRDCVYS------PYKAPEL-LLGYTGYSTPIDVWAVGCIFAE 200
           +ADFGLAR +    KE+  D V++      P K   L  L    ++T  DVW+ G +  E
Sbjct: 179 VADFGLARDM--YDKEF--DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 234
Query: 201 MIT-GKPLFP 209
           ++T G P +P
Sbjct: 235 LMTRGAPPYP 244

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 102/209 (48%), Gaps = 15/209 (7%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSY---IIREVSLLKELEHENIVRLLDVQSSRK 79
           VYK      G+KV I +   +  +   P     I+ E  ++  +++ ++ RLL +  +  
Sbjct: 31  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-S 89
Query: 80  DVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLL 138
            V L+ + +    L  ++  HK+ +    +     QI  G+ Y    +++HRDL   N+L
Sbjct: 90  TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL 149
Query: 139 IDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGC 196
           +   ++ VK+ DFG A+ +G  +KEY  +    P K  A E +L +  Y+   DVW+ G 
Sbjct: 150 VKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGV 207
Query: 197 IFAEMITGKPLFPSKKHDHL--SLIFSLL 223
              E++T    F SK +D +  S I S+L
Sbjct: 208 TVWELMT----FGSKPYDGIPASEISSIL 232

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 96/190 (50%), Gaps = 18/190 (9%)
Query: 32  GQKV--AIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDV-QSSRKDVFLVFEYL 88
           G+K+  A+K +   T+  G  S  + E  ++K+  H N++ LL +   S     +V  Y+
Sbjct: 56  GKKIHCAVKSLNRITDI-GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 114
Query: 89  DL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVK 147
              DL +FI    +   +  +     Q+  G+ +  S K +HRDL   N ++D ++ TVK
Sbjct: 115 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD-EKFTVK 173
Query: 148 LADFGLARAIGVPQKEYSRDCVYS------PYKAPEL-LLGYTGYSTPIDVWAVGCIFAE 200
           +ADFGLAR +    KE+  D V++      P K   L  L    ++T  DVW+ G +  E
Sbjct: 174 VADFGLARDM--YDKEF--DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 229
Query: 201 MIT-GKPLFP 209
           ++T G P +P
Sbjct: 230 LMTRGAPPYP 239

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 96/185 (51%), Gaps = 18/185 (9%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD---- 89
           KVA+K  T++     V +++  E +++K L+H+ +V+L  V  +++ ++++ E++     
Sbjct: 41  KVAVK--TMKPGSMSVEAFLA-EANVMKTLQHDKLVKLHAV-VTKEPIYIITEFMAKGSL 96
Query: 90  LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLA 149
           LD        K  L  L+      QI  G+A+      +HRDL+  N+L+       K+A
Sbjct: 97  LDFLKSDEGSKQPLPKLI--DFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL-VCKIA 153
Query: 150 DFGLARAIGVPQKEY-SRDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT-GK 205
           DFGLAR I     EY +R+    P K  APE  + +  ++   DVW+ G +  E++T G+
Sbjct: 154 DFGLARVI--EDNEYTAREGAKFPIKWTAPE-AINFGSFTIKSDVWSFGILLMEIVTYGR 210
Query: 206 PLFPS 210
             +P 
Sbjct: 211 IPYPG 215

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 96/190 (50%), Gaps = 18/190 (9%)
Query: 32  GQKV--AIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDV-QSSRKDVFLVFEYL 88
           G+K+  A+K +   T+  G  S  + E  ++K+  H N++ LL +   S     +V  Y+
Sbjct: 56  GKKIHCAVKSLNRITDI-GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 114
Query: 89  DL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVK 147
              DL +FI    +   +  +     Q+  G+ +  S K +HRDL   N ++D ++ TVK
Sbjct: 115 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD-EKFTVK 173
Query: 148 LADFGLARAIGVPQKEYSRDCVYS------PYKAPEL-LLGYTGYSTPIDVWAVGCIFAE 200
           +ADFGLAR +    KE+  D V++      P K   L  L    ++T  DVW+ G +  E
Sbjct: 174 VADFGLARDM--YDKEF--DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 229
Query: 201 MIT-GKPLFP 209
           ++T G P +P
Sbjct: 230 LMTRGAPPYP 239

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 96/190 (50%), Gaps = 18/190 (9%)
Query: 32  GQKV--AIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDV-QSSRKDVFLVFEYL 88
           G+K+  A+K +   T+  G  S  + E  ++K+  H N++ LL +   S     +V  Y+
Sbjct: 57  GKKIHCAVKSLNRITDI-GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 115
Query: 89  DL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVK 147
              DL +FI    +   +  +     Q+  G+ +  S K +HRDL   N ++D ++ TVK
Sbjct: 116 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD-EKFTVK 174
Query: 148 LADFGLARAIGVPQKEYSRDCVYS------PYKAPEL-LLGYTGYSTPIDVWAVGCIFAE 200
           +ADFGLAR +    KE+  D V++      P K   L  L    ++T  DVW+ G +  E
Sbjct: 175 VADFGLARDM--LDKEF--DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 230
Query: 201 MIT-GKPLFP 209
           ++T G P +P
Sbjct: 231 LMTRGAPPYP 240

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 96/190 (50%), Gaps = 18/190 (9%)
Query: 32  GQKV--AIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDV-QSSRKDVFLVFEYL 88
           G+K+  A+K +   T+  G  S  + E  ++K+  H N++ LL +   S     +V  Y+
Sbjct: 54  GKKIHCAVKSLNRITDI-GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 112
Query: 89  DL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVK 147
              DL +FI    +   +  +     Q+  G+ +  S K +HRDL   N ++D ++ TVK
Sbjct: 113 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD-EKFTVK 171
Query: 148 LADFGLARAIGVPQKEYSRDCVYS------PYKAPEL-LLGYTGYSTPIDVWAVGCIFAE 200
           +ADFGLAR +    KE+  D V++      P K   L  L    ++T  DVW+ G +  E
Sbjct: 172 VADFGLARDM--YDKEF--DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 227
Query: 201 MIT-GKPLFP 209
           ++T G P +P
Sbjct: 228 LMTRGAPPYP 237

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 57/106 (53%), Gaps = 8/106 (7%)
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARA---IGVPQKEYSRDCVY 170
           +I +GL +  S  I++RDLK +N+++D     +K+ADFG+ +     GV  K +   C  
Sbjct: 450 EIAIGLFFLQSKGIIYRDLKLDNVMLD-SEGHIKIADFGMCKENIWDGVTTKXF---CGT 505
Query: 171 SPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHL 216
             Y APE++  Y  Y   +D WA G +  EM+ G+  F  +  D L
Sbjct: 506 PDYIAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 550

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 99/233 (42%), Gaps = 38/233 (16%)
Query: 22  EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHE-------NIVRLLDV 74
           +V +C +  TGQK A+K++    +               +E++H        +IV +LDV
Sbjct: 25  KVLECFHRRTGQKCALKLLYDSPKAR-------------QEVDHHWQASGGPHIVCILDV 71
Query: 75  ----QSSRKDVFLVFEYLDL-DLHSFIT-RHKNTLNLLVIKAILKQILLGLAYCHSLKIL 128
                  ++ + ++ E ++  +L S I  R            I++ I   + + HS  I 
Sbjct: 72  YENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIA 131
Query: 129 HRDLKPNNLLIDLKRN--TVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYS 186
           HRD+KP NLL   K     +KL DFG A+     Q      C Y+PY     +LG   Y 
Sbjct: 132 HRDVKPENLLYTSKEKDAVLKLTDFGFAKE--TTQNALQTPC-YTPYYVAPEVLGPEKYD 188
Query: 187 TPIDVWAVGCIFAEMITGKPLFPSKKHDHLS------LIFSLLGTPTDESWAE 233
              D+W++G I   ++ G P F S     +S      +     G P  E W+E
Sbjct: 189 KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPE-WSE 240

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 96/185 (51%), Gaps = 18/185 (9%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD---- 89
           KVA+K  T++     V +++  E +++K L+H+ +V+L  V  +++ ++++ E++     
Sbjct: 214 KVAVK--TMKPGSMSVEAFLA-EANVMKTLQHDKLVKLHAV-VTKEPIYIITEFMAKGSL 269
Query: 90  LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLA 149
           LD        K  L  L+      QI  G+A+      +HRDL+  N+L+       K+A
Sbjct: 270 LDFLKSDEGSKQPLPKLI--DFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL-VCKIA 326
Query: 150 DFGLARAIGVPQKEYS-RDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT-GK 205
           DFGLAR I     EY+ R+    P K  APE  + +  ++   DVW+ G +  E++T G+
Sbjct: 327 DFGLARVI--EDNEYTAREGAKFPIKWTAPE-AINFGSFTIKSDVWSFGILLMEIVTYGR 383
Query: 206 PLFPS 210
             +P 
Sbjct: 384 IPYPG 388

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 99/203 (48%), Gaps = 25/203 (12%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDVFLVFE 86
           N VT  KVA+KM+     ++ + S +I E+ ++K + +H+NI+ LL   +    ++++ E
Sbjct: 50  NRVT--KVAVKMLKSDATEKDL-SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVE 106
Query: 87  YLDL-DLHSFITRHK------------NTLNLLVIKAILK---QILLGLAYCHSLKILHR 130
           Y    +L  ++   +            N    L  K ++    Q+  G+ Y  S K +HR
Sbjct: 107 YASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHR 166
Query: 131 DLKPNNLLIDLKRNTVKLADFGLARAIGVPQ--KEYSRDCVYSPYKAPELLLGYTGYSTP 188
           DL   N+L+  + N +K+ADFGLAR I      K+ +   +   + APE L     Y+  
Sbjct: 167 DLAARNVLV-TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQ 224
Query: 189 IDVWAVGCIFAEMIT-GKPLFPS 210
            DVW+ G +  E+ T G   +P 
Sbjct: 225 SDVWSFGVLLWEIFTLGGSPYPG 247

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 98/200 (49%), Gaps = 26/200 (13%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDVFLVFE 86
           N VT  KVA+KM+     ++ + S +I E+ ++K + +H+NI+ LL   +    ++++ E
Sbjct: 51  NRVT--KVAVKMLKSDATEKDL-SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVE 107
Query: 87  YLDL-DLHSFITRHK------------NTLNLLVIKAILK---QILLGLAYCHSLKILHR 130
           Y    +L  ++   +            N    L  K ++    Q+  G+ Y  S K +HR
Sbjct: 108 YASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHR 167
Query: 131 DLKPNNLLIDLKRNTVKLADFGLARAIGVPQ--KEYSRDCVYSPYKAPELLLGYTGYSTP 188
           DL   N+L+  + N +K+ADFGLAR I      K+ +   +   + APE L     Y+  
Sbjct: 168 DLAARNVLV-TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQ 225
Query: 189 IDVWAVGCIFAEMIT--GKP 206
            DVW+ G +  E+ T  G P
Sbjct: 226 SDVWSFGVLLWEIFTLGGSP 245

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 98/200 (49%), Gaps = 26/200 (13%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDVFLVFE 86
           N VT  KVA+KM+     ++ + S +I E+ ++K + +H+NI+ LL   +    ++++ E
Sbjct: 58  NRVT--KVAVKMLKSDATEKDL-SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVE 114
Query: 87  YLDL-DLHSFITRHK------------NTLNLLVIKAILK---QILLGLAYCHSLKILHR 130
           Y    +L  ++   +            N    L  K ++    Q+  G+ Y  S K +HR
Sbjct: 115 YASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHR 174
Query: 131 DLKPNNLLIDLKRNTVKLADFGLARAIGVPQ--KEYSRDCVYSPYKAPELLLGYTGYSTP 188
           DL   N+L+  + N +K+ADFGLAR I      K+ +   +   + APE L     Y+  
Sbjct: 175 DLAARNVLV-TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQ 232
Query: 189 IDVWAVGCIFAEMIT--GKP 206
            DVW+ G +  E+ T  G P
Sbjct: 233 SDVWSFGVLLWEIFTLGGSP 252

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 98/200 (49%), Gaps = 26/200 (13%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDVFLVFE 86
           N VT  KVA+KM+     ++ + S +I E+ ++K + +H+NI+ LL   +    ++++ E
Sbjct: 58  NRVT--KVAVKMLKSDATEKDL-SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVE 114
Query: 87  YLDL-DLHSFITRHK------------NTLNLLVIKAILK---QILLGLAYCHSLKILHR 130
           Y    +L  ++   +            N    L  K ++    Q+  G+ Y  S K +HR
Sbjct: 115 YASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHR 174
Query: 131 DLKPNNLLIDLKRNTVKLADFGLARAIGVPQ--KEYSRDCVYSPYKAPELLLGYTGYSTP 188
           DL   N+L+  + N +K+ADFGLAR I      K+ +   +   + APE L     Y+  
Sbjct: 175 DLAARNVLV-TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQ 232
Query: 189 IDVWAVGCIFAEMIT--GKP 206
            DVW+ G +  E+ T  G P
Sbjct: 233 SDVWSFGVLLWEIFTLGGSP 252

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 98/200 (49%), Gaps = 26/200 (13%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDVFLVFE 86
           N VT  KVA+KM+     ++ + S +I E+ ++K + +H+NI+ LL   +    ++++ E
Sbjct: 47  NRVT--KVAVKMLKSDATEKDL-SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVE 103
Query: 87  YLDL-DLHSFITRHK------------NTLNLLVIKAILK---QILLGLAYCHSLKILHR 130
           Y    +L  ++   +            N    L  K ++    Q+  G+ Y  S K +HR
Sbjct: 104 YASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHR 163
Query: 131 DLKPNNLLIDLKRNTVKLADFGLARAIGVPQ--KEYSRDCVYSPYKAPELLLGYTGYSTP 188
           DL   N+L+  + N +K+ADFGLAR I      K+ +   +   + APE L     Y+  
Sbjct: 164 DLAARNVLV-TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQ 221
Query: 189 IDVWAVGCIFAEMIT--GKP 206
            DVW+ G +  E+ T  G P
Sbjct: 222 SDVWSFGVLLWEIFTLGGSP 241

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 98/200 (49%), Gaps = 26/200 (13%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDVFLVFE 86
           N VT  KVA+KM+     ++ + S +I E+ ++K + +H+NI+ LL   +    ++++ E
Sbjct: 43  NRVT--KVAVKMLKSDATEKDL-SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVE 99
Query: 87  YLDL-DLHSFITRHK------------NTLNLLVIKAILK---QILLGLAYCHSLKILHR 130
           Y    +L  ++   +            N    L  K ++    Q+  G+ Y  S K +HR
Sbjct: 100 YASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHR 159
Query: 131 DLKPNNLLIDLKRNTVKLADFGLARAIGVPQ--KEYSRDCVYSPYKAPELLLGYTGYSTP 188
           DL   N+L+  + N +K+ADFGLAR I      K+ +   +   + APE L     Y+  
Sbjct: 160 DLAARNVLV-TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQ 217
Query: 189 IDVWAVGCIFAEMIT--GKP 206
            DVW+ G +  E+ T  G P
Sbjct: 218 SDVWSFGVLLWEIFTLGGSP 237

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 98/200 (49%), Gaps = 26/200 (13%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDVFLVFE 86
           N VT  KVA+KM+     ++ + S +I E+ ++K + +H+NI+ LL   +    ++++ E
Sbjct: 99  NRVT--KVAVKMLKSDATEKDL-SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVE 155
Query: 87  YLDL-DLHSFITRHK------------NTLNLLVIKAILK---QILLGLAYCHSLKILHR 130
           Y    +L  ++   +            N    L  K ++    Q+  G+ Y  S K +HR
Sbjct: 156 YASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHR 215
Query: 131 DLKPNNLLIDLKRNTVKLADFGLARAIGVPQ--KEYSRDCVYSPYKAPELLLGYTGYSTP 188
           DL   N+L+  + N +K+ADFGLAR I      K+ +   +   + APE L     Y+  
Sbjct: 216 DLAARNVLV-TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQ 273
Query: 189 IDVWAVGCIFAEMIT--GKP 206
            DVW+ G +  E+ T  G P
Sbjct: 274 SDVWSFGVLLWEIFTLGGSP 293

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 88/180 (48%), Gaps = 15/180 (8%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD-LDLH 93
           VA+KM+ +             EV +L++  H NI+  +   S+   + +V ++ +   L+
Sbjct: 33  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STAPQLAIVTQWCEGSSLY 91
Query: 94  SFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLI--DLKRNTVKLADF 151
             +   +    ++ +  I +Q   G+ Y H+  I+HRDLK NN+ +  DL   TVK+ DF
Sbjct: 92  HHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL---TVKIGDF 148
Query: 152 GLA----RAIGVPQKEYSRDCVYSPYKAPEL--LLGYTGYSTPIDVWAVGCIFAEMITGK 205
           GLA    R  G  Q E     +   + APE+  +     YS   DV+A G +  E++TG+
Sbjct: 149 GLATVKSRWSGSHQFEQLSGSIL--WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 50/217 (23%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLD--------- 73
           V++ +N V     AIK + +   +E     ++REV  L +LEH  IVR  +         
Sbjct: 21  VFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTE 79
Query: 74  -VQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLL------------VIKAILKQILLGLA 120
            +Q S   V+L   Y+ + L     R +N  + +            V   I  QI   + 
Sbjct: 80  KLQPSSPKVYL---YIQMQL----CRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVE 132
Query: 121 YCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-------- 172
           + HS  ++HRDLKP+N+   +  + VK+ DFGL  A+   ++E +   V +P        
Sbjct: 133 FLHSKGLMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQT---VLTPMPAYARHT 188
Query: 173 -------YKAPELLLGYTGYSTPIDVWAVGCIFAEMI 202
                  Y +PE + G   YS  +D++++G I  E++
Sbjct: 189 GQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELL 224

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 93/218 (42%), Gaps = 34/218 (15%)
Query: 80  DVFLVFEYLDLDLHSF---ITRHKNTLNLLVIKAILKQILLGLAYCHS-LKILHRDLKPN 135
           DV++  E  D  L  F   +     T+   ++  I   I+  L + HS L ++HRD+KP+
Sbjct: 107 DVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPS 166
Query: 136 NLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELL---LGYTGYSTPIDVW 192
           N+LI+     VK  DFG++  + V       D    PY APE +   L   GYS   D+W
Sbjct: 167 NVLIN-ALGQVKXCDFGISGYL-VDDVAKDIDAGCKPYXAPERINPELNQKGYSVKSDIW 224
Query: 193 AVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANL 252
           ++G    E+                   ++L  P D SW   T   ++  +     P   
Sbjct: 225 SLGITXIEL-------------------AILRFPYD-SWG--TPFQQLKQVVEEPSPQLP 262
Query: 253 AEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           A+KF       VD  SQ L  N K+R T  +  +H + 
Sbjct: 263 ADKF---SAEFVDFTSQCLKKNSKERPTYPELXQHPFF 297

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 98/200 (49%), Gaps = 26/200 (13%)
Query: 28  NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDVFLVFE 86
           N VT  KVA+KM+     ++ + S +I E+ ++K + +H+NI+ LL   +    ++++ E
Sbjct: 58  NRVT--KVAVKMLKSDATEKDL-SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVE 114
Query: 87  YLDL-DLHSFITRHK------------NTLNLLVIKAILK---QILLGLAYCHSLKILHR 130
           Y    +L  ++   +            N    L  K ++    Q+  G+ Y  S K +HR
Sbjct: 115 YASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHR 174
Query: 131 DLKPNNLLIDLKRNTVKLADFGLARAIGVPQ--KEYSRDCVYSPYKAPELLLGYTGYSTP 188
           DL   N+L+  + N +K+ADFGLAR I      K+ +   +   + APE L     Y+  
Sbjct: 175 DLAARNVLV-TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQ 232
Query: 189 IDVWAVGCIFAEMIT--GKP 206
            DVW+ G +  E+ T  G P
Sbjct: 233 SDVWSFGVLLWEIFTLGGSP 252

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 92/193 (47%), Gaps = 24/193 (12%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDVFLVFEYLDL-DL 92
           VA+KM+     +E + S ++ E+ ++K + +H+NI+ LL   +    ++++ EY    +L
Sbjct: 70  VAVKMLKDDATEEDL-SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 128
Query: 93  HSFITRHK---------------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
             ++   +                 +    + +   Q+  G+ Y  S K +HRDL   N+
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 188
Query: 138 LIDLKRNTVKLADFGLARAIGVPQ--KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVG 195
           L+  + N +K+ADFGLAR I      K+ +   +   + APE L     Y+   DVW+ G
Sbjct: 189 LV-TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFG 246
Query: 196 CIFAEMIT--GKP 206
            +  E+ T  G P
Sbjct: 247 VLMWEIFTLGGSP 259

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 96/198 (48%), Gaps = 13/198 (6%)
Query: 22  EVYKCRNTVTGQKVAIKMMTI------QTEQEGVPSYIIREVSLLKELEHENIVRLLDVQ 75
           EVY CR   TG+  A+K +        Q E   +   I+  +SL+   +   IV +    
Sbjct: 204 EVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM--LSLVSTGDCPFIVCMSYAF 261
Query: 76  SSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKP 134
            +   +  + + ++  DLH  +++H    +   ++    +I+LGL + H+  +++RDLKP
Sbjct: 262 HTPDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKP 320
Query: 135 NNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAV 194
            N+L+D +   V+++D GL  A    +K+         Y APE+L     Y +  D +++
Sbjct: 321 ANILLD-EHGHVRISDLGL--ACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSL 377
Query: 195 GCIFAEMITGKPLFPSKK 212
           GC+  +++ G   F   K
Sbjct: 378 GCMLFKLLRGHSPFRQHK 395

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 96/198 (48%), Gaps = 13/198 (6%)
Query: 22  EVYKCRNTVTGQKVAIKMMTI------QTEQEGVPSYIIREVSLLKELEHENIVRLLDVQ 75
           EVY CR   TG+  A+K +        Q E   +   I+  +SL+   +   IV +    
Sbjct: 204 EVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM--LSLVSTGDCPFIVCMSYAF 261
Query: 76  SSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKP 134
            +   +  + + ++  DLH  +++H    +   ++    +I+LGL + H+  +++RDLKP
Sbjct: 262 HTPDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKP 320
Query: 135 NNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAV 194
            N+L+D +   V+++D GL  A    +K+         Y APE+L     Y +  D +++
Sbjct: 321 ANILLD-EHGHVRISDLGL--ACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSL 377
Query: 195 GCIFAEMITGKPLFPSKK 212
           GC+  +++ G   F   K
Sbjct: 378 GCMLFKLLRGHSPFRQHK 395

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 96/198 (48%), Gaps = 13/198 (6%)
Query: 22  EVYKCRNTVTGQKVAIKMMTI------QTEQEGVPSYIIREVSLLKELEHENIVRLLDVQ 75
           EVY CR   TG+  A+K +        Q E   +   I+  +SL+   +   IV +    
Sbjct: 204 EVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM--LSLVSTGDCPFIVCMSYAF 261
Query: 76  SSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKP 134
            +   +  + + ++  DLH  +++H    +   ++    +I+LGL + H+  +++RDLKP
Sbjct: 262 HTPDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKP 320
Query: 135 NNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAV 194
            N+L+D +   V+++D GL  A    +K+         Y APE+L     Y +  D +++
Sbjct: 321 ANILLD-EHGHVRISDLGL--ACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSL 377
Query: 195 GCIFAEMITGKPLFPSKK 212
           GC+  +++ G   F   K
Sbjct: 378 GCMLFKLLRGHSPFRQHK 395

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 96/198 (48%), Gaps = 13/198 (6%)
Query: 22  EVYKCRNTVTGQKVAIKMMTI------QTEQEGVPSYIIREVSLLKELEHENIVRLLDVQ 75
           EVY CR   TG+  A+K +        Q E   +   I+  +SL+   +   IV +    
Sbjct: 203 EVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM--LSLVSTGDCPFIVCMSYAF 260
Query: 76  SSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKP 134
            +   +  + + ++  DLH  +++H    +   ++    +I+LGL + H+  +++RDLKP
Sbjct: 261 HTPDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKP 319
Query: 135 NNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAV 194
            N+L+D +   V+++D GL  A    +K+         Y APE+L     Y +  D +++
Sbjct: 320 ANILLD-EHGHVRISDLGL--ACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSL 376
Query: 195 GCIFAEMITGKPLFPSKK 212
           GC+  +++ G   F   K
Sbjct: 377 GCMLFKLLRGHSPFRQHK 394

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 92/190 (48%), Gaps = 23/190 (12%)
Query: 33  QKVAIKMMTIQTEQEGVPSYIIREVSLLK-ELEHENIVRLLDVQSSRKDVFLVFEYLDL- 90
           Q VAIK  T++ + EG      R  ++L+  L+H N+V LL V +  + + ++F Y    
Sbjct: 57  QAVAIK--TLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHG 114
Query: 91  DLHSFITRHK------NTLNLLVIKAILK---------QILLGLAYCHSLKILHRDLKPN 135
           DLH F+          +T +   +K+ L+         QI  G+ Y  S  ++H+DL   
Sbjct: 115 DLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATR 174
Query: 136 NLLIDLKRNTVKLADFGLARAIGVPQ--KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           N+L+  K N VK++D GL R +      K      +   + APE ++ Y  +S   D+W+
Sbjct: 175 NVLVYDKLN-VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIM-YGKFSIDSDIWS 232
Query: 194 VGCIFAEMIT 203
            G +  E+ +
Sbjct: 233 YGVVLWEVFS 242

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 80/173 (46%), Gaps = 9/173 (5%)
Query: 34  KVAIKMMTIQTEQEGVPSY--IIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDLD 91
           KVAIK     T +EG  S    I E  ++ +L H  +V+L  V   +  + LV E+++  
Sbjct: 34  KVAIK-----TIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHG 88
Query: 92  -LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLAD 150
            L  ++   +       +  +   +  G+AY     ++HRDL   N L+  +   +K++D
Sbjct: 89  CLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG-ENQVIKVSD 147
Query: 151 FGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           FG+ R +   Q   S    +    A   +  ++ YS+  DVW+ G +  E+ +
Sbjct: 148 FGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 200

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 92/190 (48%), Gaps = 23/190 (12%)
Query: 33  QKVAIKMMTIQTEQEGVPSYIIREVSLLK-ELEHENIVRLLDVQSSRKDVFLVFEYLDL- 90
           Q VAIK  T++ + EG      R  ++L+  L+H N+V LL V +  + + ++F Y    
Sbjct: 40  QAVAIK--TLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHG 97
Query: 91  DLHSFITRHK------NTLNLLVIKAILK---------QILLGLAYCHSLKILHRDLKPN 135
           DLH F+          +T +   +K+ L+         QI  G+ Y  S  ++H+DL   
Sbjct: 98  DLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATR 157
Query: 136 NLLIDLKRNTVKLADFGLARAIGVPQ--KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWA 193
           N+L+  K N VK++D GL R +      K      +   + APE ++ Y  +S   D+W+
Sbjct: 158 NVLVYDKLN-VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIM-YGKFSIDSDIWS 215
Query: 194 VGCIFAEMIT 203
            G +  E+ +
Sbjct: 216 YGVVLWEVFS 225

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 86/182 (47%), Gaps = 16/182 (8%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD-LDL 92
           +VAI+++ I+ + E       REV   ++  HEN+V  +    S   + ++        L
Sbjct: 57  EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTL 116
Query: 93  HSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFG 152
           +S +   K  L++   + I ++I+ G+ Y H+  ILH+DLK  N+  D     V + DFG
Sbjct: 117 YSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD--NGKVVITDFG 174
Query: 153 LARAIGVPQKEYSRDCV-----YSPYKAPELLLGYT--------GYSTPIDVWAVGCIFA 199
           L    GV Q     D +     +  + APE++   +         +S   DV+A+G I+ 
Sbjct: 175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWY 234
Query: 200 EM 201
           E+
Sbjct: 235 EL 236

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 92/193 (47%), Gaps = 24/193 (12%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDVFLVFEYLDL-DL 92
           VA+KM+     ++ + S ++ E+ ++K + +H+NI+ LL   +    ++++ EY    +L
Sbjct: 70  VAVKMLKDDATEKDL-SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 128
Query: 93  HSFITRHK---------------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
             ++   +                 +    + +   Q+  G+ Y  S K +HRDL   N+
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 188
Query: 138 LIDLKRNTVKLADFGLARAIGV--PQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVG 195
           L+  + N +K+ADFGLAR I      K+ +   +   + APE L     Y+   DVW+ G
Sbjct: 189 LV-TENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFG 246
Query: 196 CIFAEMIT--GKP 206
            +  E+ T  G P
Sbjct: 247 VLMWEIFTLGGSP 259

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 92/193 (47%), Gaps = 24/193 (12%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDVFLVFEYLDL-DL 92
           VA+KM+     ++ + S ++ E+ ++K + +H+NI+ LL   +    ++++ EY    +L
Sbjct: 70  VAVKMLKDDATEKDL-SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 128
Query: 93  HSFITRHK---------------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
             ++   +                 +    + +   Q+  G+ Y  S K +HRDL   N+
Sbjct: 129 REYLRARRPPGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 188
Query: 138 LIDLKRNTVKLADFGLARAIGV--PQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVG 195
           L+  + N +K+ADFGLAR I      K+ +   +   + APE L     Y+   DVW+ G
Sbjct: 189 LV-TENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFG 246
Query: 196 CIFAEMIT--GKP 206
            +  E+ T  G P
Sbjct: 247 VLMWEIFTLGGSP 259

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP- 172
           +++L L   HS+  +HRD+KP+N+L+D K   +KLADFG    +           V +P 
Sbjct: 181 EVVLALDAIHSMGFIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 239
Query: 173 YKAPELLLGYTG---YSTPIDVWAVGCIFAEMITGKPLF 208
           Y +PE+L    G   Y    D W+VG    EM+ G   F
Sbjct: 240 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 92/195 (47%), Gaps = 28/195 (14%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDVFLVFEYLDL-DL 92
           VA+KM+     ++ + S ++ E+ ++K + +H+NI+ LL   +    ++++ EY    +L
Sbjct: 70  VAVKMLKDDATEKDL-SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 128
Query: 93  HSFITRHK---------------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
             ++   +                 +    + +   Q+  G+ Y  S K +HRDL   N+
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 188
Query: 138 LIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS----PYKAPELLLGYTGYSTPIDVWA 193
           L+  + N +K+ADFGLAR I     +Y ++         + APE L     Y+   DVW+
Sbjct: 189 LV-TENNVMKIADFGLARDIN--NIDYYKNTTNGRLPVKWMAPEALFDRV-YTHQSDVWS 244
Query: 194 VGCIFAEMIT--GKP 206
            G +  E+ T  G P
Sbjct: 245 FGVLMWEIFTLGGSP 259

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP- 172
           +++L L   HS+  +HRD+KP+N+L+D K   +KLADFG    +           V +P 
Sbjct: 181 EVVLALDAIHSMGFIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 239
Query: 173 YKAPELLLGYTG---YSTPIDVWAVGCIFAEMITGKPLF 208
           Y +PE+L    G   Y    D W+VG    EM+ G   F
Sbjct: 240 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 38/136 (27%), Positives = 73/136 (53%), Gaps = 7/136 (5%)
Query: 79  KDVFLVFEY-LDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
            +++LV +Y +  DL + +++ ++ L   + +  L ++++ +   H L  +HRD+KP+N+
Sbjct: 147 NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNI 206
Query: 138 LIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGYTG----YSTPIDVW 192
           L+D+  + ++LADFG    +       S   V +P Y +PE+L    G    Y    D W
Sbjct: 207 LMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWW 265
Query: 193 AVGCIFAEMITGKPLF 208
           ++G    EM+ G+  F
Sbjct: 266 SLGVCMYEMLYGETPF 281

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP- 172
           +++L L   HS+  +HRD+KP+N+L+D K   +KLADFG    +           V +P 
Sbjct: 176 EVVLALDAIHSMGFIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 234
Query: 173 YKAPELLLGYTG---YSTPIDVWAVGCIFAEMITGKPLF 208
           Y +PE+L    G   Y    D W+VG    EM+ G   F
Sbjct: 235 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 92/193 (47%), Gaps = 24/193 (12%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDVFLVFEYLDL-DL 92
           VA+KM+     ++ + S ++ E+ ++K + +H+NI+ LL   +    ++++ EY    +L
Sbjct: 62  VAVKMLKDDATEKDL-SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 120
Query: 93  HSFITRHK---------------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
             ++   +                 +    + +   Q+  G+ Y  S K +HRDL   N+
Sbjct: 121 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 180
Query: 138 LIDLKRNTVKLADFGLARAIGVPQ--KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVG 195
           L+  + N +K+ADFGLAR I      K+ +   +   + APE L     Y+   DVW+ G
Sbjct: 181 LV-TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFG 238
Query: 196 CIFAEMIT--GKP 206
            +  E+ T  G P
Sbjct: 239 VLMWEIFTLGGSP 251

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 92/193 (47%), Gaps = 24/193 (12%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDVFLVFEYLDL-DL 92
           VA+KM+     ++ + S ++ E+ ++K + +H+NI+ LL   +    ++++ EY    +L
Sbjct: 59  VAVKMLKDDATEKDL-SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 117
Query: 93  HSFITRHK---------------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
             ++   +                 +    + +   Q+  G+ Y  S K +HRDL   N+
Sbjct: 118 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 177
Query: 138 LIDLKRNTVKLADFGLARAIGVPQ--KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVG 195
           L+  + N +K+ADFGLAR I      K+ +   +   + APE L     Y+   DVW+ G
Sbjct: 178 LV-TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFG 235
Query: 196 CIFAEMIT--GKP 206
            +  E+ T  G P
Sbjct: 236 VLMWEIFTLGGSP 248

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 92/193 (47%), Gaps = 24/193 (12%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDVFLVFEYLDL-DL 92
           VA+KM+     ++ + S ++ E+ ++K + +H+NI+ LL   +    ++++ EY    +L
Sbjct: 57  VAVKMLKDDATEKDL-SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 115
Query: 93  HSFITRHK---------------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
             ++   +                 +    + +   Q+  G+ Y  S K +HRDL   N+
Sbjct: 116 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNV 175
Query: 138 LIDLKRNTVKLADFGLARAIGVPQ--KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVG 195
           L+  + N +K+ADFGLAR I      K+ +   +   + APE L     Y+   DVW+ G
Sbjct: 176 LV-TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFG 233
Query: 196 CIFAEMIT--GKP 206
            +  E+ T  G P
Sbjct: 234 VLMWEIFTLGGSP 246

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 37/155 (23%), Positives = 86/155 (55%), Gaps = 8/155 (5%)
Query: 53  IIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAI 111
           ++ E +++++L++  IVR++ +  + +   LV E  +L  L+ ++ ++++  +  +I+ +
Sbjct: 59  LLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIE-L 116
Query: 112 LKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS 171
           + Q+ +G+ Y      +HRDL   N+L+ + ++  K++DFGL++A+   +  Y       
Sbjct: 117 VHQVSMGMKYLEESNFVHRDLAARNVLL-VTQHYAKISDFGLSKALRADENXYKAQTHGK 175
Query: 172 ---PYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
               + APE  + Y  +S+  DVW+ G +  E  +
Sbjct: 176 WPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 92/193 (47%), Gaps = 24/193 (12%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDVFLVFEYLDL-DL 92
           VA+KM+     ++ + S ++ E+ ++K + +H+NI+ LL   +    ++++ EY    +L
Sbjct: 116 VAVKMLKDDATEKDL-SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 174
Query: 93  HSFITRHK---------------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
             ++   +                 +    + +   Q+  G+ Y  S K +HRDL   N+
Sbjct: 175 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 234
Query: 138 LIDLKRNTVKLADFGLARAIGVPQ--KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVG 195
           L+  + N +K+ADFGLAR I      K+ +   +   + APE L     Y+   DVW+ G
Sbjct: 235 LV-TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFG 292
Query: 196 CIFAEMIT--GKP 206
            +  E+ T  G P
Sbjct: 293 VLMWEIFTLGGSP 305

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 87/184 (47%), Gaps = 17/184 (9%)
Query: 32  GQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK-DVFLVFEYLDL 90
           G KVA+K +    + +      + E S++ +L H N+V+LL V    K  +++V EY+  
Sbjct: 35  GNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 90
Query: 91  D--LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKL 148
              +    +R ++ L    +      +   + Y      +HRDL   N+L+  + N  K+
Sbjct: 91  GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS-EDNVAKV 149
Query: 149 ADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT-GK 205
           +DFGL +     +   ++D    P K  APE L     +ST  DVW+ G +  E+ + G+
Sbjct: 150 SDFGLTK-----EASSTQDTGKLPVKWTAPEALR-EAAFSTKSDVWSFGILLWEIYSFGR 203
Query: 206 PLFP 209
             +P
Sbjct: 204 VPYP 207

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 92/193 (47%), Gaps = 24/193 (12%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDVFLVFEYLDL-DL 92
           VA+KM+     ++ + S ++ E+ ++K + +H+NI+ LL   +    ++++ EY    +L
Sbjct: 70  VAVKMLKDDATEKDL-SDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNL 128
Query: 93  HSFITRHK---------------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
             ++   +                 +    + +   Q+  G+ Y  S K +HRDL   N+
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 188
Query: 138 LIDLKRNTVKLADFGLARAIGVPQ--KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVG 195
           L+  + N +K+ADFGLAR I      K+ +   +   + APE L     Y+   DVW+ G
Sbjct: 189 LV-TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFG 246
Query: 196 CIFAEMIT--GKP 206
            +  E+ T  G P
Sbjct: 247 VLMWEIFTLGGSP 259

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 92/193 (47%), Gaps = 24/193 (12%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDVFLVFEYLDL-DL 92
           VA+KM+     ++ + S ++ E+ ++K + +H+NI+ LL   +    ++++ EY    +L
Sbjct: 70  VAVKMLKDDATEKDL-SDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNL 128
Query: 93  HSFITRHK---------------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
             ++   +                 +    + +   Q+  G+ Y  S K +HRDL   N+
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 188
Query: 138 LIDLKRNTVKLADFGLARAIGVPQ--KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVG 195
           L+  + N +K+ADFGLAR I      K+ +   +   + APE L     Y+   DVW+ G
Sbjct: 189 LV-TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFG 246
Query: 196 CIFAEMIT--GKP 206
            +  E+ T  G P
Sbjct: 247 VLMWEIFTLGGSP 259

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 37/155 (23%), Positives = 86/155 (55%), Gaps = 8/155 (5%)
Query: 53  IIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAI 111
           ++ E +++++L++  IVR++ +  + +   LV E  +L  L+ ++ ++++  +  +I+ +
Sbjct: 417 LLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIE-L 474
Query: 112 LKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS 171
           + Q+ +G+ Y      +HRDL   N+L+ + ++  K++DFGL++A+   +  Y       
Sbjct: 475 VHQVSMGMKYLEESNFVHRDLAARNVLL-VTQHYAKISDFGLSKALRADENYYKAQTHGK 533
Query: 172 ---PYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
               + APE  + Y  +S+  DVW+ G +  E  +
Sbjct: 534 WPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 81/157 (51%), Gaps = 11/157 (7%)
Query: 56  EVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQ 114
           EV++L++  H NI+  +   + + ++ +V ++ +   L+  +   +    +  +  I +Q
Sbjct: 82  EVAVLRKTRHVNILLFMGYMT-KDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQ 140
Query: 115 ILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLA----RAIGVPQKEYSRDCVY 170
              G+ Y H+  I+HRD+K NN+ +  +  TVK+ DFGLA    R  G  Q E     V 
Sbjct: 141 TAQGMDYLHAKNIIHRDMKSNNIFLH-EGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVL 199
Query: 171 SPYKAPEL--LLGYTGYSTPIDVWAVGCIFAEMITGK 205
             + APE+  +     +S   DV++ G +  E++TG+
Sbjct: 200 --WMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGE 234

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 37/155 (23%), Positives = 86/155 (55%), Gaps = 8/155 (5%)
Query: 53  IIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAI 111
           ++ E +++++L++  IVR++ +  + +   LV E  +L  L+ ++ ++++  +  +I+ +
Sbjct: 418 LLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIE-L 475
Query: 112 LKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS 171
           + Q+ +G+ Y      +HRDL   N+L+ + ++  K++DFGL++A+   +  Y       
Sbjct: 476 VHQVSMGMKYLEESNFVHRDLAARNVLL-VTQHYAKISDFGLSKALRADENYYKAQTHGK 534
Query: 172 ---PYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
               + APE  + Y  +S+  DVW+ G +  E  +
Sbjct: 535 WPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 37/155 (23%), Positives = 86/155 (55%), Gaps = 8/155 (5%)
Query: 53  IIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAI 111
           ++ E +++++L++  IVR++ +  + +   LV E  +L  L+ ++ ++++  +  +I+ +
Sbjct: 65  LLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIE-L 122
Query: 112 LKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS 171
           + Q+ +G+ Y      +HRDL   N+L+ + ++  K++DFGL++A+   +  Y       
Sbjct: 123 VHQVSMGMKYLEESNFVHRDLAARNVLL-VTQHYAKISDFGLSKALRADENYYKAQTHGK 181
Query: 172 ---PYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
               + APE  + Y  +S+  DVW+ G +  E  +
Sbjct: 182 WPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 215

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 37/155 (23%), Positives = 86/155 (55%), Gaps = 8/155 (5%)
Query: 53  IIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAI 111
           ++ E +++++L++  IVR++ +  + +   LV E  +L  L+ ++ ++++  +  +I+ +
Sbjct: 53  LLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIE-L 110
Query: 112 LKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS 171
           + Q+ +G+ Y      +HRDL   N+L+ + ++  K++DFGL++A+   +  Y       
Sbjct: 111 VHQVSMGMKYLEESNFVHRDLAARNVLL-VTQHYAKISDFGLSKALRADENYYKAQTHGK 169
Query: 172 ---PYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
               + APE  + Y  +S+  DVW+ G +  E  +
Sbjct: 170 WPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 203

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 37/155 (23%), Positives = 86/155 (55%), Gaps = 8/155 (5%)
Query: 53  IIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAI 111
           ++ E +++++L++  IVR++ +  + +   LV E  +L  L+ ++ ++++  +  +I+ +
Sbjct: 73  LLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIE-L 130
Query: 112 LKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS 171
           + Q+ +G+ Y      +HRDL   N+L+ + ++  K++DFGL++A+   +  Y       
Sbjct: 131 VHQVSMGMKYLEESNFVHRDLAARNVLL-VTQHYAKISDFGLSKALRADENYYKAQTHGK 189
Query: 172 ---PYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
               + APE  + Y  +S+  DVW+ G +  E  +
Sbjct: 190 WPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 223

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 82/183 (44%), Gaps = 16/183 (8%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDVFLVFEYLDL-D 91
           KVA+KM+   T        ++ E+ ++  L +HENIV LL   +    V ++ EY    D
Sbjct: 70  KVAVKMLK-STAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 128
Query: 92  LHSFITRHKNT---------LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK 142
           L +F+ R             L L  +     Q+  G+A+  S   +HRD+   N+L+   
Sbjct: 129 LLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL-TN 187
Query: 143 RNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAE 200
            +  K+ DFGLAR I        +     P K  APE +     Y+   DVW+ G +  E
Sbjct: 188 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWE 246
Query: 201 MIT 203
           + +
Sbjct: 247 IFS 249

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/246 (24%), Positives = 98/246 (39%), Gaps = 57/246 (23%)
Query: 101 NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAI--- 157
           N+L+   ++  +  +   L   H   I+HRD+KP+N L + +     L DFGLA+     
Sbjct: 112 NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT 171
Query: 158 ---------GVPQKEY----------SRDCVYSP------YKAPELLLGYTGYSTPIDVW 192
                       Q+E           SR    +P      ++APE+L      +T ID+W
Sbjct: 172 KIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMW 231
Query: 193 AVGCIFAEMITGKPLFPSKKHD--HLSLIFSLLGTPTDESWAESTYISEIL--PLYPHFE 248
           + G IF  +++G+  F     D   L+ I ++ G+  +   A  T+   IL     P  +
Sbjct: 232 SAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGS-RETIQAAKTFGKSILCSKEVPAQD 290
Query: 249 PANLAEKFPNLEPAGVDLLSQM------------------------LCLNPKQRITAMDA 284
              L E+   ++ +   L S +                        L LNP  RITA +A
Sbjct: 291 LRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEA 350
Query: 285 LKHEYL 290
           L H + 
Sbjct: 351 LLHPFF 356

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 37/155 (23%), Positives = 86/155 (55%), Gaps = 8/155 (5%)
Query: 53  IIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAI 111
           ++ E +++++L++  IVR++ +  + +   LV E  +L  L+ ++ ++++  +  +I+ +
Sbjct: 59  LLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIE-L 116
Query: 112 LKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS 171
           + Q+ +G+ Y      +HRDL   N+L+ + ++  K++DFGL++A+   +  Y       
Sbjct: 117 VHQVSMGMKYLEESNFVHRDLAARNVLL-VTQHYAKISDFGLSKALRADENYYKAQTHGK 175
Query: 172 ---PYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
               + APE  + Y  +S+  DVW+ G +  E  +
Sbjct: 176 WPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 37/155 (23%), Positives = 86/155 (55%), Gaps = 8/155 (5%)
Query: 53  IIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAI 111
           ++ E +++++L++  IVR++ +  + +   LV E  +L  L+ ++ ++++  +  +I+ +
Sbjct: 55  LLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIE-L 112
Query: 112 LKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS 171
           + Q+ +G+ Y      +HRDL   N+L+ + ++  K++DFGL++A+   +  Y       
Sbjct: 113 VHQVSMGMKYLEESNFVHRDLAARNVLL-VTQHYAKISDFGLSKALRADENYYKAQTHGK 171
Query: 172 ---PYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
               + APE  + Y  +S+  DVW+ G +  E  +
Sbjct: 172 WPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 205

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/155 (23%), Positives = 86/155 (55%), Gaps = 8/155 (5%)
Query: 53  IIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAI 111
           ++ E +++++L++  IVR++ +  + +   LV E  +L  L+ ++ ++++  +  +I+ +
Sbjct: 75  LLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIE-L 132
Query: 112 LKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS 171
           + Q+ +G+ Y      +HRDL   N+L+ + ++  K++DFGL++A+   +  Y       
Sbjct: 133 VHQVSMGMKYLEESNFVHRDLAARNVLL-VTQHYAKISDFGLSKALRADENYYKAQTHGK 191
Query: 172 ---PYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
               + APE  + Y  +S+  DVW+ G +  E  +
Sbjct: 192 WPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/155 (23%), Positives = 86/155 (55%), Gaps = 8/155 (5%)
Query: 53  IIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDLD-LHSFITRHKNTLNLLVIKAI 111
           ++ E +++++L++  IVR++ +  + +   LV E  +L  L+ ++ ++++  +  +I+ +
Sbjct: 75  LLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIE-L 132
Query: 112 LKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS 171
           + Q+ +G+ Y      +HRDL   N+L+ + ++  K++DFGL++A+   +  Y       
Sbjct: 133 VHQVSMGMKYLEESNFVHRDLAARNVLL-VTQHYAKISDFGLSKALRADENYYKAQTHGK 191
Query: 172 ---PYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT 203
               + APE  + Y  +S+  DVW+ G +  E  +
Sbjct: 192 WPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 92/193 (47%), Gaps = 24/193 (12%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDVFLVFEYLDL-DL 92
           VA+KM+     ++ + S ++ E+ ++K + +H+NI+ LL   +    ++++ EY    +L
Sbjct: 70  VAVKMLKDDATEKDL-SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 128
Query: 93  HSFITRHK---------------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
             ++   +                 +    + +   Q+  G+ Y  S K +HRDL   N+
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 188
Query: 138 LIDLKRNTVKLADFGLARAIGVPQ--KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVG 195
           L+  + N +++ADFGLAR I      K+ +   +   + APE L     Y+   DVW+ G
Sbjct: 189 LV-TENNVMRIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFG 246
Query: 196 CIFAEMIT--GKP 206
            +  E+ T  G P
Sbjct: 247 VLMWEIFTLGGSP 259

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 88/192 (45%), Gaps = 27/192 (14%)
Query: 31  TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDV---QSS----RKDVFL 83
           T  KVA+K M +    +      + E + +K+  H N++RLL V    SS    +  V L
Sbjct: 61  TSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVIL 120
Query: 84  VF-EYLDLDLHSFITRHKNTLNLLVIKAILK---QILLGLAYCHSLKILHRDLKPNNLLI 139
            F +Y DL  +   +R +     + ++ +LK    I LG+ Y  +   LHRDL   N ++
Sbjct: 121 PFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML 180
Query: 140 DLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTG--------YSTPIDV 191
                TV +ADFGL++ I      YS D  Y   +  ++ + +          Y++  DV
Sbjct: 181 R-DDMTVCVADFGLSKKI------YSGD-YYRQGRIAKMPVKWIAIESLADRVYTSKSDV 232
Query: 192 WAVGCIFAEMIT 203
           WA G    E+ T
Sbjct: 233 WAFGVTMWEIAT 244

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 82/183 (44%), Gaps = 16/183 (8%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDVFLVFEYLDL-D 91
           KVA+KM+   T        ++ E+ ++  L +HENIV LL   +    V ++ EY    D
Sbjct: 78  KVAVKMLK-STAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 136
Query: 92  LHSFITRHKNT---------LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK 142
           L +F+ R             L L  +     Q+  G+A+  S   +HRD+   N+L+   
Sbjct: 137 LLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL-TN 195
Query: 143 RNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAE 200
            +  K+ DFGLAR I        +     P K  APE +     Y+   DVW+ G +  E
Sbjct: 196 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWE 254
Query: 201 MIT 203
           + +
Sbjct: 255 IFS 257

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 81/184 (44%), Gaps = 16/184 (8%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQ-SSRKDVFLVFEYLDL-- 90
           KVA+KM+             +RE + +KE +H ++ +L+ V   SR    L    + L  
Sbjct: 53  KVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPF 112
Query: 91  ----DLHSF-----ITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL 141
               DLH+F     I  +   L L  +   +  I  G+ Y  S   +HRDL   N ++  
Sbjct: 113 MKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCML-A 171
Query: 142 KRNTVKLADFGLARAIGVPQKEYSRDCVYS-PYKAPEL-LLGYTGYSTPIDVWAVGCIFA 199
           +  TV +ADFGL+R I      Y + C    P K   L  L    Y+   DVWA G    
Sbjct: 172 EDMTVCVADFGLSRKI-YSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMW 230
Query: 200 EMIT 203
           E++T
Sbjct: 231 EIMT 234

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 85/187 (45%), Gaps = 20/187 (10%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDVFLVFEYLDL-D 91
           KVA+KM+   T        ++ E+ ++  L +HENIV LL   +    V ++ EY    D
Sbjct: 78  KVAVKMLK-STAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 136
Query: 92  LHSFITRHKNTL----------NLLVIKAIL---KQILLGLAYCHSLKILHRDLKPNNLL 138
           L +F+ R    L          + L  + +L    Q+  G+A+  S   +HRD+   N+L
Sbjct: 137 LLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVL 196
Query: 139 IDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGC 196
           +    +  K+ DFGLAR I        +     P K  APE +     Y+   DVW+ G 
Sbjct: 197 L-TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGI 254
Query: 197 IFAEMIT 203
           +  E+ +
Sbjct: 255 LLWEIFS 261

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 72/134 (53%), Gaps = 7/134 (5%)
Query: 81  VFLVFEY-LDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLI 139
           ++LV +Y +  DL + +++ ++ L   + +  + +++L +   H L  +HRD+KP+N+L+
Sbjct: 165 LYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLL 224
Query: 140 DLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLL----GYTGYSTPIDVWAV 194
           D+  + ++LADFG    +       S   V +P Y +PE+L     G   Y    D W++
Sbjct: 225 DVNGH-IRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSL 283
Query: 195 GCIFAEMITGKPLF 208
           G    EM+ G+  F
Sbjct: 284 GVCMYEMLYGETPF 297

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 82/187 (43%), Gaps = 20/187 (10%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDVFLVFEYLDL-D 91
           KVA+KM+   T        ++ E+ ++  L +HENIV LL   +    V ++ EY    D
Sbjct: 78  KVAVKMLK-STAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 136
Query: 92  LHSFITRHKNTLNLLVIKAILK-------------QILLGLAYCHSLKILHRDLKPNNLL 138
           L +F+ R    L      AI               Q+  G+A+  S   +HRD+   N+L
Sbjct: 137 LLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVL 196
Query: 139 IDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGC 196
           +    +  K+ DFGLAR I        +     P K  APE +     Y+   DVW+ G 
Sbjct: 197 L-TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGI 254
Query: 197 IFAEMIT 203
           +  E+ +
Sbjct: 255 LLWEIFS 261

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 72/134 (53%), Gaps = 7/134 (5%)
Query: 81  VFLVFEY-LDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLI 139
           ++LV +Y +  DL + +++ ++ L   + +  + +++L +   H L  +HRD+KP+N+L+
Sbjct: 149 LYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLL 208
Query: 140 DLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLL----GYTGYSTPIDVWAV 194
           D+  + ++LADFG    +       S   V +P Y +PE+L     G   Y    D W++
Sbjct: 209 DVNGH-IRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSL 267
Query: 195 GCIFAEMITGKPLF 208
           G    EM+ G+  F
Sbjct: 268 GVCMYEMLYGETPF 281

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 91/196 (46%), Gaps = 16/196 (8%)
Query: 34  KVAIKMM-TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYL-DLD 91
           +VA+K +  + +EQ+ +    + E  ++ +L H+NIVR + V       F++ E +   D
Sbjct: 77  QVAVKTLPEVCSEQDELD--FLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGD 134
Query: 92  LHSFI--TRHK----NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL--KR 143
           L SF+  TR +    ++L +L +  + + I  G  Y      +HRD+   N L+      
Sbjct: 135 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 194
Query: 144 NTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAEM 201
              K+ DFG+AR I          C   P K   PE  +    +++  D W+ G +  E+
Sbjct: 195 RVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEI 253
Query: 202 IT-GKPLFPSKKHDHL 216
            + G   +PSK +  +
Sbjct: 254 FSLGYMPYPSKSNQEV 269

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 87/184 (47%), Gaps = 17/184 (9%)
Query: 32  GQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK-DVFLVFEYLDL 90
           G KVA+K +    + +      + E S++ +L H N+V+LL V    K  +++V EY+  
Sbjct: 216 GNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 271
Query: 91  D--LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKL 148
              +    +R ++ L    +      +   + Y      +HRDL   N+L+  + N  K+
Sbjct: 272 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS-EDNVAKV 330
Query: 149 ADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT-GK 205
           +DFGL +     +   ++D    P K  APE L     +ST  DVW+ G +  E+ + G+
Sbjct: 331 SDFGLTK-----EASSTQDTGKLPVKWTAPEALR-EKKFSTKSDVWSFGILLWEIYSFGR 384
Query: 206 PLFP 209
             +P
Sbjct: 385 VPYP 388

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 41/222 (18%)
Query: 35  VAIKMMTIQTEQEGVPSYI---IREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL- 90
           VA+KM+    ++   PS +   + E ++LK++ H ++++L    S    + L+ EY    
Sbjct: 56  VAVKML----KENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYG 111
Query: 91  DLHSFITRHK-----------------------NTLNLLVIKAILKQILLGLAYCHSLKI 127
            L  F+   +                         L +  + +   QI  G+ Y   +K+
Sbjct: 112 SLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKL 171
Query: 128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGY 185
           +HRDL   N+L+   R  +K++DFGL+R +        R     P K  A E L  +  Y
Sbjct: 172 VHRDLAARNILVAEGRK-MKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHI-Y 229
Query: 186 STPIDVWAVGCIFAEMIT--GKPLFPSKKHDHLSLIFSLLGT 225
           +T  DVW+ G +  E++T  G P +P    + L   F+LL T
Sbjct: 230 TTQSDVWSFGVLLWEIVTLGGNP-YPGIPPERL---FNLLKT 267

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 87/184 (47%), Gaps = 17/184 (9%)
Query: 32  GQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK-DVFLVFEYLDL 90
           G KVA+K +    + +      + E S++ +L H N+V+LL V    K  +++V EY+  
Sbjct: 44  GNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 99
Query: 91  D--LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKL 148
              +    +R ++ L    +      +   + Y      +HRDL   N+L+  + N  K+
Sbjct: 100 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS-EDNVAKV 158
Query: 149 ADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT-GK 205
           +DFGL +     +   ++D    P K  APE L     +ST  DVW+ G +  E+ + G+
Sbjct: 159 SDFGLTK-----EASSTQDTGKLPVKWTAPEALR-EKKFSTKSDVWSFGILLWEIYSFGR 212
Query: 206 PLFP 209
             +P
Sbjct: 213 VPYP 216

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 87/184 (47%), Gaps = 17/184 (9%)
Query: 32  GQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK-DVFLVFEYLDL 90
           G KVA+K +    + +      + E S++ +L H N+V+LL V    K  +++V EY+  
Sbjct: 29  GNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 84
Query: 91  D--LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKL 148
              +    +R ++ L    +      +   + Y      +HRDL   N+L+  + N  K+
Sbjct: 85  GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS-EDNVAKV 143
Query: 149 ADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT-GK 205
           +DFGL +     +   ++D    P K  APE L     +ST  DVW+ G +  E+ + G+
Sbjct: 144 SDFGLTK-----EASSTQDTGKLPVKWTAPEALR-EKKFSTKSDVWSFGILLWEIYSFGR 197
Query: 206 PLFP 209
             +P
Sbjct: 198 VPYP 201

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 31/208 (14%)
Query: 23  VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDV 81
            Y    T    +VA+KM+  + +     + ++ E+ ++ +L  HENIV LL   +    +
Sbjct: 66  AYGISKTGVSIQVAVKMLKEKADSSEREA-LMSELKMMTQLGSHENIVNLLGACTLSGPI 124
Query: 82  FLVFEYLDL-DLHSFITRHKNT-------------------LNLLVIKAIL---KQILLG 118
           +L+FEY    DL +++   +                     LN+L  + +L    Q+  G
Sbjct: 125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKG 184
Query: 119 LAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--AP 176
           + +      +HRDL   N+L+   +  VK+ DFGLAR I        R     P K  AP
Sbjct: 185 MEFLEFKSCVHRDLAARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAP 243
Query: 177 ELLLGYTG-YSTPIDVWAVGCIFAEMIT 203
           E L  + G Y+   DVW+ G +  E+ +
Sbjct: 244 ESL--FEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/136 (27%), Positives = 63/136 (46%), Gaps = 2/136 (1%)
Query: 81  VFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLID 140
           +F V E+++     F  +     +    +    +I+  L + H   I++RDLK +N+L+D
Sbjct: 99  LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLD 158
Query: 141 LKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAE 200
                 KLADFG+ +         +  C    Y APE+L     Y   +D WA+G +  E
Sbjct: 159 -HEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEML-YGPAVDWWAMGVLLYE 216
Query: 201 MITGKPLFPSKKHDHL 216
           M+ G   F ++  D L
Sbjct: 217 MLCGHAPFEAENEDDL 232

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 91/196 (46%), Gaps = 16/196 (8%)
Query: 34  KVAIKMM-TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYL-DLD 91
           +VA+K +  + +EQ+ +    + E  ++ +L H+NIVR + V       F++ E +   D
Sbjct: 63  QVAVKTLPEVCSEQDELD--FLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGD 120
Query: 92  LHSFI--TRHK----NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL--KR 143
           L SF+  TR +    ++L +L +  + + I  G  Y      +HRD+   N L+      
Sbjct: 121 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 180
Query: 144 NTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAEM 201
              K+ DFG+AR I          C   P K   PE  +    +++  D W+ G +  E+
Sbjct: 181 RVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEI 239
Query: 202 IT-GKPLFPSKKHDHL 216
            + G   +PSK +  +
Sbjct: 240 FSLGYMPYPSKSNQEV 255

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 90/196 (45%), Gaps = 16/196 (8%)
Query: 34  KVAIKMMT-IQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYL-DLD 91
           +VA+K +  + +EQ+ +    + E  ++ +  H+NIVR + V       F++ E +   D
Sbjct: 77  QVAVKTLPEVYSEQDELD--FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 134
Query: 92  LHSFI--TRHK----NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL--KR 143
           L SF+  TR +    ++L +L +  + + I  G  Y      +HRD+   N L+      
Sbjct: 135 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 194
Query: 144 NTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAEM 201
              K+ DFG+AR I          C   P K   PE  +    +++  D W+ G +  E+
Sbjct: 195 RVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEI 253
Query: 202 IT-GKPLFPSKKHDHL 216
            + G   +PSK +  +
Sbjct: 254 FSLGYMPYPSKSNQEV 269

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 41/222 (18%)
Query: 35  VAIKMMTIQTEQEGVPSYI---IREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL- 90
           VA+KM+    ++   PS +   + E ++LK++ H ++++L    S    + L+ EY    
Sbjct: 56  VAVKML----KENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYG 111
Query: 91  DLHSFITRHK-----------------------NTLNLLVIKAILKQILLGLAYCHSLKI 127
            L  F+   +                         L +  + +   QI  G+ Y   +K+
Sbjct: 112 SLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKL 171
Query: 128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGY 185
           +HRDL   N+L+   R  +K++DFGL+R +        R     P K  A E L  +  Y
Sbjct: 172 VHRDLAARNILVAEGRK-MKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI-Y 229
Query: 186 STPIDVWAVGCIFAEMIT--GKPLFPSKKHDHLSLIFSLLGT 225
           +T  DVW+ G +  E++T  G P +P    + L   F+LL T
Sbjct: 230 TTQSDVWSFGVLLWEIVTLGGNP-YPGIPPERL---FNLLKT 267

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 91/193 (47%), Gaps = 24/193 (12%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDVFLVFEYLDL-DL 92
           VA+KM+     ++ + S ++ E+ ++K + +H+NI+ LL   +    ++++  Y    +L
Sbjct: 70  VAVKMLKDDATEKDL-SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNL 128
Query: 93  HSFITRHK---------------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
             ++   +                 +    + +   Q+  G+ Y  S K +HRDL   N+
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 188
Query: 138 LIDLKRNTVKLADFGLARAIGVPQ--KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVG 195
           L+  + N +K+ADFGLAR I      K+ +   +   + APE L     Y+   DVW+ G
Sbjct: 189 LV-TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFG 246
Query: 196 CIFAEMIT--GKP 206
            +  E+ T  G P
Sbjct: 247 VLMWEIFTLGGSP 259

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 81/165 (49%), Gaps = 18/165 (10%)
Query: 53  IIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTL-------- 103
            + E S++KE    ++VRLL V S  +   ++ E +   DL S++   +  +        
Sbjct: 69  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 128
Query: 104 -NLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ- 161
            +L  +  +  +I  G+AY ++ K +HRDL   N ++  +  TVK+ DFG+ R I     
Sbjct: 129 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV-AEDFTVKIGDFGMTRDIXETDX 187
Query: 162 -KEYSRDCVYSPYKAPELLLG--YTGYSTPIDVWAVGCIFAEMIT 203
            ++  +  +   + +PE L    +T YS   DVW+ G +  E+ T
Sbjct: 188 XRKGGKGLLPVRWMSPESLKDGVFTTYS---DVWSFGVVLWEIAT 229

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 81/165 (49%), Gaps = 18/165 (10%)
Query: 53  IIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTL-------- 103
            + E S++KE    ++VRLL V S  +   ++ E +   DL S++   +  +        
Sbjct: 60  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 119
Query: 104 -NLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ- 161
            +L  +  +  +I  G+AY ++ K +HRDL   N ++  +  TVK+ DFG+ R I     
Sbjct: 120 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV-AEDFTVKIGDFGMTRDIXETDX 178
Query: 162 -KEYSRDCVYSPYKAPELLLG--YTGYSTPIDVWAVGCIFAEMIT 203
            ++  +  +   + +PE L    +T YS   DVW+ G +  E+ T
Sbjct: 179 XRKGGKGLLPVRWMSPESLKDGVFTTYS---DVWSFGVVLWEIAT 220

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 81/167 (48%), Gaps = 22/167 (13%)
Query: 53  IIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTL-------- 103
            + E S++KE    ++VRLL V S  +   ++ E +   DL S++   +  +        
Sbjct: 75  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 134
Query: 104 -NLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK 162
            +L  +  +  +I  G+AY ++ K +HRDL   N ++  +  TVK+ DFG+ R I   + 
Sbjct: 135 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV-AEDFTVKIGDFGMTRDIY--ET 191
Query: 163 EYSRDCVYS----PYKAPELLLG--YTGYSTPIDVWAVGCIFAEMIT 203
           +Y R          + +PE L    +T YS   DVW+ G +  E+ T
Sbjct: 192 DYYRKGGKGLLPVRWMSPESLKDGVFTTYS---DVWSFGVVLWEIAT 235

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 81/167 (48%), Gaps = 22/167 (13%)
Query: 53  IIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTL-------- 103
            + E S++KE    ++VRLL V S  +   ++ E +   DL S++   +  +        
Sbjct: 65  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 124
Query: 104 -NLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK 162
            +L  +  +  +I  G+AY ++ K +HRDL   N ++  +  TVK+ DFG+ R I   + 
Sbjct: 125 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV-AEDFTVKIGDFGMTRDI--YET 181
Query: 163 EYSRDCVYS----PYKAPELLLG--YTGYSTPIDVWAVGCIFAEMIT 203
           +Y R          + +PE L    +T YS   DVW+ G +  E+ T
Sbjct: 182 DYYRKGGKGLLPVRWMSPESLKDGVFTTYS---DVWSFGVVLWEIAT 225

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 90/196 (45%), Gaps = 16/196 (8%)
Query: 34  KVAIKMM-TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYL-DLD 91
           +VA+K +  + +EQ+ +    + E  ++ +  H+NIVR + V       F++ E +   D
Sbjct: 77  QVAVKTLPEVCSEQDELD--FLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGD 134
Query: 92  LHSFI--TRHK----NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL--KR 143
           L SF+  TR +    ++L +L +  + + I  G  Y      +HRD+   N L+      
Sbjct: 135 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 194
Query: 144 NTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAEM 201
              K+ DFG+AR I          C   P K   PE  +    +++  D W+ G +  E+
Sbjct: 195 RVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEI 253
Query: 202 IT-GKPLFPSKKHDHL 216
            + G   +PSK +  +
Sbjct: 254 FSLGYMPYPSKSNQEV 269

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 92/202 (45%), Gaps = 16/202 (7%)
Query: 28  NTVTGQKVAIKMMT-IQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE 86
           N  +  +VA+K +  + +EQ+ +    + E  ++ +  H+NIVR + V       F++ E
Sbjct: 48  NDPSPLQVAVKTLPEVCSEQDELD--FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLE 105
Query: 87  YL-DLDLHSFI--TRHK----NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLI 139
            +   DL SF+  TR +    ++L +L +  + + I  G  Y      +HRD+   N L+
Sbjct: 106 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLL 165
Query: 140 DL--KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVG 195
                    K+ DFG+AR I          C   P K   PE  +    +++  D W+ G
Sbjct: 166 TCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFG 224
Query: 196 CIFAEMIT-GKPLFPSKKHDHL 216
            +  E+ + G   +PSK +  +
Sbjct: 225 VLLWEIFSLGYMPYPSKSNQEV 246

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 91/193 (47%), Gaps = 24/193 (12%)
Query: 35  VAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDVFLVFEYLDL-DL 92
           VA+KM+     ++ + S ++ E+ ++K + +H+NI+ LL   +    ++++  Y    +L
Sbjct: 70  VAVKMLKDDATEKDL-SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNL 128
Query: 93  HSFITRHK---------------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNL 137
             ++   +                 +    + +   Q+  G+ Y  S K +HRDL   N+
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 188
Query: 138 LIDLKRNTVKLADFGLARAIGVPQ--KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVG 195
           L+  + N +K+ADFGLAR I      K+ +   +   + APE L     Y+   DVW+ G
Sbjct: 189 LV-TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFG 246
Query: 196 CIFAEMIT--GKP 206
            +  E+ T  G P
Sbjct: 247 VLMWEIFTLGGSP 259

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 91/183 (49%), Gaps = 24/183 (13%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD---- 89
           KVA+K  T++     V +++  E +++K L+H+ +V+L  V  +++ ++++ E++     
Sbjct: 208 KVAVK--TMKPGSMSVEAFLA-EANVMKTLQHDKLVKLHAV-VTKEPIYIITEFMAKGSL 263
Query: 90  LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLA 149
           LD        K  L  L+      QI  G+A+      +HRDL+  N+L+       K+A
Sbjct: 264 LDFLKSDEGSKQPLPKLI--DFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL-VCKIA 320
Query: 150 DFGLAR-AIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPL 207
           DFGLAR     P K          + APE  + +  ++   DVW+ G +  E++T G+  
Sbjct: 321 DFGLARVGAKFPIK----------WTAPE-AINFGSFTIKSDVWSFGILLMEIVTYGRIP 369
Query: 208 FPS 210
           +P 
Sbjct: 370 YPG 372

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 85/189 (44%), Gaps = 22/189 (11%)
Query: 34  KVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDVFLVFEYLDL-D 91
           KVA+KM+   T        ++ E+ ++  L +HENIV LL   +    V ++ EY    D
Sbjct: 78  KVAVKMLK-STAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 136
Query: 92  LHSFITRHK------------NTLNLLVIKAIL---KQILLGLAYCHSLKILHRDLKPNN 136
           L +F+ R +            N    L  + +L    Q+  G+A+  S   +HRD+   N
Sbjct: 137 LLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARN 196
Query: 137 LLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAV 194
           +L+    +  K+ DFGLAR I        +     P K  APE +     Y+   DVW+ 
Sbjct: 197 VLL-TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSY 254
Query: 195 GCIFAEMIT 203
           G +  E+ +
Sbjct: 255 GILLWEIFS 263

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 92/202 (45%), Gaps = 16/202 (7%)
Query: 28  NTVTGQKVAIKMMT-IQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE 86
           N  +  +VA+K +  + +EQ+ +    + E  ++ +  H+NIVR + V       F++ E
Sbjct: 56  NDPSPLQVAVKTLPEVCSEQDELD--FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLE 113
Query: 87  YL-DLDLHSFI--TRHK----NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLI 139
            +   DL SF+  TR +    ++L +L +  + + I  G  Y      +HRD+   N L+
Sbjct: 114 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLL 173
Query: 140 DL--KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVG 195
                    K+ DFG+AR I          C   P K   PE  +    +++  D W+ G
Sbjct: 174 TCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFG 232
Query: 196 CIFAEMIT-GKPLFPSKKHDHL 216
            +  E+ + G   +PSK +  +
Sbjct: 233 VLLWEIFSLGYMPYPSKSNQEV 254

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 90/196 (45%), Gaps = 16/196 (8%)
Query: 34  KVAIKMM-TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYL-DLD 91
           +VA+K +  + +EQ+ +    + E  ++ +  H+NIVR + V       F++ E +   D
Sbjct: 79  QVAVKTLPEVCSEQDELD--FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 136
Query: 92  LHSFI--TRHK----NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL--KR 143
           L SF+  TR +    ++L +L +  + + I  G  Y      +HRD+   N L+      
Sbjct: 137 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 196
Query: 144 NTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAEM 201
              K+ DFG+AR I          C   P K   PE  +    +++  D W+ G +  E+
Sbjct: 197 RVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEI 255
Query: 202 IT-GKPLFPSKKHDHL 216
            + G   +PSK +  +
Sbjct: 256 FSLGYMPYPSKSNQEV 271

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 92/202 (45%), Gaps = 16/202 (7%)
Query: 28  NTVTGQKVAIKMMT-IQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE 86
           N  +  +VA+K +  + +EQ+ +    + E  ++ +  H+NIVR + V       F++ E
Sbjct: 56  NDPSPLQVAVKTLPEVCSEQDELD--FLMEALIISKFNHQNIVRCIGVSLQSLPRFILME 113
Query: 87  YL-DLDLHSFI--TRHK----NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLI 139
            +   DL SF+  TR +    ++L +L +  + + I  G  Y      +HRD+   N L+
Sbjct: 114 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLL 173
Query: 140 DL--KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVG 195
                    K+ DFG+AR I          C   P K   PE  +    +++  D W+ G
Sbjct: 174 TCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFG 232
Query: 196 CIFAEMIT-GKPLFPSKKHDHL 216
            +  E+ + G   +PSK +  +
Sbjct: 233 VLLWEIFSLGYMPYPSKSNQEV 254

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 81/167 (48%), Gaps = 22/167 (13%)
Query: 53  IIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTL-------- 103
            + E S++KE    ++VRLL V S  +   ++ E +   DL S++   +  +        
Sbjct: 68  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 127
Query: 104 -NLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK 162
            +L  +  +  +I  G+AY ++ K +HRDL   N ++  +  TVK+ DFG+ R I   + 
Sbjct: 128 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV-AEDFTVKIGDFGMTRDI--YET 184
Query: 163 EYSRDCVYS----PYKAPELLLG--YTGYSTPIDVWAVGCIFAEMIT 203
           +Y R          + +PE L    +T YS   DVW+ G +  E+ T
Sbjct: 185 DYYRKGGKGLLPVRWMSPESLKDGVFTTYS---DVWSFGVVLWEIAT 228

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 88/196 (44%), Gaps = 10/196 (5%)
Query: 22  EVYKCRNTVTGQKVAIKMMT-IQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKD 80
           EV   +   TGQ  A+K+M      + G  S    E  +L   +   I +L         
Sbjct: 76  EVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENY 135
Query: 81  VFLVFEY-LDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLI 139
           ++LV EY +  DL + +++    +   + +  L +I++ +   H L  +HRD+KP+N+L+
Sbjct: 136 LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL 195
Query: 140 DLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGYTGYST------PIDVW 192
           D +   ++LADFG    +       S   V +P Y +PE+L    G           D W
Sbjct: 196 D-RCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWW 254
Query: 193 AVGCIFAEMITGKPLF 208
           A+G    EM  G+  F
Sbjct: 255 ALGVFAYEMFYGQTPF 270

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 81/167 (48%), Gaps = 22/167 (13%)
Query: 53  IIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTL-------- 103
            + E S++KE    ++VRLL V S  +   ++ E +   DL S++   +  +        
Sbjct: 62  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 121
Query: 104 -NLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK 162
            +L  +  +  +I  G+AY ++ K +HRDL   N ++  +  TVK+ DFG+ R I   + 
Sbjct: 122 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV-AEDFTVKIGDFGMTRDI--YET 178
Query: 163 EYSRDCVYS----PYKAPELLLG--YTGYSTPIDVWAVGCIFAEMIT 203
           +Y R          + +PE L    +T YS   DVW+ G +  E+ T
Sbjct: 179 DYYRKGGKGLLPVRWMSPESLKDGVFTTYS---DVWSFGVVLWEIAT 222

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 90/196 (45%), Gaps = 16/196 (8%)
Query: 34  KVAIKMM-TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYL-DLD 91
           +VA+K +  + +EQ+ +    + E  ++ +  H+NIVR + V       F++ E +   D
Sbjct: 69  QVAVKTLPEVCSEQDELD--FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 126
Query: 92  LHSFI--TRHK----NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL--KR 143
           L SF+  TR +    ++L +L +  + + I  G  Y      +HRD+   N L+      
Sbjct: 127 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 186
Query: 144 NTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAEM 201
              K+ DFG+AR I          C   P K   PE  +    +++  D W+ G +  E+
Sbjct: 187 RVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEI 245
Query: 202 IT-GKPLFPSKKHDHL 216
            + G   +PSK +  +
Sbjct: 246 FSLGYMPYPSKSNQEV 261

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 82/167 (49%), Gaps = 22/167 (13%)
Query: 53  IIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLN---LLVI 108
            + E S++KE    ++VRLL V S  +   ++ E +   DL S++   +  +    +L  
Sbjct: 75  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 134
Query: 109 KAILKQILL------GLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK 162
            ++ K I +      G+AY ++ K +HRDL   N ++  +  TVK+ DFG+ R I   + 
Sbjct: 135 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV-AEDFTVKIGDFGMTRDIY--ET 191
Query: 163 EYSRDCVYS----PYKAPELLLG--YTGYSTPIDVWAVGCIFAEMIT 203
           +Y R          + +PE L    +T YS   DVW+ G +  E+ T
Sbjct: 192 DYYRKGGKGLLPVRWMSPESLKDGVFTTYS---DVWSFGVVLWEIAT 235

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 81/167 (48%), Gaps = 22/167 (13%)
Query: 53  IIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTL-------- 103
            + E S++KE    ++VRLL V S  +   ++ E +   DL S++   +  +        
Sbjct: 69  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 128
Query: 104 -NLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK 162
            +L  +  +  +I  G+AY ++ K +HRDL   N ++  +  TVK+ DFG+ R I   + 
Sbjct: 129 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV-AEDFTVKIGDFGMTRDI--YET 185
Query: 163 EYSRDCVYS----PYKAPELLLG--YTGYSTPIDVWAVGCIFAEMIT 203
           +Y R          + +PE L    +T YS   DVW+ G +  E+ T
Sbjct: 186 DYYRKGGKGLLPVRWMSPESLKDGVFTTYS---DVWSFGVVLWEIAT 229

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 81/167 (48%), Gaps = 22/167 (13%)
Query: 53  IIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTL-------- 103
            + E S++KE    ++VRLL V S  +   ++ E +   DL S++   +  +        
Sbjct: 66  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 125
Query: 104 -NLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK 162
            +L  +  +  +I  G+AY ++ K +HRDL   N ++  +  TVK+ DFG+ R I   + 
Sbjct: 126 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV-AEDFTVKIGDFGMTRDI--YET 182
Query: 163 EYSRDCVYS----PYKAPELLLG--YTGYSTPIDVWAVGCIFAEMIT 203
           +Y R          + +PE L    +T YS   DVW+ G +  E+ T
Sbjct: 183 DYYRKGGKGLLPVRWMSPESLKDGVFTTYS---DVWSFGVVLWEIAT 226

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 81/167 (48%), Gaps = 22/167 (13%)
Query: 53  IIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTL-------- 103
            + E S++KE    ++VRLL V S  +   ++ E +   DL S++   +  +        
Sbjct: 68  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 127
Query: 104 -NLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK 162
            +L  +  +  +I  G+AY ++ K +HRDL   N ++  +  TVK+ DFG+ R I   + 
Sbjct: 128 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV-AEDFTVKIGDFGMTRDI--YET 184
Query: 163 EYSRDCVYS----PYKAPELLLG--YTGYSTPIDVWAVGCIFAEMIT 203
           +Y R          + +PE L    +T YS   DVW+ G +  E+ T
Sbjct: 185 DYYRKGGKGLLPVRWMSPESLKDGVFTTYS---DVWSFGVVLWEIAT 228

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 90/196 (45%), Gaps = 16/196 (8%)
Query: 34  KVAIKMM-TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYL-DLD 91
           +VA+K +  + +EQ+ +    + E  ++ +  H+NIVR + V       F++ E +   D
Sbjct: 63  QVAVKTLPEVCSEQDELD--FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 120
Query: 92  LHSFI--TRHK----NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL--KR 143
           L SF+  TR +    ++L +L +  + + I  G  Y      +HRD+   N L+      
Sbjct: 121 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 180
Query: 144 NTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAEM 201
              K+ DFG+AR I          C   P K   PE  +    +++  D W+ G +  E+
Sbjct: 181 RVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEI 239
Query: 202 IT-GKPLFPSKKHDHL 216
            + G   +PSK +  +
Sbjct: 240 FSLGYMPYPSKSNQEV 255

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 90/196 (45%), Gaps = 16/196 (8%)
Query: 34  KVAIKMM-TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYL-DLD 91
           +VA+K +  + +EQ+ +    + E  ++ +  H+NIVR + V       F++ E +   D
Sbjct: 103 QVAVKTLPEVCSEQDELD--FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 160
Query: 92  LHSFI--TRHK----NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL--KR 143
           L SF+  TR +    ++L +L +  + + I  G  Y      +HRD+   N L+      
Sbjct: 161 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 220
Query: 144 NTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAEM 201
              K+ DFG+AR I          C   P K   PE  +    +++  D W+ G +  E+
Sbjct: 221 RVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEI 279
Query: 202 IT-GKPLFPSKKHDHL 216
            + G   +PSK +  +
Sbjct: 280 FSLGYMPYPSKSNQEV 295

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 57/105 (54%), Gaps = 8/105 (7%)
Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           QI  G++Y   ++++HRDL   N+L+    N VK+ DFGLAR + + + EY  D    P 
Sbjct: 127 QIAKGMSYLEDVRLVHRDLAARNVLVK-SPNHVKITDFGLARLLDIDETEYHADGGKVPI 185
Query: 174 K--APELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHL 216
           K  A E +L    ++   DVW+ G    E++T    F +K +D +
Sbjct: 186 KWMALESIL-RRRFTHQSDVWSYGVTVWELMT----FGAKPYDGI 225

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 90/196 (45%), Gaps = 16/196 (8%)
Query: 34  KVAIKMM-TIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYL-DLD 91
           +VA+K +  + +EQ+ +    + E  ++ +  H+NIVR + V       F++ E +   D
Sbjct: 80  QVAVKTLPEVCSEQDELD--FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 137
Query: 92  LHSFI--TRHK----NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL--KR 143
           L SF+  TR +    ++L +L +  + + I  G  Y      +HRD+   N L+      
Sbjct: 138 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 197
Query: 144 NTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTPIDVWAVGCIFAEM 201
              K+ DFG+AR I          C   P K   PE  +    +++  D W+ G +  E+
Sbjct: 198 RVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEI 256
Query: 202 IT-GKPLFPSKKHDHL 216
            + G   +PSK +  +
Sbjct: 257 FSLGYMPYPSKSNQEV 272
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	324
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-138
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-138
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-137
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-136
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-136
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-136
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-136
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-135
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-135
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-133
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-127
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-127
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-125
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-113
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-111
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-110
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-106
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-103
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-100
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-100
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-98
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-97
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-96
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-96
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	8e-96
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-95
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-95
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-92
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-88
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	7e-88
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	4e-87
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-73
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-71
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-71
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-65
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-64
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-63
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	5e-63
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-62
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	5e-62
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-61
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	8e-61
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-60
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	7e-60
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-59
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-59
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-59
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-59
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-59
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-58
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-58
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-57
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-57
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-57
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	8e-57
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	9e-57
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	9e-57
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-56
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-56
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-56
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	7e-56
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	8e-56
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	8e-56
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-55
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	6e-55
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	6e-55
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	6e-55
3bhy_A	283	Death-associated protein kinase 3; death associate	6e-55
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	8e-55
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-54
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-54
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-54
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-54
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-54
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-54
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	5e-54
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	6e-54
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	8e-54
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	9e-54
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-53
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-53
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-53
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-53
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-52
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-52
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-52
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-52
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	4e-52
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	5e-52
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	6e-52
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	8e-52
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-51
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-51
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-51
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	4e-50
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	6e-50
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-49
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-49
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-49
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-49
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	5e-49
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-48
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-48
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-48
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-48
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-48
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	4e-48
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	7e-48
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-47
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-47
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-47
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	5e-47
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-46
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-46
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-46
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-46
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-45
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	9e-45
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-44
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-44
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	5e-44
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	7e-44
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-43
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-43
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	8e-43
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-42
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-42
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	8e-42
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-41
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-41
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-41
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-40
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-40
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	6e-40
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	7e-40
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-39
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-39
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-39
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-39
3aln_A	327	Dual specificity mitogen-activated protein kinase;	7e-39
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	9e-39
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	9e-39
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	9e-39
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-38
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-38
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-37
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-37
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-36
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	4e-36
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-35
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	4e-35
3soc_A	322	Activin receptor type-2A; structural genomics cons	6e-35
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-34
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-34
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-34
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	5e-34
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	6e-34
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	8e-34
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-33
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-33
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-33
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-33
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-33
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-33
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	5e-33
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	5e-33
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-32
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-32
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	4e-32
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	4e-32
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	5e-32
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	9e-32
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-31
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-31
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	9e-31
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-30
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-30
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-30
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-30
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	6e-30
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	6e-30
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	6e-30
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	8e-30
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-29
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-29
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-29
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-29
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-29
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-29
4aoj_A	329	High affinity nerve growth factor receptor; transf	4e-29
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	4e-29
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	8e-29
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-28
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-28
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-28
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-28
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-28
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-28
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	5e-28
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	5e-28
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-27
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	4e-27
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-26
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-25
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	5e-25
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	7e-25
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	7e-25
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-24
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-24
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-24
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-24
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	6e-24
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	6e-24
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-23
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-23
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-23
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-23
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-23
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-23
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	7e-23
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	7e-23
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-22
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-22
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-22
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	4e-22
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	5e-22
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-21
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-21
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	3e-21
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-21
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-21
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	9e-21
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	3e-19
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	6e-19
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-18
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-04

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  393 bits (1012), Expect = e-138
 Identities = 133/283 (46%), Positives = 187/283 (66%), Gaps = 3/283 (1%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y  ++KIG G YG VYK +N   G+  A+K + ++ E EG+PS  IRE+S+LKEL+H N
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
           IV+L DV  ++K + LVFE+LD DL   +   +  L  +  K+ L Q+L G+AYCH  ++
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV 121

Query: 128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYST 187
           LHRDLKP NLLI+ +   +K+ADFGLARA G+P ++Y+ + V   Y+AP++L+G   YST
Sbjct: 122 LHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180

Query: 188 PIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPH 246
            ID+W+VGCIFAEM+ G PLFP     D L  IF +LGTP  ++W   T + +  P +  
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240

Query: 247 FEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEY 289
           +EP         L+ +G+DLLS+ML L+P QRITA  AL+H Y
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  390 bits (1003), Expect = e-137
 Identities = 106/289 (36%), Positives = 156/289 (53%), Gaps = 12/289 (4%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y+KI KIG G YG V+KCRN  TGQ VAIK      +   +    +RE+ +LK+L+H N
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPN 63

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
           +V LL+V   ++ + LVFEY D  +   + R++  +   ++K+I  Q L  + +CH    
Sbjct: 64  LVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNC 123

Query: 128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYST 187
           +HRD+KP N+LI  K + +KL DFG AR +  P   Y  +     Y++PELL+G T Y  
Sbjct: 124 IHRDVKPENILIT-KHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGP 182

Query: 188 PIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPH 246
           P+DVWA+GC+FAE+++G PL+P K   D L LI   LG          +        +  
Sbjct: 183 PVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST----NQYFSG 238

Query: 247 FE------PANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEY 289
            +         L  KFPN+    + LL   L ++P +R+T    L H Y
Sbjct: 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  389 bits (1001), Expect = e-136
 Identities = 104/287 (36%), Positives = 152/287 (52%), Gaps = 8/287 (2%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y+ +  +G G YG V KCRN  TG+ VAIK      + + V    +RE+ LLK+L HEN
Sbjct: 26  KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHEN 85

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
           +V LL+V   +K  +LVFE++D  +   +    N L+  V++  L QI+ G+ +CHS  I
Sbjct: 86  LVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNI 145

Query: 128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYST 187
           +HRD+KP N+L+  +   VKL DFG AR +  P + Y  +     Y+APELL+G   Y  
Sbjct: 146 IHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGK 204

Query: 188 PIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAEST----YISEILP 242
            +DVWA+GC+  EM  G+PLFP     D L  I   LG               +    LP
Sbjct: 205 AVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLP 264

Query: 243 LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEY 289
                EP  L  ++P L    +DL  + L ++P +R    + L H++
Sbjct: 265 EIKEREP--LERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  388 bits (998), Expect = e-136
 Identities = 136/288 (47%), Positives = 184/288 (63%), Gaps = 12/288 (4%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y+K++K+G G YG VYK +++  G+ VA+K + +  E EG+PS  IRE+SLLKEL H N
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
           IV L+DV  S + + LVFE+++ DL   +  +K  L    IK  L Q+L G+A+CH  +I
Sbjct: 81  IVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRI 140

Query: 128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYST 187
           LHRDLKP NLLI+     +KLADFGLARA G+P + Y+ + V   Y+AP++L+G   YST
Sbjct: 141 LHRDLKPQNLLIN-SDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYST 199

Query: 188 PIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLY-- 244
            +D+W++GCIFAEMITGKPLFP     D L  IFS+LGTP    W +       LPL+  
Sbjct: 200 SVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQE----LPLWKQ 255

Query: 245 ---PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEY 289
                FE    +   P     G+DLLS MLC +P +RI+A DA+ H Y
Sbjct: 256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY 303

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  388 bits (998), Expect = e-136
 Identities = 121/288 (42%), Positives = 182/288 (63%), Gaps = 7/288 (2%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y++I K+G G YGEVYK  +TVT + VAIK + ++ E+EGVP   IREVSLLKEL+H N
Sbjct: 35  RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRN 94

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
           I+ L  V      + L+FEY + DL  ++ ++ + +++ VIK+ L Q++ G+ +CHS + 
Sbjct: 95  IIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPD-VSMRVIKSFLYQLINGVNFCHSRRC 153

Query: 128 LHRDLKPNNLLID----LKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYT 183
           LHRDLKP NLL+      +   +K+ DFGLARA G+P ++++ + +   Y+ PE+LLG  
Sbjct: 154 LHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSR 213

Query: 184 GYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILP 242
            YST +D+W++ CI+AEM+   PLFP     D L  IF +LG P D +W   T + +   
Sbjct: 214 HYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQ 273

Query: 243 LYPHFEPANLAEKFPN-LEPAGVDLLSQMLCLNPKQRITAMDALKHEY 289
            +P F    L       L+  G+DLL+ ML ++P +RI+A +AL+H Y
Sbjct: 274 SFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  386 bits (995), Expect = e-136
 Identities = 132/284 (46%), Positives = 179/284 (63%), Gaps = 3/284 (1%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y+K++KIG G YG V+K +N  T + VA+K + +  + EGVPS  +RE+ LLKEL+H+N
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
           IVRL DV  S K + LVFE+ D DL  +       L+  ++K+ L Q+L GL +CHS  +
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNV 122

Query: 128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYST 187
           LHRDLKP NLLI+ +   +KLA+FGLARA G+P + YS + V   Y+ P++L G   YST
Sbjct: 123 LHRDLKPQNLLIN-RNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181

Query: 188 PIDVWAVGCIFAEMIT-GKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYP 245
            ID+W+ GCIFAE+   G+PLFP     D L  IF LLGTPT+E W   T + +  P   
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241

Query: 246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEY 289
           +    +L    P L   G DLL  +L  NP QRI+A +AL+H Y
Sbjct: 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  386 bits (994), Expect = e-135
 Identities = 134/284 (47%), Positives = 178/284 (62%), Gaps = 4/284 (1%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y K+ K+G G Y  VYK ++ +T   VA+K + ++ E EG P   IREVSLLK+L+H N
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHAN 61

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
           IV L D+  + K + LVFEYLD DL  ++    N +N+  +K  L Q+L GLAYCH  K+
Sbjct: 62  IVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKV 121

Query: 128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYST 187
           LHRDLKP NLLI+ +R  +KLADFGLARA  +P K Y  + V   Y+ P++LLG T YST
Sbjct: 122 LHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYST 180

Query: 188 PIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPL-YP 245
            ID+W VGCIF EM TG+PLFP     + L  IF +LGTPT+E+W       E     YP
Sbjct: 181 QIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYP 240

Query: 246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEY 289
            +    L    P L+  G DLL+++L    + RI+A DA+KH +
Sbjct: 241 KYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  386 bits (993), Expect = e-135
 Identities = 115/289 (39%), Positives = 156/289 (53%), Gaps = 12/289 (4%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIK---MMTIQTEQEGVPSYIIREVSLLKELE 64
            Y+K+  +G G +  VYK R+  T Q VAIK   +      ++G+    +RE+ LL+EL 
Sbjct: 11  RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS 70

Query: 65  HENIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
           H NI+ LLD    + ++ LVF++++ DL   I  +   L    IKA +   L GL Y H 
Sbjct: 71  HPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 130

Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTG 184
             ILHRDLKPNNLL+D +   +KLADFGLA++ G P + Y+   V   Y+APELL G   
Sbjct: 131 HWILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARM 189

Query: 185 YSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPL 243
           Y   +D+WAVGCI AE++   P  P     D L+ IF  LGTPT+E W +       LP 
Sbjct: 190 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS----LPD 245

Query: 244 Y---PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEY 289
           Y     F    L   F       +DL+  +   NP  RITA  ALK +Y
Sbjct: 246 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  380 bits (977), Expect = e-133
 Identities = 130/293 (44%), Positives = 177/293 (60%), Gaps = 13/293 (4%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            +K+++K+G G Y  VYK  N  TG  VA+K + + +E EG PS  IRE+SL+KEL+HEN
Sbjct: 6   QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHEN 64

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFITRH-----KNTLNLLVIKAILKQILLGLAYC 122
           IVRL DV  +   + LVFE++D DL  ++           L L ++K    Q+L GLA+C
Sbjct: 65  IVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124

Query: 123 HSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGY 182
           H  KILHRDLKP NLLI+ KR  +KL DFGLARA G+P   +S + V   Y+AP++L+G 
Sbjct: 125 HENKILHRDLKPQNLLIN-KRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGS 183

Query: 183 TGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEIL 241
             YST ID+W+ GCI AEMITGKPLFP     + L LIF ++GTP +  W   T + +  
Sbjct: 184 RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYN 243

Query: 242 PLYPHFEPANLAEKF-----PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEY 289
           P      P +L +         L+   +D L  +L LNP  R++A  AL H +
Sbjct: 244 PNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW 296

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  366 bits (942), Expect = e-127
 Identities = 111/295 (37%), Positives = 164/295 (55%), Gaps = 20/295 (6%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNT-VTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL--- 63
            Y+ + +IG G YG+V+K R+    G+ VA+K + +QT +EG+P   IREV++L+ L   
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 71

Query: 64  EHENIVRLLDV-----QSSRKDVFLVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILL 117
           EH N+VRL DV           + LVFE++D DL +++ +     +    IK ++ Q+L 
Sbjct: 72  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 131

Query: 118 GLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPE 177
           GL + HS +++HRDLKP N+L+      +KLADFGLAR         +   V   Y+APE
Sbjct: 132 GLDFLHSHRVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMA-LTSVVVTLWYRAPE 189

Query: 178 LLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTY 236
           +LL  + Y+TP+D+W+VGCIFAEM   KPLF      D L  I  ++G P +E W     
Sbjct: 190 VLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 248

Query: 237 ISEILPLY--PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEY 289
               LP           + +   +++  G DLL + L  NP +RI+A  AL H Y
Sbjct: 249 ----LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  364 bits (936), Expect = e-127
 Identities = 122/305 (40%), Positives = 167/305 (54%), Gaps = 22/305 (7%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEG---VPSYIIREVSLLKEL- 63
            Y+ + +IG G YG VYK R+  +G  VA+K + +     G   +P   +REV+LL+ L 
Sbjct: 10  RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69

Query: 64  --EHENIVRLLDV-----QSSRKDVFLVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQI 115
             EH N+VRL+DV           V LVFE++D DL +++ +     L    IK +++Q 
Sbjct: 70  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 129

Query: 116 LLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKA 175
           L GL + H+  I+HRDLKP N+L+     TVKLADFGLAR         +   V   Y+A
Sbjct: 130 LRGLDFLHANCIVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMA-LTPVVVTLWYRA 187

Query: 176 PELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAES 234
           PE+LL  T Y+TP+D+W+VGCIFAEM   KPLF      D L  IF L+G P ++ W   
Sbjct: 188 PEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 246

Query: 235 TYISEILPLY--PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIG 292
                 LP    P   P  +    P +E +G  LL +ML  NP +RI+A  AL+H YL  
Sbjct: 247 VS----LPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 302

Query: 293 VENVP 297
            E  P
Sbjct: 303 DEGNP 307

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  361 bits (930), Expect = e-125
 Identities = 108/304 (35%), Positives = 164/304 (53%), Gaps = 29/304 (9%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y+K+ KIG G +GEV+K R+  TGQKVA+K + ++ E+EG P   +RE+ +L+ L+HEN
Sbjct: 18  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 77

Query: 68  IVRLLDV--------QSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGL 119
           +V L+++           +  ++LVF++ + DL   ++       L  IK +++ +L GL
Sbjct: 78  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL 137

Query: 120 AYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP------Y 173
            Y H  KILHRD+K  N+LI  +   +KLADFGLARA  + +        Y+       Y
Sbjct: 138 YYIHRNKILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNR--YTNRVVTLWY 194

Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWA 232
           + PELLLG   Y  PID+W  GCI AEM T  P+         L+LI  L G+ T E W 
Sbjct: 195 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 254

Query: 233 ESTYISEILPLY-----PHFEPANLAEKFPNL--EPAGVDLLSQMLCLNPKQRITAMDAL 285
                     LY        +   + ++      +P  +DL+ ++L L+P QRI + DAL
Sbjct: 255 NVDN----YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 310

Query: 286 KHEY 289
            H++
Sbjct: 311 NHDF 314

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  332 bits (853), Expect = e-113
 Identities = 104/322 (32%), Positives = 160/322 (49%), Gaps = 48/322 (14%)

Query: 9   YKKIK-KIGAGGYGEVYKCRN--TVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEH 65
           ++    K+G G YG VYK +       +  A+K    Q E  G+     RE++LL+EL+H
Sbjct: 22  FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALK----QIEGTGISMSACREIALLRELKH 77

Query: 66  ENIVRLLDVQSSRKD--VFLVFEYLDLDLHSFITRHKNT--------LNLLVIKAILKQI 115
            N++ L  V  S  D  V+L+F+Y + DL   I  H+ +        L   ++K++L QI
Sbjct: 78  PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137

Query: 116 LLGLAYCHSLKILHRDLKPNNLLIDLKRN---TVKLADFGLARAIGVPQKEYSRDCVYSP 172
           L G+ Y H+  +LHRDLKP N+L+  +      VK+AD G AR    P K  +      P
Sbjct: 138 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD---LDP 194

Query: 173 ------YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFP----------SKKHDHL 216
                 Y+APELLLG   Y+  ID+WA+GCIFAE++T +P+F              HD L
Sbjct: 195 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 254

Query: 217 SLIFSLLGTPTDESWAESTYISEILPLYPHFEPAN---------LAEKFPNLEPAGVDLL 267
             IF+++G P D+ W +   + E   L   F             + +     +     LL
Sbjct: 255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLL 314

Query: 268 SQMLCLNPKQRITAMDALKHEY 289
            ++L ++P +RIT+  A++  Y
Sbjct: 315 QKLLTMDPIKRITSEQAMQDPY 336

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  329 bits (845), Expect = e-111
 Identities = 103/304 (33%), Positives = 155/304 (50%), Gaps = 37/304 (12%)

Query: 7   LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHE 66
           ++Y   K IG G +G VY+ +   +G+ VAIK +           +  RE+ ++++L+H 
Sbjct: 54  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHC 107

Query: 67  NIVRLLDVQSSRKDVF------LVFEYLDLDLHSFI---TRHKNTLNLLVIKAILKQILL 117
           NIVRL     S  +        LV +Y+   ++      +R K TL ++ +K  + Q+  
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167

Query: 118 GLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAI--GVPQKEY--SRDCVYSPY 173
            LAY HS  I HRD+KP NLL+D     +KL DFG A+ +  G P   Y  SR   Y  Y
Sbjct: 168 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR---Y--Y 222

Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWA 232
           +APEL+ G T Y++ IDVW+ GC+ AE++ G+P+FP     D L  I  +LGTPT E   
Sbjct: 223 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI- 281

Query: 233 ESTYISEILPLY-----PHFEPANLAEKF-PNLEPAGVDLLSQMLCLNPKQRITAMDALK 286
                 E+ P Y     P  +     + F P   P  + L S++L   P  R+T ++A  
Sbjct: 282 -----REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336

Query: 287 HEYL 290
           H + 
Sbjct: 337 HSFF 340

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  326 bits (837), Expect = e-110
 Identities = 97/305 (31%), Positives = 157/305 (51%), Gaps = 30/305 (9%)

Query: 2   GKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLK 61
           G+ + + Y   K IG G +G V++ +   + + VAIK +      +       RE+ +++
Sbjct: 35  GEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKN------RELQIMR 87

Query: 62  ELEHENIVRLLDV------QSSRKDVFLVFEYLDLDLHSFI---TRHKNTLNLLVIKAIL 112
            ++H N+V L         +     + LV EY+   ++       + K T+ +L+IK  +
Sbjct: 88  IVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYM 147

Query: 113 KQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP 172
            Q+L  LAY HS+ I HRD+KP NLL+D     +KL DFG A+ + +  +          
Sbjct: 148 YQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL-IAGEPNVSYICSRY 206

Query: 173 YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESW 231
           Y+APEL+ G T Y+T ID+W+ GC+ AE++ G+PLFP +   D L  I  +LGTP+ E  
Sbjct: 207 YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI 266

Query: 232 AESTYISEILPLY-----PHFEPANLAEKF-PNLEPAGVDLLSQMLCLNPKQRITAMDAL 285
                   + P Y     P   P   ++ F P   P  +DL+S++L   P  R+TA++AL
Sbjct: 267 ------KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEAL 320

Query: 286 KHEYL 290
            H + 
Sbjct: 321 CHPFF 325

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  316 bits (812), Expect = e-106
 Identities = 105/349 (30%), Positives = 162/349 (46%), Gaps = 68/349 (19%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y+    IG G YG V +  + +  + VAIK +    E       I+RE+++L  L H++
Sbjct: 54  RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDH 113

Query: 68  IVRLLDVQSSR-----KDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYC 122
           +V++LD+   +      ++++V E  D D      R    L  L IK +L  +L+G+ Y 
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLF-RTPVYLTELHIKTLLYNLLVGVKYV 172

Query: 123 HSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP---------- 172
           HS  ILHRDLKP N L++ +  +VK+ DFGLAR +  P+   S+  +             
Sbjct: 173 HSAGILHRDLKPANCLVN-QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFP 231

Query: 173 -----------------YKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-----------G 204
                            Y+APEL+L    Y+  IDVW++GCIFAE++             
Sbjct: 232 HTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADR 291

Query: 205 KPLFP---------------------SKKHDHLSLIFSLLGTPTDESWA--ESTYISEIL 241
            PLFP                         D L++IF++LGTP++E     E       +
Sbjct: 292 GPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYI 351

Query: 242 PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            ++P  E  +LAE+FP      + LL +ML  NP +RIT  + L H + 
Sbjct: 352 RIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFF 400

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  304 bits (782), Expect = e-103
 Identities = 91/298 (30%), Positives = 153/298 (51%), Gaps = 26/298 (8%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHE 66
           +Y+ ++K+G G Y EV++  N    +KV +K++    +++     I RE+ +L+ L    
Sbjct: 37  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK-----IKREIKILENLRGGP 91

Query: 67  NIVRLLDV---QSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYC 122
           NI+ L D+     SR    LVFE+++  D          TL    I+  + +IL  L YC
Sbjct: 92  NIITLADIVKDPVSRTPA-LVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYC 146

Query: 123 HSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGY 182
           HS+ I+HRD+KP+N++ID +   ++L D+GLA     P +EY+       +K PELL+ Y
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVDY 205

Query: 183 TGYSTPIDVWAVGCIFAEMITGK-PLFPSKKHDH-LSLIFSLLGTPTDESWAESTYIS-- 238
             Y   +D+W++GC+ A MI  K P F    +   L  I  +LGT     + +   I   
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265

Query: 239 ----EILPLYP--HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
               +IL  +    +E    +E    + P  +D L ++L  + + R+TA +A++H Y 
Sbjct: 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  298 bits (765), Expect = e-100
 Identities = 98/332 (29%), Positives = 152/332 (45%), Gaps = 63/332 (18%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y   K +G G +G V +  +  +G++ A+K +         P Y  RE+ ++K L+H N
Sbjct: 8   KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD------PRYKNRELDIMKVLDHVN 61

Query: 68  IVRLLDV--------------------------------------QSSRKDVFLVFEYLD 89
           I++L+D                                        S  K + ++ EY+ 
Sbjct: 62  IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121

Query: 90  LDLHSFI---TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTV 146
             LH  +    R   ++ + +I   + Q+   + + HSL I HRD+KP NLL++ K NT+
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTL 181

Query: 147 KLADFGLARAI--GVPQKEY--SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMI 202
           KL DFG A+ +    P   Y  SR      Y+APEL+LG T Y+  ID+W++GC+F E+I
Sbjct: 182 KLCDFGSAKKLIPSEPSVAYICSR-----FYRAPELMLGATEYTPSIDLWSIGCVFGELI 236

Query: 203 TGKPLFPSKKH-DHLSLIFSLLGTPTDESWAE--STYISEILPLYPHFEPANLAEKFPNL 259
            GKPLF  +   D L  I  ++GTPT E        Y     P        +  +  P  
Sbjct: 237 LGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLK---AKDWRKILPEG 293

Query: 260 EPA-GVDLLSQMLCLNPKQRITAMDALKHEYL 290
            P+  +DLL Q+L   P  RI   +A+ H + 
Sbjct: 294 TPSLAIDLLEQILRYEPDLRINPYEAMAHPFF 325

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  297 bits (763), Expect = e-100
 Identities = 94/306 (30%), Positives = 151/306 (49%), Gaps = 34/306 (11%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL---E 64
            ++  +  G G +G V   +   TG  VAIK    +  Q+  P +  RE+ ++++L    
Sbjct: 24  RFQVERMAGQGTFGTVQLGKEKSTGMSVAIK----KVIQD--PRFRNRELQIMQDLAVLH 77

Query: 65  HENIVRLLDV-----QSSRKDVFL--VFEYLDLDLHSFI---TRHKNTLNLLVIKAILKQ 114
           H NIV+L        +  R+D++L  V EY+   LH       R +     ++IK  L Q
Sbjct: 78  HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQ 137

Query: 115 ILLGLAYCH--SLKILHRDLKPNNLLIDLKRNTVKLADFGLARAI--GVPQKEY--SRDC 168
           ++  +   H  S+ + HRD+KP+N+L++    T+KL DFG A+ +    P   Y  SR  
Sbjct: 138 LIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSR-- 195

Query: 169 VYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPT 227
            Y  Y+APEL+ G   Y+T +D+W+VGCIFAEM+ G+P+F        L  I  +LG P+
Sbjct: 196 -Y--YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS 252

Query: 228 DESWAE--STYISEILPLYPHFEPAN-LAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDA 284
            E   +   ++    L        +N  ++          DLLS +L   P++R+   +A
Sbjct: 253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEA 312

Query: 285 LKHEYL 290
           L H Y 
Sbjct: 313 LCHPYF 318

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  293 bits (751), Expect = 1e-98
 Identities = 92/302 (30%), Positives = 144/302 (47%), Gaps = 25/302 (8%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           Y  +K +G GG G V+   +    ++VAIK + +   Q    +   RE+ +++ L+H+NI
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL--REIKIIRRLDHDNI 70

Query: 69  VRLLDVQ--------------SSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQ 114
           V++ ++               +    V++V EY++ DL + +   +  L     +  + Q
Sbjct: 71  VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVL--EQGPLLEEHARLFMYQ 128

Query: 115 ILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-- 172
           +L GL Y HS  +LHRDLKP NL I+ +   +K+ DFGLAR +                 
Sbjct: 129 LLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188

Query: 173 -YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDE- 229
            Y++P LLL    Y+  ID+WA GCIFAEM+TGK LF      + + LI   +    +E 
Sbjct: 189 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEED 248

Query: 230 -SWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHE 288
                S     I           L +  P +    VD L Q+L  +P  R+TA +AL H 
Sbjct: 249 RQELLSVIPVYIRND-MTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHP 307

Query: 289 YL 290
           Y+
Sbjct: 308 YM 309

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  291 bits (746), Expect = 2e-97
 Identities = 99/304 (32%), Positives = 154/304 (50%), Gaps = 29/304 (9%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTI---QTEQEGVPSYIIREVSLLKELEH 65
           ++    +G G YG V    +  TG+ VAIK +                +RE+ +LK  +H
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALR----TLREIKILKHFKH 68

Query: 66  ENIVRLLDVQSSR-----KDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLA 120
           ENI+ + ++Q         +V+++ E +  DLH  I+     L+   I+  + Q L  + 
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIST--QMLSDDHIQYFIYQTLRAVK 126

Query: 121 YCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-------- 172
             H   ++HRDLKP+NLLI+     +K+ DFGLAR I     + S               
Sbjct: 127 VLHGSNVIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT 185

Query: 173 --YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDE 229
             Y+APE++L    YS  +DVW+ GCI AE+   +P+FP + +   L LIF ++GTP  +
Sbjct: 186 RWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245

Query: 230 SWAE---STYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK 286
           +      S    E +   P +  A L + FP + P G+DLL +ML  +P +RITA +AL+
Sbjct: 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305

Query: 287 HEYL 290
           H YL
Sbjct: 306 HPYL 309

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  289 bits (741), Expect = 1e-96
 Identities = 86/305 (28%), Positives = 136/305 (44%), Gaps = 31/305 (10%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSY---------IIREVSL 59
           Y   + I +G YG V    ++  G  VAIK +          +          ++RE+ L
Sbjct: 24  YTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82

Query: 60  LKELEHENIVRLLDVQSSR-----KDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQ 114
           L    H NI+ L D+           ++LV E +  DL   I   +  ++   I+  +  
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYH 142

Query: 115 ILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK--EYSRDCVYSP 172
           ILLGL   H   ++HRDL P N+L+    N + + DF LAR          Y     +  
Sbjct: 143 ILLGLHVLHEAGVVHRDLHPGNILLA-DNNDITICDFNLAREDTADANKTHY---VTHRW 198

Query: 173 YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESW 231
           Y+APEL++ + G++  +D+W+ GC+ AEM   K LF      + L+ I  ++GTP  E  
Sbjct: 199 YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDV 258

Query: 232 AE------STYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDAL 285
                     Y+   L   P           P  +P  +DL+++ML  NP++RI+   AL
Sbjct: 259 VMFSSPSARDYLRNSLSNVP---ARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQAL 315

Query: 286 KHEYL 290
           +H Y 
Sbjct: 316 RHPYF 320

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  288 bits (739), Expect = 2e-96
 Identities = 98/292 (33%), Positives = 148/292 (50%), Gaps = 16/292 (5%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y     +G+G YG V    +  +G+KVAIK ++   + E       RE+ LLK ++HEN
Sbjct: 25  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHEN 84

Query: 68  IVRLLDVQSSR------KDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAY 121
           ++ LLDV +         D +LV  ++  DL   +       +   I+ ++ Q+L GL Y
Sbjct: 85  VIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIM---GLKFSEEKIQYLVYQMLKGLKY 141

Query: 122 CHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLG 181
            HS  ++HRDLKP NL ++ +   +K+ DFGLAR        Y    V   Y+APE++L 
Sbjct: 142 IHSAGVVHRDLKPGNLAVN-EDCELKILDFGLARHADAEMTGY---VVTRWYRAPEVILS 197

Query: 182 YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWA--ESTYIS 238
           +  Y+  +D+W+VGCI AEM+TGK LF  K + D L+ I  + G P  E           
Sbjct: 198 WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAK 257

Query: 239 EILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
             +   P     +  + FP   P   DLL +ML L+  +R+TA  AL H + 
Sbjct: 258 SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  287 bits (736), Expect = 8e-96
 Identities = 106/291 (36%), Positives = 151/291 (51%), Gaps = 15/291 (5%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           Y+ ++ +G+G YG V    +  TG KVAIK +    + E       RE+ LLK + HEN+
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86

Query: 69  VRLLDVQ------SSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYC 122
           + LLDV           D +LV  ++  DL   +      L    I+ ++ Q+L GL Y 
Sbjct: 87  IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM--KHEKLGEDRIQFLVYQMLKGLRYI 144

Query: 123 HSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGY 182
           H+  I+HRDLKP NL ++ +   +K+ DFGLAR        Y    V   Y+APE++L +
Sbjct: 145 HAAGIIHRDLKPGNLAVN-EDCELKILDFGLARQADSEMTGY---VVTRWYRAPEVILNW 200

Query: 183 TGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWA--ESTYISE 239
             Y+  +D+W+VGCI AEMITGK LF    H D L  I  + GTP  E     +S     
Sbjct: 201 MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN 260

Query: 240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            +   P  E  + A    N  P  V+LL +ML L+ +QR+TA +AL H Y 
Sbjct: 261 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  285 bits (732), Expect = 3e-95
 Identities = 105/291 (36%), Positives = 153/291 (52%), Gaps = 15/291 (5%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           Y+ +  +G+G YG V    +T TG +VA+K ++   +         RE+ LLK ++HEN+
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 90

Query: 69  VRLLDVQSSR------KDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYC 122
           + LLDV +         DV+LV   +  DL++ +      L    ++ ++ QIL GL Y 
Sbjct: 91  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYI 148

Query: 123 HSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGY 182
           HS  I+HRDLKP+NL ++ +   +K+ DFGLAR        Y        Y+APE++L +
Sbjct: 149 HSADIIHRDLKPSNLAVN-EDCELKILDFGLARHTADEMTGY---VATRWYRAPEIMLNW 204

Query: 183 TGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWA--ESTYISE 239
             Y+  +D+W+VGCI AE++TG+ LFP   H D L LI  L+GTP  E      S     
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 264

Query: 240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            +         N A  F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 265 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  285 bits (732), Expect = 3e-95
 Identities = 102/295 (34%), Positives = 152/295 (51%), Gaps = 17/295 (5%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMT-IQTEQEGVPSYIIREVSLLKELEHE 66
            Y  +  IG G YG V    + +   +VAIK ++  + +     +   RE+ +L    HE
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL--REIKILLRFRHE 85

Query: 67  NIVRLLDVQSSR-----KDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAY 121
           NI+ + D+  +      KDV++V + ++ DL+  +      L+   I   L QIL GL Y
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL--KTQHLSNDHICYFLYQILRGLKY 143

Query: 122 CHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP---YKAPEL 178
            HS  +LHRDLKP+NLL++     +K+ DFGLAR              Y     Y+APE+
Sbjct: 144 IHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202

Query: 179 LLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDE--SWAEST 235
           +L   GY+  ID+W+VGCI AEM++ +P+FP K + D L+ I  +LG+P+ E  +   + 
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262

Query: 236 YISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                L   PH         FPN +   +DLL +ML  NP +RI    AL H YL
Sbjct: 263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  280 bits (718), Expect = 3e-92
 Identities = 107/341 (31%), Positives = 160/341 (46%), Gaps = 60/341 (17%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
           NY     IG G YG VY   +  T + VAIK +    E       I+RE+++L  L+ + 
Sbjct: 27  NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDY 86

Query: 68  IVRLLDVQSSR-----KDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYC 122
           I+RL D+          ++++V E  D DL     +    L    IK IL  +LLG  + 
Sbjct: 87  IIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLF-KTPIFLTEEHIKTILYNLLLGENFI 145

Query: 123 HSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP---------- 172
           H   I+HRDLKP N L++ +  +VK+ DFGLAR I   +     + +             
Sbjct: 146 HESGIIHRDLKPANCLLN-QDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNL 204

Query: 173 ------------YKAPELLLGYTGYSTPIDVWAVGCIFAEMITG-----------KPLFP 209
                       Y+APEL+L    Y+  ID+W+ GCIFAE++              PLFP
Sbjct: 205 KKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFP 264

Query: 210 ------------------SKKHDHLSLIFSLLGTPTDE--SWAESTYISEILPLYPHFEP 249
                                 D L++IF+++GTPT++         + + + L+PH +P
Sbjct: 265 GSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKP 324

Query: 250 ANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            NL +K+P++   G++LL  ML  NP +RIT   AL H YL
Sbjct: 325 INLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYL 365

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  270 bits (693), Expect = 3e-88
 Identities = 99/304 (32%), Positives = 158/304 (51%), Gaps = 30/304 (9%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           Y+ +K IG+G  G V    + V  + VAIK ++   + +       RE+ L+K + H+NI
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 123

Query: 69  VRLLDVQSSR------KDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYC 122
           + LL+V + +      +DV+LV E +D +L   I   +  L+   +  +L Q+L G+ + 
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHL 180

Query: 123 HSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK--EYSRDCVYSPYKAPELLL 180
           HS  I+HRDLKP+N+++     T+K+ DFGLAR  G       Y    V   Y+APE++L
Sbjct: 181 HSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRAPEVIL 236

Query: 181 GYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAE-STYIS 238
           G  GY   +D+W+VGCI  EM+  K LFP + + D  + +   LGTP  E   +    + 
Sbjct: 237 G-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 295

Query: 239 EILPLYPHFEPANLAEKFPN------------LEPAGVDLLSQMLCLNPKQRITAMDALK 286
             +   P +      + FP+                  DLLS+ML ++P +RI+  DAL+
Sbjct: 296 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355

Query: 287 HEYL 290
           H Y+
Sbjct: 356 HPYI 359

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  267 bits (685), Expect = 7e-88
 Identities = 104/326 (31%), Positives = 166/326 (50%), Gaps = 48/326 (14%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHEN 67
           Y+ +KK+G G YG V+K  +  TG+ VA+K +    +         RE+ +L EL  HEN
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70

Query: 68  IVRLLDVQ--SSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSL 125
           IV LL+V    + +DV+LVF+Y++ DLH+ I    N L  +  + ++ Q++  + Y HS 
Sbjct: 71  IVNLLNVLRADNDRDVYLVFDYMETDLHAVI--RANILEPVHKQYVVYQLIKVIKYLHSG 128

Query: 126 KILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP------------- 172
            +LHRD+KP+N+L++     VK+ADFGL+R+    ++  +   +                
Sbjct: 129 GLLHRDMKPSNILLN-AECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPIL 187

Query: 173 --------YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLL 223
                   Y+APE+LLG T Y+  ID+W++GCI  E++ GKP+FP     + L  I  ++
Sbjct: 188 TDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVI 247

Query: 224 GTPTDE------SWAESTYISEILPLYPHF-----------EPANLAEKFPNLE--PAGV 264
             P++E      S    T I   L                     L +  P  +     +
Sbjct: 248 DFPSNEDVESIQSPFAKTMIES-LKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEAL 306

Query: 265 DLLSQMLCLNPKQRITAMDALKHEYL 290
           DLL ++L  NP +RI+A DALKH ++
Sbjct: 307 DLLDKLLQFNPNKRISANDALKHPFV 332

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  265 bits (678), Expect = 4e-87
 Identities = 97/304 (31%), Positives = 157/304 (51%), Gaps = 30/304 (9%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           Y+ +K IG+G  G V    + +  + VAIK ++   + +       RE+ L+K + H+NI
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86

Query: 69  VRLLDVQSSR------KDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYC 122
           + LL+V + +      +DV++V E +D +L   I   +  L+   +  +L Q+L G+ + 
Sbjct: 87  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHL 143

Query: 123 HSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK--EYSRDCVYSPYKAPELLL 180
           HS  I+HRDLKP+N+++     T+K+ DFGLAR  G       Y    V   Y+APE++L
Sbjct: 144 HSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRAPEVIL 199

Query: 181 GYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAE-STYIS 238
           G  GY   +D+W+VGCI  EMI G  LFP   H D  + +   LGTP  E   +    + 
Sbjct: 200 GM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR 258

Query: 239 EILPLYPHFEPANLAEKFPN------------LEPAGVDLLSQMLCLNPKQRITAMDALK 286
             +   P +   +  + FP+                  DLLS+ML ++  +RI+  +AL+
Sbjct: 259 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318

Query: 287 HEYL 290
           H Y+
Sbjct: 319 HPYI 322

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  227 bits (582), Expect = 2e-73
 Identities = 77/302 (25%), Positives = 132/302 (43%), Gaps = 43/302 (14%)

Query: 3   KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKE 62
            +K   Y  +K+IG+GG  +V++  N    Q  AIK + ++            E++ L +
Sbjct: 24  SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 82

Query: 63  LEH--ENIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLA 120
           L+   + I+RL D + + + +++V E  ++DL+S++ + K+ ++    K+  K +L  + 
Sbjct: 83  LQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVH 141

Query: 121 YCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRD-CVYSP-YKAPEL 178
             H   I+H DLKP N LI      +KL DFG+A  +        +D  V +  Y  PE 
Sbjct: 142 TIHQHGIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 199

Query: 179 LLG----------YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTD 228
           +             +  S   DVW++GCI   M  GK  F     + +S + ++      
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-NQISKLHAI------ 252

Query: 229 ESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHE 288
                      I P +    P          E    D+L   L  +PKQRI+  + L H 
Sbjct: 253 -----------IDPNHEIEFP-------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294

Query: 289 YL 290
           Y+
Sbjct: 295 YV 296

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  225 bits (575), Expect = 2e-71
 Identities = 77/302 (25%), Positives = 133/302 (44%), Gaps = 43/302 (14%)

Query: 3   KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKE 62
            +K   Y  +K+IG+GG  +V++  N    Q  AIK + ++            E++ L +
Sbjct: 52  SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 110

Query: 63  LEH--ENIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLA 120
           L+   + I+RL D + + + +++V E  ++DL+S++ + K+ ++    K+  K +L  + 
Sbjct: 111 LQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVH 169

Query: 121 YCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRD-CVYSP-YKAPEL 178
             H   I+H DLKP N LI      +KL DFG+A  +        +D  V +  Y  PE 
Sbjct: 170 TIHQHGIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEA 227

Query: 179 LLG----------YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTD 228
           +             +  S   DVW++GCI   M  GK  F  +  + +S + ++      
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-QQIINQISKLHAI------ 280

Query: 229 ESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHE 288
                      I P +    P          E    D+L   L  +PKQRI+  + L H 
Sbjct: 281 -----------IDPNHEIEFP-------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 322

Query: 289 YL 290
           Y+
Sbjct: 323 YV 324

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  223 bits (570), Expect = 3e-71
 Identities = 77/302 (25%), Positives = 132/302 (43%), Gaps = 43/302 (14%)

Query: 3   KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKE 62
            +K   Y  +K+IG+GG  +V++  N    Q  AIK + ++            E++ L +
Sbjct: 5   SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 63

Query: 63  LEH--ENIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLA 120
           L+   + I+RL D + + + +++V E  ++DL+S++ + K+ ++    K+  K +L  + 
Sbjct: 64  LQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVH 122

Query: 121 YCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRD-CVYSP-YKAPEL 178
             H   I+H DLKP N LI      +KL DFG+A  +        +D  V +  Y  PE 
Sbjct: 123 TIHQHGIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180

Query: 179 LLG----------YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTD 228
           +             +  S   DVW++GCI   M  GK  F     + +S + ++      
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-NQISKLHAI------ 233

Query: 229 ESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHE 288
                      I P +    P          E    D+L   L  +PKQRI+  + L H 
Sbjct: 234 -----------IDPNHEIEFP-------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275

Query: 289 YL 290
           Y+
Sbjct: 276 YV 277

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  211 bits (540), Expect = 1e-65
 Identities = 69/295 (23%), Positives = 126/295 (42%), Gaps = 40/295 (13%)

Query: 3   KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKE 62
            +  +++     +G G  G +   R     + VA+K +  +           REV LL+E
Sbjct: 20  IVGKISFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRILPECFSF-----ADREVQLLRE 73

Query: 63  L-EHENIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAY 121
             EH N++R    +  R+  ++  E     L  ++ +       L    +L+Q   GLA+
Sbjct: 74  SDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAH 133

Query: 122 CHSLKILHRDLKPNNLLIDLKRNT----VKLADFGLARAIGVPQKEYSR--DCVYSP-YK 174
            HSL I+HRDLKP+N+LI +          ++DFGL + + V +  +SR      +  + 
Sbjct: 134 LHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193

Query: 175 APELLLG--YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWA 232
           APE+L        +  +D+++ GC+F  +I+       K     + I  LLG  +     
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI--LLGACS----- 246

Query: 233 ESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH 287
                           P        + +    +L+ +M+ ++P++R +A   LKH
Sbjct: 247 -----------LDCLHP------EKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  204 bits (522), Expect = 2e-64
 Identities = 70/285 (24%), Positives = 110/285 (38%), Gaps = 36/285 (12%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHE 66
           +++++ ++G G YGEV+K R+   G+  A+K            +  + EV   +++ +H 
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117

Query: 67  NIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
             VRL         ++L  E     L         +L    +   L+  LL LA+ HS  
Sbjct: 118 CCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG 177

Query: 127 ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGYTGY 185
           ++H D+KP N+ +   R   KL DFGL   +G       ++    P Y APELL G   Y
Sbjct: 178 LVHLDVKPANIFLG-PRGRCKLGDFGLLVELGTAGAGEVQEG--DPRYMAPELLQG--SY 232

Query: 186 STPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYP 245
            T  DV+++G    E+     L                     E W +      + P + 
Sbjct: 233 GTAADVFSLGLTILEVACNMELP-----------------HGGEGWQQ-LRQGYLPPEFT 274

Query: 246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                        L      +L  ML  +PK R TA   L    L
Sbjct: 275 -----------AGLSSELRSVLVMMLEPDPKLRATAEALLALPVL 308

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  202 bits (515), Expect = 3e-63
 Identities = 72/292 (24%), Positives = 120/292 (41%), Gaps = 37/292 (12%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQ---TEQEGVPSYIIREVSLLKELE 64
           N++  KKIG G + EVY+    + G  VA+K + I      +    +  I+E+ LLK+L 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKA--RADCIKEIDLLKQLN 90

Query: 65  HENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLL---VIKAILKQILLGLA 120
           H N+++         ++ +V E  D  DL   I   K    L+    +     Q+   L 
Sbjct: 91  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150

Query: 121 YCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELL 179
           + HS +++HRD+KP N+ I      VKL D GL R     +   +   V +P Y +PE +
Sbjct: 151 HMHSRRVMHRDIKPANVFIT-ATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERI 208

Query: 180 LGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISE 239
               GY+   D+W++GC+  EM   +  F   K +  SL   +           S + SE
Sbjct: 209 HE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP--LPSDHYSE 265

Query: 240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLI 291
            L                        L++  +  +P++R            +
Sbjct: 266 EL----------------------RQLVNMCINPDPEKRPDVTYVYDVAKRM 295

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  201 bits (512), Expect = 5e-63
 Identities = 75/311 (24%), Positives = 123/311 (39%), Gaps = 58/311 (18%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
           ++++I  +G G +G+V K RN +  +  AIK +    E+    S I+ EV LL  L H+ 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL---STILSEVMLLASLNHQY 63

Query: 68  IVRLLDV-------------QSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILK 113
           +VR                    +  +F+  EY +   L+  I              + +
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123

Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP- 172
           QIL  L+Y HS  I+HRDLKP N+ ID +   VK+ DFGLA+ +         D    P 
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182

Query: 173 -------------YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLI 219
                        Y A E+L G   Y+  ID++++G IF EMI   P     +  ++   
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNILKK 240

Query: 220 FSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRI 279
                            +  +   +P     N  +           ++  ++  +P +R 
Sbjct: 241 -----------------LRSVSIEFPPDFDDNKMKVE-------KKIIRLLIDHDPNKRP 276

Query: 280 TAMDALKHEYL 290
            A   L   +L
Sbjct: 277 GARTLLNSGWL 287

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  200 bits (510), Expect = 1e-62
 Identities = 61/310 (19%), Positives = 117/310 (37%), Gaps = 22/310 (7%)

Query: 1   MGKLKNLN--YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVS 58
           MG     N  +     +G G    V++ R+  TG   AIK+              +RE  
Sbjct: 1   MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFN-NISFLRPVDVQMREFE 59

Query: 59  LLKELEHENIVRLLDVQ--SSRKDVFLVFEYLDL-DLHSFITRHKNTLNL--LVIKAILK 113
           +LK+L H+NIV+L  ++  ++ +   L+ E+     L++ +    N   L       +L+
Sbjct: 60  VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119

Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDL---KRNTVKLADFGLARAIGVPQKEYSRDCVY 170
            ++ G+ +     I+HR++KP N++  +    ++  KL DFG AR +     E       
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE--DDEQFVSLYG 177

Query: 171 SP-YKAPELLLGYT-------GYSTPIDVWAVGCIFAEMITGKPLF-PSKKHDHLSLIFS 221
           +  Y  P++             Y   +D+W++G  F    TG   F P +       +  
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237

Query: 222 LLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITA 281
            + T            +E  P+    +          L+     +L+ +L  + ++    
Sbjct: 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF 297

Query: 282 MDALKHEYLI 291
                    I
Sbjct: 298 DQFFAETSDI 307

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  199 bits (509), Expect = 5e-62
 Identities = 76/286 (26%), Positives = 129/286 (45%), Gaps = 33/286 (11%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y +++KIG G +G+    ++T  G++  IK + I            REV++L  ++H N
Sbjct: 25  KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPN 84

Query: 68  IVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNT-LNLLVIKAILKQILLGLAYCHSL 125
           IV+  +       +++V +Y +  DL   I   K        I     QI L L + H  
Sbjct: 85  IVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR 144

Query: 126 KILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGYTG 184
           KILHRD+K  N+ +  K  TV+L DFG+AR +     E +R C+ +P Y +PE+      
Sbjct: 145 KILHRDIKSQNIFLT-KDGTVQLGDFGIARVLN-STVELARACIGTPYYLSPEICEN-KP 201

Query: 185 YSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLY 244
           Y+   D+WA+GC+  E+ T K  F +      +L+  ++                  P+ 
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHAFEAG--SMKNLVLKIIS-------------GSFPPVS 246

Query: 245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            H+   +L             L+SQ+   NP+ R +    L+  ++
Sbjct: 247 LHY-SYDLR-----------SLVSQLFKRNPRDRPSVNSILEKGFI 280

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  196 bits (500), Expect = 2e-61
 Identities = 75/295 (25%), Positives = 130/295 (44%), Gaps = 42/295 (14%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
           +Y+ +  IG G YG   K R    G+ +  K +   +  E     ++ EV+LL+EL+H N
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66

Query: 68  IVRLLD--VQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLL---VIKAILKQILLGLAY 121
           IVR  D  +  +   +++V EY +  DL S IT+       L    +  ++ Q+ L L  
Sbjct: 67  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126

Query: 122 CHSLK-----ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKA 175
           CH        +LHRDLKP N+ +D  +  VKL DFGLAR +      +++  V +P Y +
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGLARILN-HDTSFAKTFVGTPYYMS 184

Query: 176 PELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAEST 235
           PE +     Y+   D+W++GC+  E+    P F +       L   +             
Sbjct: 185 PEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAF--SQKELAGKIRE----------- 230

Query: 236 YISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
              +   +   +    L            +++++ML L    R +  + L++  +
Sbjct: 231 --GKFRRIPYRY-SDEL-----------NEIITRMLNLKDYHRPSVEEILENPLI 271

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  199 bits (507), Expect = 8e-61
 Identities = 89/329 (27%), Positives = 143/329 (43%), Gaps = 62/329 (18%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSY---IIREVSLLKEL-- 63
           Y+ +K IG G +G+V K  +    Q VA+KM+           +      E+ +L+ L  
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMV------RNEKRFHRQAAEEIRILEHLRK 152

Query: 64  ----EHENIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILLG 118
                  N++ +L+  + R  + + FE L ++L+  I ++K    +L +++     IL  
Sbjct: 153 QDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQC 212

Query: 119 LAYCHSLKILHRDLKPNN-LLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS-----P 172
           L   H  +I+H DLKP N LL    R+ +K+ DFG +         Y    VY+      
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC--------YEHQRVYTYIQSRF 264

Query: 173 YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSK-KHDHLSLIFSLLGTP----- 226
           Y+APE++LG   Y  PID+W++GCI AE++TG PL P + + D L+ +  LLG P     
Sbjct: 265 YRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL 323

Query: 227 --------------------TDESWAESTYISEILPLYPHF-EPANLAEKFPNLEPAG-- 263
                                      S  ++           P    E    L+     
Sbjct: 324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDP 383

Query: 264 --VDLLSQMLCLNPKQRITAMDALKHEYL 290
             +D L Q L  +P  R+T   AL+H +L
Sbjct: 384 LFLDFLKQCLEWDPAVRMTPGQALRHPWL 412

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  195 bits (498), Expect = 3e-60
 Identities = 86/312 (27%), Positives = 142/312 (45%), Gaps = 39/312 (12%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMM---TIQTEQEGVPSYIIREVSLLKELEH 65
           Y+  + IG G +  V +C N  TGQ+ A+K++      +        + RE S+   L+H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85

Query: 66  ENIVRLLDVQSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLL---VIKAILKQILLGLAY 121
            +IV LL+  SS   +++VFE++D  DL   I +  +   +    V    ++QIL  L Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145

Query: 122 CHSLKILHRDLKPNNLLIDLKRN--TVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPEL 178
           CH   I+HRD+KP+ +L+  K N   VKL  FG+A  +G          V +P + APE+
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA-GGRVGTPHFMAPEV 204

Query: 179 LLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYI- 237
           +     Y  P+DVW  G I   +++G   F                      +     + 
Sbjct: 205 VKR-EPYGKPVDVWGCGVILFILLSGCLPF----------------------YGTKERLF 241

Query: 238 SEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
             I+       P     ++ ++  +  DL+ +ML L+P +RIT  +AL H +L   +   
Sbjct: 242 EGIIKGKYKMNP----RQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYA 297

Query: 298 LVILLINRKKKL 309
             I L    ++L
Sbjct: 298 YKIHLPETVEQL 309

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  193 bits (493), Expect = 7e-60
 Identities = 68/303 (22%), Positives = 115/303 (37%), Gaps = 51/303 (16%)

Query: 6   NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEH 65
           N +Y  I+K+G GG+  V        G   A+K +    +Q+       RE  + +   H
Sbjct: 28  NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQD--REEAQREADMHRLFNH 85

Query: 66  ENIVRLLDV----QSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLL---VIKAILKQILL 117
            NI+RL+      + ++ + +L+  +     L + I R K+  N L    I  +L  I  
Sbjct: 86  PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR 145

Query: 118 GLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP----------QKEYSRD 167
           GL   H+    HRDLKP N+L+        L D G      +           Q   ++ 
Sbjct: 146 GLEAIHAKGYAHRDLKPTNILLG-DEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204

Query: 168 CVYSP-YKAPELLLG--YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLG 224
           C  +  Y+APEL     +       DVW++GC+   M+ G+  +        S+  ++  
Sbjct: 205 C--TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN 262

Query: 225 TPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDA 284
             +             +P  P    + L             LL+ M+ ++P QR      
Sbjct: 263 QLS-------------IPQSPRH-SSALW-----------QLLNSMMTVDPHQRPHIPLL 297

Query: 285 LKH 287
           L  
Sbjct: 298 LSQ 300

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  193 bits (493), Expect = 1e-59
 Identities = 63/296 (21%), Positives = 105/296 (35%), Gaps = 40/296 (13%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
                ++G G +GEV++ ++  TG + A+K + ++  +         E+     L    I
Sbjct: 60  MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV-------EELVACAGLSSPRI 112

Query: 69  VRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
           V L         V +  E L+   L   I +    L        L Q L GL Y H+ +I
Sbjct: 113 VPLYGAVREGPWVNIFMELLEGGSLGQLI-KQMGCLPEDRALYYLGQALEGLEYLHTRRI 171

Query: 128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS----PY-KAPELLLGY 182
           LH D+K +N+L+    +   L DFG A  +       S              APE+++G 
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG- 230

Query: 183 TGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILP 242
                 +D+W+  C+   M+ G    P  ++    L   +   P                
Sbjct: 231 KPCDAKVDIWSSCCMMLHMLNGCH--PWTQYFRGPLCLKIASEPP--------------- 273

Query: 243 LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPL 298
             P  E        P+  P     + + L   P  R +AM+  +       E   L
Sbjct: 274 --PIREIP------PSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGL 321

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  196 bits (499), Expect = 1e-59
 Identities = 73/312 (23%), Positives = 131/312 (41%), Gaps = 59/312 (18%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHEN 67
               K +G G  G V     +  G+ VA+K M I           + E+ LL E  +H N
Sbjct: 17  VVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDI-----ALMEIKLLTESDDHPN 70

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVI------KAILKQILLGLAY 121
           ++R    +++ + +++  E  +L+L   +     +   L +       ++L+QI  G+A+
Sbjct: 71  VIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130

Query: 122 CHSLKILHRDLKPNNLLIDLKRNT------------VKLADFGLARAIGVPQKEYS---R 166
            HSLKI+HRDLKP N+L+                  + ++DFGL + +   Q  +     
Sbjct: 131 LHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190

Query: 167 DCVYSP-YKAPELLLGYT------GYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSL 218
           +   +  ++APELL            +  ID++++GC+F  +++ GK  F          
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF---------- 240

Query: 219 IFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQR 278
                         + +  S I+      +         +L     DL+SQM+  +P +R
Sbjct: 241 ------------GDKYSRESNIIRGIFSLDEMK-CLHDRSLIAEATDLISQMIDHDPLKR 287

Query: 279 ITAMDALKHEYL 290
            TAM  L+H   
Sbjct: 288 PTAMKVLRHPLF 299

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  191 bits (488), Expect = 1e-59
 Identities = 67/302 (22%), Positives = 124/302 (41%), Gaps = 61/302 (20%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
           ++K+I+ IG+GG+G+V+K ++ + G+   IK +    E+        REV  L +L+H N
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEK------AEREVKALAKLDHVN 65

Query: 68  IVRLLD----------------VQSSRKDVFLVFEYLDL-DLHSFITRHKNT-LNLLVIK 109
           IV                     +S  K +F+  E+ D   L  +I + +   L+ ++  
Sbjct: 66  IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125

Query: 110 AILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCV 169
            + +QI  G+ Y HS K+++RDLKP+N+ +      VK+ DFGL  ++    K       
Sbjct: 126 ELFEQITKGVDYIHSKKLINRDLKPSNIFLV-DTKQVKIGDFGLVTSLKNDGKRTRS--K 182

Query: 170 YSP-YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTD 228
            +  Y +PE +     Y   +D++A+G I AE++           +              
Sbjct: 183 GTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTA----FETSKFF--------- 228

Query: 229 ESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHE 288
                +     I+                  +     LL ++L   P+ R    + L+  
Sbjct: 229 -----TDLRDGIIS--------------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTL 269

Query: 289 YL 290
            +
Sbjct: 270 TV 271

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  194 bits (494), Expect = 2e-59
 Identities = 86/339 (25%), Positives = 144/339 (42%), Gaps = 69/339 (20%)

Query: 4   LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL 63
            K+  Y  ++K+G G +  V+  ++ V    VA+K   I    +        E+ LL+ +
Sbjct: 16  YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMK---IVRGDKVYTEAAEDEIKLLQRV 72

Query: 64  -----------EHENIVRLLDV----QSSRKDVFLVFEYLDLDLHSFITRHKNT-LNLLV 107
                         +I++LLD       +   V +VFE L  +L + I ++++  + L+ 
Sbjct: 73  NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIY 132

Query: 108 IKAILKQILLGLAYCHS-LKILHRDLKPNNLLIDL-----KRNTVKLADFGLARAIGVPQ 161
           +K I KQ+LLGL Y H    I+H D+KP N+L+++         +K+AD G A       
Sbjct: 133 VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 192

Query: 162 KEY--SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFP-------SKK 212
                +R      Y++PE+LLG   +    D+W+  C+  E+ITG  LF        +K 
Sbjct: 193 TNSIQTR-----EYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246

Query: 213 HDHLSLIFSLLGTPTDESWAESTY---------------------ISEILPLYPHFEPAN 251
            DH++ I  LLG           Y                     + ++L     F    
Sbjct: 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE 306

Query: 252 LAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            A++         D LS ML L+P++R  A   + H +L
Sbjct: 307 -AKEI-------SDFLSPMLQLDPRKRADAGGLVNHPWL 337

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  193 bits (493), Expect = 4e-59
 Identities = 61/310 (19%), Positives = 117/310 (37%), Gaps = 22/310 (7%)

Query: 1   MGKLKNLN--YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVS 58
           MG     N  +     +G G    V++ R+  TG   AIK+              +RE  
Sbjct: 1   MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFN-NISFLRPVDVQMREFE 59

Query: 59  LLKELEHENIVRLLDV--QSSRKDVFLVFEYLDL-DLHSFITRHKNTLNL--LVIKAILK 113
           +LK+L H+NIV+L  +  +++ +   L+ E+     L++ +    N   L       +L+
Sbjct: 60  VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119

Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDL---KRNTVKLADFGLARAIGVPQKEYSRDCVY 170
            ++ G+ +     I+HR++KP N++  +    ++  KL DFG AR +     E       
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE--DDEQFVSLYG 177

Query: 171 SP-YKAPELLLGYT-------GYSTPIDVWAVGCIFAEMITGKPLF-PSKKHDHLSLIFS 221
           +  Y  P++             Y   +D+W++G  F    TG   F P +       +  
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237

Query: 222 LLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITA 281
            + T            +E  P+    +          L+     +L+ +L  + ++    
Sbjct: 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF 297

Query: 282 MDALKHEYLI 291
                    I
Sbjct: 298 DQFFAETSDI 307

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  191 bits (487), Expect = 2e-58
 Identities = 42/323 (13%), Positives = 92/323 (28%), Gaps = 59/323 (18%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSY-IIREVSLLKELEHE 66
             K ++ +  G    V+  R+    +  A+K+ T+  E        +         L  E
Sbjct: 63  KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122

Query: 67  NIVRLLDVQ--------------------------SSRKDVFLVFEYLDLDLHSFITR-- 98
           +     D +                           +  +  L+     +DL    +   
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182

Query: 99  ----HKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLA 154
                +    +L +  +  Q++   A   S  ++H    P+NL I      + L D    
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIM-PDGRLMLGDVSAL 241

Query: 155 RAIGVPQKEYSRDCVYSPYKAPELLLG--YTGYSTPIDVWAVGCIFAEMITGKPLFPSKK 212
             +G                AP   L      ++  ++ W +G     +      F    
Sbjct: 242 WKVG----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG--- 294

Query: 213 HDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLC 272
                     L TP  +   +   +         F           L      L+ + L 
Sbjct: 295 ----------LVTPGIKGSWKRPSLRVPGTDSLAFGSC------TPLPDFVKTLIGRFLN 338

Query: 273 LNPKQRITAMDALKHEYLIGVEN 295
            + ++R+  ++A++    + ++N
Sbjct: 339 FDRRRRLLPLEAMETPEFLQLQN 361

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  188 bits (480), Expect = 2e-58
 Identities = 67/307 (21%), Positives = 114/307 (37%), Gaps = 59/307 (19%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHE 66
            + +++KIG+G +G V+KC   + G   AIK               +REV     L +H 
Sbjct: 12  EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71

Query: 67  NIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLL---VIKAILKQILLGLAYC 122
           ++VR     +    + +  EY +   L   I+ +   ++      +K +L Q+  GL Y 
Sbjct: 72  HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131

Query: 123 HSLKILHRDLKPNNLLID------------------LKRNTVKLADFGLARAIGVPQKEY 164
           HS+ ++H D+KP+N+ I                     +   K+ D G    I  PQ E 
Sbjct: 132 HSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVE- 190

Query: 165 SRDCVYSP-YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLL 223
                    + A E+L     +    D++A+          +PL  +             
Sbjct: 191 ----EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN------------- 233

Query: 224 GTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMD 283
                + W E       LP  P             L     +LL  M+  +P++R +AM 
Sbjct: 234 ----GDQWHE--IRQGRLPRIP-----------QVLSQEFTELLKVMIHPDPERRPSAMA 276

Query: 284 ALKHEYL 290
            +KH  L
Sbjct: 277 LVKHSVL 283

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  189 bits (482), Expect = 1e-57
 Identities = 89/333 (26%), Positives = 141/333 (42%), Gaps = 63/333 (18%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSY---IIREVSLLKELEH 65
           Y+    IG G +G+V K  + V  + VAIK++      +   ++      EV LL+ +  
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII------KNKKAFLNQAQIEVRLLELMNK 109

Query: 66  E------NIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILLG 118
                   IV L      R  + LVFE L  +L+  +       ++L + +   +Q+   
Sbjct: 110 HDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTA 169

Query: 119 LAYCHS--LKILHRDLKPNN-LLIDLKRNTVKLADFGLARAIGVPQKEY--SRDCVYSPY 173
           L +  +  L I+H DLKP N LL + KR+ +K+ DFG +  +G    +Y  SR      Y
Sbjct: 170 LLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF-----Y 224

Query: 174 KAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSK-KHDHLSLIFSLLGTPTDE--- 229
           ++PE+LLG   Y   ID+W++GCI  EM TG+PLF    + D ++ I  +LG P      
Sbjct: 225 RSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILD 283

Query: 230 -----------------------------SWAESTYISEILPLY---PHFEPANLAEKFP 257
                                            +  +  IL +    P    A  +    
Sbjct: 284 QAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTV 343

Query: 258 NLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                  DL+ +ML  +PK RI    AL+H + 
Sbjct: 344 ADYLKFKDLILRMLDYDPKTRIQPYYALQHSFF 376

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  187 bits (476), Expect = 2e-57
 Identities = 71/306 (23%), Positives = 137/306 (44%), Gaps = 37/306 (12%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y   + +G G +G V++C  T + +    K + ++   +     + +E+S+L    H N
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ---VLVKKEISILNIARHRN 62

Query: 68  IVRLLDVQSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
           I+ L +   S +++ ++FE++  LD+   I      LN   I + + Q+   L + HS  
Sbjct: 63  ILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN 122

Query: 127 ILHRDLKPNNLLIDLKRNT-VKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGYTG 184
           I H D++P N++   +R++ +K+ +FG AR +  P   + R    +P Y APE+   +  
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-PGDNF-RLLFTAPEYYAPEVHQ-HDV 179

Query: 185 YSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY--ISEILP 242
            ST  D+W++G +   +++G   F                       AE+    I  I+ 
Sbjct: 180 VSTATDMWSLGTLVYVLLSGINPF----------------------LAETNQQIIENIMN 217

Query: 243 LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILL 302
               F+     E F  +    +D + ++L    K R+TA +AL+H +L          ++
Sbjct: 218 AEYTFDE----EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVI 273

Query: 303 INRKKK 308
              K +
Sbjct: 274 RTLKHR 279

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  185 bits (472), Expect = 3e-57
 Identities = 71/291 (24%), Positives = 123/291 (42%), Gaps = 41/291 (14%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
            K   +IG G +  VYK  +T T  +VA   +  +   +        E  +LK L+H NI
Sbjct: 28  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 87

Query: 69  VRLL----DVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCH 123
           VR           +K + LV E +    L +++ R K  + + V+++  +QIL GL + H
Sbjct: 88  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH 146

Query: 124 S--LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY-KAPELLL 180
           +    I+HRDLK +N+ I     +VK+ D GLA      +  +++  + +P   APE  +
Sbjct: 147 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPE--M 201

Query: 181 GYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEI 240
               Y   +DV+A G    EM T +   P  +  + + I+  +              S +
Sbjct: 202 YEEKYDESVDVYAFGMCMLEMATSEY--PYSECQNAAQIYRRVT-------------SGV 246

Query: 241 LPLYPHFEPANLAEKFPNLE-PAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            P             F  +  P   +++   +  N  +R +  D L H + 
Sbjct: 247 KP-----------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 286

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  184 bits (470), Expect = 8e-57
 Identities = 73/288 (25%), Positives = 121/288 (42%), Gaps = 33/288 (11%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
                  +G G YG VY  R+     ++AIK +  +  +   P  +  E++L K L+H+N
Sbjct: 23  ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQP--LHEEIALHKHLKHKN 80

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLD-LHSFITRHKNTLNLL--VIKAILKQILLGLAYCHS 124
           IV+ L   S    + +  E +    L + +      L      I    KQIL GL Y H 
Sbjct: 81  IVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD 140

Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY-KAPE-LLLGY 182
            +I+HRD+K +N+LI+     +K++DFG ++ +       +     +    APE +  G 
Sbjct: 141 NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL-AGINPCTETFTGTLQYMAPEIIDKGP 199

Query: 183 TGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILP 242
            GY    D+W++GC   EM TGKP F        + +F  +G              ++ P
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKPPFYELGE-PQAAMF-KVGM------------FKVHP 245

Query: 243 LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
             P            ++       + +    +P +R  A D L  E+L
Sbjct: 246 EIP-----------ESMSAEAKAFILKCFEPDPDKRACANDLLVDEFL 282

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  186 bits (473), Expect = 9e-57
 Identities = 82/342 (23%), Positives = 116/342 (33%), Gaps = 79/342 (23%)

Query: 2   GKLKNLN--YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMT---IQTEQEGVPSYIIRE 56
           G L  L   Y     IG G YG V       T    AIK+M    I+         I  E
Sbjct: 19  GSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTE 78

Query: 57  VSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVI------- 108
           V L+K+L H NI RL +V    + + LV E      L   +    +              
Sbjct: 79  VRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQ 138

Query: 109 --------------------------------KAILKQILLGLAYCHSLKILHRDLKPNN 136
                                             I++QI   L Y H+  I HRD+KP N
Sbjct: 139 ICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPEN 198

Query: 137 LLIDLKRN-TVKLADFGLARAIGVPQKEYS---RDCVYSP-YKAPELLLGYT-GYSTPID 190
            L    ++  +KL DFGL++                  +P + APE+L      Y    D
Sbjct: 199 FLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258

Query: 191 VWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY--ISEILPLYPHFE 248
            W+ G +   ++ G   F                         +    IS++L     FE
Sbjct: 259 AWSAGVLLHLLLMGAVPF----------------------PGVNDADTISQVLNKKLCFE 296

Query: 249 PANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                  +  L P   DLLS +L  N  +R  AM AL+H ++
Sbjct: 297 N----PNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWI 334

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  184 bits (470), Expect = 9e-57
 Identities = 64/310 (20%), Positives = 126/310 (40%), Gaps = 59/310 (19%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
           +++ I+ +G GG+G V++ +N V     AIK + +   +E     ++REV  L +LEH  
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRL-PNRELAREKVMREVKALAKLEHPG 64

Query: 68  IVRLLDV------------QSSRKDVFLVFEYLD-LDLHSFITRHKNTLNL--LVIKAIL 112
           IVR  +              S +  +++  +     +L  ++            V   I 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 113 KQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP 172
            QI   + + HS  ++HRDLKP+N+      + VK+ DFGL  A+   ++E +       
Sbjct: 125 LQIAEAVEFLHSKGLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183

Query: 173 ------------YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIF 220
                       Y +PE + G   YS  +D++++G I  E++       S + + +  + 
Sbjct: 184 YARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLYP----FSTQMERVRTLT 238

Query: 221 SLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRIT 280
            +             +            P    +K+P        ++  ML  +P +R  
Sbjct: 239 DVR---------NLKF------------PPLFTQKYPCE----YVMVQDMLSPSPMERPE 273

Query: 281 AMDALKHEYL 290
           A++ +++   
Sbjct: 274 AINIIENAVF 283

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  187 bits (476), Expect = 1e-56
 Identities = 65/307 (21%), Positives = 134/307 (43%), Gaps = 36/307 (11%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y  ++++G+G +G V++C    TG+    K +      +     +  E+S++ +L H  
Sbjct: 52  YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD--KYTVKNEISIMNQLHHPK 109

Query: 68  IVRLLDVQSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
           ++ L D    + ++ L+ E+L   +L   I      ++   +   ++Q   GL + H   
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 169

Query: 127 ILHRDLKPNNLLIDLKR-NTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGYTG 184
           I+H D+KP N++ + K+ ++VK+ DFGLA  +  P +   +    +  + APE++     
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLN-PDEIV-KVTTATAEFAAPEIVD-REP 226

Query: 185 YSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY--ISEILP 242
                D+WA+G +   +++G   F                        E     +  +  
Sbjct: 227 VGFYTDMWAIGVLGYVLLSGLSPF----------------------AGEDDLETLQNVKR 264

Query: 243 LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILL 302
               F+     + F ++ P   D +  +L   P++R+T  DAL+H +L G  +     + 
Sbjct: 265 CDWEFDE----DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIP 320

Query: 303 INRKKKL 309
            +R  K+
Sbjct: 321 SSRYNKI 327

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  187 bits (478), Expect = 1e-56
 Identities = 75/292 (25%), Positives = 132/292 (45%), Gaps = 39/292 (13%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIK------MMTIQTEQEGVPSYIIREVSLLK 61
            Y   K +G+G  GEV       T +KVAI+             +      +  E+ +LK
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195

Query: 62  ELEHENIVRLLDVQSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLA 120
           +L H  I+++ +   + +D ++V E ++  +L   +  +K  L     K    Q+LL + 
Sbjct: 196 KLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKR-LKEATCKLYFYQMLLAVQ 253

Query: 121 YCHSLKILHRDLKPNNLLIDLKRN--TVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPE 177
           Y H   I+HRDLKP N+L+  +     +K+ DFG ++ +G  +    R    +P Y APE
Sbjct: 254 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLAPE 311

Query: 178 LLLG--YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAEST 235
           +L+     GY+  +D W++G I    ++G P                   P  E   + +
Sbjct: 312 VLVSVGTAGYNRAVDCWSLGVILFICLSGYP-------------------PFSEHRTQVS 352

Query: 236 YISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH 287
              +I     +F P    E +  +    +DL+ ++L ++PK R T  +AL+H
Sbjct: 353 LKDQITSGKYNFIP----EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  188 bits (479), Expect = 4e-56
 Identities = 86/311 (27%), Positives = 149/311 (47%), Gaps = 40/311 (12%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           Y+++KK+G+G YGEV  CR+ VT  + AIK++   +      S ++ EV++LK L+H NI
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98

Query: 69  VRLLDVQSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
           ++L D    +++ +LV E     +L   I       N +    I+KQ+L G+ Y H   I
Sbjct: 99  MKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMK-FNEVDAAVIIKQVLSGVTYLHKHNI 157

Query: 128 LHRDLKPNNLLIDLK--RNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGYTG 184
           +HRDLKP NLL++ K     +K+ DFGL+       ++  ++ + +  Y APE+L     
Sbjct: 158 VHRDLKPENLLLESKEKDALIKIVDFGLSAVFE--NQKKMKERLGTAYYIAPEVLRK--K 213

Query: 185 YSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLY 244
           Y    DVW++G I   ++ G P F  +    +                    + ++    
Sbjct: 214 YDEKCDVWSIGVILFILLAGYPPFGGQTDQEI--------------------LRKVEKGK 253

Query: 245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIG-------VENVP 297
             F+      ++ N+     DL+ QML  + ++RI+A  AL+H ++            +P
Sbjct: 254 YTFDS----PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELP 309

Query: 298 LVILLINRKKK 308
            +   I   +K
Sbjct: 310 SLANAIENMRK 320

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  183 bits (466), Expect = 7e-56
 Identities = 77/295 (26%), Positives = 132/295 (44%), Gaps = 45/295 (15%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIK------MMTIQTEQEGVPSYIIREVSLLK 61
            Y   K +G+G  GEV       T +KVAIK             +      +  E+ +LK
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70

Query: 62  ELEHENIVRLLDVQSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLA 120
           +L H  I+++ +   + +D ++V E ++  +L   +  +K  L     K    Q+LL + 
Sbjct: 71  KLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKR-LKEATCKLYFYQMLLAVQ 128

Query: 121 YCHSLKILHRDLKPNNLLIDLKRN--TVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPE 177
           Y H   I+HRDLKP N+L+  +     +K+ DFG ++ +G  +    R    +P Y APE
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLAPE 186

Query: 178 LLLG--YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAEST 235
           +L+     GY+  +D W++G I    ++G P F                          T
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF----------------------SEHRT 224

Query: 236 YIS---EILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH 287
            +S   +I     +F P    E +  +    +DL+ ++L ++PK R T  +AL+H
Sbjct: 225 QVSLKDQITSGKYNFIP----EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  189 bits (481), Expect = 8e-56
 Identities = 61/305 (20%), Positives = 120/305 (39%), Gaps = 36/305 (11%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           Y   +++G G +G V++     TG   A K   + T  E     + +E+  +  L H  +
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKF--VMTPHESDKETVRKEIQTMSVLRHPTL 216

Query: 69  VRLLDVQSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
           V L D      ++ +++E++   +L   +    N ++       ++Q+  GL + H    
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNY 276

Query: 128 LHRDLKPNNLLIDLKR-NTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGYTGY 185
           +H DLKP N++   KR N +KL DFGL   +    K+  +    +  + APE+       
Sbjct: 277 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLD--PKQSVKVTTGTAEFAAPEVAE-GKPV 333

Query: 186 STPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY--ISEILPL 243
               D+W+VG +   +++G   F                        E+    +  +   
Sbjct: 334 GYYTDMWSVGVLSYILLSGLSPF----------------------GGENDDETLRNVKSC 371

Query: 244 YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLI 303
             + +       F  +   G D + ++L  +P  R+T   AL+H +L           + 
Sbjct: 372 DWNMDD----SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIP 427

Query: 304 NRKKK 308
           + +  
Sbjct: 428 SSRYT 432

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  181 bits (463), Expect = 8e-56
 Identities = 88/299 (29%), Positives = 137/299 (45%), Gaps = 36/299 (12%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
           NY   +++G G +  V +C +  TG + A K++  +         + RE  + ++L+H N
Sbjct: 7   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN 66

Query: 68  IVRLLDVQSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
           IVRL D        +LVF+ +   +L   I   +   +       ++QIL  +AYCHS  
Sbjct: 67  IVRLHDSIQEESFHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNG 125

Query: 127 ILHRDLKPNNLLIDLKRN--TVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGYT 183
           I+HR+LKP NLL+  K     VKLADFGLA  +    + +      +P Y +PE+L    
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAW-HGFAGTPGYLSPEVLKK-D 182

Query: 184 GYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY--ISEIL 241
            YS P+D+WA G I   ++ G P F                      W E  +   ++I 
Sbjct: 183 PYSKPVDIWACGVILYILLVGYPPF----------------------WDEDQHRLYAQIK 220

Query: 242 PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVI 300
                +       ++  + P    L+  ML +NPK+RITA  ALK  ++   E V   I
Sbjct: 221 AGAYDYPS----PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAI 275

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  185 bits (472), Expect = 2e-55
 Identities = 84/310 (27%), Positives = 141/310 (45%), Gaps = 38/310 (12%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y+  +++G G +  V +C   + GQ+ A  ++  +         + RE  + + L+H N
Sbjct: 12  EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPN 71

Query: 68  IVRLLDVQSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
           IVRL D  S     +L+F+ +   +L   I   +   +       ++QIL  + +CH + 
Sbjct: 72  IVRLHDSISEEGHHYLIFDLVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQMG 130

Query: 127 ILHRDLKPNNLLIDLKRN--TVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGYT 183
           ++HR+LKP NLL+  K     VKLADFGLA  +   Q+ +      +P Y +PE+L    
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF-GFAGTPGYLSPEVLRK-D 188

Query: 184 GYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY--ISEIL 241
            Y  P+D+WA G I   ++ G P F                      W E  +    +I 
Sbjct: 189 PYGKPVDLWACGVILYILLVGYPPF----------------------WDEDQHRLYQQIK 226

Query: 242 PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIG---VENVPL 298
                F       ++  + P   DL+++ML +NP +RITA +ALKH ++     V +   
Sbjct: 227 AGAYDFPS----PEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMH 282

Query: 299 VILLINRKKK 308
               ++  KK
Sbjct: 283 RQETVDCLKK 292

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  182 bits (463), Expect = 6e-55
 Identities = 79/342 (23%), Positives = 134/342 (39%), Gaps = 79/342 (23%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYI---IREVSLLKEL-- 63
           +  I+K+G G +G V  C++    +  A+K++        +  Y      E  +LK++  
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV------RNIKKYTRSAKIEADILKKIQN 90

Query: 64  ---EHENIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILLGL 119
               + NIV+          + L+FE L   L+  ITR+     ++  IK    +IL  L
Sbjct: 91  DDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKAL 150

Query: 120 AYCHSLKILHRDLKPNNLLI------------------------DLKRNTVKLADFGLAR 155
            Y   + + H DLKP N+L+                          K   +KL DFG A 
Sbjct: 151 NYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA- 209

Query: 156 AIGVPQKEYSRDCVYS-----PYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPS 210
                   +  D   S      Y+APE++L   G+    D+W+ GC+ AE+ TG  LF +
Sbjct: 210 -------TFKSDYHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRT 261

Query: 211 KKH-DHLSLIFSLLGTPTDE---------------------SWAESTYISEILPLYPHFE 248
            +H +HL+++ S++                           +W E+      +       
Sbjct: 262 HEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCL 321

Query: 249 PANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           P     K         D L  +L ++P  R +  + LKH++L
Sbjct: 322 PLYKIIKHELF----CDFLYSILQIDPTLRPSPAELLKHKFL 359

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  182 bits (463), Expect = 6e-55
 Identities = 88/310 (28%), Positives = 139/310 (44%), Gaps = 39/310 (12%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
           NY   +++G G +  V +C +  TG + A K++  +         + RE  + ++L+H N
Sbjct: 30  NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN 89

Query: 68  IVRLLDVQSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
           IVRL D        +LVF+ +   +L   I   +   +       ++QIL  +AYCHS  
Sbjct: 90  IVRLHDSIQEESFHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNG 148

Query: 127 ILHRDLKPNNLLIDLKRN--TVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGYT 183
           I+HR+LKP NLL+  K     VKLADFGLA  +    + +      +P Y +PE+L    
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWH-GFAGTPGYLSPEVLKK-D 205

Query: 184 GYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAES--TYISEIL 241
            YS P+D+WA G I   ++ G P F                      W E      ++I 
Sbjct: 206 PYSKPVDIWACGVILYILLVGYPPF----------------------WDEDQHRLYAQIK 243

Query: 242 PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIG---VENVPL 298
                +       ++  + P    L+  ML +NPK+RITA  ALK  ++     V +   
Sbjct: 244 AGAYDYPS----PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIH 299

Query: 299 VILLINRKKK 308
               ++  KK
Sbjct: 300 RQDTVDCLKK 309

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  185 bits (471), Expect = 6e-55
 Identities = 88/314 (28%), Positives = 146/314 (46%), Gaps = 44/314 (14%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSY---IIREVSLLKELE 64
            YK  + +G G +GEV  C++ +TGQ+ A+K   I   Q    +    ++REV LLK+L+
Sbjct: 27  RYKGQRVLGKGSFGEVILCKDKITGQECAVK--VISKRQVKQKTDKESLLREVQLLKQLD 84

Query: 65  HENIVRLLDVQSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCH 123
           H NI++L +    +   +LV E     +L   I   K   + +    I++Q+L G+ Y H
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR-FSEVDAARIIRQVLSGITYMH 143

Query: 124 SLKILHRDLKPNNLLIDLK--RNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLL 180
             KI+HRDLKP NLL++ K     +++ DFGL+        +  +D + +  Y APE+L 
Sbjct: 144 KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--ASKKMKDKIGTAYYIAPEVLH 201

Query: 181 GYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEI 240
           G   Y    DVW+ G I   +++G P F       +                    + ++
Sbjct: 202 G--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDI--------------------LKKV 239

Query: 241 LPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVE------ 294
                 FE      ++  +  +  DL+ +ML   P  RI+A DAL HE++          
Sbjct: 240 EKGKYTFEL----PQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISV 295

Query: 295 NVPLVILLINRKKK 308
           +VP +   I   ++
Sbjct: 296 DVPSLDNAILNIRQ 309

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  179 bits (457), Expect = 6e-55
 Identities = 80/292 (27%), Positives = 139/292 (47%), Gaps = 43/292 (14%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMM----TIQTEQEGVPSYIIREVSLLKEL 63
           +Y+  +++G+G +  V KCR   TG++ A K +       + +      I REV++L+E+
Sbjct: 6   HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65

Query: 64  EHENIVRLLDVQSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYC 122
            H NI+ L D+  ++ DV L+ E +   +L  F+   K +L        LKQIL G+ Y 
Sbjct: 66  RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYL 124

Query: 123 HSLKILHRDLKPNNLLI---DLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPEL 178
           HS +I H DLKP N+++   ++    +KL DFG+A  I     E+ ++   +P + APE 
Sbjct: 125 HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE-AGNEF-KNIFGTPEFVAPE- 181

Query: 179 LLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAES---T 235
           ++ Y       D+W++G I   +++G   F                        E+   T
Sbjct: 182 IVNYEPLGLEADMWSIGVITYILLSGASPF----------------------LGETKQET 219

Query: 236 YISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH 287
             + I  +   F+     E F N      D + ++L  +PK+R+T   +L+H
Sbjct: 220 L-TNISAVNYDFDE----EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  180 bits (459), Expect = 8e-55
 Identities = 79/300 (26%), Positives = 144/300 (48%), Gaps = 41/300 (13%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMM----TIQTEQEGVPSYIIREVSLLKELE 64
           Y   +++G+G +  V KCR   TG + A K +    +  + +      I REVS+L+++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73

Query: 65  HENIVRLLDVQSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCH 123
           H N++ L DV  +R DV L+ E +   +L  F+ + K +L+     + +KQIL G+ Y H
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLH 132

Query: 124 SLKILHRDLKPNNLLI---DLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELL 179
           + KI H DLKP N+++   ++    +KL DFGLA  I     E+ ++   +P + APE +
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEF-KNIFGTPEFVAPE-I 189

Query: 180 LGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY--I 237
           + Y       D+W++G I   +++G   F                        ++    +
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPF----------------------LGDTKQETL 227

Query: 238 SEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
           + I  +   F+     E F +      D + ++L    ++R+T  +AL+H ++  V+N  
Sbjct: 228 ANITSVSYDFDE----EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQ 283

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  187 bits (477), Expect = 1e-54
 Identities = 72/308 (23%), Positives = 129/308 (41%), Gaps = 22/308 (7%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            ++  +++G GG+G V +  +  TG++VAIK    +   +        E+ ++K+L H N
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRER-WCLEIQIMKKLNHPN 73

Query: 68  IVRLLDVQSSRKDV------FLVFEYLDL-DLHSFITRHKNTLNL--LVIKAILKQILLG 118
           +V   +V    + +       L  EY +  DL  ++ + +N   L    I+ +L  I   
Sbjct: 74  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133

Query: 119 LAYCHSLKILHRDLKPNNLLIDLKRN--TVKLADFGLARAIGVPQKEYSRDCVYSP-YKA 175
           L Y H  +I+HRDLKP N+++         K+ D G A+ +   Q E   + V +  Y A
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEFVGTLQYLA 191

Query: 176 PELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAEST 235
           PELL     Y+  +D W+ G +  E ITG    P   +         +   ++E      
Sbjct: 192 PELLEQ-KKYTVTVDYWSFGTLAFECITGFR--PFLPNWQPVQWHGKVREKSNEHIVVYD 248

Query: 236 YISEILPLYPHFE-PANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVE 294
            ++  +        P +L+             L  ML  + +QR T            ++
Sbjct: 249 DLTGAVKFSSVLPTPNHLSGILAGKL---ERWLQCMLMWHQRQRGTDPQNPNVGCFQALD 305

Query: 295 NVPLVILL 302
           ++  + LL
Sbjct: 306 SILSLKLL 313

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  179 bits (456), Expect = 1e-54
 Identities = 73/285 (25%), Positives = 120/285 (42%), Gaps = 37/285 (12%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMT-IQTEQEGVPSYIIREVSLLKELEHE 66
            Y + + +G GG+ + ++  +  T +  A K++      +      +  E+S+ + L H+
Sbjct: 16  RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75

Query: 67  NIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSL 125
           ++V           VF+V E      L     R K  L     +  L+QI+LG  Y H  
Sbjct: 76  HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHRN 134

Query: 126 KILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGY 185
           +++HRDLK  NL ++     VK+ DFGLA  +    +     C    Y APE+L    G+
Sbjct: 135 RVIHRDLKLGNLFLNEDLE-VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSK-KGH 192

Query: 186 STPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY--ISEILPL 243
           S  +DVW++GCI   ++ GKP                   P + S  + TY  I +    
Sbjct: 193 SFEVDVWSIGCIMYTLLVGKP-------------------PFETSCLKETYLRIKKNEYS 233

Query: 244 YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHE 288
            P            ++ P    L+ +ML  +P  R T  + L  E
Sbjct: 234 IP-----------KHINPVAASLIQKMLQTDPTARPTINELLNDE 267

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  181 bits (460), Expect = 1e-54
 Identities = 79/307 (25%), Positives = 145/307 (47%), Gaps = 41/307 (13%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMM----TIQTEQEGVPSYIIREVSLLKELE 64
           Y   +++G+G +  V KCR   TG + A K +    +  + +      I REVS+L+++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73

Query: 65  HENIVRLLDVQSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCH 123
           H NI+ L DV  +R DV L+ E +   +L  F+ + K +L+     + +KQIL G+ Y H
Sbjct: 74  HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLH 132

Query: 124 SLKILHRDLKPNNLLI---DLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELL 179
           + KI H DLKP N+++   ++    +KL DFGLA  I     E+ ++   +P + APE +
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEF-KNIFGTPEFVAPE-I 189

Query: 180 LGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY--I 237
           + Y       D+W++G I   +++G   F                        ++    +
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPF----------------------LGDTKQETL 227

Query: 238 SEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
           + I  +   F+     E F        D + ++L    ++R+T  +AL+H ++  V+   
Sbjct: 228 ANITAVSYDFD----EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQ 283

Query: 298 LVILLIN 304
            ++   +
Sbjct: 284 AMVRRES 290

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  184 bits (469), Expect = 2e-54
 Identities = 83/324 (25%), Positives = 139/324 (42%), Gaps = 54/324 (16%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIK-----------MMTIQTEQEGVPSYIIRE 56
           +Y K++K+G+G YGEV  C+      + AIK                   E     I  E
Sbjct: 37  SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNE 96

Query: 57  VSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQI 115
           +SLLK L+H NI++L DV   +K  +LV E+ +  +L   I       +      I+KQI
Sbjct: 97  ISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK-FDECDAANIMKQI 155

Query: 116 LLGLAYCHSLKILHRDLKPNNLLIDLKRN--TVKLADFGLARAIGVPQKEYSRDCVYSP- 172
           L G+ Y H   I+HRD+KP N+L++ K +   +K+ DFGL+      +    RD + +  
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS--KDYKLRDRLGTAY 213

Query: 173 YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWA 232
           Y APE+L     Y+   DVW+ G I   ++ G P F                        
Sbjct: 214 YIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPF----------------------GG 249

Query: 233 ESTY--ISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           ++    I ++     +F+       + N+     +L+  ML  +  +R TA +AL   ++
Sbjct: 250 QNDQDIIKKVEKGKYYFDF----NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWI 305

Query: 291 IG------VENVPLVILLINRKKK 308
                     +   +   ++  +K
Sbjct: 306 KKYANNINKSDQKTLCGALSNMRK 329

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  184 bits (468), Expect = 2e-54
 Identities = 82/314 (26%), Positives = 146/314 (46%), Gaps = 44/314 (14%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y  +  +G G +GEV KC++ +T Q+ A+K++   + +    S I+REV LLK+L+H N
Sbjct: 23  RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPN 82

Query: 68  IVRLLDVQSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
           I++L ++       ++V E     +L   I + K   +      I+KQ+  G+ Y H   
Sbjct: 83  IMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR-FSEHDAARIIKQVFSGITYMHKHN 141

Query: 127 ILHRDLKPNNLLIDLK--RNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGYT 183
           I+HRDLKP N+L++ K     +K+ DFGL+      Q    +D + +  Y APE+L G  
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKMKDRIGTAYYIAPEVLRG-- 197

Query: 184 GYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY--ISEIL 241
            Y    DVW+ G I   +++G P F                      + ++ Y  +  + 
Sbjct: 198 TYDEKCDVWSAGVILYILLSGTPPF----------------------YGKNEYDILKRVE 235

Query: 242 PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIG-------VE 294
                F+      ++  +     DL+ +ML  +P  RITA   L+H ++         + 
Sbjct: 236 TGKYAFDL----PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTIS 291

Query: 295 NVPLVILLINRKKK 308
           ++P +   +   ++
Sbjct: 292 DLPSLESAMTNIRQ 305

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  179 bits (456), Expect = 2e-54
 Identities = 83/291 (28%), Positives = 141/291 (48%), Gaps = 43/291 (14%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMM----TIQTEQEGVPSYIIREVSLLKELE 64
           Y   +++G+G +  V KCR   TG + A K +    T  + +      I REVS+LKE++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72

Query: 65  HENIVRLLDVQSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCH 123
           H N++ L +V  ++ DV L+ E +   +L  F+   K +L        LKQIL G+ Y H
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLH 131

Query: 124 SLKILHRDLKPNNLLI---DLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELL 179
           SL+I H DLKP N+++   ++ +  +K+ DFGLA  I     E+ ++   +P + APE +
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-FGNEF-KNIFGTPEFVAPE-I 188

Query: 180 LGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAES---TY 236
           + Y       D+W++G I   +++G   F                        ++   T 
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASPF----------------------LGDTKQETL 226

Query: 237 ISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH 287
            + +  +   FE     E F N      D + ++L  +PK+R+T  D+L+H
Sbjct: 227 -ANVSAVNYEFED----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  179 bits (455), Expect = 5e-54
 Identities = 72/285 (25%), Positives = 119/285 (41%), Gaps = 37/285 (12%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMT-IQTEQEGVPSYIIREVSLLKELEHE 66
            Y + + +G GG+ + ++  +  T +  A K++      +      +  E+S+ + L H+
Sbjct: 42  RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 101

Query: 67  NIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSL 125
           ++V           VF+V E      L     R K  L     +  L+QI+LG  Y H  
Sbjct: 102 HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHRN 160

Query: 126 KILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGY 185
           +++HRDLK  NL ++     VK+ DFGLA  +    +     C    Y APE+L    G+
Sbjct: 161 RVIHRDLKLGNLFLNEDLE-VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSK-KGH 218

Query: 186 STPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY--ISEILPL 243
           S  +DVW++GCI   ++ GKP F +                      + TY  I +    
Sbjct: 219 SFEVDVWSIGCIMYTLLVGKPPFETSCL-------------------KETYLRIKKNEYS 259

Query: 244 YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHE 288
            P            ++ P    L+ +ML  +P  R T  + L  E
Sbjct: 260 IP-----------KHINPVAASLIQKMLQTDPTARPTINELLNDE 293

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  176 bits (450), Expect = 6e-54
 Identities = 73/285 (25%), Positives = 127/285 (44%), Gaps = 36/285 (12%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMT-IQTEQEGVPSYIIREVSLLKELEHE 66
           ++K    +G G +  VY+  +  TG +VAIKM+      + G+   +  EV +  +L+H 
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71

Query: 67  NIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSL 125
           +I+ L +       V+LV E     +++ ++       +    +  + QI+ G+ Y HS 
Sbjct: 72  SILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH 131

Query: 126 KILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGY 185
            ILHRDL  +NLL+    N +K+ADFGLA  + +P +++   C    Y +PE+    + +
Sbjct: 132 GILHRDLTLSNLLLTRNMN-IKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATR-SAH 189

Query: 186 STPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY--ISEILPL 243
               DVW++GC+F  ++ G+P                   P D    ++T   +      
Sbjct: 190 GLESDVWSLGCMFYTLLIGRP-------------------PFDTDTVKNTLNKVVLADYE 230

Query: 244 YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHE 288
            P             L     DL+ Q+L  NP  R++    L H 
Sbjct: 231 MP-----------SFLSIEAKDLIHQLLRRNPADRLSLSSVLDHP 264

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  177 bits (451), Expect = 8e-54
 Identities = 74/307 (24%), Positives = 133/307 (43%), Gaps = 37/307 (12%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            +  ++ +G+G + EV+  +  +TG+  A+K   I+       S +  E+++LK+++HEN
Sbjct: 10  TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKC--IKKSPAFRDSSLENEIAVLKKIKHEN 67

Query: 68  IVRLLDVQSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
           IV L D+  S    +LV + +   +L   I   +          +++Q+L  + Y H   
Sbjct: 68  IVTLEDIYESTTHYYLVMQLVSGGELFDRILE-RGVYTEKDASLVIQQVLSAVKYLHENG 126

Query: 127 ILHRDLKPNNLLIDLKRN--TVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGYT 183
           I+HRDLKP NLL         + + DFGL++     Q         +P Y APE+L    
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKME---QNGIMSTACGTPGYVAPEVLAQ-K 182

Query: 184 GYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPL 243
            YS  +D W++G I   ++ G P F  +    L                      +I   
Sbjct: 183 PYSKAVDCWSIGVITYILLCGYPPFYEETESKL--------------------FEKIKEG 222

Query: 244 YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVE--NVPLVIL 301
           Y  FE       + ++  +  D +  +L  +P +R T   AL H ++ G    +  +   
Sbjct: 223 YYEFES----PFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTALHRDIYPS 278

Query: 302 LINRKKK 308
           +  + +K
Sbjct: 279 VSLQIQK 285

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  177 bits (451), Expect = 9e-54
 Identities = 73/306 (23%), Positives = 118/306 (38%), Gaps = 56/306 (18%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMT----IQTEQEGVPSYIIREVSLLKEL 63
            Y+    +G GG+G V+         +VAIK++     +             EV+LL ++
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91

Query: 64  ----EHENIVRLLDVQSSRKDVFLVFEYLD--LDLHSFITRHKNTLNLLVIKAILKQILL 117
                H  ++RLLD   +++   LV E      DL  +IT     L     +    Q++ 
Sbjct: 92  GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP-LGEGPSRCFFGQVVA 150

Query: 118 GLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAP 176
            + +CHS  ++HRD+K  N+LIDL+R   KL DFG      +   E   D   +  Y  P
Sbjct: 151 AIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGA---LLHDEPYTDFDGTRVYSPP 207

Query: 177 ELLLG--YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAES 234
           E +    Y     P  VW++G +  +M+ G   F                   D+   E+
Sbjct: 208 EWISRHQYHA--LPATVWSLGILLYDMVCGDIPF----ER-------------DQEILEA 248

Query: 235 TYISEILPLYPHFEPANLAEKFPN-LEPAGVDLLSQMLCLNPKQRITAMDALKHEYL-IG 292
                                FP  + P    L+ + L   P  R +  + L   ++   
Sbjct: 249 EL------------------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290

Query: 293 VENVPL 298
            E+VPL
Sbjct: 291 AEDVPL 296

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  177 bits (450), Expect = 1e-53
 Identities = 76/300 (25%), Positives = 133/300 (44%), Gaps = 53/300 (17%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKM-------MTIQTEQEGVPSYIIREVSLL 60
           NY+  + +G G    V +C +  T ++ A+K+            E + +    ++EV +L
Sbjct: 18  NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77

Query: 61  KEL-EHENIVRLLDVQSSRKDVFLVFEYLD----LDLHSFITRHKNTLNLLVIKAILKQI 115
           +++  H NI++L D   +    FLVF+ +      D   ++T  K TL+    + I++ +
Sbjct: 78  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFD---YLTE-KVTLSEKETRKIMRAL 133

Query: 116 LLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YK 174
           L  +   H L I+HRDLKP N+L+D     +KL DFG +  +     E  R+   +P Y 
Sbjct: 134 LEVICALHKLNIVHRDLKPENILLD-DDMNIKLTDFGFSCQLD--PGEKLREVCGTPSYL 190

Query: 175 APELLLG-----YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDE 229
           APE++       + GY   +D+W+ G I   ++ G P F                     
Sbjct: 191 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF--------------------- 229

Query: 230 SWAESTY--ISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH 287
            W       +  I+     F       ++ +      DL+S+ L + P++R TA +AL H
Sbjct: 230 -WHRKQMLMLRMIMSGNYQFGS----PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  177 bits (450), Expect = 1e-53
 Identities = 69/292 (23%), Positives = 107/292 (36%), Gaps = 51/292 (17%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMM----TIQTEQEGVPSYIIREVSLLKEL 63
            Y+    +G+GG+G VY          VAIK +         +    + +  EV LLK++
Sbjct: 44  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103

Query: 64  EHE--NIVRLLDVQSSRKDVFLVFEYLDL--DLHSFITRHKNTLNLLVIKAILKQILLGL 119
                 ++RLLD         L+ E  +   DL  FIT     L   + ++   Q+L  +
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAV 162

Query: 120 AYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPEL 178
            +CH+  +LHRD+K  N+LIDL R  +KL DFG      + +     D   +  Y  PE 
Sbjct: 163 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA---LLKDTVYTDFDGTRVYSPPEW 219

Query: 179 LLG--YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY 236
           +    Y G      VW++G +  +M+ G   F                   DE       
Sbjct: 220 IRYHRYHG--RSAAVWSLGILLYDMVCGDIPF----EH-------------DEEIIRGQV 260

Query: 237 ISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHE 288
                  +              +      L+   L L P  R T  +   H 
Sbjct: 261 F------FRQR-----------VSSECQHLIRWCLALRPSDRPTFEEIQNHP 295

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  177 bits (450), Expect = 3e-53
 Identities = 78/305 (25%), Positives = 139/305 (45%), Gaps = 36/305 (11%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           ++   ++G G    VY+C+   T +  A+K++    +++ V      E+ +L  L H NI
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIV----RTEIGVLLRLSHPNI 110

Query: 69  VRLLDVQSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
           ++L ++  +  ++ LV E +   +L   I   K   +       +KQIL  +AY H   I
Sbjct: 111 IKLKEIFETPTEISLVLELVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENGI 169

Query: 128 LHRDLKPNNLLIDLKRN--TVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGYTG 184
           +HRDLKP NLL         +K+ADFGL++ +   Q    +    +P Y APE+L G   
Sbjct: 170 VHRDLKPENLLYATPAPDAPLKIADFGLSKIVE-HQVLM-KTVCGTPGYCAPEILRG-CA 226

Query: 185 YSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLY 244
           Y   +D+W+VG I   ++ G   F  ++ D    +F                   IL   
Sbjct: 227 YGPEVDMWSVGIITYILLCGFEPFYDERGDQ--FMF-----------------RRILNCE 267

Query: 245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVE-NVPLVILLI 303
            +F        +  +     DL+ +++ L+PK+R+T   AL+H ++ G   N   +    
Sbjct: 268 YYFIS----PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFVHMDTAQ 323

Query: 304 NRKKK 308
            + ++
Sbjct: 324 KKLQE 328

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  177 bits (452), Expect = 3e-53
 Identities = 83/286 (29%), Positives = 142/286 (49%), Gaps = 38/286 (13%)

Query: 11  KIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVR 70
           K + +G G +G+V+KC  T TG K+A K++  +  ++     +  E+S++ +L+H N+++
Sbjct: 93  KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD--KEEVKNEISVMNQLDHANLIQ 150

Query: 71  LLDVQSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILH 129
           L D   S+ D+ LV EY+D  +L   I      L  L     +KQI  G+ + H + ILH
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILH 210

Query: 130 RDLKPNNLL-IDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGYTGYST 187
            DLKP N+L ++     +K+ DFGLAR    P+++  +    +P + APE++  Y   S 
Sbjct: 211 LDLKPENILCVNRDAKQIKIIDFGLARRYK-PREKL-KVNFGTPEFLAPEVVN-YDFVSF 267

Query: 188 PIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAES---TYISEILPLY 244
           P D+W+VG I   +++G   F                        ++   T  + IL   
Sbjct: 268 PTDMWSVGVIAYMLLSGLSPF----------------------LGDNDAETL-NNILACR 304

Query: 245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
              E     E+F ++     + +S++L      RI+A +ALKH +L
Sbjct: 305 WDLED----EEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWL 346

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  176 bits (448), Expect = 1e-52
 Identities = 77/299 (25%), Positives = 133/299 (44%), Gaps = 52/299 (17%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIK------MMTIQTEQEGVPSYIIREVSLLK 61
            Y     IG G    V +C +  TG + A+K            + E V     RE  +L+
Sbjct: 95  KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154

Query: 62  EL-EHENIVRLLDVQSSRKDVFLVFEYLD----LDLHSFITRHKNTLNLLVIKAILKQIL 116
           ++  H +I+ L+D   S   +FLVF+ +      D   ++T  K  L+    ++I++ +L
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFD---YLTE-KVALSEKETRSIMRSLL 210

Query: 117 LGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKA 175
             +++ H+  I+HRDLKP N+L+D     ++L+DFG +  +     E  R+   +P Y A
Sbjct: 211 EAVSFLHANNIVHRDLKPENILLD-DNMQIRLSDFGFSCHLE--PGEKLRELCGTPGYLA 267

Query: 176 PELLLG-----YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDES 230
           PE+L       + GY   +D+WA G I   ++ G P F                      
Sbjct: 268 PEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPF---------------------- 305

Query: 231 WAESTY--ISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH 287
           W       +  I+     F       ++ +      DL+S++L ++P+ R+TA  AL+H
Sbjct: 306 WHRRQILMLRMIMEGQYQFSS----PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  174 bits (444), Expect = 2e-52
 Identities = 75/316 (23%), Positives = 136/316 (43%), Gaps = 43/316 (13%)

Query: 13  KKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEH-ENIVRL 71
           K++G G +  V +C +  TGQ+ A K +  +   +   + I+ E+++L+  +    ++ L
Sbjct: 35  KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94

Query: 72  LDVQSSRKDVFLVFEYLD-LDLHSFIT-RHKNTLNLLVIKAILKQILLGLAYCHSLKILH 129
            +V  +  ++ L+ EY    ++ S         ++   +  ++KQIL G+ Y H   I+H
Sbjct: 95  HEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVH 154

Query: 130 RDLKPNNLLIDLKR--NTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGYTGYS 186
            DLKP N+L+        +K+ DFG++R IG    E  R+ + +P Y APE +L Y   +
Sbjct: 155 LDLKPQNILLSSIYPLGDIKIVDFGMSRKIG-HACEL-REIMGTPEYLAPE-ILNYDPIT 211

Query: 187 TPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAES---TYISEILPL 243
           T  D+W +G I   ++T    F                        E    TY   I  +
Sbjct: 212 TATDMWNIGIIAYMLLTHTSPF----------------------VGEDNQETY-LNISQV 248

Query: 244 YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENV----PLV 299
              +      E F ++     D +  +L  NP++R TA   L H +L   +      P  
Sbjct: 249 NVDYSE----ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEE 304

Query: 300 ILLINRKKKLGVDNGW 315
               ++ +   V +  
Sbjct: 305 TSSSSQTQDHSVRSSE 320

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  175 bits (445), Expect = 2e-52
 Identities = 73/335 (21%), Positives = 141/335 (42%), Gaps = 65/335 (19%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQK-VAIKMMTIQTEQEGVPSYI---IREVSLLKELE 64
           Y+ +  +G G +G+V +C +   G+  VA+K++        V  Y      E+++LK+++
Sbjct: 21  YEIVGNLGEGTFGKVVECLDHARGKSQVALKII------RNVGKYREAARLEINVLKKIK 74

Query: 65  HE------NIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILL 117
            +        V + D  +    + + FE L  +   F+  +      L  ++ +  Q+  
Sbjct: 75  EKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCH 134

Query: 118 GLAYCHSLKILHRDLKPNNLLI------------------DLKRNTVKLADFGLARAIGV 159
            L + H  ++ H DLKP N+L                    +K  ++++ADFG A     
Sbjct: 135 ALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA----- 189

Query: 160 PQKEYSRDCVYS-----PYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH- 213
               +  +   +      Y+ PE++L   G++ P DVW++GCI  E   G  LF + ++ 
Sbjct: 190 ---TFDHEHHTTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245

Query: 214 DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKF--PNLEP---------- 261
           +HL ++  +LG         +            ++  +   ++   N +P          
Sbjct: 246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSL 305

Query: 262 ---AGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
                 DL+ +ML  +P QRIT  +AL H +  G+
Sbjct: 306 EHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGL 340

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  172 bits (439), Expect = 3e-52
 Identities = 80/286 (27%), Positives = 135/286 (47%), Gaps = 37/286 (12%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y  +  +G G +GEV KC++ +T Q+ A+K++   + +    S I+REV LLK+L+H N
Sbjct: 23  RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPN 82

Query: 68  IVRLLDVQSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
           I++L ++       ++V E     +L   I + K   +      I+KQ+  G+ Y H   
Sbjct: 83  IMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR-FSEHDAARIIKQVFSGITYMHKHN 141

Query: 127 ILHRDLKPNNLLIDLKRN--TVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGYT 183
           I+HRDLKP N+L++ K     +K+ DFGL+        +   D + +  Y APE+L G  
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMK-DRIGTAYYIAPEVLRG-- 197

Query: 184 GYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY--ISEIL 241
            Y    DVW+ G I   +++G P F                      + ++ Y  +  + 
Sbjct: 198 TYDEKCDVWSAGVILYILLSGTPPF----------------------YGKNEYDILKRVE 235

Query: 242 PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH 287
                F+      ++  +     DL+ +ML  +P  RITA   L+H
Sbjct: 236 TGKYAFDL----PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  174 bits (442), Expect = 4e-52
 Identities = 69/329 (20%), Positives = 125/329 (37%), Gaps = 44/329 (13%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMM---------------TIQTEQEGVPSY 52
           +Y+ I+ +  G + ++  C      +  A+K                   +   +     
Sbjct: 32  DYRIIRTLNQGKFNKIILCEKD--NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89

Query: 53  IIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEY--------LDLDLHSFITRHKNTLN 104
              E+ ++ ++++E  +    + ++  +V++++EY         D         +   + 
Sbjct: 90  FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149

Query: 105 LLVIKAILKQILLGLAYCHSLK-ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE 163
           + VIK I+K +L   +Y H+ K I HRD+KP+N+L+D     VKL+DFG +    +  K+
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGR-VKLSDFGESEY--MVDKK 206

Query: 164 YSRDCVYSPYKAPELLLGYTGYSTP-IDVWAVGCIFAEMITGKPLFPSKKHDHLSL---I 219
                    +  PE     + Y+   +D+W++G     M      F S K   + L   I
Sbjct: 207 IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF-SLKISLVELFNNI 265

Query: 220 FSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRI 279
            +              Y  +                   L    +D L   L  NP +RI
Sbjct: 266 RT----------KNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERI 315

Query: 280 TAMDALKHEYLIGVENVPLVILLINRKKK 308
           T+ DALKHE+L       L        KK
Sbjct: 316 TSEDALKHEWLADTNIEDLREFSKELYKK 344

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  172 bits (437), Expect = 5e-52
 Identities = 74/285 (25%), Positives = 130/285 (45%), Gaps = 39/285 (13%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTI-QTEQEGVPSYIIREVSLLKELEHE 66
           +++  + +G G +G VY  R   +   +A+K++   Q E+ GV   + REV +   L H 
Sbjct: 10  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 69

Query: 67  NIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSL 125
           NI+RL         V+L+ EY  L  ++  + +     +       + ++   L+YCHS 
Sbjct: 70  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSK 128

Query: 126 KILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGY 185
           +++HRD+KP NLL+      +K+ADFG   ++  P    +  C    Y  PE++ G   +
Sbjct: 129 RVIHRDIKPENLLLGSAGE-LKIADFGW--SVHAPSSRRTDLCGTLDYLPPEMIEG-RMH 184

Query: 186 STPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY--ISEILPL 243
              +D+W++G +  E + GKP F +  +                   + TY  IS +   
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPPFEANTY-------------------QETYKRISRVEFT 225

Query: 244 YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHE 288
           +P F           +     DL+S++L  NP QR    + L+H 
Sbjct: 226 FPDF-----------VTEGARDLISRLLKHNPSQRPMLREVLEHP 259

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  171 bits (436), Expect = 6e-52
 Identities = 79/285 (27%), Positives = 119/285 (41%), Gaps = 39/285 (13%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           Y     IG G +GEV       T  + A K   I            +E+ ++K L+H NI
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAK--KIPKYFVEDVDRFKQEIEIMKSLDHPNI 68

Query: 69  VRLLDVQSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
           +RL +      D++LV E     +L   +   +          I+K +L  +AYCH L +
Sbjct: 69  IRLYETFEDNTDIYLVMELCTGGELFERVVHKRV-FRESDAARIMKDVLSAVAYCHKLNV 127

Query: 128 LHRDLKPNNLLIDLKRN--TVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGYTG 184
            HRDLKP N L         +KL DFGLA     P K   R  V +P Y +P++L G   
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK-PGKMM-RTKVGTPYYVSPQVLEG--L 183

Query: 185 YSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY--ISEILP 242
           Y    D W+ G +   ++ G P F                       A +    + +I  
Sbjct: 184 YGPECDEWSAGVMMYVLLCGYPPF----------------------SAPTDSEVMLKIRE 221

Query: 243 LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH 287
               F      + + N+ P    L+ ++L  +PKQRIT++ AL+H
Sbjct: 222 GTFTFPE----KDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  173 bits (440), Expect = 8e-52
 Identities = 85/337 (25%), Positives = 139/337 (41%), Gaps = 75/337 (22%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQK-VAIKMMTIQTEQEGVPSYI---IREVSLLKEL- 63
           Y+ +  +G G +G+V +C +   G + VA+K++      + V  Y      E+ +L+ L 
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV------KNVDRYCEAARSEIQVLEHLN 69

Query: 64  -----EHENIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILL 117
                     V++L+       + +VFE L L  + FI  +      L  I+ +  QI  
Sbjct: 70  TTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICK 129

Query: 118 GLAYCHSLKILHRDLKPNNLLI------------------DLKRNTVKLADFGLARAIGV 159
            + + HS K+ H DLKP N+L                    L    +K+ DFG A     
Sbjct: 130 SVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA----- 184

Query: 160 PQKEYSRDCVYS-----PYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-H 213
               Y  +   +      Y+APE++L   G+S P DVW++GCI  E   G  +FP+    
Sbjct: 185 ---TYDDEHHSTLVSTRHYRAPEVILAL-GWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240

Query: 214 DHLSLIFSLLGTPTDE----------------SWAEST----YISEILPLYPHFEPANLA 253
           +HL+++  +LG                      W E +    Y+S        F  +   
Sbjct: 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDV 300

Query: 254 EKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           E          DL+ +ML  +P +RIT  +ALKH + 
Sbjct: 301 EH-----ERLFDLIQKMLEYDPAKRITLREALKHPFF 332

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  172 bits (437), Expect = 2e-51
 Identities = 79/286 (27%), Positives = 132/286 (46%), Gaps = 36/286 (12%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
           NY+ +K IG G + +V   R+ +TG++VAIK++            + REV ++K L H N
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75

Query: 68  IVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
           IV+L +V  + K ++L+ EY    ++  ++  H   +     ++  +QI+  + YCH  +
Sbjct: 76  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR-MKEKEARSKFRQIVSAVQYCHQKR 134

Query: 127 ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLG--YTG 184
           I+HRDLK  NLL+D   N +K+ADFG +        +    C   PY APEL  G  Y G
Sbjct: 135 IVHRDLKAENLLLDADMN-IKIADFGFS-NEFTVGGKLDAFCGAPPYAAPELFQGKKYDG 192

Query: 185 YSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLY 244
               +DVW++G I   +++G   F      +L  +                 +       
Sbjct: 193 --PEVDVWSLGVILYTLVSGSLPF---DGQNLKELRER--------------VLRGKYRI 233

Query: 245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           P +           +     +LL + L LNP +R T    +K  ++
Sbjct: 234 PFY-----------MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWI 268

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  170 bits (433), Expect = 2e-51
 Identities = 71/289 (24%), Positives = 125/289 (43%), Gaps = 41/289 (14%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           +   +K+G+G +G+V+      +G +  IK +     Q  +   I  E+ +LK L+H NI
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQ-IEAEIEVLKSLDHPNI 82

Query: 69  VRLLDVQSSRKDVFLVFEYLD----LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
           +++ +V     ++++V E  +    L+           L+   +  ++KQ++  LAY HS
Sbjct: 83  IKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS 142

Query: 125 LKILHRDLKPNNLLIDLKRN--TVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLG 181
             ++H+DLKP N+L         +K+ DFGLA        E+S +   +  Y APE+   
Sbjct: 143 QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK--SDEHSTNAAGTALYMAPEVFKR 200

Query: 182 YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY--ISE 239
               +   D+W+ G +   ++TG   F                         S      +
Sbjct: 201 --DVTFKCDIWSAGVVMYFLLTGCLPF----------------------TGTSLEEVQQK 236

Query: 240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHE 288
                P++       +   L P  VDLL QML  +P++R +A   L HE
Sbjct: 237 ATYKEPNYAV-----ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHE 280

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  172 bits (437), Expect = 3e-51
 Identities = 77/318 (24%), Positives = 135/318 (42%), Gaps = 47/318 (14%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVS-LLKELEHEN 67
           Y+  + IG G Y    +C +  T  + A+K+  I   +         E+  LL+  +H N
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNMEFAVKI--IDKSKRDP----TEEIEILLRYGQHPN 77

Query: 68  IVRLLDVQSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
           I+ L DV    K V++V E +   +L   I R +   +     A+L  I   + Y H+  
Sbjct: 78  IITLKDVYDDGKYVYVVTELMKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQG 136

Query: 127 ILHRDLKPNNLLIDLKRN---TVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGY 182
           ++HRDLKP+N+L   +     ++++ DFG A+ +   +        Y+  + APE+L   
Sbjct: 137 VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL-RAENGLLMTPCYTANFVAPEVLER- 194

Query: 183 TGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFS--LLGTP--TDESWAESTYIS 238
            GY    D+W++G +   M+TG   F +   D    I +    G    +   W     +S
Sbjct: 195 QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNS---VS 251

Query: 239 EILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPL 298
           +                         DL+S+ML ++P QR+TA   L+H +++  + +P 
Sbjct: 252 D----------------------TAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQ 289

Query: 299 VIL---LINRKKKLGVDN 313
             L         K  +  
Sbjct: 290 YQLNRQDAPHLVKGAMAA 307

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  168 bits (428), Expect = 4e-50
 Identities = 83/284 (29%), Positives = 134/284 (47%), Gaps = 36/284 (12%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQT-EQEGVPSYIIREVSLLKELEHE 66
            Y   + +G G +G+V    +  T QKVA+K ++ Q  ++  +   + RE+S LK L H 
Sbjct: 10  PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69

Query: 67  NIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
           +I++L DV ++  D+ +V EY   +L  +I   K  +     +   +QI+  + YCH  K
Sbjct: 70  HIIKLYDVITTPTDIVMVIEYAGGELFDYIVEKKR-MTEDEGRRFFQQIICAIEYCHRHK 128

Query: 127 ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLG--YTG 184
           I+HRDLKP NLL+D   N VK+ADFGL+  I          C    Y APE++ G  Y G
Sbjct: 129 IVHRDLKPENLLLDDNLN-VKIADFGLS-NIMTDGNFLKTSCGSPNYAAPEVINGKLYAG 186

Query: 185 YSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLY 244
               +DVW+ G +   M+ G+  F     + +  +F                ++  + + 
Sbjct: 187 --PEVDVWSCGIVLYVMLVGRLPF---DDEFIPNLFKK--------------VNSCVYVM 227

Query: 245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHE 288
           P F           L P    L+ +M+  +P QRIT  +  +  
Sbjct: 228 PDF-----------LSPGAQSLIRRMIVADPMQRITIQEIRRDP 260

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  168 bits (427), Expect = 6e-50
 Identities = 73/301 (24%), Positives = 129/301 (42%), Gaps = 36/301 (11%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHEN 67
             K K +G G +    KC +  + Q  A+K+  I    E   +   +E++ LK    H N
Sbjct: 13  DLKDKPLGEGSFSICRKCVHKKSNQAFAVKI--ISKRME---ANTQKEITALKLCEGHPN 67

Query: 68  IVRLLDVQSSRKDVFLVFEYLD----LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCH 123
           IV+L +V   +   FLV E L+     +    I + K+  +      I+++++  +++ H
Sbjct: 68  IVKLHEVFHDQLHTFLVMELLNGGELFER---IKKKKH-FSETEASYIMRKLVSAVSHMH 123

Query: 124 SLKILHRDLKPNNLLIDLKRN--TVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLL 180
            + ++HRDLKP NLL   + +   +K+ DFG AR      +       ++  Y APELL 
Sbjct: 124 DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK-TPCFTLHYAAPELLN 182

Query: 181 GYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEI 240
              GY    D+W++G I   M++G+  F S            +             + +I
Sbjct: 183 Q-NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEI-------------MKKI 228

Query: 241 LPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVI 300
                 FE     E + N+     DL+  +L ++P +R+       +E+L     +    
Sbjct: 229 KKGDFSFEG----EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNP 284

Query: 301 L 301
           L
Sbjct: 285 L 285

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  166 bits (423), Expect = 1e-49
 Identities = 62/302 (20%), Positives = 118/302 (39%), Gaps = 63/302 (20%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQT--EQEGVPSYIIREVSLLKELEH 65
            Y     +G G YG+V +  ++ T  + A+K++  +         + + +E+ LL+ L H
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65

Query: 66  ENIVRLLDV--QSSRKDVFLVFEYL---DLDLHSFITRHKNTLNLLVIKAILKQILLGLA 120
           +N+++L+DV     ++ +++V EY      ++   +   +    +        Q++ GL 
Sbjct: 66  KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR--FPVCQAHGYFCQLIDGLE 123

Query: 121 YCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRD--CVYSPYKAPEL 178
           Y HS  I+H+D+KP NLL+      +K++  G+A A+     + +         ++ PE+
Sbjct: 124 YLHSQGIVHKDIKPGNLLLTTGGT-LKISALGVAEALHPFAADDTCRTSQGSPAFQPPEI 182

Query: 179 LLGYTGYSTP-IDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYI 237
             G   +S   +D+W+ G     + TG                                 
Sbjct: 183 ANGLDTFSGFKVDIWSAGVTLYNITTGL-------------------------------- 210

Query: 238 SEILPLYPHFEPANLAE----------KFPN-LEPAGVDLLSQMLCLNPKQRITAMDALK 286
               P    FE  N+ +            P    P   DLL  ML   P +R +     +
Sbjct: 211 ---YP----FEGDNIYKLFENIGKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263

Query: 287 HE 288
           H 
Sbjct: 264 HS 265

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  167 bits (424), Expect = 2e-49
 Identities = 73/324 (22%), Positives = 131/324 (40%), Gaps = 67/324 (20%)

Query: 6   NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-E 64
            L  +  + +  GG+  VY+ ++  +G++ A+K +    E++     II+EV  +K+L  
Sbjct: 27  ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN--RAIIQEVCFMKKLSG 84

Query: 65  HENIVRLLDVQSSRKD--------VFLVFEYLDLDLHSFI--TRHKNTLNLLVIKAILKQ 114
           H NIV+     S  K+          L+ E     L  F+     +  L+   +  I  Q
Sbjct: 85  HPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQ 144

Query: 115 ILLGLAYCHSLK--ILHRDLKPNNLLIDLKRNTVKLADFGLARA-------------IGV 159
               + + H  K  I+HRDLK  NLL+   + T+KL DFG A                 +
Sbjct: 145 TCRAVQHMHRQKPPIIHRDLKVENLLLS-NQGTIKLCDFGSATTISHYPDYSWSAQRRAL 203

Query: 160 PQKEYSRDCVYSP-YKAPELLLGYTG--YSTPIDVWAVGCIFAEMITGKPLFPSKKHDHL 216
            ++E +R+   +P Y+ PE++  Y+        D+WA+GCI   +   +  F     D  
Sbjct: 204 VEEEITRNT--TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF----EDGA 257

Query: 217 SL-IFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNP 275
            L I +              Y    +P +           +         L+  ML +NP
Sbjct: 258 KLRIVN------------GKY---SIPPHDTQ--------YTVFH----SLIRAMLQVNP 290

Query: 276 KQRITAMDALKH-EYLIGVENVPL 298
           ++R++  + +   + +    NV  
Sbjct: 291 EERLSIAEVVHQLQEIAAARNVNP 314

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  166 bits (421), Expect = 4e-49
 Identities = 66/300 (22%), Positives = 124/300 (41%), Gaps = 49/300 (16%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMT------IQTEQEGVPSYIIREVSLLK 61
            Y  +  +G+G +G V+   +    ++V +K +           ++     +  E+++L 
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 62  ELEHENIVRLLDVQSSRKDVFLVFEYLD--LDLHSFITRHKNTLNLLVIKAILKQILLGL 119
            +EH NI+++LD+  ++    LV E     LDL +FI RH   L+  +   I +Q++  +
Sbjct: 85  RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR-LDEPLASYIFRQLVSAV 143

Query: 120 AYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELL 179
            Y     I+HRD+K  N++I      +KL DFG A A     K +   C    Y APE+L
Sbjct: 144 GYLRLKDIIHRDIKDENIVIAEDFT-IKLIDFGSA-AYLERGKLFYTFCGTIEYCAPEVL 201

Query: 180 LG--YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYI 237
           +G  Y G    +++W++G     ++  +  F       L                E+   
Sbjct: 202 MGNPYRG--PELEMWSLGVTLYTLVFEENPF-----CELEETV------------EAAIH 242

Query: 238 SEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
                  P+            +    + L+S +L   P++R T    +   ++    N+ 
Sbjct: 243 ------PPYL-----------VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLA 285

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  164 bits (417), Expect = 5e-49
 Identities = 73/285 (25%), Positives = 127/285 (44%), Gaps = 39/285 (13%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTI-QTEQEGVPSYIIREVSLLKELEHE 66
           ++   + +G G +G VY  R       +A+K++   Q E+EGV   + RE+ +   L H 
Sbjct: 15  DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 74

Query: 67  NIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSL 125
           NI+R+ +    RK ++L+ E+    +L+  + +H    +       ++++   L YCH  
Sbjct: 75  NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCHER 133

Query: 126 KILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGY 185
           K++HRD+KP NLL+  K   +K+ADFG   ++  P       C    Y  PE++ G   +
Sbjct: 134 KVIHRDIKPENLLMGYKGE-LKIADFGW--SVHAPSLRRRTMCGTLDYLPPEMIEG-KTH 189

Query: 186 STPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY--ISEILPL 243
              +D+W  G +  E + G P F S  H                     T+  I  +   
Sbjct: 190 DEKVDLWCAGVLCYEFLVGMPPFDSPSH-------------------TETHRRIVNVDLK 230

Query: 244 YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHE 288
           +P F           L     DL+S++L  +P QR+     ++H 
Sbjct: 231 FPPF-----------LSDGSKDLISKLLRYHPPQRLPLKGVMEHP 264

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  164 bits (417), Expect = 2e-48
 Identities = 84/305 (27%), Positives = 134/305 (43%), Gaps = 38/305 (12%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQ-EGVPSYIIREVSLLKELEHEN 67
           +  +++IG G +G VY  R+    + VAIK M+   +Q       II+EV  L++L H N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
            ++           +LV EY        +  HK  L  + I A+    L GLAY HS  +
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 175

Query: 128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY-KAPELLLGYT--G 184
           +HRD+K  N+L+      VKL DFG A          +   V +PY  APE++L      
Sbjct: 176 IHRDVKAGNILLSEPGL-VKLGDFGSA-----SIMAPANSFVGTPYWMAPEVILAMDEGQ 229

Query: 185 YSTPIDVWAVGCIFA-EMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPL 243
           Y   +DVW++G I   E+   KP  P    + +S ++ +     +ES             
Sbjct: 230 YDGKVDVWSLG-ITCIELAERKP--PLFNMNAMSALYHI---AQNES------------- 270

Query: 244 YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLI 303
            P  +  + +E F        + +   L   P+ R T+   LKH +++      +++ LI
Sbjct: 271 -PALQSGHWSEYF-------RNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLI 322

Query: 304 NRKKK 308
            R K 
Sbjct: 323 QRTKD 327

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  163 bits (415), Expect = 2e-48
 Identities = 72/295 (24%), Positives = 129/295 (43%), Gaps = 27/295 (9%)

Query: 13  KKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-HENIVRL 71
             +G G +  V  C N +T Q+ A+K+  I+ +   + S + REV +L + + H N++ L
Sbjct: 19  DVLGEGAHARVQTCINLITSQEYAVKI--IEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76

Query: 72  LDVQSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHR 130
           ++        +LVFE +    + S I + ++  N L    +++ +   L + H+  I HR
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSHIHKRRH-FNELEASVVVQDVASALDFLHNKGIAHR 135

Query: 131 DLKPNNLLIDLKRN--TVKLADFGLARAIGVPQKEYSRDC------VYSP-YKAPELLLG 181
           DLKP N+L +       VK+ DF L   I +                 S  Y APE++  
Sbjct: 136 DLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEA 195

Query: 182 Y----TGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYI 237
           +    + Y    D+W++G I   +++G P F  +                     ES   
Sbjct: 196 FSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFES--- 252

Query: 238 SEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIG 292
             I      F      + + ++  A  DL+S++L  + KQR++A   L+H ++ G
Sbjct: 253 --IQEGKYEFP----DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQG 301

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  163 bits (414), Expect = 2e-48
 Identities = 70/311 (22%), Positives = 127/311 (40%), Gaps = 60/311 (19%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMM------------------------TIQ 43
            Y    +IG G YG V    N       A+K++                           
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73

Query: 44  TEQEGVPSYIIREVSLLKELEHENIVRLLDV--QSSRKDVFLVFEYLDL-DLHSFITRHK 100
            +  G    + +E+++LK+L+H N+V+L++V    +   +++VFE ++   +    T   
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP 133

Query: 101 NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP 160
             L+    +   + ++ G+ Y H  KI+HRD+KP+NLL+    + +K+ADFG++      
Sbjct: 134 --LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGH-IKIADFGVS-NEFKG 189

Query: 161 QKEYSRDCVYSP-YKAPELLLGYT-GYSTP-IDVWAVGCIFAEMITGKPLFPSKKHDHLS 217
                 + V +P + APE L      +S   +DVWA+G      + G+  F     + + 
Sbjct: 190 SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF---MDERIM 246

Query: 218 LIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQ 277
            + S               I      +P           P++     DL+++ML  NP+ 
Sbjct: 247 CLHSK--------------IKSQALEFP---------DQPDIAEDLKDLITRMLDKNPES 283

Query: 278 RITAMDALKHE 288
           RI   +   H 
Sbjct: 284 RIVVPEIKLHP 294

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  162 bits (412), Expect = 2e-48
 Identities = 81/285 (28%), Positives = 132/285 (46%), Gaps = 37/285 (12%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMT-IQTEQEGVPSYIIREVSLLKELEHE 66
           +Y     +G G +G+V    + +TG KVA+K++   +     V   I RE+  LK   H 
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71

Query: 67  NIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSL 125
           +I++L  V S+  D F+V EY+   +L  +I +H   +  +  + + +QIL  + YCH  
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGR-VEEMEARRLFQQILSAVDYCHRH 130

Query: 126 KILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLG--YT 183
            ++HRDLKP N+L+D   N  K+ADFGL+  +    +     C    Y APE++ G  Y 
Sbjct: 131 MVVHRDLKPENVLLDAHMN-AKIADFGLS-NMMSDGEFLRTSCGSPNYAAPEVISGRLYA 188

Query: 184 GYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPL 243
           G    +D+W+ G I   ++ G   F     +H+  +F                I   +  
Sbjct: 189 G--PEVDIWSCGVILYALLCGTLPFD---DEHVPTLFKK--------------IRGGVFY 229

Query: 244 YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHE 288
            P +           L  +   LL  ML ++P +R T  D  +HE
Sbjct: 230 IPEY-----------LNRSVATLLMHMLQVDPLKRATIKDIREHE 263

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  161 bits (411), Expect = 3e-48
 Identities = 72/286 (25%), Positives = 118/286 (41%), Gaps = 35/286 (12%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
           ++  ++ +G G YGEV    N VT + VA+K++         P  I +E+ + K L HEN
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD-MKRAVDCPENIKKEICINKMLNHEN 66

Query: 68  IVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
           +V+    +      +L  EY    +L   I      +     +    Q++ G+ Y H + 
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYLHGIG 125

Query: 127 ILHRDLKPNNLLIDLKRNTVKLADFGL-ARAIGVPQKEYSRDCVYSP-YKAPELLLG--Y 182
           I HRD+KP NLL+D + N +K++DFGL        ++        +  Y APELL    +
Sbjct: 126 ITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184

Query: 183 TGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILP 242
                P+DVW+ G +   M+ G+  +                      W E         
Sbjct: 185 HA--EPVDVWSCGIVLTAMLAGELPW----DQPSDSCQEYS------DWKEKKT------ 226

Query: 243 LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHE 288
               +        +  ++ A + LL ++L  NP  RIT  D  K  
Sbjct: 227 ----YLN-----PWKKIDSAPLALLHKILVENPSARITIPDIKKDR 263

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  162 bits (412), Expect = 4e-48
 Identities = 84/307 (27%), Positives = 151/307 (49%), Gaps = 44/307 (14%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           Y + +KIG G  G VY   +  TGQ+VAI+ M +Q + +     II E+ +++E ++ NI
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNI 79

Query: 69  VRLLDVQSSRKDVFLVFEYLD----LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
           V  LD      ++++V EYL      D+       +  ++   I A+ ++ L  L + HS
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHS 134

Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY-KAPELLLGYT 183
            +++HRD+K +N+L+ +  + VKL DFG   A   P++      V +PY  APE++    
Sbjct: 135 NQVIHRDIKSDNILLGMDGS-VKLTDFGFC-AQITPEQSKRSTMVGTPYWMAPEVVTR-K 191

Query: 184 GYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIF--SLLGTPTDESWAESTYISEIL 241
            Y   +D+W++G +  EMI G+P  P    + L  ++  +  GTP  +            
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEP--PYLNENPLRALYLIATNGTPELQ------------ 237

Query: 242 PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVIL 301
                  P  L+  F        D L++ L ++ ++R +A + L+H++L   + +  +  
Sbjct: 238 ------NPEKLSAIF-------RDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSSLTP 284

Query: 302 LINRKKK 308
           LI   K+
Sbjct: 285 LIAAAKE 291

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  164 bits (417), Expect = 7e-48
 Identities = 85/313 (27%), Positives = 129/313 (41%), Gaps = 52/313 (16%)

Query: 13  KKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRL 71
           + +G G  G+V +  N  T +K A+KM  +Q   +       REV L     +  +IVR+
Sbjct: 68  QVLGLGINGKVLQIFNKRTQEKFALKM--LQDCPK-----ARREVELHWRASQCPHIVRI 120

Query: 72  LDV----QSSRKDVFLVFEYLD---LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
           +DV     + RK + +V E LD   L       R            I+K I   + Y HS
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGEL-FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 179

Query: 125 LKILHRDLKPNNLLIDLKRN--TVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLG 181
           + I HRD+KP NLL   KR    +KL DFG A+              Y+P Y APE+L  
Sbjct: 180 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-TSHNSL-TTPCYTPYYVAPEVLGP 237

Query: 182 YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLS-LIFS--LLGTPT--DESWAESTY 236
              Y    D+W++G I   ++ G P F S     +S  + +   +G     +  W+E   
Sbjct: 238 -EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE--- 293

Query: 237 ISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENV 296
           +SE                          L+  +L   P QR+T  + + H +++    V
Sbjct: 294 VSE----------------------EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 331

Query: 297 PLVILLINRKKKL 309
           P   L  +R  K 
Sbjct: 332 PQTPLHTSRVLKE 344

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  161 bits (410), Expect = 1e-47
 Identities = 72/286 (25%), Positives = 118/286 (41%), Gaps = 35/286 (12%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
           ++  ++ +G G YGEV    N VT + VA+K++         P  I +E+ + K L HEN
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD-MKRAVDCPENIKKEICINKMLNHEN 66

Query: 68  IVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
           +V+    +      +L  EY    +L   I      +     +    Q++ G+ Y H + 
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYLHGIG 125

Query: 127 ILHRDLKPNNLLIDLKRNTVKLADFGL-ARAIGVPQKEYSRDCVYSP-YKAPELLLG--Y 182
           I HRD+KP NLL+D + N +K++DFGL        ++        +  Y APELL    +
Sbjct: 126 ITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184

Query: 183 TGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILP 242
                P+DVW+ G +   M+ G+  +                      W E         
Sbjct: 185 HA--EPVDVWSCGIVLTAMLAGELPW----DQPSDSCQEYS------DWKEKKT------ 226

Query: 243 LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHE 288
               +        +  ++ A + LL ++L  NP  RIT  D  K  
Sbjct: 227 ----YLN-----PWKKIDSAPLALLHKILVENPSARITIPDIKKDR 263

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  160 bits (407), Expect = 2e-47
 Identities = 72/310 (23%), Positives = 136/310 (43%), Gaps = 43/310 (13%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           ++ + ++G G +G+VYK +N  TG   A K++  ++E+E      I E+ +L   +H  I
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE--LEDYIVEIEILATCDHPYI 78

Query: 69  VRLLDVQSSRKDVFLVFEYLD----LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
           V+LL        ++++ E+        +   +      L    I+ + +Q+L  L + HS
Sbjct: 79  VKLLGAYYHDGKLWIMIEFCPGGAVDAI---MLELDRGLTEPQIQVVCRQMLEALNFLHS 135

Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY-KAPELLLGYT 183
            +I+HRDLK  N+L+ L+   ++LADFG++ A  +   +     + +PY  APE+++  T
Sbjct: 136 KRIIHRDLKAGNVLMTLE-GDIRLADFGVS-AKNLKTLQKRDSFIGTPYWMAPEVVMCET 193

Query: 184 ----GYSTPIDVWAVGCIFA-EMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYIS 238
                Y    D+W++G I   EM   +P  P  + + + ++                   
Sbjct: 194 MKDTPYDYKADIWSLG-ITLIEMAQIEP--PHHELNPMRVLL------------------ 232

Query: 239 EILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPL 298
                    +P  L            D L   L  NP+ R +A   L+H ++  + +   
Sbjct: 233 ----KIAKSDPPTLLTP-SKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKA 287

Query: 299 VILLINRKKK 308
           +  L+   K 
Sbjct: 288 LRELVAEAKA 297

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  160 bits (408), Expect = 2e-47
 Identities = 86/311 (27%), Positives = 144/311 (46%), Gaps = 46/311 (14%)

Query: 6   NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEH 65
              +  ++K+G G YG VYK  +  TGQ VAIK + ++++       II+E+S++++ + 
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDS 83

Query: 66  ENIVRLLDVQSSRKDVFLVFEYLD----LDLHSFITRHKNTLNLLVIKAILKQILLGLAY 121
            ++V+         D+++V EY       D+   I     TL    I  IL+  L GL Y
Sbjct: 84  PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDI---IRLRNKTLTEDEIATILQSTLKGLEY 140

Query: 122 CHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY-KAPELLL 180
            H ++ +HRD+K  N+L++ + +  KLADFG+A  +           + +P+  APE++ 
Sbjct: 141 LHFMRKIHRDIKAGNILLNTEGH-AKLADFGVAGQL-TDTMAKRNTVIGTPFWMAPEVIQ 198

Query: 181 GYTGYSTPIDVWAVGCIFA-EMITGKPLFPSKKHDHLSLIF--SLLGTPTDESWAESTYI 237
              GY+   D+W++G I A EM  GKP  P      +  IF       PT          
Sbjct: 199 E-IGYNCVADIWSLG-ITAIEMAEGKP--PYADIHPMRAIFMIPTNPPPTFR-------- 246

Query: 238 SEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
                     +P   ++ F        D + Q L  +P+QR TA   L+H ++   + V 
Sbjct: 247 ----------KPELWSDNF-------TDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVS 289

Query: 298 LVILLINRKKK 308
           ++  LIN    
Sbjct: 290 ILRDLINEAMD 300

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  160 bits (406), Expect = 5e-47
 Identities = 74/309 (23%), Positives = 139/309 (44%), Gaps = 48/309 (15%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
                KIG G  G V   R   +G++VA+KMM ++ +Q      +  EV ++++ +H N+
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR--RELLFNEVVIMRDYQHFNV 104

Query: 69  VRLLDVQSSRKDVFLVFEYLD----LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
           V +       ++++++ E+L      D+       +  LN   I  + + +L  LAY H+
Sbjct: 105 VEMYKSYLVGEELWVLMEFLQGGALTDI-----VSQVRLNEEQIATVCEAVLQALAYLHA 159

Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY-KAPELLLGYT 183
             ++HRD+K +++L+ L    VKL+DFG    I        +  V +PY  APE++   +
Sbjct: 160 QGVIHRDIKSDSILLTLDGR-VKLSDFGFCAQI-SKDVPKRKSLVGTPYWMAPEVISR-S 216

Query: 184 GYSTPIDVWAVGCIFAEMITGKP----LFPSKKHDHLSLIFSLLGTPTDESWAESTYISE 239
            Y+T +D+W++G +  EM+ G+P      P +    +  +      P  +          
Sbjct: 217 LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA---MKRL-RDSPPPKLK---------- 262

Query: 240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLV 299
                       ++           D L +ML  +P++R TA + L H +L+       +
Sbjct: 263 --------NSHKVSPVL-------RDFLERMLVRDPQERATAQELLDHPFLLQTGLPECL 307

Query: 300 ILLINRKKK 308
           + LI   +K
Sbjct: 308 VPLIQLYRK 316

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  159 bits (405), Expect = 1e-46
 Identities = 72/301 (23%), Positives = 120/301 (39%), Gaps = 53/301 (17%)

Query: 13  KKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRL 71
           + +G G  G+V +C +  TGQK A+K+  +    +       +EV    +     +IV +
Sbjct: 35  QVLGLGVNGKVLECFHRRTGQKCALKL--LYDSPK-----ARQEVDHHWQASGGPHIVCI 87

Query: 72  LDV----QSSRKDVFLVFEYL---DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
           LDV       ++ + ++ E +   +L       R            I++ I   + + HS
Sbjct: 88  LDVYENMHHGKRCLLIIMECMEGGEL-FSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS 146

Query: 125 LKILHRDLKPNNLLIDLKRN--TVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLG 181
             I HRD+KP NLL   K     +KL DFG A+          +   Y+P Y APE+L  
Sbjct: 147 HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL---QTPCYTPYYVAPEVLGP 203

Query: 182 YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLS-LIFS--LLGTPT--DESWAESTY 236
              Y    D+W++G I   ++ G P F S     +S  +     LG     +  W+E   
Sbjct: 204 -EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSE--- 259

Query: 237 ISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENV 296
           +SE                          L+  +L  +P +R+T    + H ++     V
Sbjct: 260 VSE----------------------DAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVV 297

Query: 297 P 297
           P
Sbjct: 298 P 298

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  161 bits (408), Expect = 1e-46
 Identities = 91/364 (25%), Positives = 146/364 (40%), Gaps = 89/364 (24%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE---- 64
           Y  I+K+G G +  V+   +    + VA+K   +    E      + E+ LLK +     
Sbjct: 39  YHVIRKLGWGHFSTVWLSWDIQGKKFVAMK---VVKSAEHYTETALDEIRLLKSVRNSDP 95

Query: 65  ----HENIVRLLD---VQSSRKD-VFLVFEYLDLDLHSFITRHKN-TLNLLVIKAILKQI 115
                E +V+LLD   +       + +VFE L   L  +I +     L L  +K I++Q+
Sbjct: 96  NDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQV 155

Query: 116 LLGLAYCHS-LKILHRDLKPNNLLI----------------------------------- 139
           L GL Y H+  +I+H D+KP N+L+                                   
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215

Query: 140 -------------DLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYS 186
                        + ++  VK+AD G A       K ++ D     Y++ E+L+G +GY+
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNAC---WVHKHFTEDIQTRQYRSLEVLIG-SGYN 271

Query: 187 TPIDVWAVGCIFAEMITGKPLFPSKKH-------DHLSLIFSLLGTPTDESWAESTYISE 239
           TP D+W+  C+  E+ TG  LF            DH++LI  LLG    +      Y  E
Sbjct: 272 TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKE 331

Query: 240 I------------LPLYPHFEPANLAEKFPNLE-PAGVDLLSQMLCLNPKQRITAMDALK 286
                        L  +  FE      ++   E     D L  ML L P++R TA + L+
Sbjct: 332 FFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391

Query: 287 HEYL 290
           H +L
Sbjct: 392 HPWL 395

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  162 bits (411), Expect = 2e-46
 Identities = 82/296 (27%), Positives = 134/296 (45%), Gaps = 59/296 (19%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMT-IQTEQEGVPSYIIREVSLLKELEHE 66
           +Y     +G G +G+V   ++ +TG KVA+K++   +     V   I RE+  LK   H 
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76

Query: 67  NIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSL 125
           +I++L  V S+  D+F+V EY+   +L  +I ++   L+    + + +QIL G+ YCH  
Sbjct: 77  HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGR-LDEKESRRLFQQILSGVDYCHRH 135

Query: 126 KILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLG--YT 183
            ++HRDLKP N+L+D   N  K+ADFGL+  +    +     C    Y APE++ G  Y 
Sbjct: 136 MVVHRDLKPENVLLDAHMN-AKIADFGLS-NMMSDGEFLRTSCGSPNYAAPEVISGRLYA 193

Query: 184 GYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPL 243
           G    +D+W+ G I   ++ G                                    LP 
Sbjct: 194 G--PEVDIWSSGVILYALLCGT-----------------------------------LP- 215

Query: 244 YPHFEPANLAEKF-----------PNLEPAGVDLLSQMLCLNPKQRITAMDALKHE 288
              F+  ++   F             L P+ + LL  ML ++P +R T  D  +HE
Sbjct: 216 ---FDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHE 268

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  157 bits (399), Expect = 4e-46
 Identities = 70/298 (23%), Positives = 129/298 (43%), Gaps = 37/298 (12%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
           +Y+  + IG+G    V         +KVAIK + ++  Q  +   +++E+  + +  H N
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSM-DELLKEIQAMSQCHHPN 74

Query: 68  IVRLLDVQSSRKDVFLVFEYLD----LDL----HSFITRHKNTLNLLVIKAILKQILLGL 119
           IV        + +++LV + L     LD+     +        L+   I  IL+++L GL
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134

Query: 120 AYCHSLKILHRDLKPNNLLIDLKRNTVKLADFG----LARAIGVPQKEYSRDCVYSPY-K 174
            Y H    +HRD+K  N+L+  +  +V++ADFG    LA    + + +  +  V +P   
Sbjct: 135 EYLHKNGQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 193

Query: 175 APELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLL--GTPTDESWA 232
           APE++    GY    D+W+ G    E+ TG    P  K+  + ++   L    P+ E   
Sbjct: 194 APEVMEQVRGYDFKADIWSFGITAIELATGAA--PYHKYPPMKVLMLTLQNDPPSLE--- 248

Query: 233 ESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                                E       +   ++S  L  +P++R TA + L+H++ 
Sbjct: 249 ---------------TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFF 291

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  156 bits (397), Expect = 4e-45
 Identities = 63/335 (18%), Positives = 120/335 (35%), Gaps = 37/335 (11%)

Query: 9   YKKIKKIGAG--GYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHE 66
           Y+ +  IG G      V   R   TG+ V ++ + ++     + +++  E+ + K   H 
Sbjct: 27  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86

Query: 67  NIVRLLDVQSSRKDVFLVFEYLD----LDLHSFITRHKNTLNLLVIKAILKQILLGLAYC 122
           NIV       +  ++++V  ++      DL    T   + +N L I  IL+ +L  L Y 
Sbjct: 87  NIVPYRATFIADNELWVVTSFMAYGSAKDLIC--THFMDGMNELAIAYILQGVLKALDYI 144

Query: 123 HSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK------EYSRDCVYSPY-KA 175
           H +  +HR +K +++LI      V L+      ++    +      ++ +  V      +
Sbjct: 145 HHMGYVHRSVKASHILIS-VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS 203

Query: 176 PELLL-GYTGYSTPIDVWAVGCIFAEMITGKP----------LF--PSKKHDHLSLIFSL 222
           PE+L     GY    D+++VG    E+  G            L    +     L    ++
Sbjct: 204 PEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTI 263

Query: 223 LGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGV------DLLSQMLCLNPK 276
                  S + S   S +        P       P+              + Q L  NP 
Sbjct: 264 PAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPD 323

Query: 277 QRITAMDALKHEYLIGVENVPLVIL--LINRKKKL 309
            R +A   L H +   ++      L  L+     +
Sbjct: 324 ARPSASTLLNHSFFKQIKRRASEALPELLRPVTPI 358

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  154 bits (390), Expect = 9e-45
 Identities = 57/212 (26%), Positives = 100/212 (47%), Gaps = 19/212 (8%)

Query: 13  KKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLL 72
           + +G G +G+  K  +  TG+ + +K +    E+       ++EV +++ LEH N+++ +
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEET--QRTFLKEVKVMRCLEHPNVLKFI 73

Query: 73  DVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRD 131
            V    K +  + EY+    L   I    +        +  K I  G+AY HS+ I+HRD
Sbjct: 74  GVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRD 133

Query: 132 LKPNNLLIDLKRNTVKLADFGLARAI-------------GVPQKEYSRDCVYSPY-KAPE 177
           L  +N L+  +   V +ADFGLAR +               P ++     V +PY  APE
Sbjct: 134 LNSHNCLVR-ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192

Query: 178 LLLGYTGYSTPIDVWAVGCIFAEMITGKPLFP 209
           ++ G + Y   +DV++ G +  E+I      P
Sbjct: 193 MINGRS-YDEKVDVFSFGIVLCEIIGRVNADP 223

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  154 bits (391), Expect = 2e-44
 Identities = 71/291 (24%), Positives = 114/291 (39%), Gaps = 45/291 (15%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y  +K IG+G +G     R+ +T + VA+K +        +   + RE+   + L H N
Sbjct: 21  RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIE---RGAAIDENVQREIINHRSLRHPN 77

Query: 68  IVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
           IVR  +V  +   + ++ EY    +L+  I       +    +   +Q+L G++YCHS++
Sbjct: 78  IVRFKEVILTPTHLAIIMEYASGGELYERICNAGR-FSEDEARFFFQQLLSGVSYCHSMQ 136

Query: 127 ILHRDLKPNNLLIDLK-RNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLG--YT 183
           I HRDLK  N L+D      +K+ DFG +    V   +         Y APE+LL   Y 
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLRQEYD 195

Query: 184 GYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEIL-- 241
           G     DVW+ G     M+ G   F   +       +                I  IL  
Sbjct: 196 G--KIADVWSCGVTLYVMLVGAYPF---EDPEEPRDYRKT-------------IQRILSV 237

Query: 242 ----PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHE 288
               P                  P    L+S++   +P  RI+  +   H 
Sbjct: 238 KYSIPDDIRI------------SPECCHLISRIFVADPATRISIPEIKTHS 276

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  154 bits (389), Expect = 4e-44
 Identities = 42/325 (12%), Positives = 89/325 (27%), Gaps = 83/325 (25%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIRE----------- 56
              +   +G        +  +  TG+   + +              ++E           
Sbjct: 74  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133

Query: 57  ---------------VSLLKELEHENIVRLLDVQSSR--KDVFLVFEYLDLDLHSFI--- 96
                            L+K+ + + ++R+   +        F ++  +  +L +F    
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193

Query: 97  ---TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGL 153
              +    +L       +  Q++  LA  H   ++H  L+P ++++D +R  V L  F  
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD-QRGGVFLTGFEH 252

Query: 154 ARAIGVPQKEYSRDCVYSPYKAPELL----------LGYTGYSTPIDVWAVGCIFAEMIT 203
               G          V   ++ PEL              T  +   D WA+G +   +  
Sbjct: 253 LVRDG----ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308

Query: 204 GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAG 263
                     D                         I     +              P  
Sbjct: 309 ADLPI---TKDAALGGSEW-----------------IFRSCKNI-------------PQP 335

Query: 264 V-DLLSQMLCLNPKQRITAMDALKH 287
           V  LL   L    + R+  + A++ 
Sbjct: 336 VRALLEGFLRYPKEDRLLPLQAMET 360

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  153 bits (388), Expect = 5e-44
 Identities = 72/326 (22%), Positives = 131/326 (40%), Gaps = 46/326 (14%)

Query: 1   MGKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLL 60
           +G+LK+ +++KI ++GAG  G V+K  +  +G  +A K++ +   +  + + IIRE+ +L
Sbjct: 27  VGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVL 85

Query: 61  KELEHENIVRLLDVQSSRKDVFLVFEYLD---LDLHSFITRHKNTLNLLVIKAILKQILL 117
            E     IV       S  ++ +  E++D   LD    + +    +   ++  +   ++ 
Sbjct: 86  HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ---VLKKAGRIPEQILGKVSIAVIK 142

Query: 118 GLAYCHS-LKILHRDLKPNNLLIDLKRNTVKLADFGLARA---------IGVPQKEYSRD 167
           GL Y     KI+HRD+KP+N+L++ +   +KL DFG++           +G         
Sbjct: 143 GLTYLREKHKIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSMANSFVGTR------- 194

Query: 168 CVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPT 227
                Y +PE L G T YS   D+W++G    EM  G+   P      L L+F       
Sbjct: 195 ----SYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 249

Query: 228 DESWAESTYISEILPLYPHFEPANLAEKF-----------PNLEPAG-----VDLLSQML 271
                               +       F           P L          D +++ L
Sbjct: 250 AAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCL 309

Query: 272 CLNPKQRITAMDALKHEYLIGVENVP 297
             NP +R      + H ++   +   
Sbjct: 310 IKNPAERADLKQLMVHAFIKRSDAEE 335

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  151 bits (384), Expect = 7e-44
 Identities = 81/307 (26%), Positives = 141/307 (45%), Gaps = 44/307 (14%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           + K++KIG G +GEV+K  +  T + VAIK++ ++  ++ +   I +E+++L + +   +
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEI-EDIQQEITVLSQCDSPYV 82

Query: 69  VRLLDVQSSRKDVFLVFEYLD----LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
            +          ++++ EYL     LDL          L+   I  IL++IL GL Y HS
Sbjct: 83  TKYYGSYLKDTKLWIIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYLHS 137

Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY-KAPELLLGYT 183
            K +HRD+K  N+L+  +   VKLADFG+A  +    +      V +P+  APE++   +
Sbjct: 138 EKKIHRDIKAANVLLS-EHGEVKLADFGVAGQL-TDTQIKRNTFVGTPFWMAPEVIKQ-S 194

Query: 184 GYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPL 243
            Y +  D+W++G    E+  G+P  P  +   + ++F                      L
Sbjct: 195 AYDSKADIWSLGITAIELARGEP--PHSELHPMKVLF----------------------L 230

Query: 244 YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVIL-- 301
            P   P  L   +        + +   L   P  R TA + LKH++ I         L  
Sbjct: 231 IPKNNPPTLEGNYS---KPLKEFVEACLNKEPSFRPTAKELLKHKF-ILRNAKKTSYLTE 286

Query: 302 LINRKKK 308
           LI+R K+
Sbjct: 287 LIDRYKR 293

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  154 bits (389), Expect = 1e-43
 Identities = 36/318 (11%), Positives = 82/318 (25%), Gaps = 72/318 (22%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE--------------------QEG 48
             +   +G        +  +  TG+   + +                             
Sbjct: 80  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 49  VPSYIIREVSLLKE---LEHENIVRLLDVQSSRKD-----VFLVFEYLDLDLHSFI---- 96
                   +  +     ++     +++ V+   +D      F ++  +  +L +F     
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 97  --TRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLA 154
             +    +L       +  Q++  LA  H   ++H  L+P ++++D +R  V L  F   
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD-QRGGVFLTGFEHL 258

Query: 155 RAIGVPQKEYSRDCVYSP-YKAPELLLGY----TGYSTPIDVWAVGCIFAEMITGKPLFP 209
              G             P   A  +L       T  +   D W +G     +        
Sbjct: 259 VRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNT 318

Query: 210 SKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQ 269
                                       + +      F          N+      LL  
Sbjct: 319 DD--------------------------AALGGSEWIFRSC------KNIPQPVRALLEG 346

Query: 270 MLCLNPKQRITAMDALKH 287
            L    + R+  + A++ 
Sbjct: 347 FLRYPKEDRLLPLQAMET 364

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  151 bits (383), Expect = 2e-43
 Identities = 84/322 (26%), Positives = 136/322 (42%), Gaps = 57/322 (17%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHEN 67
           ++ ++ +G G YG+VYK R+  TGQ  AIK+M +  ++E     I +E+++LK+   H N
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE---EEIKQEINMLKKYSHHRN 82

Query: 68  IVRLLD------VQSSRKDVFLVFEYLD----LDLHSFITRHKNTLNLLVIKAILKQILL 117
           I                  ++LV E+       DL        NTL    I  I ++IL 
Sbjct: 83  IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK--NTKGNTLKEEWIAYICREILR 140

Query: 118 GLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRD-CVYSPY-KA 175
           GL++ H  K++HRD+K  N+L+  +   VKL DFG++  +        R+  + +PY  A
Sbjct: 141 GLSHLHQHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGR--RNTFIGTPYWMA 197

Query: 176 PELLLGYT----GYSTPIDVWAVGCIFA-EMITGKPLFPSKKHDHLSLIFSLLGTPTDES 230
           PE++         Y    D+W++G I A EM  G P  P      +  +F +   P    
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLG-ITAIEMAEGAP--PLCDMHPMRALFLIPRNPA--- 251

Query: 231 WAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                         P  +    ++KF          +   L  N  QR      +KH ++
Sbjct: 252 --------------PRLKSKKWSKKF-------QSFIESCLVKNHSQRPATEQLMKHPFI 290

Query: 291 IGVEN----VPLVILLINRKKK 308
               N       +   I+R KK
Sbjct: 291 RDQPNERQVRIQLKDHIDRTKK 312

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  148 bits (376), Expect = 8e-43
 Identities = 73/309 (23%), Positives = 114/309 (36%), Gaps = 64/309 (20%)

Query: 13  KKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRL 71
           + +G G  G+V +  N  T +K A+KM  +Q   +       REV L     +  +IVR+
Sbjct: 24  QVLGLGINGKVLQIFNKRTQEKFALKM--LQDCPK-----ARREVELHWRASQCPHIVRI 76

Query: 72  LDV----QSSRKDVFLVFEYL---DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
           +DV     + RK + +V E L   +L       R            I+K I   + Y HS
Sbjct: 77  VDVYENLYAGRKCLLIVMECLDGGEL-FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 135

Query: 125 LKILHRDLKPNNLLIDLKRN--TVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGY 182
           + I HRD+KP NLL   KR    +KL DFG                      A E     
Sbjct: 136 INIAHRDVKPENLLYTSKRPNAILKLTDFGF---------------------AKETTGE- 173

Query: 183 TGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILP 242
             Y    D+W++G I   ++ G P F S                           + I  
Sbjct: 174 -KYDKSCDMWSLGVIMYILLCGYPPFYSN----------------HGLAISPGMKTRIRM 216

Query: 243 LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIG---VENVPLV 299
               F       ++  +      L+  +L   P QR+T  + + H +++    V   PL 
Sbjct: 217 GQYEFP----NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLH 272

Query: 300 ILLINRKKK 308
              + ++ K
Sbjct: 273 TSRVLKEDK 281

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  149 bits (377), Expect = 1e-42
 Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 23/213 (10%)

Query: 13  KKIGAGGYGEVYK--CRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVR 70
           + IG G +G+VY       V     AI+++ I+ + E       REV   ++  HEN+V 
Sbjct: 39  ELIGKGRFGQVYHGRWHGEV-----AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVL 93

Query: 71  LLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILH 129
            +    S   + ++        L+S +   K  L++   + I ++I+ G+ Y H+  ILH
Sbjct: 94  FMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILH 153

Query: 130 RDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-----YKAPELLLGYTG 184
           +DLK  N+  D     V + DFGL    GV Q     D +        + APE++   + 
Sbjct: 154 KDLKSKNVFYD--NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211

Query: 185 --------YSTPIDVWAVGCIFAEMITGKPLFP 209
                   +S   DV+A+G I+ E+   +  F 
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHAREWPFK 244

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  148 bits (376), Expect = 3e-42
 Identities = 50/309 (16%), Positives = 103/309 (33%), Gaps = 59/309 (19%)

Query: 3   KLKNLNYKKIKKIGAGGYGEVYKCR-----NTVTGQKVAIKMMTIQTEQEGVPSYIIREV 57
           +L +        +G G + +VY+       +    QK  +K+       E    YI  ++
Sbjct: 61  QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWE---FYIGTQL 117

Query: 58  -SLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNT----LNLLVIKAI 111
              LK       ++       +    LV E      L + I  +KNT    +   ++ + 
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177

Query: 112 LKQILLGLAYCHSLKILHRDLKPNNLLI----------DLKRNTVKLADFGLARAIGVPQ 161
             ++L  +   H  +I+H D+KP+N ++          D     + L D G +  + +  
Sbjct: 178 AMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP 237

Query: 162 KE--YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLI 219
           K   ++  C  S ++  E+L     ++  ID + V      M+ G  +    +       
Sbjct: 238 KGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE---- 292

Query: 220 FSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRI 279
                               +    PH +  N             +    ML +     +
Sbjct: 293 ---------------CKPEGLFRRLPHLDMWN-------------EFFHVMLNIPDCHHL 324

Query: 280 TAMDALKHE 288
            ++D L+ +
Sbjct: 325 PSLDLLRQK 333

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  145 bits (369), Expect = 8e-42
 Identities = 57/233 (24%), Positives = 97/233 (41%), Gaps = 21/233 (9%)

Query: 3   KLKNLNYKKI---KKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYII----- 54
           +L  L   +I   K+IG GG+G V+K R       VAIK + +   +             
Sbjct: 12  RLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQ 71

Query: 55  REVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILK 113
           REV ++  L H NIV+L  +        +V E++   DL+  +    + +   V   ++ 
Sbjct: 72  REVFIMSNLNHPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLML 129

Query: 114 QILLGLAYCHSLK--ILHRDLKPNNLLIDLKRN----TVKLADFGLARAIGVPQKEYSRD 167
            I LG+ Y  +    I+HRDL+  N+ +           K+ADFGL++         S  
Sbjct: 130 DIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS---VHSVSGL 186

Query: 168 CVYSPYKAPELLLGYTG-YSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLI 219
                + APE +      Y+   D ++   I   ++TG+  F    +  +  I
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI 239

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  145 bits (368), Expect = 1e-41
 Identities = 54/204 (26%), Positives = 96/204 (47%), Gaps = 14/204 (6%)

Query: 13  KKIGAGGYGEVYK--CRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVR 70
           ++IG+G +G VYK      V     A+KM+ +             EV +L++  H NI+ 
Sbjct: 30  QRIGSGSFGTVYKGKWHGDV-----AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 84

Query: 71  LLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILH 129
            +   S+   + +V ++ +   L+  +   +    +  +  I +Q   G+ Y H+  I+H
Sbjct: 85  FMGY-STAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIH 143

Query: 130 RDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTG--Y 185
           RDLK NN+ +  + NTVK+ DFGLA         +  + +       APE++       Y
Sbjct: 144 RDLKSNNIFLH-EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202

Query: 186 STPIDVWAVGCIFAEMITGKPLFP 209
           S   DV+A G +  E++TG+  + 
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYS 226

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  145 bits (369), Expect = 1e-41
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 24/209 (11%)

Query: 10  KKIKKIGAGGYGEVYK--CRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
           +  + +G G +G V K   R     + VAIK +  ++E++      I E+  L  + H N
Sbjct: 11  EVEEVVGRGAFGVVCKAKWR----AKDVAIKQIESESERKAF----IVELRQLSRVNHPN 62

Query: 68  IVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNL---LVIKAILKQILLGLAYCH 123
           IV+L         V LV EY +   L++ +   +          +     Q   G+AY H
Sbjct: 63  IVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMS-WCLQCSQGVAYLH 119

Query: 124 SLK---ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLL 180
           S++   ++HRDLKP NLL+      +K+ DFG A  I   Q   + +   + + APE+  
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNNKGSAAWMAPEVFE 176

Query: 181 GYTGYSTPIDVWAVGCIFAEMITGKPLFP 209
           G + YS   DV++ G I  E+IT +  F 
Sbjct: 177 G-SNYSEKCDVFSWGIILWEVITRRKPFD 204

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  142 bits (361), Expect = 2e-40
 Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 9/202 (4%)

Query: 13  KKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLL 72
           +KIGAG +G V++      G  VA+K++  Q       +  +REV+++K L H NIV  +
Sbjct: 43  EKIGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100

Query: 73  DVQSSRKDVFLVFEYLDL-DLHSFITRH--KNTLNLLVIKAILKQILLGLAYCHSLK--I 127
              +   ++ +V EYL    L+  + +   +  L+     ++   +  G+ Y H+    I
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPI 160

Query: 128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYST 187
           +HR+LK  NLL+D K+ TVK+ DFGL+R                 + APE+L      + 
Sbjct: 161 VHRNLKSPNLLVD-KKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRD-EPSNE 218

Query: 188 PIDVWAVGCIFAEMITGKPLFP 209
             DV++ G I  E+ T +  + 
Sbjct: 219 KSDVYSFGVILWELATLQQPWG 240

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  142 bits (359), Expect = 2e-40
 Identities = 61/207 (29%), Positives = 108/207 (52%), Gaps = 20/207 (9%)

Query: 10  KKIKKIGAGGYGEVYKCR----NTVTGQKVAIKMMTIQTEQEGVPSYI---IREVSLLKE 62
           K ++++G G +G V  CR       TG+ VA+K +     Q     ++    RE+ +LK 
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-----QHSTEEHLRDFEREIEILKS 67

Query: 63  LEHENIVRLLDV--QSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGL 119
           L+H+NIV+   V   + R+++ L+ EYL    L  ++ +HK  ++ + +     QI  G+
Sbjct: 68  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127

Query: 120 AYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY-SRDCVYSPYK--AP 176
            Y  + + +HRDL   N+L++   N VK+ DFGL + +   ++ +  ++   SP    AP
Sbjct: 128 EYLGTKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAP 186

Query: 177 ELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           E L   + +S   DVW+ G +  E+ T
Sbjct: 187 ESLT-ESKFSVASDVWSFGVVLYELFT 212

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  140 bits (355), Expect = 6e-40
 Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 24/212 (11%)

Query: 13  KKIGAGGYGEVYK--CRNTVTGQKVAIKMMTIQTEQEGVPSY--IIREVSLLKELEHENI 68
           + IG GG+G+VY+        G +VA+K      +++   +   + +E  L   L+H NI
Sbjct: 13  EIIGIGGFGKVYRAFWI----GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNI 68

Query: 69  VRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK- 126
           + L  V     ++ LV E+     L+  +      +   ++     QI  G+ Y H    
Sbjct: 69  IALRGVCLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQIARGMNYLHDEAI 126

Query: 127 --ILHRDLKPNNLLID-------LKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPE 177
             I+HRDLK +N+LI        L    +K+ DFGLAR     +           + APE
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH--RTTKMSAAGAYAWMAPE 184

Query: 178 LLLGYTGYSTPIDVWAVGCIFAEMITGKPLFP 209
           ++     +S   DVW+ G +  E++TG+  F 
Sbjct: 185 VIRASM-FSKGSDVWSYGVLLWELLTGEVPFR 215

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  141 bits (358), Expect = 7e-40
 Identities = 62/207 (29%), Positives = 108/207 (52%), Gaps = 20/207 (9%)

Query: 10  KKIKKIGAGGYGEVYKCR----NTVTGQKVAIKMMTIQTEQEGVPSYI---IREVSLLKE 62
           K ++++G G +G V  CR       TG+ VA+K +     Q     ++    RE+ +LK 
Sbjct: 44  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-----QHSTEEHLRDFEREIEILKS 98

Query: 63  LEHENIVRLLDV--QSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGL 119
           L+H+NIV+   V   + R+++ L+ EYL    L  ++ +HK  ++ + +     QI  G+
Sbjct: 99  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 158

Query: 120 AYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY-SRDCVYSPYK--AP 176
            Y  + + +HRDL   N+L++   N VK+ DFGL + +   ++ Y  ++   SP    AP
Sbjct: 159 EYLGTKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAP 217

Query: 177 ELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           E L   + +S   DVW+ G +  E+ T
Sbjct: 218 ESLT-ESKFSVASDVWSFGVVLYELFT 243

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  140 bits (355), Expect = 1e-39
 Identities = 70/306 (22%), Positives = 120/306 (39%), Gaps = 58/306 (18%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVS-LLKELEHEN 67
            + I ++G G YG V K R+  +GQ +A+K +   T        ++ ++   ++ ++   
Sbjct: 9   LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRA-TVNSQEQKRLLMDLDISMRTVDCPF 67

Query: 68  IVRLLDVQSSRKDVFLVFEYLD---LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
            V          DV++  E +D      +  +     T+   ++  I   I+  L + HS
Sbjct: 68  TVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS 127

Query: 125 -LKILHRDLKPNNLLIDLKRNTVKLADFG--------LARA--IGVPQKEYSRDCVYSPY 173
            L ++HRD+KP+N+LI+     VK+ DFG        +A+    G             PY
Sbjct: 128 KLSVIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGCK-----------PY 175

Query: 174 KAPELLLGY---TGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDES 230
            APE +       GYS   D+W++G    E+   +  + S         F  L       
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT-----PFQQL------- 223

Query: 231 WAESTYISEILPLYPHFEPANL-AEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEY 289
                 +              L A+KF       VD  SQ L  N K+R T  + ++H +
Sbjct: 224 ----KQV-------VEEPSPQLPADKFS---AEFVDFTSQCLKKNSKERPTYPELMQHPF 269

Query: 290 LIGVEN 295
               E+
Sbjct: 270 FTLHES 275

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  140 bits (356), Expect = 1e-39
 Identities = 63/305 (20%), Positives = 116/305 (38%), Gaps = 53/305 (17%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVS-LLKELEHEN 67
            + + ++G+G  G+V+K R   TG  +A+K M   +  +     I+ ++  +LK  +   
Sbjct: 27  LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRR-SGNKEENKRILMDLDVVLKSHDCPY 85

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS-LK 126
           IV+      +  DVF+  E +         R +  +   ++  +   I+  L Y      
Sbjct: 86  IVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG 145

Query: 127 ILHRDLKPNNLLIDLKRNTVKLADFGLA----------RAIGVPQKEYSRDCVYSPYKAP 176
           ++HRD+KP+N+L+D +R  +KL DFG++          R+ G              Y AP
Sbjct: 146 VIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCA-----------AYMAP 193

Query: 177 E----LLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWA 232
           E           Y    DVW++G    E+ TG+  + +         F +L         
Sbjct: 194 ERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN-----CKTDFEVL--------- 239

Query: 233 ESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIG 292
             T +          EP  L              +   L  + ++R      L+H ++  
Sbjct: 240 --TKV-------LQEEPPLLPGH-MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289

Query: 293 VENVP 297
            E + 
Sbjct: 290 YETLE 294

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  140 bits (354), Expect = 1e-39
 Identities = 69/214 (32%), Positives = 113/214 (52%), Gaps = 12/214 (5%)

Query: 1   MGKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYI---IREV 57
           +GK+ N  YK + K+G GG   VY   +T+   KVAIK + I   ++     +    REV
Sbjct: 5   IGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREK--EETLKRFEREV 62

Query: 58  SLLKELEHENIVRLLDVQSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQIL 116
               +L H+NIV ++DV       +LV EY++   L  +I  H   L++        QIL
Sbjct: 63  HNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQIL 121

Query: 117 LGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKA 175
            G+ + H ++I+HRD+KP N+LID    T+K+ DFG+A+A+       +   + +  Y +
Sbjct: 122 DGIKHAHDMRIVHRDIKPQNILID-SNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFS 180

Query: 176 PELLLGYTGYSTP-IDVWAVGCIFAEMITGKPLF 208
           PE   G    +    D++++G +  EM+ G+P F
Sbjct: 181 PEQAKG--EATDECTDIYSIGIVLYEMLVGEPPF 212

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  140 bits (356), Expect = 1e-39
 Identities = 67/204 (32%), Positives = 98/204 (48%), Gaps = 14/204 (6%)

Query: 10  KKIKKIGAGGYGEVYKCR----NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEH 65
           K I ++G G +G V  CR       TG  VA+K +  Q           RE+ +LK L  
Sbjct: 26  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL--QHSGPDQQRDFQREIQILKALHS 83

Query: 66  ENIVRLLDV--QSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYC 122
           + IV+   V     R+ + LV EYL    L  F+ RH+  L+   +     QI  G+ Y 
Sbjct: 84  DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL 143

Query: 123 HSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY-SRDCVYSPYK--APELL 179
            S + +HRDL   N+L++     VK+ADFGLA+ + + +  Y  R+   SP    APE L
Sbjct: 144 GSRRCVHRDLAARNILVE-SEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL 202

Query: 180 LGYTGYSTPIDVWAVGCIFAEMIT 203
                +S   DVW+ G +  E+ T
Sbjct: 203 S-DNIFSRQSDVWSFGVVLYELFT 225

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  138 bits (351), Expect = 7e-39
 Identities = 69/309 (22%), Positives = 126/309 (40%), Gaps = 54/309 (17%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVS-LLKELEHE 66
           + K + +IG G YG V K  +  +GQ +A+K +   T  E     ++ ++  +++  +  
Sbjct: 23  DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRS-TVDEKEQKQLLMDLDVVMRSSDCP 81

Query: 67  NIVRLLDVQSSRKDVFLVFEY----LDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYC 122
            IV+         D ++  E      D       +   + +   ++  I    +  L + 
Sbjct: 82  YIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHL 141

Query: 123 HS-LKILHRDLKPNNLLIDLKRNTVKLADFG--------LARA--IGVPQKEYSRDCVYS 171
              LKI+HRD+KP+N+L+D   N +KL DFG        +A+    G             
Sbjct: 142 KENLKIIHRDIKPSNILLDRSGN-IKLCDFGISGQLVDSIAKTRDAGCR----------- 189

Query: 172 PYKAPELLLGYT---GYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTD 228
           PY APE +       GY    DVW++G    E+ TG+  FP   +   + +F  L     
Sbjct: 190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR--FP---YPKWNSVFDQL----- 239

Query: 229 ESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHE 288
                 T + +  P  P     +   +F    P+ ++ ++  L  +  +R    + LKH 
Sbjct: 240 ------TQVVKGDP--PQL-SNSEEREFS---PSFINFVNLCLTKDESKRPKYKELLKHP 287

Query: 289 YLIGVENVP 297
           +++  E   
Sbjct: 288 FILMYEERA 296

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  144 bits (364), Expect = 9e-39
 Identities = 55/232 (23%), Positives = 95/232 (40%), Gaps = 33/232 (14%)

Query: 9   YKKIKKIGAGGYGEVYKCRNT-VTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
           Y+    I  GG G +Y   +  V G+ V +K +    + E   +  + E   L E+ H +
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQ-AMAMAERQFLAEVVHPS 140

Query: 68  IVRLLDV-----QSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAY 121
           IV++ +      +      ++V EY+    L     +    L +    A L +IL  L+Y
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSY 197

Query: 122 CHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAI-------GVPQKEYSRDCVYSPYK 174
            HS+ +++ DLKP N+++      +KL D G    I       G P            ++
Sbjct: 198 LHSIGLVYNDLKPENIMLT--EEQLKLIDLGAVSRINSFGYLYGTPG-----------FQ 244

Query: 175 APELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTP 226
           APE++    G +   D++ VG   A +    P    +  D L     +L T 
Sbjct: 245 APEIVRT--GPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTY 294

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  138 bits (350), Expect = 9e-39
 Identities = 53/303 (17%), Positives = 109/303 (35%), Gaps = 47/303 (15%)

Query: 4   LKNLNYKKI-KKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKE 62
           L  L +  I +   A       K +  +    +  +                 ++  +  
Sbjct: 58  LAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDP 117

Query: 63  LEHENIVRLLDVQSSRKDVFLVFEYLD-LDLHSFITRHKNTLNL--LVIKAILKQILLGL 119
              +N V  L   S +  +++  +     +L  ++ R  +  +    V   I  QI   +
Sbjct: 118 FSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAV 177

Query: 120 AYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP------- 172
            + HS  ++HRDLKP+N+      + VK+ DFGL  A+   ++E +              
Sbjct: 178 EFLHSKGLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQ 236

Query: 173 -----YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPT 227
                Y +PE + G   YS  +D++++G I  E++       S + + + +I  +     
Sbjct: 237 VGTKLYMSPEQIHG-NNYSHKVDIFSLGLILFELLYS----FSTQMERVRIITDVR---- 287

Query: 228 DESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH 287
                   +            P    +K+P        ++  ML  +P +R  A D +++
Sbjct: 288 -----NLKF------------PLLFTQKYPQE----HMMVQDMLSPSPTERPEATDIIEN 326

Query: 288 EYL 290
              
Sbjct: 327 AIF 329

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  138 bits (349), Expect = 9e-39
 Identities = 62/204 (30%), Positives = 108/204 (52%), Gaps = 13/204 (6%)

Query: 10  KKIKKIGAGGYGEVYKCR----NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEH 65
           K+I+ +G G +G+V  CR       TG++VA+K +  ++      + + +E+ +L+ L H
Sbjct: 24  KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN-HIADLKKEIEILRNLYH 82

Query: 66  ENIVRLLDV--QSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYC 122
           ENIV+   +  +     + L+ E+L    L  ++ ++KN +NL        QI  G+ Y 
Sbjct: 83  ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL 142

Query: 123 HSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY-SRDCVYSPYK--APELL 179
            S + +HRDL   N+L++   + VK+ DFGL +AI   ++ Y  +D   SP    APE L
Sbjct: 143 GSRQYVHRDLAARNVLVE-SEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECL 201

Query: 180 LGYTGYSTPIDVWAVGCIFAEMIT 203
           +  + +    DVW+ G    E++T
Sbjct: 202 M-QSKFYIASDVWSFGVTLHELLT 224

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  135 bits (341), Expect = 5e-38
 Identities = 36/219 (16%), Positives = 86/219 (39%), Gaps = 25/219 (11%)

Query: 5   KNLNYKKI---KKIGAGGYGEVYK--CRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSL 59
             +++K++    K+     GE++K   +    G  + +K++ ++            E   
Sbjct: 5   SGIDFKQLNFLTKLNENHSGELWKGRWQ----GNDIVVKVLKVRDWSTRKSRDFNEECPR 60

Query: 60  LKELEHENIVRLLDV--QSSRKDVFLVFEYLDL-DLHSFITRHKN-TLNLLVIKAILKQI 115
           L+   H N++ +L            L+  ++    L++ +    N  ++          +
Sbjct: 61  LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120

Query: 116 LLGLAYCHSLK--ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP- 172
             G+A+ H+L+  I    L   +++ID +  T +++   +  +        S   +Y+P 
Sbjct: 121 ARGMAFLHTLEPLIPRHALNSRSVMID-EDMTARISMADVKFS------FQSPGRMYAPA 173

Query: 173 YKAPELLLG--YTGYSTPIDVWAVGCIFAEMITGKPLFP 209
           + APE L            D+W+   +  E++T +  F 
Sbjct: 174 WVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFA 212

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  134 bits (340), Expect = 2e-37
 Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 12/207 (5%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYI---IREVSLLKELEH 65
           Y+  + +G GG G+VY+  +TV  + VA+K+M+     +  P +     RE      L+ 
Sbjct: 36  YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSD--PVFRTRMQREARTAGRLQE 93

Query: 66  ENIVRLLDVQSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
            ++V + D       +++    ++ +DL + + R    L      AI++QI   L   H+
Sbjct: 94  PHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHA 152

Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGYT 183
               HRD+KP N+L+    +   L DFG+A A    +     + V +  Y APE      
Sbjct: 153 AGATHRDVKPENILVS-ADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSE-- 209

Query: 184 GYSTP-IDVWAVGCIFAEMITGKPLFP 209
            ++T   D++A+ C+  E +TG P + 
Sbjct: 210 SHATYRADIYALTCVLYECLTGSPPYQ 236

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  134 bits (339), Expect = 3e-37
 Identities = 66/204 (32%), Positives = 101/204 (49%), Gaps = 15/204 (7%)

Query: 10  KKIKKIGAGGYGEVYKCR----NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEH 65
           KKI+ +G G +G+V        N  TG+ VA+K +          S   +E+ +L+ L H
Sbjct: 34  KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK-ADAGPQHRSGWKQEIDILRTLYH 92

Query: 66  ENIVRLLDV--QSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYC 122
           E+I++       +    + LV EY+ L  L  ++ RH   L  L++ A   QI  G+AY 
Sbjct: 93  EHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQ--QICEGMAYL 150

Query: 123 HSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY-SRDCVYSPYK--APELL 179
           H+   +HRDL   N+L+D     VK+ DFGLA+A+    + Y  R+   SP    APE L
Sbjct: 151 HAQHYIHRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 209

Query: 180 LGYTGYSTPIDVWAVGCIFAEMIT 203
                +    DVW+ G    E++T
Sbjct: 210 K-EYKFYYASDVWSFGVTLYELLT 232

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  131 bits (333), Expect = 2e-36
 Identities = 59/223 (26%), Positives = 96/223 (43%), Gaps = 40/223 (17%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYI---IREVSLLKELEH 65
           Y+  + +G GG  EV+  R+    + VA+K++  + +    PS+     RE      L H
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVL--RADLARDPSFYLRFRREAQNAAALNH 71

Query: 66  ENIVRLLDV----QSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLA 120
             IV + D       +    ++V EY+D + L   +      +       ++      L 
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALN 130

Query: 121 YCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARA--------------IGVPQKEYSR 166
           + H   I+HRD+KP N++I    N VK+ DFG+ARA              IG  Q     
Sbjct: 131 FSHQNGIIHRDVKPANIMIS-ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ----- 184

Query: 167 DCVYSPYKAPELLLGYTGYSTP-IDVWAVGCIFAEMITGKPLF 208
                 Y +PE   G         DV+++GC+  E++TG+P F
Sbjct: 185 ------YLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPF 219

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  131 bits (332), Expect = 4e-36
 Identities = 60/201 (29%), Positives = 100/201 (49%), Gaps = 11/201 (5%)

Query: 10  KKIKKIGAGGYGEVYKCRNTVTGQK----VAIKMMTIQTEQEGVPSYIIREVSLLKELEH 65
           KKIK +G+G +G VYK      G+K    VAIK +   T  +     I+ E  ++  +++
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-ANKEILDEAYVMASVDN 76

Query: 66  ENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
            ++ RLL +      V L+ + +    L  ++  HK+ +    +     QI  G+ Y   
Sbjct: 77  PHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 135

Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGY 182
            +++HRDL   N+L+      VK+ DFGLA+ +G  +KEY  +    P K  A E +L +
Sbjct: 136 RRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL-H 193

Query: 183 TGYSTPIDVWAVGCIFAEMIT 203
             Y+   DVW+ G    E++T
Sbjct: 194 RIYTHQSDVWSYGVTVWELMT 214

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  128 bits (325), Expect = 2e-35
 Identities = 59/202 (29%), Positives = 93/202 (46%), Gaps = 11/202 (5%)

Query: 10  KKIKKIGAGGYGEVYKCR-NTVTGQ--KVAIKMM-TIQTEQEGVPSYIIREVSLLKELEH 65
           + ++K+G G +G V +   +  +G+   VA+K +      Q       IREV+ +  L+H
Sbjct: 21  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80

Query: 66  ENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
            N++RL  V      + +V E   L  L   + +H+    L  +     Q+  G+ Y  S
Sbjct: 81  RNLIRLYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 139

Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY-SRDCVYSPYK--APELLLG 181
            + +HRDL   NLL+   R+ VK+ DFGL RA+      Y  ++    P+   APE L  
Sbjct: 140 KRFIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK- 197

Query: 182 YTGYSTPIDVWAVGCIFAEMIT 203
              +S   D W  G    EM T
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFT 219

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  129 bits (326), Expect = 4e-35
 Identities = 70/302 (23%), Positives = 118/302 (39%), Gaps = 42/302 (13%)

Query: 10  KKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYII-REVSLLKELEHENI 68
           + +K+IG G YGEV+       G+KVA+K+     E     S+    E+     + HENI
Sbjct: 40  QMVKQIGKGRYGEVWMG--KWRGEKVAVKVFFTTEEA----SWFRETEIYQTVLMRHENI 93

Query: 69  VRLL----DVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCH 123
           +  +        S   ++L+ +Y +   L+ ++     TL+   +  +    + GL + H
Sbjct: 94  LGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSVSGLCHLH 151

Query: 124 SL--------KILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP--- 172
           +          I HRDLK  N+L+  K  T  +AD GLA            D   +    
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVKF--ISDTNEVDIPPNTRVG 208

Query: 173 ---YKAPELLLGYTG-----YSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLG 224
              Y  PE+L               D+++ G I  E+            +   L +  L 
Sbjct: 209 TKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCV--SGGIVEEYQLPYHDL- 265

Query: 225 TPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDA 284
            P+D S+ +   I  I  L P F     +++          L+++    NP  R+TA+  
Sbjct: 266 VPSDPSYEDMREIVCIKKLRPSFPNRWSSDECL---RQMGKLMTECWAHNPASRLTALRV 322

Query: 285 LK 286
            K
Sbjct: 323 KK 324

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  128 bits (324), Expect = 6e-35
 Identities = 62/303 (20%), Positives = 121/303 (39%), Gaps = 38/303 (12%)

Query: 7   LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHE 66
           +  + ++    G +G V+K    +  + VA+K+  IQ +Q         EV  L  ++HE
Sbjct: 24  MPLQLLEVKARGRFGCVWKA--QLLNEYVAVKIFPIQDKQS---WQNEYEVYSLPGMKHE 78

Query: 67  NIVRLL--DVQSSRKDV--FLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAY 121
           NI++ +  + + +  DV  +L+  + +   L  F+    N ++   +  I + +  GLAY
Sbjct: 79  NILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIAETMARGLAY 136

Query: 122 CHS----------LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVY- 170
            H             I HRD+K  N+L+     T  +ADFGLA      +          
Sbjct: 137 LHEDIPGLKDGHKPAISHRDIKSKNVLLK-NNLTACIADFGLALKFEAGKSAGDTHGQVG 195

Query: 171 -SPYKAPELLLGYTGYSTP----IDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGT 225
              Y APE+L G   +       ID++A+G +  E+ +          +++      +G 
Sbjct: 196 TRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ 255

Query: 226 -PTDESWAESTYISEILP-LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMD 283
            P+ E   E     +  P L  +++                + + +    + + R++A  
Sbjct: 256 HPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAML-------CETIEECWDHDAEARLSAGC 308

Query: 284 ALK 286
             +
Sbjct: 309 VGE 311

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  127 bits (320), Expect = 1e-34
 Identities = 55/223 (24%), Positives = 95/223 (42%), Gaps = 42/223 (18%)

Query: 10  KKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYII-REVSLLKELEHENI 68
             ++ +G G YGEV++   +  G+ VA+K+ + + E+    S+    E+     L HENI
Sbjct: 11  TLLECVGKGRYGEVWRG--SWQGENVAVKIFSSRDEK----SWFRETELYNTVMLRHENI 64

Query: 69  VRLL----DVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCH 123
           +  +      + S   ++L+  Y ++  L+ ++     TL+ +    I+  I  GLA+ H
Sbjct: 65  LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLH 122

Query: 124 SL--------KILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP--- 172
                      I HRDLK  N+L+  K     +AD GLA          S + +      
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVK-KNGQCCIADLGLAV-----MHSQSTNQLDVGNNP 176

Query: 173 ------YKAPELL-----LGYTGYSTPIDVWAVGCIFAEMITG 204
                 Y APE+L     +        +D+WA G +  E+   
Sbjct: 177 RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  127 bits (322), Expect = 3e-34
 Identities = 65/290 (22%), Positives = 122/290 (42%), Gaps = 39/290 (13%)

Query: 12  IKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQT--EQEGVPSYIIREVSLLKELEHENIV 69
           ++ IG G +G+V   +   T +  A+K M  Q   E+  V   + +E+ +++ LEH  +V
Sbjct: 20  LRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEV-RNVFKELQIMQGLEHPFLV 78

Query: 70  RLLDVQSSRKDVFLVFEYL---DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
            L       +D+F+V + L   DL  H    +         +K  + ++++ L Y  + +
Sbjct: 79  NLWYSFQDEEDMFMVVDLLLGGDLRYH---LQQNVHFKEETVKLFICELVMALDYLQNQR 135

Query: 127 ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLL--GYTG 184
           I+HRD+KP+N+L+D   + V + DF +A  +    +  +      PY APE+       G
Sbjct: 136 IIHRDMKPDNILLDEHGH-VHITDFNIAAMLPRETQITTM-AGTKPYMAPEMFSSRKGAG 193

Query: 185 YSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLY 244
           YS  +D W++G    E++ G+  +  +       I                         
Sbjct: 194 YSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT-----------------FETTV 236

Query: 245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK-HEYLIGV 293
             + P              V LL ++L  NP QR + +  ++   Y+  +
Sbjct: 237 VTY-P-------SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  126 bits (319), Expect = 3e-34
 Identities = 53/201 (26%), Positives = 98/201 (48%), Gaps = 11/201 (5%)

Query: 10  KKIKKIGAGGYGEVYKCRNTVTGQ----KVAIKMMTIQTEQEGVPSYIIREVSLLKELEH 65
           +K+K +G+G +G V+K      G+     V IK++  ++ ++     +   +  +  L+H
Sbjct: 16  RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQ-SFQAVTDHMLAIGSLDH 74

Query: 66  ENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
            +IVRLL +      + LV +YL L  L   + +H+  L   ++     QI  G+ Y   
Sbjct: 75  AHIVRLLGL-CPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE 133

Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGY 182
             ++HR+L   N+L+    + V++ADFG+A  +    K+       +P K  A E +  +
Sbjct: 134 HGMVHRNLAARNVLLK-SPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH-F 191

Query: 183 TGYSTPIDVWAVGCIFAEMIT 203
             Y+   DVW+ G    E++T
Sbjct: 192 GKYTHQSDVWSYGVTVWELMT 212

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  126 bits (320), Expect = 5e-34
 Identities = 55/195 (28%), Positives = 93/195 (47%), Gaps = 6/195 (3%)

Query: 12  IKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRL 71
            ++IG G +GEV+  R       VA+K        +      ++E  +LK+  H NIVRL
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK-FLQEARILKQYSHPNIVRL 177

Query: 72  LDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHR 130
           + V + ++ +++V E +   D  +F+      L +  +  ++     G+ Y  S   +HR
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHR 237

Query: 131 DLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYSTP 188
           DL   N L+  ++N +K++DFG++R         S      P K  APE L  Y  YS+ 
Sbjct: 238 DLAARNCLVT-EKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALN-YGRYSSE 295

Query: 189 IDVWAVGCIFAEMIT 203
            DVW+ G +  E  +
Sbjct: 296 SDVWSFGILLWETFS 310

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  125 bits (317), Expect = 6e-34
 Identities = 60/201 (29%), Positives = 100/201 (49%), Gaps = 11/201 (5%)

Query: 10  KKIKKIGAGGYGEVYKCRNTVTGQK----VAIKMMTIQTEQEGVPSYIIREVSLLKELEH 65
           KKIK +G+G +G VYK      G+K    VAIK +   T  +     I+ E  ++  +++
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-ANKEILDEAYVMASVDN 76

Query: 66  ENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
            ++ RLL +      V L+ + +    L  ++  HK+ +    +     QI  G+ Y   
Sbjct: 77  PHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 135

Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGY 182
            +++HRDL   N+L+      VK+ DFGLA+ +G  +KEY  +    P K  A E +L +
Sbjct: 136 RRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL-H 193

Query: 183 TGYSTPIDVWAVGCIFAEMIT 203
             Y+   DVW+ G    E++T
Sbjct: 194 RIYTHQSDVWSYGVTVWELMT 214

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  125 bits (317), Expect = 1e-33
 Identities = 58/201 (28%), Positives = 105/201 (52%), Gaps = 10/201 (4%)

Query: 10  KKIKKIGAGGYGEVYKCRNTVTGQK---VAIKMMTIQTEQEGVPSYIIREVSLLKELEHE 66
              K +GAG +GEV   R  +  +K   VAIK + +   ++    ++  E S++ + +H 
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFDHP 106

Query: 67  NIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSL 125
           NI+RL  V +  K V +V EY++   L SF+ +H     ++ +  +L+ I  G+ Y   +
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166

Query: 126 KILHRDLKPNNLLIDLKRNTVKLADFGLARAIG-VPQKEYSRDCVYSPYK--APELLLGY 182
             +HRDL   N+LI+      K++DFGL R +   P+  Y+      P +  +PE +  Y
Sbjct: 167 GYVHRDLAARNILIN-SNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA-Y 224

Query: 183 TGYSTPIDVWAVGCIFAEMIT 203
             +++  DVW+ G +  E+++
Sbjct: 225 RKFTSASDVWSYGIVLWEVMS 245

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  123 bits (312), Expect = 2e-33
 Identities = 34/214 (15%), Positives = 85/214 (39%), Gaps = 31/214 (14%)

Query: 10  KKIKKIGAGGYGEVYK-------CRNTVTGQKVAIKMM---TIQTEQEGVPSYIIREVSL 59
              + +G G + +++K           +   +V +K++        +           S+
Sbjct: 11  IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSES-----FFEAASM 65

Query: 60  LKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLG 118
           + +L H+++V    V     +  LV E++    L +++ ++KN +N+L    + KQ+   
Sbjct: 66  MSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAA 125

Query: 119 LAYCHSLKILHRDLKPNNLLIDLKR-------NTVKLADFGLARAIGVPQKEYSRDCVYS 171
           + +     ++H ++   N+L+  +          +KL+D G++  +        +D +  
Sbjct: 126 MHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV------LPKDILQE 179

Query: 172 PYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT 203
                 PE +      +   D W+ G    E+ +
Sbjct: 180 RIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  124 bits (313), Expect = 2e-33
 Identities = 56/201 (27%), Positives = 97/201 (48%), Gaps = 10/201 (4%)

Query: 10  KKIKKIGAGGYGEVYKCRNTVTGQ---KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHE 66
              K IG+G  GEV   R  V GQ    VAIK +     +     ++  E S++ + +H 
Sbjct: 52  HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFL-SEASIMGQFDHP 110

Query: 67  NIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSL 125
           NI+RL  V +  +   +V EY++   L +F+  H     ++ +  +L+ +  G+ Y   L
Sbjct: 111 NIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL 170

Query: 126 KILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY-SRDCVYSPYK--APELLLGY 182
             +HRDL   N+L+D      K++DFGL+R +        +      P +  APE +  +
Sbjct: 171 GYVHRDLAARNVLVD-SNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA-F 228

Query: 183 TGYSTPIDVWAVGCIFAEMIT 203
             +S+  DVW+ G +  E++ 
Sbjct: 229 RTFSSASDVWSFGVVMWEVLA 249

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  123 bits (310), Expect = 3e-33
 Identities = 56/196 (28%), Positives = 99/196 (50%), Gaps = 10/196 (5%)

Query: 14  KIGAGGYGEVYK--CRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRL 71
           ++G G +G V +   R       VAIK++   TE+      ++RE  ++ +L++  IVRL
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA-DTEEMMREAQIMHQLDNPYIVRL 75

Query: 72  LDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHR 130
           + V    + + LV E      LH F+   +  + +  +  +L Q+ +G+ Y      +HR
Sbjct: 76  IGV-CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 134

Query: 131 DLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY-SRDCVYSPYK--APELLLGYTGYST 187
           DL   N+L+   R+  K++DFGL++A+G     Y +R     P K  APE +  +  +S+
Sbjct: 135 DLAARNVLLV-NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN-FRKFSS 192

Query: 188 PIDVWAVGCIFAEMIT 203
             DVW+ G    E ++
Sbjct: 193 RSDVWSYGVTMWEALS 208

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  123 bits (312), Expect = 4e-33
 Identities = 60/206 (29%), Positives = 104/206 (50%), Gaps = 19/206 (9%)

Query: 10  KKIKKIGAGGYGEVYK-CRNTVTGQ---KVAIKMMTIQTEQEGVPSY----IIREVSLLK 61
            + K IGAG +GEVYK    T +G+    VAIK +     + G         + E  ++ 
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-----KAGYTEKQRVDFLGEAGIMG 101

Query: 62  ELEHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLA 120
           +  H NI+RL  V S  K + ++ EY++   L  F+       ++L +  +L+ I  G+ 
Sbjct: 102 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 161

Query: 121 YCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIG-VPQKEYSRDCVYSPYK--APE 177
           Y  ++  +HRDL   N+L++      K++DFGL+R +   P+  Y+      P +  APE
Sbjct: 162 YLANMNYVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 220

Query: 178 LLLGYTGYSTPIDVWAVGCIFAEMIT 203
            +  Y  +++  DVW+ G +  E++T
Sbjct: 221 AIS-YRKFTSASDVWSFGIVMWEVMT 245

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  122 bits (309), Expect = 4e-33
 Identities = 48/199 (24%), Positives = 103/199 (51%), Gaps = 10/199 (5%)

Query: 11  KIKKIGAGGYGEVYK--CRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           + K++G+G +G V K   +     + VA+K++  +     +   ++ E +++++L++  I
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80

Query: 69  VRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
           VR++ +    +   LV E  +L  L+ ++ +    +    I  ++ Q+ +G+ Y      
Sbjct: 81  VRMIGI-CEAESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEESNF 138

Query: 128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY-SRDCVYSPYK--APELLLGYTG 184
           +HRDL   N+L+   ++  K++DFGL++A+   +  Y ++     P K  APE +  Y  
Sbjct: 139 VHRDLAARNVLLV-TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN-YYK 196

Query: 185 YSTPIDVWAVGCIFAEMIT 203
           +S+  DVW+ G +  E  +
Sbjct: 197 FSSKSDVWSFGVLMWEAFS 215

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  124 bits (312), Expect = 5e-33
 Identities = 53/223 (23%), Positives = 95/223 (42%), Gaps = 42/223 (18%)

Query: 10  KKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYII-REVSLLKELEHENI 68
              + IG G +GEV++      G++VA+K+ + + E+    S+    E+     L HENI
Sbjct: 45  VLQESIGKGRFGEVWRG--KWRGEEVAVKIFSSREER----SWFREAEIYQTVMLRHENI 98

Query: 69  VRLL----DVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCH 123
           +  +        +   ++LV +Y +   L  ++  ++ T+ +  +  +      GLA+ H
Sbjct: 99  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLH 156

Query: 124 S--------LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP--- 172
                      I HRDLK  N+L+  K  T  +AD GLA      + + + D +      
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAV-----RHDSATDTIDIAPNH 210

Query: 173 ------YKAPELLLGYTG-----YSTPIDVWAVGCIFAEMITG 204
                 Y APE+L               D++A+G +F E+   
Sbjct: 211 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  123 bits (311), Expect = 5e-33
 Identities = 67/315 (21%), Positives = 123/315 (39%), Gaps = 46/315 (14%)

Query: 6   NLNYKKIK---KIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYII-REVSLLK 61
           +L+   +K    IG G YG VYK   ++  + VA+K+ +    Q    ++I  + +  + 
Sbjct: 9   SLDLDNLKLLELIGRGRYGAVYKG--SLDERPVAVKVFSFANRQ----NFINEKNIYRVP 62

Query: 62  ELEHENIVRLL-----DVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQI 115
            +EH+NI R +          R +  LV EY     L  ++    +T + +    +   +
Sbjct: 63  LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL--SLHTSDWVSSCRLAHSV 120

Query: 116 LLGLAYCHS---------LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSR 166
             GLAY H+           I HRDL   N+L+     T  ++DFGL+  +   +     
Sbjct: 121 TRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK-NDGTCVISDFGLSMRLTGNRLVRPG 179

Query: 167 DCVYSP--------YKAPELLLG------YTGYSTPIDVWAVGCIFAEMITGK-PLFPSK 211
           +   +         Y APE+L G             +D++A+G I+ E+      LFP +
Sbjct: 180 EEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239

Query: 212 KHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQML 271
                 + F         ++ +   +       P F P    E    +  +  + +    
Sbjct: 240 SVPEYQMAFQTE-VGNHPTFEDMQVLVSREKQRPKF-PEAWKENSLAV-RSLKETIEDCW 296

Query: 272 CLNPKQRITAMDALK 286
             + + R+TA  A +
Sbjct: 297 DQDAEARLTAQXAEE 311

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  121 bits (305), Expect = 1e-32
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 32/208 (15%)

Query: 10  KKIKKIGAGGYGEVYK--CRNTVTGQKVAIKMMTIQTEQEGVPSY--IIREVSLLKELEH 65
             +++IG+G +G V+     N     KVAIK +     +EG  S    I E  ++ +L H
Sbjct: 11  TFVQEIGSGQFGLVHLGYWLNKD---KVAIKTI-----REGAMSEEDFIEEAEVMMKLSH 62

Query: 66  ENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
             +V+L  V   +  + LV E+++   L  ++   +       +  +   +  G+AY   
Sbjct: 63  PKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 122

Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS-------PYK--A 175
             ++HRDL   N L+  +   +K++DFG+ R +         D  Y+       P K  +
Sbjct: 123 ACVIHRDLAARNCLVG-ENQVIKVSDFGMTRFV--------LDDQYTSSTGTKFPVKWAS 173

Query: 176 PELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           PE+   ++ YS+  DVW+ G +  E+ +
Sbjct: 174 PEVFS-FSRYSSKSDVWSFGVLMWEVFS 200

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  125 bits (314), Expect = 3e-32
 Identities = 55/197 (27%), Positives = 99/197 (50%), Gaps = 10/197 (5%)

Query: 13  KKIGAGGYGEVYK--CRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVR 70
            ++G G +G V +   R       VAIK++   TE+      ++RE  ++ +L++  IVR
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA-DTEEMMREAQIMHQLDNPYIVR 400

Query: 71  LLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILH 129
           L+ V    + + LV E      LH F+   +  + +  +  +L Q+ +G+ Y      +H
Sbjct: 401 LIGV-CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 459

Query: 130 RDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY-SRDCVYSPYK--APELLLGYTGYS 186
           R+L   N+L+   R+  K++DFGL++A+G     Y +R     P K  APE +  +  +S
Sbjct: 460 RNLAARNVLLV-NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN-FRKFS 517

Query: 187 TPIDVWAVGCIFAEMIT 203
           +  DVW+ G    E ++
Sbjct: 518 SRSDVWSYGVTMWEALS 534

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  119 bits (301), Expect = 4e-32
 Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 32/206 (15%)

Query: 12  IKKIGAGGYGEVYK--CRNTVTGQKVAIKMMTIQTEQEGVPSYI--IREVSLLKELEHEN 67
           +K++G+G +G V     +       VA+KM+     +EG  S     +E   + +L H  
Sbjct: 13  LKELGSGQFGVVKLGKWKGQY---DVAVKMI-----KEGSMSEDEFFQEAQTMMKLSHPK 64

Query: 68  IVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
           +V+   V S    +++V EY+    L +++  H   L    +  +   +  G+A+  S +
Sbjct: 65  LVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ 124

Query: 127 ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS-------PYK--APE 177
            +HRDL   N L+D +   VK++DFG+ R +         D  Y        P K  APE
Sbjct: 125 FIHRDLAARNCLVD-RDLCVKVSDFGMTRYV--------LDDQYVSSVGTKFPVKWSAPE 175

Query: 178 LLLGYTGYSTPIDVWAVGCIFAEMIT 203
           +   Y  YS+  DVWA G +  E+ +
Sbjct: 176 VFH-YFKYSSKSDVWAFGILMWEVFS 200

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  120 bits (302), Expect = 4e-32
 Identities = 56/208 (26%), Positives = 101/208 (48%), Gaps = 32/208 (15%)

Query: 10  KKIKKIGAGGYGEVYK--CRNTVTGQKVAIKMMTIQTEQEGVPSYI--IREVSLLKELEH 65
             +K++G G +G V     R       VAIKM+     +EG  S    I E  ++  L H
Sbjct: 27  TFLKELGTGQFGVVKYGKWRGQY---DVAIKMI-----KEGSMSEDEFIEEAKVMMNLSH 78

Query: 66  ENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
           E +V+L  V + ++ +F++ EY+    L +++   ++      +  + K +   + Y  S
Sbjct: 79  EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 138

Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS-------PYK--A 175
            + LHRDL   N L++  +  VK++DFGL+R +         D  Y+       P +   
Sbjct: 139 KQFLHRDLAARNCLVN-DQGVVKVSDFGLSRYV--------LDDEYTSSVGSKFPVRWSP 189

Query: 176 PELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           PE+L+ Y+ +S+  D+WA G +  E+ +
Sbjct: 190 PEVLM-YSKFSSKSDIWAFGVLMWEIYS 216

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  119 bits (301), Expect = 5e-32
 Identities = 53/210 (25%), Positives = 98/210 (46%), Gaps = 31/210 (14%)

Query: 10  KKIKKIGAGGYGEVYK---CRNTVTGQKVAIKMM----TIQTEQEGVPSYIIREVSLLKE 62
              + +G G +GEVY+     +      VA+K      T+  +++      + E  ++K 
Sbjct: 15  VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEK-----FMSEAVIMKN 69

Query: 63  LEHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAY 121
           L+H +IV+L+ +    +  +++ E     +L  ++ R+KN+L +L +     QI   +AY
Sbjct: 70  LDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAY 128

Query: 122 CHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS------PYK- 174
             S+  +HRD+   N+L+      VKL DFGL+R I         +  Y       P K 
Sbjct: 129 LESINCVHRDIAVRNILVA-SPECVKLGDFGLSRYIE-------DEDYYKASVTRLPIKW 180

Query: 175 -APELLLGYTGYSTPIDVWAVGCIFAEMIT 203
            +PE +  +  ++T  DVW       E+++
Sbjct: 181 MSPESIN-FRRFTTASDVWMFAVCMWEILS 209

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  118 bits (299), Expect = 9e-32
 Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 23/206 (11%)

Query: 10  KKIKKIGAGGYGEVYK---CRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHE 66
           +  + IG G +G+V++            VAIK     T       ++ +E   +++ +H 
Sbjct: 18  ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL-QEALTMRQFDHP 76

Query: 67  NIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSL 125
           +IV+L+ V  +   V+++ E   L +L SF+   K +L+L  +     Q+   LAY  S 
Sbjct: 77  HIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK 135

Query: 126 KILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS------PYK--APE 177
           + +HRD+   N+L+    + VKL DFGL+R +            Y       P K  APE
Sbjct: 136 RFVHRDIAARNVLVS-SNDCVKLGDFGLSRYM-------EDSTYYKASKGKLPIKWMAPE 187

Query: 178 LLLGYTGYSTPIDVWAVGCIFAEMIT 203
            +  +  +++  DVW  G    E++ 
Sbjct: 188 SIN-FRRFTSASDVWMFGVCMWEILM 212

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  119 bits (300), Expect = 1e-31
 Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 28/205 (13%)

Query: 12  IKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYI--IREVSLLKELEHENIV 69
             K+G G YGEVY+         VA+K +     +E        ++E +++KE++H N+V
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIKHPNLV 72

Query: 70  RLLDVQSSRKDVFLVFEYLDL-DLHSFI-TRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
           +LL V +     +++ E++   +L  ++   ++  ++ +V+  +  QI   + Y      
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 132

Query: 128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS-------PYK--APEL 178
           +HRDL   N L+  + + VK+ADFGL+R +            Y+       P K  APE 
Sbjct: 133 IHRDLAARNCLVG-ENHLVKVADFGLSRLM--------TGDTYTAHAGAKFPIKWTAPES 183

Query: 179 LLGYTGYSTPIDVWAVGCIFAEMIT 203
           L  Y  +S   DVWA G +  E+ T
Sbjct: 184 LA-YNKFSIKSDVWAFGVLLWEIAT 207

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  122 bits (308), Expect = 1e-31
 Identities = 59/207 (28%), Positives = 102/207 (49%), Gaps = 15/207 (7%)

Query: 10  KKIKKIGAGGYGEVYKCRNTVTGQKVAIKMM-TIQTEQEGVPSYIIREVSLLKELEHENI 68
               K+G G YGEVY+         VA+K +     E E      ++E +++KE++H N+
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAAVMKEIKHPNL 278

Query: 69  VRLLDVQSSRKDVFLVFEYLDL-DLHSFI-TRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
           V+LL V +     +++ E++   +L  ++   ++  ++ +V+  +  QI   + Y     
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 338

Query: 127 ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY-SRDCVYSPYK--APELLLGYT 183
            +HR+L   N L+  + + VK+ADFGL+R +      Y +      P K  APE L  Y 
Sbjct: 339 FIHRNLAARNCLVG-ENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPESLA-YN 394

Query: 184 GYSTPIDVWAVGCIFAEMIT-GKPLFP 209
            +S   DVWA G +  E+ T G   +P
Sbjct: 395 KFSIKSDVWAFGVLLWEIATYGMSPYP 421

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  116 bits (294), Expect = 9e-31
 Identities = 68/284 (23%), Positives = 119/284 (41%), Gaps = 47/284 (16%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMT----IQTEQEGVPSYIIREVSLLKEL 63
           ++K  K +G G +  V   R   T ++ AIK++     I+  +     Y+ RE  ++  L
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKV---PYVTRERDVMSRL 87

Query: 64  EHENIVRLLDV-QSSRKDVFLVFEYL---DLDLHSFITRHKNTLNLLVIKAILKQILLGL 119
           +H   V+L    Q   K ++    Y    +L  +    R   + +    +    +I+  L
Sbjct: 88  DHPFFVKLYFTFQDDEK-LYFGLSYAKNGELLKY---IRKIGSFDETCTRFYTAEIVSAL 143

Query: 120 AYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRD--CVYSPYKAPE 177
            Y H   I+HRDLKP N+L++   + +++ DFG A+ +    K+   +     + Y +PE
Sbjct: 144 EYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 202

Query: 178 LLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYI 237
           LL          D+WA+GCI  +++ G P F +       LIF                 
Sbjct: 203 LLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEY---LIFQK--------------- 243

Query: 238 SEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITA 281
             I+ L   F P           P   DL+ ++L L+  +R+  
Sbjct: 244 --IIKLEYDF-P-------EKFFPKARDLVEKLLVLDATKRLGC 277

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  120 bits (303), Expect = 1e-30
 Identities = 67/277 (24%), Positives = 111/277 (40%), Gaps = 44/277 (15%)

Query: 12  IKKIGAGGYGEVYKCRNTVTGQKVAIKMMT----IQTEQEGVPSYIIREVSLLKELEHEN 67
            + +G GG+GEV  C+   TG+  A K +      + + E   +  + E  +L+++    
Sbjct: 189 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGE---AMALNEKQILEKVNSRF 245

Query: 68  IVRLLDVQSSRKDVFLVFEYL---DLDLHSFITRH-KNTLNLLVIKAILKQILLGLAYCH 123
           +V L     ++  + LV   +   DL  H  I    +             +I  GL   H
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGGDLKFH--IYHMGQAGFPEARAVFYAAEICCGLEDLH 303

Query: 124 SLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYT 183
             +I++RDLKP N+L+D   + ++++D GLA  +   Q    R      Y APE++    
Sbjct: 304 RERIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGR-VGTVGYMAPEVVKN-E 360

Query: 184 GYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLS--LIFSLLGTPTDESWAESTYISEIL 241
            Y+   D WA+GC+  EMI G+  F  +K       +   +   P               
Sbjct: 361 RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP--------------- 405

Query: 242 PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQR 278
             Y                P    L SQ+LC +P +R
Sbjct: 406 EEYS-----------ERFSPQARSLCSQLLCKDPAER 431

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score =  117 bits (294), Expect = 1e-30
 Identities = 61/340 (17%), Positives = 108/340 (31%), Gaps = 83/340 (24%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTI------QTEQEGVPSYIIREVSLLK 61
             ++ +KIG G +GEV++         VAIK++ I          +     I+ E+ + K
Sbjct: 21  KLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78

Query: 62  ELE---------HENIVRLLDV------------------------------QSSRKDVF 82
           EL           E  + L  V                                    +F
Sbjct: 79  ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138

Query: 83  LVFEYLD--LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCH-SLKILHRDLKPNNLLI 139
           +V E+    +DL           +L   K+IL Q+   LA    SL+  HRDL   N+L+
Sbjct: 139 IVLEFEFGGIDLEQM---RTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL 195

Query: 140 DLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFA 199
             K +  KL      ++  +P                   +    Y+          +F 
Sbjct: 196 K-KTSLKKLHYTLNGKSSTIPSCGLQ--------------VSIIDYTLSRLERDGIVVFC 240

Query: 200 EMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAEST---------YISEILPLYPHFEPA 250
           ++   + LF     D+   I+ L+    +  W E           Y+++ +     F+  
Sbjct: 241 DVSMDEDLFTG-DGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTK 299

Query: 251 NLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                   ++    +    ML  +     +A D L    L
Sbjct: 300 CNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL 334

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  116 bits (292), Expect = 1e-30
 Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 26/210 (12%)

Query: 10  KKIKKIGAGGYGEVYKCRNTVTGQ---KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHE 66
              + IG G +G VY        Q   + AIK ++  TE + V +++ RE  L++ L H 
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFL-REGLLMRGLNHP 82

Query: 67  NIVRLLDVQSSRKDV-FLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
           N++ L+ +    + +  ++  Y+   DL  FI   +    +  + +   Q+  G+ Y   
Sbjct: 83  NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE 142

Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK---------- 174
            K +HRDL   N ++D +  TVK+ADFGLAR I        R+  YS  +          
Sbjct: 143 QKFVHRDLAARNCMLD-ESFTVKVADFGLARDI------LDRE-YYSVQQHRHARLPVKW 194

Query: 175 -APELLLGYTGYSTPIDVWAVGCIFAEMIT 203
            A E L     ++T  DVW+ G +  E++T
Sbjct: 195 TALESLQ-TYRFTTKSDVWSFGVLLWELLT 223

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  117 bits (296), Expect = 3e-30
 Identities = 64/294 (21%), Positives = 125/294 (42%), Gaps = 40/294 (13%)

Query: 2   GKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMM----TIQTEQEGVPSYIIREV 57
            +L   +++ +K IG G +GEV   +     +  A+K++     ++  +    +    E 
Sbjct: 69  MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAET---ACFREER 125

Query: 58  SLLKELEHENIVRLL-DVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQI 115
            +L   + + I  L    Q     ++LV +Y    DL + +++ ++ L   + +  L ++
Sbjct: 126 DVLVNGDSKWITTLHYAFQDDNN-LYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEM 184

Query: 116 LLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YK 174
           ++ +   H L  +HRD+KP+N+L+D     ++LADFG    +       S   V +P Y 
Sbjct: 185 VIAIDSVHQLHYVHRDIKPDNILMD-MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYI 243

Query: 175 APELLL----GYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDES 230
           +PE+L     G   Y    D W++G    EM+ G+  F                    ES
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF------------------YAES 285

Query: 231 WAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDA 284
             E TY  +I+     F       +  ++     DL+ +++C + + R+     
Sbjct: 286 LVE-TY-GKIMNHKERF---QFPTQVTDVSENAKDLIRRLIC-SREHRLGQNGI 333

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  114 bits (288), Expect = 6e-30
 Identities = 64/225 (28%), Positives = 99/225 (44%), Gaps = 47/225 (20%)

Query: 12  IKKIGAGGYGEVYKC--RNTVTGQ---KVAIKMM---TIQTEQEGVPSYIIREVSLLKEL 63
            +++G G +G+V+     N    +    VA+K +   T+   ++       RE  LL  L
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKD-----FQREAELLTNL 74

Query: 64  EHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRH---------------KNTLNLLV 107
           +HE+IV+   V      + +VFEY+   DL+ F+  H               K  L L  
Sbjct: 75  QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134

Query: 108 IKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRD 167
           +  I  QI  G+ Y  S   +HRDL   N L+      VK+ DFG++R +      YS D
Sbjct: 135 MLHIASQIASGMVYLASQHFVHRDLATRNCLVG-ANLLVKIGDFGMSRDV------YSTD 187

Query: 168 CVYS-------PYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT 203
             Y        P +   PE ++ Y  ++T  DVW+ G I  E+ T
Sbjct: 188 -YYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVILWEIFT 230

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  114 bits (288), Expect = 6e-30
 Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 30/210 (14%)

Query: 12  IKKIGAGGYGEVYKCRNTVTGQK---VAIKMM-TIQTEQEGVPSYIIREVSLLKELEHEN 67
            + IG G +G VY         K    A+K +  I    E   S  + E  ++K+  H N
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE--VSQFLTEGIIMKDFSHPN 87

Query: 68  IVRLLDVQSSRKD--VFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
           ++ LL +   R +    +V  Y+   DL +FI    +   +  +     Q+  G+ Y  S
Sbjct: 88  VLSLLGI-CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 146

Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK---------- 174
            K +HRDL   N ++D ++ TVK+ADFGLAR +      Y ++  YS +           
Sbjct: 147 KKFVHRDLAARNCMLD-EKFTVKVADFGLARDM------YDKE-YYSVHNKTGAKLPVKW 198

Query: 175 -APELLLGYTGYSTPIDVWAVGCIFAEMIT 203
            A E L     ++T  DVW+ G +  E++T
Sbjct: 199 MALESLQ-TQKFTTKSDVWSFGVLLWELMT 227

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  114 bits (287), Expect = 6e-30
 Identities = 53/197 (26%), Positives = 92/197 (46%), Gaps = 18/197 (9%)

Query: 12  IKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRL 71
           ++ IG G +G+V        G KVA+K +      +      + E S++ +L H N+V+L
Sbjct: 26  LQTIGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQA----FLAEASVMTQLRHSNLVQL 79

Query: 72  LDVQSSRKD-VFLVFEYLDL-DLHSFI-TRHKNTLNLLVIKAILKQILLGLAYCHSLKIL 128
           L V    K  +++V EY+    L  ++ +R ++ L    +      +   + Y      +
Sbjct: 80  LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV 139

Query: 129 HRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTGYS 186
           HRDL   N+L+  + N  K++DFGL +         ++D    P K  APE L     +S
Sbjct: 140 HRDLAARNVLVS-EDNVAKVSDFGLTKEA-----SSTQDTGKLPVKWTAPEALR-EKKFS 192

Query: 187 TPIDVWAVGCIFAEMIT 203
           T  DVW+ G +  E+ +
Sbjct: 193 TKSDVWSFGILLWEIYS 209

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  116 bits (292), Expect = 8e-30
 Identities = 70/287 (24%), Positives = 118/287 (41%), Gaps = 44/287 (15%)

Query: 12  IKKIGAGGYGEVYKCRNTVTGQKVAIKMM----TIQTEQEGVPSYIIREVSLLKELEHEN 67
           +K IG G + EV   +   TGQ  A+K+M     ++  +    S    E  +L   +   
Sbjct: 66  LKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEV---SCFREERDVLVNGDRRW 122

Query: 68  IVRLLDVQSSRKDVFLVFEYL---DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
           I +L         ++LV EY    DL     +++    +   + +  L +I++ +   H 
Sbjct: 123 ITQLHFAFQDENYLYLVMEYYVGGDLLTL--LSKFGERIPAEMARFYLAEIVMAIDSVHR 180

Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLG-- 181
           L  +HRD+KP+N+L+D +   ++LADFG    +       S   V +P Y +PE+L    
Sbjct: 181 LGYVHRDIKPDNILLD-RCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVG 239

Query: 182 ----YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYI 237
                  Y    D WA+G    EM  G+  F                    +S AE TY 
Sbjct: 240 GGPGTGSYGPECDWWALGVFAYEMFYGQTPF------------------YADSTAE-TY- 279

Query: 238 SEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDA 284
            +I+    + E  +L      +     D + ++LC  P+ R+    A
Sbjct: 280 GKIV---HYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGA 322

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  118 bits (296), Expect = 1e-29
 Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 11/200 (5%)

Query: 10  KKIKKIGAGGYGEVYKCRNTVTGQK---VAIKMMTIQTEQEGVPSYIIREVSLLKELEHE 66
           +  + IG G +G+V++            VAIK     T         ++E   +++ +H 
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK-FLQEALTMRQFDHP 451

Query: 67  NIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSL 125
           +IV+L+ V  +   V+++ E   L +L SF+   K +L+L  +     Q+   LAY  S 
Sbjct: 452 HIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK 510

Query: 126 KILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYT 183
           + +HRD+   N+L+    + VKL DFGL+R +      Y       P K  APE +  + 
Sbjct: 511 RFVHRDIAARNVLVS-SNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESIN-FR 567

Query: 184 GYSTPIDVWAVGCIFAEMIT 203
            +++  DVW  G    E++ 
Sbjct: 568 RFTSASDVWMFGVCMWEILM 587

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  117 bits (295), Expect = 1e-29
 Identities = 67/275 (24%), Positives = 109/275 (39%), Gaps = 37/275 (13%)

Query: 12  IKKIGAGGYGEVYKCRNTVTGQKVAIKMMT----IQTEQEGVPSYIIREVSLLKELEHEN 67
            + +G GG+GEV+ C+   TG+  A K +      + +        + E  +L ++    
Sbjct: 190 FRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGY---QGAMVEKKILAKVHSRF 246

Query: 68  IVRLLDVQSSRKDVFLVFEYL---DLDLH-SFITRHKNTLNLLVIKAILKQILLGLAYCH 123
           IV L     ++ D+ LV   +   D+  H   +                 QI+ GL + H
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306

Query: 124 SLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYT 183
              I++RDLKP N+L+D   N V+++D GLA  +   Q +         + APELLLG  
Sbjct: 307 QRNIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-E 364

Query: 184 GYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPL 243
            Y   +D +A+G    EMI  +  F ++                 E       + E    
Sbjct: 365 EYDFSVDYFALGVTLYEMIAARGPFRARGEK----------VENKELKQR---VLEQAVT 411

Query: 244 YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQR 278
           YP               PA  D    +L  +P++R
Sbjct: 412 YP-----------DKFSPASKDFCEALLQKDPEKR 435

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  114 bits (287), Expect = 2e-29
 Identities = 55/210 (26%), Positives = 92/210 (43%), Gaps = 30/210 (14%)

Query: 12  IKKIGAGGYGEVYKCRNTVTGQK---VAIKMM-TIQTEQEGVPSYIIREVSLLKELEHEN 67
            + IG G +G VY         K    A+K +  I    E   S  + E  ++K+  H N
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE--VSQFLTEGIIMKDFSHPN 151

Query: 68  IVRLLDVQSSRKD-VFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSL 125
           ++ LL +    +    +V  Y+   DL +FI    +   +  +     Q+  G+ +  S 
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 211

Query: 126 KILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK----------- 174
           K +HRDL   N ++D ++ TVK+ADFGLAR +      Y ++  +               
Sbjct: 212 KFVHRDLAARNCMLD-EKFTVKVADFGLARDM------YDKE--FDSVHNKTGAKLPVKW 262

Query: 175 -APELLLGYTGYSTPIDVWAVGCIFAEMIT 203
            A E L     ++T  DVW+ G +  E++T
Sbjct: 263 MALESLQ-TQKFTTKSDVWSFGVLLWELMT 291

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  113 bits (284), Expect = 3e-29
 Identities = 53/219 (24%), Positives = 93/219 (42%), Gaps = 40/219 (18%)

Query: 12  IKKIGAGGYGEVYKCR-----NTVTGQKVAIKMM----TIQTEQEGVPSYIIREVSLLKE 62
           I+ +G G +GEVY+ +     N  +  +VA+K +    + Q E +      + E  ++ +
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-----FLMEALIISK 89

Query: 63  LEHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKN------TLNLLVIKAILKQI 115
             H+NIVR + V       F++ E +   DL SF+   +       +L +L +  + + I
Sbjct: 90  FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149

Query: 116 LLGLAYCHSLKILHRDLKPNNLLIDLK--RNTVKLADFGLARAIGVPQKEYSRDCVYS-- 171
             G  Y      +HRD+   N L+         K+ DFG+AR I      Y     Y   
Sbjct: 150 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI------YRASY-YRKG 202

Query: 172 -----PYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT 203
                P K   PE  +    +++  D W+ G +  E+ +
Sbjct: 203 GCAMLPVKWMPPEAFM-EGIFTSKTDTWSFGVLLWEIFS 240

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  115 bits (289), Expect = 3e-29
 Identities = 54/199 (27%), Positives = 93/199 (46%), Gaps = 18/199 (9%)

Query: 10  KKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIV 69
           K ++ IG G +G+V        G KVA+K +      +      + E S++ +L H N+V
Sbjct: 196 KLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQA----FLAEASVMTQLRHSNLV 249

Query: 70  RLLDVQSSRK-DVFLVFEYLDL-DLHSFI-TRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
           +LL V    K  +++V EY+    L  ++ +R ++ L    +      +   + Y     
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 309

Query: 127 ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK--APELLLGYTG 184
            +HRDL   N+L+  + N  K++DFGL +         ++D    P K  APE L     
Sbjct: 310 FVHRDLAARNVLVS-EDNVAKVSDFGLTKEA-----SSTQDTGKLPVKWTAPEALR-EKK 362

Query: 185 YSTPIDVWAVGCIFAEMIT 203
           +ST  DVW+ G +  E+ +
Sbjct: 363 FSTKSDVWSFGILLWEIYS 381

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  116 bits (292), Expect = 4e-29
 Identities = 61/280 (21%), Positives = 118/280 (42%), Gaps = 50/280 (17%)

Query: 12  IKKIGAGGYGEVYKCRNTVTGQKVAIKMMT----IQTEQEGVPSYIIREVSLLKELEHEN 67
            + IG GG+GEVY CR   TG+  A+K +        + E   +  + E  +L  +   +
Sbjct: 194 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE---TLALNERIMLSLVSTGD 250

Query: 68  ---IVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCH 123
              IV +     +   +  + + ++  DLH  +++H    +   ++    +I+LGL + H
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV-FSEADMRFYAAEIILGLEHMH 309

Query: 124 SLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS-----PYKAPEL 178
           +  +++RDLKP N+L+D   + V+++D GLA        ++S+   ++      Y APE+
Sbjct: 310 NRFVVYRDLKPANILLDEHGH-VRISDLGLA-------CDFSKKKPHASVGTHGYMAPEV 361

Query: 179 LLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYIS 238
           L     Y +  D +++GC+  +++ G   F   K      I  +                
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM--------------TL 407

Query: 239 EILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQR 278
            +    P            +  P    LL  +L  +  +R
Sbjct: 408 TMAVELP-----------DSFSPELRSLLEGLLQRDVNRR 436

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  113 bits (284), Expect = 4e-29
 Identities = 64/221 (28%), Positives = 100/221 (45%), Gaps = 40/221 (18%)

Query: 12  IKKIGAGGYGEVYKC--RNTVTGQ---KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHE 66
             ++G G +G+V+     N +  Q    VA+K +   +E         RE  LL  L+H+
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA--RQDFQREAELLTMLQHQ 103

Query: 67  NIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRH--------------KNTLNLLVIKAI 111
           +IVR   V +  + + +VFEY+   DL+ F+  H                 L L  + A+
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163

Query: 112 LKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS 171
             Q+  G+ Y   L  +HRDL   N L+  +   VK+ DFG++R I      YS D  Y 
Sbjct: 164 ASQVAAGMVYLAGLHFVHRDLATRNCLVG-QGLVVKIGDFGMSRDI------YSTD-YYR 215

Query: 172 -------PYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT 203
                  P +   PE +L Y  ++T  DVW+ G +  E+ T
Sbjct: 216 VGGRTMLPIRWMPPESIL-YRKFTTESDVWSFGVVLWEIFT 255

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  115 bits (290), Expect = 4e-29
 Identities = 66/208 (31%), Positives = 103/208 (49%), Gaps = 19/208 (9%)

Query: 10  KKIKKIGAGGYGEVYK--CRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
           +   K+G G +GEV+      T    +VAIK +   T         ++E  ++K+L HE 
Sbjct: 270 RLEVKLGQGCFGEVWMGTWNGTT---RVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEK 323

Query: 68  IVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSL 125
           +V+L  V  S + +++V EY+    L  F+       L L  +  +  QI  G+AY   +
Sbjct: 324 LVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 382

Query: 126 KILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY-SRDCVYSPYK--APELLLGY 182
             +HRDL+  N+L+  +    K+ADFGLAR I     EY +R     P K  APE  L Y
Sbjct: 383 NYVHRDLRAANILVG-ENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAAL-Y 438

Query: 183 TGYSTPIDVWAVGCIFAEMIT-GKPLFP 209
             ++   DVW+ G +  E+ T G+  +P
Sbjct: 439 GRFTIKSDVWSFGILLTELTTKGRVPYP 466

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  114 bits (287), Expect = 8e-29
 Identities = 66/208 (31%), Positives = 103/208 (49%), Gaps = 19/208 (9%)

Query: 10  KKIKKIGAGGYGEVYK--CRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
           +   K+G G +GEV+      T    +VAIK +   T         ++E  ++K+L HE 
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTT---RVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEK 240

Query: 68  IVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSL 125
           +V+L  V  S + +++V EY+    L  F+       L L  +  +  QI  G+AY   +
Sbjct: 241 LVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 299

Query: 126 KILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY-SRDCVYSPYK--APELLLGY 182
             +HRDL+  N+L+  +    K+ADFGLAR I     EY +R     P K  APE  L Y
Sbjct: 300 NYVHRDLRAANILVG-ENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAAL-Y 355

Query: 183 TGYSTPIDVWAVGCIFAEMIT-GKPLFP 209
             ++   DVW+ G +  E+ T G+  +P
Sbjct: 356 GRFTIKSDVWSFGILLTELTTKGRVPYP 383

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  111 bits (280), Expect = 1e-28
 Identities = 57/216 (26%), Positives = 93/216 (43%), Gaps = 33/216 (15%)

Query: 12  IKKIGAGGYGEVYKCR---NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
            + +G G +G V + +      +  KVA+KM+             +RE + +KE +H ++
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 69  VRLLDV------QSSRKDVFLVFEYLDL-DLHSFI-----TRHKNTLNLLVIKAILKQIL 116
            +L+ V      +       ++  ++   DLH+F+       +   L L  +   +  I 
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147

Query: 117 LGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS----- 171
            G+ Y  S   +HRDL   N ++  +  TV +ADFGL+R I      YS D  Y      
Sbjct: 148 CGMEYLSSRNFIHRDLAARNCMLA-EDMTVCVADFGLSRKI------YSGD-YYRQGCAS 199

Query: 172 --PYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT 203
             P K  A E L     Y+   DVWA G    E++T
Sbjct: 200 KLPVKWLALESLA-DNLYTVHSDVWAFGVTMWEIMT 234

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  112 bits (282), Expect = 1e-28
 Identities = 53/219 (24%), Positives = 94/219 (42%), Gaps = 40/219 (18%)

Query: 12  IKKIGAGGYGEVYKCR-----NTVTGQKVAIKMM----TIQTEQEGVPSYIIREVSLLKE 62
           I+ +G G +GEVY+ +     N  +  +VA+K +    + Q E +      + E  ++ +
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-----FLMEALIISK 130

Query: 63  LEHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHK------NTLNLLVIKAILKQI 115
             H+NIVR + V       F++ E +   DL SF+   +      ++L +L +  + + I
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190

Query: 116 LLGLAYCHSLKILHRDLKPNNLLIDLK--RNTVKLADFGLARAIGVPQKEYSRDCVYS-- 171
             G  Y      +HRD+   N L+         K+ DFG+AR I      Y     Y   
Sbjct: 191 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI------YRAGY-YRKG 243

Query: 172 -----PYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT 203
                P K   PE  +    +++  D W+ G +  E+ +
Sbjct: 244 GCAMLPVKWMPPEAFM-EGIFTSKTDTWSFGVLLWEIFS 281

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  112 bits (282), Expect = 1e-28
 Identities = 65/288 (22%), Positives = 126/288 (43%), Gaps = 52/288 (18%)

Query: 2   GKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMT----IQTEQEGVPSYIIREV 57
              +   + +IK +G G +G V   ++  +G   A+K++     ++ +Q     + + E 
Sbjct: 36  NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI---EHTLNEK 92

Query: 58  SLLKELEHENIVRLLDVQSSRKDVFLVFEYL---DLDLHSFITRHKNTLNLLVIKAILKQ 114
            +L+ +    +V+L        ++++V EY+   ++  H    R     +    +    Q
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSH---LRRIGRFSEPHARFYAAQ 149

Query: 115 ILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYK 174
           I+L   Y HSL +++RDLKP NLLID ++  +++ DFG A+   V  + ++  C      
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKR--VKGRTWTL-CGTPEAL 205

Query: 175 APELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAES 234
           APE++L   GY+  +D WA+G +  EM  G P F + +   +                  
Sbjct: 206 APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI------------------ 246

Query: 235 TYISEIL--PLYPHFEPANLAEKFP-NLEPAGVDLLSQMLCLNPKQRI 279
               +I+   +           +FP +      DLL  +L ++  +R 
Sbjct: 247 --YEKIVSGKV-----------RFPSHFSSDLKDLLRNLLQVDLTKRF 281

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  111 bits (280), Expect = 1e-28
 Identities = 58/220 (26%), Positives = 102/220 (46%), Gaps = 42/220 (19%)

Query: 12  IKKIGAGGYGEVYKC--RNTVTGQ---KVAIKMM----TIQTEQEGVPSYIIREVSLLKE 62
            +++G G +G VY+   +  V  +   +VAIK +    +++   E      + E S++KE
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-----FLNEASVMKE 84

Query: 63  LEHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHK---------NTLNLLVIKAIL 112
               ++VRLL V S  +   ++ E +   DL S++   +            +L  +  + 
Sbjct: 85  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144

Query: 113 KQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS- 171
            +I  G+AY ++ K +HRDL   N ++  +  TVK+ DFG+ R I      Y  D  Y  
Sbjct: 145 GEIADGMAYLNANKFVHRDLAARNCMVA-EDFTVKIGDFGMTRDI------YETD-YYRK 196

Query: 172 ------PYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT 203
                 P +  +PE L     ++T  DVW+ G +  E+ T
Sbjct: 197 GGKGLLPVRWMSPESLK-DGVFTTYSDVWSFGVVLWEIAT 235

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  110 bits (277), Expect = 2e-28
 Identities = 61/201 (30%), Positives = 107/201 (53%), Gaps = 18/201 (8%)

Query: 10  KKIKKIGAGGYGEVYKC--RNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
           K ++++GAG +GEV+           KVA+K +   +     P   + E +L+K+L+H+ 
Sbjct: 16  KLVERLGAGQFGEVWMGYYNGHT---KVAVKSLKQGSMS---PDAFLAEANLMKQLQHQR 69

Query: 68  IVRLLDVQSSRKDVFLVFEYLDL-DLHSFI-TRHKNTLNLLVIKAILKQILLGLAYCHSL 125
           +VRL  V  +++ ++++ EY++   L  F+ T     L +  +  +  QI  G+A+    
Sbjct: 70  LVRLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128

Query: 126 KILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY-SRDCVYSPYK--APELLLGY 182
             +HRDL+  N+L+     + K+ADFGLAR I     EY +R+    P K  APE +  Y
Sbjct: 129 NYIHRDLRAANILVS-DTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAIN-Y 184

Query: 183 TGYSTPIDVWAVGCIFAEMIT 203
             ++   DVW+ G +  E++T
Sbjct: 185 GTFTIKSDVWSFGILLTEIVT 205

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  112 bits (281), Expect = 3e-28
 Identities = 67/295 (22%), Positives = 122/295 (41%), Gaps = 46/295 (15%)

Query: 2   GKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMM----TIQTEQEGVPSYIIREV 57
            ++K  +Y+ +K IG G +GEV   R+  T +  A+K++     I+       ++   E 
Sbjct: 64  LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDS---AFFWEER 120

Query: 58  SLLKELEHENIVRLLDVQSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQIL 116
            ++       +V+L       + +++V EY+   DL + ++ +   +     +    +++
Sbjct: 121 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVV 178

Query: 117 LGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKA 175
           L L   HS+  +HRD+KP+N+L+D K   +KLADFG    +           V +P Y +
Sbjct: 179 LALDAIHSMGFIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYIS 237

Query: 176 PELLL---GYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWA 232
           PE+L    G   Y    D W+VG    EM+ G   F                    +S  
Sbjct: 238 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF------------------YADSLV 279

Query: 233 ESTYISEILPLYPHFEPANLAEKFP---NLEPAGVDLLSQMLCLNPKQRITAMDA 284
             TY S+I+              FP   ++     +L+   L  + + R+     
Sbjct: 280 G-TY-SKIMNHKNSL-------TFPDDNDISKEAKNLICAFLT-DREVRLGRNGV 324

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  109 bits (274), Expect = 5e-28
 Identities = 61/239 (25%), Positives = 103/239 (43%), Gaps = 51/239 (21%)

Query: 2   GKLKNLNYKKI---KKIGAGGYGEVYKCR--NTVTGQ---KVAIKMM----TIQTEQEGV 49
           GKLK ++   +   +++G   +G+VYK        G+    VAIK +         +E  
Sbjct: 1   GKLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREE-- 58

Query: 50  PSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRH--------- 99
                 E  L   L+H N+V LL V +  + + ++F Y    DLH F+            
Sbjct: 59  ---FRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGST 115

Query: 100 ------KNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGL 153
                 K+ L       ++ QI  G+ Y  S  ++H+DL   N+L+   +  VK++D GL
Sbjct: 116 DDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY-DKLNVKISDLGL 174

Query: 154 ARAIGVPQKEYSRDCVYS-------PYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT 203
            R +      Y+ D  Y        P +  APE ++ Y  +S   D+W+ G +  E+ +
Sbjct: 175 FREV------YAAD-YYKLLGNSLLPIRWMAPEAIM-YGKFSIDSDIWSYGVVLWEVFS 225

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  109 bits (275), Expect = 5e-28
 Identities = 58/215 (26%), Positives = 91/215 (42%), Gaps = 32/215 (14%)

Query: 12  IKKIGAGGYGEVYKCR---NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
            K +G G +G V +        T  KVA+K M +    +      + E + +K+  H N+
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 69  VRLLDV-----QSSRKDVFLVFEYLDL-DLHSFITRHK-----NTLNLLVIKAILKQILL 117
           +RLL V             ++  ++   DLH+++   +       + L  +   +  I L
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158

Query: 118 GLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS------ 171
           G+ Y  +   LHRDL   N ++     TV +ADFGL++ I      YS D  Y       
Sbjct: 159 GMEYLSNRNFLHRDLAARNCMLR-DDMTVCVADFGLSKKI------YSGD-YYRQGRIAK 210

Query: 172 -PYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT 203
            P K  A E L     Y++  DVWA G    E+ T
Sbjct: 211 MPVKWIAIESLA-DRVYTSKSDVWAFGVTMWEIAT 244

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  107 bits (268), Expect = 3e-27
 Identities = 31/276 (11%), Positives = 75/276 (27%), Gaps = 63/276 (22%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQ-TEQEGVPSYIIREVSLLKELEHEN 67
           Y+ +   G     + ++  +T   ++VA+  +  Q    + V    +     L  ++   
Sbjct: 33  YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92

Query: 68  IVRLLDVQSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKA--ILKQILLGLAYCHS 124
           + R+LDV  +R    +V E++    L               + A   ++ +       H 
Sbjct: 93  VARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHR 147

Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTG 184
             +      P+ + +      V LA                                   
Sbjct: 148 AGVALSIDHPSRVRVS-IDGDVVLAYPATMPDANPQD----------------------- 183

Query: 185 YSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLY 244
                D+  +G     ++  +   P                       E+   S + P  
Sbjct: 184 -----DIRGIGASLYALLVNRWPLP-----------------------EAGVRSGLAPAE 215

Query: 245 PHF--EPANLAEKFPNLEPAGVDLLSQMLCLNPKQR 278
                +P   A+   ++      + ++ +  +   R
Sbjct: 216 RDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR 251

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  109 bits (275), Expect = 4e-27
 Identities = 58/203 (28%), Positives = 102/203 (50%), Gaps = 22/203 (10%)

Query: 10  KKIKKIGAGGYGEVYK--CRNTVTGQKVAIKMM--TIQTEQEGVPSYIIREVSLLKELEH 65
           K  KK+GAG +GEV+           KVA+K M     + +       + E +++K L+H
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHT---KVAVKTMKPGSMSVEA-----FLAEANVMKTLQH 242

Query: 66  ENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNT-LNLLVIKAILKQILLGLAYCH 123
           + +V+L  V  +++ ++++ E++    L  F+   + +   L  +     QI  G+A+  
Sbjct: 243 DKLVKLHAV-VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 301

Query: 124 SLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY-SRDCVYSPYK--APELLL 180
               +HRDL+  N+L+       K+ADFGLAR I     EY +R+    P K  APE + 
Sbjct: 302 QRNYIHRDLRAANILVS-ASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAIN 358

Query: 181 GYTGYSTPIDVWAVGCIFAEMIT 203
            +  ++   DVW+ G +  E++T
Sbjct: 359 -FGSFTIKSDVWSFGILLMEIVT 380

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  105 bits (264), Expect = 2e-26
 Identities = 64/282 (22%), Positives = 113/282 (40%), Gaps = 62/282 (21%)

Query: 12  IKKIGAGGYGEVYKCRNTVTGQKVAIKMMT----IQTEQEGVPSYIIREVSLLKELEHEN 67
           ++ +G G +G V+  R+   G+  A+K++     ++ +Q     +   E  +L  + H  
Sbjct: 11  LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQV---EHTNDERLMLSIVTHPF 67

Query: 68  IVRLLDVQSSRKDVFLVFEYL---DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
           I+R+       + +F++ +Y+   +L       R        V K    ++ L L Y HS
Sbjct: 68  IIRMWGTFQDAQQIFMIMDYIEGGELFSL---LRKSQRFPNPVAKFYAAEVCLALEYLHS 124

Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAI--------GVPQKEYSRDCVYSPYKAP 176
             I++RDLKP N+L+D K   +K+ DFG A+ +        G P            Y AP
Sbjct: 125 KDIIYRDLKPENILLD-KNGHIKITDFGFAKYVPDVTYTLCGTPD-----------YIAP 172

Query: 177 ELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY 236
           E++     Y+  ID W+ G +  EM+ G   F     + +     +L             
Sbjct: 173 EVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDS--NTMKTYEKILNAE---------- 219

Query: 237 ISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQR 278
                  +P           P       DLLS+++  +  QR
Sbjct: 220 -----LRFP-----------PFFNEDVKDLLSRLITRDLSQR 245

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  103 bits (258), Expect = 2e-25
 Identities = 66/234 (28%), Positives = 102/234 (43%), Gaps = 56/234 (23%)

Query: 12  IKKIGAGGYGEVYKCR-----NTVTGQKVAIKMM----TIQTEQEGVPSYIIREVSLLKE 62
           ++ IG G +G V++ R            VA+KM+    +   + +       RE +L+ E
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD-----FQREAALMAE 106

Query: 63  LEHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHK--------------------- 100
            ++ NIV+LL V +  K + L+FEY+   DL+ F+                         
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166

Query: 101 --NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIG 158
               L+      I +Q+  G+AY    K +HRDL   N L+  +   VK+ADFGL+R I 
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG-ENMVVKIADFGLSRNI- 224

Query: 159 VPQKEYSRDCVYS-------PYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT 203
                YS D  Y        P +   PE +  Y  Y+T  DVWA G +  E+ +
Sbjct: 225 -----YSAD-YYKADGNDAIPIRWMPPESIF-YNRYTTESDVWAYGVVLWEIFS 271

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  101 bits (254), Expect = 5e-25
 Identities = 58/228 (25%), Positives = 92/228 (40%), Gaps = 49/228 (21%)

Query: 12  IKKIGAGGYGEVYKCR-----NTVTGQKVAIKMM---TIQTEQEGVPSYIIREVSLLKEL 63
            K +GAG +G+V +        +     VA+KM+      TE+E     ++ E+ +L  L
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA----LMSELKVLSYL 83

Query: 64  -EHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILK-------- 113
             H NIV LL   +      ++ EY    DL +F+ R +++         +         
Sbjct: 84  GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143

Query: 114 ---------QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY 164
                    Q+  G+A+  S   +HRDL   N+L+       K+ DFGLAR I       
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT-HGRITKICDFGLARDI------K 196

Query: 165 SRDCVYS-------PYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           +    Y        P K  APE +     Y+   DVW+ G    E+ +
Sbjct: 197 NDS-NYVVKGNARLPVKWMAPESIF-NCVYTFESDVWSYGIFLWELFS 242

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  101 bits (253), Expect = 7e-25
 Identities = 54/234 (23%), Positives = 95/234 (40%), Gaps = 56/234 (23%)

Query: 12  IKKIGAGGYGEVYKCR-----NTVTGQKVAIKMM----TIQTEQEGVPSYIIREVSLLKE 62
            K +G G +G+V K              VA+KM+    +    ++     ++ E ++LK+
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRD-----LLSEFNVLKQ 82

Query: 63  LEHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILK-------- 113
           + H ++++L    S    + L+ EY     L  F+   +      +     +        
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 114 ---------------QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIG 158
                          QI  G+ Y   +K++HRDL   N+L+  +   +K++DFGL+R + 
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA-EGRKMKISDFGLSRDV- 200

Query: 159 VPQKEYSRDCVYS-------PYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT 203
                Y  D  Y        P K  A E L     Y+T  DVW+ G +  E++T
Sbjct: 201 -----YEED-SYVKRSQGRIPVKWMAIESLF-DHIYTTQSDVWSFGVLLWEIVT 247

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  101 bits (254), Expect = 7e-25
 Identities = 68/281 (24%), Positives = 113/281 (40%), Gaps = 57/281 (20%)

Query: 12  IKKIGAGGYGEVYKCRNTVTGQKVAIKMMT----IQTEQEGVPSYIIREVSLLKELEHEN 67
           +K +G G +G+V   R   TG+  A+K++     I  ++    ++ + E  +L+   H  
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEV---AHTVTESRVLQNTRHPF 66

Query: 68  IVRLLDVQSSRKDVFLVFEYL---DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
           +  L     +   +  V EY    +L  H      +        +    +I+  L Y HS
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFH---LSRERVFTEERARFYGAEIVSALEYLHS 123

Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRD-------CVYSPYKAPE 177
             +++RD+K  NL++D   + +K+ DFGL        KE   D       C    Y APE
Sbjct: 124 RDVVYRDIKLENLMLDKDGH-IKITDFGLC-------KEGISDGATMKTFCGTPEYLAPE 175

Query: 178 LLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYI 237
           +L     Y   +D W +G +  EM+ G+  F ++ H+ L   F L              I
Sbjct: 176 VLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL---FEL--------------I 217

Query: 238 SEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQR 278
                 +P             L P    LL+ +L  +PKQR
Sbjct: 218 LMEEIRFPRT-----------LSPEAKSLLAGLLKKDPKQR 247

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  103 bits (257), Expect = 2e-24
 Identities = 54/276 (19%), Positives = 105/276 (38%), Gaps = 46/276 (16%)

Query: 12  IKKIGAGGYGEVYKCRNTVTGQKVAIKMM---TIQTEQEGVPSYIIREVSLLKELEHENI 68
           +  +G G +G+V       T +  A+K++    +  + +   + + + V L    +   +
Sbjct: 346 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRV-LALPGKPPFL 404

Query: 69  VRLLDVQSSRKDVFLVFEYL---DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSL 125
            +L     +   ++ V EY+   DL  H    +               +I +GL +  S 
Sbjct: 405 TQLHSCFQTMDRLYFVMEYVNGGDLMYH---IQQVGRFKEPHAVFYAAEIAIGLFFLQSK 461

Query: 126 KILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGY 185
            I++RDLK +N+++D + + +K+ADFG+ +            C    Y APE++     Y
Sbjct: 462 GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY-QPY 519

Query: 186 STPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEIL---P 242
              +D WA G +  EM+ G+  F  +  D L                       I+    
Sbjct: 520 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL--------------------FQSIMEHNV 559

Query: 243 LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQR 278
            YP             +    V +   ++  +P +R
Sbjct: 560 AYPKS-----------MSKEAVAICKGLMTKHPGKR 584

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 99.7 bits (249), Expect = 2e-24
 Identities = 57/229 (24%), Positives = 98/229 (42%), Gaps = 52/229 (22%)

Query: 12  IKKIGAGGYGEVYKCR-----NTVTGQKVAIKMM----TIQTEQEGVPSYIIREVSLLKE 62
            K +G G +G+V +        T T + VA+KM+    T    +      ++ E+ +L  
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA-----LMSELKILIH 86

Query: 63  L-EHENIVRLLDVQSSRKD--VFLVFEYLDL-DLHSFITRH---------------KNTL 103
           +  H N+V LL    ++    + ++ E+    +L +++                  K+ L
Sbjct: 87  IGHHLNVVNLLGA-CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145

Query: 104 NLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE 163
            L  +     Q+  G+ +  S K +HRDL   N+L+  ++N VK+ DFGLAR I      
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLARDI------ 198

Query: 164 YSRDCVYS-------PYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           Y     Y        P K  APE +     Y+   DVW+ G +  E+ +
Sbjct: 199 YKDP-DYVRKGDARLPLKWMAPETIF-DRVYTIQSDVWSFGVLLWEIFS 245

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  100 bits (250), Expect = 2e-24
 Identities = 57/229 (24%), Positives = 98/229 (42%), Gaps = 51/229 (22%)

Query: 12  IKKIGAGGYGEVYKCR-------NTVTGQKVAIKMM----TIQTEQEGVPSYIIREVSLL 60
            K +G G +G+V                  VA+KM+    T +   +     ++ E+ ++
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-----LVSEMEMM 94

Query: 61  KEL-EHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTL------------NLL 106
           K + +H+NI+ LL   +    ++++ EY    +L  ++   +                 +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154

Query: 107 VIKAILK---QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE 163
             K ++    Q+  G+ Y  S K +HRDL   N+L+  + N +K+ADFGLAR I      
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLARDI------ 207

Query: 164 YSRDCVYS-------PYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT 203
            + D  Y        P K  APE L     Y+   DVW+ G +  E+ T
Sbjct: 208 NNID-YYKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLMWEIFT 254

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  100 bits (250), Expect = 3e-24
 Identities = 56/229 (24%), Positives = 97/229 (42%), Gaps = 51/229 (22%)

Query: 12  IKKIGAGGYGEVYKCR-------NTVTGQKVAIKMM----TIQTEQEGVPSYIIREVSLL 60
            K +G G +G+V                  VA+KM+    T +   +     ++ E+ ++
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-----LVSEMEMM 140

Query: 61  KEL-EHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHK---------------NTL 103
           K + +H+NI+ LL   +    ++++ EY    +L  ++   +                 +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200

Query: 104 NLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE 163
               + +   Q+  G+ Y  S K +HRDL   N+L+  + N +K+ADFGLAR I      
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLARDI------ 253

Query: 164 YSRDCVYS-------PYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT 203
            + D  Y        P K  APE L     Y+   DVW+ G +  E+ T
Sbjct: 254 NNID-YYKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLMWEIFT 300

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  100 bits (251), Expect = 6e-24
 Identities = 69/274 (25%), Positives = 116/274 (42%), Gaps = 42/274 (15%)

Query: 12  IKKIGAGGYGEVYKCRNTVTGQKVAIKMM---TIQTEQEGVPSYIIREVSLLKELEHENI 68
           +K +G G +G+V   +   TG+  A+K++    I  + E   ++ + E  +L+   H  +
Sbjct: 153 LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEV--AHTLTENRVLQNSRHPFL 210

Query: 69  VRLLDVQSSRKDVFLVFEYL---DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSL 125
             L     +   +  V EY    +L  H  ++R +   +    +    +I+  L Y HS 
Sbjct: 211 TALKYSFQTHDRLCFVMEYANGGELFFH--LSRER-VFSEDRARFYGAEIVSALDYLHSE 267

Query: 126 K-ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTG 184
           K +++RDLK  NL++D   + +K+ DFGL +            C    Y APE+L     
Sbjct: 268 KNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED-ND 325

Query: 185 YSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLY 244
           Y   +D W +G +  EM+ G+  F ++ H+ L   F L              I      +
Sbjct: 326 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---FEL--------------ILMEEIRF 368

Query: 245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQR 278
           P             L P    LLS +L  +PKQR
Sbjct: 369 PRT-----------LGPEAKSLLSGLLKKDPKQR 391

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 99.8 bits (249), Expect = 6e-24
 Identities = 59/229 (25%), Positives = 99/229 (43%), Gaps = 51/229 (22%)

Query: 12  IKKIGAGGYGEVYKCR-------NTVTGQKVAIKMM----TIQTEQEGVPSYIIREVSLL 60
            K +G G +G+V                 KVA+KM+    T +   +     +I E+ ++
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-----LISEMEMM 128

Query: 61  KEL-EHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHK---------------NTL 103
           K + +H+NI+ LL   +    ++++ EY    +L  ++   +                 L
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188

Query: 104 NLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE 163
           +   + +   Q+  G+ Y  S K +HRDL   N+L+  + N +K+ADFGLAR I      
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT-EDNVMKIADFGLARDI------ 241

Query: 164 YSRDCVYS-------PYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           +  D  Y        P K  APE L     Y+   DVW+ G +  E+ T
Sbjct: 242 HHID-YYKKTTNGRLPVKWMAPEALF-DRIYTHQSDVWSFGVLLWEIFT 288

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 98.5 bits (246), Expect = 1e-23
 Identities = 59/225 (26%), Positives = 94/225 (41%), Gaps = 47/225 (20%)

Query: 12  IKKIGAGGYGEVYKC-----RNTVTGQKVAIKMM----TIQTEQEGVPSYIIREVSLLKE 62
            K +GAG +G+V +             KVA+KM+        ++      ++ E+ ++  
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA-----LMSELKIMSH 105

Query: 63  L-EHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILK------- 113
           L +HENIV LL   +    V ++ EY    DL +F+ R    L      AI         
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165

Query: 114 ------QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRD 167
                 Q+  G+A+  S   +HRD+   N+L+    +  K+ DFGLAR I       +  
Sbjct: 166 LLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDI------MNDS 218

Query: 168 CVYS-------PYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT 203
             Y        P K  APE +     Y+   DVW+ G +  E+ +
Sbjct: 219 -NYIVKGNARLPVKWMAPESIF-DCVYTVQSDVWSYGILLWEIFS 261

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 98.0 bits (245), Expect = 1e-23
 Identities = 74/287 (25%), Positives = 126/287 (43%), Gaps = 65/287 (22%)

Query: 12  IKKIGAGGYGEVYKCRNTV---TGQKVAIKMM---TIQTEQEGVPSYIIREVSLLKELEH 65
           ++ +G GGYG+V++ R      TG+  A+K++    I    +   ++   E ++L+E++H
Sbjct: 22  LRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDT-AHTKAERNILEEVKH 80

Query: 66  ENIVRLLDV-QSSRKDVFLVFEYL---DLDLHSFITRHKNTLNLLVIKAILKQILLGLAY 121
             IV L+   Q+  K ++L+ EYL   +L +       +           L +I + L +
Sbjct: 81  PFIVDLIYAFQTGGK-LYLILEYLSGGELFMQ---LEREGIFMEDTACFYLAEISMALGH 136

Query: 122 CHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRD-------CVYSPYK 174
            H   I++RDLKP N++++ + + VKL DFGL        KE   D       C    Y 
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQGH-VKLTDFGLC-------KESIHDGTVTHTFCGTIEYM 188

Query: 175 APELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAES 234
           APE+L+  +G++  +D W++G +  +M+TG P F  +                       
Sbjct: 189 APEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT------------------ 229

Query: 235 TYISEIL---PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQR 278
             I +IL      P           P L     DLL ++L  N   R
Sbjct: 230 --IDKILKCKLNLP-----------PYLTQEARDLLKKLLKRNAASR 263

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 98.4 bits (246), Expect = 1e-23
 Identities = 73/292 (25%), Positives = 119/292 (40%), Gaps = 62/292 (21%)

Query: 12  IKKIGAGGYGEVYKCRNTVTGQKVAIKMM---TIQTEQEGVPSYIIREVSLLKELEHENI 68
            K +G G +G+V+      T Q  AIK +    +  + +   + + + V L    EH  +
Sbjct: 22  HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV-LSLAWEHPFL 80

Query: 69  VRLLDV-QSSRKDVFLVFEYL---DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
             +    Q+    +F V EYL   DL  H    +  +  +L        +I+LGL + HS
Sbjct: 81  THMFCTFQTKEN-LFFVMEYLNGGDLMYH---IQSCHKFDLSRATFYAAEIILGLQFLHS 136

Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRD-------CVYSPYKAPE 177
             I++RDLK +N+L+D   + +K+ADFG+        KE           C    Y APE
Sbjct: 137 KGIVYRDLKLDNILLDKDGH-IKIADFGMC-------KENMLGDAKTNTFCGTPDYIAPE 188

Query: 178 LLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYI 237
           +LLG   Y+  +D W+ G +  EM+ G+  F  +  + L                     
Sbjct: 189 ILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL--------------------F 227

Query: 238 SEIL---PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK 286
             I    P YP             LE    DLL ++    P++R+     ++
Sbjct: 228 HSIRMDNPFYP-----------RWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 98.1 bits (245), Expect = 1e-23
 Identities = 56/221 (25%), Positives = 91/221 (41%), Gaps = 43/221 (19%)

Query: 12  IKKIGAGGYGEVYKCR--NTVTGQKVAIKMM-TIQTEQEGVPSYIIREVSLLKEL-EHEN 67
              IG G +G+V K R          AIK M    ++ +        E+ +L +L  H N
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD--HRDFAGELEVLCKLGHHPN 87

Query: 68  IVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRH---------------KNTLNLLVIKAI 111
           I+ LL     R  ++L  EY    +L  F+ +                 +TL+   +   
Sbjct: 88  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147

Query: 112 LKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS 171
              +  G+ Y    + +HRDL   N+L+  +    K+ADFGL+R      +E      Y 
Sbjct: 148 AADVARGMDYLSQKQFIHRDLAARNILVG-ENYVAKIADFGLSR-----GQEV-----YV 196

Query: 172 -------PYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT 203
                  P +  A E L  Y+ Y+T  DVW+ G +  E+++
Sbjct: 197 KKTMGRLPVRWMAIESLN-YSVYTTNSDVWSYGVLLWEIVS 236

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 97.0 bits (242), Expect = 3e-23
 Identities = 59/233 (25%), Positives = 97/233 (41%), Gaps = 54/233 (23%)

Query: 12  IKKIGAGGYGEVYKCR-----NTVTGQKVAIKMM---TIQTEQEGVPSYIIREVSLLKEL 63
            K +G+G +G+V          T    +VA+KM+      +E+E     ++ E+ ++ +L
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREA----LMSELKMMTQL 105

Query: 64  -EHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILK-------- 113
             HENIV LL   +    ++L+FEY    DL +++   +   +   I+   +        
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165

Query: 114 --------------QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGV 159
                         Q+  G+ +      +HRDL   N+L+      VK+ DFGLAR I  
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT-HGKVVKICDFGLARDI-- 222

Query: 160 PQKEYSRDCVYS-------PYK--APELLLGYTGYSTPIDVWAVGCIFAEMIT 203
                S    Y        P K  APE L     Y+   DVW+ G +  E+ +
Sbjct: 223 ----MSDS-NYVVRGNARLPVKWMAPESLF-EGIYTIKSDVWSYGILLWEIFS 269

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 96.9 bits (242), Expect = 4e-23
 Identities = 65/281 (23%), Positives = 110/281 (39%), Gaps = 56/281 (19%)

Query: 12  IKKIGAGGYGEVYKCRNTVTGQKVAIKMM---TIQTEQEGVPSYIIREVSLLKELEHENI 68
           I+ +G G +G+V   R   TG   A+K++    I  + +   +   + + L     H  +
Sbjct: 28  IRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRI-LSLARNHPFL 86

Query: 69  VRLLDV-QSSRKDVFLVFEYL---DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
            +L    Q+  + +F V E++   DL  H    +     +    +    +I+  L + H 
Sbjct: 87  TQLFCCFQTPDR-LFFVMEFVNGGDLMFH---IQKSRRFDEARARFYAAEIISALMFLHD 142

Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRD-------CVYSPYKAPE 177
             I++RDLK +N+L+D + +  KLADFG+        KE   +       C    Y APE
Sbjct: 143 KGIIYRDLKLDNVLLDHEGH-CKLADFGMC-------KEGICNGVTTATFCGTPDYIAPE 194

Query: 178 LLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYI 237
           +L     Y   +D WA+G +  EM+ G   F ++  D L                    I
Sbjct: 195 ILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL-----------------FEAI 236

Query: 238 SEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQR 278
                +YP +           L      +L   +  NP  R
Sbjct: 237 LNDEVVYPTW-----------LHEDATGILKSFMTKNPTMR 266

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 95.7 bits (239), Expect = 7e-23
 Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 27/218 (12%)

Query: 14  KIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYI--IREVSLLKELEHENIVRL 71
           K+G GG+G VYK    V    VA+K +    +           +E+ ++ + +HEN+V L
Sbjct: 38  KMGEGGFGVVYK--GYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95

Query: 72  LDVQSSRKDVFLVFEYL---DLDLHSFITRHKNTLN----LLVIKAILKQILLGLAYCHS 124
           L   S   D+ LV+ Y+    L            L+      + +        G+ + H 
Sbjct: 96  LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN----GINFLHE 151

Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCV---YSPYKAPELLLG 181
              +HRD+K  N+L+D      K++DFGLARA     +      +    + Y APE    
Sbjct: 152 NHHIHRDIKSANILLDEAFTA-KISDFGLARASEKFAQTVMTSRIVGTTA-YMAPE---- 205

Query: 182 Y-TGYSTP-IDVWAVGCIFAEMITG-KPLFPSKKHDHL 216
              G  TP  D+++ G +  E+ITG   +   ++   L
Sbjct: 206 ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL 243

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 96.1 bits (240), Expect = 7e-23
 Identities = 57/283 (20%), Positives = 107/283 (37%), Gaps = 60/283 (21%)

Query: 12  IKKIGAGGYGEVYKCRNTVTGQKVAIKMM---TIQTEQEGVPSYIIREVSLLKELEHENI 68
           +  +G G +G+V       T +  A+K++    +  + +   + + + V L    +   +
Sbjct: 25  LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRV-LALPGKPPFL 83

Query: 69  VRLLDVQSSRKDVFLVFEYL---DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSL 125
            +L     +   ++ V EY+   DL  H    +               +I +GL +  S 
Sbjct: 84  TQLHSCFQTMDRLYFVMEYVNGGDLMYH---IQQVGRFKEPHAVFYAAEIAIGLFFLQSK 140

Query: 126 KILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRD-------CVYSPYKAPEL 178
            I++RDLK +N+++D + + +K+ADFG+        KE   D       C    Y APE+
Sbjct: 141 GIIYRDLKLDNVMLDSEGH-IKIADFGMC-------KENIWDGVTTKTFCGTPDYIAPEI 192

Query: 179 LLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYIS 238
           +     Y   +D WA G +  EM+ G+  F  +  D L                      
Sbjct: 193 IAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL--------------------FQ 231

Query: 239 EIL---PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQR 278
            I+     YP             +    V +   ++  +P +R
Sbjct: 232 SIMEHNVAYPKS-----------MSKEAVAICKGLMTKHPGKR 263

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 95.8 bits (239), Expect = 2e-22
 Identities = 71/284 (25%), Positives = 113/284 (39%), Gaps = 62/284 (21%)

Query: 12  IKKIGAGGYGEVYKCRNTVTGQKVAIKMM---TIQTEQEGVPSYIIREVSLLKELEHENI 68
           +K IG G +G+V   R+       A+K++    I  ++E       R V LLK ++H  +
Sbjct: 43  LKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNV-LLKNVKHPFL 101

Query: 69  VRLLDV-QSSRKDVFLVFEYL---DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
           V L    Q++ K ++ V +Y+   +L  H    + +        +    +I   L Y HS
Sbjct: 102 VGLHFSFQTADK-LYFVLDYINGGELFYH---LQRERCFLEPRARFYAAEIASALGYLHS 157

Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRD-------CVYSPYKAPE 177
           L I++RDLKP N+L+D + + + L DFGL        KE           C    Y APE
Sbjct: 158 LNIVYRDLKPENILLDSQGH-IVLTDFGLC-------KENIEHNSTTSTFCGTPEYLAPE 209

Query: 178 LLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYI 237
           +L     Y   +D W +G +  EM+ G P F S+    +                     
Sbjct: 210 VLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM--------------------Y 248

Query: 238 SEIL---PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQR 278
             IL                  PN+  +   LL  +L  +  +R
Sbjct: 249 DNILNKPLQLK-----------PNITNSARHLLEGLLQKDRTKR 281

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 94.2 bits (235), Expect = 3e-22
 Identities = 71/287 (24%), Positives = 116/287 (40%), Gaps = 67/287 (23%)

Query: 12  IKKIGAGGYGEVYKCRNTV---TGQKVAIKMM---TIQTEQEGVPSYIIREVSLLKELEH 65
           +K +G G +G+V+  +        Q  A+K++   T++            E  +L E+ H
Sbjct: 29  LKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDR---VRTKMERDILVEVNH 85

Query: 66  ENIVRLLDV-QSSRKDVFLVFEYL---DLDLHSFITRHKNTLNLLVIKAILKQILLGLAY 121
             IV+L    Q+  K ++L+ ++L   DL     +++         +K  L ++ L L +
Sbjct: 86  PFIVKLHYAFQTEGK-LYLILDFLRGGDLFTR--LSKEV-MFTEEDVKFYLAELALALDH 141

Query: 122 CHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRD-------CVYSPYK 174
            HSL I++RDLKP N+L+D + + +KL DFGL+       KE           C    Y 
Sbjct: 142 LHSLGIIYRDLKPENILLDEEGH-IKLTDFGLS-------KESIDHEKKAYSFCGTVEYM 193

Query: 175 APELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAES 234
           APE++    G++   D W+ G +  EM+TG   F  K                       
Sbjct: 194 APEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET------------------ 234

Query: 235 TYISEIL---PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQR 278
             ++ IL      P             L P    LL  +   NP  R
Sbjct: 235 --MTMILKAKLGMP-----------QFLSPEAQSLLRMLFKRNPANR 268

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 94.2 bits (235), Expect = 4e-22
 Identities = 68/284 (23%), Positives = 112/284 (39%), Gaps = 53/284 (18%)

Query: 12  IKKIGAGGYGEVYKCRNTVTGQKVAIKMM---TIQTEQEGVPSYIIREVSLLKELEHENI 68
           ++ IG G Y +V   R   T +  A+K++    +  +++       + V   +   H  +
Sbjct: 14  LRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHV-FEQASNHPFL 72

Query: 69  VRLLDV-QSSRKDVFLVFEYL---DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
           V L    Q+  + +F V EY+   DL  H    + +  L     +    +I L L Y H 
Sbjct: 73  VGLHSCFQTESR-LFFVIEYVNGGDLMFH---MQRQRKLPEEHARFYSAEISLALNYLHE 128

Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRD-------CVYSPYKAPE 177
             I++RDLK +N+L+D + + +KL D+G+        KE  R        C    Y APE
Sbjct: 129 RGIIYRDLKLDNVLLDSEGH-IKLTDYGMC-------KEGLRPGDTTSTFCGTPNYIAPE 180

Query: 178 LLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYI 237
           +L G   Y   +D WA+G +  EM+ G+  F                +   +   E    
Sbjct: 181 ILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVG-----------SSDNPDQNTEDYLF 228

Query: 238 SEIL---PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQR 278
             IL      P            +L      +L   L  +PK+R
Sbjct: 229 QVILEKQIRIP-----------RSLSVKAASVLKSFLNKDPKER 261

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 94.3 bits (235), Expect = 4e-22
 Identities = 68/283 (24%), Positives = 127/283 (44%), Gaps = 49/283 (17%)

Query: 12  IKKIGAGGYGEVYKCRNTV---TGQKVAIKMM---TIQTEQEGVPSYIIREVSLLKELEH 65
           +K +G G YG+V+  R      TG+  A+K++   TI  + +    +   E  +L+ +  
Sbjct: 59  LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTT-EHTRTERQVLEHIRQ 117

Query: 66  EN-IVRLLDV-QSSRKDVFLVFEYL---DLDLHSFITRHKNTLNLLVIKAILKQILLGLA 120
              +V L    Q+  K + L+ +Y+   +L  H      +       ++  + +I+L L 
Sbjct: 118 SPFLVTLHYAFQTETK-LHLILDYINGGELFTH---LSQRERFTEHEVQIYVGEIVLALE 173

Query: 121 YCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELL 179
           + H L I++RD+K  N+L+D   + V L DFGL++     + E + D   +  Y AP+++
Sbjct: 174 HLHKLGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 232

Query: 180 LGY-TGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYIS 238
            G  +G+   +D W++G +  E++TG   F                T   E  +++    
Sbjct: 233 RGGDSGHDKAVDWWSLGVLMYELLTGASPF----------------TVDGEKNSQAEISR 276

Query: 239 EIL---PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQR 278
            IL   P YP             +     DL+ ++L  +PK+R
Sbjct: 277 RILKSEPPYP-----------QEMSALAKDLIQRLLMKDPKKR 308

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 94.3 bits (235), Expect = 5e-22
 Identities = 67/283 (23%), Positives = 110/283 (38%), Gaps = 51/283 (18%)

Query: 12  IKKIGAGGYGEVYKCRNTVTGQKVAIKMM---TIQTEQEGVPSYIIREVSLLKELEHENI 68
           ++ IG G Y +V   R   T +  A++++    +  +++       + V   +   H  +
Sbjct: 57  LRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHV-FEQASNHPFL 115

Query: 69  VRLLDVQSSRKDVFLVFEYL---DLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSL 125
           V L     +   +F V EY+   DL  H  + R +  L     +    +I L L Y H  
Sbjct: 116 VGLHSCFQTESRLFFVIEYVNGGDLMFH--MQRQR-KLPEEHARFYSAEISLALNYLHER 172

Query: 126 KILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRD-------CVYSPYKAPEL 178
            I++RDLK +N+L+D + + +KL D+G+        KE  R        C    Y APE+
Sbjct: 173 GIIYRDLKLDNVLLDSEGH-IKLTDYGMC-------KEGLRPGDTTSTFCGTPNYIAPEI 224

Query: 179 LLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYIS 238
           L G   Y   +D WA+G +  EM+ G+  F                +   +   E     
Sbjct: 225 LRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVG-----------SSDNPDQNTEDYLFQ 272

Query: 239 EIL---PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQR 278
            IL      P             L      +L   L  +PK+R
Sbjct: 273 VILEKQIRIPRS-----------LSVKAASVLKSFLNKDPKER 304

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 94.3 bits (234), Expect = 1e-21
 Identities = 42/151 (27%), Positives = 74/151 (49%), Gaps = 7/151 (4%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-HE 66
            ++  +KIG+G +GE+Y   N  T ++VAIK+  ++T+       ++ E  + + L+   
Sbjct: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGT 63

Query: 67  NIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
            I  +           LV + L   L          L+L  +  +  Q++  + + HS  
Sbjct: 64  GIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123

Query: 127 ILHRDLKPNNLLIDL--KRNTVKLADFGLAR 155
            LHRD+KP+N L+ L  + N V + DFGLA+
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 91.7 bits (228), Expect = 1e-21
 Identities = 41/151 (27%), Positives = 73/151 (48%), Gaps = 7/151 (4%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEH-E 66
            Y+  +KIG+G +G++Y   +   G++VAIK+  ++T+       +  E  + K ++   
Sbjct: 10  RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGV 65

Query: 67  NIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
            I  +    +      +V E L   L           +L  +  +  Q++  + Y HS  
Sbjct: 66  GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 125

Query: 127 ILHRDLKPNNLLIDL--KRNTVKLADFGLAR 155
            +HRD+KP+N L+ L  K N V + DFGLA+
Sbjct: 126 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 90.9 bits (226), Expect = 3e-21
 Identities = 35/153 (22%), Positives = 65/153 (42%), Gaps = 9/153 (5%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEH-E 66
           +YK  ++IG G +G +++  N +  Q+VAIK    +++       +  E    K L    
Sbjct: 11  HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCT 66

Query: 67  NIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
            I  +           LV + L   L   +       ++  +    KQ+L  +   H   
Sbjct: 67  GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 126

Query: 127 ILHRDLKPNNLLIDL----KRNTVKLADFGLAR 155
           +++RD+KP+N LI        N + + DFG+ +
Sbjct: 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 91.3 bits (227), Expect = 3e-21
 Identities = 41/153 (26%), Positives = 70/153 (45%), Gaps = 9/153 (5%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEH-E 66
           N++  KKIG G +GE+   +N  T + VAIK+  +++        +  E    K+L   +
Sbjct: 10  NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGD 65

Query: 67  NIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
            I ++       K   +V E L   L         T +L  +  I  Q++  + Y HS  
Sbjct: 66  GIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN 125

Query: 127 ILHRDLKPNNLLIDL----KRNTVKLADFGLAR 155
           +++RD+KP N LI       +  + + DF LA+
Sbjct: 126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 91.3 bits (227), Expect = 3e-21
 Identities = 39/194 (20%), Positives = 81/194 (41%), Gaps = 31/194 (15%)

Query: 1   MGKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLL 60
           +  ++   +   KKIG+GG+G +Y    T   +K A  ++ ++ ++ G    +  E+   
Sbjct: 31  LDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGP---LFSELKFY 87

Query: 61  KELEHENIVRLLDVQSSRKDV-------------------FLVFEYLDLDLHSFITRHKN 101
           + +  ++ ++    +     +                   F+V E L +DL     ++  
Sbjct: 88  QRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG- 146

Query: 102 TLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK-RNTVKLADFGLARAIGVP 160
           T     +  +  ++L  L Y H  + +H D+K  NLL+  K  + V LAD+GL+      
Sbjct: 147 TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLS------ 200

Query: 161 QKEYSRDCVYSPYK 174
              Y  +  +  Y+
Sbjct: 201 -YRYCPNGNHKQYQ 213

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 90.0 bits (224), Expect = 9e-21
 Identities = 62/231 (26%), Positives = 100/231 (43%), Gaps = 38/231 (16%)

Query: 1   MGKLKNLNYKKIK----------KIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVP 50
           +G+LK  + ++++           +G GG+G+VYK R    G  VA+K +  +  Q G  
Sbjct: 14  LGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQ-GGE 71

Query: 51  SYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLD---LDLHSF-ITRHKNTLNLL 106
                EV ++    H N++RL     +  +  LV+ Y+    +          +  L+  
Sbjct: 72  LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWP 131

Query: 107 VIKAILKQILLGLAYCH---SLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE 163
             + I      GLAY H     KI+HRD+K  N+L+D +     + DFGLA       K 
Sbjct: 132 KRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD-EEFEAVVGDFGLA-------KL 183

Query: 164 YSRDCVYSP--------YKAPELLLGYTGYSTP-IDVWAVGCIFAEMITGK 205
                 +          + APE L   TG S+   DV+  G +  E+ITG+
Sbjct: 184 MDYKDTHVTTAVRGTIGHIAPEYLS--TGKSSEKTDVFGYGVMLLELITGQ 232

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 85.7 bits (213), Expect = 3e-19
 Identities = 58/236 (24%), Positives = 103/236 (43%), Gaps = 46/236 (19%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
           N+     IG G +G+VYK      G KVA+K  T ++ Q G+  +   E+  L    H +
Sbjct: 40  NFDHKFLIGHGVFGKVYKGV-LRDGAKVALKRRTPESSQ-GIEEFET-EIETLSFCRHPH 96

Query: 68  IVRLLDVQSSRKDVFLVFEYL---DLDLH-----------SFITRHKNTLNLLVIKAILK 113
           +V L+     R ++ L+++Y+   +L  H           S+  R +             
Sbjct: 97  LVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLE------------- 143

Query: 114 QILL----GLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY-SRDC 168
            I +    GL Y H+  I+HRD+K  N+L+D +    K+ DFG+++      + + S   
Sbjct: 144 -ICIGAARGLHYLHTRAIIHRDVKSINILLD-ENFVPKITDFGISKKGTELDQTHLSTVV 201

Query: 169 VYSP-YKAPELLLGY--TGYSTP-IDVWAVGCIFAEMITGK-PLFPSKKHDHLSLI 219
             +  Y  PE    Y   G  T   DV++ G +  E++  +  +  S   + ++L 
Sbjct: 202 KGTLGYIDPE----YFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA 253

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 85.2 bits (211), Expect = 6e-19
 Identities = 32/186 (17%), Positives = 59/186 (31%), Gaps = 26/186 (13%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTG--------QKVAIKM--------MTIQTEQEGVPS 51
            +K          G +Y+   T T         QK ++K+              Q     
Sbjct: 43  QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKP 102

Query: 52  YIIREVSLLKELEHENIVRLLDVQSSRKDV-FLVFEYLDLDLHS-FITRHKNTLNLLVIK 109
             + +   L       I   +     +    FLV   L   L S      K+ L+   + 
Sbjct: 103 LQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVL 162

Query: 110 AILKQILLGLAYCHSLKILHRDLKPNNLLIDL-KRNTVKLADFGLARAIGVPQKEYSRDC 168
            +  ++L  L + H  + +H ++   N+ +D   ++ V LA +G A         Y    
Sbjct: 163 QVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFA-------FRYCPSG 215

Query: 169 VYSPYK 174
            +  Y 
Sbjct: 216 KHVAYV 221

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 83.3 bits (206), Expect = 3e-18
 Identities = 31/173 (17%), Positives = 60/173 (34%), Gaps = 31/173 (17%)

Query: 8   NYKKIKKIGAGGYGEVYKCR-----NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKE 62
            +K    IG GG+G +Y        +  +     +K+             +  E+   + 
Sbjct: 36  AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGP------LFTELKFYQR 89

Query: 63  LEHENIVRLLDVQSSRKDV-------------------FLVFEYLDLDLHSFITRHKNTL 103
                 ++        K +                   F++ +    DL      +    
Sbjct: 90  AAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRF 149

Query: 104 NLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKR-NTVKLADFGLAR 155
           +   +  +  +IL  L Y H  + +H D+K +NLL++ K  + V L D+GLA 
Sbjct: 150 SRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 63.0 bits (153), Expect = 2e-11
 Identities = 31/92 (33%), Positives = 47/92 (51%), Gaps = 4/92 (4%)

Query: 114 QILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPY 173
           Q+  G+ +  S K +HRDL   N+L+  ++N VK+ DFGLAR I        +     P 
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPL 259

Query: 174 K--APELLLGYTGYSTPIDVWAVGCIFAEMIT 203
           K  APE +     Y+   DVW+ G +  E+ +
Sbjct: 260 KWMAPETIF-DRVYTIQSDVWSFGVLLWEIFS 290

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 47.6 bits (113), Expect = 3e-06
 Identities = 22/106 (20%), Positives = 45/106 (42%), Gaps = 9/106 (8%)

Query: 13  KKIGAGGYGEVYKCR-----NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHE 66
           K +G G +G+V +        T T + VA+KM+          +  + E+ +L  +  H 
Sbjct: 28  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL-MSELKILIHIGHHL 86

Query: 67  NIVRLLDVQSSRKD-VFLVFEYLDL-DLHSFITRHKNTLNLLVIKA 110
           N+V LL   +     + ++ E+    +L +++   +N       K 
Sbjct: 87  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKG 132

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 56.8 bits (136), Expect = 4e-09
 Identities = 55/303 (18%), Positives = 98/303 (32%), Gaps = 83/303 (27%)

Query: 3   KLKNLNYKKIKKI---GAGGYG------EVYKCRNTVTGQKVAIKM------MTIQTEQE 47
            L  L  +  K +   G  G G      +V  C +     KV  KM      + +     
Sbjct: 143 ALLEL--RPAKNVLIDGVLGSGKTWVALDV--CLS----YKVQCKMDFKIFWLNL----- 189

Query: 48  GVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNT-LNLL 106
                     ++L+ L+       L  Q            +D +  S      N  L + 
Sbjct: 190 ---KNCNSPETVLEMLQK------LLYQ------------IDPNWTSRSDHSSNIKLRIH 228

Query: 107 VIKAILKQILLGLAYCHSLKILHRDLKPNNLL--IDLK-------RNTVKLADFGLARAI 157
            I+A L+++L    Y + L +L  +++        +L        R   ++ DF  A   
Sbjct: 229 SIQAELRRLLKSKPYENCLLVL-LNVQNAKAWNAFNLSCKILLTTRFK-QVTDFLSAATT 286

Query: 158 GVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLS 217
                ++      +P +   LLL Y              +  E++T  P         LS
Sbjct: 287 THISLDHHSM-TLTPDEVKSLLLKYLDCR-------PQDLPREVLTTNPR-------RLS 331

Query: 218 LIFSLL--GTPTDESWAESTY--ISEILPL-YPHFEPANLAEKFPNLE--PAGVDLLSQM 270
           +I   +  G  T ++W       ++ I+       EPA   + F  L   P    + + +
Sbjct: 332 IIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTIL 391

Query: 271 LCL 273
           L L
Sbjct: 392 LSL 394

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 41.4 bits (96), Expect = 3e-04
 Identities = 48/349 (13%), Positives = 89/349 (25%), Gaps = 110/349 (31%)

Query: 39  MMTIQTEQEGVPSYIIREVSLLKELEHEN--IVRLLDVQSSRKDVFLVFEYLDLD---LH 93
              I+     + + + R   LLK   +EN  +V LL+VQ+++      +   +L    L 
Sbjct: 220 SSNIKLRIHSIQAELRR---LLKSKPYENCLLV-LLNVQNAK-----AWNAFNLSCKIL- 269

Query: 94  SFITRHKNTLNLL----VIKAILKQILLGLAYCHSLKILHR-------DLKP-----NNL 137
              TR K   + L         L    + L       +L +       DL       N  
Sbjct: 270 -LTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPR 328

Query: 138 LIDL----KRNTVKLADF-------GLARAIGV------P--QKEYSRDC------VYSP 172
            + +     R+ +   D         L   I        P   ++            + P
Sbjct: 329 RLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIP 388

Query: 173 YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDE--- 229
                L+      S  + V         ++  +P   S      S+   L     +E   
Sbjct: 389 TILLSLIWFDVIKSDVMVV-VNKLHKYSLVEKQP-KESTISIP-SIYLELKVKLENEYAL 445

Query: 230 ---------------SWAEST-----YISEILPLYPHFEPANLAEK---FPNL------- 259
                          S          Y    +  + H +     E+   F  +       
Sbjct: 446 HRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIG-H-HLKNIEHPERMTLFRMVFLDFRFL 503

Query: 260 ------------EPAGV-DLLSQMLCLNPKQRITAMDALKHEYLIGVEN 295
                           + + L Q+     K  I   D      +  + +
Sbjct: 504 EQKIRHDSTAWNASGSILNTLQQL--KFYKPYICDNDPKYERLVNAILD 550

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	324
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.93
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.88
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.84
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.73
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.46
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.28
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.17
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.05
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.88
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.78
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.68
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.56
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.39
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.37
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	98.37
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.35
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.14
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.94
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.92
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.86
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.69
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.62
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.58
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.5
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.42
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.12
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.12
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.11
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.07
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.86
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.68
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.19
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	88.63
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	86.62

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=7.5e-63  Score=427.34  Aligned_cols=267  Identities=25%  Similarity=0.429  Sum_probs=229.1

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE   86 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   86 (324)
                      ..|++++.||+|+||.||+|.++.+|+.||+|++......  ..+.+.+|+.++++++||||+++++++.+++.+|||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE  151 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME  151 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS--SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            5699999999999999999999999999999999765433  35678899999999999999999999999999999999


Q ss_pred             ecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccc
Q 045787           87 YLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYS  165 (324)
Q Consensus        87 ~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~  165 (324)
                      |++| +|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...........
T Consensus       152 y~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~-~~g~vKl~DFGla~~~~~~~~~~~  228 (346)
T 4fih_A          152 FLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRK  228 (346)
T ss_dssp             CCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC-TTCCEEECCCTTCEECCSSSCCBC
T ss_pred             CCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEC-CCCCEEEecCcCceecCCCCCccc
Confidence            9985 78877765  4699999999999999999999999999999999999999 899999999999998765555666


Q ss_pred             ccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCC
Q 045787          166 RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYP  245 (324)
Q Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (324)
                      ..+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.....+...                
T Consensus       229 ~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~----------------  291 (346)
T 4fih_A          229 SLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLK----------------  291 (346)
T ss_dssp             CCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCS----------------
T ss_pred             ccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCC----------------
Confidence            7799999999999987 67899999999999999999999999887765544433321111111                


Q ss_pred             CCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchhhhhhhh
Q 045787          246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLIN  304 (324)
Q Consensus       246 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~~~~~~~  304 (324)
                               .+..+++++++||.+||+.||.+|||++|+++||||++...+....+++.
T Consensus       292 ---------~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~p~~l~pl~~  341 (346)
T 4fih_A          292 ---------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVPLMR  341 (346)
T ss_dssp             ---------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCGGGTGGGST
T ss_pred             ---------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCCCcccCcccc
Confidence                     12358899999999999999999999999999999998876554444443

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=6.9e-63  Score=415.97  Aligned_cols=255  Identities=31%  Similarity=0.524  Sum_probs=207.5

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      ++|++.+.||+|+||+||+|.+..+|+.||+|++..... .......+.+|+.++++++||||+++++++.+++.+|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            689999999999999999999999999999999976543 3334567899999999999999999999999999999999


Q ss_pred             EecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccc
Q 045787           86 EYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYS  165 (324)
Q Consensus        86 e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~  165 (324)
                      ||++|+|.+.+.+. +++++..++.++.||+.||.|||++|++||||||+|||++ .++.+||+|||++..... .....
T Consensus        93 Ey~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~-~~~~vkl~DFGla~~~~~-~~~~~  169 (275)
T 3hyh_A           93 EYAGNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLD-EHLNVKIADFGLSNIMTD-GNFLK  169 (275)
T ss_dssp             ECCCEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEEC-TTCCEEECCSSCC-----------
T ss_pred             eCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEEC-CCCCEEEeecCCCeecCC-CCccC
Confidence            99999999998774 5699999999999999999999999999999999999999 899999999999987653 23344


Q ss_pred             ccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCC
Q 045787          166 RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYP  245 (324)
Q Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (324)
                      ..+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+...+...+.....+                   
T Consensus       170 ~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~-------------------  230 (275)
T 3hyh_A          170 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYT-------------------  230 (275)
T ss_dssp             -----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-------------------
T ss_pred             CeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC-------------------
Confidence            5689999999999998555678999999999999999999999887765544433221110                   


Q ss_pred             CCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccC
Q 045787          246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIG  292 (324)
Q Consensus       246 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~  292 (324)
                               ....+++++++||.+||+.||.+|||++|+++||||+.
T Consensus       231 ---------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          231 ---------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             ---------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             ---------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence                     11257899999999999999999999999999999974

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5.8e-63  Score=421.93  Aligned_cols=265  Identities=23%  Similarity=0.408  Sum_probs=228.9

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeecc-ccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQT-EQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   83 (324)
                      ..++|++.+.||+|+||+||+|+++.+|+.||+|++.+.. ......+.+.+|++++++++||||+++++++++++.+|+
T Consensus        30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yi  109 (311)
T 4aw0_A           30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF  109 (311)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            3467999999999999999999999999999999998654 233445779999999999999999999999999999999


Q ss_pred             EEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC-
Q 045787           84 VFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ-  161 (324)
Q Consensus        84 v~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~-  161 (324)
                      ||||++| +|.+++... +.+++..++.++.||+.||.|||++|++||||||+|||++ .++.+||+|||++....... 
T Consensus       110 vmEy~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~-~~g~vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          110 GLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESK  187 (311)
T ss_dssp             EECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-TTSCEEECCCTTCEECCTTTT
T ss_pred             EEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEc-CCCCEEEEEcCCceecCCCCC
Confidence            9999985 999988764 5699999999999999999999999999999999999999 89999999999998875332 


Q ss_pred             -CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcc
Q 045787          162 -KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEI  240 (324)
Q Consensus       162 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (324)
                       ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+...+...+......              
T Consensus       188 ~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~--------------  252 (311)
T 4aw0_A          188 QARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYD--------------  252 (311)
T ss_dssp             CCCBCCCCSCGGGCCHHHHHH-SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--------------
T ss_pred             cccccCcccCcccCCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC--------------
Confidence             23445689999999999988 67899999999999999999999999887765554433321100              


Q ss_pred             cCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHH------HhcCccccCCCCchhhh
Q 045787          241 LPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMD------ALKHEYLIGVENVPLVI  300 (324)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~------~l~hp~~~~~~~~~~~~  300 (324)
                                    ....+++++++||.+||+.||.+|||++|      +++||||+++++..+..
T Consensus       253 --------------~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~~  304 (311)
T 4aw0_A          253 --------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQ  304 (311)
T ss_dssp             --------------CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGG
T ss_pred             --------------CCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhcC
Confidence                          11257899999999999999999999988      58999999999887754

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.6e-63  Score=429.96  Aligned_cols=263  Identities=27%  Similarity=0.394  Sum_probs=220.0

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE   86 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   86 (324)
                      ++|++++.||+|+||+||+|++..+|+.||+|++..........+.+.+|+.++++++||||+++++++.+++.+|||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            58999999999999999999999999999999998765444445678999999999999999999999999999999999


Q ss_pred             ecC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcc
Q 045787           87 YLD-LDLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY  164 (324)
Q Consensus        87 ~~~-g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~  164 (324)
                      |++ |+|.+++...+ ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.........
T Consensus       104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~-~~g~vKl~DFGla~~~~~~~~~~  182 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT-KDGTVQLGDFGIARVLNSTVELA  182 (350)
T ss_dssp             CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEEC-TTCCEEECSTTEESCCCHHHHHH
T ss_pred             CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEEC-CCCCEEEcccccceeecCCcccc
Confidence            997 59999987654 3579999999999999999999999999999999999999 89999999999998765332333


Q ss_pred             cccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCC
Q 045787          165 SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLY  244 (324)
Q Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (324)
                      ...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.....++                 
T Consensus       183 ~~~~GT~~YmAPE~l~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~-----------------  244 (350)
T 4b9d_A          183 RACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP-----------------  244 (350)
T ss_dssp             HHHHSCCTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC-----------------
T ss_pred             cccCCCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC-----------------
Confidence            44579999999999988 678999999999999999999999998887655544333222111                 


Q ss_pred             CCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchh
Q 045787          245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~  298 (324)
                                ....+++++.+||.+||+.||.+|||++|+|+||||++-....+
T Consensus       245 ----------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~~~~~  288 (350)
T 4b9d_A          245 ----------VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFL  288 (350)
T ss_dssp             ----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTTGGGTS
T ss_pred             ----------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcCCCcCC
Confidence                      12368899999999999999999999999999999987544433

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.8e-61  Score=428.54  Aligned_cols=268  Identities=25%  Similarity=0.429  Sum_probs=230.3

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE   86 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   86 (324)
                      +.|++++.||+|+||.||+|.++.+|+.||+|++......  ..+.+.+|+.++++++||||+++++++.+++.+|||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE  228 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME  228 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS--SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence            5699999999999999999999999999999999765432  35678999999999999999999999999999999999


Q ss_pred             ecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccc
Q 045787           87 YLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYS  165 (324)
Q Consensus        87 ~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~  165 (324)
                      |++| +|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...........
T Consensus       229 y~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~-~~g~vKl~DFGla~~~~~~~~~~~  305 (423)
T 4fie_A          229 FLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRK  305 (423)
T ss_dssp             CCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEEC-TTCCEEECCCTTCEECCSSCCCBC
T ss_pred             CCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc-CCCCEEEecCccceECCCCCcccc
Confidence            9985 78877754  4599999999999999999999999999999999999999 899999999999998766656666


Q ss_pred             ccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCC
Q 045787          166 RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYP  245 (324)
Q Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (324)
                      ..+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.....+..                 
T Consensus       306 ~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~-----------------  367 (423)
T 4fie_A          306 SLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL-----------------  367 (423)
T ss_dssp             CCEECTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-----------------
T ss_pred             ccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC-----------------
Confidence            7799999999999987 6789999999999999999999999988776554444332211111                 


Q ss_pred             CCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchhhhhhhhc
Q 045787          246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLINR  305 (324)
Q Consensus       246 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~~~~~~~~  305 (324)
                              ..+..+++++++||.+||+.||.+|||+.|+|+||||++........+++.+
T Consensus       368 --------~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~p~~l~pl~~~  419 (423)
T 4fie_A          368 --------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVPLMRQ  419 (423)
T ss_dssp             --------SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCGGGTGGGSGG
T ss_pred             --------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCCCccccchhhh
Confidence                    1123689999999999999999999999999999999988766554444433

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=6.9e-62  Score=415.27  Aligned_cols=263  Identities=25%  Similarity=0.388  Sum_probs=217.7

Q ss_pred             CcCcceeEeecccCceEEEEEEEc---cCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNT---VTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF   82 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~---~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   82 (324)
                      .++|++++.||+|+||+||+|++.   .+++.||+|++............+.+|+.++++++||||+++++++.+++.+|
T Consensus        23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  102 (304)
T 3ubd_A           23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY  102 (304)
T ss_dssp             GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred             ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence            467999999999999999999874   46789999999765533333456788999999999999999999999999999


Q ss_pred             EEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC
Q 045787           83 LVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        83 iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~  161 (324)
                      +||||++ |+|.+++... +.+++..++.++.||+.||.|||++|++||||||+|||++ .++.+||+|||++.......
T Consensus       103 ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~-~~g~vKl~DFGla~~~~~~~  180 (304)
T 3ubd_A          103 LILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHE  180 (304)
T ss_dssp             EEECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC-TTSCEEEESSEEEEC-----
T ss_pred             EEEEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEc-CCCCEEecccccceeccCCC
Confidence            9999998 5888888764 5699999999999999999999999999999999999999 89999999999998765444


Q ss_pred             CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhccc
Q 045787          162 KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEIL  241 (324)
Q Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (324)
                      ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.....+               
T Consensus       181 ~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~---------------  244 (304)
T 3ubd_A          181 KKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLG---------------  244 (304)
T ss_dssp             CCCCSCCCCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---------------
T ss_pred             ccccccccCcccCCHHHhcc-CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCC---------------
Confidence            55556789999999999988 77899999999999999999999999888765554433221110               


Q ss_pred             CCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCC-----HHHHhcCccccCCCCchhh
Q 045787          242 PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRIT-----AMDALKHEYLIGVENVPLV  299 (324)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~~~l~hp~~~~~~~~~~~  299 (324)
                                   ....+|+++.+||.+||+.||.+|||     ++|+++||||+++++..+.
T Consensus       245 -------------~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~  294 (304)
T 3ubd_A          245 -------------MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLY  294 (304)
T ss_dssp             -------------CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHHH
T ss_pred             -------------CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHHH
Confidence                         11257899999999999999999998     4799999999999876653

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.2e-61  Score=426.27  Aligned_cols=291  Identities=34%  Similarity=0.615  Sum_probs=242.8

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeec------C
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS------R   78 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~   78 (324)
                      .+++|++++.||+|+||+||+|.+..+|+.||+|++..........+.+.+|+.++++++||||+++++++..      .
T Consensus        52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~  131 (398)
T 4b99_A           52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF  131 (398)
T ss_dssp             CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred             CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence            3568999999999999999999999999999999997654433334668899999999999999999998753      4


Q ss_pred             CeEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeecc
Q 045787           79 KDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIG  158 (324)
Q Consensus        79 ~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~  158 (324)
                      +.+|+||||++|+|.+++.. .+++++..++.++.||+.||.|||++|++||||||+|||++ .++.+||+|||++....
T Consensus       132 ~~~~ivmE~~~g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~-~~~~~Ki~DFGla~~~~  209 (398)
T 4b99_A          132 KSVYVVLDLMESDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVN-ENCELKIGDFGMARGLC  209 (398)
T ss_dssp             CCEEEEEECCSEEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC-TTCCEEECCCTTCBCC-
T ss_pred             CEEEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccC-CCCCEEEeecceeeecc
Confidence            67999999999999998876 45799999999999999999999999999999999999999 99999999999997654


Q ss_pred             CC----CCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHHcCCCCcccccc
Q 045787          159 VP----QKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-HDHLSLIFSLLGTPTDESWAE  233 (324)
Q Consensus       159 ~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~  233 (324)
                      ..    .......+||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+ .+.+..+....+.++...+..
T Consensus       210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~  289 (398)
T 4b99_A          210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA  289 (398)
T ss_dssp             ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred             cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence            32    2233456899999999999886778999999999999999999999998887 455566777777777655443


Q ss_pred             h--hhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCch
Q 045787          234 S--TYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP  297 (324)
Q Consensus       234 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~  297 (324)
                      .  ..............+..+...++.+++++.+||.+||..||.+|||+.|+|+||||++..++.
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~  355 (398)
T 4b99_A          290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPD  355 (398)
T ss_dssp             ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGG
T ss_pred             hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCc
Confidence            2  112222333444555666777888999999999999999999999999999999999987644

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.7e-60  Score=402.67  Aligned_cols=258  Identities=26%  Similarity=0.356  Sum_probs=211.9

Q ss_pred             ccCcCc-ceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeec----C
Q 045787            4 LKNLNY-KKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS----R   78 (324)
Q Consensus         4 ~~~~~y-~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~   78 (324)
                      ...++| ++.+.||+|+||+||+|.+..++..||+|++..........+.+.+|+.++++++||||+++++++.+    +
T Consensus        22 ~~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~  101 (290)
T 3fpq_A           22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK  101 (290)
T ss_dssp             CTTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTE
T ss_pred             CCCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCC
Confidence            344566 77788999999999999999999999999997665444345678999999999999999999999865    4


Q ss_pred             CeEEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcccCCCCCceEeecCCCcEEEeecccee
Q 045787           79 KDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK--ILHRDLKPNNLLIDLKRNTVKLADFGLAR  155 (324)
Q Consensus        79 ~~~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g--~~H~di~p~nIll~~~~~~v~l~d~g~~~  155 (324)
                      ..+|+||||++ |+|.+++... +++++..++.++.||+.||.|||++|  ++||||||+|||++..++.+||+|||+|.
T Consensus       102 ~~~~lvmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~  180 (290)
T 3fpq_A          102 KCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             cEEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence            56899999998 5888888764 57999999999999999999999999  99999999999998457899999999997


Q ss_pred             eccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHHcCCCCcccccch
Q 045787          156 AIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD-HLSLIFSLLGTPTDESWAES  234 (324)
Q Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~  234 (324)
                      ....  ......+||+.|+|||++.+  .++.++|||||||++|+|+||+.||...+.. .+..... .+..+.      
T Consensus       181 ~~~~--~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~-~~~~~~------  249 (290)
T 3fpq_A          181 LKRA--SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT-SGVKPA------  249 (290)
T ss_dssp             GCCT--TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHT-TTCCCG------
T ss_pred             eCCC--CccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHH-cCCCCC------
Confidence            5432  23345689999999999875  5899999999999999999999999765432 2222211 111110      


Q ss_pred             hhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccC
Q 045787          235 TYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIG  292 (324)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~  292 (324)
                                         ......++++.+||.+||+.||.+|||++|+++||||++
T Consensus       250 -------------------~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          250 -------------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             -------------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             -------------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence                               111256789999999999999999999999999999985

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=6.2e-59  Score=401.70  Aligned_cols=257  Identities=24%  Similarity=0.315  Sum_probs=214.3

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE   86 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   86 (324)
                      +.|++.++||+|+||.||+|+++.+|+.||+|++.....       ..+|+.++++++||||+++++++.+++.+|||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE  130 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFME  130 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            468899999999999999999999999999999975432       2379999999999999999999999999999999


Q ss_pred             ecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCC-cEEEeeccceeeccCCCC--
Q 045787           87 YLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN-TVKLADFGLARAIGVPQK--  162 (324)
Q Consensus        87 ~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~-~v~l~d~g~~~~~~~~~~--  162 (324)
                      |++ |+|.+++... +++++..++.++.||+.||.|||++|++||||||+|||++ .++ .+||+|||++........  
T Consensus       131 y~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~-~~g~~vKl~DFGla~~~~~~~~~~  208 (336)
T 4g3f_A          131 LLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS-SDGSRAALCDFGHALCLQPDGLGK  208 (336)
T ss_dssp             CCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEC-TTSCCEEECCCTTCEEC-------
T ss_pred             ccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEe-CCCCEEEEeeCCCCeEccCCCccc
Confidence            998 5888888764 5799999999999999999999999999999999999999 665 799999999987653322  


Q ss_pred             ---cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhc
Q 045787          163 ---EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISE  239 (324)
Q Consensus       163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
                         .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+...+...+.... +             
T Consensus       209 ~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~-~-------------  273 (336)
T 4g3f_A          209 SLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEP-P-------------  273 (336)
T ss_dssp             -----CCCCCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSC-C-------------
T ss_pred             ceecCCccccCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCC-C-------------
Confidence               1223479999999999988 778999999999999999999999998766443332222111 0             


Q ss_pred             ccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHH-------------hcCccccCCCCchh
Q 045787          240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDA-------------LKHEYLIGVENVPL  298 (324)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~-------------l~hp~~~~~~~~~~  298 (324)
                                 ...+..+.+++.+.++|.+||+.||.+|||+.|+             ++|||+++...++.
T Consensus       274 -----------~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr~  334 (336)
T 4g3f_A          274 -----------PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPRG  334 (336)
T ss_dssp             -----------GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCCC
T ss_pred             -----------CchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCCC
Confidence                       1112335789999999999999999999999997             67999999876643

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=4.1e-57  Score=397.15  Aligned_cols=282  Identities=25%  Similarity=0.404  Sum_probs=215.2

Q ss_pred             cCcCcceeEeecccCceEEEEEEEc---cCCceEEEEEeeeccccCCCchHHHHHHHHHHhc-CCCCeeEEEeeeecCCe
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNT---VTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKD   80 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~---~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~   80 (324)
                      +.++|++.+.||+|+||+||+|.++   .+++.||+|.+....    ....+.+|+.+++.+ +||||+++++++.+++.
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~   94 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH   94 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence            4678999999999999999999875   357789999886432    235678999999998 59999999999999999


Q ss_pred             EEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccC
Q 045787           81 VFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGV  159 (324)
Q Consensus        81 ~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~  159 (324)
                      +|+||||++ |+|.+.+.    .+++..++.++.||+.||.|||++|++||||||+|||++.+.+.+||+|||+|.....
T Consensus        95 ~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~  170 (361)
T 4f9c_A           95 VVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD  170 (361)
T ss_dssp             EEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred             EEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence            999999997 58888773    4999999999999999999999999999999999999994448999999999976542


Q ss_pred             CCC----------------------------cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 045787          160 PQK----------------------------EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSK  211 (324)
Q Consensus       160 ~~~----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  211 (324)
                      ...                            .....+||+.|+|||++.+...++.++||||+||++|+|++|+.||...
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~  250 (361)
T 4f9c_A          171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA  250 (361)
T ss_dssp             CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred             ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence            211                            1233479999999999988667899999999999999999999999654


Q ss_pred             C--hhHHHHHHHHcCCCCcccccch----------------hhhhcccCC----CCC-----CCCcchhhhCCCCChhHH
Q 045787          212 K--HDHLSLIFSLLGTPTDESWAES----------------TYISEILPL----YPH-----FEPANLAEKFPNLEPAGV  264 (324)
Q Consensus       212 ~--~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~----~~~-----~~~~~~~~~~~~~~~~l~  264 (324)
                      +  .+.+..+....+.+....+...                ....+....    .+.     .........+..++++++
T Consensus       251 ~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~  330 (361)
T 4f9c_A          251 SDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAY  330 (361)
T ss_dssp             SSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHH
T ss_pred             CCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHH
Confidence            4  3444555554443221111000                000000000    000     001112234567899999


Q ss_pred             HHHHHhhcCCCCCCCCHHHHhcCccccCCC
Q 045787          265 DLLSQMLCLNPKQRITAMDALKHEYLIGVE  294 (324)
Q Consensus       265 ~li~~~l~~dP~~Rps~~~~l~hp~~~~~~  294 (324)
                      +||++||+.||.+|+|++|+|+||||++++
T Consensus       331 DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          331 DLLDKLLDLNPASRITAEEALLHPFFKDMS  360 (361)
T ss_dssp             HHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred             HHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence            999999999999999999999999999875

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.7e-57  Score=389.51  Aligned_cols=258  Identities=23%  Similarity=0.424  Sum_probs=197.3

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCC-------
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK-------   79 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-------   79 (324)
                      ++|++++.||+|+||+||+|.++.+|+.||+|++...... ...+.+.+|+.++++++||||+++++++.+.+       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE-LAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCH-HHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            3599999999999999999999999999999999765422 22356889999999999999999999986543       


Q ss_pred             -----eEEEEEEecC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeec
Q 045787           80 -----DVFLVFEYLD-LDLHSFITRHKN--TLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADF  151 (324)
Q Consensus        80 -----~~~iv~e~~~-g~l~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~  151 (324)
                           .+|+||||+. |+|.+++.....  ..+...++.++.||+.||.|||++|++||||||+|||++ .++.+||+||
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~-~~~~vKl~DF  162 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT-MDDVVKVGDF  162 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC-TTCCEEECCC
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEEC-CCCcEEEccC
Confidence                 4799999997 588888876532  355677899999999999999999999999999999999 8999999999


Q ss_pred             cceeeccCCCC------------cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 045787          152 GLARAIGVPQK------------EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLI  219 (324)
Q Consensus       152 g~~~~~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~  219 (324)
                      |++........            .....+||+.|+|||++.+ ..++.++|||||||++|+|++   ||..... ....+
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyell~---Pf~~~~~-~~~~~  237 (299)
T 4g31_A          163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFSTQME-RVRTL  237 (299)
T ss_dssp             CCC--------------------------CCCTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHS---CCSSHHH-HHHHH
T ss_pred             ccceecCCCccccccccccccccccCCcccCccccCHHHHcC-CCCCCHHHHHHHHHHHHHHcc---CCCCccH-HHHHH
Confidence            99987643221            1223479999999999988 778999999999999999996   7754321 11122


Q ss_pred             HHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCc
Q 045787          220 FSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENV  296 (324)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~  296 (324)
                      ........+                         ..+...++.+.+||.+||+.||.+|||+.|+++||||++++.+
T Consensus       238 ~~~~~~~~p-------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p  289 (299)
T 4g31_A          238 TDVRNLKFP-------------------------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFP  289 (299)
T ss_dssp             HHHHTTCCC-------------------------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC---
T ss_pred             HHHhcCCCC-------------------------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCC
Confidence            111111100                         1112345677899999999999999999999999999998754

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=3.4e-55  Score=379.82  Aligned_cols=291  Identities=46%  Similarity=0.815  Sum_probs=244.8

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF   82 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   82 (324)
                      +.+.++|++++.||+|+||+||+|.+. +|+.||+|++............+.+|+.++++++||||+++++++.+++..+
T Consensus        17 q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   95 (311)
T 3niz_A           17 QGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLT   95 (311)
T ss_dssp             ECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEE
T ss_pred             cchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEE
Confidence            457789999999999999999999985 5899999999876555544567889999999999999999999999999999


Q ss_pred             EEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC
Q 045787           83 LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK  162 (324)
Q Consensus        83 iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~  162 (324)
                      +||||++|++.+.+......+++..++.++.|++.||.|||+.|++|+||||+||+++ .++.++|+|||.+........
T Consensus        96 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~-~~~~~kl~Dfg~a~~~~~~~~  174 (311)
T 3niz_A           96 LVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLIN-SDGALKLADFGLARAFGIPVR  174 (311)
T ss_dssp             EEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC-TTCCEEECCCTTCEETTSCCC
T ss_pred             EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEEC-CCCCEEEccCcCceecCCCcc
Confidence            9999999999999988777899999999999999999999999999999999999999 889999999999988765555


Q ss_pred             cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHHcCCCCcccccchhhhhccc
Q 045787          163 EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-HDHLSLIFSLLGTPTDESWAESTYISEIL  241 (324)
Q Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (324)
                      ......+++.|+|||++.+...++.++||||||+++|+|++|..||.+.. .+....+....+.+....|..........
T Consensus       175 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  254 (311)
T 3niz_A          175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK  254 (311)
T ss_dssp             ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHH
T ss_pred             cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhh
Confidence            55666789999999999876778999999999999999999999998766 55666777777777776665543333222


Q ss_pred             C-CCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCC
Q 045787          242 P-LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVEN  295 (324)
Q Consensus       242 ~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~  295 (324)
                      . ..............+.+++++.+||.+||+.||.+|||++++++||||++++.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  309 (311)
T 3niz_A          255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP  309 (311)
T ss_dssp             SCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred             hcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence            2 22233444556667789999999999999999999999999999999999875

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=4.2e-55  Score=376.08  Aligned_cols=287  Identities=45%  Similarity=0.763  Sum_probs=247.3

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE   86 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   86 (324)
                      ++|++++.||+|++|+||+|.+..+++.||+|++............+.+|+.++++++||||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            58999999999999999999999999999999998776555555778899999999999999999999999999999999


Q ss_pred             ecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcccc
Q 045787           87 YLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSR  166 (324)
Q Consensus        87 ~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~  166 (324)
                      |+++++.+.+......+++..++.++.|++.||.+||++|++|+||||+||+++ .++.++|+|||.+............
T Consensus        82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~  160 (292)
T 3o0g_A           82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN-RNGELKLANFGLARAFGIPVRCYSA  160 (292)
T ss_dssp             CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC-TTSCEEECCCTTCEECCSCCSCCCS
T ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc-CCCCEEEeecccceecCCccccccC
Confidence            999999999988778899999999999999999999999999999999999999 8999999999999887655555666


Q ss_pred             cccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCC-CCCC-hhHHHHHHHHcCCCCcccccchhhhhcccCCC
Q 045787          167 DCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF-PSKK-HDHLSLIFSLLGTPTDESWAESTYISEILPLY  244 (324)
Q Consensus       167 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (324)
                      ..+|+.|+|||++.+...++.++||||||+++|+|++|..|| ...+ .+....+....+.+....|..........+..
T Consensus       161 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  240 (292)
T 3o0g_A          161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP  240 (292)
T ss_dssp             CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCC
T ss_pred             CccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccc
Confidence            788999999999987566899999999999999999988775 4444 45566777777888777776655444443333


Q ss_pred             CCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCC
Q 045787          245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVE  294 (324)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~  294 (324)
                      ............+.++..+++||.+||+.||.+|||++|+++||||++..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             cccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence            33334444555667899999999999999999999999999999999865

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=6.8e-55  Score=374.04  Aligned_cols=285  Identities=47%  Similarity=0.837  Sum_probs=240.1

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE   86 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   86 (324)
                      ++|++++.||+|+||+||+|.+ .+|+.+|+|++..........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence            5899999999999999999998 578999999998766555556788899999999999999999999999999999999


Q ss_pred             ecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcccc
Q 045787           87 YLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSR  166 (324)
Q Consensus        87 ~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~  166 (324)
                      |+++++.+.+....+.+++..++.++.|++.||.+||++|++|+||||+||+++ .++.++|+|||.+............
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~  159 (288)
T 1ob3_A           81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKYTH  159 (288)
T ss_dssp             CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC-TTSCEEECCTTHHHHHCC-------
T ss_pred             ecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc-CCCCEEEeECccccccCcccccccc
Confidence            999999999988777899999999999999999999999999999999999999 8999999999999876544444455


Q ss_pred             cccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHHcCCCCcccccchhhhhcccCCCC
Q 045787          167 DCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-HDHLSLIFSLLGTPTDESWAESTYISEILPLYP  245 (324)
Q Consensus       167 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (324)
                      ..+|+.|+|||++.+...++.++||||||+++|+|++|..||...+ .+....+....+.+....|..........+...
T Consensus       160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T 1ob3_A          160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT  239 (288)
T ss_dssp             --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCC
T ss_pred             ccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccc
Confidence            6789999999999875678999999999999999999999998877 445556666677777666665444444444444


Q ss_pred             CCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCC
Q 045787          246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV  293 (324)
Q Consensus       246 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~  293 (324)
                      ...+.........+++++.++|.+||+.||.+|||+.++++||||++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             CCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             cccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence            444455556667899999999999999999999999999999999875

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=6e-56  Score=410.29  Aligned_cols=265  Identities=24%  Similarity=0.387  Sum_probs=219.2

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHH---HHHHHhcCCCCeeEEEeeeecCC
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIRE---VSLLKELEHENIVRLLDVQSSRK   79 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e---~~~l~~l~~~~i~~~~~~~~~~~   79 (324)
                      +.-++|++++.||+|+||.||+|+++.+|+.||+|++.+... .........+|   +.+++.++||||+++++++++.+
T Consensus       186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~  265 (689)
T 3v5w_A          186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD  265 (689)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred             CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence            455789999999999999999999999999999999976542 22223334444   55666778999999999999999


Q ss_pred             eEEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeecc
Q 045787           80 DVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIG  158 (324)
Q Consensus        80 ~~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~  158 (324)
                      .+|+||||+. |+|...+... +.+++..++.++.||+.||.|||++||+||||||+|||++ .+|.+||+|||++....
T Consensus       266 ~lylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld-~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          266 KLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFS  343 (689)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEEC-TTSCEEECCCTTCEECS
T ss_pred             EEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEe-CCCCEEecccceeeecC
Confidence            9999999998 5888888764 5699999999999999999999999999999999999999 99999999999998765


Q ss_pred             CCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHH-HHcCCCCcccccchhhh
Q 045787          159 VPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIF-SLLGTPTDESWAESTYI  237 (324)
Q Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  237 (324)
                      ..  .....+||+.|+|||++.+...++.++|+|||||++|+|++|.+||.+.+......+. .....+.          
T Consensus       344 ~~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~----------  411 (689)
T 3v5w_A          344 KK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV----------  411 (689)
T ss_dssp             SC--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCC----------
T ss_pred             CC--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCC----------
Confidence            33  3345689999999999976567899999999999999999999999765422211111 1111100          


Q ss_pred             hcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCC-----HHHHhcCccccCCCCchh
Q 045787          238 SEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRIT-----AMDALKHEYLIGVENVPL  298 (324)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~~~l~hp~~~~~~~~~~  298 (324)
                                      .....+++++++||.+||+.||.+|++     ++++++||||+++++..+
T Consensus       412 ----------------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l  461 (689)
T 3v5w_A          412 ----------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMV  461 (689)
T ss_dssp             ----------------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHH
T ss_pred             ----------------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHH
Confidence                            112368999999999999999999998     799999999999998766

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.7e-55  Score=375.49  Aligned_cols=257  Identities=21%  Similarity=0.346  Sum_probs=205.5

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   83 (324)
                      +..+++++.+.||+|+||+||+|...   ..+|+|+++.........+.+.+|+.++++++||||+++++++.+ +.+||
T Consensus        33 i~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i  108 (307)
T 3omv_A           33 IEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI  108 (307)
T ss_dssp             CCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred             EcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence            45678899999999999999999864   369999987655444445678999999999999999999998765 56899


Q ss_pred             EEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC--
Q 045787           84 VFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP--  160 (324)
Q Consensus        84 v~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~--  160 (324)
                      ||||++ |+|.+++.....++++..+..++.||+.||.|||++|++||||||+|||++ +++.+||+|||++......  
T Consensus       109 VmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~-~~~~~Ki~DFGla~~~~~~~~  187 (307)
T 3omv_A          109 VTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLH-EGLTVKIGDFGLATVKSRWSG  187 (307)
T ss_dssp             EEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEE-TTEEEEECCCSSCBC------
T ss_pred             EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEEC-CCCcEEEeeccCceecccCCc
Confidence            999998 699999988777899999999999999999999999999999999999999 9999999999999765422  


Q ss_pred             CCcccccccccccCCchhhcC--CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhh
Q 045787          161 QKEYSRDCVYSPYKAPELLLG--YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYIS  238 (324)
Q Consensus       161 ~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (324)
                      .......+||+.|+|||++.+  ..+++.++|||||||++|||+||+.||.+.+...........+...           
T Consensus       188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~-----------  256 (307)
T 3omv_A          188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYAS-----------  256 (307)
T ss_dssp             ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCC-----------
T ss_pred             ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC-----------
Confidence            223345689999999999964  2468999999999999999999999998766433222222111110           


Q ss_pred             cccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcC
Q 045787          239 EILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH  287 (324)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~h  287 (324)
                                 .........+++.+.+|+.+||+.||.+|||+.+++++
T Consensus       257 -----------p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          257 -----------PDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             -----------CCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             -----------CCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                       01112234688999999999999999999999988653

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=6e-56  Score=379.38  Aligned_cols=258  Identities=24%  Similarity=0.362  Sum_probs=212.6

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEc-----cCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeec
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNT-----VTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS   77 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   77 (324)
                      .+..++|++.+.||+|+||.||+|...     .++..||+|++......  ..+.+.+|++++++++||||+++++++.+
T Consensus         9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~--~~~~f~~E~~il~~l~HpnIV~l~g~~~~   86 (299)
T 4asz_A            9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDN--ARKDFHREAELLTNLQHEHIVKFYGVCVE   86 (299)
T ss_dssp             BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHH--HHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChH--HHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence            455678999999999999999999864     35788999998754322  24678999999999999999999999999


Q ss_pred             CCeEEEEEEecC-CCHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCC
Q 045787           78 RKDVFLVFEYLD-LDLHSFITRHK------------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN  144 (324)
Q Consensus        78 ~~~~~iv~e~~~-g~l~~~~~~~~------------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~  144 (324)
                      ++.+|+||||++ |+|.+++....            ..+++..+..++.||+.||.|||+++++||||||+|||++ .++
T Consensus        87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~-~~~  165 (299)
T 4asz_A           87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG-ENL  165 (299)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC-GGG
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEEC-CCC
Confidence            999999999997 69999987642            4699999999999999999999999999999999999999 899


Q ss_pred             cEEEeeccceeeccCCCC--cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHH
Q 045787          145 TVKLADFGLARAIGVPQK--EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFS  221 (324)
Q Consensus       145 ~v~l~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~  221 (324)
                      .+||+|||+++.......  ......+|+.|+|||++.+ ..++.++|||||||++|||+| |+.||.+.+...+.....
T Consensus       166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~  244 (299)
T 4asz_A          166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT  244 (299)
T ss_dssp             CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred             cEEECCcccceecCCCCceeecCceecChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            999999999976543222  2233468899999999987 678999999999999999998 899999888666554443


Q ss_pred             HcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCC
Q 045787          222 LLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV  293 (324)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~  293 (324)
                      ....++                           ....+++++.+|+.+||+.||.+|||+.+++  +|++++
T Consensus       245 ~~~~~~---------------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~~~  287 (299)
T 4asz_A          245 QGRVLQ---------------------------RPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQNL  287 (299)
T ss_dssp             HTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHHHH
T ss_pred             cCCCCC---------------------------CCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHHHH
Confidence            322111                           1125789999999999999999999999994  566654

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=3.7e-55  Score=406.53  Aligned_cols=262  Identities=23%  Similarity=0.394  Sum_probs=225.3

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE   86 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   86 (324)
                      ++|++.+.||+|+||.||+|.++.+|+.||+|++.......  .+.+.+|+.+++.++||||+++++++.++..+|+|||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~--~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E  234 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD--KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  234 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH--HHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhh--HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            68999999999999999999999999999999987654322  4668899999999999999999999999999999999


Q ss_pred             ecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecC-CCcEEEeeccceeeccCCCCcc
Q 045787           87 YLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK-RNTVKLADFGLARAIGVPQKEY  164 (324)
Q Consensus        87 ~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~-~~~v~l~d~g~~~~~~~~~~~~  164 (324)
                      |++ |+|.+++....+.+++..++.++.||+.||.|||++|++||||||+|||++.. .+.+||+|||++..... ....
T Consensus       235 ~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~-~~~~  313 (573)
T 3uto_A          235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP-KQSV  313 (573)
T ss_dssp             CCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT-TSEE
T ss_pred             ecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccC-CCce
Confidence            997 59999988766789999999999999999999999999999999999999833 37999999999988753 3344


Q ss_pred             cccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCC
Q 045787          165 SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLY  244 (324)
Q Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (324)
                      ...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.......                 
T Consensus       314 ~~~~GT~~y~APEv~~~-~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~-----------------  375 (573)
T 3uto_A          314 KVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNM-----------------  375 (573)
T ss_dssp             EEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC-----------------
T ss_pred             eeeEECccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCC-----------------
Confidence            45689999999999988 678999999999999999999999998887655544333211110                 


Q ss_pred             CCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCc
Q 045787          245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENV  296 (324)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~  296 (324)
                             ....+..+++++++||.+||+.||.+|||+.|+|+||||+...+.
T Consensus       376 -------~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~  420 (573)
T 3uto_A          376 -------DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP  420 (573)
T ss_dssp             -------CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCT
T ss_pred             -------CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCC
Confidence                   112234689999999999999999999999999999999987654

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2e-54  Score=374.87  Aligned_cols=252  Identities=26%  Similarity=0.392  Sum_probs=203.9

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEc-----cCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecC
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNT-----VTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR   78 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   78 (324)
                      +...+|.+.++||+|+||.||+|...     .++..||+|++......  ..+.+.+|++++++++||||+++++++.+.
T Consensus        38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~--~~~~f~~E~~il~~l~HpnIV~l~g~~~~~  115 (329)
T 4aoj_A           38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASES--ARQDFQREAELLTMLQHQHIVRFFGVCTEG  115 (329)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHH--HHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             cCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHH--HHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence            44567899999999999999999864     36789999998754322  246789999999999999999999999999


Q ss_pred             CeEEEEEEecC-CCHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCC
Q 045787           79 KDVFLVFEYLD-LDLHSFITRHK--------------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKR  143 (324)
Q Consensus        79 ~~~~iv~e~~~-g~l~~~~~~~~--------------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~  143 (324)
                      +.+|+||||++ |+|.+++....              .++++..+..++.||+.||.|||+++++||||||+|||++ .+
T Consensus       116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~-~~  194 (329)
T 4aoj_A          116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG-QG  194 (329)
T ss_dssp             SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE-TT
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC-CC
Confidence            99999999998 69999887542              4689999999999999999999999999999999999999 99


Q ss_pred             CcEEEeeccceeeccCCCC--cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 045787          144 NTVKLADFGLARAIGVPQK--EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIF  220 (324)
Q Consensus       144 ~~v~l~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~  220 (324)
                      +.+||+|||+++.......  ......||+.|+|||++.+ ..++.++|||||||++|||+| |+.||...+.......+
T Consensus       195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i  273 (329)
T 4aoj_A          195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI  273 (329)
T ss_dssp             TEEEECCCC----------------CCCCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH
T ss_pred             CcEEEcccccceeccCCCcceecCcccccccccChhhhcC-CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            9999999999986643322  2334578999999999988 778999999999999999999 89999887765554433


Q ss_pred             HHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          221 SLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      .....++                           ....+++++.+|+.+||+.||.+|||+.++++
T Consensus       274 ~~g~~~~---------------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~  312 (329)
T 4aoj_A          274 TQGRELE---------------------------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHA  312 (329)
T ss_dssp             HHTCCCC---------------------------CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHH
T ss_pred             HcCCCCC---------------------------CcccccHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence            3221111                           11357899999999999999999999999986

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.3e-54  Score=372.71  Aligned_cols=255  Identities=22%  Similarity=0.319  Sum_probs=211.9

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEc-----cCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeec
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNT-----VTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS   77 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   77 (324)
                      ++...++++.+.||+|+||+||+|...     .+++.||+|++.... .....+.+.+|+.++++++||||+++++++.+
T Consensus        22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~  100 (308)
T 4gt4_A           22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTK  100 (308)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence            455678899999999999999999853     467899999987543 23345779999999999999999999999999


Q ss_pred             CCeEEEEEEecC-CCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeec
Q 045787           78 RKDVFLVFEYLD-LDLHSFITRHK---------------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL  141 (324)
Q Consensus        78 ~~~~~iv~e~~~-g~l~~~~~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~  141 (324)
                      ++.+++||||++ |+|.+++....               ..+++..+..++.||+.||.|||+++++||||||+|||++ 
T Consensus       101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~-  179 (308)
T 4gt4_A          101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY-  179 (308)
T ss_dssp             SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC-
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC-
Confidence            999999999998 69999986532               3589999999999999999999999999999999999999 


Q ss_pred             CCCcEEEeeccceeeccCCC--CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 045787          142 KRNTVKLADFGLARAIGVPQ--KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSL  218 (324)
Q Consensus       142 ~~~~v~l~d~g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~  218 (324)
                      +++.+||+|||+++......  ......+||+.|+|||++.+ ..++.++|||||||++|||+| |..||.+.+...+..
T Consensus       180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~  258 (308)
T 4gt4_A          180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE  258 (308)
T ss_dssp             GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred             CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            89999999999998664322  22344578999999999987 678999999999999999998 899999888666554


Q ss_pred             HHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcC
Q 045787          219 IFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH  287 (324)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~h  287 (324)
                      .+.....++                           ....+++.+.+|+.+||+.||.+|||+.+|+++
T Consensus       259 ~i~~~~~~~---------------------------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          259 MIRNRQVLP---------------------------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHTTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCCCC---------------------------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            433221111                           113578899999999999999999999999873

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.1e-53  Score=369.60  Aligned_cols=291  Identities=45%  Similarity=0.772  Sum_probs=226.7

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      .++|++++.||+|++|.||+|.+..+|+.||+|++..... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   82 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF   82 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence            5789999999999999999999999999999999976542 333567889999999999999999999999999999999


Q ss_pred             EecCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           86 EYLDLDLHSFITRHK-----NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        86 e~~~g~l~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      ||++|+|.+++....     ..+++..++.++.|++.||.|||+.|++|+||||+||+++ .++.++|+|||.+......
T Consensus        83 e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~  161 (317)
T 2pmi_A           83 EFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLIN-KRGQLKLGDFGLARAFGIP  161 (317)
T ss_dssp             ECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC-TTCCEEECCCSSCEETTSC
T ss_pred             EecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEc-CCCCEEECcCccceecCCC
Confidence            999999999887653     3589999999999999999999999999999999999999 8999999999999887655


Q ss_pred             CCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHHcCCCCcccccchhhhhc
Q 045787          161 QKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISE  239 (324)
Q Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
                      ........+|+.|+|||++.+...++.++||||||+++|+|++|..||.+.+. +....+....+.+....|........
T Consensus       162 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  241 (317)
T 2pmi_A          162 VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPK  241 (317)
T ss_dssp             CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTT
T ss_pred             cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhh
Confidence            55555667899999999998756789999999999999999999999988774 44556666677777666655443333


Q ss_pred             ccCCCCCCCCcch-----hhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchh
Q 045787          240 ILPLYPHFEPANL-----AEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       240 ~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~  298 (324)
                      .............     ......++.++.+||.+||+.||.+|||+.++++||||++......
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~  305 (317)
T 2pmi_A          242 YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHAS  305 (317)
T ss_dssp             CCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC---
T ss_pred             cccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchhh
Confidence            2222222211111     1223368899999999999999999999999999999998776543

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=9e-54  Score=373.84  Aligned_cols=293  Identities=42%  Similarity=0.770  Sum_probs=232.6

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   83 (324)
                      ...++|++++.||+|++|+||+|.+..+++.||+|++............+.+|+.++++++||||+++++++.+++..++
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL  110 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence            45678999999999999999999999999999999998766555445667899999999999999999999999999999


Q ss_pred             EEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEee----cCCCcEEEeeccceeeccC
Q 045787           84 VFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLID----LKRNTVKLADFGLARAIGV  159 (324)
Q Consensus        84 v~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~----~~~~~v~l~d~g~~~~~~~  159 (324)
                      ||||++|+|.+++.... .+++..++.++.+|+.||.+||++|++|+||||+||+++    ...+.++|+|||.+.....
T Consensus       111 v~e~~~~~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~  189 (329)
T 3gbz_A          111 IFEYAENDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI  189 (329)
T ss_dssp             EEECCSEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-
T ss_pred             EEecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCC
Confidence            99999999999987754 599999999999999999999999999999999999995    1445699999999987765


Q ss_pred             CCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHHcCCCCcccccchhhhh
Q 045787          160 PQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-HDHLSLIFSLLGTPTDESWAESTYIS  238 (324)
Q Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (324)
                      .........+++.|+|||++.+...++.++||||||+++|+|++|..||...+ .+....+....+.++...|.......
T Consensus       190 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (329)
T 3gbz_A          190 PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALP  269 (329)
T ss_dssp             ----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             cccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhh
Confidence            54555556789999999999876678999999999999999999999998877 44555666677777776665544444


Q ss_pred             cccCCCCCCCCcchhhhC-CCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCch
Q 045787          239 EILPLYPHFEPANLAEKF-PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP  297 (324)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~  297 (324)
                      .................. ..+++++.+||.+||+.||.+|||++++++||||++....|
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~P  329 (329)
T 3gbz_A          270 DWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFDP  329 (329)
T ss_dssp             TCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCSCC
T ss_pred             hhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCCCC
Confidence            433333333332222222 23789999999999999999999999999999999988764

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=6.2e-53  Score=365.27  Aligned_cols=292  Identities=41%  Similarity=0.734  Sum_probs=231.8

Q ss_pred             CCcccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc---cCCCchHHHHHHHHHHhcC---CCCeeEEEee
Q 045787            1 MGKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE---QEGVPSYIIREVSLLKELE---HENIVRLLDV   74 (324)
Q Consensus         1 ~~~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~---~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~   74 (324)
                      +|++..++|++++.||+|+||+||+|.+..+++.||+|++.....   .......+.+|+.++++++   ||||++++++
T Consensus         3 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~   82 (308)
T 3g33_A            3 LGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDV   82 (308)
T ss_dssp             -------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred             CCcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeee
Confidence            478899999999999999999999999999999999999976542   2223456778888887775   9999999999


Q ss_pred             eecCC-----eEEEEEEecCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEE
Q 045787           75 QSSRK-----DVFLVFEYLDLDLHSFITRHKN-TLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKL  148 (324)
Q Consensus        75 ~~~~~-----~~~iv~e~~~g~l~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l  148 (324)
                      +....     ..++|+||++++|.+++..... .+++..++.++.+++.||.|||++|++|+||||+||+++ .++.++|
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~-~~~~~kl  161 (308)
T 3g33_A           83 CATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVT-SGGTVKL  161 (308)
T ss_dssp             EEECCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEEC-TTSCEEE
T ss_pred             eeccCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc-CCCCEEE
Confidence            87654     5899999999999999887654 499999999999999999999999999999999999999 8999999


Q ss_pred             eeccceeeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHHcCCCC
Q 045787          149 ADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-HDHLSLIFSLLGTPT  227 (324)
Q Consensus       149 ~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~  227 (324)
                      +|||.+...... .......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+ ......+....+.++
T Consensus       162 ~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  239 (308)
T 3g33_A          162 ADFGLARIYSYQ-MALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP  239 (308)
T ss_dssp             CSCSCTTTSTTC-CCSGGGGCCCSSCCHHHHHT-SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             eeCccccccCCC-cccCCccccccccCchHHcC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            999999765432 33344578999999999987 668999999999999999999999998877 445556667777777


Q ss_pred             cccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCch
Q 045787          228 DESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP  297 (324)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~  297 (324)
                      ...|.........  .+............+.+++.+.+||.+||+.||.+|||+.++++||||++....+
T Consensus       240 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~~~~  307 (308)
T 3g33_A          240 EDDWPRDVSLPRG--AFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGNP  307 (308)
T ss_dssp             TTTSCSSCSSCGG--GSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC-------
T ss_pred             hhhccchhhcccc--ccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCCCCC
Confidence            7666543332221  2223334455666778999999999999999999999999999999999876543

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.6e-54  Score=372.87  Aligned_cols=290  Identities=46%  Similarity=0.798  Sum_probs=235.7

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE   86 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   86 (324)
                      ++|++++.||+|+||+||+|.+..+++.||+|++........ ...+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA-PCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   80 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccccc-chhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence            589999999999999999999999999999999875543221 2234579999999999999999999999999999999


Q ss_pred             ecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcccc
Q 045787           87 YLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSR  166 (324)
Q Consensus        87 ~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~  166 (324)
                      |++|++.+++......+++..++.++.+++.||.+||+.|++|+||||+||+++ .++.++|+|||.+............
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~-~~~~~kl~Dfg~a~~~~~~~~~~~~  159 (324)
T 3mtl_A           81 YLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYDN  159 (324)
T ss_dssp             CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEEC-TTCCEEECSSSEEECC---------
T ss_pred             ccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEEC-CCCCEEEccCcccccccCCcccccc
Confidence            999999999998877899999999999999999999999999999999999999 8899999999999876655555555


Q ss_pred             cccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHHcCCCCcccccchhhhhccc-CCC
Q 045787          167 DCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-HDHLSLIFSLLGTPTDESWAESTYISEIL-PLY  244 (324)
Q Consensus       167 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  244 (324)
                      ..+++.|+|||++.+...++.++||||||+++|+|++|..||.+.+ .+....+....+.+....|.......... ...
T Consensus       160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
T 3mtl_A          160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNY  239 (324)
T ss_dssp             ---CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCC
T ss_pred             ccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccccc
Confidence            6789999999999876778999999999999999999999998887 44556667777777776665433222211 123


Q ss_pred             CCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchh
Q 045787          245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~  298 (324)
                      ............+.+++++.+||.+||+.||.+|||++|+++||||.++.....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  293 (324)
T 3mtl_A          240 PKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIH  293 (324)
T ss_dssp             CCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTS
T ss_pred             ccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccc
Confidence            333444455666789999999999999999999999999999999999876443

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=3.4e-52  Score=363.02  Aligned_cols=260  Identities=29%  Similarity=0.495  Sum_probs=223.3

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLV   84 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   84 (324)
                      ..++|++++.||+|+||.||+|.+..+|+.||+|++..........+.+.+|+.+++.++||||+++++++.+++..|+|
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            45789999999999999999999999999999999987654444456788999999999999999999999999999999


Q ss_pred             EEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCc
Q 045787           85 FEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE  163 (324)
Q Consensus        85 ~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~  163 (324)
                      |||++ |+|.+++... +.+++..++.++.|++.||.|||+.|++|+||||+||+++ .++.++|+|||.+...... ..
T Consensus        93 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~~-~~  169 (328)
T 3fe3_A           93 MEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTVG-GK  169 (328)
T ss_dssp             ECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC-TTSCEEECSTTCCGGGSSS-CG
T ss_pred             EECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEc-CCCCEEEeeccCceecCCC-Cc
Confidence            99997 5888888764 4699999999999999999999999999999999999999 8999999999999766533 33


Q ss_pred             ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCC
Q 045787          164 YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPL  243 (324)
Q Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (324)
                      ....++|+.|+|||++.+....+.++||||||+++|+|++|..||.+.+..............                 
T Consensus       170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-----------------  232 (328)
T 3fe3_A          170 LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR-----------------  232 (328)
T ss_dssp             GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-----------------
T ss_pred             cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-----------------
Confidence            455679999999999988555568999999999999999999999888766554433321111                 


Q ss_pred             CCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCC
Q 045787          244 YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVEN  295 (324)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~  295 (324)
                                 ....+++++.++|++||..||.+|||++++++||||+....
T Consensus       233 -----------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~  273 (328)
T 3fe3_A          233 -----------IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHE  273 (328)
T ss_dssp             -----------CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred             -----------CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCc
Confidence                       01247889999999999999999999999999999987654

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1e-51  Score=355.77  Aligned_cols=267  Identities=29%  Similarity=0.477  Sum_probs=227.3

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLV   84 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   84 (324)
                      ..++|++++.||+|+||+||+|.+..+++.||+|++......  ..+.+.+|+.++++++||||+++++++...+..|+|
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   95 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc--HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence            357899999999999999999999999999999998765433  256788999999999999999999999999999999


Q ss_pred             EEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCc
Q 045787           85 FEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE  163 (324)
Q Consensus        85 ~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~  163 (324)
                      |||++ |+|.+++...  .+++..++.++.+++.||.|||++|++|+||||+||+++ .++.++|+|||.+.........
T Consensus        96 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~  172 (297)
T 3fxz_A           96 MEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSK  172 (297)
T ss_dssp             EECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC-TTCCEEECCCTTCEECCSTTCC
T ss_pred             EECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEC-CCCCEEEeeCCCceecCCcccc
Confidence            99996 5888887663  599999999999999999999999999999999999999 8999999999999887655555


Q ss_pred             ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCC
Q 045787          164 YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPL  243 (324)
Q Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (324)
                      .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||...+.............+...              
T Consensus       173 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------  237 (297)
T 3fxz_A          173 RSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQ--------------  237 (297)
T ss_dssp             BCCCCSCGGGCCHHHHHC-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCS--------------
T ss_pred             cCCccCCcCccChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC--------------
Confidence            566689999999999987 67899999999999999999999999877755443333322221110              


Q ss_pred             CCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchhhhhh
Q 045787          244 YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILL  302 (324)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~~~~~  302 (324)
                                 ....++..+.++|.+||+.||.+|||+.++++||||+.........+.
T Consensus       238 -----------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~~~~p~  285 (297)
T 3fxz_A          238 -----------NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSSLTPL  285 (297)
T ss_dssp             -----------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCGGGGHHH
T ss_pred             -----------CccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccCcccccchH
Confidence                       012578899999999999999999999999999999988766554433

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.8e-52  Score=381.54  Aligned_cols=292  Identities=36%  Similarity=0.637  Sum_probs=228.6

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeec-----CC
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS-----RK   79 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~   79 (324)
                      ..++|++++.||+|+||.||+|.+..+++.||+|++..........+.+.+|+.++++++||||+++++++..     ..
T Consensus        51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  130 (458)
T 3rp9_A           51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD  130 (458)
T ss_dssp             SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence            4578999999999999999999999999999999987654433335678899999999999999999999843     35


Q ss_pred             eEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccC
Q 045787           80 DVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGV  159 (324)
Q Consensus        80 ~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~  159 (324)
                      .+|+|||+++++|...+.. ...+++..++.++.||+.||.|||+.|++||||||+|||++ .++.+||+|||++.....
T Consensus       131 ~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~-~~~~~kl~DFGla~~~~~  208 (458)
T 3rp9_A          131 ELYVVLEIADSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVN-QDCSVKVCDFGLARTVDY  208 (458)
T ss_dssp             CEEEEECCCSEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC-TTCCEEECCCTTCBCTTS
T ss_pred             eEEEEEeccccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEEC-CCCCEeecccccchhccC
Confidence            7999999999999988876 45699999999999999999999999999999999999999 899999999999987643


Q ss_pred             CCC---------------------------cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh---------
Q 045787          160 PQK---------------------------EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT---------  203 (324)
Q Consensus       160 ~~~---------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~---------  203 (324)
                      ...                           .....++|+.|+|||++.....++.++|||||||++|+|++         
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~  288 (458)
T 3rp9_A          209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH  288 (458)
T ss_dssp             CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSG
T ss_pred             ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccc
Confidence            221                           12334679999999987665779999999999999999999         


Q ss_pred             --CCCCCCCCC---------------------hhHHHHHHHHcCCCCcccccch--hhhhcccCCCCCCCCcchhhhCCC
Q 045787          204 --GKPLFPSKK---------------------HDHLSLIFSLLGTPTDESWAES--TYISEILPLYPHFEPANLAEKFPN  258 (324)
Q Consensus       204 --g~~pf~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  258 (324)
                        |.++|.+.+                     .+.+..+....+.++...+...  .....................++.
T Consensus       289 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (458)
T 3rp9_A          289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPA  368 (458)
T ss_dssp             GGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTT
T ss_pred             ccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCC
Confidence              677776654                     3556667777777776544331  122233344455555666777788


Q ss_pred             CChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchh
Q 045787          259 LEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       259 ~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~  298 (324)
                      .++++.+||.+||..||.+|||++|+|+||||+++.+...
T Consensus       369 ~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~  408 (458)
T 3rp9_A          369 SSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEV  408 (458)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGG
T ss_pred             CCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCcc
Confidence            9999999999999999999999999999999999987654

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.4e-52  Score=358.96  Aligned_cols=292  Identities=36%  Similarity=0.609  Sum_probs=224.1

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      -++|++++.||+|++|+||+|.+..+|+.||+|++..........+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            46899999999999999999999999999999998765544333466788999999999999999999999999999999


Q ss_pred             EecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccc
Q 045787           86 EYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYS  165 (324)
Q Consensus        86 e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~  165 (324)
                      ||++++++..+......+++..++.++.+++.||.+||+.|++|+||||+||+++ .++.++|+|||.+...........
T Consensus        82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~  160 (311)
T 4agu_A           82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILIT-KHSVIKLCDFGFARLLTGPSDYYD  160 (311)
T ss_dssp             ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC-TTSCEEECCCTTCEECC-------
T ss_pred             EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEc-CCCCEEEeeCCCchhccCcccccC
Confidence            9999876666666667799999999999999999999999999999999999999 899999999999987765544455


Q ss_pred             ccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHH-HHHHHHcCCCCcccccchhhhh--cccC
Q 045787          166 RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHL-SLIFSLLGTPTDESWAESTYIS--EILP  242 (324)
Q Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~--~~~~  242 (324)
                      ...+++.|+|||++.+...++.++||||||+++|+|++|..||.+...... ..+....+..............  ....
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (311)
T 4agu_A          161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK  240 (311)
T ss_dssp             -----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCC
T ss_pred             CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCc
Confidence            567899999999998767789999999999999999999999988774433 3333333333221111000000  0000


Q ss_pred             CCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchh
Q 045787          243 LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~  298 (324)
                      ..............+.++..+.++|.+||+.||.+|||++++++||||+++++..-
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  296 (311)
T 4agu_A          241 IPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIED  296 (311)
T ss_dssp             CCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC----
T ss_pred             CCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHHH
Confidence            01111122233445679999999999999999999999999999999999986654

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3.3e-52  Score=376.67  Aligned_cols=293  Identities=38%  Similarity=0.637  Sum_probs=239.6

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecC-----C
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR-----K   79 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~   79 (324)
                      +.++|++.+.||+|++|.||+|.+..+++.||+|++..........+.+.+|+.++++++||||+++++++...     .
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence            56899999999999999999999999999999999976544433456788999999999999999999998765     5


Q ss_pred             eEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccC
Q 045787           80 DVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGV  159 (324)
Q Consensus        80 ~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~  159 (324)
                      ..|+||||++|+|.+.+.. ...+++..++.++.||+.||.|||+.|++||||||+||+++ .++.+||+|||++.....
T Consensus       104 ~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~-~~~~~kL~DFGla~~~~~  181 (432)
T 3n9x_A          104 ELYIVLEIADSDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLN-QDCSVKVCDFGLARTINS  181 (432)
T ss_dssp             CEEEEEECCSEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC-TTCCEEECCCTTCEEC--
T ss_pred             eEEEEEecCCcCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEEC-CCCCEEEccCCCcccccc
Confidence            7999999999999998876 45699999999999999999999999999999999999999 899999999999987653


Q ss_pred             CCC----------------------cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhC-----------CC
Q 045787          160 PQK----------------------EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITG-----------KP  206 (324)
Q Consensus       160 ~~~----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g-----------~~  206 (324)
                      ...                      .....++|+.|+|||++.....++.++|||||||++|+|++|           .+
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p  261 (432)
T 3n9x_A          182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP  261 (432)
T ss_dssp             -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCC
T ss_pred             cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccc
Confidence            321                      134567899999999986657799999999999999999984           44


Q ss_pred             CCCCCC------------------hhHHHHHHHHcCCCCcccccc--hhhhhcccCCCCCCCCcchhhhCCCCChhHHHH
Q 045787          207 LFPSKK------------------HDHLSLIFSLLGTPTDESWAE--STYISEILPLYPHFEPANLAEKFPNLEPAGVDL  266 (324)
Q Consensus       207 pf~~~~------------------~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  266 (324)
                      +|.+.+                  ...+..+....+.|+...+..  ......................++.+++++.+|
T Consensus       262 ~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL  341 (432)
T 3n9x_A          262 LFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINL  341 (432)
T ss_dssp             SCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHH
T ss_pred             cCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHH
Confidence            454443                  356667777788887654433  122223333444455566667778899999999


Q ss_pred             HHHhhcCCCCCCCCHHHHhcCccccCCCCchhh
Q 045787          267 LSQMLCLNPKQRITAMDALKHEYLIGVENVPLV  299 (324)
Q Consensus       267 i~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~~  299 (324)
                      |.+||+.||.+|||++|+|+||||+++.+....
T Consensus       342 l~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e  374 (432)
T 3n9x_A          342 LESMLKFNPNKRITIDQALDHPYLKDVRKKKLE  374 (432)
T ss_dssp             HHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC
T ss_pred             HHHHhcCCcccCCCHHHHhcChhhhhccCcccC
Confidence            999999999999999999999999999876554

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.1e-51  Score=360.85  Aligned_cols=264  Identities=24%  Similarity=0.412  Sum_probs=226.4

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF   82 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   82 (324)
                      +.-++|++++.||+|+||.||+|.++.+|+.||+|++..... .......+.+|+.+++.++||+|+++++++.+.+.+|
T Consensus         2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~   81 (337)
T 1o6l_A            2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence            456799999999999999999999999999999999976532 3334567889999999999999999999999999999


Q ss_pred             EEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC
Q 045787           83 LVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        83 iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~  161 (324)
                      +||||++| +|...+.. .+.+++..++.++.+|+.||.|||++|++|+||||+||+++ .++.++|+|||.+.......
T Consensus        82 lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~-~~g~vkL~DFG~a~~~~~~~  159 (337)
T 1o6l_A           82 FVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC-TTSCEEECCCTTCBCSCCTT
T ss_pred             EEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEEC-CCCCEEEeeccchhhcccCC
Confidence            99999985 77777765 45699999999999999999999999999999999999999 89999999999998654444


Q ss_pred             CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhccc
Q 045787          162 KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEIL  241 (324)
Q Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (324)
                      ......+||+.|+|||++.+ ..++.++|+||||+++|+|++|..||...+.......+......               
T Consensus       160 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~---------------  223 (337)
T 1o6l_A          160 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR---------------  223 (337)
T ss_dssp             CCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---------------
T ss_pred             CcccccccChhhCChhhhcC-CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---------------
Confidence            45556789999999999987 67899999999999999999999999887765544333221100               


Q ss_pred             CCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCC-----CHHHHhcCccccCCCCchh
Q 045787          242 PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRI-----TAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~~l~hp~~~~~~~~~~  298 (324)
                                   ....+++++.++|.+||+.||.+||     ++.++++||||+++++..+
T Consensus       224 -------------~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~  272 (337)
T 1o6l_A          224 -------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV  272 (337)
T ss_dssp             -------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHH
T ss_pred             -------------CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHH
Confidence                         1125789999999999999999999     8999999999999987655

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-51  Score=362.16  Aligned_cols=290  Identities=39%  Similarity=0.677  Sum_probs=235.8

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeecccc---CCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQ---EGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV   81 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   81 (324)
                      ..++|++.+.||+|++|.||+|.+..+|+.||+|++......   ......+.+|+.++++++||||+++++++.+.+..
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            457899999999999999999999999999999999754322   22345688999999999999999999999999999


Q ss_pred             EEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC
Q 045787           82 FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        82 ~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~  161 (324)
                      ++|+||+++++...+......+++..++.++.+++.||.|||+.|++|+||||+||+++ .++.++|+|||.+.......
T Consensus        88 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~-~~~~~kl~Dfg~a~~~~~~~  166 (346)
T 1ua2_A           88 SLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPN  166 (346)
T ss_dssp             EEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC-TTCCEEECCCGGGSTTTSCC
T ss_pred             EEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEc-CCCCEEEEecccceeccCCc
Confidence            99999999999999888777899999999999999999999999999999999999999 89999999999998776555


Q ss_pred             CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHHcCCCCcccccchhhhhcc
Q 045787          162 KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-HDHLSLIFSLLGTPTDESWAESTYISEI  240 (324)
Q Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (324)
                      .......+|+.|+|||++.+...++.++||||||+++|+|++|.+||.+.+ .+....+....+.+....|.......+.
T Consensus       167 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  246 (346)
T 1ua2_A          167 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY  246 (346)
T ss_dssp             CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred             ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCccc
Confidence            555566789999999999775668999999999999999999999998877 4445566666677766665543332222


Q ss_pred             cCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCc
Q 045787          241 LPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENV  296 (324)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~  296 (324)
                      .. ...............++.++.+||.+||+.||.+|||+.|+++||||++....
T Consensus       247 ~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~  301 (346)
T 1ua2_A          247 VT-FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP  301 (346)
T ss_dssp             CC-CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred             cc-ccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCC
Confidence            11 11122233445567789999999999999999999999999999999987643

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3.2e-51  Score=361.01  Aligned_cols=266  Identities=29%  Similarity=0.451  Sum_probs=224.3

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCC----CchHHHHHHHHHHhcCCCCeeEEEeeeecCC
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEG----VPSYIIREVSLLKELEHENIVRLLDVQSSRK   79 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   79 (324)
                      ...++|++.+.||+|+||.||+|.++.+|+.||+|++........    ..+.+.+|+.++++++||||+++++++.+..
T Consensus         9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~   88 (361)
T 2yab_A            9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT   88 (361)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC
Confidence            456789999999999999999999999999999999986553321    3467889999999999999999999999999


Q ss_pred             eEEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCC----cEEEeeccce
Q 045787           80 DVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN----TVKLADFGLA  154 (324)
Q Consensus        80 ~~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~----~v~l~d~g~~  154 (324)
                      .+|+||||+. |+|.+++.. ...+++..++.++.+|+.||.|||+.|++|+||||+||+++ .++    .++|+|||.+
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~-~~~~~~~~vkl~DFG~a  166 (361)
T 2yab_A           89 DVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL-DKNIPIPHIKLIDFGLA  166 (361)
T ss_dssp             EEEEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEES-CTTSSSCCEEECCCSSC
T ss_pred             EEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEe-CCCCCccCEEEEecCCc
Confidence            9999999996 588888765 45799999999999999999999999999999999999998 554    7999999999


Q ss_pred             eeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccch
Q 045787          155 RAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAES  234 (324)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (324)
                      ...... ......+||+.|+|||++.+ ..++.++|+||||+++|+|++|..||.+.+.......+......        
T Consensus       167 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~--------  236 (361)
T 2yab_A          167 HEIEDG-VEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYD--------  236 (361)
T ss_dssp             EECCTT-CCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC--------
T ss_pred             eEcCCC-CccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--------
Confidence            876532 33445679999999999987 67899999999999999999999999887755543333211110        


Q ss_pred             hhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCch
Q 045787          235 TYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP  297 (324)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~  297 (324)
                                      .....+..+++.+.+||.+||..||.+|||+.++++||||+++....
T Consensus       237 ----------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~  283 (361)
T 2yab_A          237 ----------------FDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQ  283 (361)
T ss_dssp             ----------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSSHHH
T ss_pred             ----------------CCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCchhh
Confidence                            01123346899999999999999999999999999999999876543

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=6e-52  Score=364.77  Aligned_cols=264  Identities=25%  Similarity=0.378  Sum_probs=219.1

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeecc-ccCCCchHHHHHHHHHHhc-CCCCeeEEEeeeecCCeE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQT-EQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDV   81 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   81 (324)
                      +.-++|++++.||+|+||.||+|+++.+|+.||+|++.... ........+.+|..+++.+ +||+|+++++++.+.+.+
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~   99 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL   99 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence            45578999999999999999999999999999999998653 2233356688899999988 699999999999999999


Q ss_pred             EEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           82 FLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        82 ~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      |+||||++| +|...+... ..+++..++.++.+|+.||.|||++|++||||||+||+++ .++.++|+|||++......
T Consensus       100 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~-~~g~ikL~DFG~a~~~~~~  177 (353)
T 3txo_A          100 FFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLD-HEGHCKLADFGMCKEGICN  177 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC-TTSCEEECCCTTCBCSCC-
T ss_pred             EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEEC-CCCCEEEccccceeecccC
Confidence            999999985 888777664 5699999999999999999999999999999999999999 8999999999999865444


Q ss_pred             CCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcc
Q 045787          161 QKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEI  240 (324)
Q Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (324)
                      .......+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+......              
T Consensus       178 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~--------------  242 (353)
T 3txo_A          178 GVTTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV--------------  242 (353)
T ss_dssp             --------CCGGGCCHHHHHH-HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--------------
T ss_pred             CccccccCCCcCeEChhhcCC-CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC--------------
Confidence            445556689999999999987 66899999999999999999999999888766554433321110              


Q ss_pred             cCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCH------HHHhcCccccCCCCchh
Q 045787          241 LPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITA------MDALKHEYLIGVENVPL  298 (324)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~------~~~l~hp~~~~~~~~~~  298 (324)
                                    ....+++.+.++|++||+.||.+||++      .++++||||+++++..+
T Consensus       243 --------------~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l  292 (353)
T 3txo_A          243 --------------YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQL  292 (353)
T ss_dssp             --------------CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHH
T ss_pred             --------------CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHH
Confidence                          012478899999999999999999998      89999999999987655

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=3.1e-51  Score=360.96  Aligned_cols=297  Identities=36%  Similarity=0.639  Sum_probs=237.8

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeec--------
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS--------   77 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--------   77 (324)
                      .++|++++.||+|++|.||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            478999999999999999999999999999999998776666556778899999999999999999999876        


Q ss_pred             CCeEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeec
Q 045787           78 RKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAI  157 (324)
Q Consensus        78 ~~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~  157 (324)
                      .+..++||||++|++.+.+......+++..++.++.|++.||.+||++|++|+||||+||+++ .++.++|+|||.+...
T Consensus        96 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~-~~~~~kl~Dfg~a~~~  174 (351)
T 3mi9_A           96 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT-RDGVLKLADFGLARAF  174 (351)
T ss_dssp             -CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC-TTSCEEECCCTTCEEC
T ss_pred             CceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc-CCCCEEEccchhcccc
Confidence            456899999999999999988777899999999999999999999999999999999999999 8999999999999876


Q ss_pred             cCC----CCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHHcCCCCccccc
Q 045787          158 GVP----QKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD-HLSLIFSLLGTPTDESWA  232 (324)
Q Consensus       158 ~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~  232 (324)
                      ...    ........+|+.|+|||++.+...++.++||||||+++|+|++|..||.+.+.. ....+....+.++...+.
T Consensus       175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  254 (351)
T 3mi9_A          175 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP  254 (351)
T ss_dssp             CCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred             cccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence            422    222344567899999999987677899999999999999999999999888744 444555556666655544


Q ss_pred             chhhhhcccCCCC-CCCCcchhhhC--CCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchhhhhhh
Q 045787          233 ESTYISEILPLYP-HFEPANLAEKF--PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLI  303 (324)
Q Consensus       233 ~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~~~~~~  303 (324)
                      ............. ...........  ...++.+.+||.+||+.||.+|||++++++||||++...+.....++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~  328 (351)
T 3mi9_A          255 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDLKGML  328 (351)
T ss_dssp             TGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCCCSHHHH
T ss_pred             ccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCcccccccc
Confidence            4332221111000 00000000000  01477899999999999999999999999999999887766655444

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=4.1e-52  Score=363.16  Aligned_cols=253  Identities=23%  Similarity=0.359  Sum_probs=206.2

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccC-----CceEEEEEeeeccccCCCchHHHHHHHHHHhcCC-CCeeEEEeeeec-
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVT-----GQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEH-ENIVRLLDVQSS-   77 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~-----~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~-   77 (324)
                      -.++|++.+.||+|+||.||+|.....     ++.||+|.+....... ..+.+.+|+.++.+++| |||+++++++.+ 
T Consensus        62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~-~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~  140 (353)
T 4ase_A           62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHLNVVNLLGACTKP  140 (353)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHH-HHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChH-HHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence            356899999999999999999987643     3579999986543221 24568899999999976 899999999865 


Q ss_pred             CCeEEEEEEecC-CCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeec
Q 045787           78 RKDVFLVFEYLD-LDLHSFITRHK---------------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL  141 (324)
Q Consensus        78 ~~~~~iv~e~~~-g~l~~~~~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~  141 (324)
                      ++.+++||||++ |+|.+++....               ..+++..+..++.||+.||.|||+++++||||||+|||++ 
T Consensus       141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~-  219 (353)
T 4ase_A          141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-  219 (353)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC-
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeC-
Confidence            457899999998 69999987642               3488999999999999999999999999999999999999 


Q ss_pred             CCCcEEEeeccceeeccCCCC--cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCh-hHHH
Q 045787          142 KRNTVKLADFGLARAIGVPQK--EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKH-DHLS  217 (324)
Q Consensus       142 ~~~~v~l~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~-~~~~  217 (324)
                      .++.+||+|||+++.......  .....++|+.|+|||++.+ ..++.++|||||||++|||+| |..||.+.+. ..+.
T Consensus       220 ~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~  298 (353)
T 4ase_A          220 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC  298 (353)
T ss_dssp             GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH
T ss_pred             CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc-CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            899999999999987643322  2344578899999999987 678999999999999999998 8999987663 3333


Q ss_pred             HHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcC
Q 045787          218 LIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH  287 (324)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~h  287 (324)
                      ........++                           .....++++.+++.+||+.||.+|||+.++++|
T Consensus       299 ~~i~~g~~~~---------------------------~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          299 RRLKEGTRMR---------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHHTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCCCCC---------------------------CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            3322211111                           112578899999999999999999999999986

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-51  Score=365.38  Aligned_cols=288  Identities=36%  Similarity=0.600  Sum_probs=230.5

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCC-----
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK-----   79 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----   79 (324)
                      ..++|++++.||+|+||.||+|.+..+|+.||+|++..........+.+.+|+.++++++||||+++++++....     
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  102 (367)
T 1cm8_A           23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF  102 (367)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence            467899999999999999999999999999999998665443333466889999999999999999999987653     


Q ss_pred             -eEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeecc
Q 045787           80 -DVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIG  158 (324)
Q Consensus        80 -~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~  158 (324)
                       .+|+||||++++|.+++..  ..+++..++.++.|++.||.|||+.|++|+||||+||+++ .++.++|+|||.+....
T Consensus       103 ~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~  179 (367)
T 1cm8_A          103 TDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN-EDCELKILDFGLARQAD  179 (367)
T ss_dssp             CCCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC-TTCCEEECCCTTCEECC
T ss_pred             ceEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEc-CCCCEEEEeeecccccc
Confidence             4699999998899888876  4699999999999999999999999999999999999999 89999999999998754


Q ss_pred             CCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHHcCCCCcccccch--h
Q 045787          159 VPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-HDHLSLIFSLLGTPTDESWAES--T  235 (324)
Q Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~--~  235 (324)
                      .   ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+ .+.+..+....+.++...+...  .
T Consensus       180 ~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~  256 (367)
T 1cm8_A          180 S---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD  256 (367)
T ss_dssp             S---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred             c---ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhH
Confidence            3   23445788999999999876778999999999999999999999998877 4555666677777765443221  1


Q ss_pred             hhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchh
Q 045787          236 YISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~  298 (324)
                      .....................+..++.+.+||.+||+.||.+|||+.++++||||++..+...
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~  319 (367)
T 1cm8_A          257 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTED  319 (367)
T ss_dssp             HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC----
T ss_pred             HHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCcc
Confidence            111222223333445556667789999999999999999999999999999999999876543

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.6e-51  Score=359.58  Aligned_cols=262  Identities=29%  Similarity=0.461  Sum_probs=220.5

Q ss_pred             CcccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeecc-ccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCe
Q 045787            2 GKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQT-EQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKD   80 (324)
Q Consensus         2 ~~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   80 (324)
                      +....++|++.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++.+.+.
T Consensus         4 ~~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~   83 (336)
T 3h4j_B            4 SKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTD   83 (336)
T ss_dssp             CCSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             CccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence            4456689999999999999999999999999999999997653 233445678999999999999999999999999999


Q ss_pred             EEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           81 VFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        81 ~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      .++||||++|++.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||+++ .++.++|+|||.+..... 
T Consensus        84 ~~lv~E~~~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~-~~~~~kl~DFG~s~~~~~-  160 (336)
T 3h4j_B           84 IVMVIEYAGGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLD-DNLNVKIADFGLSNIMTD-  160 (336)
T ss_dssp             EEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEEC-TTCCEEECCSSCTBTTTT-
T ss_pred             EEEEEECCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEc-CCCCEEEEEeccceeccC-
Confidence            9999999999999998775 4699999999999999999999999999999999999999 899999999999876542 


Q ss_pred             CCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcc
Q 045787          161 QKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEI  240 (324)
Q Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (324)
                      .......+||+.|+|||++.+....+.++||||||+++|+|++|..||........                        
T Consensus       161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~------------------------  216 (336)
T 3h4j_B          161 GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL------------------------  216 (336)
T ss_dssp             SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC------------------------
T ss_pred             CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH------------------------
Confidence            33345567999999999998755558899999999999999999999965432110                        


Q ss_pred             cCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCC
Q 045787          241 LPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVE  294 (324)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~  294 (324)
                      ....    ..........+++.+.++|++||+.||.+|||++++++||||+...
T Consensus       217 ~~~i----~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  266 (336)
T 3h4j_B          217 FKKV----NSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNL  266 (336)
T ss_dssp             BCCC----CSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTTC
T ss_pred             HHHH----HcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccCC
Confidence            0000    0001112235789999999999999999999999999999998643

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=7.2e-51  Score=362.05  Aligned_cols=264  Identities=25%  Similarity=0.391  Sum_probs=219.9

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhc-CCCCeeEEEeeeecCCeE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDV   81 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   81 (324)
                      +.-++|++++.||+|+||.||+|+++.+++.||+|++..... .....+.+.+|..++.++ +||||+++++++.+.+.+
T Consensus        49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~  128 (396)
T 4dc2_A           49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL  128 (396)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence            445789999999999999999999999999999999986542 233456688999999887 799999999999999999


Q ss_pred             EEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           82 FLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        82 ~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      |+||||++| +|...+... ..+++..++.++.+|+.||.|||++|++||||||+||+++ .++.++|+|||++......
T Consensus       129 ~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~-~~g~ikL~DFGla~~~~~~  206 (396)
T 4dc2_A          129 FFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRP  206 (396)
T ss_dssp             EEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC-TTSCEEECCCTTCBCCCCT
T ss_pred             EEEEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEC-CCCCEEEeecceeeecccC
Confidence            999999985 777777664 5699999999999999999999999999999999999999 8999999999999865444


Q ss_pred             CCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChh---------HHHHHHHHcCCCCcccc
Q 045787          161 QKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD---------HLSLIFSLLGTPTDESW  231 (324)
Q Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---------~~~~~~~~~~~~~~~~~  231 (324)
                      .......+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||......         .+...+.. ..      
T Consensus       207 ~~~~~~~~gt~~Y~aPE~l~~-~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~-~~------  278 (396)
T 4dc2_A          207 GDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-KQ------  278 (396)
T ss_dssp             TCCBCCCCBCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH-CC------
T ss_pred             CCccccccCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc-cc------
Confidence            555666789999999999988 67899999999999999999999999643211         11111110 00      


Q ss_pred             cchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCH------HHHhcCccccCCCCchh
Q 045787          232 AESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITA------MDALKHEYLIGVENVPL  298 (324)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~------~~~l~hp~~~~~~~~~~  298 (324)
                                           ......++.++.+||++||+.||.+||++      +++++||||+++++..+
T Consensus       279 ---------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l  330 (396)
T 4dc2_A          279 ---------------------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMM  330 (396)
T ss_dssp             ---------------------CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHH
T ss_pred             ---------------------cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHH
Confidence                                 01123578999999999999999999985      89999999999987655

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.1e-51  Score=375.72  Aligned_cols=285  Identities=34%  Similarity=0.581  Sum_probs=225.1

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecC------
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR------   78 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------   78 (324)
                      ..++|++++.||+|+||.||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++...      
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence            35789999999999999999999999999999999986644444456788999999999999999999998654      


Q ss_pred             CeEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeecc
Q 045787           79 KDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIG  158 (324)
Q Consensus        79 ~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~  158 (324)
                      ...|+||||+++++.+.+..   .+++..++.++.||+.||.|||+.|++||||||+||+++ .++.+||+|||.+....
T Consensus       140 ~~~~lv~E~~~~~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~-~~~~~kl~DFG~a~~~~  215 (464)
T 3ttj_A          140 QDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAG  215 (464)
T ss_dssp             CEEEEEEECCSEEHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC-TTSCEEECCCCCC----
T ss_pred             CeEEEEEeCCCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEe-CCCCEEEEEEEeeeecC
Confidence            45799999999998887754   499999999999999999999999999999999999999 89999999999998765


Q ss_pred             CCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHHcCCCCcccccchh-h
Q 045787          159 VPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-HDHLSLIFSLLGTPTDESWAEST-Y  236 (324)
Q Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~-~  236 (324)
                      .. ......++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+ .+....+....+.+....+.... .
T Consensus       216 ~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~  293 (464)
T 3ttj_A          216 TS-FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT  293 (464)
T ss_dssp             -C-CCC----CCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHH
T ss_pred             CC-cccCCCcccccccCHHHHcC-CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchh
Confidence            32 23444678999999999988 678999999999999999999999998887 55666777777777655443321 1


Q ss_pred             hhcccCCCCCCCCcchhhhCCC------------CChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCC
Q 045787          237 ISEILPLYPHFEPANLAEKFPN------------LEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVEN  295 (324)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~------------~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~  295 (324)
                      ...................++.            .++++.+||.+||+.||.+|||++|+|+||||+...+
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~  364 (464)
T 3ttj_A          294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD  364 (464)
T ss_dssp             HHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred             hhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccC
Confidence            1111122222222222222222            1567899999999999999999999999999986544

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.4e-52  Score=370.15  Aligned_cols=293  Identities=35%  Similarity=0.583  Sum_probs=220.9

Q ss_pred             CcccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcC-CCCeeEEEeeeecC--
Q 045787            2 GKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-HENIVRLLDVQSSR--   78 (324)
Q Consensus         2 ~~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--   78 (324)
                      +....++|++++.||+|+||.||+|.+..+|+.||+|++............+.+|+.+++++. ||||+++++++..+  
T Consensus         4 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~   83 (388)
T 3oz6_A            4 DRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADND   83 (388)
T ss_dssp             CHHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS
T ss_pred             cCcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC
Confidence            445668999999999999999999999999999999998755443334566788999999997 99999999998754  


Q ss_pred             CeEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeecc
Q 045787           79 KDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIG  158 (324)
Q Consensus        79 ~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~  158 (324)
                      ..+|+||||++++|...+..  ..+++..+..++.|++.||.|||+.|++||||||+||+++ .++.++|+|||++....
T Consensus        84 ~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~  160 (388)
T 3oz6_A           84 RDVYLVFDYMETDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLN-AECHVKVADFGLSRSFV  160 (388)
T ss_dssp             SCEEEEEECCSEEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC-TTCCEEECCCTTCEESS
T ss_pred             CEEEEEecccCcCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEc-CCCCEEecCCccccccc
Confidence            37999999999999988876  4699999999999999999999999999999999999999 89999999999997653


Q ss_pred             CC---------------------CCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-hhHH
Q 045787          159 VP---------------------QKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-HDHL  216 (324)
Q Consensus       159 ~~---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~  216 (324)
                      ..                     .......++|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+ ...+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~  240 (388)
T 3oz6_A          161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL  240 (388)
T ss_dssp             SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            21                     1122335789999999999876778999999999999999999999998877 4555


Q ss_pred             HHHHHHcCCCCcccccchhh------hh---cccCCCCCCCCcch---------hhhCCCCChhHHHHHHHhhcCCCCCC
Q 045787          217 SLIFSLLGTPTDESWAESTY------IS---EILPLYPHFEPANL---------AEKFPNLEPAGVDLLSQMLCLNPKQR  278 (324)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~------~~---~~~~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~R  278 (324)
                      ..+....+.|....+.....      ..   ..............         ......+++++.+||.+||+.||.+|
T Consensus       241 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R  320 (388)
T 3oz6_A          241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKR  320 (388)
T ss_dssp             HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGS
T ss_pred             HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccC
Confidence            66666666666543221000      00   00000000000000         01123678999999999999999999


Q ss_pred             CCHHHHhcCccccCCCCch
Q 045787          279 ITAMDALKHEYLIGVENVP  297 (324)
Q Consensus       279 ps~~~~l~hp~~~~~~~~~  297 (324)
                      ||++++++||||+...+..
T Consensus       321 ~t~~e~l~Hp~~~~~~~~~  339 (388)
T 3oz6_A          321 ISANDALKHPFVSIFHNPN  339 (388)
T ss_dssp             CCHHHHTTSTTTTTTCCGG
T ss_pred             CCHHHHhCCHHHHHhcCCc
Confidence            9999999999998876543

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=4.4e-51  Score=362.22  Aligned_cols=286  Identities=23%  Similarity=0.406  Sum_probs=232.6

Q ss_pred             CcccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeecc-ccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCe
Q 045787            2 GKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQT-EQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKD   80 (324)
Q Consensus         2 ~~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   80 (324)
                      +.+..++|++++.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++.+.+.
T Consensus        10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~   89 (384)
T 4fr4_A           10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED   89 (384)
T ss_dssp             CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            4567789999999999999999999999999999999997654 233445678899999999999999999999999999


Q ss_pred             EEEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccC
Q 045787           81 VFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGV  159 (324)
Q Consensus        81 ~~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~  159 (324)
                      .|+||||+.| +|...+.. ...+++..++.++.+|+.||.|||+.|++|+||||+||+++ .++.++|+|||.+.....
T Consensus        90 ~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~-~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           90 MFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLD-EHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             EEEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC-TTSCEEECCCTTCEECCT
T ss_pred             EEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEC-CCCCEEEeccceeeeccC
Confidence            9999999975 77777665 45699999999999999999999999999999999999999 899999999999987653


Q ss_pred             CCCcccccccccccCCchhhcC--CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhh
Q 045787          160 PQKEYSRDCVYSPYKAPELLLG--YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYI  237 (324)
Q Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (324)
                       .......+||+.|+|||++.+  ...++.++|+|||||++|+|++|..||...................          
T Consensus       168 -~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~----------  236 (384)
T 4fr4_A          168 -ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV----------  236 (384)
T ss_dssp             -TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC----------
T ss_pred             -CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc----------
Confidence             334455679999999999874  2457999999999999999999999997655332222221110000          


Q ss_pred             hcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCC-HHHHhcCccccCCCCchhh-----hhhhhcccCCCC
Q 045787          238 SEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRIT-AMDALKHEYLIGVENVPLV-----ILLINRKKKLGV  311 (324)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-~~~~l~hp~~~~~~~~~~~-----~~~~~~~~~~~~  311 (324)
                                     ......++..+.++|.+||+.||.+||+ +.++++||||+++++..+.     +..+|....++.
T Consensus       237 ---------------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~~~~~~~~~p~~~p~~~~~~~  301 (384)
T 4fr4_A          237 ---------------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVFQKRLIPGFIPNKGRLNC  301 (384)
T ss_dssp             ---------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHHHHHTTCSCCCCCCSCCSSCC
T ss_pred             ---------------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHHHHHhCCCCCCCCCCCCCCCC
Confidence                           0011257899999999999999999998 8999999999999876653     344444445555


Q ss_pred             CCCc
Q 045787          312 DNGW  315 (324)
Q Consensus       312 ~~~~  315 (324)
                      +..+
T Consensus       302 ~~~~  305 (384)
T 4fr4_A          302 DPTF  305 (384)
T ss_dssp             CCCC
T ss_pred             CCcc
Confidence            4444

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=4.6e-51  Score=357.87  Aligned_cols=264  Identities=27%  Similarity=0.426  Sum_probs=224.0

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeecc-ccCCCchHHHHHHHHHHhc-CCCCeeEEEeeeecCCeE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQT-EQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDV   81 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   81 (324)
                      +..++|++.+.||+|+||.||+|.++.+|+.||+|++.... ........+..|..++..+ +||+|+++++++.+.+.+
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            45689999999999999999999999999999999998654 2233456678899999887 899999999999999999


Q ss_pred             EEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           82 FLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        82 ~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      |+||||++ |+|.+++... +.+++..++.++.+|+.||.|||++|++|+||||+||+++ .++.++|+|||.+......
T Consensus        94 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~-~~g~vkL~DFG~a~~~~~~  171 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD-KDGHIKIADFGMCKENMLG  171 (345)
T ss_dssp             EEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC-TTSCEEECCCTTCBCCCCT
T ss_pred             EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEEC-CCCCEEEeEChhhhhcccC
Confidence            99999997 5888887764 4699999999999999999999999999999999999999 8999999999999865434


Q ss_pred             CCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcc
Q 045787          161 QKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEI  240 (324)
Q Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (324)
                      .......+||+.|+|||++.+ ..++.++|+||||+++|+|++|..||.+.+.......+......              
T Consensus       172 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~--------------  236 (345)
T 1xjd_A          172 DAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF--------------  236 (345)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--------------
T ss_pred             CCcccCCCCCcccCChhhhcC-CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCC--------------
Confidence            444556689999999999987 66899999999999999999999999887765544433221100              


Q ss_pred             cCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHH-HHhcCccccCCCCchh
Q 045787          241 LPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAM-DALKHEYLIGVENVPL  298 (324)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~-~~l~hp~~~~~~~~~~  298 (324)
                                    ....+++++.++|.+||+.||.+||++. ++++||||+++++..+
T Consensus       237 --------------~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~~l  281 (345)
T 1xjd_A          237 --------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEEL  281 (345)
T ss_dssp             --------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHH
T ss_pred             --------------CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCHHHH
Confidence                          0124788999999999999999999998 9999999999986544

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.1e-50  Score=356.02  Aligned_cols=266  Identities=26%  Similarity=0.393  Sum_probs=221.4

Q ss_pred             CcccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeecccc-CCCchHHHHHHHHHHhc-CCCCeeEEEeeeecCC
Q 045787            2 GKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQ-EGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRK   79 (324)
Q Consensus         2 ~~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   79 (324)
                      ..+.-++|++++.||+|+||.||+|+++.+++.||+|++...... ....+.+.+|..+++++ +||||+++++++.+++
T Consensus         4 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~   83 (345)
T 3a8x_A            4 DPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES   83 (345)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             CCCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC
Confidence            456678999999999999999999999999999999999865422 22235578899999988 7999999999999999


Q ss_pred             eEEEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeecc
Q 045787           80 DVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIG  158 (324)
Q Consensus        80 ~~~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~  158 (324)
                      ..|+||||++| +|..++... ..+++..++.++.+|+.||.|||++|++|+||||+||+++ .++.++|+|||.+....
T Consensus        84 ~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~-~~g~~kL~DFG~a~~~~  161 (345)
T 3a8x_A           84 RLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGL  161 (345)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC-TTSCEEECCGGGCBCSC
T ss_pred             EEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEC-CCCCEEEEecccccccc
Confidence            99999999975 888777664 4699999999999999999999999999999999999999 89999999999998654


Q ss_pred             CCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh---------hHHHHHHHHcCCCCcc
Q 045787          159 VPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH---------DHLSLIFSLLGTPTDE  229 (324)
Q Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---------~~~~~~~~~~~~~~~~  229 (324)
                      .........+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.....         ..+...+.. ..    
T Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~-~~----  235 (345)
T 3a8x_A          162 RPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-KQ----  235 (345)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH-CC----
T ss_pred             CCCCcccccCCCccccCccccCC-CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc-CC----
Confidence            44445556689999999999987 6789999999999999999999999965321         111111110 00    


Q ss_pred             cccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCH------HHHhcCccccCCCCchh
Q 045787          230 SWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITA------MDALKHEYLIGVENVPL  298 (324)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~------~~~l~hp~~~~~~~~~~  298 (324)
                                             ......++..+.++|.+||+.||.+||++      .++++||||+++.+..+
T Consensus       236 -----------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~  287 (345)
T 3a8x_A          236 -----------------------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMM  287 (345)
T ss_dssp             -----------------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHH
T ss_pred             -----------------------CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHH
Confidence                                   00113578999999999999999999995      89999999999986554

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=6.2e-51  Score=356.23  Aligned_cols=290  Identities=35%  Similarity=0.601  Sum_probs=226.1

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLV   84 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   84 (324)
                      .-++|++++.||+|++|.||+|.+..+|+.||+|++..........+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  102 (331)
T 4aaa_A           23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV  102 (331)
T ss_dssp             CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence            45789999999999999999999999999999999876544433345677899999999999999999999999999999


Q ss_pred             EEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcc
Q 045787           85 FEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY  164 (324)
Q Consensus        85 ~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~  164 (324)
                      |||++++++..+......+++..++.++.+++.||.+||+.|++|+||||+||+++ .++.++|+|||.+..........
T Consensus       103 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~  181 (331)
T 4aaa_A          103 FEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVY  181 (331)
T ss_dssp             EECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC-TTSCEEECCCTTC----------
T ss_pred             EecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEc-CCCcEEEEeCCCceeecCCcccc
Confidence            99999877777766667899999999999999999999999999999999999999 88999999999998765544455


Q ss_pred             cccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhH-HHHHHHHcCCCCcccccchhhhh--ccc
Q 045787          165 SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDH-LSLIFSLLGTPTDESWAESTYIS--EIL  241 (324)
Q Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~--~~~  241 (324)
                      ....+++.|+|||++.+...++.++||||||+++|+|++|..||....... ...+....+..............  ...
T Consensus       182 ~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (331)
T 4aaa_A          182 DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGV  261 (331)
T ss_dssp             --CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTC
T ss_pred             CCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccc
Confidence            556789999999999876678999999999999999999999998877443 33333333333221111000000  000


Q ss_pred             CCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCC
Q 045787          242 PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVEN  295 (324)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~  295 (324)
                      ...............+.+++.+.+||.+||+.||.+|||+.++++||||+....
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  315 (331)
T 4aaa_A          262 RLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGF  315 (331)
T ss_dssp             CCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGGH
T ss_pred             cCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCCh
Confidence            000111223344556678999999999999999999999999999999987643

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-51  Score=356.41  Aligned_cols=261  Identities=23%  Similarity=0.387  Sum_probs=222.1

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLV   84 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   84 (324)
                      +.++|++.+.||+|+||.||+|.+..+++.+|+|.+......   ...+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv   79 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD---QVLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH---HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCccc---HHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence            468999999999999999999999999999999998754322   35688999999999999999999999999999999


Q ss_pred             EEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecC-CCcEEEeeccceeeccCCCC
Q 045787           85 FEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK-RNTVKLADFGLARAIGVPQK  162 (324)
Q Consensus        85 ~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~-~~~v~l~d~g~~~~~~~~~~  162 (324)
                      |||++| +|.+.+......+++..++.++.|++.||.|||+.|++|+||||+||+++.. ++.++|+|||.+...... .
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~-~  158 (321)
T 1tki_A           80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-D  158 (321)
T ss_dssp             ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-C
T ss_pred             EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-C
Confidence            999985 8999887766679999999999999999999999999999999999999832 789999999999876532 3


Q ss_pred             cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccC
Q 045787          163 EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILP  242 (324)
Q Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (324)
                      ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||...+...............               
T Consensus       159 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~---------------  222 (321)
T 1tki_A          159 NFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF---------------  222 (321)
T ss_dssp             EEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC---------------
T ss_pred             ccccccCChhhcCcHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCC---------------
Confidence            3344578999999999987 567999999999999999999999998877555443332211110               


Q ss_pred             CCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCC
Q 045787          243 LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVE  294 (324)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~  294 (324)
                               ....++.++.++.++|.+||..||.+|||+.++++||||++..
T Consensus       223 ---------~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  265 (321)
T 1tki_A          223 ---------DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI  265 (321)
T ss_dssp             ---------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred             ---------ChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence                     1122346899999999999999999999999999999998754

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.1e-51  Score=363.46  Aligned_cols=287  Identities=36%  Similarity=0.605  Sum_probs=221.3

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecC------
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR------   78 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------   78 (324)
                      ..++|++++.||+|++|.||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++...      
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  106 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF  106 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence            35799999999999999999999999999999999876543333346678999999999999999999998654      


Q ss_pred             CeEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeecc
Q 045787           79 KDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIG  158 (324)
Q Consensus        79 ~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~  158 (324)
                      ...|+|+++++++|.+++..  ..+++..++.++.||+.||.|||+.|++|+||||+||+++ .++.++|+|||.+....
T Consensus       107 ~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~-~~~~~kL~DFG~a~~~~  183 (367)
T 2fst_X          107 NDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLARHTA  183 (367)
T ss_dssp             CCCEEEEECCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC-TTCCEEECC--------
T ss_pred             CeEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEEC-CCCCEEEeecccccccc
Confidence            56899999998888887765  4699999999999999999999999999999999999999 89999999999997654


Q ss_pred             CCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHHcCCCCcccccch--h
Q 045787          159 VPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-HDHLSLIFSLLGTPTDESWAES--T  235 (324)
Q Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~--~  235 (324)
                      .   ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+ ...+..+....+.+....+...  .
T Consensus       184 ~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~  260 (367)
T 2fst_X          184 D---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE  260 (367)
T ss_dssp             ----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCH
T ss_pred             c---cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence            2   23345788999999999876778999999999999999999999998877 4556666677777765443321  1


Q ss_pred             hhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCch
Q 045787          236 YISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP  297 (324)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~  297 (324)
                      ....................++..++.+.+||.+||+.||.+|||+.++|+||||++.....
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~  322 (367)
T 2fst_X          261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD  322 (367)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGG
T ss_pred             HHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCC
Confidence            11222233334445556667778999999999999999999999999999999999887654

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.5e-50  Score=360.61  Aligned_cols=284  Identities=31%  Similarity=0.541  Sum_probs=226.4

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeec------
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS------   77 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------   77 (324)
                      ...++|++.+.||+|+||.||+|.+..+|+.||+|++......      ..+|+.+++.++||||+++++++..      
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            4568999999999999999999999999999999998654322      2379999999999999999998833      


Q ss_pred             --------------------------------CCeEEEEEEecCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH
Q 045787           78 --------------------------------RKDVFLVFEYLDLDLHSFITR---HKNTLNLLVIKAILKQILLGLAYC  122 (324)
Q Consensus        78 --------------------------------~~~~~iv~e~~~g~l~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~L  122 (324)
                                                      +...++||||++|+|.+.+..   ....+++..++.++.||+.||.||
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             --------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                            345899999999987777653   356799999999999999999999


Q ss_pred             HhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHH
Q 045787          123 HSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMI  202 (324)
Q Consensus       123 h~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~  202 (324)
                      |+.|++|+||||+||+++..++.++|+|||.+...... .......+++.|+|||++.+...++.++|||||||++|+|+
T Consensus       158 H~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell  236 (383)
T 3eb0_A          158 HSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS-EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI  236 (383)
T ss_dssp             HTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT-SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred             HHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC-CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHH
Confidence            99999999999999999856889999999999876533 33344567899999999987667899999999999999999


Q ss_pred             hCCCCCCCCC-hhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhh-CCCCChhHHHHHHHhhcCCCCCCCC
Q 045787          203 TGKPLFPSKK-HDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEK-FPNLEPAGVDLLSQMLCLNPKQRIT  280 (324)
Q Consensus       203 ~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rps  280 (324)
                      +|+.||.+.+ .+....+....+.+....+......... ..+.......+... ....++++.+||.+||+.||.+|||
T Consensus       237 ~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  315 (383)
T 3eb0_A          237 LGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTE-VRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRIN  315 (383)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC---CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC
T ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCccccc-ccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCC
Confidence            9999998877 5556677777777765443332111100 11122222223332 3358899999999999999999999


Q ss_pred             HHHHhcCccccCCCC
Q 045787          281 AMDALKHEYLIGVEN  295 (324)
Q Consensus       281 ~~~~l~hp~~~~~~~  295 (324)
                      +.|+++||||+++++
T Consensus       316 ~~e~l~hp~f~~~~~  330 (383)
T 3eb0_A          316 PYEAMAHPFFDHLRN  330 (383)
T ss_dssp             HHHHHTSGGGHHHHH
T ss_pred             HHHHhcCHHHHHHHh
Confidence            999999999998754

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=5e-51  Score=359.42  Aligned_cols=264  Identities=30%  Similarity=0.477  Sum_probs=219.7

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc---cCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCe
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE---QEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKD   80 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   80 (324)
                      +..++|++.+.||+|+||.||+|.+..+|+.||+|++.....   .....+.+.+|+.+++.++||||+++++++.+++.
T Consensus        21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  100 (351)
T 3c0i_A           21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM  100 (351)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            456789999999999999999999999999999999975432   12235678999999999999999999999999999


Q ss_pred             EEEEEEecC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCC---cEEEeeccc
Q 045787           81 VFLVFEYLD-LDLHSFITRHK---NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN---TVKLADFGL  153 (324)
Q Consensus        81 ~~iv~e~~~-g~l~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~---~v~l~d~g~  153 (324)
                      .|+||||++ ++|.+.+....   ..+++..++.++.||+.||.|||++|++|+||||+||+++ .++   .++|+|||.
T Consensus       101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~-~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLA-SKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-SSSTTCCEEECCCTT
T ss_pred             EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEe-cCCCCCcEEEecCcc
Confidence            999999998 58877776532   3589999999999999999999999999999999999998 443   499999999


Q ss_pred             eeeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccc
Q 045787          154 ARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAE  233 (324)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  233 (324)
                      +..............+|+.|+|||++.+ ..++.++||||||+++|+|++|..||..........+.....         
T Consensus       180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~~~~---------  249 (351)
T 3c0i_A          180 AIQLGESGLVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKY---------  249 (351)
T ss_dssp             CEECCTTSCBCCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHHTCC---------
T ss_pred             eeEecCCCeeecCCcCCcCccCHHHHcC-CCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHcCCC---------
Confidence            9887654444555679999999999987 668999999999999999999999998754433222221100         


Q ss_pred             hhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCC
Q 045787          234 STYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVE  294 (324)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~  294 (324)
                                      ......+..+++++.++|.+||+.||.+|||+.++++||||++..
T Consensus       250 ----------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~  294 (351)
T 3c0i_A          250 ----------------KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERD  294 (351)
T ss_dssp             ----------------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHH
T ss_pred             ----------------CCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCc
Confidence                            001122346899999999999999999999999999999999754

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-50  Score=349.89  Aligned_cols=261  Identities=25%  Similarity=0.385  Sum_probs=223.3

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF   82 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   82 (324)
                      +.-++|++++.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|..+++.++||||+++++++.+...+|
T Consensus         3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~   82 (318)
T 1fot_A            3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF   82 (318)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred             CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence            456789999999999999999999999999999999976542 2334567889999999999999999999999999999


Q ss_pred             EEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC
Q 045787           83 LVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        83 iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~  161 (324)
                      +||||+.| +|.+++... ..+++..++.++.+|+.||.+||++|++|+||||+||+++ .++.++|+|||.+.....  
T Consensus        83 lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~-~~g~~kL~Dfg~a~~~~~--  158 (318)
T 1fot_A           83 MIMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD-KNGHIKITDFGFAKYVPD--  158 (318)
T ss_dssp             EEECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC-TTSCEEECCCSSCEECSS--
T ss_pred             EEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEc-CCCCEEEeecCcceecCC--
Confidence            99999985 888887764 5699999999999999999999999999999999999999 899999999999987542  


Q ss_pred             CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhccc
Q 045787          162 KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEIL  241 (324)
Q Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (324)
                       .....+||+.|+|||++.+ ..++.++|+||||+++|+|++|..||...+.......+.....                
T Consensus       159 -~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~----------------  220 (318)
T 1fot_A          159 -VTYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL----------------  220 (318)
T ss_dssp             -CBCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC----------------
T ss_pred             -ccccccCCccccCHhHhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC----------------
Confidence             2344578999999999987 6789999999999999999999999987765444332221110                


Q ss_pred             CCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCC-----CHHHHhcCccccCCCCchh
Q 045787          242 PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRI-----TAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~~l~hp~~~~~~~~~~  298 (324)
                                  ...+.+++++.++|.+||..||.+||     +++++++||||+++.+..+
T Consensus       221 ------------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~  270 (318)
T 1fot_A          221 ------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKL  270 (318)
T ss_dssp             ------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHH
T ss_pred             ------------CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHHH
Confidence                        01125788999999999999999999     9999999999999987655

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=9.5e-51  Score=366.96  Aligned_cols=264  Identities=29%  Similarity=0.471  Sum_probs=222.8

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   83 (324)
                      ...++|++.+.||+|+||.||+|.+..+|+.+|+|++..........+.+.+|+.+++.++||||+++++++.+++..|+
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   87 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL   87 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence            34578999999999999999999999999999999998655433335678899999999999999999999999999999


Q ss_pred             EEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeec--CCCcEEEeeccceeeccCC
Q 045787           84 VFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL--KRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        84 v~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~--~~~~v~l~d~g~~~~~~~~  160 (324)
                      ||||+.| +|.+.+... ..+++..++.++.||+.||.|||++|++|+||||+||+++.  .++.++|+|||.+......
T Consensus        88 v~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~  166 (444)
T 3soa_A           88 IFDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE  166 (444)
T ss_dssp             EECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred             EEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence            9999975 888888774 56999999999999999999999999999999999999984  3478999999999877655


Q ss_pred             CCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcc
Q 045787          161 QKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEI  240 (324)
Q Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (324)
                      ........||+.|+|||++.+ ..++.++||||||+++|+|++|..||...+................            
T Consensus       167 ~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~------------  233 (444)
T 3soa_A          167 QQAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFP------------  233 (444)
T ss_dssp             CCBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC------------
T ss_pred             CceeecccCCcccCCHHHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCC------------
Confidence            555556689999999999987 6789999999999999999999999988776555444332211110            


Q ss_pred             cCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCC
Q 045787          241 LPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV  293 (324)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~  293 (324)
                                  ...+..+++++.+||.+||+.||.+|||+.++|+||||++.
T Consensus       234 ------------~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          234 ------------SPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             ------------TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             ------------ccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence                        11234689999999999999999999999999999999754

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=4.6e-50  Score=354.98  Aligned_cols=299  Identities=27%  Similarity=0.465  Sum_probs=233.0

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCC---------chHHHHHHHHHHhcCCCCeeEEEee
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGV---------PSYIIREVSLLKELEHENIVRLLDV   74 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~---------~~~~~~e~~~l~~l~~~~i~~~~~~   74 (324)
                      ...++|++.+.||+|++|.||+|.+.. |..||+|++.........         .+.+.+|+.++++++||||++++++
T Consensus        19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   97 (362)
T 3pg1_A           19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI   97 (362)
T ss_dssp             HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred             HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence            356899999999999999999999865 899999999765433221         2668899999999999999999998


Q ss_pred             eec-----CCeEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEe
Q 045787           75 QSS-----RKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLA  149 (324)
Q Consensus        75 ~~~-----~~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~  149 (324)
                      +..     ....|+||||++|++.+.+......+++..++.++.+++.||.+||+.|++|+||||+||+++ .++.++|+
T Consensus        98 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~-~~~~~kl~  176 (362)
T 3pg1_A           98 FVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLA-DNNDITIC  176 (362)
T ss_dssp             EEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC-TTCCEEEC
T ss_pred             EEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEc-CCCCEEEE
Confidence            843     346899999999999999988777899999999999999999999999999999999999999 89999999


Q ss_pred             eccceeeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHHcCCCCc
Q 045787          150 DFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-HDHLSLIFSLLGTPTD  228 (324)
Q Consensus       150 d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~  228 (324)
                      |||.+...... .......+++.|+|||++.+...++.++||||||+++|+|++|+.||.+.+ ......+....+.+..
T Consensus       177 Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  255 (362)
T 3pg1_A          177 DFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI  255 (362)
T ss_dssp             CTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred             ecCcccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence            99999755422 233445788889999999876778999999999999999999999998877 4444555555565554


Q ss_pred             ccccc---hhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchhhhhhhhc
Q 045787          229 ESWAE---STYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLINR  305 (324)
Q Consensus       229 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~~~~~~~~  305 (324)
                      ..+..   .......................+..++.+.+||.+||+.||.+|||+.++++||||+++....-.......
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~  335 (362)
T 3pg1_A          256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEGLSE  335 (362)
T ss_dssp             HHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGGGTTTCCC
T ss_pred             HHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCcccccccccc
Confidence            32211   111111122233344455566677889999999999999999999999999999999999766555544333

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.9e-50  Score=355.06  Aligned_cols=264  Identities=21%  Similarity=0.336  Sum_probs=224.1

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhc-CCCCeeEEEeeeecCCeE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDV   81 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   81 (324)
                      +..++|++++.||+|+||.||+|.++.+|+.||+|++..... .....+.+..|..++..+ +||+|+++++++.+.+..
T Consensus        17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   96 (353)
T 2i0e_A           17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL   96 (353)
T ss_dssp             --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred             CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence            456899999999999999999999999999999999986542 233456788899999888 799999999999999999


Q ss_pred             EEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           82 FLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        82 ~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      |+||||++| +|.+++... +.+++..++.++.+|+.||.|||++|++|+||||+||+++ .++.++|+|||.+......
T Consensus        97 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~-~~g~vkL~DFG~a~~~~~~  174 (353)
T 2i0e_A           97 YFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD-SEGHIKIADFGMCKENIWD  174 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC-TTSCEEECCCTTCBCCCCT
T ss_pred             EEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEc-CCCcEEEEeCCcccccccC
Confidence            999999975 888887764 4699999999999999999999999999999999999999 8999999999999865444


Q ss_pred             CCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcc
Q 045787          161 QKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEI  240 (324)
Q Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (324)
                      .......+||+.|+|||++.+ ..++.++|+||||+++|+|++|..||.+.+.......+......              
T Consensus       175 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~--------------  239 (353)
T 2i0e_A          175 GVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA--------------  239 (353)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--------------
T ss_pred             CcccccccCCccccChhhhcC-CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCC--------------
Confidence            444556689999999999987 67899999999999999999999999887765544333221100              


Q ss_pred             cCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCC-----HHHHhcCccccCCCCchh
Q 045787          241 LPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRIT-----AMDALKHEYLIGVENVPL  298 (324)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~~~l~hp~~~~~~~~~~  298 (324)
                                    ....+++++.++|.+||..||.+||+     ++++++||||+++++..+
T Consensus       240 --------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l  288 (353)
T 2i0e_A          240 --------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL  288 (353)
T ss_dssp             --------------CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHH
T ss_pred             --------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHH
Confidence                          11257899999999999999999994     699999999999987655

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.5e-50  Score=350.57  Aligned_cols=265  Identities=30%  Similarity=0.488  Sum_probs=222.5

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCC----CchHHHHHHHHHHhcCCCCeeEEEeeeecCCe
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEG----VPSYIIREVSLLKELEHENIVRLLDVQSSRKD   80 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   80 (324)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++........    ..+.+.+|+.++++++||||+++++++.+...
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   88 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   88 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            45689999999999999999999999999999999986543221    34678899999999999999999999999999


Q ss_pred             EEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCC----cEEEeecccee
Q 045787           81 VFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN----TVKLADFGLAR  155 (324)
Q Consensus        81 ~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~----~v~l~d~g~~~  155 (324)
                      .++||||+. ++|.+++.. ...+++..++.++.+++.||.|||+.|++|+||||+||+++ .++    .++|+|||.+.
T Consensus        89 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~-~~~~~~~~~kl~Dfg~a~  166 (326)
T 2y0a_A           89 VILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLL-DRNVPKPRIKIIDFGLAH  166 (326)
T ss_dssp             EEEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEES-CSSSSSCCEEECCCTTCE
T ss_pred             EEEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEe-cCCCCCCCEEEEECCCCe
Confidence            999999997 588888765 45699999999999999999999999999999999999998 555    89999999998


Q ss_pred             eccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchh
Q 045787          156 AIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAEST  235 (324)
Q Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (324)
                      ..... .......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.................        
T Consensus       167 ~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--------  236 (326)
T 2y0a_A          167 KIDFG-NEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF--------  236 (326)
T ss_dssp             ECCTT-SCCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCC--------
T ss_pred             ECCCC-CccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCc--------
Confidence            76532 23344578999999999977 678999999999999999999999998777554433332211110        


Q ss_pred             hhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCch
Q 045787          236 YISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP  297 (324)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~  297 (324)
                                      ....+..++..+.++|.+||+.||.+|||+.++++||||++.....
T Consensus       237 ----------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~  282 (326)
T 2y0a_A          237 ----------------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ  282 (326)
T ss_dssp             ----------------CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCSHHH
T ss_pred             ----------------CccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCcchh
Confidence                            1122346789999999999999999999999999999999877543

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.9e-50  Score=358.45  Aligned_cols=287  Identities=34%  Similarity=0.579  Sum_probs=231.3

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeE---
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV---   81 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~---   81 (324)
                      +.++|++.+.||+|++|.||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++...+..   
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  119 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  119 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence            45799999999999999999999999999999999976544433456788999999999999999999999876654   


Q ss_pred             ---EEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeecc
Q 045787           82 ---FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIG  158 (324)
Q Consensus        82 ---~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~  158 (324)
                         |+|+||+++++.+.+.   ..+++..++.++.+++.||.+||+.|++|+||||+||+++ .++.++|+|||.+....
T Consensus       120 ~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~-~~~~~kL~Dfg~a~~~~  195 (371)
T 4exu_A          120 YDFYLVMPFMQTDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN-EDCELKILDFGLARHAD  195 (371)
T ss_dssp             CCCEEEEECCCEEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC-TTCCEEECSTTCC----
T ss_pred             eeEEEEEccccccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEEC-CCCCEEEEecCcccccc
Confidence               9999999998887763   3599999999999999999999999999999999999999 89999999999998654


Q ss_pred             CCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHHcCCCCcccccch--h
Q 045787          159 VPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-HDHLSLIFSLLGTPTDESWAES--T  235 (324)
Q Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~--~  235 (324)
                      .   ......+|+.|+|||++.+...++.++||||||+++|+|++|..||.+.+ .+....+....+.++...+...  .
T Consensus       196 ~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  272 (371)
T 4exu_A          196 A---EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK  272 (371)
T ss_dssp             -------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCH
T ss_pred             c---CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhh
Confidence            2   23345678999999999876778999999999999999999999998877 4444555555665554332221  1


Q ss_pred             hhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchh
Q 045787          236 YISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~  298 (324)
                      .....................+.+++.+.+||.+||+.||.+|||++++++||||++......
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  335 (371)
T 4exu_A          273 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEE  335 (371)
T ss_dssp             HHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGG
T ss_pred             hhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCccc
Confidence            111122223333444556667789999999999999999999999999999999998875543

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=3.9e-50  Score=355.64  Aligned_cols=288  Identities=35%  Similarity=0.606  Sum_probs=234.6

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecC-----Ce
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR-----KD   80 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~   80 (324)
                      .++|++++.||+|++|.||+|.+..++..||+|++..... ....+.+.+|+.++++++||||+++++++...     ..
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH-QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTC-HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccC-cHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            3799999999999999999999999999999999874332 22235688999999999999999999998654     46


Q ss_pred             EEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           81 VFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        81 ~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      .|+|+|+++|+|.+++..  ..+++..++.++.+++.||.+||++|++|+||||+||+++ .++.++|+|||.+......
T Consensus       105 ~~iv~e~~~~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~-~~~~~kl~Dfg~a~~~~~~  181 (364)
T 3qyz_A          105 VYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPD  181 (364)
T ss_dssp             EEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC-TTCCEEECCCTTCEECCGG
T ss_pred             EEEEEcccCcCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEEC-CCCCEEEEeCcceEecCCC
Confidence            899999999999998876  3599999999999999999999999999999999999999 8999999999999876533


Q ss_pred             CCc---ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHHcCCCCcccccchhh
Q 045787          161 QKE---YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-HDHLSLIFSLLGTPTDESWAESTY  236 (324)
Q Consensus       161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  236 (324)
                      ...   .....+|+.|+|||++.+...++.++||||||+++|+|++|..||.+.+ .+....+....+.+....+.....
T Consensus       182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  261 (364)
T 3qyz_A          182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN  261 (364)
T ss_dssp             GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCC
T ss_pred             CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence            221   2345789999999998765778999999999999999999999998877 555566666666666543322111


Q ss_pred             --hhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCch
Q 045787          237 --ISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP  297 (324)
Q Consensus       237 --~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~  297 (324)
                        ....................+.++.++.+||.+||+.||.+|||+.++++||||++.....
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~  324 (364)
T 3qyz_A          262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS  324 (364)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred             hhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCcc
Confidence              1111112223334445566678999999999999999999999999999999999975543

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=5.8e-50  Score=357.76  Aligned_cols=287  Identities=33%  Similarity=0.574  Sum_probs=227.7

Q ss_pred             CcccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCC--
Q 045787            2 GKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK--   79 (324)
Q Consensus         2 ~~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--   79 (324)
                      |.....+|++.+.||+|+||+||+|.+..++. +|+|.+......      ..+|+.+++.++||||+++++++...+  
T Consensus        35 ~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~  107 (394)
T 4e7w_A           35 GEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDK  107 (394)
T ss_dssp             CCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSS
T ss_pred             CCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCC
Confidence            45567789999999999999999999876665 888877543222      237999999999999999999985433  


Q ss_pred             ----eEEEEEEecCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeecc
Q 045787           80 ----DVFLVFEYLDLDLHSFITR---HKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFG  152 (324)
Q Consensus        80 ----~~~iv~e~~~g~l~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g  152 (324)
                          ..++||||+++++...+..   ....+++..++.++.||+.||.|||++|++|+||||+||+++..++.++|+|||
T Consensus       108 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG  187 (394)
T 4e7w_A          108 KDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFG  187 (394)
T ss_dssp             SSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             CCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence                3889999999887766543   345799999999999999999999999999999999999998668999999999


Q ss_pred             ceeeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHHcCCCCcccc
Q 045787          153 LARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-HDHLSLIFSLLGTPTDESW  231 (324)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~  231 (324)
                      .+...... .......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+ .+....+....+.+....+
T Consensus       188 ~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~  266 (394)
T 4e7w_A          188 SAKILIAG-EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI  266 (394)
T ss_dssp             TCEECCTT-CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             CcccccCC-CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            99876433 233345678999999999876678999999999999999999999998877 4556667777777765544


Q ss_pred             cchhhhhcccCCCCCCCCcchhhhC-CCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCch
Q 045787          232 AESTYISEILPLYPHFEPANLAEKF-PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP  297 (324)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~  297 (324)
                      ...... .....+...........+ +.+++++.+||.+||+.||.+|||+.++++||||+++++..
T Consensus       267 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  332 (394)
T 4e7w_A          267 KTMNPN-YMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGE  332 (394)
T ss_dssp             HHHCGG-GSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSC
T ss_pred             HhhChh-hhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcccc
Confidence            332111 111122222333333333 35899999999999999999999999999999999987543

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.6e-50  Score=356.30  Aligned_cols=283  Identities=28%  Similarity=0.425  Sum_probs=221.5

Q ss_pred             CcccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcC-----CCCeeEEEeeee
Q 045787            2 GKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-----HENIVRLLDVQS   76 (324)
Q Consensus         2 ~~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-----~~~i~~~~~~~~   76 (324)
                      |.++.++|++++.||+|+||+||+|.+..+++.||+|++......   ......|+.+++.+.     ||||+++++++.
T Consensus        30 g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~  106 (360)
T 3llt_A           30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKY---TRSAKIEADILKKIQNDDINNNNIVKYHGKFM  106 (360)
T ss_dssp             TCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHH---HHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred             ceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhh---hhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence            567889999999999999999999999999999999998743221   345678999999997     999999999999


Q ss_pred             cCCeEEEEEEecCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeec--------------
Q 045787           77 SRKDVFLVFEYLDLDLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL--------------  141 (324)
Q Consensus        77 ~~~~~~iv~e~~~g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~--------------  141 (324)
                      ..+..++||||++++|.+++.... ..+++..++.++.||+.||.|||+.|++|+||||+||+++.              
T Consensus       107 ~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~  186 (360)
T 3llt_A          107 YYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVT  186 (360)
T ss_dssp             ETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred             ECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccc
Confidence            999999999999889999998764 35999999999999999999999999999999999999972              


Q ss_pred             ----------CCCcEEEeeccceeeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 045787          142 ----------KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSK  211 (324)
Q Consensus       142 ----------~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  211 (324)
                                .++.++|+|||.+.....   ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...
T Consensus       187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~  262 (360)
T 3llt_A          187 DGKKIQIYRTKSTGIKLIDFGCATFKSD---YHGSIINTRQYRAPEVILN-LGWDVSSDMWSFGCVLAELYTGSLLFRTH  262 (360)
T ss_dssp             TCCEEEEEEESCCCEEECCCTTCEETTS---CCCSCCSCGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccccccccCCCCEEEEeccCceecCC---CCcCccCcccccCcHHHcC-CCCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence                      378999999999987543   2344578999999999987 67899999999999999999999999887


Q ss_pred             ChhH-HHHHHHHcCCCCcccccchhhhhcc--c------CCCCCCCCc---------chhhhCCCCChhHHHHHHHhhcC
Q 045787          212 KHDH-LSLIFSLLGTPTDESWAESTYISEI--L------PLYPHFEPA---------NLAEKFPNLEPAGVDLLSQMLCL  273 (324)
Q Consensus       212 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~--~------~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~  273 (324)
                      +... ...+....+..+...+.........  .      .........         .........++.+.+||.+||+.
T Consensus       263 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~  342 (360)
T 3llt_A          263 EHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQI  342 (360)
T ss_dssp             SHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCS
T ss_pred             cHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcC
Confidence            7444 3444444444443222111100000  0      000000000         00000112357788999999999


Q ss_pred             CCCCCCCHHHHhcCcccc
Q 045787          274 NPKQRITAMDALKHEYLI  291 (324)
Q Consensus       274 dP~~Rps~~~~l~hp~~~  291 (324)
                      ||.+|||++++|+||||+
T Consensus       343 dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          343 DPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             SGGGSCCHHHHTTSGGGC
T ss_pred             ChhhCCCHHHHhcCcccC
Confidence            999999999999999996

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2.7e-49  Score=345.10  Aligned_cols=288  Identities=38%  Similarity=0.691  Sum_probs=234.1

Q ss_pred             cCcCcceeEeecccCceEEEEEEEc-cCCceEEEEEeeeccccCCCchHHHHHHHHHHhc---CCCCeeEEEeeee----
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNT-VTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL---EHENIVRLLDVQS----   76 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~-~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~----   76 (324)
                      ..++|++++.||+|++|.||+|.+. .+|+.||+|++............+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            3589999999999999999999995 6788999999987665544455677888888777   8999999999986    


Q ss_pred             -cCCeEEEEEEecCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccce
Q 045787           77 -SRKDVFLVFEYLDLDLHSFITRHKN-TLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLA  154 (324)
Q Consensus        77 -~~~~~~iv~e~~~g~l~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~  154 (324)
                       .....++|+||++|+|.+++..... .+++..++.++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+
T Consensus        89 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~-~~~~~kl~Dfg~~  167 (326)
T 1blx_A           89 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT-SSGQIKLADFGLA  167 (326)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC-TTCCEEECSCCSC
T ss_pred             CCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEc-CCCCEEEecCccc
Confidence             5667999999999999999887543 499999999999999999999999999999999999999 8999999999998


Q ss_pred             eeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHHcCCCCcccccc
Q 045787          155 RAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAE  233 (324)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~  233 (324)
                      ...... .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+. .....+....+.+....|..
T Consensus       168 ~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  245 (326)
T 1blx_A          168 RIYSFQ-MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR  245 (326)
T ss_dssp             CCCCGG-GGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred             ccccCC-CCccccccccceeCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcc
Confidence            765422 23344568899999999987 6689999999999999999999999988774 44455556666666555543


Q ss_pred             hhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCch
Q 045787          234 STYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP  297 (324)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~  297 (324)
                      .......  .+............+.++..+.+||.+||+.||.+|||+.++++||||++++...
T Consensus       246 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~  307 (326)
T 1blx_A          246 DVALPRQ--AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK  307 (326)
T ss_dssp             TCSSCGG--GSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred             ccccchh--hhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhh
Confidence            2221111  1111222334455668999999999999999999999999999999999987543

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=5.4e-50  Score=352.07  Aligned_cols=261  Identities=24%  Similarity=0.408  Sum_probs=224.6

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeecc-ccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQT-EQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF   82 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   82 (324)
                      ..-++|++++.||+|+||.||+|.+..+|+.||+|++.... ......+.+.+|+.+++.++||+|+++++++.+++.+|
T Consensus        38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  117 (350)
T 1rdq_E           38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY  117 (350)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence            45578999999999999999999999999999999997654 23334567889999999999999999999999999999


Q ss_pred             EEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC
Q 045787           83 LVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        83 iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~  161 (324)
                      +||||++ |+|.+++... +.+++..++.++.+|+.||.|||++|++|+||||+||+++ .++.++|+|||.+.....  
T Consensus       118 lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~-~~g~~kL~DFg~a~~~~~--  193 (350)
T 1rdq_E          118 MVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVKG--  193 (350)
T ss_dssp             EEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC-TTSCEEECCCTTCEECSS--
T ss_pred             EEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEEC-CCCCEEEcccccceeccC--
Confidence            9999997 5888888764 4699999999999999999999999999999999999999 899999999999987643  


Q ss_pred             CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhccc
Q 045787          162 KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEIL  241 (324)
Q Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (324)
                       .....+||+.|+|||++.+ ..++.++|+||||+++|+|++|..||...+.......+......               
T Consensus       194 -~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~---------------  256 (350)
T 1rdq_E          194 -RTWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR---------------  256 (350)
T ss_dssp             -CBCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---------------
T ss_pred             -CcccccCCccccCHHHhcC-CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCC---------------
Confidence             2344578999999999987 66899999999999999999999999887755544333221100               


Q ss_pred             CCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCC-----HHHHhcCccccCCCCchh
Q 045787          242 PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRIT-----AMDALKHEYLIGVENVPL  298 (324)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~~~l~hp~~~~~~~~~~  298 (324)
                                   ....++.++.++|.+||+.||.+||+     ++++++||||+++++..+
T Consensus       257 -------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~  305 (350)
T 1rdq_E          257 -------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAI  305 (350)
T ss_dssp             -------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHH
T ss_pred             -------------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHHH
Confidence                         11257899999999999999999998     999999999999987655

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=8.8e-50  Score=341.46  Aligned_cols=269  Identities=31%  Similarity=0.474  Sum_probs=225.6

Q ss_pred             CcccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeE
Q 045787            2 GKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV   81 (324)
Q Consensus         2 ~~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   81 (324)
                      |....++|++.+.||+|++|.||+|.+..+++.||+|++..........+.+.+|+.++++++||||+++++++.+++..
T Consensus         1 s~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (284)
T 3kk8_A            1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH   80 (284)
T ss_dssp             CCTTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CchhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEE
Confidence            35678999999999999999999999999999999999986654443456788999999999999999999999999999


Q ss_pred             EEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCC---cEEEeeccceeec
Q 045787           82 FLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN---TVKLADFGLARAI  157 (324)
Q Consensus        82 ~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~---~v~l~d~g~~~~~  157 (324)
                      ++|+||+.| ++.+.+... ..+++..++.++.+++.||.+||+.|++|+||+|+||+++ .++   .++|+|||.+...
T Consensus        81 ~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~-~~~~~~~~kl~Dfg~~~~~  158 (284)
T 3kk8_A           81 YLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLA-SKAKGAAVKLADFGLAIEV  158 (284)
T ss_dssp             EEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEES-SSSTTCCEEECCCTTCEEC
T ss_pred             EEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEe-cCCCCCcEEEeeceeeEEc
Confidence            999999975 787777764 5699999999999999999999999999999999999997 444   4999999999876


Q ss_pred             cCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhh
Q 045787          158 GVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYI  237 (324)
Q Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (324)
                      ... .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||...+................         
T Consensus       159 ~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---------  227 (284)
T 3kk8_A          159 NDS-EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP---------  227 (284)
T ss_dssp             CSS-CBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC---------
T ss_pred             ccC-ccccCCCCCcCCcCchhhcC-CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCC---------
Confidence            533 23344578899999999987 6689999999999999999999999988776555444332211110         


Q ss_pred             hcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchh
Q 045787          238 SEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~  298 (324)
                                     ...+..+++.+.++|.+||+.||.+|||+.++++||||++......
T Consensus       228 ---------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~  273 (284)
T 3kk8_A          228 ---------------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVAS  273 (284)
T ss_dssp             ---------------TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGG
T ss_pred             ---------------chhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHHh
Confidence                           1112367899999999999999999999999999999998765543

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.7e-50  Score=355.86  Aligned_cols=262  Identities=31%  Similarity=0.479  Sum_probs=219.4

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLV   84 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   84 (324)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++..........+.+.+|+.++++++||||+++++++.+++..|+|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            45689999999999999999999999999999999976544333346788999999999999999999999999999999


Q ss_pred             EEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecC--CCcEEEeeccceeeccCCC
Q 045787           85 FEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK--RNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        85 ~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~--~~~v~l~d~g~~~~~~~~~  161 (324)
                      |||+.| +|.+.+... ..+++..++.++.+|+.||.|||++|++|+||||+||+++..  ++.++|+|||.+...... 
T Consensus       107 ~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~-  184 (362)
T 2bdw_A          107 FDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-  184 (362)
T ss_dssp             ECCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC-
T ss_pred             EecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC-
Confidence            999985 888877664 569999999999999999999999999999999999999832  246999999999876532 


Q ss_pred             CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhccc
Q 045787          162 KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEIL  241 (324)
Q Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (324)
                      .......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||...+.......+........             
T Consensus       185 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~-------------  250 (362)
T 2bdw_A          185 EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP-------------  250 (362)
T ss_dssp             CSCCCSCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC-------------
T ss_pred             cccccCCCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC-------------
Confidence            33344578999999999987 6789999999999999999999999988775554433332211100             


Q ss_pred             CCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCC
Q 045787          242 PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV  293 (324)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~  293 (324)
                                 ...+..+++++.+||.+||+.||.+||++.++++||||++.
T Consensus       251 -----------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  291 (362)
T 2bdw_A          251 -----------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR  291 (362)
T ss_dssp             -----------TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred             -----------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence                       01123578999999999999999999999999999999864

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-50  Score=351.11  Aligned_cols=258  Identities=26%  Similarity=0.308  Sum_probs=210.0

Q ss_pred             CcccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhc-CCCCeeEEEeeeecCCe
Q 045787            2 GKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKD   80 (324)
Q Consensus         2 ~~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~   80 (324)
                      |++..++|++++.||+|+||+||+|.+..+|+.||+|++...............|+..+.++ +|||++++++++.+.+.
T Consensus        52 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~  131 (311)
T 3p1a_A           52 ESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI  131 (311)
T ss_dssp             SCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             cchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCE
Confidence            34555789999999999999999999999999999999765443322233445566655555 89999999999999999


Q ss_pred             EEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           81 VFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        81 ~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      .++||||++++|.+.+......+++..++.++.+++.||.|||+.|++|+||||+||+++ .++.++|+|||.+......
T Consensus       132 ~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~-~~~~~kl~DFG~a~~~~~~  210 (311)
T 3p1a_A          132 LYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLG-PRGRCKLGDFGLLVELGTA  210 (311)
T ss_dssp             EEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC-GGGCEEECCCTTCEECC--
T ss_pred             EEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC-CCCCEEEccceeeeecccC
Confidence            999999999999999988887899999999999999999999999999999999999999 8899999999998876533


Q ss_pred             CCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcc
Q 045787          161 QKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEI  240 (324)
Q Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (324)
                       .......||+.|+|||++.+  .++.++||||||+++|+|++|..|+......  ..+   ....              
T Consensus       211 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~--~~~---~~~~--------------  268 (311)
T 3p1a_A          211 -GAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGW--QQL---RQGY--------------  268 (311)
T ss_dssp             -----CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH--HHH---TTTC--------------
T ss_pred             -CCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHH--HHH---hccC--------------
Confidence             23344568999999999876  5799999999999999999997666432211  110   0000              


Q ss_pred             cCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccC
Q 045787          241 LPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIG  292 (324)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~  292 (324)
                                ........+++.+.++|.+||+.||.+|||++++++||||++
T Consensus       269 ----------~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          269 ----------LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             ----------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             ----------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence                      011223468999999999999999999999999999999985

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=5.7e-50  Score=361.42  Aligned_cols=288  Identities=29%  Similarity=0.487  Sum_probs=226.4

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhc------CCCCeeEEEeeee
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL------EHENIVRLLDVQS   76 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~   76 (324)
                      +....+|++++.||+|+||.||+|.+..+++.||+|++......   ...+.+|+.+++.+      +|+|++++++.+.
T Consensus        93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~  169 (429)
T 3kvw_A           93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRF---HRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT  169 (429)
T ss_dssp             CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHH---HHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred             CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccch---HHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence            44567899999999999999999999999999999998754321   34567788888887      4679999999999


Q ss_pred             cCCeEEEEEEecCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCc--EEEeeccc
Q 045787           77 SRKDVFLVFEYLDLDLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNT--VKLADFGL  153 (324)
Q Consensus        77 ~~~~~~iv~e~~~g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~--v~l~d~g~  153 (324)
                      .....++||||++++|.+++.... ..+++..++.++.+|+.||.|||+.|++|+||||+||+++ .++.  ++|+|||.
T Consensus       170 ~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~-~~~~~~vkL~DFG~  248 (429)
T 3kvw_A          170 FRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLK-QQGRSGIKVIDFGS  248 (429)
T ss_dssp             ETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEES-STTSCCEEECCCTT
T ss_pred             cCCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEc-cCCCcceEEeeccc
Confidence            999999999999999999988765 3599999999999999999999999999999999999999 6665  99999999


Q ss_pred             eeeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHHcCCCCccccc
Q 045787          154 ARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-HDHLSLIFSLLGTPTDESWA  232 (324)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~  232 (324)
                      +.....   ......+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+ .+.+..+....+.++...+.
T Consensus       249 a~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~  324 (429)
T 3kvw_A          249 SCYEHQ---RVYTYIQSRFYRAPEVILG-ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD  324 (429)
T ss_dssp             CEETTC---CCCSSCSCGGGCCHHHHHT-BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             ceecCC---cccccCCCCCccChHHHhC-CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence            976542   2334578899999999988 668999999999999999999999998877 45556666677777665444


Q ss_pred             chhhhhcccCCCCC-----------------------------CCCcchh-hhCCCCChhHHHHHHHhhcCCCCCCCCHH
Q 045787          233 ESTYISEILPLYPH-----------------------------FEPANLA-EKFPNLEPAGVDLLSQMLCLNPKQRITAM  282 (324)
Q Consensus       233 ~~~~~~~~~~~~~~-----------------------------~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~  282 (324)
                      ..............                             .....+. ......++.+.+||.+||++||.+|||++
T Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~  404 (429)
T 3kvw_A          325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG  404 (429)
T ss_dssp             TBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             hhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHH
Confidence            33322222111100                             0011111 11224578899999999999999999999


Q ss_pred             HHhcCccccCCCCchh
Q 045787          283 DALKHEYLIGVENVPL  298 (324)
Q Consensus       283 ~~l~hp~~~~~~~~~~  298 (324)
                      |+|+||||++....+.
T Consensus       405 e~L~Hpw~~~~~~~~~  420 (429)
T 3kvw_A          405 QALRHPWLRRRLPKPP  420 (429)
T ss_dssp             HHHTSTTTC-------
T ss_pred             HHhCChhhccCCCCCC
Confidence            9999999998765544

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.1e-50  Score=345.97  Aligned_cols=260  Identities=25%  Similarity=0.412  Sum_probs=210.6

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeecccc------------------------CCCchHHHHHHHH
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQ------------------------EGVPSYIIREVSL   59 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~------------------------~~~~~~~~~e~~~   59 (324)
                      +..++|++.+.||+|+||.||+|.+..+++.||+|++......                        ....+.+.+|+.+
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   89 (298)
T 2zv2_A           10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI   89 (298)
T ss_dssp             CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred             eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence            4568999999999999999999999999999999999755321                        1123568899999


Q ss_pred             HHhcCCCCeeEEEeeeec--CCeEEEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 045787           60 LKELEHENIVRLLDVQSS--RKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNN  136 (324)
Q Consensus        60 l~~l~~~~i~~~~~~~~~--~~~~~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~n  136 (324)
                      +++++||||+++++++.+  ....|+||||+++ +|.++..  ..++++..++.++.|++.||.+||+.|++|+||||+|
T Consensus        90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N  167 (298)
T 2zv2_A           90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN  167 (298)
T ss_dssp             HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred             HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence            999999999999999876  5689999999985 5655322  3579999999999999999999999999999999999


Q ss_pred             eEeecCCCcEEEeeccceeeccCCCCcccccccccccCCchhhcCCCC--CCCchhhHHHHHHHHHHHhCCCCCCCCChh
Q 045787          137 LLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTG--YSTPIDVWAVGCIFAEMITGKPLFPSKKHD  214 (324)
Q Consensus       137 Ill~~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~DiwslG~il~~l~~g~~pf~~~~~~  214 (324)
                      |+++ .++.++|+|||.+..............+|+.|+|||++.+...  .+.++||||||+++|+|++|..||...+..
T Consensus       168 il~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~  246 (298)
T 2zv2_A          168 LLVG-EDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM  246 (298)
T ss_dssp             EEEC-TTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             EEEC-CCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence            9999 8899999999999877654444455678999999999976332  478899999999999999999999877654


Q ss_pred             HHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccC
Q 045787          215 HLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIG  292 (324)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~  292 (324)
                      .............                          ...+.+++.+.++|.+||+.||.+|||+.++++||||+.
T Consensus       247 ~~~~~~~~~~~~~--------------------------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~  298 (298)
T 2zv2_A          247 CLHSKIKSQALEF--------------------------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR  298 (298)
T ss_dssp             HHHHHHHHCCCCC--------------------------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred             HHHHHHhcccCCC--------------------------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence            4333222111100                          011368899999999999999999999999999999963

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=3e-49  Score=343.90  Aligned_cols=269  Identities=26%  Similarity=0.438  Sum_probs=225.4

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEe
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEY   87 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   87 (324)
                      .|+..+.||+|++|.||+|.+..+|+.||+|++.....  ...+.+.+|+.++++++||||+++++++...+..++||||
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  123 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF  123 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence            47888999999999999999999999999999875432  2356788999999999999999999999999999999999


Q ss_pred             cCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcccc
Q 045787           88 LDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSR  166 (324)
Q Consensus        88 ~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~  166 (324)
                      ++| +|.+++..  ..+++..++.++.+++.||.+||+.|++|+||||+||+++ .++.++|+|||.+............
T Consensus       124 ~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~~  200 (321)
T 2c30_A          124 LQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKS  200 (321)
T ss_dssp             CCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC-TTCCEEECCCTTCEECCSSSCCBCC
T ss_pred             CCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC-CCCcEEEeeeeeeeecccCcccccc
Confidence            975 77776654  4699999999999999999999999999999999999999 8999999999999877654444455


Q ss_pred             cccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCC
Q 045787          167 DCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPH  246 (324)
Q Consensus       167 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (324)
                      ..+|+.|+|||++.+ ..++.++||||||+++|+|++|..||.................+..                  
T Consensus       201 ~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~------------------  261 (321)
T 2c30_A          201 LVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKL------------------  261 (321)
T ss_dssp             CCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC------------------
T ss_pred             ccCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCc------------------
Confidence            678999999999987 6789999999999999999999999987765444333222111110                  


Q ss_pred             CCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchhhhhhhhccc
Q 045787          247 FEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLINRKK  307 (324)
Q Consensus       247 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~~~~~~~~~~  307 (324)
                             .....+++.+.++|.+||+.||.+|||+.++++||||.+...+....++++..+
T Consensus       262 -------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~~~~~~~~~~~~  315 (321)
T 2c30_A          262 -------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPECLVPLIQLYR  315 (321)
T ss_dssp             -------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCCCGGGGHHHHHHC-
T ss_pred             -------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCCCcccchHHHHHHH
Confidence                   011247889999999999999999999999999999999887777766666554

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=5.7e-50  Score=348.69  Aligned_cols=268  Identities=28%  Similarity=0.447  Sum_probs=217.3

Q ss_pred             CCcccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCe
Q 045787            1 MGKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKD   80 (324)
Q Consensus         1 ~~~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   80 (324)
                      |+.-..++|++++.||+|+||.||+|.+..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+.+.
T Consensus         1 m~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~   79 (323)
T 3tki_A            1 MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNI   79 (323)
T ss_dssp             -CCTTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             CCCcHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc-chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCe
Confidence            4556778999999999999999999999999999999998754432 223568899999999999999999999999999


Q ss_pred             EEEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccC
Q 045787           81 VFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGV  159 (324)
Q Consensus        81 ~~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~  159 (324)
                      .|+||||++| +|.+++.. ...+++..++.++.|++.||.|||+.|++|+||||+||+++ .++.++|+|||.+.....
T Consensus        80 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~  157 (323)
T 3tki_A           80 QYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRY  157 (323)
T ss_dssp             EEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-TTCCEEECCCTTCEECEE
T ss_pred             EEEEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEe-CCCCEEEEEeeccceecc
Confidence            9999999975 78777655 44699999999999999999999999999999999999999 889999999999976542


Q ss_pred             CC--CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhh
Q 045787          160 PQ--KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYI  237 (324)
Q Consensus       160 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (324)
                      ..  .......+++.|+|||++.+....+.++||||||+++|+|++|..||...................          
T Consensus       158 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~----------  227 (323)
T 3tki_A          158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY----------  227 (323)
T ss_dssp             TTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT----------
T ss_pred             CCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc----------
Confidence            22  223345789999999999875555889999999999999999999997665432211111100000          


Q ss_pred             hcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCc
Q 045787          238 SEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENV  296 (324)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~  296 (324)
                                     ...+..++..+.+||.+||+.||.+|||+.|+++||||++....
T Consensus       228 ---------------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~  271 (323)
T 3tki_A          228 ---------------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKK  271 (323)
T ss_dssp             ---------------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCCC
T ss_pred             ---------------CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccccc
Confidence                           00123578999999999999999999999999999999876543

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.1e-49  Score=347.58  Aligned_cols=265  Identities=26%  Similarity=0.419  Sum_probs=211.9

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEc---cCCceEEEEEeeeccc--cCCCchHHHHHHHHHHhcCCCCeeEEEeeeec
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNT---VTGQKVAIKMMTIQTE--QEGVPSYIIREVSLLKELEHENIVRLLDVQSS   77 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~---~~~~~~~~K~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   77 (324)
                      .+..++|++.+.||+|+||.||+|.+.   .+|+.||+|++.....  .......+.+|+.++++++||||+++++++..
T Consensus        13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   92 (327)
T 3a62_A           13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT   92 (327)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence            456789999999999999999999985   6889999999976532  22234567889999999999999999999999


Q ss_pred             CCeEEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceee
Q 045787           78 RKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARA  156 (324)
Q Consensus        78 ~~~~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~  156 (324)
                      .+..|+||||+. ++|.+++... +.+++..++.++.+|+.||.|||++|++|+||||+||+++ .++.++|+|||.+..
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~-~~~~~kl~Dfg~~~~  170 (327)
T 3a62_A           93 GGKLYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLN-HQGHVKLTDFGLCKE  170 (327)
T ss_dssp             SSCEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEEC-TTSCEEECCCSCC--
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEEC-CCCcEEEEeCCcccc
Confidence            999999999997 5888887664 4699999999999999999999999999999999999999 899999999999876


Q ss_pred             ccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhh
Q 045787          157 IGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY  236 (324)
Q Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (324)
                      ...........+|++.|+|||++.+ ..++.++||||||+++|+|++|..||...+.............           
T Consensus       171 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~-----------  238 (327)
T 3a62_A          171 SIHDGTVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL-----------  238 (327)
T ss_dssp             --------CTTSSCCTTSCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-----------
T ss_pred             cccCCccccccCCCcCccCHhhCcC-CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC-----------
Confidence            5434344445678999999999987 6679999999999999999999999988775544332221110           


Q ss_pred             hhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCC-----CHHHHhcCccccCCCCchh
Q 045787          237 ISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRI-----TAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~~l~hp~~~~~~~~~~  298 (324)
                                       ...+.++..+.++|.+||..||.+||     ++.++++||||+++.+..+
T Consensus       239 -----------------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~~  288 (327)
T 3a62_A          239 -----------------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEEL  288 (327)
T ss_dssp             -----------------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHHH
T ss_pred             -----------------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHHH
Confidence                             01125788999999999999999999     8999999999999876544

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=6.1e-50  Score=360.49  Aligned_cols=272  Identities=21%  Similarity=0.357  Sum_probs=226.7

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeecc-ccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQT-EQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF   82 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   82 (324)
                      +..++|++++.||+|+||.||+|.++.+++.||+|++.... ........+.+|..++..++||+|+++++++.+++.+|
T Consensus        71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~  150 (437)
T 4aw2_A           71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLY  150 (437)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred             CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEE
Confidence            34578999999999999999999999999999999997643 22223455889999999999999999999999999999


Q ss_pred             EEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC
Q 045787           83 LVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        83 iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~  161 (324)
                      +||||+. |+|.+++......+++..++.++.+++.||.|||+.|++||||||+|||++ .++.+||+|||++.......
T Consensus       151 lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~-~~g~vkL~DFGla~~~~~~~  229 (437)
T 4aw2_A          151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD-MNGHIRLADFGSCLKLMEDG  229 (437)
T ss_dssp             EEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC-TTSCEEECCCTTCEECCTTS
T ss_pred             EEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEc-CCCCEEEcchhhhhhcccCC
Confidence            9999996 699998887667899999999999999999999999999999999999999 99999999999997765333


Q ss_pred             C-cccccccccccCCchhhc----CCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhh
Q 045787          162 K-EYSRDCVYSPYKAPELLL----GYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY  236 (324)
Q Consensus       162 ~-~~~~~~~~~~y~aPE~~~----~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (324)
                      . .....+||+.|+|||++.    +...++.++|||||||++|+|++|+.||.+.+.......+....            
T Consensus       230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------------  297 (437)
T 4aw2_A          230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK------------  297 (437)
T ss_dssp             CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH------------
T ss_pred             CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcc------------
Confidence            2 233457999999999986    23568999999999999999999999998877554433222100            


Q ss_pred             hhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCC--CCCHHHHhcCccccCCCCchhh
Q 045787          237 ISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQ--RITAMDALKHEYLIGVENVPLV  299 (324)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~~~l~hp~~~~~~~~~~~  299 (324)
                        ..         .........+++++++||++||..+|.+  |++++++++||||+++++..+.
T Consensus       298 --~~---------~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l~  351 (437)
T 4aw2_A          298 --ER---------FQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNIR  351 (437)
T ss_dssp             --HH---------CCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTGG
T ss_pred             --cc---------ccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHHh
Confidence              00         0001112358999999999999999988  9999999999999999987763

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.8e-50  Score=365.69  Aligned_cols=265  Identities=25%  Similarity=0.401  Sum_probs=215.7

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeecc-ccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQT-EQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF   82 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   82 (324)
                      +..++|++++.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.++||||+++++++.+.+..|
T Consensus       145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~  224 (446)
T 4ejn_A          145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC  224 (446)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEE
T ss_pred             CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEE
Confidence            44578999999999999999999999999999999997653 22233456778999999999999999999999999999


Q ss_pred             EEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           83 LVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS-LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        83 iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      +||||++| +|...+... ..+++..++.++.+|+.||.|||+ .|++|+||||+|||++ .++.++|+|||++......
T Consensus       225 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          225 FVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKD  302 (446)
T ss_dssp             EEECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEEC-SSSCEEECCCCCCCTTCC-
T ss_pred             EEEeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEEC-CCCCEEEccCCCceeccCC
Confidence            99999985 777777654 579999999999999999999998 9999999999999999 8899999999999765444


Q ss_pred             CCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcc
Q 045787          161 QKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEI  240 (324)
Q Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (324)
                      .......+||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...+..............              
T Consensus       303 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~--------------  367 (446)
T 4ejn_A          303 GATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--------------  367 (446)
T ss_dssp             ----CCSSSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--------------
T ss_pred             CcccccccCCccccCHhhcCC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC--------------
Confidence            445556789999999999987 67899999999999999999999999887766554443321111              


Q ss_pred             cCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCC-----CHHHHhcCccccCCCCchhh
Q 045787          241 LPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRI-----TAMDALKHEYLIGVENVPLV  299 (324)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~~l~hp~~~~~~~~~~~  299 (324)
                                    ....+++++.+||.+||+.||.+||     +++++++||||+++.+..+.
T Consensus       368 --------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~~  417 (446)
T 4ejn_A          368 --------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVY  417 (446)
T ss_dssp             --------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHH
T ss_pred             --------------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHHh
Confidence                          1125789999999999999999999     99999999999999876654

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2.5e-50  Score=357.60  Aligned_cols=288  Identities=33%  Similarity=0.552  Sum_probs=214.5

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCC-----
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK-----   79 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----   79 (324)
                      ..++|++++.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++...+     
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  102 (371)
T 2xrw_A           23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  102 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred             hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence            457999999999999999999999999999999999765433333466889999999999999999999987654     


Q ss_pred             -eEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeecc
Q 045787           80 -DVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIG  158 (324)
Q Consensus        80 -~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~  158 (324)
                       ..|+||||+++++.+.+..   .+++..++.++.|++.||.+||++|++|+||||+||+++ .++.++|+|||.+....
T Consensus       103 ~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~-~~~~~kl~Dfg~a~~~~  178 (371)
T 2xrw_A          103 QDVYIVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAG  178 (371)
T ss_dssp             CEEEEEEECCSEEHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC-TTSCEEECCCCC-----
T ss_pred             cceEEEEEcCCCCHHHHHhh---ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc-CCCCEEEEEeecccccc
Confidence             7899999999999888753   589999999999999999999999999999999999999 89999999999998665


Q ss_pred             CCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHHcCCCCcccccchhh-
Q 045787          159 VPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD-HLSLIFSLLGTPTDESWAESTY-  236 (324)
Q Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~-  236 (324)
                      .. .......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+.. ....+....+.+....+..... 
T Consensus       179 ~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  256 (371)
T 2xrw_A          179 TS-FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT  256 (371)
T ss_dssp             ------------CTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHH
T ss_pred             cc-cccCCceecCCccCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence            32 22334578899999999987 67899999999999999999999999887743 3344444444443322211100 


Q ss_pred             hhcccCCCCCCCCcchhhhCC------------CCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchh
Q 045787          237 ISEILPLYPHFEPANLAEKFP------------NLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~------------~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~  298 (324)
                      ....................+            ..+.++.+||.+||+.||.+|||++++++||||+...+...
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~  330 (371)
T 2xrw_A          257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSE  330 (371)
T ss_dssp             HHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCHHH
T ss_pred             HHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCccc
Confidence            000000111111111111111            12567899999999999999999999999999997665443

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=8e-50  Score=350.99  Aligned_cols=268  Identities=27%  Similarity=0.392  Sum_probs=224.0

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      ++|++++.||+|+||+||+|.+..+|+.||+|++..... .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            569999999999999999999999999999999875432 1222356889999999999999999999999999999999


Q ss_pred             EecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccc
Q 045787           86 EYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYS  165 (324)
Q Consensus        86 e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~  165 (324)
                      ||+.|++.+.+.....++++..++.++.+++.||.+||+.|++|+||||+||+++ .++.++|+|||.+.....    ..
T Consensus       134 e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~~kL~DfG~a~~~~~----~~  208 (348)
T 1u5q_A          134 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS-EPGLVKLGDFGSASIMAP----AN  208 (348)
T ss_dssp             ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE-TTTEEEECCCTTCBSSSS----BC
T ss_pred             ecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC-CCCCEEEeeccCceecCC----CC
Confidence            9999999999887777899999999999999999999999999999999999999 899999999999876542    23


Q ss_pred             ccccccccCCchhhcC--CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCC
Q 045787          166 RDCVYSPYKAPELLLG--YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPL  243 (324)
Q Consensus       166 ~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (324)
                      ...+++.|+|||++.+  ...++.++||||||+++|+|++|..||...+.............+..               
T Consensus       209 ~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~---------------  273 (348)
T 1u5q_A          209 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL---------------  273 (348)
T ss_dssp             CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC---------------
T ss_pred             cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC---------------
Confidence            4568999999999852  36689999999999999999999999987764433222221111110               


Q ss_pred             CCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchhhhhhhhc
Q 045787          244 YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLINR  305 (324)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~~~~~~~~  305 (324)
                                 ....+++.+.++|.+||+.||.+|||++++++||||............+.+
T Consensus       274 -----------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~~~~~~~~~~~  324 (348)
T 1u5q_A          274 -----------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQR  324 (348)
T ss_dssp             -----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCTTHHHHHHHH
T ss_pred             -----------CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccCCcchhhHHHHH
Confidence                       012578899999999999999999999999999999988766655444433

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.4e-49  Score=358.15  Aligned_cols=284  Identities=33%  Similarity=0.556  Sum_probs=224.5

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeec------CC
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS------RK   79 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~   79 (324)
                      ..+|++.+.||+|+||.||+|.+..+|+.||+|++.....      ...+|+.++++++||||+++++++..      ..
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~  126 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV  126 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence            4579999999999999999999999999999999864322      22479999999999999999998743      22


Q ss_pred             eEEEEEEecCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceee
Q 045787           80 DVFLVFEYLDLDLHSFITR---HKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARA  156 (324)
Q Consensus        80 ~~~iv~e~~~g~l~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~  156 (324)
                      .+++||||+++++...+..   ....+++..++.++.||+.||.|||+.|++|+||||+|||++.+++.+||+|||.+..
T Consensus       127 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~  206 (420)
T 1j1b_A          127 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  206 (420)
T ss_dssp             EEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             eEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence            4789999999987776653   3457999999999999999999999999999999999999994457789999999987


Q ss_pred             ccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHHcCCCCcccccchh
Q 045787          157 IGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-HDHLSLIFSLLGTPTDESWAEST  235 (324)
Q Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~  235 (324)
                      .... .......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+ .+.+..+....+.+....+....
T Consensus       207 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~  285 (420)
T 1j1b_A          207 LVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN  285 (420)
T ss_dssp             CCTT-CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHC
T ss_pred             cccC-CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence            6533 223345789999999999875678999999999999999999999998877 45566677777777654433211


Q ss_pred             hhhcccCCCCCCCCcchhhh-CCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCch
Q 045787          236 YISEILPLYPHFEPANLAEK-FPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP  297 (324)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~  297 (324)
                      ..... ..+.......+... .+.+++++.+||.+||+.||.+||++.++++||||+++.+..
T Consensus       286 ~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  347 (420)
T 1j1b_A          286 PNYTE-FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN  347 (420)
T ss_dssp             SCCCC-CCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTT
T ss_pred             hhhhh-hccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccccc
Confidence            00000 01111122222222 246789999999999999999999999999999999876543

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=6.7e-50  Score=353.92  Aligned_cols=264  Identities=26%  Similarity=0.391  Sum_probs=216.0

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeecccc-CCCchHHHHHHHH-HHhcCCCCeeEEEeeeecCCeE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQ-EGVPSYIIREVSL-LKELEHENIVRLLDVQSSRKDV   81 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~-~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~~~   81 (324)
                      +..++|++++.||+|+||.||+|+++.+++.||+|++...... ......+.+|..+ ++.++||+|+++++++.+.+.+
T Consensus        35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~  114 (373)
T 2r5t_A           35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL  114 (373)
T ss_dssp             CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence            4567899999999999999999999999999999999866432 2223445667666 4678999999999999999999


Q ss_pred             EEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           82 FLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        82 ~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      |+||||++| +|.+.+... ..+++..++.++.+|+.||.|||++|++||||||+||+++ .++.++|+|||.+......
T Consensus       115 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~-~~g~ikL~DFG~a~~~~~~  192 (373)
T 2r5t_A          115 YFVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD-SQGHIVLTDFGLCKENIEH  192 (373)
T ss_dssp             EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC-TTSCEEECCCCBCGGGBCC
T ss_pred             EEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEC-CCCCEEEeeCccccccccC
Confidence            999999985 787777664 5699999999999999999999999999999999999999 8999999999999865444


Q ss_pred             CCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcc
Q 045787          161 QKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEI  240 (324)
Q Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (324)
                      .......+||+.|+|||++.+ ..++.++|+||||+++|+|++|..||...+.......+.....               
T Consensus       193 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~---------------  256 (373)
T 2r5t_A          193 NSTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL---------------  256 (373)
T ss_dssp             CCCCCSBSCCCCCCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCC---------------
T ss_pred             CCccccccCCccccCHHHhCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc---------------
Confidence            445566789999999999987 6789999999999999999999999988775554333221100               


Q ss_pred             cCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCH----HHHhcCccccCCCCchh
Q 045787          241 LPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITA----MDALKHEYLIGVENVPL  298 (324)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~----~~~l~hp~~~~~~~~~~  298 (324)
                                   ...+.++..+.++|.+||+.||.+||++    .++++||||+++++..+
T Consensus       257 -------------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l  305 (373)
T 2r5t_A          257 -------------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDL  305 (373)
T ss_dssp             -------------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHH
T ss_pred             -------------CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHH
Confidence                         0113578999999999999999999987    69999999999987665

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=5.3e-49  Score=341.45  Aligned_cols=281  Identities=28%  Similarity=0.443  Sum_probs=226.8

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF   82 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   82 (324)
                      ....++|++.+.||+|++|.||+|.+..+|+.||+|.+....    ....+.+|+.++++++|||++++++++...+..+
T Consensus        25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  100 (314)
T 3com_A           25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW  100 (314)
T ss_dssp             -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence            345688999999999999999999999999999999987542    2467889999999999999999999999999999


Q ss_pred             EEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC
Q 045787           83 LVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        83 iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~  161 (324)
                      +|+||+++ +|.+++......+++..++.++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+.......
T Consensus       101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~-~~~~~kl~dfg~~~~~~~~~  179 (314)
T 3com_A          101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLN-TEGHAKLADFGVAGQLTDTM  179 (314)
T ss_dssp             EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC-TTCCEEECCCTTCEECBTTB
T ss_pred             EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEEC-CCCCEEEeecccchhhhhhc
Confidence            99999986 88888876667899999999999999999999999999999999999999 88999999999998776444


Q ss_pred             CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhccc
Q 045787          162 KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEIL  241 (324)
Q Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (324)
                      .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.................+..             
T Consensus       180 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------  245 (314)
T 3com_A          180 AKRNTVIGTPFWMAPEVIQE-IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTF-------------  245 (314)
T ss_dssp             SCBCCCCSCGGGCCHHHHSS-SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-------------
T ss_pred             cccCccCCCCCccChhhcCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCccc-------------
Confidence            44455678899999999987 6689999999999999999999999987664433222221111100             


Q ss_pred             CCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchhhhhhhhcccCCCCCCC
Q 045787          242 PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLINRKKKLGVDNG  314 (324)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (324)
                                  .....++..+.++|.+||..||.+|||+.++++||||++.........+++......+...
T Consensus       246 ------------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (314)
T 3com_A          246 ------------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSILRDLINEAMDVKLKRQ  306 (314)
T ss_dssp             ------------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCCGGGGHHHHHHHC-------
T ss_pred             ------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCcchHHHHHhhhhhhhhhhhh
Confidence                        0012468899999999999999999999999999999999999998888777666555443

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.2e-49  Score=355.92  Aligned_cols=267  Identities=22%  Similarity=0.349  Sum_probs=221.8

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeecc-ccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQT-EQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF   82 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   82 (324)
                      +..++|++++.||+|+||.||+|.++.+++.||+|++.... ........+.+|+.+++.++||||+++++++.+.+.+|
T Consensus        66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~  145 (410)
T 3v8s_A           66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY  145 (410)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence            45678999999999999999999999999999999997643 22333466889999999999999999999999999999


Q ss_pred             EEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC
Q 045787           83 LVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        83 iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~  161 (324)
                      +||||++ |+|.+++..  ..+++..++.++.+|+.||.|||++|++||||||+||+++ .++.++|+|||.+.......
T Consensus       146 lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~-~~g~ikL~DFG~a~~~~~~~  222 (410)
T 3v8s_A          146 MVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEG  222 (410)
T ss_dssp             EEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC-TTSCEEECCCTTCEECCTTS
T ss_pred             EEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeEC-CCCCEEEeccceeEeeccCC
Confidence            9999996 588887765  3599999999999999999999999999999999999999 89999999999998765433


Q ss_pred             C-cccccccccccCCchhhcCCCC---CCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhh
Q 045787          162 K-EYSRDCVYSPYKAPELLLGYTG---YSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYI  237 (324)
Q Consensus       162 ~-~~~~~~~~~~y~aPE~~~~~~~---~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (324)
                      . .....+||+.|+|||++.+...   ++.++|+||||+++|+|++|+.||.+.+.......+......           
T Consensus       223 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~-----------  291 (410)
T 3v8s_A          223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS-----------  291 (410)
T ss_dssp             EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH-----------
T ss_pred             cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccc-----------
Confidence            2 2335679999999999976332   688999999999999999999999887755443332210000           


Q ss_pred             hcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCC--CCCHHHHhcCccccCCCCch
Q 045787          238 SEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQ--RITAMDALKHEYLIGVENVP  297 (324)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~~~l~hp~~~~~~~~~  297 (324)
                          ..++         ....+++++++||.+||..+|.+  ||+++++++||||+++.+..
T Consensus       292 ----~~~p---------~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~  340 (410)
T 3v8s_A          292 ----LTFP---------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAW  340 (410)
T ss_dssp             ----CCCC---------TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCS
T ss_pred             ----ccCC---------CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHH
Confidence                0000         01258899999999999999998  99999999999999987643

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.3e-49  Score=355.34  Aligned_cols=291  Identities=20%  Similarity=0.286  Sum_probs=217.3

Q ss_pred             cCcCcceeEeeccc--CceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 045787            5 KNLNYKKIKKIGAG--GYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF   82 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g--~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   82 (324)
                      ..++|++++.||+|  ++|.||+|.+..+|+.||+|++..........+.+.+|+.+++.++||||+++++++.+++..|
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  102 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW  102 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence            56889999999999  9999999999999999999999876544444567888999999999999999999999999999


Q ss_pred             EEEEecC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           83 LVFEYLD-LDLHSFITRH-KNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        83 iv~e~~~-g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      +||||+. |+|.+++... ...+++..++.++.||+.||.|||++|++|+||||+||+++ .++.++|+|||.+......
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~-~~~~~kl~dfg~~~~~~~~  181 (389)
T 3gni_B          103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS-VDGKVYLSGLRSNLSMISH  181 (389)
T ss_dssp             EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC-TTCCEEECCGGGCEECEET
T ss_pred             EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc-CCCCEEEcccccceeeccc
Confidence            9999998 5888887764 25699999999999999999999999999999999999999 8999999999987654221


Q ss_pred             C-------CcccccccccccCCchhhcCC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCC-----
Q 045787          161 Q-------KEYSRDCVYSPYKAPELLLGY-TGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPT-----  227 (324)
Q Consensus       161 ~-------~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-----  227 (324)
                      .       .......+++.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+.............+.     
T Consensus       182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  261 (389)
T 3gni_B          182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTS  261 (389)
T ss_dssp             TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------------
T ss_pred             cccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccc
Confidence            1       122334688889999999764 568999999999999999999999998766433322111100000     


Q ss_pred             ----cccccch-------hhhhcccC--CCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCC
Q 045787          228 ----DESWAES-------TYISEILP--LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVE  294 (324)
Q Consensus       228 ----~~~~~~~-------~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~  294 (324)
                          .......       ........  ................+++.+.+||.+||+.||.+|||+.++++||||+++.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~  341 (389)
T 3gni_B          262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  341 (389)
T ss_dssp             --------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred             ccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence                0000000       00000000  0000001111123346889999999999999999999999999999999987


Q ss_pred             Cc
Q 045787          295 NV  296 (324)
Q Consensus       295 ~~  296 (324)
                      ..
T Consensus       342 ~~  343 (389)
T 3gni_B          342 RR  343 (389)
T ss_dssp             --
T ss_pred             hc
Confidence            54

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2e-49  Score=345.21  Aligned_cols=267  Identities=28%  Similarity=0.450  Sum_probs=223.4

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCC----CchHHHHHHHHHHhcCCCCeeEEEeeeecCC
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEG----VPSYIIREVSLLKELEHENIVRLLDVQSSRK   79 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   79 (324)
                      ...++|++.+.||+|++|.||+|.+..+|+.||+|++........    ..+.+.+|+.++++++||||+++++++.+..
T Consensus         9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   88 (321)
T 2a2a_A            9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT   88 (321)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            456789999999999999999999999999999999986543322    2466889999999999999999999999999


Q ss_pred             eEEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCC----cEEEeeccce
Q 045787           80 DVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN----TVKLADFGLA  154 (324)
Q Consensus        80 ~~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~----~v~l~d~g~~  154 (324)
                      ..++||||++ ++|.+++.. ...+++..++.++.+++.||.+||+.|++|+||+|+||+++ .++    .++|+|||.+
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~-~~~~~~~~~kl~Dfg~~  166 (321)
T 2a2a_A           89 DVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL-DKNIPIPHIKLIDFGLA  166 (321)
T ss_dssp             EEEEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEES-CTTSSSCCEEECCCTTC
T ss_pred             EEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEe-cCCCCcCCEEEccCccc
Confidence            9999999997 588888765 45699999999999999999999999999999999999998 565    7999999999


Q ss_pred             eeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccch
Q 045787          155 RAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAES  234 (324)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (324)
                      ...... .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||..................        
T Consensus       167 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~--------  236 (321)
T 2a2a_A          167 HEIEDG-VEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYD--------  236 (321)
T ss_dssp             EECCTT-CCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC--------
T ss_pred             eecCcc-ccccccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccc--------
Confidence            876533 23344568999999999987 67899999999999999999999999877655443322211100        


Q ss_pred             hhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchh
Q 045787          235 TYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~  298 (324)
                                      ........++..+.++|.+||+.||.+|||+.++++||||+.+.....
T Consensus       237 ----------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~~~~  284 (321)
T 2a2a_A          237 ----------------FDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQA  284 (321)
T ss_dssp             ----------------CCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSHHHH
T ss_pred             ----------------cChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCcccc
Confidence                            011223468899999999999999999999999999999998875544

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.9e-50  Score=357.36  Aligned_cols=271  Identities=25%  Similarity=0.367  Sum_probs=223.8

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF   82 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   82 (324)
                      +..++|++++.||+|+||.||+|+++.+|+.||+|++..... .......+.+|..++..++||+|+++++++.+.+.+|
T Consensus        58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~  137 (412)
T 2vd5_A           58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLY  137 (412)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred             CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence            456889999999999999999999999999999999975431 2222355889999999999999999999999999999


Q ss_pred             EEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC
Q 045787           83 LVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        83 iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~  161 (324)
                      +||||+. |+|.+++...+..+++..++.++.+|+.||.|||++|++||||||+||+++ .++.+||+|||.+.......
T Consensus       138 lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld-~~g~vkL~DFGla~~~~~~~  216 (412)
T 2vd5_A          138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLD-RCGHIRLADFGSCLKLRADG  216 (412)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC-TTSCEEECCCTTCEECCTTS
T ss_pred             EEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeec-CCCCEEEeechhheeccCCC
Confidence            9999996 699999887666899999999999999999999999999999999999999 89999999999998765433


Q ss_pred             C-cccccccccccCCchhhcC------CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccch
Q 045787          162 K-EYSRDCVYSPYKAPELLLG------YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAES  234 (324)
Q Consensus       162 ~-~~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (324)
                      . .....+||+.|+|||++..      ...++.++|+|||||++|+|++|+.||...+.......+......        
T Consensus       217 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~--------  288 (412)
T 2vd5_A          217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH--------  288 (412)
T ss_dssp             CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH--------
T ss_pred             ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC--------
Confidence            2 2334579999999999873      256799999999999999999999999887755443322210000        


Q ss_pred             hhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCC---CCHHHHhcCccccCCCCchhh
Q 045787          235 TYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQR---ITAMDALKHEYLIGVENVPLV  299 (324)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R---ps~~~~l~hp~~~~~~~~~~~  299 (324)
                            .         ........+++++++||++||. +|.+|   |+++++++||||+++++..+.
T Consensus       289 ------~---------~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~  340 (412)
T 2vd5_A          289 ------L---------SLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLR  340 (412)
T ss_dssp             ------C---------CCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTST
T ss_pred             ------c---------CCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHh
Confidence                  0         0000113689999999999999 99998   599999999999999887663

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-49  Score=353.54  Aligned_cols=262  Identities=23%  Similarity=0.411  Sum_probs=220.2

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      .++|++++.||+|+||.||+|.+..+|+.+|+|++.......  ...+.+|+.++++++||||+++++++.+....++||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~--~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  127 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD--KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL  127 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH--HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhh--HHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence            468999999999999999999999999999999987553222  346889999999999999999999999999999999


Q ss_pred             EecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeec-CCCcEEEeeccceeeccCCCCc
Q 045787           86 EYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL-KRNTVKLADFGLARAIGVPQKE  163 (324)
Q Consensus        86 e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~-~~~~v~l~d~g~~~~~~~~~~~  163 (324)
                      ||+. |+|.+.+......+++..++.++.+|+.||.|||+.|++|+||||+||+++. ..+.++|+|||.+...... ..
T Consensus       128 E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~-~~  206 (387)
T 1kob_A          128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EI  206 (387)
T ss_dssp             ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-SC
T ss_pred             EcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC-cc
Confidence            9997 5888888776667999999999999999999999999999999999999973 3478999999999876532 23


Q ss_pred             ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCC
Q 045787          164 YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPL  243 (324)
Q Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (324)
                      .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+...............                
T Consensus       207 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~----------------  269 (387)
T 1kob_A          207 VKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEF----------------  269 (387)
T ss_dssp             EEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCC----------------
T ss_pred             eeeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC----------------
Confidence            334578999999999987 678999999999999999999999998877544433322211110                


Q ss_pred             CCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCC
Q 045787          244 YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVEN  295 (324)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~  295 (324)
                              ....+..+++++.+||.+||+.||.+|||+.++++||||++...
T Consensus       270 --------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  313 (387)
T 1kob_A          270 --------DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS  313 (387)
T ss_dssp             --------CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred             --------CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence                    01123468999999999999999999999999999999997653

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=3.2e-49  Score=338.21  Aligned_cols=260  Identities=26%  Similarity=0.426  Sum_probs=213.2

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLV   84 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   84 (324)
                      ..++|++.+.||+|+||.||+|.+..++..+|+|++..... ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   98 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV   98 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence            45789999999999999999999999999999999876543 23357788999999999999999999999999999999


Q ss_pred             EEecCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeec--CCCcEEEeeccceeecc
Q 045787           85 FEYLDL-DLHSFITRH---KNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL--KRNTVKLADFGLARAIG  158 (324)
Q Consensus        85 ~e~~~g-~l~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~--~~~~v~l~d~g~~~~~~  158 (324)
                      |||++| +|.+.+...   ...+++..++.++.+++.||.+||+.|++|+||||+||+++.  .++.++|+|||.+....
T Consensus        99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A           99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            999985 888887653   357999999999999999999999999999999999999952  45789999999997654


Q ss_pred             CCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhh
Q 045787          159 VPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYIS  238 (324)
Q Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (324)
                      .. .......+++.|+|||++.+  .++.++||||||+++|+|++|..||...+................          
T Consensus       179 ~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~----------  245 (285)
T 3is5_A          179 SD-EHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYA----------  245 (285)
T ss_dssp             ---------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----------
T ss_pred             Cc-ccCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccc----------
Confidence            32 23344568899999999864  578999999999999999999999988776555443332221110          


Q ss_pred             cccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCC
Q 045787          239 EILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV  293 (324)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~  293 (324)
                                     .....+++.+.++|.+||+.||.+|||+.++++||||+++
T Consensus       246 ---------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~a  285 (285)
T 3is5_A          246 ---------------VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA  285 (285)
T ss_dssp             ---------------C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC-
T ss_pred             ---------------cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhcC
Confidence                           0112478899999999999999999999999999999864

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=3.5e-49  Score=348.11  Aligned_cols=292  Identities=34%  Similarity=0.587  Sum_probs=231.7

Q ss_pred             CcccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecC---
Q 045787            2 GKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR---   78 (324)
Q Consensus         2 ~~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---   78 (324)
                      +..+.++|++.+.||+|++|.||+|.+..+|+.||+|++..... ......+.+|+.++++++||||+++++++...   
T Consensus         6 ~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   84 (353)
T 2b9h_A            6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK-PLFALRTLREIKILKHFKHENIITIFNIQRPDSFE   84 (353)
T ss_dssp             CCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCST
T ss_pred             ccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccccc-chHHHHHHHHHHHHHhCcCCCcCCeeeeecccccC
Confidence            34567899999999999999999999999999999999864322 22234577899999999999999999987654   


Q ss_pred             --CeEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceee
Q 045787           79 --KDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARA  156 (324)
Q Consensus        79 --~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~  156 (324)
                        ...++|+||++++|.+.+..  ..+++..++.++.+++.||.+||++|++|+||||+||+++ .++.++|+|||.+..
T Consensus        85 ~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~-~~~~~kl~Dfg~a~~  161 (353)
T 2b9h_A           85 NFNEVYIIQELMQTDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLIN-SNCDLKVCDFGLARI  161 (353)
T ss_dssp             TCCCEEEEECCCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC-TTCCEEECCCTTCEE
T ss_pred             ccceEEEEEeccCccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEc-CCCcEEEEecccccc
Confidence              67999999999999998876  4699999999999999999999999999999999999999 899999999999987


Q ss_pred             ccCCCCc----------ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHHcCC
Q 045787          157 IGVPQKE----------YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD-HLSLIFSLLGT  225 (324)
Q Consensus       157 ~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~  225 (324)
                      .......          .....+++.|+|||++.+...++.++||||||+++|+|++|..||.+.+.. ....+....+.
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  241 (353)
T 2b9h_A          162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT  241 (353)
T ss_dssp             CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence            6432211          222467889999999876577899999999999999999999999888743 44445555555


Q ss_pred             CCcccccc---hhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCch
Q 045787          226 PTDESWAE---STYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP  297 (324)
Q Consensus       226 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~  297 (324)
                      +.......   .....+.................+.+++.+.++|.+||+.||.+|||+.++++||||+......
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~  316 (353)
T 2b9h_A          242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPN  316 (353)
T ss_dssp             CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTT
T ss_pred             CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcc
Confidence            54322111   1111112222222333445556678999999999999999999999999999999999887543

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.4e-49  Score=349.75  Aligned_cols=259  Identities=25%  Similarity=0.418  Sum_probs=201.9

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLV   84 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   84 (324)
                      ..++|++++.||+|+||+||+|.+..+++.||+|++.....   ..+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   94 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAII   94 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT---SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc---ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEE
Confidence            46899999999999999999999999999999999875432   246788999999999999999999999999999999


Q ss_pred             EEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCC--cEEEeeccceeeccCCC
Q 045787           85 FEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN--TVKLADFGLARAIGVPQ  161 (324)
Q Consensus        85 ~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~--~v~l~d~g~~~~~~~~~  161 (324)
                      |||+. |+|.+++... +.+++..++.++.+++.||.|||++|++|+||||+||+++ .++  .++|+|||.+..... .
T Consensus        95 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~-~~~~~~~kl~Dfg~a~~~~~-~  171 (361)
T 3uc3_A           95 MEYASGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVL-H  171 (361)
T ss_dssp             EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEEC-SSSSCCEEECCCCCC-------
T ss_pred             EEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc-CCCCceEEEeecCccccccc-c
Confidence            99997 5888887664 4699999999999999999999999999999999999998 554  499999999875432 2


Q ss_pred             CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChh-HHHH-HHHHcCCCCcccccchhhhhc
Q 045787          162 KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD-HLSL-IFSLLGTPTDESWAESTYISE  239 (324)
Q Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~  239 (324)
                      .......+|+.|+|||++.+....+.++||||||+++|+|++|+.||...... .... ..........           
T Consensus       172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~-----------  240 (361)
T 3uc3_A          172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYS-----------  240 (361)
T ss_dssp             ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCC-----------
T ss_pred             CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCC-----------
Confidence            23344578999999999987444455699999999999999999999765421 1111 1111111000           


Q ss_pred             ccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCC
Q 045787          240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV  293 (324)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~  293 (324)
                          .         .....+++.+.+||.+||+.||.+|||+.++++||||.+.
T Consensus       241 ----~---------~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          241 ----I---------PDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             ----C---------CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             ----C---------CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence                0         0012578999999999999999999999999999999654

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=7e-50  Score=349.79  Aligned_cols=253  Identities=23%  Similarity=0.374  Sum_probs=213.0

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCC------CchHHHHHHHHHHhcCCCCeeEEEeeeecC
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEG------VPSYIIREVSLLKELEHENIVRLLDVQSSR   78 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   78 (324)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++........      ....+.+|+.++++++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            35789999999999999999999999999999999986543221      345677899999999999999999999999


Q ss_pred             CeEEEEEEecC-C-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceee
Q 045787           79 KDVFLVFEYLD-L-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARA  156 (324)
Q Consensus        79 ~~~~iv~e~~~-g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~  156 (324)
                      +..++||||+. | ++.+++.. ...+++..++.++.+++.||.|||+.|++|+||||+||+++ .++.++|+|||.+..
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~-~~~~~kL~Dfg~a~~  179 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIA-EDFTIKLIDFGSAAY  179 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-TTSCEEECCCTTCEE
T ss_pred             CEEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEc-CCCcEEEeecccceE
Confidence            99999999986 5 77777765 44699999999999999999999999999999999999999 889999999999987


Q ss_pred             ccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhh
Q 045787          157 IGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY  236 (324)
Q Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (324)
                      .... .......+|+.|+|||++.+....+.++||||||+++|+|++|..||......                      
T Consensus       180 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------------------  236 (335)
T 3dls_A          180 LERG-KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET----------------------  236 (335)
T ss_dssp             CCTT-CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----------------------
T ss_pred             CCCC-CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----------------------
Confidence            6533 23344578999999999988454588999999999999999999999542210                      


Q ss_pred             hhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCC
Q 045787          237 ISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVE  294 (324)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~  294 (324)
                          ....        ......+++++.++|.+||+.||.+|||+.++++||||++..
T Consensus       237 ----~~~~--------~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  282 (335)
T 3dls_A          237 ----VEAA--------IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV  282 (335)
T ss_dssp             ----TTTC--------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred             ----Hhhc--------cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence                0000        001124789999999999999999999999999999998754

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.9e-49  Score=359.51  Aligned_cols=262  Identities=31%  Similarity=0.498  Sum_probs=222.8

Q ss_pred             CcccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeecc-ccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCe
Q 045787            2 GKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQT-EQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKD   80 (324)
Q Consensus         2 ~~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   80 (324)
                      |.+..++|++.+.||+|+||.||+|.+..+|+.||+|++.... ...+....+.+|+.+++.++||||+++++++.+.+.
T Consensus        11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~   90 (476)
T 2y94_A           11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSD   90 (476)
T ss_dssp             SCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             CCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            5677889999999999999999999999999999999997654 223345678999999999999999999999999999


Q ss_pred             EEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccC
Q 045787           81 VFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGV  159 (324)
Q Consensus        81 ~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~  159 (324)
                      .|+||||++ |+|.+++.. .+.+++..++.++.||+.||.|||+.|++|+||||+||+++ .++.++|+|||.+.....
T Consensus        91 ~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~-~~~~vkL~DFG~a~~~~~  168 (476)
T 2y94_A           91 IFMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLD-AHMNAKIADFGLSNMMSD  168 (476)
T ss_dssp             EEEEEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEC-TTCCEEECCCSSCEECCT
T ss_pred             EEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEe-cCCCeEEEeccchhhccc
Confidence            999999996 588887765 45699999999999999999999999999999999999999 899999999999987653


Q ss_pred             CCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhc
Q 045787          160 PQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISE  239 (324)
Q Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
                       .......+|++.|+|||++.+....+.++||||||+++|+|++|..||...+.......+.....              
T Consensus       169 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--------------  233 (476)
T 2y94_A          169 -GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF--------------  233 (476)
T ss_dssp             -TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC--------------
T ss_pred             -cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc--------------
Confidence             23344567999999999998855557899999999999999999999987765444332221100              


Q ss_pred             ccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCC
Q 045787          240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVE  294 (324)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~  294 (324)
                                    .....+++++.++|.+||+.||.+|||+.++++||||++..
T Consensus       234 --------------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~  274 (476)
T 2y94_A          234 --------------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDL  274 (476)
T ss_dssp             --------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTC
T ss_pred             --------------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhcC
Confidence                          01124788999999999999999999999999999998743

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.1e-49  Score=341.73  Aligned_cols=268  Identities=24%  Similarity=0.341  Sum_probs=205.0

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF   82 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   82 (324)
                      ++..++|++++.||+|++|.||+|.+..+|+.||+|++..........+.+.++...++.++|||++++++++.+++..+
T Consensus         3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~   82 (290)
T 3fme_A            3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW   82 (290)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred             cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence            46778999999999999999999999999999999999765433322344555555678889999999999999999999


Q ss_pred             EEEEecCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCCCCceEeecCCCcEEEeeccceeecc
Q 045787           83 LVFEYLDLDLHSFITR---HKNTLNLLVIKAILKQILLGLAYCHSL-KILHRDLKPNNLLIDLKRNTVKLADFGLARAIG  158 (324)
Q Consensus        83 iv~e~~~g~l~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~-g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~  158 (324)
                      +||||++|++.+++..   ....+++..++.++.+++.||.+||++ |++|+||||+||+++ .++.++|+|||.+....
T Consensus        83 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           83 ICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLIN-ALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEEC-TTCCEEBCCC-------
T ss_pred             EEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEEC-CCCCEEEeecCCccccc
Confidence            9999999988777654   456799999999999999999999998 999999999999999 88999999999987665


Q ss_pred             CCCCcccccccccccCCchhhc---CCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchh
Q 045787          159 VPQKEYSRDCVYSPYKAPELLL---GYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAEST  235 (324)
Q Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (324)
                      .. .......+++.|+|||++.   ....++.++||||||+++|+|++|..||..................+..      
T Consensus       162 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------  234 (290)
T 3fme_A          162 DD-VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL------  234 (290)
T ss_dssp             ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCC------
T ss_pred             cc-ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCc------
Confidence            32 2233346889999999973   3366899999999999999999999999764422221111111111100      


Q ss_pred             hhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCch
Q 045787          236 YISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP  297 (324)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~  297 (324)
                                         ....+++++.+++.+||+.||.+|||+.++++||||+......
T Consensus       235 -------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~~~~  277 (290)
T 3fme_A          235 -------------------PADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKG  277 (290)
T ss_dssp             -------------------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHSC
T ss_pred             -------------------ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCcccc
Confidence                               0125788999999999999999999999999999998765433

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=5.9e-49  Score=339.26  Aligned_cols=274  Identities=24%  Similarity=0.353  Sum_probs=221.8

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   83 (324)
                      -..++|++++.||+|++|.||+|.+..+++.+++|++.....  ...+.+.+|+.+++.++||||+++++++..++..++
T Consensus        16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   93 (302)
T 2j7t_A           16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE--EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWI   93 (302)
T ss_dssp             CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEE
T ss_pred             CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH--HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEE
Confidence            346789999999999999999999999999999999875432  335678899999999999999999999999999999


Q ss_pred             EEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC
Q 045787           84 VFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK  162 (324)
Q Consensus        84 v~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~  162 (324)
                      |+||+++ ++.+++......+++..++.++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+........
T Consensus        94 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~  172 (302)
T 2j7t_A           94 MIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMT-LEGDIRLADFGVSAKNLKTLQ  172 (302)
T ss_dssp             EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC-TTSCEEECCCHHHHHHHHHHH
T ss_pred             EEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEC-CCCCEEEEECCCCcccccccc
Confidence            9999985 78777777667899999999999999999999999999999999999999 889999999998754322222


Q ss_pred             cccccccccccCCchhhc----CCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhh
Q 045787          163 EYSRDCVYSPYKAPELLL----GYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYIS  238 (324)
Q Consensus       163 ~~~~~~~~~~y~aPE~~~----~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (324)
                      ......+++.|+|||++.    ....++.++||||||+++|+|++|..||...+.............+..          
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----------  242 (302)
T 2j7t_A          173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL----------  242 (302)
T ss_dssp             C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC----------
T ss_pred             ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc----------
Confidence            233446888999999984    336689999999999999999999999987775443332222111110          


Q ss_pred             cccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchhhhhhhhc
Q 045787          239 EILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLINR  305 (324)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~~~~~~~~  305 (324)
                                     .....++..+.++|.+||+.||.+|||+.++++||||+++.........+..
T Consensus       243 ---------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~~~~~  294 (302)
T 2j7t_A          243 ---------------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRELVAE  294 (302)
T ss_dssp             ---------------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCCHHHHHHHHH
T ss_pred             ---------------CCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhccchhHHHHHHH
Confidence                           0012468899999999999999999999999999999999988876655543

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.7e-49  Score=338.74  Aligned_cols=260  Identities=27%  Similarity=0.471  Sum_probs=196.0

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLV   84 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   84 (324)
                      -++|++.+.||+|++|.||+|.+..+|+.||+|++..... .....+.+.+|+.++++++|||++++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            3579999999999999999999999999999999976542 333456788999999999999999999999999999999


Q ss_pred             EEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCc
Q 045787           85 FEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE  163 (324)
Q Consensus        85 ~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~  163 (324)
                      +||+++ +|.+++.....++++..++.++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+.........
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~-~~~~~kl~dfg~~~~~~~~~~~  168 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLT-RNMNIKIADFGLATQLKMPHEK  168 (278)
T ss_dssp             EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEEC-TTCCEEECCCTTCEECC-----
T ss_pred             EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc-CCCCEEEEeecceeeccCCCCc
Confidence            999974 88888887767899999999999999999999999999999999999999 8999999999999876544444


Q ss_pred             ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCC
Q 045787          164 YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPL  243 (324)
Q Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (324)
                      .....+++.|+|||++.+ ..++.++||||||+++|+|++|+.||...........                    ... 
T Consensus       169 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~--------------------~~~-  226 (278)
T 3cok_A          169 HYTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK--------------------VVL-  226 (278)
T ss_dssp             ------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------------------CCS-
T ss_pred             ceeccCCCCcCCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHH--------------------Hhh-
Confidence            445578899999999887 6679999999999999999999999976543221100                    000 


Q ss_pred             CCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCC
Q 045787          244 YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVEN  295 (324)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~  295 (324)
                             ........++.++.++|.+||+.||.+|||++++++||||++...
T Consensus       227 -------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  271 (278)
T 3cok_A          227 -------ADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSS  271 (278)
T ss_dssp             -------SCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC----
T ss_pred             -------cccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCCC
Confidence                   000112357889999999999999999999999999999987553

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=5.8e-49  Score=335.25  Aligned_cols=262  Identities=28%  Similarity=0.445  Sum_probs=220.8

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLV   84 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   84 (324)
                      ..++|++.+.||+|++|.||+|.+..++..+++|.+......  ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE--DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV   84 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence            457899999999999999999999999999999998765433  257789999999999999999999999999999999


Q ss_pred             EEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEe---ecCCCcEEEeeccceeeccCC
Q 045787           85 FEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLI---DLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        85 ~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll---~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      |||++| +|.+.+... ..+++..++.++.+++.||.+||++|++|+||+|+||++   + .++.++|+|||.+......
T Consensus        85 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~~~~l~Dfg~~~~~~~~  162 (277)
T 3f3z_A           85 MELCTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDS-PDSPLKLIDFGLAARFKPG  162 (277)
T ss_dssp             EECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSS-TTCCEEECCCTTCEECCTT
T ss_pred             EeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCC-CCCcEEEEecccceeccCc
Confidence            999975 887877664 569999999999999999999999999999999999999   5 7789999999999876533


Q ss_pred             CCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcc
Q 045787          161 QKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEI  240 (324)
Q Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (324)
                       .......+++.|+|||++.+  .++.++||||||+++|+|++|..||...................             
T Consensus       163 -~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------------  226 (277)
T 3f3z_A          163 -KMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTF-------------  226 (277)
T ss_dssp             -SCBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-------------
T ss_pred             -cchhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC-------------
Confidence             33445578999999999876  37999999999999999999999998877655444333221111             


Q ss_pred             cCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCch
Q 045787          241 LPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP  297 (324)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~  297 (324)
                                 ....+..+++.+.++|.+||+.||.+|||+.++++||||++....+
T Consensus       227 -----------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~~  272 (277)
T 3f3z_A          227 -----------PEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSS  272 (277)
T ss_dssp             -----------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHCCS
T ss_pred             -----------CchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcccccc
Confidence                       1112235789999999999999999999999999999998755443

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.5e-49  Score=350.57  Aligned_cols=286  Identities=34%  Similarity=0.582  Sum_probs=226.2

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCe----
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKD----   80 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~----   80 (324)
                      +.++|++.+.||+|++|.||+|.+..+|+.||+|++............+.+|+.++++++||||+++++++.....    
T Consensus        22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  101 (353)
T 3coi_A           22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  101 (353)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence            3578999999999999999999999999999999987654333334667899999999999999999999877653    


Q ss_pred             --EEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeecc
Q 045787           81 --VFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIG  158 (324)
Q Consensus        81 --~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~  158 (324)
                        +|+||||++++|.+.+.   ..+++..++.++.+++.||.+||++|++|+||||+||+++ .++.++|+|||.+....
T Consensus       102 ~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~-~~~~~kl~Dfg~~~~~~  177 (353)
T 3coi_A          102 YDFYLVMPFMQTDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN-EDCELKILDFGLARHAD  177 (353)
T ss_dssp             CCCEEEEECCSEEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC-TTCCEEECSTTCTTC--
T ss_pred             eeEEEEeccccCCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeEC-CCCcEEEeecccccCCC
Confidence              59999999998887654   3599999999999999999999999999999999999999 89999999999987654


Q ss_pred             CCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHHcCCCCcccccchh--
Q 045787          159 VPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAEST--  235 (324)
Q Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~--  235 (324)
                      .   ......+++.|+|||++.+...++.++||||||+++|+|++|..||.+.+. +....+....+.++...+....  
T Consensus       178 ~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  254 (353)
T 3coi_A          178 A---EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK  254 (353)
T ss_dssp             ---------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCH
T ss_pred             C---CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhH
Confidence            2   233446789999999998767789999999999999999999999988774 3444555555555443222110  


Q ss_pred             hhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCch
Q 045787          236 YISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP  297 (324)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~  297 (324)
                      .....................+.+++.+.++|.+||+.||.+|||++++++||||+......
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~  316 (353)
T 3coi_A          255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPE  316 (353)
T ss_dssp             HHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred             HHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCcc
Confidence            00111111222222333445567899999999999999999999999999999999887643

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.1e-49  Score=356.58  Aligned_cols=284  Identities=32%  Similarity=0.532  Sum_probs=225.0

Q ss_pred             CCcccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcC--------CCCeeEEE
Q 045787            1 MGKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE--------HENIVRLL   72 (324)
Q Consensus         1 ~~~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~--------~~~i~~~~   72 (324)
                      +|++..++|++++.||+|+||+||+|.+..+++.||+|++.....   ..+.+.+|+.+++.++        |++|++++
T Consensus        31 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~  107 (397)
T 1wak_A           31 IGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEH---YTETALDEIRLLKSVRNSDPNDPNREMVVQLL  107 (397)
T ss_dssp             TTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH---HHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEE
T ss_pred             hhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCc---chHHHHHHHHHHHHHhhcCCCCCCcceeeeee
Confidence            467888999999999999999999999999999999999874422   2356788999999985        77899999


Q ss_pred             eeee----cCCeEEEEEEecCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCCCCceEeecCCC--
Q 045787           73 DVQS----SRKDVFLVFEYLDLDLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSL-KILHRDLKPNNLLIDLKRN--  144 (324)
Q Consensus        73 ~~~~----~~~~~~iv~e~~~g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~-g~~H~di~p~nIll~~~~~--  144 (324)
                      +++.    +....|+||||+++++++.+.... ..+++..++.++.||+.||.|||++ |++|+||||+|||++ .++  
T Consensus       108 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~-~~~~~  186 (397)
T 1wak_A          108 DDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLS-VNEQY  186 (397)
T ss_dssp             EEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEEC-CCHHH
T ss_pred             cceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEe-ccchh
Confidence            9987    566899999999999999888754 5699999999999999999999998 999999999999998 553  


Q ss_pred             -----------------------------------------------cEEEeeccceeeccCCCCcccccccccccCCch
Q 045787          145 -----------------------------------------------TVKLADFGLARAIGVPQKEYSRDCVYSPYKAPE  177 (324)
Q Consensus       145 -----------------------------------------------~v~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE  177 (324)
                                                                     .++|+|||.+.....   ......+|+.|+|||
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~---~~~~~~gt~~y~aPE  263 (397)
T 1wak_A          187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK---HFTEDIQTRQYRSLE  263 (397)
T ss_dssp             HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB---CSCSCCSCGGGCCHH
T ss_pred             hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc---cCccCCCCCcccCCh
Confidence                                                           799999999987653   234457899999999


Q ss_pred             hhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-------hhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCc
Q 045787          178 LLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-------HDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPA  250 (324)
Q Consensus       178 ~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (324)
                      ++.+ ..++.++|||||||++|+|++|..||...+       ......+....+.++...+...................
T Consensus       264 ~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  342 (397)
T 1wak_A          264 VLIG-SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHI  342 (397)
T ss_dssp             HHHT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSC
T ss_pred             hhcC-CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccc
Confidence            9988 668999999999999999999999997654       23455566666666654443333322222211111000


Q ss_pred             ------ch----h---hhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccC
Q 045787          251 ------NL----A---EKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIG  292 (324)
Q Consensus       251 ------~~----~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~  292 (324)
                            ..    .   ......+..+.+||.+||+.||.+|||++++++||||++
T Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          343 TKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             CCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             cccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence                  00    0   001123567889999999999999999999999999974

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.9e-49  Score=344.98  Aligned_cols=270  Identities=26%  Similarity=0.408  Sum_probs=221.7

Q ss_pred             ccCcCccee-EeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcC-CCCeeEEEeeeecCCeE
Q 045787            4 LKNLNYKKI-KKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-HENIVRLLDVQSSRKDV   81 (324)
Q Consensus         4 ~~~~~y~i~-~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~   81 (324)
                      ...++|.+. +.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.+. ||+|+++++++.+.+..
T Consensus        25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~  104 (327)
T 3lm5_A           25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEI  104 (327)
T ss_dssp             HHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             hhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeE
Confidence            345678888 8999999999999999999999999999876655555677889999999995 69999999999999999


Q ss_pred             EEEEEecCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecC---CCcEEEeeccceee
Q 045787           82 FLVFEYLDL-DLHSFITRH-KNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK---RNTVKLADFGLARA  156 (324)
Q Consensus        82 ~iv~e~~~g-~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~---~~~v~l~d~g~~~~  156 (324)
                      ++||||+.| +|.+++... ...+++..++.++.+++.||.+||+.|++|+||||+||+++ .   ++.++|+|||.+..
T Consensus       105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~-~~~~~~~~kL~Dfg~a~~  183 (327)
T 3lm5_A          105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLS-SIYPLGDIKIVDFGMSRK  183 (327)
T ss_dssp             EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEES-CBTTBCCEEECCGGGCEE
T ss_pred             EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEe-cCCCCCcEEEeeCccccc
Confidence            999999985 888776543 35699999999999999999999999999999999999998 5   68999999999987


Q ss_pred             ccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhh
Q 045787          157 IGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY  236 (324)
Q Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (324)
                      .... .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||...+................        
T Consensus       184 ~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~--------  253 (327)
T 3lm5_A          184 IGHA-CELREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYS--------  253 (327)
T ss_dssp             C----------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC--------
T ss_pred             cCCc-cccccccCCcCccCCeeecC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccC--------
Confidence            6532 23344578999999999987 6789999999999999999999999988775544333332211111        


Q ss_pred             hhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchhhh
Q 045787          237 ISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVI  300 (324)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~~~  300 (324)
                                      ......+++.+.++|.+||+.||.+|||++++++||||++.....+..
T Consensus       254 ----------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~~~  301 (327)
T 3lm5_A          254 ----------------EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFH  301 (327)
T ss_dssp             ----------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC--
T ss_pred             ----------------chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccccccC
Confidence                            112246789999999999999999999999999999999998776644

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3.7e-49  Score=362.71  Aligned_cols=261  Identities=32%  Similarity=0.540  Sum_probs=216.0

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      .++|++++.||+|+||+||+|.+..++..+|+|++............+.+|+.+++.++||||+++++++.+...+|+||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            45799999999999999999999999999999999876655555678899999999999999999999999999999999


Q ss_pred             EecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecC--CCcEEEeeccceeeccCCCC
Q 045787           86 EYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK--RNTVKLADFGLARAIGVPQK  162 (324)
Q Consensus        86 e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~--~~~v~l~d~g~~~~~~~~~~  162 (324)
                      ||+.| +|.+.+... ..+++..++.++.+|+.||.|||++|++|+||||+||+++..  ++.++|+|||.+...... .
T Consensus       116 e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~-~  193 (494)
T 3lij_A          116 ECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ-K  193 (494)
T ss_dssp             ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT-B
T ss_pred             ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC-c
Confidence            99975 888877764 469999999999999999999999999999999999999722  356999999999876533 3


Q ss_pred             cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccC
Q 045787          163 EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILP  242 (324)
Q Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (324)
                      .....++|+.|+|||++.+  .++.++|||||||++|+|++|..||.+.+................              
T Consensus       194 ~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~--------------  257 (494)
T 3lij_A          194 KMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFD--------------  257 (494)
T ss_dssp             CBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC--------------
T ss_pred             cccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--------------
Confidence            3445679999999999864  589999999999999999999999988886655444332221111              


Q ss_pred             CCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCC
Q 045787          243 LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVE  294 (324)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~  294 (324)
                                ...+..+++.+.+||.+||+.||.+|||+.++++||||++..
T Consensus       258 ----------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  299 (494)
T 3lij_A          258 ----------SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMC  299 (494)
T ss_dssp             ----------SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred             ----------chhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCc
Confidence                      112346889999999999999999999999999999998754

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=6.7e-49  Score=347.19  Aligned_cols=288  Identities=28%  Similarity=0.446  Sum_probs=215.0

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCC------
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK------   79 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------   79 (324)
                      -++|++.+.||+|+||.||+|.+..+|+.||+|++.....   ......+++..+..++||||+++++++...+      
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~   98 (360)
T 3e3p_A           22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR---FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD   98 (360)
T ss_dssp             HTTEEEC----------CEEEEETTTCCEEEEEEEECCTT---CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc---ccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence            4689999999999999999999999999999999865432   2345678888889999999999999986533      


Q ss_pred             -eEEEEEEecCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH--hCCCcccCCCCCceEeecCCCcEEEeeccc
Q 045787           80 -DVFLVFEYLDLDLHSFITR---HKNTLNLLVIKAILKQILLGLAYCH--SLKILHRDLKPNNLLIDLKRNTVKLADFGL  153 (324)
Q Consensus        80 -~~~iv~e~~~g~l~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh--~~g~~H~di~p~nIll~~~~~~v~l~d~g~  153 (324)
                       ..++||||+++++...+..   ....+++..++.++.+++.||.+||  +.|++|+||||+||+++..++.++|+|||.
T Consensus        99 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~  178 (360)
T 3e3p_A           99 IYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGS  178 (360)
T ss_dssp             EEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred             eeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence             3899999999988776653   3457899999999999999999999  999999999999999994489999999999


Q ss_pred             eeeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHHcCCCCccccc
Q 045787          154 ARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWA  232 (324)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~  232 (324)
                      +...... .......+|+.|+|||++.+...++.++||||||+++|+|++|..||...+. .....+....+.++...+.
T Consensus       179 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  257 (360)
T 3e3p_A          179 AKKLSPS-EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLR  257 (360)
T ss_dssp             CBCCCTT-SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             ceecCCC-CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHH
Confidence            9876533 2333456789999999997766789999999999999999999999988774 4445555666666544332


Q ss_pred             chhhhhcccCCCCCCCCcchhhh----CCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchh
Q 045787          233 ESTYISEILPLYPHFEPANLAEK----FPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~  298 (324)
                      ............ ......+...    ....++++.+||.+||+.||.+|||+.++++||||+++.+...
T Consensus       258 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~  326 (360)
T 3e3p_A          258 KLNPSHTDVDLY-NSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPAT  326 (360)
T ss_dssp             HHCTTCCCGGGG-CCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTC
T ss_pred             hcccchhhcccc-ccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccc
Confidence            211111100000 0011111112    2236788999999999999999999999999999999876543

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=4.8e-49  Score=361.30  Aligned_cols=265  Identities=29%  Similarity=0.509  Sum_probs=222.1

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLV   84 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   84 (324)
                      ..++|++++.||+|+||+||+|.+..+++.||+|++............+.+|+.++++++||||+++++++.+...+|+|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            35689999999999999999999999999999999987655555567889999999999999999999999999999999


Q ss_pred             EEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeec--CCCcEEEeeccceeeccCCC
Q 045787           85 FEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL--KRNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        85 ~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~--~~~~v~l~d~g~~~~~~~~~  161 (324)
                      +||+. |+|.+.+... ..+++..++.++.+|+.||.|||++|++|+||||+||+++.  .++.++|+|||.+..... .
T Consensus       100 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~-~  177 (486)
T 3mwu_A          100 GELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ-N  177 (486)
T ss_dssp             ECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC-C
T ss_pred             EEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC-C
Confidence            99997 4888887764 46999999999999999999999999999999999999962  446799999999876543 2


Q ss_pred             CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhccc
Q 045787          162 KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEIL  241 (324)
Q Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (324)
                      .......+|+.|+|||++.+  .++.++||||||+++|+|++|..||.+.+.............+..             
T Consensus       178 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-------------  242 (486)
T 3mwu_A          178 TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD-------------  242 (486)
T ss_dssp             ----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSC-------------
T ss_pred             CccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-------------
Confidence            33445578999999999976  479999999999999999999999988876555443332211110             


Q ss_pred             CCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCch
Q 045787          242 PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP  297 (324)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~  297 (324)
                                 ...+..+++++.+||.+||+.||.+|||+.++++||||++.....
T Consensus       243 -----------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~  287 (486)
T 3mwu_A          243 -----------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSET  287 (486)
T ss_dssp             -----------SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCCC
T ss_pred             -----------CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcccC
Confidence                       011235789999999999999999999999999999999876543

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=7e-49  Score=334.51  Aligned_cols=265  Identities=29%  Similarity=0.463  Sum_probs=215.0

Q ss_pred             CcccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeecc-ccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCe
Q 045787            2 GKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQT-EQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKD   80 (324)
Q Consensus         2 ~~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   80 (324)
                      |.+..++|++.+.||+|++|.||+|.+..+|+.|++|++.... ......+.+.+|+.+++.++||||+++++++.+.+.
T Consensus         6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   85 (276)
T 2h6d_A            6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD   85 (276)
T ss_dssp             -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCe
Confidence            5678899999999999999999999999999999999997654 233445678899999999999999999999999999


Q ss_pred             EEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccC
Q 045787           81 VFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGV  159 (324)
Q Consensus        81 ~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~  159 (324)
                      .++|+||+. ++|.+++... ..+++..++.++.+++.||.+||++|++|+||+|+||+++ .++.++|+|||.+.....
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~-~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           86 FFMVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLD-AHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             EEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEEC-TTSCEEECCCCGGGCCCC
T ss_pred             EEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEEC-CCCCEEEeecccccccCC
Confidence            999999997 5888888764 4699999999999999999999999999999999999999 889999999999876643


Q ss_pred             CCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhc
Q 045787          160 PQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISE  239 (324)
Q Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
                      . .......+++.|+|||++.+....+.++|+||||+++|+|++|..||..................             
T Consensus       164 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------------  229 (276)
T 2h6d_A          164 G-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFY-------------  229 (276)
T ss_dssp             --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-------------
T ss_pred             C-cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc-------------
Confidence            2 22334568889999999987444578999999999999999999999877655443332211100             


Q ss_pred             ccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCch
Q 045787          240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP  297 (324)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~  297 (324)
                                     ....++..+.++|.+||+.||.+|||+.++++||||++.-...
T Consensus       230 ---------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~~~  272 (276)
T 2h6d_A          230 ---------------IPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLPSY  272 (276)
T ss_dssp             ---------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTCCGG
T ss_pred             ---------------CchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccCchhc
Confidence                           0124688999999999999999999999999999998765443

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.7e-49  Score=343.96  Aligned_cols=292  Identities=33%  Similarity=0.532  Sum_probs=218.8

Q ss_pred             CcccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeee-----
Q 045787            2 GKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQS-----   76 (324)
Q Consensus         2 ~~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----   76 (324)
                      |..+.++|++++.||+|++|.||+|.+..+++.||+|++......  ..+.+.+|+.++++++|||++++++++.     
T Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   83 (320)
T 2i6l_A            6 GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQ--SVKHALREIKIIRRLDHDNIVKVFEILGPSGSQ   83 (320)
T ss_dssp             CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHH--HHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCB
T ss_pred             cCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChH--HHHHHHHHHHHHHhcCCCCeeEEEEeccccccc
Confidence            456789999999999999999999999999999999998754322  2466889999999999999999999873     


Q ss_pred             ---------cCCeEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEE
Q 045787           77 ---------SRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVK  147 (324)
Q Consensus        77 ---------~~~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~  147 (324)
                               +....++|+||++|+|.+++..  +++++..++.++.+++.||.+||+.|++|+||||+||+++..++.++
T Consensus        84 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           84 LTDDVGSLTELNSVYIVQEYMETDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             CCC----CCSCSEEEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEE
T ss_pred             cccccccccccCceeEEeeccCCCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEE
Confidence                     3467899999999999988864  56999999999999999999999999999999999999985667999


Q ss_pred             EeeccceeeccCCC---CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHH-HHHHHc
Q 045787          148 LADFGLARAIGVPQ---KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLS-LIFSLL  223 (324)
Q Consensus       148 l~d~g~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~~~~~  223 (324)
                      |+|||.+.......   .......+++.|+|||++.+...++.++||||||+++|+|++|+.||...+..... .+....
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  241 (320)
T 2i6l_A          162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI  241 (320)
T ss_dssp             ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred             EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            99999998664221   12233456888999999876577899999999999999999999999887754333 232222


Q ss_pred             CCCCcccccchhh-hhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCch
Q 045787          224 GTPTDESWAESTY-ISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP  297 (324)
Q Consensus       224 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~  297 (324)
                      ............. ....................+.++.++.++|.+||+.||.+|||+.++++||||+....+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~  316 (320)
T 2i6l_A          242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPM  316 (320)
T ss_dssp             CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC--
T ss_pred             CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCcc
Confidence            2222111100000 0000000001112233445567899999999999999999999999999999999876554

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=4.4e-49  Score=336.33  Aligned_cols=262  Identities=26%  Similarity=0.452  Sum_probs=218.9

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeecc-ccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeE
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQT-EQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV   81 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   81 (324)
                      ...-++|++.+.||+|++|.||+|.+..++..+|+|++.... ........+.+|+.++++++||||+++++++.+.+..
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   84 (279)
T 3fdn_A            5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV   84 (279)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence            345688999999999999999999999999999999987544 2233356788999999999999999999999999999


Q ss_pred             EEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           82 FLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        82 ~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      ++||||+++ +|.+.+... ..+++..++.++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+..... 
T Consensus        85 ~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~-~~~~~~l~Dfg~~~~~~~-  161 (279)
T 3fdn_A           85 YLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWSVHAPS-  161 (279)
T ss_dssp             EEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEEC-TTSCEEECSCCEESCC---
T ss_pred             EEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEc-CCCCEEEEeccccccCCc-
Confidence            999999985 888877664 4699999999999999999999999999999999999999 899999999998865432 


Q ss_pred             CCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcc
Q 045787          161 QKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEI  240 (324)
Q Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (324)
                       .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||...+..............              
T Consensus       162 -~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------------  225 (279)
T 3fdn_A          162 -SRRTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT--------------  225 (279)
T ss_dssp             -------CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC--------------
T ss_pred             -ccccccCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCC--------------
Confidence             22334568899999999987 67799999999999999999999999887755444333221111              


Q ss_pred             cCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCch
Q 045787          241 LPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP  297 (324)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~  297 (324)
                                    ....+++.+.++|.+||+.||.+|||++++++||||++....+
T Consensus       226 --------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~  268 (279)
T 3fdn_A          226 --------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP  268 (279)
T ss_dssp             --------------CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCSSC
T ss_pred             --------------CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCccCc
Confidence                          1124788999999999999999999999999999999877554

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3.3e-49  Score=346.14  Aligned_cols=260  Identities=27%  Similarity=0.465  Sum_probs=212.4

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEEE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~i   83 (324)
                      ..++|++.+.||+|+||.||+|.++.+|+.||+|++......      ..+|++++.++ +||||+++++++.+.+..|+
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l   93 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYV   93 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence            456899999999999999999999999999999998754322      35788888888 79999999999999999999


Q ss_pred             EEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCC---cEEEeeccceeeccC
Q 045787           84 VFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN---TVKLADFGLARAIGV  159 (324)
Q Consensus        84 v~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~---~v~l~d~g~~~~~~~  159 (324)
                      ||||+. |+|.+.+... +.+++..++.++.+|+.||.|||++|++|+||||+||++...++   .++|+|||.+.....
T Consensus        94 v~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~  172 (342)
T 2qr7_A           94 VTELMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA  172 (342)
T ss_dssp             EECCCCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred             EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence            999997 5888887764 56999999999999999999999999999999999999853333   599999999987765


Q ss_pred             CCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhc
Q 045787          160 PQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISE  239 (324)
Q Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
                      ........++|+.|+|||++.+ ..++.++||||||+++|+|++|..||..........+........            
T Consensus       173 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~------------  239 (342)
T 2qr7_A          173 ENGLLMTPCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGK------------  239 (342)
T ss_dssp             TTCCBCCSSCCSSCCCHHHHHH-HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCC------------
T ss_pred             CCCceeccCCCccccCHHHhcC-CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCC------------
Confidence            5555556688999999999987 557889999999999999999999997643222211111110000            


Q ss_pred             ccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCC
Q 045787          240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV  293 (324)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~  293 (324)
                               .......+..+++++.+||.+||..||.+||++.++++||||.+.
T Consensus       240 ---------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  284 (342)
T 2qr7_A          240 ---------FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW  284 (342)
T ss_dssp             ---------CCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred             ---------cccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence                     000011234689999999999999999999999999999999764

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1e-48  Score=344.24  Aligned_cols=265  Identities=27%  Similarity=0.437  Sum_probs=204.1

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   83 (324)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++.....    .+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  125 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD----KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL  125 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh----HHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence            456789999999999999999999999999999999875432    3457789999999999999999999999999999


Q ss_pred             EEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeec--CCCcEEEeeccceeeccCC
Q 045787           84 VFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL--KRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        84 v~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~--~~~~v~l~d~g~~~~~~~~  160 (324)
                      ||||+. |+|.+.+.. .+.+++..++.++.+++.||.|||+.|++|+||||+||+++.  .++.++|+|||.+......
T Consensus       126 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  204 (349)
T 2w4o_A          126 VLELVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ  204 (349)
T ss_dssp             EECCCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred             EEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence            999997 588887766 456999999999999999999999999999999999999972  3789999999998765432


Q ss_pred             CCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcc
Q 045787          161 QKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEI  240 (324)
Q Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (324)
                       .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||...................             
T Consensus       205 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~-------------  269 (349)
T 2w4o_A          205 -VLMKTVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYY-------------  269 (349)
T ss_dssp             ---------CGGGSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCC-------------
T ss_pred             -cccccccCCCCccCHHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCc-------------
Confidence             22334578999999999987 668999999999999999999999997666443211111111000             


Q ss_pred             cCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchh
Q 045787          241 LPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~  298 (324)
                                .....+..++..+.++|.+||+.||.+|||+.++++||||++......
T Consensus       270 ----------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~~  317 (349)
T 2w4o_A          270 ----------FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFV  317 (349)
T ss_dssp             ----------CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCCCS
T ss_pred             ----------cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCccchh
Confidence                      001123468899999999999999999999999999999998775443

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.5e-48  Score=358.78  Aligned_cols=265  Identities=25%  Similarity=0.352  Sum_probs=223.3

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF   82 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   82 (324)
                      +..++|++.+.||+|+||.||+|+++.+|+.||+|++..... .......+.+|+.++++++||+|+++++++.+...+|
T Consensus       182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  261 (543)
T 3c4z_A          182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC  261 (543)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence            456899999999999999999999999999999999976542 2334567889999999999999999999999999999


Q ss_pred             EEEEecC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeecc
Q 045787           83 LVFEYLD-LDLHSFITRHK---NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIG  158 (324)
Q Consensus        83 iv~e~~~-g~l~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~  158 (324)
                      +||||++ |+|..++....   ..+++..++.++.+|+.||.|||++|++|+||||+||+++ .++.++|+|||.+....
T Consensus       262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~-~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLD-DDGNVRISDLGLAVELK  340 (543)
T ss_dssp             EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC-TTSCEEECCCTTCEECC
T ss_pred             EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEe-CCCCEEEeecceeeecc
Confidence            9999998 58888776543   3699999999999999999999999999999999999999 89999999999998776


Q ss_pred             CCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh----hHHHHHHHHcCCCCcccccch
Q 045787          159 VPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH----DHLSLIFSLLGTPTDESWAES  234 (324)
Q Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~  234 (324)
                      .........+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.....    ..+...... ...        
T Consensus       341 ~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~-~~~--------  410 (543)
T 3c4z_A          341 AGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE-QAV--------  410 (543)
T ss_dssp             TTCCCBCCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH-CCC--------
T ss_pred             CCCcccccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh-ccc--------
Confidence            44444445589999999999987 6789999999999999999999999976542    112111110 000        


Q ss_pred             hhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCC-----HHHHhcCccccCCCCchh
Q 045787          235 TYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRIT-----AMDALKHEYLIGVENVPL  298 (324)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~~~l~hp~~~~~~~~~~  298 (324)
                                         .....+++.+.++|.+||+.||.+||+     ++++++||||+++.+..+
T Consensus       411 -------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l  460 (543)
T 3c4z_A          411 -------------------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQL  460 (543)
T ss_dssp             -------------------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHHH
T ss_pred             -------------------CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHHH
Confidence                               011367899999999999999999995     589999999999987655

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=5.6e-49  Score=344.59  Aligned_cols=287  Identities=26%  Similarity=0.436  Sum_probs=222.7

Q ss_pred             CcccCcCcceeEeecccCceEEEEEEE-ccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCC------CeeEEEee
Q 045787            2 GKLKNLNYKKIKKIGAGGYGEVYKCRN-TVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHE------NIVRLLDV   74 (324)
Q Consensus         2 ~~~~~~~y~i~~~Lg~g~~~~v~~a~~-~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~------~i~~~~~~   74 (324)
                      |++..++|++.+.||+|++|.||+|.+ ..+++.||+|++.....   ..+.+.+|+.+++.++|+      ++++++++
T Consensus         9 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~   85 (339)
T 1z57_A            9 GDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDR---YCEAARSEIQVLEHLNTTDPNSTFRCVQMLEW   85 (339)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHH---HHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEE
T ss_pred             CCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHHhhhcCCCCceeeEeeecc
Confidence            778899999999999999999999998 56789999999874432   235678899999988754      59999999


Q ss_pred             eecCCeEEEEEEecCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecC-----------
Q 045787           75 QSSRKDVFLVFEYLDLDLHSFITRHKN-TLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK-----------  142 (324)
Q Consensus        75 ~~~~~~~~iv~e~~~g~l~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~-----------  142 (324)
                      +...+..++||||++++|.+++..... ++++..++.++.|++.||.+||++|++|+||||+||+++..           
T Consensus        86 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~  165 (339)
T 1z57_A           86 FEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIK  165 (339)
T ss_dssp             EEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred             cccCCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccc
Confidence            999999999999999999999887653 68999999999999999999999999999999999999822           


Q ss_pred             -------CCcEEEeeccceeeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhH
Q 045787          143 -------RNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDH  215 (324)
Q Consensus       143 -------~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~  215 (324)
                             ++.++|+|||.+.....   ......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||...+...
T Consensus       166 ~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  241 (339)
T 1z57_A          166 RDERTLINPDIKVVDFGSATYDDE---HHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE  241 (339)
T ss_dssp             CEEEEESCCCEEECCCSSCEETTS---CCCSSCSCGGGCCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred             cccccccCCCceEeeCcccccCcc---ccccccCCccccChHHhhC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence                   56799999999987542   2344578899999999987 678999999999999999999999998877443


Q ss_pred             -HHHHHHHcCCCCcccccchhhhhcccCCCCCCC---------------CcchhhhCCCCChhHHHHHHHhhcCCCCCCC
Q 045787          216 -LSLIFSLLGTPTDESWAESTYISEILPLYPHFE---------------PANLAEKFPNLEPAGVDLLSQMLCLNPKQRI  279 (324)
Q Consensus       216 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp  279 (324)
                       ...+....+..+...+...............+.               ...........++.+.+||.+||+.||.+||
T Consensus       242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  321 (339)
T 1z57_A          242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI  321 (339)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence             344444445444322211110000000000000               0000011122356789999999999999999


Q ss_pred             CHHHHhcCccccCCCC
Q 045787          280 TAMDALKHEYLIGVEN  295 (324)
Q Consensus       280 s~~~~l~hp~~~~~~~  295 (324)
                      |+.++++||||++++.
T Consensus       322 t~~ell~hp~f~~~~~  337 (339)
T 1z57_A          322 TLREALKHPFFDLLKK  337 (339)
T ss_dssp             CHHHHTTSGGGGGGGC
T ss_pred             CHHHHhcCHHHHHHhc
Confidence            9999999999998765

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=3.5e-49  Score=349.97  Aligned_cols=263  Identities=29%  Similarity=0.426  Sum_probs=214.1

Q ss_pred             cCcce--eEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 045787            7 LNYKK--IKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLV   84 (324)
Q Consensus         7 ~~y~i--~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   84 (324)
                      ..|++  .+.||+|+||.||+|.+..+|+.||+|++......  ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  164 (373)
T 2x4f_A           87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK--DKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV  164 (373)
T ss_dssp             GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHH--HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccc--cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            34555  67899999999999999999999999998765422  246788999999999999999999999999999999


Q ss_pred             EEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeec-CCCcEEEeeccceeeccCCCC
Q 045787           85 FEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL-KRNTVKLADFGLARAIGVPQK  162 (324)
Q Consensus        85 ~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~-~~~~v~l~d~g~~~~~~~~~~  162 (324)
                      |||++ ++|.+.+......+++..++.++.+|+.||.|||+.|++|+||||+||++.. .++.++|+|||.+...... .
T Consensus       165 ~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~-~  243 (373)
T 2x4f_A          165 MEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR-E  243 (373)
T ss_dssp             EECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT-C
T ss_pred             EeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc-c
Confidence            99997 5888888876667999999999999999999999999999999999999942 5679999999999876533 3


Q ss_pred             cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccC
Q 045787          163 EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILP  242 (324)
Q Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (324)
                      ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.......               
T Consensus       244 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~---------------  307 (373)
T 2x4f_A          244 KLKVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDL---------------  307 (373)
T ss_dssp             BCCCCCSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCS---------------
T ss_pred             ccccccCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC---------------
Confidence            3344578999999999977 667999999999999999999999998877554333222111100               


Q ss_pred             CCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCch
Q 045787          243 LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP  297 (324)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~  297 (324)
                               ....+..+++++.+||.+||+.||.+|||+.++++||||++.+...
T Consensus       308 ---------~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~~~~  353 (373)
T 2x4f_A          308 ---------EDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHS  353 (373)
T ss_dssp             ---------CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHHHHH
T ss_pred             ---------ChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCchhh
Confidence                     0112346899999999999999999999999999999999876443

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.1e-50  Score=348.89  Aligned_cols=267  Identities=22%  Similarity=0.266  Sum_probs=189.1

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCC----eE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK----DV   81 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~   81 (324)
                      ..+|.+.+.||+|+||+||+|..  +|+.||+|++......   ......|+..+.+++||||+++++++.+++    .+
T Consensus         2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~---~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~   76 (303)
T 3hmm_A            2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHH---HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh---hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence            46799999999999999999986  5889999998654322   122334555667889999999999987653    58


Q ss_pred             EEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCcccCCCCCceEeecCCCcEEEeecc
Q 045787           82 FLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSL--------KILHRDLKPNNLLIDLKRNTVKLADFG  152 (324)
Q Consensus        82 ~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~--------g~~H~di~p~nIll~~~~~~v~l~d~g  152 (324)
                      |+||||++ |+|.+++..  .+++++.+..++.+++.||.|||++        |++||||||+|||++ .++.+||+|||
T Consensus        77 ~lV~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~-~~~~~Ki~DFG  153 (303)
T 3hmm_A           77 WLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLG  153 (303)
T ss_dssp             EEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEEC-TTSCEEECCCT
T ss_pred             EEEecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEEC-CCCCEEEEeCC
Confidence            99999998 689988876  3589999999999999999999987        899999999999999 99999999999


Q ss_pred             ceeeccCCCCc----ccccccccccCCchhhcCCC-----CCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHc
Q 045787          153 LARAIGVPQKE----YSRDCVYSPYKAPELLLGYT-----GYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLL  223 (324)
Q Consensus       153 ~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~  223 (324)
                      ++.........    ....+||+.|+|||++.+..     .++.++|||||||++|||+||..||...........    
T Consensus       154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~----  229 (303)
T 3hmm_A          154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY----  229 (303)
T ss_dssp             TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT----
T ss_pred             CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccch----
Confidence            99876543322    22347999999999997632     357799999999999999999887754332110000    


Q ss_pred             CCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          224 GTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      +..+ ..................+.... .......+..+.+|+.+||+.||.+|||+.++++
T Consensus       230 ~~~~-~~~~~~~~~~~~~~~~~rp~~p~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~  290 (303)
T 3hmm_A          230 DLVP-SDPSVEEMRKVVCEQKLRPNIPN-RWQSCEALRVMAKIMRECWYANGAARLTALRIKK  290 (303)
T ss_dssp             TTSC-SSCCHHHHHHHHTTSCCCCCCCG-GGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred             hccc-ccchHHHHHHHHhcccCCCCCCc-cccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence            0000 00000000000000000000000 0001123456889999999999999999999986

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1e-49  Score=347.39  Aligned_cols=261  Identities=27%  Similarity=0.472  Sum_probs=193.7

Q ss_pred             cCccee---EeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcC-CCCeeEEEeeeecCCeEE
Q 045787            7 LNYKKI---KKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-HENIVRLLDVQSSRKDVF   82 (324)
Q Consensus         7 ~~y~i~---~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~   82 (324)
                      ++|++.   +.||+|+||.||+|.+..+++.||+|++....     ...+.+|+.+++.+. ||||+++++++.++...|
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~   82 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM-----EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTF   82 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG-----HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh-----hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEE
Confidence            456665   78999999999999999999999999986432     345778999999997 999999999999999999


Q ss_pred             EEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCC---cEEEeeccceeecc
Q 045787           83 LVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN---TVKLADFGLARAIG  158 (324)
Q Consensus        83 iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~---~v~l~d~g~~~~~~  158 (324)
                      +||||++| +|.+++... ..+++..++.++.+++.||.|||++|++|+||||+||+++ .++   .++|+|||.+....
T Consensus        83 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~-~~~~~~~~kl~Dfg~a~~~~  160 (325)
T 3kn6_A           83 LVMELLNGGELFERIKKK-KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFT-DENDNLEIKIIDFGFARLKP  160 (325)
T ss_dssp             EEECCCCSCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEE-C----CEEEECCCTTCEECC
T ss_pred             EEEEccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEe-cCCCcccEEEeccccceecC
Confidence            99999975 888887764 5799999999999999999999999999999999999998 444   89999999998776


Q ss_pred             CCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhH----HHHHHHHcCCCCcccccch
Q 045787          159 VPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDH----LSLIFSLLGTPTDESWAES  234 (324)
Q Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~  234 (324)
                      .........++|+.|+|||++.+ ..++.++||||||+++|+|++|..||...+...    ...........        
T Consensus       161 ~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~--------  231 (325)
T 3kn6_A          161 PDNQPLKTPCFTLHYAAPELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG--------  231 (325)
T ss_dssp             C-----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT--------
T ss_pred             CCCCcccccCCCcCccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC--------
Confidence            55555556678999999999987 678999999999999999999999997654210    01111110000        


Q ss_pred             hhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCc
Q 045787          235 TYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENV  296 (324)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~  296 (324)
                                   ........+..+++++.+||.+||+.||.+|||+.++++||||++....
T Consensus       232 -------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~  280 (325)
T 3kn6_A          232 -------------DFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQL  280 (325)
T ss_dssp             -------------CCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCC
T ss_pred             -------------CCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccC
Confidence                         0001112223689999999999999999999999999999999987543

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.1e-48  Score=360.76  Aligned_cols=266  Identities=25%  Similarity=0.433  Sum_probs=223.4

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeecc-ccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeE
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQT-EQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV   81 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   81 (324)
                      .+..++|++.+.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.++||||+++++++.+.+.+
T Consensus       180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l  259 (576)
T 2acx_A          180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL  259 (576)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEE
Confidence            356788999999999999999999999999999999997654 2233456688999999999999999999999999999


Q ss_pred             EEEEEecC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccC
Q 045787           82 FLVFEYLD-LDLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGV  159 (324)
Q Consensus        82 ~iv~e~~~-g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~  159 (324)
                      |+||||++ |+|.+.+.... ..+++..++.++.+|+.||.|||++|++|+||||+||+++ .++.++|+|||.+.....
T Consensus       260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld-~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLD-DHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC-TTSCEEECCCTTCEECCT
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEe-CCCCeEEEecccceeccc
Confidence            99999997 58888776643 3499999999999999999999999999999999999999 899999999999987653


Q ss_pred             CCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh----hHHHHHHHHcCCCCcccccchh
Q 045787          160 PQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH----DHLSLIFSLLGTPTDESWAEST  235 (324)
Q Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~  235 (324)
                      . ......+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.....    ..+.......  +.        
T Consensus       339 ~-~~~~~~~GT~~Y~APEvl~~-~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~--~~--------  406 (576)
T 2acx_A          339 G-QTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV--PE--------  406 (576)
T ss_dssp             T-CCEECCCSCGGGCCHHHHTT-CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC--CC--------
T ss_pred             C-ccccccCCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc--cc--------
Confidence            2 23334579999999999987 6689999999999999999999999977542    2222211110  00        


Q ss_pred             hhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCC-----CHHHHhcCccccCCCCchhh
Q 045787          236 YISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRI-----TAMDALKHEYLIGVENVPLV  299 (324)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~~l~hp~~~~~~~~~~~  299 (324)
                                        .....+++++.+||.+||+.||.+||     +++++++||||+++++..+.
T Consensus       407 ------------------~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l~  457 (576)
T 2acx_A          407 ------------------EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLG  457 (576)
T ss_dssp             ------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHHH
T ss_pred             ------------------cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHHHh
Confidence                              01135789999999999999999999     89999999999999876553

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=3e-48  Score=333.70  Aligned_cols=262  Identities=26%  Similarity=0.404  Sum_probs=221.4

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeecccc-CCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQ-EGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF   82 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   82 (324)
                      ...++|++.+.||+|++|.||+|.+..+++.+++|++...... ....+.+.+|+.+++.++||||+++++++.+++..+
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (294)
T 2rku_A           12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF   91 (294)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence            4678999999999999999999999999999999998765422 223456888999999999999999999999999999


Q ss_pred             EEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC
Q 045787           83 LVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        83 iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~  161 (324)
                      +|+||+++ +|.+++.. ...+++..++.++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+.......
T Consensus        92 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~-~~~~~kl~dfg~~~~~~~~~  169 (294)
T 2rku_A           92 VVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDG  169 (294)
T ss_dssp             EEEECCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC-TTCCEEECCCTTCEECCSTT
T ss_pred             EEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEc-CCCCEEEEeccCceecccCc
Confidence            99999985 77776655 45699999999999999999999999999999999999999 89999999999998776544


Q ss_pred             CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhccc
Q 045787          162 KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEIL  241 (324)
Q Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (324)
                      .......+++.|+|||++.+ ..++.++|+||||+++|+|++|..||.................                
T Consensus       170 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~----------------  232 (294)
T 2rku_A          170 ERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY----------------  232 (294)
T ss_dssp             CCBCCCCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC----------------
T ss_pred             cccccccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccC----------------
Confidence            45555678999999999987 6679999999999999999999999987765433222211000                


Q ss_pred             CCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCc
Q 045787          242 PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENV  296 (324)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~  296 (324)
                                  .....++..+.++|.+||+.||.+|||++++++||||.+...+
T Consensus       233 ------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~  275 (294)
T 2rku_A          233 ------------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP  275 (294)
T ss_dssp             ------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred             ------------CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcC
Confidence                        0112578899999999999999999999999999999876543

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=5.8e-49  Score=360.76  Aligned_cols=265  Identities=31%  Similarity=0.518  Sum_probs=222.9

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeE
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV   81 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   81 (324)
                      ....++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.++++++||||+++++++.+.+..
T Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  101 (484)
T 3nyv_A           22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYF  101 (484)
T ss_dssp             CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            3456789999999999999999999999999999999976543 234457789999999999999999999999999999


Q ss_pred             EEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeec--CCCcEEEeeccceeecc
Q 045787           82 FLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL--KRNTVKLADFGLARAIG  158 (324)
Q Consensus        82 ~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~--~~~~v~l~d~g~~~~~~  158 (324)
                      |+|+||+. |+|.+.+... ..+++..++.++.+++.||.|||++|++|+||||+||+++.  .++.++|+|||.+....
T Consensus       102 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  180 (484)
T 3nyv_A          102 YLVGEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE  180 (484)
T ss_dssp             EEEECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred             EEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence            99999997 5888877664 56999999999999999999999999999999999999952  56899999999987665


Q ss_pred             CCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhh
Q 045787          159 VPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYIS  238 (324)
Q Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (324)
                      .. .......+|+.|+|||++.+  .++.++||||||+++|+|++|.+||.+.+................          
T Consensus       181 ~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----------  247 (484)
T 3nyv_A          181 AS-KKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFE----------  247 (484)
T ss_dssp             CC-CSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----------
T ss_pred             cc-cccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC----------
Confidence            33 33344578999999999976  579999999999999999999999988876555444332211110          


Q ss_pred             cccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCC
Q 045787          239 EILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVEN  295 (324)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~  295 (324)
                                    ...+..+++.+.+||.+||+.||.+|||+.++++||||+....
T Consensus       248 --------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~  290 (484)
T 3nyv_A          248 --------------LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK  290 (484)
T ss_dssp             --------------SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred             --------------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence                          0112357899999999999999999999999999999987654

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=8.7e-49  Score=335.13  Aligned_cols=265  Identities=28%  Similarity=0.466  Sum_probs=218.6

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccC----CCchHHHHHHHHHHhcCCCCeeEEEeeeecCC
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQE----GVPSYIIREVSLLKELEHENIVRLLDVQSSRK   79 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   79 (324)
                      ++.++|++.+.||+|++|.||+|.+..+++.+|+|++.......    ...+.+.+|+.++++++||||+++++++.+..
T Consensus         2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   81 (283)
T 3bhy_A            2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT   81 (283)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             chhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCC
Confidence            56688999999999999999999999999999999997654322    13567899999999999999999999999999


Q ss_pred             eEEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCC----cEEEeeccce
Q 045787           80 DVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN----TVKLADFGLA  154 (324)
Q Consensus        80 ~~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~----~v~l~d~g~~  154 (324)
                      ..++|+||++ ++|.+++... ..+++..++.++.+++.||.+||+.|++|+||+|+||+++ .++    .++|+|||.+
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~-~~~~~~~~~kl~dfg~~  159 (283)
T 3bhy_A           82 DVVLILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLL-DKNVPNPRIKLIDFGIA  159 (283)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEES-CSSSSSCCEEECCCTTC
T ss_pred             eEEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEe-cCCCCCCceEEEecccc
Confidence            9999999997 5888887663 5699999999999999999999999999999999999998 555    8999999999


Q ss_pred             eeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccch
Q 045787          155 RAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAES  234 (324)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (324)
                      ...... .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||..................        
T Consensus       160 ~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------  229 (283)
T 3bhy_A          160 HKIEAG-NEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYD--------  229 (283)
T ss_dssp             EECC---------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC--------
T ss_pred             eeccCC-CcccccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccC--------
Confidence            876532 22334568899999999987 66899999999999999999999999877755443332211110        


Q ss_pred             hhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCc
Q 045787          235 TYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENV  296 (324)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~  296 (324)
                                      ........++..+.++|.+||..||.+|||+.++++||||+.++..
T Consensus       230 ----------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~  275 (283)
T 3bhy_A          230 ----------------FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR  275 (283)
T ss_dssp             ----------------CCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred             ----------------CcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence                            1112234678999999999999999999999999999999987543

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.8e-48  Score=336.61  Aligned_cols=261  Identities=26%  Similarity=0.429  Sum_probs=216.6

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   83 (324)
                      ...++|++.+.||+|++|.||+|.+..+|+.||+|++.......  ...+.+|+.++++++||||+++++++.+.+..++
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (304)
T 2jam_A            6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR--DSSLENEIAVLKKIKHENIVTLEDIYESTTHYYL   83 (304)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccc--hHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEE
Confidence            45678999999999999999999999999999999998554322  3568899999999999999999999999999999


Q ss_pred             EEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEe---ecCCCcEEEeeccceeeccC
Q 045787           84 VFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLI---DLKRNTVKLADFGLARAIGV  159 (324)
Q Consensus        84 v~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll---~~~~~~v~l~d~g~~~~~~~  159 (324)
                      |+||++ ++|.+.+... +.+++..++.++.+++.||.+||+.|++|+||+|+||++   + .++.++|+|||.+.....
T Consensus        84 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~-~~~~~kl~Dfg~~~~~~~  161 (304)
T 2jam_A           84 VMQLVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPE-ENSKIMITDFGLSKMEQN  161 (304)
T ss_dssp             EECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSS-TTCCEEBCSCSTTCCCCC
T ss_pred             EEEcCCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCC-CCCCEEEccCCcceecCC
Confidence            999997 5888887664 469999999999999999999999999999999999999   5 678999999999875432


Q ss_pred             CCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhc
Q 045787          160 PQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISE  239 (324)
Q Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
                        .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||...................            
T Consensus       162 --~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~------------  226 (304)
T 2jam_A          162 --GIMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEF------------  226 (304)
T ss_dssp             --BTTHHHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCC------------
T ss_pred             --CccccccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC------------
Confidence              22334468899999999987 678999999999999999999999998877554433332211100            


Q ss_pred             ccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCC
Q 045787          240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVEN  295 (324)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~  295 (324)
                                  .......+++.+.++|.+||..||.+|||+.++++||||++...
T Consensus       227 ------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  270 (304)
T 2jam_A          227 ------------ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTA  270 (304)
T ss_dssp             ------------CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSCS
T ss_pred             ------------CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCCc
Confidence                        01122368899999999999999999999999999999988653

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.9e-48  Score=368.76  Aligned_cols=264  Identities=21%  Similarity=0.335  Sum_probs=225.8

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeecc-ccCCCchHHHHHHHHHHhc-CCCCeeEEEeeeecCCeE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQT-EQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDV   81 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   81 (324)
                      +..++|++++.||+|+||.||+|.+..+++.||+|++.... ......+.+..|..++..+ +||+|+++++++.+.+.+
T Consensus       338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~  417 (674)
T 3pfq_A          338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL  417 (674)
T ss_dssp             --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred             ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence            34578999999999999999999999999999999998653 2334456788899999888 699999999999999999


Q ss_pred             EEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           82 FLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        82 ~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      |+||||++| +|..++... +.+++..++.++.+|+.||.|||++|++||||||+|||++ .++.++|+|||++......
T Consensus       418 ~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~-~~g~ikL~DFGla~~~~~~  495 (674)
T 3pfq_A          418 YFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD-SEGHIKIADFGMCKENIWD  495 (674)
T ss_dssp             EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEEC-SSSCEEECCCTTCEECCCT
T ss_pred             EEEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEc-CCCcEEEeecceeeccccC
Confidence            999999974 888777764 5699999999999999999999999999999999999999 8999999999999875544


Q ss_pred             CCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcc
Q 045787          161 QKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEI  240 (324)
Q Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (324)
                      .......+||+.|+|||++.+ ..++.++|+||||+++|+|++|..||.+.+...+...+.....               
T Consensus       496 ~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~---------------  559 (674)
T 3pfq_A          496 GVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV---------------  559 (674)
T ss_dssp             TCCBCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCC---------------
T ss_pred             CcccccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC---------------
Confidence            455566789999999999987 6789999999999999999999999988776555443321110               


Q ss_pred             cCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCH-----HHHhcCccccCCCCchh
Q 045787          241 LPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITA-----MDALKHEYLIGVENVPL  298 (324)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~~~l~hp~~~~~~~~~~  298 (324)
                                   .....+++++.+||++||+.||.+||++     +++++||||+++++..+
T Consensus       560 -------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l  609 (674)
T 3pfq_A          560 -------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL  609 (674)
T ss_dssp             -------------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHH
T ss_pred             -------------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHH
Confidence                         0113588999999999999999999997     99999999999987665

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.9e-48  Score=357.56  Aligned_cols=264  Identities=30%  Similarity=0.478  Sum_probs=219.2

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeecccc-----------CCCchHHHHHHHHHHhcCCCCeeEEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQ-----------EGVPSYIIREVSLLKELEHENIVRLL   72 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~-----------~~~~~~~~~e~~~l~~l~~~~i~~~~   72 (324)
                      .+.++|++++.||+|+||+||+|.+..+++.+|+|++......           ....+.+.+|+.++++++||||++++
T Consensus        33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  112 (504)
T 3q5i_A           33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF  112 (504)
T ss_dssp             CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            3568999999999999999999999999999999999765422           13456788999999999999999999


Q ss_pred             eeeecCCeEEEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCC---cEEE
Q 045787           73 DVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN---TVKL  148 (324)
Q Consensus        73 ~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~---~v~l  148 (324)
                      +++.+....|+||||++| +|.+.+... ..+++..++.++.+|+.||.|||+.|++|+||||+||+++ .++   .++|
T Consensus       113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~-~~~~~~~~kl  190 (504)
T 3q5i_A          113 DVFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLE-NKNSLLNIKI  190 (504)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEES-STTCCSSEEE
T ss_pred             EEEEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEe-cCCCCccEEE
Confidence            999999999999999975 888887764 5699999999999999999999999999999999999998 444   6999


Q ss_pred             eeccceeeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCc
Q 045787          149 ADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTD  228 (324)
Q Consensus       149 ~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  228 (324)
                      +|||.+...... .......+|+.|+|||++.+  .++.++||||||+++|+|++|..||.+.+............... 
T Consensus       191 ~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~-  266 (504)
T 3q5i_A          191 VDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYF-  266 (504)
T ss_dssp             CCCTTCEECCTT-SCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-
T ss_pred             EECCCCEEcCCC-CccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC-
Confidence            999999876533 33445678999999999875  57999999999999999999999998887665544433221111 


Q ss_pred             ccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCc
Q 045787          229 ESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENV  296 (324)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~  296 (324)
                                             ....+..+++++.+||.+||+.||.+|||+.++++||||++....
T Consensus       267 -----------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~  311 (504)
T 3q5i_A          267 -----------------------DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANN  311 (504)
T ss_dssp             -----------------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCC
T ss_pred             -----------------------CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhc
Confidence                                   111234689999999999999999999999999999999876643

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.5e-49  Score=354.32  Aligned_cols=288  Identities=34%  Similarity=0.596  Sum_probs=215.1

Q ss_pred             cCcCccee-EeecccCceEEEEEEEc--cCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeee--cCC
Q 045787            5 KNLNYKKI-KKIGAGGYGEVYKCRNT--VTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQS--SRK   79 (324)
Q Consensus         5 ~~~~y~i~-~~Lg~g~~~~v~~a~~~--~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~   79 (324)
                      ..+.|++. ++||+|+||+||+|.+.  .+++.||+|++....    ....+.+|+.++++++||||+++++++.  ...
T Consensus        18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   93 (405)
T 3rgf_A           18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSHADR   93 (405)
T ss_dssp             HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS----CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred             hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC----CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence            34567774 47999999999999965  568899999986432    2356889999999999999999999984  467


Q ss_pred             eEEEEEEecCCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEee---cCCCcEEE
Q 045787           80 DVFLVFEYLDLDLHSFITRHK--------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLID---LKRNTVKL  148 (324)
Q Consensus        80 ~~~iv~e~~~g~l~~~~~~~~--------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~---~~~~~v~l  148 (324)
                      ..|+||||++|+|.+.+....        ..+++..++.++.+|+.||.|||+.|++|+||||+||++.   ..++.++|
T Consensus        94 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl  173 (405)
T 3rgf_A           94 KVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI  173 (405)
T ss_dssp             EEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred             eEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence            899999999999998886432        2499999999999999999999999999999999999993   26789999


Q ss_pred             eeccceeeccCCC---CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh----------hH
Q 045787          149 ADFGLARAIGVPQ---KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH----------DH  215 (324)
Q Consensus       149 ~d~g~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----------~~  215 (324)
                      +|||.+.......   ......++|+.|+|||++.+...++.++|||||||++|+|++|..||.....          +.
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  253 (405)
T 3rgf_A          174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ  253 (405)
T ss_dssp             CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred             EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence            9999998765322   2233457899999999998766689999999999999999999999976553          66


Q ss_pred             HHHHHHHcCCCCcccccchhhhhcccCCC--------CCCCC-cchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          216 LSLIFSLLGTPTDESWAESTYISEILPLY--------PHFEP-ANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      +..+....+.+....|.......+.....        ..... ..........+..+.+||.+||+.||.+|||++|+|+
T Consensus       254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  333 (405)
T ss_dssp             HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            77888888888877765533221111000        00000 0011112234788999999999999999999999999


Q ss_pred             CccccCCCCc
Q 045787          287 HEYLIGVENV  296 (324)
Q Consensus       287 hp~~~~~~~~  296 (324)
                      ||||++....
T Consensus       334 hp~f~~~~~~  343 (405)
T 3rgf_A          334 DPYFLEDPLP  343 (405)
T ss_dssp             SGGGTSSSCC
T ss_pred             ChhhccCCCC
Confidence            9999987654

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.9e-48  Score=346.89  Aligned_cols=287  Identities=30%  Similarity=0.469  Sum_probs=221.8

Q ss_pred             CcccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcC-CC-----CeeEEEeee
Q 045787            2 GKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-HE-----NIVRLLDVQ   75 (324)
Q Consensus         2 ~~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~~-----~i~~~~~~~   75 (324)
                      |+...++|++.+.||+|+||+||+|.+..+++.||+|++.....   ....+..|+.+++.++ |+     +++++++++
T Consensus        49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~  125 (382)
T 2vx3_A           49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKA---FLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF  125 (382)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHH---HHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred             CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHH---HHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence            44567899999999999999999999999999999999874322   1345677888888885 44     499999999


Q ss_pred             ecCCeEEEEEEecCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCCcccCCCCCceEeec-CCCcEEEeec
Q 045787           76 SSRKDVFLVFEYLDLDLHSFITRHK-NTLNLLVIKAILKQILLGLAYCH--SLKILHRDLKPNNLLIDL-KRNTVKLADF  151 (324)
Q Consensus        76 ~~~~~~~iv~e~~~g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh--~~g~~H~di~p~nIll~~-~~~~v~l~d~  151 (324)
                      ...+..|+||||++|+|.+++.... ..+++..++.++.+++.||.+||  +.|++|+||||+||+++. .++.++|+||
T Consensus       126 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DF  205 (382)
T 2vx3_A          126 MFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDF  205 (382)
T ss_dssp             EETTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred             ccCCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence            9999999999999999999998764 46999999999999999999999  579999999999999952 4678999999


Q ss_pred             cceeeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHHcCCCCccc
Q 045787          152 GLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDES  230 (324)
Q Consensus       152 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~  230 (324)
                      |.+.....   ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+. +.+..+....+.++...
T Consensus       206 G~a~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  281 (382)
T 2vx3_A          206 GSSCQLGQ---RIYQYIQSRFYRSPEVLLG-MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHI  281 (382)
T ss_dssp             TTCEETTC---CCCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             cCceeccc---ccccccCCccccChHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            99987643   2344578899999999988 6689999999999999999999999988774 44556666666666544


Q ss_pred             ccchhhhhcccCCCCC-----------------CCCcchhhhCC-----------C-------CChhHHHHHHHhhcCCC
Q 045787          231 WAESTYISEILPLYPH-----------------FEPANLAEKFP-----------N-------LEPAGVDLLSQMLCLNP  275 (324)
Q Consensus       231 ~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~-----------~-------~~~~l~~li~~~l~~dP  275 (324)
                      +...............                 ...........           .       .++++.+||.+||+.||
T Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP  361 (382)
T 2vx3_A          282 LDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDP  361 (382)
T ss_dssp             HTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCT
T ss_pred             HHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCCh
Confidence            3332221111111110                 00000000000           0       01378999999999999


Q ss_pred             CCCCCHHHHhcCccccCCCC
Q 045787          276 KQRITAMDALKHEYLIGVEN  295 (324)
Q Consensus       276 ~~Rps~~~~l~hp~~~~~~~  295 (324)
                      .+|||++|+|+||||++..+
T Consensus       362 ~~Rpta~e~L~hp~f~~~~~  381 (382)
T 2vx3_A          362 KTRIQPYYALQHSFFKKTAD  381 (382)
T ss_dssp             TTSCCHHHHTTSGGGCC---
T ss_pred             hhCCCHHHHhcCcccccCCC
Confidence            99999999999999998654

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3.9e-48  Score=339.01  Aligned_cols=262  Identities=26%  Similarity=0.408  Sum_probs=221.7

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF   82 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   82 (324)
                      ...++|++.+.||+|+||.||+|.+..+++.+++|++..... .....+.+.+|+.+++.++||||+++++++.+++..+
T Consensus        38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  117 (335)
T 2owb_A           38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF  117 (335)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence            356789999999999999999999999999999999876542 2223456888999999999999999999999999999


Q ss_pred             EEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC
Q 045787           83 LVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        83 iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~  161 (324)
                      +||||+++ +|.+++.. ...+++..++.++.+++.||.+||++|++|+||+|+||+++ .++.++|+|||.+.......
T Consensus       118 lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~  195 (335)
T 2owb_A          118 VVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDG  195 (335)
T ss_dssp             EEECCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC-TTCCEEECCCTTCEECCSTT
T ss_pred             EEEecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEc-CCCCEEEeeccCceecccCc
Confidence            99999985 77777665 45699999999999999999999999999999999999999 88999999999998776554


Q ss_pred             CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhccc
Q 045787          162 KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEIL  241 (324)
Q Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (324)
                      .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.................                
T Consensus       196 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~----------------  258 (335)
T 2owb_A          196 ERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY----------------  258 (335)
T ss_dssp             CCBCCCCSCCSSCCHHHHHT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC----------------
T ss_pred             ccccccCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCC----------------
Confidence            45555678999999999987 6679999999999999999999999987764443322221100                


Q ss_pred             CCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCc
Q 045787          242 PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENV  296 (324)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~  296 (324)
                                  .....++..+.++|.+||+.||.+|||++++++||||.+....
T Consensus       259 ------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~  301 (335)
T 2owb_A          259 ------------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP  301 (335)
T ss_dssp             ------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred             ------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCcc
Confidence                        0112578899999999999999999999999999999987543

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=4.2e-48  Score=338.14  Aligned_cols=282  Identities=31%  Similarity=0.527  Sum_probs=214.2

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcC-CCCeeEEEeeeec--CCeE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-HENIVRLLDVQSS--RKDV   81 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~   81 (324)
                      ..++|++.+.||+|++|.||+|.+..+++.||+|++...     ..+.+.+|+.++++++ ||||+++++++.+  ....
T Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~  108 (330)
T 3nsz_A           34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  108 (330)
T ss_dssp             EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred             CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence            467899999999999999999999999999999998632     2466889999999997 9999999999987  6679


Q ss_pred             EEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           82 FLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        82 ~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      ++||||+++ ++.+.+.    .+++..++.++.+++.||.+||++|++|+||||+||+++.++..++|+|||.+......
T Consensus       109 ~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          109 ALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             EEEEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             EEEEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            999999985 6666553    38999999999999999999999999999999999999934448999999999876533


Q ss_pred             CCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC--hhHHHHHHHHcCCCCcccccc-----
Q 045787          161 QKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK--HDHLSLIFSLLGTPTDESWAE-----  233 (324)
Q Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~-----  233 (324)
                       .......+++.|+|||++.+...++.++||||||+++|+|++|..||....  .+.+..+....+.+....+..     
T Consensus       185 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  263 (330)
T 3nsz_A          185 -QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE  263 (330)
T ss_dssp             -CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred             -CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccc
Confidence             334455788889999999876778999999999999999999999995544  223333222222111100000     


Q ss_pred             -hhhhhcccCCCCCC--CCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCc
Q 045787          234 -STYISEILPLYPHF--EPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENV  296 (324)
Q Consensus       234 -~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~  296 (324)
                       .....+........  ...........+++++.+||.+||+.||.+|||++++++||||+++.+.
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~  329 (330)
T 3nsz_A          264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD  329 (330)
T ss_dssp             CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC--
T ss_pred             cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhccC
Confidence             00000000000000  0000111122378999999999999999999999999999999998754

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2.3e-48  Score=331.25  Aligned_cols=270  Identities=27%  Similarity=0.442  Sum_probs=218.4

Q ss_pred             CCcccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCe
Q 045787            1 MGKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKD   80 (324)
Q Consensus         1 ~~~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   80 (324)
                      |+.-..++|++.+.||+|++|.||+|.+..+++.||+|++..... ....+.+.+|+.+++.++|||++++++++.+++.
T Consensus         1 M~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (276)
T 2yex_A            1 MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNI   79 (276)
T ss_dssp             -CHHHHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             CCCceecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCE
Confidence            445556789999999999999999999999999999999875543 2334678899999999999999999999999999


Q ss_pred             EEEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccC
Q 045787           81 VFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGV  159 (324)
Q Consensus        81 ~~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~  159 (324)
                      .++|+||+++ +|.+++.. ...+++..++.++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+.....
T Consensus        80 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~-~~~~~kl~dfg~~~~~~~  157 (276)
T 2yex_A           80 QYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRY  157 (276)
T ss_dssp             EEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-TTCCEEECCCTTCEECEE
T ss_pred             EEEEEEecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEc-cCCCEEEeeCCCccccCC
Confidence            9999999985 88877654 34699999999999999999999999999999999999999 889999999999876542


Q ss_pred             CC--CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhh
Q 045787          160 PQ--KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYI  237 (324)
Q Consensus       160 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (324)
                      ..  .......+++.|+|||++.+....+.++||||||+++|+|++|..||..................           
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------  226 (276)
T 2yex_A          158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT-----------  226 (276)
T ss_dssp             TTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCT-----------
T ss_pred             CcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccc-----------
Confidence            22  12334568889999999987454578999999999999999999999765533211110000000           


Q ss_pred             hcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchh
Q 045787          238 SEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~  298 (324)
                                    .......++..+.++|.+||+.||.+|||+.++++||||++......
T Consensus       227 --------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~  273 (276)
T 2yex_A          227 --------------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGA  273 (276)
T ss_dssp             --------------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC---
T ss_pred             --------------ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChhhccC
Confidence                          00012357889999999999999999999999999999998765543

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2e-48  Score=343.27  Aligned_cols=289  Identities=24%  Similarity=0.424  Sum_probs=223.8

Q ss_pred             CCcccCcCcceeEeecccCceEEEEEEEccCC-ceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCC------eeEEEe
Q 045787            1 MGKLKNLNYKKIKKIGAGGYGEVYKCRNTVTG-QKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN------IVRLLD   73 (324)
Q Consensus         1 ~~~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~-~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~------i~~~~~   73 (324)
                      +|+.+.++|++++.||+|++|.||+|.+..++ ..||+|++.....   ..+.+.+|+.++++++|++      ++.+++
T Consensus        13 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~   89 (355)
T 2eu9_A           13 IGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGK---YREAARLEINVLKKIKEKDKENKFLCVLMSD   89 (355)
T ss_dssp             TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHH---HHHHHHHHHHHHHHHHHHCTTSCSCBCCEEE
T ss_pred             cCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccccc---chhHHHHHHHHHHHHhhcCCCCceeEEEeee
Confidence            47888999999999999999999999998776 6899999875332   2356778999999987654      899999


Q ss_pred             eeecCCeEEEEEEecCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEee------------
Q 045787           74 VQSSRKDVFLVFEYLDLDLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLID------------  140 (324)
Q Consensus        74 ~~~~~~~~~iv~e~~~g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~------------  140 (324)
                      ++...+..++||||+++++++.+.... .++++..++.++.||+.||.+||++|++|+||||+||+++            
T Consensus        90 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~  169 (355)
T 2eu9_A           90 WFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHK  169 (355)
T ss_dssp             EEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred             eeeeCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccc
Confidence            999999999999999999999888765 4699999999999999999999999999999999999993            


Q ss_pred             ------cCCCcEEEeeccceeeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChh
Q 045787          141 ------LKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD  214 (324)
Q Consensus       141 ------~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~  214 (324)
                            ..++.++|+|||.+.....   ......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||......
T Consensus       170 ~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  245 (355)
T 2eu9_A          170 SCEEKSVKNTSIRVADFGSATFDHE---HHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENR  245 (355)
T ss_dssp             CCCEEEESCCCEEECCCTTCEETTS---CCCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccCCCcEEEeecCccccccc---cccCCcCCCcccCCeeeec-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence                  1678999999999986542   2344578999999999987 67899999999999999999999999887744


Q ss_pred             -HHHHHHHHcCCCCcccccchhhhhcccCCCCCCCC---------------cchhhhCCCCChhHHHHHHHhhcCCCCCC
Q 045787          215 -HLSLIFSLLGTPTDESWAESTYISEILPLYPHFEP---------------ANLAEKFPNLEPAGVDLLSQMLCLNPKQR  278 (324)
Q Consensus       215 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~l~~li~~~l~~dP~~R  278 (324)
                       ....+....+..+...+...............+..               ..........+.++.+||.+||+.||.+|
T Consensus       246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  325 (355)
T 2eu9_A          246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR  325 (355)
T ss_dssp             HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence             34444555555544322111100000000000000               00000011234578899999999999999


Q ss_pred             CCHHHHhcCccccCCCCc
Q 045787          279 ITAMDALKHEYLIGVENV  296 (324)
Q Consensus       279 ps~~~~l~hp~~~~~~~~  296 (324)
                      ||++++++||||+++...
T Consensus       326 pt~~e~l~hp~f~~~~~~  343 (355)
T 2eu9_A          326 ITLAEALLHPFFAGLTPE  343 (355)
T ss_dssp             CCHHHHTTSGGGGGCCHH
T ss_pred             cCHHHHhcChhhcCCChh
Confidence            999999999999998653

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.7e-48  Score=341.10  Aligned_cols=263  Identities=27%  Similarity=0.410  Sum_probs=209.7

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCC--CCeeEEEeeeecCCe
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEH--ENIVRLLDVQSSRKD   80 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~   80 (324)
                      .+.+++|++++.||+|+||.||+|.+. +++.||+|++..........+.+.+|+.++++++|  |+|+++++++.++..
T Consensus         5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~   83 (343)
T 3dbq_A            5 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY   83 (343)
T ss_dssp             ESSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             eeecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence            356889999999999999999999985 58899999998665443334678899999999986  999999999999999


Q ss_pred             EEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           81 VFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        81 ~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      .++|||+.+++|.+++... ..+++..++.++.+++.||.|||+.|++|+||||+||+++  ++.++|+|||.+......
T Consensus        84 ~~lv~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~--~~~~kl~DFG~a~~~~~~  160 (343)
T 3dbq_A           84 IYMVMECGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPD  160 (343)
T ss_dssp             EEEEECCCSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE--TTEEEECCCSSSCCC---
T ss_pred             EEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE--CCcEEEeecccccccCcc
Confidence            9999998888999998874 5699999999999999999999999999999999999998  578999999999766433


Q ss_pred             CC--cccccccccccCCchhhcC----------CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCc
Q 045787          161 QK--EYSRDCVYSPYKAPELLLG----------YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTD  228 (324)
Q Consensus       161 ~~--~~~~~~~~~~y~aPE~~~~----------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  228 (324)
                      ..  ......||+.|+|||++.+          ...++.++||||||+++|+|++|..||........ ...........
T Consensus       161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~  239 (343)
T 3dbq_A          161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-KLHAIIDPNHE  239 (343)
T ss_dssp             ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-HHHHHHCTTSC
T ss_pred             cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH-HHHHHhcCCcc
Confidence            22  2234578999999999853          25678899999999999999999999976543221 11111111111


Q ss_pred             ccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCC
Q 045787          229 ESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVE  294 (324)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~  294 (324)
                      .                        ......+..+.++|.+||+.||.+|||+.++++||||+...
T Consensus       240 ~------------------------~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  281 (343)
T 3dbq_A          240 I------------------------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  281 (343)
T ss_dssp             C------------------------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             c------------------------CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence            0                        01124567899999999999999999999999999998643

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=3.2e-48  Score=336.83  Aligned_cols=281  Identities=26%  Similarity=0.422  Sum_probs=206.9

Q ss_pred             cccCcCccee-EeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhc-CCCCeeEEEeeeecCCe
Q 045787            3 KLKNLNYKKI-KKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKD   80 (324)
Q Consensus         3 ~~~~~~y~i~-~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~   80 (324)
                      ....++|++. +.||+|++|.||+|.+..+++.||+|++....  ......+.+|+.++.++ +||||+++++++.+++.
T Consensus         8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~   85 (316)
T 2ac3_A            8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDR   85 (316)
T ss_dssp             CCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             cccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence            4456789996 78999999999999999999999999987553  23356788999999985 79999999999999999


Q ss_pred             EEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCc---EEEeeccceee
Q 045787           81 VFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNT---VKLADFGLARA  156 (324)
Q Consensus        81 ~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~---v~l~d~g~~~~  156 (324)
                      .|+||||++ |+|.+++... ..+++..++.++.|++.||.+||++|++|+||||+||+++ .++.   ++|+|||.+..
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~-~~~~~~~~kl~Dfg~~~~  163 (316)
T 2ac3_A           86 FYLVFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCE-HPNQVSPVKICDFDLGSG  163 (316)
T ss_dssp             EEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEES-CSSSSCSEEECCTTCCC-
T ss_pred             EEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEc-cCCCcCceEEEEccCccc
Confidence            999999997 5888888764 4699999999999999999999999999999999999998 5544   99999999876


Q ss_pred             ccCCC-------CcccccccccccCCchhhcC----CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCC
Q 045787          157 IGVPQ-------KEYSRDCVYSPYKAPELLLG----YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGT  225 (324)
Q Consensus       157 ~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  225 (324)
                      .....       .......+++.|+|||++.+    ...++.++||||||+++|+|++|..||.........       .
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-------~  236 (316)
T 2ac3_A          164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCG-------W  236 (316)
T ss_dssp             ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSC-------C
T ss_pred             cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccc-------c
Confidence            53221       11223458899999999864    134688999999999999999999999765422100       0


Q ss_pred             CCccccc--chhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchh
Q 045787          226 PTDESWA--ESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       226 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~  298 (324)
                      .......  ............    .......+..++..+.+||.+||+.||.+|||+.++++||||++......
T Consensus       237 ~~~~~~~~~~~~~~~~i~~~~----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~~  307 (316)
T 2ac3_A          237 DRGEACPACQNMLFESIQEGK----YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENT  307 (316)
T ss_dssp             ----CCHHHHHHHHHHHHHCC----CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-------
T ss_pred             cccccchhHHHHHHHHHhccC----cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCCccc
Confidence            0000000  000000000000    00011123468899999999999999999999999999999998765543

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=4.1e-48  Score=331.18  Aligned_cols=260  Identities=26%  Similarity=0.470  Sum_probs=220.4

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeE
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV   81 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   81 (324)
                      .+..++|++.+.||+|++|.||+|.+..++..+|+|++..... .......+.+|+.++++++|||++++++++.+.+..
T Consensus        10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   89 (284)
T 2vgo_A           10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI   89 (284)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence            3556899999999999999999999999999999999976542 233456788999999999999999999999999999


Q ss_pred             EEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           82 FLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        82 ~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      ++|+||+++ +|.+++... +.+++..++.++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+......
T Consensus        90 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~-~~~~~kl~Dfg~~~~~~~~  167 (284)
T 2vgo_A           90 YLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMG-YKGELKIADFGWSVHAPSL  167 (284)
T ss_dssp             EEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEEC-TTCCEEECCCTTCEECSSS
T ss_pred             EEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEc-CCCCEEEecccccccCccc
Confidence            999999975 888888765 4699999999999999999999999999999999999999 8899999999998765432


Q ss_pred             CCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcc
Q 045787          161 QKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEI  240 (324)
Q Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (324)
                        ......+++.|+|||++.+ ..++.++|+||||+++|+|++|..||...+.............               
T Consensus       168 --~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~---------------  229 (284)
T 2vgo_A          168 --RRRTMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL---------------  229 (284)
T ss_dssp             --CBCCCCSCGGGCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC---------------
T ss_pred             --ccccccCCCCcCCHHHhcc-CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcccc---------------
Confidence              2334568899999999987 6679999999999999999999999987765443332221100               


Q ss_pred             cCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCC
Q 045787          241 LPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVEN  295 (324)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~  295 (324)
                                   .....++..+.++|.+||+.||.+||++.++++||||++...
T Consensus       230 -------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~  271 (284)
T 2vgo_A          230 -------------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR  271 (284)
T ss_dssp             -------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred             -------------CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence                         011357889999999999999999999999999999987654

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.9e-48  Score=333.64  Aligned_cols=259  Identities=25%  Similarity=0.351  Sum_probs=211.0

Q ss_pred             CcccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhc-CCCCeeEEEeeeecCCe
Q 045787            2 GKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKD   80 (324)
Q Consensus         2 ~~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~   80 (324)
                      .....++|++.+.||+|++|+||+|.+..+++.||+|++............+.+|+..+..+ +||||+++++++.+++.
T Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~   85 (289)
T 1x8b_A            6 KSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDH   85 (289)
T ss_dssp             CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTE
T ss_pred             cccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCe
Confidence            34456889999999999999999999999999999999987654444456788899999999 89999999999999999


Q ss_pred             EEEEEEecCC-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeec---------------
Q 045787           81 VFLVFEYLDL-DLHSFITRHK---NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL---------------  141 (324)
Q Consensus        81 ~~iv~e~~~g-~l~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~---------------  141 (324)
                      .++||||++| +|.+++....   ..+++..++.++.|++.||.+||++|++|+||||+||+++.               
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           86 MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----------------
T ss_pred             EEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence            9999999975 9998887642   56999999999999999999999999999999999999972               


Q ss_pred             ---CCCcEEEeeccceeeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 045787          142 ---KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSL  218 (324)
Q Consensus       142 ---~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~  218 (324)
                         ....++|+|||.+......    ....+++.|+|||++.+...++.++||||||+++|+|++|.+|+.....  ...
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--~~~  239 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ--WHE  239 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH--HHH
T ss_pred             ccCCceEEEEcccccccccCCc----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH--HHH
Confidence               2237999999999876532    2335889999999998755677899999999999999999877643321  111


Q ss_pred             HHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCC
Q 045787          219 IFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVE  294 (324)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~  294 (324)
                      +..  +                          ........+++.+.++|.+||+.||.+|||+.++++||||++..
T Consensus       240 ~~~--~--------------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  287 (289)
T 1x8b_A          240 IRQ--G--------------------------RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS  287 (289)
T ss_dssp             HHT--T--------------------------CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred             HHc--C--------------------------CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence            100  0                          00111236789999999999999999999999999999999764

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-47  Score=334.08  Aligned_cols=264  Identities=27%  Similarity=0.383  Sum_probs=212.3

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhc-CCCCeeEEEeeeec------
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSS------   77 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~------   77 (324)
                      ..++|++.+.||+|++|.||+|.+..+|+.||+|++.....   ..+.+.+|+.+++++ +||||+++++++..      
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   98 (326)
T 2x7f_A           22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   98 (326)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc---cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence            46799999999999999999999999999999999875433   246788999999999 79999999999876      


Q ss_pred             CCeEEEEEEecCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeecccee
Q 045787           78 RKDVFLVFEYLDL-DLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLAR  155 (324)
Q Consensus        78 ~~~~~iv~e~~~g-~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~  155 (324)
                      ....++||||+++ +|.+++.... ..+++..++.++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+.
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~-~~~~~kl~Dfg~~~  177 (326)
T 2x7f_A           99 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSA  177 (326)
T ss_dssp             CCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC-TTCCEEECCCTTTC
T ss_pred             cceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEc-CCCCEEEeeCcCce
Confidence            4689999999985 8998887653 4699999999999999999999999999999999999999 89999999999987


Q ss_pred             eccCCCCcccccccccccCCchhhcC----CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccc
Q 045787          156 AIGVPQKEYSRDCVYSPYKAPELLLG----YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESW  231 (324)
Q Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  231 (324)
                      .............+++.|+|||++..    ...++.++||||||+++|+|++|..||.................+..   
T Consensus       178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---  254 (326)
T 2x7f_A          178 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL---  254 (326)
T ss_dssp             -------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC---
T ss_pred             ecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccC---
Confidence            76543333445578899999999862    35678999999999999999999999987765443322221111100   


Q ss_pred             cchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchh
Q 045787          232 AESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~  298 (324)
                                             ....++..+.++|.+||..||.+||++.++++||||++.....-
T Consensus       255 -----------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~~~  298 (326)
T 2x7f_A          255 -----------------------KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQ  298 (326)
T ss_dssp             -----------------------SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTTHHH
T ss_pred             -----------------------CccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCccccc
Confidence                                   11357889999999999999999999999999999999876554

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2e-48  Score=342.19  Aligned_cols=266  Identities=28%  Similarity=0.388  Sum_probs=214.2

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc---cCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE---QEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF   82 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   82 (324)
                      .++|++.+.||+|++|.||+|.+..++..+|+|++.....   .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  104 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC  104 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence            4789999999999999999999999999999999976532   2334567889999999999999999999999999999


Q ss_pred             EEEEecC-CCHHHHHHhc---------------------------------------CCCCCHHHHHHHHHHHHHHHHHH
Q 045787           83 LVFEYLD-LDLHSFITRH---------------------------------------KNTLNLLVIKAILKQILLGLAYC  122 (324)
Q Consensus        83 iv~e~~~-g~l~~~~~~~---------------------------------------~~~~~~~~~~~i~~~i~~~l~~L  122 (324)
                      +||||++ |+|.+++...                                       ...+++..++.++.+++.||.+|
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L  184 (345)
T 3hko_A          105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL  184 (345)
T ss_dssp             EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence            9999997 5888776421                                       11246778899999999999999


Q ss_pred             HhCCCcccCCCCCceEeecCCC--cEEEeeccceeeccCCCC----cccccccccccCCchhhcC-CCCCCCchhhHHHH
Q 045787          123 HSLKILHRDLKPNNLLIDLKRN--TVKLADFGLARAIGVPQK----EYSRDCVYSPYKAPELLLG-YTGYSTPIDVWAVG  195 (324)
Q Consensus       123 h~~g~~H~di~p~nIll~~~~~--~v~l~d~g~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG  195 (324)
                      |+.|++|+||||+||+++ .++  .++|+|||.+........    ......+++.|+|||++.+ ...++.++||||||
T Consensus       185 H~~~ivH~Dlkp~NIll~-~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG  263 (345)
T 3hko_A          185 HNQGICHRDIKPENFLFS-TNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG  263 (345)
T ss_dssp             HHTTEECCCCCGGGEEES-CSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHH
T ss_pred             HHCCccccCCChhhEEEe-cCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHH
Confidence            999999999999999998 554  899999999987643222    2344578899999999864 36689999999999


Q ss_pred             HHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCC
Q 045787          196 CIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNP  275 (324)
Q Consensus       196 ~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP  275 (324)
                      +++|+|++|..||...+................                        ......+++.+.++|.+||+.||
T Consensus       264 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~li~~~l~~~p  319 (345)
T 3hko_A          264 VLLHLLLMGAVPFPGVNDADTISQVLNKKLCFE------------------------NPNYNVLSPLARDLLSNLLNRNV  319 (345)
T ss_dssp             HHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTT------------------------SGGGGGSCHHHHHHHHHHSCSCT
T ss_pred             HHHHHHHHCCCCCCCCChHHHHHHHHhcccccC------------------------CcccccCCHHHHHHHHHHcCCCh
Confidence            999999999999988775544333322111110                        01112478899999999999999


Q ss_pred             CCCCCHHHHhcCccccCCCCc
Q 045787          276 KQRITAMDALKHEYLIGVENV  296 (324)
Q Consensus       276 ~~Rps~~~~l~hp~~~~~~~~  296 (324)
                      .+||++.++++||||++..+.
T Consensus       320 ~~Rps~~~~l~hp~~~~~~~~  340 (345)
T 3hko_A          320 DERFDAMRALQHPWISQFSDK  340 (345)
T ss_dssp             TTSCCHHHHHHSHHHHTTSSC
T ss_pred             hHCCCHHHHhcChhhccChHh
Confidence            999999999999999988753

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.1e-47  Score=331.44  Aligned_cols=261  Identities=26%  Similarity=0.421  Sum_probs=221.8

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLV   84 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   84 (324)
                      ...+|++++.||+|++|.||+|.+..+++.||+|++...... ...+.+.+|+.++++++|||++++++++.++...++|
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   98 (303)
T 3a7i_A           20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII   98 (303)
T ss_dssp             GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence            457899999999999999999999999999999998765432 3357789999999999999999999999999999999


Q ss_pred             EEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCc
Q 045787           85 FEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE  163 (324)
Q Consensus        85 ~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~  163 (324)
                      |||++| +|.+++..  +++++..++.++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+.........
T Consensus        99 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~  175 (303)
T 3a7i_A           99 MEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIK  175 (303)
T ss_dssp             EECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC-TTSCEEECCCTTCEECBTTBCC
T ss_pred             EEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEEC-CCCCEEEeecccceecCccccc
Confidence            999986 77777654  5699999999999999999999999999999999999999 8899999999999877654444


Q ss_pred             ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCC
Q 045787          164 YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPL  243 (324)
Q Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (324)
                      .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||.................+                 
T Consensus       176 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------------  237 (303)
T 3a7i_A          176 RNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPP-----------------  237 (303)
T ss_dssp             BCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-----------------
T ss_pred             cCccCCCcCccCHHHHhc-CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCC-----------------
Confidence            455678899999999987 66789999999999999999999999877655443332211110                 


Q ss_pred             CCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCch
Q 045787          244 YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP  297 (324)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~  297 (324)
                                .....++..+.++|.+||+.||.+|||+.++++||||.......
T Consensus       238 ----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~  281 (303)
T 3a7i_A          238 ----------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKT  281 (303)
T ss_dssp             ----------CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHCCCG
T ss_pred             ----------CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCCCcc
Confidence                      01135788999999999999999999999999999997765443

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1e-48  Score=337.78  Aligned_cols=276  Identities=23%  Similarity=0.359  Sum_probs=196.8

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF   82 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   82 (324)
                      .+..++|++.+.||+|++|.||+|.+..+++.||+|.+...... ...+.+.+|+.++++++||||+++++++...+..+
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   89 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ-TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW   89 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred             ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc-hhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence            35678999999999999999999999889999999998755322 22456788999999999999999999999999999


Q ss_pred             EEEEecC-CCHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccce
Q 045787           83 LVFEYLD-LDLHSFITR-------HKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLA  154 (324)
Q Consensus        83 iv~e~~~-g~l~~~~~~-------~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~  154 (324)
                      +||||++ ++|.+++..       ....+++..++.++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+
T Consensus        90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~-~~~~~kl~dfg~~  168 (303)
T 2vwi_A           90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLG-EDGSVQIADFGVS  168 (303)
T ss_dssp             EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC-TTCCEEECCCHHH
T ss_pred             EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEc-CCCCEEEEeccch
Confidence            9999996 588888764       244699999999999999999999999999999999999999 8899999999988


Q ss_pred             eeccCCC-----CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcc
Q 045787          155 RAIGVPQ-----KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDE  229 (324)
Q Consensus       155 ~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  229 (324)
                      .......     .......+++.|+|||++.+...++.++||||||+++|+|++|..||.................+...
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  248 (303)
T 2vwi_A          169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE  248 (303)
T ss_dssp             HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTT
T ss_pred             heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccc
Confidence            6554221     11233468889999999876456799999999999999999999999877654433222211111100


Q ss_pred             cccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchh
Q 045787          230 SWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~  298 (324)
                                        ...........++..+.++|.+||+.||.+|||+.++++||||++.+....
T Consensus       249 ------------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~  299 (303)
T 2vwi_A          249 ------------------TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEF  299 (303)
T ss_dssp             ------------------C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC--------
T ss_pred             ------------------cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCCcc
Confidence                              001112233468899999999999999999999999999999998876543

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=3e-49  Score=345.43  Aligned_cols=257  Identities=25%  Similarity=0.408  Sum_probs=204.6

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCC-----
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK-----   79 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----   79 (324)
                      ..++|++++.||+|+||.||+|.+..+|+.||+|++.... .....+.+.+|+.++++++||||+++++++.+..     
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   82 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ   82 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence            3468999999999999999999999999999999997654 2333567899999999999999999999875433     


Q ss_pred             ----------------------------------------------------eEEEEEEecCC-CHHHHHHhcCC--CCC
Q 045787           80 ----------------------------------------------------DVFLVFEYLDL-DLHSFITRHKN--TLN  104 (324)
Q Consensus        80 ----------------------------------------------------~~~iv~e~~~g-~l~~~~~~~~~--~~~  104 (324)
                                                                          ..++||||++| +|.+++.....  ..+
T Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  162 (332)
T 3qd2_B           83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE  162 (332)
T ss_dssp             HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred             hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence                                                                38999999985 88888876543  356


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC------------Ccccccccccc
Q 045787          105 LLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ------------KEYSRDCVYSP  172 (324)
Q Consensus       105 ~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~------------~~~~~~~~~~~  172 (324)
                      +..++.++.|++.||.|||++|++|+||||+||+++ .++.++|+|||.+.......            .......+|+.
T Consensus       163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC-TTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEe-CCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            677899999999999999999999999999999999 88999999999998775432            12233468999


Q ss_pred             cCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcch
Q 045787          173 YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANL  252 (324)
Q Consensus       173 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (324)
                      |+|||++.+ ..++.++||||||+++|+|++|..|+..    .............                         
T Consensus       242 y~aPE~~~~-~~~~~~~Di~slG~il~el~~~~~~~~~----~~~~~~~~~~~~~-------------------------  291 (332)
T 3qd2_B          242 YMSPEQIHG-NNYSHKVDIFSLGLILFELLYSFSTQME----RVRIITDVRNLKF-------------------------  291 (332)
T ss_dssp             GSCHHHHHC-CCCCTHHHHHHHHHHHHHHHSCCCCHHH----HHHHHHHHHTTCC-------------------------
T ss_pred             ccChHHhcC-CCCcchhhHHHHHHHHHHHHHcCCChhH----HHHHHHHhhccCC-------------------------
Confidence            999999987 6789999999999999999998765411    1111111111000                         


Q ss_pred             hhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCC
Q 045787          253 AEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV  293 (324)
Q Consensus       253 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~  293 (324)
                      .......++.+.++|.+||+.||.+|||++++++||||+++
T Consensus       292 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          292 PLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL  332 (332)
T ss_dssp             CHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred             CcccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence            01112356778999999999999999999999999999875

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.4e-47  Score=328.81  Aligned_cols=259  Identities=26%  Similarity=0.337  Sum_probs=210.7

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeec----CCe
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS----RKD   80 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~   80 (324)
                      .+..|++.+.||+|++|.||+|.+..++..|++|.+..........+.+.+|+.++++++||||+++++++..    ...
T Consensus        24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  103 (290)
T 1t4h_A           24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC  103 (290)
T ss_dssp             TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred             CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence            3556899999999999999999999999999999998665444445678899999999999999999998765    456


Q ss_pred             EEEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcccCCCCCceEeecCCCcEEEeeccceeec
Q 045787           81 VFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK--ILHRDLKPNNLLIDLKRNTVKLADFGLARAI  157 (324)
Q Consensus        81 ~~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g--~~H~di~p~nIll~~~~~~v~l~d~g~~~~~  157 (324)
                      .++||||+++ +|.+++... ..+++..++.++.+++.||.+||+.|  ++|+||||+||+++..++.++|+|||.+...
T Consensus       104 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~  182 (290)
T 1t4h_A          104 IVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence            8999999975 888887664 56999999999999999999999999  9999999999999757789999999998654


Q ss_pred             cCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhh
Q 045787          158 GVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYI  237 (324)
Q Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (324)
                      ...  ......+++.|+|||++.+  .++.++||||||+++|+|++|..||...............+..+          
T Consensus       183 ~~~--~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----------  248 (290)
T 1t4h_A          183 RAS--FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP----------  248 (290)
T ss_dssp             CTT--SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC----------
T ss_pred             ccc--ccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc----------
Confidence            322  2334468899999999875  47999999999999999999999997655332221111111110          


Q ss_pred             hcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCC
Q 045787          238 SEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV  293 (324)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~  293 (324)
                                     .......++.+.++|.+||+.||.+|||+.++++||||++-
T Consensus       249 ---------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~  289 (290)
T 1t4h_A          249 ---------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             ---------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             ---------------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence                           01112467889999999999999999999999999999863

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=3.9e-48  Score=332.94  Aligned_cols=271  Identities=27%  Similarity=0.443  Sum_probs=217.6

Q ss_pred             CCcccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeecccc-CCCchHHHHHHHHHHhcCCCCeeEEEeeeecCC
Q 045787            1 MGKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQ-EGVPSYIIREVSLLKELEHENIVRLLDVQSSRK   79 (324)
Q Consensus         1 ~~~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   79 (324)
                      +|.++.++|++++.||+|++|.||+|.+..++..||+|.+...... ....+.+.+|+.++++++||||+++++++.+++
T Consensus         5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~   84 (294)
T 4eqm_A            5 IGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDD   84 (294)
T ss_dssp             CSSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSS
T ss_pred             hhhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCC
Confidence            5888999999999999999999999999999999999998654432 223456889999999999999999999999999


Q ss_pred             eEEEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeecc
Q 045787           80 DVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIG  158 (324)
Q Consensus        80 ~~~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~  158 (324)
                      ..|+||||++| +|.+++... +++++..++.++.+++.||.+||+.|++|+||||+||+++ .++.++|+|||.+....
T Consensus        85 ~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~-~~~~~kl~Dfg~~~~~~  162 (294)
T 4eqm_A           85 CYYLVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILID-SNKTLKIFDFGIAKALS  162 (294)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC-TTSCEEECCCSSSTTC-
T ss_pred             eEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC-CCCCEEEEeCCCccccc
Confidence            99999999975 888887764 4699999999999999999999999999999999999999 88999999999987654


Q ss_pred             CCCC-cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhh
Q 045787          159 VPQK-EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYI  237 (324)
Q Consensus       159 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (324)
                      .... ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+.............            
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~------------  229 (294)
T 4eqm_A          163 ETSLTQTNHVLGTVQYFSPEQAKG-EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSV------------  229 (294)
T ss_dssp             ------------CCSSCCHHHHHT-CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCC------------
T ss_pred             cccccccCccccCccccCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccC------------
Confidence            3322 2333468999999999988 6679999999999999999999999987775443322221111            


Q ss_pred             hcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCch
Q 045787          238 SEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP  297 (324)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~  297 (324)
                                 +.......+.+++.+.++|.+||+.||.+||+..+.+.+.|..-+....
T Consensus       230 -----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~  278 (294)
T 4eqm_A          230 -----------PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR  278 (294)
T ss_dssp             -----------CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred             -----------CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence                       1111223357899999999999999999999777777766665544433

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.5e-47  Score=329.96  Aligned_cols=267  Identities=26%  Similarity=0.459  Sum_probs=219.3

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeecccc-------CCCchHHHHHHHHHHhcC-CCCeeEEEeee
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQ-------EGVPSYIIREVSLLKELE-HENIVRLLDVQ   75 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~-------~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~   75 (324)
                      ...++|++.+.||+|++|.||+|.+..+|+.||+|++......       ....+.+.+|+.+++++. ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            3568999999999999999999999999999999999755321       112355778999999996 99999999999


Q ss_pred             ecCCeEEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccce
Q 045787           76 SSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLA  154 (324)
Q Consensus        76 ~~~~~~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~  154 (324)
                      ..++..++||||++ ++|.+++... ..+++..++.++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~-~~~~~kl~dfg~~  171 (298)
T 1phk_A           94 ETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD-DDMNIKLTDFGFS  171 (298)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-TTCCEEECCCTTC
T ss_pred             ccCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEc-CCCcEEEecccch
Confidence            99999999999998 5888887764 5699999999999999999999999999999999999999 8899999999999


Q ss_pred             eeccCCCCcccccccccccCCchhhc-----CCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcc
Q 045787          155 RAIGVPQKEYSRDCVYSPYKAPELLL-----GYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDE  229 (324)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  229 (324)
                      ...... .......+++.|+|||++.     ....++.++||||||+++|+|++|..||...+................ 
T Consensus       172 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-  249 (298)
T 1phk_A          172 CQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG-  249 (298)
T ss_dssp             EECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC-
T ss_pred             hhcCCC-cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccC-
Confidence            876532 3334456889999999985     235678999999999999999999999987775544333322111100 


Q ss_pred             cccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCch
Q 045787          230 SWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP  297 (324)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~  297 (324)
                                             ...+..++..+.++|.+||+.||.+|||+.++++||||++.....
T Consensus       250 -----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  294 (298)
T 1phk_A          250 -----------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEE  294 (298)
T ss_dssp             -----------------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC---
T ss_pred             -----------------------cccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccchh
Confidence                                   011235788999999999999999999999999999999876543

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=6.7e-48  Score=343.86  Aligned_cols=261  Identities=27%  Similarity=0.407  Sum_probs=208.8

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcC--CCCeeEEEeeeecCCeEE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE--HENIVRLLDVQSSRKDVF   82 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~   82 (324)
                      ...+|++.+.||+|+||.||+|.+.. ++.||+|++..........+.+.+|+.++++++  ||||+++++++..++.+|
T Consensus        54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~  132 (390)
T 2zmd_A           54 KGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY  132 (390)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             cCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence            45679999999999999999999875 889999999765544334567889999999997  599999999999999999


Q ss_pred             EEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC
Q 045787           83 LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK  162 (324)
Q Consensus        83 iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~  162 (324)
                      +|||+.+++|.+++... ..+++..++.++.+|+.||.|||+.|++|+||||+||+++  ++.+||+|||++........
T Consensus       133 lv~E~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~--~~~~kl~DFG~a~~~~~~~~  209 (390)
T 2zmd_A          133 MVMECGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTT  209 (390)
T ss_dssp             EEEECCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES--SSCEEECCCSSSCCC-----
T ss_pred             EEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE--CCeEEEEecCccccccCCCc
Confidence            99997778999988875 4689999999999999999999999999999999999997  57899999999986643222


Q ss_pred             --cccccccccccCCchhhcC----------CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCccc
Q 045787          163 --EYSRDCVYSPYKAPELLLG----------YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDES  230 (324)
Q Consensus       163 --~~~~~~~~~~y~aPE~~~~----------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  230 (324)
                        .....+||+.|+|||++.+          ...++.++|||||||++|+|++|..||....... ..............
T Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-~~~~~~~~~~~~~~  288 (390)
T 2zmd_A          210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-SKLHAIIDPNHEIE  288 (390)
T ss_dssp             ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHHHHHCTTSCCC
T ss_pred             cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH-HHHHHHhCccccCC
Confidence              2334578999999999864          2357899999999999999999999997654321 11111111111000


Q ss_pred             ccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCC
Q 045787          231 WAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVE  294 (324)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~  294 (324)
                                              .....+..+.+||.+||+.||.+|||+.++++||||+...
T Consensus       289 ------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  328 (390)
T 2zmd_A          289 ------------------------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  328 (390)
T ss_dssp             ------------------------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             ------------------------CCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence                                    0113467899999999999999999999999999998654

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.3e-48  Score=350.00  Aligned_cols=272  Identities=26%  Similarity=0.461  Sum_probs=209.4

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc------cCCCchHHHHHHHHHHhcCCCCeeEEEeeeecC
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE------QEGVPSYIIREVSLLKELEHENIVRLLDVQSSR   78 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   78 (324)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++.....      .......+.+|+.++++++||||+++++++.. 
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-  211 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-  211 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence            35789999999999999999999999999999999976432      12223457899999999999999999999865 


Q ss_pred             CeEEEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeec--CCCcEEEeecccee
Q 045787           79 KDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL--KRNTVKLADFGLAR  155 (324)
Q Consensus        79 ~~~~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~--~~~~v~l~d~g~~~  155 (324)
                      +..|+||||+.+ +|.+.+.. ...+++..++.++.|++.||.|||++|++|+||||+||+++.  .+..++|+|||.+.
T Consensus       212 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~  290 (419)
T 3i6u_A          212 EDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK  290 (419)
T ss_dssp             SEEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred             CceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence            457999999975 78777655 456999999999999999999999999999999999999972  23469999999998


Q ss_pred             eccCCCCcccccccccccCCchhhcC--CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHHcCCCCccccc
Q 045787          156 AIGVPQKEYSRDCVYSPYKAPELLLG--YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD-HLSLIFSLLGTPTDESWA  232 (324)
Q Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~  232 (324)
                      .... .......++|+.|+|||++.+  ...++.++||||||+++|+|++|..||...... .........         
T Consensus       291 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~---------  360 (419)
T 3i6u_A          291 ILGE-TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG---------  360 (419)
T ss_dssp             SCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTT---------
T ss_pred             ecCC-CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcC---------
Confidence            7653 223344578999999999853  356788999999999999999999999765422 121111110         


Q ss_pred             chhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchhhhhhh
Q 045787          233 ESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLI  303 (324)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~~~~~~  303 (324)
                                     ........+..+++.+.++|.+||+.||.+|||++++++||||++.........++
T Consensus       361 ---------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~~~~~ll  416 (419)
T 3i6u_A          361 ---------------KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLL  416 (419)
T ss_dssp             ---------------CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHHHHHHHHHHH
T ss_pred             ---------------CCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChhHHHHHHHHh
Confidence                           01111233456899999999999999999999999999999999877665554443

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.2e-47  Score=328.90  Aligned_cols=263  Identities=30%  Similarity=0.513  Sum_probs=220.4

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLV   84 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   84 (324)
                      ..++|++++.||+|++|.||+|.+..+++.||+|++..........+.+.+|+.++++++||||+++++++.+....++|
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   99 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence            45789999999999999999999999999999999987666555667899999999999999999999999999999999


Q ss_pred             EEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecC--CCcEEEeeccceeeccCCC
Q 045787           85 FEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK--RNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        85 ~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~--~~~v~l~d~g~~~~~~~~~  161 (324)
                      +||+. ++|.+.+... ..+++..++.++.+++.||.+||+.|++|+||+|+||+++..  ++.++|+|||.+...... 
T Consensus       100 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~-  177 (287)
T 2wei_A          100 GELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-  177 (287)
T ss_dssp             ECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC-
T ss_pred             EEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC-
Confidence            99997 5888877664 469999999999999999999999999999999999999732  347999999998765432 


Q ss_pred             CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhccc
Q 045787          162 KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEIL  241 (324)
Q Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (324)
                      .......+++.|+|||++.+  .++.++||||||+++|+|++|..||...+................             
T Consensus       178 ~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------  242 (287)
T 2wei_A          178 TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD-------------  242 (287)
T ss_dssp             SSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-------------
T ss_pred             CccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC-------------
Confidence            22334467888999999876  379999999999999999999999988775554433322111100             


Q ss_pred             CCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCC
Q 045787          242 PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVEN  295 (324)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~  295 (324)
                                 ...+..++..+.++|.+||+.||.+|||+.++++||||++...
T Consensus       243 -----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~  285 (287)
T 2wei_A          243 -----------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (287)
T ss_dssp             -----------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCC
T ss_pred             -----------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcccc
Confidence                       1112367899999999999999999999999999999987654

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=3e-48  Score=331.15  Aligned_cols=261  Identities=28%  Similarity=0.443  Sum_probs=216.1

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeee--cCCeEE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQS--SRKDVF   82 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~   82 (324)
                      ..++|++++.||+|++|.||+|.+..+++.+++|.+..........+.+.+|+.++++++||||+++++++.  .+...+
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   83 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   83 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred             chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence            457999999999999999999999999999999999866544334567889999999999999999999874  467899


Q ss_pred             EEEEecCC-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC-----CcccCCCCCceEeecCCCcEEEeeccc
Q 045787           83 LVFEYLDL-DLHSFITRHK---NTLNLLVIKAILKQILLGLAYCHSLK-----ILHRDLKPNNLLIDLKRNTVKLADFGL  153 (324)
Q Consensus        83 iv~e~~~g-~l~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~Lh~~g-----~~H~di~p~nIll~~~~~~v~l~d~g~  153 (324)
                      +||||++| +|.+++....   ..+++..++.++.+++.||.+||+.|     ++|+||+|+||+++ .++.++|+|||.
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~-~~~~~kl~dfg~  162 (279)
T 2w5a_A           84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGL  162 (279)
T ss_dssp             EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEEC-SSSCEEECCCCH
T ss_pred             EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEc-CCCCEEEecCch
Confidence            99999975 8988887643   35999999999999999999999999     99999999999999 899999999999


Q ss_pred             eeeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccc
Q 045787          154 ARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAE  233 (324)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  233 (324)
                      +..............+++.|+|||++.+ ..++.++||||||+++|+|++|..||...+.............+.      
T Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~------  235 (279)
T 2w5a_A          163 ARILNHDTSFAKTFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR------  235 (279)
T ss_dssp             HHHC---CHHHHHHHSCCTTCCHHHHHC-C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC------
T ss_pred             heeeccccccccccCCCccccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccccc------
Confidence            8766533333334567889999999987 668999999999999999999999998877554443332211110      


Q ss_pred             hhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCC
Q 045787          234 STYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVE  294 (324)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~  294 (324)
                                           ....++..+.++|.+||+.||.+|||+.++++|+|+.+-.
T Consensus       236 ---------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  275 (279)
T 2w5a_A          236 ---------------------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH  275 (279)
T ss_dssp             ---------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred             ---------------------CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence                                 1125788999999999999999999999999999998754

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.1e-47  Score=337.95  Aligned_cols=259  Identities=28%  Similarity=0.506  Sum_probs=215.5

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccC------CCchHHHHHHHHHHhc-CCCCeeEEEeeeecCC
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQE------GVPSYIIREVSLLKEL-EHENIVRLLDVQSSRK   79 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~------~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   79 (324)
                      ++|++.+.||+|++|.||+|.+..+|+.||+|++.......      ...+.+.+|+.+++++ +||||+++++++...+
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            57999999999999999999999899999999987654221      1134578899999999 7999999999999999


Q ss_pred             eEEEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeecc
Q 045787           80 DVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIG  158 (324)
Q Consensus        80 ~~~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~  158 (324)
                      ..|+||||++| +|.+++... ..+++..++.++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+....
T Consensus       174 ~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~-~~~~ikl~DfG~~~~~~  251 (365)
T 2y7j_A          174 FMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLD-DNMQIRLSDFGFSCHLE  251 (365)
T ss_dssp             EEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-TTCCEEECCCTTCEECC
T ss_pred             EEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC-CCCCEEEEecCcccccC
Confidence            99999999985 888877654 5699999999999999999999999999999999999999 89999999999988765


Q ss_pred             CCCCcccccccccccCCchhhcC-----CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccc
Q 045787          159 VPQKEYSRDCVYSPYKAPELLLG-----YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAE  233 (324)
Q Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  233 (324)
                      .. .......+|+.|+|||++.+     ...++.++||||||+++|+|++|..||...+...............      
T Consensus       252 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~------  324 (365)
T 2y7j_A          252 PG-EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQF------  324 (365)
T ss_dssp             TT-CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC------
T ss_pred             CC-cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC------
Confidence            32 33445678999999999863     2357889999999999999999999998776544433322211110      


Q ss_pred             hhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccC
Q 045787          234 STYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIG  292 (324)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~  292 (324)
                                        ....+..++..+.++|.+||+.||.+|||+.++++||||+.
T Consensus       325 ------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          325 ------------------SSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             ------------------CHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             ------------------CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence                              01122367889999999999999999999999999999974

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2.2e-48  Score=343.93  Aligned_cols=292  Identities=24%  Similarity=0.389  Sum_probs=221.7

Q ss_pred             CCcccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCe
Q 045787            1 MGKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKD   80 (324)
Q Consensus         1 ~~~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   80 (324)
                      +|.+..++|++++.||+|++|.||+|.+..++..||+|++..... ....+.+.+|+.++++++||||+++++++.+++.
T Consensus        27 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  105 (360)
T 3eqc_A           27 VGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE  105 (360)
T ss_dssp             CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCC-HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTE
T ss_pred             ccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccC-HHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCE
Confidence            477889999999999999999999999999999999999876532 2224568899999999999999999999999999


Q ss_pred             EEEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCCCCceEeecCCCcEEEeeccceeecc
Q 045787           81 VFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSL-KILHRDLKPNNLLIDLKRNTVKLADFGLARAIG  158 (324)
Q Consensus        81 ~~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~  158 (324)
                      .++||||++| +|.+++... ..+++..++.++.+++.||.+||+. |++|+||||+||+++ .++.++|+|||.+....
T Consensus       106 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~  183 (360)
T 3eqc_A          106 ISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLI  183 (360)
T ss_dssp             EEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEEC-TTCCEEECCCCCCHHHH
T ss_pred             EEEEEECCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEEC-CCCCEEEEECCCCcccc
Confidence            9999999975 888887764 4699999999999999999999986 999999999999999 88999999999886543


Q ss_pred             CCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCccccc-chhhh
Q 045787          159 VPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWA-ESTYI  237 (324)
Q Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  237 (324)
                      ..  ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||...+.................... .....
T Consensus       184 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (360)
T 3eqc_A          184 DS--MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP  260 (360)
T ss_dssp             HH--C----CCCCTTCCHHHHTT-CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred             cc--cccCCCCCCCeECHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence            22  2233468899999999987 67899999999999999999999999887766554333211100000000 00000


Q ss_pred             hcccCCCCC--CCC-------------cchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchh
Q 045787          238 SEILPLYPH--FEP-------------ANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       238 ~~~~~~~~~--~~~-------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~  298 (324)
                      ......+..  ...             .........++.++.+||.+||+.||.+|||++++++||||++......
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~  336 (360)
T 3eqc_A          261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEV  336 (360)
T ss_dssp             -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHSCC
T ss_pred             CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHhhh
Confidence            000000000  000             0000011247889999999999999999999999999999998765443

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=4.6e-48  Score=340.30  Aligned_cols=284  Identities=22%  Similarity=0.358  Sum_probs=222.3

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCc---------------hHHHHHHHHHHhcCCCC
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVP---------------SYIIREVSLLKELEHEN   67 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~---------------~~~~~e~~~l~~l~~~~   67 (324)
                      +...++|++.+.||+|++|.||+|.+  +|+.||+|++..........               +.+.+|+.++++++|||
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~  104 (348)
T 2pml_X           27 DKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEY  104 (348)
T ss_dssp             CEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTT
T ss_pred             ccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCC
Confidence            45568999999999999999999998  79999999998654332211               77899999999999999


Q ss_pred             eeEEEeeeecCCeEEEEEEecCC-CHHHH------HHhc-CCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCceE
Q 045787           68 IVRLLDVQSSRKDVFLVFEYLDL-DLHSF------ITRH-KNTLNLLVIKAILKQILLGLAYCHS-LKILHRDLKPNNLL  138 (324)
Q Consensus        68 i~~~~~~~~~~~~~~iv~e~~~g-~l~~~------~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~-~g~~H~di~p~nIl  138 (324)
                      ++++++++.+.+..++||||++| +|.++      +... ...+++..++.++.+++.||.+||+ .|++|+||+|+||+
T Consensus       105 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil  184 (348)
T 2pml_X          105 CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL  184 (348)
T ss_dssp             BCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred             cceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence            99999999999999999999986 88776      4432 4579999999999999999999999 99999999999999


Q ss_pred             eecCCCcEEEeeccceeeccCCCCcccccccccccCCchhhcCCCCCCC-chhhHHHHHHHHHHHhCCCCCCCCCh-hHH
Q 045787          139 IDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYST-PIDVWAVGCIFAEMITGKPLFPSKKH-DHL  216 (324)
Q Consensus       139 l~~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~DiwslG~il~~l~~g~~pf~~~~~-~~~  216 (324)
                      ++ .++.++|+|||.+......  ......+++.|+|||++.+...++. ++||||||+++|+|++|..||..... ...
T Consensus       185 ~~-~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  261 (348)
T 2pml_X          185 MD-KNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL  261 (348)
T ss_dssp             EC-TTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred             Ec-CCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence            99 8999999999999876433  3344578899999999987445555 99999999999999999999987765 333


Q ss_pred             HHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCc
Q 045787          217 SLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENV  296 (324)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~  296 (324)
                      ...... +...... ....       ................++..+.++|.+||+.||.+|||+.++++||||++.+..
T Consensus       262 ~~~i~~-~~~~~~~-~~~~-------~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~~  332 (348)
T 2pml_X          262 FNNIRT-KNIEYPL-DRNH-------FLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIE  332 (348)
T ss_dssp             HHHHTS-CCCCCCC-SSSS-------STTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCHH
T ss_pred             HHHHhc-cCcCCcc-chhh-------hhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCHH
Confidence            222211 1111000 0000       000111111122235789999999999999999999999999999999999877


Q ss_pred             hhhh
Q 045787          297 PLVI  300 (324)
Q Consensus       297 ~~~~  300 (324)
                      .+..
T Consensus       333 ~~~~  336 (348)
T 2pml_X          333 DLRE  336 (348)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            6544

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.4e-47  Score=341.28  Aligned_cols=258  Identities=29%  Similarity=0.416  Sum_probs=202.5

Q ss_pred             CcCccee-EeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHh-cCCCCeeEEEeeeec----CC
Q 045787            6 NLNYKKI-KKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKE-LEHENIVRLLDVQSS----RK   79 (324)
Q Consensus         6 ~~~y~i~-~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~----~~   79 (324)
                      .++|++. +.||.|+||+||+|.+..+|+.||+|++..       ...+.+|+.++.+ .+||||+++++++..    ..
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~  132 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRK  132 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-------chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence            4567777 789999999999999999999999999863       2456788888754 479999999998865    66


Q ss_pred             eEEEEEEecCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecC--CCcEEEeecccee
Q 045787           80 DVFLVFEYLDL-DLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK--RNTVKLADFGLAR  155 (324)
Q Consensus        80 ~~~iv~e~~~g-~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~--~~~v~l~d~g~~~  155 (324)
                      .+|+||||+.| +|.+++.... ..+++..++.++.+|+.||.|||+.|++|+||||+||+++..  ++.+||+|||.+.
T Consensus       133 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~  212 (400)
T 1nxk_A          133 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  212 (400)
T ss_dssp             EEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence            79999999975 9999887654 369999999999999999999999999999999999999832  6889999999998


Q ss_pred             eccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhH----HHHHHHHcCCCCcccc
Q 045787          156 AIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDH----LSLIFSLLGTPTDESW  231 (324)
Q Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~  231 (324)
                      .... .......++|+.|+|||++.+ ..++.++|||||||++|+|++|..||.......    ....+.....      
T Consensus       213 ~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~------  284 (400)
T 1nxk_A          213 ETTS-HNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY------  284 (400)
T ss_dssp             ECC------------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCC------
T ss_pred             ccCC-CCccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcc------
Confidence            7642 233345678999999999977 678999999999999999999999997655221    1111110000      


Q ss_pred             cchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCc
Q 045787          232 AESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENV  296 (324)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~  296 (324)
                                        ......+..++.++.+||.+||+.||.+|||+.++++||||.+....
T Consensus       285 ------------------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~  331 (400)
T 1nxk_A          285 ------------------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV  331 (400)
T ss_dssp             ------------------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTTS
T ss_pred             ------------------cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCCC
Confidence                              00011234689999999999999999999999999999999876543

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.1e-48  Score=339.08  Aligned_cols=269  Identities=23%  Similarity=0.357  Sum_probs=214.6

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeecccc-CCCchHHHHHHHHHHhcCCCCeeEEEeeeecCC--
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQ-EGVPSYIIREVSLLKELEHENIVRLLDVQSSRK--   79 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--   79 (324)
                      ..+.++|++.+.||+|++|.||+|.+..+++.||+|++...... ......+.+|+.++++++||||+++++++....  
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   87 (311)
T 3ork_A            8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA   87 (311)
T ss_dssp             SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT
T ss_pred             ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC
Confidence            45678999999999999999999999999999999999765322 222356789999999999999999999987654  


Q ss_pred             --eEEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceee
Q 045787           80 --DVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARA  156 (324)
Q Consensus        80 --~~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~  156 (324)
                        ..|+||||++ ++|.+++... +++++..++.++.+++.||.|||++|++|+||||+||+++ .++.++|+|||.+..
T Consensus        88 ~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~a~~  165 (311)
T 3ork_A           88 GPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS-ATNAVKVMDFGIARA  165 (311)
T ss_dssp             EEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTSCEEECCCSCC--
T ss_pred             CcccEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEc-CCCCEEEeeccCccc
Confidence              3499999997 5888887664 4699999999999999999999999999999999999999 889999999999976


Q ss_pred             ccCCCC---cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccc
Q 045787          157 IGVPQK---EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAE  233 (324)
Q Consensus       157 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  233 (324)
                      ......   ......+++.|+|||++.+ ..++.++||||||+++|+|++|+.||...+..............+      
T Consensus       166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~------  238 (311)
T 3ork_A          166 IADSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP------  238 (311)
T ss_dssp             ----------------CCTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC------
T ss_pred             ccccccccccccccCcCcccCCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCC------
Confidence            643322   2223468999999999987 678999999999999999999999998877655433322221111      


Q ss_pred             hhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchh
Q 045787          234 STYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~  298 (324)
                                        .......++.++.++|.+||+.||.+||++.+++.|+|++.....+.
T Consensus       239 ------------------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~  285 (311)
T 3ork_A          239 ------------------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPP  285 (311)
T ss_dssp             ------------------HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCC
T ss_pred             ------------------cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCC
Confidence                              11223468999999999999999999999999999999987665443

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=5e-48  Score=336.12  Aligned_cols=282  Identities=19%  Similarity=0.296  Sum_probs=212.9

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCC--e
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK--D   80 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~   80 (324)
                      .+..++|++.+.||+|+||+||+|.+..+++.||+|++....... ..+.+.+|+.++++++||||+++++++....  .
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   83 (319)
T 4euu_A            5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH   83 (319)
T ss_dssp             ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred             cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc-hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCce
Confidence            567899999999999999999999999999999999997654332 2566789999999999999999999987654  7


Q ss_pred             EEEEEEecC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEe----ecCCCcEEEeeccc
Q 045787           81 VFLVFEYLD-LDLHSFITRHKN--TLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLI----DLKRNTVKLADFGL  153 (324)
Q Consensus        81 ~~iv~e~~~-g~l~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll----~~~~~~v~l~d~g~  153 (324)
                      .++||||++ ++|.+++.....  .+++..++.++.+++.||.|||+.|++|+||||+||++    + .++.++|+|||.
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~-~~~~~kL~Dfg~  162 (319)
T 4euu_A           84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGED-GQSVYKLTDFGA  162 (319)
T ss_dssp             EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTT-SCEEEEECCCTT
T ss_pred             EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCC-CCceEEEccCCC
Confidence            899999997 588888876543  39999999999999999999999999999999999998    5 667899999999


Q ss_pred             eeeccCCCCcccccccccccCCchhhcC-------CCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh--hHHHHHHHHcC
Q 045787          154 ARAIGVPQKEYSRDCVYSPYKAPELLLG-------YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH--DHLSLIFSLLG  224 (324)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~  224 (324)
                      +...... .......+++.|+|||++..       ...++.++||||||+++|+|++|..||.....  ...........
T Consensus       163 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  241 (319)
T 4euu_A          163 ARELEDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (319)
T ss_dssp             CEECCTT-CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred             ceecCCC-CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence            9876533 33344568999999999862       36789999999999999999999999964431  11122222222


Q ss_pred             CCCcccccchhhhhc-ccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCcc
Q 045787          225 TPTDESWAESTYISE-ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEY  289 (324)
Q Consensus       225 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~  289 (324)
                      ..+...+........ ........  .........++..+.++|.+||+.||.+|||++|+++||-
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          242 GKPSGAISGVQKAENGPIDWSGDM--PVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             HCCTTCCEEEECSTTCCEEEESSC--CTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             CCCcccchhhhcccCCccccCccC--CcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            222211111100000 00000000  0000111245668889999999999999999999999874

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=3e-49  Score=351.45  Aligned_cols=252  Identities=15%  Similarity=0.193  Sum_probs=202.0

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHH---HHHhcCCCCeeEEE-------ee
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVS---LLKELEHENIVRLL-------DV   74 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~---~l~~l~~~~i~~~~-------~~   74 (324)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.   .+++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            5789999999999999999999998999999999986532 3334567889994   45555799999988       66


Q ss_pred             eecCC-----------------eEEEEEEecCCCHHHHHHhcCCCCC-------HHHHHHHHHHHHHHHHHHHhCCCccc
Q 045787           75 QSSRK-----------------DVFLVFEYLDLDLHSFITRHKNTLN-------LLVIKAILKQILLGLAYCHSLKILHR  130 (324)
Q Consensus        75 ~~~~~-----------------~~~iv~e~~~g~l~~~~~~~~~~~~-------~~~~~~i~~~i~~~l~~Lh~~g~~H~  130 (324)
                      +.+.+                 ..|+||||++|+|.+++..... ++       +..++.++.||+.||.|||++|++|+
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~-~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr  230 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS-HSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  230 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHH-TTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccc-cccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            55543                 3899999999999999887532 33       47888899999999999999999999


Q ss_pred             CCCCCceEeecCCCcEEEeeccceeeccCCCCcccccccccccCCchhhcCC----------CCCCCchhhHHHHHHHHH
Q 045787          131 DLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGY----------TGYSTPIDVWAVGCIFAE  200 (324)
Q Consensus       131 di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------~~~~~~~DiwslG~il~~  200 (324)
                      ||||+|||++ .++.+||+|||.+...+.   ......| +.|+|||++.+.          ..++.++||||||+++|+
T Consensus       231 Dikp~NIll~-~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e  305 (377)
T 3byv_A          231 YLRPVDIVLD-QRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW  305 (377)
T ss_dssp             CCCGGGEEEC-TTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred             CCCHHHEEEc-CCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence            9999999999 889999999999986432   3334456 889999999873          268999999999999999


Q ss_pred             HHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCC
Q 045787          201 MITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRIT  280 (324)
Q Consensus       201 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps  280 (324)
                      |++|..||........                                ..........+++++.++|.+||+.||.+|||
T Consensus       306 lltg~~Pf~~~~~~~~--------------------------------~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt  353 (377)
T 3byv_A          306 IWCADLPITKDAALGG--------------------------------SEWIFRSCKNIPQPVRALLEGFLRYPKEDRLL  353 (377)
T ss_dssp             HHHSSCCC------CC--------------------------------SGGGGSSCCCCCHHHHHHHHHHTCSSGGGCCC
T ss_pred             HHHCCCCCcccccccc--------------------------------hhhhhhhccCCCHHHHHHHHHHcCCCchhCCC
Confidence            9999999954432110                                00111122478999999999999999999999


Q ss_pred             HHHHhcCccccCCCC
Q 045787          281 AMDALKHEYLIGVEN  295 (324)
Q Consensus       281 ~~~~l~hp~~~~~~~  295 (324)
                      +.++++||||+++..
T Consensus       354 ~~e~l~hp~f~~~~~  368 (377)
T 3byv_A          354 PLQAMETPEYEQLRT  368 (377)
T ss_dssp             HHHHHTSHHHHHHHH
T ss_pred             HHHHhhChHHHHHHH
Confidence            999999999998754

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.9e-47  Score=330.32  Aligned_cols=265  Identities=22%  Similarity=0.347  Sum_probs=216.2

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc--cCCCchHHHHHHHHHHhcCCCCeeEEEeee--ecCCe
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE--QEGVPSYIIREVSLLKELEHENIVRLLDVQ--SSRKD   80 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~   80 (324)
                      +.++|++.+.||+|++|.||+|.+..++..+++|++.....  .......+.+|+.++++++||||+++++++  .+...
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            45799999999999999999999999999999999976542  233456789999999999999999999998  45568


Q ss_pred             EEEEEEecCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccC
Q 045787           81 VFLVFEYLDLDLHSFITRH-KNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGV  159 (324)
Q Consensus        81 ~~iv~e~~~g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~  159 (324)
                      .++||||+++++.+.+... ...+++..++.++.+++.||.+||++|++|+||||+||+++ .++.++|+|||.+.....
T Consensus        83 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~-~~~~~kl~dfg~~~~~~~  161 (305)
T 2wtk_C           83 MYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLT-TGGTLKISALGVAEALHP  161 (305)
T ss_dssp             EEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-TTCCEEECCCTTCEECCT
T ss_pred             EEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEc-CCCcEEeeccccccccCc
Confidence            9999999998888877764 34699999999999999999999999999999999999999 899999999999987643


Q ss_pred             CC--CcccccccccccCCchhhcCCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhh
Q 045787          160 PQ--KEYSRDCVYSPYKAPELLLGYT-GYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY  236 (324)
Q Consensus       160 ~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (324)
                      ..  .......+++.|+|||++.+.. ..+.++||||||+++|+|++|..||...+.............           
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~-----------  230 (305)
T 2wtk_C          162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY-----------  230 (305)
T ss_dssp             TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC-----------
T ss_pred             cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCC-----------
Confidence            22  2233456889999999987622 347799999999999999999999987765444333221110           


Q ss_pred             hhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchh
Q 045787          237 ISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~  298 (324)
                                       .....+++.+.++|.+||+.||.+|||+.++++||||++......
T Consensus       231 -----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~  275 (305)
T 2wtk_C          231 -----------------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAE  275 (305)
T ss_dssp             -----------------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-C
T ss_pred             -----------------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCcC
Confidence                             011257889999999999999999999999999999998765543

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2e-47  Score=330.59  Aligned_cols=262  Identities=24%  Similarity=0.342  Sum_probs=206.8

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF   82 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   82 (324)
                      ++..++|++.+.||+|+||+||+|.+  +|..||+|++..........+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        33 ~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  110 (309)
T 3p86_A           33 DIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS  110 (309)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCE
T ss_pred             cCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceE
Confidence            45678999999999999999999986  5789999998765544333456889999999999999999999999999999


Q ss_pred             EEEEecCC-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--CcccCCCCCceEeecCCCcEEEeeccceeec
Q 045787           83 LVFEYLDL-DLHSFITRHKN--TLNLLVIKAILKQILLGLAYCHSLK--ILHRDLKPNNLLIDLKRNTVKLADFGLARAI  157 (324)
Q Consensus        83 iv~e~~~g-~l~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~Lh~~g--~~H~di~p~nIll~~~~~~v~l~d~g~~~~~  157 (324)
                      +||||++| +|.+++.....  .+++..++.++.+++.||.+||+.|  ++|+||||+||+++ .++.++|+|||.+...
T Consensus       111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~-~~~~~kL~Dfg~a~~~  189 (309)
T 3p86_A          111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD-KKYTVKVCDFGLSRLK  189 (309)
T ss_dssp             EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEEC-TTCCEEECCCC-----
T ss_pred             EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEe-CCCcEEECCCCCCccc
Confidence            99999975 88888876432  3999999999999999999999999  99999999999999 8999999999999765


Q ss_pred             cCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhh
Q 045787          158 GVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYI  237 (324)
Q Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (324)
                      ...........+++.|+|||++.+ ..++.++||||||+++|+|++|..||...+...............          
T Consensus       190 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~----------  258 (309)
T 3p86_A          190 ASTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL----------  258 (309)
T ss_dssp             ------------CCTTSCHHHHTT-CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCC----------
T ss_pred             cccccccccCCCCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC----------
Confidence            544444455678999999999987 667999999999999999999999998877655443332211111          


Q ss_pred             hcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc--CccccCCC
Q 045787          238 SEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK--HEYLIGVE  294 (324)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~--hp~~~~~~  294 (324)
                                      .....+++.+.++|.+||+.||.+|||+.++++  .++++...
T Consensus       259 ----------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~  301 (309)
T 3p86_A          259 ----------------EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV  301 (309)
T ss_dssp             ----------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred             ----------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence                            112367899999999999999999999999997  56665543

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.2e-48  Score=347.04  Aligned_cols=269  Identities=16%  Similarity=0.187  Sum_probs=198.9

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhc--CCCCeeEEE-------eeee
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKEL--EHENIVRLL-------DVQS   76 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l--~~~~i~~~~-------~~~~   76 (324)
                      .+|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.+++.+  +|||+++++       +++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            359999999999999999999999999999999987543 222345677785555554  699988755       4443


Q ss_pred             cC-----------------CeEEEEEEecCCCHHHHHHhcCCCCCHHHH------HHHHHHHHHHHHHHHhCCCcccCCC
Q 045787           77 SR-----------------KDVFLVFEYLDLDLHSFITRHKNTLNLLVI------KAILKQILLGLAYCHSLKILHRDLK  133 (324)
Q Consensus        77 ~~-----------------~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~------~~i~~~i~~~l~~Lh~~g~~H~di~  133 (324)
                      .+                 ...|+||||++|+|.+++...+..++....      ..++.||+.||.|||++|++|+|||
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDik  221 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT  221 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCC
Confidence            32                 348999999999999999886555655555      6778999999999999999999999


Q ss_pred             CCceEeecCCCcEEEeeccceeeccCCCCcccccccccccCCchhhcC-CCCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 045787          134 PNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLG-YTGYSTPIDVWAVGCIFAEMITGKPLFPSKK  212 (324)
Q Consensus       134 p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  212 (324)
                      |+|||++ .++.+||+|||.+...+.   ......+++.|+|||++.+ ...++.++||||||+++|+|++|+.||....
T Consensus       222 p~NIll~-~~~~~kL~DFG~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~  297 (371)
T 3q60_A          222 PDNLFIM-PDGRLMLGDVSALWKVGT---RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT  297 (371)
T ss_dssp             GGGEEEC-TTSCEEECCGGGEEETTC---EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCC
T ss_pred             HHHEEEC-CCCCEEEEecceeeecCC---CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcC
Confidence            9999999 899999999999987642   2224456688999999964 2467999999999999999999999997654


Q ss_pred             hhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccC
Q 045787          213 HDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIG  292 (324)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~  292 (324)
                      ....            ..+...       ...............+.+++.+.+||.+||+.||.+|||+.++++||||++
T Consensus       298 ~~~~------------~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  358 (371)
T 3q60_A          298 PGIK------------GSWKRP-------SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ  358 (371)
T ss_dssp             TTCT------------TCCCBC-------CTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred             cccc------------cchhhh-------hhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence            3210            000000       000000111111223478999999999999999999999999999999998


Q ss_pred             CCCchh
Q 045787          293 VENVPL  298 (324)
Q Consensus       293 ~~~~~~  298 (324)
                      +.+...
T Consensus       359 ~~~~~~  364 (371)
T 3q60_A          359 LQNEIS  364 (371)
T ss_dssp             HHHHHH
T ss_pred             HHHHHh
Confidence            876544

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=7.5e-48  Score=342.05  Aligned_cols=287  Identities=28%  Similarity=0.484  Sum_probs=221.7

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcC-----------CCCeeEEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-----------HENIVRLL   72 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-----------~~~i~~~~   72 (324)
                      +..++|++.+.||+|++|.||+|.+..+++.||+|++......   ...+.+|+.++++++           ||||++++
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~   92 (373)
T 1q8y_A           16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY---TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL   92 (373)
T ss_dssp             ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHH---HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred             ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccc---hhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence            4568999999999999999999999999999999998744322   355778999998886           78999999


Q ss_pred             eeeecCC----eEEEEEEecCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCCCCceEeec-----
Q 045787           73 DVQSSRK----DVFLVFEYLDLDLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSL-KILHRDLKPNNLLIDL-----  141 (324)
Q Consensus        73 ~~~~~~~----~~~iv~e~~~g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~-g~~H~di~p~nIll~~-----  141 (324)
                      +++...+    ..++|+|+++++|.+++.... ..+++..++.++.||+.||.+||++ |++|+||||+||+++.     
T Consensus        93 ~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           93 DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred             HHhhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCc
Confidence            9987654    799999999889999988753 4599999999999999999999998 9999999999999952     


Q ss_pred             CCCcEEEeeccceeeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-------hh
Q 045787          142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-------HD  214 (324)
Q Consensus       142 ~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-------~~  214 (324)
                      ..+.++|+|||.+.....   ......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||...+       ..
T Consensus       173 ~~~~~kl~Dfg~a~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  248 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  248 (373)
T ss_dssp             TEEEEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             CcceEEEcccccccccCC---CCCCCCCCccccCcHHHhC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence            334799999999987653   2334578899999999988 668999999999999999999999997654       34


Q ss_pred             HHHHHHHHcCCCCcccccchhhhhcccCCCCCC------CC---cchhh----hCCCCChhHHHHHHHhhcCCCCCCCCH
Q 045787          215 HLSLIFSLLGTPTDESWAESTYISEILPLYPHF------EP---ANLAE----KFPNLEPAGVDLLSQMLCLNPKQRITA  281 (324)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~---~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~  281 (324)
                      ....+....+.++...+................      ..   .....    ....++.++.+||.+||+.||.+|||+
T Consensus       249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  328 (373)
T 1q8y_A          249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA  328 (373)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence            455666666666654433332222221111000      00   00000    112345788899999999999999999


Q ss_pred             HHHhcCccccCCCCch
Q 045787          282 MDALKHEYLIGVENVP  297 (324)
Q Consensus       282 ~~~l~hp~~~~~~~~~  297 (324)
                      +++++||||++.....
T Consensus       329 ~ell~hp~f~~~~~~~  344 (373)
T 1q8y_A          329 GGLVNHPWLKDTLGME  344 (373)
T ss_dssp             HHHHTCGGGTTCTTCT
T ss_pred             HHHhhChhhhcccCcc
Confidence            9999999999876443

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.5e-47  Score=333.53  Aligned_cols=272  Identities=27%  Similarity=0.467  Sum_probs=214.5

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc------cCCCchHHHHHHHHHHhcCCCCeeEEEeeeec
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE------QEGVPSYIIREVSLLKELEHENIVRLLDVQSS   77 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   77 (324)
                      .+.++|++.+.||+|+||.||+|.+..+++.||+|++.....      .......+.+|+.++++++||||+++++++..
T Consensus         7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   86 (322)
T 2ycf_A            7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA   86 (322)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred             hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence            456789999999999999999999999999999999875432      12223458899999999999999999999876


Q ss_pred             CCeEEEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCC---cEEEeeccc
Q 045787           78 RKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN---TVKLADFGL  153 (324)
Q Consensus        78 ~~~~~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~---~v~l~d~g~  153 (324)
                      +. .|+||||+.+ +|.+.+.. ...+++..++.++.+++.||.+||++|++|+||||+||+++ .++   .++|+|||.
T Consensus        87 ~~-~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~-~~~~~~~~kl~Dfg~  163 (322)
T 2ycf_A           87 ED-YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLS-SQEEDCLIKITDFGH  163 (322)
T ss_dssp             SS-EEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEES-SSSSSCCEEECCCTT
T ss_pred             Cc-eEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEe-cCCCCCeEEEccCcc
Confidence            55 8999999975 88887765 45699999999999999999999999999999999999998 444   499999999


Q ss_pred             eeeccCCCCcccccccccccCCchhhc--CCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHHcCCCCccc
Q 045787          154 ARAIGVPQKEYSRDCVYSPYKAPELLL--GYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD-HLSLIFSLLGTPTDES  230 (324)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~  230 (324)
                      +...... .......+++.|+|||++.  +...++.++||||||+++|+|++|..||...... ...........     
T Consensus       164 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-----  237 (322)
T 2ycf_A          164 SKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY-----  237 (322)
T ss_dssp             CEECCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCC-----
T ss_pred             ceecccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcc-----
Confidence            9876422 2223346889999999974  3466899999999999999999999999765432 22111111100     


Q ss_pred             ccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchhhhhhh
Q 045787          231 WAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLI  303 (324)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~~~~~~  303 (324)
                                         .........++..+.++|.+||+.||.+||++.++++||||++.....-....+
T Consensus       238 -------------------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~~~~~~~~~~  291 (322)
T 2ycf_A          238 -------------------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLL  291 (322)
T ss_dssp             -------------------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHHHHHHHHHHH
T ss_pred             -------------------ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHHHHHHHHHHh
Confidence                               011223346889999999999999999999999999999999877655544443

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.3e-47  Score=332.96  Aligned_cols=266  Identities=23%  Similarity=0.416  Sum_probs=214.7

Q ss_pred             cCcCcceeEeecccCceEEEEEEEc---cCCceEEEEEeeeccc--cCCCchHHHHHHHHHHhc-CCCCeeEEEeeeecC
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNT---VTGQKVAIKMMTIQTE--QEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSR   78 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~---~~~~~~~~K~~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~   78 (324)
                      ..++|++.+.||+|+||.||+|.+.   .+++.||+|++.....  .......+.+|+.+++++ +||+|+++++++..+
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  131 (355)
T 1vzo_A           52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE  131 (355)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred             cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence            3479999999999999999999984   5789999999875432  223345567899999999 699999999999999


Q ss_pred             CeEEEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeec
Q 045787           79 KDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAI  157 (324)
Q Consensus        79 ~~~~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~  157 (324)
                      ...++||||+++ +|.+++... ..+++..++.++.|++.||.|||++|++|+||||+||+++ .++.++|+|||.+...
T Consensus       132 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~~kl~DfG~a~~~  209 (355)
T 1vzo_A          132 TKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD-SNGHVVLTDFGLSKEF  209 (355)
T ss_dssp             TEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC-TTSCEEESCSSEEEEC
T ss_pred             ceEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC-CCCcEEEeeCCCCeec
Confidence            999999999975 888887764 4699999999999999999999999999999999999999 8999999999999765


Q ss_pred             cCCC-CcccccccccccCCchhhcC-CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChh----HHHHHHHHcCCCCcccc
Q 045787          158 GVPQ-KEYSRDCVYSPYKAPELLLG-YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD----HLSLIFSLLGTPTDESW  231 (324)
Q Consensus       158 ~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~  231 (324)
                      .... .......+|+.|+|||++.+ ...++.++||||||+++|+|++|..||......    .+...... ..+     
T Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~~-----  283 (355)
T 1vzo_A          210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK-SEP-----  283 (355)
T ss_dssp             CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH-CCC-----
T ss_pred             ccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhc-cCC-----
Confidence            4222 22334578999999999975 345789999999999999999999999654321    11111110 000     


Q ss_pred             cchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCC-----CHHHHhcCccccCCCCchhhh
Q 045787          232 AESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRI-----TAMDALKHEYLIGVENVPLVI  300 (324)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~~l~hp~~~~~~~~~~~~  300 (324)
                                            .....++..+.+||.+||..||.+||     +++++++||||+++++..+..
T Consensus       284 ----------------------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l~~  335 (355)
T 1vzo_A          284 ----------------------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAA  335 (355)
T ss_dssp             ----------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHT
T ss_pred             ----------------------CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHhhh
Confidence                                  01135788999999999999999999     999999999999987655543

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=4.7e-47  Score=329.67  Aligned_cols=264  Identities=23%  Similarity=0.358  Sum_probs=197.8

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLV   84 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   84 (324)
                      .-++|++++.||+|++|.||+|.+..+|+.||+|++..........+.+.++..+++.++||||+++++++.+++..++|
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv  102 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA  102 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence            45789999999999999999999999999999999976543332233444555677888999999999999999999999


Q ss_pred             EEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCc
Q 045787           85 FEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSL-KILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE  163 (324)
Q Consensus        85 ~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~  163 (324)
                      |||+++.+..........+++..++.++.+++.||.+||++ |++|+||+|+||+++ .++.++|+|||.+...... ..
T Consensus       103 ~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~~~~~-~~  180 (318)
T 2dyl_A          103 MELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDD-KA  180 (318)
T ss_dssp             ECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEEC-TTSCEEECCCTTC---------
T ss_pred             EeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEEC-CCCCEEEEECCCchhccCC-cc
Confidence            99997666666666567899999999999999999999995 999999999999999 8999999999998765432 22


Q ss_pred             ccccccccccCCchhhc----CCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhc
Q 045787          164 YSRDCVYSPYKAPELLL----GYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISE  239 (324)
Q Consensus       164 ~~~~~~~~~y~aPE~~~----~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
                      .....+++.|+|||++.    ....++.++||||||+++|+|++|..||.................++..          
T Consensus       181 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----------  250 (318)
T 2dyl_A          181 KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLL----------  250 (318)
T ss_dssp             ------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCC----------
T ss_pred             ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCC----------
Confidence            33456889999999985    2356789999999999999999999999764422211111111111100          


Q ss_pred             ccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCC
Q 045787          240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVE  294 (324)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~  294 (324)
                                    .....++..+.++|.+||+.||.+||+++++++||||++.+
T Consensus       251 --------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (318)
T 2dyl_A          251 --------------PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE  291 (318)
T ss_dssp             --------------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred             --------------CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence                          01125789999999999999999999999999999998765

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=4e-47  Score=330.94  Aligned_cols=270  Identities=24%  Similarity=0.369  Sum_probs=193.2

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCc---eEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCe
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQ---KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKD   80 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~---~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   80 (324)
                      +..++|++.+.||+|++|.||+|.+..++.   .||+|++..........+.+.+|+.++++++||||+++++++.....
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   99 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA   99 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence            567889999999999999999999887665   89999997665444445778899999999999999999999877665


Q ss_pred             E------EEEEEecCC-CHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEE
Q 045787           81 V------FLVFEYLDL-DLHSFITRHK-----NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKL  148 (324)
Q Consensus        81 ~------~iv~e~~~g-~l~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l  148 (324)
                      .      ++|+||+.+ +|.+++....     ..+++..++.++.+++.||.+||+.|++|+||||+||+++ .++.++|
T Consensus       100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~-~~~~~kl  178 (323)
T 3qup_A          100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA-EDMTVCV  178 (323)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC-TTSCEEE
T ss_pred             ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEc-CCCCEEE
Confidence            4      999999985 8888876543     1589999999999999999999999999999999999999 8899999


Q ss_pred             eeccceeeccCCCC--cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCC
Q 045787          149 ADFGLARAIGVPQK--EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGT  225 (324)
Q Consensus       149 ~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~  225 (324)
                      +|||.+........  ......+++.|+|||++.+ ..++.++||||||+++|+|++ |..||...+.............
T Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~  257 (323)
T 3qup_A          179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR  257 (323)
T ss_dssp             CCCCC-----------------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC
T ss_pred             eeccccccccccccccccccccCcccccCchhhcC-CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC
Confidence            99999976643221  1223345677999999987 668999999999999999999 9999988776554433322111


Q ss_pred             CCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCC-------HHHHhcCccccCCCCchh
Q 045787          226 PTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRIT-------AMDALKHEYLIGVENVPL  298 (324)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-------~~~~l~hp~~~~~~~~~~  298 (324)
                      +.                           ....+++.+.+++.+||+.||.+|||       ++++++|||+......|+
T Consensus       258 ~~---------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl  310 (323)
T 3qup_A          258 LK---------------------------QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPL  310 (323)
T ss_dssp             CC---------------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----------
T ss_pred             CC---------------------------CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCC
Confidence            11                           12367889999999999999999999       888999999999988887


Q ss_pred             hhhh
Q 045787          299 VILL  302 (324)
Q Consensus       299 ~~~~  302 (324)
                      ....
T Consensus       311 ~~~~  314 (323)
T 3qup_A          311 YINI  314 (323)
T ss_dssp             ----
T ss_pred             CCCC
Confidence            6543

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=4.7e-47  Score=330.04  Aligned_cols=262  Identities=26%  Similarity=0.361  Sum_probs=217.9

Q ss_pred             CcccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccC----CCchHHHHHHHHHHhcC--CCCeeEEEeee
Q 045787            2 GKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQE----GVPSYIIREVSLLKELE--HENIVRLLDVQ   75 (324)
Q Consensus         2 ~~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~----~~~~~~~~e~~~l~~l~--~~~i~~~~~~~   75 (324)
                      ++...++|++.+.||+|+||.||+|.+..+++.||+|++.......    .....+.+|+.++++++  |++++++++++
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~  117 (320)
T 3a99_A           38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF  117 (320)
T ss_dssp             --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred             cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence            4567889999999999999999999999999999999997654322    22355778999999996  59999999999


Q ss_pred             ecCCeEEEEEEecC--CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccc
Q 045787           76 SSRKDVFLVFEYLD--LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGL  153 (324)
Q Consensus        76 ~~~~~~~iv~e~~~--g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~  153 (324)
                      ...+..++|+|++.  ++|.+++... ..+++..++.++.+++.||.+||+.|++|+||||+||+++..++.++|+|||.
T Consensus       118 ~~~~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~  196 (320)
T 3a99_A          118 ERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS  196 (320)
T ss_dssp             ECSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred             ecCCcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence            99999999999997  5888888764 56999999999999999999999999999999999999985678999999999


Q ss_pred             eeeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccc
Q 045787          154 ARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAE  233 (324)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  233 (324)
                      +......  ......+++.|+|||++.+....+.++||||||+++|+|++|..||......     ..  ...       
T Consensus       197 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~~--~~~-------  260 (320)
T 3a99_A          197 GALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-----IR--GQV-------  260 (320)
T ss_dssp             CEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH-----HH--CCC-------
T ss_pred             ccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh-----hc--ccc-------
Confidence            9876532  2334568899999999987455578999999999999999999999543210     00  000       


Q ss_pred             hhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchhhh
Q 045787          234 STYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVI  300 (324)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~~~  300 (324)
                                          .....+++.+.++|.+||+.||.+|||+.++++||||+++.......
T Consensus       261 --------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~~~~~  307 (320)
T 3a99_A          261 --------------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETA  307 (320)
T ss_dssp             --------------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCHHHHH
T ss_pred             --------------------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccCccccc
Confidence                                01135789999999999999999999999999999999987655433

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2.3e-46  Score=321.95  Aligned_cols=263  Identities=26%  Similarity=0.370  Sum_probs=208.0

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE   86 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   86 (324)
                      .+|.....||+|++|.||+|.+..++..||+|.+.....  ...+.+.+|+.+++.++||||+++++++...+..++|+|
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   99 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS--RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFME   99 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC-----HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch--HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEE
Confidence            344555599999999999999999999999999875532  335678899999999999999999999999999999999


Q ss_pred             ecC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCc
Q 045787           87 YLD-LDLHSFITRHKN--TLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE  163 (324)
Q Consensus        87 ~~~-g~l~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~  163 (324)
                      |++ ++|.+++.....  .+++..++.++.+++.||.+||+.|++|+||+|+||+++..++.++|+|||.+.........
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~  179 (295)
T 2clq_A          100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC  179 (295)
T ss_dssp             CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred             eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCc
Confidence            997 588888876533  46789999999999999999999999999999999999944899999999999876544333


Q ss_pred             ccccccccccCCchhhcCC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHH-HHcCCCCcccccchhhhhccc
Q 045787          164 YSRDCVYSPYKAPELLLGY-TGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIF-SLLGTPTDESWAESTYISEIL  241 (324)
Q Consensus       164 ~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  241 (324)
                      .....+++.|+|||++.+. ..++.++||||||+++|+|++|..||............ ......               
T Consensus       180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------------  244 (295)
T 2clq_A          180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVH---------------  244 (295)
T ss_dssp             -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCC---------------
T ss_pred             ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccc---------------
Confidence            4455788999999998752 23789999999999999999999999654432221111 111100               


Q ss_pred             CCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCch
Q 045787          242 PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP  297 (324)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~  297 (324)
                                 ......++..+.++|.+||+.||.+||++.++++||||+.....+
T Consensus       245 -----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~  289 (295)
T 2clq_A          245 -----------PEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKK  289 (295)
T ss_dssp             -----------CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-----
T ss_pred             -----------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhccccC
Confidence                       011235789999999999999999999999999999999876544

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=8.5e-47  Score=325.61  Aligned_cols=265  Identities=27%  Similarity=0.391  Sum_probs=206.8

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeec-------
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS-------   77 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-------   77 (324)
                      ..++|++++.||+|++|.||+|.+..+++.||+|.+......   .+.+.+|+.++++++|||++++++++.+       
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK---LSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP   80 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHH---HHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHH---HHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence            356899999999999999999999999999999999654322   3668899999999999999999998754       


Q ss_pred             ------CCeEEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEee
Q 045787           78 ------RKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLAD  150 (324)
Q Consensus        78 ------~~~~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d  150 (324)
                            ....|+||||++ |+|.+++......+++..++.++.+++.||.+||++|++|+||+|+||+++ .++.++|+|
T Consensus        81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~-~~~~~kl~d  159 (303)
T 1zy4_A           81 MTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFID-ESRNVKIGD  159 (303)
T ss_dssp             -----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC-TTSCEEECC
T ss_pred             hcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEc-CCCCEEEee
Confidence                  457899999997 599999987766789999999999999999999999999999999999999 899999999


Q ss_pred             ccceeeccCC--------------CCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-hhH
Q 045787          151 FGLARAIGVP--------------QKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-HDH  215 (324)
Q Consensus       151 ~g~~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~  215 (324)
                      ||.+......              ........+++.|+|||++.+...++.++||||||+++|+|++   ||.... ...
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~  236 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN  236 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence            9998765422              1122344678889999999875678999999999999999998   554322 111


Q ss_pred             HHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCC
Q 045787          216 LSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVEN  295 (324)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~  295 (324)
                      ...........                        .........+..+.++|.+||+.||.+|||+.++++||||+....
T Consensus       237 ~~~~~~~~~~~------------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  292 (303)
T 1zy4_A          237 ILKKLRSVSIE------------------------FPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQ  292 (303)
T ss_dssp             HHHHHHSTTCC------------------------CCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCCH
T ss_pred             HHHhccccccc------------------------cCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCCh
Confidence            11111100000                        001112356778999999999999999999999999999987665


Q ss_pred             chhhh
Q 045787          296 VPLVI  300 (324)
Q Consensus       296 ~~~~~  300 (324)
                      .....
T Consensus       293 ~~~~~  297 (303)
T 1zy4_A          293 DEVIK  297 (303)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            54433

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=4.4e-47  Score=331.28  Aligned_cols=269  Identities=22%  Similarity=0.395  Sum_probs=194.2

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHH-HHHhcCCCCeeEEEeeeecCCeE
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVS-LLKELEHENIVRLLDVQSSRKDV   81 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~   81 (324)
                      .+..++|++++.||+|+||.||+|.+..+|+.||+|++........ ...+..|+. +++.++||||+++++++..++..
T Consensus        18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~   96 (327)
T 3aln_A           18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE-QKQLLMDLDVVMRSSDCPYIVQFYGALFREGDC   96 (327)
T ss_dssp             CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHH-HHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEE
T ss_pred             ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchH-HHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCce
Confidence            3567899999999999999999999999999999999976532221 233445555 67778999999999999999999


Q ss_pred             EEEEEecCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCCCCceEeecCCCcEEEeeccceee
Q 045787           82 FLVFEYLDLDLHSFITR----HKNTLNLLVIKAILKQILLGLAYCHSL-KILHRDLKPNNLLIDLKRNTVKLADFGLARA  156 (324)
Q Consensus        82 ~iv~e~~~g~l~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~Lh~~-g~~H~di~p~nIll~~~~~~v~l~d~g~~~~  156 (324)
                      ++||||++|++.+++..    ....+++..++.++.+++.||.+||+. |++|+||||+||+++ .++.++|+|||.+..
T Consensus        97 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~-~~~~~kl~Dfg~~~~  175 (327)
T 3aln_A           97 WICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLD-RSGNIKLCDFGISGQ  175 (327)
T ss_dssp             EEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEE-TTTEEEECCCSSSCC
T ss_pred             EEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEc-CCCCEEEccCCCcee
Confidence            99999999988887764    245799999999999999999999998 999999999999999 899999999999876


Q ss_pred             ccCCCCcccccccccccCCchhhc---CCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccc
Q 045787          157 IGVPQKEYSRDCVYSPYKAPELLL---GYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAE  233 (324)
Q Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  233 (324)
                      .... .......+++.|+|||++.   ....++.++||||||+++|+|++|..||........ .    .          
T Consensus       176 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~----~----------  239 (327)
T 3aln_A          176 LVDS-IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-Q----L----------  239 (327)
T ss_dssp             -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------------------
T ss_pred             cccc-cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-H----H----------
Confidence            6432 2233346889999999984   235679999999999999999999999965432110 0    0          


Q ss_pred             hhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCc
Q 045787          234 STYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENV  296 (324)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~  296 (324)
                          ..   ................+++.+.++|.+||+.||.+|||+.++++||||.+....
T Consensus       240 ----~~---~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~  295 (327)
T 3aln_A          240 ----TQ---VVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEER  295 (327)
T ss_dssp             ----CC---CCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHS
T ss_pred             ----HH---HhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHhh
Confidence                00   000000111111224688999999999999999999999999999999876543

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.6e-46  Score=322.03  Aligned_cols=259  Identities=20%  Similarity=0.256  Sum_probs=212.8

Q ss_pred             CcccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhc-CCCCeeEEEeeeecCCe
Q 045787            2 GKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKD   80 (324)
Q Consensus         2 ~~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~   80 (324)
                      +++..++|++.+.||+|++|.||+|.+..+++.||+|++.....    ...+.+|+.+++.+ +|++++++++++.+...
T Consensus         5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~   80 (298)
T 1csn_A            5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH   80 (298)
T ss_dssp             -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred             CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCce
Confidence            56789999999999999999999999999999999999864432    34578999999999 69999999999999999


Q ss_pred             EEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCc-----EEEeecccee
Q 045787           81 VFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNT-----VKLADFGLAR  155 (324)
Q Consensus        81 ~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~-----v~l~d~g~~~  155 (324)
                      .++|+||++++|.+++.....++++..++.++.|++.||.+||++|++|+||||+||+++ .++.     ++|+|||.+.
T Consensus        81 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~-~~~~~~~~~~kl~Dfg~~~  159 (298)
T 1csn_A           81 NVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIG-RPNSKNANMIYVVDFGMVK  159 (298)
T ss_dssp             EEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC-CSSSTTTTCEEECCCTTCE
T ss_pred             eEEEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEec-cCCCCCCCeEEEEECcccc
Confidence            999999998899999988777899999999999999999999999999999999999998 5554     9999999998


Q ss_pred             eccCCCC-------cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCc
Q 045787          156 AIGVPQK-------EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTD  228 (324)
Q Consensus       156 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  228 (324)
                      .......       ......+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||...+..............  
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~--  236 (298)
T 1csn_A          160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK--  236 (298)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH--
T ss_pred             ccccccccccccccCccCCCCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh--
Confidence            7654322       2344568899999999987 66899999999999999999999999875422111111000000  


Q ss_pred             ccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          229 ESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                        ............+++.+.+++.+||+.||.+||+++++++
T Consensus       237 ------------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          237 ------------------KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             ------------------HHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             ------------------ccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence                              0001112233468999999999999999999999999985

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.4e-46  Score=325.62  Aligned_cols=260  Identities=23%  Similarity=0.346  Sum_probs=211.8

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   83 (324)
                      +..++|++.+.||+|+||+||+|.+..+++.+|+|.+.....  ...+.+.+|+.++++++||||+++++++.+++..++
T Consensus         7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   84 (310)
T 3s95_A            7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDE--ETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNF   84 (310)
T ss_dssp             ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCH--HHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEE
Confidence            456899999999999999999999999999999998854322  224678899999999999999999999999999999


Q ss_pred             EEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC
Q 045787           84 VFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK  162 (324)
Q Consensus        84 v~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~  162 (324)
                      ||||++| +|.+++......+++..+..++.+++.||.+||++|++|+||||+||+++ .++.++|+|||.+........
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           85 ITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVR-ENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             EEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEC-TTSCEEECCCTTCEECC----
T ss_pred             EEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEEC-CCCCEEEeecccceecccccc
Confidence            9999975 99999888777899999999999999999999999999999999999999 899999999999987643322


Q ss_pred             cc--------------cccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCc
Q 045787          163 EY--------------SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTD  228 (324)
Q Consensus       163 ~~--------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  228 (324)
                      ..              ....||+.|+|||++.+ ..++.++||||||+++|+|++|..||........           .
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~-----------~  231 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM-----------D  231 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCT-----------T
T ss_pred             cccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHH-----------H
Confidence            11              13468899999999987 7789999999999999999999998854332110           0


Q ss_pred             ccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCC
Q 045787          229 ESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVE  294 (324)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~  294 (324)
                      .......              .......+.+++.+.+++.+||+.||.+|||+.++++  |++.+.
T Consensus       232 ~~~~~~~--------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l~  281 (310)
T 3s95_A          232 FGLNVRG--------------FLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETLR  281 (310)
T ss_dssp             SSBCHHH--------------HHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHH
T ss_pred             Hhhhhhc--------------cccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHHH
Confidence            0000000              0001112468889999999999999999999999997  555543

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.8e-46  Score=318.42  Aligned_cols=251  Identities=21%  Similarity=0.322  Sum_probs=210.0

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   83 (324)
                      +..++|++++.||+|++|.||+|.+. ++..||+|++......   .+.+.+|+.++++++||||+++++++.+++..++
T Consensus         7 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (269)
T 4hcu_A            7 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL   82 (269)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             eChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEE
Confidence            45689999999999999999999986 4678999998754432   3568899999999999999999999999999999


Q ss_pred             EEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC
Q 045787           84 VFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK  162 (324)
Q Consensus        84 v~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~  162 (324)
                      ||||+++ +|.+++......+++..++.++.+++.||.+||+.|++|+||||+||+++ .++.++|+|||.+........
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~  161 (269)
T 4hcu_A           83 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG-ENQVIKVSDFGMTRFVLDDQY  161 (269)
T ss_dssp             EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC-GGGCEEECCTTGGGGBCCHHH
T ss_pred             EEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEc-CCCCEEecccccccccccccc
Confidence            9999975 88888887777899999999999999999999999999999999999999 889999999999876542211


Q ss_pred             -cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcc
Q 045787          163 -EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEI  240 (324)
Q Consensus       163 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (324)
                       ......+++.|+|||++.+ ..++.++||||||+++|+|++ |..||.................+.             
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~-------------  227 (269)
T 4hcu_A          162 TSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY-------------  227 (269)
T ss_dssp             HSTTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC-------------
T ss_pred             ccccCcccccccCCHHHhcC-CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCC-------------
Confidence             2223345677999999987 668999999999999999999 999998877655443332111110             


Q ss_pred             cCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcC
Q 045787          241 LPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH  287 (324)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~h  287 (324)
                                    ....+++.+.+++.+||+.||.+|||+.++++|
T Consensus       228 --------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          228 --------------KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             --------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence                          112468899999999999999999999999974

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.4e-46  Score=327.64  Aligned_cols=254  Identities=24%  Similarity=0.346  Sum_probs=209.6

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccCCc---eEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCC
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQ---KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK   79 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~---~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   79 (324)
                      .+..++|++.+.||+|+||.||+|.+..++.   .||+|++...... ...+.+.+|+.++++++||||+++++++.+.+
T Consensus        45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  123 (325)
T 3kul_A           45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTE-RQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR  123 (325)
T ss_dssp             BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG
T ss_pred             ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCH-HHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            5677899999999999999999999986555   4999998754321 22356889999999999999999999999999


Q ss_pred             eEEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeecc
Q 045787           80 DVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIG  158 (324)
Q Consensus        80 ~~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~  158 (324)
                      ..++||||++ |+|.+++......+++..++.++.+++.||.+||+.|++|+||||+||+++ .++.++|+|||.+....
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          124 LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVD-SNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-TTCCEEECCCSSCEECC
T ss_pred             ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEC-CCCCEEECCCCcccccc
Confidence            9999999997 489888877767899999999999999999999999999999999999999 89999999999998765


Q ss_pred             CCCCc---ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccch
Q 045787          159 VPQKE---YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAES  234 (324)
Q Consensus       159 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (324)
                      .....   .....+++.|+|||++.+ ..++.++||||||+++|+|++ |..||..................+       
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~-------  274 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIAF-RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP-------  274 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC-------
T ss_pred             cCccceeeccCCCCcccccCHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCC-------
Confidence            33222   222344667999999987 567999999999999999999 999998877655544333211111       


Q ss_pred             hhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          235 TYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                          ....+++.+.++|.+||+.||.+|||+.++++
T Consensus       275 --------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          275 --------------------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             --------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                                11257899999999999999999999999996

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2.7e-46  Score=317.21  Aligned_cols=252  Identities=23%  Similarity=0.311  Sum_probs=210.9

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF   82 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   82 (324)
                      ++..++|++++.||+|++|.||+|.+. ++..||+|++......   .+.+.+|+.++++++||||+++++++.++...+
T Consensus         4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (268)
T 3sxs_A            4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS---EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIY   79 (268)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred             EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc---HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceE
Confidence            467889999999999999999999876 5678999998754432   356889999999999999999999999999999


Q ss_pred             EEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC
Q 045787           83 LVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        83 iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~  161 (324)
                      +||||++ ++|.+++......+++..++.++.+++.||.+||+.|++|+||||+||+++ .++.++|+|||.+.......
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~-~~~~~~l~Dfg~~~~~~~~~  158 (268)
T 3sxs_A           80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVD-RDLCVKVSDFGMTRYVLDDQ  158 (268)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEEC-TTCCEEECCTTCEEECCTTC
T ss_pred             EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEEC-CCCCEEEccCccceecchhh
Confidence            9999997 589998888777799999999999999999999999999999999999999 89999999999998765332


Q ss_pred             Cc-ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhc
Q 045787          162 KE-YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISE  239 (324)
Q Consensus       162 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
                      .. .....+++.|+|||++.+ ..++.++||||||+++|+|++ |..||....................           
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~-----------  226 (268)
T 3sxs_A          159 YVSSVGTKFPVKWSAPEVFHY-FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR-----------  226 (268)
T ss_dssp             EEECCSCCCCGGGCCHHHHHH-SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC-----------
T ss_pred             hhcccCCCcCcccCCHHHHhc-cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCC-----------
Confidence            22 222345667999999987 567999999999999999999 9999987775554433321111110           


Q ss_pred             ccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcC
Q 045787          240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH  287 (324)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~h  287 (324)
                                      ....++.+.+++.+||+.||.+|||+.+++++
T Consensus       227 ----------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          227 ----------------PHLASDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             ----------------CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ----------------CCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                            12467889999999999999999999999973

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=3.1e-46  Score=323.98  Aligned_cols=263  Identities=27%  Similarity=0.413  Sum_probs=207.9

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcC--CCCeeEEEeeeecCCe
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE--HENIVRLLDVQSSRKD   80 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~   80 (324)
                      .+..++|++++.||+|++|.||+|.+. +++.||+|++..........+.+.+|+.++++++  ||+++++++++.+++.
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~  102 (313)
T 3cek_A           24 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY  102 (313)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred             eeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence            356788999999999999999999986 4889999999765444334567889999999997  5999999999999999


Q ss_pred             EEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           81 VFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        81 ~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      .++|||+.+++|.+++... ..+++..++.++.+++.||.+||+.|++|+||||+||+++  ++.++|+|||.+......
T Consensus       103 ~~lv~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~--~~~~kL~Dfg~~~~~~~~  179 (313)
T 3cek_A          103 IYMVMECGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPD  179 (313)
T ss_dssp             EEEEECCCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE--TTEEEECCCSSSCC----
T ss_pred             EEEEEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE--CCeEEEeeccccccccCc
Confidence            9999997778999998874 4699999999999999999999999999999999999998  489999999998766433


Q ss_pred             CC--cccccccccccCCchhhcC----------CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCc
Q 045787          161 QK--EYSRDCVYSPYKAPELLLG----------YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTD  228 (324)
Q Consensus       161 ~~--~~~~~~~~~~y~aPE~~~~----------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  228 (324)
                      ..  ......+++.|+|||++.+          ...++.++||||||+++|+|++|..||......... ..........
T Consensus       180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~  258 (313)
T 3cek_A          180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK-LHAIIDPNHE  258 (313)
T ss_dssp             ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH-HHHHHCTTSC
T ss_pred             cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH-HHHHHhcccc
Confidence            22  1233468899999999865          146788999999999999999999999765432211 1111111000


Q ss_pred             ccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCC
Q 045787          229 ESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVE  294 (324)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~  294 (324)
                                              .......+..+.++|.+||+.||.+||++.++++||||+...
T Consensus       259 ------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  300 (313)
T 3cek_A          259 ------------------------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  300 (313)
T ss_dssp             ------------------------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred             ------------------------cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence                                    001124578899999999999999999999999999998754

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=6.2e-46  Score=324.42  Aligned_cols=256  Identities=23%  Similarity=0.302  Sum_probs=209.5

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDVF   82 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~   82 (324)
                      +.+++|++.+.||+|+||.||+|.+..+|+.||+|++.....    .+.+.+|+.+++++ +||||+++++++......+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~   81 (330)
T 2izr_A            6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA   81 (330)
T ss_dssp             EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred             EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence            467889999999999999999999999999999999875432    24588999999999 8999999999999999999


Q ss_pred             EEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCc-----EEEeeccceeec
Q 045787           83 LVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNT-----VKLADFGLARAI  157 (324)
Q Consensus        83 iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~-----v~l~d~g~~~~~  157 (324)
                      +||||++++|.+++......+++..++.++.+++.||.|||+.|++|+||||+||+++ .++.     ++|+|||.+...
T Consensus        82 lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~-~~~~~~~~~~kl~DFg~a~~~  160 (330)
T 2izr_A           82 MVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIG-RPGNKTQQVIHIIDFALAKEY  160 (330)
T ss_dssp             EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC-CGGGTCTTSEEECCCTTCEES
T ss_pred             EEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec-cCCCCCCceEEEEEcccceee
Confidence            9999998899999988777899999999999999999999999999999999999998 6666     999999999876


Q ss_pred             cCCCCc-------ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCccc
Q 045787          158 GVPQKE-------YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDES  230 (324)
Q Consensus       158 ~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  230 (324)
                      ......       .....||+.|+|||++.+ ..++.++||||||+++|+|++|..||...+................  
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~--  237 (330)
T 2izr_A          161 IDPETKKHIPYREHKSLTGTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR--  237 (330)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH--
T ss_pred             ecCCCCccccccccCCcCCCccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc--
Confidence            433221       245578999999999988 6789999999999999999999999987654332222111100000  


Q ss_pred             ccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          231 WAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                        ...........+ ++.+++..||+.||.+||+++++++
T Consensus       238 ------------------~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          238 ------------------ATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             ------------------HSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             ------------------cCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence                              000011112345 8999999999999999999999886

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=9.8e-46  Score=316.87  Aligned_cols=255  Identities=24%  Similarity=0.316  Sum_probs=209.8

Q ss_pred             CcccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCC-----CchHHHHHHHHHHhcCCCCeeEEEeeee
Q 045787            2 GKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEG-----VPSYIIREVSLLKELEHENIVRLLDVQS   76 (324)
Q Consensus         2 ~~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~   76 (324)
                      ..+..++|++.+.||+|++|.||+|.+..+++.||+|++........     ..+.+.+|+.++++++||||+++++++.
T Consensus        14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   93 (287)
T 4f0f_A           14 PTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH   93 (287)
T ss_dssp             CBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET
T ss_pred             hhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeec
Confidence            45778999999999999999999999999999999999876543322     2267889999999999999999999997


Q ss_pred             cCCeEEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcccCCCCCceEeecCCCc-----EEE
Q 045787           77 SRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK--ILHRDLKPNNLLIDLKRNT-----VKL  148 (324)
Q Consensus        77 ~~~~~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g--~~H~di~p~nIll~~~~~~-----v~l  148 (324)
                      +..  ++||||+. |+|.+.+.....++++..++.++.+++.||.+||+.|  ++|+||||+||+++ .++.     ++|
T Consensus        94 ~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~-~~~~~~~~~~kl  170 (287)
T 4f0f_A           94 NPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQ-SLDENAPVCAKV  170 (287)
T ss_dssp             TTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEES-CCCTTCSCCEEE
T ss_pred             CCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEe-ccCCCCceeEEe
Confidence            665  69999998 6898988887778999999999999999999999999  99999999999998 5554     999


Q ss_pred             eeccceeeccCCCCcccccccccccCCchhhcC-CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCC
Q 045787          149 ADFGLARAIGVPQKEYSRDCVYSPYKAPELLLG-YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPT  227 (324)
Q Consensus       149 ~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  227 (324)
                      +|||.+....   .......+++.|+|||++.. ...++.++||||||+++|+|++|..||...................
T Consensus       171 ~Dfg~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  247 (287)
T 4f0f_A          171 ADFGLSQQSV---HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL  247 (287)
T ss_dssp             CCCTTCBCCS---SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC
T ss_pred             CCCCcccccc---ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC
Confidence            9999987543   23344578899999999843 3556889999999999999999999998766544422222111110


Q ss_pred             cccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          228 DESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      .                        ......+++.+.++|.+||+.||.+|||+.++++
T Consensus       248 ~------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          248 R------------------------PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             C------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             C------------------------CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            0                        0012357889999999999999999999999986

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-46  Score=332.12  Aligned_cols=261  Identities=22%  Similarity=0.355  Sum_probs=212.2

Q ss_pred             CcccCcCcceeEeecccCceEEEEEE-----EccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeee
Q 045787            2 GKLKNLNYKKIKKIGAGGYGEVYKCR-----NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQS   76 (324)
Q Consensus         2 ~~~~~~~y~i~~~Lg~g~~~~v~~a~-----~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   76 (324)
                      ..+..++|++.+.||+|+||.||+|.     +..++..||+|++...... .....+.+|+.++++++||||+++++++.
T Consensus        66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  144 (367)
T 3l9p_A           66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFLMEALIISKFNHQNIVRCIGVSL  144 (367)
T ss_dssp             CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccCh-hhHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            34567899999999999999999999     4557789999998643222 12345788999999999999999999999


Q ss_pred             cCCeEEEEEEecC-CCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCC---cE
Q 045787           77 SRKDVFLVFEYLD-LDLHSFITRHK------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN---TV  146 (324)
Q Consensus        77 ~~~~~~iv~e~~~-g~l~~~~~~~~------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~---~v  146 (324)
                      +....++||||+. |+|.+++....      ..+++..++.++.+++.||.|||++|++||||||+||+++ .++   .+
T Consensus       145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~-~~~~~~~~  223 (367)
T 3l9p_A          145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLT-CPGPGRVA  223 (367)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEES-CSSTTCCE
T ss_pred             cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEe-cCCCCceE
Confidence            9999999999996 59999888754      3589999999999999999999999999999999999998 444   59


Q ss_pred             EEeeccceeeccCC--CCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHc
Q 045787          147 KLADFGLARAIGVP--QKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLL  223 (324)
Q Consensus       147 ~l~d~g~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~  223 (324)
                      +|+|||.+......  ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||...............
T Consensus       224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~  302 (367)
T 3l9p_A          224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG  302 (367)
T ss_dssp             EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred             EECCCccccccccccccccCCCcCCcccEECHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            99999998754321  222334567888999999987 678999999999999999998 99999888766554444322


Q ss_pred             CCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccC
Q 045787          224 GTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIG  292 (324)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~  292 (324)
                      ..+..                           ...++..+.+++.+||+.||.+|||+.+++++.++..
T Consensus       303 ~~~~~---------------------------~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          303 GRMDP---------------------------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             CCCCC---------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCC---------------------------CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            21111                           1257889999999999999999999999999877653

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=4.8e-46  Score=319.06  Aligned_cols=249  Identities=16%  Similarity=0.288  Sum_probs=206.4

Q ss_pred             CcccCcCcceeEeecccCceEEEEEEEccCC-------ceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEee
Q 045787            2 GKLKNLNYKKIKKIGAGGYGEVYKCRNTVTG-------QKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDV   74 (324)
Q Consensus         2 ~~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~-------~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~   74 (324)
                      ..+..++|++.+.||+|+||.||+|.+..++       ..+++|++......  ..+.+.+|+.++++++||||++++++
T Consensus         3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~   80 (289)
T 4fvq_A            3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRN--YSESFFEAASMMSKLSHKHLVLNYGV   80 (289)
T ss_dssp             CBCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGG--GHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred             EEechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHH--HHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence            5678899999999999999999999988776       46999998654332  34678899999999999999999999


Q ss_pred             eecCCeEEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCc--------
Q 045787           75 QSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNT--------  145 (324)
Q Consensus        75 ~~~~~~~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~--------  145 (324)
                      +.+++..++||||++ |+|.+++......+++..++.++.+++.||.+||++|++|+||||+||+++ .++.        
T Consensus        81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~-~~~~~~~~~~~~  159 (289)
T 4fvq_A           81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLI-REEDRKTGNPPF  159 (289)
T ss_dssp             ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-ECCBGGGTBCCE
T ss_pred             EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEe-cCCcccccccce
Confidence            999999999999998 599999988766799999999999999999999999999999999999998 6665        


Q ss_pred             EEEeeccceeeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhC-CCCCCCCChhHHHHHHHHcC
Q 045787          146 VKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITG-KPLFPSKKHDHLSLIFSLLG  224 (324)
Q Consensus       146 v~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g-~~pf~~~~~~~~~~~~~~~~  224 (324)
                      ++|+|||.+....    ......+++.|+|||++.+...++.++||||||+++|+|++| .+||................
T Consensus       160 ~kl~Dfg~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~  235 (289)
T 4fvq_A          160 IKLSDPGISITVL----PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRH  235 (289)
T ss_dssp             EEECCCCSCTTTS----CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC
T ss_pred             eeeccCccccccc----CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccC
Confidence            9999999886442    223345788899999998756789999999999999999995 45555544433322222110


Q ss_pred             CCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          225 TPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      .                             .....++.+.+++.+||+.||.+|||+.++++
T Consensus       236 ~-----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  268 (289)
T 4fvq_A          236 Q-----------------------------LPAPKAAELANLINNCMDYEPDHRPSFRAIIR  268 (289)
T ss_dssp             C-----------------------------CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             C-----------------------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            0                             11245778999999999999999999999997

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=8.5e-46  Score=328.13  Aligned_cols=253  Identities=25%  Similarity=0.384  Sum_probs=208.5

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEc-------cCCceEEEEEeeeccccCCCchHHHHHHHHHHhc-CCCCeeEEEeee
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNT-------VTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQ   75 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~-------~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~   75 (324)
                      +..++|++.+.||+|+||.||+|.+.       .++..||+|++..... ....+.+.+|+.+++.+ +||||+++++++
T Consensus        78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  156 (370)
T 2psq_A           78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGAC  156 (370)
T ss_dssp             CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCB-HHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred             ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcC-HHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            34578999999999999999999874       3455799999875432 22245688999999999 899999999999


Q ss_pred             ecCCeEEEEEEecC-CCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEe
Q 045787           76 SSRKDVFLVFEYLD-LDLHSFITRHK---------------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLI  139 (324)
Q Consensus        76 ~~~~~~~iv~e~~~-g~l~~~~~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll  139 (324)
                      .+++.+|+||||+. |+|.+++....               ..++...++.++.||+.||.|||++|++|+||||+||++
T Consensus       157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll  236 (370)
T 2psq_A          157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV  236 (370)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred             ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE
Confidence            99999999999997 49999887753               247899999999999999999999999999999999999


Q ss_pred             ecCCCcEEEeeccceeeccCCCC--cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHH
Q 045787          140 DLKRNTVKLADFGLARAIGVPQK--EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHL  216 (324)
Q Consensus       140 ~~~~~~v~l~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~  216 (324)
                      + .++.+||+|||.+........  ......+++.|+|||++.+ ..++.++||||||+++|+|++ |..||........
T Consensus       237 ~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~  314 (370)
T 2psq_A          237 T-ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  314 (370)
T ss_dssp             C-TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred             C-CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence            9 899999999999987653322  2233456778999999987 678999999999999999999 9999987775554


Q ss_pred             HHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          217 SLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      .........+                           .....++..+.++|.+||+.||.+||++.++++
T Consensus       315 ~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~  357 (370)
T 2psq_A          315 FKLLKEGHRM---------------------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE  357 (370)
T ss_dssp             HHHHHTTCCC---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhcCCCC---------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            4332211111                           011357889999999999999999999999996

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=5.3e-46  Score=319.78  Aligned_cols=270  Identities=25%  Similarity=0.382  Sum_probs=205.2

Q ss_pred             CcccCcCcceeEeecccCceEEEEEE----EccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeec
Q 045787            2 GKLKNLNYKKIKKIGAGGYGEVYKCR----NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS   77 (324)
Q Consensus         2 ~~~~~~~y~i~~~Lg~g~~~~v~~a~----~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   77 (324)
                      +++..++|++++.||+|+||+||+|.    +..+++.||+|++......  ..+.+.+|+.++++++||||+++++++..
T Consensus         5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   82 (295)
T 3ugc_A            5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVKYKGVCYS   82 (295)
T ss_dssp             -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHH--HHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred             CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            46788999999999999999999998    5678899999998754322  23568899999999999999999998854


Q ss_pred             --CCeEEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccce
Q 045787           78 --RKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLA  154 (324)
Q Consensus        78 --~~~~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~  154 (324)
                        ....++||||++ |+|.+++......+++..++.++.+++.||.+||+.|++|+||||+||+++ .++.++|+|||.+
T Consensus        83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~-~~~~~kl~Dfg~~  161 (295)
T 3ugc_A           83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE-NENRVKIGDFGLT  161 (295)
T ss_dssp             HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE-ETTEEEECCCCSC
T ss_pred             CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEc-CCCeEEEccCccc
Confidence              456899999996 599999988777799999999999999999999999999999999999999 8899999999999


Q ss_pred             eeccCCCC---cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccc
Q 045787          155 RAIGVPQK---EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESW  231 (324)
Q Consensus       155 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  231 (324)
                      ........   ......+++.|+|||++.+ ..++.++||||||+++|+|++|..|+.........    ..+.......
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~----~~~~~~~~~~  236 (295)
T 3ugc_A          162 KVLPQDKEFFKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMR----MIGNDKQGQM  236 (295)
T ss_dssp             C-------------CTTCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHH----HHCTTCCTHH
T ss_pred             ccccCCcceeeeccCCCCccceeCcHHhcC-CCCChHHHHHHHHHHHHHHHhcccccCCChHHHHh----hhcCccccch
Confidence            87643322   1222345667999999987 66899999999999999999999998654322111    1111111100


Q ss_pred             cchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          232 AESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      ..............       ......+++++.+++.+||+.||.+|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          237 IVFHLIELLKNNGR-------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HHHHHHHHHHTTCC-------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hHHHHHHHHhccCc-------CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            00000000000000       0112367899999999999999999999999985

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=9e-46  Score=316.47  Aligned_cols=251  Identities=21%  Similarity=0.316  Sum_probs=206.7

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   83 (324)
                      +..++|++++.||+|+||.||++.+. ++..||+|++......   .+.+.+|+.++++++||||+++++++.+++..++
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   96 (283)
T 3gen_A           21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI   96 (283)
T ss_dssp             CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC---HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEE
Confidence            56689999999999999999999876 5678999998754332   3668899999999999999999999999999999


Q ss_pred             EEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC
Q 045787           84 VFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK  162 (324)
Q Consensus        84 v~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~  162 (324)
                      ||||++ ++|.+++......+++..++.++.+++.||.+||++|++|+||||+||+++ .++.++|+|||.+........
T Consensus        97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~-~~~~~kl~Dfg~~~~~~~~~~  175 (283)
T 3gen_A           97 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN-DQGVVKVSDFGLSRYVLDDEY  175 (283)
T ss_dssp             EECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEEC-TTSCEEECSTTGGGGBCCHHH
T ss_pred             EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEc-CCCCEEEcccccccccccccc
Confidence            999996 589998887667899999999999999999999999999999999999999 899999999999876542211


Q ss_pred             -cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcc
Q 045787          163 -EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEI  240 (324)
Q Consensus       163 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (324)
                       ......+++.|+|||++.+ ..++.++||||||+++|+|++ |..||...................             
T Consensus       176 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~-------------  241 (283)
T 3gen_A          176 TSSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY-------------  241 (283)
T ss_dssp             HSTTSTTSCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC-------------
T ss_pred             ccccCCccCcccCCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCC-------------
Confidence             1222345677999999987 567999999999999999998 999998877655444333211110             


Q ss_pred             cCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcC
Q 045787          241 LPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH  287 (324)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~h  287 (324)
                                    .....++.+.++|.+||+.||.+|||+.++++|
T Consensus       242 --------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          242 --------------RPHLASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             --------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             --------------CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                          012467899999999999999999999999974

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-46  Score=325.14  Aligned_cols=258  Identities=25%  Similarity=0.393  Sum_probs=201.5

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccC----CCchHHHHHHHHHHhc----CCCCeeEEEee
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQE----GVPSYIIREVSLLKEL----EHENIVRLLDV   74 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~----~~~~~~~~e~~~l~~l----~~~~i~~~~~~   74 (324)
                      ....++|++.+.||+|++|.||+|.+..+++.||+|++.......    .....+.+|+.++.++    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            456789999999999999999999999999999999997554221    1233456799999998    89999999999


Q ss_pred             eecCCeEEEEEEe-cC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeecc
Q 045787           75 QSSRKDVFLVFEY-LD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFG  152 (324)
Q Consensus        75 ~~~~~~~~iv~e~-~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g  152 (324)
                      +...+..++|+|+ +. ++|.+++... ..+++..++.++.+++.||.+||+.|++|+||+|+||+++..++.++|+|||
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg  185 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG  185 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCS
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcc
Confidence            9999999999999 55 5888888764 4699999999999999999999999999999999999998667899999999


Q ss_pred             ceeeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCccccc
Q 045787          153 LARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWA  232 (324)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  232 (324)
                      .+......  ......+++.|+|||++.+....+.++||||||+++|+|++|+.||.....     ...  ..       
T Consensus       186 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~--~~-------  249 (312)
T 2iwi_A          186 SGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-----ILE--AE-------  249 (312)
T ss_dssp             SCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----HHH--TC-------
T ss_pred             hhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-----Hhh--hc-------
Confidence            98876532  234456889999999987645456689999999999999999999964321     000  00       


Q ss_pred             chhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCch
Q 045787          233 ESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP  297 (324)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~  297 (324)
                                          ......++..+.++|.+||+.||.+|||+.++++||||+......
T Consensus       250 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~~~  294 (312)
T 2iwi_A          250 --------------------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDV  294 (312)
T ss_dssp             --------------------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-----
T ss_pred             --------------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchhcc
Confidence                                001135788999999999999999999999999999999876543

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1e-45  Score=322.35  Aligned_cols=253  Identities=22%  Similarity=0.299  Sum_probs=206.1

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCce----EEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCC
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQK----VAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK   79 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~----~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   79 (324)
                      +..++|++++.||+|+||.||+|.+..++..    +++|.+..... ......+.+|+.++++++||||+++++++. ++
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~   87 (325)
T 3kex_A           10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GS   87 (325)
T ss_dssp             CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BS
T ss_pred             cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CC
Confidence            5678999999999999999999999888876    66666643332 223455778999999999999999999886 45


Q ss_pred             eEEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeecc
Q 045787           80 DVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIG  158 (324)
Q Consensus        80 ~~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~  158 (324)
                      ..++|+||+. |+|.+++......+++..++.++.+++.||.|||+.|++|+||||+||+++ .++.++|+|||.+....
T Consensus        88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~-~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLK-SPSQVQVADFGVADLLP  166 (325)
T ss_dssp             SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEES-SSSCEEECSCSGGGGSC
T ss_pred             ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEEC-CCCeEEECCCCcccccC
Confidence            6889999997 699999887767899999999999999999999999999999999999999 89999999999998764


Q ss_pred             CCCC--cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchh
Q 045787          159 VPQK--EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAEST  235 (324)
Q Consensus       159 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (324)
                      ....  ......+++.|+|||++.+ ..++.++||||||+++|+|++ |..||....................       
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~-------  238 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHF-GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQ-------  238 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCC-------
T ss_pred             cccccccccCCCCcccccChHHhcc-CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCC-------
Confidence            3322  2233456778999999987 668999999999999999999 9999988776655444332211111       


Q ss_pred             hhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcC
Q 045787          236 YISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH  287 (324)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~h  287 (324)
                                          ....+..+.+++.+||+.||.+||++.+++++
T Consensus       239 --------------------~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          239 --------------------PQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             --------------------CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             --------------------CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                12357788899999999999999999999975

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=4.4e-46  Score=330.93  Aligned_cols=253  Identities=25%  Similarity=0.370  Sum_probs=210.0

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   83 (324)
                      +..++|++.+.||+|+||.||+|.+..+++.||+|++..... ....+.+.+|+.++++++||||+++++++..++..++
T Consensus       111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  189 (377)
T 3cbl_A          111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP-PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI  189 (377)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSC-HHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCC-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence            456789999999999999999999998999999999874321 1123457789999999999999999999999999999


Q ss_pred             EEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC
Q 045787           84 VFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK  162 (324)
Q Consensus        84 v~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~  162 (324)
                      ||||++ |+|.+++......+++..+..++.+++.||.|||++|++|+||||+||+++ .++.+||+|||.+........
T Consensus       190 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~-~~~~~kl~DfG~s~~~~~~~~  268 (377)
T 3cbl_A          190 VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVT-EKNVLKISDFGMSREEADGVY  268 (377)
T ss_dssp             EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-TTCCEEECCGGGCEECTTSEE
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEc-CCCcEEECcCCCceecCCCce
Confidence            999997 699999887767799999999999999999999999999999999999999 899999999999876532211


Q ss_pred             c--ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhc
Q 045787          163 E--YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISE  239 (324)
Q Consensus       163 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
                      .  .....+++.|+|||++.+ ..++.++||||||+++|+|++ |..||...+..............+            
T Consensus       269 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~------------  335 (377)
T 3cbl_A          269 AASGGLRQVPVKWTAPEALNY-GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLP------------  335 (377)
T ss_dssp             ECCSSCCEEEGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCC------------
T ss_pred             eecCCCCCCCcCcCCHhHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC------------
Confidence            1  112234667999999986 567999999999999999998 999998877655544333211111            


Q ss_pred             ccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                     ....+++.+.+++.+||+.||.+|||+.++++
T Consensus       336 ---------------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          336 ---------------CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             ---------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                           11247889999999999999999999999985

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3.3e-45  Score=317.01  Aligned_cols=259  Identities=26%  Similarity=0.387  Sum_probs=197.7

Q ss_pred             CcccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCe
Q 045787            2 GKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKD   80 (324)
Q Consensus         2 ~~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   80 (324)
                      |....++|++.+.||+|++|.||+|.+..+|+.||+|++..... .......+.+|+.++++++||||+++++++..++.
T Consensus        27 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~  106 (310)
T 2wqm_A           27 GYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE  106 (310)
T ss_dssp             TTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             ccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCc
Confidence            45567899999999999999999999999999999999875332 22234568899999999999999999999999999


Q ss_pred             EEEEEEecCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceee
Q 045787           81 VFLVFEYLDL-DLHSFITR---HKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARA  156 (324)
Q Consensus        81 ~~iv~e~~~g-~l~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~  156 (324)
                      .++|+||+++ +|.+++..   ....+++..++.++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+..
T Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~-~~~~~kl~Dfg~~~~  185 (310)
T 2wqm_A          107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT-ATGVVKLGDLGLGRF  185 (310)
T ss_dssp             EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC-TTSCEEECCC-----
T ss_pred             EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEc-CCCCEEEEeccceee
Confidence            9999999985 88887764   345699999999999999999999999999999999999999 899999999999877


Q ss_pred             ccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhh
Q 045787          157 IGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY  236 (324)
Q Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (324)
                      ............+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.................         
T Consensus       186 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------  255 (310)
T 2wqm_A          186 FSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY---------  255 (310)
T ss_dssp             -------------CCSSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCS---------
T ss_pred             ecCCCccccccCCCeeEeChHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccC---------
Confidence            6544444444568899999999987 678999999999999999999999997654322211111111000         


Q ss_pred             hhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          237 ISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                              ..       .....++..+.++|.+||+.||.+|||+.++++
T Consensus       256 --------~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~  290 (310)
T 2wqm_A          256 --------PP-------LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD  290 (310)
T ss_dssp             --------CC-------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------CC-------CcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                    00       001357889999999999999999999999996

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.2e-45  Score=315.04  Aligned_cols=257  Identities=23%  Similarity=0.351  Sum_probs=198.5

Q ss_pred             CcccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeE
Q 045787            2 GKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV   81 (324)
Q Consensus         2 ~~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   81 (324)
                      +++..++|++.+.||+|+||+||++.+.   ..+|+|++..........+.+.+|+.++++++|||+++++++. .....
T Consensus        19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~   94 (289)
T 3og7_A           19 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQL   94 (289)
T ss_dssp             CBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSC
T ss_pred             CccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCcc
Confidence            5788999999999999999999999864   3599999976654444456788999999999999999999965 55678


Q ss_pred             EEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           82 FLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        82 ~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      ++|+||++ ++|.+.+......+++..++.++.+++.||.+||+.|++|+||||+||+++ .++.++|+|||.+......
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~  173 (289)
T 3og7_A           95 AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLH-EDNTVKIGDFGLATEKSRW  173 (289)
T ss_dssp             EEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE-TTTEEEECCCC--------
T ss_pred             EEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC-CCCCEEEccceeccccccc
Confidence            99999998 588888877777899999999999999999999999999999999999999 8899999999998765421


Q ss_pred             --CCcccccccccccCCchhhc--CCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhH-HHHHHHHcCCCCcccccchh
Q 045787          161 --QKEYSRDCVYSPYKAPELLL--GYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDH-LSLIFSLLGTPTDESWAEST  235 (324)
Q Consensus       161 --~~~~~~~~~~~~y~aPE~~~--~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~  235 (324)
                        ........+++.|+|||++.  ....++.++||||||+++|+|++|+.||....... ...........+        
T Consensus       174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--------  245 (289)
T 3og7_A          174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP--------  245 (289)
T ss_dssp             ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCC--------
T ss_pred             cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCc--------
Confidence              22233456889999999986  23567889999999999999999999997755332 222222111111        


Q ss_pred             hhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          236 YISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                     ........+++.+.+++.+||+.||.+|||+.++++
T Consensus       246 ---------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          246 ---------------DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             ---------------CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                           011122367899999999999999999999999986

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=6.9e-46  Score=324.76  Aligned_cols=265  Identities=25%  Similarity=0.371  Sum_probs=186.0

Q ss_pred             ccCcCcceeE-eecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeec----C
Q 045787            4 LKNLNYKKIK-KIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS----R   78 (324)
Q Consensus         4 ~~~~~y~i~~-~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~   78 (324)
                      ...++|++++ .||+|++|.||+|.+..+|+.||+|++....      ....+....++.++|||++++++++..    .
T Consensus        25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~   98 (336)
T 3fhr_A           25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP------KARQEVDHHWQASGGPHIVCILDVYENMHHGK   98 (336)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH------HHHHHHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence            4678999976 5999999999999999999999999986431      222233334567789999999999876    4


Q ss_pred             CeEEEEEEecCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecC--CCcEEEeeccce
Q 045787           79 KDVFLVFEYLDL-DLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK--RNTVKLADFGLA  154 (324)
Q Consensus        79 ~~~~iv~e~~~g-~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~--~~~v~l~d~g~~  154 (324)
                      ...++||||++| +|.+++.... ..+++..++.++.+++.||.+||++|++|+||||+||+++..  ++.++|+|||.+
T Consensus        99 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A           99 RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             ceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence            568999999985 9999888754 369999999999999999999999999999999999999722  456999999999


Q ss_pred             eeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccch
Q 045787          155 RAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAES  234 (324)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (324)
                      .....  .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||..............            
T Consensus       179 ~~~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~------------  243 (336)
T 3fhr_A          179 KETTQ--NALQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR------------  243 (336)
T ss_dssp             EEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------------
T ss_pred             eeccc--cccccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH------------
Confidence            86542  22334567899999999876 6678999999999999999999999976553322110000            


Q ss_pred             hhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCch
Q 045787          235 TYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP  297 (324)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~  297 (324)
                              .............+..++..+.++|.+||+.||.+|||+.++++||||++....+
T Consensus       244 --------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~  298 (336)
T 3fhr_A          244 --------RIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVP  298 (336)
T ss_dssp             ---------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSC
T ss_pred             --------hhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccCC
Confidence                    0000000111122346899999999999999999999999999999999865433

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.6e-46  Score=334.75  Aligned_cols=259  Identities=25%  Similarity=0.432  Sum_probs=200.8

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEEEE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDVFLV   84 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv   84 (324)
                      ..+|++.+.||+|++|+|+. ....+|+.||+|++.....     ....+|+.+++++ +||||+++++++.+....|+|
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv   96 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA   96 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence            45799999999999999774 4456789999999864332     3356899999999 799999999999999999999


Q ss_pred             EEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeec----CCCcEEEeeccceeeccCC
Q 045787           85 FEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL----KRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        85 ~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~----~~~~v~l~d~g~~~~~~~~  160 (324)
                      ||+++|+|.+++........+..++.++.||+.||.|||+.|++|+||||+||+++.    ....++|+|||.+......
T Consensus        97 ~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~  176 (432)
T 3p23_A           97 IELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG  176 (432)
T ss_dssp             EECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred             EECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence            999999999999887666777677899999999999999999999999999999952    2236889999999876533


Q ss_pred             C---CcccccccccccCCchhhcC--CCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccch
Q 045787          161 Q---KEYSRDCVYSPYKAPELLLG--YTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAES  234 (324)
Q Consensus       161 ~---~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (324)
                      .   .......||+.|+|||++.+  ...++.++|||||||++|+|++ |..||.............   .......   
T Consensus       177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~---~~~~~~~---  250 (432)
T 3p23_A          177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLG---ACSLDCL---  250 (432)
T ss_dssp             ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTT---CCCCTTS---
T ss_pred             CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhc---cCCcccc---
Confidence            2   22334568999999999974  3556889999999999999999 899996655443322211   1100000   


Q ss_pred             hhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCC
Q 045787          235 TYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVEN  295 (324)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~  295 (324)
                                         ......+..+.+||.+||+.||.+|||+.++++||||.++.+
T Consensus       251 -------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~~  292 (432)
T 3p23_A          251 -------------------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK  292 (432)
T ss_dssp             -------------------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHHH
T ss_pred             -------------------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChHH
Confidence                               000123456789999999999999999999999999987654

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.6e-45  Score=325.74  Aligned_cols=254  Identities=26%  Similarity=0.385  Sum_probs=211.0

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEcc-------CCceEEEEEeeeccccCCCchHHHHHHHHHHhc-CCCCeeEEEee
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTV-------TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDV   74 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~-------~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~   74 (324)
                      .+..++|++.+.||+|+||.||+|.+..       .+..||+|++...... .....+.+|+++++++ +||||++++++
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~hpnIv~~~~~  143 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEMEMMKMIGKHKNIINLLGA  143 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCH-HHHHHHHHHHHHHHHhcCCchhhhheee
Confidence            3566899999999999999999999753       3357999998754322 2235688999999999 89999999999


Q ss_pred             eecCCeEEEEEEecCC-CHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceE
Q 045787           75 QSSRKDVFLVFEYLDL-DLHSFITRHK---------------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLL  138 (324)
Q Consensus        75 ~~~~~~~~iv~e~~~g-~l~~~~~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIl  138 (324)
                      +.+++..++||||+++ +|.+++....               ..+++..++.++.+++.||.+||+.|++|+||||+||+
T Consensus       144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl  223 (382)
T 3tt0_A          144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL  223 (382)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEE
Confidence            9999999999999974 9999888754               35899999999999999999999999999999999999


Q ss_pred             eecCCCcEEEeeccceeeccCCC--CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhH
Q 045787          139 IDLKRNTVKLADFGLARAIGVPQ--KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDH  215 (324)
Q Consensus       139 l~~~~~~v~l~d~g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~  215 (324)
                      ++ .++.++|+|||.+.......  .......+++.|+|||++.+ ..++.++||||||+++|+|++ |..||...+...
T Consensus       224 l~-~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~  301 (382)
T 3tt0_A          224 VT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  301 (382)
T ss_dssp             EC-TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             Ec-CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            99 88999999999998665332  22333456788999999987 678999999999999999999 999998877665


Q ss_pred             HHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          216 LSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      ..........+.                           ....+++++.++|.+||+.||.+|||+.++++
T Consensus       302 ~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  345 (382)
T 3tt0_A          302 LFKLLKEGHRMD---------------------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  345 (382)
T ss_dssp             HHHHHHTTCCCC---------------------------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcCCCCC---------------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            544433211111                           11357889999999999999999999999997

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.8e-45  Score=314.32  Aligned_cols=253  Identities=25%  Similarity=0.373  Sum_probs=197.2

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccC---CceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCC
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVT---GQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK   79 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~---~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   79 (324)
                      .+..++|++.+.||+|+||.||+|.+..+   +..+++|.+..... ....+.+.+|+.++++++||||+++++++. ++
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~   88 (281)
T 1mp8_A           11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS-DSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN   88 (281)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred             EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCccceEEEEEc-cC
Confidence            45678999999999999999999998653   45699998764322 222456889999999999999999999984 46


Q ss_pred             eEEEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeecc
Q 045787           80 DVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIG  158 (324)
Q Consensus        80 ~~~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~  158 (324)
                      ..++||||+++ +|.+++......+++..++.++.+++.||.+||+.|++|+||||+||+++ .++.++|+|||.+....
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~  167 (281)
T 1mp8_A           89 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS-SNDCVKLGDFGLSRYME  167 (281)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE-ETTEEEECC--------
T ss_pred             ccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEEC-CCCCEEECccccccccC
Confidence            78999999985 99999887766899999999999999999999999999999999999999 88999999999987764


Q ss_pred             CCCC-cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhh
Q 045787          159 VPQK-EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY  236 (324)
Q Consensus       159 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (324)
                      .... ......+++.|+|||++.+ ..++.++||||||+++|+|++ |..||.................+          
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~----------  236 (281)
T 1mp8_A          168 DSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL----------  236 (281)
T ss_dssp             -----------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC----------
T ss_pred             cccccccccCCCcccccChhhccc-CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCC----------
Confidence            3322 1223345678999999986 667999999999999999997 99999877655443322211100          


Q ss_pred             hhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          237 ISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                       ...+.+++.+.+++.+||+.||.+|||+.++++
T Consensus       237 -----------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  269 (281)
T 1mp8_A          237 -----------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA  269 (281)
T ss_dssp             -----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                             012367899999999999999999999999986

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.9e-45  Score=315.19  Aligned_cols=252  Identities=24%  Similarity=0.372  Sum_probs=213.0

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF   82 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   82 (324)
                      .+..++|++.+.||+|++|.||+|.+..++..+|+|.+.....   ..+.+.+|+.++++++||||+++++++.+++..+
T Consensus         9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   85 (288)
T 3kfa_A            9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   85 (288)
T ss_dssp             BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST---HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred             cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence            4678899999999999999999999999999999999875432   2467889999999999999999999999999999


Q ss_pred             EEEEecC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           83 LVFEYLD-LDLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        83 iv~e~~~-g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      +||||++ ++|.+++.... ..+++..++.++.+++.||.+||+.|++|+||||+||+++ .++.++|+|||.+......
T Consensus        86 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~-~~~~~~l~Dfg~~~~~~~~  164 (288)
T 3kfa_A           86 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHLVKVADFGLSRLMTGD  164 (288)
T ss_dssp             EEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEEC-GGGCEEECCCCGGGTSCSS
T ss_pred             EEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEc-CCCCEEEccCccceeccCC
Confidence            9999998 59999887743 4599999999999999999999999999999999999999 8899999999998766533


Q ss_pred             CC-cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhh
Q 045787          161 QK-EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYIS  238 (324)
Q Consensus       161 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (324)
                      .. ......+++.|+|||++.+ ..++.++||||||+++|+|++ |..||...+.............+            
T Consensus       165 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~------------  231 (288)
T 3kfa_A          165 TYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM------------  231 (288)
T ss_dssp             SSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC------------
T ss_pred             ccccccCCccccCcCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCC------------
Confidence            22 2233445678999999987 568999999999999999999 99999887765554433321111            


Q ss_pred             cccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          239 EILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                     .....+++.+.+++.+||..||.+|||+.++++
T Consensus       232 ---------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          232 ---------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             ---------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence                           011357899999999999999999999999986

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=9.5e-45  Score=311.94  Aligned_cols=256  Identities=20%  Similarity=0.259  Sum_probs=202.0

Q ss_pred             CCcccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEe-eeecCC
Q 045787            1 MGKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLD-VQSSRK   79 (324)
Q Consensus         1 ~~~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~-~~~~~~   79 (324)
                      |.....++|++.+.||+|++|.||+|.+..+++.||+|++......    ..+.+|+.+++.++|++++..+. ++....
T Consensus         3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~   78 (296)
T 4hgt_A            3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGD   78 (296)
T ss_dssp             --------CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETT
T ss_pred             cccccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCC
Confidence            3445678999999999999999999999999999999987654432    34788999999999877665555 456778


Q ss_pred             eEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEe---ecCCCcEEEeeccceee
Q 045787           80 DVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLI---DLKRNTVKLADFGLARA  156 (324)
Q Consensus        80 ~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll---~~~~~~v~l~d~g~~~~  156 (324)
                      ..++||||++++|.+++......+++..++.++.+++.||.+||+.|++|+||||+||++   + .++.++|+|||.+..
T Consensus        79 ~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~-~~~~~kL~Dfg~a~~  157 (296)
T 4hgt_A           79 YNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGK-KGNLVYIIDFGLAKK  157 (296)
T ss_dssp             EEEEEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGG-GTTCEEECCCTTCEE
T ss_pred             ceEEEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccC-CCCeEEEecCcccee
Confidence            899999999889999998777789999999999999999999999999999999999999   5 788999999999987


Q ss_pred             ccCCCC-------cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChh----HHHHHHHHcCC
Q 045787          157 IGVPQK-------EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD----HLSLIFSLLGT  225 (324)
Q Consensus       157 ~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~  225 (324)
                      ......       ......+++.|+|||++.+ ..++.++||||||+++|+|++|+.||...+..    .......... 
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-  235 (296)
T 4hgt_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM-  235 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH-
T ss_pred             ccCcccCccCCCCcccccCCCccccchHHhcC-CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc-
Confidence            654322       2234578899999999987 66899999999999999999999999764421    1111111000 


Q ss_pred             CCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          226 PTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                             ..........+++.+.+++.+||+.||.+|||+.++++
T Consensus       236 -----------------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          236 -----------------------STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             -----------------------HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             -----------------------cchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence                                   00111222467899999999999999999999999996

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=8.6e-46  Score=322.37  Aligned_cols=255  Identities=24%  Similarity=0.361  Sum_probs=209.2

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEc-----cCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeec
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNT-----VTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS   77 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   77 (324)
                      .+..++|++.+.||+|++|.||+|.+.     .+++.||+|.+...... .....+.+|+.+++.++||||+++++++.+
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   99 (322)
T 1p4o_A           21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFLNEASVMKEFNCHHVVRLLGVVSQ   99 (322)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH-HHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence            355789999999999999999999876     35778999998744321 123457899999999999999999999999


Q ss_pred             CCeEEEEEEecC-CCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEE
Q 045787           78 RKDVFLVFEYLD-LDLHSFITRHK---------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVK  147 (324)
Q Consensus        78 ~~~~~iv~e~~~-g~l~~~~~~~~---------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~  147 (324)
                      .+..++||||++ |+|.+++....         .++++..++.++.+++.||.+||++|++|+||||+||+++ .++.++
T Consensus       100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~-~~~~~k  178 (322)
T 1p4o_A          100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA-EDFTVK  178 (322)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEEC-TTCCEE
T ss_pred             CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEc-CCCeEE
Confidence            999999999997 59998887643         3578999999999999999999999999999999999999 889999


Q ss_pred             EeeccceeeccCCCC--cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcC
Q 045787          148 LADFGLARAIGVPQK--EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLG  224 (324)
Q Consensus       148 l~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~  224 (324)
                      |+|||.+........  ......+++.|+|||++.+ ..++.++||||||+++|+|++ |..||...+............
T Consensus       179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~  257 (322)
T 1p4o_A          179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG  257 (322)
T ss_dssp             ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC
T ss_pred             ECcCccccccccccccccccCCCCCCCccChhhhcc-CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCC
Confidence            999999876542221  1223356788999999987 668999999999999999999 899998877655443332111


Q ss_pred             CCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcC
Q 045787          225 TPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH  287 (324)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~h  287 (324)
                      .+                           .....++..+.++|.+||+.||.+|||+.+++++
T Consensus       258 ~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          258 LL---------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             CC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cC---------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            11                           0113678899999999999999999999999985

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.5e-45  Score=319.09  Aligned_cols=253  Identities=25%  Similarity=0.376  Sum_probs=203.6

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccCCceE----EEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecC
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKV----AIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR   78 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~----~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   78 (324)
                      .+..++|++++.||+|+||.||+|.+..+++.+    ++|.+... ........+.+|+.++++++||||+++++++..+
T Consensus        11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   89 (327)
T 3lzb_A           11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS   89 (327)
T ss_dssp             ECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC-SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred             ccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc-cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence            466799999999999999999999998888766    55554432 2333457788999999999999999999999876


Q ss_pred             CeEEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeec
Q 045787           79 KDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAI  157 (324)
Q Consensus        79 ~~~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~  157 (324)
                      . .++|++++. |+|.+++......+++..++.++.|++.||.|||+.|++|+||||+||+++ .++.++|+|||.+...
T Consensus        90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~-~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK-TPQHVKITDFGLAKLL  167 (327)
T ss_dssp             S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE-ETTEEEECCTTC----
T ss_pred             C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEc-CCCCEEEccCcceeEc
Confidence            5 777888886 699999988778899999999999999999999999999999999999999 8899999999999876


Q ss_pred             cCCCCc--ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccch
Q 045787          158 GVPQKE--YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAES  234 (324)
Q Consensus       158 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (324)
                      ......  .....+++.|+|||++.+ ..++.++||||||+++|+|++ |..||..................+.      
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~------  240 (327)
T 3lzb_A          168 GAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ------  240 (327)
T ss_dssp             ------------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC------
T ss_pred             cCccccccccCCCccccccCHHHHcC-CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC------
Confidence            433222  222345677999999987 678999999999999999999 9999988876665544432221111      


Q ss_pred             hhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          235 TYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                           ...++.++.++|.+||+.||.+||++.++++
T Consensus       241 ---------------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          241 ---------------------PPICTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             ---------------------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------CccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                 1257889999999999999999999999997

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.8e-45  Score=319.11  Aligned_cols=255  Identities=25%  Similarity=0.380  Sum_probs=210.6

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEc-----cCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeec
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNT-----VTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS   77 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   77 (324)
                      ++..++|++.+.||+|+||.||+|.+.     .++..||+|++..... ....+.+.+|+.++++++||||+++++++.+
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   97 (314)
T 2ivs_A           19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS-PSELRDLLSEFNVLKQVNHPHVIKLYGACSQ   97 (314)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCC-HHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence            355789999999999999999999873     4557899999874432 2223568899999999999999999999999


Q ss_pred             CCeEEEEEEecC-CCHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 045787           78 RKDVFLVFEYLD-LDLHSFITRHK-----------------------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLK  133 (324)
Q Consensus        78 ~~~~~iv~e~~~-g~l~~~~~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~  133 (324)
                      ++..++||||++ ++|.+++....                       ..+++..++.++.+++.||.+||++|++|+|||
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dik  177 (314)
T 2ivs_A           98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLA  177 (314)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccc
Confidence            999999999998 69998887643                       238899999999999999999999999999999


Q ss_pred             CCceEeecCCCcEEEeeccceeeccCCCC--cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCC
Q 045787          134 PNNLLIDLKRNTVKLADFGLARAIGVPQK--EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPS  210 (324)
Q Consensus       134 p~nIll~~~~~~v~l~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~  210 (324)
                      |+||+++ .++.++|+|||.+........  ......+++.|+|||++.+ ..++.++||||||+++|+|++ |..||..
T Consensus       178 p~NIli~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~  255 (314)
T 2ivs_A          178 ARNILVA-EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPG  255 (314)
T ss_dssp             GGGEEEE-TTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             hheEEEc-CCCCEEEccccccccccccccceeccCCCCcccccChhhhcC-CCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999 899999999999987653322  2233456778999999987 667999999999999999999 9999988


Q ss_pred             CChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcC
Q 045787          211 KKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH  287 (324)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~h  287 (324)
                      ...............+                           .....+++.+.++|.+||+.||.+||++.+++++
T Consensus       256 ~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          256 IPPERLFNLLKTGHRM---------------------------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             CCGGGHHHHHHTTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHhhcCCcC---------------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            7766554433321111                           0113678999999999999999999999999863

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.8e-44  Score=310.34  Aligned_cols=256  Identities=20%  Similarity=0.249  Sum_probs=207.6

Q ss_pred             CcccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEe-eeecCCe
Q 045787            2 GKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLD-VQSSRKD   80 (324)
Q Consensus         2 ~~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~-~~~~~~~   80 (324)
                      .....++|++.+.||+|++|.||+|.+..+++.||+|++.....    .+.+.+|+.+++.++|++++..+. +......
T Consensus         4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~   79 (296)
T 3uzp_A            4 ELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDY   79 (296)
T ss_dssp             -CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred             cceeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc----hhHHHHHHHHHHHhhcCCCCCccccccCCCCc
Confidence            34567899999999999999999999999999999999865432    346889999999999877555554 4466778


Q ss_pred             EEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEee--cCCCcEEEeeccceeecc
Q 045787           81 VFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLID--LKRNTVKLADFGLARAIG  158 (324)
Q Consensus        81 ~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~--~~~~~v~l~d~g~~~~~~  158 (324)
                      .++||||++++|.+++......+++..++.++.+++.||.+||++|++|+||||+||+++  ..++.++|+|||.+....
T Consensus        80 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           80 NVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             EEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             eEEEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence            899999998899999987777899999999999999999999999999999999999994  377899999999998765


Q ss_pred             CCCC-------cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChh----HHHHHHHHcCCCC
Q 045787          159 VPQK-------EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHD----HLSLIFSLLGTPT  227 (324)
Q Consensus       159 ~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~  227 (324)
                      ....       ......+++.|+|||++.+ ..++.++||||||+++|+|++|+.||......    ....+......  
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--  236 (296)
T 3uzp_A          160 DARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS--  236 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH--
T ss_pred             ccccccccccccccccccccccCChhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC--
Confidence            4332       1244578899999999987 66899999999999999999999999764321    11111110000  


Q ss_pred             cccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          228 DESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                            .........+++.+.+++.+||+.||.+|||+.++++
T Consensus       237 ----------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          237 ----------------------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             ----------------------SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             ----------------------CchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence                                  0011222468899999999999999999999999996

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=3.2e-45  Score=319.45  Aligned_cols=254  Identities=26%  Similarity=0.377  Sum_probs=204.0

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccCCceE----EEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecC
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKV----AIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR   78 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~----~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   78 (324)
                      .+..++|++.+.||+|+||+||+|.+..+++.+    ++|.+.... .....+.+.+|+.++++++||||+++++++.+.
T Consensus        11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   89 (327)
T 3poz_A           11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS   89 (327)
T ss_dssp             ECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred             hcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence            456789999999999999999999988777654    777665432 223356788999999999999999999999876


Q ss_pred             CeEEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeec
Q 045787           79 KDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAI  157 (324)
Q Consensus        79 ~~~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~  157 (324)
                      . .++|++++. |+|.+++......+++..++.++.+++.||.|||+.|++|+||||+||+++ .++.++|+|||.+...
T Consensus        90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~-~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK-TPQHVKITDFGLAKLL  167 (327)
T ss_dssp             S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE-ETTEEEECCTTHHHHH
T ss_pred             C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEEC-CCCCEEEccCcceeEc
Confidence            5 678888886 699999988778899999999999999999999999999999999999999 8899999999999876


Q ss_pred             cCCCCc--ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccch
Q 045787          158 GVPQKE--YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAES  234 (324)
Q Consensus       158 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (324)
                      ......  .....+++.|+|||++.+ ..++.++||||||+++|+|++ |..||..................+.      
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~------  240 (327)
T 3poz_A          168 GAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ------  240 (327)
T ss_dssp             TTTCC-------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC------
T ss_pred             cCCcccccccCCCccccccChHHhcc-CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCC------
Confidence            533322  222345678999999987 678999999999999999999 9999988776665544432221111      


Q ss_pred             hhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcC
Q 045787          235 TYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH  287 (324)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~h  287 (324)
                                           ....+..+.+++.+||+.||.+||++.+++++
T Consensus       241 ---------------------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          241 ---------------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             ---------------------CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             ---------------------CccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                                 12577899999999999999999999999974

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.4e-45  Score=321.85  Aligned_cols=264  Identities=22%  Similarity=0.356  Sum_probs=209.6

Q ss_pred             CCcccCcCcceeEeecccCceEEEEEE-----EccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeee
Q 045787            1 MGKLKNLNYKKIKKIGAGGYGEVYKCR-----NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQ   75 (324)
Q Consensus         1 ~~~~~~~~y~i~~~Lg~g~~~~v~~a~-----~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~   75 (324)
                      ++++..++|++.+.||+|++|.||+|.     +..++..||+|.+...... .....+.+|+.++++++||||+++++++
T Consensus        24 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~  102 (327)
T 2yfx_A           24 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFLMEALIISKFNHQNIVRCIGVS  102 (327)
T ss_dssp             SCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccch-hhHHHHHHHHHHHhhCCCCCCCeEEEEE
Confidence            356788999999999999999999999     5567889999998643221 1235678899999999999999999999


Q ss_pred             ecCCeEEEEEEecC-CCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeec--CCCcE
Q 045787           76 SSRKDVFLVFEYLD-LDLHSFITRHK------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL--KRNTV  146 (324)
Q Consensus        76 ~~~~~~~iv~e~~~-g~l~~~~~~~~------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~--~~~~v  146 (324)
                      .+....|+||||++ ++|.+++....      ..+++..++.++.+++.||.+||+.|++|+||||+||+++.  .+..+
T Consensus       103 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~  182 (327)
T 2yfx_A          103 LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA  182 (327)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred             cCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceE
Confidence            99999999999996 59999988754      34899999999999999999999999999999999999982  23469


Q ss_pred             EEeeccceeeccCCC--CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHc
Q 045787          147 KLADFGLARAIGVPQ--KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLL  223 (324)
Q Consensus       147 ~l~d~g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~  223 (324)
                      +|+|||.+.......  .......+++.|+|||++.+ ..++.++||||||+++|+|++ |..||...............
T Consensus       183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~  261 (327)
T 2yfx_A          183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG  261 (327)
T ss_dssp             EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred             EECccccccccccccccccCCCcCCCcceeCHhHhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcC
Confidence            999999987553222  12233456788999999977 668999999999999999998 99999887755544333221


Q ss_pred             CCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCC
Q 045787          224 GTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV  293 (324)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~  293 (324)
                      ..+.                           ....++..+.++|.+||+.||.+||++.+++++.|+..-
T Consensus       262 ~~~~---------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  304 (327)
T 2yfx_A          262 GRMD---------------------------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  304 (327)
T ss_dssp             CCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCC---------------------------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence            1110                           113578899999999999999999999999999886543

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.6e-45  Score=325.42  Aligned_cols=255  Identities=25%  Similarity=0.389  Sum_probs=205.5

Q ss_pred             ccCcCcceeEeecccCceEEEEEE-----EccCCceEEEEEeeeccccCCCchHHHHHHHHHHhc-CCCCeeEEEeeeec
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCR-----NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSS   77 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~-----~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   77 (324)
                      +..++|++.+.||+|+||.||+|.     +..+++.||+|++...... ...+.+.+|+.++.++ +||||+++++++.+
T Consensus        19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~   97 (359)
T 3vhe_A           19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGHHLNVVNLLGACTK   97 (359)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCH-HHHHHHHHHHHHHHhhcCCcceeeeeeeeec
Confidence            456899999999999999999998     5567789999998754322 1235688999999999 68999999999877


Q ss_pred             CC-eEEEEEEecCC-CHHHHHHhcCC------------------------------------------------------
Q 045787           78 RK-DVFLVFEYLDL-DLHSFITRHKN------------------------------------------------------  101 (324)
Q Consensus        78 ~~-~~~iv~e~~~g-~l~~~~~~~~~------------------------------------------------------  101 (324)
                      .+ ..++||||+.| +|.+++.....                                                      
T Consensus        98 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (359)
T 3vhe_A           98 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE  177 (359)
T ss_dssp             TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred             CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence            54 49999999985 88888876532                                                      


Q ss_pred             -----------CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC--cccccc
Q 045787          102 -----------TLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK--EYSRDC  168 (324)
Q Consensus       102 -----------~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~--~~~~~~  168 (324)
                                 .+++..++.++.+++.||.|||++|++|+||||+||+++ .++.++|+|||.+........  ......
T Consensus       178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  256 (359)
T 3vhe_A          178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDAR  256 (359)
T ss_dssp             ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC-GGGCEEECCCGGGSCTTSCTTCEEC--CE
T ss_pred             hcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEc-CCCcEEEEeccceeeecccccchhccccC
Confidence                       188999999999999999999999999999999999999 889999999999986643222  233456


Q ss_pred             cccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCC
Q 045787          169 VYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHF  247 (324)
Q Consensus       169 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (324)
                      +|+.|+|||++.+ ..++.++||||||+++|+|++ |..||...............+....                   
T Consensus       257 ~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------  316 (359)
T 3vhe_A          257 LPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR-------------------  316 (359)
T ss_dssp             ECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC-------------------
T ss_pred             CCceeEChhhhcC-CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCC-------------------
Confidence            7888999999987 678999999999999999998 9999987664332222111111100                   


Q ss_pred             CCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcC
Q 045787          248 EPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH  287 (324)
Q Consensus       248 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~h  287 (324)
                             ....+++++.+++.+||+.||.+|||+.++++|
T Consensus       317 -------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          317 -------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             -------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence                   112478899999999999999999999999974

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-45  Score=323.22  Aligned_cols=254  Identities=27%  Similarity=0.412  Sum_probs=208.8

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEc-----cCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeec
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNT-----VTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS   77 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   77 (324)
                      .+..++|++.+.||+|+||.||+|.+.     .+++.||+|++..... ....+.+.+|+.++++++||||+++++++.+
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  121 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMAEFDNPNIVKLLGVCAV  121 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence            345689999999999999999999987     3458899999875432 2224568899999999999999999999999


Q ss_pred             CCeEEEEEEecCC-CHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 045787           78 RKDVFLVFEYLDL-DLHSFITRHK-----------------------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLK  133 (324)
Q Consensus        78 ~~~~~iv~e~~~g-~l~~~~~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~  133 (324)
                      ++..++||||+++ +|.+++....                       .++++..++.++.+|+.||.+||++|++|+|||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk  201 (343)
T 1luf_A          122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA  201 (343)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            9999999999975 9999887642                       568999999999999999999999999999999


Q ss_pred             CCceEeecCCCcEEEeeccceeeccCCC--CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCC
Q 045787          134 PNNLLIDLKRNTVKLADFGLARAIGVPQ--KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPS  210 (324)
Q Consensus       134 p~nIll~~~~~~v~l~d~g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~  210 (324)
                      |+||+++ .++.++|+|||.+.......  .......+++.|+|||++.+ ..++.++||||||+++|+|++ |..||..
T Consensus       202 p~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~  279 (343)
T 1luf_A          202 TRNCLVG-ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYG  279 (343)
T ss_dssp             GGGEEEC-GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             cceEEEC-CCCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc-CCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence            9999999 88999999999987654221  12233456788999999987 568999999999999999999 9999988


Q ss_pred             CChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          211 KKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      ...............+                           .....++..+.+++.+||+.||.+|||+.++++
T Consensus       280 ~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~  328 (343)
T 1luf_A          280 MAHEEVIYYVRDGNIL---------------------------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  328 (343)
T ss_dssp             SCHHHHHHHHHTTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CChHHHHHHHhCCCcC---------------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            7755543332211110                           011357889999999999999999999999986

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.9e-45  Score=309.81  Aligned_cols=250  Identities=21%  Similarity=0.308  Sum_probs=208.6

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   83 (324)
                      +..++|++.+.||+|++|.||++.+. ++..+|+|++......   .+.+.+|+.++++++|||++++++++.+++..++
T Consensus         5 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (267)
T 3t9t_A            5 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL   80 (267)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred             EchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEE
Confidence            45689999999999999999999986 5778999998755432   3678899999999999999999999999999999


Q ss_pred             EEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC-
Q 045787           84 VFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ-  161 (324)
Q Consensus        84 v~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~-  161 (324)
                      ||||++ ++|.+++......+++..++.++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+....... 
T Consensus        81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~-~~~~~kl~dfg~~~~~~~~~~  159 (267)
T 3t9t_A           81 VTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG-ENQVIKVSDFGMTRFVLDDQY  159 (267)
T ss_dssp             EECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC-GGGCEEECCTTGGGGBCCHHH
T ss_pred             EEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEC-CCCCEEEcccccccccccccc
Confidence            999997 589999888777899999999999999999999999999999999999999 88999999999987653221 


Q ss_pred             CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcc
Q 045787          162 KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEI  240 (324)
Q Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (324)
                      .......+++.|+|||++.+ ..++.++||||||+++|+|++ |..||...+.............+              
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~--------------  224 (267)
T 3t9t_A          160 TSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL--------------  224 (267)
T ss_dssp             HSTTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC--------------
T ss_pred             cccccccccccccChhhhcC-CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcC--------------
Confidence            11223345677999999987 567999999999999999999 89999877755443332211000              


Q ss_pred             cCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          241 LPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                   ......+..+.+++.+||+.||.+|||+.++++
T Consensus       225 -------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  257 (267)
T 3t9t_A          225 -------------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLR  257 (267)
T ss_dssp             -------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------CCCccCcHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                         011246889999999999999999999999986

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=9e-45  Score=308.27  Aligned_cols=252  Identities=24%  Similarity=0.345  Sum_probs=196.1

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeecccc--CCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCe
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQ--EGVPSYIIREVSLLKELEHENIVRLLDVQSSRKD   80 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   80 (324)
                      ++..++|++.+.||+|++|.||+|.+.  +..+|+|++......  ....+.+.+|+.+++.++||||+++++++.+++.
T Consensus         3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (271)
T 3dtc_A            3 EIDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN   80 (271)
T ss_dssp             BCCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred             ccchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence            466789999999999999999999975  789999998765432  2334678899999999999999999999999999


Q ss_pred             EEEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcccCCCCCceEeec-------CCCcEEEe
Q 045787           81 VFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK---ILHRDLKPNNLLIDL-------KRNTVKLA  149 (324)
Q Consensus        81 ~~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g---~~H~di~p~nIll~~-------~~~~v~l~  149 (324)
                      .++||||++| +|.+++.  ...+++..++.++.+++.||.+||+.|   ++|+||||+||+++.       .++.++|+
T Consensus        81 ~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~  158 (271)
T 3dtc_A           81 LCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT  158 (271)
T ss_dssp             CEEEEECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred             eEEEEEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence            9999999975 6766654  347999999999999999999999999   889999999999983       26789999


Q ss_pred             eccceeeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcc
Q 045787          150 DFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDE  229 (324)
Q Consensus       150 d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  229 (324)
                      |||.+.......  .....+++.|+|||++.+ ..++.++||||||+++|+|++|+.||...+...............  
T Consensus       159 Dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--  233 (271)
T 3dtc_A          159 DFGLAREWHRTT--KMSAAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLAL--  233 (271)
T ss_dssp             CCCC---------------CCGGGSCHHHHHH-CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCC--
T ss_pred             cCCccccccccc--ccCCCCccceeCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCC--
Confidence            999997654322  224468899999999987 668999999999999999999999998777554433322111110  


Q ss_pred             cccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcC
Q 045787          230 SWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH  287 (324)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~h  287 (324)
                                              .....+++.+.+++.+||+.||.+|||+.+++++
T Consensus       234 ------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          234 ------------------------PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             ------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence                                    0113578899999999999999999999999874

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=6.3e-45  Score=314.08  Aligned_cols=270  Identities=24%  Similarity=0.392  Sum_probs=207.7

Q ss_pred             CcccCcCcceeEeecccCceEEEEEE----EccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeec
Q 045787            2 GKLKNLNYKKIKKIGAGGYGEVYKCR----NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS   77 (324)
Q Consensus         2 ~~~~~~~y~i~~~Lg~g~~~~v~~a~----~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   77 (324)
                      +.+...+|++++.||+|++|.||+|.    +..+++.||+|++..... ....+.+.+|+.++++++|||++++++++..
T Consensus        16 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   94 (302)
T 4e5w_A           16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVKYKGICTE   94 (302)
T ss_dssp             TBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence            34567789999999999999999998    667899999999876543 3335778899999999999999999999987


Q ss_pred             C--CeEEEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccce
Q 045787           78 R--KDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLA  154 (324)
Q Consensus        78 ~--~~~~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~  154 (324)
                      .  ...++||||+++ +|.+++......+++..++.++.+++.||.+||+.|++|+||||+||+++ .++.++|+|||.+
T Consensus        95 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~-~~~~~kl~Dfg~~  173 (302)
T 4e5w_A           95 DGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE-SEHQVKIGDFGLT  173 (302)
T ss_dssp             ---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE-ETTEEEECCCTTC
T ss_pred             CCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEc-CCCCEEECccccc
Confidence            6  678999999975 99999877777899999999999999999999999999999999999999 8899999999999


Q ss_pred             eeccCCCC---cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccc
Q 045787          155 RAIGVPQK---EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESW  231 (324)
Q Consensus       155 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  231 (324)
                      ........   ......++..|+|||++.+ ..++.++||||||+++|+|++|..|+......    .......... ..
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~-~~  247 (302)
T 4e5w_A          174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQ-SKFYIASDVWSFGVTLHELLTYCDSDSSPMAL----FLKMIGPTHG-QM  247 (302)
T ss_dssp             EECCTTCCEEECCCCTTCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH----HHHHHCSCCG-GG
T ss_pred             ccccCCCcceeccCCCCCCccccCCeeecC-CCCCcchhHHHHHHHHHHHHHccCCCcchhhH----HhhccCCccc-cc
Confidence            87754432   2333456777999999987 56789999999999999999999886332211    1111111111 10


Q ss_pred             cchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          232 AESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      .............       .......+++.+.++|.+||+.||.+|||+.++++
T Consensus       248 ~~~~~~~~~~~~~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          248 TVTRLVNTLKEGK-------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HHHHHHHHHHTTC-------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHhccC-------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            1111111110000       01122368899999999999999999999999986

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.9e-45  Score=319.20  Aligned_cols=256  Identities=23%  Similarity=0.347  Sum_probs=206.1

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEc-----cCCceEEEEEeeeccccCCCchHHHHHHHHHHhc-CCCCeeEEEeeeec
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNT-----VTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSS   77 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   77 (324)
                      +..++|++.+.||+|++|.||+|.+.     .++..||+|++..... ....+.+.+|+.+++++ +||||+++++++..
T Consensus        42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  120 (344)
T 1rjb_A           42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-SSEREALMSELKMMTQLGSHENIVNLLGACTL  120 (344)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccC-HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence            34578999999999999999999973     3566899999975432 33357789999999999 89999999999999


Q ss_pred             CCeEEEEEEecC-CCHHHHHHhcCC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 045787           78 RKDVFLVFEYLD-LDLHSFITRHKN----------------------TLNLLVIKAILKQILLGLAYCHSLKILHRDLKP  134 (324)
Q Consensus        78 ~~~~~iv~e~~~-g~l~~~~~~~~~----------------------~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p  134 (324)
                      .+..++||||++ |+|.+++.....                      .+++..++.++.+++.||.+||+.|++|+||||
T Consensus       121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp  200 (344)
T 1rjb_A          121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA  200 (344)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred             CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence            999999999997 599998877543                      378999999999999999999999999999999


Q ss_pred             CceEeecCCCcEEEeeccceeeccCCCC--cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCC
Q 045787          135 NNLLIDLKRNTVKLADFGLARAIGVPQK--EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSK  211 (324)
Q Consensus       135 ~nIll~~~~~~v~l~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~  211 (324)
                      +||+++ .++.++|+|||.+........  ......+++.|+|||++.+ ..++.++||||||+++|+|++ |..||...
T Consensus       201 ~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~  278 (344)
T 1rjb_A          201 RNVLVT-HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGI  278 (344)
T ss_dssp             GGEEEE-TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             hhEEEc-CCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc-CCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence            999999 899999999999986643322  2233456778999999977 668999999999999999998 99999776


Q ss_pred             ChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCc
Q 045787          212 KHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHE  288 (324)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp  288 (324)
                      ............+...                          .....+++.+.++|.+||+.||.+|||+.+++++.
T Consensus       279 ~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l  329 (344)
T 1rjb_A          279 PVDANFYKLIQNGFKM--------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL  329 (344)
T ss_dssp             CCSHHHHHHHHTTCCC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CcHHHHHHHHhcCCCC--------------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence            6433222111111000                          01125788999999999999999999999999743

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.3e-45  Score=325.60  Aligned_cols=254  Identities=24%  Similarity=0.363  Sum_probs=198.7

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEc---cCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCC
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNT---VTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK   79 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~---~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   79 (324)
                      .+..++|++.+.||+|+||.||+|.+.   .++..||+|.+..... ....+.+.+|+.++++++||||+++++++.+.+
T Consensus        41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  119 (373)
T 2qol_A           41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT-EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK  119 (373)
T ss_dssp             BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence            355678999999999999999999876   4577899999875432 122356889999999999999999999999999


Q ss_pred             eEEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeecc
Q 045787           80 DVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIG  158 (324)
Q Consensus        80 ~~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~  158 (324)
                      ..++||||++ |+|.+++......+++..++.++.+++.||.|||+.|++|+||||+||+++ .++.++|+|||.+....
T Consensus       120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN-SNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC-TTCCEEECCC-------
T ss_pred             ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEc-CCCCEEECcCccccccc
Confidence            9999999996 699999887777899999999999999999999999999999999999999 89999999999998765


Q ss_pred             CCCCcc---cccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccch
Q 045787          159 VPQKEY---SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAES  234 (324)
Q Consensus       159 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (324)
                      ......   ....+++.|+|||++.+ ..++.++||||||+++|+|++ |..||...+..............+       
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~-------  270 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLP-------  270 (373)
T ss_dssp             ---------------CTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECC-------
T ss_pred             cCCccceeccCCCcCCCccChhhhcc-CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-------
Confidence            332211   11234567999999987 668999999999999999998 999998777554433322110000       


Q ss_pred             hhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          235 TYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                          ....++..+.+++.+||+.||.+||++.++++
T Consensus       271 --------------------~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          271 --------------------PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             --------------------CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------CCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence                                01257889999999999999999999999986

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=9.1e-45  Score=314.58  Aligned_cols=253  Identities=24%  Similarity=0.348  Sum_probs=208.0

Q ss_pred             ccCcCcceeEeecccCceEEEEEEE-----ccCCceEEEEEeeeccccCCCchHHHHHHHHHHhc-CCCCeeEEEeeeec
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRN-----TVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSS   77 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~-----~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   77 (324)
                      +..++|++.+.||+|+||.||+|.+     ..+++.||+|++...... ...+.+.+|+.+++++ +||||+++++++.+
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   98 (313)
T 1t46_A           20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL-TEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (313)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhH-HHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence            4567999999999999999999985     456789999998754321 1246688999999999 89999999999999


Q ss_pred             CCeEEEEEEecCC-CHHHHHHhcCC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEe
Q 045787           78 RKDVFLVFEYLDL-DLHSFITRHKN-----------------TLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLI  139 (324)
Q Consensus        78 ~~~~~iv~e~~~g-~l~~~~~~~~~-----------------~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll  139 (324)
                      ++..++||||+++ +|.+++.....                 ++++..++.++.+++.||.+||++|++|+||||+||++
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~  178 (313)
T 1t46_A           99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL  178 (313)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE
Confidence            9999999999975 99998877543                 48999999999999999999999999999999999999


Q ss_pred             ecCCCcEEEeeccceeeccCCCC--cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHH
Q 045787          140 DLKRNTVKLADFGLARAIGVPQK--EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHL  216 (324)
Q Consensus       140 ~~~~~~v~l~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~  216 (324)
                      + .++.++|+|||.+........  ......+++.|+|||++.+ ..++.++||||||+++|+|++ |..||........
T Consensus       179 ~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~  256 (313)
T 1t46_A          179 T-HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK  256 (313)
T ss_dssp             E-TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred             c-CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence            9 899999999999987654332  1233456778999999887 678999999999999999999 9999977664332


Q ss_pred             -HHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          217 -SLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       217 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                       .........+.                           ....++..+.+++.+||+.||.+|||+.++++
T Consensus       257 ~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  300 (313)
T 1t46_A          257 FYKMIKEGFRML---------------------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (313)
T ss_dssp             HHHHHHHTCCCC---------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhccCCCCC---------------------------CcccCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence             22211110000                           01257889999999999999999999999996

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.4e-45  Score=311.45  Aligned_cols=254  Identities=25%  Similarity=0.371  Sum_probs=208.1

Q ss_pred             ccCcCcceeE-eecccCceEEEEEEEc--cCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCe
Q 045787            4 LKNLNYKKIK-KIGAGGYGEVYKCRNT--VTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKD   80 (324)
Q Consensus         4 ~~~~~y~i~~-~Lg~g~~~~v~~a~~~--~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   80 (324)
                      +..++|.+++ .||+|++|.||+|.+.  .++..||+|++..... ....+.+.+|+.++++++||||+++++++ ..+.
T Consensus         6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~   83 (287)
T 1u59_A            6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEA   83 (287)
T ss_dssp             CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSS
T ss_pred             ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccc-hhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCC
Confidence            4567888888 9999999999999854  4677899999876432 22346688999999999999999999999 4567


Q ss_pred             EEEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccC
Q 045787           81 VFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGV  159 (324)
Q Consensus        81 ~~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~  159 (324)
                      .++|+||+++ +|.+++......+++..++.++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+.....
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~-~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           84 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV-NRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE-ETTEEEECCCTTCEECTT
T ss_pred             cEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEc-CCCCEEECcccceeeecc
Confidence            9999999985 88888877667899999999999999999999999999999999999999 889999999999987653


Q ss_pred             CCCc---ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchh
Q 045787          160 PQKE---YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAEST  235 (324)
Q Consensus       160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (324)
                      ....   .....+++.|+|||++.+ ..++.++||||||+++|+|++ |..||.................+         
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~---------  232 (287)
T 1u59_A          163 DDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM---------  232 (287)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC---------
T ss_pred             CcceeeccccccccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcC---------
Confidence            3221   222345788999999976 567999999999999999998 99999877755444333211110         


Q ss_pred             hhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCc
Q 045787          236 YISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHE  288 (324)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp  288 (324)
                                        .....+++.+.++|.+||+.||.+||++.+++++.
T Consensus       233 ------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l  267 (287)
T 1u59_A          233 ------------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM  267 (287)
T ss_dssp             ------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             ------------------CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence                              11236789999999999999999999999999753

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=4.4e-45  Score=330.09  Aligned_cols=263  Identities=28%  Similarity=0.423  Sum_probs=198.8

Q ss_pred             CcccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhc-CCCCeeEEEeeeecCCe
Q 045787            2 GKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKD   80 (324)
Q Consensus         2 ~~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~   80 (324)
                      ...+.+.|.+.+.||+|+||+||.+. ..+|+.||+|++....     .+.+.+|+.+++++ +||||+++++++.+++.
T Consensus        10 ~~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~   83 (434)
T 2rio_A           10 EQSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETTDRF   83 (434)
T ss_dssp             SCSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSE
T ss_pred             hhhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCe
Confidence            34567888899999999999998764 4579999999986532     24567899999887 79999999999999999


Q ss_pred             EEEEEEecCCCHHHHHHhcCCC------CCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeec------------C
Q 045787           81 VFLVFEYLDLDLHSFITRHKNT------LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL------------K  142 (324)
Q Consensus        81 ~~iv~e~~~g~l~~~~~~~~~~------~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~------------~  142 (324)
                      .|+||||++|+|.+++......      .++..++.++.||+.||.|||++|++|+||||+||+++.            .
T Consensus        84 ~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~  163 (434)
T 2rio_A           84 LYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAE  163 (434)
T ss_dssp             EEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCC
T ss_pred             EEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCC
Confidence            9999999999999998765321      123345779999999999999999999999999999972            2


Q ss_pred             CCcEEEeeccceeeccCCCCc----ccccccccccCCchhhcC------CCCCCCchhhHHHHHHHHHHHh-CCCCCCCC
Q 045787          143 RNTVKLADFGLARAIGVPQKE----YSRDCVYSPYKAPELLLG------YTGYSTPIDVWAVGCIFAEMIT-GKPLFPSK  211 (324)
Q Consensus       143 ~~~v~l~d~g~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~~-g~~pf~~~  211 (324)
                      +..++|+|||.+.........    .....||+.|+|||++.+      ...++.++|||||||++|+|++ |..||...
T Consensus       164 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~  243 (434)
T 2rio_A          164 NLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK  243 (434)
T ss_dssp             SCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred             ceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence            348999999999876543221    234578999999999965      2567999999999999999999 99999765


Q ss_pred             ChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCcccc
Q 045787          212 KHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLI  291 (324)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~  291 (324)
                      ..............+.                   ...    .....+++++.++|.+||+.||.+|||+.++++||||.
T Consensus       244 ~~~~~~i~~~~~~~~~-------------------~~~----~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~  300 (434)
T 2rio_A          244 YSRESNIIRGIFSLDE-------------------MKC----LHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFW  300 (434)
T ss_dssp             TTHHHHHHHTCCCCCC-------------------CTT----CCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred             hhhHHHHhcCCCCccc-------------------ccc----cccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccC
Confidence            5433211111000000                   000    00013457899999999999999999999999999997


Q ss_pred             CC
Q 045787          292 GV  293 (324)
Q Consensus       292 ~~  293 (324)
                      ..
T Consensus       301 ~~  302 (434)
T 2rio_A          301 PK  302 (434)
T ss_dssp             CH
T ss_pred             Cc
Confidence            64

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1e-44  Score=311.21  Aligned_cols=252  Identities=19%  Similarity=0.313  Sum_probs=204.6

Q ss_pred             ccCcCcceeE-eecccCceEEEEEEE--ccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCe
Q 045787            4 LKNLNYKKIK-KIGAGGYGEVYKCRN--TVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKD   80 (324)
Q Consensus         4 ~~~~~y~i~~-~Lg~g~~~~v~~a~~--~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   80 (324)
                      +..++|++.+ .||+|++|.||+|.+  ...++.+|+|++..........+.+.+|+.+++.++||||+++++++ ..+.
T Consensus        13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~   91 (291)
T 1xbb_A           13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAES   91 (291)
T ss_dssp             CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred             ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence            4467899999 999999999999954  56678999999986654444456788999999999999999999999 5677


Q ss_pred             EEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccC
Q 045787           81 VFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGV  159 (324)
Q Consensus        81 ~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~  159 (324)
                      .++|+||+. ++|.+++... ..+++..++.++.+++.||.+||+.|++|+||||+||+++ .++.++|+|||.+.....
T Consensus        92 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~-~~~~~kl~Dfg~~~~~~~  169 (291)
T 1xbb_A           92 WMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV-TQHYAKISDFGLSKALRA  169 (291)
T ss_dssp             EEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE-ETTEEEECCCTTCEECCT
T ss_pred             cEEEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEe-CCCcEEEccCCcceeecc
Confidence            899999998 5888887764 5699999999999999999999999999999999999999 889999999999987653


Q ss_pred             CCCc---ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchh
Q 045787          160 PQKE---YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAEST  235 (324)
Q Consensus       160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (324)
                      ....   .....+++.|+|||++.+ ..++.++||||||+++|+|++ |..||...+.............+.        
T Consensus       170 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~--------  240 (291)
T 1xbb_A          170 DENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG--------  240 (291)
T ss_dssp             TCSEEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC--------
T ss_pred             CCCcccccccCCCCceeeChHHhcc-CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC--------
Confidence            3321   122345677999999976 557899999999999999999 999998877665544433211110        


Q ss_pred             hhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          236 YISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                         ....+++.+.++|.+||+.||.+||++.++++
T Consensus       241 -------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          241 -------------------CPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             -------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                               11367899999999999999999999999986

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-44  Score=315.45  Aligned_cols=254  Identities=24%  Similarity=0.363  Sum_probs=202.5

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccCC----ceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecC
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVTG----QKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR   78 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~----~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   78 (324)
                      .+...+|++.+.||+|++|.||+|.+..++    ..||+|.+...... .....+.+|+.++++++||||+++++++.+.
T Consensus        40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  118 (333)
T 1mqb_A           40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE-KQRVDFLGEAGIMGQFSHHNIIRLEGVISKY  118 (333)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCH-HHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence            456789999999999999999999876543    35999998754321 2234678999999999999999999999999


Q ss_pred             CeEEEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeec
Q 045787           79 KDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAI  157 (324)
Q Consensus        79 ~~~~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~  157 (324)
                      +..++||||+++ +|.+++......+++..++.++.+++.||.+||+.|++|+||||+||+++ .++.++|+|||.+...
T Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~-~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN-SNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC-TTCCEEECCCCC----
T ss_pred             CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEEC-CCCcEEECCCCcchhh
Confidence            999999999985 99998887767899999999999999999999999999999999999999 8999999999999876


Q ss_pred             cCCCCc---ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccc
Q 045787          158 GVPQKE---YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAE  233 (324)
Q Consensus       158 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  233 (324)
                      ......   .....+++.|+|||++.+ ..++.++||||||+++|+|++ |..||...+.............++      
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~------  270 (333)
T 1mqb_A          198 EDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP------  270 (333)
T ss_dssp             -------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC------
T ss_pred             ccccccccccCCCCccccccCchhccc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCC------
Confidence            533221   122234677999999987 668999999999999999999 999998777554433322111110      


Q ss_pred             hhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          234 STYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                           ....++..+.+++.+||+.||.+||++.++++
T Consensus       271 ---------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  302 (333)
T 1mqb_A          271 ---------------------TPMDCPSAIYQLMMQCWQQERARRPKFADIVS  302 (333)
T ss_dssp             ---------------------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ---------------------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                 11257889999999999999999999999986

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.2e-44  Score=313.42  Aligned_cols=254  Identities=23%  Similarity=0.344  Sum_probs=200.2

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeecccc-CCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQ-EGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   83 (324)
                      ..++|++.+.||+|++|.||+|.+..+++.||+|++...... ....+.+.+|+.++++++||||+++++++..++..++
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            457899999999999999999999999999999998765432 2223668899999999999999999999999999999


Q ss_pred             EEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC-
Q 045787           84 VFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ-  161 (324)
Q Consensus        84 v~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~-  161 (324)
                      |+||++| +|.+++... .++++..++.++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+....... 
T Consensus       112 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~  189 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVS-ADDFAYLVDFGIASATTDEKL  189 (309)
T ss_dssp             EEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC-TTSCEEECSCCC---------
T ss_pred             EEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEc-CCCCEEEecCccCcccccccc
Confidence            9999986 888887764 5699999999999999999999999999999999999999 88999999999987654332 


Q ss_pred             CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhccc
Q 045787          162 KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEIL  241 (324)
Q Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (324)
                      .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.......+.........                
T Consensus       190 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~----------------  252 (309)
T 2h34_A          190 TQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIP----------------  252 (309)
T ss_dssp             -------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCC----------------
T ss_pred             ccccccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCC----------------
Confidence            22334568889999999987 6779999999999999999999999987665533332221110                


Q ss_pred             CCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCC-CHHHHhc
Q 045787          242 PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRI-TAMDALK  286 (324)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-s~~~~l~  286 (324)
                               ......+.++..+.++|.+||+.||.+|| +++++++
T Consensus       253 ---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          253 ---------RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             ---------CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             ---------CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence                     01122346899999999999999999999 7777775

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.3e-44  Score=307.14  Aligned_cols=250  Identities=16%  Similarity=0.250  Sum_probs=207.1

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecC--Ce
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR--KD   80 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~   80 (324)
                      .+..++|++.+.||+|++|.||+|.+.  +..+|+|++..........+.+.+|+.++++++||||+++++++.+.  ..
T Consensus         6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   83 (271)
T 3kmu_A            6 GIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH   83 (271)
T ss_dssp             CCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSS
T ss_pred             CCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCC
Confidence            456789999999999999999999985  88999999987654443456788999999999999999999999877  78


Q ss_pred             EEEEEEecC-CCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC--CcccCCCCCceEeecCCCcEEEeeccceee
Q 045787           81 VFLVFEYLD-LDLHSFITRHKN-TLNLLVIKAILKQILLGLAYCHSLK--ILHRDLKPNNLLIDLKRNTVKLADFGLARA  156 (324)
Q Consensus        81 ~~iv~e~~~-g~l~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~g--~~H~di~p~nIll~~~~~~v~l~d~g~~~~  156 (324)
                      .++||||++ |+|.+++..... .+++..++.++.+++.||.|||+.|  ++|+||||+||+++ .++.++|+|||.+..
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~-~~~~~~l~~~~~~~~  162 (271)
T 3kmu_A           84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMID-EDMTARISMADVKFS  162 (271)
T ss_dssp             CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEEC-TTSCEEEEGGGSCCT
T ss_pred             eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEc-CCcceeEEeccceee
Confidence            999999998 599998887554 5899999999999999999999999  99999999999999 889999999988754


Q ss_pred             ccCCCCcccccccccccCCchhhcCCCC--CCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccch
Q 045787          157 IGVPQKEYSRDCVYSPYKAPELLLGYTG--YSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAES  234 (324)
Q Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (324)
                      ..     .....+|+.|+|||++.+...  .+.++||||||+++|+|++|+.||...+...........+..+.      
T Consensus       163 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~------  231 (271)
T 3kmu_A          163 FQ-----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT------  231 (271)
T ss_dssp             TS-----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCC------
T ss_pred             ec-----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCC------
Confidence            32     223467889999999986322  23489999999999999999999987775554333322221111      


Q ss_pred             hhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          235 TYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                          ....+++.+.+++.+||+.||.+|||+.++++
T Consensus       232 --------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          232 --------------------IPPGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             --------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                11357899999999999999999999999986

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=9.4e-45  Score=310.15  Aligned_cols=250  Identities=27%  Similarity=0.448  Sum_probs=207.4

Q ss_pred             CcccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeec----
Q 045787            2 GKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS----   77 (324)
Q Consensus         2 ~~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----   77 (324)
                      +....++|++++.||+|++|.||+|.+..+++.||+|.+....      ..+.+|+.++++++|||++++++++..    
T Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   79 (284)
T 2a19_B            6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYD   79 (284)
T ss_dssp             CHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC
T ss_pred             cchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccC
Confidence            4556788999999999999999999999999999999987542      346789999999999999999998754    


Q ss_pred             ------------CCeEEEEEEecCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCC
Q 045787           78 ------------RKDVFLVFEYLDL-DLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKR  143 (324)
Q Consensus        78 ------------~~~~~iv~e~~~g-~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~  143 (324)
                                  ....++||||+++ +|.+++.... ..+++..++.++.+++.||.+||+.|++|+||+|+||+++ .+
T Consensus        80 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~-~~  158 (284)
T 2a19_B           80 PETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV-DT  158 (284)
T ss_dssp             ---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE-ET
T ss_pred             cccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEc-CC
Confidence                        4568999999985 9999887643 5699999999999999999999999999999999999999 89


Q ss_pred             CcEEEeeccceeeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHc
Q 045787          144 NTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLL  223 (324)
Q Consensus       144 ~~v~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~  223 (324)
                      +.++|+|||.+...... .......+++.|+|||++.+ ..++.++||||||+++|+|++|..|+....     ......
T Consensus       159 ~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~-----~~~~~~  231 (284)
T 2a19_B          159 KQVKIGDFGLVTSLKND-GKRTRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFETS-----KFFTDL  231 (284)
T ss_dssp             TEEEECCCTTCEESSCC-SCCCCCCSCCTTSCHHHHHC-SCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-----HHHHHH
T ss_pred             CCEEECcchhheecccc-ccccccCCcccccChhhhcc-CCCcchhhhHHHHHHHHHHHhcCCcchhHH-----HHHHHh
Confidence            99999999998876533 23344568899999999987 668999999999999999999998873211     000000


Q ss_pred             CCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccC
Q 045787          224 GTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIG  292 (324)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~  292 (324)
                      .                 ..          .....++..+.++|.+||+.||.+|||+.+++++.+.-.
T Consensus       232 ~-----------------~~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          232 R-----------------DG----------IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             H-----------------TT----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             h-----------------cc----------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            0                 00          011257889999999999999999999999999877544

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2e-44  Score=307.88  Aligned_cols=254  Identities=23%  Similarity=0.328  Sum_probs=204.8

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccC---CceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCC
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVT---GQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK   79 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~---~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   79 (324)
                      .+..++|++.+.||+|++|.||+|.+...   +..||+|.+..... ....+.+.+|+.++++++|||++++++++.++ 
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-   85 (281)
T 3cc6_A            8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCT-LDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-   85 (281)
T ss_dssp             SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSC-HHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-
T ss_pred             eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccC-chHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-
Confidence            35568999999999999999999986533   34699999875432 12246688999999999999999999998754 


Q ss_pred             eEEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeecc
Q 045787           80 DVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIG  158 (324)
Q Consensus        80 ~~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~  158 (324)
                      ..++|+||+. ++|.+++......+++..++.++.+++.||.+||++|++|+||||+||+++ .++.++|+|||.+....
T Consensus        86 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           86 PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVA-SPECVKLGDFGLSRYIE  164 (281)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE-ETTEEEECCCCGGGCC-
T ss_pred             CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEC-CCCcEEeCccCCCcccc
Confidence            5689999998 589999888777799999999999999999999999999999999999999 88999999999987664


Q ss_pred             CCCC-cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhh
Q 045787          159 VPQK-EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY  236 (324)
Q Consensus       159 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (324)
                      .... ......+++.|+|||++.+ ..++.++||||||+++|+|++ |..||.................++.        
T Consensus       165 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~--------  235 (281)
T 3cc6_A          165 DEDYYKASVTRLPIKWMSPESINF-RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK--------  235 (281)
T ss_dssp             --------CCCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCC--------
T ss_pred             cccccccccCCCCcceeCchhhcc-CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCC--------
Confidence            3322 2233456778999999976 667999999999999999998 9999987665544433332211111        


Q ss_pred             hhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcC
Q 045787          237 ISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH  287 (324)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~h  287 (324)
                                         ...+++.+.++|.+||..||.+|||+.+++++
T Consensus       236 -------------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          236 -------------------PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             -------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------------CCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence                               12578899999999999999999999999963

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=8e-45  Score=317.00  Aligned_cols=252  Identities=27%  Similarity=0.347  Sum_probs=204.5

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceE--EEEEeeeccccCCCchHHHHHHHHHHhc-CCCCeeEEEeeeecCCe
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKV--AIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKD   80 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~--~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~   80 (324)
                      +..++|++.+.||+|++|.||+|.+..++..+  ++|.+..... ....+.+.+|+.+++++ +||||+++++++.+++.
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  100 (327)
T 1fvr_A           22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY  100 (327)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred             ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccc-hHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCc
Confidence            45689999999999999999999999888865  9998874332 23356788999999999 89999999999999999


Q ss_pred             EEEEEEecC-CCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCC
Q 045787           81 VFLVFEYLD-LDLHSFITRHK---------------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN  144 (324)
Q Consensus        81 ~~iv~e~~~-g~l~~~~~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~  144 (324)
                      .++||||++ |+|.+++....               ..+++..++.++.+++.||.+||+.|++|+||||+||+++ .++
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~  179 (327)
T 1fvr_A          101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG-ENY  179 (327)
T ss_dssp             EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-GGG
T ss_pred             eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEc-CCC
Confidence            999999997 59999887653               4699999999999999999999999999999999999999 889


Q ss_pred             cEEEeeccceeeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHc
Q 045787          145 TVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLL  223 (324)
Q Consensus       145 ~v~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~  223 (324)
                      .++|+|||.+...... .......+++.|+|||++.+ ..++.++||||||+++|+|++ |..||...+...........
T Consensus       180 ~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~  257 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG  257 (327)
T ss_dssp             CEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred             eEEEcccCcCcccccc-ccccCCCCCccccChhhhcc-ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcC
Confidence            9999999998743321 12233356778999999977 567899999999999999998 99999877755433221110


Q ss_pred             CCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          224 GTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      ..                           ......+++.+.++|.+||+.||.+|||+.++++
T Consensus       258 ~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  293 (327)
T 1fvr_A          258 YR---------------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  293 (327)
T ss_dssp             CC---------------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CC---------------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            00                           0011257889999999999999999999999997

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.5e-45  Score=329.66  Aligned_cols=277  Identities=20%  Similarity=0.306  Sum_probs=208.5

Q ss_pred             CcccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCC--
Q 045787            2 GKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK--   79 (324)
Q Consensus         2 ~~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--   79 (324)
                      +.+..++|++.+.||+|+||+||+|.+..+|+.||+|++....... ..+.+.+|+.++++++||||+++++++....  
T Consensus         4 ~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~   82 (396)
T 4eut_A            4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR   82 (396)
T ss_dssp             EECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred             CCCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc-hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCC
Confidence            3567899999999999999999999999999999999997654322 2466789999999999999999999987655  


Q ss_pred             eEEEEEEecC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEe----ecCCCcEEEeecc
Q 045787           80 DVFLVFEYLD-LDLHSFITRHKN--TLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLI----DLKRNTVKLADFG  152 (324)
Q Consensus        80 ~~~iv~e~~~-g~l~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll----~~~~~~v~l~d~g  152 (324)
                      ..++||||+. |+|.+++.....  .+++..++.++.+++.||.|||+.|++|+||||+||++    + .++.++|+|||
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~-~~~~~kL~DFG  161 (396)
T 4eut_A           83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGED-GQSVYKLTDFG  161 (396)
T ss_dssp             CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTT-SCEEEEECCGG
T ss_pred             eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCC-CceeEEEecCC
Confidence            7899999997 588888776433  39999999999999999999999999999999999998    5 66779999999


Q ss_pred             ceeeccCCCCcccccccccccCCchhhcCC-------CCCCCchhhHHHHHHHHHHHhCCCCCCCCC--hhHHHHHHHHc
Q 045787          153 LARAIGVPQKEYSRDCVYSPYKAPELLLGY-------TGYSTPIDVWAVGCIFAEMITGKPLFPSKK--HDHLSLIFSLL  223 (324)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~~~~~  223 (324)
                      .+...... .......+++.|+|||++.+.       ..++.++||||||+++|+|++|..||....  ......+....
T Consensus       162 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  240 (396)
T 4eut_A          162 AARELEDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII  240 (396)
T ss_dssp             GCEECCCG-GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred             CceEccCC-CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence            99876532 333445789999999998641       346789999999999999999999996433  11112222222


Q ss_pred             CCCCcccccchhhhh----cccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          224 GTPTDESWAESTYIS----EILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       224 ~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      ...+...+.......    ........     .......++..+.++|.+||+.||.+||+++++++
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          241 TGKPSGAISGVQKAENGPIDWSGDMPV-----SCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             HSCCTTCCEEEECSTTCCEEEESSCCT-----TCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             cCCCcccchhheeccCCCcccCccCCc-----ccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence            222222111110000    00000000     00111235667889999999999999999999864

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=5.4e-45  Score=320.35  Aligned_cols=260  Identities=19%  Similarity=0.183  Sum_probs=200.1

Q ss_pred             CcccCcCcceeEeecccCceEEEEEEEcc---CCceEEEEEeeecccc---------CCCchHHHHHHHHHHhcCCCCee
Q 045787            2 GKLKNLNYKKIKKIGAGGYGEVYKCRNTV---TGQKVAIKMMTIQTEQ---------EGVPSYIIREVSLLKELEHENIV   69 (324)
Q Consensus         2 ~~~~~~~y~i~~~Lg~g~~~~v~~a~~~~---~~~~~~~K~~~~~~~~---------~~~~~~~~~e~~~l~~l~~~~i~   69 (324)
                      +++..++|++.+.||+|+||.||+|.+..   ++..+|+|+.......         ......+.+|+..++.++||||+
T Consensus        32 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~  111 (345)
T 2v62_A           32 DDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIP  111 (345)
T ss_dssp             ECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCC
T ss_pred             ccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcc
Confidence            34567899999999999999999999987   7889999998754321         01123466788888999999999


Q ss_pred             EEEeeeec----CCeEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCC-
Q 045787           70 RLLDVQSS----RKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN-  144 (324)
Q Consensus        70 ~~~~~~~~----~~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~-  144 (324)
                      ++++++..    ....|+||||++++|.+++.... .+++..++.++.|++.||.|||+.|++|+||||+||+++ .++ 
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~  189 (345)
T 2v62_A          112 LFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLG-YKNP  189 (345)
T ss_dssp             CEEEEEEEESSSCEEEEEEEECEEEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE-SSST
T ss_pred             eeecccccccCCCcEEEEEEeccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEc-cCCC
Confidence            99999877    77899999999778988877654 799999999999999999999999999999999999998 666 


Q ss_pred             -cEEEeeccceeeccCCC-------CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC--hh
Q 045787          145 -TVKLADFGLARAIGVPQ-------KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK--HD  214 (324)
Q Consensus       145 -~v~l~d~g~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~  214 (324)
                       .++|+|||.+.......       .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||....  ..
T Consensus       190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~  268 (345)
T 2v62_A          190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG-VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV  268 (345)
T ss_dssp             TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred             CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence             99999999997664221       11234468899999999987 678999999999999999999999996532  22


Q ss_pred             HHHHHHHH-cCCCCcccccchhhhhcccCCCCCCCCcchhhhC--CCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          215 HLSLIFSL-LGTPTDESWAESTYISEILPLYPHFEPANLAEKF--PNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       215 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      ........ ....+                      .......  ..++..+.++|.+||..||.+||++.++++
T Consensus       269 ~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          269 AVQTAKTNLLDELP----------------------QSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             HHHHHHHHHHHTTT----------------------HHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHhhccccc----------------------HHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            22111111 11110                      0111111  168899999999999999999999999996

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=7.6e-45  Score=317.14  Aligned_cols=267  Identities=27%  Similarity=0.349  Sum_probs=207.2

Q ss_pred             ccCcCcceeEeecccCceEEEEEE----EccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeee--c
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCR----NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQS--S   77 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~----~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~   77 (324)
                      +..++|++++.||+|++|.||+|.    +..+++.||+|++......  ..+.+.+|+.++++++||||+++++++.  +
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   97 (327)
T 3lxl_A           20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD--QQRDFQREIQILKALHSDFIVKYRGVSYGPG   97 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHH--HHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHH--HHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence            346899999999999999999998    5678899999998755322  2356889999999999999999999876  4


Q ss_pred             CCeEEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceee
Q 045787           78 RKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARA  156 (324)
Q Consensus        78 ~~~~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~  156 (324)
                      ....++||||++ ++|.+++......+++..++.++.+++.||.+||+.|++|+||||+||+++ .++.++|+|||.+..
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~-~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A           98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVE-SEAHVKIADFGLAKL  176 (327)
T ss_dssp             SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE-ETTEEEECCGGGCEE
T ss_pred             CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEEC-CCCCEEEccccccee
Confidence            567999999996 689998887667799999999999999999999999999999999999999 899999999999987


Q ss_pred             ccCCCC---cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccc
Q 045787          157 IGVPQK---EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAE  233 (324)
Q Consensus       157 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  233 (324)
                      ......   ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.................+     ..
T Consensus       177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~-----~~  250 (327)
T 3lxl_A          177 LPLDKDYYVVREPGQSPIFWYAPESLSD-NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVP-----AL  250 (327)
T ss_dssp             CCTTCSEEECSSCCCSCGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CC-----HH
T ss_pred             cccCCccceeeccCCccccccCHHHhcc-CCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccc-----cH
Confidence            653332   2233456777999999987 56799999999999999999999998654433211110000000     00


Q ss_pred             hhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          234 STYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      ...........       .......+++.+.++|.+||+.||.+|||+.++++
T Consensus       251 ~~~~~~~~~~~-------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  296 (327)
T 3lxl_A          251 SRLLELLEEGQ-------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGP  296 (327)
T ss_dssp             HHHHHHHHTTC-------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhhccc-------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            00000000000       01112468899999999999999999999999975

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2e-44  Score=315.34  Aligned_cols=253  Identities=24%  Similarity=0.382  Sum_probs=207.6

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEc-------cCCceEEEEEeeeccccCCCchHHHHHHHHHHhc-CCCCeeEEEeee
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNT-------VTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQ   75 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~-------~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~   75 (324)
                      +..++|++.+.||+|+||.||+|.+.       .++..||+|++...... ...+.+.+|+.+++++ +||||+++++++
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  110 (334)
T 2pvf_A           32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE-KDLSDLVSEMEMMKMIGKHKNIINLLGAC  110 (334)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcH-HHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence            45689999999999999999999975       45678999998754321 2245688999999999 899999999999


Q ss_pred             ecCCeEEEEEEecCC-CHHHHHHhcCC---------------CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEe
Q 045787           76 SSRKDVFLVFEYLDL-DLHSFITRHKN---------------TLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLI  139 (324)
Q Consensus        76 ~~~~~~~iv~e~~~g-~l~~~~~~~~~---------------~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll  139 (324)
                      .+++..++||||+++ +|.+++.....               .+++..++.++.+++.||.+||+.|++|+||||+||++
T Consensus       111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV  190 (334)
T ss_dssp             CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred             ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE
Confidence            999999999999974 99998876532               48899999999999999999999999999999999999


Q ss_pred             ecCCCcEEEeeccceeeccCCCC--cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHH
Q 045787          140 DLKRNTVKLADFGLARAIGVPQK--EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHL  216 (324)
Q Consensus       140 ~~~~~~v~l~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~  216 (324)
                      + .++.++|+|||.+........  ......+++.|+|||++.+ ..++.++||||||+++|+|++ |..||........
T Consensus       191 ~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~  268 (334)
T 2pvf_A          191 T-ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  268 (334)
T ss_dssp             C-TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             c-CCCCEEEccccccccccccccccccCCCCcccceeChHHhcC-CCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH
Confidence            9 899999999999987653322  1223345678999999977 567999999999999999999 9999988776554


Q ss_pred             HHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          217 SLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      .........+.                           ....++..+.++|.+||+.||.+|||+.++++
T Consensus       269 ~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  311 (334)
T 2pvf_A          269 FKLLKEGHRMD---------------------------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVE  311 (334)
T ss_dssp             HHHHHHTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhcCCCCC---------------------------CCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            44333211110                           11357889999999999999999999999996

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.7e-44  Score=312.96  Aligned_cols=254  Identities=22%  Similarity=0.311  Sum_probs=197.5

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEcc---CCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCC-
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTV---TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK-   79 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~---~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-   79 (324)
                      +..++|++.+.||+|++|.||+|.+..   ++..||+|.+..........+.+.+|+.++++++||||+++++++.+.. 
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  110 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS  110 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence            456899999999999999999998765   4558999998765444333466889999999999999999999987654 


Q ss_pred             ----eEEEEEEecC-CCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEe
Q 045787           80 ----DVFLVFEYLD-LDLHSFITRH-----KNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLA  149 (324)
Q Consensus        80 ----~~~iv~e~~~-g~l~~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~  149 (324)
                          ..++|+||+. |+|.+++...     ...+++..++.++.+++.||.+||++|++|+||||+||+++ .++.++|+
T Consensus       111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~-~~~~~kl~  189 (313)
T 3brb_A          111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR-DDMTVCVA  189 (313)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEEC-TTSCEEEC
T ss_pred             cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc-CCCcEEEe
Confidence                4599999998 4888887532     35699999999999999999999999999999999999999 88999999


Q ss_pred             eccceeeccCCC--CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCC
Q 045787          150 DFGLARAIGVPQ--KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTP  226 (324)
Q Consensus       150 d~g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~  226 (324)
                      |||.+.......  .......+++.|+|||++.+ ..++.++||||||+++|+|++ |..||.................+
T Consensus       190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~  268 (313)
T 3brb_A          190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRL  268 (313)
T ss_dssp             SCSCC----------------CCGGGSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC
T ss_pred             ecCcceecccccccCcccccCCCccccCchhhcC-CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCC
Confidence            999987664322  12223356778999999987 678999999999999999999 88999877755443332211111


Q ss_pred             CcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          227 TDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                                 .....+++.+.++|.+||..||.+|||+.++++
T Consensus       269 ---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  301 (313)
T 3brb_A          269 ---------------------------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRL  301 (313)
T ss_dssp             ---------------------------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             ---------------------------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                       011357889999999999999999999999986

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.1e-44  Score=317.23  Aligned_cols=252  Identities=25%  Similarity=0.387  Sum_probs=188.8

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcC-CCCeeEEEeee-------
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-HENIVRLLDVQ-------   75 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~-------   75 (324)
                      +...+|++.+.||+|+||.||+|.+..+++.||+|++......  ..+.+.+|+.+++++. ||||+++++++       
T Consensus        25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~  102 (337)
T 3ll6_A           25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEE--KNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES  102 (337)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHH--HHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred             ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchH--HHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence            3456899999999999999999999999999999998654322  2456789999999996 99999999988       


Q ss_pred             -ecCCeEEEEEEecCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcccCCCCCceEeecCCCcEEEee
Q 045787           76 -SSRKDVFLVFEYLDLDLHSFITR--HKNTLNLLVIKAILKQILLGLAYCHSLK--ILHRDLKPNNLLIDLKRNTVKLAD  150 (324)
Q Consensus        76 -~~~~~~~iv~e~~~g~l~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~g--~~H~di~p~nIll~~~~~~v~l~d  150 (324)
                       .....+++|+||++|+|.+++..  ...++++..++.++.+|+.||.+||+.|  ++|+||||+||+++ .++.++|+|
T Consensus       103 ~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~-~~~~~kl~D  181 (337)
T 3ll6_A          103 DTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS-NQGTIKLCD  181 (337)
T ss_dssp             TTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEEC-TTSCEEBCC
T ss_pred             ccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEEC-CCCCEEEec
Confidence             34456899999999999998875  3456999999999999999999999999  99999999999999 889999999


Q ss_pred             ccceeeccCCCCc------------ccccccccccCCchhhc--CCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHH
Q 045787          151 FGLARAIGVPQKE------------YSRDCVYSPYKAPELLL--GYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHL  216 (324)
Q Consensus       151 ~g~~~~~~~~~~~------------~~~~~~~~~y~aPE~~~--~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~  216 (324)
                      ||.+.........            .....+++.|+|||++.  ....++.++||||||+++|+|++|..||........
T Consensus       182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~  261 (337)
T 3ll6_A          182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI  261 (337)
T ss_dssp             CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh
Confidence            9999876532211            11345788899999984  236678999999999999999999999965432211


Q ss_pred             HHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCc
Q 045787          217 SLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHE  288 (324)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp  288 (324)
                      ..  ...                      .      .......+..+.++|.+||+.||.+|||+.+++++-
T Consensus       262 ~~--~~~----------------------~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l  303 (337)
T 3ll6_A          262 VN--GKY----------------------S------IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL  303 (337)
T ss_dssp             ------C----------------------C------CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             hc--Ccc----------------------c------CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            00  000                      0      001134677899999999999999999999999863

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=318.76  Aligned_cols=254  Identities=16%  Similarity=0.154  Sum_probs=201.2

Q ss_pred             cCcCcceeEeecccCceEEEEEEEcc--------CCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeE------
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTV--------TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVR------   70 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~--------~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~------   70 (324)
                      ..++|++.+.||+|++|.||+|.+..        +++.||+|++...       ..+.+|+.++++++|||+++      
T Consensus        40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~  112 (352)
T 2jii_A           40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLY  112 (352)
T ss_dssp             TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred             cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhc
Confidence            36899999999999999999999987        4889999998743       35789999999999998887      


Q ss_pred             ---------EEeeeec-CCeEEEEEEecCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEe
Q 045787           71 ---------LLDVQSS-RKDVFLVFEYLDLDLHSFITRH-KNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLI  139 (324)
Q Consensus        71 ---------~~~~~~~-~~~~~iv~e~~~g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll  139 (324)
                               +++++.. +...|+||||++++|.+++... ...+++..++.++.||+.||.|||++|++|+||||+||++
T Consensus       113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~  192 (352)
T 2jii_A          113 STPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV  192 (352)
T ss_dssp             TCTTCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE
T ss_pred             cCCccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence                     5666655 6789999999977999999875 3579999999999999999999999999999999999999


Q ss_pred             ecCCC--cEEEeeccceeeccCCCC-------cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 045787          140 DLKRN--TVKLADFGLARAIGVPQK-------EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPS  210 (324)
Q Consensus       140 ~~~~~--~v~l~d~g~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  210 (324)
                      + .++  .++|+|||.+........       ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||..
T Consensus       193 ~-~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~  270 (352)
T 2jii_A          193 D-PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG-CGPSRRSDLQSLGYCMLKWLYGFLPWTN  270 (352)
T ss_dssp             E-TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             c-CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            9 776  899999999976543211       1233478899999999987 6789999999999999999999999976


Q ss_pred             CC--hhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          211 KK--HDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       211 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      ..  ...+..........+....                   ........++..+.++|.+||+.||.+|||+.++++
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          271 CLPNTEDIMKQKQKFVDKPGPFV-------------------GPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             GTTCHHHHHHHHHHHHHSCCCEE-------------------CTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             CCcCHHHHHHHHHhccCChhhhh-------------------hhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence            54  2222222211111110000                   000012257899999999999999999999999986

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.8e-44  Score=319.35  Aligned_cols=263  Identities=15%  Similarity=0.162  Sum_probs=199.3

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccC-----CceEEEEEeeecccc---------CCCchHHHHHHHHHHhcCCCCee
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVT-----GQKVAIKMMTIQTEQ---------EGVPSYIIREVSLLKELEHENIV   69 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~-----~~~~~~K~~~~~~~~---------~~~~~~~~~e~~~l~~l~~~~i~   69 (324)
                      +..++|++.+.||+|+||.||+|.+..+     ++.||+|++......         .........|+..+..++||||+
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            4566999999999999999999998764     578999998654311         00112233455566677899999


Q ss_pred             EEEeeeecC----CeEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeec-CCC
Q 045787           70 RLLDVQSSR----KDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL-KRN  144 (324)
Q Consensus        70 ~~~~~~~~~----~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~-~~~  144 (324)
                      ++++++...    ...|+||||++++|.+++......+++..++.++.+|+.||.|||+.|++|+||||+||+++. .++
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~  191 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD  191 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred             eEEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence            999988664    568999999977999999887778999999999999999999999999999999999999973 458


Q ss_pred             cEEEeeccceeeccCCCC-------cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhH-H
Q 045787          145 TVKLADFGLARAIGVPQK-------EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDH-L  216 (324)
Q Consensus       145 ~v~l~d~g~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~  216 (324)
                      .++|+|||.+........       ......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||....... .
T Consensus       192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~  270 (364)
T 3op5_A          192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG-VAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY  270 (364)
T ss_dssp             CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred             eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCccccccCHHH
Confidence            999999999976643211       1123358999999999987 668999999999999999999999997543221 1


Q ss_pred             H-HHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          217 S-LIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       217 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      . ...........      .......             ....++.++.+++..|+..||.+||++.++++
T Consensus       271 ~~~~~~~~~~~~~------~~~~~~~-------------~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          271 VRDSKIRYRENIA------SLMDKCF-------------PAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHHHCHH------HHHHHHS-------------CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHhhhhHH------HHHHHhc-------------ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            1 11111000000      0000000             01367899999999999999999999999985

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.6e-43  Score=321.34  Aligned_cols=245  Identities=24%  Similarity=0.387  Sum_probs=203.0

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCC-eEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK-DVF   82 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~   82 (324)
                      +..++|++.+.||+|+||.||++...  |+.||+|++....    ..+.+.+|+.++++++||||+++++++.... ..+
T Consensus       190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  263 (450)
T 1k9a_A          190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY  263 (450)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEE
T ss_pred             cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceE
Confidence            45678999999999999999999875  7799999987543    3567899999999999999999999976654 799


Q ss_pred             EEEEecC-CCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           83 LVFEYLD-LDLHSFITRHKN-TLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        83 iv~e~~~-g~l~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      +||||++ |+|.+++..... .+++..+..++.+++.||.|||++|++|+||||+||+++ .++.+||+|||.+......
T Consensus       264 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~-~~~~~kl~DfG~a~~~~~~  342 (450)
T 1k9a_A          264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS-EDNVAKVSDFGLTKEASST  342 (450)
T ss_dssp             EEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC-TTSCEEECCCTTCEECC--
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEC-CCCCEEEeeCCCccccccc
Confidence            9999997 599999887654 379999999999999999999999999999999999999 8999999999999865422


Q ss_pred             CCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhc
Q 045787          161 QKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISE  239 (324)
Q Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
                      .   ....+++.|+|||++.+ ..++.++||||||+++|+|++ |..||...+.............+             
T Consensus       343 ~---~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~-------------  405 (450)
T 1k9a_A          343 Q---DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM-------------  405 (450)
T ss_dssp             -------CCCTTTSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCC-------------
T ss_pred             c---cCCCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-------------
Confidence            1   22356778999999987 678999999999999999998 99999876654433322211000             


Q ss_pred             ccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                    .....+++.+.++|.+||+.||.+|||+.++++
T Consensus       406 --------------~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          406 --------------DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             --------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                          012367899999999999999999999999985

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.4e-44  Score=329.27  Aligned_cols=251  Identities=24%  Similarity=0.368  Sum_probs=210.5

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   83 (324)
                      +...+|++.+.||+|+||.||++.+..++..||+|++.....   ..+.+.+|+.++++++||||+++++++......++
T Consensus       217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  293 (495)
T 1opk_A          217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI  293 (495)
T ss_dssp             CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc---chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence            345789999999999999999999998899999999875432   25678999999999999999999999999999999


Q ss_pred             EEEecC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC
Q 045787           84 VFEYLD-LDLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        84 v~e~~~-g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~  161 (324)
                      ||||+. |+|.+++.... ..+++..++.++.+|+.||.|||++|++|+||||+|||++ .++.+||+|||++.......
T Consensus       294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~~~  372 (495)
T 1opk_A          294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVG-ENHLVKVADFGLSRLMTGDT  372 (495)
T ss_dssp             EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-GGGCEEECCTTCEECCTTCC
T ss_pred             EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEC-CCCcEEEeecccceeccCCc
Confidence            999998 69999987643 4689999999999999999999999999999999999999 88999999999998764322


Q ss_pred             Cc-ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhc
Q 045787          162 KE-YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISE  239 (324)
Q Consensus       162 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
                      .. .....+++.|+|||++.+ ..++.++||||||+++|+|++ |..||.+.+..............             
T Consensus       373 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-------------  438 (495)
T 1opk_A          373 YTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM-------------  438 (495)
T ss_dssp             EECCTTCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC-------------
T ss_pred             eeecCCCcCCcceeCHhHHhc-CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-------------
Confidence            11 222345667999999987 567999999999999999999 99999887755544332211000             


Q ss_pred             ccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                    .....+++.+.++|.+||+.||.+|||+.++++
T Consensus       439 --------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          439 --------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             --------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence                          012357899999999999999999999999986

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3.2e-44  Score=311.56  Aligned_cols=254  Identities=25%  Similarity=0.393  Sum_probs=205.1

Q ss_pred             ccCcCcceeEeecccCceEEEEEEE-----ccCCceEEEEEeeeccccCCCchHHHHHHHHHHhc-CCCCeeEEEeeeec
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRN-----TVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSS   77 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~-----~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   77 (324)
                      +..++|++.+.||+|++|.||+|.+     ..+++.||+|++...... ...+.+.+|+.+++++ +||||+++++++..
T Consensus        24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  102 (316)
T 2xir_A           24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGHHLNVVNLLGACTK  102 (316)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCc-HHHHHHHHHHHHHHhcccCCCeeeEEEEEec
Confidence            4568999999999999999999985     356789999998754322 1235688999999999 68999999999876


Q ss_pred             CC-eEEEEEEecCC-CHHHHHHhcCCC---------------CCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEee
Q 045787           78 RK-DVFLVFEYLDL-DLHSFITRHKNT---------------LNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLID  140 (324)
Q Consensus        78 ~~-~~~iv~e~~~g-~l~~~~~~~~~~---------------~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~  140 (324)
                      .+ .+++|+||++| +|.+++......               +++..++.++.+++.||.+||+.|++|+||||+||+++
T Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~  182 (316)
T 2xir_A          103 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS  182 (316)
T ss_dssp             TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred             CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC
Confidence            54 59999999985 899888775432               78999999999999999999999999999999999999


Q ss_pred             cCCCcEEEeeccceeeccCCCC--cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhH-H
Q 045787          141 LKRNTVKLADFGLARAIGVPQK--EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDH-L  216 (324)
Q Consensus       141 ~~~~~v~l~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~-~  216 (324)
                       .++.++|+|||.+........  ......+++.|+|||++.+ ..++.++||||||+++|+|++ |..||....... .
T Consensus       183 -~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~  260 (316)
T 2xir_A          183 -EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF  260 (316)
T ss_dssp             -GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred             -CCCCEEECCCccccccccCccceeccCCCcceeecCchhhcc-ccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHH
Confidence             889999999999986643322  2233456788999999987 668999999999999999998 999997766332 2


Q ss_pred             HHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcC
Q 045787          217 SLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH  287 (324)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~h  287 (324)
                      ...........                           ....+++.+.+++.+||+.||.+|||+.++++|
T Consensus       261 ~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          261 CRRLKEGTRMR---------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHHTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhccCccCC---------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            22221111100                           112478899999999999999999999999975

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-43  Score=305.25  Aligned_cols=249  Identities=24%  Similarity=0.310  Sum_probs=199.9

Q ss_pred             CcceeEeecccCceEEEEEEEccCCc---eEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeE-EE
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQ---KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV-FL   83 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~---~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~-~i   83 (324)
                      .|++.+.||+|+||+||+|.+..++.   .+|+|.+..... ....+.+.+|+.++++++||||+++++++.+.+.. ++
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  100 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITE-MQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV  100 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccccc-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence            45666999999999999999765544   799998864322 12245678999999999999999999999776654 99


Q ss_pred             EEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC--
Q 045787           84 VFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP--  160 (324)
Q Consensus        84 v~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~--  160 (324)
                      |+||+. |+|.+++......+++..++.++.+++.||.+||+.|++|+||||+||+++ .++.++|+|||.+......  
T Consensus       101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~-~~~~~kl~Dfg~~~~~~~~~~  179 (298)
T 3pls_A          101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLD-ESFTVKVADFGLARDILDREY  179 (298)
T ss_dssp             EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC-TTCCEEECCTTSSCTTTTGGG
T ss_pred             EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc-CCCcEEeCcCCCcccccCCcc
Confidence            999986 699999887677899999999999999999999999999999999999999 8899999999998755322  


Q ss_pred             --CCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhC-CCCCCCCChhHHHHHHHHcCCCCcccccchhhh
Q 045787          161 --QKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITG-KPLFPSKKHDHLSLIFSLLGTPTDESWAESTYI  237 (324)
Q Consensus       161 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (324)
                        ........+++.|+|||.+.+ ..++.++||||||+++|+|++| .+||...+..............+.         
T Consensus       180 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~---------  249 (298)
T 3pls_A          180 YSVQQHRHARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQ---------  249 (298)
T ss_dssp             GCSCCSSCTTCGGGGSCHHHHTT-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCC---------
T ss_pred             cccccCcCCCCCccccChhhhcc-CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCC---------
Confidence              122233456788999999987 6789999999999999999995 555655555444333332211111         


Q ss_pred             hcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          238 SEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                        ...+++.+.+++.+||+.||.+|||+.++++
T Consensus       250 ------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          250 ------------------PEYCPDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             ------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------CccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                              1257889999999999999999999999986

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=7.3e-45  Score=316.49  Aligned_cols=269  Identities=21%  Similarity=0.268  Sum_probs=198.8

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCC----
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK----   79 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----   79 (324)
                      +..++|++.+.||+|+||.||+|.+.  ++.||+|++......   ......|+.++++++||||+++++++....    
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   95 (322)
T 3soc_A           21 FQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQ---SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDV   95 (322)
T ss_dssp             ETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHH---HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred             cchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchH---HHHHHHHHHHHhcCCCCCchhhcceeccCCCCCc
Confidence            45679999999999999999999875  789999998754332   234556888899999999999999987744    


Q ss_pred             eEEEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCcccCCCCCceEeecCCCcEEE
Q 045787           80 DVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSL----------KILHRDLKPNNLLIDLKRNTVKL  148 (324)
Q Consensus        80 ~~~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~----------g~~H~di~p~nIll~~~~~~v~l  148 (324)
                      .+++||||+++ +|.+++..  ..+++..++.++.+++.||.|||+.          |++|+||||+||+++ .++.+||
T Consensus        96 ~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~-~~~~~kL  172 (322)
T 3soc_A           96 DLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK-NNLTACI  172 (322)
T ss_dssp             EEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEEC-TTCCEEE
T ss_pred             eEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEEC-CCCeEEE
Confidence            47999999975 89888866  3599999999999999999999999          999999999999999 8999999


Q ss_pred             eeccceeeccCCCC--cccccccccccCCchhhcCC----CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHH-H
Q 045787          149 ADFGLARAIGVPQK--EYSRDCVYSPYKAPELLLGY----TGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIF-S  221 (324)
Q Consensus       149 ~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~-~  221 (324)
                      +|||.+........  ......+|+.|+|||++.+.    ..++.++||||||+++|+|++|..||.+.......... .
T Consensus       173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~  252 (322)
T 3soc_A          173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE  252 (322)
T ss_dssp             CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred             ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence            99999977653322  23335789999999999763    23466889999999999999999999765432111000 0


Q ss_pred             HcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          222 LLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      ....+....+.     ............... ......+..+.++|.+||+.||.+|||+.++++
T Consensus       253 ~~~~~~~~~~~-----~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          253 IGQHPSLEDMQ-----EVVVHKKKRPVLRDY-WQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             HCSSCCHHHHH-----HHHTTSCCCCCCCGG-GGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hccCCchhhhh-----hhhhcccCCCCcccc-ccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            11111110000     000000000000000 000122345899999999999999999999986

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=8.4e-44  Score=303.62  Aligned_cols=249  Identities=24%  Similarity=0.378  Sum_probs=204.2

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   83 (324)
                      +..++|++++.||+|++|.||+|.+. ++..+|+|.+.....   ..+.+.+|+.++++++|||++++++++.+ +..++
T Consensus        10 v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   84 (279)
T 1qpc_A           10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI   84 (279)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             cCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc---cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEE
Confidence            55689999999999999999999975 567899999865432   24678899999999999999999998864 56899


Q ss_pred             EEEecC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC
Q 045787           84 VFEYLD-LDLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        84 v~e~~~-g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~  161 (324)
                      |+||++ ++|.+++.... ..+++..+..++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+.......
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~  163 (279)
T 1qpc_A           85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS-DTLSCKIADFGLARLIEDNE  163 (279)
T ss_dssp             EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-TTSCEEECCCTTCEECSSSC
T ss_pred             EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEc-CCCCEEECCCcccccccCcc
Confidence            999996 58888876543 2699999999999999999999999999999999999999 89999999999998765332


Q ss_pred             Cc-ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhc
Q 045787          162 KE-YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISE  239 (324)
Q Consensus       162 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
                      .. .....+++.|+|||++.+ ..++.++||||||+++|+|++ |..||...+.............+             
T Consensus       164 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~-------------  229 (279)
T 1qpc_A          164 YTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM-------------  229 (279)
T ss_dssp             EECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-------------
T ss_pred             cccccCCCCccCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCC-------------
Confidence            22 223345678999999976 567899999999999999999 89999877755443322211000             


Q ss_pred             ccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                    .....++..+.+++.+||..||.+|||+.++++
T Consensus       230 --------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          230 --------------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             --------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------CCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence                          011257889999999999999999999999986

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.1e-44  Score=312.97  Aligned_cols=254  Identities=26%  Similarity=0.376  Sum_probs=200.4

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeee----cCC
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQS----SRK   79 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~   79 (324)
                      +..++|++.+.||+|++|.||+|.+..+|+.||+|++......  ..+.+.+|+.+++.++||||+++++++.    ...
T Consensus        26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (317)
T 2buj_A           26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQ--DREEAQREADMHRLFNHPNILRLVAYCLRERGAKH  103 (317)
T ss_dssp             ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHH--HHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEE
T ss_pred             ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHH--HHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCc
Confidence            4568999999999999999999999999999999998764322  2466889999999999999999999886    345


Q ss_pred             eEEEEEEecCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeecccee
Q 045787           80 DVFLVFEYLDL-DLHSFITR---HKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLAR  155 (324)
Q Consensus        80 ~~~iv~e~~~g-~l~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~  155 (324)
                      ..++|+||+.+ +|.+++..   ....+++..++.++.+++.||.+||+.|++|+||||+||+++ .++.++|+|||.+.
T Consensus       104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~-~~~~~kl~dfg~~~  182 (317)
T 2buj_A          104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLG-DEGQPVLMDLGSMN  182 (317)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC-TTSCEEECCCSSCE
T ss_pred             eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEc-CCCCEEEEecCcch
Confidence            78999999985 88888876   346799999999999999999999999999999999999999 88999999999877


Q ss_pred             eccCCCCc---------ccccccccccCCchhhcCCC--CCCCchhhHHHHHHHHHHHhCCCCCCCCCh--hHHHHHHHH
Q 045787          156 AIGVPQKE---------YSRDCVYSPYKAPELLLGYT--GYSTPIDVWAVGCIFAEMITGKPLFPSKKH--DHLSLIFSL  222 (324)
Q Consensus       156 ~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~  222 (324)
                      ........         .....+++.|+|||++.+..  .++.++||||||+++|+|++|..||.....  ........ 
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-  261 (317)
T 2buj_A          183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ-  261 (317)
T ss_dssp             ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH-
T ss_pred             hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh-
Confidence            54321111         11234688899999987522  368899999999999999999999943110  01100000 


Q ss_pred             cCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcC
Q 045787          223 LGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH  287 (324)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~h  287 (324)
                       .                  ...       ......++..+.++|.+||+.||.+|||+.+++++
T Consensus       262 -~------------------~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          262 -N------------------QLS-------IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             -C------------------C---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -c------------------cCC-------CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence             0                  000       00113578899999999999999999999999974

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=6e-44  Score=312.18  Aligned_cols=253  Identities=25%  Similarity=0.356  Sum_probs=205.7

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCc-----eEEEEEeeeccccCCCchHHHHHHHHHHhc-CCCCeeEEEeeeec
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQ-----KVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSS   77 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~-----~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   77 (324)
                      +..++|++.+.||+|+||.||+|.+..++.     .+|+|.+...... ...+.+.+|+.+++++ +||||+++++++.+
T Consensus        43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  121 (333)
T 2i1m_A           43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHA-DEKEALMSELKIMSHLGQHENIVNLLGACTH  121 (333)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccCh-HHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence            456789999999999999999999876654     7999998754321 2245688999999999 89999999999999


Q ss_pred             CCeEEEEEEecCC-CHHHHHHhc-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCC
Q 045787           78 RKDVFLVFEYLDL-DLHSFITRH-------------KNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKR  143 (324)
Q Consensus        78 ~~~~~iv~e~~~g-~l~~~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~  143 (324)
                      .+..++||||+++ +|.+++...             ...+++..++.++.+++.||.+||+.|++|+||||+||+++ .+
T Consensus       122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~-~~  200 (333)
T 2i1m_A          122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT-NG  200 (333)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE-GG
T ss_pred             CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC-CC
Confidence            9999999999975 999888764             23589999999999999999999999999999999999999 88


Q ss_pred             CcEEEeeccceeeccCCCC--cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHH-HH
Q 045787          144 NTVKLADFGLARAIGVPQK--EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLS-LI  219 (324)
Q Consensus       144 ~~v~l~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~-~~  219 (324)
                      +.++|+|||.+........  ......+++.|+|||++.+ ..++.++||||||+++|+|++ |..||......... ..
T Consensus       201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~  279 (333)
T 2i1m_A          201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL  279 (333)
T ss_dssp             GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHH
T ss_pred             CeEEECccccccccccccceeecCCCCCCccccCHHHhcc-CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHH
Confidence            9999999999986643322  1233456778999999987 668999999999999999998 89999776533322 22


Q ss_pred             HHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          220 FSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      ......+.                           .....++.+.+++.+||+.||.+|||+.++++
T Consensus       280 ~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  319 (333)
T 2i1m_A          280 VKDGYQMA---------------------------QPAFAPKNIYSIMQACWALEPTHRPTFQQICS  319 (333)
T ss_dssp             HHHTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HhcCCCCC---------------------------CCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            11111000                           11246789999999999999999999999986

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.5e-44  Score=314.38  Aligned_cols=267  Identities=21%  Similarity=0.269  Sum_probs=204.7

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLV   84 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   84 (324)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|.+.....  ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        37 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  113 (321)
T 2qkw_B           37 ATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESS--QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILI  113 (321)
T ss_dssp             CCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCS--SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEE
T ss_pred             HHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence            3579999999999999999999964 688999998765432  2356788999999999999999999999999999999


Q ss_pred             EEecC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           85 FEYLD-LDLHSFITRHK---NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        85 ~e~~~-g~l~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      |||++ |+|.+++....   ..+++..++.++.+++.||.+||++|++|+||||+||+++ .++.++|+|||.+......
T Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~  192 (321)
T 2qkw_B          114 YKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLD-ENFVPKITDFGISKKGTEL  192 (321)
T ss_dssp             EECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEEC-TTCCEEECCCTTCEECSSS
T ss_pred             EEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEEC-CCCCEEEeecccccccccc
Confidence            99997 58888776543   2589999999999999999999999999999999999999 8999999999999865432


Q ss_pred             CC--cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhh
Q 045787          161 QK--EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYIS  238 (324)
Q Consensus       161 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (324)
                      ..  ......+++.|+|||++.+ ..++.++||||||+++|+|++|+.||..............         .......
T Consensus       193 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~---------~~~~~~~  262 (321)
T 2qkw_B          193 DQTHLSTVVKGTLGYIDPEYFIK-GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEW---------AVESHNN  262 (321)
T ss_dssp             SCCCCBCCCEEETTTCCHHHHHH-CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHH---------THHHHTT
T ss_pred             cccccccccCCCccccCHHHhcC-CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHH---------hhhcccc
Confidence            22  2233458899999999977 5689999999999999999999999976543211100000         0000000


Q ss_pred             cccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcC
Q 045787          239 EILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH  287 (324)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~h  287 (324)
                      ......  ..........+..+..+.+++.+||+.||.+|||+.+++++
T Consensus       263 ~~~~~~--~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  309 (321)
T 2qkw_B          263 GQLEQI--VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK  309 (321)
T ss_dssp             TCCCSS--SSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccHHHh--cChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            000000  00000111112356678999999999999999999999974

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=3.9e-44  Score=307.46  Aligned_cols=254  Identities=25%  Similarity=0.361  Sum_probs=198.7

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEcc-CCc--eEEEEEeeeccc-cCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCC
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTV-TGQ--KVAIKMMTIQTE-QEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK   79 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~-~~~--~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   79 (324)
                      +..++|++.+.||+|++|+||+|.+.. ++.  .|++|++..... .....+.+.+|+.++++++||||+++++++..+.
T Consensus        15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   94 (291)
T 1u46_A           15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP   94 (291)
T ss_dssp             CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence            557899999999999999999998643 333  689999875532 2233467889999999999999999999998765


Q ss_pred             eEEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeecc
Q 045787           80 DVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIG  158 (324)
Q Consensus        80 ~~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~  158 (324)
                       .++|+||+. ++|.+++......+++..++.++.+++.||.+||+.|++|+||||+||+++ .++.++|+|||.+....
T Consensus        95 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~-~~~~~kl~Dfg~~~~~~  172 (291)
T 1u46_A           95 -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA-TRDLVKIGDFGLMRALP  172 (291)
T ss_dssp             -CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE-ETTEEEECCCTTCEECC
T ss_pred             -ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEc-CCCCEEEcccccccccc
Confidence             889999997 699999988777899999999999999999999999999999999999999 88999999999998765


Q ss_pred             CCCCc---ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccch
Q 045787          159 VPQKE---YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAES  234 (324)
Q Consensus       159 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (324)
                      .....   .....+++.|+|||++.+ ..++.++||||||+++|+|++ |..||...+...............       
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-------  244 (291)
T 1u46_A          173 QNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL-------  244 (291)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC-------
T ss_pred             ccccchhhhccCCCCceeeCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCC-------
Confidence            33321   223356678999999977 567899999999999999999 999998877555433332111110       


Q ss_pred             hhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          235 TYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                         .....++..+.++|.+||..||.+|||+.++++
T Consensus       245 -------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  277 (291)
T 1u46_A          245 -------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  277 (291)
T ss_dssp             -------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                               011357899999999999999999999999997

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=7.8e-44  Score=306.69  Aligned_cols=252  Identities=24%  Similarity=0.338  Sum_probs=199.3

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCC---ceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeee-ecCCe
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTG---QKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQ-SSRKD   80 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~---~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~   80 (324)
                      ...+|++.+.||+|+||+||+|.+..++   ..+++|.+..... ....+.+.+|+.++++++||||+++++++ ..++.
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  101 (298)
T 3f66_A           23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS  101 (298)
T ss_dssp             GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred             cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCC-HHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence            3467999999999999999999965433   3588888764322 12235688999999999999999999985 55678


Q ss_pred             EEEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccC
Q 045787           81 VFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGV  159 (324)
Q Consensus        81 ~~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~  159 (324)
                      .++||||+++ +|.+++......+++..++.++.+++.||.+||+.|++|+||||+||+++ .++.++|+|||.+.....
T Consensus       102 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~-~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             CEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC-TTCCEEECSCGGGCCCSC
T ss_pred             eEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEC-CCCCEEECcccccccccc
Confidence            8999999985 99999887677799999999999999999999999999999999999999 899999999999976542


Q ss_pred             CC----CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccch
Q 045787          160 PQ----KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAES  234 (324)
Q Consensus       160 ~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (324)
                      ..    .......+++.|+|||++.+ ..++.++||||||+++|+|++ +.+||...+...............       
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~-------  252 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL-------  252 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCC-------
T ss_pred             cchhccccccCCCCCccccChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCC-------
Confidence            21    12223356678999999987 668999999999999999999 667776655444333222111110       


Q ss_pred             hhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          235 TYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                          ....++..+.+++.+||+.||.+|||+.++++
T Consensus       253 --------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          253 --------------------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             --------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                01246889999999999999999999999996

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=3.5e-44  Score=309.18  Aligned_cols=258  Identities=25%  Similarity=0.345  Sum_probs=195.5

Q ss_pred             CCcccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHh--cCCCCeeEEEeeeec-
Q 045787            1 MGKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKE--LEHENIVRLLDVQSS-   77 (324)
Q Consensus         1 ~~~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~~-   77 (324)
                      |+.+..++|++.+.||+|+||+||++.+  +++.||+|++....     ......|.+++..  ++||||+++++++.. 
T Consensus         2 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~   74 (301)
T 3q4u_A            2 MQRTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD-----EKSWFRETELYNTVMLRHENILGFIASDMTS   74 (301)
T ss_dssp             --CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEE
T ss_pred             ccccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc-----chhhHHHHHHHHHhhccCcCeeeEEEeeccc
Confidence            5788999999999999999999999987  58899999986532     2345567777766  789999999998543 


Q ss_pred             ---CCeEEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCcccCCCCCceEeecCCCc
Q 045787           78 ---RKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCH--------SLKILHRDLKPNNLLIDLKRNT  145 (324)
Q Consensus        78 ---~~~~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh--------~~g~~H~di~p~nIll~~~~~~  145 (324)
                         ....++||||++ |+|.+++..  ..+++..++.++.+++.||.|||        +.|++|+||||+||+++ .++.
T Consensus        75 ~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~-~~~~  151 (301)
T 3q4u_A           75 RHSSTQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK-KNGQ  151 (301)
T ss_dssp             ETTEEEEEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEEC-TTSC
T ss_pred             cCCCceeEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEc-CCCC
Confidence               356899999998 488888854  46999999999999999999999        99999999999999999 8999


Q ss_pred             EEEeeccceeeccCCCCc----ccccccccccCCchhhcCCC-----CCCCchhhHHHHHHHHHHHhC----------CC
Q 045787          146 VKLADFGLARAIGVPQKE----YSRDCVYSPYKAPELLLGYT-----GYSTPIDVWAVGCIFAEMITG----------KP  206 (324)
Q Consensus       146 v~l~d~g~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~l~~g----------~~  206 (324)
                      ++|+|||.+.........    .....+|+.|+|||++.+..     .++.++||||||+++|+|++|          ..
T Consensus       152 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~  231 (301)
T 3q4u_A          152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP  231 (301)
T ss_dssp             EEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             EEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccc
Confidence            999999999766533322    22347899999999998733     334789999999999999999          77


Q ss_pred             CCCCCCh--hHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHH
Q 045787          207 LFPSKKH--DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDA  284 (324)
Q Consensus       207 pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~  284 (324)
                      ||.....  ..............                  ..............++.+.+++.+||+.||.+|||+.++
T Consensus       232 pf~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i  293 (301)
T 3q4u_A          232 PFYDVVPNDPSFEDMRKVVCVDQ------------------QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI  293 (301)
T ss_dssp             TTTTTSCSSCCHHHHHHHHTTSC------------------CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             cccccCCCCcchhhhhHHHhccC------------------CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHH
Confidence            8754321  11111111100000                  000000000111355789999999999999999999999


Q ss_pred             hc
Q 045787          285 LK  286 (324)
Q Consensus       285 l~  286 (324)
                      ++
T Consensus       294 ~~  295 (301)
T 3q4u_A          294 KK  295 (301)
T ss_dssp             HH
T ss_pred             HH
Confidence            86

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=8.3e-44  Score=303.51  Aligned_cols=245  Identities=23%  Similarity=0.378  Sum_probs=195.7

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeec-CCeEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS-RKDVF   82 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~   82 (324)
                      +..++|++.+.||+|++|.||++.+.  |+.+|+|++....    ..+.+.+|+.++++++|||++++++++.+ .+..+
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (278)
T 1byg_A           18 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY   91 (278)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred             CChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceE
Confidence            55689999999999999999999874  8899999987432    34678899999999999999999998654 45799


Q ss_pred             EEEEecCC-CHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           83 LVFEYLDL-DLHSFITRHKN-TLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        83 iv~e~~~g-~l~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      +|+||+++ +|.+++..... .+++..++.++.+++.||.+||++|++|+||+|+||+++ .++.++|+|||.+......
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~-~~~~~~l~Dfg~~~~~~~~  170 (278)
T 1byg_A           92 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS-EDNVAKVSDFGLTKEASST  170 (278)
T ss_dssp             EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC-TTSCEEECCCCC-------
T ss_pred             EEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEe-CCCcEEEeecccccccccc
Confidence            99999985 99998876543 389999999999999999999999999999999999999 8999999999998765432


Q ss_pred             CCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhc
Q 045787          161 QKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISE  239 (324)
Q Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
                         .....+++.|+|||++.+ ..++.++||||||+++|+|++ |..||...+.............              
T Consensus       171 ---~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~--------------  232 (278)
T 1byg_A          171 ---QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK--------------  232 (278)
T ss_dssp             --------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC--------------
T ss_pred             ---ccCCCccccccCHHHhCC-CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC--------------
Confidence               223356788999999987 667999999999999999998 9999977665443322111000              


Q ss_pred             ccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                   ......+++.+.++|.+||+.||.+|||+.++++
T Consensus       233 -------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          233 -------------MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             -------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence                         0112367899999999999999999999999986

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.9e-44  Score=314.50  Aligned_cols=271  Identities=24%  Similarity=0.290  Sum_probs=205.6

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   83 (324)
                      +..++|++.+.||+|++|.||+|.+. +|+.||+|++....... ....+.+|+.+++.++||||+++++++.+.+..++
T Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  104 (326)
T 3uim_A           27 VASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL  104 (326)
T ss_dssp             TTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEE
T ss_pred             HHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCch-HHHHHHHHHHHHHhccCCCccceEEEEecCCceEE
Confidence            45789999999999999999999854 68899999987654332 23468899999999999999999999999999999


Q ss_pred             EEEecCC-CHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CCcccCCCCCceEeecCCCcEEEeeccceee
Q 045787           84 VFEYLDL-DLHSFITRHKN---TLNLLVIKAILKQILLGLAYCHSL---KILHRDLKPNNLLIDLKRNTVKLADFGLARA  156 (324)
Q Consensus        84 v~e~~~g-~l~~~~~~~~~---~~~~~~~~~i~~~i~~~l~~Lh~~---g~~H~di~p~nIll~~~~~~v~l~d~g~~~~  156 (324)
                      ||||+.+ +|.+++.....   ++++..++.++.+++.||.+||+.   |++|+||||+||+++ .++.++|+|||.+..
T Consensus       105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~-~~~~~kl~Dfg~~~~  183 (326)
T 3uim_A          105 VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD-EEFEAVVGDFGLAKL  183 (326)
T ss_dssp             EEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEEC-TTCCEEECCCSSCEE
T ss_pred             EEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEEC-CCCCEEeccCccccc
Confidence            9999975 88888876432   489999999999999999999999   999999999999999 889999999999987


Q ss_pred             ccCCCCc-ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-----hhHHHHHHHHcCCCCccc
Q 045787          157 IGVPQKE-YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-----HDHLSLIFSLLGTPTDES  230 (324)
Q Consensus       157 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-----~~~~~~~~~~~~~~~~~~  230 (324)
                      ....... .....+|+.|+|||++.+ ..++.++||||||+++|+|++|..||....     .........  .....  
T Consensus       184 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~--  258 (326)
T 3uim_A          184 MDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK--GLLKE--  258 (326)
T ss_dssp             CCSSSSCEECCCCSCGGGCCHHHHHH-SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT--TTTSS--
T ss_pred             cCcccccccccccCCcCccCHHHhcc-CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH--HHhhc--
Confidence            6533322 333458999999999977 557999999999999999999999995211     100000000  00000  


Q ss_pred             ccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccC
Q 045787          231 WAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIG  292 (324)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~  292 (324)
                              .......  ............+..+.+++.+||+.||.+|||+.++++|-.-.+
T Consensus       259 --------~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  310 (326)
T 3uim_A          259 --------KKLEALV--DVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG  310 (326)
T ss_dssp             --------CCSTTSS--CTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred             --------hhhhhhc--ChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence                    0000000  000000111123467899999999999999999999998665433

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.9e-43  Score=303.35  Aligned_cols=244  Identities=30%  Similarity=0.422  Sum_probs=193.4

Q ss_pred             cCcCccee-EeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHH-HhcCCCCeeEEEeeeec----C
Q 045787            5 KNLNYKKI-KKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLL-KELEHENIVRLLDVQSS----R   78 (324)
Q Consensus         5 ~~~~y~i~-~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~----~   78 (324)
                      ..++|+++ +.||+|++|.||+|.+..+++.||+|++..       .....+|+.++ +..+||||+++++++..    .
T Consensus        15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~   87 (299)
T 3m2w_A           15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYAGR   87 (299)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence            44678887 789999999999999999999999999863       24567889888 55589999999999876    6


Q ss_pred             CeEEEEEEecCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecC--CCcEEEeeccce
Q 045787           79 KDVFLVFEYLDL-DLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK--RNTVKLADFGLA  154 (324)
Q Consensus        79 ~~~~iv~e~~~g-~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~--~~~v~l~d~g~~  154 (324)
                      ...++||||++| +|.+++.... ..+++..++.++.+++.||.+||+.|++|+||||+||+++..  ++.++|+|||.+
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           88 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             ceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            789999999975 9999888754 369999999999999999999999999999999999999932  788999999988


Q ss_pred             eeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccch
Q 045787          155 RAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAES  234 (324)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (324)
                      ....                      + ..++.++||||||+++|+|++|..||.........                 
T Consensus       168 ~~~~----------------------~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----------------  207 (299)
T 3m2w_A          168 KETT----------------------G-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------------  207 (299)
T ss_dssp             EECT----------------------T-CGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------------
T ss_pred             cccc----------------------c-ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----------------
Confidence            6432                      1 34578999999999999999999999655432110                 


Q ss_pred             hhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchh
Q 045787          235 TYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~  298 (324)
                         .....................+++++.++|.+||+.||.+|||+.++++||||++....+.
T Consensus       208 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~~  268 (299)
T 3m2w_A          208 ---PGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ  268 (299)
T ss_dssp             ---CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSCC
T ss_pred             ---HHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCCC
Confidence               0000011111111112223468999999999999999999999999999999998765544

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=3e-43  Score=320.56  Aligned_cols=261  Identities=20%  Similarity=0.272  Sum_probs=210.0

Q ss_pred             CCcccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCC-CCeeEEEeeeecCC
Q 045787            1 MGKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEH-ENIVRLLDVQSSRK   79 (324)
Q Consensus         1 ~~~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~   79 (324)
                      |...+.++|++.+.||+|+||.||+|.+..+++.||+|++......    ..+.+|+.+++.++| +++..+..++....
T Consensus         1 m~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~   76 (483)
T 3sv0_A            1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGD   76 (483)
T ss_dssp             -CCEETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETT
T ss_pred             CCCCcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCC
Confidence            5567889999999999999999999999999999999987654432    347899999999986 56666666777888


Q ss_pred             eEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEee--cCCCcEEEeeccceeec
Q 045787           80 DVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLID--LKRNTVKLADFGLARAI  157 (324)
Q Consensus        80 ~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~--~~~~~v~l~d~g~~~~~  157 (324)
                      ..++||||++++|.+++......+++..++.++.+|+.||.|||++|++|+||||+|||++  ..++.++|+|||++...
T Consensus        77 ~~~lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~  156 (483)
T 3sv0_A           77 YNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY  156 (483)
T ss_dssp             EEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             EEEEEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence            9999999998899999987777899999999999999999999999999999999999993  27889999999999876


Q ss_pred             cCCCCc-------ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCccc
Q 045787          158 GVPQKE-------YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDES  230 (324)
Q Consensus       158 ~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  230 (324)
                      ......       .....+++.|+|||++.+ ..++.++|||||||++|+|++|..||..................    
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~----  231 (483)
T 3sv0_A          157 RDTSTHQHIPYRENKNLTGTARYASVNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK----  231 (483)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHH----
T ss_pred             cCCccccccccccccccCCCccccCHHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhc----
Confidence            543221       224578999999999988 67899999999999999999999999775532211111100000    


Q ss_pred             ccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          231 WAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                              .        ...........++.++.++|..||+.||.+||++.++++
T Consensus       232 --------~--------~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          232 --------K--------VATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             --------H--------HHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             --------c--------ccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                    0        001111222467899999999999999999999988765

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.7e-43  Score=303.11  Aligned_cols=256  Identities=27%  Similarity=0.383  Sum_probs=199.6

Q ss_pred             CcccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeE
Q 045787            2 GKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDV   81 (324)
Q Consensus         2 ~~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   81 (324)
                      ..+..++|++.+.||+|+||.||++.+.  ++.+|+|.+....    ..+.+.+|+.++++++||||+++++++.+  ..
T Consensus         3 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~   74 (307)
T 2eva_A            3 HMIDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESES----ERKAFIVELRQLSRVNHPNIVKLYGACLN--PV   74 (307)
T ss_dssp             CBCCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSSTT----HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TT
T ss_pred             CcCCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecChh----HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--Cc
Confidence            3566789999999999999999999875  7889999986432    24568899999999999999999998874  47


Q ss_pred             EEEEEecC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCCcccCCCCCceEeecCCCc-EEEeeccce
Q 045787           82 FLVFEYLD-LDLHSFITRHKN--TLNLLVIKAILKQILLGLAYCHS---LKILHRDLKPNNLLIDLKRNT-VKLADFGLA  154 (324)
Q Consensus        82 ~iv~e~~~-g~l~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~Lh~---~g~~H~di~p~nIll~~~~~~-v~l~d~g~~  154 (324)
                      ++||||++ |+|.+++.....  .++...++.++.+++.||.+||+   +|++|+||||+||+++ .++. ++|+|||.+
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~-~~~~~~kl~Dfg~~  153 (307)
T 2eva_A           75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLV-AGGTVLKICDFGTA  153 (307)
T ss_dssp             EEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEE-TTTTEEEECCCCC-
T ss_pred             EEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEe-CCCCEEEEcccccc
Confidence            89999997 588888876543  47899999999999999999999   8999999999999999 6654 899999998


Q ss_pred             eeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccch
Q 045787          155 RAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAES  234 (324)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (324)
                      ......   .....+++.|+|||++.+ ..++.++||||||+++|+|++|+.||...................       
T Consensus       154 ~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-------  222 (307)
T 2eva_A          154 CDIQTH---MTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR-------  222 (307)
T ss_dssp             --------------CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCC-------
T ss_pred             cccccc---cccCCCCCceEChhhhCC-CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCC-------
Confidence            765422   233468899999999987 678999999999999999999999997654333222211111100       


Q ss_pred             hhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc-----CccccCCCC
Q 045787          235 TYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK-----HEYLIGVEN  295 (324)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~-----hp~~~~~~~  295 (324)
                                        ......++..+.+++.+||+.||.+|||++++++     ..++.+...
T Consensus       223 ------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~  270 (307)
T 2eva_A          223 ------------------PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADE  270 (307)
T ss_dssp             ------------------CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTS
T ss_pred             ------------------CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCC
Confidence                              0112367889999999999999999999999987     455555443

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=6.1e-45  Score=339.13  Aligned_cols=280  Identities=25%  Similarity=0.321  Sum_probs=206.4

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeec------C
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS------R   78 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~   78 (324)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++..... ....+.+.+|+.++++++||||+++++++..      +
T Consensus        12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~-~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~   90 (676)
T 3qa8_A           12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELS-PKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN   90 (676)
T ss_dssp             -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCC-HHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred             CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCC-HHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence            45899999999999999999999999999999999865422 2224568889999999999999999998755      6


Q ss_pred             CeEEEEEEecC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCC---cEEEeecc
Q 045787           79 KDVFLVFEYLD-LDLHSFITRHKN--TLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN---TVKLADFG  152 (324)
Q Consensus        79 ~~~~iv~e~~~-g~l~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~---~v~l~d~g  152 (324)
                      +..++||||++ |+|.+++.....  .+++..++.++.+++.||.|||+.|++|+||+|+||+++ .++   .++|+|||
T Consensus        91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~-~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQ-PGPQRLIHKIIDLG  169 (676)
T ss_dssp             SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEE-CCSSSCEEEECSCC
T ss_pred             CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEee-cCCCceeEEEcccc
Confidence            77899999996 588888876543  589999999999999999999999999999999999998 554   48999999


Q ss_pred             ceeeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCccccc
Q 045787          153 LARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWA  232 (324)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  232 (324)
                      .+...... .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||........     ...........
T Consensus       170 ~a~~~~~~-~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~-----~~~~i~~~~~~  242 (676)
T 3qa8_A          170 YAKELDQG-ELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ-----WHGKVREKSNE  242 (676)
T ss_dssp             CCCBTTSC-CCCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHH-----SSTTCC-----
T ss_pred             cccccccc-cccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhh-----hhhhhhcccch
Confidence            99876533 23344578899999999987 6789999999999999999999999976542210     00000000000


Q ss_pred             chhhhhcccCCCCCC--CCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCC
Q 045787          233 ESTYISEILPLYPHF--EPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVE  294 (324)
Q Consensus       233 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~  294 (324)
                      .. ...+........  ...........+++.+.++|.+||..||.+|||+.++++||||+++.
T Consensus       243 ~~-~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~  305 (676)
T 3qa8_A          243 HI-VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALD  305 (676)
T ss_dssp             -C-CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHH
T ss_pred             hh-hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHH
Confidence            00 000000000000  00011112234678899999999999999999999999999998865

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.7e-43  Score=321.61  Aligned_cols=249  Identities=24%  Similarity=0.366  Sum_probs=205.1

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   83 (324)
                      +..++|++.+.||+|+||.||++.+. .+..||+|++.....   ..+.+.+|+.++++++||||+++++++. .+..++
T Consensus       185 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l  259 (454)
T 1qcf_A          185 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI  259 (454)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB---CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             echHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc---cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence            45678999999999999999999986 467899999875432   2567899999999999999999999986 567899


Q ss_pred             EEEecC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC
Q 045787           84 VFEYLD-LDLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        84 v~e~~~-g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~  161 (324)
                      ||||+. |+|.+++.... ..+++..+..++.+|+.||.|||++|++|+||||+|||++ .++.+||+|||.+.......
T Consensus       260 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~-~~~~~kl~DFG~a~~~~~~~  338 (454)
T 1qcf_A          260 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS-ASLVCKIADFGLARVIEDNE  338 (454)
T ss_dssp             EECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEEC-TTCCEEECSTTGGGGBCCHH
T ss_pred             EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEC-CCCcEEEeeCCCceEcCCCc
Confidence            999997 59999887543 3689999999999999999999999999999999999999 89999999999997654221


Q ss_pred             C-cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhc
Q 045787          162 K-EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISE  239 (324)
Q Consensus       162 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
                      . ......+++.|+|||++.. ..++.++||||||+++|+|++ |..||.+.+..............+            
T Consensus       339 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~------------  405 (454)
T 1qcf_A          339 YTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP------------  405 (454)
T ss_dssp             HHTTCSSSSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC------------
T ss_pred             eeccCCCcccccccCHHHhcc-CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC------------
Confidence            1 1122345677999999986 668999999999999999999 999998877655444333211111            


Q ss_pred             ccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                     ....+++.+.++|.+||+.||.+|||++++++
T Consensus       406 ---------------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          406 ---------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             ---------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence                           01257889999999999999999999999986

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1e-43  Score=308.79  Aligned_cols=253  Identities=24%  Similarity=0.321  Sum_probs=205.5

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF   82 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   82 (324)
                      .+..++|++.+.||+|++|.||++.+..   .+++|++..........+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (319)
T 2y4i_B           29 DIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLA  105 (319)
T ss_dssp             SSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEE
T ss_pred             cCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceE
Confidence            4567899999999999999999998753   5999999876655555566788999999999999999999999999999


Q ss_pred             EEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC-
Q 045787           83 LVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP-  160 (324)
Q Consensus        83 iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~-  160 (324)
                      +|+||++ ++|.+++......+++..++.++.+++.||.+||+.|++|+||+|+||+++  ++.++|+|||.+...... 
T Consensus       106 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~--~~~~~l~Dfg~~~~~~~~~  183 (319)
T 2y4i_B          106 IITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD--NGKVVITDFGLFSISGVLQ  183 (319)
T ss_dssp             EECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC----CCEECCCSCCC------
T ss_pred             EEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe--CCCEEEeecCCcccccccc
Confidence            9999997 588888877666799999999999999999999999999999999999998  578999999987654321 


Q ss_pred             ----CCcccccccccccCCchhhcC--------CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCc
Q 045787          161 ----QKEYSRDCVYSPYKAPELLLG--------YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTD  228 (324)
Q Consensus       161 ----~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  228 (324)
                          ........+++.|+|||++.+        ...++.++||||||+++|+|++|..||.................+..
T Consensus       184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  263 (319)
T 2y4i_B          184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNL  263 (319)
T ss_dssp             ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCC
T ss_pred             ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCC
Confidence                122333468889999999874        24578899999999999999999999988776554333221111100


Q ss_pred             ccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          229 ESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                                ....++..+.+++.+||..||.+|||+.++++
T Consensus       264 --------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  295 (319)
T 2y4i_B          264 --------------------------SQIGMGKEISDILLFCWAFEQEERPTFTKLMD  295 (319)
T ss_dssp             --------------------------CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred             --------------------------CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                                      01247889999999999999999999999996

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.5e-43  Score=308.75  Aligned_cols=269  Identities=25%  Similarity=0.371  Sum_probs=205.8

Q ss_pred             cccCcCcceeEeecccCceEEEEEE----EccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecC
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCR----NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR   78 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~----~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   78 (324)
                      .+..++|++++.||+|++|.||+|.    +..+++.||+|++....  ....+.+.+|+.++++++||||+++++++...
T Consensus        37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  114 (326)
T 2w1i_A           37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVKYKGVCYSA  114 (326)
T ss_dssp             CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC--SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred             ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence            4567789999999999999999998    46688999999987542  22245688999999999999999999988654


Q ss_pred             C--eEEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeecccee
Q 045787           79 K--DVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLAR  155 (324)
Q Consensus        79 ~--~~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~  155 (324)
                      +  ..++|+||++ ++|.+++......+++..++.++.+++.||.+||+.|++|+||||+||+++ .++.++|+|||.+.
T Consensus       115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~-~~~~~kL~Dfg~~~  193 (326)
T 2w1i_A          115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE-NENRVKIGDFGLTK  193 (326)
T ss_dssp             ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE-ETTEEEECCCTTCE
T ss_pred             CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEc-CCCcEEEecCcchh
Confidence            3  7899999997 599999988777799999999999999999999999999999999999999 88999999999998


Q ss_pred             eccCCCCc---ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCccccc
Q 045787          156 AIGVPQKE---YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWA  232 (324)
Q Consensus       156 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  232 (324)
                      ........   .....++..|+|||++.+ ..++.++||||||+++|+|++|..||........    ...+........
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~----~~~~~~~~~~~~  268 (326)
T 2w1i_A          194 VLPQDKEYYKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM----RMIGNDKQGQMI  268 (326)
T ss_dssp             ECCSSCSEEECSSCCSCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHH----HHHCTTCCTHHH
T ss_pred             hccccccccccccCCCCceeEECchhhcC-CCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHH----Hhhccccchhhh
Confidence            76543321   222345667999999987 5678999999999999999999998854321111    111111110000


Q ss_pred             chhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          233 ESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      ............ .      ......++.++.++|.+||+.||.+|||+.++++
T Consensus       269 ~~~~~~~~~~~~-~------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          269 VFHLIELLKNNG-R------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHHHHHHHTTC-C------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhhcCC-C------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            000000000000 0      0112367899999999999999999999999985

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=3.6e-44  Score=322.14  Aligned_cols=252  Identities=15%  Similarity=0.158  Sum_probs=195.6

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeecc-ccCCCchHHHHHHHHHHhcCC-CCee---------------
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQT-EQEGVPSYIIREVSLLKELEH-ENIV---------------   69 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~-~~i~---------------   69 (324)
                      ..|+..+.||+|+||.||+|.+..+|+.||+|++.... ......+.+.+|+.+++.++| ++..               
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            34888999999999999999999999999999987433 233346778999999999976 2111               


Q ss_pred             ------EEEeeeec-----CCeEEEEEEecCCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 045787           70 ------RLLDVQSS-----RKDVFLVFEYLDLDLHSFITRH------KNTLNLLVIKAILKQILLGLAYCHSLKILHRDL  132 (324)
Q Consensus        70 ------~~~~~~~~-----~~~~~iv~e~~~g~l~~~~~~~------~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di  132 (324)
                            .+..++..     ...++++|+...++|.+++...      ..++++..+..++.|++.||.|||++|++||||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi  237 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL  237 (413)
T ss_dssp             ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred             ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence                  11111111     2247889999999999888522      345778889999999999999999999999999


Q ss_pred             CCCceEeecCCCcEEEeeccceeeccCCCCcccccccccccCCchhhc---------CCCCCCCchhhHHHHHHHHHHHh
Q 045787          133 KPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLL---------GYTGYSTPIDVWAVGCIFAEMIT  203 (324)
Q Consensus       133 ~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~---------~~~~~~~~~DiwslG~il~~l~~  203 (324)
                      ||+|||++ .++.+||+|||.+...+..   ....+| +.|+|||++.         ....++.++|||||||++|+|++
T Consensus       238 Kp~NILl~-~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt  312 (413)
T 3dzo_A          238 RPVDIVLD-QRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC  312 (413)
T ss_dssp             CGGGEEEC-TTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred             ccceEEEe-cCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence            99999999 8899999999998865432   344566 8899999993         33557889999999999999999


Q ss_pred             CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHH
Q 045787          204 GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMD  283 (324)
Q Consensus       204 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~  283 (324)
                      |+.||...+....                                ..........+++.+.++|.+||+.||.+||++.+
T Consensus       313 g~~Pf~~~~~~~~--------------------------------~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~  360 (413)
T 3dzo_A          313 ADLPNTDDAALGG--------------------------------SEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQ  360 (413)
T ss_dssp             SSCCCCTTGGGSC--------------------------------SGGGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCCCcchhhh--------------------------------HHHHHhhcccCCHHHHHHHHHHccCChhhCcCHHH
Confidence            9999965442210                                00011122367899999999999999999999999


Q ss_pred             HhcCccccCCCC
Q 045787          284 ALKHEYLIGVEN  295 (324)
Q Consensus       284 ~l~hp~~~~~~~  295 (324)
                      +++||||+++..
T Consensus       361 ~l~~~~~~~~~~  372 (413)
T 3dzo_A          361 AMETPEYEQLRT  372 (413)
T ss_dssp             HTTSHHHHHHHH
T ss_pred             HHhCHHHHHHHH
Confidence            999999998754

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.6e-43  Score=320.17  Aligned_cols=256  Identities=27%  Similarity=0.388  Sum_probs=204.1

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   83 (324)
                      +..++|++.+.||+|+||.||++.+.. +..||+|++.....   ..+.+.+|+.++++++||||+++++++.+ +..++
T Consensus       181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~i  255 (452)
T 1fmk_A          181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI  255 (452)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEE
Confidence            456789999999999999999999864 46799999875432   24678999999999999999999999876 67899


Q ss_pred             EEEecC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC
Q 045787           84 VFEYLD-LDLHSFITRH-KNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        84 v~e~~~-g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~  161 (324)
                      ||||+. |+|.+++... ...+++..+..++.+++.||.|||++|++|+||||+||+++ .++.+||+|||.+.......
T Consensus       256 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~-~~~~~kl~DfG~a~~~~~~~  334 (452)
T 1fmk_A          256 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIEDNE  334 (452)
T ss_dssp             EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC-GGGCEEECCCCTTC------
T ss_pred             EehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEC-CCCCEEECCCccceecCCCc
Confidence            999997 5999988754 34699999999999999999999999999999999999999 88999999999997654322


Q ss_pred             C-cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhc
Q 045787          162 K-EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISE  239 (324)
Q Consensus       162 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
                      . ......+++.|+|||++.+ ..++.++||||||+++|+|++ |..||.+................+            
T Consensus       335 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~------------  401 (452)
T 1fmk_A          335 YTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP------------  401 (452)
T ss_dssp             --------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC------------
T ss_pred             eecccCCcccccccCHhHHhc-CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC------------
Confidence            1 1222345677999999987 668999999999999999999 999998877554433322111100            


Q ss_pred             ccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc--CccccCC
Q 045787          240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK--HEYLIGV  293 (324)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~--hp~~~~~  293 (324)
                                     ....+++.+.++|.+||+.||.+|||++++++  ..++...
T Consensus       402 ---------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~  442 (452)
T 1fmk_A          402 ---------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  442 (452)
T ss_dssp             ---------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             ---------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence                           11357889999999999999999999999997  4555443

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=8.9e-44  Score=309.15  Aligned_cols=266  Identities=26%  Similarity=0.374  Sum_probs=200.2

Q ss_pred             ccCcCc-ceeEeecccCceEEEEEE----EccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeec-
Q 045787            4 LKNLNY-KKIKKIGAGGYGEVYKCR----NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS-   77 (324)
Q Consensus         4 ~~~~~y-~i~~~Lg~g~~~~v~~a~----~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-   77 (324)
                      +..++| ++++.||+|+||+||++.    +..+++.||+|++..... ....+.+.+|+.++++++||||+++++++.+ 
T Consensus        27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  105 (318)
T 3lxp_A           27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAG-PQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA  105 (318)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccC-hHHHHHHHHHHHHHHhCCCcchhhEEEEEecC
Confidence            456677 999999999999997764    445788999999875432 1224568899999999999999999999987 


Q ss_pred             -CCeEEEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeecccee
Q 045787           78 -RKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLAR  155 (324)
Q Consensus        78 -~~~~~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~  155 (324)
                       ...+++||||+++ +|.+++...  .+++..++.++.+++.||.+||+.|++|+||||+||+++ .++.++|+|||.+.
T Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~-~~~~~kl~Dfg~a~  182 (318)
T 3lxp_A          106 GAASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLD-NDRLVKIGDFGLAK  182 (318)
T ss_dssp             TTTEEEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-TTCCEEECCGGGCE
T ss_pred             CCceEEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEc-CCCCEEECCccccc
Confidence             4678999999975 888877653  499999999999999999999999999999999999999 88999999999998


Q ss_pred             eccCCCC---cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCccccc
Q 045787          156 AIGVPQK---EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWA  232 (324)
Q Consensus       156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  232 (324)
                      .......   ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||..........    ...... ...
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~----~~~~~~-~~~  256 (318)
T 3lxp_A          183 AVPEGHEYYRVREDGDSPVFWYAPECLKE-YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLEL----IGIAQG-QMT  256 (318)
T ss_dssp             ECCTTCSEEEC---CCCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH----HCSCCH-HHH
T ss_pred             cccccccccccccCCCCCceeeChHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhh----hccccc-chh
Confidence            7754332   1233456777999999987 567899999999999999999999986543221100    000000 000


Q ss_pred             chhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          233 ESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      ... ..+.....      ........++..+.++|.+||+.||.+|||+.++++
T Consensus       257 ~~~-~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          257 VLR-LTELLERG------ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HHH-HHHHHHTT------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHH-HHHHHhcc------cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            000 00000000      001112367899999999999999999999999995

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-43  Score=313.73  Aligned_cols=250  Identities=24%  Similarity=0.322  Sum_probs=192.4

Q ss_pred             cCcceeEeecccCceEEEEEEEccCC---ceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeee-cCCeEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTG---QKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQS-SRKDVF   82 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~---~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~   82 (324)
                      ..|++.+.||+|+||.||+|....++   ..+|+|.+.... .....+.+.+|+.++++++||||+++++++. .++..+
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~  167 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  167 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence            45888999999999999999875433   368999876432 2223466889999999999999999999864 456889


Q ss_pred             EEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC
Q 045787           83 LVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        83 iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~  161 (324)
                      +||||++ |+|.+++......+++..++.++.|++.||.|||++|++|+||||+||+++ .++.+||+|||.+.......
T Consensus       168 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~-~~~~~kL~DFG~a~~~~~~~  246 (373)
T 3c1x_A          168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKE  246 (373)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC-TTCCEEECCC----------
T ss_pred             EEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEEC-CCCCEEEeeccccccccccc
Confidence            9999998 499999887767799999999999999999999999999999999999999 89999999999997654222


Q ss_pred             C----cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhh
Q 045787          162 K----EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY  236 (324)
Q Consensus       162 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (324)
                      .    ......+++.|+|||++.+ ..++.++||||||+++|+|++ |.+||...+.............+.         
T Consensus       247 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~---------  316 (373)
T 3c1x_A          247 FDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL---------  316 (373)
T ss_dssp             -----------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCC---------
T ss_pred             cccccccCCCCCcccccChHHhcC-CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCC---------
Confidence            1    1222345678999999987 678999999999999999999 678887665443332222111100         


Q ss_pred             hhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          237 ISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                        ....++..+.+++.+||+.||.+|||+.++++
T Consensus       317 ------------------~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~  348 (373)
T 3c1x_A          317 ------------------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  348 (373)
T ss_dssp             ------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                              11257889999999999999999999999996

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.6e-42  Score=325.40  Aligned_cols=250  Identities=24%  Similarity=0.366  Sum_probs=201.0

Q ss_pred             CcCcceeE-eecccCceEEEEEEEc--cCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 045787            6 NLNYKKIK-KIGAGGYGEVYKCRNT--VTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF   82 (324)
Q Consensus         6 ~~~y~i~~-~Lg~g~~~~v~~a~~~--~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   82 (324)
                      .+++.+.+ .||+|+||.||++...  .++..||+|++.... .....+.+.+|+.++++++||||+++++++.. +..+
T Consensus       334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~  411 (613)
T 2ozo_A          334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM  411 (613)
T ss_dssp             TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEE
T ss_pred             ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeE
Confidence            34556666 8999999999999875  345679999987653 23345778999999999999999999999976 5699


Q ss_pred             EEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC
Q 045787           83 LVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        83 iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~  161 (324)
                      +||||++ |+|.+++......+++..++.++.+|+.||.|||++|++|+||||+||+++ .++.+||+|||++.......
T Consensus       412 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~-~~~~vkL~DFGla~~~~~~~  490 (613)
T 2ozo_A          412 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLV-NRHYAKISDFGLSKALGADD  490 (613)
T ss_dssp             EEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE-ETTEEEECCCSTTTTCC---
T ss_pred             EEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEc-CCCcEEEeeccCcccccCCC
Confidence            9999997 588888877777899999999999999999999999999999999999999 89999999999997654322


Q ss_pred             Cc---ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhh
Q 045787          162 KE---YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYI  237 (324)
Q Consensus       162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (324)
                      ..   .....+++.|+|||++.+ ..++.++||||||+++|+|++ |..||...+.......+......           
T Consensus       491 ~~~~~~~~~~~~~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~-----------  558 (613)
T 2ozo_A          491 SYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM-----------  558 (613)
T ss_dssp             -----------CCTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCC-----------
T ss_pred             ceeeeccCCCCccceeCHhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-----------
Confidence            21   122234578999999987 678999999999999999998 99999887765544333221111           


Q ss_pred             hcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          238 SEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                      .....+++++.++|.+||+.||.+||++.++++
T Consensus       559 ----------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          559 ----------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             ----------------CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             ----------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                            011358899999999999999999999999875

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.8e-42  Score=325.89  Aligned_cols=243  Identities=20%  Similarity=0.352  Sum_probs=198.4

Q ss_pred             EeecccCceEEEEEEE--ccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEecCC
Q 045787           13 KKIGAGGYGEVYKCRN--TVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL   90 (324)
Q Consensus        13 ~~Lg~g~~~~v~~a~~--~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~g   90 (324)
                      +.||+|+||.||++..  ...++.||+|++..........+.+.+|+.++++++||||+++++++.. +..++||||+.+
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            4799999999999954  4566889999998765555456779999999999999999999999865 458899999984


Q ss_pred             -CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC---cccc
Q 045787           91 -DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK---EYSR  166 (324)
Q Consensus        91 -~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~---~~~~  166 (324)
                       +|.+++.. ...+++..++.++.+|+.||.|||++|++|+||||+||+++ .++.+||+|||++........   ....
T Consensus       454 g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~~  531 (635)
T 4fl3_A          454 GPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV-TQHYAKISDFGLSKALRADENYYKAQTH  531 (635)
T ss_dssp             EEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE-ETTEEEECCTTHHHHTTC----------
T ss_pred             CCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEe-CCCCEEEEEcCCccccccCccccccccC
Confidence             88888765 45699999999999999999999999999999999999999 889999999999976643321   1222


Q ss_pred             cccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCC
Q 045787          167 DCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYP  245 (324)
Q Consensus       167 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (324)
                      ..+++.|+|||++.+ ..++.++||||||+++|+|++ |..||.+.+.............+.                  
T Consensus       532 ~~~t~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~------------------  592 (635)
T 4fl3_A          532 GKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG------------------  592 (635)
T ss_dssp             ---CGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC------------------
T ss_pred             CCCceeeeChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC------------------
Confidence            345677999999977 678999999999999999998 999998888665544443221111                  


Q ss_pred             CCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       246 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                               ....+++++.++|.+||+.||.+||++.++++
T Consensus       593 ---------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          593 ---------CPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             ---------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ---------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                     11257899999999999999999999999985

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=5.4e-43  Score=309.96  Aligned_cols=251  Identities=16%  Similarity=0.254  Sum_probs=198.7

Q ss_pred             ccCcCcceeEeecccCceEEEEE-----EEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcC---CCCeeEEEeee
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKC-----RNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE---HENIVRLLDVQ   75 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a-----~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~   75 (324)
                      +..++|++.+.||+|+||+||+|     .+..+++.||+|++....     ...+..|+.+++.++   |++++++++++
T Consensus        62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~  136 (365)
T 3e7e_A           62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKFYSAH  136 (365)
T ss_dssp             CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred             ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence            44678999999999999999999     467789999999986432     345778888888887   89999999999


Q ss_pred             ecCCeEEEEEEecC-CCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecC--------
Q 045787           76 SSRKDVFLVFEYLD-LDLHSFITR----HKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK--------  142 (324)
Q Consensus        76 ~~~~~~~iv~e~~~-g~l~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~--------  142 (324)
                      ..++..|+||||++ |+|.+++..    ....+++..++.++.||+.||.|||++|++||||||+|||++ .        
T Consensus       137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~-~~~~~~~~~  215 (365)
T 3e7e_A          137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILG-NGFLEQDDE  215 (365)
T ss_dssp             ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEEC-GGGTCC---
T ss_pred             ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEec-ccccCcccc
Confidence            99999999999997 689988875    345699999999999999999999999999999999999998 6        


Q ss_pred             ---CCcEEEeeccceeeccC--CCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHH
Q 045787          143 ---RNTVKLADFGLARAIGV--PQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLS  217 (324)
Q Consensus       143 ---~~~v~l~d~g~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~  217 (324)
                         ++.++|+|||.+.....  ........+||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.......  
T Consensus       216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--  292 (365)
T 3e7e_A          216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--  292 (365)
T ss_dssp             ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE--
T ss_pred             ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC-CCCCccccHHHHHHHHHHHHhCCCccccCCCCc--
Confidence               78999999999976542  2333455678999999999988 668999999999999999999999984322110  


Q ss_pred             HHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc---CccccCC
Q 045787          218 LIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK---HEYLIGV  293 (324)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~---hp~~~~~  293 (324)
                                          .........          ...++.+.+++..||+.+|.+|++..+.+.   ..|+...
T Consensus       293 --------------------~~~~~~~~~----------~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~  341 (365)
T 3e7e_A          293 --------------------CKPEGLFRR----------LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH  341 (365)
T ss_dssp             --------------------EEECSCCTT----------CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             --------------------eeechhccc----------cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence                                000000000          023567789999999999999976555444   4455443

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.7e-42  Score=320.68  Aligned_cols=256  Identities=27%  Similarity=0.387  Sum_probs=207.5

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   83 (324)
                      +..++|++.+.||+|+||.||++.+.. +..||+|++.....   ..+.+.+|+.++++++||||+++++++.+ +..|+
T Consensus       264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~l  338 (535)
T 2h8h_A          264 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI  338 (535)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             cchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceE
Confidence            456789999999999999999999864 46799999875432   24678999999999999999999999876 67899


Q ss_pred             EEEecC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC
Q 045787           84 VFEYLD-LDLHSFITRH-KNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        84 v~e~~~-g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~  161 (324)
                      ||||+. |+|.+++... ...+++..+..++.+|+.||.|||++|++|+||||+|||++ .++.+||+|||++.......
T Consensus       339 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~~~  417 (535)
T 2h8h_A          339 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIEDNE  417 (535)
T ss_dssp             EECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC-GGGCEEECCTTSTTTCCCHH
T ss_pred             eeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEc-CCCcEEEcccccceecCCCc
Confidence            999997 4999998754 34699999999999999999999999999999999999999 88999999999987653211


Q ss_pred             C-cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhc
Q 045787          162 K-EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISE  239 (324)
Q Consensus       162 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
                      . ......++..|+|||++.+ ..++.++||||||+++|+|++ |..||.+................             
T Consensus       418 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~-------------  483 (535)
T 2h8h_A          418 YTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-------------  483 (535)
T ss_dssp             HHTTCSTTSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCC-------------
T ss_pred             eecccCCcCcccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-------------
Confidence            1 1122345677999999987 668999999999999999999 99999887755443332211000             


Q ss_pred             ccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc--CccccCC
Q 045787          240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK--HEYLIGV  293 (324)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~--hp~~~~~  293 (324)
                                    .....++..+.+||.+||+.||.+|||++++++  ..+|...
T Consensus       484 --------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  525 (535)
T 2h8h_A          484 --------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  525 (535)
T ss_dssp             --------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred             --------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence                          011357889999999999999999999999997  3555444

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.7e-42  Score=299.53  Aligned_cols=260  Identities=26%  Similarity=0.342  Sum_probs=199.8

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeecc--ccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQT--EQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      .|...+.||+|++|.||+|.+  ++..+|+|.+....  ......+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  109 (307)
T 2nru_A           32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVY  109 (307)
T ss_dssp             TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEE
Confidence            345559999999999999986  57899999987543  22333567889999999999999999999999999999999


Q ss_pred             EecC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC
Q 045787           86 EYLD-LDLHSFITRH--KNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK  162 (324)
Q Consensus        86 e~~~-g~l~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~  162 (324)
                      ||++ ++|.+++...  ..++++..++.++.+++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+........
T Consensus       110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~  188 (307)
T 2nru_A          110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLD-EAFTAKISDFGLARASEKFAQ  188 (307)
T ss_dssp             ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC-TTCCEEECCCTTCEECCSCSS
T ss_pred             EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEc-CCCcEEEeecccccccccccc
Confidence            9996 5888888653  34699999999999999999999999999999999999999 899999999999887653322


Q ss_pred             --cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHH-HHHHHHcCCCCcccccchhhhhc
Q 045787          163 --EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHL-SLIFSLLGTPTDESWAESTYISE  239 (324)
Q Consensus       163 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
                        ......+++.|+|||++.+  .++.++||||||+++|+|++|..||........ ..+.........       ....
T Consensus       189 ~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------~~~~  259 (307)
T 2nru_A          189 TVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEK-------TIED  259 (307)
T ss_dssp             CEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSC-------CHHH
T ss_pred             cccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhh-------hhhh
Confidence              1233468899999999876  368999999999999999999999976553211 111110000000       0000


Q ss_pred             ccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      ......       .......+..+.+++.+||+.||.+|||+.++++
T Consensus       260 ~~~~~~-------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~  299 (307)
T 2nru_A          260 YIDKKM-------NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ  299 (307)
T ss_dssp             HSCSSC-------SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             hccccc-------cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            000000       0011134567889999999999999999999986

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-42  Score=301.97  Aligned_cols=255  Identities=24%  Similarity=0.322  Sum_probs=190.2

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhc--CCCCeeEEEeeeecC--
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL--EHENIVRLLDVQSSR--   78 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l--~~~~i~~~~~~~~~~--   78 (324)
                      ....++|++.+.||+|+||.||+|.+.  ++.||+|++.....     .....|.+++...  +||||+++++++...  
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~-----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~  105 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE-----ASWFRETEIYQTVLMRHENILGFIAADIKGTG  105 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred             cccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc-----chhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence            345678999999999999999999875  88999999864322     3345566666555  899999999998776  


Q ss_pred             --CeEEEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCcccCCCCCceEeecCCCcEE
Q 045787           79 --KDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSL--------KILHRDLKPNNLLIDLKRNTVK  147 (324)
Q Consensus        79 --~~~~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~--------g~~H~di~p~nIll~~~~~~v~  147 (324)
                        ...++||||+.+ +|.+++...  .+++..++.++.+++.||.|||+.        |++|+||||+||+++ .++.++
T Consensus       106 ~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~-~~~~~k  182 (337)
T 3mdy_A          106 SWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK-KNGTCC  182 (337)
T ss_dssp             GGCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEEC-TTSCEE
T ss_pred             CCCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEEC-CCCCEE
Confidence              789999999975 999888653  599999999999999999999999        999999999999999 899999


Q ss_pred             EeeccceeeccCCCCc----ccccccccccCCchhhcCCCCCCC------chhhHHHHHHHHHHHhC----------CCC
Q 045787          148 LADFGLARAIGVPQKE----YSRDCVYSPYKAPELLLGYTGYST------PIDVWAVGCIFAEMITG----------KPL  207 (324)
Q Consensus       148 l~d~g~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~------~~DiwslG~il~~l~~g----------~~p  207 (324)
                      |+|||.+.........    .....+|+.|+|||++.+ ...+.      ++||||||+++|+|++|          ..|
T Consensus       183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p  261 (337)
T 3mdy_A          183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE-SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP  261 (337)
T ss_dssp             ECCCTTCEECC---------CCSSCSCGGGCCHHHHTT-CCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEeCCCceeeccccccccCCCCCCccCcceeChhhccc-ccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence            9999999766433222    124478899999999987 33333      49999999999999999          566


Q ss_pred             CCCCChh--HHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHh
Q 045787          208 FPSKKHD--HLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDAL  285 (324)
Q Consensus       208 f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l  285 (324)
                      |......  ...........                .......+.  ......+++.+.+++.+||+.||.+|||+.+++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell  323 (337)
T 3mdy_A          262 YHDLVPSDPSYEDMREIVCI----------------KKLRPSFPN--RWSSDECLRQMGKLMTECWAHNPASRLTALRVK  323 (337)
T ss_dssp             TTTTSCSSCCHHHHHHHHTT----------------SCCCCCCCG--GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             HhhhcCCCCchhhhHHHHhh----------------hccCccccc--cchhhHHHHHHHHHHHHhhhhChhhCCCHHHHH
Confidence            6432211  01111000000                000000000  000124567799999999999999999999999


Q ss_pred             c
Q 045787          286 K  286 (324)
Q Consensus       286 ~  286 (324)
                      +
T Consensus       324 ~  324 (337)
T 3mdy_A          324 K  324 (337)
T ss_dssp             H
T ss_pred             H
Confidence            7

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.1e-41  Score=321.65  Aligned_cols=252  Identities=24%  Similarity=0.361  Sum_probs=203.4

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccC---CceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCe
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVT---GQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKD   80 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~---~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   80 (324)
                      +..++|++.+.||+|+||.||+|.+..+   +..+|+|.+..... ....+.+.+|+.++++++||||+++++++. ++.
T Consensus       387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~  464 (656)
T 2j0j_A          387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTS-DSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP  464 (656)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred             cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence            4567899999999999999999998643   45789998764322 122356889999999999999999999985 456


Q ss_pred             EEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccC
Q 045787           81 VFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGV  159 (324)
Q Consensus        81 ~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~  159 (324)
                      .++||||++ |+|.+++......+++..++.++.+++.||.|||++|++|+||||+||+++ .++.++|+|||.+.....
T Consensus       465 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~-~~~~vkL~DFG~a~~~~~  543 (656)
T 2j0j_A          465 VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS-SNDCVKLGDFGLSRYMED  543 (656)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE-ETTEEEECCCCCCCSCCC
T ss_pred             eEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEe-CCCCEEEEecCCCeecCC
Confidence            899999998 699998887766799999999999999999999999999999999999999 899999999999986643


Q ss_pred             CCC-cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhh
Q 045787          160 PQK-EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYI  237 (324)
Q Consensus       160 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (324)
                      ... ......+++.|+|||++.+ ..++.++||||||+++|+|++ |..||.+...............++          
T Consensus       544 ~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~----------  612 (656)
T 2j0j_A          544 STYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP----------  612 (656)
T ss_dssp             ----------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCC----------
T ss_pred             CcceeccCCCCCcceeCHHHhcC-CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC----------
Confidence            322 1223345678999999987 578999999999999999997 999998877555443332211111          


Q ss_pred             hcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          238 SEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                       ..+.+++.+.++|.+||+.||.+|||+.++++
T Consensus       613 -----------------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          613 -----------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             -----------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------CCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                             11357899999999999999999999999985

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.8e-41  Score=288.72  Aligned_cols=231  Identities=13%  Similarity=0.110  Sum_probs=187.7

Q ss_pred             Cc-ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeecccc-CCCchHHHHHHHHHHhcCCCCeeEEEeeeecCC
Q 045787            2 GK-LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQ-EGVPSYIIREVSLLKELEHENIVRLLDVQSSRK   79 (324)
Q Consensus         2 ~~-~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   79 (324)
                      |+ ++.++|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+.+|+..+.+++||||+++++++.+++
T Consensus        25 g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~  104 (286)
T 3uqc_A           25 GARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRA  104 (286)
T ss_dssp             TCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             CCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECC
Confidence            55 7889999999999999999999999999999999999765432 222366889999999999999999999999999


Q ss_pred             eEEEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeecc
Q 045787           80 DVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIG  158 (324)
Q Consensus        80 ~~~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~  158 (324)
                      ..|+||||++| +|.+++..  + .....+..++.|++.||.|||++|++|+||||+||+++ .++.++|++++      
T Consensus       105 ~~~lv~e~~~g~~L~~~l~~--~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~-~~g~~kl~~~~------  174 (286)
T 3uqc_A          105 GGLVVAEWIRGGSLQEVADT--S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVS-IDGDVVLAYPA------  174 (286)
T ss_dssp             EEEEEEECCCEEEHHHHHTT--C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE-TTSCEEECSCC------
T ss_pred             cEEEEEEecCCCCHHHHHhc--C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEc-CCCCEEEEecc------
Confidence            99999999985 88888743  2 46667889999999999999999999999999999999 89999988433      


Q ss_pred             CCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhh
Q 045787          159 VPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYIS  238 (324)
Q Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (324)
                                    |++        +++.++||||||+++|+|++|+.||.+.+....              .       
T Consensus       175 --------------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~--------------~-------  211 (286)
T 3uqc_A          175 --------------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSG--------------L-------  211 (286)
T ss_dssp             --------------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCC--------------S-------
T ss_pred             --------------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchh--------------h-------
Confidence                          333        368899999999999999999999976542210              0       


Q ss_pred             cccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          239 EILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      ..................+.+++.+.++|.+||+.||.+| |+.++++
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~  258 (286)
T 3uqc_A          212 APAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN  258 (286)
T ss_dssp             EECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred             HHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence            0000011112222334556799999999999999999999 9999997

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=303.61  Aligned_cols=269  Identities=24%  Similarity=0.310  Sum_probs=187.9

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHH--HHhcCCCCeeEEEeeee----
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSL--LKELEHENIVRLLDVQS----   76 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~--l~~l~~~~i~~~~~~~~----   76 (324)
                      .+..++|++.+.||+|+||.||++..  +++.||+|++.....     ..+..|.++  +..++||||+++++.+.    
T Consensus         9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~   81 (336)
T 3g2f_A            9 SLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR-----QNFINEKNIYRVPLMEHDNIARFIVGDERVTA   81 (336)
T ss_dssp             CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECT
T ss_pred             CcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch-----hhHHHHHHHHHHHhccCcchhhheeccccccc
Confidence            35678999999999999999999976  588999999875432     233444444  44578999999997542    


Q ss_pred             -cCCeEEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCcccCCCCCceEeecCCCc
Q 045787           77 -SRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSL---------KILHRDLKPNNLLIDLKRNT  145 (324)
Q Consensus        77 -~~~~~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---------g~~H~di~p~nIll~~~~~~  145 (324)
                       ....+++||||++ |+|.+++...  ..++..++.++.+++.||.|||+.         |++|+||||+||+++ .++.
T Consensus        82 ~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~-~~~~  158 (336)
T 3g2f_A           82 DGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK-NDGT  158 (336)
T ss_dssp             TSCEEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEEC-TTSC
T ss_pred             CCCceEEEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEc-CCCc
Confidence             2346799999996 5998888664  358889999999999999999999         999999999999999 8899


Q ss_pred             EEEeeccceeeccCCC--------CcccccccccccCCchhhcCC------CCCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 045787          146 VKLADFGLARAIGVPQ--------KEYSRDCVYSPYKAPELLLGY------TGYSTPIDVWAVGCIFAEMITGKPLFPSK  211 (324)
Q Consensus       146 v~l~d~g~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~------~~~~~~~DiwslG~il~~l~~g~~pf~~~  211 (324)
                      ++|+|||.+.......        .......+|+.|+|||++.+.      ..++.++||||||+++|+|++|..||...
T Consensus       159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~  238 (336)
T 3g2f_A          159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG  238 (336)
T ss_dssp             EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred             EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence            9999999998764321        122234689999999999762      23567899999999999999997665332


Q ss_pred             C-hhHH--HHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          212 K-HDHL--SLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       212 ~-~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      . ....  .........+.......     .....................++.+.++|.+||+.||.+|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~  311 (336)
T 3g2f_A          239 ESVPEYQMAFQTEVGNHPTFEDMQV-----LVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE  311 (336)
T ss_dssp             SCCCCCCCTTHHHHCSSCCHHHHHH-----HHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cchhHHHHhhhcccCCCchHHHHHh-----hhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence            2 1100  00000011111000000     000000000000000111124557999999999999999999999964

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.4e-41  Score=298.22  Aligned_cols=255  Identities=23%  Similarity=0.322  Sum_probs=197.0

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHh--cCCCCeeEEEeeeecCC--
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKE--LEHENIVRLLDVQSSRK--   79 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~~~~--   79 (324)
                      .+.++|++.+.||+|++|.||++.+  +|+.||+|++....     ...+.+|.++++.  ++||||+++++++....  
T Consensus        39 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~  111 (342)
T 1b6c_B           39 TIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGT  111 (342)
T ss_dssp             HHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred             cccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh-----HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence            4457899999999999999999987  48899999986432     2456788898887  68999999999998765  


Q ss_pred             --eEEEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCcccCCCCCceEeecCCCcEEE
Q 045787           80 --DVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCH--------SLKILHRDLKPNNLLIDLKRNTVKL  148 (324)
Q Consensus        80 --~~~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh--------~~g~~H~di~p~nIll~~~~~~v~l  148 (324)
                        ..++||||+++ +|.+++..  ..+++..++.++.+++.||.+||        +.|++|+||||+||+++ .++.++|
T Consensus       112 ~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~-~~~~~kL  188 (342)
T 1b6c_B          112 WTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCI  188 (342)
T ss_dssp             CCCEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEEC-TTSCEEE
T ss_pred             cceeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEEC-CCCCEEE
Confidence              79999999985 99998876  36999999999999999999999        89999999999999999 8899999


Q ss_pred             eeccceeeccCCCC----cccccccccccCCchhhcCCCC-----CCCchhhHHHHHHHHHHHhC----------CCCCC
Q 045787          149 ADFGLARAIGVPQK----EYSRDCVYSPYKAPELLLGYTG-----YSTPIDVWAVGCIFAEMITG----------KPLFP  209 (324)
Q Consensus       149 ~d~g~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~-----~~~~~DiwslG~il~~l~~g----------~~pf~  209 (324)
                      +|||.+........    ......+++.|+|||++.+...     ++.++||||||+++|+|++|          ..||.
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~  268 (342)
T 1b6c_B          189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY  268 (342)
T ss_dssp             CCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             EECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcc
Confidence            99999987654332    2344578899999999976332     23689999999999999999          67875


Q ss_pred             CCChh--HHHHHHHHc-CCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          210 SKKHD--HLSLIFSLL-GTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       210 ~~~~~--~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      .....  ......... .......                 .+..  ......+..+.+++.+||+.||.+|||+.++++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~--~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~  329 (342)
T 1b6c_B          269 DLVPSDPSVEEMRKVVCEQKLRPN-----------------IPNR--WQSCEALRVMAKIMRECWYANGAARLTALRIKK  329 (342)
T ss_dssp             TTSCSSCCHHHHHHHHTTSCCCCC-----------------CCGG--GGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ccCcCcccHHHHHHHHHHHHhCCC-----------------Cccc--ccchhHHHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            54311  111111110 0000000                 0000  001134567889999999999999999999997


Q ss_pred             C
Q 045787          287 H  287 (324)
Q Consensus       287 h  287 (324)
                      |
T Consensus       330 ~  330 (342)
T 1b6c_B          330 T  330 (342)
T ss_dssp             H
T ss_pred             H
Confidence            3

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=3.8e-43  Score=307.53  Aligned_cols=248  Identities=22%  Similarity=0.267  Sum_probs=189.6

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc------cCCCchHHHHHHHHHHhcC---------CCCee
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE------QEGVPSYIIREVSLLKELE---------HENIV   69 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~------~~~~~~~~~~e~~~l~~l~---------~~~i~   69 (324)
                      ..++|++.+.||+|+||.||+|.+  +|+.||+|++.....      .....+.+.+|+.+++.++         |||++
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv   95 (336)
T 2vuw_A           18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI   95 (336)
T ss_dssp             CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred             ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence            457899999999999999999998  689999999987642      2223367889999999886         66666


Q ss_pred             EEEee-----------------eec-------------CCeEEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHH
Q 045787           70 RLLDV-----------------QSS-------------RKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLG  118 (324)
Q Consensus        70 ~~~~~-----------------~~~-------------~~~~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~  118 (324)
                      ++.++                 +.+             .+..|+||||+. |++++.+..  ..+++..++.++.||+.|
T Consensus        96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHH
T ss_pred             hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHH
Confidence            66654                 332             678999999996 456666644  568999999999999999


Q ss_pred             HHHHH-hCCCcccCCCCCceEeecCCC--------------------cEEEeeccceeeccCCCCcccccccccccCCch
Q 045787          119 LAYCH-SLKILHRDLKPNNLLIDLKRN--------------------TVKLADFGLARAIGVPQKEYSRDCVYSPYKAPE  177 (324)
Q Consensus       119 l~~Lh-~~g~~H~di~p~nIll~~~~~--------------------~v~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE  177 (324)
                      |.||| +.|++||||||+|||++ .++                    .+||+|||++.....     ....||+.|+|||
T Consensus       174 L~~lH~~~~ivHrDlKp~NILl~-~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-----~~~~gt~~y~aPE  247 (336)
T 2vuw_A          174 LAVAEASLRFEHRDLHWGNVLLK-KTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-----GIVVFCDVSMDED  247 (336)
T ss_dssp             HHHHHHHHCCBCSCCCGGGEEEE-ECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-----TEEECCCCTTCSG
T ss_pred             HHHHHHhCCEeECCCCHHHEEEe-ccCCcceeeeccCccccccCCCceEEEeeccccEecCC-----CcEEEeecccChh
Confidence            99999 99999999999999999 655                    899999999987653     2347899999999


Q ss_pred             hhcCCCCCCCchhhHHHHHH-HHHHHhCCCCCCCCCh-hHHH-HHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhh
Q 045787          178 LLLGYTGYSTPIDVWAVGCI-FAEMITGKPLFPSKKH-DHLS-LIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAE  254 (324)
Q Consensus       178 ~~~~~~~~~~~~DiwslG~i-l~~l~~g~~pf~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (324)
                      ++.+..  +.++||||||++ .++++.|..||..... .... .+......                      .......
T Consensus       248 ~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~  303 (336)
T 2vuw_A          248 LFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTF----------------------KTKCNTP  303 (336)
T ss_dssp             GGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCC----------------------SSCCCSH
T ss_pred             hhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhcc----------------------Ccccchh
Confidence            998733  889999998776 7778889998843211 0010 11100000                      0000111


Q ss_pred             hCCCCChhHHHHHHHhhcCCCCCCCCHHHHh-cCcccc
Q 045787          255 KFPNLEPAGVDLLSQMLCLNPKQRITAMDAL-KHEYLI  291 (324)
Q Consensus       255 ~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l-~hp~~~  291 (324)
                      ..+.+++++.+||++||++|     |++|+| +||||+
T Consensus       304 ~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          304 AMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             HHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred             hhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence            22347889999999999987     999999 999995

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.6e-42  Score=327.50  Aligned_cols=246  Identities=22%  Similarity=0.332  Sum_probs=199.3

Q ss_pred             CcccCcCcceeEeecccCceEEEEEEEcc-CCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCe
Q 045787            2 GKLKNLNYKKIKKIGAGGYGEVYKCRNTV-TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKD   80 (324)
Q Consensus         2 ~~~~~~~y~i~~~Lg~g~~~~v~~a~~~~-~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   80 (324)
                      |+++.++|++.+.||+|+||.||++.+.. +|+.||+|++..... ......+.+|+.++++++||||+++++++...+.
T Consensus        75 g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  153 (681)
T 2pzi_A           75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGD-AEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDR  153 (681)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCC-HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECT
T ss_pred             CCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCC-HHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCC
Confidence            56778999999999999999999999976 789999998864322 1223567899999999999999999999987655


Q ss_pred             -----EEEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccce
Q 045787           81 -----VFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLA  154 (324)
Q Consensus        81 -----~~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~  154 (324)
                           .|+||||++| +|.+.+..   .+++..++.++.+|+.+|.|||++|++|+||||+||+++ . +.+||+|||.+
T Consensus       154 ~~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~-~-~~~kl~DFG~a  228 (681)
T 2pzi_A          154 HGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT-E-EQLKLIDLGAV  228 (681)
T ss_dssp             TSCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC-S-SCEEECCCTTC
T ss_pred             CCCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEe-C-CcEEEEecccc
Confidence                 7999999985 66665443   699999999999999999999999999999999999999 4 48999999999


Q ss_pred             eeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccch
Q 045787          155 RAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAES  234 (324)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (324)
                      ......    ....||+.|+|||++.+ . .+.++||||||+++|+|++|..||.......                   
T Consensus       229 ~~~~~~----~~~~gt~~y~aPE~~~~-~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-------------------  283 (681)
T 2pzi_A          229 SRINSF----GYLYGTPGFQAPEIVRT-G-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG-------------------  283 (681)
T ss_dssp             EETTCC----SCCCCCTTTSCTTHHHH-C-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS-------------------
T ss_pred             hhcccC----CccCCCccccCHHHHcC-C-CCCceehhhhHHHHHHHHhCCCCCccccccc-------------------
Confidence            876532    44578999999999976 3 3889999999999999999998875321110                   


Q ss_pred             hhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCC
Q 045787          235 TYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV  293 (324)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~  293 (324)
                               ...  ...    ....++.+.++|.+||+.||.+||+..+.+.|+|+.-+
T Consensus       284 ---------~~~--~~~----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          284 ---------LPE--DDP----VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             ---------CCT--TCH----HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             ---------ccc--ccc----ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence                     000  000    01245788999999999999999999999999988654

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=6.1e-34  Score=264.27  Aligned_cols=186  Identities=17%  Similarity=0.084  Sum_probs=132.7

Q ss_pred             eecccCceEEEEEEEccCCceEEEEEeeecccc--------CCCchHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEEEE
Q 045787           14 KIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQ--------EGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKDVFLV   84 (324)
Q Consensus        14 ~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~--------~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv   84 (324)
                      ..+.|+.+....++....|+.|++|++......        +...+.+.+|+++|+++ .|+||+++++++++++..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            355677777888888888999999999765321        12235688999999999 699999999999999999999


Q ss_pred             EEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCc
Q 045787           85 FEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE  163 (324)
Q Consensus        85 ~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~  163 (324)
                      |||++| +|.+.+.. .+++++.   .|+.||+.||.|+|++||+||||||+|||++ .++.+||+|||+++........
T Consensus       321 MEyv~G~~L~d~i~~-~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~-~dg~vKL~DFGlAr~~~~~~~~  395 (569)
T 4azs_A          321 MEKLPGRLLSDMLAA-GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVD-ARQHARLIDFGSIVTTPQDCSW  395 (569)
T ss_dssp             EECCCSEEHHHHHHT-TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEEC-TTSCEEECCCTTEESCC---CC
T ss_pred             EecCCCCcHHHHHHh-CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEEC-CCCCEEEeecccCeeCCCCCcc
Confidence            999987 88887766 4567765   4789999999999999999999999999999 8999999999999877655555


Q ss_pred             ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCC
Q 045787          164 YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKP  206 (324)
Q Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~  206 (324)
                      ....+||+.|+|||++.+  ....++|+||+|++++.+.++..
T Consensus       396 ~~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~~  436 (569)
T 4azs_A          396 PTNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPWS  436 (569)
T ss_dssp             SHHHHHHHHHHHHHHC-------------------CCCCTTHH
T ss_pred             ccCceechhhccHHHhCC--CCCCcccccccccchhhhccccc
Confidence            566789999999999986  34678999999999887765543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.93  E-value=8.7e-27  Score=215.15  Aligned_cols=185  Identities=17%  Similarity=0.187  Sum_probs=138.8

Q ss_pred             ceeEeecccCceEEEEEEEccCCceEEEEEeeeccccC------CCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 045787           10 KKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQE------GVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus        10 ~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   83 (324)
                      ...+.||+|+||.||++.  ..+..+++|.........      ...+.+.+|++++++++||||+++..+....+..|+
T Consensus       339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  416 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI  416 (540)
T ss_dssp             ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred             CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence            345689999999999994  457889999865432111      112447899999999999999955555556667799


Q ss_pred             EEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC
Q 045787           84 VFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK  162 (324)
Q Consensus        84 v~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~  162 (324)
                      ||||++ ++|.+++..         +..++.|++.+|.|||++|++|+||||+||+++ .  .+||+|||++........
T Consensus       417 VmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~-~--~~kL~DFGla~~~~~~~~  484 (540)
T 3en9_A          417 MMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFD-K--DLYIIDFGLGKISNLDED  484 (540)
T ss_dssp             EEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEES-S--SEEECCCTTCEECCCHHH
T ss_pred             EEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEEC-C--eEEEEECccCEECCCccc
Confidence            999997 588887665         568999999999999999999999999999999 5  999999999987753221


Q ss_pred             c-------ccccccccccCCchhhcC-CCCCCCchhhHHHHHHHHHHHhCCCCC
Q 045787          163 E-------YSRDCVYSPYKAPELLLG-YTGYSTPIDVWAVGCIFAEMITGKPLF  208 (324)
Q Consensus       163 ~-------~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~il~~l~~g~~pf  208 (324)
                      .       ....++|+.|+|||++.. ...|+..+|+|+..+-..+-+.++.+|
T Consensus       485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            1       124578999999999975 133577789999998888888777665

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.88  E-value=5.3e-23  Score=174.74  Aligned_cols=146  Identities=18%  Similarity=0.193  Sum_probs=113.4

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCC----------------CchHHHHHHHHHHhcCCCCeeE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEG----------------VPSYIIREVSLLKELEHENIVR   70 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~----------------~~~~~~~e~~~l~~l~~~~i~~   70 (324)
                      ..|++.+.||+|++|.||+|.+ .+|+.+|+|++........                ....+.+|+.++++++  | ++
T Consensus        90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~  165 (282)
T 1zar_A           90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA  165 (282)
T ss_dssp             SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred             eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence            3455669999999999999999 7899999999865432110                1245789999999999  4 55


Q ss_pred             EEeeeecCCeEEEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEe
Q 045787           71 LLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLA  149 (324)
Q Consensus        71 ~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~  149 (324)
                      +.+++.. +..|+||||++| +|.+ +..       .....++.+++.||.+||+.|++|+||||+||+++  ++.++|+
T Consensus       166 v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~--~~~vkl~  234 (282)
T 1zar_A          166 VPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS--EEGIWII  234 (282)
T ss_dssp             SCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE--TTEEEEC
T ss_pred             cCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE--CCcEEEE
Confidence            5555443 556999999986 7776 311       23457999999999999999999999999999999  8899999


Q ss_pred             eccceeeccCCCCcccccccccccCCchhhc
Q 045787          150 DFGLARAIGVPQKEYSRDCVYSPYKAPELLL  180 (324)
Q Consensus       150 d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~  180 (324)
                      |||.+...             ..+.|||++.
T Consensus       235 DFG~a~~~-------------~~~~a~e~l~  252 (282)
T 1zar_A          235 DFPQSVEV-------------GEEGWREILE  252 (282)
T ss_dssp             CCTTCEET-------------TSTTHHHHHH
T ss_pred             ECCCCeEC-------------CCCCHHHHHH
Confidence            99998743             2257888875

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.84  E-value=6.9e-21  Score=159.79  Aligned_cols=139  Identities=18%  Similarity=0.250  Sum_probs=106.9

Q ss_pred             CcceeEeecccCceEEEEEEEccCCce--EEEEEeeeccccCC----------------------CchHHHHHHHHHHhc
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQK--VAIKMMTIQTEQEG----------------------VPSYIIREVSLLKEL   63 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~--~~~K~~~~~~~~~~----------------------~~~~~~~e~~~l~~l   63 (324)
                      -|++.+.||+|++|.||+|.+..+|+.  ||+|++........                      ....+.+|+.+++++
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            478999999999999999998778888  99999764321100                      012578899999999


Q ss_pred             CCCCe--eEEEeeeecCCeEEEEEEecC--C----CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCCcccCCCC
Q 045787           64 EHENI--VRLLDVQSSRKDVFLVFEYLD--L----DLHSFITRHKNTLNLLVIKAILKQILLGLAYCH-SLKILHRDLKP  134 (324)
Q Consensus        64 ~~~~i--~~~~~~~~~~~~~~iv~e~~~--g----~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh-~~g~~H~di~p  134 (324)
                      .|+++  +.+++.    ...++||||++  |    +|.+....    .++..+..++.+++.+|.+|| +.|++|+||||
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp  199 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADLSE  199 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence            87753  344432    35689999995  3    45544322    234567789999999999999 99999999999


Q ss_pred             CceEeecCCCcEEEeeccceeec
Q 045787          135 NNLLIDLKRNTVKLADFGLARAI  157 (324)
Q Consensus       135 ~nIll~~~~~~v~l~d~g~~~~~  157 (324)
                      +|||++ .  .++|+|||.+...
T Consensus       200 ~NILl~-~--~~~liDFG~a~~~  219 (258)
T 1zth_A          200 YNIMYI-D--KVYFIDMGQAVTL  219 (258)
T ss_dssp             TSEEES-S--SEEECCCTTCEET
T ss_pred             HHEEEc-C--cEEEEECcccccC
Confidence            999999 5  8999999999764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.73  E-value=1.2e-17  Score=145.88  Aligned_cols=139  Identities=15%  Similarity=0.224  Sum_probs=98.7

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCC------------Cch--------HHHHHHHHHHhcCCC
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEG------------VPS--------YIIREVSLLKELEHE   66 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~------------~~~--------~~~~e~~~l~~l~~~   66 (324)
                      .-|++.+.||.|++|.||+|.+. +|+.+|+|+++.......            ...        ...+|...+.++.+.
T Consensus        95 ~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~  173 (397)
T 4gyi_A           95 DVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE  173 (397)
T ss_dssp             SCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             CEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence            34999999999999999999985 689999999864321100            000        023466777777544


Q ss_pred             Cee--EEEeeeecCCeEEEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCC
Q 045787           67 NIV--RLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKR  143 (324)
Q Consensus        67 ~i~--~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~  143 (324)
                      ++.  ..++.  .  ..++||||++| ++... .      .......++.|++.+|.+||+.|++||||||.|||++ ++
T Consensus       174 gv~vp~p~~~--~--~~~LVME~i~G~~L~~l-~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~-~d  241 (397)
T 4gyi_A          174 GFPVPEPIAQ--S--RHTIVMSLVDALPMRQV-S------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIR-EE  241 (397)
T ss_dssp             TCSCCCEEEE--E--TTEEEEECCSCEEGGGC-C------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-EE
T ss_pred             CCCCCeeeec--c--CceEEEEecCCccHhhh-c------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEe-CC
Confidence            432  22222  1  23799999997 44332 1      1223456889999999999999999999999999998 55


Q ss_pred             C----------cEEEeeccceeecc
Q 045787          144 N----------TVKLADFGLARAIG  158 (324)
Q Consensus       144 ~----------~v~l~d~g~~~~~~  158 (324)
                      +          .+.|+||+.+....
T Consensus       242 gd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          242 KDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             ECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             CCcccccccccceEEEEeCCcccCC
Confidence            4          48999999887543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.46  E-value=6.4e-13  Score=111.43  Aligned_cols=138  Identities=17%  Similarity=0.173  Sum_probs=108.0

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcC-CCCeeEEEeeeecCCeEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-HENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      ..|++...++.|+.+.||++...  +..+++|+.......  ....+.+|+.+++.+. +..+++++++..+.+..|+||
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~--~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~   89 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM   89 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred             ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCC--CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence            46899999999999999999754  679999998753221  1345889999999995 567888999988888999999


Q ss_pred             EecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 045787           86 EYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS----------------------------------------  124 (324)
Q Consensus        86 e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~----------------------------------------  124 (324)
                      |+++| ++.+.+.      +......++.++..+|..||+                                        
T Consensus        90 e~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (263)
T 3tm0_A           90 SEADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP  163 (263)
T ss_dssp             ECCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred             EecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence            99998 5544311      122234677889999999998                                        


Q ss_pred             -------------------CCCcccCCCCCceEeecCCCcEEEeecccee
Q 045787          125 -------------------LKILHRDLKPNNLLIDLKRNTVKLADFGLAR  155 (324)
Q Consensus       125 -------------------~g~~H~di~p~nIll~~~~~~v~l~d~g~~~  155 (324)
                                         .+++|||++|.||+++ +++.+.|+||+.+.
T Consensus       164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~-~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK-DGKVSGFIDLGRSG  212 (263)
T ss_dssp             SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE-TTEEEEECCCTTCE
T ss_pred             CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE-CCcEEEEEEchhcc
Confidence                               4489999999999998 65556799998765

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.28  E-value=1.7e-11  Score=102.38  Aligned_cols=133  Identities=14%  Similarity=0.098  Sum_probs=95.7

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCC--eeEEEeeeecCCeEEEEE
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN--IVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~~~~~iv~   85 (324)
                      .|.+....+.|..+.||++.. .+|..+++|.....     ....+.+|+.+++.+.+.+  +++++++...++..++||
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~   94 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL   94 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred             CCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence            455544444666799999964 46778999987543     1245789999999986434  566888888888899999


Q ss_pred             EecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 045787           86 EYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK---------------------------------------  126 (324)
Q Consensus        86 e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g---------------------------------------  126 (324)
                      ||++|..+. ..    ..+.   ..++.+++..|..||+..                                       
T Consensus        95 e~i~G~~l~-~~----~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (264)
T 1nd4_A           95 GEVPGQDLL-SS----HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA  166 (264)
T ss_dssp             ECCSSEETT-TS----CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred             EecCCcccC-cC----cCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence            999984333 11    1222   245666777777777643                                       


Q ss_pred             -------------------CcccCCCCCceEeecCCCcEEEeecccee
Q 045787          127 -------------------ILHRDLKPNNLLIDLKRNTVKLADFGLAR  155 (324)
Q Consensus       127 -------------------~~H~di~p~nIll~~~~~~v~l~d~g~~~  155 (324)
                                         ++|+|++|.||+++ +++.+.|+||+.+.
T Consensus       167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~-~~~~~~liD~~~a~  213 (264)
T 1nd4_A          167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVE-NGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEE-TTEEEEECCCTTCE
T ss_pred             HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEE-CCcEEEEEcchhcc
Confidence                               89999999999998 66666799999765

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.17  E-value=2e-10  Score=100.73  Aligned_cols=142  Identities=15%  Similarity=0.222  Sum_probs=103.7

Q ss_pred             cceeEeecccCceEEEEEEEccCCceEEEEEee--eccccCCCchHHHHHHHHHHhcCC--CCeeEEEeeeecC---CeE
Q 045787            9 YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMT--IQTEQEGVPSYIIREVSLLKELEH--ENIVRLLDVQSSR---KDV   81 (324)
Q Consensus         9 y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~--~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~---~~~   81 (324)
                      ...++.|+.|.++.||++...  +..+++|...  ..... .....+.+|+.+++.+..  ..+++++.++.+.   +..
T Consensus        40 ~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~-~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~  116 (359)
T 3dxp_A           40 PLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL-PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA  116 (359)
T ss_dssp             CCEEEECCC-CCSCEEEEECS--SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred             CceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC-CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence            345788999999999999864  4689999876  32211 123467889999999974  4578888887766   458


Q ss_pred             EEEEEecCCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------
Q 045787           82 FLVFEYLDLD-LHSFITRHKNTLNLLVIKAILKQILLGLAYCHS------------------------------------  124 (324)
Q Consensus        82 ~iv~e~~~g~-l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~------------------------------------  124 (324)
                      |+|||+++|. +.+.   .-..+++.....++.++...|..||+                                    
T Consensus       117 ~~vme~v~G~~l~~~---~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (359)
T 3dxp_A          117 FYIMEFVSGRVLWDQ---SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES  193 (359)
T ss_dssp             EEEEECCCCBCCCCT---TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred             EEEEEecCCeecCCC---ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence            9999999973 3221   11246788888899999999999997                                    


Q ss_pred             ----------------------CCCcccCCCCCceEeecCCC-cEEEeeccceee
Q 045787          125 ----------------------LKILHRDLKPNNLLIDLKRN-TVKLADFGLARA  156 (324)
Q Consensus       125 ----------------------~g~~H~di~p~nIll~~~~~-~v~l~d~g~~~~  156 (324)
                                            .+++|||++|.||+++.++. .+.|+||+.+..
T Consensus       194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                  35899999999999983332 368999998764

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.05  E-value=2.3e-10  Score=97.91  Aligned_cols=184  Identities=18%  Similarity=0.199  Sum_probs=117.4

Q ss_pred             eEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcC-CCC--eeEEEeeeecCC---eEEEEE
Q 045787           12 IKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-HEN--IVRLLDVQSSRK---DVFLVF   85 (324)
Q Consensus        12 ~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~--i~~~~~~~~~~~---~~~iv~   85 (324)
                      ++.++.|....||++.     ..+++|.....    .....+.+|...++.+. +..  +.+++......+   ..|+||
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm   95 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF   95 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence            4568999999999874     46999986533    12356889999998884 322  445555443333   458999


Q ss_pred             EecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 045787           86 EYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS----------------------------------------  124 (324)
Q Consensus        86 e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~----------------------------------------  124 (324)
                      ++++| ++.....   ..++......++.+++..+..||+                                        
T Consensus        96 ~~i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A           96 TKIKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             ECCCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             cccCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            99998 4433222   236777777788888888888885                                        


Q ss_pred             ------------------CCCcccCCCCCceEeecC-CCcEEEeeccceeeccCCCCcccccccccccCCchhhc----C
Q 045787          125 ------------------LKILHRDLKPNNLLIDLK-RNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLL----G  181 (324)
Q Consensus       125 ------------------~g~~H~di~p~nIll~~~-~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~----~  181 (324)
                                        ..++|+|++|.||+++.+ +..+.|+||+.+...... ...........-..|+...    .
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-~Dl~~~~~~~~~~~~~~~~~~l~~  251 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-NDFISLMEDDEEYGMEFVSKILNH  251 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-HHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-HHHHHHHhhccccCHHHHHHHHHH
Confidence                              136999999999999932 456789999988654321 1111000000002222211    0


Q ss_pred             CCC---------CCCchhhHHHHHHHHHHHhCCCCC
Q 045787          182 YTG---------YSTPIDVWAVGCIFAEMITGKPLF  208 (324)
Q Consensus       182 ~~~---------~~~~~DiwslG~il~~l~~g~~pf  208 (324)
                      ...         .....+.|+++.+++.+.+|..+|
T Consensus       252 Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          252 YKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             cCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            000         022368999999999999998765

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.78  E-value=6.3e-08  Score=81.17  Aligned_cols=131  Identities=15%  Similarity=0.170  Sum_probs=93.4

Q ss_pred             ecccCce-EEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcC-CCCeeEEEeeeecCCeEEEEEEecCC-C
Q 045787           15 IGAGGYG-EVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-HENIVRLLDVQSSRKDVFLVFEYLDL-D   91 (324)
Q Consensus        15 Lg~g~~~-~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv~e~~~g-~   91 (324)
                      +..|..+ .||++.....+..+++|+.....     ...+..|...++.+. +-.+.+++.+..+.+..++||++++| +
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~-----~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~  106 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGSV-----ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT  106 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETHH-----HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCCC-----HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence            3345444 69999888788899999866432     245788999998885 33477888888888999999999998 4


Q ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------------
Q 045787           92 LHSFITRHKNTLNLLVIKAILKQILLGLAYCHSL----------------------------------------------  125 (324)
Q Consensus        92 l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~----------------------------------------------  125 (324)
                      +.+.....     ......+..++...|..||+.                                              
T Consensus       107 ~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          107 AFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             HHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             ccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            44433221     112234556666666666641                                              


Q ss_pred             ------------CCcccCCCCCceEeecCCCcEEEeeccceee
Q 045787          126 ------------KILHRDLKPNNLLIDLKRNTVKLADFGLARA  156 (324)
Q Consensus       126 ------------g~~H~di~p~nIll~~~~~~v~l~d~g~~~~  156 (324)
                                  .++|||+.+.||+++ .++.+-|+||+.+..
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~-~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIFD-EGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEEE-TTEEEEECCCTTCEE
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEEE-CCeEEEEEECccccc
Confidence                        158999999999999 666677999987763

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.68  E-value=3.4e-07  Score=78.17  Aligned_cols=135  Identities=16%  Similarity=0.162  Sum_probs=88.9

Q ss_pred             eeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCC---CeeEEEeeee-cCCeEEEEEE
Q 045787           11 KIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHE---NIVRLLDVQS-SRKDVFLVFE   86 (324)
Q Consensus        11 i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~i~~~~~~~~-~~~~~~iv~e   86 (324)
                      -++.++.|....||++     |..+++|+....    .....+.+|..+++.+.+.   .+.+++.+.. ..+..++||+
T Consensus        23 ~v~~l~~G~~n~v~~v-----g~~~VlR~~~~~----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e   93 (306)
T 3tdw_A           23 SVESLGEGFRNYAILV-----NGDWVFRFPKSQ----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR   93 (306)
T ss_dssp             CEEEEEECSSEEEEEE-----TTTEEEEEESSH----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred             eeeecCCCcceeEEEE-----CCEEEEEecCCc----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence            4567888999999998     568999985322    1235688999999999742   3556666653 4566889999


Q ss_pred             ecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 045787           87 YLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS------------------------------------------  124 (324)
Q Consensus        87 ~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~------------------------------------------  124 (324)
                      +++|.......-  ..++......+..++...|..||+                                          
T Consensus        94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A           94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            999833322110  113344444444444444444443                                          


Q ss_pred             ------------------CCCcccCCCCCceEeecC---CCc-EEEeeccceeec
Q 045787          125 ------------------LKILHRDLKPNNLLIDLK---RNT-VKLADFGLARAI  157 (324)
Q Consensus       125 ------------------~g~~H~di~p~nIll~~~---~~~-v~l~d~g~~~~~  157 (324)
                                        ..++|+|++|.||+++ .   ++. +.|+||+.+...
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~-~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTN-LNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEEC-TTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEe-cCCCCCceEEEEehhhcCCC
Confidence                              2359999999999999 4   344 589999987654

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.39  E-value=1.1e-06  Score=76.73  Aligned_cols=81  Identities=9%  Similarity=0.115  Sum_probs=55.3

Q ss_pred             ceeEee-cccCceEEEEEEEc--c----CCceEEEEEeeeccc-cCCCchHHHHHHHHHHhcCC---CCeeEEEeeeecC
Q 045787           10 KKIKKI-GAGGYGEVYKCRNT--V----TGQKVAIKMMTIQTE-QEGVPSYIIREVSLLKELEH---ENIVRLLDVQSSR   78 (324)
Q Consensus        10 ~i~~~L-g~g~~~~v~~a~~~--~----~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~~---~~i~~~~~~~~~~   78 (324)
                      ..++.| +.|....+|++...  .    ++..+++|....... .......+.+|+.+++.+..   -.+.+++.+..+.
T Consensus        23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~  102 (357)
T 3ats_A           23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG  102 (357)
T ss_dssp             EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred             EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence            445778 88999999998753  1    256899998654331 00012457789998888852   3567777776654


Q ss_pred             ---CeEEEEEEecCC
Q 045787           79 ---KDVFLVFEYLDL   90 (324)
Q Consensus        79 ---~~~~iv~e~~~g   90 (324)
                         +..++|||+++|
T Consensus       103 ~~~g~~~~v~e~l~G  117 (357)
T 3ats_A          103 DVLGTPFFLMDYVEG  117 (357)
T ss_dssp             TTTSSCEEEEECCCC
T ss_pred             CccCCceEEEEecCC
Confidence               357899999987

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.37  E-value=3.6e-06  Score=74.52  Aligned_cols=79  Identities=16%  Similarity=0.103  Sum_probs=51.5

Q ss_pred             ceeEeecccCceEEEEEEEccCCceEEEEEeeeccc----c-CCCchHHHHHHHHHHhcCC--C-CeeEEEeeeecCCeE
Q 045787           10 KKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE----Q-EGVPSYIIREVSLLKELEH--E-NIVRLLDVQSSRKDV   81 (324)
Q Consensus        10 ~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~----~-~~~~~~~~~e~~~l~~l~~--~-~i~~~~~~~~~~~~~   81 (324)
                      ..++.||.|..+.||++....+++.+++|.......    . ....+.+..|.++++.+..  + .+++++.+  +.+..
T Consensus        33 ~~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~  110 (397)
T 2olc_A           33 LTCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMA  110 (397)
T ss_dssp             CEEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTT
T ss_pred             eEEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCcc
Confidence            346789999999999998666678899998653221    0 1234566789999988742  3 34455544  33456


Q ss_pred             EEEEEecCC
Q 045787           82 FLVFEYLDL   90 (324)
Q Consensus        82 ~iv~e~~~g   90 (324)
                      ++|||+++|
T Consensus       111 ~lvmE~l~g  119 (397)
T 2olc_A          111 VTVMEDLSH  119 (397)
T ss_dssp             EEEECCCTT
T ss_pred             EEEEEeCCC
Confidence            899999976

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=98.37  E-value=7.7e-06  Score=64.80  Aligned_cols=135  Identities=16%  Similarity=0.039  Sum_probs=94.4

Q ss_pred             CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccccccc
Q 045787           91 DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS-LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCV  169 (324)
Q Consensus        91 ~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~~~~  169 (324)
                      +|.+.+...+.+++++++|.++.|.+.+|..+-. ..-...=+.|..|++. .+|.|.+.+- .+.            ..
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~-~dG~V~f~~~-~s~------------~~   99 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVW-RDGAVTLAPA-ADD------------AG   99 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEE-TTSCEEECCC------------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEe-cCCceecccc-ccc------------cc
Confidence            7999999999999999999999999999877622 2212334567899999 8888876641 110            11


Q ss_pred             ccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCC
Q 045787          170 YSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEP  249 (324)
Q Consensus       170 ~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (324)
                      ...+.|||...  ...+.+.-|||||+++|.-+--..|=                                         
T Consensus       100 ~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~e-----------------------------------------  136 (229)
T 2yle_A          100 EPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLKE-----------------------------------------  136 (229)
T ss_dssp             -------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCCT-----------------------------------------
T ss_pred             ccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCCc-----------------------------------------
Confidence            12367888764  34578899999999999999855431                                         


Q ss_pred             cchhhhCCCCChhHHHHHHHhhcC-------------------------CCCCCCCHHHHhc
Q 045787          250 ANLAEKFPNLEPAGVDLLSQMLCL-------------------------NPKQRITAMDALK  286 (324)
Q Consensus       250 ~~~~~~~~~~~~~l~~li~~~l~~-------------------------dP~~Rps~~~~l~  286 (324)
                          ...+.+|+.|.+||..|..-                         -+..|.+.++|++
T Consensus       137 ----~eE~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~  194 (229)
T 2yle_A          137 ----NEERELSPPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK  194 (229)
T ss_dssp             ----TEEECCCHHHHHHHHHHTTCCC--------------------CCSCCCCCCSHHHHHH
T ss_pred             ----ccchhhCHHHHHHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHH
Confidence                01137899999999999866                         2468888888885

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.14  E-value=1.8e-05  Score=68.31  Aligned_cols=72  Identities=17%  Similarity=0.234  Sum_probs=42.5

Q ss_pred             eeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCC--CCeeEEEe------eeecCCeEE
Q 045787           11 KIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEH--ENIVRLLD------VQSSRKDVF   82 (324)
Q Consensus        11 i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~------~~~~~~~~~   82 (324)
                      -++.|+.|..+.||++...  +..+++|.....      ...+..|..+++.+..  -.+++++.      +....+..+
T Consensus        36 ~~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~------~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~  107 (346)
T 2q83_A           36 KIDVIQGNQMALVWKVHTD--SGAVCLKRIHRP------EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLF  107 (346)
T ss_dssp             EEEECC----CEEEEEEET--TEEEEEEEECSC------HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEE
T ss_pred             EeeeccccccCcEEEEEeC--CCCEEEEecCCC------HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEE
Confidence            3556777778999999753  345999988742      1334456666666541  12344443      123456789


Q ss_pred             EEEEecCC
Q 045787           83 LVFEYLDL   90 (324)
Q Consensus        83 iv~e~~~g   90 (324)
                      +|++|++|
T Consensus       108 ~l~~~i~G  115 (346)
T 2q83_A          108 VVYDWIEG  115 (346)
T ss_dssp             EEEECCCC
T ss_pred             EEEEeecC
Confidence            99999987

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.94  E-value=7.1e-05  Score=63.51  Aligned_cols=71  Identities=15%  Similarity=0.173  Sum_probs=46.2

Q ss_pred             cceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCe-eEEEeeeecCCeEEEEEEe
Q 045787            9 YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI-VRLLDVQSSRKDVFLVFEY   87 (324)
Q Consensus         9 y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~iv~e~   87 (324)
                      +.-++.|+.|....+|++      ..+++|+.......   .....+|..+++.+...++ .+++...  .+.-+++++|
T Consensus        20 ~~~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~---~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~   88 (301)
T 3dxq_A           20 YTGPLERLGGLTNLVFRA------GDLCLRIPGKGTEE---YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRY   88 (301)
T ss_dssp             CCSCEEEESCSSEEEEEE------TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEEC
T ss_pred             ccceeEcCCcccccccee------eeEEEECCCCCccc---eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEee
Confidence            344788999999999999      56999987653221   1224578888887753222 4555543  3334689999


Q ss_pred             c-CC
Q 045787           88 L-DL   90 (324)
Q Consensus        88 ~-~g   90 (324)
                      + +|
T Consensus        89 i~~g   92 (301)
T 3dxq_A           89 IAGA   92 (301)
T ss_dssp             CTTC
T ss_pred             cCCC
Confidence            9 66

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.92  E-value=0.00011  Score=62.66  Aligned_cols=74  Identities=23%  Similarity=0.266  Sum_probs=58.9

Q ss_pred             ceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcC---CCCeeEEEeeeecCCeEEEEEE
Q 045787           10 KKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE---HENIVRLLDVQSSRKDVFLVFE   86 (324)
Q Consensus        10 ~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~iv~e   86 (324)
                      .-++.|+.|....+|++..  ++..+++|+.....     ...+..|...++.+.   ...+++++.+....+..++|||
T Consensus        39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~-----~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme  111 (312)
T 3jr1_A           39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERSY-----RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE  111 (312)
T ss_dssp             CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGGG-----HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred             eeeEEeCCccceeeeEEEE--CCCeEEEEeCCccc-----HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence            4467899999999999985  46789999876431     356788999998884   3567888888877888999999


Q ss_pred             ecCC
Q 045787           87 YLDL   90 (324)
Q Consensus        87 ~~~g   90 (324)
                      +++|
T Consensus       112 ~l~G  115 (312)
T 3jr1_A          112 ALNK  115 (312)
T ss_dssp             CCCC
T ss_pred             eccC
Confidence            9986

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.86  E-value=0.00015  Score=64.67  Aligned_cols=77  Identities=17%  Similarity=0.231  Sum_probs=46.9

Q ss_pred             ceeEeecccCceEEEEEEEccCCceEEEEEeeeccc--cCC---CchHHHHHHHHHHhc---CCCCeeEEEeeeecCCeE
Q 045787           10 KKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE--QEG---VPSYIIREVSLLKEL---EHENIVRLLDVQSSRKDV   81 (324)
Q Consensus        10 ~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~--~~~---~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~~   81 (324)
                      .-++.||.|..+.||++..  ++..+++|.......  ...   .......|.+++..+   ....+++++.+.  .+..
T Consensus        37 ~~i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~  112 (420)
T 2pyw_A           37 LVIKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMA  112 (420)
T ss_dssp             CEEEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTT
T ss_pred             eEEEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCcc
Confidence            3567899999999999964  467899995432211  111   012223344433332   234566666655  4667


Q ss_pred             EEEEEec-CC
Q 045787           82 FLVFEYL-DL   90 (324)
Q Consensus        82 ~iv~e~~-~g   90 (324)
                      ++|||++ +|
T Consensus       113 ~lv~e~l~~g  122 (420)
T 2pyw_A          113 LIGMRYLEPP  122 (420)
T ss_dssp             EEEECCCCTT
T ss_pred             EEEEeecCCc
Confidence            8999999 76

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.69  E-value=0.00015  Score=60.97  Aligned_cols=80  Identities=15%  Similarity=0.182  Sum_probs=57.0

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCC---CCeeEEEeeeecCCe
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEH---ENIVRLLDVQSSRKD   80 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~---~~i~~~~~~~~~~~~   80 (324)
                      +.+....-++.+|.|..+.||++.. .+|+.|++|+.....  ......+..|+..|+.+..   -.+++++.+.    .
T Consensus        12 l~G~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~   84 (288)
T 3f7w_A           12 LTGREVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDA--PALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----D   84 (288)
T ss_dssp             HHCCCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTC--CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----T
T ss_pred             hcCCCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCC--cchhhHHHHHHHHHHHHHhhCCCCcceEEecc----C
Confidence            4456677889999999999999985 478999999865432  2223567889999998852   2345555442    2


Q ss_pred             EEEEEEecCC
Q 045787           81 VFLVFEYLDL   90 (324)
Q Consensus        81 ~~iv~e~~~g   90 (324)
                      .++|||++.+
T Consensus        85 ~~lv~e~l~~   94 (288)
T 3f7w_A           85 RTLAMEWVDE   94 (288)
T ss_dssp             TEEEEECCCC
T ss_pred             ceEEEEeecc
Confidence            3689999864

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.62  E-value=0.00023  Score=62.25  Aligned_cols=138  Identities=16%  Similarity=0.205  Sum_probs=79.6

Q ss_pred             eEeecccCceEEEEEEEcc-------CCceEEEEEeeeccccCCCchHHHHHHHHHHhcC-CCCeeEEEeeeecCCeEEE
Q 045787           12 IKKIGAGGYGEVYKCRNTV-------TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-HENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus        12 ~~~Lg~g~~~~v~~a~~~~-------~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~i   83 (324)
                      ++.|..|-...+|++....       ++..+++|+....   ......+.+|..+++.+. +.-.+++++.+.+.    +
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~---~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~  127 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI---LQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----R  127 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----E
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc---cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----c
Confidence            4667778889999998642       3578999986432   122355668999998885 33345666665542    8


Q ss_pred             EEEecCC-CHH----------HHH-------HhcC----CCCC--HHHHHHHHHHHHH-------------------HHH
Q 045787           84 VFEYLDL-DLH----------SFI-------TRHK----NTLN--LLVIKAILKQILL-------------------GLA  120 (324)
Q Consensus        84 v~e~~~g-~l~----------~~~-------~~~~----~~~~--~~~~~~i~~~i~~-------------------~l~  120 (324)
                      |+||++| ++.          ..+       ....    .+..  ...+..+..++..                   .+.
T Consensus       128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~  207 (379)
T 3feg_A          128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG  207 (379)
T ss_dssp             EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred             EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence            9999986 211          001       1111    1122  2445555444321                   122


Q ss_pred             HH----Hh----CCCcccCCCCCceEeecC---CCcEEEeeccceee
Q 045787          121 YC----HS----LKILHRDLKPNNLLIDLK---RNTVKLADFGLARA  156 (324)
Q Consensus       121 ~L----h~----~g~~H~di~p~nIll~~~---~~~v~l~d~g~~~~  156 (324)
                      .|    ..    ..++|+|+.+.||+++.+   .+.+.++||+.+..
T Consensus       208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            22    22    248999999999999833   26899999997753

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.58  E-value=0.00017  Score=61.63  Aligned_cols=140  Identities=14%  Similarity=0.109  Sum_probs=77.9

Q ss_pred             ceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCC--eeEEEee------eecCCeE
Q 045787           10 KKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN--IVRLLDV------QSSRKDV   81 (324)
Q Consensus        10 ~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~------~~~~~~~   81 (324)
                      .-++.|+.|....+|++...  +..+++|......    ....+..|..+++.+...+  +++++..      ....+..
T Consensus        25 ~~~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~   98 (322)
T 2ppq_A           25 TSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP   98 (322)
T ss_dssp             EEEEEECC---EEEEEEEES--SCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred             eEeeccCCCcccceEEEEeC--CccEEEEEeCCCC----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEE
Confidence            34667888888999999754  3378999886531    1245677888888775222  3333321      1224567


Q ss_pred             EEEEEecCCCHH-----H----------HHHhcC----CC----CCHHHHHH---------------HHHHHHHHHHHHH
Q 045787           82 FLVFEYLDLDLH-----S----------FITRHK----NT----LNLLVIKA---------------ILKQILLGLAYCH  123 (324)
Q Consensus        82 ~iv~e~~~g~l~-----~----------~~~~~~----~~----~~~~~~~~---------------i~~~i~~~l~~Lh  123 (324)
                      ++++++++|...     .          .+....    .+    .....-..               +...+...+..++
T Consensus        99 ~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~  178 (322)
T 2ppq_A           99 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA  178 (322)
T ss_dssp             EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred             EEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHH
Confidence            899999987211     0          111110    01    11100000               0011333444444


Q ss_pred             h-------CCCcccCCCCCceEeecCCCcEEEeeccceee
Q 045787          124 S-------LKILHRDLKPNNLLIDLKRNTVKLADFGLARA  156 (324)
Q Consensus       124 ~-------~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~  156 (324)
                      .       .+++|+|+++.||+++ .++.+.++||+.+..
T Consensus       179 ~~~~~~~~~~liHgDl~~~Nil~~-~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          179 AHWPKDLPAGVIHADLFQDNVFFL-GDELSGLIDFYFACN  217 (322)
T ss_dssp             HHCCCSSCEEEECSCCCGGGEEEE-TTEEEEECCCTTCEE
T ss_pred             hhCcccCCcccCCCCCCccCEEEe-CCceEEEecchhccC
Confidence            2       3689999999999999 655568999987653

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.50  E-value=0.00049  Score=59.13  Aligned_cols=137  Identities=18%  Similarity=0.169  Sum_probs=71.1

Q ss_pred             eEeecccCceE-EEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCC--CCeeEEEeeeecCCeEEEEEEec
Q 045787           12 IKKIGAGGYGE-VYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEH--ENIVRLLDVQSSRKDVFLVFEYL   88 (324)
Q Consensus        12 ~~~Lg~g~~~~-v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~iv~e~~   88 (324)
                      ++.|+.|.... +|++.. .++..+++|.......     ..+..|+.+++.+..  -.+++++.+...++  ++++|++
T Consensus        23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~~-----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l   94 (333)
T 3csv_A           23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEEG-----GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDL   94 (333)
T ss_dssp             ECC--------CCEEEEC-TTCCEEEEEECCTTTT-----CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCC
T ss_pred             eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCCC-----ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeC
Confidence            45666665554 667653 2366788886543211     234567777777742  23556666543333  6899998


Q ss_pred             CC-CHHHHHHhcC-------------------------CCCCHHHHH-------H-HH------------HHHHHHHHHH
Q 045787           89 DL-DLHSFITRHK-------------------------NTLNLLVIK-------A-IL------------KQILLGLAYC  122 (324)
Q Consensus        89 ~g-~l~~~~~~~~-------------------------~~~~~~~~~-------~-i~------------~~i~~~l~~L  122 (324)
                      ++ ++.+.+....                         ..++.....       . +.            ..+...+..+
T Consensus        95 ~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l  174 (333)
T 3csv_A           95 GDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQI  174 (333)
T ss_dssp             CSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHH
T ss_pred             CCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHH
Confidence            76 4433322100                         012221110       0 00            0111122222


Q ss_pred             ------HhCCCcccCCCCCceEeecCC----CcEEEeeccceeec
Q 045787          123 ------HSLKILHRDLKPNNLLIDLKR----NTVKLADFGLARAI  157 (324)
Q Consensus       123 ------h~~g~~H~di~p~nIll~~~~----~~v~l~d~g~~~~~  157 (324)
                            +...++|||+.+.||+++ .+    +.+.++||+.+..-
T Consensus       175 ~~~~~~~~~~lvHgD~~~~Nil~~-~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          175 LSAQLEGDMVFVHRDFHAQNLLWL-PEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             HHHHCCSCCEEECSCCSGGGEEEC-TTSCGGGGEEECCCTTCEEE
T ss_pred             HHhcccCCCeeEeCCcCcccEEec-cCcCCCCCeEEEeCCCcCcC
Confidence                  234699999999999998 43    67899999987654

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.42  E-value=0.00061  Score=60.81  Aligned_cols=72  Identities=19%  Similarity=0.259  Sum_probs=49.3

Q ss_pred             eeEeecccCceEEEEEEEcc-------CCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCC-eeEEEeeeecCCeEE
Q 045787           11 KIKKIGAGGYGEVYKCRNTV-------TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN-IVRLLDVQSSRKDVF   82 (324)
Q Consensus        11 i~~~Lg~g~~~~v~~a~~~~-------~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~   82 (324)
                      -++.|+.|....+|++....       .+..+++|+....    .....+.+|..+++.+...+ .+++++.+.+    .
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~----~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g  148 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ETESHLVAESVIFTLLSERHLGPKLYGIFSG----G  148 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC----CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence            46778889999999998642       2578999987432    11144557999998885333 3566665543    2


Q ss_pred             EEEEecCC
Q 045787           83 LVFEYLDL   90 (324)
Q Consensus        83 iv~e~~~g   90 (324)
                      +|++|++|
T Consensus       149 ~v~e~l~G  156 (429)
T 1nw1_A          149 RLEEYIPS  156 (429)
T ss_dssp             EEECCCCE
T ss_pred             EEEEEeCC
Confidence            88999976

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.12  E-value=0.0048  Score=52.64  Aligned_cols=74  Identities=12%  Similarity=0.198  Sum_probs=47.8

Q ss_pred             eEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCC--eeEEEee-----eecCCeEEEE
Q 045787           12 IKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN--IVRLLDV-----QSSRKDVFLV   84 (324)
Q Consensus        12 ~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~-----~~~~~~~~iv   84 (324)
                      +..|+ |....||++... +|+.+++|.......   ....+..|..+++.+....  +++++..     ...++..+++
T Consensus        31 ~~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~---~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l  105 (328)
T 1zyl_A           31 LTPLN-SYENRVYQFQDE-DRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV  105 (328)
T ss_dssp             CEEEC-CSSSEEEEECCT-TCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred             EEeec-CcccceEEEEcC-CCCEEEEEEcCCCCC---CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence            35566 778899988643 466899999763321   2356777888888875222  3444432     1224567889


Q ss_pred             EEecCC
Q 045787           85 FEYLDL   90 (324)
Q Consensus        85 ~e~~~g   90 (324)
                      +++++|
T Consensus       106 ~~~i~G  111 (328)
T 1zyl_A          106 FPSVGG  111 (328)
T ss_dssp             EECCCC
T ss_pred             EEecCC
Confidence            999987

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.11  E-value=0.0078  Score=51.78  Aligned_cols=32  Identities=16%  Similarity=0.374  Sum_probs=27.3

Q ss_pred             CCCcccCCCCCceEeecCCCcEEEeeccceeec
Q 045787          125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAI  157 (324)
Q Consensus       125 ~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~  157 (324)
                      .+++|+|+.+.||+++ .++.+.++||+.+...
T Consensus       206 ~~~~HgD~~~~N~l~~-~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVG-NEESIYIIDWDEPMLA  237 (339)
T ss_dssp             CEEECSCCCGGGEEEC-GGGCEEECCCSSCEEE
T ss_pred             ceeEeCCCCcCCEEEe-CCCeEEEEECCCCeeC
Confidence            4589999999999998 6778999999877643

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.07  E-value=0.0032  Score=54.88  Aligned_cols=73  Identities=15%  Similarity=0.162  Sum_probs=44.4

Q ss_pred             eeEeecccCceEEEEEEEcc--------CCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCC-eeEEEeeeecCCeE
Q 045787           11 KIKKIGAGGYGEVYKCRNTV--------TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN-IVRLLDVQSSRKDV   81 (324)
Q Consensus        11 i~~~Lg~g~~~~v~~a~~~~--------~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~   81 (324)
                      -++.++.|....+|++....        .+..+++|+........   .....|..+++.+...+ ++++++..  .  -
T Consensus        37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~---~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~  109 (369)
T 3c5i_A           37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL---YNTISEFEVYKTMSKYKIAPQLLNTF--N--G  109 (369)
T ss_dssp             EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT---SCHHHHHHHHHHHHHTTSSCCEEEEE--T--T
T ss_pred             EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce---ecHHHHHHHHHHHHhcCCCCceEEec--C--C
Confidence            45678888889999998643        13689999875432211   12467888888885333 44566544  2  2


Q ss_pred             EEEEEecCC
Q 045787           82 FLVFEYLDL   90 (324)
Q Consensus        82 ~iv~e~~~g   90 (324)
                      ++|++|++|
T Consensus       110 ~~v~e~i~G  118 (369)
T 3c5i_A          110 GRIEEWLYG  118 (369)
T ss_dssp             EEEEECCCS
T ss_pred             cEEEEEecC
Confidence            689999987

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.86  E-value=0.0097  Score=53.38  Aligned_cols=74  Identities=18%  Similarity=0.178  Sum_probs=48.7

Q ss_pred             ceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCe-eEEEeeeecCCeEEEEEEec
Q 045787           10 KKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI-VRLLDVQSSRKDVFLVFEYL   88 (324)
Q Consensus        10 ~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~iv~e~~   88 (324)
                      .-++.|+.|....+|++.....+..+++|+.....  ... -...+|..+++.+...++ +++++.+.  +.  .|++|+
T Consensus       111 ~~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~--~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~G--~v~e~I  183 (458)
T 2qg7_A          111 LEFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT--DEI-INREREKKISCILYNKNIAKKIYVFFT--NG--RIEEFM  183 (458)
T ss_dssp             EEEEEECC--CEEEEEEEETTTTEEEEEEEECC-C--CSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--TE--EEEECC
T ss_pred             eEEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh--hhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--Ce--EEEEee
Confidence            34678888999999999875445789999875432  111 123689999999975444 56676663  22  599999


Q ss_pred             CC
Q 045787           89 DL   90 (324)
Q Consensus        89 ~g   90 (324)
                      +|
T Consensus       184 ~G  185 (458)
T 2qg7_A          184 DG  185 (458)
T ss_dssp             CS
T ss_pred             CC
Confidence            76

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.68  E-value=0.0089  Score=52.99  Aligned_cols=73  Identities=10%  Similarity=0.080  Sum_probs=48.5

Q ss_pred             eeEeecccCceEEEEEEEccC-------CceEEEEEeeeccccCCCchHHHHHHHHHHhcC-CCCeeEEEeeeecCCeEE
Q 045787           11 KIKKIGAGGYGEVYKCRNTVT-------GQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-HENIVRLLDVQSSRKDVF   82 (324)
Q Consensus        11 i~~~Lg~g~~~~v~~a~~~~~-------~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~   82 (324)
                      -++.+..|-...+|++.....       +..+++|+.......   .-...+|..+++.+. +.-.+++++.+.  +  +
T Consensus        74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~---~idR~~E~~~l~~L~~~gi~P~l~~~~~--~--~  146 (424)
T 3mes_A           74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK---FYDSKVELDVFRYLSNINIAPNIIADFP--E--G  146 (424)
T ss_dssp             EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C---CCCHHHHHHHHHHHHHTTSSCCEEEEET--T--E
T ss_pred             EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch---hcCHHHHHHHHHHHHhcCCCCCEEEEcC--C--C
Confidence            466778888999999986521       578999987543211   123467888888885 333455565432  2  6


Q ss_pred             EEEEecCC
Q 045787           83 LVFEYLDL   90 (324)
Q Consensus        83 iv~e~~~g   90 (324)
                      .|++|++|
T Consensus       147 ~I~efI~G  154 (424)
T 3mes_A          147 RIEEFIDG  154 (424)
T ss_dssp             EEEECCCS
T ss_pred             EEEEEeCC
Confidence            88999987

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=96.19  E-value=0.022  Score=50.20  Aligned_cols=30  Identities=23%  Similarity=0.389  Sum_probs=25.1

Q ss_pred             CcccCCCCCceEeec-----CCCcEEEeeccceee
Q 045787          127 ILHRDLKPNNLLIDL-----KRNTVKLADFGLARA  156 (324)
Q Consensus       127 ~~H~di~p~nIll~~-----~~~~v~l~d~g~~~~  156 (324)
                      ++|+|+.+.||++..     +++.+.++||..+..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            689999999999941     457799999998764

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=88.63  E-value=1.1  Score=35.27  Aligned_cols=114  Identities=12%  Similarity=0.054  Sum_probs=74.0

Q ss_pred             CCCCeeEEEeeeecCCeEEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecC
Q 045787           64 EHENIVRLLDVQSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK  142 (324)
Q Consensus        64 ~~~~i~~~~~~~~~~~~~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~  142 (324)
                      .+|+++.. .+-.+++.+.+.++.-+ +.....+.    ..+....++++.+|+....++++  -.|--++|+|++++ .
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik----~~~~~eKlr~l~ni~~l~~~~~~--r~tf~L~P~NL~f~-~  114 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK----SFTKNEKLRYLLNIKNLEEVNRT--RYTFVLAPDELFFT-R  114 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG----GSCHHHHHHHHHHGGGGGGGGGS--SEECCCSGGGEEEC-T
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH----hcCHHHHHHHHHHHHHHHHHhcC--ceEEEEecceEEEc-C
Confidence            57888766 45555666555555443 22222222    37888899999999887744433  36888999999999 9


Q ss_pred             CCcEEEeeccceeeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCC
Q 045787          143 RNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF  208 (324)
Q Consensus       143 ~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf  208 (324)
                      ++.+++.--|....+                 +|.      ..+...=.-..=|++..+++++..|
T Consensus       115 ~~~p~i~~RGik~~l-----------------~P~------~~~ee~fL~qyKAliiall~~K~~F  157 (215)
T 4ann_A          115 DGLPIAKTRGLQNVV-----------------DPL------PVSEAEFLTRYKALVICAFNEKQSF  157 (215)
T ss_dssp             TSCEEESCCEETTTB-----------------SCC------CCCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred             CCCEEEEEccCccCC-----------------CCC------CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence            999998877643321                 221      1122223334777888999988777

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=86.62  E-value=2  Score=33.99  Aligned_cols=113  Identities=15%  Similarity=0.156  Sum_probs=72.9

Q ss_pred             CCCCeeEEEeeeecCCeEEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHH-HHHhCCCcccCCCCCceEeec
Q 045787           64 EHENIVRLLDVQSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLA-YCHSLKILHRDLKPNNLLIDL  141 (324)
Q Consensus        64 ~~~~i~~~~~~~~~~~~~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~-~Lh~~g~~H~di~p~nIll~~  141 (324)
                      .||++  -..+-.+++.+.+.++.-. +.....+.    ..+....++++.+|+.... ++  ..-.|--++|+|++++ 
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~----~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~-  118 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR----KTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFN-  118 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH----TSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEEC-
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH----hcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEe-
Confidence            57777  3334466677777666654 33333333    3788888888888887654 33  3457888999999999 


Q ss_pred             CCCcEEEeeccceeeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCC
Q 045787          142 KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF  208 (324)
Q Consensus       142 ~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf  208 (324)
                      .++.+++.-.|....                 ++|.      ..+...=.-+.=|++..++.++..|
T Consensus       119 ~~~~p~i~hRGi~~~-----------------lpP~------e~~ee~fl~qyKali~all~~K~~F  162 (219)
T 4ano_A          119 RALEPFFLHVGVKES-----------------LPPD------EWDDERLLREVKATVLALTEGEYRF  162 (219)
T ss_dssp             TTCCEEESCCEETTT-----------------BSSC------SCCHHHHHHHHHHHHHHHTTCSSCH
T ss_pred             CCCcEEEEEcCCccc-----------------CCCC------CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence            999999988775432                 2221      1122222234667888888887665

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	324
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	6e-83
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	7e-83
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	6e-81
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	9e-79
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-77
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	7e-77
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	8e-75
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	9e-74
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-73
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-72
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	4e-72
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-71
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-70
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-70
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-69
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-69
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-68
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	4e-68
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-67
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	4e-66
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-65
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-64
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-63
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	5e-63
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-62
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-62
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	4e-60
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-59
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	6e-59
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-58
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-58
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-57
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-56
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-55
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-54
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-51
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	4e-51
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	5e-51
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-50
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-50
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-50
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-50
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	5e-49
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	7e-49
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-48
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-48
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	6e-48
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-47
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-47
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-47
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-47
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-47
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-46
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-46
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-45
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-44
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-44
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	7e-43
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	7e-41
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-40
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-40
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	4e-39
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	8e-25

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  250 bits (639), Expect = 6e-83
 Identities = 133/284 (46%), Positives = 187/284 (65%), Gaps = 3/284 (1%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y  ++KIG G YG VYK +N   G+  A+K + ++ E EG+PS  IRE+S+LKEL+H N
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
           IV+L DV  ++K + LVFE+LD DL   +   +  L  +  K+ L Q+L G+AYCH  ++
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV 121

Query: 128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYST 187
           LHRDLKP NLLI+ +   +K+ADFGLARA G+P ++Y+ + V   Y+AP++L+G   YST
Sbjct: 122 LHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180

Query: 188 PIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPH 246
            ID+W+VGCIFAEM+ G PLFP     D L  IF +LGTP  ++W   T + +  P +  
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240

Query: 247 FEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           +EP         L+ +G+DLLS+ML L+P QRITA  AL+H Y 
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  250 bits (640), Expect = 7e-83
 Identities = 140/285 (49%), Positives = 189/285 (66%), Gaps = 3/285 (1%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
           N++K++KIG G YG VYK RN +TG+ VA+K + + TE EGVPS  IRE+SLLKEL H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNT-LNLLVIKAILKQILLGLAYCHSLK 126
           IV+LLDV  +   ++LVFE+L  DL  F+     T + L +IK+ L Q+L GLA+CHS +
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122

Query: 127 ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYS 186
           +LHRDLKP NLLI+     +KLADFGLARA GVP + Y+ + V   Y+APE+LLG   YS
Sbjct: 123 VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181

Query: 187 TPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYP 245
           T +D+W++GCIFAEM+T + LFP     D L  IF  LGTP +  W   T + +  P +P
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241

Query: 246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            +   + ++  P L+  G  LLSQML  +P +RI+A  AL H + 
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  245 bits (627), Expect = 6e-81
 Identities = 111/284 (39%), Positives = 155/284 (54%), Gaps = 6/284 (2%)

Query: 11  KIKKIGAGGYGEVYKCRNTVTGQKVAIKMM---TIQTEQEGVPSYIIREVSLLKELEHEN 67
           K+  +G G +  VYK R+  T Q VAIK +        ++G+    +RE+ LL+EL H N
Sbjct: 2   KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPN 61

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
           I+ LLD    + ++ LVF++++ DL   I  +   L    IKA +   L GL Y H   I
Sbjct: 62  IIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWI 121

Query: 128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYST 187
           LHRDLKPNNLL+D +   +KLADFGLA++ G P + Y+   V   Y+APELL G   Y  
Sbjct: 122 LHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGV 180

Query: 188 PIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYPH 246
            +D+WAVGCI AE++   P  P     D L+ IF  LGTPT+E W +   + + +  +  
Sbjct: 181 GVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV-TFKS 239

Query: 247 FEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           F    L   F       +DL+  +   NP  RITA  ALK +Y 
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 283

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  240 bits (612), Expect = 9e-79
 Identities = 131/285 (45%), Positives = 177/285 (62%), Gaps = 3/285 (1%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y+K++KIG G YG V+K +N  T + VA+K + +  + EGVPS  +RE+ LLKEL+H+N
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
           IVRL DV  S K + LVFE+ D DL  +       L+  ++K+ L Q+L GL +CHS  +
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNV 122

Query: 128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYST 187
           LHRDLKP NLLI+ +   +KLA+FGLARA G+P + YS + V   Y+ P++L G   YST
Sbjct: 123 LHRDLKPQNLLIN-RNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181

Query: 188 PIDVWAVGCIFAEMITGK-PLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLYP 245
            ID+W+ GCIFAE+     PLFP     D L  IF LLGTPT+E W   T + +  P   
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241

Query: 246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
           +    +L    P L   G DLL  +L  NP QRI+A +AL+H Y 
Sbjct: 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  237 bits (605), Expect = 3e-77
 Identities = 73/304 (24%), Positives = 131/304 (43%), Gaps = 22/304 (7%)

Query: 4   LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL 63
           LK+ +++KI ++GAG  G V+K  +  +G  +A K++ ++  +  + + IIRE+ +L E 
Sbjct: 3   LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHEC 61

Query: 64  EHENIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCH 123
               IV       S  ++ +  E++D      + +    +   ++  +   ++ GL Y  
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121

Query: 124 S-LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGY 182
              KI+HRD+KP+N+L++  R  +KL DFG++  +       +       Y +PE L G 
Sbjct: 122 EKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQL--IDSMANSFVGTRSYMSPERLQG- 177

Query: 183 TGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIF------SLLGTPTDESWAESTY 236
           T YS   D+W++G    EM  G+   P      L L+F          TP          
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237

Query: 237 ISEILPLYPHFEPANLAEKFPNLEP----------AGVDLLSQMLCLNPKQRITAMDALK 286
            S  +   P      L +   N  P             D +++ L  NP +R      + 
Sbjct: 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297

Query: 287 HEYL 290
           H ++
Sbjct: 298 HAFI 301

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  237 bits (605), Expect = 7e-77
 Identities = 95/300 (31%), Positives = 151/300 (50%), Gaps = 19/300 (6%)

Query: 2   GKLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLK 61
            + + ++Y   K IG G +G VY+ +   +G+ VAIK +           +  RE+ +++
Sbjct: 15  DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMR 68

Query: 62  ELEHENIVRLLDV------QSSRKDVFLVFEYLD---LDLHSFITRHKNTLNLLVIKAIL 112
           +L+H NIVRL         +     + LV +Y+      +    +R K TL ++ +K  +
Sbjct: 69  KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 128

Query: 113 KQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP 172
            Q+   LAY HS  I HRD+KP NLL+D     +KL DFG A+ +   +   S       
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRY 187

Query: 173 YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESW 231
           Y+APEL+ G T Y++ IDVW+ GC+ AE++ G+P+FP     D L  I  +LGTPT E  
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247

Query: 232 AESTYISEILPLYPHFEPANLAEKF-PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            E    +     +P  +     + F P   P  + L S++L   P  R+T ++A  H + 
Sbjct: 248 REMNP-NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  230 bits (588), Expect = 8e-75
 Identities = 107/299 (35%), Positives = 161/299 (53%), Gaps = 17/299 (5%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y+K+ KIG G +GEV+K R+  TGQKVA+K + ++ E+EG P   +RE+ +L+ L+HEN
Sbjct: 11  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70

Query: 68  IVRLLDV--------QSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGL 119
           +V L+++           +  ++LVF++ + DL   ++       L  IK +++ +L GL
Sbjct: 71  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL 130

Query: 120 AYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRD----CVYSPYKA 175
            Y H  KILHRD+K  N+LI  +   +KLADFGLARA  + +           V   Y+ 
Sbjct: 131 YYIHRNKILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189

Query: 176 PELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAES 234
           PELLLG   Y  PID+W  GCI AEM T  P+         L+LI  L G+ T E W   
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNV 249

Query: 235 T---YISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                  ++  +           K    +P  +DL+ ++L L+P QRI + DAL H++ 
Sbjct: 250 DNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 308

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  229 bits (584), Expect = 9e-74
 Identities = 62/286 (21%), Positives = 120/286 (41%), Gaps = 32/286 (11%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
           +Y   +++G G +G V++     TG   A K +    E +     + +E+  +  L H  
Sbjct: 27  HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD--KETVRKEIQTMSVLRHPT 84

Query: 68  IVRLLDVQSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
           +V L D      ++ +++E++   +L   +    N ++       ++Q+  GL + H   
Sbjct: 85  LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 144

Query: 127 ILHRDLKPNNLLIDLKRN-TVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGY 185
            +H DLKP N++   KR+  +KL DFGL   +  P++        + + APE+  G    
Sbjct: 145 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD-PKQSVKVTTGTAEFAAPEVAEG-KPV 202

Query: 186 STPIDVWAVGCIFAEMITGKPLFPSKKHDH-LSLIFSLLGTPTDESWAESTYISEILPLY 244
               D+W+VG +   +++G   F  +  D  L  + S      D ++             
Sbjct: 203 GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF------------- 249

Query: 245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                         +   G D + ++L  +P  R+T   AL+H +L
Sbjct: 250 ------------SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWL 283

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  228 bits (581), Expect = 2e-73
 Identities = 104/293 (35%), Positives = 147/293 (50%), Gaps = 15/293 (5%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           Y  +  IG G YG V    + V   +VAIK ++   E +      +RE+ +L    HENI
Sbjct: 10  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILLRFRHENI 68

Query: 69  VRLLDVQSS-----RKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCH 123
           + + D+  +      KDV+LV   +  DL+  +      L+   I   L QIL GL Y H
Sbjct: 69  IGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL--KTQHLSNDHICYFLYQILRGLKYIH 126

Query: 124 SLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRD---CVYSPYKAPELLL 180
           S  +LHRDLKP+NLL++     +K+ DFGLAR                    Y+APE++L
Sbjct: 127 SANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185

Query: 181 GYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTY--I 237
              GY+  ID+W+VGCI AEM++ +P+FP K + D L+ I  +LG+P+ E          
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 245

Query: 238 SEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
              L   PH         FPN +   +DLL +ML  NP +RI    AL H YL
Sbjct: 246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 298

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  223 bits (569), Expect = 3e-72
 Identities = 74/303 (24%), Positives = 125/303 (41%), Gaps = 37/303 (12%)

Query: 5   KNLN----YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLL 60
           ++LN    ++ I ++G G +G+VYK +N  T    A K++  ++E+E      + E+ +L
Sbjct: 6   RDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE--LEDYMVEIDIL 63

Query: 61  KELEHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGL 119
              +H NIV+LLD      +++++ E+     + + +   +  L    I+ + KQ L  L
Sbjct: 64  ASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDAL 123

Query: 120 AYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELL 179
            Y H  KI+HRDLK  N+L       +KLADFG++       +          + APE++
Sbjct: 124 NYLHDNKIIHRDLKAGNILFT-LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVV 182

Query: 180 LGYT----GYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAEST 235
           +  T     Y    DVW++G    EM   +P                             
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM--------------------- 221

Query: 236 YISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVEN 295
               +L      EP  L  +         D L + L  N   R T    L+H ++    N
Sbjct: 222 ---RVLLKIAKSEPPTL-AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSN 277

Query: 296 VPL 298
            P+
Sbjct: 278 KPI 280

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  224 bits (573), Expect = 4e-72
 Identities = 63/305 (20%), Positives = 133/305 (43%), Gaps = 32/305 (10%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y  ++++G+G +G V++C    TG+    K +      +     +  E+S++ +L H  
Sbjct: 30  YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD--KYTVKNEISIMNQLHHPK 87

Query: 68  IVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
           ++ L D    + ++ L+ E+L   +L   I      ++   +   ++Q   GL + H   
Sbjct: 88  LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 147

Query: 127 ILHRDLKPNNLLIDLKRN-TVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGY 185
           I+H D+KP N++ + K+  +VK+ DFGLA  +  P +        + + APE++      
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKLN-PDEIVKVTTATAEFAAPEIVDR-EPV 205

Query: 186 STPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTYISEILPLY 244
               D+WA+G +   +++G   F  +   + L  +        ++++             
Sbjct: 206 GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF------------- 252

Query: 245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLIN 304
                        ++ P   D +  +L   P++R+T  DAL+H +L G  +     +  +
Sbjct: 253 ------------SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSS 300

Query: 305 RKKKL 309
           R  K+
Sbjct: 301 RYNKI 305

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  223 bits (569), Expect = 1e-71
 Identities = 107/291 (36%), Positives = 154/291 (52%), Gaps = 15/291 (5%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           Y+ ++ +G+G YG V    +  TG KVAIK +    + E       RE+ LLK + HEN+
Sbjct: 20  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79

Query: 69  VRLLDVQSSRK------DVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYC 122
           + LLDV +  +      D +LV  ++  DL   +   K  L    I+ ++ Q+L GL Y 
Sbjct: 80  IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK--LGEDRIQFLVYQMLKGLRYI 137

Query: 123 HSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGY 182
           H+  I+HRDLKP NL ++ +   +K+ DFGLAR       E +   V   Y+APE++L +
Sbjct: 138 HAAGIIHRDLKPGNLAVN-EDCELKILDFGLARQAD---SEMTGYVVTRWYRAPEVILNW 193

Query: 183 TGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAE--STYISE 239
             Y+  +D+W+VGCI AEMITGK LF    H D L  I  + GTP  E      S     
Sbjct: 194 MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN 253

Query: 240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
            +   P  E  + A    N  P  V+LL +ML L+ +QR+TA +AL H Y 
Sbjct: 254 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 304

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (557), Expect = 1e-70
 Identities = 77/285 (27%), Positives = 130/285 (45%), Gaps = 29/285 (10%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
           ++  ++ +G G YGEV    N VT + VA+K++ ++   +  P  I +E+ + K L HEN
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHEN 64

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
           +V+    +      +L  EY               +     +    Q++ G+ Y H + I
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 124

Query: 128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE--YSRDCVYSPYKAPELLLGYTGY 185
            HRD+KP NLL+D +R+ +K++DFGLA       +E   ++ C   PY APELL     +
Sbjct: 125 THRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183

Query: 186 STPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYP 245
           + P+DVW+ G +   M+ G+  +                 P+D     S +  +   L P
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELPWDQ---------------PSDSCQEYSDWKEKKTYLNP 228

Query: 246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                     +  ++ A + LL ++L  NP  RIT  D  K  + 
Sbjct: 229 ----------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWY 263

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (557), Expect = 2e-70
 Identities = 77/301 (25%), Positives = 144/301 (47%), Gaps = 30/301 (9%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y + +KIG G  G VY   +  TGQ+VAI+ M +Q + +     II E+ +++E ++ N
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPN 78

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
           IV  LD      ++++V EYL     + +   +  ++   I A+ ++ L  L + HS ++
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDV-VTETCMDEGQIAAVCRECLQALEFLHSNQV 137

Query: 128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYST 187
           +HRD+K +N+L+     +VKL DFG    I   Q + S       + APE++     Y  
Sbjct: 138 IHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGP 195

Query: 188 PIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPHF 247
            +D+W++G +  EMI G+P + ++       + +  GTP  ++                 
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP---------------- 239

Query: 248 EPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLINRKK 307
                      L     D L++ L ++ ++R +A + L+H++L   + +  +  LI   K
Sbjct: 240 ---------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAK 290

Query: 308 K 308
           +
Sbjct: 291 E 291

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (550), Expect = 1e-69
 Identities = 71/284 (25%), Positives = 125/284 (44%), Gaps = 33/284 (11%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTI-QTEQEGVPSYIIREVSLLKELEHE 66
           +++  + +G G +G VY  R   +   +A+K++   Q E+ GV   + REV +   L H 
Sbjct: 7   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66

Query: 67  NIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
           NI+RL         V+L+ EY  L       +  +  +       + ++   L+YCHS +
Sbjct: 67  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 126

Query: 127 ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYS 186
           ++HRD+KP NLL+      +K+ADFG +     P    +  C    Y  PE++ G   + 
Sbjct: 127 VIHRDIKPENLLLG-SAGELKIADFGWSVHA--PSSRRTTLCGTLDYLPPEMIEG-RMHD 182

Query: 187 TPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPH 246
             +D+W++G +  E + GKP F +  +                       IS +   +P 
Sbjct: 183 EKVDLWSLGVLCYEFLVGKPPFEANTYQET-----------------YKRISRVEFTFP- 224

Query: 247 FEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                       +     DL+S++L  NP QR    + L+H ++
Sbjct: 225 ----------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (553), Expect = 2e-69
 Identities = 61/286 (21%), Positives = 127/286 (44%), Gaps = 33/286 (11%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y   + +G G +G V++C  T + +    K + ++   +     + +E+S+L    H N
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ---VLVKKEISILNIARHRN 62

Query: 68  IVRLLDVQSSRKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
           I+ L +   S +++ ++FE++  LD+   I      LN   I + + Q+   L + HS  
Sbjct: 63  ILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN 122

Query: 127 ILHRDLKPNNLLIDLKRN-TVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGY 185
           I H D++P N++   +R+ T+K+ +FG AR +             +P      +  +   
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT--APEYYAPEVHQHDVV 180

Query: 186 STPIDVWAVGCIFAEMITGKPLFPSKKHDH-LSLIFSLLGTPTDESWAESTYISEILPLY 244
           ST  D+W++G +   +++G   F ++ +   +  I +   T  +E++             
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF------------- 227

Query: 245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                         +    +D + ++L    K R+TA +AL+H +L
Sbjct: 228 ------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (550), Expect = 1e-68
 Identities = 106/292 (36%), Positives = 156/292 (53%), Gaps = 15/292 (5%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y+ +  +G+G YG V    +T TG +VA+K ++   +         RE+ LLK ++HEN
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 78

Query: 68  IVRLLDVQSSRK------DVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAY 121
           ++ LLDV +  +      DV+LV   +  DL++ +   K  L    ++ ++ QIL GL Y
Sbjct: 79  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKY 136

Query: 122 CHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLG 181
            HS  I+HRDLKP+NL ++ +   +K+ DFGLAR        Y        Y+APE++L 
Sbjct: 137 IHSADIIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLN 192

Query: 182 YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAE--STYIS 238
           +  Y+  +D+W+VGCI AE++TG+ LFP   H D L LI  L+GTP  E   +  S    
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252

Query: 239 EILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
             +         N A  F    P  VDLL +ML L+  +RITA  AL H Y 
Sbjct: 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (542), Expect = 4e-68
 Identities = 106/300 (35%), Positives = 164/300 (54%), Gaps = 16/300 (5%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVT-GQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL--- 63
            Y+ + +IG G YG+V+K R+    G+ VA+K + +QT +EG+P   IREV++L+ L   
Sbjct: 8   QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67

Query: 64  EHENIVRLLDVQSSRKD-----VFLVFEYLDLDLHSFITRHKN-TLNLLVIKAILKQILL 117
           EH N+VRL DV +  +      + LVFE++D DL +++ +     +    IK ++ Q+L 
Sbjct: 68  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 127

Query: 118 GLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPE 177
           GL + HS +++HRDLKP N+L+      +KLADFGLAR         S   V + +    
Sbjct: 128 GLDFLHSHRVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTS--VVVTLWYRAP 184

Query: 178 LLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTY 236
            +L  + Y+TP+D+W+VGCIFAEM   KPLF      D L  I  ++G P +E W     
Sbjct: 185 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 244

Query: 237 ISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENV 296
           +      +       + +   +++  G DLL + L  NP +RI+A  AL H Y   +E  
Sbjct: 245 LPR--QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC 302

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  212 bits (540), Expect = 1e-67
 Identities = 77/303 (25%), Positives = 129/303 (42%), Gaps = 34/303 (11%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQ-EGVPSYIIREVSLLKELEHEN 67
           +  +++IG G +G VY  R+    + VAIK M+   +Q       II+EV  L++L H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
            ++           +LV EY        +  HK  L  + I A+    L GLAY HS  +
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136

Query: 128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLG--YTGY 185
           +HRD+K  N+L+  +   VKL DFG A  +       +       + APE++L      Y
Sbjct: 137 IHRDVKAGNILLS-EPGLVKLGDFGSASIM----APANSFVGTPYWMAPEVILAMDEGQY 191

Query: 186 STPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYP 245
              +DVW++G    E+   KP   +   + +S ++ +                      P
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNM--NAMSALYHIAQNE-----------------SP 232

Query: 246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLINR 305
             +  + +E F        + +   L   P+ R T+   LKH +++      +++ LI R
Sbjct: 233 ALQSGHWSEYF-------RNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQR 285

Query: 306 KKK 308
            K 
Sbjct: 286 TKD 288

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (527), Expect = 4e-66
 Identities = 75/294 (25%), Positives = 127/294 (43%), Gaps = 40/294 (13%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
           +Y+ +  IG G YG   K R    G+ +  K +   +  E     ++ EV+LL+EL+H N
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 68  IVRLLDVQSSRKD--VFLVFEYLDL-DLHSFITRH---KNTLNLLVIKAILKQILLGLAY 121
           IVR  D    R +  +++V EY +  DL S IT+    +  L+   +  ++ Q+ L L  
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124

Query: 122 CHSL-----KILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAP 176
           CH        +LHRDLKP N+ +D  +  VKL DFGLAR +               Y +P
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183

Query: 177 ELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY 236
           E +     Y+   D+W++GC+  E+    P F +     L                    
Sbjct: 184 EQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL-------------------- 222

Query: 237 ISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
             +I        P   +++         +++++ML L    R +  + L++  +
Sbjct: 223 AGKIREGKFRRIPYRYSDEL-------NEIITRMLNLKDYHRPSVEEILENPLI 269

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  207 bits (528), Expect = 1e-65
 Identities = 90/300 (30%), Positives = 154/300 (51%), Gaps = 24/300 (8%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHE 66
           +Y+ ++K+G G Y EV++  N    +KV +K++    +++     I RE+ +L+ L    
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK-----IKREIKILENLRGGP 90

Query: 67  NIVRLLDV--QSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCH 123
           NI+ L D+      +   LVFE+++  D          TL    I+  + +IL  L YCH
Sbjct: 91  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH 146

Query: 124 SLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYT 183
           S+ I+HRD+KP+N++ID +   ++L D+GLA     P +EY+       +K PELL+ Y 
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLVDYQ 205

Query: 184 GYSTPIDVWAVGCIFAEMITGK-PLFPSKKH-DHLSLIFSLLGTPTDESWAE------ST 235
            Y   +D+W++GC+ A MI  K P F    + D L  I  +LGT     + +        
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 265

Query: 236 YISEILPLYPH--FEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
             ++IL  +    +E    +E    + P  +D L ++L  + + R+TA +A++H Y   V
Sbjct: 266 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  203 bits (517), Expect = 1e-64
 Identities = 74/297 (24%), Positives = 137/297 (46%), Gaps = 41/297 (13%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQT-------EQEGVPSYIIREVSLL 60
           NY+  + +G G    V +C +  T ++ A+K++ +         E + +    ++EV +L
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 61  KEL-EHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLG 118
           +++  H NI++L D   +    FLVF+ +   +L  ++T    TL+    + I++ +L  
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEV 122

Query: 119 LAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPEL 178
           +   H L I+HRDLKP N+L+D     +KL DFG +  +  P ++    C    Y APE+
Sbjct: 123 ICALHKLNIVHRDLKPENILLD-DDMNIKLTDFGFSCQLD-PGEKLREVCGTPSYLAPEI 180

Query: 179 LLG-----YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAE 233
           +       + GY   +D+W+ G I   ++ G P F  +K   +                 
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM----------------- 223

Query: 234 STYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
              +  I+     F       ++ +      DL+S+ L + P++R TA +AL H + 
Sbjct: 224 ---LRMIMSGNYQFGS----PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  200 bits (510), Expect = 3e-63
 Identities = 73/287 (25%), Positives = 127/287 (44%), Gaps = 31/287 (10%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           Y     +G G + EV    +  T + VAIK +  +   EG    +  E+++L +++H NI
Sbjct: 11  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKK-ALEGKEGSMENEIAVLHKIKHPNI 69

Query: 69  VRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
           V L D+  S   ++L+ + +   +L   I   K          ++ Q+L  + Y H L I
Sbjct: 70  VALDDIYESGGHLYLIMQLVSGGELFDRI-VEKGFYTERDASRLIFQVLDAVKYLHDLGI 128

Query: 128 LHRDLKPNNLLIDL--KRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGY 185
           +HRDLKP NLL     + + + ++DFGL++    P    S  C    Y APE+L     Y
Sbjct: 129 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMED-PGSVLSTACGTPGYVAPEVLAQ-KPY 186

Query: 186 STPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYP 245
           S  +D W++G I   ++ G P F  +    L                      +IL    
Sbjct: 187 SKAVDCWSIGVIAYILLCGYPPFYDENDAKL--------------------FEQILKAEY 226

Query: 246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIG 292
            F+       + ++  +  D +  ++  +P++R T   AL+H ++ G
Sbjct: 227 EFDS----PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (508), Expect = 5e-63
 Identities = 79/294 (26%), Positives = 135/294 (45%), Gaps = 35/294 (11%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMM----TIQTEQEGVPSYIIREVSLLKELE 64
           Y   +++G+G +  V KCR   TG + A K +    T  + +      I REVS+LKE++
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71

Query: 65  HENIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
           H N++ L +V  ++ DV L+ E +           K +L        LKQIL G+ Y HS
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 131

Query: 125 LKILHRDLKPNNLLID---LKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLG 181
           L+I H DLKP N+++    + +  +K+ DFGLA  I     E+        + APE++  
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-FGNEFKNIFGTPEFVAPEIVN- 189

Query: 182 YTGYSTPIDVWAVGCIFAEMITGKPLFPSK-KHDHLSLIFSLLGTPTDESWAESTYISEI 240
           Y       D+W++G I   +++G   F    K + L+ + ++     DE +         
Sbjct: 190 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF--------- 240

Query: 241 LPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVE 294
                            N      D + ++L  +PK+R+T  D+L+H ++   +
Sbjct: 241 ----------------SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 278

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 2e-62
 Identities = 62/286 (21%), Positives = 116/286 (40%), Gaps = 33/286 (11%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQ-TEQEGVPSYIIREVSLLKELEHE 66
           ++K  K +G G +  V   R   T ++ AIK++  +   +E    Y+ RE  ++  L+H 
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 67  NIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
             V+L       + ++    Y          R   + +    +    +I+  L Y H   
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 128

Query: 127 ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCV--YSPYKAPELLLGYTG 184
           I+HRDLKP N+L++ +   +++ DFG A+ +    K+   +     + Y +PELL     
Sbjct: 129 IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK-S 186

Query: 185 YSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLY 244
                D+WA+GCI  +++ G P F +     +                      +I+ L 
Sbjct: 187 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI--------------------FQKIIKLE 226

Query: 245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
             F             P   DL+ ++L L+  +R+   +   +  L
Sbjct: 227 YDFP--------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPL 264

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 2e-62
 Identities = 65/289 (22%), Positives = 113/289 (39%), Gaps = 37/289 (12%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
            K   +IG G +  VYK  +T T  +VA   +  +   +        E  +LK L+H NI
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70

Query: 69  VRLLDV----QSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
           VR  D        +K + LV E +         +    + + V+++  +QIL GL + H+
Sbjct: 71  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 130

Query: 125 LK--ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLG 181
               I+HRDLK +N+ I     +VK+ D GLA    + +  +++  + +P + APE+   
Sbjct: 131 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT---LKRASFAKAVIGTPEFMAPEMYEE 187

Query: 182 YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEIL 241
              Y   +DV+A G    EM T +  +                    E    +     + 
Sbjct: 188 --KYDESVDVYAFGMCMLEMATSEYPYS-------------------ECQNAAQIYRRVT 226

Query: 242 PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL 290
                              P   +++   +  N  +R +  D L H + 
Sbjct: 227 SGVKPASFD------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 4e-60
 Identities = 98/303 (32%), Positives = 156/303 (51%), Gaps = 26/303 (8%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
            Y+ +K IG+G  G V    + V  + VAIK ++   + +       RE+ L+K + H+N
Sbjct: 18  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77

Query: 68  IVRLLDVQSSRK------DVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAY 121
           I+ LL+V + +K      DV+LV E +D +L   I       +   +  +L Q+L G+ +
Sbjct: 78  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL---DHERMSYLLYQMLCGIKH 134

Query: 122 CHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLG 181
            HS  I+HRDLKP+N+++     T+K+ DFGLAR  G      +   V   Y+APE++LG
Sbjct: 135 LHSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFM-MTPYVVTRYYRAPEVILG 192

Query: 182 YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAESTY-ISE 239
             GY   +D+W+VGCI  EM+  K LFP + + D  + +   LGTP  E   +    +  
Sbjct: 193 M-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251

Query: 240 ILPLYPHFEPANLAEKFPN------------LEPAGVDLLSQMLCLNPKQRITAMDALKH 287
            +   P +      + FP+                  DLLS+ML ++P +RI+  DAL+H
Sbjct: 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311

Query: 288 EYL 290
            Y+
Sbjct: 312 PYI 314

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  192 bits (488), Expect = 3e-59
 Identities = 59/296 (19%), Positives = 116/296 (39%), Gaps = 37/296 (12%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMM----TIQTEQEGVPSYIIREVSLLKEL 63
           ++   + IG GG+GEVY CR   TG+  A+K +        + E +       +SL+   
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64

Query: 64  EHENIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCH 123
           +   IV +     +   +  + + ++     +        +   ++    +I+LGL + H
Sbjct: 65  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 124

Query: 124 SLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYT 183
           +  +++RDLKP N+L+D +   V+++D GLA      +   S       Y APE+L    
Sbjct: 125 NRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHASVGTHG--YMAPEVLQKGV 181

Query: 184 GYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPL 243
            Y +  D +++GC+  +++ G   F   K      I  +  T   E              
Sbjct: 182 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP------------ 229

Query: 244 YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRIT-----AMDALKHEYLIGVE 294
                         +  P    LL  +L  +  +R+      A +  +  +   ++
Sbjct: 230 -------------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 272

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 6e-59
 Identities = 72/290 (24%), Positives = 127/290 (43%), Gaps = 35/290 (12%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMM--TIQTEQEGVPSYIIREVSLLKELEH 65
           ++   K +G G +G+V+      T Q  AIK +   +    + V   ++ +  L    EH
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 66  ENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS 124
             +  +     +++++F V EYL+  DL   I +  +  +L        +I+LGL + HS
Sbjct: 63  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI-QSCHKFDLSRATFYAAEIILGLQFLHS 121

Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTG 184
             I++RDLK +N+L+D K   +K+ADFG+ +   +   + +  C    Y APE+LLG   
Sbjct: 122 KGIVYRDLKLDNILLD-KDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG-QK 179

Query: 185 YSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLY 244
           Y+  +D W+ G +  EM+ G+  F  +  + L                    I    P Y
Sbjct: 180 YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL-----------------FHSIRMDNPFY 222

Query: 245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK-HEYLIGV 293
           P             LE    DLL ++    P++R+     ++ H     +
Sbjct: 223 P-----------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 1e-58
 Identities = 61/285 (21%), Positives = 120/285 (42%), Gaps = 32/285 (11%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
                ++IG+G +G VYK +       VA+KM+ +             EV +L++  H N
Sbjct: 9   QITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65

Query: 68  IVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
           I+  +   ++   + +V ++ +   L+  +   +    ++ +  I +Q   G+ Y H+  
Sbjct: 66  ILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 124

Query: 127 ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP--YKAPELLLG--Y 182
           I+HRDLK NN+ +  +  TVK+ DFGLA         +  + +     + APE++     
Sbjct: 125 IIHRDLKSNNIFLH-EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183

Query: 183 TGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILP 242
             YS   DV+A G +  E++TG+  + +   ++   I  ++G                  
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYSNI--NNRDQIIFMVGR----------------- 224

Query: 243 LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH 287
               +   +L++   N   A   L+++ L     +R      L  
Sbjct: 225 ---GYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 2e-58
 Identities = 82/311 (26%), Positives = 128/311 (41%), Gaps = 39/311 (12%)

Query: 8   NYKKIKK-IGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVS-LLKELEH 65
           +YK   + +G G  G+V +  N  T +K A+KM+    +         REV    +  + 
Sbjct: 12  DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-------ARREVELHWRASQC 64

Query: 66  ENIVRLLDV----QSSRKDVFLVFEYLDL-DLHSFITRHKN-TLNLLVIKAILKQILLGL 119
            +IVR++DV     + RK + +V E LD  +L S I    +          I+K I   +
Sbjct: 65  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 124

Query: 120 AYCHSLKILHRDLKPNNLLIDLKRN--TVKLADFGLARAIGVPQKEYSRDCVYSPYKAPE 177
            Y HS+ I HRD+KP NLL   KR    +KL DFG A+         +       Y APE
Sbjct: 125 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTP-YYVAPE 183

Query: 178 LLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYI 237
           +L     Y    D+W++G I   ++ G P F S                   S    T I
Sbjct: 184 VLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSN-------------HGLAISPGMKTRI 229

Query: 238 SEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP 297
                 +P+        ++  +      L+  +L   P QR+T  + + H +++    VP
Sbjct: 230 RMGQYEFPN-------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 282

Query: 298 LVILLINRKKK 308
              L  +R  K
Sbjct: 283 QTPLHTSRVLK 293

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 1e-57
 Identities = 69/293 (23%), Positives = 110/293 (37%), Gaps = 45/293 (15%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMM----TIQTEQEGVPSYIIREVSLLKEL- 63
           Y+    +G+GG+G VY          VAIK +         +    + +  EV LLK++ 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65

Query: 64  -EHENIVRLLDVQSSRKDVFLVFEYLD--LDLHSFITRHKNTLNLLVIKAILKQILLGLA 120
                ++RLLD         L+ E  +   DL  FIT     L   + ++   Q+L  + 
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVR 124

Query: 121 YCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLL 180
           +CH+  +LHRD+K  N+LIDL R  +KL DFG    +      Y+       Y  PE + 
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSPPEWIR 182

Query: 181 GYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEI 240
            +  +     VW++G +  +M+ G   F                              EI
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHD--------------------------EEI 216

Query: 241 LPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV 293
           +     F           +      L+   L L P  R T  +   H ++  V
Sbjct: 217 IRGQVFFR--------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  183 bits (466), Expect = 2e-56
 Identities = 65/292 (22%), Positives = 116/292 (39%), Gaps = 39/292 (13%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQT-EQEGVPSYIIREVSLLKELEHE 66
           +++ ++ +G G +G V+  R+   G+  A+K++  +   +     +   E  +L  + H 
Sbjct: 5   DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 64

Query: 67  NIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
            I+R+       + +F++ +Y++      + R        V K    ++ L L Y HS  
Sbjct: 65  FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD 124

Query: 127 ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYS 186
           I++RDLKP N+L+D K   +K+ DFG A+ +          C    Y APE++     Y+
Sbjct: 125 IIYRDLKPENILLD-KNGHIKITDFGFAKYVPDVTYTL---CGTPDYIAPEVVST-KPYN 179

Query: 187 TPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPH 246
             ID W+ G +  EM+ G   F                              +IL     
Sbjct: 180 KSIDWWSFGILIYEMLAGYTPFYDSNTMKT--------------------YEKILNAELR 219

Query: 247 FEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRI-----TAMDALKHEYLIGV 293
           F         P       DLLS+++  +  QR+        D   H +   V
Sbjct: 220 FP--------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (459), Expect = 3e-55
 Identities = 62/292 (21%), Positives = 118/292 (40%), Gaps = 36/292 (12%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQT-EQEGVPSYIIREVSLLKELEHE 66
           ++  +K +G G +G+V   R   TG+  A+K++  +    +   ++ + E  +L+   H 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65

Query: 67  NIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
            +  L     +   +  V EY +     F    +        +    +I+  L Y HS  
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125

Query: 127 ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYS 186
           +++RD+K  NL++D K   +K+ DFGL +  G+      +    +P      +L    Y 
Sbjct: 126 VVYRDIKLENLMLD-KDGHIKITDFGLCKE-GISDGATMKTFCGTPEYLAPEVLEDNDYG 183

Query: 187 TPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPH 246
             +D W +G +  EM+ G+  F ++ H+ L                       IL     
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERL--------------------FELILMEEIR 223

Query: 247 FEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRI-----TAMDALKHEYLIGV 293
           F           L P    LL+ +L  +PKQR+      A + ++H + + +
Sbjct: 224 FP--------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  177 bits (449), Expect = 1e-54
 Identities = 64/295 (21%), Positives = 114/295 (38%), Gaps = 35/295 (11%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQ-EGVPSYIIREVSLLKELEHEN 67
           Y+  + +G GG  EV+  R+    + VA+K++     +         RE      L H  
Sbjct: 9   YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68

Query: 68  IVRLLDVQSSRKD----VFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCH 123
           IV + D   +        ++V EY+D      I   +  +       ++      L + H
Sbjct: 69  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 128

Query: 124 SLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRD---CVYSPYKAPELLL 180
              I+HRD+KP N++I    N VK+ DFG+ARAI       ++       + Y +PE   
Sbjct: 129 QNGIIHRDVKPANIMIS-ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 187

Query: 181 GYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEI 240
           G        DV+++GC+  E++TG+P F                               +
Sbjct: 188 G-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------------------------VSV 222

Query: 241 LPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVEN 295
              +   +P   + +   L      ++ + L  NP+ R      ++ + L+ V N
Sbjct: 223 AYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD-LVRVHN 276

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 2e-51
 Identities = 59/284 (20%), Positives = 110/284 (38%), Gaps = 42/284 (14%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
             K ++ IG G +G+V        G KVA+K +      +      + E S++ +L H N
Sbjct: 8   ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQA----FLAEASVMTQLRHSN 61

Query: 68  IVRLLDV-QSSRKDVFLVFEYLDL-DLHSFI-TRHKNTLNLLVIKAILKQILLGLAYCHS 124
           +V+LL V    +  +++V EY+    L  ++ +R ++ L    +      +   + Y   
Sbjct: 62  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121

Query: 125 LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTG 184
              +HRDL   N+L+  + N  K++DFGL +     Q       +   + APE L     
Sbjct: 122 NNFVHRDLAARNVLVS-EDNVAKVSDFGLTKEASSTQDTG---KLPVKWTAPEALRE-KK 176

Query: 185 YSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPL 243
           +ST  DVW+ G +  E+ + G+  +P                                 +
Sbjct: 177 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---------------------------V 209

Query: 244 YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH 287
            P  E     +      PA  +++     L+   R + +   + 
Sbjct: 210 VPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 4e-51
 Identities = 62/291 (21%), Positives = 114/291 (39%), Gaps = 36/291 (12%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
             K ++++GAG +GEV+         KVA+K +   +     P   + E +L+K+L+H+ 
Sbjct: 14  TLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQR 69

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKA--ILKQILLGLAYCHSL 125
           +VRL  V +  + ++++ EY++        +  + + L + K   +  QI  G+A+    
Sbjct: 70  LVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128

Query: 126 KILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGY 185
             +HRDL+  N+L+     + K+ADFGLAR I   +        +         + Y  +
Sbjct: 129 NYIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 187

Query: 186 STPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYP 245
           +   DVW+ G +  E++T                    G            I  +   Y 
Sbjct: 188 TIKSDVWSFGILLTEIVTH-------------------GRIPYPGMTNPEVIQNLERGYR 228

Query: 246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK--HEYLIGVE 294
              P N  E+          L+       P+ R T         ++    E
Sbjct: 229 MVRPDNCPEEL-------YQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  170 bits (432), Expect = 5e-51
 Identities = 77/326 (23%), Positives = 135/326 (41%), Gaps = 43/326 (13%)

Query: 4   LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL 63
            K+  Y  ++K+G G +  V+  ++ V    VA+K++      +        E+ LL+ +
Sbjct: 10  YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV---RGDKVYTEAAEDEIKLLQRV 66

Query: 64  EHENIVRLLDVQSSR---------------KDVFLVFEYLDLDLHSFITRHKNTLN-LLV 107
              +  +   + ++                  V +VFE L  +L + I ++++    L+ 
Sbjct: 67  NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIY 126

Query: 108 IKAILKQILLGLAYC-HSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSR 166
           +K I KQ+LLGL Y      I+H D+KP N+L+++  +   L    +A        +   
Sbjct: 127 VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 186

Query: 167 DCVYSP--YKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFP-------SKKHDHLS 217
                   Y++PE+LLG   +    D+W+  C+  E+ITG  LF        +K  DH++
Sbjct: 187 TNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245

Query: 218 LIFSLLGTPTDESWAESTYISEI------------LPLYPHFEPANLAEKFP-NLEPAGV 264
            I  LLG           Y                L  +P  +      KF  +      
Sbjct: 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 305

Query: 265 DLLSQMLCLNPKQRITAMDALKHEYL 290
           D LS ML L+P++R  A   + H +L
Sbjct: 306 DFLSPMLQLDPRKRADAGGLVNHPWL 331

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  169 bits (429), Expect = 1e-50
 Identities = 64/292 (21%), Positives = 118/292 (40%), Gaps = 39/292 (13%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQ-TEQEGVPSYIIREVSLLKELEHE 66
            + +IK +G G +G V   ++  +G   A+K++  Q   +     + + E  +L+ +   
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101

Query: 67  NIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
            +V+L        ++++V EY+         R     +    +    QI+L   Y HSL 
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161

Query: 127 ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYS 186
           +++RDLKP NLLID ++  +++ DFG A+ +          C      APE++L   GY+
Sbjct: 162 LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTWTL---CGTPEALAPEIILSK-GYN 216

Query: 187 TPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPH 246
             +D WA+G +  EM  G P F + +   +                      +I+     
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQI--------------------YEKIVSGKVR 256

Query: 247 FEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRI-----TAMDALKHEYLIGV 293
           F          +      DLL  +L ++  +R         D   H++    
Sbjct: 257 F--------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 1e-50
 Identities = 56/282 (19%), Positives = 112/282 (39%), Gaps = 34/282 (12%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
               +++IG+G +G V+         KVAIK +      E      I E  ++ +L H  
Sbjct: 6   ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPK 61

Query: 68  IVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
           +V+L  V   +  + LVFE+++   L  ++   +       +  +   +  G+AY     
Sbjct: 62  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121

Query: 127 ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP-YKAPELLLGYTGY 185
           ++HRDL   N L+  +   +K++DFG+ R +   Q   S    +   + +PE+    + Y
Sbjct: 122 VIHRDLAARNCLVG-ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRY 179

Query: 186 STPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYP 245
           S+  DVW+ G +  E+ +                    G    E+ + S  + +I   + 
Sbjct: 180 SSKSDVWSFGVLMWEVFSE-------------------GKIPYENRSNSEVVEDISTGFR 220

Query: 246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH 287
            ++P   +            +++      P+ R      L+ 
Sbjct: 221 LYKPRLASTHV-------YQIMNHCWKERPEDRPAFSRLLRQ 255

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (420), Expect = 2e-50
 Identities = 59/282 (20%), Positives = 114/282 (40%), Gaps = 34/282 (12%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
           +   +K++G G +G V   +       VAIKM+   +  E      I E  ++  L HE 
Sbjct: 5   DLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEK 60

Query: 68  IVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
           +V+L  V + ++ +F++ EY+    L +++   ++      +  + K +   + Y  S +
Sbjct: 61  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120

Query: 127 ILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYS 186
            LHRDL   N L++  +  VK++DFGL+R +   +   S    +    +P  +L Y+ +S
Sbjct: 121 FLHRDLAARNCLVN-DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 179

Query: 187 TPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYP 245
           +  D+WA G +  E+ + GK  +    +                          I     
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMPYERFTNSET--------------------AEHIAQGLR 219

Query: 246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH 287
            + P   +EK          ++         +R T    L +
Sbjct: 220 LYRPHLASEKV-------YTIMYSCWHEKADERPTFKILLSN 254

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  166 bits (422), Expect = 3e-50
 Identities = 49/292 (16%), Positives = 97/292 (33%), Gaps = 38/292 (13%)

Query: 9   YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI 68
           Y+  +KIG+G +G++Y   +   G++VAIK+  ++T+       +  E  + K ++    
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ----LHIESKIYKMMQGGVG 64

Query: 69  VRLL-DVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
           +  +    +      +V E L   L           +L  +  +  Q++  + Y HS   
Sbjct: 65  IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNF 124

Query: 128 LHRDLKPNNLLIDLKR--NTVKLADFGLARAIGVPQKEYSRDCVYS-------PYKAPEL 178
           +HRD+KP+N L+ L +  N V + DFGLA+     +         +        Y +   
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184

Query: 179 LLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYIS 238
            LG    S   D+ ++G +      G   +   K                          
Sbjct: 185 HLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK------------------- 224

Query: 239 EILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITA---MDALKH 287
               +        +              L+    L    +          ++
Sbjct: 225 -YERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  163 bits (413), Expect = 5e-49
 Identities = 61/282 (21%), Positives = 110/282 (39%), Gaps = 34/282 (12%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
           +     K+G G YGEVY+         VA+K +   T +       ++E +++KE++H N
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPN 74

Query: 68  IVRLLDVQSSRKDVFLVFEYLD--LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSL 125
           +V+LL V +     +++ E++     L      ++  ++ +V+  +  QI   + Y    
Sbjct: 75  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 134

Query: 126 KILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGY 185
             +HRDL   N L+  + + VK+ADFGL+R +            +         L Y  +
Sbjct: 135 NFIHRDLAARNCLVG-ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 193

Query: 186 STPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLY 244
           S   DVWA G +  E+ T G   +P      +  +                    +   Y
Sbjct: 194 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL--------------------LEKDY 233

Query: 245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK 286
               P    EK         +L+      NP  R +  +  +
Sbjct: 234 RMERPEGCPEKV-------YELMRACWQWNPSDRPSFAEIHQ 268

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 7e-49
 Identities = 60/299 (20%), Positives = 122/299 (40%), Gaps = 38/299 (12%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTV---TGQKVAIKMMTIQT--EQEGVPSYIIREVSLLKE 62
           N++ +K +G G YG+V+  R      TG+  A+K++   T  ++     +   E  +L+ 
Sbjct: 25  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84

Query: 63  LEHE-NIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAY 121
           +     +V L     +   + L+ +Y++          +       ++  + +I+L L +
Sbjct: 85  IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEH 144

Query: 122 CHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP--YKAPELL 179
            H L I++RD+K  N+L+D     V L DFGL++     + E + D   +        + 
Sbjct: 145 LHKLGIIYRDIKLENILLD-SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203

Query: 180 LGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISE 239
            G +G+   +D W++G +  E++TG   F      +                      +E
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--------------------QAE 243

Query: 240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRI-----TAMDALKHEYLIGV 293
           I       EP         +     DL+ ++L  +PK+R+      A +  +H +   +
Sbjct: 244 ISRRILKSEP----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 298

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 1e-48
 Identities = 64/291 (21%), Positives = 116/291 (39%), Gaps = 37/291 (12%)

Query: 4   LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQ----KVAIKMMTIQTEQEGVPSYIIREVSL 59
           LK   +KKIK +G+G +G VYK      G+     VAIK +   T  +     I+ E  +
Sbjct: 6   LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAYV 64

Query: 60  LKELEHENIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGL 119
           +  +++ ++ RLL +  +     +        L  ++  HK+ +    +     QI  G+
Sbjct: 65  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 124

Query: 120 AYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP--YKAPE 177
            Y    +++HRDL   N+L+      VK+ DFGLA+ +G  +KEY  +    P  + A E
Sbjct: 125 NYLEDRRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183

Query: 178 LLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY 236
            +L    Y+   DVW+ G    E++T G   +       +S I                 
Sbjct: 184 SILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI----------------- 225

Query: 237 ISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH 287
           + +   L           + P        ++ +   ++   R    + +  
Sbjct: 226 LEKGERL----------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 2e-48
 Identities = 64/296 (21%), Positives = 115/296 (38%), Gaps = 40/296 (13%)

Query: 3   KLKNLNYKKIKKIGAGGYGEVYKC--RNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLL 60
           K  NL    I+ +G G +G V +   R       VAIK++   TE+      ++RE  ++
Sbjct: 6   KRDNLLIADIE-LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT-EEMMREAQIM 63

Query: 61  KELEHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGL 119
            +L++  IVRL+ V  +   + LV E      LH F+   +  + +  +  +L Q+ +G+
Sbjct: 64  HQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGM 122

Query: 120 AYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRD--CVYSPYKAPE 177
            Y      +HRDL   N+L+   R+  K++DFGL++A+G     Y+      +       
Sbjct: 123 KYLEEKNFVHRDLAARNVLLV-NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 181

Query: 178 LLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY 236
             + +  +S+  DVW+ G    E ++ G+  +   K                        
Sbjct: 182 ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--------------------- 220

Query: 237 ISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITA---MDALKHEY 289
                 +    E     E  P   P    L+S       + R         ++  Y
Sbjct: 221 ------VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 6e-48
 Identities = 54/286 (18%), Positives = 117/286 (40%), Gaps = 39/286 (13%)

Query: 13  KKIGAGGYGEVYKC--RNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVR 70
           K++G+G +G V K   +     + VA+K++  +     +   ++ E +++++L++  IVR
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 71  LLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHR 130
           ++ +    +   LV E  +L   +   +    +    I  ++ Q+ +G+ Y      +HR
Sbjct: 73  MIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 131

Query: 131 DLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRD---CVYSPYKAPELLLGYTGYST 187
           DL   N+L+   ++  K++DFGL++A+   +  Y           + APE +  Y  +S+
Sbjct: 132 DLAARNVLLV-TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY-KFSS 189

Query: 188 PIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYPH 246
             DVW+ G +  E  + G+  +   K   +                     + +      
Sbjct: 190 KSDVWSFGVLMWEAFSYGQKPYRGMKGSEV--------------------TAMLEKGERM 229

Query: 247 FEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITA---MDALKHEY 289
             PA    +         DL++     + + R         L++ Y
Sbjct: 230 GCPAGCPREM-------YDLMNLCWTYDVENRPGFAAVELRLRNYY 268

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 1e-47
 Identities = 59/284 (20%), Positives = 108/284 (38%), Gaps = 33/284 (11%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVT---GQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE 64
             +  + IG G +G+V++            VAIK     T    V    ++E   +++ +
Sbjct: 8   RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD-SVREKFLQEALTMRQFD 66

Query: 65  HENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCH 123
           H +IV+L+ V +    V+++ E   L +L SF+   K +L+L  +     Q+   LAY  
Sbjct: 67  HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125

Query: 124 SLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYT 183
           S + +HRD+   N+L+    + VKL DFGL+R +       +              + + 
Sbjct: 126 SKRFVHRDIAARNVLVS-SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 184

Query: 184 GYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPL 243
            +++  DVW  G    E++                     G    +    +  I  I   
Sbjct: 185 RFTSASDVWMFGVCMWEILMH-------------------GVKPFQGVKNNDVIGRIENG 225

Query: 244 YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH 287
                P       PN  P    L+++    +P +R    +    
Sbjct: 226 ERLPMP-------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 1e-47
 Identities = 65/292 (22%), Positives = 115/292 (39%), Gaps = 38/292 (13%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
           + +   K+G G +GEV+         +VAIK +   T         ++E  ++K+L HE 
Sbjct: 18  SLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEK 73

Query: 68  IVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKN--TLNLLVIKAILKQILLGLAYCHSL 125
           +V+L  V S  + +++V EY+         + +    L L  +  +  QI  G+AY   +
Sbjct: 74  LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 132

Query: 126 KILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGY 185
             +HRDL+  N+L+  +    K+ADFGLAR I   +    +   +           Y  +
Sbjct: 133 NYVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 191

Query: 186 STPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLY 244
           +   DVW+ G +  E+ T G+  +P   +  +                    + ++   Y
Sbjct: 192 TIKSDVWSFGILLTELTTKGRVPYPGMVNREV--------------------LDQVERGY 231

Query: 245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK--HEYLIGVE 294
               P    E          DL+ Q     P++R T         +Y    E
Sbjct: 232 RMPCPPECPESL-------HDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  159 bits (403), Expect = 2e-47
 Identities = 51/283 (18%), Positives = 94/283 (33%), Gaps = 37/283 (13%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEH-E 66
           +YK  ++IG G +G +++  N +  Q+VAIK    +++       +  E    K L    
Sbjct: 6   HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP----QLRDEYRTYKLLAGCT 61

Query: 67  NIVRLLDVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK 126
            I  +           LV + L   L   +       ++  +    KQ+L  +   H   
Sbjct: 62  GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121

Query: 127 ILHRDLKPNNLLIDLKR----NTVKLADFGLARAIG-------VPQKEYSRDCVYSPYKA 175
           +++RD+KP+N LI        N + + DFG+ +          +P +E       + Y +
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181

Query: 176 PELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAEST 235
               LG    S   D+ A+G +F   + G   +   K       +  +G           
Sbjct: 182 INTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG----------- 229

Query: 236 YISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQR 278
                       +   L E            +     L     
Sbjct: 230 ---------EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDAT 263

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 2e-47
 Identities = 62/312 (19%), Positives = 112/312 (35%), Gaps = 61/312 (19%)

Query: 8   NYKKIKKIGAGGYGEVYKCRN-----TVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKE 62
           N +  K +G+G +G+V          T    +VA+KM+  + +     + ++ E+ ++ +
Sbjct: 38  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREA-LMSELKMMTQ 96

Query: 63  LE-HENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHK-------------------- 100
           L  HENIV LL   +    ++L+FEY    DL +++   +                    
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 101 --NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIG 158
             N L    +     Q+  G+ +      +HRDL   N+L+      VK+ DFGLAR I 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT-HGKVVKICDFGLARDIM 215

Query: 159 VPQKEYSRDCVYSP--YKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDH 215
                  R     P  + APE L     Y+   DVW+ G +  E+ + G   +P    D 
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274

Query: 216 LSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNP 275
                                       Y   +     ++          ++      + 
Sbjct: 275 N--------------------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDS 308

Query: 276 KQRITAMDALKH 287
           ++R +  +    
Sbjct: 309 RKRPSFPNLTSF 320

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 2e-47
 Identities = 60/288 (20%), Positives = 103/288 (35%), Gaps = 36/288 (12%)

Query: 8   NYKKIKKIGAGGYGEVYKCR---NTVTGQKVAIKMMTIQT-EQEGVPSYIIREVSLLKEL 63
           + + ++K+G G +G V +      +     VA+K +      Q       IREV+ +  L
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68

Query: 64  EHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYC 122
           +H N++RL  V  +   + +V E   L  L   + +H+    L  +     Q+  G+ Y 
Sbjct: 69  DHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127

Query: 123 HSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY--SRDCVYSPYKAPELLL 180
            S + +HRDL   NLL+   R+ VK+ DFGL RA+      Y                 L
Sbjct: 128 ESKRFIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186

Query: 181 GYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISE 239
               +S   D W  G    EM T G+  +       +                    + +
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI--------------------LHK 226

Query: 240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH 287
           I              +  +      +++ Q     P+ R T +     
Sbjct: 227 IDKEGERL------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 268

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  157 bits (398), Expect = 1e-46
 Identities = 55/290 (18%), Positives = 116/290 (40%), Gaps = 40/290 (13%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQK---VAIKMMTIQTEQEGVPSYIIREVSLLKELE 64
             K  + IGAG +GEV      + G++   VAIK +     ++      + E S++ + +
Sbjct: 27  CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQR-RDFLSEASIMGQFD 85

Query: 65  HENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCH 123
           H N++ L  V +    V ++ E+++   L SF+ ++     ++ +  +L+ I  G+ Y  
Sbjct: 86  HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA 145

Query: 124 SLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSR-----DCVYSPYKAPEL 178
            +  +HRDL   N+L++      K++DFGL+R +     + +        +   + APE 
Sbjct: 146 DMNYVHRDLAARNILVN-SNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 204

Query: 179 LLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYI 237
           +     +++  DVW+ G +  E+++ G+  +    +  +                    I
Sbjct: 205 IQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV--------------------I 243

Query: 238 SEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH 287
           + I   Y    P +              L+      +   R      +  
Sbjct: 244 NAIEQDYRLPPPMDCPSAL-------HQLMLDCWQKDRNHRPKFGQIVNT 286

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 3e-46
 Identities = 61/301 (20%), Positives = 115/301 (38%), Gaps = 36/301 (11%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN 67
                + IG G +GEV++ +    G++VA+K+ + + E+     +   E+     L HEN
Sbjct: 4   TIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSW---FREAEIYQTVMLRHEN 58

Query: 68  IVRLLDV----QSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYC 122
           I+  +        +   ++LV +Y +   L  ++  ++ T+ +  +  +      GLA+ 
Sbjct: 59  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHL 116

Query: 123 HS--------LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYS----RDCVY 170
           H           I HRDLK  N+L+  K  T  +AD GLA                    
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175

Query: 171 SPYKAPELLLG-----YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGT 225
             Y APE+L       +       D++A+G +F E+     +    +   L     +   
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235

Query: 226 PTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDAL 285
           P+ E   +     ++ P  P+   +               ++ +    N   R+TA+   
Sbjct: 236 PSVEEMRKVVCEQKLRPNIPNRWQS------CEALRVMAKIMRECWYANGAARLTALRIK 289

Query: 286 K 286
           K
Sbjct: 290 K 290

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  153 bits (388), Expect = 4e-45
 Identities = 70/311 (22%), Positives = 117/311 (37%), Gaps = 62/311 (19%)

Query: 8   NYKKIKKIGAGGYGEVYKCR-----NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKE 62
           N + ++ IG G +G V++ R            VA+KM+  +   +   +   RE +L+ E
Sbjct: 14  NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ-ADFQREAALMAE 72

Query: 63  LEHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRH---------------------- 99
            ++ NIV+LL V +  K + L+FEY+   DL+ F+                         
Sbjct: 73  FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132

Query: 100 -KNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIG 158
               L+      I +Q+  G+AY    K +HRDL   N L+  +   VK+ADFGL+R I 
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG-ENMVVKIADFGLSRNIY 191

Query: 159 VPQKEYSRDCVYSP--YKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDH 215
                 +      P  +  PE +     Y+T  DVWA G +  E+ + G   +    H+ 
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250

Query: 216 LSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNP 275
           +                    I  +        P N   +         +L+       P
Sbjct: 251 V--------------------IYYVRDGNILACPENCPLEL-------YNLMRLCWSKLP 283

Query: 276 KQRITAMDALK 286
             R +     +
Sbjct: 284 ADRPSFCSIHR 294

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 4e-44
 Identities = 65/299 (21%), Positives = 109/299 (36%), Gaps = 49/299 (16%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQK--VAIKMMTIQTEQEGVPSYIIREVSLLKELE- 64
           + K    IG G +G+V K R    G +   AIK M     ++        E+ +L +L  
Sbjct: 11  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLGH 69

Query: 65  HENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRH---------------KNTLNLLVI 108
           H NI+ LL     R  ++L  EY    +L  F+ +                 +TL+   +
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 109 KAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDC 168
                 +  G+ Y    + +HRDL   N+L+  +    K+ADFGL+R   V  K+     
Sbjct: 130 LHFAADVARGMDYLSQKQFIHRDLAARNILVG-ENYVAKIADFGLSRGQEVYVKKTM--G 186

Query: 169 VYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTD 228
                      L Y+ Y+T  DVW+ G +  E+++                    G    
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL-------------------GGTPY 227

Query: 229 ESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH 287
                +    ++   Y   +P N  ++         DL+ Q     P +R +    L  
Sbjct: 228 CGMTCAELYEKLPQGYRLEKPLNCDDEV-------YDLMRQCWREKPYERPSFAQILVS 279

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 4e-44
 Identities = 60/287 (20%), Positives = 110/287 (38%), Gaps = 37/287 (12%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVTGQK----VAIKMMTIQTEQEGVPSYIIREVSLLKEL 63
              + K IGAG +GEVYK     +  K    VAIK +     ++      + E  ++ + 
Sbjct: 8   CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD-FLGEAGIMGQF 66

Query: 64  EHENIVRLLDVQSSRKDVFLVFEYLDLDLH-SFITRHKNTLNLLVIKAILKQILLGLAYC 122
            H NI+RL  V S  K + ++ EY++      F+       ++L +  +L+ I  G+ Y 
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126

Query: 123 HSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYS---PYKAPELL 179
            ++  +HRDL   N+L++      K++DFGL+R +    +             + APE +
Sbjct: 127 ANMNYVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185

Query: 180 LGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISE 239
                +++  DVW+ G +  E++T                    G       +    +  
Sbjct: 186 SY-RKFTSASDVWSFGIVMWEVMTY-------------------GERPYWELSNHEVMKA 225

Query: 240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK 286
           I   +    P +              L+ Q       +R    D + 
Sbjct: 226 INDGFRLPTPMDCPSAI-------YQLMMQCWQQERARRPKFADIVS 265

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (373), Expect = 7e-43
 Identities = 62/305 (20%), Positives = 107/305 (35%), Gaps = 54/305 (17%)

Query: 8   NYKKIKKIGAGGYGEVYKCR-----NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKE 62
                K +GAG +G+V +        +     VA+KM+          + ++ E+ +L  
Sbjct: 24  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA-LMSELKVLSY 82

Query: 63  LE-HENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHKNT-----------------L 103
           L  H NIV LL   +      ++ EY    DL +F+ R +++                 L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 104 NLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE 163
           +L  + +   Q+  G+A+  S   +HRDL   N+L+       K+ DFGLAR I      
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT-HGRITKICDFGLARDIKNDSNY 201

Query: 164 Y-SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFS 221
               +            +    Y+   DVW+ G    E+ + G   +P            
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM---------- 251

Query: 222 LLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITA 281
                  +S            L P   PA +            D++      +P +R T 
Sbjct: 252 -----PVDSKFYKMIKEGFRMLSPEHAPAEMY-----------DIMKTCWDADPLKRPTF 295

Query: 282 MDALK 286
              ++
Sbjct: 296 KQIVQ 300

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 7e-41
 Identities = 61/298 (20%), Positives = 112/298 (37%), Gaps = 48/298 (16%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNT-----VTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKE 62
                +++G G +G VY+             +VAIK +             + E S++KE
Sbjct: 21  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER-IEFLNEASVMKE 79

Query: 63  LEHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHK---------NTLNLLVIKAIL 112
               ++VRLL V S  +   ++ E +   DL S++   +            +L  +  + 
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 113 KQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP 172
            +I  G+AY ++ K +HRDL   N ++  +  TVK+ DFG+ R I              P
Sbjct: 140 GEIADGMAYLNANKFVHRDLAARNCMVA-EDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198

Query: 173 --YKAPELLLGYTGYSTPIDVWAVGCIFAEMITG-KPLFPSKKHDHLSLIFSLLGTPTDE 229
             + +PE L     ++T  DVW+ G +  E+ T  +  +    ++               
Sbjct: 199 VRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-------------- 243

Query: 230 SWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH 287
                        +        L +K  N      +L+      NPK R + ++ +  
Sbjct: 244 -------------VLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 2e-40
 Identities = 61/306 (19%), Positives = 115/306 (37%), Gaps = 55/306 (17%)

Query: 8   NYKKIKKIGAGGYGEVYKCRNTVT-------GQKVAIKMMTIQTEQEGVPSYIIREVSLL 60
                K +G G +G+V                 KVA+KM+     ++ + S +I E+ ++
Sbjct: 14  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL-SDLISEMEMM 72

Query: 61  KEL-EHENIVRLLDVQSSRKDVFLVFEYLDL-DLHSFITRHK---------------NTL 103
           K + +H+NI+ LL   +    ++++ EY    +L  ++   +                 L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 104 NLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIG-VPQK 162
           +   + +   Q+  G+ Y  S K +HRDL   N+L+  + N +K+ADFGLAR I  +   
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT-EDNVMKIADFGLARDIHHIDYY 191

Query: 163 EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFS 221
           + + +            L    Y+   DVW+ G +  E+ T G   +P    +       
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE------ 245

Query: 222 LLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITA 281
                                L+   +  +  +K  N       ++       P QR T 
Sbjct: 246 ---------------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF 284

Query: 282 MDALKH 287
              ++ 
Sbjct: 285 KQLVED 290

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 2e-40
 Identities = 60/284 (21%), Positives = 110/284 (38%), Gaps = 38/284 (13%)

Query: 13  KKIGAGGYGEVYKCR---NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIV 69
           + IG G +G VY      N       A+K +   T+   V S  + E  ++K+  H N++
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNVL 91

Query: 70  RLLDV-QSSRKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKI 127
            LL +   S     +V  Y+   DL +FI    +   +  +     Q+  G+ +  S K 
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF 151

Query: 128 LHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSRDCVYSP----YKAPELLLGYT 183
           +HRDL   N ++D ++ TVK+ADFGLAR +   + +   +   +     + A E L    
Sbjct: 152 VHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT-Q 209

Query: 184 GYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPL 243
            ++T  DVW+ G +  E++T                    G P             +L  
Sbjct: 210 KFTTKSDVWSFGVLLWELMTR-------------------GAPPYPDVNTFDITVYLLQG 250

Query: 244 YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH 287
               +P    +          +++ +      + R +  + +  
Sbjct: 251 RRLLQPEYCPDPL-------YEVMLKCWHPKAEMRPSFSELVSR 287

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (347), Expect = 4e-39
 Identities = 62/305 (20%), Positives = 106/305 (34%), Gaps = 53/305 (17%)

Query: 8   NYKKIKKIGAGGYGEVYKCR-----NTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKE 62
             K  K +G G +G+V +        T T + VA+KM+          + +     L+  
Sbjct: 14  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73

Query: 63  LEHENIVRLLDV-QSSRKDVFLVFEYLDL-DLHSFITRHKN---------------TLNL 105
             H N+V LL         + ++ E+    +L +++   +N                L L
Sbjct: 74  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133

Query: 106 LVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYS 165
             +     Q+  G+ +  S K +HRDL   N+L+  ++N VK+ DFGLAR I        
Sbjct: 134 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVR 192

Query: 166 RDCVYSP--YKAPELLLGYTGYSTPIDVWAVGCIFAEMITG-KPLFPSKKHDHLSLIFSL 222
           +     P  + APE +     Y+   DVW+ G +  E+ +     +P  K D        
Sbjct: 193 KGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------ 245

Query: 223 LGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAM 282
                                    +            P     +       P QR T  
Sbjct: 246 --------------------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS 285

Query: 283 DALKH 287
           + ++H
Sbjct: 286 ELVEH 290

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 96.8 bits (240), Expect = 8e-25
 Identities = 28/199 (14%), Positives = 62/199 (31%), Gaps = 34/199 (17%)

Query: 13  KKIGAGGYGEVYKCRNTVTGQKVAIKMM--------TIQTEQEGVPSYIIREVSLLKELE 64
           K +G G    V+ C +     +  +K           ++ +++    +           E
Sbjct: 6   KLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 65  HENIVRLLDVQSSRK----DVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLA 120
              + +L  +   +        ++ E +D      +              +L  IL  +A
Sbjct: 65  FRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENP-------DEVLDMILEEVA 117

Query: 121 YCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY--SRDC--VYSPYKAP 176
             +   I+H DL   N+L+      + + DF  +  +G         RD   + + +   
Sbjct: 118 KFYHRGIVHGDLSQYNVLVS--EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRT 175

Query: 177 ELLLGYTGYSTPIDVWAVG 195
                   Y T  D+ +  
Sbjct: 176 --------YRTEKDINSAI 186

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	324
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.89
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.79
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.3
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.21
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.35
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.27
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.11

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-61  Score=407.07  Aligned_cols=269  Identities=29%  Similarity=0.479  Sum_probs=227.7

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      .++|++++.||+|+||+||+|.+..+|+.||+|++......  ..+.+.+|+.++++++||||+++++++.+++.+|+||
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   96 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh--HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence            35899999999999999999999999999999998765432  2567899999999999999999999999999999999


Q ss_pred             EecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcc
Q 045787           86 EYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY  164 (324)
Q Consensus        86 e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~  164 (324)
                      ||++| +|.+++..  +.+++..++.++.||+.||.|||++|++||||||+|||++ .++.+||+|||.+..........
T Consensus        97 Ey~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~-~~~~vkl~DFG~a~~~~~~~~~~  173 (293)
T d1yhwa1          97 EYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKR  173 (293)
T ss_dssp             ECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC-TTCCEEECCCTTCEECCSTTCCB
T ss_pred             EecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEEC-CCCcEeeccchhheeeccccccc
Confidence            99985 77776554  4699999999999999999999999999999999999999 88999999999998876555556


Q ss_pred             cccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCC
Q 045787          165 SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLY  244 (324)
Q Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (324)
                      ...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.............+...               
T Consensus       174 ~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~---------------  237 (293)
T d1yhwa1         174 STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQ---------------  237 (293)
T ss_dssp             CCCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCS---------------
T ss_pred             cccccCCCccChhhhcC-CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCC---------------
Confidence            66789999999999988 67899999999999999999999999877754433333222221111               


Q ss_pred             CCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchhhhhhhhc
Q 045787          245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILLINR  305 (324)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~~~~~~~~  305 (324)
                                ....+++++++||.+||+.||.+|||++|+++||||+.....+...+++..
T Consensus       238 ----------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~~~~~~l~p~~~~  288 (293)
T d1yhwa1         238 ----------NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAA  288 (293)
T ss_dssp             ----------SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGCCCGGGGHHHHHH
T ss_pred             ----------CcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCCCCCcCCCCCcc
Confidence                      112578999999999999999999999999999999876655544444443

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-60  Score=406.87  Aligned_cols=289  Identities=48%  Similarity=0.847  Sum_probs=251.3

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE   86 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   86 (324)
                      ++|++++.||+|+||+||+|.+..+|+.||+|++..........+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            58999999999999999999999999999999997766555556789999999999999999999999999999999999


Q ss_pred             ecCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccc
Q 045787           87 YLDLDLHSFITRH-KNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYS  165 (324)
Q Consensus        87 ~~~g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~  165 (324)
                      |+++++.+.+... ...+++..++.++.|++.||.|||++|++||||||+|||++ .++.+||+|||.+...........
T Consensus        82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~-~~~~~kl~DFG~a~~~~~~~~~~~  160 (298)
T d1gz8a_          82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYT  160 (298)
T ss_dssp             CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC-TTSCEEECSTTHHHHHCCCSBCTT
T ss_pred             ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeec-ccCcceeccCCcceeccCCcccce
Confidence            9998877776554 45699999999999999999999999999999999999999 889999999999988776666666


Q ss_pred             ccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHHcCCCCcccccchhhhhcccCCC
Q 045787          166 RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-HDHLSLIFSLLGTPTDESWAESTYISEILPLY  244 (324)
Q Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (324)
                      ...+|+.|+|||++......+.++|+|||||++|+|++|+.||.+.+ .+.+..+....+.+....+.............
T Consensus       161 ~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  240 (298)
T d1gz8a_         161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF  240 (298)
T ss_dssp             CCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTS
T ss_pred             eecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccccc
Confidence            67899999999998876777999999999999999999999998877 44556667777777777776666666666666


Q ss_pred             CCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCc
Q 045787          245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENV  296 (324)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~  296 (324)
                      ............+.+++++.+||.+||+.||.+|||+.|+++||||+++.++
T Consensus       241 ~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p  292 (298)
T d1gz8a_         241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP  292 (298)
T ss_dssp             CCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             ccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence            6666777778888999999999999999999999999999999999998764

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-60  Score=403.85  Aligned_cols=266  Identities=26%  Similarity=0.360  Sum_probs=224.4

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE   86 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   86 (324)
                      +.|++++.||+|+||.||+|++..+|..||+|++......  ..+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE   89 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE--ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE   89 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG--GGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHH--HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence            4699999999999999999999999999999998765322  35678899999999999999999999999999999999


Q ss_pred             ecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccc
Q 045787           87 YLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYS  165 (324)
Q Consensus        87 ~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~  165 (324)
                      |++| +|.+++.+..+++++..++.++.||+.||.|||++|++||||||+|||++ .++.+||+|||++...........
T Consensus        90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~-~~~~~Kl~DFG~a~~~~~~~~~~~  168 (288)
T d2jfla1          90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFT-LDGDIKLADFGVSAKNTRTIQRRD  168 (288)
T ss_dssp             CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC-TTSCEEECCCTTCEECHHHHHHHT
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeEC-CCCCEEEEechhhhccCCCccccc
Confidence            9985 88888777777899999999999999999999999999999999999999 899999999999976543333445


Q ss_pred             ccccccccCCchhhcC----CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhccc
Q 045787          166 RDCVYSPYKAPELLLG----YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEIL  241 (324)
Q Consensus       166 ~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (324)
                      ..+||+.|+|||++..    ...++.++|||||||++|+|++|+.||.+.+.............+..             
T Consensus       169 ~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~-------------  235 (288)
T d2jfla1         169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL-------------  235 (288)
T ss_dssp             CCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCC-------------
T ss_pred             ccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC-------------
Confidence            5679999999999852    35678999999999999999999999988775554333322211110             


Q ss_pred             CCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchhhh
Q 045787          242 PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVI  300 (324)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~~~  300 (324)
                                  .....+++++.+||.+||+.||.+|||+.|+++||||+.-...++..
T Consensus       236 ------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~~~~p~~~  282 (288)
T d2jfla1         236 ------------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRE  282 (288)
T ss_dssp             ------------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCCCCHHHHH
T ss_pred             ------------CccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCCCcHH
Confidence                        01125789999999999999999999999999999998766655543

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-60  Score=398.54  Aligned_cols=254  Identities=26%  Similarity=0.448  Sum_probs=219.2

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeecc-ccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQT-EQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLV   84 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   84 (324)
                      -++|++.+.||+|+||+||+|.++.+++.||+|++.... ........+.+|+.++++++||||+++++++.+++..|+|
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv   84 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   84 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence            367999999999999999999999999999999997654 3344456788999999999999999999999999999999


Q ss_pred             EEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCc
Q 045787           85 FEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE  163 (324)
Q Consensus        85 ~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~  163 (324)
                      |||++ |+|.+++... .++++..++.++.||+.||.|||++|++||||||+|||++ .++.+||+|||.+.....  ..
T Consensus        85 mEy~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~-~~~~~kl~DFG~a~~~~~--~~  160 (263)
T d2j4za1          85 LEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWSVHAPS--SR  160 (263)
T ss_dssp             EECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC-TTSCEEECCCCSCSCCCC--CC
T ss_pred             EeecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceec-CCCCEeecccceeeecCC--Cc
Confidence            99998 5888877764 4699999999999999999999999999999999999999 889999999999976543  23


Q ss_pred             ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCC
Q 045787          164 YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPL  243 (324)
Q Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (324)
                      .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..............                 
T Consensus       161 ~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~-----------------  222 (263)
T d2j4za1         161 RTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------------  222 (263)
T ss_dssp             CEETTEEGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC-----------------
T ss_pred             ccccCCCCcccCHHHHcC-CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-----------------
Confidence            345679999999999988 67899999999999999999999999887765544332211100                 


Q ss_pred             CCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccC
Q 045787          244 YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIG  292 (324)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~  292 (324)
                                 ....+++++.+||.+||+.||.+|||++|+++||||++
T Consensus       223 -----------~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         223 -----------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             -----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             -----------CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence                       11257899999999999999999999999999999975

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-60  Score=400.52  Aligned_cols=259  Identities=28%  Similarity=0.476  Sum_probs=214.3

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      .++|++++.||+|+||+||+|.++.+|+.||+|++....... ..+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm   82 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   82 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence            468999999999999999999999999999999997654322 2456889999999999999999999999999999999


Q ss_pred             EecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC--
Q 045787           86 EYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK--  162 (324)
Q Consensus        86 e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~--  162 (324)
                      ||++| +|.+++.. ...+++..++.++.||+.||.|||++|++||||||+|||++ .++.+||+|||.+........  
T Consensus        83 Ey~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~-~~~~~KL~DFG~a~~~~~~~~~~  160 (271)
T d1nvra_          83 EYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRER  160 (271)
T ss_dssp             ECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC-TTCCEEECCCTTCEECEETTEEC
T ss_pred             eccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEEC-CCCCEEEccchhheeeccCCccc
Confidence            99985 88887755 45799999999999999999999999999999999999999 889999999999987643322  


Q ss_pred             cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccC
Q 045787          163 EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILP  242 (324)
Q Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (324)
                      .....+||+.|+|||++.+...++.++|||||||++|+|++|+.||...+...............               
T Consensus       161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~---------------  225 (271)
T d1nvra_         161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY---------------  225 (271)
T ss_dssp             CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT---------------
T ss_pred             cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC---------------
Confidence            23446799999999999885555788999999999999999999997665332222111111110               


Q ss_pred             CCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccC
Q 045787          243 LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIG  292 (324)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~  292 (324)
                                ...+..+++++.+||.+||+.||.+|||++|+++||||++
T Consensus       226 ----------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         226 ----------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             ----------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             ----------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence                      0112357899999999999999999999999999999975

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=3.3e-59  Score=398.06  Aligned_cols=284  Identities=47%  Similarity=0.846  Sum_probs=247.1

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE   86 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   86 (324)
                      ++|++++.||+|+||+||+|.++ +|+.||+|++..........+.+.+|+.++++++||||+++++.+.+++..+++++
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e   80 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence            58999999999999999999986 78999999998776666667889999999999999999999999999999999999


Q ss_pred             ecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcccc
Q 045787           87 YLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSR  166 (324)
Q Consensus        87 ~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~  166 (324)
                      ++.++++..+....+.+++..++.++.||+.||+|||+.|++|+||||+|||++ .++.+||+|||.+............
T Consensus        81 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~-~~~~~kl~DfG~a~~~~~~~~~~~~  159 (286)
T d1ob3a_          81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKYTH  159 (286)
T ss_dssp             CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC-TTSCEEECCTTHHHHHCC-------
T ss_pred             eehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEc-CCCCEEecccccceecccCccccce
Confidence            999988888888788899999999999999999999999999999999999999 8999999999999887655555555


Q ss_pred             cccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHHcCCCCcccccchhhhhcccCCCC
Q 045787          167 DCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-HDHLSLIFSLLGTPTDESWAESTYISEILPLYP  245 (324)
Q Consensus       167 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (324)
                      ..+++.|+|||.+.+...++.++|||||||++|+|++|+.||.+.+ .+....+....+.+....+..............
T Consensus       160 ~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T d1ob3a_         160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT  239 (286)
T ss_dssp             --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCC
T ss_pred             ecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccc
Confidence            6788999999999887788999999999999999999999998776 445566677778887777776666665555566


Q ss_pred             CCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccC
Q 045787          246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIG  292 (324)
Q Consensus       246 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~  292 (324)
                      ...........+.+++.+.+||++||+.||++|||++|+++||||++
T Consensus       240 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             CCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             cccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence            66666677778889999999999999999999999999999999985

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-59  Score=401.24  Aligned_cols=284  Identities=39%  Similarity=0.682  Sum_probs=237.6

Q ss_pred             ceeEeecccCceEEEEEEEccCCceEEEEEeeecccc---CCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEE
Q 045787           10 KKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQ---EGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE   86 (324)
Q Consensus        10 ~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   86 (324)
                      +.++.||+|+||+||+|.++.+|+.||+|++......   ....+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus         1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE   80 (299)
T d1ua2a_           1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD   80 (299)
T ss_dssp             CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred             CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence            4578999999999999999999999999999765432   2234678899999999999999999999999999999999


Q ss_pred             ecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcccc
Q 045787           87 YLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSR  166 (324)
Q Consensus        87 ~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~  166 (324)
                      |+.|++...+......+++..++.++.||+.||.|||++|++||||||+|||++ .++.+||+|||.+............
T Consensus        81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~-~~~~~KL~DFG~a~~~~~~~~~~~~  159 (299)
T d1ua2a_          81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPNRAYTH  159 (299)
T ss_dssp             CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC-TTCCEEECCCGGGSTTTSCCCCCCC
T ss_pred             hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEec-CCCccccccCccccccCCCcccccc
Confidence            999888888877777899999999999999999999999999999999999999 9999999999999877655555556


Q ss_pred             cccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHHcCCCCcccccchhhhhcccCCCC
Q 045787          167 DCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-HDHLSLIFSLLGTPTDESWAESTYISEILPLYP  245 (324)
Q Consensus       167 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (324)
                      .++|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+ .+.+..+....+.+....+.......... ...
T Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~-~~~  238 (299)
T d1ua2a_         160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV-TFK  238 (299)
T ss_dssp             SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC-CCC
T ss_pred             eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhh-hhc
Confidence            6899999999999876778999999999999999999999998877 44556677777777776665543332222 122


Q ss_pred             CCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCC
Q 045787          246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVEN  295 (324)
Q Consensus       246 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~  295 (324)
                      ...........+.+++++.+||.+||+.||.+|||++|+|+||||++.+.
T Consensus       239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~  288 (299)
T d1ua2a_         239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG  288 (299)
T ss_dssp             CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred             cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCC
Confidence            23344455666788999999999999999999999999999999998764

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-60  Score=399.55  Aligned_cols=268  Identities=24%  Similarity=0.400  Sum_probs=225.1

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeecc-ccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQT-EQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   83 (324)
                      ..++|++.+.||+|+||+||+|.++.+|+.||+|++.... ......+.+.+|++++++++||||+++++++.+++.+|+
T Consensus         6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i   85 (288)
T d1uu3a_           6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF   85 (288)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred             CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence            4568999999999999999999999999999999997654 234445778999999999999999999999999999999


Q ss_pred             EEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC
Q 045787           84 VFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK  162 (324)
Q Consensus        84 v~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~  162 (324)
                      ||||++| +|.+++... +.+++..++.++.|++.||.|||++|++||||||+||+++ +++.++|+|||.+........
T Consensus        86 vmEy~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~-~~~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          86 GLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             EECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-TTSCEEECCCTTCEECC----
T ss_pred             EEEccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccC-CCceEEecccccceecccCCc
Confidence            9999985 888877664 5699999999999999999999999999999999999999 899999999999987653322


Q ss_pred             --cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcc
Q 045787          163 --EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEI  240 (324)
Q Consensus       163 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (324)
                        .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.... +              
T Consensus       164 ~~~~~~~~GT~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~-~--------------  227 (288)
T d1uu3a_         164 QARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-Y--------------  227 (288)
T ss_dssp             ------CCCCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC-C--------------
T ss_pred             ccccccccCCccccCceeecc-CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC-C--------------
Confidence              2334579999999999988 678999999999999999999999998877555433322110 0              


Q ss_pred             cCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHH------HhcCccccCCCCchhhhhhh
Q 045787          241 LPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMD------ALKHEYLIGVENVPLVILLI  303 (324)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~------~l~hp~~~~~~~~~~~~~~~  303 (324)
                                   .....+++++++||++||+.||.+|||++|      +++||||+++++..+.....
T Consensus       228 -------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~~~p  283 (288)
T d1uu3a_         228 -------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP  283 (288)
T ss_dssp             -------------CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSCC
T ss_pred             -------------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhhcCCC
Confidence                         011257899999999999999999999988      57899999999887765433

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-60  Score=396.37  Aligned_cols=256  Identities=28%  Similarity=0.450  Sum_probs=206.5

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeec--CCeEEE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS--RKDVFL   83 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~i   83 (324)
                      .++|++++.||+|+||+||+|+++.+|+.||+|.+..........+.+.+|+.++++++||||+++++++.+  ++.+|+
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            468999999999999999999999999999999998765444445678899999999999999999998854  457899


Q ss_pred             EEEecC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC-----CcccCCCCCceEeecCCCcEEEeeccce
Q 045787           84 VFEYLD-LDLHSFITRH---KNTLNLLVIKAILKQILLGLAYCHSLK-----ILHRDLKPNNLLIDLKRNTVKLADFGLA  154 (324)
Q Consensus        84 v~e~~~-g~l~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~g-----~~H~di~p~nIll~~~~~~v~l~d~g~~  154 (324)
                      ||||++ |+|.+++...   ...+++..++.++.|++.||.|||++|     ++||||||+|||++ .++.+||+|||.+
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~-~~~~vkl~DFG~a  161 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGLA  161 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEEC-TTSCEEECCHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcC-CCCcEEEeeccce
Confidence            999998 5888887643   457999999999999999999999876     99999999999999 8899999999999


Q ss_pred             eeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccch
Q 045787          155 RAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAES  234 (324)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (324)
                      ..............||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+...+...+.....+        
T Consensus       162 ~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~--------  232 (269)
T d2java1         162 RILNHDTSFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR--------  232 (269)
T ss_dssp             HHC-----------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC--------
T ss_pred             eecccCCCccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC--------
Confidence            877644444555689999999999987 67899999999999999999999999887766554433321111        


Q ss_pred             hhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccc
Q 045787          235 TYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYL  290 (324)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~  290 (324)
                                         .....+++++.+||.+||+.||.+|||++|+++|||+
T Consensus       233 -------------------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         233 -------------------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             -------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             -------------------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence                               0112578999999999999999999999999999996

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5e-59  Score=399.11  Aligned_cols=264  Identities=27%  Similarity=0.392  Sum_probs=220.4

Q ss_pred             CcceeEeecccCceEEEEEEEccCCceEEEEEeeecccc-CCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEE
Q 045787            8 NYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQ-EGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE   86 (324)
Q Consensus         8 ~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   86 (324)
                      .|++++.||+|+||+||+|.+..+|+.||+|++...... ....+.+.+|+.++++++||||+++++++.+++..|+|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            499999999999999999999999999999998765422 2223568899999999999999999999999999999999


Q ss_pred             ecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcccc
Q 045787           87 YLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSR  166 (324)
Q Consensus        87 ~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~  166 (324)
                      |+.|+++..+.....++++..++.++.||+.||.|||++|++||||||+|||++ .++.+||+|||.+.....    ...
T Consensus        96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~-~~~~~Kl~DFG~a~~~~~----~~~  170 (309)
T d1u5ra_          96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS-EPGLVKLGDFGSASIMAP----ANS  170 (309)
T ss_dssp             CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE-TTTEEEECCCTTCBSSSS----BCC
T ss_pred             ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEC-CCCCEEEeecccccccCC----CCc
Confidence            999766666666667899999999999999999999999999999999999999 899999999999986542    234


Q ss_pred             cccccccCCchhhcC--CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCC
Q 045787          167 DCVYSPYKAPELLLG--YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLY  244 (324)
Q Consensus       167 ~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (324)
                      ..||+.|+|||++.+  ...++.++|||||||++|+|++|..||...+.............+..                
T Consensus       171 ~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~----------------  234 (309)
T d1u5ra_         171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL----------------  234 (309)
T ss_dssp             CCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC----------------
T ss_pred             cccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC----------------
Confidence            579999999999864  34589999999999999999999999987765443332222211111                


Q ss_pred             CCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchhhhhh
Q 045787          245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILL  302 (324)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~~~~~  302 (324)
                                ....+++++.+||.+||+.||.+|||++++++||||+.-........+
T Consensus       235 ----------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~~~~~~~~~  282 (309)
T d1u5ra_         235 ----------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDL  282 (309)
T ss_dssp             ----------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCTTHHHHH
T ss_pred             ----------CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCCCCchhhHHH
Confidence                      012578999999999999999999999999999999876655443333

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-58  Score=399.74  Aligned_cols=263  Identities=24%  Similarity=0.410  Sum_probs=228.6

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeecc-ccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQT-EQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   83 (324)
                      .-++|++++.||+|+||.||+|+++.+|+.||+|++.... ......+.+.+|+.++++++||||+++++++.+++.+|+
T Consensus         3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i   82 (337)
T d1o6la_           3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF   82 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred             chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccc
Confidence            4468999999999999999999999999999999998654 233445778899999999999999999999999999999


Q ss_pred             EEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC
Q 045787           84 VFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK  162 (324)
Q Consensus        84 v~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~  162 (324)
                      ||||++| +|.+++.. .+.+++..++.++.||+.||.|||++|++||||||+|||++ .++.+||+|||.+........
T Consensus        83 v~ey~~gg~L~~~~~~-~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~-~~g~vkl~DFG~a~~~~~~~~  160 (337)
T d1o6la_          83 VMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC-TTSCEEECCCTTCBCSCCTTC
T ss_pred             ceeccCCCchhhhhhc-ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEec-CCCCEEEeecccccccccCCc
Confidence            9999985 77777665 45699999999999999999999999999999999999999 889999999999987765555


Q ss_pred             cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccC
Q 045787          163 EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILP  242 (324)
Q Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (324)
                      .....+||+.|+|||++.+ ..++.++|+|||||++|+|++|++||.+.+...+..........                
T Consensus       161 ~~~~~~GT~~Y~aPE~~~~-~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~----------------  223 (337)
T d1o6la_         161 TMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR----------------  223 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC----------------
T ss_pred             ccccceeCHHHhhhhhccC-CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCC----------------
Confidence            5666789999999999988 67899999999999999999999999988876655444322111                


Q ss_pred             CCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCC-----HHHHhcCccccCCCCchh
Q 045787          243 LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRIT-----AMDALKHEYLIGVENVPL  298 (324)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~~~l~hp~~~~~~~~~~  298 (324)
                                  ....+++++++||++||++||.+|++     +.++++||||+++++..+
T Consensus       224 ------------~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l  272 (337)
T d1o6la_         224 ------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV  272 (337)
T ss_dssp             ------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHH
T ss_pred             ------------CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCHHHH
Confidence                        11358899999999999999999994     899999999999875544

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.2e-59  Score=397.36  Aligned_cols=262  Identities=26%  Similarity=0.406  Sum_probs=205.3

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLV   84 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   84 (324)
                      +.++|++.+.||+|+||+||+|.++.+|+.||+|++........ ...+.+|+.++++++||||+++++++.+++.+|+|
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   85 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK-EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI   85 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhH-HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            46789999999999999999999999999999999986553322 35678999999999999999999999999999999


Q ss_pred             EEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeec--CCCcEEEeeccceeeccCCC
Q 045787           85 FEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL--KRNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        85 ~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~--~~~~v~l~d~g~~~~~~~~~  161 (324)
                      |||++ |+|.+++.. .+.+++..++.++.||+.||.|||++|++||||||+||++..  .++.+||+|||++..... .
T Consensus        86 mE~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~-~  163 (307)
T d1a06a_          86 MQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP-G  163 (307)
T ss_dssp             ECCCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred             EeccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccC-C
Confidence            99998 588888876 457999999999999999999999999999999999999952  468999999999986653 2


Q ss_pred             CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhccc
Q 045787          162 KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEIL  241 (324)
Q Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (324)
                      ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.......              
T Consensus       164 ~~~~~~~GT~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~--------------  228 (307)
T d1a06a_         164 SVLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEF--------------  228 (307)
T ss_dssp             ---------CTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCC--------------
T ss_pred             CeeeeeeeCccccCcHHHcC-CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCC--------------
Confidence            33345679999999999988 678999999999999999999999998877555433332211111              


Q ss_pred             CCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCC
Q 045787          242 PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVE  294 (324)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~  294 (324)
                                .....+.+|+++.+||.+||+.||.+|||++|+++||||++-.
T Consensus       229 ----------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  271 (307)
T d1a06a_         229 ----------DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDT  271 (307)
T ss_dssp             ----------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSC
T ss_pred             ----------CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence                      0112346899999999999999999999999999999998643

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-58  Score=388.55  Aligned_cols=260  Identities=26%  Similarity=0.364  Sum_probs=213.2

Q ss_pred             CCcccCcCc-ceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeec--
Q 045787            1 MGKLKNLNY-KKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS--   77 (324)
Q Consensus         1 ~~~~~~~~y-~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--   77 (324)
                      +|....++| +..+.||+|+||+||+|.+..++..||+|.+..........+.+.+|++++++++||||+++++++.+  
T Consensus         2 ~g~~~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   81 (270)
T d1t4ha_           2 VGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV   81 (270)
T ss_dssp             CEECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred             CCcCCCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc
Confidence            356677788 67778999999999999999999999999987665443335678899999999999999999999864  


Q ss_pred             --CCeEEEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcccCCCCCceEeecCCCcEEEeecc
Q 045787           78 --RKDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLK--ILHRDLKPNNLLIDLKRNTVKLADFG  152 (324)
Q Consensus        78 --~~~~~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g--~~H~di~p~nIll~~~~~~v~l~d~g  152 (324)
                        +..+|+||||++| +|.+++... ..+++..++.++.||+.||.|||++|  ++||||||+|||++.+++.+||+|||
T Consensus        82 ~~~~~~~ivmE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFG  160 (270)
T d1t4ha_          82 KGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG  160 (270)
T ss_dssp             SSCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred             ccCCEEEEEEeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecC
Confidence              4568999999985 888877664 56999999999999999999999998  99999999999997467899999999


Q ss_pred             ceeeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhH-HHHHHHHcCCCCcccc
Q 045787          153 LARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDH-LSLIFSLLGTPTDESW  231 (324)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~  231 (324)
                      ++.....  ......+||+.|+|||++.+  .++.++|||||||++|+|++|+.||....... ...... .+..+.   
T Consensus       161 la~~~~~--~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~-~~~~~~---  232 (270)
T d1t4ha_         161 LATLKRA--SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT-SGVKPA---  232 (270)
T ss_dssp             GGGGCCT--TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHT-TTCCCG---
T ss_pred             cceeccC--CccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHH-cCCCCc---
Confidence            9975432  23344579999999999875  48999999999999999999999997655332 222111 111110   


Q ss_pred             cchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCcccc
Q 045787          232 AESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLI  291 (324)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~  291 (324)
                                            ......++++.++|.+||+.||++|||++|+++||||+
T Consensus       233 ----------------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         233 ----------------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             ----------------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             ----------------------ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence                                  11125788999999999999999999999999999996

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.2e-58  Score=403.10  Aligned_cols=261  Identities=23%  Similarity=0.405  Sum_probs=222.9

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE   86 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   86 (324)
                      ++|++++.||+|+||.||+|.+..+|+.||+|++.......  .+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE  103 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD--KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  103 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHH--HHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhh--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            58999999999999999999999999999999987554322  4678899999999999999999999999999999999


Q ss_pred             ecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeec-CCCcEEEeeccceeeccCCCCcc
Q 045787           87 YLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL-KRNTVKLADFGLARAIGVPQKEY  164 (324)
Q Consensus        87 ~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~-~~~~v~l~d~g~~~~~~~~~~~~  164 (324)
                      |++ |+|.+.+....+++++..++.++.||+.||.|||++|++||||||+|||++. .++.+||+|||++...... ...
T Consensus       104 ~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~-~~~  182 (350)
T d1koaa2         104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-QSV  182 (350)
T ss_dssp             CCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-SCE
T ss_pred             cCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc-ccc
Confidence            998 5888988776778999999999999999999999999999999999999963 3578999999999877533 333


Q ss_pred             cccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCC
Q 045787          165 SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLY  244 (324)
Q Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (324)
                      ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+........                
T Consensus       183 ~~~~gT~~Y~aPEv~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~----------------  245 (350)
T d1koaa2         183 KVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD----------------  245 (350)
T ss_dssp             EEECSCTTTCCHHHHHT-CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSC----------------
T ss_pred             ceecCcccccCHHHHcC-CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----------------
Confidence            44678999999999988 6789999999999999999999999988776554443332211111                


Q ss_pred             CCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCC
Q 045787          245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVEN  295 (324)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~  295 (324)
                              ....+.+++++++||.+||+.||.+|||++|+|+||||++.+.
T Consensus       246 --------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~  288 (350)
T d1koaa2         246 --------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA  288 (350)
T ss_dssp             --------CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred             --------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence                    1122358899999999999999999999999999999998764

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-58  Score=392.33  Aligned_cols=268  Identities=29%  Similarity=0.472  Sum_probs=220.4

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccC----CCchHHHHHHHHHHhcCCCCeeEEEeeeecCCe
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQE----GVPSYIIREVSLLKELEHENIVRLLDVQSSRKD   80 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   80 (324)
                      +.++|++.+.||+|+||+||+|+++.+|+.||+|++.......    ...+.+.+|+.++++++||||+++++++.+++.
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   87 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            3578999999999999999999999999999999997654322    234678999999999999999999999999999


Q ss_pred             EEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCC----cEEEeecccee
Q 045787           81 VFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN----TVKLADFGLAR  155 (324)
Q Consensus        81 ~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~----~v~l~d~g~~~  155 (324)
                      +|+||||++ |+|.+++... +.+++..++.++.|++.||.|||+.|++||||||+||+++ .++    .+||+|||.+.
T Consensus        88 ~~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~-~~~~~~~~vkl~DfG~a~  165 (293)
T d1jksa_          88 VILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLL-DRNVPKPRIKIIDFGLAH  165 (293)
T ss_dssp             EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEES-CSSSSSCCEEECCCTTCE
T ss_pred             EEEEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEe-cCCCcccceEecchhhhh
Confidence            999999998 5888887664 4699999999999999999999999999999999999998 444    59999999998


Q ss_pred             eccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchh
Q 045787          156 AIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAEST  235 (324)
Q Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (324)
                      ..... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+......         
T Consensus       166 ~~~~~-~~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~---------  234 (293)
T d1jksa_         166 KIDFG-NEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE---------  234 (293)
T ss_dssp             ECTTS-CBCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCC---------
T ss_pred             hcCCC-ccccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC---------
Confidence            77533 33445578899999999987 67899999999999999999999999887755543333221111         


Q ss_pred             hhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchhhh
Q 045787          236 YISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVI  300 (324)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~~~  300 (324)
                                     ......+.+++.+++||++||+.||.+|||++|+++||||++.+......
T Consensus       235 ---------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~l~  284 (293)
T d1jksa_         235 ---------------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALS  284 (293)
T ss_dssp             ---------------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--------
T ss_pred             ---------------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCChhHhhc
Confidence                           11122346899999999999999999999999999999999887766543

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.3e-58  Score=395.43  Aligned_cols=259  Identities=24%  Similarity=0.365  Sum_probs=222.1

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeecc-ccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQT-EQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      ++|++++.||+|+||+||+|+++.+|+.||+|++.... ......+.+.+|+.++++++||||+++++++.+++.+|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            57999999999999999999999999999999997654 23444677899999999999999999999999999999999


Q ss_pred             EecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCccc
Q 045787           86 EYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYS  165 (324)
Q Consensus        86 e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~  165 (324)
                      ||+.|+.+..+......+++..++.++.||+.||.|||++|++||||||+|||++ .++.+||+|||.+.....   ...
T Consensus        84 E~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~-~~g~vkL~DFG~a~~~~~---~~~  159 (316)
T d1fota_          84 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD-KNGHIKITDFGFAKYVPD---VTY  159 (316)
T ss_dssp             CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC-TTSCEEECCCSSCEECSS---CBC
T ss_pred             eecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEc-CCCCEEEecCccceEecc---ccc
Confidence            9998644444444566799999999999999999999999999999999999999 899999999999987653   234


Q ss_pred             ccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCC
Q 045787          166 RDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYP  245 (324)
Q Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (324)
                      ..+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+......                   
T Consensus       160 ~~~Gt~~Y~APE~l~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~-------------------  219 (316)
T d1fota_         160 TLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR-------------------  219 (316)
T ss_dssp             CCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCC-------------------
T ss_pred             cccCcccccCHHHHcC-CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCC-------------------
Confidence            5689999999999987 67899999999999999999999999887765544333211110                   


Q ss_pred             CCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCC-----CHHHHhcCccccCCCCchh
Q 045787          246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRI-----TAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       246 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~~l~hp~~~~~~~~~~  298 (324)
                               ..+.+++++.++|.+||..||.+|+     |++++++||||+++++..+
T Consensus       220 ---------~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l  268 (316)
T d1fota_         220 ---------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKL  268 (316)
T ss_dssp             ---------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHH
T ss_pred             ---------CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHHHH
Confidence                     1135789999999999999999996     8999999999999986655

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-59  Score=406.24  Aligned_cols=288  Identities=25%  Similarity=0.404  Sum_probs=218.8

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF   82 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   82 (324)
                      ++..++|++++.||+|+||+||+|.+..+|+.||+|++..... ......+.+|+.++++++||||+++++++.+++.+|
T Consensus         2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   80 (322)
T d1s9ja_           2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   80 (322)
T ss_dssp             CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC-TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred             CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            4678999999999999999999999999999999999876432 333467889999999999999999999999999999


Q ss_pred             EEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           83 LVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS-LKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        83 iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      +||||+.| +|.+++.+. +.+++..++.++.|++.||.|||+ +|++||||||+|||++ .++.+||+|||+|......
T Consensus        81 iVmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~-~~~~vkl~DFGla~~~~~~  158 (322)
T d1s9ja_          81 ICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDS  158 (322)
T ss_dssp             EEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEEC-TTCCEEECCCCCCHHHHHH
T ss_pred             EEEEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeEC-CCCCEEEeeCCCccccCCC
Confidence            99999985 888777664 569999999999999999999997 5999999999999999 8999999999999865422


Q ss_pred             CCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHH--HcCCCCccc----ccch
Q 045787          161 QKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFS--LLGTPTDES----WAES  234 (324)
Q Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~----~~~~  234 (324)
                        .....+||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+.........  ..+.+....    ....
T Consensus       159 --~~~~~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (322)
T d1s9ja_         159 --MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR  235 (322)
T ss_dssp             --TC---CCSSCCCCHHHHHC-SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred             --ccccccCCccccCchHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence              2234579999999999998 778999999999999999999999998776443322211  111111000    0000


Q ss_pred             hhhhcccCCCCCCCCcch----------hhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCc
Q 045787          235 TYISEILPLYPHFEPANL----------AEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENV  296 (324)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~  296 (324)
                      ..................          ......++.++.+||.+||+.||.+|||++|+|+||||++.+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~~  307 (322)
T d1s9ja_         236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE  307 (322)
T ss_dssp             ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHHS
T ss_pred             cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCcc
Confidence            000000000000000000          00012367899999999999999999999999999999876543

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3.7e-58  Score=400.37  Aligned_cols=261  Identities=23%  Similarity=0.424  Sum_probs=222.6

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      .++|++++.||+|+||.||+|.+..+|+.||+|++.......  ...+.+|+.++++++||||+++++++.+++.+|+||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm  105 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD--KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL  105 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH--HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            367999999999999999999999999999999987654322  356889999999999999999999999999999999


Q ss_pred             EecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeec-CCCcEEEeeccceeeccCCCCc
Q 045787           86 EYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL-KRNTVKLADFGLARAIGVPQKE  163 (324)
Q Consensus        86 e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~-~~~~v~l~d~g~~~~~~~~~~~  163 (324)
                      ||++ |+|.+.+.....++++..++.++.||+.||.|||++|++||||||+|||++. .++.+||+|||++..... ...
T Consensus       106 E~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~-~~~  184 (352)
T d1koba_         106 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP-DEI  184 (352)
T ss_dssp             ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT-TSC
T ss_pred             EcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCC-CCc
Confidence            9998 5888887776678999999999999999999999999999999999999973 458999999999988763 333


Q ss_pred             ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCC
Q 045787          164 YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPL  243 (324)
Q Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (324)
                      .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+........               
T Consensus       185 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~---------------  248 (352)
T d1koba_         185 VKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD---------------  248 (352)
T ss_dssp             EEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC---------------
T ss_pred             eeeccCcccccCHHHHcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---------------
Confidence            444678999999999988 7789999999999999999999999988776554433332221111               


Q ss_pred             CCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCC
Q 045787          244 YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVE  294 (324)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~  294 (324)
                               ...++.+++++.+||.+||+.||.+|||++|+|+||||++..
T Consensus       249 ---------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~  290 (352)
T d1koba_         249 ---------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  290 (352)
T ss_dssp             ---------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             ---------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence                     112346899999999999999999999999999999998754

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-57  Score=387.62  Aligned_cols=286  Identities=39%  Similarity=0.695  Sum_probs=233.4

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccC-CceEEEEEeeeccccCCCchHHHHHHHHHHhc---CCCCeeEEEeeeec---
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVT-GQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL---EHENIVRLLDVQSS---   77 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~---   77 (324)
                      ..++|++++.||+|+||+||+|++..+ ++.||+|++............+.+|+.+++.+   +||||+++++++..   
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            357999999999999999999999654 66799999987765555556677888888776   79999999998853   


Q ss_pred             --CCeEEEEEEecCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccce
Q 045787           78 --RKDVFLVFEYLDLDLHSFITR-HKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLA  154 (324)
Q Consensus        78 --~~~~~iv~e~~~g~l~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~  154 (324)
                        ....++++|++++++...... ....+++..++.++.|++.||.|||++|++||||||+|||++ .++.++|+|||.+
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~-~~~~~kl~dfg~~  163 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT-SSGQIKLADFGLA  163 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC-TTCCEEECSCCSC
T ss_pred             ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEc-CCCCeeecchhhh
Confidence              357899999999876655443 445699999999999999999999999999999999999999 8999999999998


Q ss_pred             eeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHHcCCCCcccccc
Q 045787          155 RAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-HDHLSLIFSLLGTPTDESWAE  233 (324)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~  233 (324)
                      .... .........||+.|+|||++.+ .+++.++|||||||++|+|++|+.||.+.+ .+.+..+....+.+....+..
T Consensus       164 ~~~~-~~~~~~~~~gT~~Y~APE~~~~-~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  241 (305)
T d1blxa_         164 RIYS-FQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR  241 (305)
T ss_dssp             CCCC-GGGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred             hhhc-ccccCCCcccChhhcCcchhcC-CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccc
Confidence            7654 2334455689999999999988 778999999999999999999999998887 445566667777777666554


Q ss_pred             hhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCC
Q 045787          234 STYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVEN  295 (324)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~  295 (324)
                      ........  ...............+++.+.+||.+||+.||.+|||++|+|+||||++++.
T Consensus       242 ~~~~~~~~--~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~  301 (305)
T d1blxa_         242 DVALPRQA--FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  301 (305)
T ss_dssp             TCSSCGGG--SCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             cccchhhh--hccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence            33332221  1222233344556678999999999999999999999999999999999864

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-56  Score=383.81  Aligned_cols=288  Identities=44%  Similarity=0.747  Sum_probs=246.5

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFE   86 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   86 (324)
                      ++|++++.||+|+||+||+|.+..+|+.||+|++............+.+|+.++++++||||+++++++.+....+++++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            58999999999999999999999999999999998766555566788999999999999999999999999999999999


Q ss_pred             ecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcccc
Q 045787           87 YLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEYSR  166 (324)
Q Consensus        87 ~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~~~  166 (324)
                      ++.|..+..+....+.+++..++.++.|++.||+|||++|++|+||||+|||++ .++.++|+|||.+............
T Consensus        82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~-~~~~~kl~DFG~a~~~~~~~~~~~~  160 (292)
T d1unla_          82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN-RNGELKLANFGLARAFGIPVRCYSA  160 (292)
T ss_dssp             CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC-TTCCEEECCCTTCEECCSCCSCCCS
T ss_pred             eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccc-cCCceeeeecchhhcccCCCcccee
Confidence            999877777777777899999999999999999999999999999999999999 8899999999999988766555555


Q ss_pred             cccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCC-CC-hhHHHHHHHHcCCCCcccccchhhhhcccCCC
Q 045787          167 DCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPS-KK-HDHLSLIFSLLGTPTDESWAESTYISEILPLY  244 (324)
Q Consensus       167 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (324)
                      ..+++.|+|||++.+...++.++|||||||++|+|++|+.||.. .+ .+.+..+....+.+....+.......+.....
T Consensus       161 ~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (292)
T d1unla_         161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP  240 (292)
T ss_dssp             CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCC
T ss_pred             eccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccc
Confidence            66778899999998767789999999999999999999988644 33 44556677777777777666655554444433


Q ss_pred             CCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCC
Q 045787          245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVEN  295 (324)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~  295 (324)
                      ............+.+++.+.+||++||+.||.+|||++|+|+||||++..+
T Consensus       241 ~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~  291 (292)
T d1unla_         241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP  291 (292)
T ss_dssp             CCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSC
T ss_pred             cccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCC
Confidence            333444555566778999999999999999999999999999999998654

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4e-57  Score=393.82  Aligned_cols=259  Identities=24%  Similarity=0.413  Sum_probs=223.2

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeecc-ccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQT-EQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++.... ......+.+.+|+.+++.++||||+++++++.+....++|+
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            68999999999999999999999999999999987654 33344567889999999999999999999999999999999


Q ss_pred             EecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCcc
Q 045787           86 EYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKEY  164 (324)
Q Consensus        86 e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~~  164 (324)
                      ||+.| ++...+... +.+++..++.++.||+.||.|||++|++||||||+|||++ .++.+||+|||++.....   ..
T Consensus       121 e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~-~~g~ikL~DFG~a~~~~~---~~  195 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVKG---RT  195 (350)
T ss_dssp             ECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC-TTSCEEECCCTTCEECSS---CB
T ss_pred             ccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccC-CCCCEEeeeceeeeeccc---cc
Confidence            99985 777777654 5699999999999999999999999999999999999999 889999999999987653   23


Q ss_pred             cccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCC
Q 045787          165 SRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLY  244 (324)
Q Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (324)
                      ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+......                  
T Consensus       196 ~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~------------------  256 (350)
T d1rdqe_         196 WTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR------------------  256 (350)
T ss_dssp             CCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC------------------
T ss_pred             ccccCccccCCHHHHcC-CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCC------------------
Confidence            44679999999999988 67899999999999999999999999887755544333221111                  


Q ss_pred             CCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCC-----CHHHHhcCccccCCCCchhh
Q 045787          245 PHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRI-----TAMDALKHEYLIGVENVPLV  299 (324)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~~l~hp~~~~~~~~~~~  299 (324)
                                ....+++++.++|++||+.||.+|+     |++++++||||+++++..+.
T Consensus       257 ----------~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~  306 (350)
T d1rdqe_         257 ----------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY  306 (350)
T ss_dssp             ----------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHH
T ss_pred             ----------CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHHHHH
Confidence                      1135889999999999999999995     99999999999999876553

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.7e-56  Score=377.72  Aligned_cols=261  Identities=27%  Similarity=0.476  Sum_probs=220.7

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCC-------chHHHHHHHHHHhcC-CCCeeEEEeeeec
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGV-------PSYIIREVSLLKELE-HENIVRLLDVQSS   77 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~-------~~~~~~e~~~l~~l~-~~~i~~~~~~~~~   77 (324)
                      .++|++.+.||+|+||+||+|++..+|+.||+|++.........       .+.+.+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            57999999999999999999999999999999999876533221       235778999999997 9999999999999


Q ss_pred             CCeEEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceee
Q 045787           78 RKDVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARA  156 (324)
Q Consensus        78 ~~~~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~  156 (324)
                      ++..|+||||++ |+|.+++.. .+++++..++.++.||+.||.|||++|++||||||+||+++ .++.+||+|||.+..
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~-~~~~~kl~DFG~a~~  159 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD-DDMNIKLTDFGFSCQ  159 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-TTCCEEECCCTTCEE
T ss_pred             CcceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEc-CCCCeEEccchheeE
Confidence            999999999997 588888876 45799999999999999999999999999999999999999 999999999999988


Q ss_pred             ccCCCCcccccccccccCCchhhcC-----CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccc
Q 045787          157 IGVPQKEYSRDCVYSPYKAPELLLG-----YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESW  231 (324)
Q Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  231 (324)
                      .... .......||+.|+|||++.+     ...++.++||||+||++|+|++|+.||.+.+.......+........   
T Consensus       160 ~~~~-~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~---  235 (277)
T d1phka_         160 LDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG---  235 (277)
T ss_dssp             CCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC---
T ss_pred             ccCC-CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCC---
Confidence            7643 33445678999999999863     34578899999999999999999999988876554433332111100   


Q ss_pred             cchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCC
Q 045787          232 AESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV  293 (324)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~  293 (324)
                                           ......+|+++++||.+||+.||.+|||++|+++||||++.
T Consensus       236 ---------------------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         236 ---------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             ---------------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             ---------------------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence                                 01123688999999999999999999999999999999863

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-57  Score=387.59  Aligned_cols=260  Identities=27%  Similarity=0.436  Sum_probs=222.7

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeecc-ccCCCchHHHHHHHHHH-hcCCCCeeEEEeeeecCCeEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQT-EQEGVPSYIIREVSLLK-ELEHENIVRLLDVQSSRKDVFLV   84 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~iv   84 (324)
                      ++|++.+.||+|+||+||+|.++.+|+.||+|++.... ......+.+..|..++. .++||||+++++++.+++.+|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57999999999999999999999999999999997654 22333455667777664 68999999999999999999999


Q ss_pred             EEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCc
Q 045787           85 FEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE  163 (324)
Q Consensus        85 ~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~  163 (324)
                      |||++| +|.+++.. ...+++..++.++.||+.||.|||++|++||||||+|||++ .++.+||+|||.+.........
T Consensus        82 mEy~~~g~L~~~i~~-~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~-~~~~~kl~DFG~a~~~~~~~~~  159 (320)
T d1xjda_          82 MEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD-KDGHIKIADFGMCKENMLGDAK  159 (320)
T ss_dssp             EECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC-TTSCEEECCCTTCBCCCCTTCC
T ss_pred             EeecCCCcHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeec-CCCceeccccchhhhccccccc
Confidence            999985 88887765 45699999999999999999999999999999999999999 8999999999999877655666


Q ss_pred             ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCC
Q 045787          164 YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPL  243 (324)
Q Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (324)
                      .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+...+...+.... +.                
T Consensus       160 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-~~----------------  221 (320)
T d1xjda_         160 TNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-PF----------------  221 (320)
T ss_dssp             BCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CC----------------
T ss_pred             ccccCCCCCcCCHHHHcC-CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CC----------------
Confidence            666789999999999988 678999999999999999999999999888666554433211 11                


Q ss_pred             CCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHH-HHhcCccccCCCCch
Q 045787          244 YPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAM-DALKHEYLIGVENVP  297 (324)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~-~~l~hp~~~~~~~~~  297 (324)
                                 ....+++++.+||++||+.||.+||++. ++++||||+++++..
T Consensus       222 -----------~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~~~  265 (320)
T d1xjda_         222 -----------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEE  265 (320)
T ss_dssp             -----------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHH
T ss_pred             -----------CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCCHHH
Confidence                       1125789999999999999999999996 899999999986543

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=8.4e-57  Score=393.82  Aligned_cols=265  Identities=23%  Similarity=0.375  Sum_probs=218.4

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccc-cCCCchHHHHH---HHHHHhcCCCCeeEEEeeeecCCe
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-QEGVPSYIIRE---VSLLKELEHENIVRLLDVQSSRKD   80 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e---~~~l~~l~~~~i~~~~~~~~~~~~   80 (324)
                      .-++|++.+.||+|+||.||+|++..+|+.||+|++..... .......+.+|   +.+++.++||||+++++++.+++.
T Consensus         2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~   81 (364)
T d1omwa3           2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK   81 (364)
T ss_dssp             CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred             CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence            34689999999999999999999999999999999875432 11222334444   666777789999999999999999


Q ss_pred             EEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccC
Q 045787           81 VFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGV  159 (324)
Q Consensus        81 ~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~  159 (324)
                      +|+||||++ |+|.+++... ..+++..++.++.||+.||.|||++|++||||||+|||++ .++.+||+|||++.....
T Consensus        82 ~~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~-~~g~iKl~DFGla~~~~~  159 (364)
T d1omwa3          82 LSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSK  159 (364)
T ss_dssp             EEEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC-SSSCEEECCCTTCEECSS
T ss_pred             EEEEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEc-CCCcEEEeeeceeeecCC
Confidence            999999998 5888877664 5699999999999999999999999999999999999999 899999999999987653


Q ss_pred             CCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhc
Q 045787          160 PQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISE  239 (324)
Q Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
                      .  .....+||+.|+|||++.+...++.++|||||||++|+|++|+.||...+......+.......+.           
T Consensus       160 ~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~-----------  226 (364)
T d1omwa3         160 K--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-----------  226 (364)
T ss_dssp             S--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCC-----------
T ss_pred             C--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC-----------
Confidence            3  334567999999999997657789999999999999999999999987664433333222111111           


Q ss_pred             ccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCC-----HHHHhcCccccCCCCchh
Q 045787          240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRIT-----AMDALKHEYLIGVENVPL  298 (324)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~~~l~hp~~~~~~~~~~  298 (324)
                                    .....+++++++||.+||+.||.+|||     ++++++||||+++++..+
T Consensus       227 --------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~  276 (364)
T d1omwa3         227 --------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMV  276 (364)
T ss_dssp             --------------CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHH
T ss_pred             --------------CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHHH
Confidence                          112368999999999999999999999     799999999999976544

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-57  Score=388.73  Aligned_cols=259  Identities=24%  Similarity=0.395  Sum_probs=220.8

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLV   84 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   84 (324)
                      +.++|++.+.||+|+||+||+|.++.+|+.||+|++......   ...+.+|++++++++||||+++++++.+++.+|+|
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~---~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   79 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD---QVLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH---HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc---HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            457899999999999999999999999999999999765432   35678999999999999999999999999999999


Q ss_pred             EEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecC-CCcEEEeeccceeeccCCCC
Q 045787           85 FEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLK-RNTVKLADFGLARAIGVPQK  162 (324)
Q Consensus        85 ~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~-~~~v~l~d~g~~~~~~~~~~  162 (324)
                      |||++| +|.+++...+.++++..++.++.||+.||.|||++|++||||||+|||++.. ...++|+|||.+..... ..
T Consensus        80 mE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~-~~  158 (321)
T d1tkia_          80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-GD  158 (321)
T ss_dssp             ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT-TC
T ss_pred             EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcccc-CC
Confidence            999985 8999888776689999999999999999999999999999999999999732 35899999999987653 33


Q ss_pred             cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccC
Q 045787          163 EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILP  242 (324)
Q Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (324)
                      ......+++.|+|||...+ ..++.++|||||||++|+|++|..||...+.......+......                
T Consensus       159 ~~~~~~~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~----------------  221 (321)
T d1tkia_         159 NFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYT----------------  221 (321)
T ss_dssp             EEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC----------------
T ss_pred             cccccccccccccchhccC-CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC----------------
Confidence            3445678899999999987 66899999999999999999999999888765544333221111                


Q ss_pred             CCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccC
Q 045787          243 LYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIG  292 (324)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~  292 (324)
                              .....++.+++++++||.+||+.||.+|||++|+++||||++
T Consensus       222 --------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         222 --------FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             --------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             --------CChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence                    111233468999999999999999999999999999999975

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-56  Score=390.98  Aligned_cols=287  Identities=37%  Similarity=0.616  Sum_probs=228.3

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCC-----
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK-----   79 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----   79 (324)
                      ..++|++++.||+|+||+||+|.+..+|+.||+|++..........+.+.+|+.++++++|||++++++++...+     
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            578999999999999999999999999999999999765444434567889999999999999999999987654     


Q ss_pred             -eEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeecc
Q 045787           80 -DVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIG  158 (324)
Q Consensus        80 -~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~  158 (324)
                       .+|+||||+++++......  ..+++..++.++.||+.||.|||++|++|+||||+|||++ .++.++++|||.+....
T Consensus        96 ~~~~lv~e~~~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~-~~~~~kl~Dfg~a~~~~  172 (346)
T d1cm8a_          96 TDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN-EDCELKILDFGLARQAD  172 (346)
T ss_dssp             CCCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC-TTCCEEECCCTTCEECC
T ss_pred             ceEEEEEecccccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcc-cccccccccccceeccC
Confidence             5799999998777776654  4699999999999999999999999999999999999999 99999999999998764


Q ss_pred             CCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHHcCCCCcccccchh--
Q 045787          159 VPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH-DHLSLIFSLLGTPTDESWAEST--  235 (324)
Q Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~--  235 (324)
                      .   ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+. ..+.......+.++...+....  
T Consensus       173 ~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (346)
T d1cm8a_         173 S---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD  249 (346)
T ss_dssp             S---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred             C---ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcch
Confidence            3   334567899999999998767789999999999999999999999988774 3445555555665543332211  


Q ss_pred             hhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCch
Q 045787          236 YISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP  297 (324)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~  297 (324)
                      .......................+++++.+||.+||+.||.+|||++|+|+||||+++.+..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~  311 (346)
T d1cm8a_         250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE  311 (346)
T ss_dssp             HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC---
T ss_pred             hhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCcc
Confidence            11111122233344455566678999999999999999999999999999999999987543

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-56  Score=379.18  Aligned_cols=257  Identities=26%  Similarity=0.376  Sum_probs=214.0

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeecccc----CCCchHHHHHHHHHHhcC--CCCeeEEEeeeecC
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQ----EGVPSYIIREVSLLKELE--HENIVRLLDVQSSR   78 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~----~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~   78 (324)
                      +.++|++.+.||+|+||+||+|.+..+|+.||+|++......    ......+.+|+.++++++  ||||+++++++.++
T Consensus         2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~   81 (273)
T d1xwsa_           2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP   81 (273)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence            467999999999999999999999999999999999764322    122345678999999997  89999999999999


Q ss_pred             CeEEEEEEecCC--CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceee
Q 045787           79 KDVFLVFEYLDL--DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARA  156 (324)
Q Consensus        79 ~~~~iv~e~~~g--~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~  156 (324)
                      +..++||||+.+  ++.+++.. ...+++..++.++.||+.||.|||++|++||||||+||+++.+++.+||+|||.+..
T Consensus        82 ~~~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~  160 (273)
T d1xwsa_          82 DSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL  160 (273)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             CeEEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccccee
Confidence            999999999974  56666555 457999999999999999999999999999999999999995558999999999987


Q ss_pred             ccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccchhh
Q 045787          157 IGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAESTY  236 (324)
Q Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (324)
                      ...  .......||+.|+|||++.+...++.++|||||||++|+|++|+.||...+.     +..  +..          
T Consensus       161 ~~~--~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----i~~--~~~----------  221 (273)
T d1xwsa_         161 LKD--TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----IIR--GQV----------  221 (273)
T ss_dssp             CCS--SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----HHH--CCC----------
T ss_pred             ccc--ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-----Hhh--ccc----------
Confidence            543  2334567999999999998755567889999999999999999999965321     000  000          


Q ss_pred             hhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchh
Q 045787          237 ISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~  298 (324)
                                       .....+|+++.+||++||+.||.+|||++|+++||||+++..+..
T Consensus       222 -----------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~p~e  266 (273)
T d1xwsa_         222 -----------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQE  266 (273)
T ss_dssp             -----------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCHHH
T ss_pred             -----------------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCCCCC
Confidence                             011358999999999999999999999999999999998865443

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-55  Score=384.64  Aligned_cols=283  Identities=33%  Similarity=0.548  Sum_probs=224.7

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeec------CCe
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS------RKD   80 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~   80 (324)
                      .+|+.++.||+|+||+||+|++..+|+.||+|++......      ..+|+.++++++||||+++++++..      ..+
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~   93 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY   93 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred             CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence            4799999999999999999999999999999998754322      2479999999999999999998743      345


Q ss_pred             EEEEEEecCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeec
Q 045787           81 VFLVFEYLDLDLHSFITR---HKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAI  157 (324)
Q Consensus        81 ~~iv~e~~~g~l~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~  157 (324)
                      +|+||||+++++...+..   ....+++..++.++.||+.||.|||++|++||||||+|||++.++..+||+|||++...
T Consensus        94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            899999999876665543   34579999999999999999999999999999999999999944458999999999876


Q ss_pred             cCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHHcCCCCcccccchhh
Q 045787          158 GVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-HDHLSLIFSLLGTPTDESWAESTY  236 (324)
Q Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  236 (324)
                      .. ........+++.|+|||.+.+...++.++|||||||++|+|++|+.||...+ .+.+..+....+.+....+.....
T Consensus       174 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~  252 (350)
T d1q5ka_         174 VR-GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP  252 (350)
T ss_dssp             CT-TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC
T ss_pred             cC-CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhcc
Confidence            53 2334445789999999998876788999999999999999999999998777 445556666667766544433221


Q ss_pred             hhcccCCCCCCCCcc-hhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCch
Q 045787          237 ISEILPLYPHFEPAN-LAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP  297 (324)
Q Consensus       237 ~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~  297 (324)
                      ..... .+....... .....+..++++.+||.+||+.||.+|||+.|+|+||||+++.+..
T Consensus       253 ~~~~~-~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~  313 (350)
T d1q5ka_         253 NYTEF-KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN  313 (350)
T ss_dssp             ---CC-CCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTT
T ss_pred             chhhc-cccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCC
Confidence            11111 111111111 1223346899999999999999999999999999999999987643

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-55  Score=377.23  Aligned_cols=286  Identities=38%  Similarity=0.682  Sum_probs=223.4

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeec--------
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS--------   77 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--------   77 (324)
                      .++|++++.||+|+||+||+|++..+|+.||+|++............+.+|+.++++++|||++++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            379999999999999999999999999999999998776666667788999999999999999999998754        


Q ss_pred             CCeEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeec
Q 045787           78 RKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAI  157 (324)
Q Consensus        78 ~~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~  157 (324)
                      +...|+||||+++++..........+++..++.++.|++.||.|||++|++||||||+|||++ .++.++|+|||.+...
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~-~~~~~kl~dfg~~~~~  167 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT-RDGVLKLADFGLARAF  167 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC-TTSCEEECCCTTCEEC
T ss_pred             CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeec-CCCcEEeeecceeeec
Confidence            456899999999888888777777899999999999999999999999999999999999999 8999999999999766


Q ss_pred             cCCC----CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhH-HHHHHHHcCCCCccccc
Q 045787          158 GVPQ----KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDH-LSLIFSLLGTPTDESWA  232 (324)
Q Consensus       158 ~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~  232 (324)
                      ....    ......++|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+... ...+....+.+....+.
T Consensus       168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  247 (318)
T d3blha1         168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP  247 (318)
T ss_dssp             CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred             ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhcc
Confidence            4322    223335789999999999876788999999999999999999999998877444 34455555555544332


Q ss_pred             chhhhhcccC--CCCCCCCcchhhhC--CCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCC
Q 045787          233 ESTYISEILP--LYPHFEPANLAEKF--PNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGV  293 (324)
Q Consensus       233 ~~~~~~~~~~--~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~  293 (324)
                      ..........  ..... ........  ...++++.+||.+||+.||++|||++|+|+||||++.
T Consensus       248 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~  311 (318)
T d3blha1         248 NVDNYELYEKLELVKGQ-KRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  311 (318)
T ss_dssp             TCCCC-------CCSSC-CBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred             ccchhhhhhhhcccccc-cccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence            2211111100  00000 00011100  1247788999999999999999999999999999963

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-55  Score=378.45  Aligned_cols=262  Identities=28%  Similarity=0.383  Sum_probs=209.9

Q ss_pred             cCcCcceeE-eecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhc-CCCCeeEEEeeeec----C
Q 045787            5 KNLNYKKIK-KIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSS----R   78 (324)
Q Consensus         5 ~~~~y~i~~-~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~----~   78 (324)
                      .-++|++++ .||+|+||+||+|.+..+++.||+|++..       ...+.+|+.++.++ +||||+++++++.+    +
T Consensus         9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~   81 (335)
T d2ozaa1           9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYAGR   81 (335)
T ss_dssp             GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence            356899986 59999999999999999999999999863       25577899987655 79999999999865    4


Q ss_pred             CeEEEEEEecC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeec--CCCcEEEeeccce
Q 045787           79 KDVFLVFEYLD-LDLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL--KRNTVKLADFGLA  154 (324)
Q Consensus        79 ~~~~iv~e~~~-g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~--~~~~v~l~d~g~~  154 (324)
                      ..+|+||||++ |+|.+++...+ ..+++..++.++.||+.||.|||++|++||||||+||+++.  ..+.+||+|||++
T Consensus        82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccccee
Confidence            67999999997 59999987653 46999999999999999999999999999999999999983  2457999999999


Q ss_pred             eeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccch
Q 045787          155 RAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAES  234 (324)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (324)
                      ...... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..........            
T Consensus       162 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~------------  227 (335)
T d2ozaa1         162 KETTSH-NSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT------------  227 (335)
T ss_dssp             EECCCC-CCCCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------------------
T ss_pred             eeccCC-CccccccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHH------------
Confidence            877533 34455689999999999987 6789999999999999999999999976553322111000            


Q ss_pred             hhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCC
Q 045787          235 TYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVEN  295 (324)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~  295 (324)
                              .............+..+++++.+||++||+.||.+|||+.|+++||||++...
T Consensus       228 --------~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~  280 (335)
T d2ozaa1         228 --------RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK  280 (335)
T ss_dssp             --------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTS
T ss_pred             --------HHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCC
Confidence                    00000000001112357899999999999999999999999999999976543

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-54  Score=376.17  Aligned_cols=287  Identities=35%  Similarity=0.585  Sum_probs=225.5

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCC-----eE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK-----DV   81 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~   81 (324)
                      .+|++++.||+|+||+||+|.+..+|+.||+|++..... ....+.+.+|+.++++++||+++++++++....     .+
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH-QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTC-HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcC-hHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            889999999999999999999999999999999875432 222356789999999999999999999986543     46


Q ss_pred             EEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC
Q 045787           82 FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        82 ~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~  161 (324)
                      |++++..+|+|.+++..  ..+++..++.++.|++.||.|||++|++||||||+|||++ .++.+||+|||.+.......
T Consensus        87 ~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~-~~~~~kl~DfG~a~~~~~~~  163 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDH  163 (345)
T ss_dssp             EEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC-TTCCEEECCCTTCEECCGGG
T ss_pred             EEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEEC-CCCCEEEcccCceeeccCCC
Confidence            77777777899998875  3699999999999999999999999999999999999999 88999999999997664332


Q ss_pred             C---cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhH-HHHHHHHcCCCCcccccchh--
Q 045787          162 K---EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDH-LSLIFSLLGTPTDESWAEST--  235 (324)
Q Consensus       162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~--  235 (324)
                      .   .....++++.|+|||++.....++.++||||+||++|+|++|+.||...+... ..........+.........  
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (345)
T d1pmea_         164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL  243 (345)
T ss_dssp             CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred             ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhh
Confidence            2   23445788999999998776778999999999999999999999998877433 33333334444332211110  


Q ss_pred             hhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCch
Q 045787          236 YISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP  297 (324)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~  297 (324)
                      .....................+.++.++.+||.+||+.||.+|||+.|+|+||||+......
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~  305 (345)
T d1pmea_         244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS  305 (345)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred             hhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCc
Confidence            11111222333344455667778999999999999999999999999999999999776653

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=6e-54  Score=372.42  Aligned_cols=281  Identities=31%  Similarity=0.528  Sum_probs=216.4

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcC-CCCeeEEEeeeec--CCeE
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-HENIVRLLDVQSS--RKDV   81 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~   81 (324)
                      ..++|++++.||+|+||+||+|++..+|+.||+|++....     .+.+.+|+.++++++ ||||+++++++..  ....
T Consensus        33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~  107 (328)
T d3bqca1          33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  107 (328)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred             CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence            3578999999999999999999999999999999986432     356889999999996 9999999999874  4579


Q ss_pred             EEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           82 FLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        82 ~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      ++||||+++ +|...    .+.+++..++.++.||+.||.|||++|++|+||||+|||++.+++.++|+|||.+......
T Consensus       108 ~~v~e~~~~~~L~~~----~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~  183 (328)
T d3bqca1         108 ALVFEHVNNTDFKQL----YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  183 (328)
T ss_dssp             EEEEECCCSCBGGGT----TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred             eEEEeecCCCcHHHH----hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC
Confidence            999999996 55443    2469999999999999999999999999999999999999945567999999999876533


Q ss_pred             CCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh--hHHHHHHHHcCCCCcccccc-----
Q 045787          161 QKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKH--DHLSLIFSLLGTPTDESWAE-----  233 (324)
Q Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~-----  233 (324)
                       .......+|+.|+|||.+.+...++.++|+||+||++|+|++|+.||.....  .....+....+.+....+..     
T Consensus       184 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  262 (328)
T d3bqca1         184 -QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE  262 (328)
T ss_dssp             -CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred             -CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence             3445567889999999998867789999999999999999999999976553  22333333333221111100     


Q ss_pred             -hhhhhcccCCCCCCCC--cchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCC
Q 045787          234 -STYISEILPLYPHFEP--ANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVEN  295 (324)
Q Consensus       234 -~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~  295 (324)
                       ................  .........+++++.+||++||+.||.+|||++|+|+||||+++.+
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~  327 (328)
T d3bqca1         263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  327 (328)
T ss_dssp             CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred             cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence             0000111111111111  1111122357889999999999999999999999999999999876

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-54  Score=379.02  Aligned_cols=291  Identities=33%  Similarity=0.517  Sum_probs=217.0

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeec------CC
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS------RK   79 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~   79 (324)
                      .++|++++.||+|+||+||+|.+..+|+.||+|++............+.+|+.++++++||||+++++++..      ..
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence            378999999999999999999999999999999998665444445678899999999999999999999853      46


Q ss_pred             eEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccC
Q 045787           80 DVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGV  159 (324)
Q Consensus        80 ~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~  159 (324)
                      .+|+||||+.|++++.+.   ..+++..++.++.||+.||.|||++|++|+||||+|||++ .++.++++|||.+.....
T Consensus        96 ~~~iv~Ey~~~~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~-~~~~~kl~df~~~~~~~~  171 (355)
T d2b1pa1          96 DVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGT  171 (355)
T ss_dssp             EEEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC-TTCCEEECCCCC------
T ss_pred             eeEEEEeccchHHHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccc-cccceeeechhhhhcccc
Confidence            899999999998888764   3589999999999999999999999999999999999999 889999999998876653


Q ss_pred             CCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhH-HHHHHHHcCCCCcccccchhhh-
Q 045787          160 PQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDH-LSLIFSLLGTPTDESWAESTYI-  237 (324)
Q Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~-  237 (324)
                       ........+|+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+... ...+......+..+.+...... 
T Consensus       172 -~~~~~~~~~t~~y~aPE~l~~-~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  249 (355)
T d2b1pa1         172 -SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV  249 (355)
T ss_dssp             ----------CCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHH
T ss_pred             -ccccccccccccccChhhhcC-CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhH
Confidence             334445578899999999988 678999999999999999999999998877443 3444444444443333221111 


Q ss_pred             hcccCCCCCCCCcchhh------------hCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCchhhhhh
Q 045787          238 SEILPLYPHFEPANLAE------------KFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVPLVILL  302 (324)
Q Consensus       238 ~~~~~~~~~~~~~~~~~------------~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~~~~~~  302 (324)
                      .+...............            .....++++.+||++||+.||++|||++|+|+||||++..+.......
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~~~~~~~  326 (355)
T d2b1pa1         250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAP  326 (355)
T ss_dssp             HHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHTCC
T ss_pred             HHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCcccccCC
Confidence            11111111111111111            111246788999999999999999999999999999987654444333

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-54  Score=362.51  Aligned_cols=256  Identities=23%  Similarity=0.344  Sum_probs=207.8

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   83 (324)
                      +..++|++.+.||+|+||+||+|..+   ..||+|++..........+.+.+|+.++++++||||+++++++.+ +.+++
T Consensus         5 i~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~l   80 (276)
T d1uwha_           5 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAI   80 (276)
T ss_dssp             CCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred             cccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEE
Confidence            56789999999999999999999753   369999998766555556788999999999999999999998754 56899


Q ss_pred             EEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC-
Q 045787           84 VFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ-  161 (324)
Q Consensus        84 v~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~-  161 (324)
                      ||||++ |+|.+++...+.++++..+..++.||+.||.|||++|++||||||+|||++ .++.+||+|||++....... 
T Consensus        81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~-~~~~~Kl~DFGla~~~~~~~~  159 (276)
T d1uwha_          81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH-EDLTVKIGDFGLATVKSRWSG  159 (276)
T ss_dssp             EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE-TTSSEEECCCCCSCC------
T ss_pred             EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEc-CCCCEEEccccceeeccccCC
Confidence            999998 699999887777899999999999999999999999999999999999999 89999999999997664322 


Q ss_pred             -CcccccccccccCCchhhcC--CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHH-HHHHHHcCCCCcccccchhhh
Q 045787          162 -KEYSRDCVYSPYKAPELLLG--YTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHL-SLIFSLLGTPTDESWAESTYI  237 (324)
Q Consensus       162 -~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  237 (324)
                       .......||+.|+|||++.+  ...++.++|||||||++|||+||+.||.+.+.... .........++          
T Consensus       160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p----------  229 (276)
T d1uwha_         160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP----------  229 (276)
T ss_dssp             ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCC----------
T ss_pred             cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC----------
Confidence             23344578999999999864  24578999999999999999999999987664332 22222111111          


Q ss_pred             hcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcC
Q 045787          238 SEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH  287 (324)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~h  287 (324)
                                   ........+++++.+++.+||+.||.+|||+++++++
T Consensus       230 -------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         230 -------------DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             -------------CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                         1122334688999999999999999999999999975

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-54  Score=375.26  Aligned_cols=286  Identities=36%  Similarity=0.615  Sum_probs=226.0

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecC------C
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR------K   79 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~   79 (324)
                      .++|++++.||+|+||+||+|++..+|+.||+|++..........+.+.+|+.++++++|||++++++++...      .
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            4789999999999999999999999999999999986654443446688999999999999999999988532      3


Q ss_pred             eEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccC
Q 045787           80 DVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGV  159 (324)
Q Consensus        80 ~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~  159 (324)
                      .+++++++.+|+|.+++..  +++++..++.++.||+.||.|||++|++||||||+||+++ .++.++++|||.+.... 
T Consensus        97 ~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~-~~~~~kl~dfg~a~~~~-  172 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLARHTD-  172 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC-TTCCEEECCC----CCT-
T ss_pred             eEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccc-ccccccccccchhcccC-
Confidence            3555555555788887754  4699999999999999999999999999999999999999 89999999999987643 


Q ss_pred             CCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhH-HHHHHHHcCCCCcccccc--hhh
Q 045787          160 PQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDH-LSLIFSLLGTPTDESWAE--STY  236 (324)
Q Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~--~~~  236 (324)
                        .......+++.|+|||+..+...++.++|||||||++|+|++|+.||.+.+... ...+....+.+.......  ...
T Consensus       173 --~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  250 (348)
T d2gfsa1         173 --DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES  250 (348)
T ss_dssp             --GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHH
T ss_pred             --cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchh
Confidence              334445788899999998886778999999999999999999999998887443 344444444444322211  111


Q ss_pred             hhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCccccCCCCch
Q 045787          237 ISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLIGVENVP  297 (324)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~~~~~~~  297 (324)
                      ......................+++++++||.+||+.||.+|||++|+|+||||++..+..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~  311 (348)
T d2gfsa1         251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD  311 (348)
T ss_dssp             HHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTT
T ss_pred             hhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCc
Confidence            2222233344445555666778999999999999999999999999999999999886543

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-53  Score=357.83  Aligned_cols=251  Identities=21%  Similarity=0.312  Sum_probs=201.6

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   83 (324)
                      +..++|++.+.||+|+||+||+|.+. +++.||+|++.....   ..+.+.+|+.++++++||||+++++++.+++..++
T Consensus         2 idp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~l   77 (263)
T d1sm2a_           2 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL   77 (263)
T ss_dssp             BCCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             CChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC---cHHHHHHHHHHHHhcCCCCcccccceeccCCceEE
Confidence            35689999999999999999999976 567899999875432   24678999999999999999999999999999999


Q ss_pred             EEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC
Q 045787           84 VFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK  162 (324)
Q Consensus        84 v~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~  162 (324)
                      ||||+. |+|.+++......+++..+..++.|++.||.|||+++++||||||+||+++ .++.+||+|||++........
T Consensus        78 v~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~-~~~~~Kl~DFGla~~~~~~~~  156 (263)
T d1sm2a_          78 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG-ENQVIKVSDFGMTRFVLDDQY  156 (263)
T ss_dssp             EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEEC-GGGCEEECSCC----------
T ss_pred             EEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeec-CCCCeEecccchheeccCCCc
Confidence            999997 688888887777899999999999999999999999999999999999999 899999999999977653322


Q ss_pred             c-ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcc
Q 045787          163 E-YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEI  240 (324)
Q Consensus       163 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (324)
                      . .....+|+.|+|||++.+ ..++.++||||||+++|||+| |.+||...+...+.........+..            
T Consensus       157 ~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~------------  223 (263)
T d1sm2a_         157 TSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK------------  223 (263)
T ss_dssp             --------CTTSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCC------------
T ss_pred             eeecceecCcccCChHHhcC-CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCC------------
Confidence            2 233567889999999987 678999999999999999999 5666766665554443332211111            


Q ss_pred             cCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcC
Q 045787          241 LPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH  287 (324)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~h  287 (324)
                                     ....++++.+++.+||+.||.+|||++++++|
T Consensus       224 ---------------p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         224 ---------------PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             ---------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------ccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                           12467899999999999999999999999975

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=6.5e-54  Score=363.30  Aligned_cols=261  Identities=23%  Similarity=0.360  Sum_probs=206.2

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeecccc-CCCchHHHHHHHHHHhcCCCCeeEEEeeeecCC---
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQ-EGVPSYIIREVSLLKELEHENIVRLLDVQSSRK---   79 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---   79 (324)
                      .+.++|++.+.||+|+||+||+|.+..+|+.||+|++...... ......+.+|+.+++.++||||+++++++..++   
T Consensus         4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~   83 (277)
T d1o6ya_           4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG   83 (277)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred             CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCC
Confidence            4678999999999999999999999999999999999765432 223456889999999999999999999987643   


Q ss_pred             -eEEEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeec
Q 045787           80 -DVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAI  157 (324)
Q Consensus        80 -~~~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~  157 (324)
                       .+|+||||++| +|.+++.. .+++++..++.++.||+.||.|||++|++||||||+||+++ .++.++++|||.+...
T Consensus        84 ~~~~lvmE~~~g~~L~~~~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~-~~~~~~l~d~~~~~~~  161 (277)
T d1o6ya_          84 PLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS-ATNAVKVMDFGIARAI  161 (277)
T ss_dssp             EEEEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE-TTSCEEECCCTTCEEC
T ss_pred             ceEEEEEECCCCCEehhhhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccC-ccccceeehhhhhhhh
Confidence             48999999985 77776655 45799999999999999999999999999999999999999 8999999999988765


Q ss_pred             cCCCC---cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCcccccch
Q 045787          158 GVPQK---EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWAES  234 (324)
Q Consensus       158 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (324)
                      .....   .....+||+.|+|||++.+ ..++.++|||||||++|+|+||++||...+..............+       
T Consensus       162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~-------  233 (277)
T d1o6ya_         162 ADSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP-------  233 (277)
T ss_dssp             C----------------TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC-------
T ss_pred             ccccccccccccccCcccccCHHHHcC-CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCC-------
Confidence            43322   3344578999999999987 678999999999999999999999998877554433322211111       


Q ss_pred             hhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcCcccc
Q 045787          235 TYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKHEYLI  291 (324)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~hp~~~  291 (324)
                                       .....+.+|+++.++|.+||+.||.+||+..+.+.|+|.+
T Consensus       234 -----------------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         234 -----------------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             -----------------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             -----------------CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence                             1122346899999999999999999999555555566653

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-53  Score=355.64  Aligned_cols=251  Identities=21%  Similarity=0.312  Sum_probs=214.1

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   83 (324)
                      +..++|++.+.||+|+||+||+++.+ +++.||+|++......   .+.+.+|+.++++++||||+++++++.+++.+++
T Consensus         1 ~~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~---~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~i   76 (258)
T d1k2pa_           1 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI   76 (258)
T ss_dssp             CCCCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC---HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEE
T ss_pred             CChHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC---HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Confidence            35689999999999999999999985 6779999998865433   4678999999999999999999999999999999


Q ss_pred             EEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC
Q 045787           84 VFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK  162 (324)
Q Consensus        84 v~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~  162 (324)
                      ||||++ |++..++......+++..+++++.|++.||.|||++|++|+||||+||+++ .++.+||+|||.+........
T Consensus        77 v~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~-~~~~~kl~DfG~a~~~~~~~~  155 (258)
T d1k2pa_          77 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN-DQGVVKVSDFGLSRYVLDDEY  155 (258)
T ss_dssp             EEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEEC-TTCCEEECCCSSCCBCSSSSC
T ss_pred             EEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEc-CCCcEEECcchhheeccCCCc
Confidence            999997 688888777777899999999999999999999999999999999999999 899999999999976643322


Q ss_pred             -cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcc
Q 045787          163 -EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEI  240 (324)
Q Consensus       163 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (324)
                       ......+|+.|+|||++.+ ..++.++||||||+++|||+| |+.||...+.............++.            
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~-~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~------------  222 (258)
T d1k2pa_         156 TSSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR------------  222 (258)
T ss_dssp             CCCCCSCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC------------
T ss_pred             eeecccCCCCCcCCcHHhcC-CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCC------------
Confidence             2333567888999999987 678999999999999999998 8999998886665544332111110            


Q ss_pred             cCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcC
Q 045787          241 LPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH  287 (324)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~h  287 (324)
                                     ....++.+.+||.+||+.||++|||+.++++|
T Consensus       223 ---------------p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         223 ---------------PHLASEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             ---------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ---------------cccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                           12567899999999999999999999999986

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=9.2e-54  Score=363.21  Aligned_cols=251  Identities=24%  Similarity=0.345  Sum_probs=208.9

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   83 (324)
                      +..++|++.+.||+|+||+||+|.++.+|+.||+|++.....   ..+.+.+|+.++++++||||+++++++.+++..++
T Consensus        14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   90 (287)
T d1opja_          14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   90 (287)
T ss_dssp             CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc---hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence            456789999999999999999999999999999999865432   24678999999999999999999999999999999


Q ss_pred             EEEecC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC
Q 045787           84 VFEYLD-LDLHSFITRH-KNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        84 v~e~~~-g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~  161 (324)
                      ||||++ |++.+++... ...+++..+..++.||+.||.|||++|++||||||+|||++ .++.+||+|||++.......
T Consensus        91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~-~~~~~Kl~DFG~a~~~~~~~  169 (287)
T d1opja_          91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHLVKVADFGLSRLMTGDT  169 (287)
T ss_dssp             EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC-GGGCEEECCCCCTTTCCSSS
T ss_pred             EeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEEC-CCCcEEEccccceeecCCCC
Confidence            999998 6888888654 35789999999999999999999999999999999999999 88999999999998764332


Q ss_pred             C-cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCC-CCCChhHHHHHHHHcCCCCcccccchhhhhc
Q 045787          162 K-EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF-PSKKHDHLSLIFSLLGTPTDESWAESTYISE  239 (324)
Q Consensus       162 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
                      . ......+++.|+|||++.+ ..++.++|||||||++|+|++|..|| ...+...+.........+             
T Consensus       170 ~~~~~~~~g~~~y~aPE~~~~-~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~-------------  235 (287)
T d1opja_         170 YTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM-------------  235 (287)
T ss_dssp             SEEETTEEECGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC-------------
T ss_pred             ceeeccccccccccChHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCC-------------
Confidence            2 2233457888999999987 67899999999999999999976554 455544443332211111             


Q ss_pred             ccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                    .....+++++.+||.+||+.||.+|||++++++
T Consensus       236 --------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         236 --------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             --------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                          112367899999999999999999999999976

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.8e-53  Score=360.33  Aligned_cols=254  Identities=20%  Similarity=0.333  Sum_probs=199.3

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCc---eEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCe
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQ---KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKD   80 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~---~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   80 (324)
                      +..++|++.+.||+|+||+||+|.++.+++   .+|+|.+...... ...+.+.+|+.++++++||||+++++++.+++.
T Consensus        23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~  101 (299)
T d1jpaa_          23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE-KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP  101 (299)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCH-HHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence            445789999999999999999999876665   5788877643322 223568899999999999999999999999999


Q ss_pred             EEEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccC
Q 045787           81 VFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGV  159 (324)
Q Consensus        81 ~~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~  159 (324)
                      .++||||+++ +|.+++....+.+++..+..++.||+.||.|||++|++||||||+|||++ .++.+||+|||++.....
T Consensus       102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~-~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVN-SNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC-TTCCEEECCC--------
T ss_pred             EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEEC-CCCcEEECCcccceEccC
Confidence            9999999985 78887877677899999999999999999999999999999999999999 899999999999987643


Q ss_pred             CCCc-----ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccc
Q 045787          160 PQKE-----YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAE  233 (324)
Q Consensus       160 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  233 (324)
                      ....     .....+|+.|+|||++.+ ..++.++|||||||++|||+| |..||...+.............++      
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~------  253 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP------  253 (299)
T ss_dssp             ---------------CGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC------
T ss_pred             CCCcceeeecccccCCccccCHHHHhc-CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC------
Confidence            3221     112346788999999987 678999999999999999998 899998877655444333211111      


Q ss_pred             hhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcC
Q 045787          234 STYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH  287 (324)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~h  287 (324)
                                           ....+++++.+|+.+||+.||.+|||+.+++++
T Consensus       254 ---------------------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         254 ---------------------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             ---------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ---------------------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                 112578999999999999999999999999863

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-53  Score=358.43  Aligned_cols=255  Identities=24%  Similarity=0.369  Sum_probs=207.3

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFL   83 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   83 (324)
                      +..++|++.+.||+|+||.||+|.++ ++..||+|++.....   ..+.+.+|+.++++++||||+++++++.+ +..++
T Consensus        10 i~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~i   84 (272)
T d1qpca_          10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI   84 (272)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             cCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC---CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEE
Confidence            45678999999999999999999975 567899999865432   24678999999999999999999998755 56789


Q ss_pred             EEEecC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCC
Q 045787           84 VFEYLD-LDLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQ  161 (324)
Q Consensus        84 v~e~~~-g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~  161 (324)
                      ||||++ |+|.+.+.... .++++..+..++.||+.||.|||++|++||||||+|||++ .++.+||+|||++.......
T Consensus        85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~-~~~~~Kl~DFGla~~~~~~~  163 (272)
T d1qpca_          85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS-DTLSCKIADFGLARLIEDNE  163 (272)
T ss_dssp             EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-TTSCEEECCCTTCEECSSSC
T ss_pred             EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeee-cccceeeccccceEEccCCc
Confidence            999998 57777665433 3699999999999999999999999999999999999999 89999999999998775433


Q ss_pred             C-cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCC-CCCCCCChhHHHHHHHHcCCCCcccccchhhhhc
Q 045787          162 K-EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGK-PLFPSKKHDHLSLIFSLLGTPTDESWAESTYISE  239 (324)
Q Consensus       162 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
                      . ......+++.|+|||++.+ ..++.++|||||||++|||+||. +||...+.............++            
T Consensus       164 ~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~------------  230 (272)
T d1qpca_         164 YTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV------------  230 (272)
T ss_dssp             EECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC------------
T ss_pred             cccccccCCcccccChHHHhC-CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC------------
Confidence            2 2334568889999999987 56899999999999999999965 5555555444333322111111            


Q ss_pred             ccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc--CccccC
Q 045787          240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK--HEYLIG  292 (324)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~--hp~~~~  292 (324)
                                     ....+++++.+|+.+||+.||.+|||++++++  ++||..
T Consensus       231 ---------------~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         231 ---------------RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             ---------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---------------CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence                           11257889999999999999999999999998  888864

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-53  Score=357.08  Aligned_cols=256  Identities=25%  Similarity=0.390  Sum_probs=208.9

Q ss_pred             ccCcCcceeEe-ecccCceEEEEEEEcc--CCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCe
Q 045787            4 LKNLNYKKIKK-IGAGGYGEVYKCRNTV--TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKD   80 (324)
Q Consensus         4 ~~~~~y~i~~~-Lg~g~~~~v~~a~~~~--~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   80 (324)
                      +..++|.+.+. ||+|+||+||+|.++.  ++..||+|++...... ...+.+.+|+.++++++||||+++++++.+ +.
T Consensus         5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~   82 (285)
T d1u59a_           5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA   82 (285)
T ss_dssp             CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred             ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCH-HHHHHHHHHHHHHHhCCCCCEeeEeeeecc-Ce
Confidence            34567888885 9999999999997653  4457999998754322 224678899999999999999999999875 45


Q ss_pred             EEEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccC
Q 045787           81 VFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGV  159 (324)
Q Consensus        81 ~~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~  159 (324)
                      +|+||||++| +|.+++...+..+++..+..++.|++.||.|||++|++||||||+||+++ .++.+||+|||++.....
T Consensus        83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~-~~~~~Kl~DFGla~~~~~  161 (285)
T d1u59a_          83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV-NRHYAKISDFGLSKALGA  161 (285)
T ss_dssp             EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE-ETTEEEECCCTTCEECTT
T ss_pred             EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeec-cCCceeeccchhhhcccc
Confidence            8999999984 88888877777899999999999999999999999999999999999999 899999999999987754


Q ss_pred             CCC---cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchh
Q 045787          160 PQK---EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAEST  235 (324)
Q Consensus       160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (324)
                      ...   ......+|+.|+|||++.+ ..++.++|||||||++|||+| |..||...+...+...+.....+         
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~---------  231 (285)
T d1u59a_         162 DDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM---------  231 (285)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC---------
T ss_pred             cccccccccccccCccccChHHHhC-CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence            332   2233467888999999987 568999999999999999998 89999887765544433211111         


Q ss_pred             hhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHH---hcCccc
Q 045787          236 YISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDA---LKHEYL  290 (324)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~---l~hp~~  290 (324)
                                        ...+.+++++.+||.+||+.||.+|||+.++   |+|+|+
T Consensus       232 ------------------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~  271 (285)
T d1u59a_         232 ------------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  271 (285)
T ss_dssp             ------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------------------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                              1123688999999999999999999999888   456665

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-53  Score=357.04  Aligned_cols=248  Identities=20%  Similarity=0.351  Sum_probs=199.2

Q ss_pred             EeecccCceEEEEEEEc--cCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEEecCC
Q 045787           13 KKIGAGGYGEVYKCRNT--VTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVFLVFEYLDL   90 (324)
Q Consensus        13 ~~Lg~g~~~~v~~a~~~--~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~g   90 (324)
                      +.||+|+||+||+|...  ..++.||+|++..........+.+.+|+.++++++||||+++++++.+ +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            36999999999999864  345789999997655444445678999999999999999999999865 457899999985


Q ss_pred             -CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCCc---ccc
Q 045787           91 -DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQKE---YSR  166 (324)
Q Consensus        91 -~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~~---~~~  166 (324)
                       +|.+++.. ..++++..+..++.||+.||.|||++|++||||||+||+++ .++.++|+|||++.........   ...
T Consensus        92 g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~-~~~~~kl~DFGla~~~~~~~~~~~~~~~  169 (277)
T d1xbba_          92 GPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV-TQHYAKISDFGLSKALRADENYYKAQTH  169 (277)
T ss_dssp             EEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE-ETTEEEECCCTTCEECCTTCSEEEC---
T ss_pred             CcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhccc-ccCcccccchhhhhhccccccccccccc
Confidence             78877765 45699999999999999999999999999999999999999 8999999999999876533222   223


Q ss_pred             cccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhcccCCCC
Q 045787          167 DCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISEILPLYP  245 (324)
Q Consensus       167 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (324)
                      ..+|+.|+|||++.+ ..++.++||||||+++|||++ |+.||.+.+...+...+.....++                  
T Consensus       170 ~~gt~~y~APE~l~~-~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~------------------  230 (277)
T d1xbba_         170 GKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG------------------  230 (277)
T ss_dssp             -CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC------------------
T ss_pred             cCCCceecCchhhcC-CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCC------------------
Confidence            467889999999987 667999999999999999998 899998887665544433211111                  


Q ss_pred             CCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHh---cCcccc
Q 045787          246 HFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDAL---KHEYLI  291 (324)
Q Consensus       246 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l---~hp~~~  291 (324)
                               ....+++++.+|+.+||+.||.+|||+++++   +|+|+.
T Consensus       231 ---------~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         231 ---------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             ---------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             ---------CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence                     1135789999999999999999999999985   565553

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-52  Score=359.14  Aligned_cols=253  Identities=23%  Similarity=0.373  Sum_probs=205.2

Q ss_pred             cCcCcceeEeecccCceEEEEEEEccCCc-----eEEEEEeeeccccCCCchHHHHHHHHHHhc-CCCCeeEEEeeeecC
Q 045787            5 KNLNYKKIKKIGAGGYGEVYKCRNTVTGQ-----KVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSR   78 (324)
Q Consensus         5 ~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~-----~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~   78 (324)
                      ..++|++.+.||+|+||+||+|.+...++     .||+|.+...... .....+.+|+.++.++ +||||+++++++.++
T Consensus        35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~  113 (325)
T d1rjba_          35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS-SEREALMSELKMMTQLGSHENIVNLLGACTLS  113 (325)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCH-HHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence            34789999999999999999999875543     6899988654332 3356788999999998 899999999999999


Q ss_pred             CeEEEEEEecC-CCHHHHHHhcC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 045787           79 KDVFLVFEYLD-LDLHSFITRHK----------------------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPN  135 (324)
Q Consensus        79 ~~~~iv~e~~~-g~l~~~~~~~~----------------------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~  135 (324)
                      +..|+||||++ |+|.+++....                      ..+++..++.++.||+.||.|||++|++||||||+
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~  193 (325)
T d1rjba_         114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR  193 (325)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred             CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchh
Confidence            99999999997 59999887643                      24788999999999999999999999999999999


Q ss_pred             ceEeecCCCcEEEeeccceeeccCCCCc--ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCC
Q 045787          136 NLLIDLKRNTVKLADFGLARAIGVPQKE--YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKK  212 (324)
Q Consensus       136 nIll~~~~~~v~l~d~g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~  212 (324)
                      ||+++ .++.+||+|||++.........  .....+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+
T Consensus       194 Nill~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~  271 (325)
T d1rjba_         194 NVLVT-HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  271 (325)
T ss_dssp             GEEEE-TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             ccccc-cCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC-CCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence            99999 8999999999999876543322  234567899999999987 678999999999999999998 899998766


Q ss_pred             hhH-HHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcC
Q 045787          213 HDH-LSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH  287 (324)
Q Consensus       213 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~h  287 (324)
                      ... +..+... +..+                          .....+++++.+||.+||+.||.+|||++||++|
T Consensus       272 ~~~~~~~~~~~-~~~~--------------------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         272 VDANFYKLIQN-GFKM--------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             CSHHHHHHHHT-TCCC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHhc-CCCC--------------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            433 3222221 1110                          0113578999999999999999999999999975

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-52  Score=361.38  Aligned_cols=265  Identities=23%  Similarity=0.420  Sum_probs=214.7

Q ss_pred             cCcceeEeecccCceEEEEEEEc---cCCceEEEEEeeecc--ccCCCchHHHHHHHHHHhcCC-CCeeEEEeeeecCCe
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNT---VTGQKVAIKMMTIQT--EQEGVPSYIIREVSLLKELEH-ENIVRLLDVQSSRKD   80 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~---~~~~~~~~K~~~~~~--~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~   80 (324)
                      ++|++++.||+|+||+||+|.+.   .+|+.||+|++....  ......+.+.+|+.++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            67999999999999999999874   468899999987543  233345678899999999976 899999999999999


Q ss_pred             EEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccC
Q 045787           81 VFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGV  159 (324)
Q Consensus        81 ~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~  159 (324)
                      .++++||+. |+|.+++... +.+++..++.++.||+.||.|||++|++|+||||+||+++ .++.++|+|||.+.....
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~-~~~~vkL~DFG~a~~~~~  181 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD-SNGHVVLTDFGLSKEFVA  181 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC-TTSCEEESCSSEEEECCG
T ss_pred             eeeeeecccccHHHHHHHhc-ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeec-CCCCEEEeeccchhhhcc
Confidence            999999998 4888877664 4588999999999999999999999999999999999999 889999999999976643


Q ss_pred             C-CCcccccccccccCCchhhcCC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHH-HHHHHH--cCCCCcccccch
Q 045787          160 P-QKEYSRDCVYSPYKAPELLLGY-TGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHL-SLIFSL--LGTPTDESWAES  234 (324)
Q Consensus       160 ~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~--~~~~~~~~~~~~  234 (324)
                      . ........+++.|+|||.+.+. ..++.++|||||||++|+|++|..||...+.... ..+...  ...+        
T Consensus       182 ~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~--------  253 (322)
T d1vzoa_         182 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--------  253 (322)
T ss_dssp             GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC--------
T ss_pred             cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCC--------
Confidence            2 2234445788999999999753 3578899999999999999999999976653221 111111  0100        


Q ss_pred             hhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCC-----CHHHHhcCccccCCCCchhhh
Q 045787          235 TYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRI-----TAMDALKHEYLIGVENVPLVI  300 (324)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~~l~hp~~~~~~~~~~~~  300 (324)
                                         .....+++++.+||++||+.||.+||     |++|+++||||+++++..+..
T Consensus       254 -------------------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~  305 (322)
T d1vzoa_         254 -------------------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAA  305 (322)
T ss_dssp             -------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHT
T ss_pred             -------------------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHh
Confidence                               01236899999999999999999999     589999999999988655543

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-51  Score=355.59  Aligned_cols=253  Identities=25%  Similarity=0.376  Sum_probs=205.1

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCc----eEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCC
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQ----KVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK   79 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~----~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   79 (324)
                      ++..+|++++.||+|+||+||+|.+..+|+    .||+|.+.... .....+.+.+|+.++++++||||+++++++.++.
T Consensus         6 ~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~   84 (317)
T d1xkka_           6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST   84 (317)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             CCHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            456789999999999999999999887776    47777765432 2334577899999999999999999999998765


Q ss_pred             eEEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeecc
Q 045787           80 DVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIG  158 (324)
Q Consensus        80 ~~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~  158 (324)
                       .+++++++. |+|.+.+......+++..++.++.||+.||.|||++|++||||||+||+++ .++.+||+|||++....
T Consensus        85 -~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~-~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          85 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             -EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE-ETTEEEECCCSHHHHTT
T ss_pred             -eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeC-CCCCeEeeccccceecc
Confidence             455666665 799999988888899999999999999999999999999999999999999 89999999999998765


Q ss_pred             CCCCc--ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchh
Q 045787          159 VPQKE--YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAEST  235 (324)
Q Consensus       159 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (324)
                      .....  .....+|+.|+|||++.+ ..++.++|||||||++|||+| |.+||.+.+...+.........++.       
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~-------  234 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ-------  234 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCC-------
T ss_pred             cccccccccccccCccccChHHHhc-CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC-------
Confidence            33222  223457899999999987 678999999999999999998 7899988876666555443222211       


Q ss_pred             hhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcC
Q 045787          236 YISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH  287 (324)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~h  287 (324)
                                          .+.+++.+.+++.+||+.||.+|||+.++++|
T Consensus       235 --------------------p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         235 --------------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             --------------------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------------CcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence                                12578899999999999999999999999987

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-51  Score=347.90  Aligned_cols=253  Identities=24%  Similarity=0.360  Sum_probs=198.2

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCC---ceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCe
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTG---QKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKD   80 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~---~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   80 (324)
                      +..++|++.+.||+|+||.||+|.+..++   ..+|+|.+..... ....+.+.+|+.++++++||||+++++++. ++.
T Consensus         4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~   81 (273)
T d1mp8a_           4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS-DSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP   81 (273)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred             cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCe
Confidence            45679999999999999999999876443   4678888754322 222456889999999999999999999986 467


Q ss_pred             EEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccC
Q 045787           81 VFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGV  159 (324)
Q Consensus        81 ~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~  159 (324)
                      .|+||||+. |++.+++.....++++..++.++.||+.||.|||++|++||||||+||+++ .++.+||+|||.+.....
T Consensus        82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~-~~~~~Kl~DfG~a~~~~~  160 (273)
T d1mp8a_          82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS-SNDCVKLGDFGLSRYMED  160 (273)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE-ETTEEEECC---------
T ss_pred             EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeec-CCCcEEEccchhheeccC
Confidence            899999998 588888777777899999999999999999999999999999999999999 899999999999987653


Q ss_pred             CCC-cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhh
Q 045787          160 PQK-EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYI  237 (324)
Q Consensus       160 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (324)
                      ... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||...+...+.........+           
T Consensus       161 ~~~~~~~~~~gt~~y~apE~l~~-~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~-----------  228 (273)
T d1mp8a_         161 STYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL-----------  228 (273)
T ss_dssp             ----------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-----------
T ss_pred             CcceeccceecCcccchhhHhcc-CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-----------
Confidence            322 2334567888999999987 678999999999999999998 89999887766554433321111           


Q ss_pred             hcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcC
Q 045787          238 SEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH  287 (324)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~h  287 (324)
                                      ...+.+++.+.+||.+||+.||.+|||+.+++++
T Consensus       229 ----------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         229 ----------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             ----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                            1123688999999999999999999999999874

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-51  Score=348.11  Aligned_cols=258  Identities=26%  Similarity=0.373  Sum_probs=203.9

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKDVF   82 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   82 (324)
                      ++..++|++.+.||+|+||.||+|.+.. +..||+|++.....   ..+.+.+|+.++++++||||+++++++.+ +..+
T Consensus        13 ~i~~~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~   87 (285)
T d1fmka3          13 EIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY   87 (285)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             EcCHHHEEEeeEEeeCCCeEEEEEEECC-CCEEEEEEECcccC---CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeE
Confidence            3556889999999999999999999864 45799999874433   24679999999999999999999999865 5578


Q ss_pred             EEEEecC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           83 LVFEYLD-LDLHSFITRH-KNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        83 iv~e~~~-g~l~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      +||||+. |++..++... ...+++..+..++.+|+.||.|||++|++||||||+|||++ .++++||+|||++......
T Consensus        88 lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~-~~~~~kl~DfGla~~~~~~  166 (285)
T d1fmka3          88 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIEDN  166 (285)
T ss_dssp             EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC-GGGCEEECCCCTTC-----
T ss_pred             EEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEEC-CCCcEEEcccchhhhccCC
Confidence            9999998 5777776643 34699999999999999999999999999999999999999 8899999999999766433


Q ss_pred             C-CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCC-CCCChhHHHHHHHHcCCCCcccccchhhhh
Q 045787          161 Q-KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLF-PSKKHDHLSLIFSLLGTPTDESWAESTYIS  238 (324)
Q Consensus       161 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (324)
                      . .......+|+.|+|||++.+ ..++.++||||||+++|+|++|..|+ .................+            
T Consensus       167 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~------------  233 (285)
T d1fmka3         167 EYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM------------  233 (285)
T ss_dssp             ---------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC------------
T ss_pred             CceeeccccccccccChHHHhC-CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC------------
Confidence            2 22333568899999999987 67899999999999999999965554 444444333332211111            


Q ss_pred             cccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc--CccccCCC
Q 045787          239 EILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK--HEYLIGVE  294 (324)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~--hp~~~~~~  294 (324)
                                     .....+++++.++|.+||+.||++|||++++++  ++||.+..
T Consensus       234 ---------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         234 ---------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             ---------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             ---------------CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence                           012367899999999999999999999999998  89998765

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-51  Score=344.81  Aligned_cols=254  Identities=23%  Similarity=0.349  Sum_probs=199.6

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccCC----ceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecC
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVTG----QKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR   78 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~----~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   78 (324)
                      .+....|++.+.||+|+||.||+|..+.++    ..||+|++....... ....+.+|+.++++++||||+++++++.+.
T Consensus         3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~~~g~~~~~   81 (283)
T d1mqba_           3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK-QRVDFLGEAGIMGQFSHHNIIRLEGVISKY   81 (283)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHH-HHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChH-HHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence            456678999999999999999999877544    369999986543222 234688999999999999999999999999


Q ss_pred             CeEEEEEEecCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeec
Q 045787           79 KDVFLVFEYLDL-DLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAI  157 (324)
Q Consensus        79 ~~~~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~  157 (324)
                      +..++|+||+.+ ++.+.+......+++..+..++.+++.||.|||++|++||||||+|||++ .++.+||+|||++...
T Consensus        82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~-~~~~~Kl~DFGla~~~  160 (283)
T d1mqba_          82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN-SNLVCKVSDFGLSRVL  160 (283)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC-TTCCEEECCCCC----
T ss_pred             CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEEC-CCCeEEEcccchhhcc
Confidence            999999999985 77777777777899999999999999999999999999999999999999 8999999999999876


Q ss_pred             cCCCC---cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCC-CCCCChhHHHHHHHHcCCCCcccccc
Q 045787          158 GVPQK---EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPL-FPSKKHDHLSLIFSLLGTPTDESWAE  233 (324)
Q Consensus       158 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~  233 (324)
                      .....   ......+|+.|+|||++.+ ..++.++||||||+++|||+++..| +...+...+.........++      
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~------  233 (283)
T d1mqba_         161 EDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP------  233 (283)
T ss_dssp             -------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC------
T ss_pred             cCCCccceEeccCCCCccccCHHHHcc-CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCC------
Confidence            43322   1223457888999999987 6789999999999999999996554 55444444433322111111      


Q ss_pred             hhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          234 STYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                           ....++..+.++|.+||+.||.+|||+.++++
T Consensus       234 ---------------------~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         234 ---------------------TPMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             ---------------------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ---------------------CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence                                 11257889999999999999999999999986

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-51  Score=343.63  Aligned_cols=254  Identities=24%  Similarity=0.354  Sum_probs=198.8

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEcc-CC--ceEEEEEeeecccc-CCCchHHHHHHHHHHhcCCCCeeEEEeeeecCC
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTV-TG--QKVAIKMMTIQTEQ-EGVPSYIIREVSLLKELEHENIVRLLDVQSSRK   79 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~-~~--~~~~~K~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   79 (324)
                      +..++|++.+.||+|+||.||+|.... ++  ..||+|++...... ....+.+.+|+.++++++||||+++++++.+ .
T Consensus         5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~   83 (273)
T d1u46a_           5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P   83 (273)
T ss_dssp             CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence            456789999999999999999998643 33  36899998765432 2334678999999999999999999999976 4


Q ss_pred             eEEEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeecc
Q 045787           80 DVFLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIG  158 (324)
Q Consensus        80 ~~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~  158 (324)
                      ..++|+||++ |++.+.+.....++++..+..++.||+.||.|||++|++||||||+||+++ .++.+||+|||++....
T Consensus        84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~-~~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA-TRDLVKIGDFGLMRALP  162 (273)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE-ETTEEEECCCTTCEECC
T ss_pred             chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccc-cccceeeccchhhhhcc
Confidence            6789999998 688888888777899999999999999999999999999999999999999 88999999999998775


Q ss_pred             CCCCc---ccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccch
Q 045787          159 VPQKE---YSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAES  234 (324)
Q Consensus       159 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (324)
                      .....   .....+++.|+|||++.+ ..++.++||||||+++|||++ |..||.+.+.......+...+..+       
T Consensus       163 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~-------  234 (273)
T d1u46a_         163 QNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL-------  234 (273)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC-------
T ss_pred             cCCCcceecCccccCcccCCHHHHhC-CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCC-------
Confidence            43332   223356778999999987 678999999999999999998 899998887665544332211111       


Q ss_pred             hhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          235 TYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                         .....++..+.++|.+||+.||++|||+.++++
T Consensus       235 -------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         235 -------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             -------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                               112368899999999999999999999999974

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-50  Score=335.83  Aligned_cols=245  Identities=23%  Similarity=0.376  Sum_probs=196.7

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeec-CCeEE
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS-RKDVF   82 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~   82 (324)
                      +..++|++.+.||+|+||.||+|..+  |..||+|++..+.    ..+.+.+|++++++++||||+++++++.+ ++.+|
T Consensus         4 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~   77 (262)
T d1byga_           4 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY   77 (262)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred             cCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEE
Confidence            45678999999999999999999974  7899999986432    34678999999999999999999998854 56789


Q ss_pred             EEEEecC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCC
Q 045787           83 LVFEYLD-LDLHSFITRHK-NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVP  160 (324)
Q Consensus        83 iv~e~~~-g~l~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~  160 (324)
                      +||||++ |+|.+++.... ..+++..++.++.+|+.||.|||+.+++|+||||+||+++ .++.++|+|||.+..... 
T Consensus        78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~-~~~~~kl~dfg~s~~~~~-  155 (262)
T d1byga_          78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS-EDNVAKVSDFGLTKEASS-  155 (262)
T ss_dssp             EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC-TTSCEEECCCCC-------
T ss_pred             EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheec-CCCCEeecccccceecCC-
Confidence            9999997 58998886543 3589999999999999999999999999999999999999 899999999999986542 


Q ss_pred             CCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHcCCCCcccccchhhhhc
Q 045787          161 QKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHLSLIFSLLGTPTDESWAESTYISE  239 (324)
Q Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
                        ......+++.|+|||++.+ ..++.++||||||+++|||+| |++||...+...+...+.....              
T Consensus       156 --~~~~~~~~~~y~aPE~l~~-~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~--------------  218 (262)
T d1byga_         156 --TQDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK--------------  218 (262)
T ss_dssp             --------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC--------------
T ss_pred             --CCccccccccCCChHHHhC-CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC--------------
Confidence              2233467888999999987 678999999999999999998 7888877775554333221100              


Q ss_pred             ccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          240 ILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                   .......++++.+||++||+.||.+|||+.++++
T Consensus       219 -------------~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~  252 (262)
T d1byga_         219 -------------MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  252 (262)
T ss_dssp             -------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence                         1122357889999999999999999999999987

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-49  Score=337.63  Aligned_cols=253  Identities=26%  Similarity=0.381  Sum_probs=204.8

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCC-------ceEEEEEeeeccccCCCchHHHHHHHHHHhc-CCCCeeEEEeee
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTG-------QKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQ   75 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~-------~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~   75 (324)
                      +..++|++.+.||+|+||.||+|.+...+       ..||+|++....... ....+.+|...+.++ +||||+++++++
T Consensus        10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~e~~~l~~~~~HpnIv~~~~~~   88 (299)
T d1fgka_          10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK-DLSDLISEMEMMKMIGKHKNIINLLGAC   88 (299)
T ss_dssp             CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHH-HHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChH-HHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence            44689999999999999999999876443       379999987554322 235677888888888 799999999999


Q ss_pred             ecCCeEEEEEEecC-CCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEe
Q 045787           76 SSRKDVFLVFEYLD-LDLHSFITRHK---------------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLI  139 (324)
Q Consensus        76 ~~~~~~~iv~e~~~-g~l~~~~~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll  139 (324)
                      .+++..++||||+. |++.+++....               ..+++..++.++.||+.||+|||+.|++||||||+|||+
T Consensus        89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl  168 (299)
T d1fgka_          89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV  168 (299)
T ss_dssp             CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee
Confidence            99999999999998 68888886543               358999999999999999999999999999999999999


Q ss_pred             ecCCCcEEEeeccceeeccCCCC--cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhHH
Q 045787          140 DLKRNTVKLADFGLARAIGVPQK--EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDHL  216 (324)
Q Consensus       140 ~~~~~~v~l~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~  216 (324)
                      + .++.+||+|||.+........  ......+++.|+|||.+.+ ..++.++||||||+++|+|++ |++||...+...+
T Consensus       169 ~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~  246 (299)
T d1fgka_         169 T-EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  246 (299)
T ss_dssp             C-TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             c-CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC-CCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH
Confidence            9 899999999999987754322  2344568888999999987 678999999999999999998 7899988887665


Q ss_pred             HHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          217 SLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      .........++                           ....+++++.+||.+||+.||++|||+.|+++
T Consensus       247 ~~~i~~~~~~~---------------------------~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         247 FKLLKEGHRMD---------------------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHHTTCCCC---------------------------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHcCCCCC---------------------------CCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            54433221111                           11257889999999999999999999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.3e-49  Score=338.92  Aligned_cols=251  Identities=27%  Similarity=0.398  Sum_probs=205.6

Q ss_pred             CcCcceeEeecccCceEEEEEEEc-----cCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCCe
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNT-----VTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRKD   80 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   80 (324)
                      .++|++.+.||+|+||+||+|..+     .+++.||+|++..... ....+.+.+|+.++++++|||++++++++.+.+.
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~   90 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP   90 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcC-hHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence            467999999999999999999865     3567899999864432 2224568999999999999999999999999999


Q ss_pred             EEEEEEecC-CCHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 045787           81 VFLVFEYLD-LDLHSFITRHK-----------------------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNN  136 (324)
Q Consensus        81 ~~iv~e~~~-g~l~~~~~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~n  136 (324)
                      .++++||+. |+|.+++....                       ..+++..+..++.|++.||+|||++|++||||||+|
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~N  170 (301)
T d1lufa_          91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN  170 (301)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccc
Confidence            999999997 68888876432                       247889999999999999999999999999999999


Q ss_pred             eEeecCCCcEEEeeccceeeccCCC--CcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCC-CCCCCCCh
Q 045787          137 LLIDLKRNTVKLADFGLARAIGVPQ--KEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGK-PLFPSKKH  213 (324)
Q Consensus       137 Ill~~~~~~v~l~d~g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~-~pf~~~~~  213 (324)
                      |+++ .++.+||+|||++.......  .......+++.|+|||.+.+ ..++.++|||||||++|||++|. +||...+.
T Consensus       171 ILld-~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~  248 (301)
T d1lufa_         171 CLVG-ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH  248 (301)
T ss_dssp             EEEC-GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             eEEC-CCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-CCCChhhhhccchhhHHHHHccCCCCCCCCCH
Confidence            9999 88999999999987654222  22334567888999999987 77899999999999999999985 67887776


Q ss_pred             hHHHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          214 DHLSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      ............+                           .....+++++.+|+.+||+.||.+|||+.||++
T Consensus       249 ~e~~~~v~~~~~~---------------------------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         249 EEVIYYVRDGNIL---------------------------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             HHHHHHHHTTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcCCCC---------------------------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            6554443321111                           112367889999999999999999999999965

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-49  Score=340.49  Aligned_cols=253  Identities=26%  Similarity=0.324  Sum_probs=204.2

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEccCCce--EEEEEeeeccccCCCchHHHHHHHHHHhc-CCCCeeEEEeeeecCCe
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTVTGQK--VAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSSRKD   80 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~--~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~   80 (324)
                      +..++|++.+.||+|+||.||+|.++.+|..  ||+|.+...... +..+.+.+|+.+++++ +||||+++++++.+++.
T Consensus         7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~   85 (309)
T d1fvra_           7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY   85 (309)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred             cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccCh-HHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCe
Confidence            5567999999999999999999999888775  566766533322 2356789999999999 69999999999999999


Q ss_pred             EEEEEEecC-CCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCC
Q 045787           81 VFLVFEYLD-LDLHSFITRH---------------KNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRN  144 (324)
Q Consensus        81 ~~iv~e~~~-g~l~~~~~~~---------------~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~  144 (324)
                      +++||||++ |+|.+++...               ...+++..+..++.||+.||.|||++|++||||||+|||++ .++
T Consensus        86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~-~~~  164 (309)
T d1fvra_          86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG-ENY  164 (309)
T ss_dssp             EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-GGG
T ss_pred             eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEc-CCC
Confidence            999999998 6888887643               24689999999999999999999999999999999999999 889


Q ss_pred             cEEEeeccceeeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCC-CCCCCCChhHHHHHHHHc
Q 045787          145 TVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGK-PLFPSKKHDHLSLIFSLL  223 (324)
Q Consensus       145 ~v~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~-~pf~~~~~~~~~~~~~~~  223 (324)
                      .+||+|||.+...... .......+|+.|+|||.+.+ ..++.++||||||+++|+|++|. +||...+...+.......
T Consensus       165 ~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~  242 (309)
T d1fvra_         165 VAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG  242 (309)
T ss_dssp             CEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred             ceEEcccccccccccc-ccccceecCCcccchHHhcc-CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Confidence            9999999999765422 22234467889999999987 66899999999999999999965 678777765544332211


Q ss_pred             CCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcC
Q 045787          224 GTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH  287 (324)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~h  287 (324)
                      ..+                           .....+++++.+||.+||+.||++|||+.+++++
T Consensus       243 ~~~---------------------------~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         243 YRL---------------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             CCC---------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCC---------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            111                           1123578999999999999999999999999986

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-49  Score=337.19  Aligned_cols=254  Identities=24%  Similarity=0.354  Sum_probs=194.5

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEcc-----CCceEEEEEeeeccccCCCchHHHHHHHHHHhc-CCCCeeEEEeeeec
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTV-----TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSS   77 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   77 (324)
                      +..++|++.+.||+|+||.||+|.+..     +++.||+|++....... ..+.+.+|...+.++ +|++|+.+++++..
T Consensus        10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~-~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~   88 (299)
T d1ywna1          10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHLNVVNLLGACTK   88 (299)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHH-HHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcH-HHHHHHHHHHHHHhhcCCCeEEEeeeeecc
Confidence            456789999999999999999999753     34689999987543322 234567788888777 58899999998755


Q ss_pred             -CCeEEEEEEecC-CCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEee
Q 045787           78 -RKDVFLVFEYLD-LDLHSFITRHK---------------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLID  140 (324)
Q Consensus        78 -~~~~~iv~e~~~-g~l~~~~~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~  140 (324)
                       +..+++||||++ |+|.+++....               ..+++..+..++.||+.||.|||++|++||||||+|||++
T Consensus        89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~  168 (299)
T d1ywna1          89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS  168 (299)
T ss_dssp             TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred             CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeEC
Confidence             457899999998 68888886542               2488999999999999999999999999999999999999


Q ss_pred             cCCCcEEEeeccceeeccCCCC--cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhC-CCCCCCCChhH-H
Q 045787          141 LKRNTVKLADFGLARAIGVPQK--EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITG-KPLFPSKKHDH-L  216 (324)
Q Consensus       141 ~~~~~v~l~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g-~~pf~~~~~~~-~  216 (324)
                       .++.+||+|||++........  ......||+.|+|||++.+ ..++.++|||||||++|+|+++ .+||...+... +
T Consensus       169 -~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~  246 (299)
T d1ywna1         169 -EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF  246 (299)
T ss_dssp             -GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred             -CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence             889999999999976643322  2334578999999999987 6789999999999999999986 56787665332 2


Q ss_pred             HHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcC
Q 045787          217 SLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH  287 (324)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~h  287 (324)
                      .........+.                           ....+++++.+++.+||+.||.+|||++++++|
T Consensus       247 ~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         247 CRRLKEGTRMR---------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHHHHTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhcCCCCC---------------------------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            22222111111                           112578899999999999999999999999986

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.6e-48  Score=332.49  Aligned_cols=264  Identities=20%  Similarity=0.258  Sum_probs=208.3

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCC-eeEEEeeeecCCeE
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHEN-IVRLLDVQSSRKDV   81 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~   81 (324)
                      --.+++|++.+.||+|+||.||+|.+..+|+.||+|++......    ..+..|+++++.++|++ ++.+.+++.+++..
T Consensus         3 ~~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~   78 (299)
T d1ckia_           3 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN   78 (299)
T ss_dssp             CEETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEE
T ss_pred             CeECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEE
Confidence            34568999999999999999999999999999999987754332    35788999999998765 55566677888899


Q ss_pred             EEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeec--CCCcEEEeeccceeeccC
Q 045787           82 FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL--KRNTVKLADFGLARAIGV  159 (324)
Q Consensus        82 ~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~--~~~~v~l~d~g~~~~~~~  159 (324)
                      ++||||+++++...+......+++..+..++.|++.||+|||++|++||||||+||+++.  .+..++|+|||.+.....
T Consensus        79 ~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          79 VMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             EEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             EEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            999999999999998888888999999999999999999999999999999999999862  345799999999987753


Q ss_pred             CCC-------cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHcCCCCccccc
Q 045787          160 PQK-------EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLLGTPTDESWA  232 (324)
Q Consensus       160 ~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  232 (324)
                      ...       ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||..................      
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~------  231 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK------  231 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCSSSCCHHHHTT-BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH------
T ss_pred             cccccceeccccCCcCCCccccCHHHHhC-CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc------
Confidence            322       2234478999999999988 67899999999999999999999999776533221111100000      


Q ss_pred             chhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHH---hcCcccc
Q 045787          233 ESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDA---LKHEYLI  291 (324)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~---l~hp~~~  291 (324)
                                    ............+|+++.+++..|++.||.+||++.++   |+|+|.+
T Consensus       232 --------------~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         232 --------------KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             --------------HHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             --------------cCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence                          00011222345789999999999999999999998754   5666543

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-49  Score=337.54  Aligned_cols=253  Identities=24%  Similarity=0.352  Sum_probs=207.7

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEcc-----CCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecC
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNTV-----TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSR   78 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   78 (324)
                      +..++|++.+.||+|+||+||+|.++.     .+..||+|++....... ....+.+|+.++++++||||+++++++..+
T Consensus        17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~~~~~~~~~   95 (308)
T d1p4oa_          17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-ERIEFLNEASVMKEFNCHHVVRLLGVVSQG   95 (308)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHH-HHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChH-HHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence            556899999999999999999998752     35689999987543222 234588999999999999999999999999


Q ss_pred             CeEEEEEEecC-CCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEE
Q 045787           79 KDVFLVFEYLD-LDLHSFITRHK---------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKL  148 (324)
Q Consensus        79 ~~~~iv~e~~~-g~l~~~~~~~~---------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l  148 (324)
                      ...++||||+. |++.+++....         ..++...+..++.+++.||.|||+++++||||||+|||++ .++++||
T Consensus        96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld-~~~~~Kl  174 (308)
T d1p4oa_          96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA-EDFTVKI  174 (308)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEEC-TTCCEEE
T ss_pred             CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeec-CCceEEE
Confidence            99999999997 68888876532         2468899999999999999999999999999999999999 9999999


Q ss_pred             eeccceeeccCCCC--cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhC-CCCCCCCChhHHHHHHHHcCC
Q 045787          149 ADFGLARAIGVPQK--EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITG-KPLFPSKKHDHLSLIFSLLGT  225 (324)
Q Consensus       149 ~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g-~~pf~~~~~~~~~~~~~~~~~  225 (324)
                      +|||++........  ......+++.|+|||.+.+ ..++.++||||||+++|||+|| ..||...+.............
T Consensus       175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~-~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~  253 (308)
T d1p4oa_         175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL  253 (308)
T ss_dssp             CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred             eecccceeccCCcceeeccceecccccCCHHHHcc-CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCC
Confidence            99999976643322  2233467899999999987 6789999999999999999998 578877776655443332111


Q ss_pred             CCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          226 PTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      ++                           ....+++.+.++|.+||+.||.+|||+.++++
T Consensus       254 ~~---------------------------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~  287 (308)
T d1p4oa_         254 LD---------------------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS  287 (308)
T ss_dssp             CC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CC---------------------------CcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            11                           11357889999999999999999999999997

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=5.4e-48  Score=328.99  Aligned_cols=258  Identities=19%  Similarity=0.230  Sum_probs=211.2

Q ss_pred             cccCcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCC-CCeeEEEeeeecCCeE
Q 045787            3 KLKNLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEH-ENIVRLLDVQSSRKDV   81 (324)
Q Consensus         3 ~~~~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~   81 (324)
                      ++++++|++.+.||+|+||+||+|++..+|+.||+|++.....    ...+.+|++.++.++| ++++.+++++..+...
T Consensus         1 ~vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~   76 (293)
T d1csna_           1 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN   76 (293)
T ss_dssp             CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred             CCCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCcc
Confidence            4678999999999999999999999999999999998765432    2457889999999975 8999999999999999


Q ss_pred             EEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeec----CCCcEEEeeccceeec
Q 045787           82 FLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDL----KRNTVKLADFGLARAI  157 (324)
Q Consensus        82 ~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~----~~~~v~l~d~g~~~~~  157 (324)
                      ++|||+++++|.+++......++...+..++.+++.||.+||++|++||||||+||+++.    .++.++|+|||.+...
T Consensus        77 ~~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          77 VLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             EEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             EEEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence            999999999999999887778999999999999999999999999999999999999962    2578999999999876


Q ss_pred             cCCCC-------cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHH-HHHcCCCCcc
Q 045787          158 GVPQK-------EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLI-FSLLGTPTDE  229 (324)
Q Consensus       158 ~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~  229 (324)
                      .....       ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+......... .......   
T Consensus       157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~---  232 (293)
T d1csna_         157 RDPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK---  232 (293)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH---
T ss_pred             ccCccccceeecccCceEEchhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhcc---
Confidence            43221       2333578999999999988 6789999999999999999999999976553221111 1000000   


Q ss_pred             cccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          230 SWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                                        ......+..+.+|+++.+++..|+..+|++||+...+.+
T Consensus       233 ------------------~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         233 ------------------QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             ------------------HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             ------------------CCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence                              001122233568899999999999999999999877653

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-47  Score=328.72  Aligned_cols=253  Identities=24%  Similarity=0.338  Sum_probs=205.5

Q ss_pred             ccCcCcceeEeecccCceEEEEEEEc-----cCCceEEEEEeeeccccCCCchHHHHHHHHHHhc-CCCCeeEEEeeeec
Q 045787            4 LKNLNYKKIKKIGAGGYGEVYKCRNT-----VTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKEL-EHENIVRLLDVQSS   77 (324)
Q Consensus         4 ~~~~~y~i~~~Lg~g~~~~v~~a~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   77 (324)
                      +..++|++.+.||+|+||.||+|...     .+++.||+|++....... ....+.+|+.+++++ +||||+++++++.+
T Consensus        20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~   98 (311)
T d1t46a_          20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT-EREALMSELKVLSYLGNHMNIVNLLGACTI   98 (311)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH-HHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHH-HHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence            44588999999999999999999853     456789999987544322 235688999999999 69999999999999


Q ss_pred             CCeEEEEEEecC-CCHHHHHHhcC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEe
Q 045787           78 RKDVFLVFEYLD-LDLHSFITRHK-----------------NTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLI  139 (324)
Q Consensus        78 ~~~~~iv~e~~~-g~l~~~~~~~~-----------------~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll  139 (324)
                      .+..++||||++ |++.+++....                 ..+++..+..++.||+.||.|||++|++||||||+||++
T Consensus        99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~  178 (311)
T d1t46a_          99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL  178 (311)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc
Confidence            999999999998 58888876532                 258999999999999999999999999999999999999


Q ss_pred             ecCCCcEEEeeccceeeccCCCC--cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhH-
Q 045787          140 DLKRNTVKLADFGLARAIGVPQK--EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMIT-GKPLFPSKKHDH-  215 (324)
Q Consensus       140 ~~~~~~v~l~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~-  215 (324)
                      + .++.++++|||.+........  ......+|+.|+|||++.+ ..++.++||||||+++|+|+| |.+||...+... 
T Consensus       179 ~-~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~  256 (311)
T d1t46a_         179 T-HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK  256 (311)
T ss_dssp             E-TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred             c-ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC-CCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9 899999999999987754322  2333578899999999987 678999999999999999999 566666655433 


Q ss_pred             HHHHHHHcCCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          216 LSLIFSLLGTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                      +..+......+.                           .....++.+.+||.+||+.||.+|||++++++
T Consensus       257 ~~~~i~~~~~~~---------------------------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         257 FYKMIKEGFRML---------------------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHHHHHTCCCC---------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhcCCCCC---------------------------CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            333322211111                           11257889999999999999999999999996

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-47  Score=328.00  Aligned_cols=246  Identities=22%  Similarity=0.297  Sum_probs=194.0

Q ss_pred             eEeecccCceEEEEEEEccCC---ceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeec-CCeEEEEEEe
Q 045787           12 IKKIGAGGYGEVYKCRNTVTG---QKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSS-RKDVFLVFEY   87 (324)
Q Consensus        12 ~~~Lg~g~~~~v~~a~~~~~~---~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~iv~e~   87 (324)
                      -+.||+|+||+||+|.+..++   ..||+|.+..... ....+.+.+|++++++++||||+++++++.+ ++..++||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~  110 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY  110 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCC-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccC-HHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence            568999999999999976543   3589999864322 2224678999999999999999999998765 5689999999


Q ss_pred             cC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeeccceeeccCCCC----
Q 045787           88 LD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFGLARAIGVPQK----  162 (324)
Q Consensus        88 ~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~~~~~~~----  162 (324)
                      ++ |++.+++.......++..+..++.|++.||.|||+.|++||||||+|||++ +++.+||+|||.+........    
T Consensus       111 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~-~~~~~kL~DFG~~~~~~~~~~~~~~  189 (311)
T d1r0pa_         111 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVH  189 (311)
T ss_dssp             CTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC-TTCCEEECSSGGGCCTTTTTCCCTT
T ss_pred             eecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeEC-CCCCEEEecccchhhccccccccce
Confidence            98 577777777667788999999999999999999999999999999999999 899999999999987643322    


Q ss_pred             cccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHHcCCCCcccccchhhhhccc
Q 045787          163 EYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-HDHLSLIFSLLGTPTDESWAESTYISEIL  241 (324)
Q Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (324)
                      ......+|+.|+|||.+.+ ..++.++||||||+++|||++|..||.... .......... +..+              
T Consensus       190 ~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~-g~~~--------------  253 (311)
T d1r0pa_         190 NKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRL--------------  253 (311)
T ss_dssp             CTTCSSCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHT-TCCC--------------
T ss_pred             ecccccccccccChHHHhc-CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-CCCC--------------
Confidence            1222457888999999887 668999999999999999999887775433 2111111111 1100              


Q ss_pred             CCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhcC
Q 045787          242 PLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALKH  287 (324)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~h  287 (324)
                                  .....+++.+.+||.+||+.||.+||++.|+++|
T Consensus       254 ------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         254 ------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             ------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                        0113578899999999999999999999999986

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=9.3e-48  Score=338.04  Aligned_cols=291  Identities=26%  Similarity=0.451  Sum_probs=212.9

Q ss_pred             CCcccC-cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcC-----------CCCe
Q 045787            1 MGKLKN-LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-----------HENI   68 (324)
Q Consensus         1 ~~~~~~-~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-----------~~~i   68 (324)
                      +|+.+. +||++++.||+|+||+||+|++..+|+.||+|++......   .+...+|+.+++.++           |+||
T Consensus         6 ~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~---~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~i   82 (362)
T d1q8ya_           6 KGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY---TEAAEDEIKLLQRVNDADNTKEDSMGANHI   82 (362)
T ss_dssp             TTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHH---HHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred             CCCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccc---hHHHHHHHHHHHHhcchhhhhhhhcCcCce
Confidence            466554 6799999999999999999999999999999999754322   245678898888875           4789


Q ss_pred             eEEEeeeec--CCeEEEEEEecC--CCHHHH-HHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCceEeecC
Q 045787           69 VRLLDVQSS--RKDVFLVFEYLD--LDLHSF-ITRHKNTLNLLVIKAILKQILLGLAYCHS-LKILHRDLKPNNLLIDLK  142 (324)
Q Consensus        69 ~~~~~~~~~--~~~~~iv~e~~~--g~l~~~-~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~g~~H~di~p~nIll~~~  142 (324)
                      +++++++..  ....+.++.++.  +..... .......+++..++.++.+++.||.+||+ .|++||||||+|||++..
T Consensus        83 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~  162 (362)
T d1q8ya_          83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV  162 (362)
T ss_dssp             CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEE
T ss_pred             EEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeecc
Confidence            999888754  345666666654  333333 33334579999999999999999999997 899999999999999832


Q ss_pred             CC-----cEEEeeccceeeccCCCCcccccccccccCCchhhcCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-----
Q 045787          143 RN-----TVKLADFGLARAIGVPQKEYSRDCVYSPYKAPELLLGYTGYSTPIDVWAVGCIFAEMITGKPLFPSKK-----  212 (324)
Q Consensus       143 ~~-----~v~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-----  212 (324)
                      +.     .++++|||.+.....   ......+|+.|+|||++.+ ..++.++|+||+||++++|++|+.||....     
T Consensus       163 ~~~~~~~~~kl~dfg~s~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~  238 (362)
T d1q8ya_         163 DSPENLIQIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYT  238 (362)
T ss_dssp             ETTTTEEEEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             CcccccceeeEeeccccccccc---ccccccccccccChhhccc-cCCCccccccchHHHHHHHHHCCCCCCCCcccccc
Confidence            22     499999999886542   3345678999999999987 667999999999999999999999996543     


Q ss_pred             --hhHHHHHHHHcCCCCcccccchhhhhcccCCCC------CCC---Ccchh----hhCCCCChhHHHHHHHhhcCCCCC
Q 045787          213 --HDHLSLIFSLLGTPTDESWAESTYISEILPLYP------HFE---PANLA----EKFPNLEPAGVDLLSQMLCLNPKQ  277 (324)
Q Consensus       213 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~---~~~~~----~~~~~~~~~l~~li~~~l~~dP~~  277 (324)
                        .+........++.++..................      ...   .....    ......++.+.+||.+||+.||.+
T Consensus       239 ~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~  318 (362)
T d1q8ya_         239 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK  318 (362)
T ss_dssp             CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred             chhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhH
Confidence              234455566666666544433332222221111      100   00001    111234678899999999999999


Q ss_pred             CCCHHHHhcCccccCCCCchh
Q 045787          278 RITAMDALKHEYLIGVENVPL  298 (324)
Q Consensus       278 Rps~~~~l~hp~~~~~~~~~~  298 (324)
                      |||++|+|+||||+++.....
T Consensus       319 Rpta~e~L~Hp~f~~~~~~~~  339 (362)
T d1q8ya_         319 RADAGGLVNHPWLKDTLGMEE  339 (362)
T ss_dssp             CBCHHHHHTCGGGTTCTTCTT
T ss_pred             CcCHHHHhcCcccCCCCCccc
Confidence            999999999999997764443

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-47  Score=325.21  Aligned_cols=267  Identities=22%  Similarity=0.260  Sum_probs=188.6

Q ss_pred             CcCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCeeEEEeeeecCC----eE
Q 045787            6 NLNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENIVRLLDVQSSRK----DV   81 (324)
Q Consensus         6 ~~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~   81 (324)
                      ..+|.+.+.||+|+||.||+|..  +|+.||+|++......   ......|+..+.+++||||+++++++.+++    .+
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~---~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~   76 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHH---HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh---HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence            45789999999999999999986  5889999998654322   122233445556789999999999987643    58


Q ss_pred             EEEEEecC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh--------CCCcccCCCCCceEeecCCCcEEEeecc
Q 045787           82 FLVFEYLD-LDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS--------LKILHRDLKPNNLLIDLKRNTVKLADFG  152 (324)
Q Consensus        82 ~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~--------~g~~H~di~p~nIll~~~~~~v~l~d~g  152 (324)
                      |+||||+. |+|.+++...  ++++.....++.+++.||.+||+        +|++|+||||+|||++ .++.+||+|||
T Consensus        77 ~lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~-~~~~~Kl~DFG  153 (303)
T d1vjya_          77 WLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLG  153 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEEC-TTSCEEECCCT
T ss_pred             EEEEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEc-CCCCeEEEecC
Confidence            99999997 5888888763  58999999999999999999996        5999999999999999 89999999999


Q ss_pred             ceeeccCCCC----cccccccccccCCchhhcCCC-----CCCCchhhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHc
Q 045787          153 LARAIGVPQK----EYSRDCVYSPYKAPELLLGYT-----GYSTPIDVWAVGCIFAEMITGKPLFPSKKHDHLSLIFSLL  223 (324)
Q Consensus       153 ~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~  223 (324)
                      ++........    ......||+.|+|||++.+..     .++.++|||||||++|||+||..||.............  
T Consensus       154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~--  231 (303)
T d1vjya_         154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL--  231 (303)
T ss_dssp             TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT--
T ss_pred             ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhc--
Confidence            9987754332    233457899999999987632     25678999999999999999998875433221000000  


Q ss_pred             CCCCcccccchhhhhcccCCCCCCCCcchhhhCCCCChhHHHHHHHhhcCCCCCCCCHHHHhc
Q 045787          224 GTPTDESWAESTYISEILPLYPHFEPANLAEKFPNLEPAGVDLLSQMLCLNPKQRITAMDALK  286 (324)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~l~  286 (324)
                         ...................+..... ..........+.+++.+||+.||.+|||+.|+++
T Consensus       232 ---~~~~~~~~~~~~~~~~~~~~p~~~~-~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~  290 (303)
T d1vjya_         232 ---VPSDPSVEEMRKVVCEQKLRPNIPN-RWQSCEALRVMAKIMRECWYANGAARLTALRIKK  290 (303)
T ss_dssp             ---SCSSCCHHHHHHHHTTSCCCCCCCG-GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred             ---ccccchHHHHHHHHhccccCCCCCc-ccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence               0000000000000000000000000 0001123345889999999999999999999986

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.89  E-value=1.3e-23  Score=166.39  Aligned_cols=165  Identities=16%  Similarity=0.155  Sum_probs=118.6

Q ss_pred             cceeEeecccCceEEEEEEEccCCceEEEEEeeeccccC----C------------CchHHHHHHHHHHhcCCCCeeEEE
Q 045787            9 YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQE----G------------VPSYIIREVSLLKELEHENIVRLL   72 (324)
Q Consensus         9 y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~----~------------~~~~~~~e~~~l~~l~~~~i~~~~   72 (324)
                      +-+-+.||+|+||+||+|.+. +|+.||+|++.......    .            .......|...+.++.|.+++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            457899999999999999985 68899999876432110    0            012244678889999999998887


Q ss_pred             eeeecCCeEEEEEEecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceEeecCCCcEEEeecc
Q 045787           73 DVQSSRKDVFLVFEYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHSLKILHRDLKPNNLLIDLKRNTVKLADFG  152 (324)
Q Consensus        73 ~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g~~H~di~p~nIll~~~~~~v~l~d~g  152 (324)
                      ++..    .+++||++++....       .++...+..++.+++.+|.+||++|++|+||||+|||++ + +.++|+|||
T Consensus        81 ~~~~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~-~-~~~~liDFG  147 (191)
T d1zara2          81 AWEG----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-E-EGIWIIDFP  147 (191)
T ss_dssp             EEET----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-T-TEEEECCCT
T ss_pred             EecC----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeee-C-CCEEEEECC
Confidence            6532    37999999974322       244555678999999999999999999999999999999 4 458999999


Q ss_pred             ceeeccCCCCcccccccccccCC------chhhcCCCCCCCchhhHHHHHH
Q 045787          153 LARAIGVPQKEYSRDCVYSPYKA------PELLLGYTGYSTPIDVWAVGCI  197 (324)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~y~a------PE~~~~~~~~~~~~DiwslG~i  197 (324)
                      .+.....+....        |..      .+.+.  ..++.++|+||+.--
T Consensus       148 ~a~~~~~~~~~~--------~l~rd~~~~~~~f~--r~y~~~~d~~s~~~~  188 (191)
T d1zara2         148 QSVEVGEEGWRE--------ILERDVRNIITYFS--RTYRTEKDINSAIDR  188 (191)
T ss_dssp             TCEETTSTTHHH--------HHHHHHHHHHHHHH--HHHCCCCCHHHHHHH
T ss_pred             CcccCCCCCcHH--------HHHHHHHHHHHHHc--CCCCCcccHHHHHHH
Confidence            987654222111        111      12222  456888999997543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.79  E-value=3.2e-08  Score=80.53  Aligned_cols=139  Identities=19%  Similarity=0.173  Sum_probs=94.2

Q ss_pred             cCcceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcC-CCCeeEEEeeeecCCeEEEEE
Q 045787            7 LNYKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-HENIVRLLDVQSSRKDVFLVF   85 (324)
Q Consensus         7 ~~y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv~   85 (324)
                      ..|++++..+.++.+.||++.  .++..+++|.........  ...+.+|...++.+. +-.+.+++.+..+++..++||
T Consensus        14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~--~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~   89 (263)
T d1j7la_          14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM   89 (263)
T ss_dssp             TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred             hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc--hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEE
Confidence            467888877666678999886  456678899876544332  345778999988885 333677888888888999999


Q ss_pred             EecCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 045787           86 EYLDLDLHSFITRHKNTLNLLVIKAILKQILLGLAYCHS-----------------------------------------  124 (324)
Q Consensus        86 e~~~g~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-----------------------------------------  124 (324)
                      ++++|........     +......++.++...+..||+                                         
T Consensus        90 ~~l~G~~~~~~~~-----~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (263)
T d1j7la_          90 SEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF  164 (263)
T ss_dssp             ECCSSEEHHHHTT-----TCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSC
T ss_pred             Eeccccccccccc-----ccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccc
Confidence            9999843322111     111122234444444555553                                         


Q ss_pred             ------------------CCCcccCCCCCceEeecCCCcEEEeecccee
Q 045787          125 ------------------LKILHRDLKPNNLLIDLKRNTVKLADFGLAR  155 (324)
Q Consensus       125 ------------------~g~~H~di~p~nIll~~~~~~v~l~d~g~~~  155 (324)
                                        ..++|+|+.|.||+++ +++.+-|+||+.+.
T Consensus       165 ~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~-~~~~~~lIDwe~a~  212 (263)
T d1j7la_         165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK-DGKVSGFIDLGRSG  212 (263)
T ss_dssp             SSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEE-TTEEEEECCCTTCE
T ss_pred             hHHHHHHHHHHhcCCcCCcEEEEeeccCcceeec-CCceEEEeechhcc
Confidence                              1258999999999999 66666799998775

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.30  E-value=1.9e-06  Score=69.33  Aligned_cols=71  Identities=14%  Similarity=0.070  Sum_probs=50.4

Q ss_pred             eecccC-ceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCC--CCeeEEEeeeecCCeEEEEEEecCC
Q 045787           14 KIGAGG-YGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEH--ENIVRLLDVQSSRKDVFLVFEYLDL   90 (324)
Q Consensus        14 ~Lg~g~-~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~iv~e~~~g   90 (324)
                      .+..|. .+.||++.. ..+..+++|......     ...+..|...++.+..  -.+.+++.+..+++..++||++++|
T Consensus        17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~-----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G   90 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG   90 (255)
T ss_dssp             ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred             EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC-----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence            344444 467898875 456778999755332     2347788888887753  3367778888888899999999987

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.21  E-value=4.8e-06  Score=71.44  Aligned_cols=78  Identities=18%  Similarity=0.129  Sum_probs=50.8

Q ss_pred             eeEeecccCceEEEEEEEccCCceEEEEEeeeccc-----cCCCchHHHHHHHHHHhcC-C--CCeeEEEeeeecCCeEE
Q 045787           11 KIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTE-----QEGVPSYIIREVSLLKELE-H--ENIVRLLDVQSSRKDVF   82 (324)
Q Consensus        11 i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~-----~~~~~~~~~~e~~~l~~l~-~--~~i~~~~~~~~~~~~~~   82 (324)
                      -.+.+|.|....||++.+...++.+++|.......     -....++...|.+.++.+. +  ..+++++.+  +.+..+
T Consensus        30 ~~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~  107 (392)
T d2pula1          30 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV  107 (392)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred             eEEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCE
Confidence            35679999999999999887788999997543211     1223355677888888774 2  345556544  344567


Q ss_pred             EEEEecCC
Q 045787           83 LVFEYLDL   90 (324)
Q Consensus        83 iv~e~~~g   90 (324)
                      +|||++++
T Consensus       108 lvmE~L~~  115 (392)
T d2pula1         108 TVMEDLSH  115 (392)
T ss_dssp             EEECCCTT
T ss_pred             EEEeccCC
Confidence            89999975

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.35  E-value=0.00038  Score=59.29  Aligned_cols=72  Identities=19%  Similarity=0.244  Sum_probs=49.9

Q ss_pred             eeEeecccCceEEEEEEEcc-------CCceEEEEEeeeccccCCCchHHHHHHHHHHhcC-CCCeeEEEeeeecCCeEE
Q 045787           11 KIKKIGAGGYGEVYKCRNTV-------TGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELE-HENIVRLLDVQSSRKDVF   82 (324)
Q Consensus        11 i~~~Lg~g~~~~v~~a~~~~-------~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~   82 (324)
                      -++.|+.|-.-.+|++....       .++.++++++....    ..-...+|..+++.+. +.-.+++++++.+    .
T Consensus        46 ~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~----~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g  117 (395)
T d1nw1a_          46 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE----TESHLVAESVIFTLLSERHLGPKLYGIFSG----G  117 (395)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC----CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred             EEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc----hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence            35688889999999998653       34568888765221    1234668999998886 3334577777654    4


Q ss_pred             EEEEecCC
Q 045787           83 LVFEYLDL   90 (324)
Q Consensus        83 iv~e~~~g   90 (324)
                      .|++|++|
T Consensus       118 ~I~efi~g  125 (395)
T d1nw1a_         118 RLEEYIPS  125 (395)
T ss_dssp             EEECCCCE
T ss_pred             eEEEEecc
Confidence            88999876

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.27  E-value=0.00056  Score=56.58  Aligned_cols=69  Identities=13%  Similarity=0.185  Sum_probs=45.1

Q ss_pred             cCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCe--eEEEe-----eeecCCeEEEEEEecCC
Q 045787           18 GGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI--VRLLD-----VQSSRKDVFLVFEYLDL   90 (324)
Q Consensus        18 g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i--~~~~~-----~~~~~~~~~iv~e~~~g   90 (324)
                      +..-.||++.. .+|..|++|+......   ..+.+..|...+..|....+  +..+.     .+...+..+.++++.+|
T Consensus        33 s~EN~vy~v~~-~dg~~~VlK~~rp~~~---s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G  108 (325)
T d1zyla1          33 SYENRVYQFQD-EDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  108 (325)
T ss_dssp             CSSSEEEEECC-TTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             cccceeEEEEc-CCCCEEEEEEeCCCCC---CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence            33468999986 4688999999764322   24668889998888853222  11111     23445678889999875

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.11  E-value=0.00019  Score=59.15  Aligned_cols=141  Identities=15%  Similarity=0.126  Sum_probs=74.0

Q ss_pred             cceeEeecccCceEEEEEEEccCCceEEEEEeeeccccCCCchHHHHHHHHHHhcCCCCe--eEEEe------eeecCCe
Q 045787            9 YKKIKKIGAGGYGEVYKCRNTVTGQKVAIKMMTIQTEQEGVPSYIIREVSLLKELEHENI--VRLLD------VQSSRKD   80 (324)
Q Consensus         9 y~i~~~Lg~g~~~~v~~a~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i--~~~~~------~~~~~~~   80 (324)
                      .+-++.|..|..-+.|++...  +..|++|++.....    .+.+..|+.++..+...++  +..+.      +......
T Consensus        20 ~~~~~~i~~G~~N~ny~v~t~--~g~yVLri~~~~~~----~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~   93 (316)
T d2ppqa1          20 LTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRVE----KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGR   93 (316)
T ss_dssp             EEEEEEECC---EEEEEEEES--SCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTE
T ss_pred             ceEeecCCCCcccCeEEEEEC--CCcEEEEEcCCCCC----HHHHHHHHHHHHhhhhccccccccceecCCCcceeeecc
Confidence            344566778888899998754  34699999864321    2456677888877753222  11111      1222344


Q ss_pred             EEEEEEecCCC------HH---------HHHHhcC--------CCC------------------CHHHHHHHHHHHHHHH
Q 045787           81 VFLVFEYLDLD------LH---------SFITRHK--------NTL------------------NLLVIKAILKQILLGL  119 (324)
Q Consensus        81 ~~iv~e~~~g~------l~---------~~~~~~~--------~~~------------------~~~~~~~i~~~i~~~l  119 (324)
                      ...++.+..|.      ..         ..+....        ...                  ........+..+...+
T Consensus        94 ~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  173 (316)
T d2ppqa1          94 PAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYL  173 (316)
T ss_dssp             EEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHH
T ss_pred             cceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhh
Confidence            55666665431      00         0000000        000                  0111122223333333


Q ss_pred             HHHHh----CCCcccCCCCCceEeecCCCcEEEeeccceee
Q 045787          120 AYCHS----LKILHRDLKPNNLLIDLKRNTVKLADFGLARA  156 (324)
Q Consensus       120 ~~Lh~----~g~~H~di~p~nIll~~~~~~v~l~d~g~~~~  156 (324)
                      ...+.    .|++|+|+.++||+++ .+...-++||+.+..
T Consensus       174 ~~~~~~~L~~giIHgDl~~dNvl~~-~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         174 AAHWPKDLPAGVIHADLFQDNVFFL-GDELSGLIDFYFACN  213 (316)
T ss_dssp             HHHCCCSSCEEEECSCCCGGGEEEE-TTEEEEECCCTTCEE
T ss_pred             hccCccccccccccCCcchhhhhcc-cccceeEeccccccc
Confidence            33332    4799999999999999 776678999997753